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Our thanks go out to all the volunteers who worked to make this conference possible, especially 
David Lilley (Univ of Dundee) for guiding the selection of the venue as the Chair of the Meetings 
Committee. We thank the keynote speakers for setting the perfect tone for the opening of the conference. 
Thanks to the session chairs, who helped select, order, introduce and run such stimulating oral sessions. 
Thanks, also, to the Junior Scientists Representatives Michael Meers, Marc-David Reupp, Rita Strack, 
and Callie Wigington, along with their faculty advisors, Katrin Karbstein and Beth Tran, for organizing 
another great set of Junior Scientist workshops and activities. 
The organizers wish to thank Dr. Marc Ruepp and Ms Isabelle Allen for their tremendous effort in 
securing sponsorship support
Throughout the program listing, the numbers next to the titles refer to corresponding Oral or Poster 
numbers in the Abstract section of this book. The letters next to each poster abstract designates the poster 
session within which that poster will be presented. These abstracts should not be cited in bibliographies. 
Material contained herein should be treated as personal communication, and should be cited only with 
the consent of the author.
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Front Cover
View of the village of Sertig Dörfli in the Sertig Valley, approx. 8 km south of Davos. The massifs of 
the Mittaghorn are in the background [photo by Raphael Koch, reprinted with permission from the 
Davos Congress Centre]. Floating above the village is the crystal structure of yeast Prp8, a compo-
nent of the U5 small nuclear ribonucleoprotein particle, in complex with Aar2, a U5 assembly factor 
[Galeij et al. (2013) Nature 493: 638]. The structure reveals the active site cavity of the spliceosome. 
Nestled in the valley is a cocrystal structure of the Stem I domain of the bacterial T-box riboswitch 
recognizing its cognate tRNA. [Zhang & Ferré-D’Amaré, manuscript in preparation].
To encourage sharing of unpublished data at the RNA Society Meeting, taking of 
photographs and/or videos during scientific sessions (oral or posters), or of posters 
outside of session hours, is strictly prohibited. Violators of this policy may have their 
equipment confiscated (cameras, cell phones, etc.) and/or they may be asked to leave 
the conference and have their registration privileges revoked without reimbursement.
Lexogen, a Vienna-based transcriptomics and next 
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on the development of technologies for comlpete 
transcriptome sequencing. 
SENSETM strand-specific mRNA-Seq library prep enables the discovery 
and quantification of antisense transcripts and overlapping genes.
• > 99,9 % strand-specific protocol.
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• the detailed analysis of transcript variants from the same genomic locus.
•  directional start- and end-site tagging, enabling detection and assembly of 
novel transcripts normally obscured by the major variants.
•  differential expression analysis carried out on individual transcripts and not  
simply on a gene-by-gene basis, providing a deeper understanding of the transcriptome.
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BNA3TM : A Revolution in Gene-Related Technology
Higher affinity to complementary nucleic acids
Superior discriminatory power
Increased target specificity
Enhanced biostability
Enzyme compatibility
Flexibility and ease of use
Antisense 
RNA Interference
Decoy
Ribozymes, DNAzymes
Antigene  
Chromosomal FISH Probes
LightUp Probes
DNA Chip
Other tools for molecular 
biology and functional genomics
Therapeutics
Research
Reagents
Diagnostics
Others
ProductsBiotechnologies
Large Scale  RNA  
RNA Ultramer
Customized Program
QSR Manufacturing
OEM
CRO Services
Bridged nucleic acids, BNA3TM  represent a novel class of nucleic acid analogues 
2’,4’-BNANC (2'-O,4'-C-aminomethylene bridged nucleic acid), containing a 
six-membered bridged structure with an N-O linkage between the 2’ and 4’ 
carbons in the sugar moiety. BNA3TM  modified oligonucleotides exhibit the 
following benefits:
Custom 
RNA Transcripts & Oligonucleotides
Specialty Nucleic Acid Experts since 1984
Bio-Synthesis is an industry leader in manufacturing high quality modified RNA oligonucleotides for research, diagnostics, OEM and 
therapeutic applications. We specialize in challenging constructs such as siRNA, microRNA, aptamers, long RNA oligomers  (up to 150 
bases), RNA transcripts ( > 3,000 bases) as well as mid-scale synthesis of up to 100 grams. 
Custom RNA and mRNA Synthesis
RNA Oligonucleotides
(up to 150 mers)
RNA oligos may also be ordered by
final yield, from 1 mg to 100 gram.
Purity and yield for mid-scale RNA
oligos are highly dependent on
sequences. 
Starting Scale Expected Yield
0.2 µmole 2-8 OD260
1.0 µmole 10-48 OD260
15 µmole 150-400 OD260
Backbone Options
PO = Phosphodiester
PS = Phosphorothioate
Backbone
2’ OH RNA
2’ OMe RNA
2’ Fluoro RNA
BNA3TM
PSPO
RNA Transcript & mRNA
µgrams to gram
>3,000 bases
Non-coding RNA
Coding RNA
Base modified
Purification options
Enzymatic treatments
QC by UV and Gel analysis
Modifications
Fluorescent Dye Labeling
Modified Bases
Linkers
Quenchers
Non-Fluorescent Conjugates
Inverted Bases
Spacers
Dimers and Trimers
Terminal Phosphates
5’ Terminal Caps  
Others
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Competitor RNA Miniprep System
ReliaPrep™ RNA System
•  Conserves precious sample
•   Concentrates RNA by eluting 
minimal volumes (15µl or less)
•  Isolates RNA free from inhibitors
•   Provides RNA ready for direct use 
in sensitive downstream assays
QUALITY RNA 
FROM 100 CELLS
The ReliaPrep™ RNA Cell Miniprep System recovers concentrated, 
high-quality RNA from samples containing as ew as 100 cells.
Visit: www.promega.com/RNAExtraction
TOO GOOD TO BE TRUE?
Request a sample and share your comparison data for a chance 
to receive discounts on Promega RNA analysis products.
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Invitation to Membership
The RNA Society was established in 1993 to facilitate sharing and 
dissemination of experimental results and emerging concepts in RNA 
research. The Society is an interdisciplinary, cohesive intellectual home for 
those interested in all aspects of RNA Science. We welcome new members 
from all disciplines and we look forward to sharing the new perspectives they 
bring to the Society.
Our members receive:
•  Subscription to the Society journal, RNA (IF 6.051) with  
•  50% discount on page charges 
• 50% discount on first color figure charge (a savings of $225)
•  For those members who wish to have their articles completely open access immediately upon 
publication can do so at a reduced cost of $1500 (a $500 savings from non-member fee)
• Reduced registration fees for the annual meeting of the Society (more than $100 saving)
•  The RNA Society Newsletter, a forum for disseminating information to members and discussing 
issues affecting the Society and RNA Science
•  Numerous opportunities for junior scientists to become involved in the Society
•  The Directory of Members, available online
•  Free job postings on the Society website
•  Opportunities to request Travel Fellowships and Meeting Support for RNA-related meetings you 
are organizing
These member savings more than offset the cost of a one-year membership in the Society. Two and 
three year memberships, as well as lifetime memberships, are now available through our online regis-
tration system with the added benefit of a discounted annual rate!  
Take a moment to start or renew your membership using our online system at  
http://rnasociety.org/become-a-member
The RNA Society •  9650 Rockville Pike 
Bethesda, MD 20814-3998
Tel: 301-634-7120, Fax: 301-634-7099; E-mail: staff@dues.faseb.org
RNAi and miRNA Noncoding RNA
Ribosomes and Translation Regulation Splicing Mechanisms
Splicing Regulation and Alternative Splicing 3’End Formation and Riboregulation of Development
RNA Turnover and Surveillance RNA Transport and Localization
Integration of Nuclear Gene Expression Processes RNP Biosynthesis and Function
RNA Regulation in Neurons and Specialized Cells RNP Structure and RNA-Protein Interactions
RNA Structure and Folding RNA Catalysis 
RNA and Disease; Therapeutic Strategies Heterochromatin Silencing
Viral RNA Mechanisms Telomerases 
Methods in RNA and RNP Research Bioinformatics
Our members work in numerous areas of RNA science including but not limited to:
Protect Your RNA Aptamers
Transcribe high complexity pools of RNase-resistant RNA aptamers 
The DuraScribe® T7 Transcription Kit produces high complexity pools of RNase-resistant RNA for studies with 
aptamers, ribozymes, shRNA or RNA probes.
•	 Resistant	to	RNases
•	 SELEX-compatible
•	 Stable	in	culture	media
•	 Suitable	for	clinical,	pharmaceutical	and	industrial	research	applications
www.epicentre.com/Durascribe
Durascribe__Abstract Society.indd   1 3/29/13   10:54 AM
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PROGRAM – RNA 2013 
The 18th Annual Meeting of the RNA Society 
Davos, Switzerland 
June 11 - June 16, 2013 
Tuesday, June 11 
11:00 – 19:00 Registration Talstrasse Foyer 
15:00 – 15:10 Welcome, Opening Remarks 
15:10 – 18:30 Plenary Session 1: Ribosome biogenesis and translation (1 - 9, 397 B)
Keynote: Venki Ramakrishnan (MRC-LMB, Cambridge) 
Chair: Nenad Ban (ETH Zürich) 
Davos Ballroom 
18:30 – 23:00 Welcome Grill Dinner and Beer Garden Kurpark, adjacent to the 
Davos Congress Center 
07:30 – 18:30 Registration 
Wednesday, June 12 
Talstrasse Foyer 
08:30 – 10:15 Plenary Session 2A: Regulation by long 
non-coding RNAs  (10 - 16) 
Chair: V. Narry Kim (Seoul National University) 
10:15 – 10:45 Coffee Break 
10:45 –  12:30
Davos Ballroom 
Foyer/Davos Ballroom 
Plenary Session 2B: RNA Modification (17 - 24) Davos Ballroom 
Chair: Juan Alfonzo (Ohio State University) 
12:30 – 14:00 Lunch Foyer/Davos Ballroom 
14:00 – 16:30 Concurrent Sessions 
Concurrent Session 1: Splicing mechanisms (25 - 33) 
Chair: Soo-chen Cheng (Academia Sinica) 
Concurrent Session 2: RNA localization (34 - 42) 
Chair: Ralf Jansen (Univ Tübingen) 
Concurrent Session 3: Viral RNAs (43 - 51) 
Chair: Karen Beemon (Johns Hopkins University) 
Davos Ballroom 
Aspen 
Sanada 
16:30 – 17:00 Refreshment Break Foyer/Davos Ballroom 
xiv
17:00 – 18:30 Workshops 
Workshop 1: The Non coding  ranscriptome 
Chairs: Constance Ciaudo (ETH Zürich) and Claus
Azzalin (ETH Zürich)-
Sponsor: LS2 
Workshop 2: RNA chemistry (59 - 65) 
Chairs: Ronald Micura (Leopold Franzens University) and 
Mark Helm (Johannes Gutenberg University) 
Workshop 3: Career Development Skills in Science 
Davos Ballroom 
Sanada 
Aspen 
Chair:  Michael Meers (University of North Carolina at Chapel Hill) 
18:30 – 20:10 
18:30 – 20:30 
Buffet Dinner 
Meetings Committee Meeting & Dinner 
Foyer/Davos Ballroom 
Wisshorn 
19:30 – 20:30 Junior Scientists Social Chamonix 
20:00 – 22:30 Poster Session A 
Poster abstracts labeled with an "A" present 
Sponsored by: Cell Press 
Abstracts 
Main Hallway and 
Sanada Foyer 
Non-coding and Regulatory RNAs 
Mechanism of RNA interference 
RNA and Epigentics 
Small RNAs 
RNA Catalysis and Riboswitches 
RNA structure and folding 
RNA chemistry 
Therapeutic RNAs 
Workshop: RNA in pharmaceutical research 
tRNA, snRNA, snoRNA, rRNA 
Ribosomes and Translation 
Translational Regulation 
3' end processing 
RNA Turnover 
RNA Editing and Modification 
Splicing Mechanisms 
Splicing Regulation 
RNA-Protein Interactions 
RNP Structure, Function and Biosynthesis 
Riboregulation in Development 
RNA Transport and Localization 
RNAs in Diseases 
Viral RNAs 
Interconnections Between Gene Expression Processes 
RNA system biology 
Bioinformatics 
Emerging & High-throughput Techniques for RNA 
156 - 204, 717, 718 
205 - 222 
223 - 231 
232 - 257 
258 - 271 
272 - 297 
298 - 306 
307 - 315 
311 
316 - 334, 722 
335 - 361 
362 - 399, 720 
400 - 414 
415 - 446 
447 - 473 
474 - 488 
489 - 529, 723 
530 - 579, 721 
580 - 598 
599 - 600, 719 
601 - 609 
610-  643 
644 - 654 
655 - 671 
672 - 679 
680 - 697 
698 - 716 
21:30 – 23:30 Beer Garden Kurpark 
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08:00 – 12:30 Registration 
Thursday, June 13 
Talstrasse Foyer 
08:30 – 10:15 Plenary Session 3A: RNA and disease (66 - 72) 
Chair: Tom Cooper (Baylor College of Medicine) 
10:15 – 10:45 Coffee Break 
10:45 – 12:30 Plenary Session 3B: RNA systems biology (73 - 80) 
Chair: Brent Graveley (University of Connecticut) 
12:30 – 13:00 Takeaway Lunch 
Davos Ballroom 
Foyer/Davos Ballroom 
Davos Ballroom 
Foyer/Davos Ballroom 
12:30 – 20:00 Free Afternoon 
16:00 – 20:00 Happy Hour in the Beer Garden 
Dinner on your own - snacks available for purchase in Beer Garden 
Kurpark 
20:00 – 22:30 Plenary Session 4: Architecture of RNPs Davos Ballroom 
Keynote: Thomas R. Cech (HHMI, University of Colorado Boulder) 
Chair: Eric Westhof (University Strasbourg) 
08:00 – 18:30 Registration 
Friday, June 14 
Talstrasse Foyer 
08:30 – 10:15 Plenary Session 5A: RNA Processing (89 - 95) 
Chair: Joan Steitz (HHMI, Yale University) 
10:45 – 12:30 Coffee Break 
Plenary Session 5B: RNA decay (96 - 102) 
Chair: Elena Conti (MPI Biochemistry) 
Davos Ballroom 
Foyer/Davos Ballroom 
Davos Ballroom 
12:30 – 14:00 Lunch Foyer/Davos Ballroom 
14:00 – 16:30 Concurrent Sessions 
Concurrent Session 4: Regulation by small non-coding 
RNAs (103 - 111) 
Chair: Jennifer Doudna (HHMI, Univ. of California  - Berkeley) 
Concurrent Session 5: Structure, dyanamics, and 
catalysis (112 - 120) 
Chair: David Rueda (Imperial College, London) 
Concurrent Session 6: High-throughput approaches 
to RNA biology (121 - 128) 
Chair: Jernej Ule (University College London) 
Davos Ballroom 
Aspen 
Sanada 
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16:30 – 17:00 Refreshment Break Foyer/Davos Ballroom 
17:00 – 18:30 Workshops 
Workshop 4: RNA in pharmaceutical research (129  -  134) 
Chairs: Nicole Meisner (Novartis Institutes for Biomedical 
Research) and David Morrissey (Novartis Institutes for 
Biomedical Research) 
Workshop 5: The evolving landscape of scientific publishing 
and how best to evaluate scientific output 
**This workshop will discuss how scientific articles and journals 
continue to evolve and will also raise questions about how best to 
evaluate the full spectrum of the scientific process. 
Chairs: Boyana Konforti (Cell Press) 
Davos Ballroom 
Aspen 
and Arianne Heinrichs (Nature Structural & Molecular Biology) 
Workshop 6: Tutorial on prediction 
of RNA secondary structure (135 - 141) 
Chair:  Alain Laederach (University of North Carolina at Chapel Hill) 
Sanada 
18:30 – 20:00 
18:30 – 20:30 
Buffet Dinner 
Board of Directors Meeting and Dinner 
Foyer/Davos Ballroom 
Wisshorn 
20:00 – 22:30 Poster Session B 
Poster abstracts labeled with a "B" present
Sponsored by: Novartis 
See Poster Session A for topic listing 
Main Hallway  and 
Sanada Foyer 
21:30 – 23:30 Beer Garden Kurpark 
Saturday, June 15 
08:00 – 18:30 Registration Talstrasse Foyer 
08:30 – 10:15 Plenary Session 6A: Interconnections in RNA 
regulation (142 - 148) 
Chair: Ulrike Kutay (ETH Zürich)
10:15 – 10:45 Coffee Break 
10:45 – 12:30 Plenary Session 6B: Alternative splicing (149 - 155) 
Chair: Javier Cáceres (MRC Edinburgh) 
12:30 – 14:00 Lunch 
Davos Ballroom 
Foyer/Davos Ballroom 
Davos Ballroom 
Foyer/Davos Ballroom 
12:30 – 14:00 Mentor -  Mentee Lunch Aspen, Sanada, Chamonix 
xvii
14:00 – 17:00 Poster Session C 
Poster abstracts labeled with a “C”  present
Sponsored by: University of Zürich 
See Poster Session A for topic listing 
Main Hallway  and 
Sanada Foyer 
18:00 – 24:00 Apero 
Banquet 
Awards Ceremony & Dance 
Sunday, June 16 
Conference Concludes 
Phone: (949) 679-1190info@zymoresearch.com www.zymoresearch.com
Quick-RNA™ Kits 
Get what you want with...
Request your sample kit today!
www.zymoresearch.com/quick-RNA-kits
Product Input* Binding Elution Cat. No. Size
Quick-RNA™ MicroPrep 1 - 10
6 cells
5 mg tissue 10 μg t 6 μl
R1050
R1051
50 Preps 
200 Preps
Quick-RNA™ MiniPrep** 10
2 
- 107 cells 
50 mg tissue 100 μg t 30 μl
R1054 
R1055
50 Preps 
200 Preps
Quick-RNA™ MidiPrep 10
6 
- 108 cells
250 mg tissue 1 mg t 200 μl R1056 25 Preps
ZR-96 Quick-RNA™ 1 - 10
6
 cells 
5 mg tissue 10 μg/well t 25 μl
R1052 
R1053
2 x 96 Preps 
4 x 96 Preps
RNeasy® is a registered trademark of Qiagen, GmbH.
* Based on animal or human cells and tissue. 
** gDNA removal column (Spin-Away™ Filters) included.
Quality
RNeasy®Quick-RNA™
DNA
Free!
Genomic
DNA
6í
6í
Total Large Small
Versatility 
6í
6í
98Quick-RNA™ RNeasy®Small RNA (t17 nt) recovery   Yes NoDNase I included Yes NogDNA removal column included Yes No
Value
3 High quality RNA from a wide range of samples - single to 107 cells. 
3 Total, large, or small RNA... you decide! 
3 DNA-free RNA for use in any downstream application.
3.29.13 Quick RNA - RNA Abstract Book.indd   1 3/29/2013   11:46:55 AM
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AddiTiONAl SCheduled eveNTS AT RNA 2013
Junior Scientists Pre-Conference Hike and Lunch - Tuesday, June 11
09:00, See Facebook page for location
•	 Open to all graduate students and post docs
•	 No additional charge (bring money for lunch), no registration required
This is an informal gathering for graduate students and post docs to meet and socialize. It will be 
a great way to discover Davos and its surroundings and catch up with colleagues before the meeting 
starts. The tour will begin in the morning by taking the gondola lift to Rhinerhorn station, followed by a 
scenic hike around the mountain. We will then take a slowly descending path to Sertig Dörfli for lunch 
at a local restaurant. The planned hike is easy and does not change much in elevation, so it should be 
feasible for hikers of any skill level. In case of bad weather an alternative program will be prepared. A 
meeting point and maps will be available over the Facebook page and by email. 
Meetings Committee Meeting - Wednesday, June 12
18:30-20:30, Wisshorn
•	 Open to the Meetings Committee, the Board of Directors, meeting sponsors, and (due to 
space constraints) a small number of additional observers
This meeting is where the venues for future RNA Society meetings are reviewed and selected. 
Any member of the RNA Society is welcome to attend, but due to space constraints one should 
request participation in advance by sending an email to the Meetings Committee Chair, David Lilley 
(d.m.j.lilley@dundee.ac.uk).
Junior Scientists Career Development Workshop - Wednesday, June 12
17:00-18:30, Aspen
•	 Open to all attendees, but tailored for junior scientists
This is an opportunity for junior scientists to hear and discuss the issues of skill development for 
careers in science, with a focus on skills for career advancement regardless of career track. The session 
will touch on a wide range of common concerns related to initiating and advancing a career in science 
such as choosing the right career, career planning, time management, networking, resume building, 
work/life balance and other related skills that are recognized by hiring companies and institutions.  The 
workshop will consist of a short talk from a career consultant followed by a panel discussion. Panel 
members include Elena Conti, Nicole Meisner-Kober, Brett Robb, and Françoise Stutz. This workshop 
should be particularly relevant to young members who are planning the next steps in their careers. 
Junior Scientists Social - Wednesday, June 12
19:30-20:30, Chamonix
•	 Open to all graduate students and post docs
•	 No additional charge, no registration required
The social is a nice setting to socialize with your fellow colleagues and talk some science over 
drinks.
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Beer Garden – Wednesday-Friday, June 12-14
June 12, 21:30-23:30, Kurpark
June 13, 16:00-20:00, Kurpark
June 14, 21:30-23:30, Kurpark
•	 Open to all attendees
Step outside for fresh air and a beer.
Free Afternoon – Thursday, June 13
 12:30-20:00 Various options
Make your own decision about how to spend your free time enjoying all that Davos has to offer.
•	 Hiking Information about hiking options, including maps, will be provided at the end of the 
morning sessions.
•	 Optional Excursions Enjoy one of many excursions offered by Davos Services.  If you 
booked an excursion through Davos Services during registration, you should have received a 
confirmation with details about your participation.  If you have any questions, please contact 
Davos Services: 
Tourismus- und Sportzentrum
Talstrasse 41
Tel +41 81 415 23 23
www.davos-services.ch
ds@davos.ch
•	 Lunch is provided to all attendees, and you’ll be able to take it with you – whether on a hike 
or just to enjoy outside in Kurpark.
•	 Beer Garden However you spend your afternoon, the beer garden will be open from 16:00 - 
20:00 for happy hour, complete with snacks for purchase. Since dinner is “on your own” on 
Thursday, this might be a fun option!
Board of Directors Meeting – Friday, June 14
18:30-20:30 Wisshorn
•	 Open to the Board of Directors and (due to space constraints) a small number of additional 
observers 
This is the business meeting of the RNA Society. Topics include an RNA journal update, results of 
the Meetings Committee deliberations, a report on finances and a vote on the next year’s budget, and 
new initiatives. Any member of the RNA Society is welcome to attend, but due to space constraints one 
should request participation in advance by sending an email to the CEO, Jim McSwiggen (mcswigj@
comcast.net).
Mentor/Mentee Lunch - Saturday, June 15
12:30-14:00, Aspen, Sanada, Chamonix
•	 Open to all attendees
•	 No additional charge, but registration is required before May 1
This lunch is an informal gathering that brings together 6-7 graduate students and post docs with 
one to two academic and industry mentors to answer student questions about careers. Topics include 
the pros and cons of academic vs industry careers, finding jobs, grant applications, and of course lots of 
interesting science. These lunches are fun for the mentors and hopefully fun and useful for the mentees 
as well. To the extent possible, mentors and mentees with common career and geographical objectives 
or experiences are grouped together.
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Conference Closing Events - Saturday, June 15
Open to all attendees who pre-registered by May 15
•	 Reception 18:00-19:00, Davos Foyer
•	 Conference Banquet 19:00-19:45, Davos Ballroom
•	 Awards Ceremony 19:45-21:00, Davos Ballroom
This is our opportunity to honor the people who have made significant contributions to RNA 
science. This year’s awardees include:
•	 Phillip Allen Sharp; RNA Society Lifetime Achievement Award
•	 RNA Society/Scaringe Award winners
	Wenwen Fang
	Je-Hyun Yoon
•	 Poster prize winners
•	 Dessert and RNA Society Dance 21:00-24:00, Davos Ballroom
Celebrate a week of great science with live music!
Superior RNAi tools for reversible gene suppression
www.mirimus.com
Any gene.
Any direction.
Let Mirimus Drive Your Research
Superior RNAi tools for reversible gene suppression
www.mirimus.com
Any gene.
Any direction.
Let Mirimus Drive Your Research
Superior RNAi tools for reversible gene suppression
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RNA 2013 AwARdS
The RNA Society lifetime Achievement Award
The RNA Society Lifetime Achievement Award acknowledges the impact of an 
outstanding RNA scientist on the general scientific community. Each year beginning 
in 2003, the Board of Directors has selected the recipient who receives a lifetime 
membership in the RNA Society in recognition of their outstanding contributions. 
The award is presented at the Annual RNA Meeting, where the recipient gives a 
special address to the RNA Society. Previous winners include Joan Steitz (2003), 
Harry Noller (2004), John Abelson (2005), Christine Guthrie (2006), Walter Keller 
(2007), Norm Pace (2008), Thomas Cech (2009), Fritz Eckstein (2010), Witold 
Filipowicz (2011), and Olke Uhlenbeck (2012).
Congratulations to Phillip Sharp who is the winner of the  
2013 RNA Society Lifetime Achievement Award.
The RNA Society/Scaringe Award
The RNA Society/Scaringe Young Scientist Award was established to recognize 
the achievement of young scientists engaged in RNA research and to encourage 
them to pursue a career in the field of RNA. In 2004 and 2005, the RNA Society/
Scaringe Award was made to the student author(s) of the best paper, as selected by 
the editors, published during the previous year in RNA. The winners of the 2004 
and 2005 awards were Stefano Marzi and Ramesh Pillai, respectively. In 2006, 
this award was revamped and opened to all junior scientists (graduate students or 
postdoctoral fellows) from all regions of the world who have made a significant 
contribution to the broad area of RNA. The award is no longer restricted to authors 
who have published in the RNA journal. The award includes a cash 
prize and support for travel and registration costs for the awardee(s) 
to attend the annual RNA Society meeting. Previous graduate student 
winners include: Jeff Barrick (2006), Malte Beringer (2007), Qi 
Zhang (2008), Jeremey Wilusz (2009), John Calarco (2010), Jasmine Perez (2011), 
Chenguang Gong (2012) and Tatjana Trcek Pulisic (2012). Previous postdoctoral 
fellow winners include Megan Talkington (2006), Zefeng Wang (2007), Alexei 
Aravin (2008), Shobha Vasudevan (2009), Luciano Marraffini (2010), Hani Zaher 
(2011), Kotaro Nakanishi (2012) and Dipali Sashital (2012).
Congratulations to graduate student Wenwen Fang, and postdoctoral fellow  
Je-Hyun Yoon, who are the winners of the 2013 RNA Society/Scaringe Award.
The RNA Society Service Award
No award recipient was chosen for 2013
xxiv
The NSMB Poster Prize
npg
Nature Structural & Molecular Biology (NRMCB) is pleased to sponsor 3 poster 
prizes to be awarded at the 2013 RNA Society Meeting. The prizes, one in the 
area of molecular biology and biochemistry, one in genetics and development, 
and one in biophysics and structural biology, consist of a free one-year print and 
online subscription to NSMB and a $200 cash award. All graduate students and 
postdoctoral fellows presenting posters at the meeting are eligible. 
The NRMCB Poster Prizes
Nature Reviews Molecular Cell Biology (NSMB) is pleased to sponsor a poster 
prize to be awarded at the 2013 RNA Society Meeting. The prize is for ‘inno-
vation and interdisciplinary research,’ and consists of a free one-year print and 
online subscription to NRMCB and a $200 cash award. All graduate students and 
postdoctoral fellows presenting posters at the meeting are eligible.
The Biochemistry Poster Prize
The journal Biochemistry is pleased to recognize junior scientists with a poster 
prize to be awarded at RNA 2013. The prize is for ‘innovation in the study of 
RNA biochemistry’, and consists of a $250 cash prize. All graduate students and 
postdoctoral fellows presenting posters at RNA 2013 are eligible.
The journal ACS Chemical Biology is pleased to recognize junior scientists with 
a poster prize to be awarded at RNA 2013. The prize is for ‘innovative use of 
chemical biology applied to the study of RNA’, and consists of a $250 cash prize. 
All graduate students and postdoctoral fellows presenting posters at RNA 2013 
are eligible.
The ACS Chemical Biology Poster Prize
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AbstrAct Listing
tuesday, June 11: 15:00 – 18:30
Session P1:  Ribosome biogenesis and translation—Davos Ballroom
Keynote: Venki Ramakrishnan (MRC-LMB, Cambridge) 
Chair: Nenad Ban (ETH Zürich)
Abstracts 1–9, 397 B
1 Keynote: Exceptions to Canonical Decoding by the Ribosome
Venki Ramakrishnan
2 Structure of the eukaryotic 40S ribosomal subunit in complex with initiation factors eIF1 and 
eIF1A
Melanie Weisser, Marc Leibundgut, Nenad Ban
3 Versatile binding of eukaryotic initiation factor 3 on the small ribosomal 40S subunit and the 
CSFV IRES
Yaser Hashem, Robert A. Grassucci, Amedee Des Georges, Robert Langlois, Vidya Dhote, Tatyana V. 
Pestova, Christopher U.T. Hellen, Joachim Frank
4 A novel strategy for protein synthesis initiation: 40S ribosomes bind to the 3’ UTR of barley 
yellow dwarf virus (BYDV) mRNA
Sohani Das Sharma, Bidisha Banerjee, Jelena Kraft, W. Allen Miller, Dixie Goss
5 Probing the dynamics of Ribosome biogenesis in yeast
Ralph D Hector, Elena Burlacu, Stuart Aitken, Atlanta Cook, Sander Granneman
6 The casein kinase 1d homolog Hrr25 promotes dissociation of the ribosome assembly factor 
Ltv1 from nascent small ribosomal subunits to allow joining of large subunits.
Homa Ghalei, Katrin Karbstein
7 Exonucleolytic processing of the 18S rRNA precursors during nuclear export in human cells
Marie-Francoise O’Donohue, Nathalie Montel-Lehry, Marie-Line Bortolin-Cavaille, Milena Preti, 
Hanna Gazda, Pierre-Emmanuel Gleizes
8 An mRNA-derived ncRNA targets and regulates the ribosome
Andreas Pircher, Kamilla Bakowska-Zywicka, Marek Zywicki, Norbert Polacek
9 Structural basis of translational regulation of msl2 mRNA by SXL and UNR during dosage 
compensation in Drosophila
Janosch Hennig, Iren Wang, Miriam Sonntag, Arie Geerlof, Cristina Militti, Fatima Gebauer, 
Grzegorz Popowicz, Michael Sattler
397 B Dom34-mediated dissociation of non-translating ribosomes allows efficient restart of translation 
after stress
Antonia van den Elzen, Bertrand Séraphin
Wednesday, June 12: 08:30 – 10:15
Session P2A:  Regulation by long non-coding RNAs—Davos Ballroom
Chair: V. Narry Kim (Seoul National University)
Abstracts 10–16
10 Circular RNAs function as efficient microRNA sponges
Jorgen Kjems, Thomas B. Hansen, Christian K Damgaard, Trine I. Jensen, Jesper B. Bramsen, Bettina 
H. Clausen, Bente Finsen
11 The regulatory circuits mediated by RNAs in Staphylococcus aureus and implication of the 
endoribonuclease III
Efthimia Lioliou, Cédric Romilly, Thomas Geissmann, François Vandenesch, Isabelle Caldelari, 
Cynthia Sharma, Joerg Vogel, Pascale Romby
12 Messenger and long non-coding RNAs: dressed for the occasion?
Alex Tuck, David Tollervey
xxvi
13 Non-coding RNAs prevent spreading of a repressive histone mark
Marc Bühler, Claudia Keller, Raghavendran Kulasegaran-Shylini, Yukiko Shimada, Hans-Rudolf 
Hotz
14 Single cell and genome-wide analysis to dissect antisense RNA-mediated gene silencing and 
pervasive transcription in S. cerevisiae
Manuele Castelnuovo, Elisa Guffanti, Jurgi Camblong, Judith Zaugg, Nick Luscombe, Zhenyu Xu, 
Lars Steinmetz, Samir Rahman, Daniel Zenklusen, Françoise Stutz
15 Telomeric non-coding RNA acts as a scaffold for telomerase high-order organization at short 
telomeres
Emilio Cusanelli, Carmina Angelica Perez Romero, Pascal Chartrand
16 Human α satellite derived transcripts interact with the active site of RNApolII
Katarzyna Matylla-Kulinska, Renee Schroeder
Wednesday, June 12: 10:45 – 12:30
Session P2B:  RNA modification—Davos Ballroom
Chair: Juan Alfonzo (Ohio State University) 
Abstracts 17–24
17 Methylated mRNA recognition by the YTH domain
Dominik Theler, Cyril Dominguez, Frederic Allain
18 Determination of N6-methyladenosine RNA modification status at single nucleotide resolution 
and the application to a long non-coding RNA-protein interaction
Nian Liu, Qing Dai, Guanqun Zheng, Chuan He, Marc Parisien, Xiaoyun Wang, Tao Pan
19 Inosine-mediated modulation of RNA sensing by innate immune sensors
Michael Gantier, Soroush Sarvestani, Bryan Williams
20 Impact of ADARs on abundance and sequence of miRNAs and other non-coding RNAs.
Cornelia Vesely, Michael F. Jantsch, Fritz J. Sedlazeck, Arndt von Haeseler, Stefanie Tauber
21 ADAR proteins suppress activation of antiviral signaling by cellular RNA.
Sam Greenwood, Niamh Mannion, Xianghua Li, Liam Keegan, Robert Young, Simona Paro, Sarah 
Cox, Leeanne McGurk, Marion Hogg, James Brindle, David Read, Rui Zhang, Christoffer Nellåker,  
Chris Ponting, Jin-Billy Li, Matthew Ronshaugen, Julia Dorin, Ian Adams, Mary O’Connell
22 Mechanism of gRNA Biogenesis in Trypanosome Mitochondria
Ruslan Afasizhev, Takuma Suematsu, Inna Afasizheva
23 Biogenesis and function of cyclic N6-threonylcarbamoyladenosine (ct6A) as a widely distributed 
tRNA hypermodification
Tsutomu Suzuki, Kenjyo Miyauchi, Takuya Sakashita, Satoshi Kimura, Tomoyuki Numata
24 Unusual non-canonical editing important for tRNA processing in Trypanosomes as revealed by 
shallow sequencing.
Mary Anne T. Rubio, Christopher R. Trotta, Juan D. Alfonzo
Wednesday, June 12: 14:00 – 16:30
Concurrent Session C1:  Splicing mechanisms—Davos Ballroom
Chair: Soo-chen Cheng (Academia Sinica) 
Abstracts 25–33
25 Structural insights into the assembly of spliceosomal U snRNPs
Clemens Grimm, Jann Pelz, Utz Fischer
26 Crystal structure of human spliceosomal U1 snRNP at 3.3 Å resolution.
Yasushi Kondo, Chris Oubridge, Marike van Roon, Kiyoshi Nagai
27 Crystal structure of Prp5p reveals intra-molecular interactions that impact splicing fidelity
Fei Yang, Zhi-Min Zhang, Jiahai Zhou, Yong-Zhen Xu
xxvii
28 Sequential contacts of DExD/H-box protein Prp28p with Prp8p, Brr2p, and Snu114p during 
splicing as captured by a chemical cross-linking approach
Fu-lung Yeh, Luh Tung, Hsien-Yeh Chou, Che-Ming Lin, Tien-Hsien Chang
29 Functional spliceosome assembly without stable U4/U6 snRNA pairing
Jordan Burke, Samuel Butcher, David Brow
30 A group II intron-like catalytic triplex in the U6 snRNA forms during spliceosome activation
Sebastian Fica, Melissa Mefford, Joseph Piccirilli, Jonathan Staley
31 3D Cryo-EM structure of the yeast activated spliceosome (Bact) and localisation of functionally 
important regions
Holger Stark, Norbert Rigo, Chengfu Sun, Prakash Dube, Kum-Loong Boon, Berthold Kastner, 
Reinhard Rauhut, Patrizia Fabrizio, Reinhard Lührmann
32 A conformational switch in PRP8 mediates metal ion coordination that promotes pre-mRNA 
exon ligation
Matthew Schellenberg, Tao Wu, Dustin Ritchie, Sebastian Fica, Jonathan Staley, Karim Atta, Paul 
Lapointe, Andrew MacMillan
33 Versatile reaction catalyzed by the Spliceosome in a competitive manner
Chi-Kang Tseng, Hui-Fang Wang, Che-Sheng Chung, Soo-Chen Cheng
Wednesday, June 12: 14:00 – 16:30
Concurrent Session C2:  RNA localization—Aspen
Chair: Ralf Jansen (University Tübingen) 
Abstracts 34–42
34 An unexpected role of the nuclear periphery for mRNA export in yeast
Mark-Albert Saroufim, Daniel Zenklusen
35 NMD3 regulates mRNA nuclear export via an XpoI-linked mechanism
Pegine Walrad, Melanie Bühlmann, Pegine Walrad, Paul Capewell, Arunasalam Naguleswaran, Isabel 
Roditi, Elisabetta Ullu, Keith R. Matthews
36 RNA recognition and architectural activity of Zipcode Binding Protein 1
Giuseppe Nicastro, David Hollingworth, Alain Oregioni, Adela Candel, Andres Ramos
37 Identification and analysis of Staufen2 target RNAs from rat brain
Jacki Heraud-Farlow, Michael Doyle, Martin Bilban, Stefanie Tauber, Michael Kiebler
38 The order of assembly and disassembly of nuclear ASH1-mRNPs
Annika Niedner, Marisa Müller, Dierk Niessing
39 Novel players and novel mRNAs transported by the Bic-D / Egl / Dynein RNA localization 
machinery
Paula Vazquez, Bogdan Schaller, Rémy Bruggmann, Samuel Neuenschwander, Henning Urlaub, Beat 
Suter
40 An RNA biosensor for imaging translation of single mRNAs in living cells.
Jeffrey Chao, Timothée Lionnet, Robert Singer
41 Single molecule systems biology of RNA silencing
Nils Walter, Sethuramasundaram Pitchiaya, Márcio Mourão, Corey Custer, Laurie Heinicke, Katelyn
Doxtader, Vishalakshi Krishnan, Santiago Schnell
42 GRSF1 regulates RNA processing in mitochondrial RNA granules
Alexis A. Jourdain, Jean-Claude Martinou
xxviii
Wednesday, June 12: 14:00 – 16:30
Concurrent Session C3: Viral RNAs—Sanada
Chair: Karen Beemon (Johns Hopkins University) 
Abstracts 43–51
43 Virus-Induced Dysregulation of Cellular mRNA Decay and Alternative Polyadenylaton – 
Implications for Pathogenesis
Stephanie L. Moon, Michael D. Barnhart, Carol J. Wilusz, Liang Liu, Bin Tian, Jeffrey Wilusz
44 A dengue virus 2 non-coding RNA downregulates translation of antiviral interferon-stimulated 
mRNAs through interaction with host RNA binding proteins.
Katell Bidet, Sharon Jamison, Mariano Garcia-Blanco
45 RNA/RNA interactions govern selective packaging of influenza A genomic segments
Cyrille Gavazzi, Matthieu Yver, Emilie Fournier, Boris Essere, Jean-Christophe Paillart, Jean-Daniel 
Sirbat, Annie Cavalier, Jean-Paul Rolland, Daniel Thomas, Manuel Rosa-Calatrava, Bruno Lina, 
Catherine Isel, Vincent Moules, Roland Marquet
46 Interplay between retroviral genomic RNA packaging and mRNA translation
Katarzyna J. Purzycka, Mastooreh Chamanian, Katarzyna J. Purzycka, Paul Wille, Janice S. Ha, 
David McDonald, Yong Gao, Stuart F.J. Le Grice, Eric J. Arts, Ryszard W. Adamiak
47 HIV1, Antisense RNA and ADAR editing
Siripong Tongjai, Keanan McGonigle, Yeou-Cherng Bor, David Rekosh, Marie-Louise Hammarskjöld
48 The Identification of a novel posttranscriptional regulatory element in gamma retroviruses
Guy Pilkington, Jenifer Bear, Katarzyna Purzycka, Stuart Le Grice, Barbara Felber
49 Shunting revisited.
Thomas Hohn
50 Inquiry into the variability of HCV IRES and its impact on function by developing and 
evaluation of a large-scale mutation database that also unfolds potential of some new 
nucleotides.
Anas Khawaja, Vaclav Vopalensky, Ludek Roznovsky, Jakub Mrazek, Ondrej Horvath, Martin 
Pospisek
51 Novel Insights from Structural Analysis of Lentiviral and Gammaretroviral Reverse 
Transcriptases in Complex with RNA/DNA Hybrids.
Stuart Le Grice, Mikalai Lapkouski, Lan Tian, Jennifer Miller, Enzbieta Nowak, Wojciech 
Potrzebowski, Peter Konarev, Jason Rausch, Marion Bona, Dmitri Svergun, Janusz Bujnick, Marcin 
Nowotny, Wei Yang
Wednesday, June 12: 17:00 – 18:30
Workshop Session W1: Function of Non coding Transcriptome—Davos Ballroom
Chairs: Constance Ciaudo (ETH Zürich) and Claus Azzalin(ETH Zürich)
Abstracts 52–58
52 RNAi dependent and independent control of LINE1 mobility and accumulation in mouse ES 
cells
Constance Ciaudo, Florence Jay, Ikuhiro Okamoto, Chong-Jian Chen, Nicolas Servant, Emmanuel 
Barillot, Edith Heard, Olivier Voinnet, Alexis Sarazin
53 Role of Telomeric Repeat-containing RNA in Alternative Lengthening of Telomeres
Rajika Arora, Claus Azzalin
54 RNA and DNA Targeting CRISPR-Cas Immune Systems of Pyrococcus furiosus
Joshua Elmore, Caryn Hale, Sonali Majumdar, Jason Carte, Hong Li, Sara Olson, Brenton Graveley, 
Lance Wells, Claiborne Glover, Rebecca Terns, Michael Terns
55 Involvement of TERT-RdRP in heterochromatin maintenance
Kenkichi Masutomi, Mami Yasukawa, Yoshiko Maida
xxix
56 The role of the Arabidopsis exosome complex in siRNA-independent silencing of 
heterochromatic loci
Junhye Shin, Hsiao-Lin Wang, Brandon Dinwiddie, Julia Chekanova
57 Involvement of the novel complex consisting of the splicing factor Prp14p/DHX38 RNA helicase 
and centromeric non-coding RNAs in the regulation of chromosome segregation
Masatoshi Mutazono, Takashi Ideue, Kanako Nishimura, Yukiko Cho, Chihiro Tsukahara, Misato 
Morita, Madoka Chinen, Jun-ichi Nakayama, Kojiro Ishii, Tokio Tani
58 A genome-wide RNAi screen draws a genetic framework for transposon control and primary 
piRNA biogenesis in Drosophila
Paloma M Guzzardo, Felix Muerdter5, Jesse Gillis, Yicheng Luo, Yang Yu, Caifu Chen, Richard 
Fekete, Gregory J Hannon
Wednesday, June 12: 17:00 – 18:30
Workshop Session W2: RNA chemistry—Sanada
Chair: Ronald Micura (Leopold Franzens University) and Mark Helm (Johannes Gutenberg University) 
Abstracts 59–65
59 New Approaches in RNA Chemical Biology
Jonathan Hall, Andreas Brunschweiger, Luca Gebert, Jochen Imig, Mario Rebhan, Ugo Pradere, Boris 
Guennewig
60 Resolving functional RNA dynamics by NMR
Christoph Wunderlich, Romana Spitzer, Thomas Moschen, Martin Tollinger, Christoph Kreutz
61 RNA-based fluorescent biosensors for live cell imaging of second messengers cyclic di-GMP and 
cyclic AMP-GMP.
Colleen Kellenberger, Stephen Wilson, Jade Sales-Lee, Ming Hammond
62 Sequence Specific Modulation of G-Quadruplex Folding
Samuel Rouleau, Jean-Denis Beaudoin, Jean-Pierre Perreault
63 Structural stabilization of toxic CUG repeats reverses mis-splicing associated with myotonic 
dystrophy
Elaine deLorimier, Jeremy Copperman, Alex Taber, Leslie Coonrod, Emily Reister, Feras Ackall, 
Kush Sharma, Peter Todd, Marina Guenza and J. Andrew Berglund
64 A chemo-enzymatic approach for selective modification of the RNA cap
Daniela Schulz, Josephin Holstein, Andrea Rentmeister
65 Bromomethylcoumarins as selective reagents for RNA labeling
Mark Helm, Stefanie Kellner
thursday, June 13: 08:30 – 10:15
Session P3A:  RNA and disease—Davos Ballroom
Chair: Tom Cooper (Baylor College of Medicine) 
Abstracts 66–72
66 Somatic spliceosomal factor mutations in bone marrow neoplasms lead to alterations in 
alternative splicing patterns that relate to the splicing mechanism
Richard Padgett, Bartloniej Przychodzen, Amina Kozaric, Hideki Makishima, Magda Konarska, 
Jaroslaw Maciejewski
67 Mnk2 alternative splicing inactivates its tumor suppressor activity as a modulator of the p38-
MAPK stress pathway
Avi Maimon, Maxim Mogilevsky, Asaf Shilo, Ben Davidson, Rikiro Fukunaga, Rotem Karni
68 Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA metabolism 
and suggest potential drug targets
Rafal Tomecki, Karolina Drazkowska, Iwo Kucinski, Krystian Stodus, Roman Szczesny, Jakub 
Gruchota, Andrzei Dziembowski
69 Defective RNP Assembly in Prostate and Other Cancers
Rosario Machado-Pinilla, Phillip J. Iaquinta, Charles L. Sawyers, U. Thomas Meier
xxx
70 Loss of MBNL1 function impairs neuronal morphology in myotonic dystrophy type 1
Ting-Yu Kuo, Pei-Ying Wang, Hsing-Jung Chen, Mi-Hua Tao, Guey-Shin Wang
71 Mutations in the gene encoding U11/U12-65K protein leads to pituitary hypoplasia and isolated 
growth hormone deficiency type I
Bhupendra Verma, Ali Oghabian, Ivon Cuscó, Gabriel Á. Martos-Moreno, Armand Gutiérrez, Julie A. 
Chowen, Jesús Argente, Luis A. Pérez-Jurado, Mikko J. Frilander
72 miR-34c-5p is a novel regulator of naive T-cell activation that impacts HIV replication
Andreia Amaral, Jorge Andrade, Ana Matos, Russel Foxall, Paula Matoso, Mariana Santa-Marta, Rita 
Tendeiro, Ana Serra-Caetano, Rui Soares, João Gonçalves, Ana Sousa, Margarida Gama-Carvalho
thursday, June 13: 10:45 – 12:30
Session P3B:  RNA systems biology—Davos Ballroom
Chair: Brent Graveley (University of Connecticut) 
Abstracts 73–80
73 Genome-wide mapping of RBM10 binding sites reveals its role in splicing regulation: 
Implications for cleft palate and TARP syndrome
Julie Rodor, David Fitzpatrick, Javier Caceres, Margarida Gama-Carvalho
74 Muscleblind-like proteins negatively regulate embryonic stem cell-specific alternative splicing 
and reprogramming
Hong Han, Manuel Irimia, Joel Ross, Hoon-Ki Sung, Babak Alipanahi, Laurent David, Azadeh 
Golipour, Mathieu Gabut, Iacovos Michael, Emil Nachman, Eric Wang, Dan Trcka, Tadeo Thompson, 
Christopher Burge, Jason Moffat, Brendan Frey, Andras Nagy, James Ellis, Jeffrey Wrana, Benjamin 
Blencowe
75 A pair of RNA binding proteins regulate neuron-subtype specific alternative splicing in C. 
elegans
Adam Norris, John Calarco
76 CFlm25 Links Global change in APA to Cell Growth Control and Glioblastoma Survival
Chioniso Masamha, Zheng Xia, Wei Li, Ann-Bin Shyu, Todd Albrecht, Eric Wagner
77 Subsets of introns are abundant in poly(A)+ RNA
Paul Boutz, Arjun Bhutkar, Phillip Sharp
78 Genome-wide analysis of pre-mRNA splicing in budding yeast from the perspective of the intron
Daoming Qin, Lei Huang, Jonathan Staley
79 Lariat Sequencing in a Unicellular Yeast Identifies Regulated Alternative Splicing of Exons that 
are Evolutionarily Conserved with Humans
Ali Awan, Amanda Manfredo, Jeffrey Pleiss
80 Global Analysis of Phosphorylation by SR Protein Kinases and Their Effects on Genome-wide 
Splicing in Schizosaccharomyces pombe
Michael Marvin, Jesse Lipp, Kevan Shokat, Christine Guthrie
thursday, June 13: 20:00 – 22:30
Plenary Session P4:  Architecture of RNPs—Davos Ballroom
Keynote: Thomas R. Cech (HHMI, University of Colorado Boulder) 
Chair: Eric Westhof (University Strasbourg) 
Abstracts 81–88
81 Keynote: The Future of RiboScience
Thomas R. Cech
82 The architecture of Tetrahymena telomerase holoenzyme
Jiansen Jiang, Edward J. Miracco, Kyungah Hong, Barbara Eckert, Henry Chan, Darian D. Cash, 
Bosun Min, Z. Hong Zhou, Kathleen Collins, Juli Feigon
83 Deciphering the assembly of box C/D snoRNP complexes
Jonathan Bizarro, Bérengère Pradet-Balade, Marc Quinternet, Xavier Manival, Bruno Charpentier, 
Christiane Branlant, Céline Verheggen, Edouard Bertrand
xxxi
84 Crystal Structure of the Bacterial Pnkp1/Rnl/Hen1 Heterohexamer: A New RNA Repair 
Complex
Pei Wang, Kiruthika Selvadurai, Raven Huang
85 Molecular basis of translation activation by the non-coding RNA RsmZ
Olivier Duss, Maxim Yulikov, Erich Michel, Mario Schubert, Gunnar Jeschke, Frédéric Allain
86 Single-molecule analysis of L7Ae protein binding to a k-turn : induced fit or conformational 
selection ?
Jia Wang, Tomáš Fessl, Kersten T. Schroeder, David M. J. Lilley
87 The structural basis of SRP receptor recruitment and GTPase activation by SRP RNA
Nikolaus Schmitz, Felix Voigts-Hoffmann, Kuang Shen, Shu-ou Shan, Sandro F. Ataide, Nenad Ban
88 Crystal structure of Prp8 and its implications for the spliceosomal active site
Wojciech Galej, Chris Oubridge, Andy Newman, Kiyoshi Nagai
Friday, June 14: 08:30 – 10:15
Session P5A: RNA processing—Davos Ballroom
Chair: Joan Steitz (HHMI, Yale University)
Abstracts 89–95
89 Structural and functional studies of pre-mRNA 5’ and 3’-end processing
Liang Tong
90 Analysis of eukaryotic orthologous groups reveals Archease as a crucial factor in human tRNA 
splicing.
Johannes Popow, Alexander Schleiffer, Javier Martinez
91 Control of myogenesis by rodent SINE-containing lncRNAs
Jiashi Wang, Chenguang Gong, Lynne Maquat
92 DNA Damage induces targeted, genome-wide variation of poly(A) sites in budding yeast
Joel Graber, Fathima Nazeer, Pei-chun Yeh4 Jason Kuehner, Sneha Borikar, Derick Hoskinson, Claire 
Moore
93 Polyadenylated histone mRNAs accumulate upon PARN knock-down
Claudia Weißbach, Christiane Harnisch, Heike Berndt, Lars Anders, Elmar Wahle
94 Non-coding Y1/3 RNAs promote the 3’-processing of canonical histone pre-mRNAs
Marcel Köhn, Stefan Hüttelmaier
95 Dicer-2 is involved in mRNA activation through cytoplasmic polyadenylation
Ana Villalba, Olga Coll, Tanit Guitart, Catherine Papin, Martine Simonelig, Fátima Gebauer
Friday, June 14: 10:45 – 12:30
Session P5B: RNA decay—Davos Ballroom
Chair: Elena Conti (MPI Biochemistry) 
Abstracts 96–102
96 Assembly and function of the NOT module of the CCR4-NOT complex
Ying Chen, Andreas Boland, Tobias Raisch, Stefanie Jonas, Duygu Kuzuoglu-Öztürk, Lara Wohlbold, 
Oliver Weichenrieder, Elisa Izaurralde
97 Structural insights into the Not module of the Ccr4-Not complex
Varun Bhaskar, Jerome Basquin, Vladimir Rudko, Bertrand Séraphin, Elena Conti
98 Roquin Promotes Constitutive mRNA Decay via a Conserved Class of Stem-Loop Recognition 
Motifs
Kathrin Leppek, Johanna Schott, Sonja Reitter, Fabian Poetz, Ming C. Hammond, Georg Stoecklin
99 The crystal structure of the nucleolar exosome engaged with RNA
Elizabeth Wasmuth, Christopher Lima
100 Nonsense mediated mRNA decay is inefficient on long ORF transcripts
Laurence Decourty, Antonia Doyen, Christophe Malabat, Emmanuel Frachon, Delphine Rispal, 
Bertrand Séraphin, Alain Jacquier, Cosmin Saveanu, Alain Jacquier
xxxii
101 eIF4E-bound mRNPs are substrates for nonsense-mediated mRNA decay in mammalian cells
Simone C. Rufener, Oliver Mühlemann
102 PAXT-1 binds XRN-2 and promotes its activity
Takashi Miki, Stefan Rueegger, Hannes Richter, Helge Grosshans
Friday, June 14: 14:00 – 16:30
Concurrent Session C4:  Regulation by small non-coding RNAs—Davos Ballroom
Chair: Jennifer Doudna (HHMI, Univ. of California - Berkeley) 
Abstracts 103–111
103 Molecular Clues to Tissue-Specific Control of MiRNA Biogenesis
Nila Roy Choudhury, Flavia de Lima Alves, Luisa de Andrés-Aguayo, Thomas Graf, Javier F. 
Cáceres, Juri Rappsilber, Gracjan Michlewski
104 Mouse Tudor domain containing 12 (Tdrd12) is essential for biogenesis of piRNAs associating 
with the nuclear Piwi protein Miwi2
Radha Raman Pandey, Zhaolin Yang, Ramesh S Pillai
105 Regulation of miRNAs and endo-siRNAs during oocyte-to-zygote transition in the mouse
Matyas Flemr, Radek Malik, Vedran Franke, Jana Nejepinska, Kristian Vlahovicek, Petr Svoboda
106 Kinetic and biophysical models improve identification of miRNA targets
Mihaela Zavolan, Jean Hausser, Mohsen Khorshid, Erik van Nimwegen, Erik Sontheimer
107 Insights into the recruitment of the PAN2-PAN3 deadenylase complex to miRNA targets by the 
GW182/TNRC6 proteins
Mary Christie, Andreas Boland, Eric Huntzinger, Oliver Weichenrieder, Elisa Izaurralde
108 Translational repression and eIF4A2 activity are critical for microRNA-mediated gene 
regulation.
Anna Wilczynska, Hedda Meijer, Wei-Ting Lu, Yi-Wen Kong, Ruth Spriggs, Jack Godfrey, Sue 
Robinson, Anne Willis, Martin Bushell
109 The conserved concave surface of the MIF4G domain of CNOT1 is involved in miRNA-
mediated translational repression
Hansruedi Mathys, Witold Filipowicz
110 Single-molecule observation of DNA targeting and cleavage by the RNA-guided Cas9 
endonuclease
Samuel Sternberg, Eric Greene, Sy Redding, Martin Jinek, Jennifer Doudna
111 Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria meningitidis
Yan Zhang, Nadja Heidrich, Biju Joseph Ampattu, Carl Gunderson, Hank Seifert, Christoph Schoen, 
Jörg Vogel, Erik Sontheimer
Friday, June 14: 14:00 – 16:30
Concurrent Session C5:  Structure, dynamics, and catalysis—Aspen
Chair: David Rueda (Imperial College, London)
Abstracts 112–120
112 T box riboswitch decodes both the information content and geometry of tRNA to affect gene 
expression
Ailong Ke, Jason Grigg, Yujie Chen, Frank Grundy, Tina Henkin, Lois Pollack, Ailong Ke
113 Structural basis of specific tRNA recognition by the T-box riboswitch
Jinwei Zhang, Adrian Ferre-D’Amare
114 Crystal Structure and Biophysical Analysis of a Class 2 PreQ1 Riboswitch
Joseph Liberman, Mohammad Salim, Jolanta Krucinska, Joseph Wedekind
115 A novel class of self-cleaving ribozymes is prevalent in many species of bacteria and eukarya
Adam Roth, Zasha Weinberg, Andy Chen, Peter Kim, Tyler Ames, Ronald Breaker
116 Spliceosomal Prp24 unwinds a minimal U2/U6 complex from yeast
Chandani Warnasooriya, Zhuojun Guo, Samuel Butcher, David Brow, David Rueda
xxxiii
117 Conformational Heterogeneity of the Protein-Free Human Spliceosomal U2-U6 snRNA Complex
Caijie Zhao, Ravichandra Bachu, Nancy Greenbaum
118 A new class of minimal Hammerhead ribozymes conserved in the eukaryotic family of Penelope-
like retroelements
Amelia Cervera, Marcos de la Peña
119 Probing EF-G Power Stoke During Ribosome Translocation
Yuhong Wang, Li Yao, Yue Li, Shoujun Xu
120 Understanding RNA Interference One Molecule at a Time
William Salomon, Victor Serebrov, Mellissa Moore, Phillip Zamore
Friday, June 14: 14:00 – 16:30
Concurrent Session C6: High-throughput approaches to RNA biology—Sanada
Chair: Jernej Ule (MRC-LMB, University College London)
Abstracts 121–128
121 Promoter directionality is controlled by U1 splicing and polyadenylation signals
Albert Almada, Xuebing Wu, Andrea Kriz, Christopher Burge, Phillip Sharp
122 Suppression of promoter upstream transcripts (PROMPTs) by polyadenylation site-induced 
RNA decay provides directionality to transcription of human promoters
Evgenia Ntini, Aino Järvelin, Jette Bornholdt-Lange, Yun Chen, Mette Jørgensen, Robin Andersson, 
Aleks Schein, Peter Refsing Andersen, Pia Kjølhede Andersen, Vicente Pelechano, Lars Steinmetz, 
Albin Sandelin, Torben Heick Jensen
123 Pathway of histone mRNA decay determined by high-throughput sequencing (HTS)
Mike Slevin, Rebecca Bigler, Staci Meaux, William Marzluff
124 Global poly(A)-tail length measurements reveal that the relationship between tail length and 
translational efficiency varies between biological contexts
Alexander Subtelny, Stephen Eichhorn, Grace Chen, Hazel Sive, David Bartel
125 Capture of a microRNA targetome using chemically modified miRNA mimics (“miR-CLIP”)
Jochen Imig, Andreas Brunschweiger, Anneke Brümmer, Nitish Mittal, Boris Guennewig, Mihaela 
Zavolan, André P. Gerber, Jonathan Hall
126 Identification of multiple regulatory microRNAs by miTRAP
Juliane Braun, Knut Krohn, Stefan Hüttelmaier
127 Neurodegenerative diseases: Quantitative predictions of protein-RNA interactions
Davide Cirillo, Gian Tartaglia
128 New in vivo RNA-binding architectures discovered by RBDmap
Alfredo Castello, Bernd Fischer, Sophia Foehr, Anne-Marie Alleaume, Tomaz Curk, Jeroen Krijgsveld 
Krijgsveld, Matthias W Hentze
Friday, June 14: 17:00 – 18:30
Workshop Session W4: RNA in pharmaceutical research—Davos Ballroom
Chairs: Nicole Meisner (Novartis Institutes for Biomedical Research) and David Morrissey (Novartis 
Institutes for Biomedical Research) 
Abstracts 129–134
129 Development of Dynamic Polyconjugates for tissue-targeted delivery of siRNA
Christine Wooddell, So Wong, Jason Klein, Andrei Blokhin, Magdolna Sebestyén, Weijun Cheng, 
Julia Hegge, Qili Chu, Vladimir Trubetskoy, Collin Hagen, Anthony Perillo-Nicholas, Jacob Griffin, 
Jonathan Benson, Jeffrey Carlson, Darren Wakefield, Holly Hamilton, Stephanie Bertin, Jessica 
Montez, Alan McLachlan, David Rozema, David Lewis
130 Specific Gene Activation by Disruption of PRC2-lncRNA Interactions
James McSwiggen
131 RNA-based immunotherapeutics against cancer
Andreas Kuhn, Janina Buck, Florian Eberle, Britta Vallazza, Joanna Kowalska, Jacek Jemiliety, 
Edward Darzynkiewicz, Ugur Sahin
xxxiv
132 Antisense Oligonucleotide Therapies for the Treatment of Neurodegenerative and Muscular 
Diseases
Frank Rigo, C. Frank Bennett
133 Extracellular RNAs are markers of muscle myogenesis following splice switching 
oligonucleotide therapy in a mouse model of Duchenne muscular dystrophy
Matthew Wood
134 Silencing gene expression by recruiting RISC
Jennifer Broderick, Neil Aronin, Phillip Zamore
Friday, June 14: 17:00 – 18:30
Workshop Session W6: Tutorial on prediction of RNA secondary structure—Sanada
Chair: Alain Laederach (University of North Carolina at Chapel Hill) 
Abstracts 135–141
135 What can you know about noncoding RNAs without doing any experiments?
Zasha Weinberg, Ronald Breaker
136 Methods of Predicting RNA Structure Change Due to Mutation
Matt Halvorsen, Joshua Martin, Justin Ritz, Alain Laederach
137 RNAsnp: Predicting SNP Effects on Local RNA Secondary Structure
Radhakrishnan Sabarinathan, Hakim Tafer, Stefan E Seemann, Ivo L Hofacker, Peter F Stadler, Jan 
Gorodkin
138 Navigating through the MC-Flashfold 2D suboptimal solution maze using simple structural 
transformation rules
Paul Dallaire, Stefanie Schirmer, Francois Major
139 How to determine binding affinities and binding motifs for RNA-bindingproteins from CLIP-
seq data
Rolf Backofen, Daniel Maticzka, Fabrizio Costa
140 The HIV-2 Rev-Response Element: Determining Secondary Structure and Defining Folding 
Intermediates
Joanna Sztuba-Solinska, Sabrina Lusvarghi, Katarzyna Purzycka, Gary Pauly, Jason Rausch, Stuart Le 
Grice
141 Structural spectrum of long non-coding RNAs revealed by experiment
Irina Novikova, Scott Hennelly, Bin Zhang, David Spector, Karissa Sanbonmatsu
saturday, June 15: 08:30 – 10:15
Session P6A: Interconnections in RNA regulation—Davos Ballroom
Chair: Ulrike Kutay (ETH Zürich)
Abstracts 142–148
142 The transcription factors ILF2 and ILF3 are trans-acting factors for 60S ribosomal biogenesis
Franziska Wandrey, Christian Montellese, Lukas Badertscher, Lukas Bammert, Ulrike Kutay
143 Novel function for human Argonaute 2 in gene regulation at the tRNA genes
Jessica Woolnough, Keith E. Giles
144 The human cap-binding complex is functionally connected to the nuclear RNA exosome
Peter Refsing Andersen, Michal Domanski, Maiken S. Kristiansen1, Evgenia Ntini1, Celine 
Verheggen, Jakob Bunkenborg, Ina Poser, Marie Hallais, Anthony Hyman, John LaCava, Michael P. 
Rout, Jens . Andersen, Edouard Bertrand, Torben Heick Jensen
145 A splicing-dependent transcriptional checkpoint
Keerthi Chathoth, Shaun Webb, David Barrass, Jean Beggs
146 The Exon Junction Complex core component MLN51 interacts with eIF3 and activates 
translation
Pierre-Etienne Chazal, Elisabeth Daguenet, Catherine Tomasetto, Bruno Sargueil, Hervé Le Hir
xxxv
147 SRSF1-mediated translational regulation and its role in cellular transformation
Magdalena Maslon, Sara Heras, Nicolas Bellora, Eneritz Aguirre, Eduardo Eyras, Javier Caceres
148 The RNA kinase CLP1 is required for efficient tRNA splicing and regulates p53 activation in 
response to oxidative stress
Stefan Weitzer, Toshikatsu Hanada, Barbara Mair, Josef Penninger, Javier Martinez
saturday, June 15: 10:45 – 12:30
Session P6B: Alternative splicing—Davos Ballroom
Chair: Javier Cáceres (MRC Edinburgh) 
Abstracts 149–155
149 Genome-Wide Identification of Recursive Splicing in Drosophila
Sara Olson, Xintao Wei, Ahmad Osman, Michael Duff, Susan Celniker, Brenton Graveley
150 Isolated pseudo-RRMs of SR proteins can regulate splicing using a non-canonical mode of RNA 
recognition
Antoine Cléry, Rahul Sinha, Olga Anczukow, Anna Corrionero, Ahmed Moursy, Gerrit Daubner, Juan 
Valcarcel, Frédéric Allain, Adrian Krainer
151 RBM5 OCRE domain modulates alternative splicing regulation by recognition of proline-rich 
motifs in spliceosomal SmN/B/B’
Lisa Warner, André Mourão, Sophie Bonnal, Juan Valcárcel, Michael Sattler
152 GSK3-Induced Regulation of the Protein- and RNA-Binding Activity of PSF Modulates Signal-
Induced Alternative Splicing.
Christopher A Yarosh, Nicole Martinez, Jinsong Qiu, Xiang-dong Fu, Kristen Lynch
153 Rhythmic U2AF26 alternative splicing regulates the circadian clock in mice
Marco Preussner, Florian Heyd
154 RNA Binding Protein Sfpq is required for the expression of neuron-specific long pre-mRNAs 
essential for brain development.
Akihide Takeuchi, Kei Iida, Kensuke Ninomiya, Mikako Ito, Kinji Ohno, Masatoshi Hagiwara
155 The SWI/SNF subunit Brahma modulates the choice of alternative terminal exons by recruiting 
the BRCA1/BARD1 ubiquitin ligase
Gabriele Fontana, Aurora Rigamonti, Reinaldo Alvarez, Silvia Lenzken, Marco Bianchi, Silvia 
Barabino
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Poster sessions
Main Hallway and Sanada Foyer
Non-coding and Regulatory RNAs
Abstracts 156–204
156 A Natural antisense transcripts in Neurospora crassa
Yamini Arthanari, Sam Griffiths-Jones, Christian Heintzen, Susan Crosthwaite
157 B Overexpression of small noncoding RNAs and its effects on biofilm-related phenotypes in 
Escherichia coli
Geunu Bak, Kwang-sun Kim, Younghoon Lee
158 C Defense against viral attack: single-molecule view on a bacterial adaptive immune system
Timothy Blosser, Edze R. Westra, Cees Dekker, Stan J. J. Brouns, Chirlmin Joo
159 A TDP-43 regulates cancer-associated microRNAs
Xiaowei Chen, Zhen Fan, Mengmeng Chen, Ruirui Kong, Pushuai Wen, Tengfei Xiao, Warren 
McGee, Xiaomin Chen, Jianghong Liu, Li Zhu, Runsheng Chen, Jane Wu
160 B An RNA Degradation Machine Sculpted by Ro Autoantigen and Noncoding RNA
Xinguo Chen, David Taylor, Casey Fowler, Soyeong Sim, Jorge Galan, Hong-Wei Wang, Sandra 
Wolin
161 C The role of RNA degradation in moderating RNAi
Cristina Cruz, Jon Houseley
162 A The role of non coding RNA at sites of DNA damage in the control of genome integrity
Fabrizio d’Adda di Fagagna
163 B The microRNA pathway mediates expression of yolk lipoproteins in the Caenorhabditis elegans 
intestine
Robert Dowen, Gary Ruvkun
164 C The exosome subunit Rrp6 regulates the expression of retrotransposons and non-coding 
heterochromatic sequences in Drosophila melanogaster
Andrea Brigitte Eberle, Viktoria Hessle, Antoni Ganez Zapater, Gilad Silberberg, Anne von Euler, 
Neus Visa
165 A Identification and Analysis of New Genes Targeted for sRNA Regulation in Bacteria
Martha Faner, Andrew Feig
166 B Novel RNA Structures Controlling RIbosomal Protein Biosynthesis in E. coli and Beyond
Yang Fu, Michelle Meyer
167 C The RNA subunit of RNase MRP: extra nucleotides at the 3’ end
Katherine Goldfarb, Elaine Podell, James Goodrich, Thomas Cech
168 A Alu RNAs as possible modulators of microRNA function
Daniele Hasler, Gunter Meister
169 B RNA annealing activity of Hfq is sensitively modulated by various physical parameters
Wonseok Hwang, Véronique Arluison, Sungchul Hohng
170 C Identification of stage specific microRNAs during the developmental stages in Triops 
cancriformis (tadpole shrimp)
Kahori Ikeda, Yuka Hirose, Kiriko Hiraoka, Emiko Noro, Kosuke Fujishima, Masaru Tomita, Akio 
Kanai
171 A A tandem-stem RNA motif mediates X-chromosome dosage compensation in Drosophila
Ibrahim Avsar Ilik, Jeffrey J. Quinn, Filipe Tavares-Cadete, Plamen Georgiev, Yue Wan, Robert C. 
Spitale, Nicholas Luscombe, Howard Y. Chang, Asifa Akhtar
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172 B Long ncRNA NEAT1-dependent SFPQ relocation between nuclear body paraspeckle and gene 
promoter region mediates the transcription of IL8 gene in immune response
Katsutoshi Imamura, Gen Akizuki, Naoto Imamachi, Michiko Kumakura, Atsushi Kawaguchi, 
Kyosuke Nagata, Akihisa Kato, Yasushi Kawaguchi, Hiroki Sato, Misako Yoneda, Chieko Kai, 
Tetsushi Yada, Shinichi Nakagawa, Kiyomi Kaneki, Kenji Inoue, Tatsuhiko Kodama, Youichiro Wada, 
Kazuhisa Sekimizu, Nobuyoshi Akimitsu
173 C A Natural Antisense Transcript is Involved in the Destabilization of Cyclooxygenase 2 mRNA by 
Acetaminophen
Hiroyuki Inaba, Emi Yoshigai, Keikichi Sugiyama, Hoyoku Nishino, Mikio Nishizawa
174 A Circular RNAs are Abundant, Conserved and Linked to ALU Repeats
William Jeck, Jessica Sorrentino, Michael Slevin, Zefeng Wang, William Marzluff, Norman Sharpless
175 B Recognition of brain cytoplasmic 200 RNA by a human anti-RNA antibody
Euihan Jung, Jungmin Lee, Hyo Jeong Hong, Insoo Park, Younghoon Lee
176 C Evf2 (Dlx6AS) long non-coding RNA regulation of interneuron gene expression and behavior
Jhumku Kohtz, Hao Luo, Sean Chen, Shari Birnbaum
177 A The double stranded RNA transcriptome of E. coli reveals novel antisense RNAs
Meghan Lybecker, Bob Zimmermann, Ivana Bilusic, Nadia Tukhtubaeva, Renee Schroeder
178 B Roles for roX RNA and the RNA helicase MLE in the assembly of the dosage compensation 
complex in Drosophila
Sylvain Maenner, Marisa Müller, Jonathan Fröhlich, Diana Langer, Peter B. Becker
179 C Molecular Mechanism Involved in Antisense-Mediated Transcriptional PHO84 Gene Silencing
Andrea Maffioletti, Nissrine Beyrouthy, Francoise Stutz
180 A MiR-19 and miR-155 role in oncogene-induced senescence bypass
Lian Mignacca, Emmanuelle Saint-Germain, Gerardo Ferbeyre
181 B Fission yeast Cactin silences chromosome ends and retrotransposons and links heterochromatin 
establishment to telomere length regulation
Martin Moravec, Luca E Lorenzi, Amadou Bah, Harry Wischnewski, Marco Santagostino, Claus M 
Azzalin
182 C Revealing the elusive molecular biology of the vault RNA
Birgit Nachbauer, Melanie Amort, Aloys Schepers, Arnd Kieser, Norbert Polacek
183 A Structure and function of Zucchini endoribonuclease in piRNA biogenesis
Osamu Nureki, Hiroshi Nishimasu, Hirotsugu Ishizu, Mikiko Siomi
184 B Malignant Transformation Changes Packaging and Targeting of Extracellular MicroRNAs
Jaime Palma, William Pearse, Mallory Havens, Michelle Hastings, Dominik Duelli
185 C Identification and functional characterization of the long non-coding RNA in myogenesis
Jinyoung Park, Jiwon Lee, Hanyoung Lee, Chanhee Jo, Ahreum Choi, Jae-Hyun Yang, Eun-Jung Cho
186 A Degradation of ribosomal RNA and ribosomal proteins constitute separate pathways of 
ribophagy
Anna Pastucha, Joanna Kufel
187 B Discovery of Hfq-binding nanoRNAs in Escherichia coli
Jennifer Patterson, Shugeng Cao, Jon Clardy, Cameron Mura
188 C  Mutations in the 5’UTR of SERPINA1 transcripts are involved in the disease associated 
mechanisms
Gabriela Phillips, Chetna Gopinath, Matt Halvorsen, Justin Ritz, Amanda Solem, Alain Laederach
189 A RNA Structure and Ligand Interactions Probed by Strategically Positioned 15N-Labels
Tobias Santner, Jasmin Levic, Christoph Kreutz, Ronald Micura
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190 B Integrated genome-wide in silico and capture array approach discovers a large spectrum of 
novel structured RNAs associated to regulatory elements
Stefan E Seemann, Claus Hansen, Claus H Bang-Berthelsen, Aashiq H Mirza, Mikkel Christensen-
Dalsgaard, Hui Xiao, Zizhen Yao, Elfar Torarinsson, Flemming Pociot, Henrik Nielsen, Niels 
Tommerup, Walter L Ruzzo, Jan Gorodkin
191 C Identification and characterization of rice non-coding RNAs involved in nitrogen-starvation 
stress response
Sang-yoon Shin, Chanseok Shin
192 A Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells
Alla Sigova, Alan Mullen, Benoit Molinie, Sumeet Gupta, David Orlando, Matthew Guenther, Albert 
Almada, Charles Lin, Phillip Sharp, Cosmas Giallourakis, Richard Young
193 B Uncovering novel microRNAs involved in homeostatic plasticity
Mariline M. Silva, Joana Fernandes, Sandra D. Santos, Ana Luísa Carvalho
194 C Transcriptional regulation and non-coding RNA: The Steroid Receptor RNA activator
Stéphane Thore, Fabiana Arieti, Caroline Gabus-Darlix, Sandrine Coquille
195 A RNA polymerase-binding elements attenuating transcription in E. coli
Nadia Tukhtubaeva, Vitaliy Epshtein, Bob Zimmermann, Meghan Lybecker, Ivana Bilusic, Evgeny 
Nudler, Renee Schroeder
196 B A link between long intervening noncoding RNAs and microRNA regulation
Igor Ulitsky, Alena Shkumatava, Hazel Sive, David Bartel
197 C Evolutionary relationships between PB1 mRNA of Influenza A virus and host microRNAs 
among vertebrates
Yuki Usui, Kahori Ikeda, Motomu Matsui, Masaru Tomita, Akio Kanai
198 A Rat mir-155 generated from the lncRNA Bic is ‘hidden’ in the alternate genomic assembly and 
reveals the existence of novel mammalian miRNAs and clusters
Paolo Uva, Letizia Da Sacco, Manuela Del Cornò, Paola Sestili, Sandra Gessani, Antonella 
Baldassarre, Massimiliano Orsini, Andrea Masotti, Alessia Palma, Mattia Locatelli
199 B HEN1-directed labeling of small non-coding RNAs
Giedrius Vilkaitis, Alexandra Plotnikova, Aleksandr Osipenko, Viktoras Masevicius, Saulius 
Klimašauskas
200 C Noncoding RNA-mediated chromosomal fusions
Xing Wang, John Bracht, Keerthi Shetty, Xiao Chen, Mariusz Nowacki, Laura Landweber
201 A Regulation of transcription by Pol II-binding RNA aptamers
Adam Weiss, Maximilian Radtke, Frederike von Pelchrzim, Jennifer Boots, Bob Zimmermann, Marek 
Zywicki, Katarzyna Matylla-Kulinska, Renée Schroeder
202 B A short guide to human long non-coding RNA gene nomenclature
Matt Wright, Ruth Seal, Elspeth Bruford
203 C RNA functional profiling by gene deletion in S. cerevisiae
Jian Wu, Steven Parker, Sara Shamsah, Daniela Delneri, Raymond O’Keefe
204 A Scaffold function of long noncoding RNA HOTAIR in protein ubiquitination
Je-Hyun Yoon, Kotb Abdelmohsen, Xiaoling Yang, Kumiko Tominaga-Yamanaka, Elizabeth J. White, 
Arturo V. Ojalo, John L. Rinn, Stefan G. Kreft, Gerald M. Wilson, Myriam Gorospe
Mechanisms of RNA interference
Abstracts 205–222
205 B Towards improved shRNA inhibitors with a Dicer-independent processing route
Ben Berkhout
206 C AGO1 requires interaction with GW182 to repress translation of miRNA targets
Andreas Boland, Eric Huntzinger, Duygu Kuzuoglu-Öztürk, Maria Fauser, Elisa Izaurralde
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207 A Argonaute-associated factors required for translational repression in plant RNA silencing
Clément Chevalier, Jacinthe Azevedo-Favory, Grégory Schott, Christophe Himber, Mohamed-Ali 
Hakimi, Olivier Voinnet
208 B Endogenous RNA interference is driven by copy number
Cristina Cruz, Jon Houseley
209 C Identification of anhydrobiosis-related genes using RNA interference with 27-bp RNA duplexes
Cláudia Evangelista, Gustavo Borges, Alan Tunnacliffe, Tiago Pereira
210 A Human Dicer caught in the act via single-molecule fluorescence spectroscopy
Mohamed Fareh, Kyu-Hyeon Yeom, Anna S. Haagsma, V. Narry Kim, Chirlmin Joo
211 B Single-molecule view on the action of Drosophila Dicer-2
Anna C. Haagsma, Mohamed Fareh, Chirlmin Joo
212 C Analysis on viral suppressors of RNA silencing in plant cell-free RISC assembly system
Taichiro Iki, Olivier Voinnet
213 A Real-time observation of target binding and dissociation of Argonaute-guide complex
Seung-Ryoung Jung, Eunji Kim, Soochul Shin, Wonseok Hwang, Ji-Joon Song, Sungchul Hohng
214 B Investigating the potential role of an archaeal Argonaute in the subtype III-B CRISPR system of 
M. piezophila
Emine Kaya, Jennifer A. Doudna
215 C NMR structural study of the two N-terminal dsRBDs of TRBP in complex with siRNA.
Gregoire Masliah, Christophe Maris, Juerg Hunziker, Nicole Meisner, Frederic Allain
216 A crRNA-guided R-loop formation and the architecture of the Type I-C Cascade
Ki Hyun Nam, Ailong Ke
217 B P body-associated RNA silencing complex PRSC of Cryptococcus effects transposon suppression
Prashanthi Natarajan, Joshua Dunn, Jonathan Weissman, Phillip Dumesic, Hiten Madhani
218 C The rough Endoplasmatic Reticulum is the central nucleation site of siRNA-mediated RNA 
silencing
Lukas Stalder, Wolf Heusermann, Lena Sokol, Dominic Trojer, Anja Fritzsche, Jan Weiler, Martin 
Hintersteiner, Florian Aeschimann, David Morrissey, Nicole Meisner Kober
219 A Functional characterization of DCL1 and DCL2 proteins from Medicago truncatula
Aleksander Tworak, Anna Urbanowicz, Jan Podkowinski, Marek Figlerowicz
220 B Distinct activities of the Dictyostelium discoideum RNA-dependent RNA polymerases in post-
transcriptional gene regulation
Stephan Wiegand, Carsten Seehafer, Marek Malicki, Patrick Hofmann, Annika Schmith, Thomas 
Winckler, Balint Földesi, Benjamin Boesler, Wolfgang Nellen, Johan Reimegård, Lotta Avesson, 
Fredrik Söderbom, Christian Hammann
221 C Computational Analyses and Experiments Indicate Role of Guide RNA Structure in 
MicroRNA::Target Interaction
Yilong Wu, Jun Zhong, Christian Köberle, Stefan Kaufmann, Volker Patzel
222 A The CCR4-NOT complex releases PABP from silenced miRNA targets in the absence of 
deadenylation
Latifa Zekri, Elisa Izaurralde
RNA and Epigenetics
Abstracts 223–231
223 B Characterization of small RNAs that contribute to ribosomal RNA gene silencing through the 
siRNA machinery
Blake Atwood, Keith Giles, Karen Beeman
224 C Structural Characterization of the RNA, Cyp33, MLL, Histone H3 Interaction Network
Markus Blatter, Charlotte Meylan, Frédéric H.-T. Allain
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225 A The Igf2as transcript is exported into the cytoplasm and is associated with polysomes
Carolina Duart-Garcia, Martin Braunschweig, Tosso Leeb
226 B Human Argonaute Suppresses Cryptic RNA Polymerase II Transcription and Chromatin 
Structure of the Silent rRNA Genes.
Keith Giles, Gaelle Lefevre, Blake Atwood, Mariana Saint Just Ribeiro, Gary Felsenfeld
227 C Histone replacement reveals distinct essential functions for H3K36 methylation
Michael Meers, A. Gregory Matera
228 A Transcriptome-wide Analysis of the m6A Landscape Reveals Pervasive Adenosine Methylation 
in 3’ UTRs and near Stop Codons
Kate Meyer, Yogesh Saletore, Paul Zumbo, Olivier Elemento, Christopher Mason, Samie Jaffrey
229 B Single cell analysis reveals aspects of antisense RNA regulation and mode of action in PHO84 
transcription repression
Samir Rahman, Manuele Castelnuovo, Elisa Guffanti, Francoise Stutz, Daniel Zenklusen
230 C Regulation of piRNA production
Prashanth Rangan
231 A Mmi1, an RNA-binding protein, mediates heterochromatin gene silencing by recruiting the 
nuclear exosome to long non-coding RNAs in fission yeast
Andre Verdel, Edwige Hiriart, Michael Reuter, Benoit Gilquin, Ravi Sachidanandam, Ramesh Pillai, 
Leila Touat-Todeschini
Small RNAs
Abstracts 232–257
232 B Introns of plant pri-miRNAs are required for proper biogenesis and function of miRNAs
Dawid Bielewicz, Malgorzata Kalak, Maria Kalyna, David Windels, Andrea Barta, Franck Vazquez, 
Zofia Szweykowska-Kulinska, Artur Jarmolowski
233 C Common regulation of micro-RNAs by oncogenic transcription factors in B-cell lymphomas
Mohan Bolisetty, Karen Beemon
234 A RNA-binding proteins vs. microRNAs: how IGF2BP1 modulates tumor-suppressive microRNA-
action in tumor cells
Bianca Busch, Juliane Braun, Stefan Hüütelmaier
235 B miRNA profiles characterise distinct states of cellular pluripotency
Jennifer Clancy, Hardip Patel, Nicole Cloonan, Andrew Corso, Mira Puri, Pete Tonge, Andras Nagy, 
Thomas Preiss
236 C Quantitative analysis reveals extensive target specificity of individual let-7 miRNA family 
members in vivo
Matyas Ecsedi, Helge Grosshans
237 A Piwi-Interacting RNAs Protect DNA Against Loss During Oxytricha Genome Rearrangement
Wenwen Fang, Xing Wang, John Bracht, Mariusz Nowacki, Laura Landweber
238 B Positive regulation of inflammation by miR-19
Michael Gantier, H. James Stunden, Bryan Williams
239 C Characterization of microRNAs derived from the HIV-1 TAR RNA hairpin
Alex Harwig, Ben Berkhout, Atze Das
240 A miRNA degradation during C. elegans development
Gert-Jan Hendriks, Dimosthenis Gaidatzis, Helge Grosshans
241 B Temporal expression of tRNA fragments in development of Triops cancriformis (Tadpole 
shrimp)
Yuka Hirose, Kahori Ikeda, Emiko Noro, Kiriko Hiraoka, Masaru Tomita, Akio Kanai
242 C Highly potent and specific siRNAs isolated from E. coli with endogenous p19 expression
Linfeng Huang, Jingmin Jin, Larry McReynolds, Judy Lieberman
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243 A Novel NFL mRNA targeting microRNAs in Amyotrophic Lateral Sclerosis
Muhammad Ishtiaq, Danae Campos-Melo, Kathryn Volkening, Michael Strong
244 B A Specialized Mechanism of Translation Regulation in Quiescence
Sooncheol Lee, Samuel Truesdell, Syed Irfan Bukhari, Ju Huck Lee, Olivier Le Tonqueze, Shobha 
Vasudevan
245 C X-ray crystal structure of Maelstrom
Naoki Matsumoto, Hiroshi Nishimasu, Kaoru Sato, Ryuichiro Ishitani, Mikiko Siomi, Osamu Nureki, 
Haruhiko Siomi
246 A DmGTSF1 is essential for effective retrotransposon silencing by Piwi in Drosophila ovarian 
somatic cells
Hitoshi Ohtani, Haruhiko Siomi
247 B Competition between spliceosome and microprocessor complex regulates processing of Splice 
site Overlapping (SO) 34b pri-miRNA
Franco Pagani, Chiara Mattioli, Giulia Pianigiani
248 C Molecular mechanisms of the piRNA biogenesis machinery
Ramesh Pillai
249 A Abstract Withdrawn
250 B Poly(A) and histone mRNA processing factor Symplekin is involved in endo-siRNA biogenesis
Mindy Steiniger, William Marzluff
251 C Sensitized Backgrounds Reveal Critical Roles for microRNA Families
Elizabeth Jeanne Thatcher, Victor Ambros
252 A A proteomic screen identifies novel regulators of micro-RNA biogenesis
Thomas Treiber, Nora Treiber, Simone Harlander, Henning Urlaub, Gunter Meister
253 B The role of the RNA chaperone protein Hfq in the translation regulation by small noncoding 
RNAs targeting ompD mRNA from Salmonella typhimurium.
Zuzanna Urbaniak, Aleksandra Kaszynska, Joanna Strózecka, Daria Grygiel, Mikolaj Olejniczak
254 C Novel stress-induced smRNAs from Brachypodium distachyon
Hsiao-Lin V. Wang, Brandon L. Dinwiddie, Herman Lee, Julia Chekanova
255 A The novel Tetrahymena gene COI12 is crucial for siRNA loading into the Argonaute protein 
Twi1p
Sophie Wöhrer, Kazufumi Mochizuki
256 B An Exchange-Induced Remnant Magnetization Technique for MicroRNA Detection
Shoujun Xu, Li Yao, Yuhong Wang
257 C Nonstop decay in C. elegans: examination of a possible role for 22G RNAs
Elaine Youngman, WeifengGu , Craig Mello
RNA Catalysis and Riboswitches
Abstracts 258–271
258 A Spliceozymes: Ribozymes that act like Spliceosomes
Zhaleh Amini, Ulrich Müller
259 B Molecular Mechanism of preQ1 Riboswitch Action: a Molecular Dynamics Study
Pavel Banáš, Petr Sklenovský, Joseph E. Wedekind, Jirí Šponer, Michal Otyepka
260 C Characterization of Metal Ion Binding Sites in the P4 Helix of Bacillus subtilis RNase P
Yu Chen, Xin Liu, Carol A. Fierke
261 A Ligand-induced stabilization of the aptamer terminal helix in the adenine riboswitch
Francesco Di Palma, Francesco Colizzi, Giovanni Bussi
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262 B Studying Conformational Changes in the Glycine Riboswitch using Electron Paramagnetic 
Resonance Spectroscopy
Jackie Esquiaqui, Gail Fanucci
263 C In vitro evolution of a calcium ion-sensing ribozyme from the natural glmS riboswitch-ribozyme
Matthew Lau, Adrian Ferré-D’Amaré
264 A Architectural Diversity of PreQ1 Riboswitches
Phillip J. McCown, Jonathan J. Liang, Ronald R. Breaker
265 B Theoretical Methods Suggest That Small Ribozymes May Use Multichannel Mechanism During 
Catalysis
Vojtech Mlynsky, Pavel Banas, Nils G. Walter, Jiri Sponer, Michal Otyepka
266 C Tuning the btuB riboswitch fold by chemically modifying its ligand coenzyme B12
Anastasia Musiari, Sofia Gallo, Kai Zhou, Felix Zelder, Roland Sigel
267 A A Riboswitch Class for the Bacterial Second Messenger c-di-AMP
James Nelson, Narasimhan Sudarsan, Kazuhiro Furukawa, Zasha Weinberg, Joy Wang, Ronald 
Breaker
268 B Metal Ion Requirement and Substrate Specificity of Kinase Ribozyme K28(1-77)C
Raghav Poudyal, Elisa Biondi, Josh Forgy, Phuong Nguyen, Donald Burke
269 C Formation of a catalytic supramolecular RNA 1D-array through self-assembly of an engineered 
group I intron RNA enzyme
Narumi Uehara, Hiroyuki Furuta, Yoshiya Ikawa
270 A A pinch model for activation of HDV-like ribozymes
Chiu-Ho Webb, Andrej Luptak
271 B The catalytic mechanism of a novel, widely disseminated small nucleolytic ribozyme
Timothy Wilson, Tomas Fessl, David Lilley
RNA structure and folding
Abstracts 272–297
272 C Anion-π or cation-π interactions in RNA?
Pascal Auffinger, Luigi D’Ascenzo, Eric Westhof
273 A The solution structure of Tetrahymena telomerase p65-RNA(TER)-TERT RBD determined by 
SAXS reveals contacts critical for particle stability
Andrea Berman, Anne Gooding, Robert Rambo, John Tainer, Thomas Cech
274 B Sizing large RNA molecules using single molecule fluorescence correlation spectroscopy
Alexander Borodavka, Roman Tuma, Peter Stockley
275 C CompaRNA: a server for continuous benchmarking of automated methods for RNA structure 
prediction
Janusz Bujnicki, Tomasz Puton, Lukasz Kozlowski, Sam Mondal, Marcin Magnus, Kristian Rother
276 A Symmetry and asymmetry in the unwinding of nucleic acids
Francesco Colizzi, Yaakov Levy, Giovanni Bussi
277 B A revised folding pathway of group II introns: Assigning specific structures to the individual 
FRET states
Erica Fiorini, Cardo Lucia, Danny Kowerko, David Rueda, Roland K.O. Sigel
278 C Elucidation of viroids structure by SHAPE
Tamara Giguère, Charith Raj Adkar-Purushothama, François Bolduc, Jean-Pierre Perreault
279 A Non-Canonical Base Pair Formation and Ion Binding in Small Bulged RNA
Neena Grover
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280 B The plasticity of a structural motif in RNA:  structural polymorphism of a k-turn in response to 
its environment
Lin Huang, Peter Daldrop, David Lilley
281 C Ligand selectivity of the neomycin RNA aptamer is highly influenced by its ionic surroundings
Muslum Ilgu, Bruce D Fulton, Ragothaman Yennamalli, Megan M Kleckler, Monica H Lamm, Taner 
Z Sen, Marit Nilsen-Hamilton
282 A A predictive value optimizing the evaluation of biological RNA G-quadruplexes formation
Rachel Jodoin, Jean-Denis Beaudoin, Jean-Pierre Perreault, Martin Bisaillon
283 B Metal ions determine the kinetics and thermodynamics of single RNA-RNA associations 
according to the Irving-Williams series
Sebastian L.B. König, Danny Kowerko, Mokrane Khier, Mélodie Hadzic, Roland Sigel
284 C Crowded Environments Compensate Destabilizing Mutations in the Azoarcus Ribozyme
Hui-Ting Lee, Duncan Kilburn, Sarah Woodson
285 A A Universal RNA Structural Motif Docking the Elbow of tRNA in the Ribosome, RNAse P and 
T-box Leaders
Jean Lehmann, Fabrice Jossinet, Daniel Gautheret
286 B One-bead coarse grained models for RNA dynamics and folding
Filip Leonarski, Fabio Trovato, Valentina Tozzini, Andrzej Les, Joanna Trylska
287 C Crystallization of the active form of the Lariat-Capping ribozyme.
Mélanie Meyer, Henrik Nielsen, Eric Westhof, Steinar Johansen, Benoît Masquida
288 A Structural characterization of the yeast telomerase RNA core by SHAPE
Rachel O. Niederer, David C. Zappulla
289 B Molecular crowding accelerates ribozyme docking and catalysis
Bishnu P. Paudel, David Rueda
290 C Imp3p unfolds conserved and stable stem structures in both U3 snoRNA and pre-rRNA to 
promote annealing
Binal Shah, Xin Liu, Carl Correll
291 A The influence of metal ions on the structure of the CPEB3 ribozyme’s P4 region
Miriam Skilandat, Magdalena Rowinska-Zyrek, Roland K. O. Sigel
292 B Structural complexity of Dengue untranslated regions: the role of cis-acting RNA motifs and 
pseudoknot interaction in modulating functionality of the viral genome.
Joanna Sztuba-Solinska, Tadahisa Teramoto, Jason Rausch, Bruce Shapiro, Radhakrishnan 
Pademanabhan, Stuart Le Grice
293 C Self-dimerizing group I ribozymes as a new class of modular units for RNA synthetic biology
Takahiro Tanaka, Hiroyuki Furuta, Yoshiya Ikawa
294 A Automated identification of RNA 3D modules with discriminative power in RNA structural 
alignments.
Corinna Theis, Christian Hoener zu Siederdissen, Ivo L. Hofacker, Jan Gorodkin
295 B The regulatory significance of RNA secondary structure in Arabidopsis
Lee Vandivier, Fan Li, Qi Zheng, Matthew Willmann, Ying Chen, Brian Gregory
296 C Crystallographic Studies of the Complex between G-quadruplex RNA and the RGG Domain of 
Fragile X Mental Retardation Protein
Nikita Vasilyev, Anna Polonskaia, Dinshaw J. Patel, Alexander Serganov
297 A How do platinum drugs interact with RNA?
Marianthi Zampakou, Daniela Donghi
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RNA chemistry
Abstracts 298–306
298 B Synthesis of fluorophore- and spin-labeled RNA using deoxyribozymes
Lea Büttner, Fatemeh Javadi-Zarnaghi, Claudia Höbartner
299 C Spin-labeled cytidine nucleotides in long synthetic RNAs: solid-phase synthesis, post-synthetic 
labeling, ligation and EPR-spectroscopic characterization
Claudia Höbartner, Jan Seikowski, Lea Büttner, Katarzyna Wawrzyniak, Anne Ochmann, Falk 
Wachowius, Giuseppe Sicoli
300 A Inhibition of Bcl-2 using photo-crosslinking antisense oligonucleotides
Akio Kobori, Yuko Nagae, Asako Yamayoshi, Akira Murakami
301 B Translational regulation by ligand-inducible formation of RNA pseudoknot
Saki Matsumoto, Changfeng Hong, Asako Murata, Kazuhiko Nakatani
302 C Targeting secondary structures of pre-miRNA by small molecules: Development of potential 
inhibitors of pre-miRNA processing
Asako Murata, Ayako Sugai, Takeo Fukuzumi, Shiori Umemoto, Chikara Dohno, Kazuhiko Nakatani
303 A Suppression of miR-29a maturation by ligand binding
Takahiro Otabe, Asako Murata, Fumie Takei, Kazuhiko Nakatani
304 B Chemical Synthesis of 3’-Aminoacyl-tRNA Mimics to Investigate Antibiotic Induced Ribosome 
Stalling
Lukas Rigger, Shanmugapriya Sothiselvam, Nora Vázquez-Laslop, Alexander Mankin, Ronald 
Micura
305 C Coumarin fluorochrome binds to Rev responsible element RNA with extremely large absorption 
shift
Tetsuya Tsuda, Takeo Fukuzumi, Kazuhiko Nakatani
306 A Versatile phosphoramidation reactions for effective labeling and conjugation of nucleic acids
Tzu-Pin Wang, Yu-Chih Su
Therapeutic RNAs
Abstracts 307–310
307 B CACNA2D4: a novel paradigm for the application of antisense-mediated gene therapy to the 
cure of retinal dystrophies
Niccolo Bacchi, Gian Carlo Demontis, Simona Casarosa, Michela Alessandra Denti
308 C Antisense RNA-induced EXON-skipping for the Gene Therapy of Frontotemporal Dementia 
and Parkinsonism Associated with Chromosome 17 (FTDP-17).
Giuseppina Covello, Kavitha Siva, Lara Mari, Elena Marchesi Marchesi, Perrone Daniela Perrone, 
Michela Alessandra Denti
309 A Messenger RNA as a novel therapeutic approach
Antonin de Fougerolles
310 B Identification of novel anti-obesity genes in primary human adipocytes using RNAi screening
Akanksha Gangar, Didier Grillot, Sandrine Martin, Valerie Linhart, Alizon Riou-Eymard, Raphaelle 
Guillard, Kim Carrein, Maarten Van Balen, Brigitta Witte, Nick Vandeghinste, Marlijn Steger, David 
Fischer, Steve De Vos, Dominique Langin, Vladimir Stich, Stephane Huet
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Workshop: RNA in pharmaceutical research
Abstract 311
311 C Inhibition of the HIV -1 virus RRE-Rev interaction by small molecule Rev mimics. A new 
synthetic scaffold for specific recognition of RNA structure.
Luis Gonzalez-Bulnes, Ignacio Ibañez, Luis Miguel Bedoya, Silvia Catalan, Jose Alcami, Santos 
Fustero, Jose Gallego
Therapeutic RNAs
Abstracts 312–315
312 A RNA aptamer C3 is  a non-ATP site inhibitor of the MAP kinase ERK2
Sabine Lennarz, Günter Mayer
313 B mRNA transfection - a transient transgene expression in human mesenchymal stem cells as an 
attractive tool for regenerative medicine
Adam Nowakowski, Anna Andrzejewska, Hanna Kozlowska, Piotr Walczak, Barbara Lukomska, 
Miroslaw Janowski
314 C Combined systemic and local morpholino treatment rescues the phenotype of the SMA Delta 7 
mouse model
Marc-David Ruepp, Monica Nizzardo, Chiara Simone, Sabrina Salani, Federica Rizzo, Margherita 
Ruggieri, Simona Brajkovic, Hong Moulton, Oliver Mühlemann, Nereo Bresolin, Giacomo P. Comi, 
Stefania Corti
315 A RNA-i Therapy for Fronto Temporal Dementia and Parkinsonism Linked to Chromosome 17
Kavitha Siva, Giuseppina Covello, Michela Alessandra Denti
tRNA, snRNA, snoRNA, rRNA
Abstracts 316–334
316 B Studies on structure-function relationships of the snoRNP assembly machinery
Christiane Branlant, Régis Back, Benjamin Rothé, Jonathan Bizarro, Magali Blaud, Marc Quinternet, 
Solange Morera, Philippe Meyer, Cyril Dominguez, Frédéric Alain, Edouard Bertrand, Xavier 
Manival, Bruno Charpentier
317 C Lateral tRNA gene transfer in Methanobrevibacter ruminantium
Patricia Chan, Todd Lowe
318 A Mitochondrial poly(A) polymerase is involved in tRNA editing
Mario Fiedler, Elmar Wahle, Christiane Rammelt
319 B  High throughput quantification of tRNA function reveals unexpected interactions between 
tRNA residues
Michael Guy, David Young, Yoshiko Kon, Xiaoju Zhang, Matthew Payea, Kimberly Dean, David 
Mathews, Elizabeth Grayhack, Stanley Fields, Eric Phizicky
320 C Gene expression analysis of nematode-specific tRNAs (nev-tRNAs) that can decode an 
alternative genetic code
Kiyofumi Hamashima, Yoshiki Andachi, Masaru Tomita, Yuji Kohara, Akio Kanai
321 A Structure and Kinetic Mechanism of Protein-only RNase P from A. thaliana
Michael Howard, Markos Koutmos, Carol Fierke
322 B Biochemical Characterization of Archaeal RNase E-like Protein, FAU-1 in Pyrococcus furiosus
Yoshiki Ikeda, Asako Sato, Masaru Tomita, Akio Kanai
323 C Strong anion exchange fast performance liquid chromatography as a versatile tool for 
preparation and purification of RNA produced by in vitro transcription
Jiri Koubek, Ku Feng Lin, Yet Ran Chen, Richard Ping Cheng, Joseph Jen Tse Huang
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324 A Identification of proteins co-purifying with the yeast RNA exosome and their effect on the 
complex stabilization
Rogerio Lourenco, Fernando Gonzales, Carla Oliveira
325 B tRNAscan-SE and GtRNAdb: Improving Detection and Functional Prediction Based on 
Genomic Context, Structure, and Expression of Transfer RNAs
Todd Lowe, Patricia Chan, Aaron Cozen, Andrew Holmes, Jay Kim, Eva Robinson
326 C RIP-seq analysis of eukaryotic Sm proteins reveals interactions between snRNPs and mature 
mRNAs
Zhipeng Lu, Xiaojun Guan, Greg Matera
327 A Absence of a Universal Element for tRNAHis Identity in Eucarya
Bhalchandra Rao, Jane Jackman
328 B Thiolation of specific tRNAs by URM1 is required for efficient translation a subset of proteins 
by promoting ribosomal A-site binding
Namit Ranjan, Vanessa Rezgui, Patrick Pedrioli, Kshitiz Tyagi, Marina Rodnina, Andrey Konevega, 
Joerg Mittelstaet, Matthias Peter
329 C A comprehensive analysis of the natural variation of tRNA modification in two Saccharomyces 
species
Peter Sarin, Sebastian Leidel
330 A A Protease that Cleaves the C-terminal Domain of the RtcB-type RNA Ligase in the 
Hyperthermophilic Archaeon Pyrococcus furiosus
Asako Sato, Takeshi Masuda, Masaru Tomita, Takashi Itoh, Akio Kanai
331 B Human mitochondrial RNase P and its multiple faces
Elisa Vilardo, Nadia Brillante, Christa Nachbagauer, Walter Rossmanith
332 C Playing RNase P evolution: replacing a complex ribonucleoprotein enzyme with a single protein
Christoph Weber, Roland K. Hartmann, Andreas Hartig, Walter Rossmanith
333 A tRNA maturation abnormalities connected to stress conditions and transcription deregulation
Dominika Wichtowska, Anita K. Hopper, Magdalena Boguta
334 B A Genome-wide Analysis to Identify Novel Genes Involved in tRNA Metabolism and Subcellular 
Trafficking
Jingyan Wu, Anita K. Hopper
Ribosomes and Translation
Abstracts 335–361
335 C Expanded Function of Trans-Editing Domains To Edit Non-canonical Amino Acids Prevents 
Errors In Translation
Jo Marie Bacusmo, Birgit Alber, Karin Musier-Forsyth
336 A Characterization of Rbtf1 and its role in ribosome synthesis
Lukas Bammert, Ulrike Kutay
337 B When p53 senses faulty ribosomes: Induction of Tp53 correlates with enhanced expression of 
c-Myc target nucleolar proteins in Rpl11-deficient zebrafish
Anirban Chakraborty, Tamayo Uechi, Pierre-Emmanuel Gleizes, Naoya Kenmochi
338 C Exploring translation in S. pombe using ribosomal profiling
Caia Duncan, Juan Mata
339 A Escherichia coli ribosomal protein S1 unfolds structured mRNAs onto the ribosome for active 
translation initiation
Mélodie Duval, Alexey Korepanov, Olivier Fuchsbauer, Pierre Fechter, Ronald Micura, Bruno 
Klaholz, Stefano Marzi, Pascale Romby
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340 B Antibiotic-mediated frameshift during translation of the leader ORF reveals a new principle of 
gene regulation
Pulkit Gupta, Nora Vazquez-Laslop, Alexander Mankin
341 C High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome
Yaser Hashem, Amedee Des Georges, Sarah Buss, Fabrice Jossinet, Amy Jobe, Qin Zhang, Robert 
Grassucci, Chandrajit Bajaj, Eric Westhof, Susan Madison-Antenucci, Joachim Frank
342 A Cryo-EM structure of the mammalian ribosomal 43S preinitiation complex
Yaser Hashem, Amedee Des Georges, Vidya Dhote, Robert Langlois, Robert Grassucci, Christopher 
U.T. Hellen, Tatyana V. Pestova, Joachim Frank
343 B Alu RNPs target 40S ribosomal subunits to repress translation initiation
Elena Ivanova, Audrey Berger, Elena Alkalaeva2 Anne Scherrer, Katharina Strub
344 C Interactions of modified oligonucleotides with RNA of the prokaryotic and eukaryotic decoding 
site
Maciej Jasinski, Sapna Thoduka, Ryszard Stolarski, Joanna Trylska
345 A The intimate connection of RNA granules with human 4Es changes with use of different protein 
variants
Klára Kazdová, Katerina Mocová, Tomáš Mašek, Silvia Mrvová, Martin Pospíšek
346 B Crystal structures of the protozoal cytoplasmic A site in complex with aminoglycosides
Jiro Kondo, Mai Koganei
347 C Rrp5 binds the pre-rRNA at multiple sites and is required for ribosomal processing and 
assembly
Simon Lebaron, Åsa Segerstolpe, Sarah French, Sander Granneman, Ann Beyer, Lars Wieslander, 
David Tollervey
348 A Function of Fap7 in the maturation of the ribosome small subunit
Jérôme Loc’h, Magali Blaud, Stéphane Réty, Simon Lebaron, Sander Granneman, David Tollervey, 
Patrick Deschamps, Julie Jombart, Joseph Bareille, Nicolas Leulliot
349 B Molecular characterization of ribosomal E-site function
Nicola Rusca, Nina Clementi, Matthias Erlacher, Norbert Polacek
350 C Evolutionary decline for a nuclear-encoded human mitochondrial aminoacyl-tRNA synthetase
Hagen Schwenzer, Gert Scheper, Nathalie Zorn, Luc Moulinier, Agnès Gaudry, Emmanuelle Leize, 
Franck Martin, Catherine Florentz, Olivier Poch, Marie Sissler
351 A The communication between ribosome biogenesis and cell cycle machinery
Md Shamsuzzaman, Mamata Thapa, Lasse Lindahl
352 B Effect of tRNA core modifications and a D-loop sequence element on ribosomal decoding
Irina Shepotinovskaya, Olke Uhlenbeck
353 C Non-ribosomal Interaction Partners of Ribosomal Protein S3
Tamsyn Stanborough, Barbara Koch, Valentin Mitterer, Johannes Niederhauser, Brigitte Pertschy
354 A Sequence-specific targeting of bacterial ribosomal RNA as a way to look for inhibition pockets
Sapna G. Thoduka, Zofia Dabrowska, Tomasz Witula, Maciej Jasinski, Anna Górska, Joanna Trylska
355 B Molecular pathogenesis of ribosomopaties in zebrafish model for Diamond-Blackfan anemia
Tamayo Uechi, Yukari Nakajima, Hiroko Sonoda, Masahiro keda, Yutaka Suzuki, Sumio Sugano, 
Naoya Kenmochi
356 C Investigating the function of the RNA helicase Prp43 and its cofactor Pfa1 in 40S ribosomal 
subunit synthesis
Stefan Unterweger, Brigitte Pertschy
357 A A New Role for NOT5 of the CCR4-NOT Complex in Connecting Transcription with 
Translation
Zoltan Villanyi, Sujatha Subbana, Olesya Panasenko, Zoltan Pahi, Imre Boros, Martine Collart
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358 B Ribosome biogenesis in plants and its impact on developmental processes
Benjamin Weis, Sandra Missbach, Enrico Schleiff
359 C Going through the motions: Network analysis reveals conserved intramolecular communication 
pathways within EF-Tu responsible for ribosome dependent GTPase activation and nucleotide 
exchange
Hans-Joachim Wieden, Evan Mercier, Fan Mo, Dylan Girodat
360 A Transcription regulation by cAMP-CRP of the rmf gene for 100S ribosome formation
Hideji Yoshida, Tomohiro Shimada, Yasushi Maki, Shou Furuike, Masami Ueta, Chieko Wada, Akira 
Wada, Akira Ishihama
361 B Towards understanding the inhibitory effects of codon-anticodon wobble base pairing on the 
ribosome
Hani Zaher, Rachel Green
Translational Regulation
Abstracts 362–399
362 C One messenger RNA and three initiation codons govern the synthesis of two human Glycyl-
tRNA synthetases isoforms
Jana Alexandrova, Caroline Paulus, Joëlle Rudinger-Thirion, Magali Frugier
363 A A tale of two termini: profiling mRNA 5’-3’ interactions in vivo.
Stuart Archer, Meghna Sobti, Claus Hallwirth, Jenni Yuan, Traude Beilharz, Thomas Preiss
364 B Translation of the human erythropoietin transcript is regulated by an upstream open reading 
frame in response to hypoxia
Cristina Barbosa, Luísa Romão
365 C Nanos recruits the CCR4-NOT complex to induce degradation of mRNA targets
Dipankar Bhandari, Tobias Raisch, Elisa Izaurralde
366 A Study of PTBP1-RRM12 in complex with an RNA-stemloop of the EMCV-IRES
Georg Braach, Christophe Maris, Frédéric H.-T. Allain
367 B CPEB3-controlled translation regulates memory consolidation
Hsu-Wen Chao, Li-Yun Tsai, Yi-Ling Lu, Pei-Yi Lin, Wen-Hsuan Huang, Hsin-Jong Chou, Wen-Hsin 
Lu, Ping-Tao Lee, Yi-Shuian Huang
368 C DDX3 Regulates Rac1 Translation, Modulates Wnt Signaling and Is Required for Cancer Cell 
Metastasis
Hung-Hsi Chen, Hsin-I Yu, Wei-Chih Cho, Woan-Yuh Tarn
369 A Inactivation of the mTORC1-eIF4E Pathway alters Stress Granules Formation
Laëtitia Coudert, Marie-Josée Fournier, Pauline Adjibade, Rachid Mazroui
370 B Identification of DDX6 as a cellular modulator of VEGF expression under hypoxia
Sebastian de Vries, Isabel S. Naarmann-de Vries, Henning Urlaub, Hongqi Lue, Jürgen Bernhagen, 
Antje Ostareck-Lederer, Dirk Ostareck
371 C Molecular characterization of SMG1-UPFs complexes
Aurelien Deniaud, Marcello Clerici1, Simonas Masiulis, Volker Boehm, Niels Gehring, Stephen 
Cusack, Christiane Schaffitzel
372 A Changes in polysomal profiles in cells with aberrant RNA degradation
Zuzana Feketova, Dmytro Ustianenko, Hana Konecna, Zbynek Zdrahal, Stepanka Vanacova
373 B Homeostatic regulation of AMPA receptors in synaptic plasticity: a posttranscriptional interplay 
between Caspr1 and the RNA-binding protein ZBP1.
Dominique Fernandes, Luís Ribeiro, Sandra Santos, Ana Luísa Carvalho
374 C When small non-coding RNAs meet the ribosome: Tuning the translational machinery
Jennifer Gebetsberger, Marek Zywicki, Norbert Polacek
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375 A Observation of mRNA Surveillance in Living Yeast by Ribosome Profiling
Rachel Green, Nicholas R. Guydosh
376 B The connection between mRNA binding by the DEAD-box helicase Ded1p and the kinetics of 
translation initiation.
Ulf-Peter Guenther, Frank Tedeschi, Akshay Tambe, Sarah Geisler, Jeff Coller, Eckhard Jankowsky
377 C Splicing factor SRSF3 represses the translation of Programmed Cell Death 4 mRNA by 
associating with the 5’UTR
Sunjoo Jeong
378 A Activation of HRI Kinase and Translation Control by Oxidative Stress
Bogdan Jovanovic, Georg Stoecklin
379 B Structural basis for translation termination by archaeal RF1 and GTP-bound EF1A complex
Kan Kobayashi, Kazuki Saito, Ryuichiro Ishitani, Koichi Ito, Osamu Nureki
380 C Translation of HTT mRNA with expanded CAGrepeats is regulated by the MID1–PP2A 
proteincomplex
Sybille Krauss, Nadine Griesche, Ewa Jastrzebska, Changwei Chen, Désiree Rutschow, Clemens 
Achmüller, Stephanie Dorn, Sylvia M. Boesch, Maciej Lalowski, Erich Wanker, Rainer Schneider, 
Susann Schweiger
381 A Posttranscriptional control of the DNA damage response through TIAR
Vanesa Lafarga, Johanna Schott, Georg Stoecklin
382 B Human DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translation
Ming-Chih Lai, Shaw-Jenq Tsai, H. Sunny Sun
383 C Exploring the role of the GW182 protein, Gawky (Gw) during early Drosophila melanogaster 
embryogenesis
Jing Li, Andrew Simmonds
384 A Global translational control during norovirus infection
Nicolas Locker, Elizabeth Royall, Lisa Roberts, Majid Al-Sailawi, Azimah Abdul-Wahad, André 
Gerber
385 B Cap-independent translational regulation of mammalian target of rapamycin (mTOR)
Ana Marques-Ramos, Alexandre Teixeira, Rafaela Lacerda, Luísa Romão
386 C NALM-6 acute lymphoblastic leukaemia cell line has elevated level of the subunit b of 
translation initiation factor 3
Silvia Mrvova, Katerina Mocova, Martin Pospisek, Tomas Masek
387 A Caspase-3 cleaves hnRNP K in erythroid differentiation
Isabel S. Naarmann-de Vries, Henning Urlaub, Dirk H. Ostareck, Antje Ostareck-Lederer
388 B Translational regulation of human hemojuvelin expression via upstream open reading frames
Cláudia Onofre, Cristina Barbosa, Luísa Romão
389 C Gene silencing using artificial small RNAs derived from a natural RNA scaffold in Escherichia 
coli
Hongmarn Park, Geunu Bak, Sun Chang Kim, Younghoon Lee
390 A Translation of human LAT2 mRNA is controlled by a short upstream open reading frame
George Perdrizet, Donghui Zhou, Allison Wu, Mariana Pavon, Tao Pan
391 B Regulation of mRNA translation in late-phase activated macrophages
Sonja Reitter, Johanna Schott, Georg Stoecklin
392 C Two Retinoblastoma associated SNVs in RB1 form a RiboSNitch.
Wes Sanders, Matt Halvorsen, Justin Ritz, Joshua Martin, Alain Laederach
393 A Regulation of translation of the most abudant protein in human body, type I collagen.
Branko Stefanovic, Lela Stefanovic, Azariyas Challa, Zarko Manojlovic
394 B Regulation of translation of collagen mRNAs by STRAP
Lela Stefanovic, Milica Vukmirovic, Branko Stefanovic
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395 C Dissecting the regulation of vFLIP expression, a Kaposi’s Sarcoma-associated Herpesvirus 
tumorigenesis factor
Mariam Sulaiman, Margaret Carter, Zulkefley Othman, David Blackbourn, Nicolas Locker, Lisa 
Roberts
396 A The role of human RLI in cell proliferation and translational regulation
Marina Toompuu, Kairi Kärblane, Cecilia Sarmiento, Erkki Truve
397 B Dom34-mediated dissociation of non-translating ribosomes allows efficient restart of translation 
after stress**
Antonia van den Elzen, Bertrand Séraphin
398 C Unravelling the role of dimerization for the STAR-domain RBP, GLD-1
Jane Wright, Lea Dümpelmann, Sanda Mülhäuser, Heinz Gut, Rafal Ciosk
399 A Tdrd7, a RNA binding protein, acts to restrict Epha2 protein synthesis in space and time during 
lens development
Ying Zhang, Richard Maas
3’ end processing
Abstracts 400–414
400 B Alternative polyadenylation in CD2 expression
Inês Boal-Carvalho, Mafalda Pinto, Juliana Miranda, João Relvas, Teresa Summavielle, Alexandre 
Carmo, Alexandra Moreira
401 C Post-transcriptional regulation of COX-2
Ashley Cornett, Carol Lutz
402 A Assessing the “geometry” of the TRAMP and exosome complexes.
Clémentine Delan-Forino, Stepanka Vanacova, David Tollervey
403 B Role of mRNA 3’ processing in the progression of the DNA damage response (DDR)
Emral Devany, Xiaokan Zhang, Mirjana Persaud, Frida Kleiman
404 C Transcriptional and translational profiles in stimulated T lymphocytes
Andreas Gruber, Georges Martin, Philipp Müller, Nitish Mittal, Alexander Schmidt, Walter Keller, 
Jean Pieters, Mihaela Zavolan
405 A Shifting targets: microRNA variants and alternative polyadenylation in cardiac hypertrophy
Carly J. Hynes, David T. Humphreys, Nicola J. Smith, Hardip R. Patel, Robert M. Graham, Jennifer 
L. Clancy, Thomas Preiss
406 B Towards the understanding of the CTD-code
Karel Kubicek, Olga Jasnovidova, Jakub Macosek, Richard Stefl
407 C Enhancer of RNA Interference -1-LIKE-1: One More Player in the RNA Processing Game of 
the Chloroplast
Glykeria Mermigka, Ioannis Vlatakis, Eugenia Vamvaka, Jutta Helm, Heiko Schumacher, Kriton 
Kalantidis
408 A FUS protein interacts with U7 snRNP and plays a role in replication-dependant histone genes 
expression
Katarzyna Dorota Raczynska, Marc David Ruepp, Zofia Szweykowska-Kulinska, Artur Jarmolowski, 
Daniel Schümperli
409 B Mammalian mRNA 3’end formation: is this the end? New insight on CstF64
Valentina Romeo, Daniel Schümperli
410 C The U7 snRNP revisited: a complex of the core U7 snRNP, FLASH and multiple polyadenylation 
factors controls 3’ end processing of histone pre-mRNAs in vertebrates and invertebrates
Ivan Sabath, Aleksandra Skrajna, Xiao-cui Yang, Michal Dadlez, William F. Marzluff, Zbigniew 
Dominski
**Abstract presented as an oral in Plenary Session 1 - Ribosome biogenesis and translation
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411 A A search for new factors involved in 3’ end processing of histone pre-mRNAs: proteins 
interacting with a complex of the conserved stem-loop and the Stem-Loop Binding Protein 
(SLBP) in Drosophila.
Aleksandra Skrajna, Xiao-cui Yang, Ivan Sabath, Michal Dadlez, William F. Marzluff, Zbigniew 
Dominski
412 B Enhancer of RNA Interference -1-LIKE-1: The ERI1 Plant Homologue Involved in the RNA 
Processing Game of the Chloroplast
Ioannis Vlatakis, Glykeria Mermigka, Jutta Helm, Heiko Schumacher, Eugenia Vamvaka, Kriton 
Kalantidis
413 C A triple helix structure is able to functionally replace a poly(A) tail
Jeremy Wilusz, Laura Lu, Phillip Sharp
414 A FPA, a regulator of alternative polyadenylation, is closely associated with cleavage and 
polyadenylation factors in vivo
Vasiliki Zacharaki, Katarzyna Rataj, Gordon Simpson
RNA Turnover
Abstracts 415–446
415 B Regulation of stress granules formation during calicivirus infection
Majid Al-Sailawi, Nicolas Locker, Elizabeth Royall, Lisa Roberts
416 C Exploring the role of mouse DEAH helicase, skiv2l2, in processing and degradation of non 
coding RNAs in neuronal N2A cells using high throughput pA-seq analysis
James Anderson, Jane Dorweiler, Fengchao Wang, Jun Zhu, Stephen Munroe
417 A Molecular genetic exploration of the yeast DEAH helicase, Mtr4, arch domain
James Anderson, Yan Li, Joseph Burclaff
418 B mRNA degradation on the ribosome in Drosophila cells
Sanja Antic, Anna Skucha, Silke Dorner
419 C The NOT2/NOT5 Module of the CCR4-NOT Complex is Required for Assembly of the Exosome
Olesya Bukach, Virginie Ribaud, Geoffroy Colau, Martine Collart
420 A Adipogenesis is efficiently regulated by SMG1 via staufen1-mediated mRNA decay
Hana Cho, Kyoung Mi Kim, Sisu Han, Yoon Ki Kim
421 B Control of mRNA metabolism by deadenylation
Jeff Coller
422 C The structural and functional organization of the TRAMP complex
Sebastian Falk, John Weir, Peter Reichelt, Jendrik Hentschel, Fabien Bonneau, Elena Conti
423 A Control of mRNA decay by Puf proteins regulates ribosome biogenesis
Anthony Fischer, Wendy Olivas
424 B Transcriptome analysis reveals thousands of targets of nonsense-mediated mRNA decay that 
offer clues to the mechanism in human, fish, and fly
Courtney French, Gang Wei, Angela Brooks, Thomas Gallagher, Li Yang, Brenton Gravely, Sharon 
Amacher, Steven Brenner
425 C Retroviral strategies for NMD evasion
Zhiyun Ge, Stacey L. Baker, J. Robert Hogg
426 A Poly(A)-specific ribonuclease (PARN): Mechanisms of processivity and catalysis
Niklas Henriksson, Mikael Nissbeck, Per Nilsson, Magnus Lindell, Samuel Flores, Santhosh Dhanraj,
Hongbing Li, Yigal Dror, Anders Virtanen
427 B DHX34 activates NMD by promoting the transition from the SURF to the DECID complex.
Nele Hug, Oscar Llorca, Javier Caceres
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428 C Identification of novel UPF1 target transcripts by direct determination of whole transcriptome 
stability.
Naoto Imamachi, Hidenori Tani, Kazi Abdus Salam, Rena Mizutani, Takuma Irie, Tetsushi Yada, 
Yutaka Suzuki, Nobuyoshi Akimitsu
429 A RT-qPCR Reference Genes and Potassium Stress Responses in the Haloarchaeon, Haloarcula 
marismortui
Matthew W. Jensen, Scott Matlock, Carlene H. Reinheimer, Andrea Gorrell
430 B Investigation of premature termination codon recognition in nonsense-mediated mRNA decay
Raphael Joncourt, Andrea Eberle, Oliver Mühlemann
431 C Expression of nonsense-mediated decay factors is controlled by conserved feedback loops and 
responds to salt stress in plants
Anil Kesarwani, Gabriele Drechsel, Andreas Wachter
432 A High-resolution characterization of regulatory sequences within a mammalian 3’ UTR
Katla Kristjansdottir, RaeAnna Wilson, Elizabeth Fogarty, Andrew Grimson
433 B Direct Visualization of Alternative RNA Substrate Recruiting Pathways in Yeast Exosome
Jun-Jie Liu, Ailong Ke, Hong-Wei Wang
434 C SMG7 recruits the CCR4-NOT complex for degradation of NMD targets
Belinda Loh, Stefanie Jonas, Elisa Izaurralde
435 A The mRNA quality control factors Ski7 and Hbs1 evolved from an alternatively spliced gene 
that produced Ski7-like and Hbs1-like proteins.
Alexandra N. Marshall, Maria Camila Montealegre, Claudia Jiménez-López, Michael C. Lorenz, 
Ambro van Hoof
436 B Functional analysis of IMP3, a RNA-binding protein
Rena Mizutani, Yutaka Suzuki, Nobuyoshi Akimitsu
437 C Global analysis of exosome target introns
Elina Niemelä, Ali Oghabian, Ger Pruijn, Mikko Frilander
438 A A Novel Role for the Arginine Methyltransferase CARM1 in Nonsense Mediated Decay: 
Implications for Spinal Muscular Atrophy
Gabriel Sanchez, Jocelyn Cote
439 B Assessing differential susceptibility of mRNAs to NMD
Christoph Schweingruber, Oliver Mühlemann
440 C Structural insights into the Dhh1-Pat1 interaction
Humayun Sharif, Sevim Ozgur, Elena Conti
441 A Acetylation of CAF1a and BTG2 accelerates general mRNA degradation
Sahil Sharma, Georg Stoecklin
442 B Mpn1, mutated in poikiloderma with neutropenia protein 1, unveils cellular surveillance of 
catalytic spliceosomal small nuclear RNAs.
Vadim Shchepachev, Charlotte Soneson, Claus M. Azzalin
443 C MKT1: a hub in a post-transcriptional regulatory network
Aditi Singh, Igor Minia, Dorothea Droll, Abeer Fadda, Esteban Erben, Christine Clayton
444 A Structural basis for the multiple roles Edc3 plays in mRNA degradation
Remco Sprangers, Simon Fromm, Charlotte Meylan, Niklas Hoffmann, Anna-Lisa Fuchs, Vincent 
Truffault
445 B CBP1 mRNA is cleaved and produces nonstop mRNA in a tRNA splicing endonuclease activity 
dependent manner
Tatsuhisa Tsuboi, Yutaka Suzuki, Tohru Yoshihisa, Toshifumi Inada
446 C Enriched density of UPF1 in 3’ untranslated regions results from its translation-dependent 
displacement from coding sequences
David Zünd, Andreas Gruber, Mihaela Zavolan, Oliver Mühlemann
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RNA Editing and Modification
Abstracts 447–473
447 A Activation of RNA cap methylation by CDK1
Michael Aregger, Victoria H. Cowling
448 B An emerging role for double-stranded RNA binding domains: regulating the sub-cellular 
localization of proteins
Pierre Barraud, Silpi Banerjee, Stephan Emmerth, Weaam Ibrahim, Katrina Woolcock, Marc Bühler, 
Michael Jantsch, Frédéric Allain
449 C Revealing the full scope of Alu editing - over a hundred million genomic sites are subject to 
primate-specific A-to-I RNA editing
Lily Bazak, Ami Haviv, Michal Barak, Jasmine Jacob-Hirsch, Karen Kesarcas, Gideon Rechavi, Jin 
Billy Li, Erez Y. Levanon, Eli Eisenberg
450 A A Hundred million sites located in majority of human genes are subject to A-to-I RNA editing
Lily Bazak, Ami Haviv, Michal Barak, Jasmine Jacob-Hirsch, Karen Kesarcas, Gideon Rechavi, Jin 
Billy Li, Erez Y. Levanon, Eli Eisenberg
451 B MODOMICS: a database of RNA modification pathways - new developments
Janusz Bujnicki, Magdalena Machnicka, Kaja Milanowska, Kristian Rother, Mark Helm, Henri 
Grosjean, Elzbieta Purta, Okan Osman Oglou4 Malgorzata Kurkowska, Anna Olchowik, Witold 
Januszewski, Stanislaw Dunin-Horkawicz, Pawel Piatkowski, Sebastian Kalinowski
452 C Alu inverted repeats induce human specific site selective A-to-I RNA editing
Chammiran Daniel, Gilad Silberberg, Marie Öhman
453 A Identifying the function of highly conserved residues for pseudouridine formation through a 
combination of in silico and in vitro studies
Jenna Friedt, Fern Leavens, Evan Mercier, Hans-Joachim Wieden, Ute Kothe
454 B Identification of the last rRNA methylase YhiR E.coli using a new technique
Anna Golovina, Margarita Dzama, Petr Sergiev, Olga Dontsova
455 C RAM: a novel and essential component of RNA cap methylation
Thomas Gonatopoulos-Pournatzis, Victoria H. Cowling
456 A Conserved circuitry in eukaryotes for crucial Trm7 modifications of the tRNA anticodon loop
Michael Guy, Eric Phizicky
457 B Structural and Functional Analysis of Archaeal ATP-dependent RNA Ligase.
Kiong Ho, Huiqiong Gu, Yuko Takagi, Katsuhiko Murakami
458 C Consequences of FilaminA editing
Mamta Jain, Maja Stulic, Dieter Pullirsch, Michael Jantsch
459 A 2´-SCF3 Modified Pyrimidine Nucleosides as Labels for Probing RNA Structure and Function 
by 19F NMR Spectroscopy
Marija Košutic, Katja Fauster, Christoph Kreutz, Ronald Micura
460 B A Quantitative Atlas of RNA Editing in Mammals Reveals Dynamic Spatiotemporal Regulation
Jin Billy Li, Meng How Tan, Robert Piskol
461 C A single-molecule study on the molecular mechanism of microRNA uridylation
Luuk Loeff, Kyu-Hyeon Yeom, Mohamed Fareh, V. Narry Kim, Chirlmin Joo
462 A Structural features of Cbf5 and guide RNA involved in the functions of archaeal box H/ACA 
RNP complexes
Mrinmoyee Majumder, Ramesh Gupta
463 B The role of ADAR1 in the innate immune response
Niamh Mannion, Sam Greenwood, Xianghua Li, Mary O’Connell
464 C Functional implications from the atomic model of the poly(U) polymerase Cid1
Paola Munoz-Tello, Caroline Gabus, Stephane Thore
liv
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465 A tRNA wobble uridine hypomodification decreases the decoding efficiency of cognate codons in vivo
Danny D. Nedialkova, Sebastian A. Leidel
466 B Localization of ADAR1 to cytoplasmic stress granules
Siew Kit Ng, Rebekka Weissbach, Deirdre Scadden
467 C A Comprehensive Analysis of RNA Modifying Enzymes in Zebrafish
Marion Pesch, Erez Raz, Jana Pfeiffer, Ursula Jordan, Sebastian Leidel
468 A Differential expression of Human ADAT subunits
Adrián Gabriel Torres, Adélaïde Saint-Leger, Francisco Miguel Torres, Eva Maria Novoa, Anna Tor, 
Lluís Ribas de Pouplana
469 B RNA methylation: a mechanism for post-transcriptional regulation that is deregulated in cancer?
Tennille Sibbritt, Hardip Patel, Brian Parker, David Humphreys, Jeffrey Squires, Susan Clark, Thomas 
Preiss
470 C Engineered guideRNA-Dependent Deaminases - A Tool to Modify mRNA
Thorsten Stafforst, Marius Schneider
471 A Impact of inverted SINEs on gene expression
Mansoureh Tajaddod, Konstantin Licht, Florian Huber, Michael Jantsch
472 B RNA-binding proteins regulate substrate-specific changes in A to I editing patterns
Aamira Tariq, Wojciech Garncarz, Oliver Pusch, Ales Balik, Michael Jantsch
473 C Enzymes involved in human cap structure formation: their structure and function
Maria Werner, Miroslaw Smietanski, Elzbieta Purta, Katarzyna H. Kaminska, Janusz Stepinski, 
Edward Darzynkiewicz, Marcin Nowotny, Janusz M. Bujnicki
Splicing Mechanisms
Abstracts 474–488
474 A Genetic analysis of the Prp28-bypass mutant reveals further insights on U1 snRNP/5’ splice site 
interaction
Shang-Lin Chang, Tien-Hsien Chang
475 B Chemical tools for investigating alternative RNA splicing
Sara De Ornellas, Ian Eperon, Glenn Burley
476 C Biophysical characterization of the recombinant S. cerevisiae Lsm2-8 complex
Elizabeth Dunn, Trushar Patel, Richard Fahlman, Calvin Yip, Sean McKenna, Stephen Rader
477 A smFRET studies of U6 during spliceosome activation in budding yeast
Megan Mayerle, John Abelson, Christine Guthrie
478 B Role of U2 stem IIb in splicing progression
Alberto Moldon, Charles Query
479 C Conserved Slu7 motif confers the preference for distal splice sites in yeast
Eva Nicova, Katerina Abrhamova, Ondrej Gahura, Vanda Munzarova, Frantisek Puta, Petr Folk
480 A Prp8-substrate interactions in yeast spliceosomes
Christine Norman, Andy Newman, Kiyoshi Nagai
481 B Identification of new natural compounds that modulate splicing in vitro and in cells
Andrea Pawellek, Ursula Ryder, Angus Lamond
482 C A new role for U2 snRNA in alternate 3’ ss selection
Jorge Pérez-Valle, Josep Vilardell
483 A BRAF branch point mutation confers Vemurafenib resistance
Maayan Salton, Ty Voss, Poulikos Poulikakos, Tom Misteli
484 B Conservation of  U2  protein – branch site interactions between yeast and human, as 
investigated by  UV crosslinking
Cornelius Schneider, Klaus Hartmuth, Dmitry Agafonov, Patrizia Fabrizio, Reinhard Lührmann
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485 C Identification of small molecule pre-mRNA splicing inhibitors using a stage-specific, high-
throughput in vitro splicing assay
Anzhela Sidarovich, Timur R. Samatov, Sonja Sievers, Cindy L. Will, Henning Urlaub, Reinhard 
Lührmann, Herbert Waldmann
486 A Localization of the pre-mRNA path in the activated yeast spliceosome by immuno-EM
Chengfu Sun, Norbert Rigo, Patrizia Fabrizio, Berthold Kastner, Reinhard Luehrmann
487 B Functional and structural analysis of Cwc25 required for first-step splicing
Hui-Fang Wang, Chi-Kang Tseng, Ting-Wei Chiang, Soo-Chen Cheng
488 C The G patch protein Spp2 couples Prp2-mediated ATP hydrolysis to catalytic activation of the 
yeast spliceosome
Zbigniew Warkocki, Jana Schmitzová, Claudia Höbartner, Patrizia Fabrizio, Reinhard Lührmann
Splicing Regulation
Abstracts 489–529
489 A Chromatin affects the splicing efficiency by regulating the U2snRNP activity
Eric Allemand, Michael P. Myers, Jose Garcia-Bernado, Annick Harel-Bellan, Adrian R. Krainer, 
Christian Muchardt
490 B The Evolutionary Landscape of Alternative Splicing and its Regulation in Vertebrate Species
Nuno Barbosa-Morais, Qun Pan, Manuel Irimia, Serge Gueroussov, Eesha Sharma, Emil Nachman, 
Hui Xiong, Leo Lee, Valentina Slobodeniuc, Claudia Kutter, Stephen Watt, Recep Çolak, TaeHyung 
Kim, Christine Misquitta-Ali, Michael Wilson, Philip Kim, Duncan Odom, Brendan Frey, Benjamin 
Blencowe
491 C TNF influences alternative stop codon usage in DAPK mRNA
Natalya Benderska, Stefan Stamm, Regine Schneider-Stock
492 A PTB regulates the alternative splicing of the apoptotic gene BCL-X
Pamela Bielli, Matteo Bordi, Claudio Sette
493 B The many lives of Co-transcriptional Splicing
Mattia Brugiolo, Lydia Herzel, Karla Neugebauer
494 C Alternative splicing in the regulation of the barley circadian clock
Cristiane Calixto, Robbie Waugh, John Brown
495 A The Nuclear Matrix Protein Matrin 3 is a Regulator of Alternative Splicing
Miguel Coelho, Melis Kayikci, Nicolas Bellora, Jernej Ule, Eduardo Eyras, Christopher Smith
496 B Damage-induced alternative splicing in MDM2: Identifying cis elements and trans factors
Daniel Comiskey, Ravi Singh, Aixa Tapia-Santos, Dawn Chandler
497 C H3K9me3 and its role in pre-mRNA splicing.
Eva Duskova, Martina Huranova, Fernando Carrillo Oesterreich, David Stanek
498 A Is Prp16 remodelling of helix I during the two steps of pre-mRNA splicing carried out through 
the Nineteen Complex protein Cwc2?
Rogerio de Almeida, Dharshika Pathiranage, Rebecca Hogg Hogg, Raymond O’Keefe
499 B Selective constraint on mRNA splicing pattern by protein structural requirement
Jean-Christophe Gelly, Hsuan-Yu Lin, Alexandre G. de Brevern, Trees-Juen Chuang, Feng-Chi Chen
500 C Alternative splicing and gene expression in cardiomyocytes and cardiac fibroblasts during 
development
Jimena Giudice, Zheng Xia, Marissa Ruddy, Wei Li, Thomas A. Cooper
501 A Assessing influence of mutations in first nucleotides of exons on splicing of the BTK and 
SERPING1 genes.
Lucie Grodecká, Pavla Lockerová, Barbora Ravcukova, Emanuelle Buratti, Francisco Baralle, Tomas 
Freiberger
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502 B Investigating the role of PTBP1 alternative exon 9 in the evolution of lineage-specific alternative 
splicing in vertebrates
Serge Gueroussov, Jean-Philippe Lambert, Nuno Barbosa-Morais, Anne-Claude Gingras, Benjamin 
Blencowe
503 C Prp45 affects early stage of spliceosome assembly and pre-mRNA abundance in yeast
Martina Hálová, Ondrej Gahura, Zdenek Cit, Tomáš Dráb, Anna Valentová, Katerina Abrhámová, 
František Puta, Petr Folk
504 A SR proteins regulate from cellular environment dependent splicing
Egle Jakubauskiene, Laurynas Vilys, Lorenz Poellinger, Yuichi Makino, Arvydas Kanopka
505 B High-resolution Rbfox2 binding patterns predict widespread splicing regulation in mouse 
embryonic stem cells
Mohini Jangi, Paul Boutz, Phillip Sharp
506 C Elucidation of UP1 binding to RNA substrates: Does RNA structure matter?
Jeffrey Levengood, Carrie Rollins, Michele Tolbert, Blanton Tolbert
507 A Thailanstatins: New Pre-mRNA Splicing Inhibitors and Potent Antiproliferative Agents 
Discovered from Burkholderia thailandensis MSMB43
Xiangyang Liu, Sreya Biswas, Michael Berg, Christopher Antapli, Gideon Dreyfuss, Yi Q. “Eric” 
Cheng
508 B Effects of SR Protein Expression on HIV-1 Splicing
Le Luo, Alan Cochrane, Blanton Tolbert
509 C Real-time kinetics of human pre-mRNA splicing
Robert Martin, José Rino, Célia Carvalho, Tomas Kirchhausen, Maria Carmo-Fonseca
510 A Sex-specific alternative splicing in the head of Drosophila melanogaster and its underlying 
regulatory mechanisms
Carmen Mohr, Marco Blanchette Blanchette, Britta Hartmann
511 B Structural investigation of hnRNP G interaction with SMN RNA
Ahmed Moursy, Antoine Clery, Frederic Allain
512 C A highly conserved GC-rich element regulates alternative splicing of mRNA for the variant 
thyroid hormone receptor TRα2
Stephen Munroe
513 A The centrosomal kinase NEK2 is a novel splicing factor kinase
Chiara Naro, Federica Barbagallo, Paolo Chieffi, James Stevenin, Maria Paola Paronetto, Claudio 
Sette
514 B Reconstructing alternative splicing of SMN exon 7 by NMR, SRM-Mass-Spectrometry and 
mathematical modeling
Yaroslav Nikolaev, Martin Soste, Paola Picotti, Dagmar Iber, Frederic Allain
515 C Comprehensive Mapping of the Splicing Regulatory Circuitry Involved in Cell Proliferation and 
Apoptosis
Panagiotis Papasaikas, Juan Ramon Tejedor, Luisa Vigevani, Juan Valcarcel
516 A Functional characterization of the RNA-binding protein Acinus: its role in pre-mRNA 
processing and apoptosis
Julie Rodor, Magdalena Maslon, Javier Caceres
517 B Widespread regulatory functions of Polypyrimidine Tract-Binding Proteins in splicing and 
development of Arabidopsis thaliana
Christina Rühl, André Kahles, Gabriele Wagner, Gabriele Drechsel, Gunnar Rätsch, Andreas Wachter
518 C hnRNP A1 promotes exon 6 inclusion of apoptotic Fas gene.
Haihong Shen
lvii
Posters labeled with an “A” present Wednesday, June 12, 20:00 – 22:30
Posters labeled with an “B” present Friday, June 14, 20:00 – 22:30
Posters labeled with an “C” present Saturday, June 15, 14:00 – 17:00
519 A Unusual evolutionary insertion of G-tracts creates splice variants of distinct localization and 
function in human cells
Muhammad Sohail, Wenguang Cao, Sam Kung, Lisheng Wang, Eftekhar Eftekharpour, Jiuyong Xie
520 B Mechanisms regulating alternative splicing of Dscam
Matthias Soller, Irmgard Haussmann, Yash Hemani, Pinar Ustaoglu
521 C A Role for the Polyadenosine Binding Protein, Nab2, in Splicing and Quality Control
Sharon Soucek, Megan Bergkessel, Deepti Bellur, Christine Guthrie, Jonathan Staley, Anita Corbett
522 A Prp40p WW Domain is Critical for Splicing of Introns Containing Non-canonical Branch Site 
Sequences in Saccharomyces cerevisiae
Luh Tung, Chung-Shu Yeh, Fu-Lung Yeh, Hsuan-Kai Wang, Jeffrey A Pleiss, Tien-Hsien Chang
523 B Muscleblind and Fox proteins cooperate to change a splicing program involved in stem cell 
differentiation and maintenance.
Julian P Venables, Laure Lapasset, Gilles Gadea, Philippe Fort, Roscoe Klinck, Emmanuel Vignal, 
Panagiotis Prinos, Benoit Chabot, Sherif Abou Elela, Pierre Roux, Jean-Marc Lemaitre, Jamal Tazi
524 C SWI/SNF regulates alternative trans-splicing of the mod(mdg4) gene
Johan Waldholm, Simei Yu, Stefanie Böhm, Neus Visa
525 A Splice-sensitive array profiling suggests a role for STAR proteins and PTB in control of smooth 
muscle cell alternative splicing.
Selina Xiao Wang, Martina Hallegger, Clare Gooding, Adrian Buckroyd, Miriam Llorian, Nicolas 
Bellora, Eduardo Eyras, Melis Kayikci, Jernej Ule, Christopher Smith
526 B EJC can regulate alternative splicing in mammalian cells
Zhen Wang, Valentine Murigneux, Hervé Le Hir
527 C The Ribosome-OME II:  Alternative Splicing for Ribosomal Proteins?
Jonathan R Warner
528 A hnRNP A1 and Secondary Structure Coordinate Alternative Splicing of Mag
Ruth Zearfoss, Emily Johnson, Sean Ryder
529 B Regulation of alternative splicing by QKI protein in lung cancer
Fengyang Zong, Xing Fu, Feng Wang, Wenjuan Wei, Lijuan Cao, Hongbin Ji, Jingyi Hui
RNA-Protein Interactions
Abstracts 530–579
530 C Site-Specific Intercalation of Doxorubicin Disrupts the Iron-Responsive Element RNA – Iron 
Regulatory Protein Interaction
Luigi Alvarado, Kyle Eggleston, Sam Lin, Virginia Smith, Adegboyega Oyelere, Kwaku Dayie
531 A Defining a eukaryotic core mRNA interactome:  the landscape of RNA-binding proteins in yeast 
and its conservation in mammals
Benedikt Beckmann, Alfredo Castello, Bernd Fischer, Rastislav Horos, Claudia Strein, Katrin 
Eichelbaum, Sophia Föhr, Thomas Preiss, Lars Steinmetz, Jeroen Krijgsveld, Matthias Hentze
532 B Regulation of human telomerase by the helicase RHAU, a quadruplex resolvase.
Evan Booy, Markus Meier, Trushar Patel, Ryan Howard, Natalie Okun, Oksana Marushchak, Jörg 
Stetefeld, Sean McKenna
533 C In vivo dynamics of SR protein-RNA interactions
Serena Capozi, Eugenia Basyuk, Antoine Cléry, Frédéric Allain, Edouard Bertrand
534 A GOLLD: a large, structured, noncoding RNA from bacteria and bacteriophages
Andy Chen, Ronald Breaker
535 B Dynamic transition upon protein-RNA complex formation: PTB RRM1 interaction with an 
IRES stem-loop
Fred F. Damberger, Christophe Maris, Frédéric H.-T. Allain, Sapna Ravindranathan
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536 C AURA 2.0: empowering post-transcriptional regulatory networks discovery
Erik Dassi, Toma Tebaldi, Angela Re, Sara Leo, Daniele Peroni, Luigi Pasini, Alessandro Quattrone
537 A The QUA2 domain of GLD-1 recognizes an additional nucleotide and modulates RNA binding 
affinity
Gerrit Daubner, Stefan Gerhardy, Frédéric Allain
538 B Control of Mammalian Germ Cell Differentiation by the RNA-Binding Protein DAZL
Renaud Desgraz, Katherine Romer, David C Page
539 C Structural and Dynamic Investigation on ETR-3 RRMs and their Interaction with AU-rich 
RNAs
Nana Diarra dit Konte, Frederic Allain
540 A Interactions between RBFOX2 and pre-microRNA-20b terminal loop
Afzal Dogar, Julian Zagalak, Moritz Stoltz, Harry Towbin, Michel Erich, Frédéric Allain, Jonathan 
Hall
541 B RNA-binding protein EWSR1 regulates CCDC6
Sujitha Duggimpudi, Erik Larrson, Arndt Borkhardt, Jessica Hoell
542 C Dead End, a protein counteracting miRNA-mediated repression of tumour suppressor genes, 
contains non-canonical RNA binding domains
Malgorzata Duszczyk, Frédéric Allain
543 A Potential substrates of the RNase MRP complex in cell cycle regulation
Franziska Eckmann, Anika Wehrle, Anika Salfelder, Romy Keppler, Ekkehart Lausch, Bernhard Zabel
544 B Post-transcriptional regulation of SMN2 expression by hnRNP G and LARP Family proteins
Ana Miguel Fernandes, Ana Luísa Gomes, Mariana Oliveira, Gonçalo Costa, Isabel Peixeiro, Ana 
Margarida Matos, Carlos Cordeiro, Margarida Gama-Carvalho
545 C Characterization of the potential role for RNA-binding protein FUS/TLS in DNA damage 
response: A quantitative proteomic approach
Giuseppe Filosa, Marc-David Ruepp, Carolina Lenzken, Alessia Loffreda, Oliver Mühlemann, Angela 
Bachi, Silvia Barabino
546 A A novel PAR-CLIP based approach using RRM mutations reveals RNA recognition mechanisms 
of HuR
Matthew Friedersdorf, Jack Keene
547 B The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a 
DNA element
Junichi Fukunaga, Yusuke Nomura, Ryo Amano, Yoichiro Tanaka, Taku Tanaka, Yoshikazu 
Nakamura, Gota Kawai, Tomoko Kozu, Taiichi Sakamoto
548 C Predicting RNA-Protein Interactions: The Hunt for the Code of Recognition
Christian Garde, Jan Gorodkin, Christopher T. Workman
549 A Testing Protein Sequestration Candidates for RNA-Mediated Disease
Marianne Goodwin, Apoorva Mohan, Maurice Swanson
550 B Computational study of interactions between amino acids and nucleobases in aqueous solvent
Matea Hajnic, Juan Osorio Iregui, Thomas Malzac, Bojan Zagrovic
551 C Codon-usage effects and functional characterization of physicochemical complementarity 
between mRNA and cognate protein sequences
Mario Hlevnjak, Lily Chan, Anton A. Polyansky, Bojan Zagrovic
552 A Establishment of a Fluorescence Cross Correlation Spectroscopy (FCCS) based assay to 
measure Argonaute – siRNA interaction
Leonhard Jakob, Michael Hannus, Stefan Hannus, Gunter Meister
553 B Post-transcriptional control of macrophage activation by HuR.
Panagiota Kafasla, Orsalia Hazapis, Martin Reczko, Dimitris Kontoyiannis
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554 C Repetitive RNA unwinding of a single RNA helicase A
Hye Ran Koh, Li Xing, Lawrence Kleiman, Sua Myong
555 A The RNA-binding Protein Repertoire of Embryonic Stem Cells
S. Chul Kwon, Hyerim Yi, Katrin Eichelbaum, Sophia Föhr, Bernd Fischer, Kwon Tae You, Tuan Anh 
Nguyen, Alfredo Castello, Jeroen Krijgsveld, Matthias W. Hentze, V. Narry Kim1
556 B Drosophila Gemin5 binds to UsnRNAs and another specific group of ncRNAs
Sheila SK Li, Jonathan PY Lau, Tinyi Chu, Brian Qin, Ting-Fung Chan, Terrence CK Lau
557 C RBP atlas: an exploration of interactions between mRNA and proteins and their impact on 
cardiomyocyte biology
Yalin Liao, Alfredo Castello, Sophia Foehr, Stefan Leicht, Rastislav Horos, Jeroen Krijgsveld, 
Matthias Hentze, Thomas Preiss
558 A Multifunctional interleukin-6 receptor aptamers
Eileen Magbanua, Ulrich Hahn
559 B Neurodegenerative diseases: quantitative predictions of protein-RNA interaction
Domenica Marchese, Davide Cirillo, Gian Gaetano Tartaglia
560 C RNA helicase function in yeast ribosome biogenesis
Roman Martin, Philipp Hackert, Maike Ruprecht, Stefan Simm, Enrico Schleiff, Markus Bohnsack
561 A Knock-out mice and HITS-CLIP reveal that the SGs assembly factor G3BP preferentially binds 
intron-retaining transcripts and controls their stability in the brain
Sophie Martin, Juan Gonzáles-Vallinas, Nicolas Bellora, Manuel Irimia, Latifa Zekri, Alexandra 
Metz, Karim Chebli, Michel Vignes, Eduardo Eyras, Javier F Caceres, Ben J Blencowe, Jamal Tazi
562 B A co-evolution network of binding contacts between protein L25 and 5S rRNA
Zhichao Miao, Eric Westhof
563 C Mechanism of action of the CCCH zinc finger protein TbZC3H11 upon heat shock
Igor Minia, Dorothea Droll, Aditi Singh, Christine Clayton
564 A Sequence specific code in RRM–RNA interactions
Martyna Nowacka, Stanislaw Dunin-Horkawicz, Kama Wojcik, Janusz Bujnicki
565 B Regulation of mRNA metabolism by U2AF65 splicing factor - novel mechanisms for the 
coordination of gene expression?
Isabel Peixeiro, Samuel Casaca, Margarida Gama-Carvalho
566 C Division of labor: separation of loading and unwinding units in an oligomer of the DEAD-box 
helicase Ded1p
Andrea Putnam, Huijue Jia, Fei Liu, Eckhard Jankowsky
567 A Manipulating endogenous RNAs with synthetic RNA-binding proteins
Oliver Rackham, MF Razif, KK Nygård, TS Chia, ME Hibbs, SM Davies, I Small, A Filipovska
568 B Imbalance of Zfp36l2-RNA-binding protein results in female infertility
Silvia Ramos
569 C Structure-specific RNase footprinting in multiple cell types reveals protein-binding sites 
throughout the human transcriptome
Ian Silverman, Fan Li, Anissa Alexander, Daniel Beiting, Nur Selamoglu, Fevzi Daldal, Brian 
Gregory
570 A Architecture of catalytic complexes essential for synthesis and co-translational insertion of 
selenocysteine in humans
Miljan Simonovic, Rachel Schmidt, Malgorzata Dobosz-Bartoszek
571 B hnRNP A1 Interacts with Conserved RNA IRES Elements in Enterovirus 71
Michele Tolbert, Jeffery Levengood, Mei-Ling Li, Blanton Tolbert
572 C Human DIS3L2 exonuclease is involved in the processing of tRNA-derived small RNAs
Dmytro Ustianenko, Biter Bilen, Katerina Chalupnikova, Zuzana Feketova, Georges Martin, Mihaela 
Zavolan, Stepanka Vanacova
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573 A HIV Nucleocapsid Protein Precursors are Effective Nucleic Acid Chaperone Proteins
Wei Wang, Mithun Mitra, Robert Gorelick, Zhengrong Wu, Karin Musier-Forsyth
574 B Tethered Domains and Flexible Regions in tRNase ZL, the Long Form of tRNase Z
Christopher Wilson, Emmanuel Chang, Louis Levinger
575 C Poly(A) binding protein 1 and formation of processing bodies in human
Jingwei Xie, Guennadi Kozlov, Kalle Gehring
576 A Crystal structure of the active conformation of the Shigella flexneri VapC toxin at 1.9 Å 
resolution
Kehan Xu, Emil Dedic, Patricia Cob-Cantal, Christian Dienemann, Andreas Bøggild, Kristoffer S. 
Winther, Kenn Gerdes, Ditlev Brodersen
577 B Alanine scanning of the aa-tRNA binding interface of Escherishia coli EF-Tu
Emine Yikilmaz, Olke Uhlenbeck
578 C Evidence of direct complementary binding between mRNAs and cognate proteins
Bojan Zagrovic, Mario Hlevnjak, Anton Polyansky
579 A Responses of the mRNA interactome to genotoxic stress
Elisabeth Zielonka, Alfredo Castello, Benedikt Beckmann, Rastislav Horos, Anne-Marie Alleaume, 
Claudia Strein, Sophia Foehr, Bernd Fischer, Jeroen Krijgsveld, Matthias Hentze
RNP Structure, Function and Biosynthesis
Abstracts 580–598
580 B A genome-wide RNAi screen identifies novel 40S ribosome synthesis factors in human cells
Lukas Badertscher, Thomas Wild, Lukas Bammert, Michael Stebler, Andreas Vonderheit, Christian 
Montellese, Karol Kozak, Gábor Csúcs, Peter Horvath, Ulrike Kutay
581 C Characterization and in vivo functional analysis of the Schizosaccharomyces pombe ICln gene
Adrien Barbarossa, Henry Neel, Etienne Antoine, Thierry Gostan, Johann Soret, Remy Bordonne
582 A Dissecting RNA-binding protein complexes
Anne Baude, Kristin Wächter, Stefan Hüttelmaier
583 B Reconstitution of the Uridine-rich snRNP Assembly Machinery
Clemens Englbrecht, Nils Neuenkirchen, Ashwin Chari, Jürgen Ohmer, Utz Fischer
584 C Ribosomal protein clusters orchestrate the hierarchical construction of eukaryotic large 
ribosomal subunit structural domains in vivo
Michael Gamalinda, Uli Ohmayer, Jelena Jakovljevic, Beril Kumcuoglu, Philipp Milkereit, John 
Woolford, Jr.
585 A 5’-cytosine methylation of C2278 in 25S rRNA stabilizes 60S ribosomal subunit in yeast
Andriana Halacheva, Martin Koš
586 B Identification of a chloroplast ribonucleoprotein complex containing trans-splicing factors, 
intron RNAs and novel components
Jessica Jacobs, Christina Marx, Vera Kock, Olga Reifschneider, Stephanie Glanz, Ulrich Kück
587 C The structural organization of the box C/D sRNP
Audrone Lapinaite, Bernd Simon, Frank Gabel, Magdalena Rakwalska-Bange, Teresa Carlomagno
588 A Budding yeast telomerase RNA: Zooming in for more definition of a large RNA.
Nancy Laterreur, Isabelle Dionne, Jean-François Noël, Stephanie Larose, Raymund Wellinger
589 B Characterisation of the human UTP-B complex and its role in ribosome biogenesis
Matthias S. Leisegang, Carmen Doebele, Ana S. Ramirez, Katherine E. Sloan, Stefan Simm, Enrico 
Schleiff, Michael Karas, Nicholas J. Watkins, Markus T. Bohnsack
590 C Messenger Ribonucleoprotein Assembly Requires the DEAD-box Protein Dbp2 and Enzymatic 
Modulation by Yra1
Wai Kit Ma, Sara Cloutier, Elizabeth Tran
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592 B Structural basis of Brr2-Prp8 interaction and its implications for Retinitis Pigmentosa disease 
type 13 and U5 snRNP biogenesis
Thi Hoang Duong Nguyen, Jade Li, Wojciech P Galej, Hiroyuki Oshikane, Andrew J Newman, 
Kiyoshi Nagai
593 C Surveillance of spliceosomal snRNP assembly in the cell nucleus
Ivan Novotny, Daniel Mateju, Martin Sveda, Zdenek Knejzlik, David Stanek
594 A Implication of the SMN complex in the biogenesis and steady state level of the Signal 
Recognition Particle
Nathalie Piazzon, Florence Schlotter, Suzie Lefebvre, Maxime Dodré, Agnès Mereau, Johann Soret, 
Aurore Besse, Martine Barkats, Rémy Bordonné, Séverine Massenet, Christiane Branlant
595 B The rRNA methyltransferase Bud23 interacts with the DEAH-box RNA helicase Ecm16 to 
promote cleavage at A2
Richa Sardana, Arlen Johnson
596 C The 5S RNP couples ribosome production to p53 regulation
Katherine Sloan, Nicholas Watkins
597 A Dissecting the splicing-dependent mRNA binding of ASAP complexes
Anna-Lena Steckelberg, Niels H. Gehring
598 B The Ribosome-OME I: Big Data & the Ribosome
Jonathan R Warner, Varun Gupta
Riboregulation in Development
Abstracts 599–600
599 C Cytoplasmic RNA regulatory networks orchestrate male gametogenesis
Ryuji Minasaki, Christina Hirsch, Christian Eckmann
600 A PX1 regulates protoxylem cell fate via RNA processing
Kamil Ruzicka, Ana Campilho, Sedeer El-Showk, Dominique Eeckhout, Geert De Jaeger, Jan 
Hejatko, Mikko Frilander, Yka Helariutta
RNA Transport and Localization
Abstracts 601–609
601 B Hepatitis B virus post-transcriptional element promotes mRNA export via the cellular mRNA 
export machinery TREX
Binkai Chi, Hong Cheng
602 C Insights into the nuclear mRNA export machinery of Trypanosoma brucei
Anna Dostalova, Sandro Käser, Marina Cristodero, Bernd Schimanski
603 A Assembly of TREX complex components on mRNAs
Agnieszka M. Gromadzka, Niels Gehring
604 B Growth cone local mRNA translation of nuclear proteins in the spatio-temporal regulation of 
neurite outgrowth
Francesca Moretti, Olivier Pertz
605 C Genome-wide identification of mRNAs associated with Survival of Motor Neuron proteins and 
whose axonal localization is decreased upon SMN deficiency
Florence Rage, Nawal Boulisfane, Rihan Khalil, Henry Neel, Thierry Gostan, Remy Bordonne, 
Johann Soret
606 A Tetramolecular Fluorescence Complementation for Detection of Specific RNAs in Vitro
Anna K. Rath, Stefanie J. Kellermann, Andrea Rentmeister
607 B Resolving conflicts between Transcription and Replication: a new potential role for the mRNA 
export factor Yra1, regulated by its post-translational modifications.
Evelina Tutucci, Noël Yeh Martin, Valentina Infantino, Benoît Palancade, Françoise Stutz
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608 C Ubiquitin and SUMO regulate Yra1: linking mRNA export factor to genome stability
Evelina Tutucci, Benoit Palancade, Noel Yeh Martin, Valentina Infantino, Françoise Stutz
609 A mRNA transport and translation regulate neuritogenesis
Hsin-I Yu, Hung-Hsi Chen, Wei-Chih Cho, Woan-Yuh Tarn
RNAs in Diseases
Abstracts 610–643
610 B S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1
Vered Ben-Hur, Polina Denichenko, Zahava Siegfried, Avi Maimon, Adrian Krainer, Ben Davidson, 
Rotem Karni
611 C Altered microRNA expression profile in ALS: Role in the regulation of NFL mRNA levels
Danae Campos-Melo, Cristian Droppelmann, Kathryn Volkening, Michael J. Strong
612 A Novel TAL1 targets beyond protein coding genes:  identification of TAL1-regulated microRNA 
genes in T-cell acute lymphoblastic leukemia
Nádia C. Correia, Francisco J. Enguita, Frank Speleman, João T Barata
613 B Retinitis pigmentosa mutations of hBrr2 reduce splicing fidelity
Zuzana Cvacková, Daniel Mateju, David Stanek
614 C An Exon-Specific U1 approach to correct SMN protein deficiency in spinal muscular atrophy 
(SMA)
Andrea Dal Mas, Erica Bussani, Malgorzata Rogalska, Franco Pagani
615 A Ddx5/Ddx17 RNA helicases control multiple layers of gene expression during TGFβ-induced 
Epithelial-to-Mesenchymal Transition (EMT)
Etienne Dardenne, Fattet Laurent, Mathieu Deygas, Micaela Polay-Espinoza, Cyril Bourgeois, Ruth 
Rimokh, Didier Auboeuf
616 B Overexpression of miR-29b and miR-122 in the invasive ductal carcinoma of the breast
Patricia R Darin, Juliana S Zanetti, Alfredo Ribeiro-Silva, Fernando L De Lucca
617 C The RNA binding protein Quaking regulates monocyte adhesion and differentiation
Ruben de Bruin, Janine van Gils, Hetty de Boer, Jacques Duijs, Erik Biessen, Ton Rabelink, Lily 
Shiue, Manuel Ares Jr, Anton Jan van Zonneveld1 Eric van der Veer
618 A Rho Guanine Nucleotide Exchange Factor: A Novel RNA Binding Protein Involved in the 
Pathology of Amyotrophic Lateral Sclerosis
Cristian Droppelmann, Brian Keller, Danae Campos-Melo, Jian Wang, Martin Duennwald, Rob 
Hegele, Kathryn Volkening, Michael J. Strong
619 B Mechanisms of Post-Trascriptional Regulation of Gene Expression in Dementias
Francesca Fontana, Margherita Grasso, Valerio Del Vescovo, Giuseppina Covello, Michela Alessandra 
Denti
620 C MicroRNAs as lung cancer biomarkers
Margherita Grasso, Valerio Del Vescovo, Chiara Cantaloni, Leonardo Ricci, Mattia Barbareschi, 
Michela Alessandra Denti, Rotem Karni
621 A hnRNP A2/B1 regulated alternative splicing of key signal transduction components and is 
essential for breast cancer metastasis.
Regina Golan-Gerstl, Ilana Lebenthal-Loinger, Ben Davidson, Jasmine Jacobs, Gideon Rechavi, 
Rotem Karni, Michela Alessandra Denti
622 B The role of the simtron, miR-1225, and its host gene, PKD1, in autosomal dominant polycystic 
kidney disease
Mallory A. Havens, Frank Rigo, Michelle L. Hastings
623 C Interplay of oncogenic transcription factor b-catenin with SR protein SRSF3 contributes to the 
alternative splicing of tumor-related genes
Jung Hur, Sunjoo Jeong
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624 A Exploring the in vivo functions of the mammalian tRNA ligase
Jennifer Jurkin, Therese Kaufmann, Johannes Popow, Javier Martinez
625 B The FUS protein is required for cell proliferation
Silvia Carolina Lenzken, Alessia Loffreda, Monica Lupi, Sudharshan Elangovan, Marc-David Ruepp, 
Raffaele Calogero, Giovanna Damia, Oliver Mühlemann, Silvia Barabino
626 C The Involvement of miRNA Dysregulation in Amyotrophic Lateral Sclerosis
Alessia Loffreda, Marc-David Ruepp, Rémy Bruggmann, Oliver Mühlemann, Silvia Barabino
627 A Differential LMNA splicing leads to metabolic disorders
Isabel Cristina Lopez-Mejía, Marion de Toledo, Carine Chavey, Celia Lopez Herrera, Patricia 
Cavelier, François Casas, Guillaume Beranger, Ez-Zoubir Amri, Lluis Fajas , Jamal Tazi
628 B Uncovering the role of microRNAs in SMA
Philipp Odermatt, Daniel Schümperli
629 C Anti-inflammatory function of miR-146a in human primary keratinocytes and atopic dermatitis
Ana Rebane, Toomas Runnel, Alar Aab, Beate Rückert, Julia Maslovskaja, Mario Plaas, Maya 
Zimmermann, Lajos Kemeny, Külli Kingo, Cezmi A. Akdis
630 A Mutation of a Zinc Finger Polyadenosine RNA Binding Protein Causes Autosomal Recessive 
Intellectual Disability
Jennifer Rha, Sara Leung, Gary Bassell, Anita Corbett
631 B A novel function for MiR-10a in the pathogenesis of atopic dermatitis
Toomas Runnel, Maya Zimmermann, Külli Kingo, Cezmi A. Akdis, Ana Rebane
632 C Splice variant specific blood biomarkers of Parkinson’s disease
Jose Santiago, Clemens Scherzer, Harvard Biomarker Study Group, Judith Potashkin
633 A Hepatitis C virus induced up-regulation of miR-27 expression promotes hepatic triglyceride 
accumulation
Ragunath Singaravelu, Ran Chen, Rodney Lyn, Daniel Jones, Rodney Russell, Shifawn O’Hara4 
Jenny Cheng, Lorne Tyrrell, Yanouchka Rouleau, John Pezacki
634 B Knockdown of human Dyskerin, the protein linked to Dyskeratosis congenita, blocks large 
ribosomal subunit production and activates p53 via RPL5 and RPL11
Katherine Sloan, Andria Pelava, Claudia Schneider, Nicholas Watkins
635 C Exonic splicing mutations in Mendelian disorders are more prevalent than currently estimated: 
the example of Lynch syndrome-associated MLH1 exon 10 variants
Omar Soukarieh, Mohamad Hamieh, Pascaline Gaildrat, Stéphanie Baert-Desurmont, Mario Tosi, 
Alexandra Martins, Thierry Frébourg
636 A RNase MRP is involved in chondrogenic differentiation
Mandy M.F. Steinbusch, Marjolein M.J. Caron, Franziska Eckmann, Ekkehart Lausch, Bernhard 
Zabel, Lodewijk W. van Rhijn, Tim J.M. Welting
637 B TDRD3 recruits FMRP and the topoisomerase TOP3ß to spliced mRNAs and provides a 
molecular link between schizophrenia and fragile X syndrome
Georg Stoll, Bastian Linder, Cornelia Brosi, Aarno Palotie, Nelson Freimer, Olli Pietilainen, Oliver 
Ploettner, Utz Fischer
638 C Spliceosome Integrity is Defective in the Motor Neuron Diseases ALS and SMA
Hitomi Tsuiji, Yohei Iguchi, Asako Furuya, Kenji Sakimura, Shigeo Murayama, Gen Sobue, Koji 
Yamanaka
639 A The RNA-binding protein Quaking critically regulates vascular smooth muscle cell phenotype
Eric van der Veer, Ruben de Bruin, Adriaan Kraaijeveld, Margreet de Vries, Tonio Pera, Filip Segers, 
Janine van Gils, Marko Roeten, Ilze Bot, Anique Janssen, Pieter Hiemstra, Ton Rabelink, Antoine de 
Vries, Paul Quax, Wouter Jukema, Erik Biessen, Anton Jan van Zonneveld
640 B Investigating the role and regulation of microRNA-10a in Acute Myeloid Leukaemia bearing the 
Nucleophosmin1 mutation
Thi Thanh Vu, Catalina Palma, Adam Bryant, Dima Al Sheikha, David Ma, Vivek jayaswal
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641 C RNA binding protein FUS acts to mediate nuclear-mitochondrial communication
Jane Wu
642 A FUS mutations strongly promote FUS-SMN and FUS-RNAP II interactions
Tomohiro Yamazaki, Robin Reed
643 B Endogenous shRNA Induces the Large-scale Trans-determination of Mesenchymal Stem Cells 
into Hematopoietic Stem Cells with High Purity.
James Yin
Viral RNAs
Abstracts 644–654
644 C Deep-sequencing of the Peach Latent Mosaic Viroid Reveals New Aspects of Population 
Heterogeneity
François Bolduc, Jean-Pierre Sehi Glouzon, Rafael Najmanovich, Shengrui Wang, Jean-Pierre Perreault
645 A Reduced HBsAg expression in occult HBV infection: alteration of a post-transcriptional 
regulatory mechanism?
Daniel Candotti, Jean-Pierre Allain
646 B Mechanistic insights into EMCV-IRES translation initiation
Nathalie Chamond, Jules Deforges, Nathalie Ulryck, Audrey Brossard, Bruno Sargueil
647 C Modulation of HIV-1 gene expression by binding of UHM-containing splicing factors to a ULM 
motif in the Rev protein
Lorenzo Corsini, Michelle Vincendeau, Marta Pabis, Kostas Tripsianes, Thomas Güttler, Toby 
Gibson, Ruth Brack-Werner, Michael Sattler
648 A HMGA1 interaction with HIV-1 TAR modulates basal and Tat-dependent HIV transcription.
Sebastian Eilebrecht, Emmanuelle Wilhelm, Brendan Bell, Arndt Benecke
649 B Thermodynamics of HIV-1 Reverse Transcriptase in action elucidates the mechanism of action 
of non-nucleoside inhibitors
Bec Guillaume, Meyer Benoit, Marie-Aline Gerard, Jessica Steger, Katja Fauster, Ronald Micura, 
Philippe Dumas, Eric Ennifar
650 C Domain interactions in adenovirus virus-associated RNA I mediate high-affinity PKR binding
Katherine Launer-Felty, James Cole
651 A Phosphorylation of hepatitis C virus RNA polymerase Ser29 and Ser42 by PRK2 regulates HCV 
replication
Jae-Su Moon, Song-Hee Han, Jong-Won Oh
652 B Structural rearrangements of HIV-2 RNA during dimerization
Katarzyna Pachulska-Wieczorek, Katarzyna J. Purzycka, Ryszard W. Adamiak
653 C RNA Packaging NTPase is Needed for Transcription in Double-stranded RNA Bacteriophage 
phi6
Xiaoyu Sun, Markus Pirttimaa, Dennis Bamford, Minna Poranen
654 A DNA habitat and RNA inhabitants: Relevant questions of a qualitative RNA sociology
Guenther Witzany
Interconnections Between Gene Expression Processes
Abstracts 655–671
655 B Distinct PPR proteins are responsible for coupling of mRNA editing, polyadenylation and 
translation in mitochondria of trypanosomes
Inna Afasizheva, Lan Huang, Ruslan Afasizhev
656 C Identification of RNA targets for the nuclear multidomain cyclophilin atCyp59 and their effect 
on PPIase activity
Olga Bannikova, Marek Zywicki, Yamile Marquez, Tatsiana Skrahina, Maria Kalyna, Andrea Barta
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657 A Impact of specific RNA Pol II CTD phosphorylation patterns
Anne Helmrich, Daniel Schümperli
658 B SC35 and Promoter-Associated Nascent RNA Function like HIV Tat and TAR to Regulate 
Transcription Pause Release
Xiong Ji, Xiang-Dong Fu
659 C Not5 of the CCR4-NOT complex contributes to assembly of the SAGA coactivator complex.
Sari Kassem, Martine Collart
660 A Paraspeckle formation during NEAT1 lncRNA biogenesis is integrated by the SWI/SNF 
chromatin remodeling complex
Tetsuya Kawaguchi, Akie Tanigawa, Takao Naganuma, Tetsuro Hirose
661 B The RNA exosome promotes a transcription termination pathway coupled to RNA decay
Jean-Francois Lemay, Marc Larochelle, Samuel Marguerat, Jürg Bähler, Francois Bachand
662 C Widespread regulation of mRNA steady-state levels through alternative splicing-dependent 
mechanisms
Eugene V. Makeyev
663 A Alternative splice variant of chromatin regulators drive specific transcription
Oriane Mauger, Eric Allemand, Christian Muchardt, Eric Batsché
664 B Traf3 alternative splicing during T cell activation: functional consequences and regulatory insights
Monika Michel, Ilka Wilhelmi, Marco Preussner, Florian Heyd
665 C The Bre5-Ubp3 complex links RNA surveillance to RNA Polymerase II regulation by 
ubiquitylation
Laura Milligan, Sander Granneman, Grzegorz Kudla, Ross Alexander, Jean Beggs, David Tollervey
666 A Double-stranded RNA-expressing plasmids selectively inhibit translation of exogenous mRNAs
Jana Nejepinska, Radek Malik, Petr Svoboda
667 B Molecular mechanisms of RNA Polymerase II termination mediated by contacts with Rat1 and 
CF IA
Erika Pearson, Claire Moore
668 C IMAGEtags for imaging Pol II activity in real time with RNA reporters
Judhajeet Ray, Ilchung Shin, Vinayak Gupta, Jonathan Beasley, Lee Bendickson, George A Kraus, 
Marit Nilsen-Hamilton
669 A A Novel Poly(A) RNA-Binding Protein Regulates a Key Subunit of ATP Synthase in Breast 
Cancer Cells
Callie Wigington, Paula Vertino, Anita Corbett
670 B Messenger RNA decay rates feedback to influence transcription and buffer gene expression in 
mammalian cells
Carol Wilusz, Ju Youn Lee, Jerome Lee, Ashley Neff, Stephen Coleman, Ashton Herrington, Bin Tian, 
Jeffrey Wilusz
671 C The human protein Nol12- ribosome biogenesis meets DNA damage and senescence
Pierre-Joachim Zindy, Christian Trahan, Karen Wei, Jordi Ros Rodriguez, Marlene Oeffinger
RNA system biology
Abstracts 672–679
672 A The tissue specific and eco-responsive transcriptome of Drosophila
James Brown, Nathan Boley, Robert Eisman, Michael Duff, Kenneth Wan, Ben Booth, Ann Hammonds, 
Carrie Davis, Lucy Cherbas, Piero Carninci, Thomas Gingeras, Peter Cherbas, Thomas Kaufman, Roger 
Hoskins, Brenton Graveley, Susan Celniker, Marcus Stoiber, Marlene Oeffinger, Peter Bickel
673 B Modeling the RNA-binding specificity of GLD-1 suggests a function of coding region-located 
sites in translational repression
Anneke Brümmer, Shivendra Kishore, Deni Subasic, Michael Hengartner, Mihaela Zavolan
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674 C Beyond the ribosome, antagonistic functions played by a pair of ribosomal proteins paralogs
Anne-Cecile Duc, Yong Zhang, Shuyun Rao, Xiao-Li Sun, Alison Bilbee, Michele Rhodes, Qin Li, 
Dietmar Kappes, Jennifer Rhodes, David Wiest
675 A Clindamycin ribosome interactions: a molecular dynamics study
Katarzyna Kulczycka-Mierzejewska, Joanna Trylska, Joanna Sadlej
676 B Global gene regulation mediated by intron retention during T cell activation
Ting Ni, Weiqun Peng, Wenjing Yang, Keji Zhao, Jun Zhu
677 C Large-scale analysis of eukaryotic RNA-binding protein binding preferences and exploration of 
their roles in post-transcriptional gene regulation
Debashish Ray, Hilal Kazan, Kate Cook, Matthew Weirauch, Hamed Najafabadi, Xiao Li, Mihai 
Albu, Hong Zheng, Ally Yang, Hong Na, Serge Gueroussov, Manuel Irimia, Andrew Fraser, Benjamin 
Blencowe, Quaid Morris, Timothy Hughes
678 A RNase disruption of transcriptional positive auto-regulation is essential for energy-efficient 
phenotypic switching
Elisabeth Wurtmann, Alexander Ratushny, Min Pan, Karlyn Beer, John Aitchison, Nitin Baliga
679 B A Potential Role for snoRNAs in PKR Activation during Metabolic Stress
Osama Youssef, Takahisa Nakamura, Gökhan Hotamisligil, Brenda Bass
Bioinformatics
Abstracts 680–697
680 C RNAs in silico: learning from accelerated molecular dynamics
Giovanni Bussi
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2 Structure of the eukaryotic 40S ribosomal subunit in complex with initiation factors eIF1 
and eIF1A
Melanie Weisser1, Marc Leibundgut1, Nenad Ban1
1Institute of Molecular Biology and Biophysics, ETH Zurich
Bacterial and eukaryotic protein synthesis differ considerably at the level of initiation. The eukaryotic small 
ribosomal subunit (40S) binds a large number of initiation factors necessary for scanning of messenger RNAs for the 
correct start codon and for assembly of the translation-competent 80S ribosome. Although biochemical and genetic 
studies have revealed the roles of various initiation factors involved in this process, little structural information exists 
on their interaction with the 40S subunit in pre-initiation complexes, which would help us understand the underlying 
molecular mechanisms.
Following up on our studies of the complex between the 40S ribosomal subunit and eukaryotic initiation factor 
1 (eIF1) [Rabl et al.,  2011] we were recently able to solve the crystal structure of a larger pre-initiation complex 
comprising the 40S ribosomal subunit and eukaryotic translation initiation factors eIF1 and eIF1A at a resolution 
of 3.7 Å. Both factors are crucial for scanning for and recognition of the correct start codon and they interact with 
numerous other initiation factors (eIF5, eIF3, eIF2) in the context of the larger 43S pre-initiation complex.
Our structure reveals the interactions of the two initiation factors with the small ribosomal subunit and their 
positions relative to each other. The eukaryotic initiation factor eIF1A binds, as expected, in the vicinity of the 
ribosomal A-site, and its eukaryotic-specific C-terminal domain extends towards the mRNA channel. The structure 
offers a good starting point for understanding the structural interactions within the 43S pre-initiation complex and the 
role of the initiation factors in ribosomal scanning and start codon recognition.
1. Rabl J, Leibundgut M, Ataide SF, Haag A, Ban N. (2011) Science 331, 730-6.
1 Exceptions to Canonical Decoding by the Ribosome
Venki Ramakrishnan1
1MRC Laboratory of Molecular Biology
The ribosome promotes the accuracy of selection of an aminoacyl tRNA that is cognate to the codon on mRNA as 
specified by the rules of the genetic code. Proper codon-anticodon pairing results in a series of conformational changes 
that results in GTP hydrolysis by elongation factor Tu, which allows the addition of the amino acid on the selected 
tRNA to the nascent peptide. However, there are notable exceptions to this rule. In one case, involving tmRNA, the 
role of both mRNA and tRNA is played by a protein. A second exception involves the read-through of stop codons 
that are modified to contain pseudouridine instead of uridine. These codons are read via a mechanism involving 
non-canonical base pairing previously thought to be forbidden by the genetic code. This talk will discuss how recent 
structures have shed light on both canonical decoding and exceptions to it.
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3 Versatile binding of eukaryotic initiation factor 3 on the small ribosomal 40S subunit and 
the CSFV IRES
Yaser Hashem1, Amedee Des Georges2, Vidya Dhote3, Robert Langlois2, Robert A. Grassucci1, Tatyana V. Pestova3, 
Christopher U.T. Hellen3, Joachim Frank1
1Columbia University / HHMI; 2Columbia University; 3SUNY Downstate Medical Center
Protein translation initiation in most eukaryotes starts by the formation of the 43S preinitiation complex, 
comprising the Met-tRNAiMet, eukaryotic initiation factors 1, 1A, 2 and 3. The 43S is poised to attach the mRNA 
and start scanning for the start codon. Certain mRNAs possess internal ribosomal entry sites (IRESs), often at their 
5′ UTR, which allows end-independent initiation to take place, circumventing canonical initiation. These IRES-
containing mRNAs don’t follow the same regulatory pathway that supervises the recruitment of most mRNAs to the 
preinitiation complex. Examples of IRES-containing mRNAs can be found in many viruses such as the Hepatitis C 
Virus (HCV) and the Classical Swine Fever Virus (CSFV). The interaction of these IRESs with the 40S subunit has 
been studied for decades by various methods and few low-resolution cryo-electron microscopy (cryo-EM) structures 
are already available, however their low-resolution was insufficient for atomic modeling and many aspects related to 
their interaction with the 40S remain unknown.
Initiation on IRES-containing mRNAs requires eIF3 that was thought to interact in a complementary fashion with 
the IRES on the 40S subunit, allowing it to maintain the same binding site on the 40S in the presence or absence of 
the IRES. Here we present several cryo-EM structures of the CSFV IRES in interaction with the 40S subunit, eIF3 
and DHX29, a DExH-box protein required for scanning on structured mRNAs and was found previously to stabilize 
the binding of eIF3 on the 40S. Our structures show that contrarily to the current model, eIF3 binds differently in 
presence of an IRES and its conserved core doesn’t interact directly anymore with the 40S (figure 1 below). In 
addition, we were able to create a convincing atomic model of the CSFV IRES into a 10Å cryo-EM map (figure 2 
below), which sheds more light on the IRES contacts with the 40S subunit. Our cryo-EM reconstructions also show 
the versatility of eIF3 binding and capture the latter in several close orientations on the CSFV IRES. Our study poses 
the first structural basis of eIF3 interaction with IRES-containing mRNAs and rectifies the erroneous eIF3●IRES●40S 
interaction model, which we anticipate to have tremendous implications on the field.
1. Hellen et al. Genes & Dev. 2001
2. Hashem et al. Cell  2013, in press
3. Spahn et al. Science 2001
4. Siridechadilok et al. Science 2005
Figure 2
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5 Probing the dynamics of Ribosome biogenesis in yeast
Ralph D Hector1, Elena Burlacu1, Stuart Aitken2, Atlanta Cook3, Sander Granneman1
1Institute of Structural and Molecular Biology, Centre for Synthetic and Systems Biology (SynthSys), 
University of Edinburgh; 2Computational Genomics Lab MRC Human Genetics Unit, University of 
Edinburgh; 3Wellcome Trust Centre for Cell Biology, University of Edinburgh
Ribosome synthesis in eukaryotes is an incredibly complex process that, besides ribosomal proteins (r-proteins), 
requires the activity of ~200 ribosome assembly factors. Many of these assembly factors contain enzymatic motifs 
and are presumed to play crucial roles in remodeling of pre-ribosomes and rRNA folding steps. Although we have a 
fairly complete picture of the stages at which ribosome assembly factors bind to intermediates, we still lack detailed 
knowledge of the RNA folding steps that take place and the role of the putative enzymes in this process.
Inspired by impressive chemical probing work done by many groups on bacterial ribosomes, we have developed 
protocols for purification and chemical modification of specific yeast ribosome assembly intermediates. By combining 
this with high-throughput sequencing we are able to quantitatively measure structural changes and remodeling steps 
during ribosome synthesis in a single chemical probing reaction. Using this methodology, dubbed ChemModSeq, we 
discovered that a large number of ribosomal proteins that interact with the head domain of the 18S rRNA r-proteins 
are not in their final conformation. Our results support the notion that many ribosome assembly factors can (also) 
function as r-protein placeholders. This rearrangement of ribosomal proteins correlates with the presence of specific 
40S ribosome assembly factors and our results show that the head domain undergoes major remodeling just before 
the final 18S rRNA cleavage event in the cytoplasm. Our data provide the first insights at nucleotide resolution into 
how assembly factors modulate the assembly of ribosomal proteins, and provide a platform for studying the role of 
NTPases in restructuring/remodeling during ribosome synthesis.
4 A novel strategy for protein synthesis initiation: 40S ribosomes bind to the 3’ UTR of 
barley yellow dwarf virus (BYDV) mRNA
Sohani Das Sharma1, Bidisha Banerjee1, Jelena Kraft2, W. Allen Miller2, Dixie Goss1
1Hunter College CUNY; 2Iowa State University
Most gene expression in uncapped RNA viruses is regulated by either an internal ribosomal entry site (IRES) or 
a cap independent translation element (CITE) that are located in the 5’ and 3’ UTR respectively of the viral mRNA. 
Barley yellow dwarf virus (BYDV) mRNA, which lacks both cap and poly (A) tail, has a translation element (BTE) 
present in the 3’ UTR that is essential for efficient translation initiation at the 5’ proximal AUG. The molecular 
mechanism of translation initiation is not well understood.  Using fluorescence anisotropy, SHAPE analysis and 
toeprinting, we report: 1) eIF4F binds to the 3’ UTR and the binding affinity correlates with the translational efficiency 
of the mutant BTEs; 2) 40S ribosomes bind to the BTE first; 3) RNA structural elements in the 3’ and 5’ UTRs interact 
to transfer ribosomes to the 5’ UTR; 4) Sequence interactions between 18S rRNA and 3’ viral RNA BTE are required 
for ribosome binding. We are currently identifying eIFs required for ribosome transfer.  Taken together, these results 
suggest a novel mechanism for eIF4F binding to the 3’ UTR to recruit the 43S ribosome followed by subsequent 
transfer of the ribosome complex to the 5’ UTR, scanning to the AUG and initiation of protein synthesis.
Grant Support: NSF MCB1157632 (DJG) and NIH 2R01 GM067104 (WAM).
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7 Exonucleolytic processing of the 18S rRNA precursors during nuclear export in human cells
Marie-Francoise O’Donohue1, Milena Preti1, Nathalie Montel-Lehry1, Marie-Line Bortolin-Cavaille1, Hanna 
Gazda2, Pierre-Emmanuel Gleizes1
1Laboratoire de Biologie Moleculaire Eucaryote, CNRS and University of Toulouse; 2Division of Genetics and 
Program in Genomics, The Manton Center for Orphan Disease Research, Children’s Hospital Boston and 
Harvard Medical School
Pre-ribosomal RNA maturation has long been considered a highly conserved process in eukaryotes, but recent studies have 
revealed evolutionary divergence between the yeast and mammalian ribosome synthesis pathways. Understanding the specifics of 
human ribosome biogenesis is likely to be important for elucidating pathological mechanisms in cancer and ribosomal diseases, 
like  Diamond-Blackfan anemia, the Treacher-Collins syndrome, or the Shwachman-Diamond syndrome. Defects in ribosome 
biogenesis trigger stress response pathways that perturb cell proliferation and differentiation. Investigating how these signaling 
pathways are activated requires further understanding of the mechanisms of pre-rRNA processing in human cells.
Mutations in Diamond-Blackfan anemia, a congenital erythroblastopenia associated to mutations in ribosomal protein genes, 
affect ITS1 processing in a large proportion of patients. Processing of the ITS1 within the pre-40S particles starts in the nucleolus 
and ends in the cytoplasm in human cells as in yeast. Using loss-of-function experiments and extensive RNA analysis, we have 
determined that endonucleolytic cleavage E in the ITS1 takes place 78 or 81 nucleotides downstream of the 18S rRNA 3’-
end. Cleavage at this site generates the 18S-E pre-rRNA, the last precursor to the 18S rRNA. Unexpectedly, we found that 
this endonucleolytic cleavage is followed by exonucleolytic processing of the cleavage products in both orientation. The 3’-5’ 
exonucleoytic trimming of the 18S-E pre-rRNA occurs during nuclear export of the pre-40S particles, as revealed by detailed 
3’-RACE analysis and cell frationation. The exosome may play some role in this process, but other exonucleases seem to be 
involved. Knockdown of several ribosomal proteins and maturation factors required for formation of the 18S rRNA results in the 
accumulation in the cytoplasm of a short form of the 18S-E pre-rRNA, whose final conversion into 18S rRNA requires the PIN-
domain containing NOB1. 
The requirement of exonucleases in the maturation of the 18S rRNA 3’-end has never been described so far in other eukaryotes, 
and might indicate a higher level of quality control in mammalian ribosome biogenesis. These results not only deliver a more 
complex picture of pre-rRNA maturation mechanisms in mammalian cells, but they also provide a mechanistic framework to 
further study the interplay of DBA-linked ribosomal proteins in this process. We are currently characterizing the exonucleases 
involved in 18S rRNA maturation, and have found that mutation of a novel DBA-associated gene encoding a large ribosomal 
subunit protein also affects ITS1 processing.
6 The casein kinase 1d homolog Hrr25 promotes dissociation of the ribosome assembly 
factor Ltv1 from nascent small ribosomal subunits to allow joining of large subunits.
Homa Ghalei1, Katrin Karbstein2
1The Scripps Research Institute, Department of Cancer Biology, Jupiter, FL; 2The Scripps Research Institute
Cytoplasmic small (40S) ribosome assembly intermediates are protected from premature translation initiation 
by assembly factors, which block recruitment of translation factors, mRNA and large subunits. Dissociation of these 
assembly factors is somehow coupled to a translation-like cycle, in which mature large (60S) subunits join to proofread 
essential activities of the maturing 40S subunit. However, how entry into this cycle is regulated and how assembly 
factors dissociate, remains unknown. Here we show that dissociation of the assembly factor Ltv1, located at the 
beak structure, initiates the cytoplasmic maturation cascade for 40S ribosomal subunits. Hrr25, the yeast homolog 
for casein kinase 1d, involved in many cellular processes, and linked to numerous human diseases, phosphorylates 
Ltv1 leading to its dissociation. Failure to release Ltv1 blocks subsequent joining of 60S subunits and entry into the 
translation-like cycle. We are now studying the effects from Ltv1 release on the incorporation of nearby ribosomal 
proteins and the 40S structure.
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9 Structural basis of translational regulation of msl2 mRNA by SXL and UNR during dosage 
compensation in Drosophila
Janosch Hennig1, Cristina Militti2, Grzegorz Popowicz4, Iren Wang1, Miriam Sonntag1, Arie Geerlof1, Fatima 
Gebauer3, Michael Sattler1
1Helmholtz Zentrum München & TU München; 2Centre for Genomic Regulation (CRG), Barcelona; 3CRG 
Barcelona; 4Helmholtz Zentrum München
The protein Upstream of N-Ras (UNR) is a key regulator of gene expression at the translational level in both 
humans and Drosophila.  In Drosophila, the role of UNR in dosage compensation is well characterized. UNR and the 
female-specific protein Sex-lethal (SXL) bind cooperatively to the 3’ UTR of msl2 mRNA, which encodes the rate-
limiting subunit of the dosage compensation complex. This interaction represses the translation ofmsl2 mRNA and 
allows female fly viability.
We have investigated the structural basis for the assembly of the SXL-UNR-msl2 ribonucleoprotein complex and 
studied the minimal relevant regions required for ternary complex formation by complementary structural biology 
methods, biochemistry and functional analysis. We report the crystal structure of the ternary complex at 2.8 Å 
resolution, which was validated by complementary data from solution NMR, SAXS and SANS. The structure reveals 
unprecedented insight into how the tandem RNA recognition motif (RRM) domains of SXL and UNR cold shock 
domains cooperate for specific the recognition of the msl-2 RNA. Structure-based mutational analysis of protein-RNA 
and protein-protein interfaces reveal molecular details for translational repression by UNR during development. Our 
structural and functional analysis provide novel insight for an important molecular mechanism of the regulation of 
X-chromosome dosage compensation.
8 An mRNA-derived ncRNA targets and regulates the ribosome
Andreas Pircher1, Kamilla Bakowska-Zywicka2, Marek Zywicki3, Norbert Polacek1
1Department of Chemistry & Biochemistry, University of Bern; 2Institute of Bioorganic Chemistry, Polish 
Academy of Science, Poznan, Poland; 3Laboratory of Computational Genomics, Adam Mickiewicz University, 
Poznan, Poland
Small non-protein-coding RNA (ncRNA) molecules have been recognized recently as major contributors to regulatory networks 
in controlling gene expression in a highly efficient manner. While the list of validated ncRNAs that regulate crucial cellular processes 
grows steadily, not a single ncRNA has been identified that directly interacts and regulates the ribosome during protein biosynthesis 
(with the notable exceptions of 7SL RNA and tmRNA). All of the recently discovered regulatory ncRNAs that act on translation (e.g. 
microRNAs, siRNAs, antisense RNAs) target the mRNA rather than the ribosome. This is unexpected, given the central position the 
ribosome plays during gene expression.
To investigate whether such a class of regulatory ncRNAs does exist we performed genomic screens for small ribosome-
associated RNAs in model organisms of all three domains [1,2]. Here we focus on the functional characterisation of an 18 
nucleotide long ncRNA candidate derived from an open reading frame of an annotated S. cerevisiae gene, which encodes a tRNA 
methyltransferase. Yeast cells lacking this tRNA methyltransferase showed clear growth defects in high salt containing media. 
Genetic analysis showed that the absence of the mRNA-derived ncRNA rather than the absence of the tRNA methyltransferase 
activity is responsible for the observed phenotype. Since we performed a screen for small ribosome-associated RNAs we examined 
the regulatory potential of the synthetic 18mer during translation in vitro and in vivo. Metabolic labeling experiments in the 
presence of the synthetic 18mer RNA revealed an inhibitory potential on the global protein biosynthesis rate. In vitro translation 
and northern blot analysis further strengthen the hypothesis, that this RNA is a ribosome-associated regulatory ncRNA.
Our studies in pro- and eukaryotic model organisms reveal the ribosome as a novel target for small regulatory ncRNAs in all 
domains of life. Ribosome-bound ncRNAs are capable of fine tuning translation and might represent a so far largely unexplored 
class of regulatory ncRNAs.
1. Zywicki, M., K. Bakowska-Zywicka, et al. (2012). “Revealing stable processing products from ribosome-associated small 
RNAs by deep-sequencing data analysis.” Nucleic Acids Res 40(9): 4013-4024.
2. Gebetsberger, J., Zywicki, M., Künzi, A., Polacek, N. (2012). „tRNA-derived fragments target the ribosome and function as 
regulatory non-coding RNA in Haloferax volcanii“ Archaea
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11 The regulatory circuits mediated by RNAs in Staphylococcus aureus and implication of the 
endoribonuclease III
Efthimia Lioliou1, Cédric Romilly1, Isabelle Caldelari3, Cynthia Sharma4, Thomas Geissmann2, François 
Vandenesch2, Joerg Vogel4, Pascale Romby1
1CNRS; 2INSERM; 3University of Strasbourg; 4University of Wurzburg
Staphylococcus aureus is a remarkable versatile pathogen, able to cause a wide spectrum of human diseases, 
and is one of the main causes of community as well as hospital-acquired infections. The contribution of regulatory 
RNAs in the establishment of virulence in this pathogen is increasingly appreciated. Our previous data emphasize the 
multitude of regulatory steps affected by RNAIII in establishing a network of S. aureusvirulence factors. We show 
that RNAIII and the endoribonuclease III coordinately repress the expression of numerous mRNAs that encode the 
transcriptional repressor of toxins, several virulence factors acting early in the infection process, and several enzymes 
involved in peptidoglycan metabolism. The repressor activity of RNAIII involves the formation of RNA-mRNA 
duplexes that results in the inhibition of translation initiation and concomitantly triggers endoribonuclease III attack. 
Identification of the RNA targets of the endoribonuclease III further illustrates the multiple functions of the enzyme 
in the regulation of RNA metabolism. Besides RNAIII, we demonstrated that the S. aureus genome likely encodes a 
high diversity of RNAs including cis-acting regulatory regions of mRNAs, cis-acting antisense RNAs, and small non-
coding RNAs. We will illustrate how some of these novel non-coding RNAs have direct consequences on biofilm and 
capsule formation, and stress responses, and how they converged to the quorum-sensing system.
10 Circular RNAs function as efficient microRNA sponges
Jorgen Kjems1, Thomas B. Hansen2, Christian K Damgaard2, Trine I. Jensen2, Jesper B. Bramsen2, Bettina H. 
Clausen3, Bente Finsen3
1Department of Molecular Biology and Genetics, Interdisciplinary Nanoscience Center, Aarhus University, Aarhus, 
Denmark; 2Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark; 3Neurobiology 
Research, Institute of MolecularMedicine, University of Southern Denmark
Circular RNAs that derive from RNA splicing events across exons are abounded in mammalian cells but their function has 
until recently been illusive. We recently reported that the antisense transcript to the neuronally expressed CDR-1 gene is almost 
exclusive circular and positively regulates the expression of the CDR-1 mRNA (Hansen et al. 2011).
We have now discovered that this circular RNA, in addition, acts as a highly efficient microRNA-7 (miR-7) sponge and named 
it ciRS-7 (Circular RNA Sponge for miR-7; Hansen et al. In press). ciRS-7 harbours more than 70 selectively conserved putative 
miRNA target sites and it is highly and widely associated with Ago-proteins in a miR-7 dependent manner. While the circular 
RNA is completely resistant towards miRNA-mediated target destabilization, it strongly suppresses miR-7 activity resulting in 
elevated levels of miR-7 targets. In the mouse brain, we observe overlapping neuronal expression patterns of ciRS-7 and miR-7 
in the neocortex and hippocampus, and in thalamus and substantia nigra suggesting a high degree of endogenous interaction. We 
also show that ciRS-7 can induce established miR-7 targets including SNCA, EGFR and IRS2, implicated in Parkinson disease, 
cancer and diabetes, respectively. The ciRS-7 is itself under the control of miR-671 that, unusually for a mammalian miR, cleaves 
the ciRS-7 and effectively removes it from the cell. Hence miR-671 may constitute a novel therapeutic reagent in a number of 
human diseases.  
The function of circular RNAs as miR sponges appears to be a general phenomenon. We demonstrate  that circular testis 
specific RNA, SRY, serves as a miR-138 sponge and that circular SRY expression can increase miR-138 targeted mRNAs. Thus, 
this serves as the first functional study of a naturally expressed circular RNA.
We are currently establishing ciRS as generic platform enabling sponging of any miR of chose by reprogramming the seed 
sequences.
1. Hansen, T. B., Wiklund, E. D., Bramsen, J. B., Villadsen, S. B., Statham, A. L., Clark, S. J., and Kjems, J. (2011) miRNA-
dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA, The EMBO journal 30, 4414-4422.
2. Thomas B Hansen; TB, Jensen, TI, Clausen, BH, Bramsen, JB, Finsen, B, Damgaard, CK, Kjems, J. (2013) Natural RNA 
circles function as efficient miRNA sponges. Nature (Published online 27 February 2013)
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13 Non-coding RNAs prevent spreading of a repressive histone mark
Marc Bühler1, Claudia Keller1, Raghavendran Kulasegaran-Shylini1, Yukiko Shimada1, Hans-Rudolf Hotz1
1Friedrich Miescher Institute for Biomedical Research
Besides messenger RNAs (mRNAs), eukaryotic cells produce a plethora of RNAs that appear to be non-protein 
coding (ncRNAs). Whereas substantial progress has been made in cataloging ncRNAs, the extent of their involvement 
in regulatory circuits and the mechanisms through which they might act remain to be explored further. In the fission 
yeast Schizosaccharomyces pombe, ncRNAs are known to play a prominent role in the assembly and maintenance of 
heterochromatin. Transcription of centromeric repeat sequences results in the production of long ncRNAs (lncRNAs) 
that are processed by Dicer (Dcr1) into short ncRNAs (siRNAs). These are found in Argonaute (Ago1) and target 
the Ago1-containing RNA-induced transcriptional silencing complex (RITS) to nascent chromatin-bound lncRNAs. 
Subsequently, RITS recruits the histone methyltransferase (HMTase) Clr4 to methylate histone H3 at Lys 9 (H3K9), a 
hallmark of heterochromatin. Thus, long and short ncRNAs cooperate in the targeting of a histone modifying activity 
to the appropriate location in the S. pombegenome. In contrast to this mode of ncRNA action, we have now discovered 
a novel class of ncRNAs that counteract H3K9 methylation. We have identified a lncRNA residing in centromeric 
heterochromatin, termed BORDERLINE, which prevents the spreading of heterochromatin beyond the pericentromeric 
repeat region. Our results demonstrate that the production of RNA is sufficient to demarcate an epigenetically distinct 
chromosomal domain, irrespective of the underlying DNA sequence. In contrast to the recurring theme that ncRNAs 
function to recruit or guide proteins to chromatin, we show that RNA can also counteract chromatin association. 
12 Messenger and long non-coding RNAs: dressed for the occasion?
Alex Tuck1, David Tollervey2
1Wellcome Trust Centre for Cell Biology, Edinburgh, UK; 2Wellcome Trust Centre for Cell Biology, 
Edinburgh, UK
In yeast, pervasive transcription generates a heterogeneous ensemble of long non-coding RNAs (lncRNAs) as 
well as mRNAs and stable, structural RNAs. The mRNAs are exported to the cytoplasm for translation, whereas 
characterized lncRNAs perform distinct functions, such as directing chromatin modifications. LncRNAs and mRNAs 
share many properties including a 5’ cap, poly(A) tail and transcription by Pol II, raising the question of why they 
have such different fates. Throughout their maturation, export and decay, mRNAs interact with a defined series of 
protein factors. We reasoned that analysis of the interactions of these proteins with other transcripts, such as lncRNAs, 
would reveal the point at which their maturation separates from that of mRNAs. We therefore determined the in vivo, 
transcriptome-wide targets of key protein factors in this pathway. This revealed distinct classes of lncRNAs and 
mRNAs, with RNP compositions tailored to the regulation and functions of transcripts within each class. Therefore, 
rather than undergoing a “standard” maturation process, mRNAs and lncRNAs are assembled into purpose-built 
RNPs. LncRNAs were abundant targets of the nuclear surveillance machinery, so are predominantly retained and 
degraded in the nucleus. However, further analyses revealed a subclass of stable lncRNAs that undergo cleavage and 
polyadenylation and are exported to the cytoplasm. In contrast, the unstable lncRNAs are subject to a distinct mode 
of termination. Therefore, 3’ end processing is a key step in RNP biogenesis at which transcript fate is determined, 
and differences here explain the origin of the marked heterogeneity amongst mRNAs and lncRNAs. In support of this 
model, we identified dual roles for two proteins in both cleavage and polyadenylation and surveillance of lncRNAs. 
Unexpectedly, we also observed “lncRNA-like” mRNAs, subject to post-transcriptional regulation in the nucleus, 
which involves early transcription termination, upstream lncRNAs, or surveillance by the nuclear poly(A) binding 
protein Nab2. In yeast subjected to a short nutrient downshift there was extensive retargeting of the nuclear surveillance 
factor Mtr4 amongst these “lncRNA-like” mRNAs. Changes in lncRNA expression are therefore rapid and may play 
a widespread role in reprogramming gene expression. In conclusion, our comprehensive atlas of RNP composition 
effectively captures the diversity within the transcriptome and has unearthed several prominent mechanisms of post-
transcriptional regulation in the nucleus.
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15 Telomeric non-coding RNA acts as a scaffold for telomerase high-order organization at 
short telomeres
Emilio Cusanelli1, Carmina Angelica Perez Romero1, Pascal Chartrand1
1Department of Biochemistry, Université de Montréal, Montréal, Qc, H3C 3J7, Canada
Telomerase, which is composed of both protein and RNA, maintains genome stability by replenishing telomeric 
repeats at the ends of chromosomes. On short telomeres, several molecules of telomerase are recruited, leading to the 
formation of telomerase foci or clusters, which reflects the distributive extension of short telomeres by this enzyme. 
How these telomerase clusters are formed on short telomeres is still unknown. Herein, we show that telomeric non-
coding RNA is involved in the nucleation of telomerase clusters at short telomeres.
Telomeres are transcribed in a strand specific manner, giving rise to a G-rich telomeric-repeat containing RNA 
(TERRA). In mammalian cells, TERRA is nuclear and accumulates to some extent at telomeres. In yeast, TERRA 
expression is negatively regulated by the 5’-3’ exonuclease Rat1, which actively degrades TERRA transcripts. Although 
several functions for TERRA have been proposed in mammalian cells, direct evidence for a specific role for TERRA 
in yeast is still missing. We developed a live-cell imaging assay based on the MS2-GFP system to study endogenous 
TERRA expression from a unique telomere at the single cell level in yeast. We show that TERRA expression is induced 
when its telomere shortens, leading to the accumulation of TERRA molecules into a single perinuclear focus. Live-cell 
imaging of a GFP-labeled TERRA and its RFP-labeled telomere revealed that a TERRA focus associates specifically 
but transiently with its telomere of origin in S phase, which was confirmed by chromatin immunoprecipitation.
Furthermore, an interaction between TERRA and the yeast telomerase RNA (TLC1) was detected in vivo by 
co-immunoprecipitation. Surprisingly, by simultaneously imaging TERRA-GFP and TLC1 RNA-CFP, we captured 
spontaneous events of nucleation of TLC1 RNA molecules on TERRA foci in S phase, suggesting that a TERRA focus 
acts as a scaffold for the recruitment of telomerase and triggers the formation of a telomerase cluster. Simultaneous 
imaging of telomere 6R- or telomere 1L-TERRA, TLC1 RNA and telomere 6R revealed that a TERRA-TLC1 RNA 
cluster forms in early S phase, and is later recruited preferentially to the telomere from which TERRA molecules 
originate. This association depends on factors involved in the recruitment of telomerase at short telomeres, such as 
Mre11, Tel1 and yKu70. We propose that a short telomere expresses non-coding RNA to nucleate telomerase molecules 
into a cluster in order to promote the simultaneous recruitment of several telomerase molecules on this telomere.
14 Single cell and genome-wide analysis to dissect antisense RNA-mediated gene silencing 
and pervasive transcription in S. cerevisiae
Manuele Castelnuovo1, Samir Rahman4, Judith Zaugg2, Elisa Guffanti1, Zhenyu Xu3, Jurgi Camblong1, Nick 
Luscombe2, Lars Steinmetz3, Daniel Zenklusen4, Françoise Stutz1
1Dept. of Cell Biology and Frontiers in Genetics, University of Geneva, Switzerland; 2EBI-EMBL Hinxton, 
England; 3European Molecular Biology Laboratory, Heildelberg, Germany; 4University of Montreal, Canada
The S. cerevisiae genome codes for a myriad of intergenic and antisense (AS) transcripts, some of which are unstable and degraded 
by the exosome component Rrp6 [1, 2]. Loss of Rrp6 results in the accumulation of long PHO84 AS RNAs and repression of sense 
transcription through a process that involves PHO84 promoter deacetylation by the Hda1/2/3 histone deacetylase (HDAC) complex 
[3]. Here, we use single molecule resolution fluorescent in situ hybridization (smFISH) [4] to investigate the mechanism of PHO84 
antisense-mediated transcription regulation in single cells. We show that PHO84 AS acts as a bimodal switch, where continuous low 
frequency PHO84 AS transcription represses sense transcription within individual cells. Surprisingly, AS RNAs do not accumulate at 
the PHO84 gene but are exported to the cytoplasm. Furthermore, loss of Rrp6, rather than stabilizing PHO84 AS RNA, promotes AS 
elongation by reducing its early transcription termination by Nrd1/Nab3/Sen1. These observations suggest that PHO84 silencing results 
from low frequency but constant AS transcription through the promoter rather than its static accumulation at the repressed gene. To 
investigate the generality of this regulation we profiled various histone modification mutants in a Drrp6 strain using high-density tiling 
arrays. We confirm a widespread occurrence of antisense-dependent gene regulation and identify three classes of genes that accumulate 
asRNA in the absence of Rrp6, which differ in whether their genes are silenced by the asRNA and whether the repression involves HDACs 
and HMT. Distinguishing features between functional and non-functional antisense RNAs include sensitivity to early termination, 
extension into the promoter region, or the promoter structure of the repressed gene. The data indicate that histone-modifying enzymes 
are particularly important for antisense-mediated silencing of highly regulated genes subjected to extensive chromatin remodeling.
1. Neil H, et al., Widespread bidirectional promoters are the major source of cryptic transcripts in yeast. Nature. 2009 Feb 
19;457(7232):1038-42.
2. Xu Z, et al., Bidirectional promoters generate pervasive transcription in yeast. Nature. 2009 Feb 19;457(7232):1033-7.
3. Camblong J, et al., Antisense RNA stabilization induces transcriptional gene silencing via histone deacetylation in S. 
cerevisiae. Cell 2007 131:706-17
4.  Zenklusen D, et al., . Analyzing mRNA expression using single mRNA resolution fluorescent in situ hybridization. 
Methods Enzymol. 2010;470:641-59.
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16 Human α satellite derived transcripts interact with the active site of RNApolII
Katarzyna Matylla-Kulinska1, Renee Schroeder1
1Max F. Perutz Laboratories (MFPL), University of Vienna, Austria
Whether repetitive regions of the human genome have a function is a very intriguing question arising from two 
recently reported facts, firstly 80 % of the human DNA is transcribed into RNA, and secondly two-thirds of the 
genome is repetitive or repeat-derived. Human α satellites consist of 171 bp monomers arranged tandemly in a head-
to-tail manner, organized into arrays of higher order repeats spanning hundreds of kilobases to megabases. They are 
predominantly located near centromeres on every human chromosome, where they assure the proper chromosome 
segregation being a site for the spindle attachment.
Here, we present that α satellite arrays are transcribed into large transcripts (more than 8 kb) in both orientations 
(direct and reverse complement) to the consensus α satellite sequence. Their expression is more pronounced in cellular 
stress conditions and restrained to the S phase of the cell cycle. Transcription of α satellites is sensitive to α amanitin 
treatment, indicating that they are RNApolII transcripts. Unlike most RNApolII transcripts, they are not polyadenylated 
and remain in the nucleus. Intriguingly, analysis of the 5’ termini of RNAs reveals that only transcripts synthesized 
in the direct orientation possess cap structure while reverse complement are not capped. Driven by this finding we 
investigated α satellites interaction with RNApolII. In genomic SELEX against RNApolII, we had isolated several 
aptamers derived from α satellite repeats. Moreover, we found that α satellite RNAs interact with the active core of 
RNApolII resulting in DRB (5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole) sensitive 3’ labeling of the RNA or/
and to the second strand synthesis, what in turn implies that RNApolII might act as RNA dependent RNA polymerase 
(RdRP) on endogenous RNAs. Using HeLa cells nucleofection with chimeric transcripts combining α satellite with an 
artificial sequence, we observed RNA dependent RNA synthesis activity on genomic derived RNA template in vivo. 
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17 Methylated mRNA recognition by the YTH domain
Dominik Theler1, Cyril Dominguez2, Frederic Allain1
1Institute of Molecular Biology & Biophysics, ETH Zurich, Switzerland; 2Department of Biochemistry, 
University of Leicester, UK
Methylation of adenosine at the N6 position is considered the most abundant messenger RNA modification and 
known since nearly 40 years. Methylation is assumed to be important based on the severe phenotypes of methylase 
knockouts in several organisms. Recently also the demethylase has been postulated to be a disease risk gene. In 
2012 two reports [1,2] were published investigating with high throughput sequencing this process and expanded 
the repertoire of known sites and lead to a better definition of the consensus sequence for methylation. One of these 
recent studies [1] investigated, which proteins bind preferentially to the methylated form of a RNA compared to 
the unmodified form. Two of the three hits in the top confidence category were YTH domain containing proteins 
(Ydf2,Ydf3).
We have previously shown that the YTH domain of YT521-B is a RNA binding domain [3] and performed NMR 
titrations using partially randomized nucleotides to better define the binding preferences of this domain, since the 
SELEX derived sequences were quite degenerate. This approach yielded a better defined binding sequence and a 
preliminary structure of this complex could be obtained.
Both studies [1,2] on N6-methylation of adenosine reported a consensus sequence for an A to get methylated, 
which resembles our NMR derived sequence. The methylated adenosine is mostly flanked 5’ by a G and 3’ by a C. This 
prompted us to perform a titration experiment using the NMR derived sequence containing a N6-methyladenosine. The 
addition of this methyl group shifted the exchange regime of this complex from fast/intermediate to slow indicating 
much higher affinity. We determined the structure with methylated RNA, which represents the first structure of this 
domain in complex with RNA.
We were able to obtain 14 InterNOEs between the protein and the methyl group, which is contacted by two 
tryptophan residues via CH-π interactions.  This resembles the recognition of methylated arginines and lysines of 
histones by their respective binding domains [4]. The two tryptophan  residues are strictly conserved in all YTH 
domains [5]. Furthermore our experiments were carried out with the domain of YT521-B and not the domains of 
YDF2 or YDF3.
The structure reveals, how the YTH domain is able to recognize a methylated adenosine and it is tempting to 
assign the YTH domain, which is on a molecular and functional level not well characterized, the role of recognizing 
mRNAs containing N6-methylated adenosines. YT521-B regulates alternative splicing and the presence of the YTH 
domain is crucial for this [3]. Our results might therefore hint at a role of mRNA methylation in the control of splicing.
1. Dominissini, D. et al. (2012), Nature 485:201-206
2. Meyer, KD. et al. (2012), Cell 149:1635-1646
3. Zhang Z. et al. (2010), JBC 285:14701-14710
4. Taverna SD. et al. (2007), NSMB  14(11):1025-1040
5. Stoilov, P. et al. (2002), Trends in Biochem Sci 27(10):495-497
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Oral Abstracts
Session 2B: RNA Modification  •   11
19 Inosine-mediated modulation of RNA sensing by innate immune sensors
Michael Gantier1, Soroush Sarvestani1, Bryan Williams1
1Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia
RNA-specific adenosine deaminase (ADAR)-mediated adenosine to inosine (A-to-I) editing is a critical arm of 
the antiviral response. However, mechanistic insights into how A-to-I RNA editing affects viral infection are lacking. 
We posited that inosine incorporation into RNA facilitates sensing of non-self RNA by innate immune sensors, and 
accordingly investigated the impact of inosine-modified RNA on Toll Like Receptor (TLR) 7/8 sensing. Inosine 
incorporation into synthetic ssRNA potentiated TNF-α or IFN-α production in human PBMCs, in a sequence-dependent 
manner, indicative of TLR7/8 recruitment. The effect of inosine incorporation on TLR7/8 sensing was restricted to 
immunostimulatory ssRNAs, and was not seen with inosine-containing short dsRNAs, nor with a deoxy-inosine-
modified ssRNA. Inosine-mediated increase of self-secondary structure of an ssRNA resulted in potentiated mouse 
Tlr7 activation, as established through the use of Tlr7-deficient cells. There was a correlation between hyper-editing 
of influenza A viral ssRNA and its ability to stimulate TNF-α, independent of 5’-triphosphate residues. Furthermore, 
A-to-I editing of viral ssRNA directly enhanced mouse Tlr7 sensing, when present in proportions reproducing 
biologically relevant levels of RNA editing. Thus we demonstrate for the first time that inosine incorporation into 
immunostimulatory ssRNA can potentiate TLR7/8 activation. Our results suggest a novel function of A-to-I RNA 
editing, which is to facilitate sensing of phagocytosed viral RNA by innate immune sensors TLR7/8.
18 Determination of N6-methyladenosine RNA modification status at single nucleotide 
resolution and the application to a long non-coding RNA-protein interaction
Nian Liu1, Marc Parisien2, Xiaoyun Wang2, Qing Dai1, Guanqun Zheng1, Chuan He1, Tao Pan2
1Department of Chemistry, University of Chicago, Chicago, IL 60637, USA; 2Department of Biochemistry and 
Molecular Biology, University of Chicago, Chicago, IL 60637, USA
N6-methyladenosine (m6A) is the most abundant modification in eukaryotic mRNA and long non-coding RNA, but 
m6A studies have been hindered by the lack of methods for its precise identification. Here we develop a method, named 
Site-specific Cleavage And Radioactively-labeling followed by Ligation-assisted Extraction and TLC (SCARLET), 
that identifies m6A and its modification fraction in mRNA/lncRNA at single nucleotide resolution. We applied 
SCARLET to locate four m6A sites on the nuclear-localized MALAT1 (metastasis associated lung adenocarcinoma 
transcript), an abundant lncRNA known to regulate alternative splicing and chromatin remodeling.
We further identified nuclear-localized proteins that selectively bind to two m6A modified sites in MALAT1. Gel 
shift using the synthetic m6A-containing RNA oligos from MALAT1 and the HeLa nuclear extract showed that m6A-
containing RNA oligos can recruit 2-5 fold more proteins compared with the unmodified RNA. Further, RNA pull 
down followed by LC-MS/MS show that heteronuclear ribonucleoprotein G (hnRNP-G) and hnRNP-C selectively 
bind to one of the two m6A-modified MALAT1 sites; both hnRNP proteins are known to be involved in RNA splicing 
and transport. We also demonstrate that hnRNP-G and hnRNP-C prefer m6A modified sites in vivo. The identification 
of m6A-selective proteins indicates that a primary role of m6A modification is to recruit specific proteins or protein 
complexes to the modification site to modulate the function or activity associated with these RNA-protein complexes.
This work is supported by a NIH EUREKA award (GM088599).
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21 ADAR proteins suppress activation of antiviral signaling by cellular RNA.
Sam Greenwood1, Niamh Mannion1, Xianghua Li1, Liam Keegan1, Robert Young1, Simona Paro1, Sarah Cox1, 
Leeanne McGurk1, Marion Hogg1, James Brindle1, David Read1, Rui Zhang2, Christoffer Nellåker4, Chris Ponting4, 
Jin-Billy Li2, Matthew Ronshaugen3, Julia Dorin1, Ian Adams1, Mary O’Connell1
1MRC Human Genetics Unit, MRC IGMM, University of Edinburgh, UK; 2Department of Genetics, Stanford 
University, USA; 3Faculty of Life Sciences, University of Manchester, UK; 4MRC Functional Genomics Unit, 
University of Oxford, UK
Mutations in the gene encoding the RNA editing enzyme ADAR1 have recently been shown to cause the rare 
autoimmune disorder Aicardi-Goutières syndrome (AGS). AGS is a clinical mimic of in utero-acquired infection 
and is associated with increased production of the antiviral cytokine interferon (IFN) alpha. Adar1-null mice also 
have aberrant expression of Type-1 IFN, interferon-stimulated genes (ISGs) and pro-inflammatory cytokines, yet 
the phenotype is more severe with embryonic lethality around E12.5. Therefore it has been proposed that ADAR1 is 
required to suppress antiviral responses.
Genetic crosses revealed that mice lacking both ADAR1 and the interferon receptor can survive to E16.5, 
suggesting the effect of the Adar1 mutation is cell autonomous. Moreover, embryonic lethality in Adar1-null mice is 
rescued by crossing with a mutant lacking a key protein involved in antiviral signaling. These double homozygous 
mice have decreased IFN production, ISG expression and pro-inflammatory cytokine levels. Analysis of cellular RNA 
from Adar1-null mice revealed increased expression of transcripts encoding specific classes of repetitive elements. 
Surprisingly, increased expression of immune-response genes and altered levels of repetitive element transcripts are 
also observed in Adar-null Drosophila, supporting a conserved role for ADAR proteins as suppressors of innate 
immunity.
20 Impact of ADARs on abundance and sequence of miRNAs and other non-coding RNAs.
Cornelia Vesely1, Stefanie Tauber2, Fritz J. Sedlazeck2, Arndt von Haeseler2, Michael F. Jantsch1
1Department of Chromosome Biology, Max F. Perutz Laboratories, University of Vienna, Dr. Bohr Gasse 
9, A-1030 Vienna, AUSTRIA; 2Center for Integrative Bioinformatics Vienna, Max F. Perutz Laboratories, 
University of Vienna, Medical University of Vienna, and University of Veterinary Medicine, Dr. Bohr Gasse 9, 
A-1030 Vienna, AUSTRIA
Adenosine deaminases that act on RNA (ADARs) bind double-stranded RNAs and deaminate adenosines to inosines. Inosines 
are recognized as guanosines and thus editing changes sequence information but also the structure of RNAs. A to I editing is 
required for normal life and development. Besides mRNAs and repetitive elements, ADARs also target miRNA precursors and 
affect their processing efficiency or alter their target specificity. Previous studies on the impact of editing of miRNAs only focused 
on few specific miRNAs. However, the genome wide effect of editing on miRNAs had not been firmly established.
Using transgenic mouse embryos lacking the editing enzymes ADAR, ADARB1, or both we compared relative abundance 
and sequence composition of mature miRNAs to wild type mice by NextGen sequencing. Deficiency of ADARB1 leads to a 
reproducible change in abundance of several miRNAs, which seem to be unrelated to editing events. The additional lack of 
ADAR has little impact on the deregulation of mature miRNAs, indicating that proper miRNA processing is primarily dependent 
on ADARB1. A to G transitions reflecting A to I editing events can be detected at few sites and at low frequency during the early 
embryonic stage investigated. Again, most editing events are ADARB1 dependent with only few editing sites being specifically 
edited by ADAR.
Due to the strong impact of ADARB1 on miRNA abundance and the known higher editing levels in adult mice we applied the 
same experimental setup to miRNAs from adult mouse brain in wild type and ADARB1 mutant mice. ADARB1 deficient mice show 
reproducible changes in abundance of specific miRNAs, of which again many are unrelated to A to I editing events. Thus, binding of 
miRNA precursors by ADARB1, without editing, influences their abundance. Unlike in the embryo, A to G transitions are found in 
many sites and with a frequency up to 80% in the mature miRNA sequence. More than half of the editing events are primarily caused 
by ADARB1. Moreover, also previously unrecognized editing sites in miRNAs were identified. Interestingly, 64% of editing events 
occur in the seed region of miRNAs, allowing a retargeting of the edited miRNA.
Lack of ADARs also affects other non coding RNAs such as snoRNAs, snRNAs, and transcripts of repetitive elements. 
Understanding the consequences of these changes is a current focus of our studies.
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23 Biogenesis and function of cyclic N6-threonylcarbamoyladenosine (ct6A) as a widely 
distributed tRNA hypermodification
Tsutomu Suzuki1, Kenjyo Miyauchi1, Takuya Sakashita1, Satoshi Kimura1, Tomoyuki Numata2
1Department of Chemistry and Biotechnology, Graduate School of Engineering, the University of Tokyo, 
Tokyo, Japan.; 2Biomedical Research Institute, National Institute of Advanced Industrial Science and 
Technology (AIST), Ibaraki, Japan.
N6-threonylcarbamoyladenosine (t6A) has been recognized as a universally conserved, essential modified nucleoside 
found in tRNAs responsible for ANN codons in all three domains of life. t6A plays a crucial role in maintaining 
decoding accuracy during protein synthesis. The presence of t6A in cellular tRNAs has been well documented for 
more than four decades. However, under conditions optimized for nucleoside preparation, we detected little t6A in 
tRNAs from Escherichia coli. Instead, we identified a novel modified base named “cyclic t6A” (ct6A) (ref1), which is a 
cyclized active ester with an oxazolone ring. ct6A is widely distributed in many bacteria, fungi, protists and plants. ct6A 
has a supportive role in promoting decoding efficiency of tRNALys. Structural modeling indicated that ct6A recognizes 
the first adenine base of ANN codon at the ribosomal A-site.
We also identified an E1-like enzyme named tRNA threonylcarbamoyladenosine dehydratase A (TcdA) which 
catalyzes ATP-dependent dehydration of t6A to form ct6A. Detailed catalytic mechanism of t6A dehydration has been 
investigated by structural and biochemical approaches. In addition, we identified a cysteine desulfurase (CsdA) and a 
sulfur carrier protein (CsdE) to be required for efficient ct6A formation, indicating that sulfur relay system is involved 
in this reaction.
1. Miyauchi et al., Nat. Chem. Biol., 9, 105-111 (2013)
22 Mechanism of gRNA Biogenesis in Trypanosome Mitochondria
Ruslan Afasizhev1, Takuma Suematsu1, Inna Afasizheva1
1Department of Molecular & Cell Biology, Boston University Medical Campus, 72 East Concord Street, Evans 
Building, E438a Boston, MA 02118
The U-insertion/deletion mRNA editing reactions are directed by guide RNAs (gRNAs). Mature 50-60 nt gRNAs 
are generated from ~800 nt precursors by 3′ end nucleolytic processing and subsequent RET1-catalyzed uridylation. 
We previously demonstrated that TbRET1 repression in T. brucei leads to a loss of 3′ oligo(U) tails and accumulation of 
gRNA precursors. The former observation is consistent with TbRET1’s uridylyl transferase activity; the latter finding 
remained puzzling because TbRET1 lacks nucleolytic activity. Here, we show that TbRET1 forms a stoichiometric 
complex with a 3’-5’ exonuclease TbDSS1 and several proteins without any discernible motifs, which we named 
TbRDS (TbRET1-TbDSS1) complex. In S. cerevisiae, DSS1 interacts with SUV3 helicase to form a mitochondrial 
degradosome. However, in T. brucei we found no evidence of stable DSS1-SUV3 interaction. Repression of TbDSS1 
led to a loss of mature gRNAs and accumulation of ~800 nt gRNA precursors indicating that TbRET1 and TbDSS1 
function in the same processing pathway. Furthermore, overexpression of enzymatically inactive DSS1 triggered 
gRNA processing defects. In addition to minicircle-encoded gRNA precursors, TbRDS complex also targets 
maxicirlce-encoded messenger and ribosomal RNA precursors leading to generation of mature molecules. In vitro, 
TbRDS complex processively degrades single-stranded RNA to 5-6 nt oligonucleotides whereas in vivo degradation 
stops precisely at the 3′ ends of gRNAs, mRNAs and rRNAs. Deep sequencing of small mitochondrial RNA fraction 
indicated that guide RNA-sized antisense transcripts may define the 3′ boundary of mature mitochondrial RNAs. 
Collectively, our data indicate that nucleolytic processing of gRNA precursors by TbDSS1 and uridylation of mature 
gRNAs by TbRET1 are coupled by virtue of both enzymes being assembled into a stable TbRDS complex. The 
degradation activity of TbRDS is likely controlled by antisense RNAs thereby the 5’ end of the antisense determines 
the 3’ end of the sense strand.
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24 Unusual non-canonical editing important for tRNA processing in Trypanosomes as 
revealed by shallow sequencing.
Mary Anne T. Rubio1, Christopher R. Trotta2, Juan D. Alfonzo1
1Department of Microbiology; Center for RNA Biology; The Ohio State University; 2PTC Therapeutics
In eukaryotes, precursor tRNAs contain introns whose cleavage is mediated by an evolutionarily conserved 
endonuclease complex that generates fully functional mature tRNAs. The Trypanosoma brucei genome encodes a 
single intron-containing tRNA (tRNATyr), responsible for decoding all tyrosine codons; therefore, intron removal is 
essential for protein synthesis and consequently cell viability. In this organism, little is known about the mechanism 
of intron processing, but owing to its early evolutionary divergence from other eukaryotes, T. brucei often reveals 
unexpected peculiarities. Bioinformatic analyses revealed only one homolog of the four conserved canonical subunits 
of the multi-protein complex endonucleases required for tRNA splicing in other eukaryotes. Here we show an 
unprecedented number of nucleotide differences within the intron-containing pre-tRNATyr and its genomic copy. 
Significantly, these differences occur at the RNA level and cannot be ascribed to canonical deamination-type editing. 
Intron editing is required for proper pre-tRNA processing, establishing its functional significance for production of the 
full complement of tRNAs needed for translation. The demonstration of a novel editing mechanism required for proper 
function of a highly divergent splicing endonuclease in kinetoplastids has great implications to our understanding of 
the evolution of tRNA processing across eukaryotes.
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25 Structural insights into the assembly of spliceosomal U snRNPs
Clemens Grimm1, Jann Pelz1, Utz Fischer1
1University of Wuerzburg
Splicing is the process in which non-coding introns are excised from the primary transcript (pre-mRNA) and 
the coding exons are joined. Splicing is catalyzed by the spliceosome, which consists of the four small nuclear 
ribonucleoproteins (snRNPs) U1, U2, U4/6 and U5 as well as a large number of other proteins. Assembly of snRNPs 
from RNA and protein is an essential pre-requisite for splicesome formation. In vivo, this is facilitated in a highly 
complex biogenesis pathway. Initially, the snRNA is transported from its site of transcription to the cytoplasm. 
Within this compartment, the common (Sm) proteins as well as some proteins specific for the respective U snRNP 
associate with the snRNA. Finally, the mature particle is transported to the nucleus and eventually incorporated into 
the spliceosome. Our group has identified a unique machinery that assists the assembly of spliceosomal U snRNPs 
(Chari et al., 2008, Cell 135, 497-509). This machinery consists of two cooperating units termed SMN-complex and 
PRMT5-complex, respectively. While the SMN-complex is an RNP assembler and loads Sm proteins onto the snRNA, 
the PRMT5 complex functions upstream in this pathway. It acts as an assembly chaperone by forcing Sm proteins 
into a higher order structure (termed 6S complex) required for the subsequent transfer onto the SMN-complex. We 
will report on the atomic structure of two key intermediates of the snRNP assembly machinery. The structure of the 
early 6S intermediate identifies pICln as an Sm-protein mimic, which enables the topological organization of five Sm 
proteins in a closed ring and prevents premature RNA binding. A second structure of the 6S assembly intermediate 
bound to the SMN-complex components SMN and Gemin2 (see figure below) uncovers the likely mechanism of 
pICln elimination and Sm protein activation for snRNA binding. These structural studies along with biochemical 
experiments reveal how assembly factors facilitate formation of RNA-protein complexes in vivo.
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27 Crystal structure of Prp5p reveals intra-molecular interactions that impact splicing fidelity
Fei Yang1, Zhi-Min Zhang2, Jiahai Zhou2, Yong-Zhen Xu1
1Institute of Plant Physiology and Ecology, SIBS, Chinese Academy of Sciences; 2Shanghai Institute of 
Organic Chemistry, Chinese Academy of Sciences
Prp5p, a DEAD-box ATPase, is essential for spliceosome assembly by facilitating U2 snRNP binding to the 
intron branch site (BS) region and proofreads splicing. However, the structural basis for the function of Prp5p remains 
unclear. Here, we report crystal structures of S. cerevisiae Prp5p alone and in complex with ADP at resolutions of 
2.12 Å and 1.95 Å, respectively. The structures reveal that two RecA-like subdomains (D1 and D2) of Prp5p adopt 
an unusual twisted ‘open state’ conformation by extensive intra-molecular interactions with flanking sequences and 
the subdomain linker. Further in vivo mutagenesis in S. cerevisiae demonstrated that a number of prp5 alleles, which 
destabilized the intra-molecular interactions, specifically inhibit splicing of suboptimal BS substrates. The mutant 
Prp5p proteins possess faster-than-WT ATPase activities in vitro. These observations suggest a mechanism in which 
the twisted ‘open state’ conformation of Prp5p must be remodeled into a ‘closed state’ conformation during branch 
site recognition in order to activate its ATPase activity and to commit the intron to the splicing pathway. Changes in 
the relative stabilities of the ‘open’ and ‘closed’ forms of Prp5p result in alteration of splicing fidelity.
26 Crystal structure of human spliceosomal U1 snRNP at 3.3 Å resolution.
Yasushi Kondo1, Chris Oubridge1, Marike van Roon1, Kiyoshi Nagai1
1MRC Laboratory of Molecular Biology
Human spliceosomal U1 snRNP consists of U1 snRNA, seven Sm proteins and three U1-specific proteins; U1-
A, U1-C, and U1-70k. The binding of U1 snRNP to the 5’ splice site (5’ss) within the mRNA precursor (pre-mRNA) 
initiates spliceosome assembly. Numerous biochemical and genetic studies showed that U1 snRNP recognizes the 5’ss 
of pre-mRNA through base-pairing with the 5’ end of U1 snRNA and that U1-C is important for the efficiency of the 
binding (1).  Our previously-reported 5.5 Å crystal structure revealed that the U1-C zinc finger domain locates next 
to U1 snRNA 5’-end: 5’ss duplex, but we could not study this interaction in detail due to the limited resolution (2). 
Although the sequence of the 5’-end of U1 snRNA is completely conserved from yeast to human, the 5’ splice site 
sequence of the pre-mRNA to which it binds shows different degrees of conservation in different species. The 5’ss is 
stringently conserved in Saccharomyces cerevisiae whereas in human only the GU di-nucleotide is strictly conserved.
In order to gain further insights into the recognition of the 5›ss by U1 snRNP, using previous structures as a guide, 
we designed a minimal sub-structure of U1 snRNP containing all the components necessary for 5›ss recognition.  We 
reconstituted and crystallised this sub-structure with the seven Sm proteins, U1-C, the N-terminal domain of U1-70k, 
and a U1 snRNA lacking stem/loop I, II and III,. 
Here we report a 3.3 Å resolution crystal structure of a U1 snRNP sub-structure to which an RNA oligonucleotide 
containing a 5’ss sequence is bound. The crystal structure reveals how the U1-70k N-terminal peptide stabilizes the 
binding of U1-C protein and how U1-C in turn facilitates the binding of the 5’ splice site. The structure also shows the 
differences between the U1 and U4 core domain structures and provides insight into the specificity of the N-terminal 
peptide of U1-70k for the U1, and not the U4 core domain.
1. Heinrichs, V., Bach, M., Winkelmann, G. & Lührmann, R. U1-specific protein C needed for efficient complex formation of 
U1 snRNP with a 5’ splice site. Science 247, 69–72 (1990).
2. Pomeranz Krummel, D. A., Oubridge, C., Leung, A. K., Li, J. and Nagai, K. Crystal structure of human spliceosomal U1 
snRNP at 5.5 Å resolution. Nature 458, 475-480 (2009).
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29 Functional spliceosome assembly without stable U4/U6 snRNA pairing
Jordan Burke1, Samuel Butcher1, David Brow1
1University of Wisconsin-Madison
The cycle of spliceosome assembly, intron excision, and disassembly involves large-scale snRNA structural 
rearrangements. U6 snRNA toggles between a U2 snRNA-bound state in the catalytically active spliceosome and a 
U4 snRNA-bound state during spliceosome assembly. The function of U4/U6 pairing is not clear, but is presumed 
to be essential since it occurs in all eukaryotes examined. Here we report the surprising finding that stable U4/U6 
pairing is dispensable for splicing in yeast. Single point mutations in U4 and U6 that disrupt their pairing are lethal 
in combination, but are rescued by a second mutation in U6 that extends U2/U6 Helix II and stabilizes the U2/U6 
complex. The resulting triple mutant strain lacks detectable U4/U6 snRNP, and accumulates a novel U2/U6 snRNP. 
NMR analysis of wild-type and mutant U2/U6 RNA constructs reveals that either single mutation in U6 disrupts the 
wild-type three-helix junction structure, but the two mutations together restore and further stabilize the U2/U6 three-
helix junction. We conclude that, in the presence of a stabilized U2/U6 snRNP, stable U4/U6 pairing is not essential 
for spliceosome assembly and function. Nevertheless, U4 snRNA is still required for cell viability, and a U4.U5.U6 tri-
snRNP accumulates even in the absence of U4/U6 pairing. We propose that, in the triple-mutant strain, the U2 snRNP 
acts as a chaperone for assembly of the tri-snRNP, as has previously been suggested for the human U4/U6 snRNP.
28 Sequential contacts of DExD/H-box protein Prp28p with Prp8p, Brr2p, and Snu114p 
during splicing as captured by a chemical cross-linking approach
Fu-lung Yeh1, Luh Tung1, Che-Ming Lin2, Hsien-Yeh Chou1, Tien-Hsien Chang1
1GRC, Academia Sinica; 2Department of Chemical Engineering of National Taiwan University
Although DExD/H-box proteins are known to unwind RNA duplexes and/or modulate RNA structures in vitro, it 
seems plausible that, in vivo, some may function as RNPases to dissociate proteins from RNA or to remodel RNA-protein 
complexes. Precisely how the latter can be achieved remains unknown. We have been trying to approach this issue by using 
yeast Prp28p as a model system.  Prp28p is an evolutionarily conserved DExD/H-box splicing factor that facilitates the U1/
U6 switch at the 5’ splice site (5’ss) during spliceosomal assembly. We have previously shown that Prp28p can be made 
dispensable in the presence of specific mutations that alter U1C, Prp42p, Snu71p, Cbp80p, and Ynl187p. These data suggest 
a model that Prp28p counteracts the stabilizing effect by those proteins on U1 snRNP/5’ss interaction. To probe how Prp28p 
contacts its targets in a splicing-dependent manner, we strategically placed a chemical cross-linker, benzoyl-phenylalanine 
(BPA), along the length of Prp28p in vivo using a nonsense-suppressor-mediated approach.  Extracts prepared from these 
strains were then used for splicing at various ATP concentrations and for UV-activated cross-linking reactions. Prp28p 
appears to transiently interact with the spliceosome at low ATP concentration, which is known to accumulate A2-1 (or B; 
mammalian system) complex. Under such a condition, we observed that Prp28p cross-links with a small number of proteins 
and some of these cross-linked products are dependent on the presence of UV, ATP, RNA, and, importantly, functional 5’ss 
and branch site. Furthermore, the cross-linked products are resistant to RNase treatment. Using mass-spec and Western 
blotting analysis, we found that Prp28p-K136BPA cross-links to Prp8p and Prp28p-K82BPA contacts both Prp8p and Snu114p. 
Furthermore, Prp28p-K27BPA and Prp28p-K41BPA were cross-linked to Brr2p and Snu114p, respectively. These data are 
consistent with the structural study of the U5–U4/U6 tri-snRNP, which placed Snu114p next to Prp8p, which is in turn 
adjacent to Brr2p. ChIP analysis revealed that alanine substitutions at Prp28p-K136 region reduce the binding of Prp28p 
to spliceosome and delay the release of U1 snRNP from spliceosome, consistent with our genetic analysis suggesting that 
Prp28p works in concert with Prp8p. Finally, mixing experiments suggested that Prp28p makes contact with Prp8p and then 
with Brr2p. Taken together, our data suggest a working model that Prp28p approaches the complex spliceosomal milieu by 
making prior contact with Prp8p to effect U1 snRNP dissociation and then with Brr2p (and perhaps Snu114p), which may 
transmit the signal to couple U1 dissociation with the U4/U6 unwinding, a key step in spliceosomal remodeling.
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31 3D Cryo-EM structure of the yeast activated spliceosome (Bact) and localisation of 
functionally important regions
Holger Stark1, Norbert Rigo1, Chengfu Sun1, Prakash Dube1, Kum-Loong Boon1, Berthold Kastner1, Reinhard 
Rauhut1, Patrizia Fabrizio1, Reinhard Lührmann1
1Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
The spliceosome, which catalyses the removal of the intron from nuclear pre-mRNAs, assembles initially into 
a pre-catalytic ensemble, termed complex B, which contains the snRNPs U1, U2 and the U4/U6.U5 tri-snRNP and 
numerous non-snRNP proteins. For catalytic activation the spliceosome undergoes a major structural rearrangement; 
this yields the Bact complex and entails the dissociation of U1 and U4 RNPs and the formation of a new RNA–RNA 
interaction network involving U6, U2 and the pre-mRNA, which lies at the heart of the emerging catalytic centre. 
At the same time the Prp19 complex proteins (NTC) and ca. 10 NTC-related proteins are  stably integrated into the 
Bact complex.
We have used single-particle electron cryomicroscopy to reconstruct the 3D structure of purified yeast Bact complexes 
at a resolution of 20–25 Å. Consistently with the dramatic change in biochemical composition that accompanies its 
formation, the structure of the Bact complex differs greatly from that of the pre-catalytic B complex. The reconstituted 
3D structure of the Bact complex from S. cerevisiae has a mushroom-like appearance.  The “mushroom cap” (the main 
body) consists of a relatively compact, prolate body about 37 nm long and 28 nm wide.  From it, the “mushroom stalk” 
is seen to emerge as a slightly tapering, 15-nm-long protuberance. At the two ends of the main body large clefts and 
tunnels are seen, while its centre is clearly more solid.  The protuberance is roughly perpendicular to the ellipsoid’s 
main axis at its base, but is slightly curved.
We have begun to map the position of selected proteins such as Cwc2, Prp2, Prp19, Brr2 and Prp8 and some U2 
proteins. These data provide initial insights into the location of the emerging catalytic centre and other functionally 
important sites in the Bact complex.
Finally, we have located certain U5- and U4/U6-specific proteins at the surface of purified pre-catalytic B 
complexes, which – in combination with our earlier electron-microscopic localisation studies of proteins in the 
purified U4/U6.U5 tri-snRNP (NSMB 2008; 15: 1206) – allows us to fit the tri-snRNP structure into the B complex at 
an unambiguously defined position.
30 A group II intron-like catalytic triplex in the U6 snRNA forms during spliceosome 
activation
Sebastian Fica1, Melissa Mefford2, Joseph Piccirilli3, Jonathan Staley4
1Graduate Program in Cell and Molecular Biology, Department of Molecular Genetics and Cell Biology, 
The University of Chicago, Chicago, USA; 2Committee on Genetics, Genomics and Systems Biology, The 
University of Chicago; present address: Department of Biology, Johns Hopkins University; 3Department of 
Chemistry and Department of Biochemistry and Molecular Biology, The University of Chicago; 4Department 
of Molecular Genetics and Cell Biology, The University of Chicago, Chicago, USA
Catalysis of pre-mRNA splicing and group II intronic RNA self-splicing has been proposed to occur by a two-metal 
ion mechanism. The crystal structure of a group II self-splicing intron shows the catalytic domain V in a configuration 
where five non-bridging oxygens of the phosphate backbone coordinate two metal ions. We have recently provided 
evidence that the corresponding five residues in the spliceosomal U6 snRNA are bona fide metal ion ligands and 
one of these ligands - the bulged U80 in the U6 ISL - plays a direct catalytic role by binding metal ions that stabilize 
the leaving groups during both steps of splicing. In the group II intron, the metal binding configuration of domain V 
depends on formation of three RNA base-triple interactions that function during both steps of splicing, and it has been 
suggested that similar interactions may occur between within the U6 snRNA between the ACAGAGA, the AGC triad, 
and U80. Consistent with this prediction we found that mutations in the AGC triad are suppressed in vivo by mutations 
that restore the base-triple interactions. Furthermore, we show by in vitro molecular genetics that the U6 base triples 
function at the catalytic stage and are required for efficient exon ligation. 
Unexpectedly, by site-directed cross-linking, we found that U6 base triples form before Prp2-dependent catalytic 
activation of the spliceosome and require the NTC complex, suggesting that the catalytic core forms already at the 
pre-catalytic stage. Preliminary evidence also suggests that Cwc2 promotes formation of the base triples, supporting 
previous proposals that Cwc2 may stabilize formation of catalytic structures in U6 by substituting in the spliceosome 
for RNA structures that in the group II intron induce the catalytic configuration of domain V. 
Our findings indicate that the U6 snRNA adopts a group II intron-like tertiary conformation to catalyze pre-mRNA 
splicing, providing further evidence that the spliceosome and group II introns share common catalytic mechanisms 
and evolutionary origins. 
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33 Versatile reaction catalyzed by the Spliceosome in a competitive manner
Chi-Kang Tseng1, Hui-Fang Wang1, Che-Sheng Chung1, Soo-Chen Cheng1
1Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan
The spliceosome is a large and dynamic ribonucleoprotein complex, which undergoes components exchange and 
structural rearrangements throughout the entire splicing pathway. During catalytic steps, Prp16 is required to facilitate 
conformational change from step one to step two by destabilization of Yju2 and Cwc25, which are required for the first 
catalytic reaction.  Despite of the energy requirement of such structural changes for the progression of the reaction, 
both steps of the splicing reaction can reverse on the purified spliceosome under appropriate conditions without 
having to replace splicing factors.  In addition, the spliceosome can catalyze hydrolytic spliced-exon reopening (SER) 
reaction when arrested in step-two conformation, and debranching of lariat-intron-exon 2 (DBR) when arrested in step-
one conformation.  The SER reaction is in competition with the reverse reaction of step-two splicing (R2), whereas 
DBR is in competition with the reverse reaction of step-one splicing (R1).  Recently we have found that changes 
in the N-terminal structure of Yju2 and Cwc25 biased the reaction toward R1 and strongly inhibited DBR.  Cwc25 
with epitope tagged at the N-terminus was destabilized from the spliceosome after the first catalytic reaction.  Such 
spliceosomes could promote high efficiency of R1 and also promote the second reaction (F2) at a low level.  Adding 
back Cwc25 inhibits the F2 reaction.  These results indicate that the spliceosome can bypass the requirement of 
Prp16 and other step-two factors to promote the second reaction under the condition of Prp16-independent Cwc25 
destabilization.  The F2 reaction that occurs in the absence of step-two factors requires KCl and is inhibited by the 
presence of Cwc25, which instead promotes the debranching reaction.  Our studies provide novel mechanistic insights 
into the molecular mechanism of the splicing reaction.
32 A conformational switch in PRP8 mediates metal ion coordination that promotes pre-
mRNA exon ligation
Matthew Schellenberg1, Tao Wu2, Dustin Ritchie2, Sebastian Fica3, Jonathan Staley3, Karim Atta2, Paul Lapointe2, 
Andrew MacMillan2
1University of Alberta, Department of Biochemistry; 2University of Alberta; 3University of Chicago
The spliceosome is a large and complex RNA-protein machine that removes introns during maturation of pre-
mRNAs by a mechanism involving two sequential phosphotransfer reactions.  A wealth of evidence shows that the 
spliceosome is a dynamic structure undergoing a series of conformational changes as it assembles on a pre-mRNA 
substrate, catalyzes two the two splicing reactions, and disassembles/recycles for subsequent rounds of catalysis.
The catalytic center of the splicing machinery includes an RNA structure comprised of the U2 and U6 spliceosomal 
snRNAs with divalent metal binding by U6 snRNA implicated in catalysis of both steps of splicing. A wealth of genetic 
and biochemical evidence places the protein PRP8 at the heart of the splicing machinery during spliceosome assembly 
through to catalysis, and suggests that it undergoes a conformational change between the two steps of splicing. 
We have obtained structural and functional evidence that the RNase H domain of PRP8 undergoes a conformational 
change between the two transesterification steps of splicing rationalizing yeast prp8 alleles that promote either the first 
or second step.  We have further discovered that this conformational switch unmasks a metal-binding site involved in 
the second transesterification reaction (see Figure 1 below).  Together these data establish that PRP8 is a metalloprotein 
that promotes exon ligation within the spliceosome.
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35 NMD3 regulates mRNA nuclear export via an XpoI-linked mechanism
Pegine Walrad1, Melanie Bühlmann2, Pegine Walrad1, Paul Capewell2, Arunasalam Naguleswaran4, Isabel Roditi4, 
Elisabetta Ullu3, Keith R. Matthews2
1Centre for Immunology and Infection, University of York; 2Centre for Immunity, Infection and Evolution, 
University of Edinburgh; 3Dept of Internal Medicine and Cell Biology, Yale Medical School; 4Institute for Cell 
Biology, University of Bern
The RBP NMD3 (Upf3) has been implicated in mRNA Nonsense Mediated Decay and rRNA processing and 
export. Interestingly, we have also discovered that NMD3 RNAi generates a strong upregulation of a specific subset 
of transcripts. RNAseq transcriptome analysis of NMD3-depleted cells show that this effect is highly specific whereas 
reporter assays demonstrate that this effect is UTR-dependent and restricted to the mRNA level (no protein elevation 
occurs).  ChIP analysis confirmed the transcript upregulation is not mediated by enhanced locus-specific transcription, 
nor is it a consequence of translational inhibition resulting from the effects of NMD3 depletion on rRNA maturation. 
Importantly, depletion of the 7SL RNA nuclear export factor, XPO1, recapitulates the effects of NMD3 depletion on 
specific mRNAs. Moreover, in situhybridisation analyses demonstrate a bulk nuclear accumulation of all mRNAs in 
response to NMD3 depletion. This invokes a novel mRNA regulatory mechanism involving the NMD3- and XPO1-
dependent nuclear export of mRNA cargos, with specific mRNA accumulation resulting from nuclear sequestration 
and hence protection from rapid cytoplasmic turnover. This novel function for NMD3 may be conserved in other 
systems.
34 An unexpected role of the nuclear periphery for mRNA export in yeast
Mark-Albert Saroufim1, Daniel Zenklusen1
1Département de Biochimie, Université de Montréal
The export of mRNAs from the nucleus to the cytoplasm is one of the many steps along the gene expression 
pathway and reflects only a short time period within the lifetime of an mRNA. However, mRNA export cannot be 
seen as an isolated process, as it has been functionally linked to different upstream and downstream processes, in 
particular the localization of the gene within the nucleus, transcription, mRNA processing and quality control. In the 
yeast S cerevisiae, many active genes are tethered to the nuclear periphery through interactions with the nuclear pore 
complex; the role of this perinuclear localization however is not fully understood. As many genes showing perinuclear 
localization are regulated by stress, NPC anchoring has been hypothesized to ensure fast and efficient export of newly 
synthetized RNAs under these conditions.
The NPC itself has to fulfill a dual function in mRNA transport, as it not only has to allow for fast export of 
mRNAs, but also ensure that only mature mRNPs are exported to the cytoplasm. Indeed, quality control steps have 
been suggested to occur at the NPC, such as the retention of unspliced pre-mRNAs. To better understand how the 
interconnection of gene localization, RNA processing and quality control affects the efficient export of mRNAs, we 
use single molecule resolution real-time microscopy to follow individual mRNAs from their site of transcription 
on their path towards to cytoplasm. We show that, different to current models, gene tethering to the periphery does 
not lead to the export of mRNAs through an adjacent nuclear pore complexes, as mRNAs are released into the 
nucleoplasm where they reach the nuclear periphery by diffusion within less then a second. Once reaching the nuclear 
periphery, they are not immediately exported but start scanning along the nuclear periphery, likely to find a nuclear 
pore that allows export. Interestingly, deleting specific components of the nuclear basket significantly reduces the time 
mRNPs scan the nuclear periphery and result in frequent release of mRNPs back into the nucleoplasm. This suggests 
that the nuclear basket not only acts as a landing platform for mRNPs at the nuclear pore but also has the capacity to 
maintain mRNAs at the periphery, possibly to allow sufficient time for quality control steps to occur without releasing 
the mRNPs back into the nucleoplasm. 
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37 Identification and analysis of Staufen2 target RNAs from rat brain
Jacki Heraud-Farlow1, Michael Doyle1, Martin Bilban2, Stefanie Tauber2, Michael Kiebler3
1Center for Brain Research, Department of Neuronal Cell Biology, Medical University of Vienna, Austria; 
2Anna Spiegel Forschungsgebäude, Medical University of Vienna, Vienna, Austria; 3Department for Anatomy 
& Cell Biology, Ludwig Maximilian University, Munich, Germany
In neurons, RNA-binding proteins (RBPs) play an important role in directing RNA translation to subregions of 
the cell, including synapses. This process is known to critically contribute to synaptic plasticity. The double-stranded 
RBP, Staufen2 (Stau2), has been implicated in cell fate determination as well as in dendritic RNA localization and 
synaptic plasticity in mammalian neurons.
In order to better elucidate the role of Stau2 in neurons and its contribution to RNA localization, we have identified 
Stau2 target RNAs in the rat brain by immunoprecipitation of endogenous soluble Stau2 particles. Many of the Stau2 
target RNAs encode functionally related proteins involved in G-protein-coupled receptor (GPCR) and small GTPase-
mediated signaling pathways. Additionally, 77% of the Stau2 targets that are expressed in the hippocampus overlap 
with a new dataset of neuronal process-localized mRNAs (Cajigas et al., Neuron, 2012) indicating most Stau2 RNPs 
can localize away from the cell body. Interestingly, the activity of extracellular signal-regulated kinases-1 and -2 
(ERK1/2) is reduced upon Stau2 knockdown, suggesting Stau2 affects intracellular signaling pathways in the brain. 
Furthermore, we present evidence that Stau2 stabilizes the expression of one of the GPCR pathway components, the 
Regulator of G-protein Signaling 4 (Rgs4) mRNA. This effect is mediated via the Rgs4 3’-UTR since downregulation 
of Stau2 in neurons leads to reduced expression of a luciferase reporter. We hypothesize that the regulation of ERK1/2 
and Rgs4 may underlie the involvement of Stau2 in dendritic spine morphogenesis and synaptic plasticity. Taken 
together, our data provide new insight into the role of Stau2 in neurons.
36 RNA recognition and architectural activity of Zipcode Binding Protein 1
Giuseppe Nicastro1, Adela Candel3, David Hollingworth1, Alain Oregioni2, Andres Ramos1
1MRC National Institute for Medical Research; 2MRC Biomedical NMR Centre; 3Universidad de Granada
IGF2 mRNA binding protein 1 (IMP1)/Zipcode binding protein 1 (ZBP1) is an oncofetal protein expressed at very 
low level in most adult tissues. ZBP1 is important for cell motility and its expression in cancer cells has been linked to 
tumor dissemination. ZBP1 is an RNA-binding protein that mediates the transport of a set of mRNAs from the nucleus 
to the cell periphery. It contains two RRM and 4 KH domains organised in three di-domain units. An important and 
well studied target of ZBP1 is the β-actin mRNA, and it has been shown that ZBP1 binds to β-actin mRNA in the 
nucleus and mediates its transport to the cell edge in a translationally repressed state. Here ZBP1 is phosphorylated 
by Src and the mRNA is released and translated. ZBP1-mediated transport takes place in large protein-RNA particles 
and the structure of the KH3 and KH4 domains, the key domains for the recognition of the β-actin RNA, suggest that 
ZBP1 may play an architectural role. We have solved the high resolution structure of ZBP1 KH3-KH4 in complex 
with the β-actin RNA target. We discuss a novel mode of KH-RNA binding and a mechanistic model for ZBP1 
recruitment and ZBP1 architectural activity.
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39 Novel players and novel mRNAs transported by the Bic-D / Egl / Dynein RNA localization 
machinery
Paula Vazquez1, Bogdan Schaller1, Rémy Bruggmann1, Samuel Neuenschwander1, Henning Urlaub2, Beat Suter1
1Biology, University of Bern, 3012 Bern, Switzerland; 2Max-Planck-Institut für biophysikalische Chemie, 
?37077 Göttingen, Germany
Many key cellular processes in eukaryotes depend on mRNA localization. In Drosophila, the mRNA transport 
machinery consisting of Bic-D, Egl and the dynein motor is used at many different developmental stages and in 
many cell types to localize key mRNAs required for oocyte differentiation, embryonic axis formation and patterning. 
Through the dynein / dynactin motor the mRNA cargo is moved on microtubules to distinct cellular compartments. 
While Egl links these motors and Bic-D with mRNA cargo, it is unclear, which additional proteins are required to 
confer mRNA target specificity and translational control during the transport. Using immunopurification of Bic-D and 
Egl complexes we have identified several novel components of the Bic-D / Egl transport machinery. Amongst them 
are the poly(A) binding protein (Pabp) and the insulin growth factor mRNA binding protein (Imp). Through a polyA 
independent activity, Pabp localizes osk mRNA in the female germ line, while Drosophila Imp is found to co-localize 
with the Bic-D/hairy mRNA–RNP complexes in embryos. Despite this, our functional analysis revealed that imp plays 
at most a redundant role in localizing this mRNA. Instead, it seems to function in repressing translation of hairy mRNA 
during transport. Two additional proteins were shown to interact with Bic-D and novel findings regarding them will 
be presented at the meeting. Encouraged by the success of the isolation of protein partners, we also screened for novel 
mRNAs present in complexes with Bic-D and Egl. We immunoprecipitated these proteins, purified the bound mRNAs 
and quantified the transcripts using high-throughput cDNA sequencing. The in situ localization patterns of the IP-
enriched mRNAs, the presence of the known targets of the Bic-D localization machinery in these complexes and the 
dependence of their localization patterns on Bic-D revealed a rewarding success rate for this approach. Such targets 
and their analyses will be presented in Davos, too.
38 The order of assembly and disassembly of nuclear ASH1-mRNPs
Annika Niedner1, Marisa Müller2, Dierk Niessing1
1Helmholtz Zentrum München, Institute of Structural Biology; 2Helmholtz Zentrum München Institute of 
Structural Biology, current address Ludwig-Maximilians-Universität München
mRNA localization is a universal feature in eukaryotes, requiring the assembly of motor-dependent transport 
particles. The cytoplasmic transport of mRNAs is preceded by the nuclear assembly of pre-mRNPs. A transit of such 
nuclear pre-mRNPs through the nucleolus has been reported. One example is the ASH1 mRNA, where the nucleolar 
protein Loc1p is required for efficient cytoplasmic ASH1 mRNA localization, most likely by remodeling the nuclear 
mRNP. Although immunoprecipitation experiments already revealed that Loc1p forms co-complexes with other nuclear 
components of the transport complex, it remains unclear how Loc1p is recruited into this mRNP. Because genomic 
deletion of LOC1 also results in impaired ribosome biogenesis, it has been suggested that impaired ASH1 mRNA 
localization might be only an indirect effect. 
Here we show that Loc1p interacts directly and specifically with the ASH1 mRNA-binding protein She2p, 
indicating a direct role of Loc1p in mRNA localization. Our data suggest that the Loc1p interaction with She2p 
and RNA results in the formation of a stable ternary complex, in which both proteins directly contact the RNA. 
A second nucleolar factor co-immunoprecipitated with She2p and ASH1 mRNA is Puf6p. We do not find a direct 
interaction of Puf6p with Loc1p and She2p, suggesting that these factors do not form a joint protein complex. After 
nuclear export, myosin-bound She3p joins the complex of ASH1 mRNA, She2p, and Puf6p. Since Loc1p remains 
in the nucleus, it must be removed from the complex prior or during export. Our competition experiments show that 
She3p is able to displace Loc1p from the ASH1 complex. Together these findings imply an ordered process of nuclear 
assembly and disassembly, and suggest that Loc1p and She3p encounter each other in the vicinity of the nuclear pore. 
Furthermore our data indicate that the mutual recruitment of Loc1p and She2p to the ASH1 mRNA enables She2p 
to escort the ASH1 mRNA through the nucle(ol)us. It confirms an integral role of Loc1p in ASH1 mRNP biogenesis.
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40 An RNA biosensor for imaging translation of single mRNAs in living cells.
Jeffrey Chao1, Timothée Lionnet2, Robert Singer2
1Friedrich Miescher Institute for Biomedical Research; 2Albert Einstein College of Medicine
After transcription, an mRNA’s fate is determined by an orchestrated series of events that is regulated both 
temporally and spatially within the cell.  The regulation of translation is crucial for control of gene expression.  While 
measurements of ribosome occupancy of mRNAs have provided a genome-wide view of translation, the cellular 
context has been lost.  Fluorescent microscopy can complement these global approaches because it allows interrogation 
of gene expression with single-molecule resolution in intact cells.  We have developed an RNA biosensor that allows 
individual untranslated mRNAs to be distinguished from mRNAs that have already been translated in living cells.
Most approaches for imaging translation have relied on either detecting the newly synthesized polypeptide or 
identifying actively translating ribosomes within the cell, which are inherently limited by low signal-to-noise.  We 
have chosen to consider translation from the perspective of the mRNA because imaging single-molecules of RNA has 
been well established.  We have utilized the orthogonal MS2 and PP7 RNA-protein complexes to label an mRNA in the 
coding sequence (PP7-GFP) and 3′ UTR (MS2-RFP) with spectrally distinct fluorescent proteins.  When this mRNA 
is untranslated it will be labeled with both fluorescent proteins, however, once the mRNA encounters the ribosome for 
the first time, the PP7-GFP signal will be displaced from the transcript resulting in only MS2-RFP labeled mRNAs. 
This simple strategy allows untranslated mRNAs (yellow) to be readily distinguished from translated ones (red).  We 
refer to this technique as translating mRNA imaging by coat protein knock-off (TRICK).     
The TRICK assay has been used to characterize the translation of a reporter mRNA in U2 O-S cells.  We find 
no evidence for translation of the reporter mRNA in the nucleus.  In the cytoplasm, however, almost every mRNA 
has been translated at least once.  By combining fixed and live cell measurements, our data suggests that the average 
mRNA takes approximately two minutes once exported to the cytoplasm to be bound, scanned and have translation 
initiated by the ribosome.   
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41 Single molecule systems biology of RNA silencing
Nils Walter1, Sethuramasundaram Pitchiaya3, Márcio Mourão2, Corey Custer1, Laurie Heinicke1, Katelyn 
Doxtader1, Vishalakshi Krishnan1, Santiago Schnell2
1Single Molecule Analysis Group, Department of Chemistry, University of Michigan, Ann Arbor, Michigan, 
USA; 2Department of Molecular & Integrative Physiology, University of Michigan Medical School, Ann 
Arbor, Michigan, USA; 3Single Molecule Analysis Group, Department of Chemistry, and 2Program in 
Chemical Biology, University of Michigan, Ann Arbor, Michigan, USA
Imagine we could use eukaryotic cells as reaction vessels in which we directly “see” physiologically low numbers 
of RNA molecules that individually go about their biological functions within their natural “habitat”, under the constant 
influence of molecular crowding amongst all known and unknown interaction partners.  This arguably ultimate 
goal of a quantitative biology for the 21st century has only just come within reach, opening entirely new avenues 
towards understanding cellular life and disease – after all, “seeing is believing”.  To realize this vision, we recently 
developed iSHiRLoC, or intracellular Single molecule, High-Resolution Localization andCounting, as an innovative 
probe concept optimized for detecting single, biologically functional RNA molecules inside live human cells.  For 
iSHiRLoC, we microinject an RNA of interest, inconspicuously labeled with a single fluorophore, into cultured human 
cells.  Microinjection allows us to keep the number of molecules low so as not to overwhelm the cellular RNA 
processing machinery, while enabling intracellular single RNA molecule detection during low-background highly 
inclined laminar optical sheet (HILO) microscopy.  At defined time points after microinjection, we then perform 
one of two experiments – single particle tracking in the live cell or, upon formaldehyde fixation, counting of the 
number of photobleaching steps per particle as a fingerprint of RNA assembly – giving us the unique opportunity 
to directly watch and quantify the dynamics of intracellular RNA pathways.  In its first successful implementation, 
we applied iSHiRLoC to gene regulation by microRNAs (miRNAs)1, key effectors of the evolutionarily conserved 
RNA silencing pathway, with profound significance for human health as a master regulator of gene expression.  We 
showed that microinjected, 3’ fluorophore labeled microRNAs retain full functionality in RNA silencing and display 
two kinetically distinct assembly pathways that we propose are sequential translational inhibition and degradation of 
the targeted messenger RNAs (mRNAs).  We have recently extended iSHiRLoC to two colors to co-track and count 
pairwise combinations of miRNAs and their target mRNA and protein interaction partners.  To further interpret these 
data, we are performing systems biology modeling through Monte-Carlo simulations in the molecular environment 
of the cell, using our experimental iSHiRLoC data as input to predict the cellular output.  To deeply integrate our 
experimental and computational approaches into the envisioned Single Molecule Systems Biology, we experimentally 
measure the extent of gene repression by miRNAs, then compare the computational prediction with experimental 
reality iteratively to derive a fully converged mechanistic description of RNA silencing.
1. Pitchiaya, S.; Androsavich, J. R.; Walter, N. G. EMBO rep 2012, 13, 709-715.
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43 Virus-Induced Dysregulation of Cellular mRNA Decay and Alternative Polyadenylaton – 
Implications for Pathogenesis
Stephanie L. Moon1, Michael D. Barnhart1, Liang Liu2, Carol J. Wilusz1, Bin Tian2, Jeffrey Wilusz1
1Department of Microbiology, Immunology & Pathology, Colorado State University, Fort Collins, CO; 
2Department of Biochemistry and Molecular Biology, UMDNJ-New Jersey Medical School, Newark, NJ
RNA viruses must successfully interface with the cellular RNA decay machinery in order to maintain the stability 
of their transcripts and promote a productive infection.  We have determined that alphaviruses interact with the cellular 
HuR protein through high affinity binding sites in their 3’ UTR to stabilize viral transcripts.  Furthermore, alphaviruses 
cause a redistribution of the cellular HuR protein from the nucleus to the cytoplasm during infection.  Transfection 
studies have revealed that this is due to the abundant cytoplasmic viral transcripts acting as molecular sponges for 
the protein.  This decrease of HuR protein in the nucleus causes alterations in patterns of alternative polyadenylation 
in the cell. To our knowledge this is the first time that a cytoplasmic RNA virus has been shown to influence patterns 
of nuclear poly(A) site choice.  The sequestration of HuR protein by alphaviruses also dramatically reduces the 
stability of cellular mRNAs that normally depend on the protein for regulated stability or to prevent miRNA targeting. 
Many of these mRNAs encode mediators of innate immune functions, cytokines or apoptosis regulators that can 
directly impact on the outcome of a virus infection.  A similar story is also evolving from our flavivirus studies.  All 
arthropod-borne flaviviruses produce a small non-coding sfRNA from their 3’ UTR as a decay intermediate from 
Xrn1 exoribonuclease digestion.  Xrn1 remains associated with sfRNA and becomes functionally repressed during 
infection.  This effectively shuts down a major pathway of cellular mRNA decay during flavivirus infection, resulting 
in stability of viral transcripts and significant dysregulation of the stability of cellular mRNAs.   Thus we believe 
that disruption of regulated mRNA stability during infections with either alphaviruses or flaviviruses likely plays an 
important and underappreciated role in cytopathology and viral pathogenesis.
42 GRSF1 regulates RNA processing in mitochondrial RNA granules
Alexis A. Jourdain1, Jean-Claude Martinou1
1University of Geneva
RNA molecules sometimes assemble into macromolecular structures called RNA granules. These large 
ribonucleoparticles, known as “stress granules”, “P-bodies” or “neuronal RNA granules” have many RNA-related 
functions such RNA storage, protection, degradation or transport.
We will describe the existence of RNA granules within mitochondria1. These mitochondrial RNA granules contain 
nascent RNA molecules together with specifically associated proteins including the G-rich RNA sequence binding 
factor 1 (GRSF1), the Fas-Activated Serine/Threonine kinase (FASTK), RNAse P, and the helicase hSuv3p. We found 
that GRSF1 is required for the processing of long polycistronic mitochondrial transcripts into mature mRNAs, tRNAs 
and rRNAs, which is an essential aspect of mitochondrial gene expression that remains poorly understood. Impairment 
of RNA processing delays the release of newly synthesized RNA from mitochondrial RNA granules, indicating that 
these structures may correspond to factories where primary RNA transcripts converge and are processed before release.
Based on these results, we hypothesize that mitochondrial RNA granules are involved in several aspects of post-
transcriptional regulation of mitochondrial gene expression and that dysfunction of key components of these RNA 
granules may lead to severe pathologies.
1. Alexis A. Jourdain, Mirko Koppen, Mateusz Wydro, Chris D. Rodley, Robert N. Lightowlers, Zofia M. Chrzanowska-
Lightowlers, Jean-Claude Martinou. GRSF1 regulates RNA processing in mitochondrial RNA granules. Cell Metabolism. 
In press.
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45 RNA/RNA interactions govern selective packaging of influenza A genomic segments
Cyrille Gavazzi1, Matthieu Yver3, Emilie Fournier1, Boris Essere3, Jean-Christophe Paillart1, Jean-Daniel Sirbat1, 
Annie Cavalier2, Jean-Paul Rolland2, Daniel Thomas2, Manuel Rosa-Calatrava3, Bruno Lina3, Catherine Isel1, 
Vincent Moules3, Roland Marquet1
1Architecture et Réactivité de l’ARN, Université de Strasbourg, CNRS, IBMC, Strasbourg, France; 
2Interactions Cellulaires et Moléculaires, Université Rennes 1, UMR 6026 CNRS, Campus de Beaulieu, 
Rennes, France; 3Virologie et Pathologie Humaine, Université Lyon 1, EMR 4610, Faculté de Médecine RTH 
Laennec, 69008 Lyon, France
The genome of influenza A viruses (IAV) is split into eight viral RNAs (vRNAs) that are encapsidated as viral 
ribonucleoproteins (vRNPs). The existence of a segment-specific packaging mechanism is well established, but the 
molecular basis of this mechanism remains to be deciphered. Selective packaging could be mediated by direct interactions 
between the vRNA packaging regions, but such interactions have never been demonstrated in virions. We showed that the 
eight vRNAs of a human H3N2 IAV (MO) form a single interaction network in vitro that involves regions of the vRNAs 
known to contain packaging signals in the most studied human H1N1 IAV strains. When we applied the same strategy to an 
avian H5N2 IAV (EN), we observed that the eight EN vRNAs of ENG also form a single network of interactions in vitro, 
but the interactions and the regions of the vRNAs they involve differed compared to the MO virus. Electron tomography 
also revealed significant differences in the interactions between vRNPs in ENG and MO viral particles. All together, these 
data suggest that the packaging signals are not conserved between IAVs. We identified at the nucleotide level the sequences 
involved in several interactions, and in a few cases, we confirmed the interactions using silent compensatory mutations in 
the interacting sequences. Then, we focused on the interaction between the PB1 and NS EN segments, which is inhibited in 
vitro by silent mutations in either vRNA, and restored when combining the two mutated segments. Using reverse genetics, 
we produced the wild type, the two single mutants, and the double mutant viruses. Quantification of the vRNAs by Q-RT-
PCR and observation of the viral particles by electron microscopy indicated that this interaction also exists in infected cells 
and/or in viral particles and revealed a global defect in vRNA packaging in single mutant viruses.  In addition, competition 
experiments between wild type and mutant vRNAs for packaging supported a role of this interaction in the selective 
packaging of these genomic RNA segments. To our knowledge, these results constitute the first direct evidence of an 
interaction between two vRNAs involved in the selective packaging of IAV vRNPs. 
44 A dengue virus 2 non-coding RNA downregulates translation of antiviral interferon-
stimulated mRNAs through interaction with host RNA binding proteins.
Katell Bidet1, Sharon Jamison2, Mariano Garcia-Blanco3
1NUS Graduate School for Integrative Sciences and Engineering, Singapore and Program in Emerging 
Infectious Diseases, Duke-NUS Graduate Medical School,; 2Center for RNA Biology and Departments of 
Molecular Genetics and Microbiology and Medicine, Duke University Medical Center, Durham, USA; 3NUS 
Graduate School for Integrative Sciences and Engineering, Singapore, Program in Emerging Infectious 
Diseases, Duke-NUS Graduate Medical School, Center for RNA Biology and Departments of Molecular 
Genetics and Microbiology and Medicine, Duke University Medical Center, Durham, USA.
Flaviviruses, as other viruses, has evolved powerful strategies to counteract the antiviral action of type I interferon 
(IFN). In particular, it was recently shown that a short, abundant, highly structured non-coding RNA termed sfRNA was 
required for evasion of the IFN response. Although the mechanism of action of the sfRNA remains to be elucidated, 
several non-coding RNAs of viral origin have been proposed to act as sponges for host RNA-binding proteins (RBPs) 
to modulate host cell function. To gain insight in the role of sfRNA we used dengue virus 2 (DENV-2) sfRNA, whose 
interactome was recently characterized in our laboratory, as a model. We found that DENV-2 sfRNA specifically 
downregulated translation of IFN-stimulated genes (ISGs) mRNAs, interfering with the establishment of the antiviral 
state. DENV-2 sfRNA was able to interact with host RBPs G3BP1, G3BP2 and CAPRIN1, which we showed were 
required for antiviral action of IFNs. Strikingly, this activity was independent from their previously described role in 
cellular stress response but they were required for translation of ISG mRNAs. Finally, we established that the ability of 
DENV-2 sfRNA to decrease ISG induction was conditional on G3BP1, G3BP2 and CAPRIN1 binding, suggesting that 
the sfRNA sequesters the host RBPs to counteract their activity. Taken together, this study identifies G3BP1, G3BP2 
and CAPRIN1 as novel cellular regulators of the IFN response, highlight translation as a previously underappreciated, 
important layer of regulation of immune responses and provide the first mechanism of action for DENV-2 sfRNA. 
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47 HIV1, Antisense RNA and ADAR editing
Siripong Tongjai1, Keanan McGonigle1, Yeou-Cherng Bor1, David Rekosh1, Marie-Louise Hammarskjöld1
1University of Virginia
The HIV1 genome consists of a 9kB “single stranded” mRNA. Structure analysis using SHAPE and other methods have 
shown a complex HIV1 genome secondary structure with several regions that are potential targets for ADAR editing.  It has 
previously been reported that HIV1 can be edited by ADAR1, as well as by ADAR2. Several recent studies have also demonstrated 
the presence of natural antisense HIV1 RNA. We have studied HIV1 inhibition mediated by a therapeutic 937nt long antisense 
(AS) HIV1 RNA as a model system for the potential effects of HIV1 AS RNA . We have previously shown that the surprisingly 
potent inhibition that is observed with this therapeutic AS RNA, requires that it traffics on the CRM1 export pathway through Rev 
and the HIV1-RRE. If the RNA is redirected to the NXF1 pathway (using RevM10Tap), efficient AS inhibition is abolished. To 
further investigate the mechanism, we sequenced the AS target region in individual RT-PCR clones from cells expressing HIV1 
+/- RRE-AS RNA.  When the RRE-AS RNA was present, we observed several A to G changes, consistent with ADAR editing. 
However, in most clones, only a few residues were altered, with only 1-8 percent of the A residues modified, rather than the 50% 
that would be expected in a long perfect sense/antisense RNA region. The changes were present throughout the AS target region, 
with different A residues changed in the different clones. These results suggest that the RNA had been subject to regulated ADAR 
editing. In the absence of AS RNA, or when the AS RNA was redirected to the NXF1 pathway, most clones contained zero or one 
modified A, demonstrating that the regulation was specific for the Rev/RRE pathway.  
When ADAR2 was over-expressed, AS inhibition was significantly relieved and even less inhibition was seen with a 
cytoplasmic mutant of ADAR2 (with aa 1-72 deleted).  RT-PCR analysis of the AS  target region did not show any increase 
in editing when ADAR2 was expressed.  However, catalytic and ds-RNA binding domain mutants of ADAR2 failed to relieve 
inhibition, indicating a role for editing. These results suggest a complex role for ADAR in the regulation of AS inhibition at the 
cytoplasmic level. Interestingly, expression of ADAR2  led to significant editing in other regions of the HIV1 genome with or 
without the therapeutic AS-RNA (in TAR and the RRE). Taken together, our results indicate that HIV1 is regulated by ADAR at 
many levels. Editing of specific residues in TAR and the RRE is likely to be involved in post-transcriptional RNA regulation of 
HIV1, whereas expression of natural HIV1 AS RNA could serve to regulate HIV1 at the translational level, potentially through 
miRNAs generated from ADAR edited AS RNA. Most intriguingly, natural AS RNA expression and regulated ADAR editing 
may also be a strategy used by the virus to increase the rate of HIV1 evolution to help the virus evade the immune system (in 
conjunction with editing by ApoBec3G regulated by the viral Vif protein).
46 Interplay between retroviral genomic RNA packaging and mRNA translation
Katarzyna J. Purzycka1, Mastooreh Chamanian4, Katarzyna J. Purzycka1, Paul Wille3, Janice S. Ha3, David 
McDonald4, Yong Gao2, Stuart F.J. Le Grice5, Eric J. Arts2, Ryszard W. Adamiak1
11RT Biochemistry Section, HIV Drug Resistance Program, National Cancer Institute, Fredrick, MD 21702, 
USA, 2RNA Structure and Function Laboratory, Institute of Bioorganic Chemistry, Polish Academy of 
Sciences, Poznan, Poland; 21 Department of Molecular Biology and Microbiology, Case Western Reserve 
University, Cleveland, OH 44106, USA, 2 Department of Medicine, Case Western Reserve University, 
Cleveland, OH 44106, USA; 3Department of Medicine, Case Western Reserve University, Cleveland, OH 
44106, USA; 4Department of Molecular Biology and Microbiology, Case Western Reserve University, 
Cleveland, OH 44106, USA; 5RT Biochemistry Section, HIV Drug Resistance Program, National Cancer 
Institute, Fredrick, MD 21702, USA
During retroviral RNA encapsidation, two full-length genomic (g) RNAs are selectively incorporated into 
assembling virions. Packaging involves a cis-acting packaging element (Ψ) within the 5′ untranslated region of 
unspliced HIV-1 RNA genome. However, the mechanism(s) that selects and limits gRNAs for packaging remains 
uncertain. Using a dual complementation system involving bipartite HIV-1 gRNA, we observed that gRNA packaging 
is additionally dependent on a cis-acting RNA element, the genomic RNA packaging enhancer (GRPE), found 
within the gag p1-p6 domain and overlapping the Gag-Pol ribosomal frameshift signal (1). Deleting or disrupting the 
structure of the two conserved GRPE stem loops diminished gRNA packaging and infectivity >50-fold, while deleting 
gag sequences between Ψ and GRPE had no effect. Our studies allowed us to conclude that only the HIV-1 RNAs 
employed for Gag-Pol translation may be specifically selected for encapsidation, possibly explaining the limitation of 
two gRNAs per virion. The basis for this mechanism will be presented.
1. M. Chamanian, K. J. Purzycka, P. T. Wille, J. S. Ha, D. McDonald, Y. Gao, S. F.J. Le Grice, E. J. Arts (2013) A cis-Acting 
Element in Retroviral Genomic RNA Links Gag-Pol Ribosomal Frameshifting to Selective Viral RNA Encapsidation, Cell 
Host and Microbe, 13, 181-192.
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49 Shunting revisited.
Thomas Hohn1
1Basel University
Viruses must manage their genome sustainably and efficient. As a consequence they developed ways to control their 
replication, transcription, splicing, and translation. For efficient translation, viruses use various types of polycistronic translation, 
alternative translation starts and stops, internal ribosome entries and bypass of sequences by shunting.
During shunting caulimovirus leaders of about 600nt are bypassed by the scanning ribosome, as originally observed 
with Cauliflower mosaic virus (CaMV). The CaMV leader is highly structured and contains several small open reading frames. Of 
importance is just the first one, which ends six to nine nucleotides in front of the root of a strong stem structure. After translation 
of this sORF the ribosome is not dissociated but jumps across the base of the stem structure, continues scanning and reinitiates 
at the main ORF. The positioning of the sORF and the strength of the stem-structure, but not their primary sequences, are 
important for successful shunting. Interestingly, this shunt structure is preserved in the in the six genera of plant pararetroviruses 
(caulimoviridae). One of these, Rice tungro bacilliform virus (RTBV), infects rice plants together with the Rice tungro spherical 
(Waika)virus (RTSV), a RNA virus. Interestingly, not only RTBV, but also the accompanying RTSV have a related shunt structure. 
It is an interesting question whether this double occurrence is coincidence or of mutual benefit for both of the viruses.
It seems puzzling that the long leader, which seemingly constitutes a basic hindrance for translation, has evolved. One reason 
might be that it harbours a series of signals, i.e. for enhancement, polyadenylation, splicing, packaging, but those signals could 
cope with much less space. Recently, we found another function. The leader spawns huge amounts of siRNAs of all size classes. 
They make up half of the total load of sRNAs present in the infected plant. The coding region of the CaMV genome is represented 
by a much lower amount of siRNAs.
The RNA-form of the CaMV genome is reverse transcribed within viral particles to yield open circular dsDNA. Since repair- 
and ligase enzymes are missing within particles and cytoplasm, the termini of the DNA strands are not joined, until the DNA 
enters the nucleus. The DNA minus strand is just interrupted between leader and coding region and if transcription is initiated 
before repair and ligation, the RNA falls off and is consequently not polyadenylated. This aberrant (“8S”) RNA, which covers just 
the leader gives rise to the production of dsRNA, the substrate for dicers and consequently the source of the massive amounts of 
leader derived siRNAs. 
Due to its strong secondary structure the CaMV leader itself is a poor substrate for the set of leader-derived siRNAs, rsp. RISC 
complexes and we argue that this set acts as decoy out-titrating the AGO proteins and thereby protecting the CaMV transcripts.
48 The Identification of a novel posttranscriptional regulatory element in gamma 
retroviruses
Guy Pilkington1, Katarzyna Purzycka2, Jenifer Bear1, Stuart Le Grice2, Barbara Felber1
1Vaccine Branch, National Cancer Institute; 2Drug Resistance Program, National Cancer Institute
Posttranscriptional regulatory mechanisms of several simple retroviruses and retroelements have been elucidated 
with the only exception being the gamma retrovirus family, e.g. MuLV. We identified a novel ~1500 nt PostTranscriptional 
regulatory Element (PTE) located in pro-pol (nt 3184-4652) of MuLV and XMRV, being transferrable and promoting 
potent expression of an HIV gag reporter  and the cat DM128 reporter transcript. Deletion of pro-pol and env from 
the provirus failed to produce Gag particles, whereas env deletion produced Gag particles, pointing to a critical role of 
the pro-pol sequence.  We showed that the pro-polsequences could be replaced by heterologous RNA export elements 
e.g. CTE. We found that the RNA encoding γ-?retroviral gag only has a reduced half-life and this defect can be 
counteracted upon insertion of a pro-pol or CTE elements acting in cis. SHAPE technology was applied to the pro-
pol RNA, with particular emphasis on the PTE, which revealed a very complex stem-loop structure. Comparisons 
of pro-pol sequences from MuLV, XMRV and related γ-retroviruses showed that despite sequence divergence in the 
3’ end of pol, their RNA structures show little variability, indicating that the RNA structure is invariant in PTE. We 
conclude that complex structural components are critical for function, in addition to sequences representing interaction 
sites for export factors. With our discovery of the PTE, we now have a complete picture of posttranscriptional regulation 
of simple retroviruses. Collectively, these viruses contain negative-acting sequences embedded in gag mediating RNA 
instability, hence impair expression. These viruses also contain positive-acting RNA elements, essential for promoting 
Gag expression. These RNA elements do not share sequence or structural features, their location within the full-length 
retroviral RNA can vary, but they depend on the cellular NXF1 export machinery.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Oral Abstracts
Concurrent Session 3: Viral RNAs  •   29
50 Inquiry into the variability of HCV IRES and its impact on function by developing and 
evaluation of a large-scale mutation database that also unfolds potential of some new 
nucleotides.
Anas Khawaja1, Vaclav Vopalensky1, Ludek Roznovsky2, Jakub Mrazek4, Ondrej Horvath3, Martin Pospisek1
1Charles University in Prague. Department of Genetics and Microbiology, Prague, Czech Republic; 
2Infectious Diseases and AIDS Clinic, University Hospital Ostrava, Ostrava, Czech Republic; 3Institute of 
Molecular Genetics AS CR, Prague, Czech Republic; 4Institute of Public Health Ostrava, Ostrava, Czech 
Republic
Synthesis of the hepatitis C virus polyprotein is fully controlled by an IRES located within 5’UTR of the viral 
RNA. We developed a new flow-cytometry-based approach allowing us to monitor patient to patient differences in 
IRES activities of their whole viral populations. Simultaneously we employed more conventional methods comprising 
cloning of PCR fragments, DGGE, TGGE, sequencing and bicistronic reporter assay for finding new HCV IRES 
mutations and measuring their activities. Sequence data from patients’ samples along with analysis of migration patterns 
by DGGE and/or TGGE allowed us to estimate the variation that may have persisted over time within one or group 
of patients individually and collectively. We also compiled from the literature a comprehensive database comprising 
~1300 IRES mutations further categorized by frequency, structural and functional behavior, experimental parameters, 
clinical data etc. Some IRESs bearing multiple mutations in various domains displayed either higher or lower levels of 
efficacy than expected after simple counting of known effects of the individual  mutations. These differences in IRES 
activities raise the question of how some mutations are capable of sustaining an IRES WT activity. Could it be a long-
range interaction between mutated nucleotides, and if yes, then how much is the extent of structure adaptability that 
IRES may need to go through for conservation of its function. We also collected  data from published studies dealing 
with induced therapeutic response of interferon and ribavirin and its possible outcome in individuals with reference to 
occurrence of mutations in HCV IRES. By mapping out these mutations in sustained and non-sustained responders we 
observed no specific distribution that may conclude a direct impact in determining the therapy response between the 
two populations. We also illustrate impact of ~25 novel mutations found in our patients on the HCV function.
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51 Novel Insights from Structural Analysis of Lentiviral and Gammaretroviral Reverse 
Transcriptases in Complex with RNA/DNA Hybrids.
Stuart Le Grice1, Mikalai Lapkouski7, Lan Tian6, Jennifer Miller1, Enzbieta Nowak4, Wojciech Potrzebowski3, Peter 
Konarev2, Jason Rausch1, Marion Bona1, Dmitri Svergun2, Janusz Bujnick3, Marcin Nowotny4, Wei Yang5
1HIV Drug Resistance Program, National Cancer Institute, Frederick, MD, USA; 2European Molecular 
Biology Laboratory, Hamburg, Germany; 3Laboratory of Bioinformatics and Protein Engineering, 
International Institute of Molecular & Cell Biology, Warsaw, Poland.; 4Laboratory of Protein Structure, 
International Institute of Molecular & Cell Biology, Warsaw, Poland.; 5National Institute of Diabetes and 
Digestive and Kidney Diseases, Bethesda, Maryland, USA; 6National Institute of Diabetes and Digestive and 
Kidney Diseases, Bethesda, MD, USA; 7National Institute of Diabetes and Digestive and Kidney Diseases, 
National Institutes of Health, Bethesda, MD, USA
Structures of HIV-1 reverse transcriptase (RT) have been reported in several forms, but only one contains an RNA/
DNA hybrid, the conformation of which has been controversial. We have been successful in obtaining three structures 
of HIV-1 RT complexed with a non-nucleoside RT inhibitor (NNRTI) and an RNA/DNA hybrid1. In the presence of 
an NNRTI, our RNA/DNA structure differs from all prior nucleic acid bound to RT including the previously-reported 
RNA/DNA hybrid derived froom the polypurine tract. The enzyme structure observed in our cocrystals also differs 
from all previous RT-DNA complexes. As a result, the hybrid has ready access to the ribonuclease H (RNase H) active 
site. These observations collectively reinforce previous proposals that an RT-nucleic acid complex may be required to 
adopt independent structural states competent for DNA synthesis and the other for RNA degradation. RT mutations 
that confer drug resistance but are distant from the inhibitor-binding sites map to the unique RT-hybrid interface that 
undergoes conformational changes between two catalytic states. Structural features of the nucleoprotein complex, 
including drug resistance mutations, have been verified by site-directed mutagenesis, and will be presented.
Although the single-subunit RT of Moloney murine leukemia virus (Mo-MLV) has been extensively characterized 
biochemically, structural information is lacking that describes the substrate binding mechanism for this RT species. 
We also present data on the first crystal structure of a complex between an RNA/DNA hybrid and the 72 kDa single-
subunit RT from the related xenotropic murine leukemia virus-related virus (XMRV)2. A comparison of this structure 
with its HIV-1 counterpart shows that substrate binding around the DNA polymerase active site is conserved but 
differs between the two enzymes in their thumb and connection subdomains. Small-angle X-ray scattering (SAXS) 
was used to model full-length XMRV RT, demonstrating its flexible RNase H domain becomes ordered in the presence 
of substrate, a key difference between monomeric and dimeric RTs.
1. Lapkouski, M., Tian, L., Miller, J.T., Le Grice, S.F.J., and Yang, W.  (2013). Complexes of HIV-1 RT, an NNRTI and an 
RNA/DNA hybrid reveal a structure compatible with RNA degradation.  Nat. Struct. Mol. Biol. 20: 230-236.
2. Nowak, E., Potrzebowski, W., Konarev, P.V., Rausch, J.W., Bona, M.K., Svergun, D.I., Bujnicki, J.M., Le Grice, S.F.J., 
and Nowotny, M.  (2013). Structural analysis of monomeric retroviral reverse transcriptase in complex with an RNA/DNA 
hybrid.  Nucleic Acids Res., in press.
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53 Role of Telomeric Repeat-containing RNA in Alternative Lengthening of Telomeres
Rajika Arora1, Claus Azzalin1
1Institute of Biochemistry, Eidgenössische Technische Hochschule (ETH) Zürich
The large majority of cancer cells maintain their telomeres indefinitely by re-activation of the specialized reverse 
transcriptase telomerase. However, certain tumors especially osteosarcomas, gastric and bladder carcinomas, and 
cancers of the central nervous system bypass telomerase re-activation and maintain telomere length by the so called 
‘alternative lengthening of telomeres’ (ALT) pathway, which relies on homologous recombination between telomeric 
sequences. Recent studies have revealed that ALT cells can also originate from telomerase-positive cancers treated with 
telomerase inhibitors. Despite the relevance of ALT in cancer biology, the molecular mechanisms behind ALT activation 
and progression remain poorly defined. A few years ago we demonstrated that human telomeres are transcribed into 
long non-coding nuclear transcripts ranging in size between approximately 500 and more than 9000 bases and named 
‘telomeric repeat-containing RNA’ (TERRA). We show here that ALT cells are characterized by extremely elevated 
rates of TERRA transcription as compared to telomerase positive cancer cells and primary fibroblasts. TERRA co-
localize with telomeres and PML within ALT-associated PML bodies (APBs), which are thought to be the nuclear 
compartments where telomeric homologous recombination takes place. Strikingly, we also find that ALT cells, but not 
telomerase positive cancer cells and primary fibroblasts, express shorter telomeric transcripts comprised between 300 
and 36 bases (small TERRRA: smTERRA). Down-regulation of Dicer leads to a decrease in smTERRA cellular levels 
and concomitant accumulation of longer transcripts. On the contrary, depletion of Drosha does not affect smTERRA 
levels, suggesting a non-canonical role for Dicer in processing TERRA into short RNA species. Our data reveal 
an unexpected scenario where different TERRA species might support ALT establishment and/or maintenance, and 
should pave the way towards the development of therapies to specifically cure or prevent ALT tumors.
52 RNAi dependent and independent control of LINE1 mobility and accumulation in mouse 
ES cells
Constance Ciaudo1, Florence Jay3, Ikuhiro Okamoto4, Chong-Jian Chen2, Nicolas Servant2, Emmanuel Barillot2, 
Edith Heard2, Olivier Voinnet3, Alexis Sarazin3
1ETHZ-IHMS; 2Curie Institute; 3ETHZ; 4Kyoto University
In most mouse tissues, long-interspersed elements-1 (L1s) are silenced via methylation of their 5’-untranslated 
regions (5’-UTR). A gradual loss-of-methylation in pre-implantation embryos coincides with L1 retrotransposition 
in blastocysts, generating potentially harmful mutations. Here, we show that Dicer- and Ago2-dependent RNAi 
restricts L1 accumulation and retrotransposition in undifferentiated embryonic stem cells (mESCs), derived from 
blastocysts. RNAi correlates with production of Dicer-dependent 22-nt small RNAs mapping overlapping sense/
antisense transcripts produced from the L1 5’-UTR. However, RNA-surveillance pathways simultaneously degrade 
these transcripts, consequently confounding the anti-L1 RNAi response. In Dicer-/- mESC complementation 
experiments, L1 silencing was rescued in cells strongly depleted of microRNAs, which proliferated and differentiated 
normally unlike their non-complemented counterparts. These results shed new light on L1 biology and, possibly, on 
the differentiation defects of Dicer-/- mESCs.
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55 Involvement of TERT-RdRP in heterochromatin maintenance
Kenkichi Masutomi1, Mami Yasukawa1, Yoshiko Maida1
1Division of Cancer Stem Cell, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045 JAPAN
Constitutive expression of telomerase in human cells prevents the onset of senescence and crisis by maintaining 
telomere homeostasis. Recent evidence suggests that the human telomerase catalytic subunit (hTERT)contributes to 
cell physiology independent of its ability to elongate telomeres. We have recently reported that hTERT form an RNA 
dependent RNA polymerase (RdRP) and produce double-stranded RNAs that can be processed into small interfering 
RNA. These observations identify a mammalian RdRP composed of hTERT (Maida et al. Nature 2009).
In fission yeast, centromeric heterochromatin is maintained by an RNA-directed RNA polymerase complex 
(RDRC) and the RNA-induced transcriptional silencing (RITS) complex in a manner that depends on the RNAi 
pathway. In association with hTERC, the telomerase reverse transcriptase (TERT) forms telomerase and counteracts 
telomere attrition; however, TERT has also been implicated in the regulation of heterochromatin at locations distinct 
from telomeres. Here, we describe a complex comprising human TERT (hTERT), Brahma-related gene 1 (BRG1), 
and nucleostemin (NS) that contributes to heterochromatin maintenance at centromeres and transposons. Acting as 
an RNA dependent RNA polymerase (RdRP), this complex produced double stranded RNAs that were processed into 
small interfering RNAs targeted to heterochromatin regions. These small interfering RNAs promoted heterochromatin 
assembly and mitotic progression in a manner dependent on the RNA interference (RNAi) pathway. These observations 
implicate the hTERT/BRG1/NS (TBN) complex in heterochromatin assembly at particular sites in the mammalian 
genome.
54 RNA and DNA Targeting CRISPR-Cas Immune Systems of Pyrococcus furiosus
Joshua Elmore1, Caryn Hale1, Sonali Majumdar1, Jason Carte1, Hong Li2, Sara Olson3, Brenton Graveley3, Lance 
Wells1, Claiborne Glover1, Rebecca Terns1, Michael Terns1
1University of Georgia; 2Florida State University; 3University of Connecticut
CRISPR-Cas systems are recently discovered, small RNA-based immune systems that control invasions of 
viruses and plasmids in archaea and bacteria.  Prokaryotes with CRISPR-Cas immune systems capture short invader 
sequences within the CRISPR loci in their genomes, and small RNAs produced from the CRISPR loci (CRISPR 
(cr)RNAs) guide Cas proteins to recognize and degrade (or otherwise silence) the invading nucleic acids.  There 
are multiple variations of the pathway found among prokaryotes, each mediated by largely distinct components and 
mechanisms that we are only beginning to delineate. 
Using the hyperthermophile Pyrococcus furiosus, we have delineated several key steps in CRISPR-Cas invader 
defense pathways.  P. furiosus has 7 transcriptionally active CRISPR loci distributed throughout the genome that 
together encode a total of ~200 crRNAs.  The 27 Cas proteins in this organism represent 3 distinct pathways and are 
primarily encoded in two large gene clusters.  The Cas6 protein “dices” large precursor CRISPR transcripts to generate 
the individual invader-targeting crRNAs.  The mature crRNAs include a signature sequence element (“5’ tag”) derived 
from the CRISPR repeat that is important for function.  crRNAs are tailored into distinct species and integrated into 
three distinct crRNA-Cas protein complexes that are likely immune effector complexes.  The complex formed by the 
Cmr (type IIIB) system proteins cleaves complementary target RNAs and can be programmed to cleave novel target 
RNAs in a prokaryotic RNAi-like manner.  The other two CRISPR-Cas systems in P. furiosus, Csa (type IA) and Cst 
(type IB), target invaders at the DNA level.  Recent work will be presented on the structure and function of CRISPR-
Cas immune effector complexes from this organism.  The results of our work in P. furiosus have revealed mechanisms 
of crRNA biogenesis and silencing for 3 of the diverse CRISPR-Cas pathways, and reveal that organisms like P. 
furiosus possess an arsenal of multiple RNA-guided mechanisms to resist diverse invaders.  
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57 Involvement of the novel complex consisting of the splicing factor Prp14p/DHX38 RNA 
helicase and centromeric non-coding RNAs in the regulation of chromosome segregation
Masatoshi Mutazono1, Takashi Ideue1, Kanako Nishimura1, Yukiko Cho1, Chihiro Tsukahara1, Misato Morita1, 
Madoka Chinen1, Jun-ichi Nakayama3, Kojiro Ishii2, Tokio Tani1
1Department of Biological Sciences, Graduate School of Science Technology, Kumamoto University; 
2Graduate School of Frontier Biosciences, Osaka University; 3Graduate School of Natural Sciences, Nagoya 
City University
prp14, of which the responsible gene encodes RNA helicase with the DEAH box motif, is one of the pre-mRNA splicing 
mutants in fission yeast Schizosaccharomyces pombe. In fission yeast, formation of heterochromatin at the centromere is 
induced by the RNAi-mediated system. Interestingly, prp14 shows defective formation of the centromeric heterochromatin, 
resulting in a high incidence of lagging chromosomes during anaphase. prp14 accumulates the unprocessed centromeric 
noncoding RNAs and shows decreased level of H3K9 methylation and Swi6p localization at the centromere, suggesting 
that the Prp14p helicase is involved in not only the splicing reaction, but also the RNAi-mediated heterochromatin assembly 
at the centromere. We found the mRNA-type intron in the dg non-coding RNA transcribed from the centromere region 
(Chinen et al, 2010). The IP analyses demonstrated that Prp14p interacts with Cid12p, a subunit of RDRC (RNA-directed 
RNA polymerase complex), implying that the spliceosome or sub-spliceosome assembled on the dg ncRNA intron works as 
a platform for recruitment of RDRC. To examine a role of the dg intron in the formation of centromeric heterochromatin, we 
constructed a minichromosome containing the centromere with or without thedg intron. Interestingly, the minichromosome 
without the dg intron showed the decreased H3K9 methylation comparing the minichromosome with the dg intron, 
supporting that the dg intron plays an important role in the methylation process of H3K9.  
We also tested the involvement of the human homologue of Prp14p (DHX38) in the process of the chromosome 
segregation. Knockdown of DHX38 in HeLa cells caused the abnormal chromosome segregation, due to the defective 
attachment of microtubles to the kinetochores at metaphase. No significant defects were observed in splicing of tested 
pre-mRNAs in the knockdown cells. Interestingly, knockdown of satellite RNAs, non-coding RNAs transcribed from the 
human centromere, resulted in the similar defects in the chromosome segregation. In addition, the RIP assay showed that 
DHX38 associates physically with the satellite ncRNAs, suggesting that the DHX38/satellite ncRNA complex plays an 
essential role in the control of chromosomal segregation in mammalian cells.
56 The role of the Arabidopsis exosome complex in siRNA-independent silencing of 
heterochromatic loci
Junhye Shin1, Hsiao-Lin Wang1, Brandon Dinwiddie1, Julia Chekanova1
1University of Missouri- Kansas City
To maintain genomic stability and prevent expansion of invasive genomic sequences such as transposable 
elements (TEs), eukaryotes have evolved defensive mechanisms to control them. Here, we examine the role of 
theArabidopsis exosome complex in such mechanisms. Depletion of the exosome allows some repetitive sequences 
to escape from silencing. Most of these transcripts emanate from centromeric and pericentromeric chromosomal 
regions and other heterochromatic loci, and many derive from repetitive and transposable elements [1]. In plants, TEs 
are targeted for de novo DNA methylation by smRNA-mediated pathways. To investigate whether exosome interacts 
with RdDM, we profiled Arabidopsis smRNAs by deep sequencing in exosome and RdDM mutants and also analyzed 
RdDM-controlled loci. We found that exosome loss had a very minor effect on global smRNA populations, suggesting 
that, in contrast to fission yeast, in Arabidopsis the exosome does not control the spurious entry of RNAs into smRNA 
pathways. Exosome defects resulted in decreased histone H3K9 dimethylation at RdDM-controlled loci, without 
affecting smRNAs or DNA methylation. Exosome also exhibits a strong genetic interaction with RNA Pol V, but not 
Pol IV, and physically associates with transcripts produced from the scaffold RNAs generating region. We also show 
that two Arabidopsis rrp6 homologues act in gene silencing [2]. Our data suggest that Arabidopsis exosome may act 
in parallel with RdDM in gene silencing, by epigenetic effects on chromatin structure, not through siRNAs or DNA 
methylation. We also propose that the Arabidopsis exosome may coordinate the transcriptional interplay of different 
RNA polymerases to modulate repression of some repetitive sequences. Results of further examination of exosome 
involvement in gene silencing in Arabidopsis will be presented.
1. Chekanova et al., (2007) A hidden component of the transcriptome and specialization of function of the exosome complex 
in Arabidopsis. Cell, 131(7), pp.1340-1353.
2. Shin et al., (2013) “The role of the Arabidopsis exosome in siRNA-independent silencing of heterochromatic loci”. PLoS 
Genetics, accepted.
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59 New Approaches in RNA Chemical Biology
Jonathan Hall1, Andreas Brunschweiger2, Luca Gebert1, Jochen Imig1, Mario Rebhan1, Ugo Pradere1, Boris 
Guennewig1
1ETH Zürich; 2TU Dortmund
Many types of oligonucleotide-based tools have advanced our knowledge of RNA biology, including microRNA 
(miRNA) mimics, LNAs and TaqMan probes. Other examples are functionalities employed for imaging RNAs, or 
identifying binding partners in cells. One of the limitations of RNA tools for chemical biology applications is their length: 
RNA synthesis using standard reagents is mostly limited to <80 nucleotides (nt). Beyond this, success is uncertain and 
characterization of the molecules by for example mass spec. is challenging. The length of pre-miRNAs typically spans 50-
90 nt. MiRNA hairpin precursors are increasingly appreciated as functional RNAs with their own regulatory elements. For 
example, a variety of RNA binding proteins (RBPs) has been shown to bind to conserved sites in the terminal loop regions 
of miRNA precursors and regulate their biogenesis. We recently synthesized a library containing a subset of biotin-labeled 
pre-miRNAs mostly with phylogenetically-conserved terminal loop regions. We used it to screen for interactions with RBPs 
Lin28, hnRNP A1, KSRP and others, in their native state, i.e. using cell lysates.  We showed that Lin28 as well as hnRNP 
A1 bind pre-let-7 family members with remarkable selectivity and that KSRP binds prominently to pre-miR-1-2 (1,2). 
Furthermore, we measured the affinities of these interactions in the presence of cellular factors. In a chemistry program, we 
used a biotin-labeled pre-miR-122 in a surface plasmon resonance assay to show that miravirsen, an LNA-based drug in 
clinical trials inhibits biogenesis of miR-122(submitted).
At the heart of these approaches are the chemical methods used to synthesize the RNAs. We have now developed 
protocols to label RNA of up to 75 nt with single and double functionality. Groups can be positioned so that they protrude 
into the major and minor grooves of RNA duplexes. A variety of groups with orthogonal functions have been examined. One 
particular combination of functions is that of biotin-psoralen, which we have used for cross-linking and deep sequencing 
experiments. Considerable experimentation was required to position groups so that the RNAs would be incorporated into 
functional RISC complexes. These RNAs were delivered into cells and under mild cross-linking conditions captured their 
RNA targets, including known and new targets.
1. Loughlin et al., Nat Struct Mol Biol. 2012, 22, 109; Towbin et al., Nucleic Acids Res 2013, 41, e47. Funding: SNF 
[CRSII3_127454; 205321_124720]
58 A genome-wide RNAi screen draws a genetic framework for transposon control and 
primary piRNA biogenesis in Drosophila
Paloma M Guzzardo*1, Felix Muerdter*5, Jesse Gillis4, Yicheng Luo1, Yang Yu1, Caifu Chen2, Richard Fekete3, 
Gregory J Hannon1
1Watson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, 
Cold Spring Harbor, NY 11724, USA; 2Genetic Analysis R&D, Life Technologies Corporation, Foster City, 
CA 94404, USA; 3Molecular Cell Biology R&D, Life Technologies Corporation, Austin, TX 78744, USA; 
“4Watson School of Biological Sciences, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory, 
Cold Spring Harbor, NY 11724, USA
*These authors contributed equally to this work
A large fraction of our genome consists of mobile genetic elements. Governing transposons in germ cells is 
critically important, and failure to do so compromises genome integrity, leading to sterility. In animals, the piRNA 
pathway is the key to transposon constraint, yet the precise molecular details of how piRNAs are formed and how 
the pathway represses mobile elements remain poorly understood. In an effort to identify general requirements for 
transposon control and novel components of the piRNA pathway, we carried out a genome-wide RNAi screen in 
Drosophila ovarian somatic sheet cells. We identified and validated 87 genes necessary for transposon silencing. 
Among these were several novel piRNA biogenesis factors. We also found a novel gene, which we named asterix, 
to be essential for transposon silencing, most likely by contributing to the effector step of transcriptional repression. 
Asterix loss leads to decreases in H3K9me3 marks on certain transposons but has no effect on piRNA levels.
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61 RNA-based fluorescent biosensors for live cell imaging of second messengers cyclic di-
GMP and cyclic AMP-GMP.
Colleen Kellenberger1, Stephen Wilson1, Jade Sales-Lee1, Ming Hammond2
1University of California, Berkeley; 2Department of Chemistry and the Department of Molecular & Cell 
Biology, University of California, Berkeley, CA 94720
Cyclic di-nucleotides are a newly expanded class of signaling molecules in bacteria that regulate important 
processes including biofilm formation, motility, and virulence. Furthermore, cyclic di-nucleotides have been shown to 
trigger the mammalian innate immune response upon bacterial secretion of these molecules into the host cell cytosol. 
However, many of the components of cyclic di-nucleotide signaling remain poorly understood, so we aim to create 
tools for monitoring their role and regulation in vivo. We have designed fluorescent RNA biosensors for cyclic di-GMP 
and cyclic AMP-GMP through fusion of the Spinach aptamer to variants of a natural GEMM-I riboswitch. In live cell 
imaging experiments, these biosensors demonstrate fluorescence turn-on in response to cyclic di-nucleotides, and 
they were used to confirm in vivo production of the newly discovered natural molecule, cyclic AMP-GMP. Ongoing 
work is focused on applying these sensors to different cell types and on studying other phylogenetic variants of 
the GEMM-I riboswitch class for biosensor optimization. It is envisioned that these cyclic di-nucleotide biosensors 
will help elucidate how the different second messengers are integrated and transduced in bacterial and mammalian 
signaling.
60 Resolving functional RNA dynamics by NMR
Christoph Wunderlich1, Romana Spitzer1, Thomas Moschen1, Martin Tollinger1, Christoph Kreutz1
1University of Innsbruck, Organic Chemsitry
The research focus in our group lies on the dynamic characterization of RNA by solution NMR spectroscopy. In the 
field of protein structural biology it is well established that biological function is often encoded in transiently populated 
conformational states, which are hard to characterize by conventional biochemical and biophysical experiments. Only 
recently the dynamic nature of ribonucleic acid was also recognized to be a crucial aspect in manifold functions 
carried out by RNA. For example, such dynamics are presumed to be of special importance in ligand recognition and/
or in catalytic processes controlled by recently discovered noncoding RNAs.
For that purpose we develop sophisticated isotope labeling protocols for RNA relying on the site-specific 
introduction of 13C-reporter spins by chemical and enzymatic methods. We then use state-of-the-art NMR experiments 
that exploit the particular features of the site-specific  13C-modified RNAs to address functionally important dynamics 
occurring at the milli- to microsecond time frame. In detail, we used 6-13C-modified pyrimidine labels to address the 
excited state structure of the HIV-1 TAR RNA further corroborating the conformational selection mechanism of this 
RNA to recognize the ligand argininamide. The approach is currently applied to RNAs with enzymatic function and 
biologically relevant RNAs involved in protein free gene regulation (i.e. riboswitches)
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63 Structural stabilization of toxic CUG repeats reverses mis-splicing associated with 
myotonic dystrophy
Elaine deLorimier1, Jeremy Copperman1, Alex Taber1, Leslie Coonrod1, Emily Reister1, Feras Ackall2, Kush 
Sharma2, Peter Todd2, Marina Guenza1 and J. Andrew Berglund1
1University of Oregon, 2University of Michigan
Myotonic dystrophy type 1 (DM1) is a dominant RNA gain of function disease caused by a trinucleotide repeat 
(CTG) expansion in the 3’ untranslated region of the DMPK gene. When transcribed, these expanded CUG repeats 
sequester the muscleblind (MBNL) family of RNA binding proteins (MBNL1, MBNL2 and MBNL3).  The MBNL 
proteins are regulators of alternative splicing, and sequestration to the CUG repeats results in the mis-splicing of 
MBNL target pre-mRNAs, leading to some of the disease symptoms.
Model CUG repeat RNA substrates and purified MBNL1 protein were used to determine how modifying the 
CUG repeats with pseudouridine and 2’ O-methyl would affect the interaction between MBNL1 and the toxic RNA. 
A reduction or full elimination of MBNL1 binding to the CUG repeats was observed with modification. The higher 
number of modifications correlated with increased inhibition of protein binding to the RNA.  Thermal melting studies 
demonstrated that pseudouridine and 2’ O-methyl modifications significantly stabilized the CUG repeats in a helical 
conformation.  Crystallographic and molecular dynamic simulations of CUG repeats containing pseudouridine suggest 
that helix stability is the result of a reduction in the dynamics of the U-U mismatch in the helical CUG repeats.  
Cell and animal DM1 models were used to determine if modification of CUG repeats could reduce molecular 
and phenotypic consequences.  In the DM1 cell model no mis-splicing defects were observed when CUG repeats 
containing 50% and 100% pseudouridylation were used.  The RNA lacking modification resulted in the sequestration 
of MBNL proteins and mis-splicing in the cell model.  Preliminary experiments in a DM1 zebrafish model showed 
that pseudouridylation of CUG repeats increased viability compared to unmodified RNA.  Motor defects (spontaneous 
coiling and touch evoked escape) observed in the CUG repeat fish were reduced in the fish containing CUG repeats 
with pseudouridines.  Our studies suggest that stabilization of toxic RNA with modifications or others means is a 
strategy that could lead to new therapeutic approaches for myotonic dystrophy and other diseases with toxic RNA 
components.
62 Sequence Specific Modulation of G-Quadruplex Folding
Samuel Rouleau1, Jean-Denis Beaudoin1, Jean-Pierre Perreault1
1Université de Sherbrooke
G-quadruplexes (G4) are highly stable non canonical structures that can be adopted by guanine rich nucleic acids. 
Over the past years, many important biological roles have been attributed to DNA as well as RNA G4. Hence, many 
research studies have focused on targeting G4 with chemical compounds that specifically bind these structures and 
either prevent or enhance their folding. Although these compounds are able to discriminate between G4 and other 
nucleic acid structures, they are not able to recognize one particular G4 sequence. Since there are more than 370 000 
potential G4 sequences in the human genome, off-target effects remain a major issue. The aim of this project was 
to target specific G4 sequences with chemically modified RNA oligonucleotides. The specificity is obtained using 
Watson-Crick base pairing between the oligonucleotide and the targeted G4. To ensure that there would not be any off-
target effects, we focused on G4 harboring a particular topology, namely a long loop 2. Oligonucleotides with specific 
chemical modifications (i.e. 2’O-methylated and LNA) were used for their high affinity and their great stability in 
human cells. By using in line probing, we showed that the oligonucleotides could modulate the folding of G4 either 
positively or negatively, depending on where the oligonucleotide is bound. This modulation was obtained on artificial 
G4 sequences as well as on sequences present in the 5’ UTR of human genes. By inserting them in the 5’UTR of a 
luciferase reporter gene, we also demonstrated that long loop 2 G4 motif can decrease translation in human cells. We 
showed that this translation inhibition can be either increased or decreased by co-transfecting oligonucleotides with 
the luciferase gene. To our knowledge this is the first report of targeting a specific G4, and it also paves the way for a 
new kind of therapeutic tool that could modulate the expression of specific genes.
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64 A chemo-enzymatic approach for selective modification of the RNA cap
Daniela Schulz1, Josephin Holstein1, Andrea Rentmeister1
1University of Hamburg, Department of Chemistry, Institute of Biochemistry and Molecular Biology, Martin-
Luther-King Platz 6, D-20146 Hamburg
The 5’-cap is a hallmark of eukaryotic mRNAs and methods for selective modification of this particular biomolecule 
are highly sought in order to produce labeled capped RNA or to isolate mRNA from total RNA. Presently, there are 
no methods for selective covalent modification of natural cap-bearing RNAs, although these are the most important 
study object in terms of expression and also subcellular localization. We developed a two-step strategy, combining 
an enzymatic and a chemical conversion to achieve this goal. It is selective for capped RNAs and site-specific for the 
exocyclic N2-position of the guanosine in the cap. We used enzymes that specifically recognize and hypermethylate the 
5’-cap, so-called trimethylguanosinsynthases (Tgs), and engineered variants that successfully transfer alternative alkyl 
groups suitable for bioorthogonal chemistry. Although wildtype enzymes showed no or very low promiscuous activity 
on the AdoMet-analogs, we can now produce site-selectively modified caps with up to 91 % yield. We demonstrated 
further chemical modification by thiol-ene and copper-catalyzed click chemistry and introduced biotin as well as a 
fluorescent dye. Importantly, the chemo-enzymatic modification was also possible in cell lysate.
Potential applications of our approach include isolation of mRNAs from total RNA of eukaryotic cells for further 
use in RNA sequencing, which has become increasingly important to study gene expression in various cell types and 
states. Commonly, isolation proceeds via the 3’-end harboring a poly(A)-tail. However, the length of this poly(A)-tail 
itself is regulated and interesting to study. Our method might allow to isolate mRNAs via the 5’-end via a covalent or 
non-covalent interaction with the matrix.
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66 Somatic spliceosomal factor mutations in bone marrow neoplasms lead to alterations in 
alternative splicing patterns that relate to the splicing mechanism
Richard Padgett1, Bartloniej Przychodzen1, Amina Kozaric1, Hideki Makishima1, Magda Konarska2, Jaroslaw 
Maciejewski1
1Cleveland Clinic, Cleveland, Ohio USA; 2Rockefeller University, New York, NY USA
Frequent somatic mutations of spliceosomal proteins such as U2AF1, SF3B1, SRSF2 and PRPF8 have been identified 
in myeloid malignancies. These mutations are usually single heterozygous missense mutations at highly recurrent sites. 
While all of these mutations affect proteins in the common splicing pathway, their downstream consequences may be 
diverse and involve distinct oncogenic pathways. To identify affected genes and gain mechanistic insight into the effects of 
these mutations, we have analyzed the tumor transcriptomes of multiple AML patients with and without spliceosomal factor 
mutations. For U2AF1, we analyzed 6 tumors with U2AF1 mutations and 14 tumors that had no known splicing factor 
mutations. Focusing on cases of alternative exon inclusion, we identified 35 exons in 35 genes whose inclusion was altered 
using stringent statistical cutoffs. Of these, 8 exons were more included while 27 were more excluded in the U2AF1 mutant 
tumors. We examined the splice site signals flanking the alternative exons and noted a highly unusual sequence pattern 
adjacent to the 3’ AG dinucleotide which is the recognition site of U2AF1. The sequence at this position showed a mutually 
exclusive pattern upon comparing the excluded to the included exons and this pattern also differed from the consensus 3’ 
splice site sequence. We speculate that the RNA recognition activity of U2AF1 is altered by these mutations. We also found 
that these splicing changes are not seen in tumors expressing low levels of unmutated U2AF1 nor are the patterns the same 
in similar tumors with mutations in splicing factors SF3B1, SRSF2 or PRPF8.
The core splicing factor PRPF8 is also often mutated or is expressed at low levels in myeloid malignancies. We identified 
9 different missense mutations in AML patients. Eight of these positions were conserved in yeast and the analogous 
mutations were introduced into the Prp8 gene. None of these mutations produced a growth, temperature sensitive or cold 
sensitive phenotype. Most showed weak suppression of a subset of splice site mutations. The mutations map to a surface of 
Prp8 that appears to associate with Brr2. Transcriptome analyses of tumors from mutant and low PRPF8 expressers showed 
characteristic alterations in exon inclusion. There was a low overlap between the genes most affected in the mutant cases 
compared to the low expression cases suggesting that the mutant PRPF8 has an altered function.  
65 Bromomethylcoumarins as selective reagents for RNA labeling
Mark Helm1, Stefanie Kellner1
1Institute of Pharmacy and Biochemistry, Johannes Gutenberg University Mainz, Staudinger Weg 5, D-55128 
Mainz, Germany
Selective alkylation of RNA nucleotides is an important field of RNA biochemistry, e.g. in applications of 
fluorescent labeling or in structural probing experiments, yet detailed structure-function studies of the labeling agents 
are rare. Here, bromomethylcoumarins as reactive dyes for fluorescent labeling of RNA are developed as an attractive 
scaffold on which electronic properties can be modulated by variegated substituents. Using semi-quantitative LC-MS/
MS analysis, the selectivity of various coumarin derivatives in labeling reaction with respect to the four major and a 
number of minor, i.e. modified nucleotides was assessed.  This allowed the development of coumarins (i) as adaptor 
modules carrying an azide or alkyne function permitting further labeling by click chemistry; (ii) as photocrosslinking 
probes at uridine moieties, (iii) tagging the naturally occurring nucleotide modification 4-thiouridine with a selectivity 
of four orders of magnitude. This establishes bromomethylcoumarins as versatile reagents with a wide range of 
applications in RNA science.
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68 Multiple myeloma-associated hDIS3 mutations cause perturbations in cellular RNA 
metabolism and suggest potential drug targets
Rafal Tomecki1, Karolina Drazkowska1, Iwo Kucinski2, Krystian Stodus2, Roman Szczesny2, Jakub Gruchota2, 
Andrzei Dziembowski1
1Institute of Biochemistry and Biophysics, Polish Academy of Sciences & Institute of Genetics and 
Biotechnology, Faculty of Biology, University of Warsaw Pawinskiego 5a, 02-106 Warsaw, Poland; 
2Department of Biophysics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences & Institute 
of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, Pawinskiego 5a, 02-106 Warsaw, 
Poland.
Dis3 is a human nuclear exosome catalytic subunits which contains  exonucleolytic (RNB) and endonucleolytic 
(PIN) active domains. Approximately 10% of multiple myeloma (MM)  cases have mutations in Dis3 which locate 
mostly in the conserved residues of  RNB domain. Moreover, Dis3 mutations were also found in other cancers like 
Acute Myeloid Leukemia or Medulloblastoma. 
We show that mutations found in MM patents interfere with Dis3 exonucleolytic activity leading to overall decrease 
of enzymatic activity, loss of processivity and inability to degrade double-stranded regions. MM Dis3 mutations when 
introduced into yeast Dis3 ortholog causes growth alterations and changes in nuclear RNA metabolism typical for yeast 
exosome dysfunction. Since the role of human Dis3 has not been intensively studied we generated conditional Dis3 
knockout in chicken B-cell  derived  DT40 cell line and found out that Dis3 is essential for cell survival suggesting 
that in its function cannot be taken over by other human exosome associated nucleases: Dis3l and Rrp6. Construction 
of human cellular model in which endogenous WT Dis3 is replaced with MM mutants reveled substantial changes in 
RNA metabolism as detected by northern blot and genome wide RNA-seq experiments.  For example, Dis3 mutations 
interfered with rRNA processing and leaded to accumulation of unstable RNAs arising from pervasive transcription. 
Finally, we analyzed vulnerabilities caused by Dis3 dysfunction what revealed potential drug targets for cancers 
bearing Dis3 mutations.
 All data mentioned above point to the conclusion that hDIS3 mutations found in MM influence cell physiology, 
disturb exosome function and may potentially cause global defects in the posttranscriptional regulation of gene 
expression. Such defects are a source of vulnerabilities which can be used for cancer drug development.
67 Mnk2 alternative splicing inactivates its tumor suppressor activity as a modulator of the 
p38-MAPK stress pathway
Avi Maimon1, Maxim Mogilevsky1, Asaf Shilo1, Ben Davidson3, Rikiro Fukunaga2, Rotem Karni1
1Department of Biochemistry and Molecular Biology, Hebrew University-Hadassah Medical School; 2Osaka 
University of Pharmaceutical Sciences; 3University of Oslo, Faculty of Medicine
The kinase Mnk2 is a substrate of the MAPK pathway and phosphorylates the translation initiation factor eIF4E. 
In humans, MKNK2, the gene encoding for Mnk2 is alternatively spliced yielding two splicing isoforms with differing 
last exons: Mnk2a, which contains a MAPK binding domain and Mnk2b which lacks this domain. We found that the 
Mnk2a isoform is downregulated in breast, lung and colon tumors and is tumor suppressive. Mnk2a directly interacts 
with, activates and translocates p38α-MAPK into the nucleus, leading to activation of its target genes, increasing cell 
death and suppression of Ras-induced transformation in vitro and in vivo. Alternatively, Mnk2b  is pro-oncogenic and 
does not activate p38-MAPK, while still enhancing eIF4E phosphorylation. Using mutants of Mnk2a that localized 
either to the  cytoplasm or the nucleus we show that Mnk2a colocalization with p38α-MAPK in the nucleus is both 
required and sufficient for its tumor suppressive activity; induction of p38α-MAPK target genes and apoptosis.  Thus, 
Mnk2a downregulation by alternative splicing is a new tumor suppressor mechanism, which is lost in some breast, 
colon and lung tumors.
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70 Loss of MBNL1 function impairs neuronal morphology in myotonic dystrophy type 1
Ting-Yu Kuo1, Pei-Ying Wang1, Hsing-Jung Chen1, Mi-Hua Tao1, Guey-Shin Wang1
1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
Myotonic dystrophy (DM) is the most common cause of adult onset muscular dystrophy. Cognitive deficits are 
found in a high percentage of individuals with DM, type 1 (DM1). The cognitive and behavioral abnormalities include 
mental retardation, attention deficit and hyperactivity disorder, excessive daytime sleepiness and psychiatric disorders. 
The genetic basis of DM1 is caused by an expansion of CTG repeats in the 3’ untranslated region (UTR) of the Dystrophia 
Myotonica Protein Kinase (DMPK) gene. DMPK mRNA containing expanded CUG repeats accumulates in nuclear 
foci and affect nuclear and cytoplasmic functions of RNA binding proteins such as muscleblind like 1 (MBNL1) and 
CELF1 (CUGBP and ETR3 Like Factor). Dysfunction of MBNL1 and CELF1 resulting in mis-regulated alternative 
splicing has been known to involve in the pathogenesis of DM1 skeletal muscle and heart respectively. However the 
molecular mechanism of how expanded CUG RNA affects central nervous system (CNS) functions in DM1 remains 
unknown. We have established a brain specific DM1 mouse model, EpA960/CaMKII-Cre, in which expanded CUG 
RNA is specifically expressed in brain. We found that mouse brains expressing expanded CUG RNA displayed several 
features of DM1 brain including mis-regulation of alternative splicing and atrophy of cortex and corpus callosum. 
Hippocampal cultured neurons expressing expanded CUG RNA or knockdown of MBNL1 exhibited similar defects 
in axonal outgrowth and dendrite development suggesting that loss of MBNL1 function plays an important role in 
DM1 CNS pathogenesis. In studying the phenotype progression in DM1 mouse brain, we found the progressive loss 
of MBNL1 in the cytoplasm that is reminisced of changes in alternative splicing of Mbnl1 exon 5. Using time-lapse 
microscopy we found that MBNL1 cytoplasmic isoform resulting from exclusion of exon 5 is involved in trafficking 
in cultured hippocampal neurons. We further demonstrated that overexpression of this spliced variant enhances neurite 
outgrowth through mediating BDNF signaling by interacting with cytoplasmic dynein light chain. More importantly 
neurons expressing expanded CUG RNA fail to respond to BDNF treatment and loss of BDNF responsiveness can be 
rescued by expression of MBNL1 cytoplasmic isoform. Thus our results provide a novel mechanism for MBNL1 in 
DM1 CNS pathogenesis. 
69 Defective RNP Assembly in Prostate and Other Cancers
Rosario Machado-Pinilla1, Phillip J. Iaquinta2, Charles L. Sawyers2, U. Thomas Meier1
1Albert Einstein College of Medicine, Bronx, NY; 2Memorial Sloan-Kettering Cancer Center, New York, NY
H/ACA RNPs, one of the two major families of snoRNPs, are important for many basic cellular processes including 
protein synthesis, pre-mRNA splicing, and genome integrity. Consisting of only one small non-coding H/ACA RNA 
and four core proteins, their biogenesis is surprisingly complex depending on at least two H/ACA-specific and four 
general assembly factors. SHQ1 is a chaperone of the central H/ACA core protein and pseudouridine synthase NAP57, 
aka dyskerin and Cbf5 in yeast and archaea. Through tight interaction, SHQ1 functions in the essential first step of H/
ACA RNP biogenesis protecting the inherently unstable NAP57 from degradation and aggregation. It is this NAP57-
SHQ1 interaction that is the target of mutations in NAP57 causing the inherited bone marrow failure syndrome 
dyskeratosis congenita. Surprisingly, although mutations in other components of H/ACA RNPs have been identified 
in this often-fatal disease, none have been uncovered in SHQ1.
 Now a prostate cancer genomics project implicates SHQ1 as a tumor suppressor in cooperation with the 
androgen-driven serine protease-transcription factor translocation TMPRSS2-ERG, which is observed in ~50% of 
prostate cancers. Indeed, knockdown of SHQ1 or NAP57 (in combination with ERG expression) in a prostate tissue 
recombination assay leads to intraepithelial neoplastic lesions in 4-6 weeks. Additionally, SHQ1 is the only one in 
a cluster of genes with copy number alterations that also carries tumor-associated mutations. Importantly, prostate 
cancer mutations are also identified in NAP57 implicating both proteins as tumor suppressors. Additional somatic 
mutations in SHQ1 and NAP57 are identified in other types of tumors, i.e., colon, lung, uterine, and glioblastoma, 
with most amino acid substitutions adorning the interface between the two proteins. We demonstrate that these cancer 
mutations, unlike SNPs or mutations of conserved amino acids required for catalysis, impair the interaction of SHQ1 
with NAP57 thereby impeding overall H/ACA RNP biogenesis. We conclude that, through SHQ1 and NAP57, H/
ACA RNP biogenesis is a target for inherited and somatic diseases and we will speculate on the underlying molecular 
mechanisms.
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71 Mutations in the gene encoding U11/U12-65K protein leads to pituitary hypoplasia and 
isolated growth hormone deficiency type I
Bhupendra Verma1, Ali Oghabian4, Ivon Cuscó3, Gabriel Á. Martos-Moreno2, Armand Gutiérrez3, Julie A. Chowen2, 
Jesús Argente2, Luis A. Pérez-Jurado3, Mikko J. Frilander4
1Institute of Biotechnology, University of Helsinki, Finland; 2Department of Pediatrics, Universidad 
Autónoma de Madrid, Departments of Pediatrics & Pediatric Endocrinology, University Hospital Niño Jesús, 
Centro de Investigación Biomédica en Red de fisiopatología de la obesidad y nutrición (CIBERobn), Madrid, 
Spain; 3Genetics Unit, Universitat Pompeu Fabra, Hospital del Mar Research Institute (IMIM) and Centro 
de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Spain; 4Institute of 
Biotechnology, University of Helsinki, Finland
We describe here the second human disease that is caused by mutations in a specific component of the U12-
dependent spliceosome. Earlier recent work by He et al. (2011) and Edery et al. (2011) have described recessive 
mutations in the U4atac snRNA that cause Microcephalic Osteodysplastic Primordial Dwarfism type 1 or Taybi-
Linder syndrome (MOPD1/TALS). The patients with this disease suffer from severe developmental defects and death 
during early childhood, most likely due to splicing defects in a subset of ~800 genes carrying U12-type introns.
Here we have studied a family with three sisters affected with severe postnatal growth retardation due to isolated 
GH deficiency and otherwise normal development. Brain MRI scans revealed hypoplasia of the anterior pituitary. 
The therapeutic response to GH replacement has been excellent to date, suggesting a diagnosis of familial isolated 
GH deficiency with associated pituitary hypoplasia. Mutational and segregation analyses discarded involvement of 
all known genes of the GH axis. Exome sequencing revealed biallelic mutations in the RNPC3 gene encoding for the 
U11/U12-65K protein. This protein is one of the seven unique protein components in the U11/U12 di-snRNP that 
recognizes the 5’ss and BPS of U12-type introns. The 65K protein is known to bind to the 3’ terminal stemloop of 
U12 snRNA and form a molecular bridge between U11 and U12 snRNPs via interactions with 59K and 48K proteins 
(Benecke et al., 2005; Turunen et al., 2008). The mutations are in the second RNA recognition motif (RRM2), which 
binds to the U12 snRNA.
Our preliminary RNAseq analyses from patient lymphocytes have identified defects in splicing of a subset of 
U12-type introns, which indicate a partial loss of function and is consistent with the observed mild pathological effects 
of the mutations. Furthermore, glycerol gradient analyses and biotinylated 2’-O-Me RNA oligo pulldown experiments 
indicate significantly reduced cellular levels of U11/U12 di-snRNPs, which is consistent with predicted consequences 
of the RRM2 mutations. Finally, we observed unexpected ~2-fold upregulation in the cellular levels of U4atac snRNA 
alone and as an U4atac/U6atac di-snRNA complex, which may be a possible compensatory mechanism for the defects 
in the 65K function.
1. Benecke, H., et al. (2005). EMBO J 24, 3057-3069.
2. Edery, P., et al (2011). Science 332, 240-243.
3. He, H., et al (2011). Science 332, 238-240.
4. Turunen, J.J., et al. (2008). Mol Cell Biol 28, 3548-3560.
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73 Genome-wide mapping of RBM10 binding sites reveals its role in splicing regulation: 
Implications for cleft palate and TARP syndrome
Julie Rodor1, David Fitzpatrick1, Javier Caceres1, Margarida Gama-Carvalho1
1MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, UK
RBM10 is an RNA-binding protein of unknown function, which comprises several motifs that bind RNA, 
including two RNA recognition motifs (RRMs) and Zinc fingers. Mutations in human RBM10, which maps to the 
X-chromosome, results in a syndromic form of cleft palate, termed TARP syndrome. This syndrome comprises 
Pierre–Robin sequence (micrognathia, glossoptosis, and cleft palate), talipes equinovarus, atrial septal defect (ASD), 
and persistence of the left superior vena cava and results in pre- or postnatal lethality in affected males1. The loss of 
function of RBM10 in TARP syndrome shows that this gene is critical for normal mammalian development.
In order to understand the role of RBM10 and how its disruption results in human disease, we aimed to identify 
endogenous RMB10 RNA targets in a tissue that is relevant to the phenotype observed in TARP syndrome. For this, we 
used the Cross-Linking Immunoprecipitation protocol (iCLIP) that allows the mapping of protein-RNA interactions 
at an individual nucleotide resolution. Given the strong conservation between the human and the orthologous murine 
RBM10 protein and the pattern of expression of the mouse RBM10 gene being consistent with the human malformations 
of the TARP syndrome, we performed the iCLIP experiment in a mouse mandibular cell line.
We identified around 57,000 RBM10 binding sites at the genomic level, with significant enrichment in intronic 
regions, in agreement with a putative role for this protein in pre-mRNA splicing. We also uncovered a variety of 
cellular RNAs, including non-coding RNAs that are bound by RBM10. We used an exon-junction array to analyze 
changes in gene expression and alternative splicing in a male X-linked Rbm10 mouse deficient cell line. This analysis 
revealed significant changes in the expression level of approximately 1,400 genes as well as changes in 200 splicing 
events. Importantly, we observed that those pre-mRNAs that display changes in splicing also contain RBM10 iCLIP 
tags, suggesting a direct role of RBM10 in splicing regulation. Furthermore, transcriptome changes in the RBM10 KO 
ES cells revealed that RBM10-regulated genes are in cellular pathways that may help explain the phenotype observed 
in the TARP syndrome. These experiments will shed light on the pathways that are disturbed in the syndromic form of 
cleft palate associated with loss of function of RBM10.
1. Johnston, J.J. et al. (2010) Am. J. Hum. Genet., 86, 743-8.
72 miR-34c-5p is a novel regulator of naive T-cell activation that impacts HIV replication
Andreia Amaral1, Jorge Andrade2, Ana Matos2, Russel Foxall3, Paula Matoso3, Mariana Santa-Marta4, Rita 
Tendeiro3, Ana Serra-Caetano3, Rui Soares3, João Gonçalves4, Ana Sousa3, Margarida Gama-Carvalho2
1BioFIG - Center for Functional and Integrative Genomics, Faculdade de Ciências and 1 Instituto de 
Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal; 2BioFIG - Center for 
Functional and Integrative Genomics, Faculdade de Ciências, Universidade de Lisboa, Portugal; 3Instituto 
de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal; 4URIA- Centro de 
Patogénese Molecular, Faculdade de Farmácia, Universidade de Lisboa, Portugal
CD4+T-cells are the main orchestrators of immune responses. They patrol the body as so-called “naïve” T-cells and 
become activated through their specific T-cell receptor (TCR) upon encounter with a cognate antigen, a process essential for 
their clonal expansion and differentiation into memory and effector T-cells. These processes  involve a delicate balance of 
cell proliferation, differentiation and death that have been shown to highly dependent upon microRNA regulation.
Activated CD4+ T-cells are the main targets of HIV infection. Moreover, HIV critically depends upon the cellular 
activation-state for effective integration into the host genome and productive viral replication. We hypothesize that HIV 
may subvert the miR profile induced by TCR stimulation.
Based on a massive parallel sequencing study of the microRnome of primary human naive CD4+T-cells, we have 
identified miR-34c-5p as a novel candidate regulator of T cell activation that is targeted during HIV infection.
miR-34c-5p was found to be expressed almost below detection limits in naive CD4+ T-cells but was induced as a late 
response to TCR stimulation. miR-34c-5p up-regulation was absent in memory cells, providing novel insights into the 
differential regulation of these two cell populations. Profiling of the naive cell response to HIV infection revealed that miR-
34c-5p was consistently down-regulated by the virus. By generating a T-cell line stably expressing high levels of miR-34c-
5p we showed that this microRNA induced a quiescent, non-proliferative phenotype and identified several relevant target 
genes for the regulation of T-cell function and response to HIV infection. Additionally, the ability of HIV to infect this T cell 
line was significantly reduced.  Our results identified miR-34c-5p as a critical regulator of HIV infection and provide data 
regarding the mechanisms controlling the expression of this miR during cell activation and virus infection.
Acknowledgements: This project is supported by a grant from the Merck Investigators Study Program, funded by the 
Merck Sharp & Dome Corp.
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75 A pair of RNA binding proteins regulate neuron-subtype specific alternative splicing in C. 
elegans
Adam Norris1, John Calarco1
1FAS Center for Systems Biology, Harvard University
Alternative splicing is an important and pervasive means of increasing the diversity of the transcriptome and proteome 
in metazoans. An increased transcriptomic repertoire has likely played a particularly important role in the cellular 
diversification of the nervous system, where different classes of neurons have evolved to perform distinct functions. 
However, it has remained a challenge to study the mechanisms and physiological impact of alternative splicing regulation 
at the level of individual neuronal subtypes. Utilizing the nematode C. elegans, with its genetic tractability and simple but 
well-differentiated nervous system, we created fluorescent two-color reporters to observe alternative splicing in vivo and at 
single neuron resolution. Our results reveal a remarkable diversity of alternative splicing patterns among individual neuron 
types. One striking example involved differential inclusion of exon 16 in UNC-16/JIP3 transcripts between GABAergic and 
cholinergic neurons (the two major classes of motor neurons in the animal). We conducted a genetic screen for regulators of 
this neuron-type specific splicing pattern and identified two broadly conserved RNA binding proteins, UNC-75/CELF and 
EXC-7/ELAV, both of which facilitate inclusion of the alternative exon. Analysis of splicing patterns in mutant animals and 
expression studies of the two factors showed that UNC-75 and EXC-7 act combinatorially to achieve neuron-type specificity 
through partially non-overlapping expression patterns. We next used mRNA-Seq experiments to profile the transcriptomes 
of wild type and mutant animals and performed CLIP-Seq to assay which transcripts were directly bound by the splicing 
factors. We found several hundred differentially regulated alternative splicing events when either or both factors are absent, 
a substantial overlap in targets between the two RNA binding proteins, and distinct modes of combinatorial regulation. 
Gene Ontology analysis indicated that targeted alternative splicing events were enriched in genes associated with synaptic 
transmission and locomotion. We are now using knockout mutant strains to explore how perturbing the network of splice 
isoforms impacts behavioral phenotypes. Initial results indicate that the splicing regulatory network can be utilized to 
implicate both known and previously uncharacterized genes in aspects of locomotory behavior and synaptic transmission, 
and that the impact of individual targeted isoforms on neuronal phenotypes can be teased apart in vivo. Taken together, our 
findings suggest that the combinatorial action of splicing factors help shape the regulatory networks contributing to the 
identity and function of distinct cell types in the nervous system. We speculate that similar regulatory strategies have been 
frequently utilized in the specification and diversification of the mammalian central nervous system.
74 Muscleblind-like proteins negatively regulate embryonic stem cell-specific alternative 
splicing and reprogramming
Hong Han1, Manuel Irimia1, Joel Ross6, Hoon-Ki Sung2, Babak Alipanahi5, Laurent David3, Azadeh Golipour3, 
Mathieu Gabut1, Iacovos Michael2, Emil Nachman1, Eric Wang4, Dan Trcka3, Tadeo Thompson6, Christopher 
Burge4, Jason Moffat1, Brendan Frey5, Andras Nagy2, James Ellis6, Jeffrey Wrana3, Benjamin Blencowe1
1Banting and Best Department of Medical Research and Donnelly Centre, University of Toronto; 2Center for 
Stem Cells and Tissue Engineering, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; 3Center 
for Systems Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital; 4Department of Biology, 
Massachusetts Institute of Technology; 5Department of Electrical and Computer Engineering, University of 
Toronto; 6Developmental and Stem Cell Biology, The Hospital for Sick Children
Previous investigations of the core gene regulatory circuitry that controls embryonic stem cell (ESC) pluripotency 
have largely focused on the roles of transcription, chromatin and non-coding RNA regulators. Alternative splicing 
(AS) represents a widely acting mode of gene regulation, yet its role in the regulation of ESC pluripotency and 
differentiation is poorly understood. Here, I identify the Muscleblind-like RNA binding proteins, MBNL1 and MBNL2, 
as conserved and direct negative regulators of a large program of AS events that are differentially regulated between 
ESCs and other cell types. Knockdown of MBNL proteins in differentiated cells causes switching to an ESC-like AS 
pattern for approximately half of these AS events. Among the events is an ESC-specific AS switch in the forkhead 
family transcription factor FOXP1 that controls pluripotency. Consistent with a central and negative regulatory role 
for MBNL proteins in pluripotency, their knockdown significantly enhances the expression of key pluripotency genes 
and the formation of induced pluripotent stem cells (iPSCs) during somatic cell reprogramming.
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77 Subsets of introns are abundant in poly(A)+ RNA
Paul Boutz1, Arjun Bhutkar1, Phillip Sharp1
1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Deep sequencing of poly(A)-selected RNA from mouse embryonic stem cells revealed many transcripts in which 
specific internal introns were significantly more abundant than the other introns within the transcript.  We validated 
a number of these high read-coverage introns by qRT-PCR and found them to be 3-80 fold more abundant than their 
downstream neighbors.  A computational pipeline was designed that identified thousands of high-coverage introns 
with a stringent statistical cutoff in both human and mouse, using our own as well as ENCODE-generated poly(A)+ 
RNA-seq data.  These introns flank both constitutive and alternatively spliced exons, on average exhibit higher 
phylogenetic sequence conservation, and the genes containing them are enriched for transcription and RNA binding/ 
processing factors as well as cell cycle and stress response genes.  After transcriptional inhibition by flavopiridol 
(30 minutes), several measured high-coverage introns were predominantly nuclear and their abundance was mostly 
unchanged; flanking downstream introns were removed by this time.  During longer flavopiridol treatments the high-
coverage introns ultimately decayed but with significantly slower kinetics than their rapidly spliced neighbors.  These 
results are consistent with high-coverage introns being posttranscriptionally-spliced introns within transcripts that are 
detained in the nucleus until all introns have been removed. We refer to these as “detained” introns (DIs) to distinguish 
them from “retained” introns, which are unspliced introns present in transcripts that are transported to the cytoplasm. 
DIs flanking cassette exons exhibited exon-specific, cotranscriptional and posttranscriptional splicing in response 
to knockdown of the splicing factor Fox2.  A number of DIs are associated with alternative splicing events that are 
predicted to function as a switch between the production of nonsense-mediated decay (NMD)-substrates and protein 
coding mRNAs. Among four human cell lines, evidence suggests that DIs are dynamically regulated and comprise a 
separate pool from previously identified mRNAs that are substrates for the NMD pathway.  We propose a modified 
exon-definition mechanism to explain how intron detention can occur, and suggest that transcripts containing DIs may 
function as a nuclear detained pool for rapid mobilization of coding mRNAs in response to cellular needs.
76 CFlm25 Links Global change in APA to Cell Growth Control and Glioblastoma Survival
Chioniso Masamha1, Zheng Xia2, Wei Li2, Ann-Bin Shyu1, Todd Albrecht1, Eric Wagner1
1University of Texas Health Science Center at Houston; 2Baylor College of Medicine
A growing body of evidence implicates alternative cleavage and polyadenylation (APA) as an important mechanism 
in regulating gene expression. In rapidly proliferating cells or tumors, widespread shortening of 3′UTRs is posited to 
result in the increased expression of genes important for these altered states.  While this observation has been known 
for some time, the underlying molecular events that lead to APA in these cells are not known.
Here, we systematically depleted each member of the mammalian cleavage and polyadenylation machinery and 
measured APA of three test genes: Cyclin D1, Timp2, and Dicer1.  Depletion of only the members of the CFIm complex 
led to shortening of these 3’UTRs with the most dramatic shortening after reduction in CFIm25.  To determine its 
global targets, we developed a novel algorithm capable of identifying and quantifying APA events from standard 
RNA-Sequencing.  Using this algorithm, we identified over 1000 genes that switched from distal to proximal PAS 
selection after knockdown of CFIm25 in Hela cells. Among the top genes whose APA is under CFIm25 regulation 
is Glutaminase (GLS), which converts glutamine to glutamate in highly proliferative tumors to support the cancer 
metabolic phenotype.  Depletion of CFIm25 leads to significant shortening of the GLS 3′UTR that causes a profound 
increase in GLS protein levels. In response, cells with CFIm25 depleted not only proliferate faster but also are sensitive 
to glutamine withdrawal demonstrating a metabolic change in response to global 3′UTR shortening.
To investigate the biological role of CFIm25 in APA we used our algorithm on data deposited in the TCGA 
database.  This analysis uncovered a previously unsuspected link between CFIm25 levels and survival in glioblastoma 
patients. Moreover, using our algorithm we compared the 3′UTR usage in RNA seq data from samples of glioblastoma 
patients who expressed either high or low levels of CFIm25 and identified a group of genes with 3′UTR shortening in 
conditions of reduced expression. Top on this list is MeCP2, which has been associated with the increased proliferation 
of several cancers and its altered expression in neurons leads to a spectrum of human neurological disorders. These 
findings identify a pivotal role of the CFIm25 in governing APA, demonstrate APA identification through standard 
RNA-Seq, and reveal a previously unknown link between APA and metabolic pathways important for enhanced cell 
proliferation.
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79 Lariat Sequencing in a Unicellular Yeast Identifies Regulated Alternative Splicing of Exons 
that are Evolutionarily Conserved with Humans
Ali Awan1, Amanda Manfredo1, Jeffrey Pleiss1
1Cornell University
Alternative splicing is a potent regulator of gene expression that vastly increases proteomic diversity in multicellular 
eukaryotes, and is associated with organismal complexity. Although it is widespread in vertebrates, little is known 
about the evolutionary origins of this process owing in part to the absence of phylogenetically conserved events 
that cross major eukaryotic clades. Here we describe a lariat sequencing approach, which offers high sensitivity for 
detecting splicing events, and its application to the unicellular fungus, Schizosaccharomyces pombe, an organism that 
shares many of the hallmarks of alternative splicing in mammalian systems but for which no previous examples of 
exon-skipping had been demonstrated. Over 200 previously unannotated splicing events were identified, including 
examples of regulated alternative splicing. Remarkably, an evolutionary analysis of four of the exons identified here 
as subject to skipping in S. pombe reveals high sequence conservation and perfect length conservation with their 
homologs in scores of plants, animals, and fungi. Moreover, alternative splicing of two of these exons have been 
documented in multiple vertebrate organisms, making these the first demonstrations of identical alternative splicing 
patterns in species that are separated by over one billion years of evolution. 
78 Genome-wide analysis of pre-mRNA splicing in budding yeast from the perspective of the 
intron
Daoming Qin1, Lei Huang2, Jonathan Staley3
1Department of Molecular Genetics and Cell Biology, University of Chicago; 2Center for Research 
Informatics, University of Chicago; 3Department of Molecular Genetics and Cell Biology
In eukaryotes, genes are interrupted by non-coding introns that are spliced out in the process of pre-mRNA 
splicing. Monitoring pre-mRNA splicing genome-wide is vital to annotating gene structure and understanding the 
role of pre-mRNA splicing in gene regulation. Pre-mRNA splicing was initially analyzed genome-wide by array-
based methods. However, microarrays suffer from low dynamic range and cross hybridization and they typically 
require prior knowledge of splicing junctions. Recently, RNA-seq, which can reveal splice junctions, has provided 
another opportunity to monitor splicing with unprecedented dynamic range and resolution. However, the mRNA 
population ,the target of array and RNA-seq approaches, is underrepresented for splicing events that yield mRNAs 
subject to non-sense mediated decay. Moreover, due to slow turnover, mRNA can be sluggish in reflecting changes in 
splicing. Additionally, mRNA sequence does not reveal the branch point, the nucleophile for 5’ splice site cleavage. 
Notably, the limitations of focusing on mRNA to monitor pre-mRNA splicing can be overcome by an alternative 
approach targeting the intron. We and others have developed approaches to target the intron. In our approach, we 
sequence the ends of the excised intron to reveal the 5’ splice site and the branch point. We have tested the utility of 
our method in budding yeast and confirmed the majority of annotated intron (~240 introns) that are expressed and 
spliced under vegetative growth conditions. Furthermore, we detected novel introns in coding regions, 3’ UTRs and 
antisense transcripts. Additionally, given the depth of our analysis, we observed evidence for splicing errors. Finally, 
although alternative splice site usage is extremely rare in budding yeast, we have uncovered and validated cases of 
alternative 5’ splice site usage and alternative branch point usage.  Intriguingly, some genes that undergo alternative 
splicing code for splicing factors. We hypothesize that alternative splicing of these transcripts enables auto-regulation 
by novel regulatory mechanisms, which we are currently testing. Our study underscores the value of viewing splicing 
from the perspective of the intron.
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81 The Future of RiboScience
Thomas R. Cech1
1University of Colorado, Boulder
“Big Data” and computational biology have accelerated the pace of discovery in RNA research.  From riboswitches 
to lncRNAs to CRISPR to circular RNAs that act as miRNA sponges, new classes of functional noncoding RNAs are 
appearing with a dizzying frequency.  The power of combining genome-wide and transcriptome-wide approaches with 
traditional biochemistry and cell biology is influencing the vision for new research institutions around the world.  It 
also needs to influence how we educate our graduate and undergraduate students, so that they see the connections 
between physics, chemistry, computer science, engineering and biology and can harness multiple disciplines to address 
problems in RNA research and in biology more generally.
80 Global Analysis of Phosphorylation by SR Protein Kinases and Their Effects on Genome-
wide Splicing in Schizosaccharomyces pombe
Michael Marvin1, Jesse Lipp1, Kevan Shokat1, Christine Guthrie1
1University of California, San Francisco, CA, USA
Phosphorylation of both core splicing factors and other co-transcriptionally associated proteins has been shown to 
influence multiple steps in pre-mRNA splicing. Some phosphorylation events have been linked to specific kinases, but a 
global analysis of splicing kinases and their substrates, as well as how these events affect splicing genome-wide, is currently 
lacking. Known substrates of splicing kinases include the conserved serine/arginine (SR) proteins, which are vital in both 
constitutive and alternative splicing. S. pombe has two SR proteins (Srp1 and Srp2), two SR specific kinases (Dsk1 and 
Kic1/Lkh1), and almost 5,000 introns making it an attractive but manageable system to study the genome-wide effects of 
phosphorylation on splicing. In order to identify specific phosphorylation events, we took a chemical genetic approach by 
mutating the “gatekeeper” residue of specific kinases. This mutation provides access to a hydrophobic region at the back 
of the ATP binding pocket enabling selective use of bulky ATP analogs. We mapped the specific sites of phosphorylation in 
extract followed by LC-MS/MS for both the Srpk1 homolog Dsk1 and the Clk/Sty homolog Kic1/Lkh1. We found extensive 
phosphorylation within the RS domains of the SR proteins Srp1 and Srp2, as well as the SR-like proteins U2AF59 and Rsd1. In 
addition, we identified proteins that are also phosphorylated in humans, such as Srrm1 and U1-70K, even though their fission 
yeast homologs have a reduced RS domain. Perhaps most surprisingly phosphorylation was identified in core splicing factors 
such as Prp8, Bpb1, and Sap155. We next found that dsk1-Δ results in a defect in spliceosome complex A assembly in extracts, 
which further underlines the importance of these phosphorylation events in splicing. Expanding on this result, we analyzed 
the genome-wide effect of dsk1-Δ and kic1-Δ on splicing and found that dsk1-Δ has a broad splicing defect. To confirm the 
importance of phosphorylation on splicing in a titratable manner, we then integrated a gatekeeper mutated dsk1 into yeast 
and observed splicing defects by specifically inhibiting its activity using a small molecule inhibitor. In the future, we will use 
varying amounts of inhibitor to analyze genetic interactions using an epistatic miniarray profile (EMAP) and in vitro assembly 
assays. We are currently investigating the in vivo importance of specific sites of phosphorylation by integrating alanine mutants 
of kinase substrates into yeast. Early analysis of these alanine mutants indicates that the Dsk1 phosphorylation of Bpb1 is 
required for normal growth. We now plan to use the microarrays to analyze splicing globally with the alanine mutants as well 
as genetic interactions via an EMAP and in vitro assembly assays. Our results from yeast support parallel results in humans and 
provide an evolutionary view of how phosphorylation is vital for splicing.
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83 Deciphering the assembly of box C/D snoRNP complexes
Jonathan Bizarro1, Bérengère Pradet-Balade1, Marc Quinternet2, Xavier Manival2, Bruno Charpentier2, Christiane 
Branlant2, Céline Verheggen1, Edouard Bertrand1
1IGMM-UMR 5535-Montpellier-France; 2IMoPA-UMR 7365- Vandoeuvre-Lès-Nancy-France
Box C/D small nucleolar Ribonucleoproteins (C/D snoRNPs) are essential complexes for gene expression as they 
direct post-transcriptional modifications of rRNAs in the nucleolus. Box C/D snoRNAs are assembled with a set of 
four core proteins. Their assembly occurs in the nucleoplasm but the mechanisms involved are not yet clearly defined 
although we know several assembly factors such as Nufip and the HSP90/R2TP system, which contain the key AAA+ 
ATPases Rvb1 and Rvb2. 
Here, we described a new snoRNP assembly factor named Trip3. We showed that Trip3 dimerizes with Nufip 
and is important for first steps of snoRNP assembly. By quantitative SILAC proteomics, we found that Nufip/Trip3 
associates with part of the R2TP complex and some snoRNP core proteins to form a complex devoid of RNA. This 
complex is subsequently recruited on nascent box C/D snoRNA, and this occurs concomitantly with removal of Trip3 
while Nufip is removed at a later stage. By performing detailed mutagenesis coupled to NMR studies and structural 
modeling, we obtained a model of the interaction of a fragment of Nufip with pre-snoRNP. This model shows that 
Nufip keeps pre-snoRNPs in an inactive state, and that Nufip must be removed to allow formation of the active 
snoRNP structure. We propose that this is catalyzed by the AAA+ ATPases Rvb1/2.
82 The architecture of Tetrahymena telomerase holoenzyme
Jiansen Jiang1, Edward J. Miracco3, Kyungah Hong6, Barbara Eckert6, Henry Chan4, Darian D. Cash3, Bosun Min6, 
Z. Hong Zhou5, Kathleen Collins6, Juli Feigon2
1Department of Microbiology, Immunology and Molecular Genetics, Department of Chemistry and 
Biochemistry, and California Nanosystems Institute, University of California, Los Angeles; 2Department 
of Chemistry and Biochemistry and California Nanosystems Institute, University of California, Los 
Angeles; 3Department of Chemistry and Biochemistry, University of California, Los Angeles; 4Department 
of Chemistry and Biochemistry, University of California, Los Angeles; 5Department of Microbiology, 
Immunology and Molecular Genetics and California Nanosystems Institute, University of California, Los 
Angeles; 6Department of Molecular and Cell Biology, University of California, Berkeley
Telomerase adds telomeric repeats to chromosome ends using an internal RNA template and specialized telomerase 
reverse transcriptase (TERT), thereby maintaining genome integrity. Little is known about the physical relationships 
among protein and RNA subunits within a biologically functional holoenzyme. Here we describe the architecture 
of Tetrahymena thermophila telomerase holoenzyme determined by electron microscopy. Six of the 7 proteins and the 
TERT-binding regions of telomerase RNA (TER) have been localized by affinity labeling. Fitting with high-resolution 
structures reveals the organization of TERT, TER, and p65 in the RNP catalytic core. Among the other holoenzyme 
proteins, p50 has an unanticipated role as a hub between the RNP catalytic core, p75-p19-p45 subcomplex, and the 
DNA-binding Teb1. A complete in vitro holoenzyme reconstitution assigns function to these interactions in processive 
telomeric repeat synthesis. These studies provide the first view of the extensive network of subunit associations 
necessary for telomerase holoenzyme assembly and physiological function. 
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85 Molecular basis of translation activation by the non-coding RNA RsmZ
Olivier Duss1, Maxim Yulikov1, Erich Michel1, Mario Schubert1, Gunnar Jeschke1, Frédéric Allain1
1ETH Zürich
In bacteria, sRNAs (small regulatory/ non-coding RNAs) coordinate global changes in gene expression. The most 
important global post-transcriptional regulatory system responsible for bacterial virulence is the Csr/Rsm system, in 
which a sRNA (CsrB/RsmZ) activates translation initiation by sequestering a homo-dimeric protein (CsrA/RsmE) 
that is binding to the ribosome binding site of a subset of mRNAs [1, 2]. However, the mechanism of translation 
derepression is only partially understood on the molecular and atomic level.
Here we show for Pseudomonas fluorescens that several RsmE protein dimers are assembling sequentially, 
specifically and cooperatively onto the sRNA RsmZ, while binding of the third RsmE protein dimer changes RsmZ 
from an RNase E accessible to a protected form. Furthermore, we elucidated the 70 kDa solution structure of RsmZ 
bound to three RsmE proteins using a combinatorial approach consisting of nuclear magnetic resonance and electron 
paramagnetic resonance spectroscopy as well as multiple segmental isotope labeling of the RNA [3].
Strikingly, we discovered two similarly populated conformations in solution, which cannot directly interconvert 
between each other. Their interconversion requires the dissociation of all three proteins and thus, shows that the first 
RsmE protein binds the sRNA RsmZ by conformational selection. To our knowledge, both conformations represent a 
global RNA fold, which has not been described before. The structures visualize how the sRNA can bind several RsmE 
protein dimers with high affinity by using the helical stems as clamps which tightly grab the proteins. Furthermore, 
both conformations explain why the third RsmE protein dimer binding to RsmZ is protecting the RNA from RNase E 
mediated cleavage.
In conclusion, our findings illustrate the molecular basis of translation activation by the sRNA RsmZ and propose 
how the targeted proteins could ultimately be released from sRNA sequestration.
1. Waters L. et al. (2009) Cell 
2. Lapouge K. et al. (2010) Mol Microbiol
3. Duss O. et al. (2010) Nucleic Acids Res
84 Crystal Structure of the Bacterial Pnkp1/Rnl/Hen1 Heterohexamer: A New RNA Repair 
Complex
Pei Wang1, Kiruthika Selvadurai1, Raven Huang1
1Department of Biochemistry, University of Illinois at Urbana-Champaign
Ribotoxins cleave essential RNAs for cell killing in vivo, and we have previously shown that the bacterial Pnkp/
Hen1 RNA repair complex was able to repair ribotoxin-cleaved RNAs in vitro.  Because of 2’-O-methylation by 
bacterial Hen1 during RNA repair, the repaired RNA resists future cleavage by the same ribotoxin that causes the 
original damage.  Through bioinformatic analysis, we have recently found a new bacterial RNA repair complex that is 
related to, but also distinct from, the Pnkp/Hen1 complex.  The newly discovered RNA repair complex is composed 
of three proteins, named Pnkp1, Rnl, and Hen1, which form a heterohexamer in vitro.  To provide insight into the 
mechanism of RNA repair and shed light on potential in vivo RNA substrates, we solved the crystal structure of the 
270 kDa Pnkp1/Rnl/Hen1 heterohexamer with cofactors (ATP, SAH, and Mg2+) occupying all eight enzymatic active 
sites.  The structure reveals the architecture of Pnkp1/Rnl/Hen1 heterohexamer as two ring-shaped Pnkp1/Rnl/Hen1 
fused at Pnkp1, which forms a homodimer.  Each Pnkp1/Rnl/Hen1 ring is formed through pairwise protein-protein 
interactions between these three proteins, but the interactions are trans in nature (e.g., Pnkp1a-to-Rnla-to-Hen1a-to-
Pnkp1b, and vice versa).  Four active sites that are required for RNA repair (kinase, phosphatase, methyltransferase, 
and ligase) are located on the inner rim of each ring, allowing RNA repair to be carried out efficiently.  A lack of a 
specific RNA-binding groove/cleft and a wide opening at the center of the ring allow a variety of damaged RNAs to 
access the four active sites for repair, indicating that the Pnkp1/Rnl/Hen1 heterohexamer might be an all-purpose RNA 
repair complex.
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87 The structural basis of SRP receptor recruitment and GTPase activation by SRP RNA
Nikolaus Schmitz1, Felix Voigts-Hoffmann1, Kuang Shen2, Shu-ou Shan2, Sandro F. Ataide3, Nenad Ban1
1ETH Zurich (Swiss Federal Institute of Technology), Institute of Molecular Biology and Biophysics, Zürich, 
Switzerland; 2Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, 
California, USA; 3University of Sydney, School of Molecular Bioscience, Sydney, Australia
The Signal Recognition Particle (SRP) pathway is a universally conserved membrane protein targeting system, 
which recognizes ribosome nascent chain complexes (RNCs) exposing a SRP signal sequence (cargo). The cargo is 
subsequently transferred to the translocon, which mediates the co-translational transport of the emerging polypeptide 
across the lipid bilayer and also guides the insertion and folding of membrane proteins. 
Transfer of the cargo to the translocon involves a large scale rearrangement of the SRP:receptor complex during 
which the SRP RNA plays a pivotal role in both receptor recruitment and GTPase activation. We have determined the 
crystal structure of prokaryotic SRP:receptor GTPase domain heterodimers bound to SRP RNA at the tetraloop and 
the distal site at 2.6 Ångström resolution. 
The interactions at the tetraloop reveal the structural basis of receptor recruitment and rationalize previously 
accumulated biochemical and structural data on the dynamics of this process. Strikingly, interactions between the 
SRP receptor and the SRP RNA at the tetraloop as well as at the distal site involve the insertion box domain (IBD), a 
domain that is unique to the SRP-GTPase family.
At the distal region, a flipped-out base of the SRP RNA inserts into the cleft between the two proteins and 
stimulates hydrolysis of receptor bound GTP by reordering of a side chain provided in trans by Ffh. Biochemical data 
confirm that these fully conserved residues are essential for GTP hydrolysis and efficient protein translocation. 
The structural findings combined with biochemical experiments reported in this study reveal the molecular basis 
of the SRP receptor recruitment to the tetraloop of the SRP RNA and allow us to suggest a possible mechanism for 
GTPase activation at the distal site of the SRP RNA. 
86 Single-molecule analysis of L7Ae protein binding to a k-turn : induced fit or 
conformational selection ?
Jia Wang1, Tomáš Fessl1, Kersten T. Schroeder1, David M. J. Lilley1
1University of Dundee
When binding of a protein causes a conformational transition to occur in the target RNA this can in principle 
result from an active induced fit process, or a passive conformational selection. The k-turn is a commonly-occurring 
structural motif that introduces a tight kink into duplex RNA. In free solution it can exist in an extended form, or be 
folding into the kinked structure. Binding of proteins including the L7Ae family generate the formation of the kinked 
geometry, raising the question of whether this occurs by conformational selection of the kinked structure, or a more 
active induced fit process in which the protein manipulates the RNA structure.
We have devised a single-molecule FRET experiment whereby immobilized L7Ae protein binds Cy3-Cy5-labelled 
RNA from free solution. We find that all bound RNA is in the kinked geometry, with no evidence for transitions to an 
extended form at a millisecond timescale. Furthermore, real-time binding experiments provide no evidence for a more 
extended transient intermediate during the binding process.
The data support a passive model by which the protein selects a fraction of RNA that is already in the kinked 
conformation, thereby drawing the equilibrium into this form.
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88 Crystal structure of Prp8 and its implications for the spliceosomal active site
Wojciech Galej1, Chris Oubridge1, Andy Newman1, Kiyoshi Nagai1
1MRC Laboratory of Molecular Biology
The active centre of the spliceosome consists of an intricate network formed by U5, U2 and U6 small nuclear 
RNAs, and a pre-messenger-RNA substrate. Prp8, a component of the U5 small nuclear ribonucleoprotein particle, 
crosslinks extensively with this RNA catalytic core. I will present the crystal structure of yeast Prp8 (residues 885-
2413) in complex with Aar2, a U5 small nuclear ribonucleoprotein particle assembly factor. The structure reveals 
tightly associated domains of Prp8 resembling a bacterial group II intron reverse transcriptase and a type II restriction 
endonuclease (Figure 1). Suppressors of splice-site mutations, and an intron branch-point crosslink, map to a large 
cavity formed by the reverse transcriptase thumb, the endonuclease-like and RNaseH-like domains. Our structure 
provides first structural insights into the architecture of the spliceosome active site, and reinforces the notion that 
nuclear pre-mRNA splicing and group II intron splicing have a common evolutionary origin.
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90 Analysis of eukaryotic orthologous groups reveals Archease as a crucial factor in human 
tRNA splicing.
Johannes Popow1, Alexander Schleiffer2, Javier Martinez1
1IMBA; 2IMP, Vienna
RNA ligases catalyze the ligation of RNA in eukaryotes, archaea and bacteria and play essential roles in many 
processes including RNA repair and stress-induced splicing of mRNA. In archaebacteria and eukaryotes, RNA ligases 
also join exonic sequences from transfer RNA precursors (pre-tRNAs) to generate functional tRNAs required for 
protein synthesis. We recently identified the RNA ligase required for tRNA splicing in humans, a multimeric protein 
complex having RTCB (also known as HSPC117, C22orf28, FAAP or D10Wsu52e) as the essential subunit. The 
human RNA ligase complex catalyzes RNA ligation only when purified from its native host indicating that additional, 
unknown components are required for its full activity. Here, taking advantage of clusters of eukaryotic orthologous 
groups (KOGs), we identified one protein of unknown function, Archease, as sharing its specific phyletic distribution 
with RTCB suggesting that these proteins cooperate to ligate RNA substrates. We show that Archease is required for 
maturation of tRNAs in human cells. Archease physically interacts with the human tRNA ligase complex, facilitating 
the formation of an RTCB- guanylate intermediate by the release of GMP associated after an initial round of catalysis. 
The widespread co-occurrence of Archease and RtcB proteins in bacterial and archaebacterial operons implies 
evolutionary conservation of the functional interplay between these two proteins.
89 Structural and functional studies of pre-mRNA 5’ and 3’-end processing
Liang Tong1
1Department of Biological Sciences, Columbia University, New York, NY 10027, USA
Most eukaryotic mRNA precursors (pre-mRNAs) must undergo extensive processing, which includes 5’-end 
capping, splicing and 3’-end cleavage and polyadenylation. We have been studying the structural basis for the 
organization and activity of the 3’-end processing machinery, and have reported the crystal structures of several 
proteins in this machinery. Histone pre-mRNAs are distinct in that they possess a stem-loop (SL) structure near the 
3’-end. Stem-loop binding protein (SLBP) specifically recognizes the SL and regulates most aspects of histone mRNA 
metabolism. We have determined the crystal structure of a 26-nt histone mRNA SL in complex with human SLBP 
RNA binding domain and the human 3’-5’ exonuclease 3’hExo (also known as Eri-1).
5’-end capping occurs early during transcription and it was generally believed that the capping process is 
always successful and no quality control mechanism was known. Our studies of yeast Rai1, a protein partner of 
the nuclear 5’-3’ exonuclease Rat1, unexpectedly revealed that it is a novel eukaryotic enzyme with RNA 5’-end 
pyrophosphohydrolase (PPH) activity as well as decapping activity (but only toward unmethylated caps). These 
observations led us to demonstrate the presence of RNA 5’-end capping defects in yeast, and that Rai1 is a central 
player in a novel RNA quality surveillance pathway, promoting the degradation of such defective RNAs.
Our recent studies with Dom3Z, the mammalian homolog of Rai1, showed that it has PPH, decapping as well as 
5’-3’ exoribonuclease activities, and hence we have renamed it DXO (decapping exonuclease). DXO preferentially 
degrades defectively capped pre-mRNAs in cells, consistent with its role in 5’-end capping quality surveillance. More 
importantly, we found that incompletely capped pre-mRNAs are inefficiently spliced at internal introns, in contrast 
to current understanding where capping is linked to the splicing of only the first intron. We have also determined the 
crystal structures of mouse DXO in complex with substrate mimic and product RNAs at up to 1.5 Å resolution, which 
provide elegant insights into the catalytic mechanism of DXO and the molecular basis for its three apparently distinct 
catalytic activities.
Supported in part by NIH grants GM077175 and GM090059.
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92 DNA Damage induces targeted, genome-wide variation of poly(A) sites in budding yeast
Joel Graber1, Fathima Nazeer4, Pei-chun Yeh4, Jason Kuehner2, Sneha Borikar3, Derick Hoskinson4, Claire Moore5
1Jackson Laboratory, Bar Harbor, Maine; 2Emmanuel College; 3Jackson Laboratory; 4Tufts University 
School of Medicine; 5Tufts University School of Medicine, Department of Molecular Biology and 
Microbiology
Systemic response to DNA damage and other stresses is a complex process that includes changes in the regulation 
and activity of nearly all stages of gene expression.  One gene regulatory mechanism used by eukaryotes is selection 
among alternative transcript isoforms that differ in polyadenylation (poly(A)) sites, resulting in either changes to the 
coding sequence or portions of the 3’-UTR that govern translation, stability, and localization.   To determine the extent 
to which this means of regulation is used in response to DNA damage, we conducted a global analysis of poly(A) site 
usage in Saccharomyces cerevisiae after exposure to the UV mimetic, 4-nitroquinoline 1-oxide (4NQO).   2031 genes 
were found to have significant variation in poly(A) site distributions following 4NQO treatment, with a strong bias 
towards loss of shortened transcripts, including many with poly(A) sites located within the protein coding sequence 
(CDS).  The change in poly(A) site profile was associated with an inhibition of cleavage and polyadenylation in cell 
extract and a decrease in the levels of several subunits in the mRNA 3’-end processing complex.  Sequence analysis 
identified differences in the cis-acting elements that flank putatively suppressed and enhanced poly(A) sites, as well 
as a common pattern that suggests a general model for differentiating variable from constitutive poly(A) sites.  Our 
analysis suggests that variation in transcripts that differ in their poly(A) sites is an important part of the regulatory 
response to DNA damage.
91 Control of myogenesis by rodent SINE-containing lncRNAs
Jiashi Wang1, Chenguang Gong1, Lynne Maquat1
1Department of Biochemistry & Biophysics; Center for RNA Biology, University of Rochester
Staufen1 (STAU1)-mediated mRNA decay (SMD), which also involves STAU21, degrades mRNAs that harbor a STAU-
binding site (SBS) in their 3’-untranslated regions (3’UTRs)2. We have reported that human SBSs can be formed by intramolecular 
base-pairing, as exemplified by a 19-base-pair stem and 100-nucleotide apex within mRNA encoding human ADP ribosylation 
factor 1 (ARF1)3. More recently, we have found that human SBSs can also form by intermolecular base-pairing between an 
mRNA 3’UTR Alu element and an Alu element within a cytoplasmic and polyadenylated long noncoding RNA (lncRNA), called a 
½-sbsRNA4. Such long (up to ~300-base-pair) duplexes undoubtedly bind more than one STAU1 and/or STAU2 molecule, which 
are known to homo- and hetero-dimerize5 if not multimerize. Alu elements are a type of short interspersed element (SINE) and 
derive from 7SL RNA. Since Alu elements are confined to primates, it was unclear how SMD occurs in rodents. SMD is clearly 
important to rodents as evidenced by our finding that the efficiency of SMD increases during the differentiation of mouse C2C12 
myoblasts to myotubes in a way that promotes the myogenic process6. SINEs in rodents include B1, B2 and B4 elements, which 
are evolutionarily unrelated. Here we mine the mouse transcriptome and report that 13.2% of annotated mouse mRNAs contain a 
single 3’UTR B SINE, and 28.4% of known mouse lncRNAs contain one or more B SINE. We show that SMD occurs in mouse 
cells via mRNA−lncRNA base-pairing of partially complementary SINEs (i.e., B1-B1, B2-B2 or B4-B4). A single mRNA can 
be regulated by multiple lncRNAs, and one lncRNA can regulate multiple mRNAs. We also provide evidence that mouse (m)½-
sbsRNA-triggered SMD regulates C2C12 cell myogenesis. For example, the SMD of tumor necrosis factor receptor-associated 
factor 6 (mTraf6) mRNA by m½-sbsRNA2, whose abundance is upregulated during the differentiation of C2C12 myoblasts to 
myotubes, promotes myogenesis. Our findings define new roles for lncRNAs and B SINEs in mouse that undoubtedly influence 
many developmental and homeostatic pathways.
1Park E, Gleghorn ML, Maquat LE (2013) Proc Natl Acad. Sci USA, 110: 405-412.
2Park E, Maquat LE (2013) Wiley Interdiscip Rev RNA, in press.
3Gong C, Maquat LE (2011) Cell Cycle 10: 1882-1883.
4Gong C, Maquat LE (2011) Nature 470: 284-288.
5Gleghorn ML, Gong C, Kielkopf CL and Maquat LE (2013) Nat Struct Mol Biol, in press.
6Gong C, Kim YK, Woeller CF, Tang Y, Maquat LE (2009) Genes Dev 23: 54-66.
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94 Non-coding Y1/3 RNAs promote the 3’-processing of canonical histone pre-mRNAs
Marcel Köhn1, Stefan Hüttelmaier2
1Martin-Luther-University Halle-Wittenberg, Institute of Molecular Medicine, Sect. of Molecular Cell 
Biology; 2Martin-Luther-University Halle-Wittenberg
The human Y RNAs constitute a family of four small (85-115nt) non-coding (nc) RNAs (Y1, Y3, Y4 and Y5). 
They are transcribed from individual genes by RNA-polymerase III and fold into characteristic stem-loop-structures. 
The depletion of Y RNAs in Xenopus and Zebrafish leads to developmental defects, resulting in embryonic lethality 
at the mid-blastula-stage. Despite their essential role during development the cellular role of Y RNAs remains largely 
elusive.
To characterize the function of Y RNAs in mammalian cells, we aimed at identifying proteins associated with these 
ncRNAs using Streptavidin-pulldown-assays. MS-analyses identified various Y RNA-associated proteins involved in 
the 3’-processing of pre-mRNAs, for instance subunits of CPSF (Cleavage and polyadenylation specificity factor). To 
test a potential role of Y RNAs in the 3’-processing of mRNAs, we used chimericantisense-Oligonucleotide (ASO)-
mediated knockdown in HEK293 cells. The depletion of Y1 and more prominently Y3 but not Y4 impaired the 
processing of replication-dependent histone mRNAs. Notably, the depletion of Y3 also induced an up-regulation 
of histone mRNA polyadenylation supporting a role of this RNA in the processing of histone mRNAs. This was 
essentially mediated via the U-rich region within the Y3 loop that promotes association with the histone pre-mRNA 
cleavage complex (HCC). However, binding of the HCC to the Y3 RNA was facilitated via FIP1L1/CPSF30 that 
directly associates with this U-rich region. Both factors are essential components of the HCC and facilitate the RNA 
dependent anchorage of the HCC on Y3 as well as histone pre-mRNAs. Pre-formation of this complex on Y3 enhances 
the association of the HCC with Histone-reporter RNAs in vitro and promotes the processing of histone pre-mRNAs 
in cells. We propose that Y3 RNA serves as a binding scaffold required to activate the HCC in order to facilitate 
efficient histone pre-mRNA processing in trans. This provides a new concept suggesting a pivotal role of ncRNAs in 
the assembly of mRNA processing complexes.
93 Polyadenylated histone mRNAs accumulate upon PARN knock-down
Claudia Weißbach1, Christiane Harnisch1, Heike Berndt3, Lars Anders1, Elmar Wahle2
1Institute of Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg, Halle, Germany; 
2Institute of Biochemistry and Biotechnology, Martin-Luther University Halle-Wittenberg, Halle; Germany; 
3Institute of Biology, Dept. of Genetics Martin- Luther- University Halle- Wittenberg, Halle, Germany
The poly(A)-specific ribonuclease (PARN) preferentially degrades poly(A). Although a 3’ exonuclease, the enzyme is 
stimulated by a 5’ cap, thus mRNAs are likely substrates. However, PARN is not involved in the degradation of bulk mRNA; 
instead it processes H/ACA box snoRNAs1 and degrades a small subset of specific mRNAs2 3. Using PARN knock-down 
we identified histone mRNAs as likely substrates by microarray and qRT-PCR analyses. Whereas histone mRNAs normally 
do not carry poly(A) tails, cDNA sequencing, Northern blot and ribonuclease protection assays show that polyadenylated 
histone mRNAs accumulate upon PARN knock-down. The poly(A) tails were up to ~200 nt long, and in many cases a 
canonical polyadenylation signal was present just upstream of the polyadenylation site, suggesting that the regular mRNA 
3’ end processing machinery is responsible for poly(A) addition. In cells transfected with a histone construct carrying a 
mutation in the histone downstream element, read-through transcripts appear in large amounts. Using this construct, we will 
address whether PARN plays a role in a “fail-safe mechanism” to produce correctly processed histone mRNAs lacking a 
poly(A) tail or whether the enzyme participates in the degradation of misprocessed histone mRNAs.
Preliminary data suggest that a PARN-knock-down may affect the cell cycle. This is interesting as improper histone 
stoichiometry leads to genomic instability4.
1. Berndt, H. et al. Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent 
trimming. RNA 18, 958–972 (2012).
2. Lee, J. E. et al. The PARN deadenylase targets a discrete set of mRNAs for decay and regulates cell motility in mouse 
myoblasts. PLoS Genet. 8, e1002901 (2012).
3. Cevher, M. A. et al. Nuclear deadenylation/polyadenylation factors regulate 3’ processing in response to DNA damage. 
EMBO J. 29, 1674–1687 (2010).
4. Herrero, A. B. & Moreno, S. Lsm1 promotes genomic stability by controlling histone mRNA decay. EMBO J. 30, 2008–
2018 (2011).
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96 Assembly and function of the NOT module of the CCR4-NOT complex
Ying Chen1, Andreas Boland1, Tobias Raisch1, Stefanie Jonas1, Duygu Kuzuoglu-Öztürk1, Lara Wohlbold1, Oliver 
Weichenrieder1, Elisa Izaurralde1
1Department of Biochemistry, Max Planck Institute for Developmental Biology, Spemannstrasse 35, D-72076 
Tübingen, Germany
The CCR4-NOT complex plays a crucial role in post-transcriptional mRNA regulation in eukaryotic cells. It 
catalyzes the removal of mRNA poly(A) tails, thereby repressing translation and committing mRNAs to degradation. 
The complex consists of a catalytic module comprising two deadenylases (POP2/CAF1 and CCR4) and the NOT 
module minimally containing the NOT1, NOT2 and NOT3 subunits. It is known that NOT1 acts as a scaffold protein 
for the assembly of the CCR4-NOT complex. However, the mechanism by which the NOT2 and NOT3 proteins 
interact with each other and dock onto the NOT1 scaffold remains unknown.NOT2 and NOT3 are related proteins 
that both contain a highly conserved C-terminal domain referred to as “NOT-box”. Here we show that the NOT-
box is a heterodimerization domain mediating the assembly of the NOT2-NOT3 subcomplex. We have solved the 
crystal structures of the human NOT2 and NOT3 NOT-boxes at 2.4Å and 2.5Å resolution, respectively. The NOT-box 
consists of a four-stranded C-terminal open b-barrel as well as N-terminally located a-helices, which are required 
for heterodimerization. We also defined the domains of NOT1, NOT2 and NOT3 required for the assembly of the 
NOT1-NOT2-NOT3 module. Functional studies in Drosophila melanogaster cells revealed that depletion of NOT1, 
NOT2 or NOT3 inhibits mRNA deadenylation with a stronger effect for the NOT1 depletion, followed by NOT3. 
Importantly, NOT3 depletion destabilizes both NOT1 and NOT2 indicating that one important function of NOT3 is 
the stabilization of the NOT1 scaffold. We used mutagenesis and functional studies to identify key residues in the 
NOT module required for mRNA deadenylation. These studies revealed that the interaction of NOT1 with NOT2-
NOT3 heterodimers is required for deadenylation in D. melanogaster cells. Similarly, NOT3 mutants that do not 
interact with NOT1 cannot restore deadenylation in cells depleted of  endogenous NOT3. Collectively, our data shed 
light on the assembly of the CCR4-NOT complex and provide the basis for dissecting the role of this complex in 
mRNA deadenylation.
95 Dicer-2 is involved in mRNA activation through cytoplasmic polyadenylation
Ana Villalba1, Olga Coll1, Tanit Guitart1, Catherine Papin2, Martine Simonelig2, Fátima Gebauer1
1Centre for Genomic Regulation (CRG) and UPF, Barcelona (Spain); 2Institute of Human Genetics, CNRS, 
Montpellier (France)
Cytoplasmic poly(A) tail elongation is a widespread mechanism to regulate mRNA translation. The biochemistry 
of cytoplasmic polyadenylation has been elucidated in vertebrates, where it requires two sequence elements in the 3’ 
UTR of substrate mRNAs: the U-rich cytoplasmic polyadenylation element (CPE) and the AAUAAA hexanucleotide 
(Hex). We have recently found CPE- and Hex- independent cytoplasmic polyadenylation inDrosophila (1). This “non-
canonical” polyadenylation mechanism operates on maternal Toll mRNA and requires a region distal to the 3’ end of 
the mRNA which we term PR (Polyadenylation Region).
To identify the components of the non-canonical cytoplasmic polyadenylation machinery we have performed RNA 
affinity chromatography using PR as bait. We have found that the cytoplasmic poly(A) polymerase Wispy and the 
siRNA processing factor Dicer-2 specifically associate to PR. Depletion and co-immunoprecipitation studies indicate 
that Dicer-2 interacts with Wispy and is necessary for polyadenylation of Toll reporters in vitro. Furthermore, embryos 
derived from Wispy or Dicer-2 mutant mothers show defects in polyadenylation of endogenous Toll mRNA. These 
results uncover a novel function of Dicer-2 in activation of mRNA translation through cytoplasmic polyadenylation.
1. Coll et al. A novel, non-canonical mechanism of cytoplasmic polyadenylation operates in Drosophila embryogenesis. 
Genes Dev. 2010, 24: 129-134.
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98 Roquin Promotes Constitutive mRNA Decay via a Conserved Class of Stem-Loop 
Recognition Motifs
Kathrin Leppek1, Johanna Schott1, Sonja Reitter1, Fabian Poetz1, Ming C. Hammond2, Georg Stoecklin1
1German Cancer Research Center, DKFZ-ZMBH Alliance, Heidelberg, Germany; 2University of California, 
Berkeley, CA, USA
Tumor necrosis factor alpha (TNFα) is the most potent pro-inflammatory cytokine in mammals. Numerous 
posttranscriptional mechanisms control the expression of this potentially harmful cytokine, including an AU-rich 
element (ARE) and a constitutive decay element (CDE) in the 3’UTR. Whereas ARE-mediated mRNA decay is 
transiently blocked during macrophage activation, the CDE causes constitutive mRNA decay, thereby limiting the 
expression of this cytokine under pro-inflammatory conditions. We now demonstrate that the CDE is a 17 nt long 
sequence that does not serve as a microRNA binding site. Rather, structural probing and mutagenesis provide evidence 
that it forms a short RNA stem-loop in its active conformation.
Using an improved streptavidin-binding aptamer-tag for RNA affinity purification, we identified CDE-associated 
proteins by mass spectrometry. Thereby, we found that the CCCH-type zinc and RING finger proteins Roquin (Rc3h1) 
and Roquin2 (Rc3h2) are CDE-binding proteins. RNA-IP, crosslinking and EMSA experiments confirmed that the 
ROQ domain of Roquin specifically and directly binds to the CDE stem-loop in cells and in vitro. Overexpression and 
knockdown analyses further showed that Roquin suppresses TNFα mRNA and protein expression in macrophages. 
TNFα mRNA expression was also upregulated by introduction of a morpholino that interferes with the Roquin-CDE 
interaction. By affinity purification followed by mass spectrometry, we found that Roquin and Roquin2 recruit the 
Ccr4-Caf1-Not deadenylase complex and thereby promote mRNA degradation.
To identify CDEs on a genome-wide scale, we developed a bioinformatics approach based on experimentally 
determined sequence and structural requirements for an active CDE. Thereby, we identified more than 50 highly 
conserved CDEs in the mouse transcriptome, many of which encode regulators of development and inflammation. 
RNA-Seq of Roquin-associated mRNAs in macrophages confirmed that CDE-containing mRNAs are the primary 
targets of Roquin. Taken together, we demonstrate that Roquin proteins act as major mediators of mRNA deadenylation 
by recognizing CDEs, a novel class of conserved stem-loop RNA degradation motifs.
97 Structural insights into the Not module of the Ccr4-Not complex
Varun Bhaskar1, Jerome Basquin1, Vladimir Rudko2, Bertrand Séraphin2, Elena Conti1
1Max Planck Institute of Biochemistry, Martinsried, Germany; 2IGBMC-CNRS, France
Deadenylation is the first and rate-limiting step in mRNA turnover. Shortening of the poly-A tail is catalyzed 
by the processive deadenylation activity of the Ccr4-Not complex and the distributive deadenylation activity of the 
Pan2-Pan3 complex. Both complexes are conserved in all eukaryotes examined to date and have been recently shown 
to be involved in microRNA-mediated silencing in human cells. The Ccr4/Not complex is a multisubunit complex 
organized around a large scaffold protein, Not1. The complex has a modular architecture with at least two distinct 
modules: a “deadenylase module” and a “Not module”. Previous studies have revealed the structure and have dissected 
the activities of the deadenylase module. However, very limited information on the structure and function of the Not 
module is currently available. We have mapped the interacting domains of yeast Not1, Not2 and Not5 proteins and 
have determined the 2.8 Å structure of this ternary complex that forms the core of the Not module. The structure 
shows how the Sm-like domains of Not2 and Not5 dock on to an extensive HEAT-repeat region in Not1. Based on the 
structural information, we are testing possible functions of the Not module using biochemical in vitro assays and in 
vivo experiments in yeast.
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99 The crystal structure of the nucleolar exosome engaged with RNA
Elizabeth Wasmuth1, Christopher Lima2
1Structural Biology Program, Sloan Kettering Institute; Louis V. Gerstner Graduate School of Biomedical 
Sciences; 2Structural Biology Program, Sloan Kettering Institute
The RNA exosome is an essential, multisubunit and multipurpose ribonuclease required for processing a large 
variety of coding and noncoding RNAs. The exosome core includes nine distinct subunits (Exo9) with a six-membered 
RNase PH-like ring on the bottom, and three S1/KH binding proteins on the top (Liu et al., 2006). The exosome core 
is catalytically inert but includes a prominent central channel that is lined with RNA binding surfaces. RNA exosome 
ribonuclease activity is catalyzed by two enzymes that associate with the exosome core, Rrp6 and Rrp44. Rrp6, a 
member of the RNase D family, is a distributive 3’ to 5’ exoribonuclease that associates with Exo9 in the nucleolus 
(Tomecki et al., 2010) to form a 10 subunit complex, Exo106. In the nucleus, Rrp6 associates with Exo9 and the 
processive 3’ to 5’ exoribonuclease and endoribonuclease, Rrp44 (Allmang et al., 1999). A longstanding question in 
the field of exosome biology is how RNA is directed to either the Rrp6 or Rrp44 active sites for processing or decay. 
A recent crystal structure has illustrated how an Rrp44-associated exosome uses the entire length of the Exo9 central 
channel to funnel RNA from the top of the S1/KH ring, through the PH-like ring, and into the Rrp44 active site (Makino 
et al., 2013). However, how Rrp6 engages RNA, and its position on the Exo9 core, has remained unclear. Using x-ray 
crystallography, we have obtained a preliminary atomic resolution structure of reconstituted Exo106 bound to an RNA 
substrate, the results of which will be discussed.
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100 Nonsense mediated mRNA decay is inefficient on long ORF transcripts
Laurence Decourty1, Antonia Doyen1, Christophe Malabat1, Emmanuel Frachon3, Delphine Rispal2, Bertrand 
Séraphin2, Alain Jacquier1, Cosmin Saveanu1, Alain Jacquier1
1Génétique des Interactions Macromoléculaires, Institut Pasteur, CNRS UMR3525, 25-28 rue du docteur 
Roux, 75015 Paris, France; 2Equipe Labellisée La Ligue, Institut de Génétique et de Biologie Moléculaire et 
Cellulaire (IGBMC), INSERM U964/CNRS UMR 7104/Université de Strasbourg, 67404 Illkirch, France; 
3Production de Protéines Recombinantes et d’Anticorps (PF5), Institut Pasteur, 25-28 rue du docteur Roux, 
75015 Paris, France
Nonsense mediated decay (NMD) is the most studied translation dependent mechanism for “quality control” of 
mRNAs, proposed to serve in removing aberrant mRNAs with premature termination codons from the cell. Conserved 
in eukaryotes and essential for mammals development, NMD was found to require the presence of a long 3’ UTR 
region (Amrani et al., Nature 2004). Our results suggest that a long 3’UTR is required but not sufficient for efficient 
NMD.
We performed a large scale study of the importance of the region upstream the stop codon in triggering NMD. 
We have built Saccharomyces cerevisiae strains that allowed the testing of hundreds of natural transcripts expressed 
from their chromosomal location and modified to have the same long 3’UTR region, known to induce NMD. We have 
used our previously developed Genetic Interactions Mapping (GIM) method (Decourty et al., PNAS 2008) to test the 
effect of NMD inactivation on the steady state levels of 650 barcoded reporter mRNAs. We measured the barcoded 
transcript level changes in cells lacking Upf1 (Nam7) or Upf2 (Nmd2) in comparison with the corresponding wild-
type strains. In contrast with short ORF containing RNAs, transcripts with long ORFs were only marginally affected 
by the addition of a long, 1.4 kb 3’UTR, a surprising result that was not predicted and could not be explained by current 
NMD models. The large scale results were confirmed on individual strains and mRNAs. Long ORF transcripts were 
only slightly destabilized by a long 3’UTR, with steady-state levels higher than 50% of those of the corresponding 
unmodified transcripts. Both long ORF and short ORF 3’ extended mRNAs were highly enriched in a Upf1 (Nam7)-
TAP purification to the same extent. Increasing the ORF length of a PGK1 NMD reporter gene, with an mRNA half-
life of 3 minutes led to the stabilization of the corresponding mRNA despite the fact that the 3’UTR length, promoter, 
initiation and stop codon were identical in the two reporter mRNAs.
These data provide an essential piece of evidence for an “early termination” model in NMD, which proposes that 
translation termination efficiency is intrinsically dependent on the length of the translated ORF. According to this 
model, early termination is inefficient and, in this context only, NMD competes with “normal” termination to avoid 
ribosome stalling at stop codons. Thus, while a long 3’ UTR is required for NMD, presumably through an increase 
in the local concentration of Upf1 (Hogg & Goff, Cell 2010; Kurosaki & Maquat PNAS 2013), our results show that 
only transcripts with short ORFs will be efficiently recognized and degraded through NMD. Our conclusions correlate 
with the fact that short ORFs are present in the vast majority of natural NMD substrates in yeast (He et al., Mol. Cell, 
2003), are compatible with previous publications and give a new perspective on how a premature termination codon 
could be detected by the NMD process in eukaryotes.
Oral Abstracts RNA 2013 •  Davos, Switzerland •  June 11-16, 2013
58  •   Session 5B: RNA decay
102 PAXT-1 binds XRN-2 and promotes its activity
Takashi Miki1, Stefan Rueegger1, Hannes Richter1, Helge Grosshans1
1Friedrich Miescher Institute for Biomedical Research
XRN-2 is a conserved 5’-to-3’ exoribonuclease in eukaryotes, which is predominantly localized in the nucleus. 
Although XRN-2 functions in turnover and processing of various classes of RNA such as rRNA, snoRNA, and 
microRNA, little is known about how XRN-2 is regulated in these processes. In order to address this issue, we screened 
for XRN-2 interacting partners in C. elegans. Using two independent approaches, immunoprecipitation of XRN-2 and 
screening for synthetic lethality of a newly engineered xrn-2 temperature-sensitive allele, we have identified PAXT-
1 (PArtner of Xrn-Two) as a cofactor of metazoan XRN-2. Endogenous XRN-2 and PAXT-1 co-immunoprecipitate 
in an RNase-insensitive manner, and depletion of one reduces levels of the other. Although wild-type animals are 
unaffected by RNAi-mediated depletion of PAXT-1, paxt-1 null animals, generated by genome engineering using 
TALENs (Transcription Activator-Like Effector Nucleases), are inviable at elevated temperature. Consistent with 
XRN-2 stabilization being a major function of PAXT-1, overexpression of XRN-2 can suppress this lethality. Thus 
we identified PAXT-1 as a novel cofactor of XRN-2, which stabilizes XRN-2 to promote its activity. We are currently 
investigating whether PAXT-1 enhances exoribonuclease activity of XRN-2 beyond stabilization of the protein. We 
will also examine functional conservation for a mammalian counterpart of PAXT-1.
101 eIF4E-bound mRNPs are substrates for nonsense-mediated mRNA decay in mammalian 
cells
Simone C. Rufener1, Oliver Mühlemann2
1Dept. of Chemistry and Biochemistry, University of Bern, Switzerland; Graduate School for Cellular and 
Biomedical Sciences, University of Bern, Switzerland; 2Dept. of Chemistry and Biochemistry, University of 
Bern, Switzerland
Eukaryotic mRNAs with premature translation-termination codons (PTCs) are recognized and degraded by a 
process referred to as nonsense-mediated mRNA decay (NMD). The evolutionary conservation of the core NMD 
factors UPF1, UPF2 and UPF3 would imply a similar basic mechanism of PTC recognition in all eukaryotes. However, 
unlike NMD in yeast, which targets PTC-containing mRNAs irrespectively of whether their 5’ cap is bound by the 
cap-binding complex (CBC) or by the eukaryotic initiation factor 4E (eIF4E), mammalian NMD has been claimed to 
be restricted to CBC-bound mRNAs during the pioneer round of translation. In our recent study we compared decay 
kinetics of two NMD reporter systems in mRNA fractions bound to either CBC or eIF4E in human cells. Our findings 
reveal that NMD destabilizes eIF4E-bound transcripts as efficiently as those associated with CBC. These results 
corroborate an emerging unified model for NMD substrate recognition, according to which NMD can ensue at every 
aberrant translation termination event. Additionally, our results indicate that the closed loop structure of mRNA forms 
only after the replacement of CBC with eIF4E at the 5’ cap.
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104 Mouse Tudor domain containing 12 (Tdrd12) is essential for biogenesis of piRNAs 
associating with the nuclear Piwi protein Miwi2
Radha Raman Pandey1, Zhaolin Yang2, Ramesh S Pillai
1European Molecular Biology Laboratory, Grenoble, France; 2European Molecular Biology Laboratory
Transposons are selfish genetic elements that spread in the population by mobilizing themselves in the germline. 
A gonad-specific class of small RNAs (25-30 nucleotides long), called Piwi-interacting RNAs (piRNAs), provide 
protection against these elements, ensuring genome integrity and fertility. The initial pool of primary piRNAs is 
derived by processing single-stranded transcripts originating from discrete genomic loci called piRNA clusters, which 
then guide endonulceolytic cleavage of transposon transcripts. An epigenetic memory of this encounter is recorded 
in germ cells by generating a secondary piRNA from one of the transposon cleavage fragments. While flies use 
the newly generated secondary piRNA to initiate a piRNA amplification loop, mice integrate this information to 
effect DNA methylation of the loci containing active transposon elements. Here we identify a Tudor and helicase 
domain-containing protein, Tdrd12, as a novel component of the secondary piRNA biogenesis machinery in mice. 
Tdrd12 is detected in complexes containing the Piwi protein Mili and other factors already implicated in this process. 
While primary piRNAs are present in mice lacking Tdrd12, the nuclear Piwi protein Miwi2 is devoid of piRNAs. 
Consequently, unloaded Miwi2 remains in the cytoplasm, contributing to the reduced promoter DNA methylation and 
derepression of transposons observed in the mutant. We used the Bombyx mori (Silkworm) BmN4 cell culture model 
to molecularly dissect the formation of a complex between BmTdrd12 and Piwi. Additionally, our studies point to the 
importance of an intact ATPase motif in BmTdrd12 for its proper sub-cellular localization in the Nuage. We propose 
that Tdrd12 function as a molecular scaffold that dynamically bridges the association between Piwi proteins engaged 
in piRNA amplification.
103 Molecular Clues to Tissue-Specific Control of MiRNA Biogenesis
Nila Roy Choudhury1, Flavia de Lima Alves1, Luisa de Andrés-Aguayo2, Thomas Graf2, Javier F. Cáceres4, Juri 
Rappsilber3, Gracjan Michlewski1
1Wellcome Trust Centre for Cell Biology, University of Edinburgh, UK; 2CRG Barcelona, Spain; 3Department 
of Biotechnology, Technische Universität Berlin, Germany; Wellcome Trust Centre for Cell Biology, 
University of Edinburgh, UK; 4IGMM, MRC Human Genetics Unit, University of Edinburgh, UK
At present, around 2000 miRNAs are annotated in the human genome. In spite of the great effort to understand 
the various biological roles of individual miRNAs there is a huge void of knowledge about the regulation of their 
own biogenesis. Until now only a handful of miRNAs have been investigated individually for their features and trans-
acting factors that play significant roles in their production.
We show the first report of tissue-specific control of brain-enriched miRNA biogenesis by defined tissue-specific 
factors. We demonstrate that the level of miR-7, which is processed from the ubiquitous hnRNP K pre-mRNA 
transcript, is shaped by the inhibition of its biogenesis in non-neural cells. Using SILAC combined with RNA pull 
down we reveal MSI2 and HuR to be factors that cooperatively inhibit miR-7 biogenesis by binding to its conserved 
terminal loop. We provide evidence that the role of HuR is to assist MSI2 binding, which is the actual factor regulating 
miR-7 maturation. Importantly, we present evidence that the MSI2/HuR complex increases the rigidity of the pri-
miR-7 structure. Due to the fact that Microprocessor cleavage is dependent on DEAD-box RNA helicase activity, 
such stabilization provides the first mechanistic clue to the inhibitory effect of tissue-specific factors on the miRNA 
processing. Finally, we confirm the physiological relevance of MSI2/HuR-mediated inhibition of miR-7 biogenesis in 
human neuronal differentiation system and in MSI2 KO mouse.
Currently we are working on the mechanisms controlling biogenesis of other tissue-specific miRNAs. Importantly, 
our methodological approach provides a platform for future studies on miRNA biogenesis and on all other processes 
involving RNA-protein interactions.
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106 Kinetic and biophysical models improve identification of miRNA targets
Mihaela Zavolan1, Jean Hausser1, Mohsen Khorshid1, Erik van Nimwegen1, Erik Sontheimer1
1Biozentrum, University of Basel
MicroRNAs (miRNAs) are small RNA regulators that are involved in the establishment of gene expression 
patterns, frequently at transitions between cellular states or developmental stages. Many types of methods have 
been developed to uncover the mRNA targets of miRNAs. Experimental methods frequently employ transfection or 
knockdown of individual miRNAs followed by the profiling (with microarrays or deep sequencing) of mRNAs, 1-2 
days after the miRNA expression was manipulated. Based on previously published data as well as new experimental 
measurements we inferred the parameters that determine the kinetics of miRNA-dependent responses, including the 
rate of loading and dissociation of miRNAs to/from Argonaute proteins, their decay rate and the relative magnitude 
of the miRNA effect on protein translation and mRNA decay rates. We show that the inferred computational models 
predict with good accuracy the mRNA, protein and ribosome footprinting response of mIRNA targets following 
miRNA transfection. The model further predicts that protein decay rates introduce substantial bottlenecks in miRNA-
dependent regulation of protein levels and that active miRNA turnover and increased protein decay are necessary to 
achieve appreciable protein changes over the time scale of a cell cycle. We further developed a biophysical model of 
miRNA-target interaction that enables accurate identification of non only canonical but also non-canonical targets. We 
found that the latter are particularly frequent when the level of miRNA expression is high. These results provide new 
insights into the dynamics of miRNA-dependent regulation of mRNA decay and translation rates.
105 Regulation of miRNAs and endo-siRNAs during oocyte-to-zygote transition in the mouse
Matyas Flemr1, Radek Malik1, Vedran Franke2, Jana Nejepinska1, Kristian Vlahovicek2, Petr Svoboda1
1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic; 2Department of Biology, 
University of Zagreb, Croatia
In the mouse, transcription ceases prior to ovulation and it is renewed during the major phase of the zygotic 
genome activation, which takes place at the 2-cell stage. Thus, mechanisms of post-transcriptional control of maternal 
transcripts play key roles during the oocyte-to-zygote transition. RNA silencing is a common name for a group of 
pathways utilizing small RNAs as sequence-specific guides regulating gene expression, usually post-transcriptionally. 
Previous research on small RNAs revealed that three different classes of small RNAs are present in the mouse oocyte: 
piRNAs, miRNAs, and endo-siRNAs. Mutation studies however, suggest that only the endogenous RNAi is essential 
for the oocyte. Furthermore, while miRNA biogenesis appears intact in the oocyte, biological activity of miRNAs is 
suppressed. This is apparently because the effector complex (miRISC) does not efficiently form in the oocyte. Our 
new data suggest that GW182 is the limiting factor for GW182-AGO2 interaction.
Our earlier analysis of dsRNA processing in transgenic animals revealed preferential production of siRNAs in the 
oocyte while siRNA production in somatic tissues was negligible. Therefore, we investigated control of small RNA 
biogenesis in the female germline. We have found that growing mouse oocytes express a unique isoform of Dicer, 
which is truncated at its N-terminus. Several lines of evidence suggest that this Dicer isoform is the factor responsible 
for increased production of endogenous siRNAs in the oocyte. The oocyte-specific Dicer isoform is the first evidence 
for molecular divergence of mammalian miRNA and RNAi mechanisms. Notably, poduction of oocyte-specific Dicer 
is controlled by a rodent-specific retrotransposon. This fact has interesting implications regarding evolution and 
conservation of RNA silencing pathways in animals.
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108 Translational repression and eIF4A2 activity are critical for microRNA-mediated gene 
regulation.
Anna Wilczynska1, Hedda Meijer1, Wei-Ting Lu1, Yi-Wen Kong1, Ruth Spriggs1, Jack Godfrey1, Sue Robinson1, Anne 
Willis1, Martin Bushell1
1MRC Toxicology Unit, Leicester, UK
In the cytoplasm, miRNAs play a major role in the control of gene expression by down-regulating the protein 
product of their target mRNAs. The binding of miRISC has been shown to exert both translational repression and 
degradation of target mRNA. However, the interplay between these processes and the precise molecular mechanisms 
involved remain unclear. We show that translational inhibition is the primary event required for mRNA degradation. 
Moreover, we demonstrate that miRNA-mediated repression is only enhanced by the poly(A) tail nor does it require 
deadenylation. The use of IRES-containing mRNAs allowed us to determine that translational inhibition depends 
on miRNAs impairing the function of the eIF4F initiation complex. We further define the RNA helicase eIF4A2 as 
the critical factor involved in this process. We uncover a correlation between the presence of miRNA target sites in 
the 3’UTR of mRNAs and secondary structure in the 5’UTR, and show that mRNAs with unstructured 5’UTRs are 
refractory to miRNA repression. Finally, immunoprecipitation studies reveal that in vivo eIF4A2 associates with the 
Ccr4-NOT complex while eIF4A1 is predominantly found to bind eIF4G. eIF4A2 may interact with CNOT1 through 
its MIF4G domain and impede the helicase activity of the eIF4F complex by clamping onto the structure in the 5’UTR 
of target mRNAs. These data support a linear model for miRNA-mediated gene regulation in which translational 
repression via eIF4A2 is required first, followed by mRNA destabilization, and suggest a mechanism by which the 
repression machinery at the 3’ end of the mRNA inhibits translational initiation on the 5’ end.
107 Insights into the recruitment of the PAN2-PAN3 deadenylase complex to miRNA targets by 
the GW182/TNRC6 proteins
Mary Christie1, Andreas Boland1, Eric Huntzinger1, Oliver Weichenrieder1, Elisa Izaurralde1
1Department of Biochemistry, Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 
Tübingen, Germany
The PAN2-PAN3 deadenylase complex functions in general and miRNA-mediated mRNA degradation and is 
specifically recruited to miRNA targets by the TNRC6 proteins. PAN3 is an adaptor protein that recruits the PAN2 
deadenylase to mRNA targets. PAN3 contains three prominent regions: an N-terminal region that is predicted to be 
unstructured, a central pseudokinase (PK) domain and a highly conserved C-terminal domain (C-term), which is 
unique to the PAN3 protein family. While the N-terminal region of PAN3 contains a well-characterized PAM2 motif, 
studies on the roles of the PK and C-term domains have been restricted to the yeast protein. In particular, yeast two-
hybrid assays have demonstrated that a C-term domain of yeast PAN3 is required for PAN2 binding, while both the 
PK+C-term domains mediated self-interaction. However, the stoichiometry and significance of PAN3 oligomerization 
has remained unclear. Here we show that PAN3 forms dimers in vitro and in vivo. Surprisingly, despite containing 
nonconservative substitutions in all the sequence motifs required for kinase activity, the PAN3 pseudokinase domain is 
capable of binding ATP and the integrity of the nucleotide binding pocket is required for deadenylation in vivo. Through 
a combined mutational and functional analysis, we have identified critical residues that mediate PAN3 interaction 
with PAN2 and TNRC6 proteins, as well as additional residues required for deadenylation in vivo. Collectively, our 
data provides a framework for understanding the role of PAN3 in recruiting PAN2 to mRNA targets to initiate their 
deadenylation and reveals a role for ATP-binding in mRNA deadenylation.
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110 Single-molecule observation of DNA targeting and cleavage by the RNA-guided Cas9 
endonuclease
Samuel Sternberg1, Eric Greene2, Sy Redding2, Martin Jinek3, Jennifer Doudna1
1University of California, Berkeley; 2Columbia University; 3University of Zurich
Bacteria and archaea maintain a history of viral infections by integrating small fragments of foreign DNA into 
specialized genomic loci called clustered regularly interspaced short palindromic repeats (CRISPRs). Subsequent 
infections trigger an adaptive immune response that relies on CRISPR-derived RNAs (crRNAs) functioning together 
with CRISPR-associated (Cas) proteins to identify and destroy complementary viral DNA sequences known as 
protospacers. In type II CRISPR/Cas immune systems, the Cas:crRNA ribonucleoprotein surveillance complex 
comprises two RNA molecules and the Cas9 endonuclease, which cleaves both strands of the protospacer following 
initial recognition. Prior studies have used oligonucleotide substrates to show that DNA targeting proceeds via RNA–
DNA base-pairing interactions and requires melting of the double-stranded substrate, as well as protein-mediated 
recognition of a protospacer adjacent motif (PAM) to discriminate self from non-self. Nevertheless, the mechanism by 
which Cas9:RNA locates and recognizes its target sequence within the larger context of genomic DNA is unknown.
To gain deeper insights into this critical step of CRISPR/Cas-based immunity, we used single-molecule 
fluorescence microscopy to visualize Cas9:RNA as it searches for DNA targets in real-time. We demonstrate that 
Cas9:RNA exhibits specific DNA binding in a highly programmable fashion. Both bulk experiments and single-
molecule observation of off-target interactions reveal that the search process relies in part on facilitated diffusion, and 
that PAM sites recruit Cas9:RNA to potential targets. Surprisingly, the Cas9:RNA complex stays tightly bound to DNA 
protospacers after the cleavage reaction, suggesting the possibility that product association is an important component 
of CRISPR interference in vivo. Collectively, these experiments have elucidated mechanistic details of DNA targeting 
and cleavage by Cas9:RNA and will facilitate future efforts to develop this system for genome engineering.
109 The conserved concave surface of the MIF4G domain of CNOT1 is involved in miRNA-
mediated translational repression
Hansruedi Mathys1, Witold Filipowicz1
1Friedrich Miescher Institute for Biomedical Research
MiRNAs are endogenous ~21-nt non-coding RNAs that act as post-transcriptional regulators of gene expression by 
base pairing to target mRNAs. Mature miRNAs form part of ribonucleoprotein complexes, miRISCs, that contain Argonaute 
(AGO) and GW182 as core proteins. Recently, we have shown that GW182 proteins recruit the CCR4-NOT deadenylase 
complex via tryptophan-containing motifs to repress both poly(A)-containing and poly(A)-free mRNAs, indicating that 
recruitment of the CCR4-NOT complex, in addition to catalyzing deadenylation, also mediates translational repression.
We have now investigated the functional role of the CCR4-NOT complex in miRNA-mediated translational repression. 
Pull-down experiments revealed that the C-terminal effector domain (CED) of the GW182 protein TNRC6C interacts, 
in a W-motifs-dependent manner, with two different non-overlapping regions of CNOT1, the large scaffold subunit of 
the CCR4-NOT complex. Deletion analysis of CNOT1 also identified a central part of CNOT1 (named CNOT1-R) as a 
region mediating translational repression of mRNA. A highly conserved region of CNOT1-R adopts a MIF4G-like fold 
and its convex surface interacts with the deadenylase CAF1 (Basquin et al., Mol Cell 2012, Petit et al., NAR 2012). 
Mutations in the convex surface of MIF4G abrogating the interaction of CNOT1 with CAF1 alleviated the CNOT1R-
mediated repression of a poly(A)+mRNA reporter but had no effect on repression of a poly(A)– mRNA. Furthermore, the 
repression of a poly(A)– reporter mRNA by tethered CAF1 was largely dependent on the ability of CAF1 to interact with 
CNOT1, strengthening the conclusion that it is CNOT1 that acts, via its CNOT1-R region, as an inhibitor of translation.
The concave surface of the MIF4G domain of the initiation factor eIF4G serves as a binding platform for the initiation 
factor eIF4A (Schutz et al., PNAS 2008). To test whether the CNOT1 MIF4G competes with eIF4G for binding to eIF4A 
and thereby interferes with translation initiation, we introduced mutations to the CNOT1 MIF4G expected to interfere with 
the eIF4A binding. Indeed, the mutations alleviated the CNOT1R-mediated repression of poly(A)+ and poly(A)– mRNAs. 
However, this effect appears not to be due to the compromised interaction with eIF4A since we were unable to detect 
interaction with either its eIF4AI or eIF4AII isoform. We will present our progress towards identification of the factor acting 
downstream of the CNOT1 MIF4G in mediating translational repression.
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111 Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria 
meningitidis
Yan Zhang1, Nadja Heidrich5, Biju Joseph Ampattu4, Carl Gunderson3, Hank Seifert3, Christoph Schoen4, Jörg 
Vogel5, Erik Sontheimer2
1Dept.of Molecular Biosciences, Northwestern University; 2Dept. of Molecular Biosciences, Northwestern 
University; 3Dept. of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University; 
4Institute for Hygiene and Microbiology, University of Würzburg; 5Institute for Molecular Infection Biology, 
University of Würzburg
CRISPR interference confers adaptive, sequence-based immunity against viruses and plasmids in bacteria and 
archaea. Interference is specified by CRISPR RNAs (crRNAs) that are transcribed and processed from spacer-repeat 
units. Most forms of CRISPR interference involve RNA-directed DNA targeting, and this mechanism is being 
exploited for facile, RNA-guided genome engineering applications. Processing of monomeric crRNAs (i.e., each 
containing only a single spacer sequence) from a multimeric precursor is essential for CRISPR interference in all 
natural systems studied thus far.
Several bacterial strains from the genus Neisseria have “Type II” CRISPR/Cas systems in which the Cas9 
protein provides the catalytic activities required for crRNA-directed DNA targeting. Type II systems are those that 
have proven most effective for eukaryotic genome engineering. Our analyses of crRNA biogenesis and CRISPR 
interference in Neisseria have revealed a unique crRNA biogenesis pathway in which crRNAs are transcribed from 
promoters that are embedded within each CRISPR repeat, yielding crRNA 5’ ends that are formed by transcription 
and not by processing. This is in contrast with previously studied systems, where pre-crRNA transcription is driven 
by promoter(s) within a “leader” sequence outside of the CRISPR array. Although Neisseria crRNA 3’ end formation 
involves RNase III-catalyzed cleavage of duplexes formed by pre-crRNA and a trans-encoded tracrRNA (as in other 
Type II CRISPR systems), this processing is dispensable for interference, and unprocessed, multimeric crRNAs 
are functional. Even though pre-crRNA processing is dispensable for interference, the tracrRNA is still required, 
indicating that the tracrRNA likely contributes to DNA binding and cleavage steps in bacterial cells, as previously 
established by others in vitro. The pathway from the deadly human pathogen Neisseria meningitidis exemplifies a 
newly defined CRISPR/Cas subtype (Type II-C) and is the most streamlined CRISPR/cas system characterized to 
date, as indicated by the number of required components and steps. Its simplicity, as well as its ability to function via 
unprocessed, multimeric crRNAs, suggests the possibility of unique practical applications for engineered systems 
in eukaryotes. Endogenous CRISPR spacers frequently target genomic sequences of other Neisseria strains and so 
limit natural transformation, which is the primary source of genetic variation that contributes to immune evasion, 
antibiotic resistance, and virulence in N. meningitidis. We conclude that native CRISPR/Cas systems can limit all three 
primary routes of horizontal gene transfer (phage transduction, conjugation, and natural transformation) in bacteria 
and archaea.
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112 T box riboswitch decodes both the information content and geometry of tRNA to affect 
gene expression
Ailong Ke1, Jason Grigg1, Yujie Chen1, Frank Grundy2, Tina Henkin2, Lois Pollack1, Ailong Ke1
1Cornell University; 2The Ohio State University
The T box riboswitch is an RNA element that controls gene expression by directly binding to a specific tRNA 
and sensing its aminoacylation state. This interaction controls expression of amino acid-related genes in a negative 
feedback loop. The T box RNA structure is highly conserved, but its tRNA binding mechanism is only partially 
understood.  Known sequence elements are the Specifier Sequence, which base-pairs with the tRNA anticodon, and the 
antiterminator loop, which base-pairs with the tRNA acceptor end.  Here, we reveal the crucial function of the highly 
conserved Stem I distal region in tRNA recognition and report its 2.65 Å crystal structure. The apex of this region 
contains an intricately woven loop-loop interaction between two conserved motifs, the AG Bulge and the Distal Loop. 
This loop-loop structure presents a base triple on its surface that is optimally positioned for base-stacking interactions. 
Mutagenesis, cross-linking and small-angle X-ray scattering data demonstrate that the apical base triple serves as a 
binding platform to dock against the tRNA D- and T-loops. Strikingly, the binding platform strongly resembles the D- 
and T-loop binding elements from RNase P and the ribosome P/E sites, suggesting that this loop-loop structure may 
represent a widespread tRNA recognition platform. We propose a new double checkpoint model for decoding tRNA, 
in which the information content of tRNA is first examined through the Specifier Sequence-anticodon interaction, the 
length of the tRNA anticodon arm is then measured by the distal loop-loop platform. When both conditions are met, 
tRNA is secured and its aminoacylation state is sensed.
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113 Structural basis of specific tRNA recognition by the T-box riboswitch
Jinwei Zhang1, Adrian Ferre-D’Amare1
1National Heart, Lung, and Blood Institute, NIH
The T-box riboswitches regulate tRNA aminoacylation, amino acid synthesis and transport in Gram-positive 
bacteria in response to cellular tRNA aminoacylation levels. They couple direct binding of non-aminoacylated tRNAs 
with formation of a transcription antiterminator allowing expression of downstream genes. The T-box consists of two 
phylogenetically conserved domains connected by a flexible, highly variable linker. These domains are an elongated 
Stem I that has extensive sequence conservation beyond the “specifier” loop that base pairs with the tRNA anticodon, 
and an antiterminator that is stabilized by base pairing with the non-aminoacylated tRNA 3’ end [1]. We employed 
isothermal titration calorimetry to monitor tRNA binding to a T-box truncation series and found that the Stem I 
is necessary and sufficient for robust and specific tRNA binding (KD~120 nM). Indeed, Stem I-tRNA association 
accounts for the majority of the binding free energy of full-length T-boxes. To elucidate the molecular basis of tRNA 
recognition by T-boxes, we have now determined the crystal structure of a representative T-box Stem I (102 nt) in 
complex with its cognate tRNA (75 nt) and a bacterial protein that binds the conserved Stem I K-turn. Stem I adopts 
an extended “C” shape that cradles the tRNA. As predicted genetically [2], the anticodon is recognized by the specifier 
element through base pairing. The specifier is in the middle of the C, and is flanked by loop E and K-turn motifs. The 
distal end of Stem I comprises two T-loop motifs that interdigitate to form a compact module with a flat molecular 
surface that recognizes the elbow of tRNA (where its D- and T-loops come together) through shape complementarity. 
Sequence conservation indicates that this bipartite mechanism of tRNA recognition, in which the specifier binds 
the anticodon, and the interdigitated T-loops reach out to recognize the tRNA elbow, is near-universal in T-box 
riboswitches.  Remarkably, recognition of the tRNA elbow by two interdigitated T-loops has been also demonstrated 
for RNase P [3], even though the T-box and RNase P recognize the opposite arms of tRNA. Thus, it appears that these 
two RNAs evolved independently to converge on using the same interdigitated T-loop module for recognizing tRNA.
1. Green et al. 2010 FEBS Lett. 584:318.
2. Grundy et al. 1993 Cell 74:475.
3. Reiter et al. 2010 Nature 468:784.
This research was supported in part by the Intramural Research Program of the NHLBI, NIH.
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114 Crystal Structure and Biophysical Analysis of a Class 2 PreQ1 Riboswitch
Joseph Liberman1, Mohammad Salim1, Jolanta Krucinska1, Joseph Wedekind1
1University of Rochester School of Medicine and Dentistry, Department of Biochemistry and Biophysics and 
Center for RNA Biology
Riboswitches are a class of cis-acting functional RNAs that regulate gene expression by directly binding ligands. 
Typically found in the 5´-leader sequences of bacterial genes, riboswitches have great potential as novel antimicrobial 
targets. Of special interest are riboswitches that bind to ligands that are unique to the bacterial metabolome. One 
such molecule is preQ1, a hypermodified guanine base that interacts with a cognate riboswitch in over 29 bacterial 
species including pathogenic organisms. Two classes of preQ1 riboswitches, termed preQ1-I and preQ1-II, have been 
discovered, but thus far structural information has been described only for class 1.
Here we present the crystallographic analysis and structure determination of a class 2 preQ1 riboswitch in the 
ligand bound state. The overall structure comprises 77 nucleotides, and reveals the mode of ribosome-binding site 
sequestration by an H-type pseudoknot whose formation is fortified by the adjacent preQ1-binding pocket. The ligand 
binds at the confluence of a three-way helical junction (figure 1) and is recognized by a readout mechanism that does 
not entail canonical Watson-Crick base pairing (figure 1).  Thermodynamic parameters of ligand binding have been 
determined by isothermal titration calorimetry to both wild type and binding site mutants, which confirm the mode of 
interaction between the riboswitch and ligand observed in the crystal structure.
In-line probing analysis has been conducted and confirms key structural changes that occur upon ligand binding. 
Combined with the crystal structure, thermodynamic analysis, and comparison with similar structures such as human 
telomerase RNA, we propose a mechanism for gene regulation whereby binding of preQ1 stabilizes formation of three 
base triples at the base of the pseudoknot that sequesters the RBS.  The model for translational regulation will be 
presented as well as a comparison to other riboswitches that bind purine-like effectors.
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115 A novel class of self-cleaving ribozymes is prevalent in many species of bacteria and 
eukarya
Adam Roth1, Zasha Weinberg1, Andy Chen2, Peter Kim2, Tyler Ames2, Ronald Breaker2
1Yale University; Howard Hughes Medical Institute; 2Yale University
Ribozymes are noncoding RNAs that promote chemical transformations with rate enhancements approaching 
those of protein enzymes1. Although ancient RNA World organisms2 likely used many types of ribozymes3, only ten 
classes have been previously verified in nature. We report the discovery and analysis of an additional self-cleaving 
ribozyme class, called twister, which is present in many species of bacteria and eukarya. More than 2690 twister 
ribozymes were identified that conform to a secondary structure consensus that is small yet complex, with three 
stems conjoined by internal and terminal loops (Fig 1a). Two pseudoknots provide tertiary structure contacts that are 
critical for catalytic activity. Many examples of these ribozymes are circularly permuted, bearing striking similarities 
to hammerhead ribozymes (Fig 1b,c). Twister ribozymes cleave RNA via an internal phosphoester transfer reaction, 
which is identical to the general mechanism used by other five classes of self-cleaving RNAs discovered previously4. 
The discovery of twister ribozymes deepens the mystery regarding the biological roles of widespread classes of self-
cleaving RNAs.
1. Cech, T.R. Ribozymes, the first 20 years. Biochem. Soc. Trans. 30, 1162-1166 (2002).
2. Gilbert, W. Origin of life: The RNA World. Nature 319, 618 (1986).
3. Benner, S.A., Ellington, A.D. & Tauer, A. Modern metabolism as a palimpsest of the RNA world. Proc. Natl. Acad. Sci. 
USA 86, 7054-7058 (1989).
4. Ferré-D’Amaré, A.R. & Scott, W.G. Small self-cleaving ribozymes. Cold Spring Harb. Perspect. Biol. doi: 10.1101/
cshperspect.a003574 (2010).
 
Figure 1 | Consensus sequence and secondary-structure model for twister self-cleaving ribozymes. (a) 
Consensus model based on 2690 twister ribozymes in its type P1 configuration, wherein the RNA chain begins and 
ends at the base of the P1 stem. The arrowhead identifies the cleavage site. Gray, black and red nucleotides 
designate conservation of at least 75, 90, and 97%, respectively; positions in which nucleotide identity is less 
conserved are represented by circles. Green shading denotes predicted base pairs supported by natural covariation. 
Notations i and ii identify predicted pseudoknots. Numbers in parentheses are the variable lengths of linker 
sequences that sometimes form stem structures as indicated. (b,c) The RNA chains of naturally occurring type P3 
and type P5 configurations enter and depart the motif at the optional P3 or P5 stems, respectively. 
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117 Conformational Heterogeneity of the Protein-Free Human Spliceosomal U2-U6 snRNA 
Complex
Caijie Zhao1, Ravichandra Bachu1, Nancy Greenbaum1
1Hunter College of The City University of New York
The complex formed between the U2 and U6 small nuclear (sn)RNA molecules of the eukaryotic spliceosome 
plays a critical role in the catalysis of precursor mRNA splicing. We used 19F NMR and enzymatic structure probing 
to characterize the fold of a protein-free paired construct representing the human U2-U6 snRNA complex. For the 
NMR studies, we included a single 5-19F-cytidine residue in a region of U2 that would be part of Stem I (i.e. double-
stranded) in a four-helix model or single-stranded in the three-helix model.  Results for both enzymatic probing and 
NMR of the complex in the absence of Mg2+ are consistent with formation of a four-helix structure as a predominant 
conformation. However, 19F NMR data also identify a lesser fraction (up to 14% at 25°C) of an alternative conformation 
presumed to be the three-helix conformer.  In the presence of 5 mM Mg2+, the fraction of the three-helix conformation 
increased to ~17%, suggesting a slight shift to the three-helix conformation.  A mutant complex designed to favor the 
four-helix conformer displayed almost complete formation of Stem I, and a complex designed to favor a three-helix 
formation showed enhanced formation of Helix 1b, a hallmark of that conformer (Zhao C, Bachu R, Popovic M, 
Devany M, Brenowitz M, Schlatterer JC, Greenbaum NL. RNA, advance publication February 20, 2013, doi:10.1261/ 
rna.038265.1130). Based upon this distribution, the calculated DG for interconversion to the four-helix structure from 
the three-helix structure is approximately -4.6 kJ/mol.  To evaluate the possibility of interconversion between the 
two conformations and the time scale, we acquired two-dimensional 19F-19F NOESY spectra of the complex labeled 
with 19F-cytidine in the Stem I site of the U2 snRNA strand.  We observed a NOE between the two peaks in a spectrum 
with a mixing time of 400 ms.  This finding provides compelling evidence of exchange between the alternative 
conformations on a slow exchange time scale.  These observations indicate conformational heterogeneity in the 
protein-free human U2-U6 snRNA complex consistent with a model in which the RNA has sufficient conformational 
flexibility to facilitate interconversion between steps of splicing in situ. 
116 Spliceosomal Prp24 unwinds a minimal U2/U6 complex from yeast
Chandani Warnasooriya1, Zhuojun Guo4, Samuel Butcher3, David Brow3, David Rueda2
1Wayne State University, Detroit, MI, USA / Department of Medicine, Imperial College, London, UK; 
2Imperial College, London, UK; 3University of Wisconsin-Madison, Madison, WI53706, USA; 4Wayne state 
University, Detroit, MI, USA
Splicing plays a major role in eukaryotic gene expression by processing pre-mRNA to form mature mRNA. 
Pre-mRNAs undergo splicing to remove introns, non-protein coding regions, and religate exons, protein coding 
regions. This process is catalyzed by the spliceosome, which consists of five small nuclear ribonucleoprotein particles 
(snRNPs: U1, U2, U4, U5 and U6) and numerous protein factors. Proper assembly of spliceosomal components is 
critical for function, and thus, defects in assembly can be lethal. Several spliceosomal proteins facilitate structural 
rearrangements important for spliceosomal assembly and function. Prp24 is an essential factor in U6 snRNP assembly, 
and it has been proposed to assist in U4/U6 formation and unwinding. Here, we address the question whether Prp24 
affects the U2/U6 complex dynamics. Using single-molecule Fluorescence Resonance Energy Transfer (smFRET), 
we have previously shown that a minimal U2/U6 complex from yeast can adopt at least three distinct conformations in 
dynamic equilibrium. Our new single molecule data show that Prp24 unwinds U2 from U2/U6 complex and stabilizes 
U6 in a low FRET conformation. We also show that the RNA Recognition Motifs of Prp24 affect the binding affinity 
of Prp24 for U6 and unwinding activity. We propose that Prp24 plays an important role in U2 and U6 snRNP recycling 
by dissociating the U2/U6 complex.
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118 A new class of minimal Hammerhead ribozymes conserved in the eukaryotic family of 
Penelope-like retroelements
Amelia Cervera1, Marcos de la Peña1
1IBMCP (CSIC-UPV)
Small self-cleaving RNAs like the paradigmatic Hammerhead ribozyme (HHR) have been recently found widespread in DNA 
genomes from bacteria to humans1,2,3. Their patchy distribution and common connection with retrotranscriptases and repetitive 
DNA suggest that most of these ribozymes would have a role in retrotransposition. Following bioinformatic and phylogenetic 
analysis, we have now discovered a new class of HHR motif conserved in the superfamily of Penelope-Like retrotransposable 
Elements (PLEs), a peculiar group of intron-containing retroelements different from the LTR and non-LTR retrotransposons of 
eukaryotes4. These new PLE-HHRs are minimalist variants of the canonical HHR that lack one of the three helixes and show 
some characteristic variations within their catalytic core. The PLE-HHR motifs consistently map in the 5’ and 3’ flanking repeats 
of PLEs from plants, invertebrates and lower vertebrates, although for some organisms, conserved PLE-HHRs can be also found 
in their genomes without any connection to a recognizable retrotransposon. In vitro analysis confirmed that these ribozymes 
may only work as dimeric forms during transcription of the retrotransposon. Our observations, together with those reported for 
HDV-like ribozymes in non-LTR retrotransposons5,6, expand the role of RNA self-cleavage to the biology of diverse eukaryotic 
retroelements and leave open the question of how many more forms of RNA self-cleaving motifs can be possible.
1. de la Peña M, García-Robles I. Intronic hammerhead ribozymes are ultraconserved in the human genome. EMBO Rep, 
2010. 11(9):711-6.
2. de la Peña M, García-Robles I. Ubiquitous presence of the hammerhead ribozyme motif along the tree of life. RNA, 2010. 
16(10):1943-50.
3. Hammann C, Luptak A, Perreault J, de la Peña M. The ubiquitous hammerhead ribozyme. RNA, 2012. 18(5):871-85
4. Arkhipova IR, Pyatkov KI, Meselson M, Evgen’ev MB. Retroelements containing introns in diverse invertebrate taxa. Nat 
Genet, 2003. 33(2):123-4.
5. Eickbush DG, Eickbush TH. R2 retrotransposons encode a self-cleaving ribozyme for processing from an rRNA 
cotranscript. Mol Cell Biol, 2010. 30(13):3142-50.
6. Ruminski DJ, Webb CH, Riccitelli NJ, Lupták A. Processing and translation initiation of non-long terminal repeat 
retrotransposons by hepatitis delta virus (HDV)-like self-cleaving ribozymes. J Biol Chem, 2011. 286(48):41286-95.
119 Probing EF-G Power Stoke During Ribosome Translocation
Yuhong Wang1, Li Yao2, Yue Li1, Shoujun Xu2
1Department of Biology and Biochemistry, University of Houston; 2Department of Chemistry, University of 
Houston
The mechanism of error control for the ribosome to move exactly three nucleotides during the translocation 
process and the role of EF-G remain elusive.  The two possible mechanisms are the “Brownian motor” model and the 
“power stroke” hypothesis. Many recent studies support the former mechanism, implying that the ribosome moves by 
intrinsic Brownian motions and EF-G biases the random motion into the forward direction. However, the spontaneous 
translocation rate is several orders slower than the translocation with EF-G catalysis. This is contradictory to the 
“Brownian motor” hypothesis in which the maximum rate is limited by the intrinsic fluctuation.  Because the EF-G 
can dramatically accelerate translocation comparing to the intrinsic rate, one intriguing question is whether EF-G 
exerts a mechanical force, i.e., a power stroke, to push the mRNA movement. At present, there has been no direct 
experimental evidence supporting such power stroke.
We have obtained direct force measurements in ribosome translocation using a combination of single-molecule 
fluorescence resonance energy transfer (FRET) and a new force-induced remnant magnetization spectroscopy (FIRMS) 
technique. The latter probes different noncovalent interactions and resolves them based on the binding forces. Single-
basepair force resolution has been achieved. The ribosome pre-translocation complex and post-translocation complex 
are well resolved, and the translocation yield can be obtained. The EF-G power stroke is directly obtained by force-
induced dissociation of a series of mRNA-DNA duplexes. A clear transition in magnetic signal by FIRMS indicates 
a substantial mechanical force produced by the EF-G. Our new results provide direct evidence, for the first time, that 
EF-G is the mechanical motor that generates power stroke to promote mRNA movement during its GTP hydrolysis 
cycle. The amplitude of the force may play an important role in determining the translocation fidelity.
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121 Promoter directionality is controlled by U1 splicing and polyadenylation signals
Albert Almada1, Xuebing Wu2, Andrea Kriz1, Christopher Burge1, Phillip Sharp1
1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 USA; 2Computational 
and Systems Biology Graduate Program, Massachusetts Institute of Technology, Cambridge, MA 02139 USA
Transcription of the mammalian genome is pervasive but productive transcription outside protein-coding genes 
is limited by unknown mechanisms. In particular, we and others recently discovered that although RNAPII initiates 
divergently from most active gene promoters, productive elongation occurs primarily in the sense coding direction. 
The data presented here reveal that asymmetric sequence determinants flanking gene transcription start sites (TSS) 
control promoter directionality by regulating promoter-proximal cleavage and polyadenylation. We demonstrate in 
various tissues of mouse and human that upstream antisense RNAs (uaRNAs) are cleaved and polyadenylated at a 
poly (A) site (PAS) shortly after their initiation. De novo motif analysis reveal PAS signals and U1 snRNP binding 
sites (U1) as the most depleted and enriched sequences, respectively, in the sense direction relative to the upstream 
antisense direction. In agreement with the recent finding that U1 snRNP suppresses cleavage and polyadenylation, 
our data suggests that a U1-PAS axis characterized by low U1 recognition and high density of PAS in the upstream 
antisense region results in early termination of uaRNAs whereas proximal sense PAS signals are primarily suppressed 
by U1. Experiments to modulate U1 snRNP levels at the upstream antisense region of divergent promoters will be 
discussed. We propose that the U1-PAS axis may limit pervasive transcription throughout the genome.
120 Understanding RNA Interference One Molecule at a Time
William Salomon1, Victor Serebrov1, Mellissa Moore1, Phillip Zamore1
1Department of Biochemistry & Molecular Pharmacology, RNA Therapeutics Institute, and Howard Hughes 
Medical Institute, University of Massachusetts Medical School
In mammals, small RNAs direct Argonaute2 (Ago2) to cleave complementary target mRNAs. For Drosophila, 
the development of efficient, cell-free systems that recapitulated RNAi led to a detailed mechanistic understanding of 
the RNAi pathway. Until recently, no such system existed for mammals because cell extracts that recapitulate RNAi 
are surprisingly inefficient. We find that cytoplasmic S100 extracts from Ago2–/–immortalized mouse embryonic 
fibroblast (MEF) cells that stably over express wild-type mouse AGO2 support highly efficient RNAi in vitro. Unlike 
extracts from HeLa or wild-type MEFs, extracts from the AGO2 over-expressing cells allow efficient assembly of a 
synthetic small RNA guide into AGO2 to form RISC, the RNA-induced silencing complex. Using a novel affinity 
purification strategy, we can readily purify AGO2-RISC assembled in these extracts with a specific guide sequence 
(1). We will present our recent studies analyzing the biochemical properties of this purified AGO2-RISC using the 
“CoSMoS” (co-localization single molecule spectroscopy) single-molecule technique.
CoSMoS can measure the kinetic properties of Ago2-RISC, including kon, koff, and kcat. Our single-molecule data 
agrees well with recently published biochemical measurements of AGO2-RISC using population-based (ensemble) 
methods (2). Consistent with ensemble measurements, we find that AGO2-RISC binds to an mRNA target at the 
speed of macromolecular diffusion. This stands in contrast to the annealing of nucleic acids in the absence of protein, 
a process whose speed is limited by its on-rate. Intriguingly we find that target cleavage by AGO2-RISC is highly 
temperature-dependent, suggesting that a conformational rearrangement is required for RISC activity in mammals. Using 
both ensemble and single molecule experiments, we are now measuring the departure from RISC of the cleaved target 
fragments, a step proposed to limit the turnover rate of AGO2-RISC. In the future, we plan to use the CoSMoS system to 
determine the evolutionarily conserved and the specialized properties of Argonaute family proteins from diverse species.
1. Flores-Jasso CF, Salomon WE, Zamore PD. Rapid and specific purification of Argonaute-small RNA complexes from crude 
cell lysates. RNA. 2013 Feb 18; 19(2):271–9.
2. Wee LM, Flores-Jasso CF, Salomon WE, Zamore PD. Argonaute divides its RNA guide into domains with distinct 
functions and RNA-binding properties. Cell. 2012 Nov 21; 151(5):1055–67.
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123 Pathway of histone mRNA decay determined by high-throughput sequencing (HTS)
Mike Slevin1, Rebecca Bigler1, Staci Meaux1, William Marzluff1
1University of North Carolina
Histone mRNAs are the only mRNAs in animal cells that are not polyadenylated ending instead in a conserved 
stemloop. Inhibition of DNA replication results in rapid histone mRNA decay directed by the stemloop. Decay of 
histone mRNA is initiated by addition of a non-templated oligouridine tail of ~10 nts, which binds Lsm 1-7. Previous 
studies used low throughput approaches for detecting non-templated additions. The low number of sequences 
generated limits the detailed analysis of mRNA decay. We have developed a high throughput sequencing strategy 
that allows detection of all intermediates in histone mRNA decay, and can specifically target mRNAs with non-
templated 3’ tails. This approach provides the depth of coverage necessary to detect patterns of decay intermediates 
for individual histone mRNAs. We find multiple oligouridylated intermediates resulting from partial decay located 
in the 3’ side of the stem and in the coding region near the stop codon. These intermediates contain oligo(U) tails 
of 4-10 nts, and many are capped indicating they result from 3’-5’ decay. Analysis of polyribosome gradients using 
HTS, show oligouridylated mRNAs are polyribosome associated, including decay intermediates degraded into the 
coding region. Blocking translation with pactamycin results in run-off of ribosomes and accumulation of monosomes 
with histone mRNAs, including capped oligouridylated decay intermediates. Thus a major pathway for histone 
mRNA decay after HU treatment is 3’ to 5’, with repeated exosome stalling, possibly when it contacts translating 
ribosomes. The degradation intermediate is then uridylated to re-prime 3’-5’ decay. Exosome knockdown results in 
accumulation of the initial intermediates in the stemloop and reduction in intermediates stalled in the coding region. 
This is consistent with initial decay stalling in the stemloop catalyzed by 3’hExo (eri-1) and subsequent decay carried 
out by the exosome.  To assess the simultaneous 5’ and 3’ pattern of decay on individual transcripts we used an anti-
biotin oligonucleotide designed to isolate both capped and uncapped intermediates from the H2a mRNAs. A capped 
luciferase mRNA ending in a stemloop transfected into cells is rapidly degraded after treatment of cells with HU with 
a similar set of decay intermediates.  This technique should be generally applicable to determining the degradation 
pathway of any set of mRNAs.
122 Suppression of promoter upstream transcripts (PROMPTs) by polyadenylation site-
induced RNA decay provides directionality to transcription of human promoters
Evgenia Ntini1, Aino Järvelin5, Jette Bornholdt-Lange3, Yun Chen3, Mette Jørgensen4, Robin Andersson4, Aleks 
Schein1, Peter Refsing Andersen1, Pia Kjølhede Andersen1, Vicente Pelechano5, Lars Steinmetz5, Albin Sandelin3, 
Torben Heick Jensen2
1Department of Molecular Biology and Genetics, Aarhus University, Denmark; 2Centre for mRNP Biogenesis 
and Metabolism, Department of Molecular Biology and Genetics, Aarhus University; 3Department of 
Biology & BRIC, University of Copenhagen, Denmark; 4Department of Biology and BRIC, University of 
Copenhagen, Denmark; 5Genome Biology Unit, EMBL, Heidelberg, Germany
Active eukaryotic promoters are associated with unorthodox transcription. In human cells, this leads to the 
production of PROMoter uPstream Transcripts (PROMPTs), which are rapidly cleared by the ribonucleolytic RNA 
exosome. How PROMPT transcription is terminated and coupled to RNA decay, while its neighboring promoter-
downstream mRNA production is not, is unknown. Here, we use exosome depletion to create genome-wide maps 
characterizing PROMPT RNAs and their termini in unprecedented detail. The clear majority of PROMPTs initiate 
in the antisense direction from 150-200bp upstream of the transcription start site (TSS) of the associated gene. 
PROMPT TSSs share features with mRNA-producing TSSs, including stalled RNA polymerase II (RNAPII) and 
the production of small TSS-associated (TSSa) RNAs. Thus, PROMPTs are unstable, capped full-length products of 
the previously reported bi-directional antisense transcription. Importantly, motif analyses around PROMPT 3’ends 
reveal polyadenylation (pA)-like signals, well-positioned to elicit PROMPT 3’end formation. However, contrary to 
their promoter-distal counterparts at mRNA 3’ends, RNA derived from TSS-proximal pA signals is highly exosome-
sensitive. Interestingly, promoter-downstream regions contain significantly less pA signal information, but are instead 
enriched, relative to their promoter upstream counterparts, for U1 snRNP binding sites, which are known to suppress 
pA site utility. We conclude that asymmetric sequence distribution around human gene promoters serves to provide 
an overall directionality to the transcription process by rapidly terminating antisense transcription and degrading its 
RNA product.
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125 Capture of a microRNA targetome using chemically modified miRNA mimics (“miR-CLIP”)
Jochen Imig1, Andreas Brunschweiger1, Anneke Brümmer2, Nitish Mittal2, Boris Guennewig1, Mihaela Zavolan2, 
André P. Gerber3, Jonathan Hall1
1Institute of Pharmaceutical Sciences, ETH Zurich, Switzerland; 2Computational and Systems Biology, 
University of Basel, Switzerland; 3University of Surrey, Faculty of Health & Medical Sciences, Department of 
Microbial & Cellular Sciences, Guildford, UK
Identification of the targets of microRNAs (miRNAs) remains a significant barrier to understanding their function. 
Recently, several methods including PAR-CLIP and affinity purification by biotinylated miRNAs have been developed to 
achieve this goal, either in a global fashion, or for selected miRNAs. All of these methods have their strengths and weaknesses. 
We have developed a two-step approach to screen in straightforward fashion for targets using miRNAs chemically modified 
with psoralen and biotin. Prior to Ago-2 immunoprecipitation as the first step in vivo photo-crosslinking is performed and 
followed by a second step by stringent affinity purification of bound target RNAs. We have termed this method “miR-CLIP”.
We applied miR-CLIP to isolate targets of miR-106a in HeLa cells by using functionally modified mimics of pre- and 
mature miR-106a. Deep sequencing of isolated RNAs yielded a large number of significantly enriched mRNAs compared to 
“mock”-treated controls. Among these were several hundred potential new targets. No enrichment was observed for predicted 
targets of unrelated miR-let-7a. Mostly, target recognition followed a canonical seed-binding mode however shorter non-
canonical seed matches were also detected in enriched RNAs. In follow-up assays, overexpression of miR-106a significantly 
repressed 8 from 10 of the top-ranked potential mRNA targets detected in the analysis validating the approach. Surprisingly, 
the sequencing also showed enrichment of the long non-coding RNA (lncRNA) H19 as an interacting partner of miR-106a. 
H19 is expressed from a paternally imprinted gene which is strongly induced during muscle development. Indeed, H19 was 
strongly and unexpectedly elevated by overexpression of miR-106a in HeLa and in myoblasts, and conversely, its inhibition 
by an anti-miR showed the opposite effect. RNAi-mediated suppression of H19 led to reduced levels of known miR-106a 
targets in myocytes leading us to speculate a mechanism in which H19 buffers the activity of miR-106a during muscle cell 
differentiation.
We are currently testing the functional consequences of this new interaction. In summary, the miR-CLIP method appears 
to be a valuable technique to uncover the “targetome” of specific miRNAs.
Funding partly by a Sinergia grant [CRSII3_127454] from the Swiss National Science Foundation to A.P G., J.H. and M.Z.
124 Global poly(A)-tail length measurements reveal that the relationship between tail length 
and translational efficiency varies between biological contexts
Alexander Subtelny1, Stephen Eichhorn1, Grace Chen1, Hazel Sive1, David Bartel1
1Massachusetts Institute of Technology, Whitehead Institute for Biomedical Research
Poly(A) tails are found at the 3′ ends of nearly all eukaryotic messenger RNAs (mRNAs) and long non-coding 
RNAs. The presence of a poly(A) tail promotes efficient mRNA translation, an effect mediated through poly(A)-
binding protein. However, an understanding of the relationship between the length of a poly(A)-tail and translational 
efficiency, as well as other aspects of mRNA metabolism, has been limited, primarily because of the lack of a 
technology that provides high-resolution poly(A)-tail length measurements in a global manner. Here, we describe 
a high-throughput-sequencing-based method that measures the tails of individual mRNA molecules by coupling a 
fluorescence-based readout of poly(A)-tail length with sequencing of the poly(A)-proximal region. We have applied 
this method to diverse eukaryotic organisms and cellular contexts, including budding and fission yeasts, insect and 
mammalian cell lines, mouse liver, and zebrafish embryos. Poly(A)-tail lengths vary across mRNAs and show some 
conservation between orthologous genes. In particular, transcripts corresponding to ribosomal protein genes and 
certain other classes of “housekeeping” genes tend to have short tails. Poly(A)-tail lengths exhibit a notably poor 
correlation with translational efficiency (as measured by ribosome profiling) across genes in nearly all systems we 
have examined. This lack of correlation also applies to different translational states of mRNAs from the same gene, 
as indicated by poly(A)-tail lengths across a polysome gradient. Unlike all other systems we have studied, the early 
zebrafish embryo exhibits a striking correlation between poly(A)-tail length and translational efficiency (Spearman 
R > 0.6). Remarkably, this correlation disappears later, indicating a dramatic and rapid developmental switch in 
the nature of translational control. Our results clarify the relationship between poly(A)-tail length and translational 
efficiency, and enable further investigations of the determinants and consequences of poly(A)-tail length.
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126 Identification of multiple regulatory microRNAs by miTRAP
Juliane Braun1, Knut Krohn2, Stefan Hüttelmaier1
1Institute of Molecular Medicine, Division of Molecular Cell Biology, Martin-Luther-University Halle-
Wittenberg, Heinrich-Damerow-Strasse 1, 06120 Halle, Germany; 2Interdisciplinary Center for Clinical 
Research, University Leipzig, Liebigstrasse 21, 04103 Leipzig
MicroRNAs (miRNAs) are endogenous, small non-coding RNAs which serve essential functions in post-
transcriptional control of gene expression. Animal miRNA target sites (MTS) are typically characterized by imperfect 
complementarity and are mainly located in the 3’UTR of mRNAs. The length of such 3’UTRs and the number of 
putative MTSs could be correlated with the morphological complexity of organisms. However, for only a few human 
targets multiple miRNA regulation has been verified as experimental identification and in silico prediction remains 
challenging and limited by various means. Aiming to provide a procedure allowing the comprehensive identification 
of regulatory miRNAs, we established miTRAP (microRNA Trapping by RNA Affinity Purification). MiTRAP co-
purifies miRNAs and RNA-binding proteins (RBPs) with in vitrotranscribed bait RNAs from cell lysates by adapting 
MS2-tethering (Figure 1). Therefore, miTRAP is independent of genetic manipulation of cellular systems and in 
silico predictions.
Applying MiTRAP allowed the validation of regulatory miRNAs and RBPs controlling the expression of the 
transcriptional regulators MYC and ZEB2. Moreover, miTRAP and subsequent deep sequencing identified 13 novel 
MYC-regulatory miRNAs all of which could be validated by gain- as well as loss-of-function studies. Four of these 
novel miRNAs target ‘non-canonical’ sites and thus could not have been identified by in silicoprediction. We consider 
miTRAP a reliable and easy to handle technology allowing the rapid and comprehensive identification of miRNAs 
targeting RNAs of interest in a given cellular context. MiTRAP thus provides a powerful tool, which will significantly 
expedite analyses aiming the characterization of miRNA-facilitated regulation of gene expression in development, 
metabolic control and diseases.
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127 Neurodegenerative diseases: Quantitative predictions of protein-RNA interactions
Davide Cirillo1, Gian Tartaglia1
1Centre for Genomic Regulation
Increasing evidence indicates that RNA plays an active role in a number of neurodegenerative diseases. We 
recently introduced a theoretical framework, to predict the binding ability of protein and RNA molecules. We use our 
approach to investigate ribonucleoprotein interactions linked to inherited intellectual disability, amyotrophic lateral 
sclerosis, Creutzfeuld-Jakob, Alzheimer’s, and Parkinson’s diseases. In my presentation, I will focus on (1) RNA 
interactions with fragile X mental retardation protein FMRP; (2) protein sequestration caused by CGG repeats; (3) 
noncoding transcripts regulated by TAR DNA-binding protein 43 TDP-43; (4) autogenous regulation of TDP-43 and 
FMRP; (5) iron-mediated expression of amyloid precursor protein APP and α-synuclein; (6) interactions between 
prions and RNA aptamers. Our results are in striking agreement with experimental evidence and provide new insights 
in processes associated with neuronal function and misfunction.
128 New in vivo RNA-binding architectures discovered by RBDmap
Alfredo Castello1, Bernd Fischer1, Sophia Foehr1, Anne-Marie Alleaume1, Tomaz Curk2, Jeroen Krijgsveld 
Krijgsveld1, Matthias W Hentze1
1European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, 69117 Heidelberg, Germany; 
2European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, 69117 Heidelberg, Germany; Faculty 
of Computer and Information Science, University of Ljubljana
The RNA interactomes of HeLa and HEK293 cells jointly comprise 1106 RNA-binding proteins (RBPs) (1, 2), 
with almost half of these lacking well-defined RNA-binding domains (RBDs), suggesting the existence of numerous 
unknown RNA-binding architectures. Here, we report RBDmap, a new method built on interactome capture (3), to 
comprehensively identify the RBDs of native RBPs in proliferative HeLa cells.  Making use of in vivo UV-crosslinking 
of RBPs to polyadenylated RNAs, capture on oligo(dT) magnetic beads, proteolytic mapping and mass spectrometry 
combined with a sophisticated scoring algorithm, RBDmap “re-discovered” the known RNA-binding sites (e.g. 
RRM, KH) of numerous well characterized RBPs, validating the approach. Strikingly, RBDmap identified dozens of 
additional RNA-binding architectures (e.g. thioredoxin, SSB, RAP, WD40) in multiple non-homologous proteins, also 
including disordered motifs such as basic patches. RBDmap thus instructs on the modes of RNA-binding of hundreds 
of proteins in their native cellular states, providing valuable structural and functional insights into RNA biology. For 
example, the identification of the thioredoxin domain as a high-confidence RBD reveals an intriguing link between the 
redox state of cells and RNA metabolism.
1. A. G. Baltz et al., Mol Cell 46, 674 (Jun 8, 2012).
2. A. Castello et al., Cell 149, 1393 (Jun 8, 2012).
3. A. Castello et al., Nat Protoc 8, 491 (Feb 14, 2013).
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130 Specific Gene Activation by Disruption of PRC2-lncRNA Interactions
James McSwiggen1
1RaNA Therapeutics
A wide variety of nucleic acid compounds are used in both the laboratory and the clinic to inhibit specific RNA 
expression and subsequent protein production. We are developing nucleic-acid-based therapeutics that activate 
genes—rather than inhibiting them—by blocking the interaction of Polycomb repressive complex 2 (PRC2) with its 
target long noncoding RNA (lncRNA).
Histone H3K27 trimethylation is generated by PRC2 and results in inhibition of transcription. Our platform is 
based on the discovery that PRC2 is recruited by non-coding RNAs to methylate histones local to the site of the 
lncRNA. The EZH2-containing PRC2 complex represses gene expression at thousands of sites across the genome. 
During its transcription, an lncRNA that contains a PRC2-recognition sequence is tethered to the site of transcription. 
This tethering leads to very localized repression of neighboring genes.  Since each PRC2-associated lncRNA interacts 
with PRC2 through distinct sequences, we are able to design single-stranded oligonucleotides that specifically block 
the binding of PRC2 to an individual lncRNA, thus de-repressing the expression of a single mRNA to elevate protein 
levels. Starting with a genome-wide pool of RNA sequences that interact with PRC2, we are now developing nucleic 
acid compounds that selectively upregulate gene expression for therapeutic benefit. We are applying this technology 
to develop new treatments in the therapeutic areas of rare genetic disorders, oncology, metabolic diseases and 
neurodegenerative diseases.
129 Development of Dynamic Polyconjugates for tissue-targeted delivery of siRNA
Christine Wooddell1, So Wong1, Jason Klein1, Andrei Blokhin1, Magdolna Sebestyén1, Weijun Cheng1, Julia Hegge1, 
Qili Chu1, Vladimir Trubetskoy1, Collin Hagen1, Anthony Perillo-Nicholas1, Jacob Griffin1, Jonathan Benson1, 
Jeffrey Carlson1, Darren Wakefield1, Holly Hamilton1, Stephanie Bertin1, Jessica Montez1, Alan McLachlan2, David 
Rozema1, David Lewis1
1Arrowhead Research Corporation; 2University of Illinois at Chicago
Dynamic Polyconjugates (DPCs) are siRNA delivery vehicles composed of reversibly-masked, membrane-active 
polymers whose activity is revealed only within endosomes. A new generation of hepatocyte-targeted DPC consists of 
a fully biodegradable peptide with membrane lytic properties (MLP) as the membrane-active polymer that is conjugated 
to N-acetylgalactosamine (NAG) for targeting. This NAG-MLP is co-injected with a liver-tropic, cholesterol-conjugated 
siRNA (chol-siRNA). Effective target gene knockdown is accomplished without complex formation or interaction of the 
NAG-MLP and the chol-siRNA prior to reaching the target cell.
We are utilizing this separately-targeted siRNA delivery approach for the treatment of chronic hepatitis B virus (HBV) 
infection. The use of RNAi therapeutics for the treatment of HBV infection enables knockdown of viral RNAs, including 
the pre-genomic RNA from which the replicative intermediates are derived, thus reducing both viral load and viral proteins. 
A single i.v. co-injection of NAG-MLP with chol-siRNAs targeting conserved human HBV sequences resulted in profound 
reduction of viral RNA and multi-log knockdown of viral proteins and DNA with long duration of effect in mouse models 
of chronic HBV infection. Using a hybridization/HPLC-based method of detection, we are able to correlate the degree 
of viral repression and duration of effect with the amount of the active form of the siRNA guide strand in the liver, the 5’ 
phosphorylated guide strand, which can be detected up to one month after a single administration.
In addition to our existing pH-labile masking reagents, we are developing DPC formulations with masking chemistry 
that is reversed by the action of proteases. These delivery vehicles are stable in the absence of lysosomal proteases, allowing 
for functional delivery of subcutaneously-administered DPC (scDPC). The protease-sensitive DPCs display long circulation 
times, indicating that the masking chemistry is stable in serum. Attachment of the NAG ligand to scDPCs results in rapid 
liver uptake and >90% knockdown at sub-mg/kg siRNA doses in mice and non-human primates. The remarkable stability 
and efficacy of protease-sensitive DPCs make them amenable for use in liver indications for which subcutaneous dosing is 
desirable as well as in targeting tumor and other extra-hepatic tissues.
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131 RNA-based immunotherapeutics against cancer
Andreas Kuhn1, Janina Buck2, Florian Eberle2, Britta Vallazza2, Joanna Kowalska3, Jacek Jemiliety3, Edward 
Darzynkiewicz3, Ugur Sahin1
1Ribological GmbH, Mainz, Germany & TRON, University Medicine Mainz, Germany; 2Ribological GmbH, 
Mainz, Germany; 3University of Warsaw, Poland
RNAs with optimized properties are increasingly investigated as a tool to deliver the genetic information of complete 
antigens into professional antigen-presenting dendritic cells for HLA haplotype-independent immunotherapies against 
cancer. Upon entering dendritic cells, the encoded antigen is translated from the RNA, and then processed into epitopes 
that are presented on MHC class I and II complexes triggering an antigen-specific T cell response (1).
The dose of the antigen and the duration of its presentation are critical factors for generating strong and sustained 
immune responses. Substantial increase of the amount of antigen produced from RNA can be achieved by optimizing 
RNA stability and translational efficiency. Both features are determined by cis-acting elements in the RNA, i.e. the 
5’ cap, the poly(A)-tail, and the sequence of the non-coding and coding regions. Continuous improvement of RNA by 
modifying the different elements for increased expression of foreign proteins in dendritic cells has been a main goal 
of our studies (2).
We have developed plasmid templates for in vitro transcription of RNAs with modified 3’ structures (3’ UTR 
and poly(A)-tail) stabilizing the RNA and optimizing its translational performance in dendritic cells. Moreover, we 
observed that RNAs capped with the D1 diastereoisomer of m2
7,2’-OGppSpG (beta-S-ARCA) have increased stability 
and translational efficiency in dendritic cells. Recently, we have analyzed the effect of the codon composition on 
the level of antigen expression by testing up to ten different constructs for several antigens. Significant differences 
can be observed, and the expression of the antigen can be enhanced up to ten-fold compared to the wild-type codon 
composition. By combining these measures we were able to profoundly improve properties of RNA-encoded 
immunotherapeutics.
To initiate human clinical testing of our RNA technology, a suitable manufacturing process to produce gram 
amounts of RNA using the modified cap analog and optimized sequence elements as given above has been established 
under “Good Manufacturing Practice”. The first patients have been treated, demonstrating safety of the treatment. 
Immunological assessment of the efficacy to induce antigen-specific immune responses in humans is in progress.
In principle, our optimized RNA technology can be generally used for exogenous protein expression in target 
cells (3). Importantly, cell-type dependent differences have been observed for the effects of the cis-acting RNA 
elements. Therefore we have started a screening program to identify the optimal combination of cap structures and 
UTR sequences for multiple cell lines and primary cells.
1. Kreiter et al. Curr. Opin. Immunol. (2011) 23: 399-406
2. Kuhn et al. Curr. Gene Ther. (2012) 12: 347-361.
3. Grudzien-Nogalska et al. Methods Mol. Biol. (2013) 969: 55-72
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132 Antisense Oligonucleotide Therapies for the Treatment of Neurodegenerative and 
Muscular Diseases
Frank Rigo1, C. Frank Bennett1
1ISIS Pharmaceuticals, Carlsbad, CA
Antisense oligonucleotides (ASOs) are chemically modified oligonucleotides that are designed to specifically bind 
to a targeted RNA through Watson-Crick base pairing. There are a variety of mechanisms by which ASOs modulate 
RNA function after hybridization, including promoting the degradation of the RNA and modulating RNA processing. 
Neurodegenerative and muscular diseases are an attractive area for antisense technology in that there a number of 
diseases in which the genetic basis is known. Because ASOs target RNA, rather than protein, they can be used to 
directly modulate a broad range of genetic defects that cannot be targeted easily by conventional small molecule 
or protein based drugs. Isis Pharmaceuticals is developing antisense drugs for several inherited neurodegenerative 
and muscular diseases including amyotrophic lateral sclerosis (ALS), spinal muscular atrophy (SMA), Huntington’s 
disease (HD), tauopathies and myotonic dystrophy (DM1). Preclinical studies in rodents and non-human primates 
demonstrate broad distribution of single stranded ASOs in CNS tissues following central administration, directly into 
the CSF, with commensurate modulation of gene expression in spinal cord and different brain regions. In addition, we 
have demonstrated that ASOs can also modulate gene expression in skeletal muscle when administered peripherally. 
The tissue half lives of the drugs in the CNS and muscle of mice and non-human primates is in the order of months. 
We have also used ASOs in mouse models of disease and will present out work in mouse models of SMA and DM1. 
We recently completed an early stage clinical study in SMA demonstrating safety and tolerability of antisense drugs 
administered by intrathecal injection. This early clinical experience supports the continued development of antisense 
drugs for severe neurodegenerative and muscular diseases.
133 Extracellular RNAs are markers of muscle myogenesis following splice switching 
oligonucleotide therapy in a mouse model of Duchenne muscular dystrophy
Matthew Wood1
1University of Oxford
Extracellular RNAs are promising disease biomarkers for a number of disease conditions. Here we report that 
in the mdx dystrophin-deficient mouse model of Duchenne muscular dystrophy (DMD), extracellular dystromiRs 
(miR-1, miR-133a and miR-206) show dynamic patterns of expression in serum throughout disease progression and 
in response to exon skipping-mediated dystrophin restoration utilizing potent peptide-morpholino oligonucleotide 
conjugates. This dynamicDystromir expression pattern is found to be distinct from the expression of the corrected 
dystrophin protein, while the extracellular RNAs show a positive correlation with the expression of myogenic 
transcription factors suggesting that these miRNAs are indices of muscle myogenic i.e. regenerative / degenerative 
status and probably reflect activity of the myogenic stem cell niche within the diseased muscles. Further data obtained 
following experimentally-induced skeletal muscle regeneration in non-dystrophic mice support this hypothesis. 
Moreover the release of these extracellular miRNAs is likely to be a regulated, specific process (i.e. not simply a 
result of passive release from degenerating muscle) given that the extracellular RNA expression pattern is significantly 
different from that found within the muscle tissue. Further, the majority of the extracellular dystromiRs are bound 
in protein/lipoprotein complexes and only a minority are found in extracellular vesicles.  These data therefore have 
important implications for understanding the biological and clinical significance of extracellular RNAs in DMD and 
other neuromuscular diseases, and in particular following splice switching oligonucleotide therapy.
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135 What can you know about noncoding RNAs without doing any experiments?
Zasha Weinberg1, Ronald Breaker1
1HHMI / Yale University
This tutorial will address computational and other non-experimental means to improve the understanding of the 
structure and function of non-coding RNAs whose secondary structure is conserved. The session is aimed primarily 
at experimental biologists, and will not assume any computational background.  Concepts to be addressed include: 
analysis of covariation to detect and understand a family of RNAs sharing a common structure, and using flanking 
genetic elements as clues to RNA function. These approaches are often useful both for finding novel noncoding RNAs 
and for developing knowledge and hypotheses about poorly understood RNAs.
134 Silencing gene expression by recruiting RISC
Jennifer Broderick1, Neil Aronin1, Phillip Zamore2
1RNA Therapeutics Institute; 2RNA Therapeutics Institute, Investigator HHMI, Gretchen Stone Cook 
Professor of Biomedical Sciences
The capacity for small RNAs to repress gene expression depends on nucleic acid base-pairing between the 
target mRNA and a small RNA guide bound to an Argonaute protein. A challenge to the successful use of small 
interfering RNA (siRNA) in mammals has been effectively triggering RNAi in vivo while simultaneously protecting 
the siRNA from nucleolytic degradation and delivering it to the correct tissue and cell type. We are exploring a new 
approach to gene silencing that takes advantage of the well understood stability and delivery properties of antisense 
oligonucleotides and the cell-type specific expression of endogenous microRNAs (miRNA). Our strategy employs 
a stablized, synthetic oligonucleotide tether that recruits  endogenous microRNAs to a specific target mRNA. The 
oligonucleotide tether contains one region complementary to the target mRNA and another to an abundant endogenous 
miRNA. The tether binds endogenous miRNA-loaded Argonaute complexes and links them to the mRNA. A tether 
designed to recruit let-7 directed a >90% reduction in luciferase reporter expression, compared to a control tether 
directed towards a miRNA not present in animal cells. Tethers designed to recruit miR-21 or let-7a to the 3´ UTR of 
an endogenous mRNA reduced mRNA abundance by ~70%. Our results suggest that it is possible to (1) redirect an 
endogenous miRNA to silence an mRNA with no binding sites for that miRNA and (2) design the tether to silence only 
in specific tissues by choosing a miRNA with an appropriate expression pattern.
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137 RNAsnp: Predicting SNP Effects on Local RNA Secondary Structure
Radhakrishnan Sabarinathan1, Hakim Tafer5, Stefan E Seemann3, Ivo L Hofacker5, Peter F Stadler4, Jan Gorodkin2
1Center for non-coding RNA in Technology and Health, IKVH, University of Copenhagen; 2Center for non-
codign RNA in Technology and Health, IKVH, University of Copenhagen; 3Center for non-coding RNA in 
Technology and Health, IKVH, University of Copenhagen; 4University of Leipzig; 5University of Vienna
The function of many noncoding RNAs and cis-regulatory elements of mRNAs largely depends on the structure, 
which is in turn determined by their sequence. Single Nucleotide Polymorphisms (SNPs) and other mutations may disrupt 
the RNA structure, interfere with the molecular function, and hence cause a phenotypic effect. Thus it is of relevance 
to search for structural changes induced by SNPs. Existing methods have addressed this problem by considering global 
folding of the wild-type and mutant sequences respectively, and then compared them in various ways. However, if the 
structural change is only local, it can be hard to detect on global scale. Therefore, we have developed RNAsnp (based 
on RNAfold from the Vienna package), which is an efficient method for prediction of SNPs effects on local RNA 
secondary structure. RNAsnp searches efficiently all subsequences (local regions) for structural effects and selects 
the one where structural difference is largest based on some distance measure (of which a number is benchmarked). 
To determine the significance of the SNP effects empirical p-values are computed from the background distribution 
generated using random sequences, for which computational efficiency is otained by using extensive precomputed 
tables describing the score distributions as a function of sequence length, G+C content, and SNP position.
Only some 30 examples are reported in the literature where the RNA structure could be the cause of dysfunction 
in the presence of the SNP. In four of these cases probing analysis was carried out and confirmed an actual structural 
change (on top of in silico predicted methods). Additionally, on a data set comprising 501 SNPs associated with 
human inherited diseases, we predicted 54 to have significant local structural effect in the UTR region of mRNAs. 
RNAsnp is available both as standalone software and as a web server. The RNAsnp Web server provide a convenient 
interface to provide input data to RNAsnp and to select different modes of operation. It helps to visualize the output 
using informative graphical representation, such as dot plot matrices comparing pair probabilities for wild-type and 
mutant. In addition, the web server is connected to a local mirror of the UCSC genome browser database that enables 
the users to select the genomic sequences of interest for analysis and to visualize the results in the UCSC genome 
browser. Both software and web server are available at http://rth.dk/resources/rnasnp.
136 Methods of Predicting RNA Structure Change Due to Mutation
Matt Halvorsen1, Joshua Martin1, Justin Ritz1, Alain Laederach1
1University of North Carolina at Chapel Hill
In determining the functional effect of a mutation in RNA, it is important to consider potential effects of the 
mutation on RNA structure.   Alteration of the structural ensemble of an RNA due to mutation can influence the 
very network of regulatory interactions an RNA is involved with in its lifetime by altering the binding affinity of 
the transcript for various interacting RNAs and proteins, and in some cases where an RNA is enzymatically active, 
influence its very catalytic activity.   We present various means of predicting the degree and nature of RNA secondary 
structure change in a given transcript from mutation.   We first compare the traditional minimum free energy model of 
RNA structure to a probabilistic model that we utilize where a full ensemble of possible structures for a given RNA 
is represented. We then review the SNPfold algorithm as a means of quantifying the global RNA structure change 
brought about by given mutations using commonly available RNA structure software.   Various flavors of the SNPfold 
algorithm, as well as a method of non-parametrically calculating the significance of global structure change brought 
about by a point mutation when compared to all other possible mutations in a transcript, are discussed.   We review 
the use of Principal Component Analysis (PCA) as a method of visualizing structure ensembles and their disruption 
upon introduction of a mutation.   We take measurements of structure change from Selective 2′-hydroxyl acylation 
analyzed by primer extension (SHAPE) experiments, and compare the experimental data to predictions made using 
the described methodology in order to determine the sensitivity and specificity of our predictions.
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138 Navigating through the MC-Flashfold 2D suboptimal solution maze using simple 
structural transformation rules
Paul Dallaire1, Stefanie Schirmer2, Francois Major1
1Institute for Research in Immunology and Cancer, and Computer Science Department, Université de 
Montréal, Montréal, Québec, Canada H3C 3J7; 2Institute for Research in Immunology and Cancer, and 
Computer Science Department, Université de Montréal, Montréal, Québec, Canada H3C 3J7
RNA 2D structure prediction from a single sequence often requires the inspection of large numbers of suboptimal 
solutions proposed by the software. This exercise is unproductive and the modeler is left with little insights about the 
native structure. However, many of the proposed structures are very similar and networks can be build, where each 
connected pair of structures in a network differs from each others by a simple transformation. Structures that cannot 
be linked by a series of simple transformations are found in other networks. We consider simple a transformation 
between two structures when they differ by a bulge loop migration, or the formation of a base pair. Even with only 
these two simple transformations, we can transform long lists of suboptimal predictions into a tractable number of 
independent networks that can help to: 1) Interpret the RNA 2D proposed structures; and, 2) Compare the networks 
of two different sequences, for instance to evaluate the structural impact of mutations. Besides, these networks 
are particularly informative when non-canonical base pairs are considered. We generated such networks under the 
statistical framework of nucleotide cyclic motifs (NCM) using a faster and leaner version of the MC-Fold program, 
MC-Flashfold. For instance, MC-Flashfold with a threshold of 8 kcal/mol produces a quarter million suboptimal 
structures, within which the native cloverleaf is found in the few first hundreds. This is a problem for the end-user 
who has no clue about selecting the right one. Among more than 7,000 networks build from the suboptimal structures, 
the native structure was found in the second one, where the networks are ranked by the free energy of its most stable 
member. Other concrete examples, benchmarks, as well as MC-Flashfold and network applications will be discussed.
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139 How to determine binding affinities and binding motifs for RNA-bindingproteins from 
CLIP-seq data
Rolf Backofen1, Daniel Maticzka1, Fabrizio Costa1
1University of Freiburg
The analysis of binding sites of RNA-binding proteins is becoming an increasingly important topic. The standard 
experimental approach for determining binding sites is CLIP-seq. Since not all possible binding sites are covered 
due to differential expression in tissues and developmental states, the main problem is to come up with good motif 
descriptions to find missing binding sites and to evaluate the binding strength.
It is well know that binding motifs for RNA-binding proteins have to contain both sequential and structural 
information [1,2]. Previous approaches used only structural profiles. Our new approach GraphProt uses an advanced 
machine learning approach based on a graph-kernel [3], and is able to use both structural profiles as well as detailed 
2D-structures, without the need to decide a priori about the weight of the different structural components. In addition, 
we are able to integrate also context information. Furthermore, we provide support for mutagenesis analysis, which is 
a non-trivial task, provided that structural information is used.
We have compared our approach with the current state of the art, RNAcontext, on the in-vitro data that where used 
for evaluation in the RNAcontext publication. We outperform RNAcompete for all 9 proteins used in this evaluation 
(see Figure1 below). Furthermore, we will report on our results of applying GraphProt on CLIP-seq data for PTB. Our 
predictions highly correlate with measured  affinities. We have used the discovered motifs to search for new binding 
sites within a mini-gene construct, which could then be verified experimentally by our cooperation partner.
1. Michael Hiller, Zhaiyi Zhang, Rolf Backofen, and Stefan Stamm. Pre-mRNA Secondary Structures Influence Exon 
Recognition. PLoS Genet, 3 no. 11 pp. e204, 2007.
2. Michael Hiller, Rainer Pudimat, Anke Busch, and Rolf Backofen. Using RNA secondary structures to guide sequence motif 
finding towards single-stranded regions. Nucleic Acids Res, 34 no. 17 pp. e117, 2006.
3. Steffen Heyne, Fabrizio Costa, Dominic Rose, and Rolf Backofen. GraphClust: alignment-free structural clustering of 
local RNA secondary structures. Bioinformatics, 28 no. 12 pp. i224-i232, 2012
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140 The HIV-2 Rev-Response Element: Determining Secondary Structure and Defining Folding 
Intermediates
Joanna Sztuba-Solinska1, Sabrina Lusvarghi1, Katarzyna Purzycka1, Gary Pauly2, Jason Rausch1, Stuart Le Grice1
1Reverse Transcriptase Biochemistry Section, HIV Drug Resistance Program; 2Chemical Biology Laboratory, 
Frederick National Laboratory for Cancer Research, Frederick, MD21702, USA
Similar to its’ HIV-1 counterpart, the Rev response element of HIV-2 (RRE2) is responsible for transporting 
unspliced and partially spliced viral RNA from the nucleus to the cytoplasm. We applied complementary chemical and 
biochemical probing techniques to determine the structure of the RRE2 RNA. SHAPE analysis indicates that the low-
energy form of RRE2 contains five peripheral stem loops linked by adjacent 4-way and 3-way junctions. Interestingly, 
electrophoretic fractionation of RRE2 RNA under non-denaturing conditions revealed additional conformers (open 
and intermediate) that undergo conversion to the more stable, low energy (closed) form in a time-dependent manner. 
This transition was verified by kinetic analysis, and the structures of the three forms were determined using a novel 
method for mathematically dissecting an ensemble of SHAPE profiles. Site-directed hydroxyl radical footprinting 
was used to examine the relative positioning of select motifs within these structures in three-dimensional space. 
Overall, our study provided detailed insight into the RRE2 conformation, and as such will aid in the development and 
application of nanoparticle-based antiviral drugs targeting cis-acting RNA regulatory signals.
For the workshop  “Tutorial on prediction of RNA secondary structure”
141 Structural spectrum of long non-coding RNAs revealed by experiment
Irina Novikova1, Scott Hennelly1, Bin Zhang3, David Spector2, Karissa Sanbonmatsu1
1Los Alamos National Laboratory; 2Cold Spring Harbor Laboratory; 3Washington University in St. Louis
Thousands of long non-coding RNAs (lncRNAs) have been identified in the past few years. These RNAs have emerged as 
key players in development, cancer and brain function in mammalian systems. As many have been discovered only recently, 
very few structural studies have been performed. Fundamental questions regarding the structure of lncRNAs have yet to be 
addressed, including, (1) do lncRNAs have structure? and (2) are lncRNAs organized into modular sub-domains or linear chains 
of stem loops [1,2]?  We have previously produced the first experimentally-derived secondary structure of an intact lncRNA by 
performing extensive biochemical studies in our wet lab using SHAPE probing, in-line probing, DMS probing and RNase V1 
digestion [3]. Recently we have developed a new divide-and-conquer experimental strategy, called Shotgun Secondary Structure 
(3S) determination. The 3S experimental strategy allows us to produce the secondary fold with little need for computational 
predictions. First, we perform SHAPE probing on the entire lncRNA transcript. We repeat the probing on several overlapping 
fragments of the transcript. If the SHAPE profile for the fragment matches the profile for the same region in the context of the full 
transcript, this strongly suggests the fragment folds into a modular sub-domain or secondary motif, eliminating a large number of 
possible folds. We have applied this technique to the steroid receptor RNA activator (SRA1), the growth arrest-specific 5 transcript 
(Gas5), portions of MALAT-1 and other lncRNA systems. We find a variety of architectures, which may each be commensurate to 
the needs of the lncRNA system. The secondary structure of SRA1 resembles the 16S rRNA in terms of the modular organization 
into sub-domains and the relative number of helices, stem loops, internal loops and junctions. The Gas5 RNA consists of a roughly 
linear chain of stem loops separated by unstructured regions of RNA. Using SHAPE probing, we validated the triplex formation of 
the 3’-end of human MALAT-1, demonstrating that this motif is also structurally conserved in other species. Other systems show 
either a compact fold or a linear chain-like architecture. Numerous studies over the past few years have displayed a tremendous 
range of functional roles and disease applications for lncRNAs. Our results demonstrate that lncRNAs also have a diverse range 
of structural architectures.
1. Sizing up long non-coding RNAs: do lncRNAs have secondary and tertiary structure? Novikova IV, Hennelly SP, 
Sanbonmatsu KY. Bioarchitecture. 2012, 2(6):189-99.
2. Rise of the RNA machines: exploring the structure of long non-coding RNAs, Novikova IV, Hennelly SP, Tung, CS, 
Sanbonmatsu KY, Journal of Molecular Biology, 2013 (in press).
3. Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Novikova IV, Hennelly SP, 
Sanbonmatsu KY. Nucleic Acids Res. 2012, 40(11):5034-51.
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142 The transcription factors ILF2 and ILF3 are trans-acting factors for 60S ribosomal 
biogenesis
Franziska Wandrey1, Christian Montellese1, Lukas Badertscher1, Lukas Bammert1, Ulrike Kutay1
1Institute of Biochemistry, ETH Zurich, Switzerland
The interleukin enhancer binding factors ILF2 (NF45) and ILF3 (NF90/NF110) were originally identified as a 
heterodimeric transcription factor complex required for Interleukin 2 expression in T-cells. Since then, the nuclear 
proteins ILF2 and ILF3 have been shown to be involved in various cellular pathways such as miRNA processing, 
DNA double-strand break repair and translation. Interestingly, ILF3 possesses two double-stranded-RNA binding 
domains (dsRBDs), allowing it to interact with different RNA species.
Using tandem affinity purification followed by mass-spectrometry analysis, we identified human ILF2 and ILF3 
as novel components of premature particles of the large ribosomal subunit (pre-60S). This was supported by sucrose 
gradient analysis of HeLa cell extract where a fraction of NF45 and NF90, but not NF110, co-sedimented with pre-
60S particles. Moreover, depletion of ILF2 or ILF3 by RNAi leads to a defect in 60S biogenesis as observed in a 
tetracycline-inducible RPL29-GFP cell line. Further, ILF2 or ILF3 downregulation results in a change in nucleolar 
size and number. These defects are not due to impaired transcription or processing of pre-28S or pre-18S ribosomal 
RNA (rRNA) as shown by fluorescence in situ hybridization and Northern blotting of different pre-rRNA species.
Notably, whereas most eukaryotic ribosomal trans-acting factors are conserved from yeast to higher eukaryotes, 
ILF2 is metazoan- and ILF3 vertebrate-specific. This suggests that the added layer of complexity in higher eukaryotes 
calls for additional regulatory factors in ribosomal biogenesis. Taken together, this indicates that ILF2 and ILF3 are 
novel, higher eukaryote-specific biogenesis factors required for the maturation of the 60S ribosomal subunit. 
143 Novel function for human Argonaute 2 in gene regulation at the tRNA genes
Jessica Woolnough1, Keith E. Giles2
1University of Alabama at Birmingham, Department of Biochemistry and Molecular Genetics; 2University of 
Alabama at Birmingham
Enhancer sequences are critical for controlling cell-type specific gene expression.  These can function at great 
distance from their target genes, and in some cases can be closer to non-target genes.  The maintenance of specificity 
in enhancer-promoter interactions remains poorly understood. However, insulator sequences are critical in ensuring 
that only proper enhancer-promoter interactions are formed.     Insulators block productive transcription when placed 
in between an enhancer and its promoter.  In humans, the zinc-finger protein, CTCF is largely responsible for insulator 
function.  It has recently been shown in Drosophila that Ago2 is essential for CTCF/CP190-dependent Fab-8 insulator 
activity.  Additionally, recent work in S.pombe, D. melanogaster and H. sapiens has shown that TFIIIC bound tRNA 
genes can function as insulator sequences.  The mechanism of how these tDNAs can function as insulators remains 
unknown.  An identification of the genome-wide binding sites for hAgo2 via ChIP-seq indicates an interaction with 
~60% of tDNAs.  We assessed TFIIIC-occupancy, which is a requirement for tDNA insulator activity in humans, and 
found that greater than 90% of Ago2-bound tDNAs are TFIIIC-occupied.  This binding is cell cycle-dependent; binding 
is abolished when cells are halted in M-phase.  We have further characterized the role of hAgo2 at human tDNAs by 
measuring changes in gene expression, histone modifications patterns, and long-range chromatin interactions in the 
absence of hAgo2.  Furthermore, we have utilized a well-studied heterologous assay for measuring insulator activity 
to accurately quantify the impact the RNAi machinery has on insulator function in human cells.  Our data suggests 
a novel function for the human RNAi machinery in regulating gene expression and large scale genome architecture. 
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144 The human cap-binding complex is functionally connected to the nuclear RNA exosome
Peter Refsing Andersen1, Michal Domanski1, Maiken S. Kristiansen1, Evgenia Ntini1, Celine Verheggen3, Jakob 
Bunkenborg2, Ina Poser5, Marie Hallais3, Anthony Hyman5, John LaCava4, Michael P. Rout4, Jens S. Andersen2, 
Edouard Bertrand3, Torben Heick Jensen1
1Centre for mRNP Biogenesis and Metabolism, Department of Molecular Biology and Genetics, Aarhus 
University, Denmark; 2Department of Biochemistry and Molecular Biology, University of Southern Denmark, 
Denmark; 3Institute de Génétique Moléculaire Montpellier, Montpellier, France; 4Laboratory of Cellular and 
Structural Biology, The Rockefeller University, New York, USA; 5Max Planck Institute of Molecular Biology 
& Genetics, Dresden, Germany
Nuclear processing and quality control of eukaryotic RNA is mediated by the multi-subunit RNA exosome, which 
utilizes accessory factors to regulate its enzymatic activity. However, the mechanism of exosome recruitment to its 
ribonucleoprotein (RNP) targets remains poorly understood. We now disclose a physical link between the human 
nuclear RNA exosome and the cap-binding complex (CBC). The CBC associates with the ARS2 protein to form 
CBC-ARS2 (CBCA), and then further connects together with the uncharacterized ZC3H18/NHN1 protein to the 
nuclear exosome targeting (NEXT) complex, forming CBC-NEXT (CBCN). RNA immunoprecipitation analysis 
using CBCN factors as baits as well as the combinatorial depletion of CBCN and exosome components underscore the 
functional relevance of CBC-exosome bridging at the level of target RNA. Furthermore, we reveal that CBCN and the 
RNA Exosome together enforce a dual-level suppression of spurious transcripts in human cells. Specifically, CBCA 
suppresses U2 snRNA read-through- and promoter upstream-transcription by promoting transcriptional termination 
in these regions. We suggest that the RNP 5’cap links transcription termination to exosomal RNA degradation via 
CBCN.
145 A splicing-dependent transcriptional checkpoint
Keerthi Chathoth1, Shaun Webb1, David Barrass1, Jean Beggs1
1University of Edinburgh
It is well established that pre-mRNA splicing and other RNA processing events often occur co-transcriptionally. 
Furthermore, high resolution kinetic studies performed in our lab showed splicing-dependent RNAPII pausing near 
the 3’ splice site of a reporter gene1. Pausing requires splicing, as mutations that block splicing lead to loss of pausing, 
and restoring splicing restores pausing. We have proposed that RNAPII pausing may occur at splicing-dependent 
transcriptional checkpoints1.
In a search for factors that are involved in coupling these processes, we identified several splicing factor mutations 
that cause transcription elongation defects. Prp5p is an RNA helicase that has been reported to act as a fidelity factor 
during pre-spliceosome formation2. We will present in vivo RNA labelling and RT-qPCR data demonstrating reduced 
transcription in PRP5 mutant at the non-permissive temperature. ChIP analysis shows polymerase accumulating 
over intron-containing genes in the mutant strain, supporting a transcription elongation defect. We also analysed the 
phosphorylation status of the CTD of the large subunit of RNAPII, revealing that the apparently stalled polymerase 
is hyper-phosphorylated at Ser5. Furthermore, ChIP-Seq analysis in the mutant strain revealed that polymerase 
accumulated on 40% of the intron-containing genes genome-wide. We then identified that this transcription elongation 
defect in prp5-1 is abolished upon removal of Cus2p, a U2 snRNP-associated protein. Our observations suggest that 
Cus2p could be a checkpoint factor in transcription prior to pre-spliceosome formation. We speculate that splicing 
fidelity factors may impose transcriptional checkpoints at different stages of splicing.
1. RD Alexander et al, Mol Cell (2010) 40: 582-93
2. YZ Xu and CC Query, Mol Cell (2007) 28: 838-49
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146 The Exon Junction Complex core component MLN51 interacts with eIF3 and activates 
translation
Pierre-Etienne Chazal1, Elisabeth Daguenet2, Catherine Tomasetto2, Bruno Sargueil3, Herve Le Hir1
1Institut de Biologie de l’Ecole Normale Supérieure, CNRS-INSERM, Paris, France; 2Institut de Génétique et 
de Biologie Moléculaire et Cellulaire, CNRS-INSERM, Illkirch, France; 3Laboratoire de Cristallographie et 
RMN Biologiques, CNRS, Paris, France
The multiprotein Exon Junction Complex (EJC) that is deposited onto mRNAs by the splicing machinery nicely 
exemplifies the impact of nuclear history on mRNP lifecycle. This processing mark influences numerous post-
transcriptional steps including splicing, transport, translation and surveillance via the nonsense-mediated mRNA 
decay pathway (NMD). The EJC notably offers a selective advantage to newly synthesized mRNAs by stimulating 
their translation efficiency. However, the exact mechanism by which the EJC functionally communicates with the 
translation machinery remains poorly understood.
The EJC is organized around a tetrameric core complex that accompanies spliced mRNAs to the cytoplasm. The 
core is composed of the DEAD-box RNA helicase eIF4AIII, MAGOH, Y14 and MLN51 (also known as Barentsz). 
Here, we show that among the EJC core components, the RNA-binding protein MLN51 is a translation enhancer. 
Overexpression of MLN51 in human cells preferentially increased the protein expression of intron-containing 
reporters through its incorporation within EJC cores. In contrast, its silencing decreased the translation of both spliced 
and unspliced reporters. In addition, modulation of MLN51 level in cell-free translational extracts confirmed its direct 
role in protein synthesis while metabolic labeling experiments demonstrated that it is a general translation activator. 
Polysome fractionation and immunoprecipitations indicated that MLN51 associates with translation initiation factors 
and ribosomal subunits in an RNase-insensitive manner. Finally, in vitro binding assays with purified factors revealed 
that MLN51 directly interacts with the central initiation factor eIF3 and that this interaction is compatible with EJC 
core assembly.
Altogether, our data define MLN51 as a new translation activator that constitutes a positive link between nuclear 
splicing and cytoplasmic translation machineries via the EJC.
147 SRSF1-mediated translational regulation and its role in cellular transformation
Magdalena Maslon1, Sara Heras2, Nicolas Bellora3, Eneritz Aguirre3, Eduardo Eyras3, Javier Caceres1
1MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, UK; 
2MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, UK 
and GENYO-Pfizer, University of Granada, Andalusian Government Centre for Genomics and Oncological 
Research, 18007, Granada, Spain;; 3Regulatory Genomics Group, Universitat Pompeu Fabra, Barcelona, Spain
The serine and arginine-rich protein family (SR proteins) are highly conserved regulators of pre-mRNA splicing. The SR 
protein prototype, SRSF1 (also known as SF2/ASF), has been initially characterized as a splicing factor but also shown to 
mediate post-splicing activities such as mRNA export and translation. SRSF1 has also been proposed to act as an oncogene (1). 
We have previously shown that SRSF1 promotes translation initiation of bound mRNAs by suppressing the activity of 4E-BP, 
a competitive inhibitor of cap-dependent translation. This activity is mediated by interactions of SRSF1 with components of 
the mTOR signaling pathway. These findings suggest the model whereby SRSF1 functions as an adaptor protein to recruit the 
signaling molecules responsible for regulation of cap-dependent translation of specific mRNAs (2).
In order to dissect the importance of SRSF1 in translational control, we have performed a high-throughput deep sequencing 
analysis of polysomal fractions in cells overexpressing SRSF1. A group of more than one thousand mRNAs shifts from the 
subpolysomal fraction to the heavier polysomal fractions upon SRSF1 overexpression. Interestingly, one third of these mRNAs 
were previously identified as bona fide RNA targets of this SR protein by CLIP-seq. Bioinformatics analyses showed that these 
mRNAs encode proteins involved in cell cycle regulation, such as spindle, kinetochore and M phase proteins, which are essential 
for accurate chromosome segregation. In parallel, protein quantification using SILAC (Stable isotope labelling by amino acids in 
cell culture) confirmed that this subset of proteins was upregulated upon SRSF1 overexpression. Notably, SILAC analysis also 
revealed an increased expression of key glycolytic enzymes upon SRSF1 overexpression and several experiments confirmed 
a role for SRSF1 in enhancing a glycolytic switch (Warburg effect), a hallmark of proliferating cancer cells. Finally, we have 
analyzed changes in alternative splicing in response to different levels of SRSF1 protein. Interestingly, a significant proportion 
of those mRNAs that display alternative splicing changes are also translationally regulated by SRSF1. This suggests that SRSF1 
influences several steps of an mRNA life.
Altogether, the finding that SRSF1 promotes the increased translation of genes associated with cell division and also regulates 
metabolic reprogramming in cancer cells could partially explain the oncogenic role of SRSF1. In summary, these data provide 
insights on the complex role of SRSF1 in the control of gene expression and its implications in cancer.
1. Karni et al. (2007) NatStruct Mol Biol., 14, 185-93.
2. Michlewski et al.(2008)Mol Cell, 30, 179-189
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149 GENOME-WIDE IDENTIFICATION OF RECURSIVE SPLICING IN DROSOPHILA
Sara Olson1, Xintao Wei1, Ahmad Osman1, Michael Duff1, Susan Celniker2, Brenton Graveley1
1Department of Genetics and Developmental Biology, Institute for Systems Genomics, University of 
Connecticut Health Center, Farmington, CT 06030 USA; 2Department of Genome Dynamics, Lawrence 
Berkeley National Laboratory, 1 Cyclotron Rd, Berkeley, CA 94720, USA
In Drosophila, the vast majority of introns are very short. As a result, the exons that are to be spliced together are in 
close proximity and can find one another easily. There are, however, many large introns (>50 kb) in Drosophila where it 
may be more difficult to juxtapose the exons that are to be spliced together. The 74 kb intron in the Ultrabithorax gene 
has been shown to be removed by a process called recursive splicing in which an upstream exon is spliced to a location 
within the intron, and the sequence of this splice junction re-creates a 5’ splice site that can be subsequently respliced to 
another 3’ splice site further downstream. The sites at which recursive splicing occurs are referred to as ratchet points. 
Though recursive splicing was discovered in 1998, only three additional genes (kuzbanian, outspread, and frizzled) 
have been experimentally shown to utilize recursive splicing to remove long introns. We have identified over 30 genes 
that undergo recursive splicing (and 70 ratchet points) by analyzing total RNA-Seq data generated from developmental 
time points, dissected tissues, and cultured cells. The recursive splicing events were identified by the presence of three 
specific features: 1) a novel splice junction that mapped to an annotated 5’ splice site and an unannotated intronic 
3’ splice site, 2) the presence of the sequence AG/GT at the unannotated 3’ splice site, and 3) a 5’ to 3’ gradient of 
RNA-Seq read intensity indicative of co-transcriptional splicing. We have validated many of these recursive splicing 
events by directed RT-PCR and sequencing. The average size of the intronic segments removed by recursive splicing 
is ~10 kb, and as many as 5 ratchet points have been identified in a single intron. Recursive splicing is detectable in 
all samples in which the host gene is abundantly expressed, indicating that recursive splicing is a constitutive process 
– we observe no evidence that recursive splicing occurs in some tissues or cell types, but not others. The ratchet points 
have a strong consensus sequence and are highly conserved among Drosophila species. We are currently performing 
RNA-Seq experiments in distantly related insects to investigate the functional conservation of recursive splicing. 
Together these results indicate that recursive splicing is commonly used in Drosophila and provides insight into the 
general mechanisms by which long introns are removed.
148 The RNA kinase CLP1 is required for efficient tRNA splicing and regulates p53 activation in 
response to oxidative stress
Stefan Weitzer1, Toshikatsu Hanada1, Barbara Mair1, Josef Penninger1, Javier Martinez2
1IMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, 1030 Vienna, Austria; 
2IMBA Vienna, Dr. Bohr-Gasse 3, A-1030 Vienna, Austria
Both in mammals and archaeabacteria CLP1 proteins have been identified as kinases that phosphorylate 
5’-hydroxyl ends of RNA molecules. Human CLP1 is a component of the mRNA 3’-end cleavage and polyadenylation 
machinery and associates in mammals with the tRNA splicing endonuclease (TSEN) complex. TSEN proteins 
remove an intronic region present within the anticodon loop of numerous pre-tRNAs generating 5’ and 3’ tRNA 
exon halves. Within the TSEN complex, CLP1 has been shown to phosphorylate the 5’-hydroxyl group of 3’tRNA 
exons in vitro, potentially contributing to tRNA splicing in mammals. Here we characterize tRNA metabolism 
in kinase-dead Clp1 (Clp1K/K) mutant mice that contain a point mutation within the ATP binding motif of the 
genomic Clp1 locus. We show that extracts prepared from Clp1K/Kembryonic fibroblasts display reduced TSEN 
cleavage activity, revealing an unexpected role for CLP1 during tRNA exon generation. Affinity purified kinase-dead 
CLP1 containing TSEN complexes were deficient in pre-tRNA cleavage, most likely due to reduced levels of TSEN2, 
TSEN34 and TSEN54 subunits. Thus CLP1 is an integral component of the TSEN complex and ATP binding and/
or hydrolysis is crucial for complex assembly. Interestingly, loss of CLP1 activity causes increased cell death upon 
H2O2 challenge and leads to accumulation of an entirely novel set of small tRNA fragments, comprising 5’ leader 
and 5’ exon sequences derived from aberrant processing of mainly tyrosine pre-tRNA. Overexpression of such tRNA 
fragments results in enhanced p53 activation in response to H2O2 challenge. We thus hypothesize that inactivation of 
CLP1’s kinase activity sensitizes cells to oxidative stress-induced p53 activation and p53-dependent cell death.
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150 Isolated pseudo-RRMs of SR proteins can regulate splicing using a non-canonical mode of 
RNA recognition
Antoine Cléry1, Rahul Sinha2, Olga Anczukow2, Anna Corrionero3, Ahmed Moursy1, Gerrit Daubner1, Juan 
Valcarcel3, Frédéric H.-T. Allain1, Adrian Krainer2
1Institute for Molecular Biology and Biophysics, Swiss Federal Insitute of Technology (ETH), Zürich, 
Switzerland; 2Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA; 3ICREA, Universitat 
Pompeau Fabra and Centre de Regulació Genòmica, Barcelona Spain
SR proteins, one of the major families of alternative-splicing regulators in Eukarya, have two types of RNA-
recognition motifs: a canonical RRM and a pseudo-RRM. Although pseudo-RRMs are crucial for activity of SR 
proteins, their mode of action was unknown. By solving the structure of the human SRSF1 pseudo-RRM bound to 
RNA, we discovered a very unusual and sequence-specific RNA binding mode that is centered on one alpha-helix and 
does not involve the beta-sheet surface of the RRM. Remarkably, this mode of binding is conserved in all pseudo-
RRMs tested. Furthermore, the isolated pseudo-RRM is sufficient to regulate splicing of about half of the SRSF1 
target genes tested, and the bound alpha-helix is a pivotal element for this function. Our results strongly suggest that 
SR proteins with a pseudo-RRM frequently regulate splicing by competing with, rather than recruiting, spliceosome 
components, using solely this unusual RRM.
151 RBM5 OCRE domain modulates alternative splicing regulation by recognition of proline-
rich motifs in spliceosomal SmN/B/B’
Lisa Warner1, André Mourão1, Sophie Bonnal2, Juan Valcárcel3, Michael Sattler1
11) Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany 2) Biomolecular 
NMR and Center for Integrated Protein Science Munich, Department Chemie, TU München, Garching, 
Germany
RBM5 is a putative tumor suppressor gene frequently inactivated in cancers of the lung and other tissues and is 
down-regulated upon oncogenic Ras activation. Its main protein product is a 92 kDa, multi-domain protein that has 
been detected in pre-spliceosomal complexes and modulates cell proliferation and Fas mediated apoptosis. RBM5 was 
identified as a component of complexes involved in 3’ splice site recognition, but contrary to classical mechanisms of 
splicing regulation, RBM5 does not affect early events of splice site recognition that lead to exon definition. Instead, 
RBM5 inhibits the transition between pre-spliceosomal complexes assembled around exons to mature spliceosome 
assembly on the flanking introns. Protein-RNA and protein-protein interactions are important for RBM5 regulation 
of alternative splicing of different target genes. Here, we examine the interaction of individual RBM5 domains with 
protein components of the spliceosome that are important to regulation of Fas exon 6 splicing.
The OCRE (OCtamer REpeat of aromatic residues) domain is important for RBM5 function in vivo and interacts 
with components of the U4/5/6 tri-snRNP. Using NMR spectroscopy, we show that the RBM5 OCRE domain adopts 
a novel β-sheet fold with a hydrophobic surface rich in tyrosine residues that are key determinants both for the 
interaction with protein partners and for splicing regulation in vivo. The structure of a complex of RBM5 OCRE with 
a proline-rich motif (PRM) from the core spliceosomal SmN proteins and mutational analysis reveal that tyrosine 
residues on the hydrophobic surface of OCRE recognize a poly-proline helix, while flanking arginines in the PRM 
define the orientation. Interestingly, OCRE binds to individual proline-rich motifs with mM affinity, but with μΜ 
affinity for the C-terminal tail of SmN, which contains multiple PRM motifs, suggesting avidity effects. Our data 
reveal how protein-protein interactions of the OCRE domain docks RBM5 to spliceosomal core protein for alternative 
splicing regulation.
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152 GSK3-Induced Regulation of the Protein- and RNA-Binding Activity of PSF Modulates 
Signal-Induced Alternative Splicing.
Christopher A Yarosh1, Nicole Martinez1, Jinsong Qiu2, Xiang-dong Fu2, Kristen Lynch1
1Department of Biochemistry and Biophysics, University of Pennsylvania Perelman School of Medicine; 
2Department of Cellular and Molecular Medicine, University of California, San Diego
To maintain viability, virtually all cells in the human body must regulate their function in response to environmental 
stimuli. Such functional regulation requires control of gene expression in a signal dependent manner, including signal-
regulated control of alternative splicing. However the molecular mechanisms by which signaling pathways impinge on 
splicing decisions remain largely unexplored.
We have recently identified hundreds of exons that display differential inclusion in response to antigen-stimulation of T 
cells. The best characterized of these T cell signal-regulated splicing events is the induced skipping of three variable exons 
of the CD45 gene. We have previously shown that signal-responsive repression of the CD45 exons is mediated in large 
part through the activity of the multifunctional RNA-processing protein PSF. PSF binds the exonic silencer elements of the 
CD45 pre-mRNA following T cell activation and favors variable exon exclusion. In resting cells, however, PSF is prevented 
from binding the ESS1 through a protein-protein interaction with TRAP150, which is dependent on phosphorylation of PSF 
at position T687 by the kinase GSK3.
Here we show that the two RNA recognition motifs (RRMs) of PSF are necessary and sufficient for binding to TRAP150. 
This interaction is direct and can be recapitulated with purified bacterial proteins. We further show that the RRMs of PSF 
interact in a mutually exclusive manner with TRAP150 and RNA, providing a mechanism for how TRAP150 blocks the 
function of PSF in the regulation of CD45 splicing. Surprisingly, the RRMs of PSF do not encompass the regulatory T687 
residue, suggesting that phosphorylation of PSF-T687 regulates interaction with TRAP150 indirectly. Interestingly, limited 
proteolysis of PSF reveals a phosphorylation-dependent difference in digestion pattern, suggesting that phosphorylation 
of T687 induces a conformational change in PSF which controls accessibility to TRAP150. Together these data provide a 
unique example of signal-dependent control of an RNA binding protein through allosteric regulation of protein and RNA 
binding. Finally, we show that inhibition of GSK3, which occurs in response to T cell stimulation, is sufficient to account for 
approximately 40% of the alternative splicing events we observe during an antigen response in T cells. Thus we conclude 
that regulation of PSF by GSK3 plays a widespread role in shaping gene expression in T cells during an immune response.
153 Rhythmic U2AF26 alternative splicing regulates the circadian clock in mice
Marco Preussner1, Florian Heyd1
1Philipps-University Marburg, Institute of Molecular Biology and Tumor Research (IMT)
The circadian clock is a cell-autonomous regulator driving daily rhythms in metabolism, behavior and physiology. 
At the molecular level, clock components of interlocking transcriptional feedback loops have been thoroughly 
investigated, whereas the impact of post-transcriptional regulation, especially alternative splicing, remains largely 
unexplored.
Here we describe a splice variant of mouse U2AF26 lacking exons 6 and 7 (U2AF26DE67) whose expression 
is strongly regulated with the circadian clock. Skipping of exons 6 and 7 induces a frameshift, thereby generating 
144 novel C-terminal amino acids with interesting properties: the new C-terminus displays homology to the D. 
melanogaster core clock component Timeless and in addition substantially reduces the half-life of U2AF26DE67 
protein, enabling diurnal expression of this specific isoform. Consistent with a function in regulating the circadian 
clock, we show that U2AF26DE67 interacts with and destabilizes Per1 protein in a cell culture model. To confirm this 
activity in vivo, we have generated U2AF26 deficient mice and analyzed the expression of core clock components at 
different circadian times. In line with our cell culture data, U2AF26 knockout mice display nearly acyclic expression 
of Per1 protein in the liver as well as a reduced and shifted peak of Per1 mRNA both in liver and cerebellum. mRNA 
expression of several other clock components such as Dbp, Npas2, and RevErba also showed a shifted expression 
profile, suggesting a broad circadian phenotype in U2AF26 deficient animals. We are now investigating whether these 
defects in the molecular clock of U2AF26 deficient mice lead to disturbed circadian locomotor activity.
In summary, we introduce U2AF26 as a novel component of the mammalian clock. We provide evidence for a 
circadian alternative splicing switch that directly regulates the expression of a central clock component in mammals. 
In addition, U2AF26 exon 6 and 7 exclusion is an interesting case for a splicing induced frameshift, resulting in 
translation into the 3’UTR to generate a protein with a new C-terminus with novel functions.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Oral Abstracts
Session 6B: Alternative splicing  •   89
155 The SWI/SNF subunit Brahma modulates the choice of alternative terminal exons by 
recruiting the BRCA1/BARD1 ubiquitin ligase
Gabriele Fontana1, Aurora Rigamonti1, Reinaldo Alvarez1, Silvia Lenzken1, Marco Bianchi3, Silvia Barabino2
1Department of Biotechnology and Biosciences, University of Milano-Bicocca Piazza della Scienza 2, 20126, 
Milan, Italy; 2Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della 
Scienza 2, 20126 Milan, Italy; 3Division of Genetics and Cell Biology, San Raffaele Scientific Institute and 
University, 20132 Milan, Italy
The choice of polyadenylation sites located in alternative terminal exons is a widespread phenomenon that 
increases transcript and protein diversity. The choice of alternative poly(A) sites generates different 3’UTRs that can 
affect translation, stability and localization of the mRNA. When coupled to the inclusion of an alternative last exon 
(ALE) alternative polyadenylation leads to the generation of mRNA variants that not only differ in their 3’UTR but 
may also encode proteins with different C-terminal regions. Whereas the molecular details of mRNA polyadenylation 
are rather well known, little is known about the choice between alternative polyadenylation sites.
Brahma (BRM), one of the two alternative ATPase subunits of the human SWI/SNF chromatin-remodeling 
complex, was previously shown to control alternative splicing by slowing down RNA polymerase II.  Here we show 
that the effect of BRM on the selection of ALEs does not involve the modulation of the elongation rate of RNAPII 
but rather implicates a different molecular mechanism. We report that BRM favors the selection of the distal ALE 
by inhibiting 3’ end processing at the proximal poly(A) site.  BRM accumulates on the proximal ALE promoting an 
interaction between the 50 kDa subunit of the 3’ end processing factor CstF and the BARD1/BRCA1 E3 ubiquitin 
ligase. Ubiquitination of CstF50 leads to dissociation of the CstF complex and consequently to the inhibition of 3’ 
end processing. We propose a model in which commitment of the proximal ALE to splicing and 3’ end processing 
would require a reduction of the RNAPII elongation rate. In contrast, selection of the distal ALE would necessarily 
require both a highly elongating polymerase and inhibition of 3’ end processing at the proximal poly(A) site to 
allow transcription to continue past the proximal ALE. This would result in the recruitment of splicing factors on the 
downstream 3’ splice site, resulting in the 3’ end processing complex at the distal poly(A) site and the splicing out of 
the proximal ALE.
154 RNA Binding Protein Sfpq is required for the expression of neuron-specific long pre-
mRNAs essential for brain development.
Akihide Takeuchi1, Kei Iida1, Kensuke Ninomiya1, Mikako Ito2, Kinji Ohno2, Masatoshi Hagiwara1
1Department of Anatomy and Developmental Biology, Kyoto University Graduate School of Medicine; 
2Department of Neurogenetics, Center for Neurological Diseases and Cancer, Nagoya University Graduate 
School of Medicine
Recent methodological advances using microarray, deep-sequencing and biochemical analysis combining 
bioinformatics provide growing evidence for the essential roles of mRNA processing on the neural development. 
The mRNA processing is mediated by the RNA-binding proteins which regulate the expression of many genes co-
transcriptionally or post-transcriptionally through direct interaction with pre-mRNAs. Here we found that RNA-binding 
protein, Sfpq (splicing factor, proline/glutaminerich) plays an essential function in mammalian brain. In embryonic 
mouse brains, Sfpq is specifically expressed in nascent cortical plate neurons after they differentiate and migrate from 
neuronal progenitor cells, suggesting its crucial functions for the development of cerebrocortical neurons. To address 
the in vivo function of Sfpq, we disrupted the Sfpq gene in mice brain. Neuronal tissue specific knockout of Sfpq caused 
apoptosis in neurons and massive loss of brain tissues in the developing brains including neocortex, indicating that 
Sfpq is essential for differentiation or maturation of neurons. Next, we produced a specific antibody against Sfpq, 
and conducted the iCLIP analysis to identify the target of Sfpq in the mouse embryonic neocortex. Distribution of the 
iCLIP tags showed saw-tooth patterns on entire pre-mRNAs of more than 7400 genes with low sequence specificity. 
The density of the tags was highest in 5’ end of introns, and gradually declined to 3’ end. In these large populations 
of Sfpq-binding genes, only specific gene subsets which express long pre-mRNAs were significantly down-regulated 
in the Sfpq-disrupted mice brain. According to the Gene Ontology, these genes have essential functions for the brain 
development, such as cell-adhesion, cell motion, axon guidance, ion channel activity or receptor related molecules, 
and synaptic vesicle transport and related molecules. Our comprehensive transcriptome analysis showed that 17.4% of 
specifically expressed pre-mRNAs exceed 262k in differentiated neurons . These data indicate that the RNA binding 
protein Sfpq is required for the expression of long pre-mRNAs which play essential roles for the survival of neurons, 
especially in the cortical plate at the developmental stages of brain.
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157 B Overexpression of small noncoding RNAs and its effects on biofilm-related phenotypes in 
Escherichia coli
Geunu Bak1, Kwang-sun Kim2, Younghoon Lee1
1Department of Chemistry, KAIST, Daejeon 305-701, Korea; 2Systems and Synthetic Biology Research 
Center, KRIBB, Daejeon 305-806, Korea
It is undoubted that noncoding RNA has been deeply involved in various metabolic pathways in organisms 
ranging from bacteria to mammals many different organisms. Although nearly 100 small noncoding RNAs (sRNAs) 
have been experimentally verified in E. coli, knowledge about their roles has been continuously expanded through 
identification of functions of newly identified sRNAs as well as new roles of previously known sRNAs. Recently, 
roles of sRNAs in bacterial group behavior or pathogenesis have received a great deal of attention. Biofilm, a surface-
bound and self-aggregate structure of bacteria embedded within extracellular polymeric substances, is one of their 
important group behaviors for survival in varying environmental challenges. In this study, a plasmid library expressing 
99 experimentally verified E. coli sRNAs was constructed on IPTG-inducible RNA expression vector pHMB1/2. 
Using this sRNA-expressing library, changes of biofilm related phenotypes upon overexpression of each sRNA were 
examined. Especially flagella-based motility and cell surface appendages were analyzed in details.
156 A Natural antisense transcripts in Neurospora crassa
Yamini Arthanari1, Sam Griffiths-Jones1, Christian Heintzen1, Susan Crosthwaite1
1University of Manchester
Antisense (AS) transcripts have been shown to play an important role in regulating the expression of genes in 
many organisms. Regulation of transcription, transcript splicing, stability and translation by AS transcripts has been 
reported. Here we report the prevalence of cis-AS transcripts in the model organism, Neurospora crassa.
RNA sequencing was performed using ABi SOLiD technology on RNA extracted from cultures grown in constant 
darkness at 25°C or exposed to a light or temperature pulse. The RNASeq reads were mapped to the genome and 
assembled into transfrags. We detected 6771 (~70%) transfrags arising from previously annotated genes that are 
expressed above a threshold level. Those transfrags that were not located close to a previously annotated transcript 
were considered to be novel transcripts. This led to the detection of over 1000 novel transcripts, only 60 of which 
were predicted to have significant coding potential. Further analysis led to the identification of more than 400 
annotated sense/AS pairs and more than 450 novel transcripts that are expressed antisense to annotated genes. 57 
and 34 novel transcripts were found to be differentially expressed in response to light and temperature respectively, 
approximately half of these were novel AS transcripts. The expression of several sense and AS transcripts was 
confirmed by RT-PCR. Hence, this study reveals the prevalence of novel N. crassa noncoding and AS transcripts and 
their expression in different environments.
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159 A TDP-43 regulates cancer-associated microRNAs
Xiaowei Chen1, Zhen Fan5, Mengmeng Chen6, Ruirui Kong5, Pushuai Wen5, Tengfei Xiao5, Warren McGee2, Xiaomin 
Chen4, Jianghong Liu4, Li Zhu4, Runsheng Chen4, Jane Wu3
1IBP, CAS; 2Department of Neurology, Center for Genetic Medicine, Lurie Cancer Center, Northwestern 
University Feinberg School of Medicine, USA; 3IBP, CAS; Northwestern University School of Medicine; 
4Institute of Biophysics, CAS; 5Institute of Biophysics, CAS, China; 6Institute of Biophysics, CAS, China; 
Department of Neurology, Center for Genetic Medicine, Lurie Cancer Center, Northwestern University 
Feinberg School of Medicine, USA
MicroRNAs (miRNAs) play important roles in a wide range of biological processes. Aberrant regulation of 
miRNA genes contributes to human diseases, including cancers. The TAR DNA binding protein 43 (TDP-43), a DNA/
RNA binding protein associated with neurodegeneration, is involved in miRNA biogenesis. Here, we systematically 
examined miRNAs whose expression levels are regulated by TDP-43 using RNA-Seq coupled with siRNA-mediated 
knockdown approach. Candidate TDP-43 targeted miRNAs were validated by quantitative RT-PCR. Some of TDP-43 
regulated miRNAs appear to interact with TDP-43. Alterations in isomiR patterns and miRNA arm selections following 
TDP-43 down-regulation indicated TDP-43 is involved in miRNA editing. We examined correlation of selected TDP-
43 regulated miRNAs and their candidate target genes and their expression patterns in human cancers. Our data show 
that TDP-43 promotes migration of lung cancer cell by regulating expression of TDP-43 target miRNAs. We have 
begun to analyze the correlation of expression of TDP-43 regulated miRNAs with disease outcome. Our experiments 
have also begun to reveal previous unknown miRNA-target gene pairs that may play important roles in cancer and 
other diseases.
158 C Defense against viral attack: single-molecule view on a bacterial adaptive immune system
Timothy Blosser1, Edze R. Westra2, Cees Dekker1, Stan J. J. Brouns2, Chirlmin Joo1
1Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, 
Delft, The Netherlands; 2Laboratory of Microbiology, Department of Agrotechnology and Food Sciences, 
Wageningen University, Dreijenplein 10, 6703 HB Wageningen, The Netherlands
Escherichia coli maintain different strategies to protect the cell against invading foreign DNA. In a recently 
discovered adaptive immune system, fragments of foreign DNA are integrated into specific loci on the bacterial 
genome, known as clustered regularly interspaced short palindromic repeats (CRISPR). Short CRISPR-derived 
RNAs (crRNAs) are incorporated into the CRISPR-associated complex for antiviral defence (Cascade) and guide 
the complex’s search for the DNA of returning invaders, which is targeted for destruction upon binding. Recent 
studies have shown that Cascade must recognize both a short “seed” sequence and an immediately adjacent PAM 
(protospacer adjacent motif) sequence in order for successful targeting of the foreign DNA. The mechanism and 
structural dynamics of this target recognition and binding process, however, are not well understood. Here we report 
a single-molecule FRET (F?rster resonance energy transfer) based assay to monitor in real time the target recognition 
and binding process of Cascade. We find that there is directionality to the base-pairing process between the crRNA and 
the target DNA. Upon binding, pairing occurs first over the seed region and then, after a time lag, proceeds through 
a region further downstream on the target sequence. This suggests a mechanism for target recognition wherein the 
seed/PAM region is identified first, followed by a distinct kinetic intermediate, perhaps a structural transition, before 
subsequent target pairing can occur. Our single-molecule study promises to reveal the mechanism of target DNA 
identification by the CRISPR immune system.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
Non-coding and Regulatory RNAs  •   93
161 C The role of RNA degradation in moderating RNAi
Cristina Cruz1, Jon Houseley1
1Babraham Institute
Endogenous antisense non-coding RNAs could theoretically hybridise to their cognate sense RNA, forming double-
stranded RNAs that are substrates for the Dicer endonuclease. Therefore, antisense transcripts have the potential to 
trigger RNA interference responses (RNAi) that would lead to the degradation of both sense and antisense RNA from 
a locus, providing a potent negative regulatory capability. Although antisense RNAs have been characterised at many 
loci in many organisms, they are generally unstable which would limit entry of sense-antisense pairs into the RNAi 
system. Antisense RNAs are susceptible to various degradation pathways acting in both the nucleus and cytoplasm, 
raising the potential for wide ranging gene expression regulation through control of antisense degradation.
S. cerevisiae does not possess an endogenous RNAi system, but such a system can be reconstituted by introducing 
Argonaute and Dicer from a related yeast species to form an RNAi+ strain [1]. We have tested the efficiency of RNAi 
in these RNAi+ cells for a number of sense-antisense systems in which the antisense RNA is unstable. Stabilisation 
of the MAL32 antisense RNA by nuclear RNA degradation mutants increases the level of siRNAs produced from 
this locus, showing that stabilisation of antisense RNA in the nucleus can alter double stranded RNA formation as 
expected. However, altering cytoplasmic RNA levels by deletion of XRN1has more subtle effects; although levels 
of GAL4 sense and antisense are increased in this mutant, there is no increase in siRNA production. In contrast, 
stabilisation of the PDR3 antisense in the same cells leads to complete degradation of sense and antisense RNA by 
RNAi as predicted.
Our data show that RNA degradation can alter the susceptibility of mRNA to degradation by RNAi. This suggests 
a previously unrecognised role for the RNA degradation machinery in regulating entry of RNA from coding loci into 
the RNAi system. We are currently using high-throughput sequencing to elucidate genome-wide the effects of RNA 
degradation mutants on RNAi.
1. Drinnenberg, I. A. et al. RNAi in budding yeast. Science 326, 544-550 (2009).
160 B An RNA Degradation Machine Sculpted by Ro Autoantigen and Noncoding RNA
Xinguo Chen1, David Taylor3, Casey Fowler2, Soyeong Sim1, Jorge Galan2, Hong-Wei Wang3, Sandra Wolin1
1Department of Cell Biology, Yale University; 2Department of Microbial Pathogenesis, Yale University; 
3Department of Molecular Biophysics and Biochemistry, Yale University
Although the functions of many RNA-protein complexes (RNPs) are well understood, the roles of others are still being 
elucidated. One class whose function remains under investigation is the Ro class of RNPs. The major protein component, 
the ring-shaped Ro 60 kDa autoantigen (Ro60), is present in many animal cells and also in ~5% of sequenced bacterial 
genomes. In all characterized species, Ro60 binds ~100 nt noncoding RNAs (ncRNAs) of unknown function called Y 
RNAs. Because Ro60 also binds misfolded rRNAs and snRNAs in some animal cell nuclei, it is proposed to function 
in ncRNA surveillance. In the only bacterium in which Ro60 has been characterized, Deinococcus radiodurans, the 
ortholog Rsr functions with 3’ to 5’ exoribonucleases during some types of environmental stress. Specifically, Rsr and the 
exoribonucleases RNase II and RNase PH are required for efficient 23S rRNA maturation during heat stress. In addition, Rsr 
and the exoribonuclease polynucleotide phosphorylase (PNPase) are involved in rRNA degradation during stationary phase.
To understand how a Ro60 protein can influence the function of an exoribonuclease, we purified the Rsr/PNPase 
complex from D. radiodurans and examined its composition, molecular architecture and activity. We discovered that Y 
RNA tethers Rsr to PNPase to form an RNA degradation machine. Single particle electron microscopy (EM), followed by 
docking Ro and PNPase atomic structures into the three-dimensional reconstruction, revealed a double ring architecture, 
suggesting that Rsr channels RNA into the PNPase cavity for degradation. Biochemical experiments revealed that Rsr and 
Y RNA specialize PNPase for degrading structured RNA. Specifically, the Rsr/Y RNA/PNPase RNP is more effective 
than PNPase alone in degrading stemloop-containing RNAs, but is less active than PNPase on single-stranded RNA. 
These studies identify a role for Y RNA and also show that ncRNA, by tethering a protein cofactor, can alter the substrate 
specificity of an enzyme.
To determine if the role we identified for Rsr and Y RNA in D. radiodurans could be conserved in other bacteria, we 
examined Salmonella Typhimurium. We found that S. Typhimurium Rsr associates with two novel ncRNAs encoded 3’ 
to rsr. One ncRNA, which we call YrlA, appears to be highly conserved, as potential orthologs are encoded adjacent to the 
Rsr ortholog in more than 100 bacterial genomes. Notably, by performing immunoaffinity experiments in S. Typhimurium, 
followed by glycerol gradient sedimentation, we found that Rsr and YrlA also associate with PNPase in this bacterium. 
Thus, assisting degradation of structured RNAs is likely to be a conserved role of bacterial Ro RNPs.
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163 B The microRNA pathway mediates expression of yolk lipoproteins in the Caenorhabditis 
elegans intestine
Robert Dowen1, Gary Ruvkun1
1Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard 
Medical School, Boston, Massachusetts, USA.
In the nematode Caenorhabditis elegans, yolk lipoproteins (VIT proteins) are synthesized in the hermaphrodite 
intestine, secreted, and internalized by the oocytes where their associated lipids provide nourishment throughout 
embryogenesis [1].  Here, we show that the microRNA (miRNA) pathway is required for proper production of the 
VIT lipoproteins, and consequently, for proper embryonic development.  An expression analysis of the vit genes 
revealed that the miRNA pathway functions upstream of vit transcription.  Moreover, two miRNAs, let-7 and lin-
4, are specifically required for proper endogenous vit gene expression, as well as activation of a GFP-based vit-
2 transcriptional reporter.  Using the vit-2 reporter, we have identified two gene inactivations that suppress the effects 
of a let-7 mutation and partially restore vit-2 gene expression.  These two genes, lin-14 and lin-41, are known targets of 
the let-7 and/or lin-4 miRNAs.  We are currently investigating whether let-7 and lin-4 function within the intestine to 
control vit gene expression, or alternatively, whether they act in surrounding tissues to regulate intestinal development.
1. Kimble J, Sharrock WJ (1983) Tissue-specific synthesis of yolk proteins in Caenorhabditis elegans. Dev Biol 96: 189–196.
162 A The role of non coding RNA at sites of DNA damage in the control of genome integrity
Fabrizio d’Adda di Fagagna1
1IFOM, the FIRC Institute of Molecular Oncology
The DNA damage response (DDR) is a signaling pathway that arrests the proliferation of cells undergoing 
genotoxic events to preserve genome integrity. DICER and DROSHA are crucial ribonucleases involved in RNA 
interference (RNAi). Components of RNAi are thought to have evolved to preserve genome stability from the attacks 
of viruses and mobile genetic elements. RNAi and DDR pathways had not been demonstrated to directly interact.
We have recently shown (Francia et al. Nature 2012) in cultured human and mouse cells and in zebrafish larvae that 
DICER and DROSHA, but not downstream elements of the RNAi pathway, are necessary to activate the DDR upon 
exogenous DNA damage and oncogene-induced genotoxic stress, as studied by DDR foci formation and by DNA-
damage checkpoint assays. DDR foci are sensitive to RNase A treatment, and DICER- and DROSHA-dependent RNA 
products are required to restore DDR foci in RNase-A-treated cells. Through RNA deep sequencing and the study 
of DDR activation at a single inducible DNA double-strand break (DSB), we identified site-specific DICER- and 
DROSHA-dependent small RNAs, named DDRNAs, with the sequence of the DNA surrounding the DSB that are 
required for DDR foci formation. DDRNAs, either chemically synthesized or in vitro generated by DICER cleavage, 
are sufficient to restore the DDR in RNase-A-treated cells, even in the absence of other cellular RNAs. Therefore, 
DDRNAs are a novel class of ncRNAs that play a direct role in the control of DDR activation at sites of DNA damage.
Our progresses in understanding DDRNAs biogenesis and functions will be presented.
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165 A Identification and Analysis of New Genes Targeted for sRNA Regulation in Bacteria
Martha Faner1, Andrew Feig1
1Wayne State University
Many bacteria use trans-encoded sRNAs to respond to environmental conditions. This pathway typically uses 
the RNA-binding protein Hfq to facilitate the identification of target mRNAs and to promote pairing between the 
sRNA and its mRNA partners. This interaction subsequently leads to altered translation or targeted RNA degradation. 
Because trans-sRNAs act by imperfect base pairing they often regulate multiple mRNAs, forming a network of 
regulatory actions. Annotation of sRNAs in bacteria has been extensive but it has been harder to identify and validate 
the direct targets of sRNA regulation.
Guided by knowledge of the motifs found on mRNAs and their common location within mRNA transcripts. We 
have identified a collection of new regulatory circuits. While the methodology for discovering these regulated genes 
still reports some false positives – validation shows that roughly 1/3 of the predicted targets do in fact undergo direct 
regulation when studied with reporter gene constructs.
The discovery of new mRNA targets demonstrates an increased complexity of the sRNA regulatory network 
in bacteria. More importantly, the ability to predict new mRNA targets provides significant benefits for genomes 
beyond E. coli where less is known about the biology of regulatory RNAs and provides a means to rapidly elucidate 
these pathways.
164 C The exosome subunit Rrp6 regulates the expression of retrotransposons and non-coding 
heterochromatic sequences in Drosophila melanogaster
Andrea Brigitte Eberle1, Viktoria Hessle1, Antoni Ganez Zapater1, Gilad Silberberg1, Anne von Euler1, Neus Visa1
1Stockholm University
The exosome is a multiprotein complex with ribonuclease activity that is highly conserved from archaea to 
eukaryotes. The exosome has many functions and acts on many different transcripts, but the mechanisms by which the 
exosome is recruited to its different substrates are not fully understood. We have applied immnoprecipitation and mass 
spectrometry to identify proteins associated with individual exosome subunits in Drosophila melanogaster S2 cells. 
Among the many proteins associated with the catalytic subunit Rrp6, we have found two functionally related factors 
involved in heterochromatin formation: the histone deacetylase Rpd3 and the histone methyltransferase specific 
for H3-Lys9, SuVar3-9. We have also shown that the Heterochromatin Protein 1, HP1a, is associated with Rrp6. 
Moreover, immunofluorescent staining of salivary gland polytene chromosomes revealed that Rrp6 is associated with 
heterochromatic regions of the genome. Knock-down of Rrp6 by RNA interference in Drosophila S2 cells resulted 
in increased levels of both transposon transcripts and non-coding RNAs originated from heterochromatic regions of 
the genome, whereas overexpression of Rrp6 had the opposite effect. Moreover, reduced levels of Rrp6 rendered the 
heterochromatin less compact, as shown by experiments of micrococcal nuclease digestion. Ongoing research aimed 
at understanding the function of Rrp6 in heterochromatin regulation will be presented.
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167 C The RNA subunit of RNase MRP: extra nucleotides at the 3’ end
Katherine Goldfarb1, Elaine Podell1, James Goodrich1, Thomas Cech1
1University of Colorado, Boulder
RNase MRP is a eukaryotic ribonucleoprotein complex with specific endoribonucleolytic activity targeting a 
variety of vital cellular RNAs.   A recent publication proposed a mechanism for regulation of the RNA subunit of MRP 
whereby RMRP RNA is a substrate for RNA dependent RNA polymerase activity when complexed with the protein 
subunit of human telomerase (hTERT)1.  Our follow-up experiments demonstrate that, contrary to the previous report, 
the hTERT active site is not required for extension of RMRP.  Instead, 3’ extension activity is sensitive to alpha-
amanitin and can be observed in vitro with purified RNA polymerase II.  Further, traditional and next generation 
sequencing of RMRP 3’ ends from total RNA of human cells reveals a distribution of terminal extensions from the 
annotated 3’-most nucleotide, including non-genomically encoded sequences.  Sequencing of 3’ ends of other common 
cellular RNAs yields somewhat more homogeneous profiles, notably lacking termini with complex non-genomically 
encoded sequences.  Our current work aims to critically examine whether the in vitro additions recapitulate these 
produced in vivo, and ultimately characterize the significance of those extensions on RMRP function.
1. Maida, Y. et al. An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA. Nature 461, 230-235, 
doi:10.1038/nature08283 (2009).
166 B Novel RNA Structures Controlling RIbosomal Protein Biosynthesis in E. coli and Beyond
Yang Fu1, Michelle Meyer1
1Boston College
The control of ribosomal protein biosynthesis is tightly coordinated in eubacteria. In E. coli there are over 10 
different RNA structures that act to autogenous regulate over half of the ribosomal protein genes. Each of these cis-
regulatory RNAs interacts with a specific ribosomal protein to inhibit transcription or translation of an entire operon 
encoding multiple ribosomal proteins. Despite the important role these RNAs play in regulating the biosynthesis of 
an essential process, our recent work shows that many of them appear to be narrowly distributed to a few groups of 
closely related bacteria. This, in combination with the discovery of several putative RNA structures associated with 
ribosomal protein genes in different phyla of bacteria, suggests that there are numerous RNA structures responsible 
for regulation of ribosomal protein biosynthesis that remain to be discovered.
Using comparative genomics we identified several RNA structures associated with ribosomal protein operons, 
including one that precedes ribosomal protein genes rpsF and rpsR, encoding ribosomal proteins S6 and S18 
respectively. This RNA structure is widely distributed to many bacterial phyla (it is found in both E. coli and B. 
subtilis), and overlaps a potential Shine-Dalgarno sequence in many organisms. Using in vitro assays we confirmed 
that this RNA interacts specifically with S18, and with an S6:S18 dimer suggesting that the RNA is a novel autogenous 
regulatory element responsible for coordinating the levels of ribosomal proteins in bacteria.  This work shows that 
comparative genomic methodologies applied so successfully to identify riboswitch candidates may also be applied to 
the discovery of RNA regulators for ribosomal protein biosynthesis that may have been overlooked using previous 
approaches.
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169 B RNA annealing activity of Hfq is sensitively modulated by various physical parameters
Wonseok Hwang1, Véronique Arluison3, Sungchul Hohng2
1(1) Department of Physics and Astronomy, (2) National Center for Creative Research Initiatives, Seoul 
National University, Seoul 151-747, Korea; 2(1) Department of Physics and Astronomy, (2) Department 
of Biophysics and Chemical Biology, (3) National Center for Creative Research Initiatives, Seoul National 
University, Seoul 151-747, Korea; 3(1) LLB, Commissariat à l’Energie Atomique, CNRS-UMR 12, CEA-
Saclay, Gif-sur-Yvette Cedex F-91191, (2) Université Paris Diderot, Sorbone Paris Cité, France
Bacteria regulate their gene expression level in response to various environmental stresses. One of their regulation 
methods is small non-coding RNAs (sRNA) which acts at the post-transcriptional level by base-paring with their target 
mRNA. For example, E. coli DsrA sRNA is expressed under cold shock and up-regulates RpoS (Sigma-S) transcription 
factor by base-paring with rpoS mRNA. It is well know that this sRNA regulation process requires the RNA chaperone 
Hfq for efficient RNA duplex formation. However, how the RNA annealing activity of Hfq is modulated under varying 
physical parameters due to various environmental stresses is ill-understood. Here we investigate how the annealing 
activity of Hfq is modulated by various physical parameters by using single-molecule FRET assays. We use dye-
labeled synthetic RNA fragments obtained from E. coli DsrA sRNA and from its target mRNA, rpoS. Our results 
show that low temperature increases the annealing efficiency by accelerating Hfq dissociation from DsrA:rpoS:Hfq 
ternary complex. Relative ratio between RNA and protein is also important as an excess Hfq lowers annealing 
efficiency by inhibiting DsrA:rpoS:Hfq ternary complex formation. The concentration of various salts greatly 
influences the annealing efficiency by increasing the turnover number of Hfq. Finally, the molecular crowding, which 
Hfq may encounter in vivo, enhances the annealing efficiency by increasing effective concentration of RNA and Hfq. 
Collectively, our results suggest that the activity of Hfq can be sensitively modulated by various physical parameters 
found in vivo.
168 A Alu RNAs as possible modulators of microRNA function
Daniele Hasler1, Gunter Meister1
1Department of Biochemistry I, University of Regensburg, Germany
Alu elements are the most abundant repetitive elements in the human genome and belong to the class of short 
interspersed elements (SINEs) which are non-autonomous retrotransposons. Approximatively one million copies of 
Alu elements pervaded the genome throughout evolution making up more than 10% of it. They derive from the 7SL 
RNA gene, which encodes the RNA moiety of the signal recognition particle (SRP).
Depending on the site of integration during retrotransposition, Alu elements can be embedded in coding genes and 
are therefore co-transcribed by RNA polymerase II (Pol II). Additionally, Alu elements can be transcribed by RNA 
polymerase III (Pol III), since they have partially retained internal promoter regions.
Under normal conditions free Alu RNAs accumulate at low levels. Their abundance increases dramatically under 
various stress conditions such as heat shock, viral infection, and exposure to toxic agents. Little is known about the 
molecular function of free Alu RNAs. Some studies pointed out that they inhibit transcription by direct interaction 
with Pol II. Other groups reported naked Alu RNAs to have a stimulatory role for protein translation, while Alu RNAs 
bound to protein components of the SRP inhibit initiation of translation.
Recent data suggest that Alu RNA might have direct toxic effects in the pathogenesis of age-related macular 
degeneration, a disease leading to progressive loss of central vision. Here, decreased protein levels of the RNAseIII 
enzyme Dicer (Dcr), which is required for microRNA (miRNA) biogenesis, have been associated with accumulation 
of Alu RNAs while miRNA expression remained unaffected. The authors claimed for a direct role of Dcr in the 
degradation of Alu RNAs. Our study aims to determine if Alu RNAs are in fact degraded or processed to small RNAs 
by Dcr and if a crosstalk between Alu RNA expression and the miRNA regulatory pathway exists.
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171 A A tandem-stem RNA motif mediates X-chromosome dosage compensation in Drosophila
Ibrahim Avsar Ilik1, Jeffrey J. Quinn3, Filipe Tavares-Cadete2, Plamen Georgiev1, Yue Wan3, Robert C. Spitale3, 
Nicholas Luscombe2, Howard Y. Chang3, Asifa Akhtar1
1Max-Planck Institute of Immunobiology and Epigenetics; 2EMBL European Bioinformatics Institute; 
3Howard Hughes Medical Institute and Program in Epithelial Biology, Stanford University School of Medicine
Long non-coding RNAs (lncRNAs) are emerging as important regulators of chromatin state and transcription in eukaryotic 
cells. They contribute to the regulation of single genes or whole chromosomes and can influence the 3-D structure of large genomic 
regions. Due to their length, which typically is in the range of kilobases, it is difficult to determine functional domains in these 
lncRNAs and therefore understand their exact contributions to transcriptional regulation. A prime example of lncRNAs regulating 
chromosome-wide gene expression is X-chromosomal dosage compensation. Sexually dimorphic organisms often correct for 
the unequal distribution of sex chromosomes in males and females in order to have a balanced gene expression between the sex 
chromosomes and the autosomes. This process, called X-chromosomal dosage compensation, requires the action of lncRNAs 
all the way from Humans to Drosophila. Interestingly though, the underlying mechanisms lie at the two opposing ends of the 
transcriptional spectrum: In humans Xist lncRNA (~17kb) plays a central role in repressing one of the two X-chromosomes in 
females; whereas in Drosophila, two redundant lncRNAs, roX1 (~3.7kb) and roX2 (~0.6kb) are necessary for the transcriptional 
up-regulation of the single X-chromosome in male flies. Dosage compensation in Drosophila is mediated by the Male-Specific 
Lethal (MSL) complex, which together with roX lncRNAs coats the male X chromosome and acetylates histone H4 lysine 16. 
Genetic evidence suggests that roX RNAs are particularly important for targeting the MSL complex to the X-chromosome, 
however, biochemical data detailing roX RNA – MSL complex interactions and how targeting of the MSL complex specifically 
to the X-chromosome can be aided by roX RNAs has been lacking.
Here, by using UV cross-linking followed by deep sequencing we show that two enzymes in the MSL complex, MLE 
RNA helicase and MSL2 ubiquitin ligase, bind evolutionarily conserved domains containing tandem stem-loops in roX1 and 
roX2 RNAs in vivo. These domains constitute the minimal RNA unit present in multiple copies in diverse arrangements for 
nucleation of the MSL complex. MLE binding to these domains is bimodal with distinct ATP-independent and ATP-dependent 
behavior. Importantly, we show that cooperative interaction of the different roX RNA domains is essential because combinatorial 
but not single mutations result in loss of dosage compensation and consequently male-specific lethality. Our study reveals 
that repetitive structural motifs in lncRNAs provide plasticity during multi-protein complex assembly to ensure efficient 
spreading in cis or trans along chromosomes.
170 C Identification of stage specific microRNAs during the developmental stages in Triops 
cancriformis (tadpole shrimp)
Kahori Ikeda1, Yuka Hirose1, Kiriko Hiraoka1, Emiko Noro1, Kosuke Fujishima2, Masaru Tomita1, Akio Kanai1
1Institute for Advanced Biosciences, Keio University, Tsuruoka 997-0017, Japan; 2NASA Ames Research 
Center, Moffett field, CA 94043
microRNAs (miRNAs) are approximately 22 nucleotide non-coding RNAs that regulate gene expression 
at the post-transcriptional level, and play important roles in the cellular processes such as development and cell 
differentiation. Although many miRNAs are identified and analyzed in various model species during their development, 
it is unclear whether the miRNA functions are conserved among species or not. Here we focused on non-traditional 
model species Triops cancriformis, which is known as a “living fossil”. T. cancriformis changes their morphology 
dramatically during the early larval developmetal stages. It was hypothesized that miRNA expression also dramatically 
changes in accordance with the morphological changes.
We first constructed small RNA libraries from six different stages of T. cancriformis development (egg, 1st to 
4th instar larvae and adult). Deep sequencing analysis of these libraries resulted approximately 47 million reads. In 
parallel, we also performed deep sequencing analysis on genomic DNA that provided approximately 133 million 
reads. Bioinformatics analysis have shown 73 conserved miRNA sequences in T. cancriformisby using known 
miRNAs in other species registered in miRBase. It was confirmed that these 73 candidates were encoded on genomic 
DNA sequences and able to form a secondary structure of precursor miRNAs. Among these miRNA candidates, the 
expressions of eight T. cancriformis miRNAs were detected by northern blotting analysis among six developmental 
stages. We compared miRNA expression patterns of T. cancriformis with those of D. melanogaster reported from 
previous studies. As a result, T. cancriformis tcf-let-7 showed conserved expression profiles, whereas tcf-miR-87 
showed different patterns. While tcf-miR-87 is strongly expressed in adult stage, D. melanogaster dme-miR-87 is 
detected in egg, 1st instar, 2nd instar, pupa, and adult stages. The inconsistency in the expression profile of conserved 
miRNAs suggest that these miRNAs may play different roles during development in each species, although they 
possess very similar sequences. The relationships between dynamic morphological changes and the miRNA expression 
pattern during the development will be discussed.
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172 B Long ncRNA NEAT1-dependent SFPQ relocation between nuclear body paraspeckle and 
gene promoter region mediates the transcription of IL8 gene in immune response
Katsutoshi Imamura1, Gen Akizuki7, Naoto Imamachi7, Michiko Kumakura2, Atsushi Kawaguchi2, Kyosuke 
Nagata2, Akihisa Kato4, Yasushi Kawaguchi4, Hiroki Sato5, Misako Yoneda5, Chieko Kai5, Tetsushi Yada3, Shinichi 
Nakagawa8, Kiyomi Kaneki6, Kenji Inoue6, Tatsuhiko Kodama6, Youichiro Wada6, Kazuhisa Sekimizu1, Nobuyoshi 
Akimitsu7
1Laboratory of Microbiology, Graduate School of Pharmaceutical Sciences, University of Tokyo, Tokyo, 
Japan; 2Department of Infection Biology, Faculty of Medicine & Graduate School of Comprehensive Hyman 
Sciences, University of Tsukuba, Tsukuba, Japan; 3Department of Intelligence Science and Technology, 
Graduate School of Informatics, Kyoto University, Kyoto, Japan; 4Division of Molecular Virology, 
Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, 
Tokyo, Japan; 5International Research Center for Infectious Diseases, The Institute of Medical Science, The 
University of Tokyo, Tokyo, Japan; 6Laboratory for Systems Biology and Medicine, Research Center for 
Advanced Science and Technology, University of Tokyo, Tokyo, Japan; 7Radioisotope Center, The University 
of Tokyo, Tokyo, Japan; 8RNA Biology Laboratory, RIKEN Advanced Research Institute, Saitama, Japan
Whole transcriptome analyses have revealed that novel classes of non-protein-coding transcripts, designated long 
noncoding RNAs (lncRNAs), were transcribed from mammalian genome. As the ratio of non-coding to protein-
coding genomic regions increased as a function of developmental complexity, it has been assumed that the roles of 
lncRNAs transcribed from non-coding genomic regions are important to understand the genome function in higher 
organisms. NEAT1, a nuclear lncRNA, is essential for the formation of paraspeckle, one of  nuclear bodies. NEAT1 
consists two isoforms, 3.7-kb NEAT1v1 and 23-kb NEAT1v2, and the ratio between NEAT1v1 and NEAT1v2 are 
regulated by alternative 3’-end processing. NEAT1v2 but not NEAT1v1 is potent for the formation of paraspeckle, 
where NEAT1v2 interacts with splicing factor, proline/glutamine-rich (SFPQ) protein. However, the function of 
paraspeckles and NEAT1v2 are largely unknown.
We found that the levels of NEAT1v2 and IL8 mRNA were raised by poly I:C transfection. Poly I:C transfection 
induced excessive formation of paraspeckles without altered expression level of SFPQ. NEAT1 knock down decreased 
polyI:C-induced IL8 mRNA level. Conversely, solo overexpression of NEAT1v2 increased IL8 mRNA level and 
excessive formation of paraspeckles.  These results suggest that NEAT1v2 regulates the expression of IL8 mRNA 
under polyI:C stimulation. Next, we investigated the mechanism how NEAT1v2 regulates IL8 mRNA expression. 
SFPQ knock down increased the IL8 promoter activity as well as IL8 mRNA level, demonstrating that SFPQ repressed 
the transcription of IL8 mRNA.  To test whether SFPQ directly binds the promoter region of IL8 or not, we performed 
chromatin immunoprecipitation. Quantitative PCR analysis of the purified immunoprecipitated DNA binding with 
endogenous SFPQ showed that SFPQ bound the IL8 promoter region in naive cells. In addition, either poly I:C 
stimulation or solo overexpression of NEAT1v2 decreased binding of SFPQ on the IL8 promoter. Finally, we tested 
whether virus infection induced up-regulation of NEAT1v2. Influenza virus or herpes simplex virus 1(HSV-1) but 
not measles virus infection induced NEAT1v2. We confirmed that HSV-1 infection induced excessive formation of 
paraspeckles. These findings suggested that viral infection increases NEAT1v2 transcription and induces excessive 
formation of paraspeckles where SFPQ is relocated from promoter region of IL8, consequently, up-regulates IL8. We 
propose that paraspeckles function as a “molecular absorber” of paraspeckle proteins to regulate gene expression in 
response to stimuli.
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174 A Circular RNAs are Abundant, Conserved and Linked to ALU Repeats
William Jeck1, Jessica Sorrentino5, Michael Slevin6, Zefeng Wang4, William Marzluff2, Norman Sharpless3
1University of North Carolina School of Medicine; 2University of North Carolina School of Medicine, 
Department of Biochemsitry and Biophysics and Program in Molecular Biology and Biotechnology; 
3University of North Carolina School of Medicine, Department of Genetics, Department of Medicine, and 
Curriculum in Toxicology; 4University of North Carolina School of Medicine, Department of Pharmacology; 
5University of North Carolina School of Medicine, Curriculum in Toxicology; 6University of North Carolina 
School of Medicine, Department of Biochemistry and Biophysics
Formerly thought to be errors of splicing, endogenous circular RNAs have recently been shown by our group 
and other to be abundant and conserved.  While circular RNAs have been identified by bioinformatic analysis, we 
sought to directly identify circular RNAs through an unbiased biochemical approach.  Toward that end, we performed 
high-throughput sequencing (RNA-seq) on libraries derived from human and murine cells prepared from ribosome-
depleted total RNA with or without digestion with RNA exonuclease. We identified >25,000 circular RNA species in 
human fibroblasts.  Circular RNAs were usually composed entirely of exonic sequence.  These exonic, circular RNAs 
(ecricRNAs) were identified by the presence of non-colinear exons (a “backsplice”) and enrichment by exonuclease 
treatment.  These species were validated as circular through biochemical approaches, and were considerably more 
stable than associated linear mRNAs.  Expression of ecircRNAs ranged from very rare to highly abundant, with circular 
molecules exceeding the number of linear mRNA molecules by >10-fold for some transcripts.   We did not identify 
ecircRNAs associated with ribosomes.  Application of this method to murine testis RNA identified 69 ecircRNAs in 
precisely orthologous locations to human circular RNAs.  We identified paralogous kinases, HIPK2 and HIPK3, that 
produce abundant ecircRNA from their second, AUG-containing exon in both humans and mice. We noted degradation 
of circular RNAs by siRNAs, suggesting these species regulate gene expression by acting as competing endogenous 
RNAs. Analysis of backsplice sites utilized by ecircRNAs revealed shared features of circularized exons, including 
long bordering introns often containing complementary ALU repeats. EcircRNAs identified by this method were 
expressed in human cancer, with differential expression among tumor types.  These data show that ecircRNAs are 
abundant, stable, and conserved products of RNA splicing that appear to regulate gene expression.
173 C A Natural Antisense Transcript is Involved in the Destabilization of Cyclooxygenase 2 
mRNA by Acetaminophen
Hiroyuki Inaba1, Emi Yoshigai3, Keikichi Sugiyama4, Hoyoku Nishino5, Mikio Nishizawa2
1Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University; Life science research 
laboratories, Research & Development headquarters, Lion corporation; 2Department of Biomedical Sciences, 
College of Life Sciences, Ritsumeikan University; 3Department of Biomedical Sciences, College of Life 
Sciences, Ritsumeikan University; Ritsumeikan Global Innovation Research Organization, Ritsumeikan 
University; 4Research & Development Headquarters, Lion Corporation; 5Ritsumeikan Global Innovation 
Research Organization, Ritsumeikan University; Department of Biochemistry, Kyoto Prefectural University 
of Medicine
Acetaminophen is a popular antipyretic and analgesic drug. Acetaminophen has a low incidence of adverse effects, 
when compared with non-steroidal anti-inflammatory drugs (NSAIDs), which inhibit cyclooxygenase 2 (COX-2), the 
key enzyme in the biosynthesis of the inflammatory mediator prostaglandin. Because the mechanisms of action of 
acetaminophen are not fully understood, we sought to clarify the mechanism how acetaminophen affected the COX-2 
expression. Similar to aspirin, a typical NSAID, acetaminophen reduced the levels of COX-2 protein and its mRNA 
in mouse macrophages treated with lipopolysaccharide (LPS). Acetaminophen suppressed the promoter activity of 
the Cox-2 gene in the LPS-treated macrophages. We found that a natural antisense transcript (asRNA) was transcribed 
from the Cox-2 gene in response to LPS, similar to the gene for inducible nitric oxide synthase, which produces 
another inflammatory mediator nitric oxide. The overexpression of COX-2 asRNA increased the expression of COX-2 
mRNA. When we examined whether COX-2 asRNA modified the stability of COX-2 mRNA by reporter gene assays, 
acetaminophen canceled the effect of COX-2 asRNA and destabilized COX-2 mRNA. Our data suggest a possibility 
that COX-2 asRNA is a novel target of acetaminophen and a potent therapeutic target.
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176 C Evf2 (Dlx6AS) long non-coding RNA regulation of interneuron gene expression and 
behavior
Jhumku Kohtz1, Hao Luo1, Sean Chen1, Shari Birnbaum2
1Department of Pediatrics, Feinberg School of Medicine, Northwestern University, and Developmental 
Biology, Lurie Children’s Research Center, 2430 N. Halsted, Chicago, IL 60614; 2Dept. Psychiatry, University 
of Texas, Southwestern, 5323 Harry Hines Blvd, Dallas, TX 75390-9070
The role of anti-sense (AS) gene regulation in controlling neural circuits and complex behavior are poorly 
understood.  We previously showed that Evf2 (Dlx6AS) long non-coding RNA (lncRNA) represses Dlx6 in embryonic 
brain, affecting circuitry in adult  hippocampus. However, behavioral effects of Evf2 loss in mice are not known. A 
battery of behavioral tests reveals that mice lacking Evf2 have reduced immobility in the forced swim test (FST), showing 
altered response to acute stress. Evf2 mutant mice behave normally in learning, motor, anxiety, and social interaction 
tests.  Interneuron genetic fate-mapping analysis indicates significant loss of interneurons in Evf2 mutant adult brain. 
However, calcium binding protein expression is dramatically increased in remaining Evf2 mutant interneurons.  Thus, 
elevated calcium binding proteins in Evf2 mutants are likely to be responsible for  normal responses in many of the 
behavioral assays, as well as reduced immobility in FST.   Truncation of Evf2 that retains anti-sense Dlx6 transcription 
does not affect Dlx6 expression or FST immobility times.  Together, these data indicate that loss of Evf2(Dlx6AS) 
anti-sense gene regulation can affect interneuron number and subtype, with behavioral consequences in adult  mice.
175 B Recognition of brain cytoplasmic 200 RNA by a human anti-RNA antibody
Euihan Jung1, Jungmin Lee1, Hyo Jeong Hong2, Insoo Park3, Younghoon Lee1
1Department of Chemistry, KAIST, Daejeon 305-701, Korea; 2Department of Systems Immunology, College 
of Biomedical Science, Kangwon National University, Chuncheon 200-701, Korea; 3Molecular Imaging & 
Therapy Branch, National Cancer Center, Goyang-si 410-769, Korea
It is known that diverse functional RNAs participate in a wide range of cellular processes. RNA structure plays an 
important role in their functions by themselves and as complex forms with proteins or ligands. Therefore, monitoring 
RNA conformation in the cell is essential for understanding their functional mechanisms, but any appropriate method 
is not established yet. Although hybridization is a general method used for analyzing specific RNA molecules through 
their base complementarity, it would be difficult to apply for monitoring RNA conformation because the hybridization 
requires partially denatured conditions, which could disturb their structural integrity. In the current study, we 
developed an efficient strategy for screening human monoclonal antibodies binding to RNA from a naïve antigen 
binding fragment (Fab) combinatorial phage library, using brain cytoplasmic 200 (BC200) RNA as a bait. BC200 
RNA is a neuron-specific non-coding RNA that operates as a translational modulator, implicated in the inhibition of 
local synaptodendritic protein synthesis, in human cells. The neuron-specific BC200 RNA has been reported to be 
also expressed at high levels in invasive carcinomas than benign tumors of the breast. We biopanned a large human 
Fab combinatorial phage library (5x1011 recombinants), and isolated two antibodies that recognize BC200 RNA, and 
one of them was selected for further affinity maturation by modifying residues in LCDR3. The best binding antibody, 
MabBC200-A3, binds specifically to the two regions of BC200 RNA (residues 76 to 85 and 96 to 104) with dissociation 
constant of about 7 nM. In the secondary structure model, the two regions were separated by approximately one-half 
helix-turn so that they could be placed in the same surface for interaction with the antibody. Various breast cancer cell 
lines were examined for their BC200 RNA expression using conventional hybridization, and BC200 RNAs expressed 
in those cells were analyzed with MabBC200-A3. MabBC200-A3 discriminates BC200 RNA from homologous 7SL 
RNA in purified total cellular RNA. The amount of BC200 RNA recognized by MabBC200-A3 in the purified total 
RNA pool was proportional to the cellular level of BC200 RNA, but the amount of antibody-recognizable BC200 
RNA in the cell was not, suggesting that BC200 RNA can exist in distinct states in the cell. Our data show that anti-
RNA antibody can provide a novel tool for RNA-detecting and analyzing that hybridization cannot provide.
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178 B Roles for roX RNA and the RNA helicase MLE in the assembly of the dosage compensation 
complex in Drosophila
Sylvain Maenner1, Marisa Müller1, Jonathan Fröhlich1, Diana Langer2, Peter B. Becker1
1Biomedical Center, Ludwig-Maximilians University, Munich, Germany; 2IGBMC, Strasbourg, France
Dosage compensation in Drosophila melanogaster involves the transcriptional activation of genes on the single 
male X chromosome to match their expression levels to those in females, where both X chromosomes are transcribed.
The regulatory dosage compensation complex (MSL-DCC) consists of five so-called male-specific lethal (MSL) 
proteins and two long, non-coding RNA, roX1 and roX2, whose function is enigmatic. RNA helicase maleless (MLE) 
is among the MSL subunits. It is crucial for dosage compensation, but its role remains unclear. Due to its unwinding 
activity and its multiple RNA-binding domains, MLE is well suited to play a key role inroX functionality and may be 
involved in regulating the association of roX with the MSL components. Up to now, biochemical analyses had found 
that MLE associates only weakly with the other MSL proteins in nuclear extracts and in vitro binding studies failed to 
reveal any specific interaction of MLE with roX RNA.
We report on the results of our recent efforts to characterize the interactions of MLE with roX RNA, combining 
by RNA pull-down assays, RNA 2D structure analysis and footprint experiments.  We found that MLE is able to 
recognize specific aspects of roX RNA and to change its 2D structure to form that is competent to initiate MSL 
assembly. Our data strongly suggest that the ATP-dependent remodeling of roX RNA by MLE may be rate limiting 
for MSL-DCC assembly.
177 A The double stranded RNA transcriptome of E. coli reveals novel antisense RNAs
Meghan Lybecker1, Bob Zimmermann1, Ivana Bilusic1, Nadia Tukhtubaeva1, Renee Schroeder1
1Department of Biochemistry and Molecular Cell Biology; Max F. Perutz Laboratories, University of Vienna. 
Dr. Bohrgasse 9/5; 1030 Vienna Austria
Antisense RNAs are transcribed from the DNA strand opposite another gene and have perfect complementarity 
to the corresponding sense mRNA.  Advances in high-throughput transcriptome analyses have revealed hundreds of 
antisense RNAs for many bacteria, although few have been characterized, and the number of functional antisense 
RNA remains unknown.  We developed a method to identify potentially functional antisense RNAs in Escherichia 
coli.  Most mechanisms of regulation via antisense RNAs require a RNA/RNA interaction with its target RNA.  We 
hypothesized that a functional antisense RNA would be found in a double stranded RNA (dsRNA), duplexed with 
its cognate mRNA in a single cell.  Therefore, we developed a method of enriching dsRNAs from total RNA by 
immunoprecipitating with a monoclonal antibody specific for dsRNA.  Total RNA and dsRNA fractions from RNase 
III wild-type and mutant strains were converted to cDNA libraries, deep sequenced and many novel, potentially 
functional antisense RNAs were identified.  The sense strand of many newly identified dsRNAs are known, functional 
sRNAs including: DsrA, Spot42, MicA, MicM, CyaR, ArcZ, MgrR and RydC.  In addition, we identified many 
asRNAs encoded opposite of 5’ ends of mRNAs and gene junctions of operons. Northern blot analyses have confirmed 
the presence of over 20 of the novel antisense RNAs and functional and mechanistic characterization is underway.
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180 A MiR-19 and miR-155 role in oncogene-induced senescence bypass
Lian Mignacca1, Emmanuelle Saint-Germain1, Gerardo Ferbeyre2
1Université de Montréal; 2Université de Montréal, Département de biochimie
Cancer establishment and progression is a multi-step process that requires various concerted modifications. 
Fortunately, cells have evolved many different mechanisms to counteract tumorigenesis. Oncogene-induced senescence 
(OIS) is one of these mechanisms and it has been shown to be triggered early on in tumorigenesis. Its establishment is 
mainly carried through the activation of two important tumor suppressor pathways: the p53/p21 pathway and the p16/
RB pathway. Thus in cancer progression, key players in these pathways must be altered in order to bypass this barrier.
Leukemia is often characterized by an over-expression of STAT5A. The latter is known to induce sets of genes 
that are antagonistic leading to either cell proliferation or senescence. Accumulating reports also provide evidence 
that microRNAs (miRNAs) are upregulated in various leukemias suggesting an oncogenic role for these. We propose 
that normal STAT5 signaling includes the regulation of the tumor suppressor SOCS1 that prevents uncontrolled cell 
proliferation and triggers senescence in part by regulating p53. We think that during leukemia, constitutively active 
STAT5A induces the oncomirs (oncogenic miRNAs) miR-19 and miR-155 resulting in down-regulation of SOCS1 by 
the miRNAs and subsequent bypass of the oncogene-induced senescence.
In order to study the role of the oncomirs in leukemia we used microRNA sponges that inhibit miRNA activity 
by titrating their levels. Our results show that sponges against miR-19 or miR-155 stabilized SOCS1 and enhanced 
p53 activation as shown by measuring p53 phosphorylation at serine 15 and its transcriptional target p21. Although 
the development of therapeutics to induce miRNA down-regulation is currently underway, or work suggests that 
inhibition if miR-19 and miR-155 can reactivate endogenous tumor suppressors in leukemia.
179 C Molecular Mechanism Involved in Antisense-Mediated Transcriptional PHO84 Gene 
Silencing
Andrea Maffioletti1, Nissrine Beyrouthy1, Francoise Stutz2
1University of Geneve; 2University of Geneve, Department of Cell Biology
The development of new technologies such as tiling arrays and RNA-seq has revealed that eukaryotic genomes 
are extensively transcribed. In Saccharomyces cerevisiae a class of non-coding transcripts produced by RNA pol 
II, called “cryptic unstable transcripts” (CUTs), is stabilized upon deletion of the nuclear exosome subunit Rrp6(1). 
Whether this broad and unstable transcriptome has a regulatory role in gene expression is still unclear.
It has been previously shown that the PHO84 gene is transcriptionally regulated by an antisense RNA that 
accumulates upon deletion of Rrp6, causing the recruitment of the histone deacetylase complex Hda1/2/3 which leads 
to the transcriptional repression of the PHO84 gene(2).
A genetic screen aimed at further characterizing this mechanism has identified new factors that could be involved in 
antisense RNA-mediated silencing of the PHO84 gene. Among those is the histone chaperone complex Hir, originally 
described as a key factor in the regulation of the histone gene expression during the cell cycle. However, more recent 
data support the idea of a possible global requirement of this complex in chromatin remodeling (3). Our aim is to better 
characterize the role of this complex in the regulation of the PHO84 gene in the absence of Rrp6. We hypothesize 
that antisense RNA production may facilitate the recruitment of the Hir complex to the PHO84 gene promoter and 
contribute to its silencing.
1. Neil et al., Nature, (2009):1038-1042
2. J.Camblong, et al., Cell. (2007):706-717
3. Fillingham J,et al., Mol. Cell. (2009): 340-51
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182 C Revealing the elusive molecular biology of the vault RNA
Birgit Nachbauer1, Melanie Amort3, Aloys Schepers2, Arnd Kieser2, Norbert Polacek4
1Innsbruck Biocenter, Division of Genomics and RNomics, Innsbruck Medical University, Innsbruck, 
Austria; University of Bern, Department of Chemistry and Biochemistry, Switzerland; 2Helmholtz Zentrum 
München, German Research Center for Environmental Health (GmbH), Department of Gene Vectors, 
Munich, Germany; 3Innsbruck Biocenter, Division of Genomics and RNomics, Innsbruck Medical University, 
Innsbruck, Austria; 4University of Bern, Department of Chemistry and Biochemistry, Switzerland; Innsbruck 
Biocenter, Division of Genomics and RNomics, Innsbruck Medical University, Innsbruck, Austria
Recently several novel and previously reported non-protein-coding RNAs (ncRNAs) have been identified to be upregulated 
upon Epstein-Barr virus (EBV) infection in human B-lymphocytes. A group of these significantly upregulated ncRNAs are 
called vault RNAs (vtRNAs).a,b Only about 5% of the total cellular vtRNAs are connected to the vault particle, the largest 
known ribonucleoprotein particle (RNP) in eukaryotic cells. However the function of this ncRNA family and moreover of the 
vault particle remains still rather unclear. Our previous findings suggest a link between EBV infection and vtRNA expression. 
Consequently we are interested which part of the viral genome is responsible for the upregulation and moreover which function 
the vtRNAs might possess during virus propagation. 
To address this question we have separately overexpressed specific EBV-encoded, latently expressed proteins in BL2-cells 
to determine the influence on the vault RNA levels. Thereby we identified one EBV-encoded protein, called Latent Membrane 
Protein 1 (LMP1), which significantly contributes to the vtRNA upregulation. We used LMP1 mutants to characterize the region 
of the protein and the responsible pathway for triggering the elevated vtRNA expression. Our results suggest that the NFkB- 
pathway might be involved in this process. To investigate a possible functional connection between the vtRNA and EBV infection, 
we have overexpressed vtRNA1-1 in BL41, a cell line usually not expressing this vault RNA. We show that overexpression of 
vtRNA1-1 leads to a better viral establishment and markedly protects cells from undergoing apoptosis. Knock-down of the major 
vault protein, the main component of the vault particle, had no effect on EBV infection and apoptosis resistance. Thus these results 
support the view that the observed phenotype is caused by the vtRNA rather than the vault particle.
a Mrázek, J., Kreutmayer, S.B., Grässer, F.A., Polacek, N., Hüttenhofer, A. (2007) Substrative hybridization identifies novel 
differentially expressed ncRNA species in EBV-infected human B cells. Nucleic Acids Res. 35,e73.
b Nandy C., Mrázek, J., Stoiber H., Grässer F.A., Hüttenhofer A., Polacek N. (2009) Epstein-barr virus- induced expression 
of a novel human vault RNA. J Mol Biol. 388 (4)
181 B Fission yeast Cactin silences chromosome ends and retrotransposons and links 
heterochromatin establishment to telomere length regulation
Martin Moravec1, Luca E Lorenzi1, Amadou Bah1, Harry Wischnewski1, Marco Santagostino1, Claus M Azzalin1
1Institute of Biochemistry, ETH Zürich, Zürich, CH-8093, Switzerland
Eukaryotic telomeres are transcribed by RNA polymerase II into diverse long non-coding RNA (ncRNA) molecules 
forming the telomeric transcriptome. Among these ncRNA species, telomeric repeat-containing RNA (TERRA) is 
conserved in eukaryotes and remains associated to telomeres post-transcriptionally, suggesting that TERRA is an 
evolutionarily conserved integral component of telomeric heterochromatin. Still, the functions and the mechanisms 
of regulation of the telomeric transcriptome remain enigmatic. We have screened a complete Schizosaccharomyces 
pombe gene-deletion collection and identified several mutants with increased TERRA cellular levels. One of these strains 
is deleted for the gene encoding ‘Fission yeast Cactin-like protein 1’ (Fyc1), the S. pombe member of the eukaryotic 
Cactin protein family, which comprises poorly characterized polypeptides possibly involved in cell cycle progression 
and cell growth. Consistently, fyc1Δ yeasts grow slower compared to wild type counterparts and are sensitive to a cold 
environment. Fyc1 binds telomeric and subtelomeric sequences at low levels in vivo, and fyc1Δ mutants accumulate 
subtelomeric and telomeric RNA and fail to silence subtelomeric reporter genes. Thus, Fyc1 is necessary to silence 
chromosome ends and to establish telomere position effect. In absence of Fyc1, telomere elongation by telomerase is 
exaggerated and the telomeric G-overhang is longer, suggesting that telomere transcription may stimulate telomerase-
mediated telomere elongation. Intriguingly, cells deleted for fyc1+ also accumulate RNA deriving from all Tf2 
retrotransposons and numerous solo LTR elements scattered throughout the genome, implying that Fyc1 promotes 
concomitant silencing of telomeres and elements of retroviral origin. Mechanistically, Fyc1 sustains establishment of 
heterochromatin at telomeres and retrotransposon-containing loci by restricting the levels of acetylated histone H3 at 
lysine 9 (H3K9) and, conversely, promoting accumulation of trimethylated H3K9. Our findings reveal that Fyc1 is a 
novel regulator of telomeric heterochromatin establishment and telomere length maintenance, and link silencing of 
telomeres and retrotransposons. We are investigating whether and to what extent the different phenotypes observed 
in fyc1Δ cells are causally linked.
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184 B Malignant Transformation Changes Packaging and Targeting of Extracellular MicroRNAs
Jaime Palma1, William Pearse1, Mallory Havens2, Michelle Hastings2, Dominik Duelli1
1Department of Cellular and Molecular Pharmacology, The Chicago Medical School at Rosalind Franklin 
University, North Chicago, IL, 60064 USA; 2Department of Cell Biology, The Chicago Medical School at 
Rosalind Franklin University, North Chicago, IL, 60064 USA
Cells regulate each other remotely in many ways. An emerging mechanism is the exchange of microRNA 
(miRNA) packaged into membrane-coated vesicles. We reported that several cellular processes associated with 
malignant transformation change the export of extracellular miRNAs (ex-miRs) by affecting whether a particular 
miRNA species is released selectively or retained by the cell. We here describe the basis of selective ex-miR release 
and transfer to target cells.
We show that ex-miRs are packaged mutually exclusively in different carriers released from breast cancer cells. 
miR-451, which is selectively released from transformed cells associates with exosomes, miR-1246 with nucleosomes, 
and neutrally released miR-16 associates with unconventional “L-“ exosomes. In contrast, normal cells release these 
ex-miRs in a single type of vesicle. Stresses upon the donor cells, including DNA damage, affect the export of miR-
16. We further demonstrate that uptake of ex-miRs and its consequences are cell-type and carrier-type specific. For 
example, T-cells accumulate ex-miR-16 and ex-miR-451, while megakaryocytes internalize miR-16 but not miR-451. 
The received miR-16 represses BCL2 in T-cells, triggering apoptosis, but causes cell cycle arrest in megakaryocytes. 
Finally, monocytes do not acquire miR-16 or miR-451 from the extracellular environment, and the cells differentiate.
Malignant transformation induces de novo extracellular vesicles, into which some ex-miRs are assorted mutually 
exclusively. This separation is key in determining the cell-type specific delivery of extravesicular cargo, and can 
explain how ex-miRs can simultaneously activate cancer-promoting cells and block anti-cancer cells. This relay is 
dynamic, as changes in the ex-miR population due to DNA damage in the cancer cell of origin is relayed to other cells 
and affects their function. We propose a model wherein ex-miR-cell signaling occurs similar to virus-cell interactions, 
including the need for ligand-receptor interactions, and subsequent cellular trafficking.
183 A Structure and function of Zucchini endoribonuclease in piRNA biogenesis
Osamu Nureki1, Hiroshi Nishimasu1, Hirotsugu Ishizu1, Mikiko Siomi1
1Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo
PIWI-interacting RNAs (piRNAs) silence transposons to maintain the integrity of the genome in animal 
germlines. piRNAs are divided into primary and secondary piRNAs depending on the biogenesis machinery. Primary 
piRNAs are processed from long non-coding RNA precursors transcribed from piRNA clusters in the genome through 
the primary processing pathway. Although the existence of a ribonuclease participating in this pathway has been 
anticipated, its molecular identity remains elusive. Here, we show that Zucchini (Zuc), a mitochondrial phospholipase 
D (PLD) superfamily member, is an endoribonuclease essential for primary piRNA biogenesis. We solved the crystal 
structure of Drosophila melanogaster Zuc (DmZuc) at 1.75-Å resolution. The structure revealed that DmZuc has a 
positively charged, narrow catalytic groove at the dimer interface, which could accommodate a single-stranded, but 
not a double-stranded, RNA. DmZuc and the mouse homolog MmZuc (also known as Pld6 and MitoPLD) exhibited 
endoribonuclease activity for single-stranded RNAs in vitro. The RNA cleavage products bear a 5′-monophosphate 
group, a hallmark of mature piRNAs. Mutational analyses showed that conserved active-site residues of DmZuc are 
critical for ribonuclease activity in vitro, and for piRNA maturation and transposon silencing in vivo.We propose a 
model for piRNA biogenesis in animal germlines, in which Zuc endoribonuclease plays a key role in primary piRNA 
maturation.
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186 A Degradation of ribosomal RNA and ribosomal proteins constitute separate pathways of 
ribophagy
Anna Pastucha1, Joanna Kufel2
1Institute of Genetics and Biochemistry, University of Warsaw, Poland; 2University of Warsaw Institute of 
Genetics and Biotechnology
Nutritional deprivation leads to severe changes in cell homeostasis, ultimately promoting destruction of 
cellular components and organelles to prevent death. Recently, a deubiquitination-dependent selective degradation 
of ribosomal proteins in yeast vacuoles, which is activated by nitrogen starvation and termed ribophagy, has been 
reported. We describe a separate ribophagy mechanism, wherein robust fragmentation of mature ribosomal RNA in 
autophagic yeast cells is independent of protein degradation. This ribosome recycling mechanism is highly specific, 
requires a subset of autophagic regulators, Atg proteins, is dependent on the TOR (target of rapamycin) regulatory 
pathway, but proceeds efficiently in the absence of the Ubp3-Bre5 complex required for the ribophagic degradation 
of ribosomal proteins. This indicates that the concurrent response on the protein part of ribosomal subunits is not a 
prerequisite. RNA cleavages take place on intact ribosomes in the cytoplasm and are carried out predominantly, but 
not solely, by the vacuolar ribonuclease Rny1, which is released from the vacuole to the cytosol upon activation of 
autophagy. Endonucleolytic cleavages generate specific and stable RNA fragments, which are further digested by 
exonucleases, including Nuc1, 5’-3’ exonuclease Xrn1 and the 3’-5’ exosome complex. In contrast, components of 
both 18S and 25S “non-functional rRNA decay” (NRD), that eliminates malfunctionning ribosomes, are not required 
for rRNA destruction during autophagy. The existence of the autonomous rRNA ribophagic pathway substantiates the 
importance of ribosome breakdown to survive the shortage of nutrients.
185 C Identification and functional characterization of the long non-coding RNA in myogenesis
Jinyoung Park1, Jiwon Lee1, Hanyoung Lee1, Chanhee Jo1, Ahreum Choi1, Jae-Hyun Yang1, Eun-Jung Cho1
1Sungkyunkwan University
Eukaryotic genomes express a diverse range of non-coding RNAs as well as protein-coding mRNAs. Among 
them, some of long non-coding RNAs are known to have functions to regulate diverse biological processes, such as 
epigenetic control of chromatin, X-chromosome inactivation, and nuclear body formation. However, comparing to the 
large portion of long non-coding RNAs in entire genome, their functions remain largely uncharacterized. In particular, 
the potential contribution of long non-coding RNAs to the cellular differentiation is rarely elucidated. Myogenesis, 
the muscle differentiation, is a multistep process during which pluripotent mesodermal cells give rise to myoblasts 
that eventually differentiate into myotubes. During the course of myogenic differentiation, many muscle genes are 
up-regulated including MyoD, Myogenin, and MCK. Here, we took the advantage of genome-wide transcriptome 
analysis and found that the expression of not only muscle genes but many long non-coding RNAs is changed during 
myogenesis. There were many non-coding RNAs which are up-or down-regulated during muscle differentiation. 
Among the non-coding RNAs, we show the long non-coding RNA transcript, UT-10, which is increased during 
myogenesis has a potential role in muscle differentiation by regulation of muscle genes
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188 C Mutations in the 5’UTR of SERPINA1 transcripts are involved in the disease associated 
mechanisms
Gabriela Phillips1, Chetna Gopinath3, Matt Halvorsen2, Justin Ritz2, Amanda Solem2, Alain Laederach2
1University of North Carolina at Chapel Hill; 2University of North Carolina; 3Wadsworth Center
Single Nucleotide Polymorphisms (SNPs) are found throughout the human genome. SNPs implicated in disease-
associated mechanisms that map to coding regions of the genome generally alter the function of the protein. However, 
disease-associated SNPs that map to non-coding regions can affect the translation regulation and/or stability of the 
mRNA. Novel high-throughput mappings of RNA binding protein sites found that most UnTranslated Regions (UTR) 
of mRNA are often targeted by proteins involved in the regulation of translation, stability of mRNA, and mRNA 
localization. Not only that many RNA binding proteins recognize specific primary sequences of the mRNA, but is also 
now well established that the secondary structure plays a critical role in the accessibility of a binding site. Thus, SNPs 
that significantly alter the structure of UTRs could affect post-transcriptional regulation. 
Alpha 1-antitrypsin deficiency (A1AD) is an autosomal recessive genetic disorder caused by the defective 
production of alpha 1-antitrypsin (A1AT), a protein encoded by SERPINA1. Severe deficiency of A1AT causes 
panacinar emphysema or Chronic Obstructive Pulmonary Disease (COPD) as well as various liver diseases. It has 
been shown that certain mutations (Glu342Lys) in the coding regions of SERPINA1 led to severe cases of COPD. A 
recent genome wide-association study identified a SNP in the 5’ UTR of SERPINA1 associated with increased risk 
of developing COPD. SHAPE structure mapping analysis reveals that this SNP alters RNA structure acting forming 
a RiboSNitch – a SNP that induces a large conformational change of RNA resulting in an altered function of RNA. 
Thus, SNP induced RNA structure change likely plays an important role in COPD predisposition.
187 B Discovery of Hfq-binding nanoRNAs in Escherichia coli
Jennifer Patterson1, Shugeng Cao2, Jon Clardy2, Cameron Mura1
1University of Virginia; 2Harvard University
RNA-based regulation enables exquisite control over the extent and timing of gene expression, thereby enabling 
bacteria to rapidly respond to their environment. The bacterial host factor Hfq acts as a post-transcriptional regulator 
of such changes in gene expression.  This cellular activity likely stems from the ability of Hfq to function as a 
generic RNA chaperone. Previous work has found that Hfq preferentially interacts with A/U-rich RNAs.  In this study, 
we discovered an Hfq that interacts with short U/C-rich nanoRNAs, when recombinantly expressed in Escherichia 
coli.  These Hfq-binding nanoRNAs interact with high affinities (nanomolar-scale) and feature specific RNA end-
chemistries (5’-monophosphate, 3’-hydroxyl).   These unanticipated Hfq···nanoRNA associations may represent a 
novel mechanism by which Hfq and Hfq•sRNA complexes modulate RNA-based regulatory circuits in vivo.
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190 B Integrated genome-wide in silico and capture array approach discovers a large spectrum 
of novel structured RNAs associated to regulatory elements
Stefan E Seemann1, Claus Hansen1, Claus H Bang-Berthelsen2, Aashiq H Mirza2, Mikkel Christensen-Dalsgaard1, 
Hui Xiao1, Zizhen Yao3, Elfar Torarinsson4, Flemming Pociot2, Henrik Nielsen1, Niels Tommerup1, Walter L Ruzzo5, 
Jan Gorodkin1
1Center for non-coding RNA in Technology and Health, Univ. of Copenhagen; 2Center for non-coding RNA in 
Technology and Health, Glostrup Hospital Copenhagen; 3Fred Hutchinson Cancer Research Center; 4Univ. of 
Copenhagen; 5Univ. of Washington
Computational predictions and high-throughput sequencing techniques, such as RNA-seq, have recently given rise to the 
discovery of many non-coding RNAS (ncRNAs). In silico methods have in particular focused on predicting RNA structure, which 
is a functional characteristic of many ncRNAs. However, these screens have primarily searched in regions of high evolutionary 
sequence conservation and lack of large scale experimental follow up analysis.
To overcome these limitations, we introduce a genome-wide (on all regions covered by MAF blocks) in silico screen for ncRNAs 
based on structural RNA alignments (of corresponding sequence from vertebrates) in direct combination with the design of a capture 
array for expression analysis. The in silico screen resulted in ~600,000 highly structured candidate regions in the human genome 
of an estimated false discovery rate of 26%. For the top ~60,000 regions the FDR is less than 10%. We also predict a genome-
wide coverage by conserved RNA structures of around 14%. The identified regions are primarily intergenic and are enriched for 
untranslated regions (UTRs) in mRNAs. We observe good overlap to known ncRNAs and recently identified long ncRNAs. The 
study reveals that structured RNAs are most adequately predicted from structural alignments and, interestingly, comprise RNA 
structures of down to 20% sequence identity.
Functional indications of the conserved RNA structures are given by their location adjacent to many regulatory features 
such as transcription factor binding sites and the evidence for their negative selection.  To provide further confidence on the in 
silico predictions we performed the first large-scale experimental analysis of structured ncRNA candidates by probe design of 
~80,000 structured candidate regions. The designed capture array reveals the expression of ~8,000 of these regions. The chosen 
strategy of RNA capture array and high-throughput sequencing found a number of low expressed ncRNAs and RNA structures in 
extended UTRs which have not been found by ordinary RNA-seq experiments. Further experiments (qPCR, RACE and structure 
probing) in human and mouse support our hypothesis of transcripts weakly conserved in sequence but with a highly conserved 
RNA structure.
189 A RNA Structure and Ligand Interactions Probed by Strategically Positioned 15N-Labels
Tobias Santner1, Jasmin Levic1, Christoph Kreutz1, Ronald Micura1
1Institute of Organic Chemistry, University of Innsbruck, Innsbruck, Austria
To explore folding and ligand recognition of metabolite-responsive RNAs is of major importance to comprehend 
gene regulation by mRNA riboswitches. On the secondary structure level, folding events often lead to changes in 
the H-bond mediated Watson-Crick base pairing pattern. The individual base pairs can be monitored by the NMR 
spectroscopic HNN-COSY experiment which detects and quantifies magnetically active 15N nuclei of the H-bond 
donor and acceptor.
Here, we present the synthesis of all four ribonucleoside phosphoramidites carrying single 15N-labels at the 
pyrimidine-3 or purine-1 positions. Their site-specific introduction into RNA has been achieved by solid-phase 
synthesis using a combination of 2’-O-TOM and 2’-O-TBDMS RNA chemistry.
To furthermore demonstrate the power of the labels for NMR spectroscopic applications, we investigate pseudoknot 
folding and ligand interaction of transcriptionally [1] as well as translationally acting preQ1 class-I aptamers in a 
Mg2+ and temperature dependent manner. The study provides detailed insights into the ligand recognition mode of 
preQ1 riboswitches.
1. T. Santner, U. Rieder, C. Kreutz, R. Micura; Pseudoknot preorganisation of the preQ1 class I riboswitch; J. Am. Chem. Soc. 
2012, 11928-11931.
Financial support from the Austrian Science Fund FWF (P21640) is gratefully acknowledged
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192 A Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells
Alla Sigova1, Alan Mullen3, Benoit Molinie3, Sumeet Gupta5, David Orlando5, Matthew Guenther5, Albert Almada2, 
Charles Lin6, Phillip Sharp2, Cosmas Giallourakis4, Richard Young7
1Whitehead Institute for Biomedical Research, Cambridge, MA 02142; 2Department of Biology, 
Massachusetts Institute of Technology, Cambridge, MA 02139; David H. Koch Institute for Integrative 
Cancer Research, Cambridge, MA 02140; 3Gastrointestinal Unit, Massachusetts General Hospital, Harvard 
Medical School, Boston, MA 02114; 4Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical 
School, Boston, MA 02114; Harvard Stem Cell Institute, Cambridge, MA 02138; 5Whitehead Institute for 
Biomedical Research; 6Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of 
Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; 7Whitehead Institute for Biomedical 
Research; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139
Many long non-coding RNA (lncRNA) species have been identified in mammalian cells, but the genomic origin 
and regulation of these molecules in individual cell types is poorly understood. We have generated catalogs of 
lncRNA species expressed in human and murine embryonic stem cells (ESCs) and mapped their genomic origin. A 
surprisingly large fraction of these transcripts (>85%) originate from divergent transcription at promoters or enhancers 
of active protein-coding genes. The divergently transcribed lncRNA/mRNA gene pairs exhibit coordinated changes 
in transcription when ESCs are differentiated into endoderm. Down-regulation of a divergently transcribed lncRNA 
by RNAi reduces the efficiency of differentiation of hESCs into the endoderm. Our results reveal that transcription of 
most lncRNA genes is coordinated with transcription of protein-coding genes.
191 C Identification and characterization of rice non-coding RNAs involved in nitrogen-
starvation stress response
Sang-yoon Shin1, Chanseok Shin2
1Seoul National University; 2Department of Agricultural Biotechnology, Seoul National University, Seoul, 151-
921, Republic of Korea
MicroRNAs and long non-coding RNAs are key regulators that control the expression level of genes by 
transcriptional and post-transcriptional regulation in animals and plants. Both of the non-coding RNAs are also 
involved in regulating plants’ responses to stress conditions. Recent studies showed that non-coding RNA pool changes 
in some environmental conditions, implying that non-coding RNAs play key roles in responding to stress condition in 
plants. In this study, we aim to identify and characterize microRNAs and long non-coding RNAs induced by nitrogen-
starvation stress in Oryza sativa. To do this, we performed RNA-Seq and small RNA-Seq using nitrogen-starvation 
stress-treated rice samples, and analyzed the expression profiling of the non-coding RNAs and their target genes. With 
this study, we investigate the relationship between the expression of nitrogen-starvation stress-specific non-coding 
RNAs and their effects on genes in Oryza sativa.
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea 
government (MEST) (No. 2012R1A2A2A01045528) and the Next-Generation BioGreen 21 Program (Plant Molecular 
Breeding Center No. PJ008011), Rural Development Administration, Republic of Korea. *Correspondence: Chanseok 
Shin, cshin@snu.ac.kr
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194 C Transcriptional regulation and non-coding RNA: The Steroid Receptor RNA activator
Stéphane Thore1, Fabiana Arieti1, Caroline Gabus-Darlix1, Sandrine Coquille1
1Department of Molecular Biology, University of Geneva
The steroid receptor RNA activator (SRA RNA) is a unique non-coding RNA which has been shown to stimulate 
hormone-mediated transcriptional responses. The SRA RNA is a member of the diverse group of factors known as the 
nuclear receptor co-regulators. The RNA has a complex secondary structure with multiple stem-loop structures which 
are the landing platform for its partners. Understanding the specific association between the SRA RNA and its regulatory 
partners will provide critical tools to modulate hormone-mediated transcriptional responses. Increased understanding 
of these signalling pathways has great potentials for breast and pancreatic hormone-responsive cancer treatment for 
example. We are studying the specific association of the SRA RNA with two transcriptional regulators: the SRA stem-
loop interacting RNA binding protein (SLIRP) and the SMRT/HDAC-associated repressor protein (SHARP). Both 
proteins are classified as transcriptional repressors. SLIRP is a small RRM-containing protein shown to specifically 
associate with SRA in the nucleus and to be a partner of the mitochondrial protein LRPPRC. SLIRP is binding to the 
SRA RNA and is thought to outcompete other transcriptional activators. The SHARP protein belongs to the split end 
protein family, initially characterized in Drosophila where it was shown to affect homeotic patterning. SHARP recruits 
the SMRT protein and histone deacetylases to the promoter regions, which in turn blocks the transcriptional machinery 
by promoting chromatin compaction.
We are characterizing in vitro the binding properties of these factors with their RNA binding sequences in the SRA 
RNA. Furthermore, we have obtained an atomic model of the N-terminal region of SHARP using X-ray crystallography. 
This region contains three RRM domains (RRM2, RRM3 and RRM4) which are conserved within the entire SHARP 
protein family. Two of these RRMs (RRM3-4) are forming a stable entity using a previously uncharacterized region. 
The third RRM (RRM2) is tethered to the others via a helical linker. Small angle X-ray scattering experiments indicates 
that the linker could be used by the protein single RRM to reach two preferential orientations located on both side of 
the stable block formed by the RRM3-4. Structural comparison, mutagenesis and in vivo experiments are validating 
the importance of the RRM organization and binding ability for the co-repressor activity mediated by SLIRP and 
SHARP.
193 B Uncovering novel microRNAs involved in homeostatic plasticity
Mariline M. Silva1, 2, 3, Joana Fernandes1, 4, Sandra D. Santos1, Ana Luísa Carvalho1, 5
1Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; 2Doctoral Program 
in Experimental Biology and Biomedicine, University of Coimbra, Coimbra, Portugal; 3Doctoral Program in 
Experimental Biology and Biomedicine, University of Coimbra, Coimbra, Portugal; 4Faculty of Pharmacy, 
University of Coimbra, Coimbra, Portugal; 5Department of Life Sciences, University of Coimbra, Coimbra, 
Portugal
Synaptic scaling is a homeostatic mechanism responsible for the adjustment of the overall synaptic strength in a 
neuron’s synapses to a set point, in order to stabilize neuronal firing. Dendritic protein synthesis is crucial for synaptic 
scaling but the mechanisms that regulate the de-repression of mRNAs are still unclear. MicroRNAs, well known 
posttranscriptional regulators, are modulated upon changes in neuronal activity, which indicates that miRNAs may 
have a role in the regulation of homeostatic plasticity. Our main goal is to unveil novel miRNA players during synaptic 
scaling and to further investigate their role in this form of plasticity.
We performed a gene expression microarray analysis of rat hippocampal neurons under chronic blockade of activity 
and submitted the results to biological interpretation using the GoMiner tool. Several gene categories, relevant for 
synaptic events, were selected and miRNA target sites were predicted for those genes using the following algorithms: 
miRanda, TargetScanS and MirTarget2. Focusing on a restricted group of altered genes with a crucial role in synaptic 
scaling and/or in synaptic function, we identified a group of 18 predicted miRNAs, and performed a screening panel 
for their expression levels in primary cultures of rat hippocampal neurons subjected to synaptic scaling up conditions. 
This analysis revealed that several miRNAs present altered expression in scaling up conditions and therefore suggests 
an important role for these miRNAs in synaptic scaling mechanisms.
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196 B A link between long intervening noncoding RNAs and microRNA regulation
Igor Ulitsky1, Alena Shkumatava1, Hazel Sive1, David Bartel2
1Whitehead Institute; 2Whitehead Institute for Biomedical Research, Howard Hughes Medical Institute and 
Department of Biology, MIT
Thousands of long intervening noncoding RNAs (lincRNAs) have been identified in mammals. To better understand 
the evolution and functions of these enigmatic RNAs, we identified more than 550 distinct lincRNAs in zebrafish. 
Although these shared many characteristics with mammalian lincRNAs, only 29 had detectable sequence similarity 
with putative mammalian orthologs, typically restricted to a single short region of high conservation. Other lincRNAs 
had conserved genomic locations without detectable sequence conservation. Morpholinos targeting conserved regions 
of two zebrafish lincRNAs caused developmental defects. Morpholinos targeting splice sites caused the same defects 
and were rescued by adding either the mature lincRNA or its human or mouse ortholog. In one of the lincRNAs, 
called cyrano, the conserved region extensively pairs to miR-7, and this pairing has been essentially unchanged 
since the dawn of vertebrates. Our experiments confirm that the conserved site is a bona fide microRNA target site 
that is bound by argonaute proteins and confers regulation by miR-7. This regulation is part of a larger network of 
miRNA-lincRNA regulations, which is revealed by multiple types of experimental evidence. We also demonstrate 
how direct comparison of lincRNA sequences across distant species can uncover miRNA complementary sites and 
other conserved elements that are missed in whole-genome alignments.
195 A RNA polymerase-binding elements attenuating transcription in E. coli
Nadia Tukhtubaeva1, Vitaliy Epshtein4, Bob Zimmermann3, Meghan Lybecker3, Ivana Bilusic2, Evgeny Nudler4, 
Renee Schroeder2
1Department of Biochemistry and Molecular Cellbiology; Max F. Perutz Laboratories, University of Vienna. 
Dr. Bohrgasse 9/5; 1030 Vienna, Austria; 2Department of Biochemistry and Molecular Cellbiology; Max 
F. Perutz Laboratories, University of Vienna. Dr. Bohrgasse 9/5; 1030 Vienna Austria; 3Department of 
Biochemistry and Molecular Cellbiology; Max F. Perutz Laboratories, University of Vienna. Dr. Bohrgasse 
9/5; 1030 Vienna, Austria; 4Department of Biochemistry and Molecular Pharmacology, New York University 
School of Medicine, New York, NY 10016, USA
Transcription is a highly controlled step of gene expression. A number of diverse RNA-based transcription 
regulatory mechanisms have been discovered to date. However, in contrast to numerous well-studied protein factors, 
there are only few known regulatory RNAs tuning transcription by a direct interaction with the RNA polymerase 
machinery. Addressing the question if such type of transcriptional riboregulation could be a frequent phenomenon in 
bacteria, we combined E. coli RNAP - genomic SELEX with next-generation sequencing. The obtained data reveal a 
large group of polymerase binding RNA elements (PBEs) located within diverse coding sequences that bind RNAP 
with high affinity. Using different in vitro and in vivo techniques we demonstrate that a subgroup of these PBEs 
attenuate transcription of the nascent RNA by promoting premature termination events under relevant biological 
conditions. Our findings let us propose a novel and potentially widespread mechanism of transcriptional regulation by 
the transcribing RNA itself. Detailed single-molecule mechanistic elucidation of the process is underway.
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198 A Rat mir-155 generated from the lncRNA Bic is ‘hidden’ in the alternate genomic assembly 
and reveals the existence of novel mammalian miRNAs and clusters
Paolo Uva1, Letizia Da Sacco3, Manuela Del Cornò2, Paola Sestili2, Sandra Gessani2, Antonella Baldassarre4, 
Massimiliano Orsini1, Andrea Masotti4, Alessia Palma5, Mattia Locatelli1
1CRS4 Bioinformatics Laboratory, Parco Scientifico e Tecnologico POLARIS, 09010 Pula, Cagliari, Italy; 
2Department of Hematology, Oncology, and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, 
Italy; 3Gene Expression - Microarrays Laboratory, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, 
Italy; 4Gene Expression–Microarrays Laboratory, Bambino Gesù Children’s Hospital, IRCCS, 00165 Rome, 
Italy; 5Genomic Core Facility, Bambino Gesù Children’s Hospital, IRCCS, 00139 Rome, Italy
MicroRNAs (miRNAs) are a class of small noncoding RNAs acting as post-transcriptional gene expression 
regulators in many physiological and pathological conditions. During the last few years, many novel mammalian 
miRNAs have been predicted experimentally with bioinformatics approaches and validated by next-generation 
sequencing. Although these strategies have prompted the discovery of several miRNAs, the total number of these 
genes still seems larger. Here, by exploiting the species conservation of human, mouse, and rat hairpin miRNAs, we 
discovered a novel rat microRNA, mir-155. We found that mature miR-155 is overexpressed in rat spleen myeloid cells 
treated with LPS, similarly to humans and mice. Rat mir-155 is annotated only on the alternate genome, suggesting 
the presence of other “hidden” miRNAs on this assembly. Therefore, we comprehensively extended the homology 
search also to mice and humans, finally validating 34 novel mammalian miRNAs (two in humans, five in mice, and up 
to 27 in rats). Surprisingly, 15 of these novel miRNAs (one for mice and 14 for rats) were found only on the alternate 
and not on the reference genomic assembly. To date, our findings indicate that the choice of genomic assembly, when 
mapping small RNA reads, is an important option that should be carefully considered, at least for these animal models. 
Finally, the discovery of these novel mammalian miRNA genes may contribute to a better understanding of already 
acquired experimental data, thereby paving the way to still unexplored investigations and to unraveling the function 
of miRNAs in disease models.
197 C Evolutionary relationships between PB1 mRNA of Influenza A virus and host microRNAs 
among vertebrates
Yuki Usui1, Kahori Ikeda2, Motomu Matsui2, Masaru Tomita2, Akio Kanai2
1Institute for Advanced Biosciences, Keio University; Faculty of Policy Management, Keio University; 
2Institute for Advanced Biosciences, Keio University; System Biology Program, Graduate School of Media 
and Governance, Keio University
Influenza A virus (IAV) undergoes rapid evolution to evade the host defense system, whereas hosts have developed 
several antiviral responses. Recently, it has been reported that three human miRNAs (miR-323, miR-491 and miR-654) are 
able to bind to almost the same site in the viral polymerase basic protein 1 (PB1) mRNA and inhibit H1N1 IAV replication 
(Song et al., J. Virol. 2010). Thus, these miRNAs have been suggested as potential novel antiviral factors against IAV. 
Meanwhile, some viruses are known to subvert host antiviral function of miRNAs, indicating that miRNAs play critical 
roles in complicated host-pathogen interaction networks.
To better understand the intricate host-IAV interactions via miRNAs, here, we investigated the evolutionary relationships 
between host miRNAs and PB1 mRNA. Firstly, to characterize the dynamic nature of human IAV evolution, we classified 
a variety of human IAV (7,368 strains) from 1918 to 2012 based on the amino acid sequence similarities. Consequently, 
large-scale spectral clustering analysis visualized a comprehensive picture of IAV evolution in whole segments, showing 
not only process of reassortment but also gradual mutations simultaneously. Secondly, conservation analysis of miRNA-
target sites in PB1 mRNA sequences based on Shannon’s information theory suggested that the miRNA-target sites were 
significantly conserved in human IAVs from 1918 to 2012. In addition, both swine and avian IAVs (1,412 and 8,257 
segments, respectively) also possessed the miRNA-target sequences in PB1 mRNA. As for host miRNAs, both miR-323 
and miR-491 were conserved in human and swine genome. Furthermore, we predicted that several other host miRNAs 
hybridized with the conserved miRNA-target sequences in human, swine and avian.
On the basis of these results, we suggested that regulatory relationships between host and IAV via miRNAs had been 
evolutionary conserved among vertebrates, and, therefore, we proposed the following hypotheses: (1) host miRNAs 
targeted immutable regions of IAV, or (2) IAV regulated appropriately its own replication in order to maintain the persistent 
infection by utilizing the host defense system of miRNAs. In this conference, evolutionary advantage of host miRNA 
regulations will be discussed from the standpoints of both hosts and viruses.
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200 C Noncoding RNA-mediated chromosomal fusions
Xing Wang1, John Bracht1, Keerthi Shetty1, Xiao Chen1, Mariusz Nowacki2, Laura Landweber1
1Department of Ecology and Evolutionary Biology, Princeton University, NJ 08544, USA; 2Institute of Cell 
Biology, University of Bern, 3012, Switzerland
Chromosomal fusion, a common occurrence in normal and cancer cells, can lead to the formation of aberrant gene 
products and chimeric transcripts. The mechanisms driving these fusions are poorly understood, but recurrent fusions 
are widespread.  Here we describe chromosomal fusion events that are driven by either long or short aberrant RNAs 
during somatic differentiation in the ciliate Oxytricha trifallax. Exposure of the germline to either long noncoding 
“template” RNAs that specify rearrangements (Nowacki et al. 2008 Nature) or to 27 nucleotide piRNAs that protect 
DNA sequences against deletion (Fang et al. 2012 Cell) can lead to fusion of chromosomes in the offspring, or even 
the formation of circular chromosomes, in one case. Furthermore, we demonstrate that these RNA-mediated inter- and 
intra-chromosomal fusions are heritable over multiple sexual generations, illustrating the ability of noncoding RNAs 
to program and reprogram genome architecture, including chromosome fusion and circularization, and expanding the 
known repertoire of RNA-mediated, transgenerational, epigenetic inheritance.
199 B HEN1-directed labeling of small non-coding RNAs
Giedrius Vilkaitis1, Alexandra Plotnikova1, Aleksandr Osipenko1, Viktoras Masevicius1, Saulius Klimašauskas1
1Department of Biological DNA Modification, Institute of Biotechnology, Vilnius University, LT-02241 Vilnius, 
Lithuania
microRNAs and siRNAs are 21-25 nucleotides long non-coding RNAs described in viruses, unicellular eukaryotes 
and a broad range of multicellular organisms, ranging from plants and insects to mammals. microRNAs control a 
variety of biological pathways including development, apoptosis, metabolism or immunological response by inhibiting 
protein translation and, in some cases, leading to degradation of mRNA transcripts. In view of numerous functions 
the connection of microRNAs with a wide range of human diseases comes as no surprise. Differences in microRNA 
expression patterns are significant in cancer, diabetes, heart malfunctions, neurodegenerative diseases etc. For this 
reason detection techniques for high-throughput microRNA profiling need to be developed. The novel small RNA 
labeling technology recruits the HEN1 methyltransferase to attach the extended side chains with functional group 
towards 3’-end of microRNA or siRNA. The method provides two strategies: quick and effortless one-step labeling 
through the direct attachment of the relevant reporter group which is embedded in the transferred radical. Alternatively, 
the two-step approach extends a choice of coupling strategies for manifold label conjugation to functional group.
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202 B A short guide to human long non-coding RNA gene nomenclature
Matt Wright1, Ruth Seal1, Elspeth Bruford1
1HUGO Gene Nomenclature Committee (HGNC), EMBL-EBI, Wellcome Trust Genome Campus, Hinxton, 
Cambridge, CB10 1SD, UK
The HUGO Gene Nomenclature Committee (HGNC) is the only organisation authorised to assign standardised 
nomenclature to human genes. Of the 34,000 approved gene symbols in our database (www.genenames.org) the majority 
represent protein-coding (pc) genes; however we also name pseudogenes, phenotypic loci, some genomic features, 
and to date have named over 5,000 human non-protein coding RNA (ncRNA) genes and ncRNA pseudogenes.  We 
have already established unique names for most of the small ncRNAs by working with experts for each class: for 
example we have named the ~1,500 human microRNA genes in collaboration with miRBase.  Small ncRNAs can 
be defined into their respective classes by their shared homology and common function. In contrast long non-coding 
RNA (lncRNA) genes represent a disparate set of loci related only by their size, over 200 bases in length, share 
little conserved sequence homology, and have variable functions.  As with pc genes wherever possible lncRNAs 
are named based on the known function of their product, e.g. ‘XIST’ ‘X (inactive)-specific transcript’ is involved in 
transcriptionally silencing one of the pair of X chromosomes in females. We have currently named ~100 lncRNA 
genes that encode a transcript with published evidence of function. There are, however, potentially thousands of 
lncRNAs, and for the vast majority their function remains unresolved. Such lncRNA genes are named based on their 
genomic context. If there is a proximal pc gene then the lncRNA genes are given a gene symbol beginning with the pc 
symbol and assigned a suffix according to whether they are: antisense (AS) e.g. BACE1-AS; intronic (IT) e.g. SPRY4-
IT1; or overlapping (OT) e.g. SOX2-OT. Whereas long intergenic lncRNAs (lincRNAs) that lie between pc gene loci 
are named with a common root symbol (LINC: “long intergenic non-coding RNA”) and an iterated, numerical suffix. 
We present a short guide to the nomenclature of lncRNA genes and provide examples of some of the genes named to 
date. For further information on ncRNA nomenclature please see the HGNC RNA webpage: www.genenames.org/
rna or email us at hgnc@genenames.org
201 A Regulation of transcription by Pol II-binding RNA aptamers
Adam Weiss1, Maximilian Radtke1, Frederike von Pelchrzim1, Jennifer Boots1, Bob Zimmermann1, Marek Zywicki2, 
Katarzyna Matylla-Kulinska1, Renée Schroeder1
1Department of Biochemistry and Molecular Cell Biology, Max F. Perutz Laboratories, University of Vienna, 
Vienna, Austria; 2Innsbruck Biocenter, Medical University of Innsbruck, Innsbruck, Austria
Transcription by RNA polymerase II (Pol II) is the first step in eukaryotic gene expression and one of the most 
important ones to regulate. As abundance of non-coding RNAs with diverse functions have been identified, it has 
become clear that RNAs regulate every step in gene expression including transcription. To investigate the regulatory 
potential of the human transcriptome, we performed Genomic SELEX with Pol II as a bait and identified many high-
affinity RNA aptamers (Polymerase-binding elements or PBEs). PBEs can be pulled down with Pol II from HeLa 
cells and they abolish transcription when fused to a reporter gene in an in vivoexpression system. Interestingly, many 
PBEs are located in repetitive regions of the human genome, with most prominent ACRO1 satellites, previously 
uncharacterized repeat elements that cluster in the pericentromeric region of chromosome 4 and can be found on 
chromosomes 1, 2, 19 and 21 as well. Another class of PBE-containing repeats are the L1 retrotransposons, which 
had been shown to inhibit their own expression by an unknown mechanism. Our results suggest a novel way of in-
cis transcription regulation by RNAs, wherein nascent transcripts bind Pol II to interfere with elongation.
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204 A Scaffold function of long noncoding RNA HOTAIR in protein ubiquitination
Je-Hyun Yoon1, Kotb Abdelmohsen1, Xiaoling Yang1, Kumiko Tominaga-Yamanaka1, Elizabeth J. White3, Arturo V. 
Ojalo2, John L. Rinn5, Stefan G. Kreft4, Gerald M. Wilson3, Myriam Gorospe1
1Laboratory of Genetics, National Institute on Aging-Intramural Research Program, NIH, Baltimore, MD 
21224, USA; 2Biosearch Technologies, Inc., Novato, CA 94949, USA; 3Department of Biochemistry and 
Molecular Biology and Marlene and Stewart Greenebaum Cancer Center, University of Maryland School 
of Medicine, Baltimore, MD 21201, USA; 4Department of Biology, University of Konstanz, 78457 Konstanz, 
Germany; 5Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, 
USA
Although mammalian long noncoding (lnc)RNAs are best known for modulating transcription, their post-
transcriptional influence on mRNA splicing, stability, and translation is emerging.  Here we report a post-translational 
function for the lncRNA HOTAIR as an inducer of ubiquitin-mediated proteolysis.  HOTAIR associated with E3 
ubiquitin ligases bearing RNA-binding domains, Dzip3 and Mex3b, as well as with their respective ubiquitination 
substrates, Ataxin-1 and Snurportin-1.  In this manner, HOTAIR facilitated the ubiquitination of Ataxin-1 by Dzip3 
and Snurportin-1 by Mex3b in cells and in vitro, and accelerated their degradation.  HOTAIR levels were highly 
upregulated in senescent cells, causing rapid decay of targets Ataxin-1 and Snurportin-1, and preventing premature 
senescence.  These results uncover a role for a lncRNA, HOTAIR, as a platform for protein ubiquitination.
203 C RNA functional profiling by gene deletion in S. cerevisiae
Jian Wu1, Steven Parker1, Sara Shamsah1, Daniela Delneri1, Raymond O’Keefe1
1University of Manchester
New sequencing technologies and high-resolution microarray analysis have revealed that an large portion of the 
genome is transcribed, generating a significant number of RNAs with non-coding capacity. The focus of current debate is 
how many of these non-coding RNAs are functional, and what is their function. The yeast Saccharomyces cerevisiae is 
an important model organism for investigating gene functions. Protein-coding gene deletion strains have provided a 
valuable research resource for studying essential cellular processes and understanding the mechanisms of drug action. 
However, the pervasively transcribed RNA-coding genes are absent from deletion strain collections, making it difficult 
to study the contribution of RNA-coding genes in biological processes. Therefore, we have constructed molecular 
barcoded RNA gene deletion strains in S. cerevisiae, including annotated snRNAs, snoRNAs, tRNAs and recently 
identified stable unannotated transcripts (SUTs) and cryptic unstable transcripts (CUTs). In addition, the verified RNA 
hemizygotes have been sporulated and dissected to generate haploid mutant collections and homozygous deletion 
strains. The majority of RNAs studied are non essential under nutrient rich (YPD) conditions. Furthermore, these 
RNA deletion strains will be used for RNA fitness profiling to explore, by next generation sequencing of barcodes, the 
role of individual RNAs to growth of yeast under a variety of conditions and treatments. Nevertheless, selected RNA 
genes will be investigated for their potential roles in regulating expression of genes nearby. Finally, all RNA deletion 
strains will be deposited with international repositories for yeast strains to allow distribution of this new resource to 
provide a comprehensive gene deletion collection for genome-wide analysis.
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206 C AGO1 requires interaction with GW182 to repress translation of miRNA targets
Andreas Boland1, Eric Huntzinger1, Duygu Kuzuoglu-Öztürk1, Maria Fauser1, Elisa Izaurralde1
1Department of Biochemistry, Max Planck Institute for Developmental Biology, Tübingen, Germany
Animal miRNAs silence the expression of mRNA targets through translational repression, deadenylation and 
subsequent mRNA degradation. Silencing requires association of miRNAs with an Argonaute protein (AGO) 
and a GW182 family protein. In turn, GW182 proteins interact with PABP and the PAN2-PAN3 and CCR4-NOT 
deadenylase complexes. These interactions are required for the translational repression, deadenylation and decay 
of miRNA targets (Huntzinger at al., 2013). Recent studies have indicated that miRNAs can also repress translation 
in a GW182-independent but AGO-dependent manner (Fukaya and Tomari, 2013). AGO1 and GW182-mediated 
repression was reported to occur by distinct mechanisms in Drosophila melanogaster (Dm) cells (Fukaya and 
Tomari, 2013). However, the contribution of these two alternative mechanisms to silencing has remained unclear. To 
address this question, we characterized the interaction of Dm AGO1 and GW182. Based on the recent structure of 
human AGO2 (Schirle and MacRae, 2012), we designed mutations that disrupt Dm AGO1 interaction with GW182. 
Functional assays in Dm cells indicate that Dm AGO1 requires interaction with GW182 to mediate translational 
repression and degradation of mRNA targets and does not possess independent repressive activity. We are combining 
cellular, biochemical and structural approaches to investigate how the GW182 proteins repress translation of miRNA 
targets.
205 B Towards improved shRNA inhibitors with a Dicer-independent processing route
Ben Berkhout1
1University of Amsterdam
Towards improved shRNA inhibitors with a Dicer-independent processing routeBen BerkhoutLaboratory of 
Experimental Virology, Academic Medical Center, University of Amsterdam, The Netherlands (b.berkhout@amc.
uva.nl)  Short hairpin RNAs (shRNAs) are widely used to induce RNA interference (RNAi). The shRNA is processed 
by the Dicer endonuclease into an siRNA duplex. One strand of the duplex instructs the RNA-induced silencing 
complex (RISC) with the catalytic AGO2 protein to mediate cleavage of the complementary mRNA target. Although 
shRNAs can potently and specifically suppress target genes, RNAi may also cause serious side-effects, which is an 
siRNA-sequence and dose-dependent phenomenon. Thus, there is a need to select potent shRNAs in order to reduce 
the required shRNA concentration. To date, only few shRNA designs have been tested. We tested a variety of shRNAs 
that differed in stem length and terminal loop size and revealed strikingly different RNAi activities and shRNA 
processing patterns. Interestingly, we identified a specific shRNA design that uses an alternative Dicer-independent 
processing pathway, which also resulted in potent knockdown of the target gene. Detailed shRNA analyses indicated 
that a short stem length is critical for avoiding Dicer processing and activation of the alternative processing route, in 
which the shRNA is incorporated into RISC and processed by the AGO2-mediated slicer activity. Such alternatively 
processed shRNAs (AgoshRNAs) yield only a single RNA strand that effectively induces RNAi, whereas conventional 
shRNA processing results in an siRNA duplex of which both strands can trigger RNAi. These results have important 
implications for the future design of more specific RNAi therapeutics.
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208 B Endogenous RNA interference is driven by copy number
Cristina Cruz1, Jon Houseley1
1The Babraham Institute
A plethora of non-protein coding RNAs (ncRNA) are produced throughout eukaryotic genomes, many of which 
are transcribed antisense to protein-coding loci. A direct interaction between antisense ncRNA and protein-coding 
mRNA would form double-stranded RNA that could instigate an RNA interference (RNAi) response, resulting in 
mRNA down-regulation. However, this occurs very rarely and the variables controlling such an RNAi response 
remain undefined. Here we use a minimal reconstituted RNAi system in budding yeast to show that gene copy number 
is a key factor controlling the RNAi response to transcripts from endogenous loci, and that increasing copy number 
is sufficient to cause the degradation of both sense and antisense RNA by RNAi. This is observed for loci expressing 
ncRNA or mRNA, and occurs even with rare or unstable antisense transcripts. Importantly, increased RNA abundance 
does not account for this effect as multi-copy loci produce more small interfering RNAs (siRNA) than single-copy 
loci with equivalent RNA expression. The difference can instead be explained by the ability of multi-copy loci to 
simultaneously transcribe sense and antisense RNA. Cells are able to identify high-copy DNA, which is an essential 
step in the suppression of newly evolved transposable elements; our experiments clearly demonstrate that identification 
of the products of high-copy DNA is an emergent property of a minimal RNAi system. Efficient surveillance of high-
copy sequences by RNAi would however require genome-wide transcription, suggesting a function for the pervasive 
transcription of eukaryotic genomes. We propose that pervasive transcription is part of a defence mechanism capable 
of directing a sequence-independent RNAi response against transposable elements amplifying within the genome.
207 A Argonaute-associated factors required for translational repression in plant RNA silencing
Clément Chevalier1, Jacinthe Azevedo-Favory4, Grégory Schott1, Christophe Himber2, Mohamed-Ali Hakimi3, 
Olivier Voinnet1
1Swiss Federal Institute of Technology (ETH-Z), Department of Biology, Zürich 8092, Switzerland; 2Institut 
de Biologie Moléculaire des Plantes, Centre National de la Recherche Scientifique, UPR 2357, Strasbourg, 
France; 3Laboratoire Adaptation et Pathogénie des Micro-organismes, CNRS UMR 5163, Université Joseph 
Fourier, Grenoble, France; 4Laboratoire Génome et Développement des Plantes, Centre National de la 
Recherche Scientifique/Université de Perpignan via Domitia, UMR5096, Perpignan, France
In Arabidopsis thaliana, microRNAs (miRNAs) are loaded in ARGONAUTE 1 (AGO1) as part of RNA induced 
silencing complexes (RISCs) to regulate target messenger RNAs (mRNAs) via base-pairing. AGO1 possesses an 
intrinsic endonuclease activity responsible for the ‘slicing’ of mRNA targets, an activity that is abrogated when bulges 
or mismatches face nucleotides 10-11 of the miRNAs. Such mismatches promote in turn alternative forms of target 
repression such as the translational inhibition and/or decay of the mRNAs. Intriguingly, the fact that in Arabidopsis most 
of the miRNAs regulates their target mRNAs via perfect or near-perfect complementarity has contributed to the 
widespread belief that plant miRNAs, unlike their animal counterparts, exert their effect mostly through target mRNA 
slicing. Yet, a previous work notably carried out in our lab suggests that these miRNAs can concurrently slice and 
transnationally inhibit a given pool of mRNAs. This raises the fundamental question of how slicing is avoided during 
translational inhibition. One possibility is that translational repressor proteins actually associate to AGO1 in order 
to change further the fate of the target mRNAs. Following this hypothesis, we have biochemically isolated three 
AGO1-associated factors. Here, we show that these proteins genetically interact with AGO1; they do not affect the 
miRNAs biogenesis, nor the stability of the main silencing factors, but clearly change the mode of action of AGO1. 
Indeed, upon deletion of these proteins, the slicing activity of AGO1 is greatly improved, favouring the cleavage of 
the target mRNAs. Surprisingly, this property also gives to these mutant plants a stronger resistance upon infection 
by the Tobacco rattle virus (TRV). Together, our results revealed the existence of three AGO1 partners that seem 
important to modulate the slicing activity of AGO1. As multiple pools of AGO1 co-exist in Arabidopsis, we propose 
that these factors act as guides and drive AGO1 toward a specific protein complex in which the translational inhibition 
is favoured over slicing.
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210 A Human Dicer caught in the act via single-molecule fluorescence spectroscopy
Mohamed Fareh1, Kyu-Hyeon Yeom1, 2, Anna S. Haagsma1, V. Narry Kim2, Chirlmin Joo1
1Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, Delft, 
The Netherlands; 2Institute for Basic Science and School of Biological Sciences, Seoul National University, 
Seoul 151-742, Korea.
The microRNAs are endogenous small non-coding RNAs generated through a series of enzymatic processing 
steps. After an RNA transcript is processed by the Drosha complex, the precursor miRNA (pre-miRNA) is exported to 
the cytoplasm where it is cleaved by the Dicer complex. The latter contains Dicer and several non-catalytic accessory 
proteins such as TRBP and PACT. Despite the discovery of the key actors in the miRNA biogenesis, the molecular 
basis of miRNA maturation remains unclear. In order to unveil the molecular mechanisms of pre-miRNA processing 
by the Dicer complex, we have developed a single-molecule technique by combining fluorescence spectroscopy with 
a protein complex pull-down assay. Using this new technique, we have shown step by step the action mechanism 
of human Dicer and its cofactors – from RNA binding and cleavage to product release. Our single-molecule data 
highlights novel coordination between Dicer and its cofactors.
209 C Identification of anhydrobiosis-related genes using RNA interference with 27-bp RNA 
duplexes
Cláudia Evangelista1, Gustavo Borges1, Alan Tunnacliffe2, Tiago Pereira1
1University of São Paulo; 2University of Cambridge
Anhydrobiosis is a highly stable state of biological organization that is achieved by certain species when exposed 
to extreme water stress. During anhydrobiosis, specimens can be submitted to diverse abiotic stresses such as UV light, 
radiation and pressure, and still remain viable. RNA interference (RNAi) has been used to identify anhydrobiosis-
related genes in order to allow the development of future technologies enabling more efficient methods for conserving 
organs, vaccines, enzymes and molecules of interest.
RNAi can be triggered in the anhydrobiotic nematode Panagrolaimus superbus through many ways, as i) micro-
injection, ii) feeding or iii) soaking.  We decided to do a screening of 25 genes that have been described as up-regulated 
during desiccation in other anhydrobiotic species, using soaking with 27 bp siRNAs (dicer substrates), approach that 
is much simpler since dicer substrates can be commercially purchased and was shown by our group as an efficiently 
technique of triggers RNAi.
Worms were grown at 20°C in the dark, collected from culture plates and transferred to tubes containing siRNAs 
against a target gene in the final concentrations of 1 mM.  They were kept in the dark for 24 hours at 21°C. Dicer 
substrates were designed in the program Strand Analysis. After soaking, to determine whether the knockdown leads to 
lethal effects, survival percentages were determined by staining with Erythrosin B. To determine the effect of RNAi 
knockdown on desiccation resistance, the worms were immobilized on 0.45 µm Supor filter membranes by vacuum 
filtration with a Sartorius funnel, then placed into 1.5 mL test tubes. Worms were then subjected to the following 
conditions: 98% relative humidity (RH) for 24 h (in a saturated solution of copper sulphate); 10% RH for 24 h (in dry 
silica gel) and pre-hydration in 100% RH for 24 h (in distilled water vapour). Rehydration was achieved by adding 
1.5 mL of M9 buffer to the tubes. Determination of viability after desiccation was done by staining with Erythrosin B.
On this screening, we were able to identify that 12% of the selected genes showed significant reduction in 
viability after silencing and desiccation. This study is important to guide our next steps on the comprehension of the 
anhydrobiotic process. Our findings may accelerate the process of identifying anhydrobiosis-related genes.
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212 C Analysis on viral suppressors of RNA silencing in plant cell-free RISC assembly system
Taichiro Iki1, Olivier Voinnet2
1Department of Biology (Plant Sciences), Swiss Federal Institute of Technology (ETH); 2Swiss Federal 
Institute of Technology Zurich Department of Biology Chair of RNA biology
Small RNAs including small interfering RNAs (siRNAs) and microRNA (miRNAs) play large roles in both 
plant and animal gene expression. The effector complex of posttranscriptional gene silencing (PTGS), RNA-induced 
silencing complex (RISC), contains a single-stranded small RNA bound to an ARGONAUTE family protein (AGO). 
RISC represses gene expression, guided by the small RNA to complementary sequences on target RNAs. RISC 
assembly is a key step of RNA silencing. On plant RISC assembly, small RNA duplexes are loaded onto AGOs in 
a manner dependent on molecular chaperone machinery, followed by removal of one strand of the duplex. PTGS is 
an important mechanism for antiviral defense in plants. To counteract this defense, viruses express viral suppressors 
of RNA silencing (VSRs). Despite accumulating evidence of VSRs, it is not clear how VSRs act on host PTGS. The 
VSR functions have not been hitherto addressed in a plant cell-free system that recapitulates RISC assembly. This 
study analyzes the roles of several VSRs, includingTomato bushy stunt virus P19, Turnip crinkle virus P38, Peanut 
clump virus P15, Cucumber mosaic virus 2b, and Potato virus Y HC-Pro, in a cell-free RISC assembly system that 
has been recently developed by using extracts of evacuolated tobacco BY-2 protoplasts (BYL). All VSRs synthesized 
by in vitro translation inhibited RISC assembly, but did not affect target RNA cleavage by preassembled RISC. The 
inhibitory effect of VSR on RISC assembly was different among tested synthetic small RNA duplexes. The present 
study can reveal novel characteristics of VSRs, and further help dissect molecular mechanisms underlying PTGS.
211 B Single-molecule view on the action of Drosophila Dicer-2
Anna C. Haagsma, Mohamed Fareh, Chirlmin Joo
#N/A
RNA interference is a novel gene regulation process which involves small interfering RNAs (~20-30 nucleotides). 
The small interfering RNAs contribute to a multitude of cellular processes including development, metabolism and 
stress responses. The RNase III family enzyme Dicer is a specialized class of endonucleases that cleave double-
stranded RNAs into small interfering RNAs [1, 2]. Despite the importance of the enzyme in RNA interference, the 
mechanism of Dicer is not yet fully understood. Drosophila has two types of Dicer with distinct biological functions. 
Among these two, Dicer-2 plays a critical role in transposon control and defense against viral infection. Dicer-2 
processes a long double-stranded RNA into many short interfering RNAs. For efficient processing of a long double-
stranded RNA, Dicer-2 may utilize a translocation mechanism through its helicase domain [3, 4]. By pulling down 
Dicer-2 out of insect cell extracts and immobilizing on a single-molecule imaging surface [5], we attempt to visualize 
the putative translocation process of the Dicer-2 protein for the first time.
1. Carthew & Sontheimer (2009) Origins and mechanisms of miRNAs and siRNAs. Cell, 136: 642-655.
2. Jinek & Doudna (2009) A three-dimensional view of the molecular machinery of RNA interference. Nature, 457: 405-412.
3. Cenik et al. (2011) Phosphate and R2D2 restrict the substrate specificity of Dicer-2, an ATP-driven ribonuclease. Mol. 
Cell., 42: 172-184.
4. Welker et al. (2011) Dicer’s helicase domain discriminates dsRNA termini to promote an altered reaction mode. Mol. 
Cell., 41: 589-599.
5. Yeom et al. (2011) Single molecule approach to immunoprecipitated protein complexes: insights into miRNA 
uridylation. EMBO reports, 12: 690-696.
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214 B Investigating the potential role of an archaeal Argonaute in the subtype III-B CRISPR 
system of M. piezophila
Emine Kaya1, Jennifer A. Doudna2
1University of California, Berkeley; 2Department of Molecular and Cell Biology, Howard Hughes Medical 
Institute, Department of Chemistry, University of California, Berkeley, California 94720, USA and Physical 
Biosciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA
Members of the Argonaute protein family are found in all higher eukaryotes and have important functions in translational 
regulation of gene products, as well as defense against viruses or transposable elements. In processes known as RNA interference 
(RNAi) and microRNA (miRNA) mediated silencing, Argonaute proteins associate with small non-coding RNAs and use them 
as guides to bind to complementary RNAs.(1) Instead of using RNAi as a defense mechanism against non-self genetic elements, 
archaeal and many bacterial genomes contain Clustered Regularly Interspaced Short Palindrome Repeats (CRISPR) and variable 
arrays of the CRISPR-associated (cas) genes, which together form the CRISPR-associated system (CASS).(2) In a manner 
analogous to RNAi, this adaptive immune system uses small RNAs to specifically target and degrade foreign genetic elements 
derived from phages and/or plasmids.
Despite the absence of homologous RNAi pathways, Argonaute proteins have been identified in prokaryotes. The crystal 
structures of several bacterial and archaeal Argonautes revealed the same domain architecture as their eukaryotic homologs. 
Furthermore, catalyltically active prokaryotic Argonautes have been shown to bind small nucleic acid guides for endonucleolytic 
cleavage of complementary targets in vitro. However, the biological function of prokaryotic Argonaute proteins remains unknown.(3)
Recent phylogenetic analyses by Makarova et al. revealed the genomic colocalization of members of the Argonaute family 
and CASS in archaea.(4) Potentially active Argonaute proteins are encoded in the CRISPR subtype III-A and III-B loci in the 
archaeal species Methanopyrus kandleri and Marinitoga piezophila, respectively. In both genomes, the Argonaute protein is in the 
same operon as Cas1 and Cas2, which are likely to be responsible for spacer acquisition. Here, I present my recent efforts towards 
characterizing the CRISPR subtype III-B operon of M. piezophila and elucidating the role of Argonaute in this system.
1. M. Jinek, J. A. Doudna, Nature 457, 405 (2009).
2. B. Wiedenheft, S. H. Sternberg, J. A. Doudna, Nature 482, 331 (2012).
3. a) Y. Wang et al., Nature 456, 921 (2008). b) J. S. Parker, S. M. Roe, D. Barford, Nature 434, 663 (2005). c) J. B. Ma et 
al., Nature 434, 666 (2005). d) Y. R. Yuan et al., Mol. Cell 19, 405 (2005).
4. K. S. Makarova, Y. I. Wolf, J. van der Oost, E. V. Koonin, Biol. Direct 4, 29 (2009).
213 A Real-time observation of target binding and dissociation of Argonaute-guide complex
Seung-Ryoung Jung1, Eunji Kim2, Soochul Shin3, Wonseok Hwang1, Ji-Joon Song2, Sungchul Hohng4
1Department of Physics and Astronomy, Seoul National University; 2Department of Biological Sciences, 
Graduate School of Nanoscience and Technology (WCU), KAIST; 3Department of Biophysics and Chemical 
Biology, Seoul National University; 4Department of Physics and Astronomy, Department of Biophysics and 
Chemical Biology, Seoul National University
Argonaute (Ago) is the key component of the RISC (RNA-induced silencing complex) which is an effector of 
small RNA(20–30nt)-based gene regulation. In the regulatory process, target recognition by Ago-guide is important 
for controlling gene expression vigorously. Target dissociation is also crucial for the recycling of Ago in the regulation. 
Here, by using single-molecule fluorescence resonance transfer (FRET) assays and Thermus thermophilus Ago 
(TtAgo), we monitor the target binding/dissociation kinetics of Ago-guide and reveal that different regions of guide-
target base pairing have different roles in their binding and dissociation.
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216 A crRNA-guided R-loop formation and the architecture of the Type I-C Cascade
Ki Hyun Nam1, Ailong Ke1
1Cornell University
CRISPR-Cas system serves as an RNA-based immune system against invasive genetic elements. In several Type I 
CRISPR-Cas systems, the subtype-specific Cas proteins assemble around the CRISPR RNA (crRNA) to form Cascade, 
which recognizes the target ds-DNA in a sequence specific fashion. Here we reveal the discrete biochemical steps 
leading to the target DNA recognition by the B. halodurans Type I-C Cascade, report its low resolution EM structure, and 
the crystal structure analysis of the scaffolding protein Csd2. We provide evidence that I-C Cascade actively promotes 
the base-pairing between crRNA spacer and the target ds-DNA, forming the R-loop structure. The architecture of B. 
halodurans Type I-C Cascade resembles E. coli Type I-E Cascade, with minor architectural differences. The Csd2 
crystal structure containss a ferredoxin fold and a positively charged groove, which upon oligomerization forms an 
extended nonspecific binding surface for crRNA or crRNA/DNA duplex. Mutagenesis guided by the crystal structure 
and EM docking further provides insights about the nucleic acid binding and oligomerization mechanisms in Csd2. 
Overall, our results define the molecular function of Type I-C Cascade.
215 C NMR structural study of the two N-terminal dsRBDs of TRBP in complex with siRNA.
Gregoire Masliah1, Christophe Maris1, Juerg Hunziker2, Nicole Meisner2, Frederic Allain1
1Institute of Molecular Biology and Biophysics, ETH Zürich, Schafmattstrasse 30, 8093 Zürich (Switzerland); 
2Novartis Institutes for Biomedical Research, Basel, Switzerland
RNA interference mediated by small interfering (si)- or micro (mi)- RNA is a cellular mechanism of gene expression 
regulation at the post-transcriptional level. The molecular effector is the RISC (RNA InducedSilencing Complex), a 
ribonucleoparticle comprising the protein Argonaute (Ago) and a single strand RNA called the siRNA ‘guide strand’. 
Messenger-RNA recognition by the RISC, occurring through the sequence specific annealing with the guide strand, 
leads to translation inhibition and/or mRNA degradation.
Si-RNA guide strand precursors are RNA duplexes of ca. 20 base pairs. However, only one strand is selected and 
loaded into Ago during each RISC formation event. For a particular class of siRNA called asymmetric siRNA, the 
guide strand selection process is strongly biased, with one strand of the siRNA duplex being preferentially loaded into 
Ago. Although this property has been shown to correlate with the thermodynamics stability of the siRNA extremities, 
the molecular mechanism of the selection process is not understood yet. The key protein factors involved in the guide 
strand selection process are Ago, TRBP, and Dicer, associated into the RLC (RISC Loading Complex), but the relative 
contribution of these is yet unknown.
In order to understand better the contribution of TRBP in RISC loading, we carried out a structural study of its two 
N-terminal dsRBDs (dsRNA Binding Domains) (dsRBD12) in complex with various siRNAs by NMR spectroscopy. 
Three-dimensional structures of the each dsRBD were solved in their RNA bound form, revealing the presence of 
an additional α-helix at the N-terminus of the first dsRBD. Intermolecular contacts observed between dsRBD12 
and a highly asymmetric siRNA indicate the presence of two major dsRBD12 binding sites. Furthermore, RDC 
(Residual Dipolar Coupling) data measured in two different media suggest that the two dsRBDs of TRBP do not bind 
siRNA independently, but rather adopt a well-defined orientation relative to one another. Interested by the impact of 
siRNA methylation in silencing activity, we tested whether siRNA methylation would also have an impact on TRBP-
siRNA binding. Our NMR data show that position specific methylation of RNA actually affects TRBP binding on 
siRNA. Overall, by helping to characterize siRNA recognition by TRBP, our results contribute to the understanding of 
the role of TRBP in RNA silencing.
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218 C The rough Endoplasmatic Reticulum is the central nucleation site of siRNA-mediated RNA 
silencing
Lukas Stalder1, Wolf Heusermann6, Lena Sokol5, Dominic Trojer4, Anja Fritzsche4, Jan Weiler4, Martin 
Hintersteiner2, Florian Aeschimann3, David Morrissey4, Nicole Meisner Kober4
1SAKK, Bern, Switzerland; 2Bioseutica Pharma; 3Friedrich Miescher Institute, Basel, Switzerland; 4Novartis 
Institutes for Biomedical Research; 5Novartis Institutes for Biomedical Research and Friedrich Miescher 
Institute, Basel, Switzerland; 6Novartis Institutes for Biomedical Research, Basel, Switzerland
Despite of progress in mechanistic understanding of the RNA interference (RNAi) pathways, the subcellular sites 
of RNA silencing still remain under debate. We will present a quantitative tracing of the fate of exogenous siRNA 
within the cell upon lipid delivery. Our data demonstrate that entry of siRNA in the RNAi pathway with current 
delivery vehicles is highly inefficient, whereas trafficking of the siRNA to the site of RISC (RNA induced silencing 
complexes) loading emerges as one major rate limiting step. We will further present data which reveal that loading of 
lipid-transfected siRNAs and endogenous microRNAs  into RISC, encounter of the target mRNA, and Ago2-mediated 
mRNA slicing in mammalian cells are nucleated at the cytosolic membrane of the rough endoplasmic reticulum 
(rER). We identify TRBP and PACT as key factors anchoring RISC to ER membranes in an RNA-independent manner. 
Finally we will discuss implications of our work on the development of next generation, subcellular targeted delivery 
strategies for RNAi therapeutics.
217 B P body-associated RNA silencing complex PRSC of Cryptococcus effects transposon 
suppression
Prashanthi Natarajan1, Joshua Dunn1, Jonathan Weissman1, Phillip Dumesic1, Hiten Madhani1
1University of California San Francisco
We recently described a novel RNA silencing system in the yeast Cryptococcus neoformans (Dumesic, Natarajan 
et al., Cell, 152, 957-968, 2013), in which stalled spliceosomes serve as a signal for RNAi-mediated genome defense. 
In addition to the nuclear SCANR complex required for siRNA accumulation, we described PRSC, a P body-associated 
RNA silencing complex.  PRSC is dispensable for siRNA accumulation, suggesting it is an effector complex.  PRSC 
contains two subunits:  the Argonaute, Ago1 and a glycine-tryptophan(GW) motif protein, Gwo1.  Gwo1 and mammalian 
GW182 family members are best reciprocal protein search hits suggesting they are orthologs.  Together with their 
similar association with Argonaute proteins and their localization to P-bodies, the effector complexes from the yeast 
and mammalian systems appear to be striking similar.  Consistent with this view, PRSC physically associates with 
mRNAs targeted by small RNAs in a siRNA-dependent manner.  To probe the biological function of RNA silencing, 
we developed a quantitative in vivo transposon mobilization assay using a marked Harbinger DNA tranposon. We 
found PRSC and SCANR are both required for suppression of transposon mobilization in vivo:  specifically, we 
observed a 1000-fold increase in the frequency excision events in null mutants in either complex, supporting the view 
that PRSC is a genome defense effector complex. Despite the magnitude of its effect on transposon mobilization, 
cells lacking PRSC display only modest increases in target RNA levels.  This raised the possibility that that PRSC, 
like mammalian GW182-Argonaute complexes, controls the translation of targets mRNAs. To probe the mechanistic 
role of PRSC, we successfully implemented ribosome profiling in Cryptococcus to examine the impact of PRSC on 
transcriptome-wide ribosome occupancy.  Insights into the role of PRSC obtained from these experiments will be 
described.
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219 A Functional characterization of DCL1 and DCL2 proteins from Medicago truncatula
Aleksander Tworak1, Anna Urbanowicz1, Jan Podkowinski1, Marek Figlerowicz1
1Department of Molecular and Systems Biology, Institute of Bioorganic Chemistry, Polish Academy of 
Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland
In eukaryotic organisms several types of 21-24 nucleotides long RNA molecules (called small regulatory RNA; 
srRNA) are involved in the sequence-specific regulation of numerous biological processes, including developmental 
and stress response pathways or pathogen defense. This widespread mechanism of RNA-mediated regulation 
is facilitated by a range of proteins which participate in processing of srRNA precursors, and enable functioning 
of the mature products. Among them ribonuclease III Dicer was identified as the key enzyme involved in the last 
step of srRNA biogenesis. Mammals and many other animals use a single Dicer enzyme to generate a complex 
spectrum of srRNAs. In contrast, there are several Dicer-like proteins (DCL) typically found in plants. In Arabidopsis 
thaliana four DCL proteins were identified (AtDCL1-4). The consecutive studies demonstrated that each AtDCL 
protein is predominantly specialized in the production of different class of small RNAs. AtDCL1 mainly produces 
21 nt long microRNAs, while the products of AtDCL2, AtDCL3, and AtDCL4 are various small interfering RNAs 
(siRNAs) of 22, 24, and 21 nucleotides in length, respectively. However, some functional overlaps for Arabidopsis 
DCL proteins were also showed. Considerably less information concerning Dicer-like proteins from other plants is 
available.
In order to increase our knowledge on DCL proteins in legume plants we attempted to determine how many 
members of a DCL family are encoded in the genome of Medicago truncatula. We obtained the full-length cDNAs 
coding for MtDCL1 and MtDCL2 proteins and determined the profile of their genes expression in different plant 
tissues and at different developmental stages. Next, we produced the peptides representing the “catalytic cores” of both 
proteins (MtDCL1-CC and MtDCL2-CC) and characterized in vitro their enzymatic activity and substrate specificity. 
Finally, we compared the enzymatic activity of MtDCL1-CC and MtDCL2-CC with the activity of two commercially 
available enzymes: human Dicer and parasitic protozoan Giardia intestinalis Dicer. The former is composed of a full 
set of functional domains typically found in Dicer-type proteins, while the latter can be classified as a minimal Dicer, 
similar to MtDCL1- and MtDCL2-CC.
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220 B Distinct activities of the Dictyostelium discoideum RNA-dependent RNA polymerases in 
post-transcriptional gene regulation
Stephan Wiegand1, Carsten Seehafer1, Marek Malicki1, Patrick Hofmann5, Annika Schmith2, Thomas Winckler2, 
Balint Földesi6, Benjamin Boesler6, Wolfgang Nellen6, Johan Reimegård4, Lotta Avesson3, Fredrik Söderbom7, 
Christian Hammann1
1Jacobs University Bremen; 2Friedrich-Schiller-Universität Jena; 3Garvan Institute of Medical Research; 
4KTH Royal Institute of Technology; 5TU Darmstadt; 6University of Kassel; 7Uppsala University
Cellular RNA dependent RNA polymerases (RdRPs) are involved in various processes of gene regulation 
and different mechanisms for their action have been proposed. To study the function of the three RdRPs in the 
amoeba Dictyostelium discoideum, we have deleted the encoding genes rrpA, rrpB and rrpC in all possible 
combinations. We show that the two RdRPs RrpA and RrpC of the amoeba exert specific, non-overlapping roles in the 
regulation of retrotransposons and microRNAs.
Strains lacking RrpC strongly accumulate transcripts of the centromeric retrotransposon DIRS-1 and show a 
dramatic loss of DIRS-1 small RNAs, which are asymmetrically distributed in the wild type, as shown by deep 
sequencing. We report the discovery of an hitherto unknown long antisense DIRS-1 transcript that is driven by the 
promoter activity of the right inverted long terminal repeat. Fluorescence in situ hybridization shows both this long 
antisense transcripts and the sense RNA in nuclear spots. We propose that in wild type cells, both DIRS-1 transcripts are 
generated, but post-transcriptionally degraded by the action of RrpC, possibly with the help a Dicer-related nucleases 
in the amoeba. By this, RrpC apparently serves to prevent retrotransposition, as we observe a strong accumulation of 
DIRS-1 copies in the genome of the rrpC gene deletion strain.
In contrast to this, the silencing of another retrotransposon, Skipper, appears to be mediated by RrpA and the 
Dicer-related nuclease DrnB. Deletion strains of the respective genes display strongly increased Skipper transcript 
levels, but here, surprisingly, also small RNA levels are elevated. Such increased RNA levels in strains lacking RdRPs 
were also observed for other types of small RNAs, including microRNAs.
To study the activity of the RdRPs molecularly, we have investigated in the rrp gene deletion strains the appearance 
of small RNAs derived by antisense or hairpin RNA constructs against the transgene lacZ. Both types of constructs 
led to a similar reduction of the enzymatic activity of β-Galactosidase. However, only in rrpC knock out strains, low 
levels of β-gal small interfering RNAs (siRNAs) could be detected in antisense RNA expressing strains. In contrast 
to this, and at considerably higher levels, all hairpin RNA expressing strains featured β-gal siRNAs. Spreading of 
the silencing signal to mRNA sequences 5’ of the original hairpin trigger was observed in all strains, except when 
the rrpC gene or that for the Dicer-related nuclease DrnB was deleted, indicating that transitivity of an RNA silencing 
signal exists in D. discoideum and that it requires the two enzymes RrpC and DrnB.
In summary, our data indicates that the RdRPs RrpA and RrpC have specific endogenous targets in D. discoideum and 
that gene silencing triggered by antisense RNA and hairpin RNA works through different mechanisms despite an 
overall similar efficiency.
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222 A The CCR4-NOT complex releases PABP from silenced miRNA targets in the absence of 
deadenylation
Latifa Zekri1, Elisa Izaurralde1
1Department of Biochemistry-Max Planck Institute for Developmental Biology
GW182 family proteins interact with Argonaute proteins and are required for the translational repression, 
deadenylation and decay of miRNA targets. To elicit these effects, GW182 proteins interact with PABP and the CCR4-
NOT deadenylase complex. Although the mechanism of miRNA target deadenylation is relatively well understood, 
how GW182 proteins repress translation is not known. Here, we demonstrate that GW182 proteins decrease the 
association of PABP with silenced targets in the absence of deadenylation. We further show that the dissociation of 
PABP contributes approximately 2-fold to repression, indicating that additional repressive mechanisms are used by 
miRISCs to achieve maximal target silencing. Remarkably, PABP dissociation requires the interaction of GW182 
proteins with the CCR4-NOT complex but not with PABP. Accordingly, NOT1, POP2 and CCR4 cause dissociation 
of PABP from bound mRNAs in the absence of deadenylation. Our findings indicate that the recruitment of the CCR4-
NOT complex to miRNA targets by GW182 proteins releases PABP from the mRNA poly(A) tail, thereby facilitating 
translational repression and deadenylation. To gain further insight into the mechanism of PABP release by the CCR4-
NOT complex, we are currently investigating which subunit(s) of the CCR4-NOT complex contacts directly PABP 
and is responsible for PABP release. Given the central role of the CCR4-NOT complex in post-transcriptional mRNA 
regulation, we anticipate that this novel activity of the complex will contribute to the translational repression of a large 
variety of different mRNAs.
221 C Computational Analyses and Experiments Indicate Role of Guide RNA Structure in 
MicroRNA::Target Interaction
Yilong Wu1, Jun Zhong1, Christian Köberle2, Stefan Kaufmann3, Volker Patzel1
1National University of Singapore; 2imaGenes GmbH; 3Max Planck Institute for Infection Biology
MicroRNAs (miRNAs) are small noncoding RNAs which regulate expression of numerous metazoan genes 
posttranscriptionally. Binding of mature miRNAs guides RNA-induced silencing complexes to complementary 
messenger RNA targets. We investigated the role of guide structures in miRNA::target interactions using computational 
RNA secondary structure analyses and experimental gene knockdown assays. The computational investigation revealed 
characteristic common and species-specific features. Virtually all structures contained at least one unpaired site 
suitable for nucleation suggesting that the kinetics of RNA-RNA interactions contribute to RISC binding. Structures 
of mature human miRNAs were found to have a preference for U/A-rich unpaired 5’ends and U/G-rich paired 3’ends. 
Unpaired sites matching with validated targets were rich in base-pairing-competent bases G and U and poor in A and 
C as compared to nonmatching sites indicating the involvement of such sites in miRNA::target interactions. One 
group of miRNAs preferred a single nucleation site, located either 5’ terminal, 3’ terminal or central, whilst others 
appeared to be bi- or multivalent. Conversely, local mRNA targets allowed only one kind of nucleation indicating that 
mRNAs select their miRNA partners as much as the other way around. We experimentally confirmed this hypothesis 
by comparing wild-type miRNAs with mutants in which target base-pairing was unchanged but which comprised 
reprogrammed guide structures and nucleation sites. Removal of nucleation sites resulted in reduced silencing, 
whereas switch from one to another allowed interactions, did not affect silencing. Nucleation site changes yielding 
site extensions enhanced silencing. We suggest a two-phase control mechanism of miRNA::target interactions: First, 
a kinetic nucleation-based control dictated by the mRNA target site repelling false-positive seed matches and second 
a thermodynamically controlled seed match verification process dominated by the sequence of the mature miRNA.
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223 B Characterization of small RNAs that contribute to ribosomal RNA gene silencing through 
the siRNA machinery
Blake Atwood1, Keith Giles1, Karen Beemon2
1University of Alabama at Birmingham; 2Johns Hopkins University
Cellular growth and division is limited by the number of ribosomes actively translating mRNA in the cell. The 
ribosomal RNA gene is highly transcribed making up to 80% of total RNA transcribed in the cells with the deregulation 
thereof leading to abnormal cellular growth and cancer. In normal human haploid cells there are approximately 200 
copies of the ribosomal RNA gene of which half are maintained in a silent and heterochromatic state. Maintaining 
the ratio of active to silent ribosomal DNA loci seems to be critical in maintaining normal cellular homeostasis. The 
major Polymerase that transcribes the ribosomal DNA locus is RNA Pol I. Data suggest that Pol II is also localized 
to the ribosomal DNA locus and that the low level of transcription by Pol II aids in maintaining the silent loci 
in a heterochromatic state. These Pol II transcripts of the ribosomal DNA locus provide Argonaute 2 with small 
RNAs which allow it to be in turn targeted to the ribosomal DNA. Argonaute 2 then recruits the necessary silencing 
machinery to maintain the silent loci in their heterochromatic state thus maintaining a normal cellular growth rate. The 
major goal of this work is to characterize the small RNAs transcribed by Pol II and how they feed into the ribosomal 
DNA silencing pathway.
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224 C Structural Characterization of the RNA, Cyp33, MLL, Histone H3 Interaction Network
Markus Blatter1, Charlotte Meylan1, Frédéric H.-T. Allain1
1ETH Zurich, Institute of Molecular Biology & Biophysics, Switzerland
The Cyclophilin 33 (Cyp33) is a member of the cis-trans peptidyl-prolyl isomerases family of cyclophilins. 
Members of this family possess various additional domains. Cyp33 includes an N-terminal RNA Recognition Motif 
(RRM) domain next to the conserved cyclophilin domain with PPIase activity.
It was shown that the RRM domain of Cyp33 mutually exclusive binds to RNA and the third Plant Homeobox 
domain (PHD3) of the Mixed Lineage Leukemia factor (MLL) [1]. This competitive binding makes Cyp33 unique 
among the RNA recognition motif. Further it was demonstrated that the binding of Cyp33 to the Mixed Lineage 
Leukemia factor down-regulates the expression of some targets of MLL, which is a transcription activator for a series 
of genes from the HOX family. RNA binding sequences of Cyp33-RRM can be found in an non-coding RNA (ncRNA) 
located in the 3’-UTR of HOXC8, which itself is a target of MLL. Addition of this ncRNA rescues the expression 
of HOXC8 in cells with a silent HOXC locus leading to the theory that Cyp33 bound to MLL is sequestered by the 
ncRNA and thereby allow MLL to switch back to it activation state. In its transcriptional active state MLL is bound 
to a specific epigenetic mark on Histone H3 (H3K4me3) mediated by the PHD3 domain, the same domain which also 
interacts with the RRM of Cyp33. MLL is an oncoprotein and it fusion variants are associated with infant leukemia. 
All of the fusion variants of MLL lack the cassette of the homeobox and all subsequent domains. It was shown that 
reinsertion of the third PHD domain (PHD3) rescues the aberrant transcription caused by MLL fusion proteins [2]. 
This emphasizes the importance of this interaction network between RNA, Cyp33, MLL and H3K4me3.
In this project we studied the various structural aspects of all four component of the beforehand described 
interaction network using Nuclear Magnetic Resonance spectroscopy and Isothermal Titration Calorimetry. Using 
different labeling schemes we expressed the RRM domain of human Cyp33 and in addition to the PHD3 domain 
of human MLL. Further we used different RNAs (AAUAAA and UAAUGUCG) and the Histone H3 peptide with 
ammonium tri-methylation at lysine four (H3K4me3).
The structure of Cyp33-RRM in free state revealed a third alpha helix in the conserved C-terminal extension 
of the RRM which folds back on the RRM beta-sheet. Different binding registers precluded an accurate structure 
determination of the RRM bound to RNA. After all we obtained a model for such a complex which shows that the third 
helix has to dissociate from the beta-sheet in order to allow complexation with RNA. Structure determination of the 
Cyp33-RRM : MLL-PHD3 complex in combination with ITC experiments involving H3K4me3 revealed an allosteric 
effect in ternary complex formation of Cyp3-RRM, MLL-PHD3 and the epigenetically marked tail of Histone H3.
1. Wang, Z., et al., Cell, 2010. 141(7): p. 1183-94.
2. Muntean, A.G., et al., Blood, 2008. 112(12): p. 4690-3.
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226 B Human Argonaute Suppresses Cryptic RNA Polymerase II Transcription and Chromatin 
Structure of the Silent rRNA Genes.
Keith Giles1, Gaelle Lefevre2, Blake Atwood1, Mariana Saint Just Ribeiro1, Gary Felsenfeld2
1University of Alabama at Birmingham; 2NIDDK/NIH
Eukaryotic cells package much of their genome into a heterochromatic structure in order to facilitate the proper regulation 
of gene expression and nuclear organization.  In S. pombe, the initiation of heterochromatin structure is mediated by the highly 
conserved RNAi machinery but it remains unclear if RNAi performs a similar function in humans.  To examine this question, 
we performed a genome-wide analysis of the chromatin binding sites of hAgo2 in the human erythroleukemia cell line, K562. 
Our results suggest that hAgo2 is found almost exclusively within repetitive DNA sequences, with a strong preference for the 
coding region of the silent ribosomal DNA loci (Figure 1, below).  This localization is Dicer-dependent, and correlates with 
Dicer-processed, hAgo2- bound, small RNAs.  Knockdown of hAgo2 causes a ~10% increase in the synthesis rate of the mature 
28S and 18S rRNAs. However, a knockdown of hAgo2 causes a ~3-fold increase in synthesis of cryptic RNA species originating 
from the rRNA gene body.  This increase corresponds with a 3-fold increase in Pol-II localization.  Ago2 is needed to maintain 
the proper histone modification pattern, as a loss of hAgo2 causes a loss of H3K9me2 and an increase in H4ac throughout the 
locus.  This change in histone modification pattern is likely a consequence of the loss of Suv39H1 recruitment in hAgo2 KD 
cells.   Consistent with a role in regulating only the silent rRNA genes, hAgo2 does not localize within the nucleolus and has no 
effect on the recruitment of the RNA Polymerase I transcription factor, UBF1.  This interaction is cell cycle specific; hAgo2 is lost 
from the rRNA genes during M-phase.  We present our model of cooperation between hAgo2 and Pol-II in maintaining the proper 
chromatin structure among the silent rRNA genes.
225 A The Igf2as transcript is exported into the cytoplasm and is associated with polysomes
Carolina Duart-Garcia1, Martin Braunschweig1, Tosso Leeb1
1Institute of Genetics, Vetsuisse Faculty, University of Bern, Switzerland
Murine insulin-like growth factor 2 antisense (Igf2as) transcripts originate from the opposite strand of the 
same Igf2 locus as the Igf2 sense mRNA. Igf2as transcripts are located in a cluster of imprinted genes together with Igf2, 
Insulin 2 (Ins2) and H19 genes on chromosome 7. Loss of imprinting of IGF2 locus in humans is associated with 
Beckwith-Wiedemann syndrome (BWS) and Silver-Russell syndrome (SRS) as well as with Wilm’s tumor and colorectal 
cancer. We developed a RNA-FISH protocol to detect and determine the location of Igf2as and Igf2 transcripts. The 
results from the RNA-FISH were confirmed with quantitative real-time PCR and clearly indicate that Igf2as transcripts 
are predominantly located in the cytoplasm of C2C12 cells. A polysome association study was used to determine 
if the Igf2as had coding potential. We showed that Igf2assedimented with polysomes in a sucrose gradient. The 
cellular localization of Igf2as transcripts together with polysome fractionation analysis provides compelling evidence 
that Igf2as is protein coding. We performed expression analysis of Igf2as transcripts in muscle, brain and liver tissues 
at different stages of development. The results showed high Igf2as expression in tissues of fetuses and newborns. 
Contrary, in adult tissues theIgf2as expression was low. These expression patterns indicate that Igf2as plays a role in 
the early developmental stages. To study the function of the new putative protein we are using two approaches. First, 
we are overexpressing Igf2as in transfected C2C12 cells to investigate its effects and to characterize putative proteins. 
Second, we perform an RNA-Seq experiment with RNA from primary muscle cells from DMR1-U2 knockout mice 
compared to wild type cells. Differentially expressed transcripts will be used to conduct a pathway analysis indicating 
potential networks in which Igf2as transcripts may be involved. Results from these experiments will be presented and 
discussed.
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228 A Transcriptome-wide Analysis of the m6A Landscape Reveals Pervasive Adenosine 
Methylation in 3’ UTRs and near Stop Codons
Kate Meyer1, Yogesh Saletore1, Paul Zumbo1, Olivier Elemento1, Christopher Mason1, Samie Jaffrey1
1Weill Medical College, Cornell University
Methylation of the N6 position of adenosine (m6A) is a post-transcriptional RNA modification whose prevalence 
and physiological relevance are poorly understood.  The recent discovery that FTO, an obesity risk gene, encodes an 
m6A demethylase implicates m6A as an important regulator of physiological processes.  Here we show that m6A is 
a highly prevalent base modification which exhibits tissue-specific regulation and is markedly increased throughout 
brain development.  Using a novel method for transcriptome-wide m6A localization termed MeRIP-Seq, we identify 
mRNAs of 7,676 genes which contain m6A, indicating that m6A is a common modification of mRNA.  We find that 
m6A sites are enriched near stop codons and in 3’ UTRs, and we uncover an association between the presence of 
m6A residues and microRNA binding sites within 3’ UTRs.  These findings are the first global identification of the 
transcripts that are substrates for adenosine methylation and reveal novel insights into the epigenetic regulation of the 
mammalian transcriptome.
227 C Histone replacement reveals distinct essential functions for H3K36 methylation
Michael Meers1, A. Gregory Matera2
1University of North Carolina at Chapel Hill; 2University of North Carolina at Chapel Hill, Department of 
Genetics
Histone post-translational modifications (PTMs) are known to function importantly in regulating gene expression, 
primarily at the level of DNA promoters and cis-regulatory elements.  However, recent evidence suggests that PTMs 
may also play important co-transcriptional roles related to RNA processing.  Methylation of lysine 36 of the histone 
H3 subunit (H3K36) in particular has been implicated in co-transcriptional suppression of cryptic transcription 
initiation and, more recently, in regulation of alternative splicing.  Though the complexity of co-transcriptional RNA-
level regulation necessitates a robust, controlled in vivo model to study the effect of depleting histone PTMs upon 
splicing, to date such a model has not been developed.  Crucially, existing studies that link H3K36 methylation 
with RNA processing rely upon perturbation of PTM-catalyzing “writer” enzymes, many of which are known to 
have non-histone substrates that can confound interpretation of phenotypes.  Here we present a novel set of tools 
in Drosophila melanogaster that enable full genetic replacement of endogenous histones with transgenic copies 
bearing PTM-inactivating mutations.  We have generated endogenous histone deletion lines complemented by 
transgenic histones containing mutant H3K36 alleles to facilitate in vivo analysis of the RNA processing consequences 
of eliminating H3K36 methylation.  We report that two H3K36 alleles, alanine (H3K36A) and arginine (H3K36R), 
rescue full histone deletion phenotypes to vastly different degrees, suggesting a separation of essential functions for 
H3K36.  Interestingly, H3K36R animals exhibit locomotion defects two days prior to lethality, suggesting potential 
defects in neuronal processes in which alternative splicing is known to play a prominent role.  We intend to use RNA-
seq to comprehensively evaluate expression and splicing phenotypes manifested in H3K36 alleles.
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230 C Regulation of piRNA production
Prashanth Rangan1
1University at Albany/ RNA Institute
Setting germ cells apart from other somatic cells in the body is crucial for all sexually reproducing organisms. This 
process of germ cell specification occurs early in embryogenesis and requires the conserved process of transcriptional 
silencing. In Drosophila germ cells global transcriptional silencing is mediated by the gene polar granule component (pgc) 
that codes for a small 7 kDa protein. pgc mutant germ cells show precocious active chromatin marks that result in the 
transcription of somatic genes that lead to their death. Thus transcriptional silencing mediated by pgc feeds into the 
epigenetic pathway and plays a critical role in specifying a germ cell fate by suppressing a somatic one. We have found 
that in Drosophila repressive transcriptional mechanisms also play an important role at a different stage of germ cell 
development, namely germ line stem cell (GSC) differentiation. Repressive marks consistent with heterochromatin, 
namely H3K9me3, H4K20me3 and HP1, are enriched in the nuclei of the differentiating GSC daughter. Interestingly, 
H3K9me3 enriched chromosomal sites correlate with the location of piRNA production. The piRNA pathway is a 
small RNA-based mechanism that is a major component of the defense against transposable elements (TE) in the germ 
line. In mutants defective in heterochromatin formation, differentiation of GSC is blocked, piRNA levels are reduced, 
and TE activity is increased. While we thus know that heterochromatin protects the germ line by activating the piRNA 
pathway and repressing transposable elements, we do not understand what controls heterochromatin formation in the 
GSC daughter. Surprisingly, we have observed that the transcriptional silencer pgc that has a known role in germ cell 
specification is also expressed during GSC differentiation. We hypothesize that pgc causes transient transcriptional 
silencing that allows heterochromatin formation on the piRNA producing clusters and thus permits proper GSC 
differentiation. We have shown that the expression of the transcriptional silencer pgc in the GSC daughter is controlled 
by translational control factors Nanos and Pumilio.
229 B Single cell analysis reveals aspects of antisense RNA regulation and mode of action in 
PHO84 transcription repression
Samir Rahman1, Manuele Castelnuovo2, Elisa Guffanti2, Francoise Stutz2, Daniel Zenklusen1
1Université de Montréal; 2University of Geneva
A large number of non-coding RNAs (ncRNAs) are transcribed in yeast; many of them are rapidly degraded by 
the nuclear exosome. The function of most of these ncRNAs, however, is still largely unknown, although a subset 
has been implicated in modulating transcription regulation. Loss of nuclear exosome component Rrp6 results in 
the accumulation of long PHO84 antisense RNAs and repression of sense transcription in a mechanism that 
involves PHO84 promoter deacetylation by the Hda1/2/3 histone deacetlylase complex. Moreover, the Set1 H3K4 
methyl transferase stimulates antisense RNA production, correlating with PHO84repression, the precise mechanisms 
that orchestrates PHO84 transcriptional silencing however is still not fully understood. Here, we use single molecule 
resolution fluorescent in situ hybridization (smFISH) to further investigate ncRNA mediated transcription regulation 
of PHO84 at the single cell level. We show that PHO84 AS transcription acts as a bimodal switch in PHO84 regulation, 
where low frequency PHO84 AS transcription efficiently represses sense transcription within individual cells. 
Surprisingly, PHO84 AS RNAs do not accumulate at the PHO84 gene but are exported to the cytoplasm where they 
are degraded by the 5’-3’ RNA degradation machinery. Furthermore, we show that loss of Rrp6 promotes antisense 
production by reducing early transcription termination by the Nrd1/Nab3/Sen1 complex, rather than by stabilizing 
the PHO84 AS RNA, and that loss of Set1 enhances early termination by promoting Nrd1 recruitment. These 
observations suggest that antisense-mediated repression is regulated, at least in part, at the level of antisense early 
termination, and that PHO84 silencing results from low frequency yet constant antisense transcription through the 
promoter rather than its static accumulation at the repressed gene.
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232 B Introns of plant pri-miRNAs are required for proper biogenesis and function of miRNAs
Dawid Bielewicz1, Malgorzata Kalak1, Maria Kalyna3, David Windels2, Andrea Barta3, Franck Vazquez2, Zofia 
Szweykowska-Kulinska1, Artur Jarmolowski1
1Department of Gene Expression, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland; 
2Botanical Institute of the University of Basel, Zürich-Basel Plant Science Center, Part of the Swiss Plant 
Science Web, Basel, Switzerland; 3Max F. Perutz Laboratories, Medical University of Vienna, Vienna, Austria
Plant MIR genes are independent transcription units that encode long primary miRNA precursors which usually 
contain introns. For two miRNA genes, MIR163 and MIR161, we show that introns are crucial for the accumulation of 
proper levels of mature miRNA. Removal of the intron in both cases led to a drop-off in the level of mature miRNAs. 
We demonstrate that the stimulating effects of the intron mostly reside in the 5’ss rather than on a genuine splicing 
event. Our findings are biologically significant since the presence of functional splice sites in the MIR163 gene appears 
mandatory for pathogen-triggered accumulation of miR163 and proper regulation of at least one of its targets.
231 A Mmi1, an RNA-binding protein, mediates heterochromatin gene silencing by recruiting 
the nuclear exosome to long non-coding RNAs in fission yeast
Andre Verdel1, Edwige Hiriart1, Michael Reuter3, Benoit Gilquin1, Ravi Sachidanandam2, Ramesh Pillai3, Leila 
Touat-Todeschini1
1INSERM, U823; Université Joseph Fourier – Grenoble 1; Institut Albert Bonniot, France; 2Department of 
Genetics and Genomic Sciences, Mount Sinai School of Medecine, New York, U.S.A.; 3European Molecular 
Biology Laboratory, Grenoble, France
RNA mediates epigenetic modifications and drives transcriptional gene silencing in a broad range of eukaryotes. 
In the fission yeast Schizosaccharomyces pombe, heterochromatic gene silencing requires a close interplay between 
RNAi-dependent and -independent processes. However, while the RNAi-dependent process is relatively well 
understood, the RNAi-independent one remains largely unknown. Our studies show that the RNA-binding protein 
Mmi1 and its associated RNA surveillance machinery, which are known to play a central role in fission yeast sexual 
differentiation control, are also involved in the deposition of the heterochromatin H3K9 methylation mark and the 
recruitment of RNAi machinery at specific meiotic genes. In addition and quite unexpectedly, they reveal that Mmi1 
also acts at non-coding regions to mediate heterochromatic gene silencing in parallel of RNAi. We will present our 
latest data defining this new RNA-based RNAi-independent epigenetic silencing mechanism.
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234 A RNA-binding proteins vs. microRNAs: how IGF2BP1 modulates tumor-suppressive 
microRNA-action in tumor cells
Bianca Busch1, Juliane Braun1, Stefan Hüütelmaier1
1Institute of Molecular Medicine,Section for Molecular cell Biology, Martin-Luther-University, Halle (Saale), 
Germany.
The RNA binding protein IGF2BP1 (insulin-like growth factor 2 mRNA binding protein) is highly expressed during 
embryonic development and is often de novo synthesized in cancer. This trait is correlated with tumor progression and 
lower patient survival rates. In the cytoplasm, the protein supports the expression of oncogenic factors like MYC, PTEN 
or ZEB1 and represses the mRNA translation of MAPK4 and ACTB. Through this post-transcriptional gene regulation 
IGF2BP1 promotes cell proliferation, migration and invasion of tumor-derived cells. Most interestingly, ‘aggressive’ tumor 
cells frequently express IGF2BP1 mRNA with shortened 3’untranslated region (UTR). These shorter isoforms usually result 
from alternative cleavage and poly-adenylation. Notably, IGF2BP1 comprises four APA-signals in an approximately 6.7kb 
long 3’UTR. The use of APA-signals eliminates large parts of the 3′UTR and thus shortens transcripts. This consequently 
causes the loss of inhibitory microRNA targeting 3’-UTR. In the case of IGF2BP1, inhibitory microRNAs include the let-7 
family, suggesting regulation of oncofetal IGF2BP1 expression by tumor-suppressive microRNAs.
To identify additional regulatory microRNAs targeting the IGF2BP1 3’UTR in tumor-derived cells, we used the 
complete 3’UTR of IGF2BP1 as a bait in an in vitro microRNA trapping RNA affinity purification assay, termed miTRAP. 
Next-generation sequencing identified co-purified microRNAs and confirmed the association of let-7 family members, 
but also identified various candidate microRNAs regulating IGF2BP1 expression. Significantly, these data indicate the 
microRNA-family 181 as putative strong posttranscriptional regulators of IGF2BP1 expression. Several of the identified 
microRNAs were previously described as tumor-suppressive microRNAs, e.g. miR-181-family and miR-191, -196, -203, 
-205, -24-3p and miR-34a. We hypothesize that IGF2BP1 downregulation is partly responsible for the tumor-suppressive 
nature of these microRNAs. Additionally, the transcription of some of these microRNAs is reduced by the oncogenes MYC 
and ZEB1. By upregulating the expression of both these oncogenes, IGF2BP1 may inhibit the expression of the same tumor 
suppressive microRNAs which we found to target its mRNA.
In brief, we have identified powerful regulatory feed-back loops potentially modulating tumor progression. Current 
studies focus on quantifying the role of IGF2BP1 3’UTR length as a possible oncogenic ‘break’ in these loops and 
understanding the role of these candidate microRNAs in suppressing the oncogenic function of IGF2BP1. 
233 C Common regulation of micro-RNAs by oncogenic transcription factors in B-cell 
lymphomas
Mohan Bolisetty1, Karen Beemon2
1Genetics & Developmental BiologyUniversity of Connecticut Health Center400 Farmington 
AvenueFarmington, CT 06030-6403; 2Biology Dept., Johns Hopkins University, Baltimore, MD 21218 USA
micro-RNAs (miRNA) are regulators of many processes including the development and maintenance of cancer. 
Many important targets of oncomiRs and tumor suppressive miRNAs have been identified; however, the regulation 
of these miRNAs in cancer is not well understood. Here we demonstrate the common regulation of miRNAs by the 
oncogenes v-Rel, c-Myc and the AP-1 transcription factor family. We performed miRNA-seq analysis, comparing 
v-Rel and c-Myc transformed chicken B-cell lines to a normal bursal (B-cell) control and have identified many miRNAs 
that are differentially regulated. More miRNAs  were upregulated than downregulated in this analysis. Using EST 
databases and ChIP-seq data generated by the ENCODE project, we predicted the promoters of 600 human miRNAs 
and found that they are conserved across vertebrates. Further, Rel, Myc, Jun and Fos bind promoters of a common set 
of human miRNAs. Interestingly, we found that most miRNAs upregulated by v-Rel and c-Myc had binding sites in 
human ChiP-seq data, indicating conserved regulation of miRNAs in chickens and humans. Furthermore, some of the 
downregulated miRNAs inhibit Rel transformation capability in an in vitro transformation assay.
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236 C Quantitative analysis reveals extensive target specificity of individual let-7 miRNA family 
members in vivo
Matyas Ecsedi1, Helge Grosshans1
1Friedrich Miescher Institute for Biomedical Research, CH-4002 Basel
Recognition and silencing of miRNA targets is thought to rely chiefly on basepairing of the miRNA ‘seed’ 
(nucleotides 2...8) with target sequence. Since miRNAs can occur in ‘families’, defined by a shared seed sequence, 
members of a given family are considered to function interchangeably in silencing specific targets. Here, we have 
used the let-7 miRNA family in C. elegans as a paradigm to test this hypothesis rigorously and under physiological 
conditions. To this end, we have developed a quantitative imaging assay that examines the effects of endogenous 
miRNAs on reporter transgenes, which we express in various tissues at defined, constitutive but low (physiological) 
levels through targeted single copy transgene integration. We find that let-7 and its sisters act in a strikingly non-
redundant manner. In particular, when examining a number of distinct targets, we observe that they differ not only 
in their spatial repression patterns but also in their response to the loss of individual let-7 family members. This 
specificity is a function of target site sequence, which we demonstrate by reengineering a target of let-7 proper to 
be repressible by distinct family members. Importantly, family member specificity is extensive but not absolute and 
appears to further depend on the cellular levels of a miRNA. Thus, miRNA targeting may simultaneously be more 
restricted as well as dynamic (e.g. across tissues, developmental stages, or in response to environmental cues) than 
anticipated, impacting on both our understanding of miRNA regulatory networks and experimental procedures for 
reliable and meaningful miRNA target validation.
235 B miRNA profiles characterise distinct states of cellular pluripotency
Jennifer Clancy1, Hardip Patel1, Nicole Cloonan2, Andrew Corso3, Mira Puri3, Pete Tonge3, Andras Nagy3, Thomas 
Preiss1
1John Curtin School of Medical Research, Australian National University, Australia; 2Genomic Biology 
Laboratory, Queensland Institute of Medical research, Australia; 3Samuel Lunenfeld Research Institute, 
Mount Sinai Hospital, Toronto, Ontario, Canada
Reprogramming of fibroblasts through induction of the Yamanaka factors (Myc, Sox2, Klf4 and Oct4) is a powerful 
approach to delineate the molecular characteristics of the pluripotent cellular state. We used an efficient secondary 
reprogramming system to monitor whole culture reprogramming over time, allowing us to characterise intermediate 
states as well as to identify several distinct pluripotent cell states. As part of this investigation we measured the 
miRNA profiles of these cell states by next-generation sequencing, which feature marked changes in the expression of 
many of the previously described core miRNA-mediators of pluripotency. We uncover the timing of their involvement 
in the process of pluripotent cell generation, which sheds light on their individual roles in the process, as well as 
on how miRNAs are regulated during reprogramming. We describe the miRNA processing variants that exist in 
these cell states, including 5’ and 3’ isomiRs, non-templated addition, editing and unusual strand bias. Many of the 
core reprogramming miRNAs have isomiRs, which can alter their targeting spectrum and lead to reinterpretation of 
their specific roles. Broader analysis of the dataset also suggests that other small RNA species may be involved in 
pluripotency as, like the miRNA population itself, the small RNA profile changes markedly after induction of the 
Yamanaka factors. This work is part of a larger collaborative study, which co-ordinately measured protein, miRNA, 
mRNA, DNA methylation and histone modification in this model of pluripotent cell generation and related data will 
be discussed in the context of miRNA regulation and function.
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238 B Positive regulation of inflammation by miR-19
Michael Gantier1, H. James Stunden2, Bryan Williams1
1Monash Institute of Medical Research, Monash University, Clayton, Victoria, Australia; 2Institute of Innate 
Immunity, University Hospitals, University of Bonn, Bonn, Germany
microRNAs (miRNAs) are critical for normal cell function, and several miRNAs (e.g. miR-146a) have already 
been found to be involved in the repression of inflammation. To identify miRNAs that enhance inflammation, we 
performed in silico bioinformatic analyses of several known negative regulators of NFκB activity. Putative targeting 
by miRNAs from the oncogenic miR-17~92 cluster was enriched in such genes. Selective inhibition of each member 
of the miR-17~92 cluster demonstrated an important role for miR-19b in the positive regulation of NFκB signaling. 
We confirmed direct targeting of several key negative regulators of NFκB signaling by miR-19b, including A20 and 
its partner RNF11. Specific depletion of miR-17~92 in primary mouse macrophages of miR-17~92 conditional knock 
out mice resulted in dampened production of pro-inflammatory cytokines following innate immune activation. In 
addition, transfection of rheumatoid arthritis primary synovial fibroblasts with miR-19b mimics resulted in increased 
IL-8 production by these cells, establishing a pro-inflammatory effect of miR-19b in the context of disease. Our 
results thereby establish the coordinate regulation of a network of regulators of NFκB activity by miR-19, promoting 
inflammation.
237 A Piwi-Interacting RNAs Protect DNA Against Loss During Oxytricha Genome 
Rearrangement
Wenwen Fang1, Xing Wang1, John Bracht1, Mariusz Nowacki2, Laura Landweber1
1Princeton University; 2Bern University
Genome duality in ciliated protozoa offers a unique system to showcase their epigenome as a model of inheritance. 
In Oxytricha, the somatic genome is responsible for vegetative growth, while the germline contributes DNA to the next 
sexual generation. Somatic nuclear development eliminates all transposons and other “junk DNA”, which constitute 
~95% of the germline. We demonstrate that Piwi-interacting small RNAs (piRNAs) from the maternal nucleus can 
specify genomic regions for retention in this process. Oxytricha piRNAs map primarily to the somatic genome, 
representing the ~5% of the germline that is retained. Furthermore, injection of synthetic piRNAs corresponding to 
normally-deleted regions leads to their retention in subsequent generations. Our findings highlight small RNAs as 
powerful transgenerational carriers of epigenetic information for genome programming.
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240 A miRNA degradation during C. elegans development
Gert-Jan Hendriks1, Dimosthenis Gaidatzis1, Helge Grosshans1
1Friedrich Miescher Institute for Biomedical Research
miRNAs are small non-coding RNAs that regulate gene expression at the posttranscriptional level. These 
endogenous small RNAs have been shown to be involved in numerous physiological and pathological processes in 
many different organisms. Their biogenesis has been widely studied and the main factors involved are conserved 
among species. Mature miRNAs can act on their targets by either translational repression or inducing transcript 
degradation. miRNAs can be specifically degraded and typical half-lives of miRNAs vary from several hours to days. 
In C. elegans, miRNAs are important players in the heterochronic pathway that regulates larval development. A strict 
regulation of transcription as well as biogenesis has been shown to be responsible for this tight control of mature 
miRNA levels. To study the impact of regulated miRNA degradation on miRNA levels during C. elegans development 
we performed small RNA sequencing at hourly intervals spanning two larval transitions. We found that a number of 
miRNAs are rapidly and extensively degraded at specific timepoints with half-lives of down to approximately one 
hour. In a particularly striking example we observed a >40-fold down-regulation of a specific miRNA over six hours. 
The factors that are involved in this rapid degradation as well as the functional relevance of this tight regulation are 
currently being investigated.
239 C Characterization of microRNAs derived from the HIV-1 TAR RNA hairpin
Alex Harwig1, Ben Berkhout1, Atze Das1
1Lab. of Experimental Virology
The transacting responsive (TAR) hairpin is present at the 5’ and the 3’ end of the HIV-1 RNA genome. This TAR 
hairpin is essential for HIV-1 replication because it binds the viral Tat transcriptional activator protein. Several groups 
have demonstrated the presence of small TAR-derived RNAs in HIV-1 infected cells. Supposedly, these small RNAs 
are microRNAs (miRNAs) produced by the RNAi pathway. We used the sensitive SOLiD ultra-deep sequencing 
method to characterize these small RNAs in HIV-1 expressing cells. This analysis revealed the presence of miRNAs 
corresponding to both the 5’ and the 3’ side of the TAR stem, with the 3’ fragments being more abundant. The cleavage 
pattern of the miRNAs differed from the patterns expected for the Drosha/Dicer mediated RNAi pathway and suggests 
the involvement of another nuclease. Northern blot analysis of the intracellular RNA confirmed the presence of the 
TAR miRNAs and their TAR RNA precursor. Analysis of TAR-mutated HIV-1 variants revealed that these TAR RNAs 
and miRNAs are produced exclusively from the TAR element present at the 5’ end of the viral transcripts. The role of 
Tat in the production of these small RNAs is currently investigated.
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242 C Highly potent and specific siRNAs isolated from E. coli with endogenous p19 expression
Linfeng Huang1, Jingmin Jin2, Larry McReynolds2, Judy Lieberman3
1Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Massachusetts, USA. Department 
of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.; 2New England Biolabs; 3Program in 
Cellular and Molecular Medicine, Boston Children’s Hospital, Boston, Massachusetts, USA. Department of 
Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
Most synthetic siRNAs have been produced by chemical synthesis. Here we present a method to produce highly 
potent siRNAs in E.coli. This method relies on ectopic expression of p19, an siRNA-binding protein found in a plant 
RNA virus. When expressed in E. coli, p19 stabilizes an ~21-nt siRNA-like species produced by bacterial RNase 
III.  These siRNAs are then isolated from bacterial total RNA by binding to p19-coupled magnetic beads.  When 
mammalian cells are transfected by siRNAs generated in bacteria expressing p19 and a hairpin RNA encoding 200 or 
more nucleotides of a target gene, they selectively knock down expression of the specific target gene by ~90% without 
immunogenicity or off-target effects.  The bacterial expression of p19 can also be used to isolated novel endogenous 
siRNAs made from anti-sense transcripts.
241 B Temporal expression of tRNA fragments in development of Triops cancriformis (Tadpole 
shrimp)
Yuka Hirose1, Kahori Ikeda1, Emiko Noro1, Kiriko Hiraoka1, Masaru Tomita1, Akio Kanai1
1Institute for Advanced Biosciences, Keio University
It is well known that microRNAs, which are 18-24 nucleotide (nt) regulatory RNAs, are deeply implicated in 
development, especially in morphogenesis. However, the relationship between other sizes of small RNAs (sRNAs) and 
development remains obscure. In this research, we chose Triops cancriformis (Tadpole shrimp) for target organisms 
since its morphology changes dramatically during the development, and focused on stage-specific sRNAs range in 
sizes from 25 to 45 nt.
In order to find the stage-specific sRNAs, we performed deep sequencing analysis of sRNA libraries constructed 
from each six developmental stage (egg, 1st-4th instar larvae, and adult) of T. cancriformis. After removing unreliable 
sequencing reads, novel sRNA candidates of 25-45 nt long were extracted. Based on the analysis of their gene 
expression (read counts) as well as comparative genomics between the candidate sRNAs and known non-coding 
RNAs in other species, many putative tRNA fragments were detected in any one of six developmental stages. To reveal 
the exact origin of these tRNA fragments, it is necessary to know the mature tRNA sequences. Therefore, we also 
conducted deep sequencing analysis of genomic DNA isolated from T. cancriformis and predicted a set of tRNA genes 
using tRNAscan-SE. As a result, at least five tRNA fragments were found to be derived from either tRNAGly(CCC), 
tRNALys(CUU), tRNAGlu(CUC), tRNAAsp(GUC), or tRNAPhe(GAA). Moreover, northern blot analysis showed that 
these tRNA fragments were actually expressed in T. cancriformis. Interestingly, in the case of the tRNALys(CUU), 
several tRNA fragments in different length were produced depending on the developmental stages. These results 
suggest that tRNA fragments are not random degradation products, but may have some important role(s) in eukaryotic 
development. Recently, it has been demonstrated that tRNA fragments are generated by endonucleolytic cleavage of 
tRNAs under specific conditions such as age, cancer, oxidative stress and amino-acid-starvation in various cell types. 
The possible function(s) of tRNA fragments in the development of T. cancriformis are discussed in the conference.
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244 B A Specialized Mechanism of Translation Regulation in Quiescence
Sooncheol Lee1, Samuel Truesdell1, Syed Irfan Bukhari1, Ju Huck Lee1, Olivier Le Tonqueze1, Shobha Vasudevan1
1Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, USA
Quiescence (G0) represents an assortment of reversible, proliferation-arrested states, implicated in the persistence 
of clinically resistant cancer cells, dormant stem cells and other distinct, arrested cells in development and in the body. 
The G0 state involves a discrete gene expression program with selective mRNA expression while decreasing general 
translation. One subset of such transcripts includes select mRNAs recruited by a distinct microRNP (microRNA-protein 
complex) containing Argonaute 2 (AGO2) and a specific isoform of Fragile X-mental-retardation-related protein 1, 
isoform-a (FXR1a). The AGO-FXR1a microRNP lacks the repressor, GW182, and promotes translation of associated 
mRNAs in G0 mammalian cells and in G0-like immature Xenopus laevis oocytes. Our data reveal that microRNA-
mediated upregulation is dependent on nuclear entry of the microRNA in immature oocytes; cytoplasmic injections 
result in repression. FXR1a overexpression rescues translation upregulation of cytoplasmically-injected RNAs 
and in low density, proliferating cells. Consistently,in vivo crosslinking-coupled nuclear-cytoplasmic fractionation 
and immunoprecipitation demonstrate significant interaction of AGO with FXR1a in the nucleus compared to the 
cytoplasm. MicroRNA targets for upregulation, Myt1 and TNFα mRNAs and reporters bearing their target sequences, 
are associated with the nuclear AGO-FXR1a microRNP. mRNAs that are repressed or lack target sites are not associated 
with this nuclear microRNP, indicating the importance of a compartmentalized AGO-FXR1a microRNP for selective 
mRNA recruitment for translation upregulation. The AGO-FXR1a microRNP interacts with a specialized translation 
factor in G0 and in immature oocytes, thereby connecting mRNAs recruited by this microRNP with the translation 
machinery for selective expression. Importantly, disruption of this mechanism in G0 abrogates microRNA-mediated 
translation upregulation and decreases G0 cell viability, indicating its relevance for maintenance of the quiescent state.
243 A Novel NFL mRNA targeting microRNAs in Amyotrophic Lateral Sclerosis
Muhammad Ishtiaq1, Danae Campos-Melo1, Kathryn Volkening1, Michael Strong1
1University of Western Ontario
Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease in which the low molecular weight neurofilament 
(NFL) mRNA level is suppressed in motor neurons. Based on previous findings, we hypothesized that microRNAs 
(miRNAs) will play a central role in NFL transcript stability, and may lead to the decrease in NFL mRNA. MiRNAs 
are small 20-25 nucleotide molecules and act as post transcriptional gene regulators by targeting 3’ untranslated 
region (UTR) of mRNA resulting in mRNA decay or translational silencing. We profiled the expression of small 
RNA from spinal cord lysates from sporadic ALS and neurologically intact controls and determined which of these 
small RNA were alternatively expressed in ALS. Out of 304 differentially expressed small RNA determined to be 
miRNA, a total of 42 (30 known, 12 novel) were predicted to target NFL mRNA (determined by targetscan and 
manual screens). Of these, 12 were found to be down-regulated in sporadic ALS and the remaining were up-regulated 
compared to neurologically intact controls. Real time PCR analyses confirmed that the majority of these miRNAs 
were up-regulated in ALS except block294889, block1336549, block11865845, block4652280, block 2403141 and 
Sblock659 which were down-regulated. Functional analysis  of these miRNAs by reporter gene assay confirmed a 
subset of these miRNAs play a potential role in NFL mRNA decrease in ALS.  This is the first report describing these 
novel sequences as miRNAs and their altered expression in ALS spinal cord lysates.
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246 A DmGTSF1 is essential for effective retrotransposon silencing by Piwi in Drosophila ovarian 
somatic cells
Hitoshi Ohtani1, Haruhiko Siomi1
1Keio University School of Medicine
Drosophila Piwi associates with PIWI-interacting RNAs (piRNAs) and silences transposons to maintain the 
integrity of the genome in the germline. Previous studies have shown that nuclear localization, but Slicer activity, of 
Piwi is necessary for Piwi-mediated transposon silencing in ovarian somatic cells (OSCs). However, the underlying 
mechanism remains unclear. We have screened 100 genes by RNA interference in OSCs and so far identified 12 genes 
required for transposon silencing in the cells. Of those, we currently focus on DmGTSF1, the Drosophila homolog 
of mouse gametocyte-specific factor 1 (GTSF1), because DmGTSF1 tightly associates with Piwi and is required 
for Piwi-mediated transposon silencing in OSCs. Mouse GTSF1 has been shown to be essential for transposon 
silencing in the testes; yet, the molecular function remains unclear. To reveal the role of DmGTSF1 in OSCs, we 
produced anti-DmGTSF1 monoclonal antibodies. Immunofluorescence on OSCs using the antibodies showed that 
DmGTSF1 localizes in the nucleus of OSCs. Disruption of DmGTSF1 affected neither the Piwi nuclear localization 
nor the expression level of piRNAs; however, Piwi-mediated transposon silencing became defective. We are currently 
analyzing how DmGTSF1 enhances Piwi-mediated nuclear transposon silencing in OSCs, which will be discussed at 
the meeting.
245 C X-ray crystal structure of Maelstrom
Naoki Matsumoto1, Hiroshi Nishimasu1, Kaoru Sato1, Ryuichiro Ishitani1, Haruhiko Siomi2, Mikiko Siomi1, Osamu 
Nureki1
1Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo; 
2Department of Molecular Biology, Keio University School of Medicine
Transposons occupy a large part of our genome and the mobilization of these elements induces genetic instability. 
PIWI-interacting RNAs (piRNAs) associate with PIWI proteins and silence transposable elements, thus maintaining 
the genomic integrity of the germ line. Maelstrom (Mael) plays a critical role in the piRNA pathway. Mael consists 
of a HMG-box domain and a MAEL domain. The HMG-box domain binds the miR-7promoter and represses miR-
7 expression, ensuring proper differentiation of Drosophila germline stem cell lineage. Bioinformatics analysis 
suggested that the MAEL domain has an RNase H-like fold but lacks catalytic residues highly conserved among 
RNase H proteins. The MAEL domain is also characterized by a conserved ECHC motif. A recent study using ovarian 
somatic cells (OSCs) showed that Mael participates in Piwi-mediated epigenetic regulation of transposons but is not 
required for piRNA biogenesis. However, the mechanism by which Mael is involved in the piRNA pathway remains 
unknown. Here, we report the crystal structure of the Drosophila melanogaster MAEL domain at 1.6 A resolution. The 
crystal structure revealed that the MAEL domain has an RNase H-like fold with a zinc ion coordinated by the ECHC 
motif. A structural comparison of the MAEL domain with RNase H proteins showed that the MAEL domain lacks 
any catalytic residue. Instead, the MAEL domain has a conserved molecular surface, which may serve as a platform 
for interacting with nucleic acids and/or proteins in the nucleus of OSCs. Functional analyses based on the crystal 
structure are undergoing.
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248 C Molecular mechanisms of the piRNA biogenesis machinery
Ramesh Pillai1
1EMBL Grenoble, France
Epigenetic silencing of transposons by Piwi-interacting RNAs (piRNAs) constitutes an RNA-based genome 
defense mechanism. Piwi endonuclease action amplifies the piRNA pool by generating new piRNAs from target 
transcripts by a poorly understood mechanism. Here, we identified mouse Fkbp6 as a factor in this biogenesis pathway 
delivering piRNAs to the Piwi protein Miwi2. Mice lacking Fkbp6 derepress LINE1 (L1) retrotransposon and display 
reduced DNA methylation due to deficient nuclear accumulation of Miwi2. Like other co-chaperones, Fkbp6 associates 
with the molecular chaperone Hsp90 via its tetratricopeptide repeat (TPR) domain. Inhibition of the ATP-dependent 
Hsp90 activity in an insect cell culture model results in the accumulation of short antisense RNAs in Piwi complexes. 
We identify these to be by-products of piRNA amplification that accumulate only in nuage-localized Piwi proteins. We 
propose that the chaperone machinery normally ejects these inhibitory RNAs, allowing turnover of Piwi complexes 
for their continued participation in piRNA amplification.
247 B Competition between spliceosome and microprocessor complex regulates processing of 
Splice site Overlapping (SO) 34b pri-miRNA
Franco Pagani1, Chiara Mattioli1, Giulia Pianigiani1
1Human Molecular Genetics ICGEB. Trieste. Italy
Several coding or non-coding PolI precursor transcripts are processed into both spliced mRNAs and micro RNAs 
(miRNA) but the mechanism that coordinates the spliceosome and the Drosha-DGCR8 Microprocessor complex 
(MPC) activities are not completely understood. We have explored the functional relationships between these two 
machineries in a peculiar class of miRNAs, we named Splice site Overlapping (SO)-miRNA, whose pri miRNA hairpins 
overlap with splice sites. We found 17 pri-miRNA hairpins overlapping with splice sites, 11 SO pri-miRNAs contain a 
3’ss, 6 a 5’ss and 8 are evolutionarily conserved among vertebrates. We focussed on the evolutionarily conserved SO 
miR-34b whose non-canonical 3’ss lacks a polypyrimidine tract.  miR34,  originally identified as a tumour suppressor 
miRNA, is involved in several physio-pathological conditions including spermatogenesis,  neurodegeneration, central 
stress response and neural stem cell differentiation. 
SO pri-miR-34b hairpin is located in the last exon of a non-coding transcript and we show that the embedded 
non-canonical acceptor site is correctly spliced in vivo in human tissues and in minigene systems. Through mutational 
analysis we identify two indispensable elements for the recognition of the non-canonical site: a strong branch point 
located in the hairpin, 18 bp upstream of the 3’ss AG dinucleotide, and a downstream purine-rich exonic splicing 
enhancer (ESE). Interestingly, in minigene systems, splicing inhibition due to ESE deletion or direct disruption of the 
AG 3’ss increases miR-34b levels. On the other hand, siRNA-mediated silencing of Drosha and/or DGCR8 improves 
splicing efficiency and abolishes miR-34b production. Thus, the processing of this 3’ SO miRNA is regulated in an 
antagonistic manner by the MPC and the spliceosome. We propose that in SO miRNAs, competition between these 
two machineries on the nascent transcript represents a novel mechanism to regulate miRNA biosynthesis.
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250 B Poly(A) and histone mRNA processing factor Symplekin is involved in endo-siRNA 
biogenesis
Mindy Steiniger1, William Marzluff2
1University of Missouri-St. Louis; 2University of North Carolina-Chapel Hill
CPSF73, CPSF100 and Symplekin form a protein complex required for 3’ end processing of both histone mRNAs 
and canonical polyadenylated mRNAs. CPSF73 is the cleavage factor, CPSF100 forms a heterodimer with CPSF73 
and Symplekin is a scaffolding protein that binds CPSF73, CPSF100 and several other proteins.  This “core cleavage 
complex” interacts with various accessory factors to cleave mRNAs with different 3’ ends. In an attempt to isolate 
other proteins involved in histone 3’ end processing, we performed a large-scale immunoprecipitation of Symplekin 
from nuclear extracts of Drosophila tissue culture cells. A protein specific antibody was used to isolate endogenous 
Symplekin, samples were separated on an SDS-PAGE gel and mass spectrometry was performed to identify bound 
proteins. Several known Symplekin-interacting proteins, including CPSF160, CPSF100, CPSF73 and CstF77, 
were isolated in addition to many factors previously not reported to be involved in polyadenylation. I also found an 
unexpected binding partner: Dicer-2 (Dcr-2).  Dcr-2 processes dsRNAs into both endo- and exo-siRNAs in Drosophila 
melanogaster. To confirm the Symplekin-Dcr-2 interaction, I did the reciprocal IP with an anti-Dcr-2 antibody. This 
experiment confirms the Dcr-2-Symplekin interaction. To determine if Symplekin is necessary for the production of 
endogenous siRNAs, I RNAi-depleted Dmel-2 tissue culture cells of Symplekin and performed a northern blot with a 
probe to esi-2.1, an endogenous siRNA. This experiment shows that when Symplekin is RNAi-depleted, the amount 
of esi-2.1 produced is drastically reduced. Preliminary data indicate that Symplekin may be required for small RNA 
biogenesis, in addition to its role in 3’ end processing.
249 A Abstract Withdrawn
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252 A A proteomic screen identifies novel regulators of micro-RNA biogenesis
Thomas Treiber1, Nora Treiber1, Simone Harlander1, Henning Urlaub2, Gunter Meister1
1University of Regensburg; 2Max Planck Institute of Biophysical Chemistry
MicroRNAs (miRNAs) are a class of small noncoding RNAs that negatively regulates gene expression by 
destabilization or translational inhibition of mRNAs. miRNAs are encoded in the genome as part of longer primary 
transcripts and subsequently processed by two nucleolytic events catalyzed by the RNase III enzymes Drosha and 
Dicer. The expression of miRNAs is tightly regulated, and in many cases deregulation of miRNA abundance has 
been linked to diseases including cancer. Apart from transcriptional regulation of the primary miRNAs it has become 
evident that also the maturation steps can be specifically regulated by RNA binding proteins. However, only a small 
number of posttranscriptional miRNA regulators has been discovered to date. Therefore, we have set up a proteomics-
based screen to identify proteins specifically binding to individual miRNA precursors. In a pulldown approach we 
have screened a set of 72 in vitro transcribed miRNA precorsor sequences against a panel of 11 cancer cell lines and 
have analyzed the bound proteins by mass spectrometry.
The obtained data revealed about 150 proteins that bind specfically to one or a small number of the tested RNA 
sequences and thus are candidates for a sequence specific recognition and regulation of individual miRNA precursors. 
Analysis of the interaction motives suggests that the terminal loop of the hairpin-shaped miRNA precursors serves as 
main interaction-site in our assay.
In a second screening stage we are currently validating a test set (30) of the candidates in knock down assays to 
investigate their role in the biogenesis of the bound miRNAs. Initial results indicate that a number of the identified 
candidates indeed regulates the processing of recognized miRNAs, already now expanding the range of regulatory 
factors in miRNA biogenesis markedly. Together with additional validation experiments, this project aims to for the 
first time generate a comprehensive view of posttranscriptional regulation of miRNA biogenesis.
251 C Sensitized Backgrounds Reveal Critical Roles for microRNA Families
Elizabeth Jeanne Thatcher1, Victor Ambros2
1Program in Molecular Medicine, University of Massachusetts Medical School, Howard Hughes Medical 
Institute Fellow of the Life Science Research Foundation; 2University of Massachusetts Medical School
MicroRNAs (miRNAs) are a class of small regulatory RNAs that have been implicated in the control of many 
cellular functions including cell specification, differentiation, proliferation, and metabolism. A smaller number of 
miRNAs are expressed in stem cells and at early stages of development, including some that are thought to maintain 
pluripotency. Interestingly, even though many C. elegans miRNAs are highly conserved, for many single deletion 
knockouts or even family knockouts, phenotypes are subtle or not evident. C. elegans have 23 miRNA families, 9 of 
which are conserved through humans. The Horvitz group showed that most miRNAs are not essential for development 
or viability on their own. This indicates a high degree of functional redundancy among miRNA family members, and 
between unrelated miRNA families in the worm. Recent findings from the Abbott group illustrated that sensitizing the 
worm may reveal several mutant phenotypes associated with loss of individual miRNAs or families.
Here, I examined the phenotypes associated with several critical miRNA effector complexes to determine whether 
combining reduced effector complex expression with miRNA family knockouts were able to alleviate or exacerbate 
the observed phenotypes.  For instance, RNAi of Alg-1 or Alg-2 (Argonaute-like genes) produces characteristic 
developmental delays and disruptions that include problems with molting, slow growth, absent or missing alae, 
and protruding vulva. These abnormalities are occasionally severe enough to produce embryonic or larval lethality. 
Examining the effects of Alg-1 or Alg-2 RNAi on miRNA family mutants produces an interesting picture. Most 
notably, the loss of some miRNAs appears to alleviate the impact of RNAi on Alg-1 or Alg-2 to produce a less severe 
phenotype as compared to RNAi on wild-type animals. Moreover, some family mutants are uniquely sensitive to 
Alg-1 versus Alg-2 RNAi or vise versa. These results produce a larger picture of the interaction of unique miRNA 
families with different effector molecules that allow for a tightly regulated environment to control highly specific and 
reproducible events throughout development.
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254 C Novel stress-induced smRNAs from Brachypodium distachyon
Hsiao-Lin V. Wang1, Brandon L. Dinwiddie1, Herman Lee1, Julia Chekanova1
1University of Missouri-Kansas City
Small non-coding RNAs (smRNAs), which include miRNAs, siRNAs, as well as other classes of endogenous 
smRNAs, have been firmly established as key regulators of the cellular and genome functions in diverse eukaryotic 
organisms, including all land plants. However, it is challenging to study common monocot plants in standard 
laboratory settings due to their large genomes, physical size, as well as demanding growth conditions. During the past 
decade, Brachypodium distachyon has emerged as a new model organism for studying functional genomics of grasses. 
The goal of this study was to investigate how smRNA transcriptome of temperate grasses responds to various biotic 
and abiotic stresses.
To address this question Brachypodium plants were challenged with different abiotic stresses such as heat, cold 
and salt, as well as with infection by the plant pathogen fungus Magnaporthe grisea, and their smRNA transcriptomes 
were examined by deep sequencing. To analyze the populations of smRNAs we deployed proximity-based algorithm, 
and also classified smRNAs on the basis of their size, the nature of their first nucleotide, and their genomic features. 
We found that challenging plants with stresses resulted in upregulation of the population of smRNAs ranging from 21 
to 25nt in length, while the populations of smRNAs shorter than 20nt in length were downregulated.
In addition to previously reported plant miRNAs and siRNAs, we also identified new groups of stress-specific 
smRNAs. Among the group of upregulated smRNAs we discovered a class of novel 24nt smRNAs. These smRNAs 
exhibit several distinct patterns and originate in a strand specific manner from 3’-UTRs of a subset of mRNA genes. 
The analysis of this group of stress-induced smRNAs and their targets will be presented.
253 B The role of the RNA chaperone protein Hfq in the translation regulation by small 
noncoding RNAs targeting ompD mRNA from Salmonella typhimurium.
Zuzanna Urbaniak1, Aleksandra Kaszynska1, Joanna Strózecka1, Daria Grygiel1, Mikolaj Olejniczak1
1Department of Biochemistry, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University
The RNA chaperone protein Hfq is a hexameric Sm-like protein, which acts as a major-regulator of bacterial gene 
expression. Hfq facilitates the binding of sRNAs to their target mRNAs and affects the stability of their complexes. 
It has been proposed that Hfq is recruited to the regulated mRNAs through (ARN)n motifs, and that the mRNA-
sRNA annealing is most accelerated when Hfq binds mRNA immediately 3’ of the sRNA binding site. Interestingly, 
the mRNA of Salmonella outer membrane protein OmpD is regulated by four Hfq-dependent sRNAs (InvR, MicC, 
RybB, SdsR), which bind partly overlapping sites located downstream of the AUG codon. The region of ompD mRNA 
containing the sRNA binding sites also includes several ARN repeat sequences, which could serve as potential Hfq 
binding sites.
The aim of this project is to elucidate the role of Hfq for the binding of different sRNAs  to the ompD mRNA 
sequence. To characterize the structures of interacting molecules the in vitro structure probing of 5’end-labeled RNAs 
in the absence or presence of Hfq was performed. The comparison of cleavage patterns allowed us to determine 
sRNA secondary structures and their Hfq binding sites. As the mRNA binding sequences of SdsR and InvR sRNAs 
are located in base-paired regions it appears possible that the Hfq role in facilitating the sRNA-mRNA annealing 
could be related to unfolding these regions. Next, we are planning to analyze the role of potential Hfq binding sites 
on ompD mRNA for promoting the sRNA-mRNA annealing. The results of these experiments could allow us to better 
understand the role of the Salmonella Hfq protein in facilitating sRNA interactions with their target mRNAs.
This study was supported by grants from the National Science Center (nr 2011/01/B/NZ1/05325) and the 
Foundation for Polish Science (TEAM/2011-8/5).
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256 B An Exchange-Induced Remnant Magnetization Technique for MicroRNA Detection
Shoujun Xu1, Li Yao1, Yuhong Wang2
1Department of Chemistry, University of Houston; 2Department of Biology and Biochemistry, University of 
Houston
We present a novel technique of exchange-induced remnant magnetization (EXIRM) for label-free microRNA 
(miRNA) detection. The characteristics of this technique are the following: ultrahigh sensitivity, broad dynamic 
range, single-base specificity, and no use of amplification or washing. MiRNAs are important regulators of genes 
and biomarkers for cancer, but their detection and sequencing remain challenging for existing techniques. The short 
length of miRNAs, which usually contains 18-25 nucleotides, makes precise sequencing difficult using conventional 
techniques. The expression levels of miRNAs are highly heterogeneous, which requires high sensitivity and broad 
dynamic range for the detecting methods.
The EXIRM technique is based on a novel concept that can be described in the following three stages. First, RNA 
duplexes are prepared on the sample well surface. One of the two strands is complimentary to the target miRNA and 
immobilized on the surface; the other strand has one mismatching base and is labeled with magnetic particles. Second, 
the sample containing various target miRNAs are incubated in the sample well with the initial RNA duplex. Exchange 
reaction takes place because the target miRNA has stronger binding with its complimentary RNA than the mismatching 
strand has. Third, the dissociated mismatching strand undergoes Brownian motion, causing randomization of the 
magnetic dipoles of the magnetic particles. Therefore, the quantity of the target miRNA is measured as a magnetic 
signal decrease. The detection of magnetic signals is achieved by an atomic magnetometer, the most sensitive device 
for magnetic sensing. The dynamic range of detection is at least five orders of magnitude and can be expanded by 
varying the size of the magnetic labels. The unique combination of zeptomole sensitivity, single-base specificity, and 
broad dynamic range makes EXIRM a well suited technique for miRNA identification.
255 A The novel Tetrahymena gene COI12 is crucial for siRNA loading into the Argonaute protein 
Twi1p
Sophie Wöhrer1, Kazufumi Mochizuki1
1IMBA - Institute of Molecular Biotechnology
RNA interference pathways have important functions in the regulation of diverse cellular processes. The ciliated 
protozoan Tetrahymena utilizes a complex RNAi pathway during its sexual reproduction, called conjugation, as 
a defense mechanism against transposon like sequences. In the somatic genome these sequences are packed into 
heterochromatin which eventually leads to elimination of the DNA. The correct targeting of these sequences is thought 
to be achieved via base pairing of ~29nt siRNAs with nascent transcripts.
At the onset of conjugation the nuclear Dicer like enzyme Dcl1p produces the ~29nt siRNAs, so called scan 
RNAs (scnRNAs). In order to form a functional effector complex these scnRNAs have to be loaded into the Argonaute 
protein Twi1p. This process takes place in the cytoplasm and is therefore clearly separated from the production of 
scnRNAs. However, how the loading is regulated is not well understood.
Here we report the characterization of the conjugation-induced gene 12 (COI12) which is essential for this loading 
process. At early stages of conjugation Coi12p localizes to the cytoplasm where scnRNA loading occurs. In the 
absence of Coi12p immunopurified Twi1p is not in a complex with scnRNAs. As a consequence these small RNAs 
as well as the Argonaute protein get degraded. Coi12p has a TPR domain, which interacts with Hsp90, and an Fk-
binding domain with a yet unclear function. We established in vitro and in vivo systems to manipulate and analyze the 
loading process at a mechanistic level in more detail and to investigate a possible function of Coi12p and Hsp90p in 
the loading process. This study could shed more light on the suggested role of the Hsp90 chaperone machinery in the 
loading process of small RNAs to Argonaute proteins.
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258 A Spliceozymes: Ribozymes that act like Spliceosomes
Zhaleh Amini1, Ulrich Müller1
1University of California, San Diego
The spliceosome is a large, dynamic RNA-protein particle (RNP) that evolved from a common ancestor with 
self-splicing group II intron ribozymes. Self-splicing intron ribozymes contain the larger group II intron ribozymes 
and the smaller group I intron ribozymes. To model the evolution of the spliceosome in the lab we generated a 
variant of trans-splicing group I intron ribozymes that acts like a spliceosome: The ribozyme variant uses its 5’- and 
3’-terminus to recognize two splice sites on a target RNA, catalyzes the removal of the internal sequence, and joins 
the flanking exons. These ‘spliceozymes’ appear general with regard to intron length and intron sequence because 
introns with lengths between 64 and 329 nucleotides were removed, with diverse intron sequences. To test whether 
these spliceozymes could function like spliceosomes inside a cell we inactivated the mRNA of chloramphenicol acetyl 
transferase (CAT) with an intron and targeted a spliceozyme to remove this intron. In E.coli cells, the spliceozyme 
processed this CAT pre-mRNA to functional CAT mRNA efficiently enough to mediate E.coli growth on medium 
containing chloramphenicol. We used this growth phenotype in E.coli cells to create a model system for the evolution 
from spliceozymes to spliceosomes: Mutations were introduced into the spliceozyme sequence by mutagenic PCR, 
and the most efficient spliceozymes were selected by plating the E.coli cells on medium containing chloramphenicol. 
Over multiple cycles of this evolution, the population of spliceozymes accumulated mutations and sampled the protein 
repertoire of the E.coli cells for interactions that benefit the expression of CAT enzyme. The preliminary results of this 
evolution will be presented at the conference. In summary, our results show that trans-splicing ribozymes can be used 
to model the first steps in the evolution of the spliceosome.
257 C Nonstop decay in C. elegans: examination of a possible role for 22G RNAs
Elaine Youngman1, WeifengGu 2, Craig Mello3
1Villanova University; 2UMass Medical School; 3UMass Medical School and Howard Hughes Medical 
Institute
In C. elegans, small noncoding RNAs known as 22G RNAs are synthesized by RNA-dependent RNA polymerases 
and target thousands of protein-coding mRNAs, repetitive sequences, and cryptic transcripts throughout the genome. 
In some cases, 22G RNA synthesis appears to be triggered as a secondary event downstream of targeting by C. 
elegans piRNAs (known as 21U RNAs) in a pathway that defends against non-self RNA species. (1, 2) However, 
the synthesis of the majority of 22G RNAs is unaffected by loss of 21U RNAs, and the triggers for biosynthesis of 
these 21U-independent 22Gs remain elusive. Using a comparative genomic approach in geographically distributed 
wild isolates of C. elegans, we have identified a locus (F43E2.6) at which loss of the stop codon is correlated with 
increased production of 22G RNAs. The F43 mRNA has a short 3’UTR with no further in frame stop codons, raising 
the intriguing possibility that 22G RNAs could be involved in a nonstop decay pathway in C. elegans. F43 is also 
targeted by an unusual Dicer product; however this Dicer product does not appear to act as a primary siRNA to trigger 
F43 22G RNAs. First, the Dicer product is expressed equally in strains with large differences (more than 10 fold) in 
22G RNA levels. Second, this product is expressed only during embryogenesis, whereas F43 22G RNAs are expressed 
most strongly in adults. We have demonstrated that the 22G RNA expression phenotype at the F43 locus is genetically 
linked to the locus itself, and are currently assaying transgenic worms carrying F43 reporter constructs that bear or 
lack a stop codon to determine whether the loss of a stop codon is indeed causal for increased 22G RNA production. 
In addition, we are generating reporter constructs that will allow us to ask whether 22G RNAs play a functional role 
in the nonsense-mediated and no-go decay pathways.
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260 C Characterization of Metal Ion Binding Sites in the P4 Helix of Bacillus subtilis RNase P
Yu Chen1, Xin Liu1, Carol A. Fierke2
1Department of Chemistry, University of Michigan; 2Department of Chemistry and Department of Biological 
Chemistry, University of Michgan
The endoribonuclease P, RNase P, is responsible for catalyzing the 5’-end maturation of precursor tRNAs.  Like many large 
ribozymes, divalent ions stabilize the folded structure and enhance catalytic function of RNase P.  P4 helix, the most highly 
conserved region in PRNA, is essential for RNase P activity and has been suggested to contain catalytic and/or cocatalytic metal 
ion binding sites. The crystal structure of T. maritima RNase P (4.2 Å) proposed a metal ion directly coordinates the O4 of the 
bulged uracil (U51 in B. subtilis) in the P4 helix1. NMR spectroscopy of a P4 stem-loop mimic suggested an inner-sphere metal 
interaction with the O6 of the base corresponding to G379 in the P4 helix of B. subtilis RNase P2.
To evaluate the structure and function of these putative metal ion sites, 4-thiouracil and 2-aminopurine are specifically 
substituted for U51 and G379, respectively. These substitutions decrease the pre-tRNA binding affinity at low concentration 
of metal ion but not at high concentration. Single turnover kinetics show that these substitutions do not affect the rate of the 
conformational change step in the RNase P - pre-tRNA complex. However, the 4-thiouracil substitution at U51 and 2-aminopurine 
substitution at G379 decrease the cleavage rate constant in Mg2+ by 20-fold and 10-fold, respectively, without altering the K1/2 for 
the Mg2+-dependent activation of cleavage. These data indicate that O4 of U51 and O6 of G379 are important both for stabilizing 
pre-tRNA affinity in a metal-dependent fashion and for enhancing catalytic activity. The magnitudes of these effects are smaller 
than expected for an inner-sphere metal ion interaction but are consistent with outer-sphere metal ion coordination.
In contrast, the rSpacer substitution of U51 does not affect the cleavage step but decreases the conformational change rate by 
6-fold. Furthermore, the rSpacer substitution of G379 decreases the cleavage rate constant by 3-fold. The modest effect of deletion 
of the base of U51 and G379 might be due to additional water molecules filling the space allowing a catalytic metal ion to be 
optimally positioned. These results further suggest that O4 of U51 and O6 of G379 form hydrogen bonds with waters coordinated 
to a magnesium ion. 
1. Reiter, N. J., Osterman, A., Torres-Larios, A., Swinger, K. K., Pan, T. & Mondragón, A. (2010). Structure of a bacterial 
ribonuclease P holoenzyme in       complex with tRNA. Nature 468, 784-789.
2. Koutmou, K. S., Casiano-Negroni, A., Getz, M. M., Pazicni, S., Andrews, A. J., Penner-Hahn, J. E., Al-Hashimi, H. M. & 
Fierke, C. A. (2010). NMR and     XAS reveal an inner-sphere metal binding site in the P4 helix of the metallo-ribozyme 
ribonuclease P. Proceedings of the National Academy of Sciences 107, 2479-2484.
259 B Molecular Mechanism of preQ1 Riboswitch Action: a Molecular Dynamics Study
Pavel Banáš1, Petr Sklenovský1, Joseph E. Wedekind2, Jirí Šponer3, Michal Otyepka1
1Department Physical Chemistry and RCPTM, Palacky University Olomouc, Czech Republic.; 2Department 
Of Biochemistry and Biophysics, University of Rochester, Rochester, USA(NY); 3Institute of Biophysics, 
Academy of Sciences of the Czech Republic, Brno, Czech Republic; CEITEC, Masaryk University, Brno, 
Czech Republic
  Riboswitches often occur in the 5’-untranslated regions of bacterial mRNA where they regulate gene expression. 
The preQ1 riboswitch controls the biosynthesis of a hypermodified nucleoside queuosine in response to binding 
the queuosine metabolic intermediate. Structures of the ligand-bound and ligand-free states of preQ1 riboswitch 
from Thermoanaerobacter tengcongensis were determined recently by crystallography.1 We used multiple, 
microsecond-long molecular dynamics simulations (29 μs in total) to characterize the structural dynamics of 
preQ1 riboswitche in both states. We observed different stability of the stem bearing part of the Shine-Dalgarno 
sequence in the bound and free states, resulting in different accessibility of the this ribosome-binding site. These 
differences are related to different stacking interaction between nucleotides of the stem and the adjacent RNA loop, 
which itself adopts different conformations in the bound and free states.1,2 We suggest that the loop serves not only 
to bind preQ1 but also transmits information about ligand binding from the ligand-binding pocket to the stem, which 
has implications for mRNA accessibility to the ribosome.2 We explain functional results obscured by a high salt 
crystallization medium and help to refine regions of disordered electron density, which demonstrates the predictive 
power of our approach. 2
1. J.L. Jenkins, J. Krucinska, R.M. McCarty, V. Bandarian and J.E. Wedekind, J Biol Chem, Comparison of a PreQ(1) 
Riboswitch Aptamer in Metabolite-bound and Free States with Implications for Gene Regulation. 2011, 286, 24626-24637.
2. P. Banas, P. Sklenovsky, J.E. Wedekind, J. Sponer, M. Otyepka, J Phys Chem B, Molecular Mechanism of preQ1 
Riboswitch Action: A Molecular Dynamics Study. 2012, 116, 12721−12734.
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261 A Ligand-induced stabilization of the aptamer terminal helix in the adenine riboswitch
Francesco Di Palma1, Francesco Colizzi1, Giovanni Bussi1
1SISSA - Scuola Internazionale Superiore di Studi Avanzati
Riboswitches are structured mRNA elements that modulate gene expression. They undergo conformational 
changes triggered by highly-specific interactions with sensed metabolites. Among the structural rearrangements 
engaged by riboswitches, the forming and melting of the aptamer terminal helix, the so-called P1 stem, is essential for 
genetic control. The P1 stem, which competes with the repressor, is formed in the ON-state, whereas it is disrupted 
in the OFF-state. It has been proposed that P1 is stabilized by the ligand and that this could be a common feature in 
many riboswitch classes. In this context a quantitative estimation of the energetic contributions associated to ligand 
binding, in particular regarding the role of direct P1-ligand interactions, has not yet been provided and the structural 
mechanisms by which this conformational change is modulated upon ligand binding mostly remain to be elucidated. 
State-of-the-art-free-energy methods combined with atomistic simulations can bridge the gap providing an unparalleled 
perspective on the mechanism and dynamics of the biomolecular process of interest. Here we used steered molecular 
dynamics simulations to study the thermodynamics of the P1 stem formation in the presence and in the absence of 
the cognate ligand for the add adenine riboswitch. The P1 ligand-dependent stabilization was quantified in terms 
of free energy (-4.4 kJ/mol) and compared with thermodynamic data from previous dsRNA melting experiments 
and single-molecule experiments, resulting in nice agreement with them. Our work provides atomistic details and 
energetic estimates of the process of interest and, altogether with the related experimental works, it suggests a model 
for the aptamer folding in which direct P1-ligand interactions play a minor role when compared with those related to 
the ligand-induced aptamer preorganization. Because the structural/functional role of the aptamer terminal helix is a 
common feature in the “straight junctional” riboswitches, we foresee a wider validity of this model.
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263 C In vitro evolution of a calcium ion-sensing ribozyme from the natural glmS riboswitch-
ribozyme
Matthew Lau1, Adrian Ferré-D’Amaré1
1National Heart, Lung and Blood Institute, NIH, Bethesda, Maryland 20892-8012, USA
The glmS ribozyme is a natural catalytic RNA widely distributed in Gram-positive bacteria that undergoes self-
cleavage under physiologic divalent metal ion concentrations upon binding to its cognate coenzyme glucosamine-
6-phosphate (GlcN6P) (1). This allows bacteria to sense their intracellular GlcN6P concentration and control its 
biosynthesis at the mRNA level through negative feedback. To address the evolution of its coenzyme dependence, we 
previously evolved a mutant ribozyme (glmSAAA) that is only 3 adenine mutations away from the wildtype ribozyme, 
and catalyzes the same RNA cleavage chemistry in the absence of GlcN6P. This mutant, in contrast to wildtype, has 
a strong preference for Ca2+, and requires higher divalent metal ion concentrations (>100 mM) for maximal activity. 
To further characterize the metal ion specificity ofglmSAAA and to generate specific metal ion-sensing ribozymes that 
could function in vivo, we have now performed two additional parallel selections. These experiments aimed to evolve 
self-cleaving ribozymes fromglmSAAA that are functional in either 2 mM Mg2+ or 2 mM Ca2+. From the Mg2+ selection, 
we isolated a fast ribozyme that is equally active in either 2 mM Mg2+ or 2 mM Ca2+. The Ca2+ selection, on the 
other hand, produced a Ca2+ specific ribozyme that discriminates strongly against Mg2+ (more than 10,000-faster in 
2 mM Ca2+ than in 2 mM Mg2+), and has a higher apparent affinity to Ca2+ than glmSAAA (K
1/2
 of 19 mM and 93 mM, 
respectively). This ribozyme is non-specific towards the sequence upstream of its cleavage site, and is not further 
activated by GlcN6P or physiological concentrations of Mg2+. Our work suggests possible evolutionary links between 
wildtype glmS ribozyme and different ligand independent self-cleaving ribozymes, providing clues as to the origin 
of the wildtype.  Our new selection experiment has generated the first example, to our knowledge, of a self-cleaving 
ribozyme with such high specificity for Ca2+. We envision that this ribozyme can be engineered to function as an in 
vivo calcium sensor.
This research was supported by the Intramural Research Program of the NIH, NHLBI.
1. W. C. Winkler, A. Nahvi, A. Roth, J. A. Collins, R. R. Breaker, Nature 428, 281 (2004).
262 B Studying Conformational Changes in the Glycine Riboswitch using Electron Paramagnetic 
Resonance Spectroscopy
Jackie Esquiaqui1, Gail Fanucci1
1University of Florida
Electron Paramagnetic Resonance (EPR) spectroscopy is used to study dynamic conformational changes in the RNA 
glycine riboswitch. The dynamic role of the leader-linker interaction within glycine riboswitch conserved sequences is 
probed through site directed spin labeling and continuous wave EPR. Inter-aptamer and aptamer-expression platform 
interactions are elucidated through double electron-electron resonance spectroscopy. Incorporation of spin labels is 
achieved through optimized ligation methodologies allowing synthetically modified RNA to be joined to larger RNA 
sequences. Expected folding and burial of riboswitch elements will lead to restricted motion of the spin label and, 
additionally, pulsed EPR experiments yield distance distribution profiles indicating conformational exchange between 
states in the absence and presence of glycine.
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264 A Architectural Diversity of PreQ1 Riboswitches
Phillip J. McCown1, Jonathan J. Liang2, Ronald R. Breaker3
1Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 06520-8103, 
USA; 2Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-8103, 
USA; 3Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT 
06520-8103, USA; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 
06520-8103, USA; Howard Hughes Medical Institute, Yale University, New Haven, CT 06520-8103, USA.
Riboswitches are RNA structures that typically bind to small molecules and regulate gene expression. Riboswitches 
are placed into different classes based on their distinct secondary and tertiary structures and based on their ligands. 
In previous studies, we determined that a class of riboswitches for pre-queuosine1 (PreQ1) has representatives that 
conform to two different types based on the presence of unique sequence sub-domains (Roth et al. 2007). Subsequently, 
we identified a second class of PreQ1 riboswitches that has no structural similarity to the first class (Meyer et al. 2008).
As DNA sequence databases continue to expand in data, additional searches for variants of the PreQ1-I and 
PreQ1-II riboswitch classes are yielding many more hits. Recently, we uncovered the presence of an additional type 
for each PreQ1 riboswitch class. For PreQ1-I riboswitches, we determined statistically that all three types of this class 
are distinct from each other. For PreQ1-II riboswitches, the newly found type is able to discriminate more strongly 
against binding the immediate biosynthetic precursor of PreQ1, called PreQ0. We have also identified an entirely new 
class of PreQ1 riboswitches, termed PreQ1-III, which has no structural similarity to the other two classes. Based on this 
diverse collection of different PreQ1-sensing riboswitches and other studies of PreQ1, it is clear that numerous species 
of bacterial make extensive use of RNA to directly sense and respond to changing concentrations of this important 
modified nucleobase.
1. Roth A, Winkler WC, Regulski EE, Lee BWK, Lim J, Jona I, Barrick JE, Ritwik A, Kim JN, Welz R, Iwata-Reuyl 
D, Breaker RR. 2007. A riboswitch selective for the queuosine precursor preQ1 contains an unusually small aptamer 
domain. Nat. Struct. Mol. Biol. 14:308-317.
2. Meyer MM, Roth A, Chervin SM, Garcia GA, Breaker RR. 2008. Confirmation of a second natural preQ1 aptamer class in 
Streptococcaceae bacteria. RNA 14:685-695.
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265 B Theoretical Methods Suggest that Small Ribozymes may use Multichannel Mechanism 
During Catalysis
Vojtech Mlynsky1, Pavel Banas1, Nils G. Walter2, Jiri Sponer3, Michal Otyepka1
1Regional Centre of Advanced Technologies and Materials, Department of Physical Chemistry, Palacky 
University Olomouc, Czech Republic; 2Department of Chemistry, Single Molecule Analysis Group, University 
of Michigan, Ann Arbor, MI, USA; 3Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, 
Czech Republic
Small self-cleaving ribozymes carry out site-specific cleavage and ligation of RNA substrates.[1] Experiments 
and biochemical studies identified nucleobases and hydrated magnesium ions as catalytically active species, but their 
exact roles in reaction mechanisms remain questionable.[2,3] We studied extensively two members of the group of 
self-cleavage ribozymes: hepatitis delta virus (HDV) and hairpin ribozymes.
X-ray structures of ribozymes have to be mutated or chemically modified in order to trap them in precursor-like states. 
We carried out all-atom molecular dynamics (MD) simulations in explicit solvent up to μs-time scales, which helped 
us to obtain native arrangement of the catalytically active sites. We tested the impact of different protonation states of 
key nucleobases on structural stability and compactness of active sites within bothribozymes. Finally, we used these 
MD simulations to generate geometries of the ribozymes in potentially reactive forms. These structures were further 
analyzed by the hybrid quantum-mechanical/molecular mechanical (QM/MM) calculations to decipher exact roles 
of chemical species (such as (de)protonated nucleobases and/or hydrated magnesium ion) involved in the catalysis. 
We used hybrid DFT functional MPW1K for the QMregion, which was carefully validated against chemically 
accurate CCSD(T)/CBS method.[4] We found that the MPW1K error in energies is less than 1 kcal/mol. The observed 
potential energy surfaces (PESs) of the sugar-phosphate backbone self-cleave reactions in both ribozymes are rather 
complex, therefore the transition states were localized using two-dimensional scans of PES.[5,6] In both ribozymes, we 
identified several reaction mechanisms having comparable free energy barriers (and thus comparable rate constants), 
which allowed us to suggest a hypothesis about multichannel mechanism of the sugar-phosphate backbone self-
cleavage in these ribozymes.
This work was supported by the Operational Program Research and Development for Innovations - European 
Regional Development Fund (CZ.1.05/2.1.00/03.0058) and European Social Funds (CZ.1.07/2.3.00/20.0058, 
CZ.1.07/2.3.00/20.0017). Grant Agency of the Czech Republic (P208/12/G016, P208/12/1878) and NIH grant 2R01 
GM062357 are also gratefully acknowledged.
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3. T. J. Wilson and D.M. Lilley, RNA 17, 213-221 (2011).
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Poster Abstracts RNA 2013 •  Davos, Switzerland •  June 11-16, 2013
150  •   RNA Catalysis and Riboswitches
266 C Tuning the btuB riboswitch fold by chemically modifying its ligand coenzyme B12
Anastasia Musiari1, Sofia Gallo1, Kai Zhou2, Felix Zelder1, Roland Sigel1
1Institute of Inorganic Chemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, 
Switzerland; 2Batochimie UNIL, EPFL, Av. Forel 2, CH-1015 Lausanne, Switzerland
The focus of our research lies in the binding mechanism between the btuB riboswitch of E. coli and its ligand 
coenzyme B
12
 (AdoCbl).[1,2] One interesting fact about this interaction is that the btuB riboswitch is highly selective 
between some derivatives of the B
12
-family, which however can strongly differ in their general structure.[2,3] In this 
regard, one of our early findings was that Adenosyl Factor A, which differs from AdoCbl in the shape and position of 
the lower group, binds and switches the riboswitch with nearly the same affinity and efficiency as the natural substrate. 
This surprising result lead to the question which are the structural requirements on the large and complex B
12
-molecule 
to bind and switch the btuB riboswitch.
We have therefore synthesized three series of B
12
-derivatives modified at the different functional sites (Figure 
1). Modifications on the corrin ring sidechains include specific monoacids as well as secondary and tertiary amides. 
Modifications on the upper ligand include the two natural occurring CN- and Adenosyl-groups as well as synthetic 
moieties based on platinum(II)-linked nucleobases. A third group comprises derivatives with a peptide backbone 
replacing the sugar phospate at the lower loop. All these modifications were introduced to study the role of the 
H-bonding and electrostatic pattern of the btuB-B
12
 interaction.
To study the influence of these chemical modifications on the structural rearrangement of the riboswitch we 
applied in-line probing assays. Our experiments confirmed the importance of an upper moiety, preferentially being 
adenosyl, for a high affinity to the RNA. The presence of a secondary or tertiary amide group in the sidechains doesn’t 
influence the KD value but leads to some differences in the structural switch of the RNA. Finally, the derivatives with 
the lower peptide loop show a strong dependence of the stereochemistry. In fact, only one isomer of this series was 
shown to switch the riboswitch, although with alterations and with a KD value in the micromolar range.
Acknowledgments. Financial support by the European Research Council (ERC starting grant 2010 259092-MIRNA 
to R.K.O.S.) and the University of Zurich is gratefully acknowledged.
1. W. Winkler, A. Nahvi, R. R. Breaker, Nature 2002, 419, 952.
2. S. Gallo, M. Oberhuber, R. K. O. Sigel, B. Kräutler, ChemBioChem 2008, 9, 1408.
3. S. Gallo, S. Mundwiler, R. Alberto, R. K. O. Sigel, Chem. Commun. 2011, 47, 403.
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267 A A Riboswitch Class for the Bacterial Second Messenger c-di-AMP
James Nelson1, Narasimhan Sudarsan3, Kazuhiro Furukawa2, Zasha Weinberg3, Joy Wang2, Ronald Breaker3
1Department of Chemistry, Yale University, New Haven, CT 06511; 2Dept. of Molecular, Cellular, and 
Developmental Biology, Yale University, New Haven, CT 06511; 3Howard Hughes Medical Institute and Dept. 
of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT 06511
Riboswitches are small, structured RNA motifs commonly found in the 5’-untranslated regions of certain mRNAs. 
Each riboswitch class has evolved to selectively recognize a small molecule or ion and change the expression of 
associated genes. More than two dozen different riboswitch classes have been validated, including RNA motifs that 
respond to various ligands such as nucleobases, amino acids, coenzymes, second messengers, toxic anions, and other 
chemicals. The ligand identity of the majority of riboswitches can often be readily deduced by their genomic contexts, 
but for a few “orphan” riboswitch classes, ligand identification can be challenging. Some orphan riboswitch candidates 
are associated with many different genes, or with genes encoding proteins of unknown functions, which make ligand 
identification difficult.
A metabolite-binding riboswitch candidate called ydaO was discovered in bacteria nearly a decade ago, but its 
ligand has remained unknown. This predicted riboswitch class ranks among the top ten most common metabolite-
sensing RNAs known, and it is associated with numerous genes for cell wall metabolism, osmotic stress response, 
and sporulation. We report that members of this noncoding RNA class selectively respond to the recently-discovered 
bacterial second messenger cyclic di-adenosine monophosphate (c-di-AMP). A representative RNA from Bacillus 
subtilis binds c-di-AMP with an affinity that is more than one million fold higher than for the c-di-AMP precursor 
ATP and for the bacterial second messenger c-di-GMP. Our findings resolve the mystery regarding the ligand for this 
extremely common riboswitch class, and expose a major portion of the super-regulon of genes that are controlled by 
the widespread bacterial second messenger c-di-AMP.
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268 B Metal Ion Requirement and Substrate Specificity of Kinase Ribozyme K28(1-77)C
Raghav Poudyal1, Elisa Biondi2, Josh Forgy3, Phuong Nguyen4, Donald Burke5
1University of Missouri-Department of Biochemistry; 2Foundation for Applied Molecular Evolution-720 SW 
2nd Ave, Suite 207, Gainesville, FL - 32601; 3Univeristy of Missouri; 4University of Missouri; 5University of 
Missouri-Department of Molecular Microbiology and immunology, Department of Biochemistry. Bond Life 
Sciences Center
The RNA world hypothesis posits that Ribonucleic Acids (RNA) played a major role as the repository for genetic 
material and as catalysts during the early evolution of life and metabolism. Phosphoryl transfer is one of the key 
reactions in metabolic pathways, signal transduction and gene regulation in all domains of contemporary life. In vitro 
selection of functional nucleic acids has identified multiple kinase ribozymes but much remains to be known about 
the mechanisms utilized by these ribozymes to carry catalysis. It is therefore important to understand the strategies 
used by kinase ribozymes to perform metabolically relevant reactions. Our lab selected ribozyme K28(1-77)C ,  a 
dual-site self(thio)phosphorylating kinase ribozyme that utilizes Cu2+ for catalysis. We used in-line cleavage assay to 
assess the role of Cu2+ during the self(thio)phosphorylation. Modulation of  in-line cleavage was observed  only when 
GTP(phosphoryl donor) or both GTP and Cu2+ were present while we saw no evidence of direct Cu2+-ribozyme 
interaction. Addition of competitor for Cu2+ resulted in the loss of in-line cleavage signal which is restored by 
supplementation with Cu2+. Self (thio) phosphorylation assays with competitors also showed similar results; loss of 
activity with competitor for Cu2+ and restoration with Cu2+supplementation. These experiments suggest that Cu2+-
GTP complex is recognized by the ribozyme. Although 6 other families of ribozymes were isolated from the same 
selection, we found that only K28 (1-77)C is dependent upon Cu2+ for phosphoryl transfer catalysis.
To understand the substrate specificity for phosphoryl acceptor, we have assembled the ribozyme in a two-strand 
construct; a 22-nt substrate and a 44-nt catalytic strand. All kinase ribozymes studied to date have used the 2’OH or 
the 5’OH of ribose sugars as phosphoryl acceptors; however, we show here that the 5’ substrate strand of the ribozyme 
can be made entirely of DNA. The DNA substrate gets phosphorylated even when the 5’ end is blocked with biotin. 
We are proposing that the catalytic strand of the two stranded version of ribozyme K28 (1-77) C is the first kinase 
ribozyme that directly phosphorylates a nucleobase of its nucleic acid substrate. Atomic level mutations on a critical 
5’ triplet GGA suggest that 2-amino moiety in the two Guanosines plays important role during catalysis plausibly 
as hydrogen bond donors. We are currently studying the pH dependence of the reaction to identify potential role of 
Electron Donating Groups (EDGs) to activate the nucleophile for the reaction. Phosphoryl transfer on the nucleobase 
is an important step during the de novo biosynthesis of nucleotides such as ATP. Study of this ribozyme could help us 
understand mechanisms utilized by kinase ribozymes to catalyze biosynthetic reactions.
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270 A A pinch model for activation of HDV-like ribozymes
Chiu-Ho Webb1, Andrej Luptak1
1University of California-Irvine
The HDV family of ribozymes are widely distributed in nature and their biological roles include processing of viral and 
retrotransposon transcripts and translation initiation of retrotransposon mRNAs. These ribozymes are characterized by their 
double-pseudoknot secondary structure. Many retrotransposon-associated ribozymes also contain large insertions predicted 
to form stable structures. We show that these peripheral domains activate the ribozymes by “pinching” two core helices 
together. A trans-cleaving construct derived from the Drosophila R2 ribozymes consisting of a ribozyme subunit and a long 
substrate strand that spans the core and peripheral domains exhibits a large activation barrier, supporting the pinch model. 
Our data point to a simple mechanism of activity modulation in HDV-like ribozymes (seeFig. 1).
269 C Formation of a catalytic supramolecular RNA 1D-array through self-assembly of an 
engineered group I intron RNA enzyme
Narumi Uehara1, Hiroyuki Furuta1, Yoshiya Ikawa1
1Department of Chemistry and Biochemistry, Graduate School of Engineering, Kyushu University
Self-assembly of biopolymers plays fundamental roles in modern biological systems. DNA duplex structure 
is essential for storage and replication of genetic information and protein quaternary structure conducts elaborate 
functions (such as enzyme allosterism) and large complexes (such as virus capsids) of proteins. Self-assembly of 
polypeptides and nucleic acids are also attractive in the field of nanobio-technology, in which DNA is regarded as one 
of the most promising materials for designing 1D, 2D, and 3D nano-objects with defined sizes and shapes.
RNA has been considered as a candidate for nanobiotechnology material because of not only its similarity with 
DNA but also its functional roles (such as catalysts and receptors) in living cells. Artificial RNA design has produced 
polygonal and polyhedral RNA nano-objects composed of relatively short (ca. 25-100 nts) RNA oligonucleotides as 
monomer strands. On the other hand, biological evolution has generated complex RNA 3D structures with sophisticated 
functions, an extreme example of which is ribosome.
Amalgamation of artificial geometrical RNA nanostructures and naturally occurring RNA 3D structures would 
generate a new class of RNA nano-objects with enzyme-like functions. In this presentation, we wish to present our 
recent study to construct self-assembling 1D-nanoarray whose monomer unit is a group I intron RNA. Modular 
engineering of the Tetrahymena group I intron (ca. 400 nts) allowed us to convert its intramolecular interactions 
for the unimolecular self-folding into the intermolecular interactions for the multimolecular self-assembly, enabling 
the engineered intron to organize a head-to-tail 1D-assembly. The engineered intron exhibited the catalytic ability 
depending on the formation of the RNA 1D-array.
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271 B The catalytic mechanism of a novel, widely disseminated small nucleolytic ribozyme
Timothy Wilson1, Tomas Fessl1, David Lilley1
1University of Dundee
The twister ribozyme, recently discovered in the Breaker laboratory, is a novel small nucleolytic ribozyme that 
is widely disseminated in the genomes of bacteria and eukarya (Roth and Breaker, personal communication). At 
its simplest, the ribozyme consists of one terminal and two internal loops joined by short helices and stabilized by 
two pseudoknots. Cleavage occurs in the internal loop distal to the terminal loop. Like other nucleolytic ribozymes, 
cleavage occurs via an internal phosphoester transfer reaction, resulting in 2’-3’-cyclic phosphate and 5’-OH termini. 
Metal ions do not appear to participate directly in the reaction as the ribozyme is active in a wide range of divalent and 
monovalent cations. The reaction is relatively independent of pH above pH 6, with activity declining with pH below 
this point.
We are investigating the importance of ten highly conserved nucleotides to the structure and activity of the 
ribozyme. All ten lie in the terminal and cleavage site loops, which are thought to interact to form the active ribozyme. 
Mutation reduces activity by one to three orders of magnitude under standard conditions and generally perturbs folding 
significantly as revealed by in-line probing. Two of these nucleotides are particularly interesting. Replacing the highly 
conserved C in the terminal loop with a U results in a 2000-fold loss in activity at pH 7, but the effect is ameliorated 
at high pH. Similarly, cleavage is 50-fold slower when the conserved G in the cleavage site loop is replaced by an A, 
with higher activity observed at lower pH. These effects are consistent with a catalytic mechanism in which the C and 
G participate in general acid-base catalysis and we are investigating this hypothesis through atomic mutagenesis and 
phosphorothiolate acid-rescue experiments. We will present our latest data and compare the proposed mechanism to 
those of other small nucleolytic ribozymes.
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272 C Anion-p or cation-p interactions in RNA?
Pascal Auffinger1, Luigi D’Ascenzo1, Eric Westhof1
1IBMC/CNRS- UPR9002
In order to better characterize RNA folding and RNA structure as well as RNA interactions with proteins and 
ligands, it is essential to refine our knowledge of the non-covalent interactions that are at play in these systems. Without 
doubt hydrogen-bonds are among the best known non-covalent interactions. But, next to them, a large diversity of 
non-covalent interactions exists. For instance, in the protein world, cation-π interactions, namely the stacking of 
cationic species over an aromatic group, became rapidly a necessary letter in the non-covalent interaction alphabet. 
Yet, despite their obvious aromatic character, no significant cation-π interactions were described so far for nucleic acid 
systems. Here we report that nucleic acid aromatic systems prefer to interact with anionic rather than cationic species.
Indeed, through the calculation of electrostatic potential surfaces, we were able to show that the protein and nucleic 
acid aromatic systems do not share the same characteristics. The formers are electron-rich systems able to establish 
cation-π contacts; the latters are electron-depleted systems that display a propensity to attract anions and establish 
anion-π interactions. This largely unnoticed dissimilarity between aromatic rings of both main biomolecular groups 
sheds new light on some of their essential properties. Through an exhaustive search of the PDB for anion-π interactions 
involving, among others, the DNA and RNA backbone phosphate groups, it is found that anion-π interactions are 
rare in DNA compared to RNA where they are mostly involved in sharp turns (75%) such as those found in tRNA 
anticodon loops and, more generally, in RNA tetraloops (see Figure 1 below that shows the stacking of a phosphate 
group under a guanine in a GAAA tetraloop). Besides, these interactions are also observed between sequence-distant 
residues in ribosomes and in crystal-lattice contacts. The relative rarity of these anion-π interactions outside of loops 
indicates that it is generally not prevailing over classical hydrogen bonds in the nucleic acid context but nevertheless 
vital for their folding, structure and function.
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273 A The solution structure of Tetrahymena telomerase p65-RNA(TER)-TERT RBD determined 
by SAXS reveals contacts critical for particle stability
Andrea Berman1, Anne Gooding4, Robert Rambo2, John Tainer3, Thomas Cech4
1University of Colorado; 2Lawrence Berkeley National Laboratory; 3Lawrence Berkeley National Laboratory, 
Physical Bioscience Division; 4University of Colorado, Boulder and HHMI
The Tetrahymena telomerase ribonucleoprotein particle catalyzes telomeric DNA synthesis at the end of 
eukaryotic chromosomes.  Although it minimally contains a reverse transcriptase protein subunit (TERT) and a 
template-containing RNA (TER), the biogenesis of the enzyme complex requires the protein p651,2, which binds TER 
and induces a conformational change that facilitates the binding of TERT3-5.  We used small-angle x-ray scattering 
(SAXS) to determine the low-resolution solution structures of p65 alone, a portion of the TER alone, p65 bound to 
TER and p65-TER in complex with the RNA binding domain (RBD) of TERT.  The SAXS analysis has allowed us to 
confidently distinguish the RNA from the protein in the scattering density.  This has significantly aided in modeling 
the SAXS envelopes with published crystal and NMR structures of the RNA and protein components, allowing us to 
understand the global arrangement of the minimal holoenzyme2.  Our structure reveals an elongated arrangement of 
the domains of p65.  The observation that p65 contacts both TER and TERT supports the hypothesis that p65 serves as 
a molecular buttress that stabilizes both the TER and TERT in their catalytically active conformations6.  Comparison 
of SAXS models of p65 complexed with constructs of TER containing and lacking the pseudoknot indicates that the 
pseudoknot is required for the proper folding of TER.  These data offer insight into how the three molecules in the 
minimal complex interact with each other to make a functional telomerase and provide additional evidence for why 
the pseudoknot is essential in catalysis7.
1. Prathapam, R., Witkin, K.L., O’Connor, C.M. & Collins, K.  A telomerase holoenzyme protein enhances telomerase RNA 
assembly with telomerase RNA assembly with telomerase reverse transcriptase.  Nat Struct Mol Biol 12, 252-7 (2005).
2. Witkin, K.L. & Collins, K. Holoenzyme proteins required for the physiological assembly and activity of telomerase. Genes 
Dev 18, 1107-18 (2004).
3. O’Connor, C.M. & Collins, K. A novel RNA binding domain in tetrahymena telomerase p65 initiates hierarchical assembly 
of telomerase holoenzyme. Mol Cell Biol 26, 2029-36 (2006).
4. Stone, M.D. et al. Stepwise protein-mediated RNA folding directs assembly of telomerase ribonucleoprotein. Nature 446, 
458-61 (2007).
5. Singh, M. et al. Structural basis for telomerase RNA recognition and RNP assembly by the holoenzyme La family protein 
p65. Mol Cell 47, 16-26 (2012).
6. Berman, A.J., Gooding, A.R. & Cech, T.R. Tetrahymena telomerase protein p65 induces conformational changes 
throughout telomerase RNA (TER) and rescues telomerase reverse transcriptase and TER assembly mutants. Mol Cell 
Biol 30, 4965-76 (2010).
7. Tzfati, Y., Knight, Z., Roy, J. & Blackburn, E.H. A novel pseudoknot element is essential for the action of a yeast 
telomerase. Genes Dev 17, 1779-88 (2003).
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275 C CompaRNA: a server for continuous benchmarking of automated methods for RNA 
structure prediction
Janusz Bujnicki1, Tomasz Puton2, Lukasz Kozlowski3, Sam Mondal3, Marcin Magnus3, Kristian Rother2
1Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell 
Biology in Warsaw, Poland; 2Bioinformatics Laboratory, Institute for Molecular Biology and Biotechnology, 
Faculty of Biology, Adam Mickiewicz University, ul. Umultowska 89, 61-614 Poznan, Poland; 3Laboratory of 
Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology in Warsaw, Ul. 
Ks. Trojdena 4, 02-109 Warsaw, Poland.
We have developed a benchmarking approach for the assessment of RNA secondary and tertiary structure 
prediction methods and implemented it in the CompaRNA web server. In the assessmend of secondary structure 
prediction methods, he performance of 28 single-sequence and 13 comparative methods has been evaluated on RNA 
sequences/structures released weekly by the Protein Data Bank. We have also calculated a static benchmark generated 
on RNA 2D structures derived from the RNAstrand database. Benchmarks on both data sets offer insight into the 
relative performance of RNA secondary structure prediction methods on RNAs of different size and with respect to 
different types of structure. The best comparative methods typically outperform the best single-sequence methods if 
an alignment of homologous RNA sequences is available. The initial tests on RNA 3D structure prediction methods 
provides additional insight into their strengths and weaknesses, and suggest strategies for the combination of the 
existing methods into meta-predictors that may aid in constructing superior models.
274 B Sizing large RNA molecules using single molecule fluorescence correlation spectroscopy
Alexander Borodavka1, Roman Tuma1, Peter Stockley1
1Astbury Centre for Structural Molecular Biology, University of Leeds
Large RNA molecules (>1kb), encompassing mRNA, long non-coding RNAs (lncRNA) and genomes of RNA 
viruses, play important role in many biological processes. However, given their size and general propensity of ssRNA 
to form extensive secondary structure it is difficult to study their folding. Single molecule fluorescence correlation 
spectroscopy (smFCS) allows to determine hydrodynamic size of large RNA molecules at concentrations approximating 
infinite dilution conditions (<1 nM), thus minimizing artifacts attributed to non-specific interactions and aggregation. 
We have labelled representative RNAs at 3’-end with a single fluorophore and examined their hydrodynamic sizes 
under low-salt conditions, i.e. in ‘good solvent’, when electrostatic interactions dominate and prevent formation of 
tertiary structure. Under these conditions most RNAs adopt an ensemble of relatively compact conformations. The 
average hydrodynamic radii can be related to the ensemble of branched structures generated by Mfold, suggesting 
that under low salt conditions the size of large RNAs is determined by electrostatic repulsion between partially double 
stranded, branched segments. The size of most large RNA molecules decreases in the presence of physiological 
concentrations of polyvalent cations, reflecting further folding into compact tertiary structure. In contrast to mRNAs 
and viral genomes, lncRNAs do not undergo similar compaction, maintaining their rather elongated shape. Such 
distinct shape may be related to their function as molecular scaffolds in gene regulation.
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276 A Symmetry and asymmetry in the unwinding of nucleic acids
Francesco Colizzi1, Yaakov Levy2, Giovanni Bussi1
1SISSA - Scuola Internazionale Superiore di Studi Avanzati; 2Department of Structural Biology, Weizmann 
Institute of Science, Rehovot, Israel
The forming and melting of complementary base pairs in RNA and DNA duplexes are conformational transitions 
required to accomplish a plethora of biological functions. Using fully atomistic simulations we have shown that 
RNA unwinding occurs by a stepwise process in which the probability of unbinding of the base on the 5´ strand is 
significantly higher than that on the 3´ strand [Colizzi and Bussi JACS, 2012]. The asymmetry in the RNA unwinding 
dynamics is compliant with the mechanism of helicase activity shown by prototypical DEx(H/D) RNA helicases and 
could allow deciphering the basis of the evolutionary pressure responsible for the unwinding mechanism catalyzed by 
RNA-duplex processing enzymes. In this spirit and from a broader standpoint, here we use a topology-based coarse-
grain model to compare and characterize the mechanism of unwinding for both DNA and RNA. The (a)symmetric 
behavior of the 3´- and 5´-strand could be related to the (bi)directionality observed in molecular machineries processing 
nucleic acids.
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277 B A revised folding pathway of group II introns: Assigning specific structures to the 
individual FRET states
Erica Fiorini1, Cardo Lucia3, Danny Kowerko1, David Rueda2, Roland K.O. Sigel1
1University of Zurich, Institute of Inorganic Chemistry, Winterthurerstrasse 190, Zurich, Switzerland; 
2Imperial College London, Section of Virology, Department of Medicine, London W12 0NN, UK; 3University 
of Zurich, Institute of Inorganic Chemistry, Winterthurerstrasse 190, Zurich, Switzerland; University of 
Birmingham, Institute of Biomedical Research, Birmingham, B15 2TT, UK
Sc.ai5γ is a large (~900 nts), multi-domain group II intron RNA transcribed from the mitochondrial genome 
of S. Cerevisiae.[1] These RNAs catalyze their self-excision upon formation of long-range tertiary interactions. Their 
folding and related catalytic activity are influenced by co-factors such as metal ions (especially Mg2+) and proteins. We 
have designed a shortened construct of Sc.ai5γ, D135-L14, labeled with the Cy3-Cy5 fluorophore pair and biotin for 
surface immobilization. This construct enables a detailed characterisation of the folding pathway by smFRET using 
TIRF microscopy, since it preserves the dynamics and the catalytic activity of the parent ribozyme.[2] Using smFRET 
spectroscopy, it becomes possible to record data from one single molecule isolated from its neighbors in real-time and 
the direct analysis of individual folding pathways of different molecules within a large ensemble. Previous studies 
revealed a linear three-state folding pathway from the unfolded to the native state devoid of kinetic traps.[2] The rate 
constants of those transitions depend on concentration and the type of metal ions (i.e. Mg2+ and Ca2+).[2, 3] Our studies 
revealed an additional folding step. Furthermore we made three distinct mutants each carrying a different mutation 
that interrupts a specific tertiary interaction, known to be involved in crucial interdomain tertiary interactions (Figure 
1). This enabled us to assign each FRET state to a specific folding intermediate. The construct carrying a tetra-loop 
mutation in Domain 5, involved in the ζ- ζ’ interaction with D1 (D13mut5-L14), basically stops the folding process at 
the lowest FRET state. A 2-point mutation in Domain 3 aimed to interrupt the μ-μ’ (D3-D5) docking (D15mut3-L14) 
does not have a drastic effect. In contrast, Domain 3 deletion (D15-L14) causes misfolding of the molecule to a 
more compact state (Figure 1). Moreover, the presence of the substrate affects the distribution of conformational 
intermediates and their dynamic equilibrium in the different mutants.
1. Fedorova O. and Zingler N. Group II introns: structure, folding and splicing mechanism. Biol. Chem., 2007, 388: 665–678.
2. M. Steiner, K.S. Karunatilaka, R.K.O. Sigel, D. Rueda, PNAS, 2008, 105, 13853.
3. M. Steiner, D. Rueda, and R.K.O. Sigel, Angew. Chem. Int. Ed., 2009, 48, 9739 –9742.
Financial support by the European Research Council (to RKOS) and the University of Zurich is gratefully 
acknowledged.
 
Figure 1. Secondary structure of labeled D135-L14 ribozyme (left). Mutations are indicated in green (D15mut3-
L14), purple (D15-L14) and pink (D13mut5-L14). Histograms allow us to identify the number of conformations 
adopted by the molecule, the relative abundance of each FRET state and therefore the differences between the 
mutant constructs (right) and D135-L14 (left). 
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279 A Non-Canonical Base Pair Formation and Ion Binding in Small Bulged RNA
Neena Grover1
1Department of Chemistry and Biochemistry, Colorado College
Bulges are found in most small and large RNA.  The presence of a bulge alters the A-form helical structure and 
allows the formation of many non-canonical base pairs. Thus unique conformations of the bulge region become sites 
for recognition and interactions with other biomolecules. We are comparing small bulged RNA to determine sequence 
and ionic conditions in which a particular non-canonical base pair forms and its contribution to RNA stability.  For our 
studies, RNA constructs containing small symmetric or asymmetric bulges are derived from functionally interesting 
and well-characterized RNA.  Thermodynamic data on small RNA constructs is collected in 1 M KCl buffers where 
charge-charge interactions are expected to be fully satisfied, based on polyelectrolyte theory of ion condensation. 
Comparative analysis of ?Go37 data on multiple RNA constructs in 1 M KCl is utilized to measure the contribution (if 
any) of non-canonical base pairs.  Measurements are also performed in 0-10 mM magnesium ions to determine the 
contributions of magnesium ions in stabilizing these constructs.  The penalty for breaking an A-form helix in RNA can 
be several kcal/mol.  Formation of strong non-canonical base pairs in the bulge, such as C+•C, provides significant 
stabilization and minimizes the cost of breaking the helical structure. In the presence of 10 mM of magnesium ions, 
RNA constructs are equally or more stable (?Go37) than in 1 M KCl.  An additional 2-4 kcal/mol of free energy is 
available in 10 mM magnesium buffer for constructs in which magnesium interactions are significant.  A-form helical 
constructs also show stabilization in magnesium ions depending on the sequence.  Bulged containing DNA constructs 
examined were not additionally stabilized by magnesium ions over 1 M KCl.  Thermodynamic analysis provides 
accurate and straightforward method to measure the strength of non-canonical base pairs and ion-binding in nucleic 
acids.  This work is supported by NSF Grant MCB-0950582.
278 C Elucidation of viroids structure by SHAPE
Tamara Giguère1, Charith Raj Adkar-Purushothama1, François Bolduc1, Jean-Pierre Perreault1
1Département de biochimie, Université de Sherbrooke, Québec, Canada
Viroids are single stranded, circular RNA with the size range of 246-400 nucleotides. They are the smallest 
known phytopathogens causing a wide array of symptoms. Viroids do not encode any pathogen-specific proteins and 
therefore both the secondary as well as the tertiary structures are of the upmost importance. In general, the secondary 
structures of viroids have been predicted based on their sequence using computer software programs, which have 
been shown to possess several important limitations. The predicted structure of a viroid needs to receive physical 
support prior to its use in the accurate interpretation of any mechanistic studies. Recently, we have adapted SHAPE 
probing coupled with fluorescence sequencing technics and computer-assisted structure prediction in order to fasten 
the structural determination of viroid species. As proof-of-concept, the secondary structure of the RNA strands of both 
the plus and minus polarities of the peach latent mosaic viroid has been determined. Both of these structures are in 
good agreement with the ones obtained using conventional SHAPE protocol. The same methodology has been applied 
to determine the secondary structure of both the strands (plus/minus) of several viroids of the Avsunviroidae family. 
This easy-to-use and fast protocol will be very useful to compare the structures of many viroid variants revealed from 
high-throughput sequencing data in a relatively short amount of time.
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281 C Ligand selectivity of the neomycin RNA aptamer is highly influenced by its ionic 
surroundings
Muslum Ilgu1, Bruce D Fulton2, Ragothaman Yennamalli4, Megan M Kleckler2, Monica H Lamm2, Taner Z Sen2, 
Marit Nilsen-Hamilton3
1Ames Laboratory, US DOE; 2Iowa State University; 3Iowa State University and Ames Laboratory, US DOE; 
4Rice University
Nucleic acid aptamers are frequently characterized as highly specific for their cognate targets, which implies 
precise molecular recognition between the aptamer and its target.  However, as short oligonucleotides, aptamers are 
likely to be structurally flexible and more responsive to environmental changes adjusting to alternative conformations 
with altered specificity.  To understand the role of aptamer structure in establishing ligand specificity, we examined 
an RNA aptamer reported as highly selective for neomycin-B over other aminoglycosides. Docking scores correlated 
well with the experimentally determined dissociation constants showing that the aptamer is more promiscuous than 
previously reported.  The ionic surroundings strongly affected the ligand affinities for its aminoglycoside ligand and 
influenced the promiscuity of aminoglycoside binding.  In parallel, the observation of a flexible pentaloop in molecular 
dynamics simulations led us to investigate the impact of this region on target selectivity.  Studies with aptamer variants, 
including those with 2-aminopurine substitutions and altered bases, showed that the aptamer conformation was ligand-
dependent and strongly affected by the ionic environment.  The results of this study demonstrate that the structure of 
the neomycin aptamer pentaloop is highly malleable, impacted by the ionic environment and coordinating with the 
binding pocket for ligand incorporation. An impact of buffer composition was also observed on the conformation of 
the malachite green aptamer interacting with malachite green. Thus, buffer composition may also characterize the 
interaction of other aptamers with their ligands. These results support a view of aptamer conformations as malleable, 
responding to the ionic environment and also the ligand structure, with potential impacts on aptamer affinity and 
specificity.
280 B The plasticity of a structural motif in RNA: structural polymorphism of a k-turn in response 
to its environment
Lin Huang1, Peter Daldrop1, David Lilley1
1CR-UK Nucleic Acid Structure Research Group, The University of Dundee
The k-turn is a widespread structural motif that introduces a tight kink into the helical axis of double-stranded 
RNA, and is frequently used to make tertiary interactions. The adenine bases of consecutive G•A pairs are directed 
towards the minor groove of the opposing helix, hydrogen bonding in a typical A-minor interaction. We find that the 
available structures of k-turns divide into two classes, depending on a key A-minor hydrogen bonding in the core of 
the structure. The two classes differ on whether N3 or N1 of the adenine at the 2b position accepts a hydrogen bond 
from the O2’ at the -1n position. There is a coordinated structural change involving a number of hydrogen bonds 
between the two classes.
We show that Kt-7 can adopt either the N3 or N1 structures depending on environment. While it has the N1 
structure in the ribosome, we find that crystal structures of the same sequence, either engineered into the SAM-I 
riboswitch or in complex with the L7Ae protein as a simple duplex, have the N3 structure. The change between the 
N1 and N3 structures results in a significant alteration in the trajectory of the helical arms, and in the rotational setting 
of the helical arms. This will be very significant for making tertiary contacts.
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282 A A predictive value optimizing the evaluation of biological RNA G-quadruplexes formation
Rachel Jodoin1, Jean-Denis Beaudoin1, Jean-Pierre Perreault1, Martin Bisaillon1
1Université de Sherbrooke, Sherbrooke, Quebec, Canada
RNA G-quadruplexes are non-canonical structures involved in many important cellular processes such as 
translation regulation and mRNA polyadenylation. They are composed of stacks of at least two G-quartets, a co-planar 
arrangement of four guanines linked together by Hoogsteen base-pairs and stabilized by monovalent cations, usually 
K+. Sequences agreeing to the algorithm Gx-N1-7-Gx-N1-7-Gx-N1-7-Gx (where x ≥ 3, N=A,U,G,C) are considered as 
potential candidates for G-quadruplexes (PG4). However, many sequences identified as forming G-quadruplexes with 
known biological functions do not correspond to this algorithm. Moreover, this algorithm led to the identification of 
a number of false positives, hence there is a need to consider other factors than the PG4 sequence only. For example, 
we previously reported that many false positive PG4s do not form G-quadruplexes because of the presence of multiple 
tracks of cytosines (C) in their genomic context competing to form Watson-Crick structures [1]. In order to determine 
the extent of the genomic context’s influence on G-quadruplex formation, we selected 12 predicted PG4s found in the 
5’- and 3’-untranslated region (UTR) of human mRNAs. In vitro, we have assessed the adoption of the G-quadruplex 
structure for the same PG4 with either 15 or 50 nucleotides of their upstream and downstream genomic context by in-
line probing. We then sought to find a predictive value representative of the competitiveness of the genomic context. 
Several analyses have allowed the development of a new scoring system for the prediction of PG4 considering the 
sequence in the vicinity. This new system could be used in combination with the standard algorithm as a scoring-
system to optimize RNA G-quadruplexes prediction.
1. Beaudoin, JD. and Perreault, JP. (2010) Nucleic Acids Research, 38, 7022-7036
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283 B Metal ions determine the kinetics and thermodynamics of single RNA-RNA associations 
according to the Irving-Williams series
Sebastian L.B. König1, Danny Kowerko1, Mokrane Khier1, Mélodie Hadzic1, Roland Sigel1
1Institute of Inorganic Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich
The formation and stability of a complex RNA architecture is to a large part dependent on base pairing, being 
the key to secondary and tertiary structure. Any such RNA-RNA interaction is only possible in the close proximity 
of cations, i.e. largely metal ions, to overcome charge repulsion of the negatively charged phosphate sugar backbone. 
Here we dissect the fundamental role of M2+ ions on the kinetics and thus also stability of RNA-RNA strand 
association. Here, we investigate the 5’-splicie site formation of group II introns representing a typical example of 
such a basic interaction. Group II introns are functional RNAs that catalyze their own excision, i.e. splicing [1]. Splice 
site recognition is provided by the association of the exon- and intron-binding sequences (EBS, IBS), which has been 
proposed to be directly dependent on divalent metal ions [2]. We now used single-molecule FRET [3] to systematically 
assess the influence of various divalent metal ions along the Irving-Williams Series on the EBS1*/IBS1* interaction 
(Figure 1): In the rigorous absence of M2+ ions, strand pairing is basically absent, i.e. the presence of M2+ is crucial 
for EBS1*/IBS1* interaction to occur to a significant extent. However, the inter-oligonucleotide affinity as well as 
docking/undocking kinetic varies by several orders of magnitude depending on the cation present. These observations 
can be rationalized by the intrinsic affinities of the individual metal ions towards the different coordinating atoms, e.g. 
ring nitrogens, carbonyl oxygens, and phosphate oxygens, of the RNA. This allowed us to dissect such a “simple” 
RNA-RNA strand association into subsequent small steps of a clearly M2+-dependent EBS1*/IBS1* folding pathway. 
Our study thus not only validates smFRET for the systematic study of metal ion-mediated nucleic acid folding, but 
also shows that metal ion-dependent RNA folding can be explained by the coordination chemistry of the metal ion 
cofactor.
Financial support by the European Research Council (ERC starting grant MIRNA 259092 to R.K.O.S.), a UZH-
Forschungskredit (57010302, to S.L.B.K.), and the University of Zurich is gratefully acknowledged.
1. O. Fedorova, N. Zingler Biol. Chem. 2007, 388, 665-678.
2. D. Kruschel, R. K. O. Sigel J. Inorg. Biochem. 2008, 102, 2147-2154.
3. L. Cardo, K. S. Karunatilaka, D. Rueda, R. K. O. Sigel, Methods Mol. Biol., 2012, 848, 227-252.
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284 C Crowded Environments Compensate Destabilizing Mutations in the Azoarcus Ribozyme
Hui-Ting Lee1, Duncan Kilburn1, Sarah Woodson1
1Johns Hopkins University, Thomas C. Jenkins Department of Biophysics
Using the Azoarcus ribozyme as a model system, our laboratory has previously shown that the native structure 
of the RNA is stabilized by the cooperative formation of tertiary interactions at different places in the RNA (1). On 
the other hand, molecular crowding stabilizes the RNA structure (2). Here, we show that crowded environments 
offset the destabilization due to RNA mutations.  We created point mutations in tetraloops (A25U and A190U) or in 
the central triple helix (G125A) to disrupt tertiary interactions and destabilize the structure. Combinations of these 
mutations create RNA molecules carrying single, double or triple mutations. We followed the RNA folding process by 
native PAGE, small angle X-ray scattering (SAXS) and ribozyme activity in the presence of 18% PEG1000.  We found 
that PEG1000 reduced the average size of RNA and altered the distribution of unfolded structures at low magnesium 
concentrations. Furthermore, PEG1000 shifted the midpoints of the folding transitions to lower magnesium. In the 
presence of 18% PEG1000, some mutants even show similar stability as the wild-type ribozyme. The magnitude of this 
compensation depends on the position of mutation. The results show that crowder molecules in solution compensate 
for the destabilization caused by mutations, and change the magnitude of cooperativity between tertiary interactions. 
Greater tolerance to mutation in physiological environments may allow for neutral drift among non-coding RNA 
sequences.
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285 A A Universal RNA Structural Motif Docking the Elbow of tRNA in the Ribosome, RNAse P 
and T-box Leaders
Jean Lehmann1, Fabrice Jossinet2, Daniel Gautheret1
1Institute of Genetics and Microbiology, University Paris-Sud, France; 2Institute of Molecular and Cellular 
Biology - CNRS, University of Strasbourg, France
The structure and function of conserved motifs constituting the apex of Stem I in T-box mRNA leaders are 
investigated. We point out that this apex shares striking similarities with the L1 Stalk (helices 76-78) of the ribosome. 
A sequence and structural analysis of both elements shows that, similarly to the head of the L1 Stalk, the function of 
the apex of Stem I lies in the docking of tRNA through a stacking interaction with the conserved G19:C56 base pair 
platform. The inferred structure in the apex of Stem I consists of a module of two T-loops bound together head-to-tail, 
a module which is also present in the head of the L1 Stalk, but went unnoticed. Supporting the analysis, we show that 
a highly conserved structure in RNAse P formerly described as the J11/12-J12/11 module, which is precisely known 
to bind the elbow of tRNA, constitutes a third instance of this T-loop module. A structural analysis explains why six 
nucleotides constituting the core of this module are highly invariant among all three types of RNA. Our finding that 
major RNA partners of tRNA bind the elbow with a same RNA structure (Figure 1) suggests an explanation for the 
origin of the tRNA L-shape.
Figure 1:
Crystallographically established (a) and model (b) of tRNA – RNA binding in which a stacking interaction between 
the G19:C56 base pair platform defining the elbow of a tRNA and a platform of a head-to-tail double T-loop module 
is involved. (a) L1 Stalk – tRNA (pdb 1VSA) and RNAse P – pre-tRNA (pdb 3Q1Q) interactions. Only a fragment of 
RNAse P is shown. (b) Model of B. subtilis ProI Stem I – tRNA interaction.
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286 B One-bead coarse grained models for RNA dynamics and folding
Filip Leonarski1, Fabio Trovato4, Valentina Tozzini3, Andrzej Les2, Joanna Trylska1
1Centre of New Technologies, University of Warsaw, Zwirki i Wigury 93, 02-089 Warszawa, Poland; 
2Department of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warszawa, Poland; 3NEST, Istituto 
Nanoscienze, Cnr and Scuola Normale Superiore, Piazza San Silvestro 12, 56127 Pisa; 4NEST, Istituto 
Nanoscienze, Cnr, Scuola Normale superiore and Center of Nanotechnology and Innovation, iit, Piazza San 
Silvestro 12, 56127 Pisa
The knowledge of RNA tertiary structure1 and its internal dynamics2 is essential for understanding key biological 
processes such as the regulation of mRNA translation. However, experimental studies of RNA structure and dynamics 
are expensive and troublesome. This is confirmed by a large discrepancy between the number of protein and RNA 
X-ray crystallography resolved structures in the Protein Data Bank. On February 19, 2013 there were more than 70 
000 deposited protein X-ray structures and only 500 RNAs. In principle, computational approaches could affordably 
complement experiments. At this moment, however, the quality of RNA simulation methods and their predictive power 
needs improvement. One of the promising approaches is molecular dynamics with a coarse-grained representation 
of RNA. Nucleic acids are modeled as sets of beads and each bead corresponds to a single nucleotide. The time-
dependent behavior of such beads is simulated by solving the classical equations of motions. This requires the formula 
for the potential energy function with parameters - the so called force field. Finding such a force field for various 
coarse-grained models of RNA is a long process, so a lot of effort has been put to find a universal force field that can 
be applied to all kinds of problems. However, in our opinion, the best results with a coarse-grained approach can only 
be obtained by carefully adapting the energy function to a particular need.
Therefore, we have created a methodological help for developers of coarse-grained models3,4. We have 
implemented a metaheuristic optimization algorithm (evolutionary algorithm) that finds a best set of parameters for 
a given one-bead RNA potential energy function. Using such an automatized routine, in short time, one can adapt a 
general model to a particular task. As an example, we will show the results of the same one-bead coarse-grained force 
field, with parameters optimized in the first case for the internal dynamics of a folded RNA helix (Figure 1A,B) and 
in the second case for the RNA structure prediction (Figure 1C,D). We will present the differences in the construction 
of the two models that are essential for their performance for a particular task. We will also show statistical studies 
performed on thousands of force field models that emphasize the importance of particular force field terms and their 
relative correlations. The results allow us to define the boundaries of one-bead representations in modeling various 
aspects of RNA structure and dynamics.
1. E. Capriotti and M. A. Marti-Renom, BMC Bioinformatics 2010, 11:322
2. H. M. Al-Hashimi and N. G. Walter, Curr. Opin. Struct. Biol. 2008, 18:321–329
3. F. Leonarski, F. Trovato, V. Tozzini, J. Trylska, Lect. Notes Comp. Sci. 2011, 6623:147–15223
4. F. Leonarski, F. Trovato, V. Tozzini, A. Les, J. Trylska, in preparation for J. Chem. Theory Comput.
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288 A Structural characterization of the yeast telomerase RNA core by SHAPE
Rachel O. Niederer1, David C. Zappulla1
1Johns Hopkins University
Telomerase is a ribonucleoprotein (RNP) that catalyzes the addition of telomere repeats to the ends of linear 
eukaryotic chromosomes. The core enzyme consists of telomerase reverse transcriptase (TERT) and telomerase RNA 
(TR). Our aim is to investigate the overall architecture of S. cerevisiae telomerase RNA (TLC1) to gain insights into 
the relationship between RNA structure and telomerase function. The large size of TLC1 (1157 nts) makes structural 
characterization difficult. To overcome this obstacle, we took advantage of an active 170-nt yeast telomerase RNA, 
Micro-T. This catalytic core RNA contains the conserved structural elements, including the 16-nt template sequence 
that is reverse transcribed, a catalytically important pseudoknot, and a poorly characterized protein-binding region. We 
find that Micro-T adopts fewer conformations compared to TLC1 in vitro by native gel electrophoresis, suggesting it 
should be more amenable to structural studies. We investigated the structure of this RNA using Selective 2’-Hydroxyl 
Acylation analyzed by Primer Extension (SHAPE), which interrogates local flexibility at each nucleotide position in a 
given RNA. Here we report the first application of SHAPE chemistry on yeast telomerase RNA. Our Micro-T SHAPE 
analysis supports the current secondary structure model for the TLC1 core. The template nucleotides and adjacent 
single-stranded region are highly SHAPE reactive, suggesting the RNA is in a biologically relevant conformation. 
Furthermore, our data indicate that the yeast pseudoknot is able to form in the absence of TERT. This is in contrast 
to the in-vitro folding of protein-free Tetrahymena thermophila TR, which does not form a pseudoknot or maintain 
an unpaired template. This suggests the intrinsic stability of the yeast pseudoknot is more similar to that of human 
TR. SHAPE will allow further examination of structure-function relationships in the telomerase RNP. For instance, 
in human telomerase evidence suggests that physical flexibility resulting from an unusual 5-nucleotide bulge within 
the pseudoknot is important for catalysis. We propose physical flexibility within the pseudoknot is a prominent feature 
of all telomerase RNAs. Although yeast does not contain a bulge at the corresponding position, it has an unusually 
long unpaired region, which we find to be reactive by SHAPE. We are now testing for conformational changes in 
telomerase RNA the presence of TERT. Results from these studies will help determine how yeast telomerase RNA and 
TERT interact and coordinate telomeric DNA synthesis.
287 C Crystallization of the active form of the Lariat-Capping ribozyme.
Mélanie Meyer1, Henrik Nielsen3, Eric Westhof2, Steinar Johansen4, Benoît Masquida5
1Génétique Moléculaire, Génomique, Microbiologie Université de Strasbourg Institut de Physiologie 
et Chimie Biologique du CNRS, 21 rue René Descartes F-67084 Strasbourg France; 2Architecture et 
Réactivité de l’ARN Université de Strasbourg Institut de biologie moléculaire et cellulaire du CNRS, 15 
rue René Descartes F-67084 Strasbourg France; 3Department of Cellular and Molecular Medecine The 
Panum Institute University of Copenhagen DK-2200N Copenhagen Denmark; 4Department of Molecular 
Biotechnology RNA Research Group Institute of Medical Biology University of Tromsø N-9037 Tromsø 
Norway; 5Génétique Moléculaire, Génomique, Microbiologie Université de Strasbourg Institut de Physiologie 
et Chimie Biologique du CNRS, 21 rue René Descartes F-67084 Strasbourg France
The lariat-capping ribozyme (LCrz) followed by an ORF encoding a homing endonuclease (HE) is embedded 
in the P2 stem of a regular group I intron named GIR2. This complex twin-ribozyme intron found in the SSU rRNA 
precursor of several eukaryotes has been mostly studied in Didymium iridis. In connection with the microorganism life 
cycle, three different intron processing pathways are observed. In the regular self-splicing pathway, GIR2 performs 
splicing to allow the LCrz branching reaction to proceed, leading to a 3’ product with the first and the third nucleotide 
linked by a 2’ 5’phosphodiester bound. This three nucleotides lariat caps the HE mRNA and replaces the conventional 
m7G cap. LCrz shares high sequence and secondary structure similarities with group I introns, but distinct three-
dimensional features. Thus, the LCrz constitutes an independent class of naturally occurring ribozymes.  The LCrz 
branching reaction takes place in a genuine structural context despite the fact it resembles the first step of splicing by 
group II introns or the spliceosome.
Formerly known as the GIR1 branching ribozyme, it has been renamed regarding the 2’ 5’ branching reaction 
it catalyzes and its specific structural features revealed by our 2.5 Å crystal structure of the full-length DiLCrz (192 
nucleotides) in the post-cleavage form. We are currently crystallizing the active form of the LCrz to better understand 
the chemical and structural basis of lariat formation. We now have data up to 4 Å and a readily interpretable electron 
density map. These data show that the unit cell of the active form of the full-length DiLCrz is shrunk along two 
dimensions as compared to the post-cleavage form indicating discrete conformational changes with respect to the 
post-catalytic state.
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290 C Imp3p unfolds conserved and stable stem structures in both U3 snoRNA and pre-rRNA to 
promote annealing
Binal Shah1, Xin Liu1, Carl Correll1
1Rosalind Franklin University of Medicine and Science
Growth of eukaryotic cells depends on ribosome biogenesis and its dysfunction is closely linked to cancer 
progression. An essential step in making ribosomes is rapid hybridization between the pre-rRNA and the U3 snoRNA, 
which is required for the pre-rRNA cleavages that liberate the small subunit (SSU) precursor. One of the three 
prerequisite U3-pre-rRNA hybridization sites, designated the U3-18S duplex, is not observed in vitro in the absence 
of protein because the bases involved in hybridization in each RNA are buried in conserved and stable structures: 
box A/A’ stem loop in U3 snoRNA and helix 1 (H1) in the 18S region of the pre-rRNA. Thus, energy to unwind 
these stems is needed to permit hybridization. Previously, we showed that Imp3p and Imp4p are required for U3-18S 
hybridization in vitro (Gerczei ’09). However, the minimal 18S substrate used in that work was unable to form H1 and 
it was unknown whether protein binding exposes the box A/A’ bases. Here, we employ larger pre-rRNA fragments 
more representative of in vivo substrates. By probing base accessibility with CMCT modification and backbone 
accessibility with RNase T1 our studies demonstrate that the larger substrates form the secondary structures observed 
in vivo and that binding of Imp3p alone provides sufficient energy to unfold the pre-rRNA H1 and the U3 box 
A/A’ stem structure. Moreover, this protein dependent unfolding activity is required to observe hybridization. These 
stable RNA structures may serve as a switch to block U3-pre-rRNA interactions until recruitment of Imp3p, which 
is expected to happen late in assembly of the 90S preribosome. Imp3p recruitment promotes U3-18S hybridization, 
which in turn leads to recruitment of the endonucleases that release the SSU precursor.
Gerczei et al (2009) JMB 390, 991.
289 B Molecular crowding accelerates ribozyme docking and catalysis
Bishnu P. Paudel1, David Rueda2
1Imperial College, London / Wayne State University, Detroit MI; 2Imperial College, London, UK
All biological processes take place in highly crowded cellular environments. However, how molecular crowding 
agents affect the folding and catalytic properties of RNA molecules remains largely unknown.  Here, we have combined 
single-molecule fluorescence resonance energy transfer (smFRET) and bulk cleavage assays to determine the effect 
of a molecular crowding agent (polyethylene glycol, PEG) in the folding and catalysis of a model RNA enzyme, 
the hairpin ribozyme. Our single-molecule data reveal that PEG favors highly the formation of the docked (active) 
structure by increasing the docking rate constant specifically with increasing PEG concentrations.  Furthermore, in the 
presence of PEG, the concentration of Mg2+ ions required to induced the active state decreases by 10-fold, near the 
physiological range (~1 mM).  Lastly, bulk cleavage assays show that the ribozyme’s activity accelerates by ~10-fold 
in the presence of the crowding agent.  Together, our data show that molecular crowding agents can affect both the 
dynamics and function of RNA enzymes, such as the hairpin ribozyme. We propose that crowding agents in the cell 
play an important role in stabilizing and accelerating the native structure of RNA enzymes in vivo.
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291 A The influence of metal ions on the structure of the CPEB3 ribozyme’s P4 region
Miriam Skilandat1, Magdalena Rowinska-Zyrek1, Roland K. O. Sigel1
1University of Zurich, Institute of Inorganic Chemistry, Winterthurerstrasse 190, CH-8057 Zurich, 
Switzerland
The CPEB3 ribozyme is one of two small ribozymes that have been discovered in mammalian genomes (Salehi-
Ashtiani et al. 2006; Teixeira et al. 2004). This small self-cleaving RNA is exclusively found in mammals with a 
highly conserved sequence and resides on an intron of the cpeb3 gene (Salehi-Ashtiani et al. 2006). The function of 
the CPEB3 ribozyme is yet unknown, but its secondary structure and cleavage mechanism have been proposed to be 
highly similar to the one of the Hepatitis Delta Virus ribozyme (Salehi-Ashtiani et al. 2006), which uses Mg2+ ions for 
cleavage (Nakano et al. 2001).
As a first step in the investigation of the 3D structure of the CPEB3 ribozyme and of its interaction with metal 
ions, we have solved the solution structure of the P4 region of the ribozyme and investigated its metal-ion binding 
sites using NMR-spectroscopy. This small hairpin is closed by a UGGU tetraloop, which is stabilized by base stacking 
interactions and an internal hydrogen bond and which contains one inner-sphere Mg2+-binding site. The tetraloop’s 
structural features are very similar to the ones previously described for an AGUU tetraloop being an RNAse III 
recognition motif in yeast (Wu et al. 2001). A second Mg2+-binding site is contained in the stem of P4, sequentially 
close to the proposed ribozyme active site. Comparison of the NMR spectra of the full-length CPEB3 ribozyme and 
the free P4 hairpin in the absence and in the presence of Mg2+indicates that the structure and the Mg2+-binding sites of 
the isolated P4 are identical or very similar to the ones found in the structural context of the full-length ribozyme, thus 
providing first information on the CPEB3 ribozyme’s fold and metal-ion interaction sites.
Financial support by the Swiss National Science Foundation, the European Research Council and the University 
of Zurich is gratefully acknowledged.
1. Nakano S, Proctor DJ, Bevilacqua PC (2001) Mechanistic Characterization of the HDV Genomic Ribozyme: 
Assessing the Catalytic and Structural Contributions of Divalent Metal Ions within a Multichannel Reaction 
Mechanism. Biochemistry 40: 12022-12038
2. Salehi-Ashtiani K, Lupták A, Litovchick A, Szostak JW (2006) A Genomewide Search for Ribozymes Reveals an HDV-
Like Sequence in the Human CPEB3 Gene. Science 313: 1788-1792
3. Teixeira A, Tahiri-Alaoui A, West S, Thomas B, Ramadass A, Martianov I, Dye M, James W, Proudfoot NJ, Akoulitchev A 
(2004) Autocatalytic RNA cleavage in the human β-globin pre-mRNA promotes transcription termination. Nature 432: 526-
530
4. Wu H, Yang PK, Butcher SE, Kang S, Chanfreau G, Feigon J (2001) A novel family of RNA tetraloop structure forms the 
recognition site for Saccharomyces cerevisiae RNase III. EMBO Journal 20: 7240-7249
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293 C Self-dimerizing group I ribozymes as a new class of modular units for RNA synthetic 
biology
Takahiro Tanaka1, Hiroyuki Furuta1, Yoshiya Ikawa1
1Department of chemistry and Biochemistry, Graduate School of Engineering, Kyushu University
Biopolymers are promising materials for nanotechnology. DNA has been used for the construction of chemically 
stable 1D, 2D and 3D nano-objects because self-assembly of DNA is easily programmable. On the other hand, 
polypeptides (proteins) form complex 3D structures and exhibit diverse functions.
From the viewpoint of a nano-biotechnology and synthetic biology, RNA is also an attractive biopolymer. Due 
to the structural similarity between RNA and DNA, design principles of DNA nano-objects can be applicable to the 
design of RNA nano-objects. Moreover, RNA is also able to perform protein-like functions such as catalysis and 
molecular recognition because RNA can also form complex 3D structures. Several RNA nano-structures such as 
polygons and polyhedrons have been reported but they were composed of relatively short and simple RNA units (ca. 
25-100 nts). In contrast, functional RNAs in living cells such as ribosomes and self-splicing ribozymes are composed 
of 200-3000 nucleotides.
We have constructed a new class of nano-structures possessing catalytic activity derived from a group I intron 
ribozyme. Because RNA nano-structures possessing the enzyme-like functions has not been reported so far. We 
converted a group I intron ribozyme to self- or hetero-dimerizing RNA that exhibits enzyme function upon self-
dimerization. Molecular design for the dimerization was carried out with modular engineering, by which intramolecular 
interactions of the parent ribozyme was redesigned to form intermolecular interactions for the dimerization. The 
dimerization proceeded highly effectively and the ribozyme activity was strongly depended on the RNA dimerization. 
The resulting dimeric ribozyme would be applicable to new device modules for RNA synthetic biology.
292 B Structural complexity of Dengue untranslated regions: the role of cis-acting RNA motifs 
and pseudoknot interaction in modulating functionality of the viral genome.
Joanna Sztuba-Solinska1, Tadahisa Teramoto3, Jason Rausch1, Bruce Shapiro2, Radhakrishnan Pademanabhan3, 
Stuart Le Grice1
1RT Biochemistry Section, HIV Drug Resistance Program, Frederick National Laboratory for Cancer 
Research, Frederick, MD 21702, USA; 2CCR Nanobiology Program, Computational RNA Structure 
Group, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA; 3Department of 
Microbiology and Immunology, Georgetown University School of Medicine, Washington, D C 20057, USA
Dengue virus (DENV) is a single-stranded positive-sense RNA virus belonging to the Flaviviridae family, whose 
members cause diseases of major health importance. The DENV genome encloses multiple cis-acting elements required for 
translation and replication. Previous studies indicated that a 719 nt subgenomic minigenome (DENV-MINI) is an efficient 
template for translation and (-) strand RNA synthesis in vitro (1, 2). We performed a detailed structural analysis of DENV-
MINI RNA, combining chemical acylation techniques (SHAPE, aiSHAPE), Pb2+ ion-induced hydrolysis and site-directed 
mutagenesis. Our results highlight protein-independent 5’–3’ terminal interactions involving hybridization between 
specific cis-acting RNA motifs. Probing analyses identified tandem dumbbell structures (DBs) within the 3’ terminus spaced 
by single-stranded regions, and internal loops and hairpins with embedded GNRA-like motifs. Analysis of conserved 
motifs and top loops (TLs) of these dumbbells, and their predicted interactions with downstream pseudoknot (PK) regions, 
predicted an H-type pseudoknot involving TL1 of the 5’ DB and the complementary region, PK2. Since disrupting the TL1/
PK2 interaction, via “flipping” mutations of PK2, previously attenuated DENV replication, this pseudoknot may participate 
in regulation of RNA synthesis. Computer modeling implied that this motif might function as autonomous structural/
regulatory element. In addition, our studies targeting elements of the 3’ DB and its complementary region PK1 indicated 
that communication between 5’-3’ terminal regions strongly depends on structure and sequence composition of the 5’ 
cyclization region.
1. Clyde, K. and Harris, E. (2006) RNA secondary structure in the coding region of dengue virus type 2 directs translation 
start codon selection and is required for viral replication. J Virol, 80, 2170-2182.
2. Nomaguchi, M., Ackermann, M., Yon, C., You, S. and Padmanabhan, R. (2003) De novo synthesis of negative-strand RNA 
by Dengue virus RNA-dependent RNA polymerase in vitro: nucleotide, primer, and template parameters. J Virol, 77, 8831-
8842.
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295 B The regulatory significance of RNA secondary structure in Arabidopsis
Lee Vandivier1, Fan Li4, Qi Zheng3, Matthew Willmann3, Ying Chen4, Brian Gregory2
1Genetics and Gene Regulation Graduate Group, PENN Genome Frontiers Institute, University of 
Pennsylvania; 2Department of Biology, PENN Genome Frontiers Institute, Cell and Molecular Biology 
Graduate Program, Genomics and Computational Biology Graduate Program, University of Pennsylvania; 
3Department of Biology, PENN Genome Frontiers Institute, University of Pennsylvania; 4Genomics and 
Computational Biology Graduate Program, PENN Genome Frontiers Institute, University of Pennsylvania
Recent transcriptome-wide studies have illustrated the role of RNA secondary structure as a post-transcriptional cis-
regulator that controls multiple steps of mRNA maturation and translation.  We have focused our attention on uncovering 
the regulatory impact of secondary structure on the Arabidopsis thaliana transcriptome. Here, we present findings from 
these recent studies revealing that mRNA structure modulates translation. For instance, we find that RNA secondary 
structure sharply decreases across translation start and stop sites, while increasing folding has significant positive 
correlation with ribosome occupancy, perhaps due to ribosomal stalling.  We also demonstrate a correspondence 
between mRNA and protein structure. Specifically, the portions of mRNAs encoding predicted protein domains are on 
average significantly more structured than portions encoding inter-domain regions.  We then reveal that RNA folding 
significantly anticorrelates with transcript abundance, due in part to increased degradation and smRNA processing of 
highly structured protein-coding mRNAs. Finally, we uncover that transcripts with similar structure not only share 
similar regulation, but also encode proteins with coherent functions. In total, we demonstrate the global impact of 
structure on post-transcriptional regulation in Arabidopsis.
294 A Automated identification of RNA 3D modules with discriminative power in RNA structural 
alignments.
Corinna Theis1, Christian Hoener zu Siederdissen2, Ivo L. Hofacker2, Jan Gorodkin1
1University of Copenhagen; 2University of Vienna
The particular three-dimensional architecture, which enables structured RNAs to accomplish a variety of functions, 
is established by local or remote tertiary interactions. A set of such tertiary interactions enclosed by canonical base 
pairs is called an RNA 3D module. The steady growth of experimentally determined atomic resolution RNA structures 
(X-ray or NMR) have revealed different types of RNA 3D modules, such as kink-turns, C-loops and G-bulges. Even 
though they in generally only consist of a few nucleotides, they play a major role in mediating protein and ligand 
docking, directing the folding process or stabilizing the structural conformation of an RNA molecule. The RNA 3D 
modules have shown up over numerous structures as recurring building blocks, which often are conserved throughout 
all kingdoms of life. Thus, it is a general interest to match RNA 3D modules known from one molecule to another 
for which the 3D structure is not known or the RNA sequences are only partially known. Recent strategies in RNA 
structure prediction include to ‘fill the gap’ in 2D RNA structure by including 3D information into the structure 
prediction, such as probing data. The assignment of such 3D information to 2D structures can improve structure 
prediction, limits the number of false positives, assign functions to unknown molecules, help to find new modules as 
well as classifying transcripts as ncRNAs.
Here, we address the usage of 3D information, by merging RNA 3D modules in existing 2D structural alignments 
of RNA. To meet this challenge we have created a pipeline, called metaRNAmodules, which completely automates 
extracting of known and unknown modules from the FR3D database and subsequently map them to Rfam structural 
RNA alignments to obtain comparative information. Subsequently, the modules are turned into graph-based statistical 
models (using Bayesian networks) for the RMDetect program, which allows for test of their discriminative power 
using real and shuffled Rfam alignments. An initial extraction of 15290 RNA 3D modules in all PDB files results 
in 977 modules with clear discriminative power. Many of these modules describe only minor variants of each other. 
Indeed, mapping of the modules onto Rfam families results in 28 unique locations in 10 different families. Our 
pipeline is available as source code along with the generated RNA 3D modules at http://rth.dk/resources/mrm.
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297 A How do platinum drugs interact with RNA?
Marianthi Zampakou1, Daniela Donghi1
1Institute of Inorganic Chemistry, University of Zurich, Winterthurerstrasse 190, CH-8057, Zurich, 
Switzerland
We are currently studying the influence of platinum drugs on RNA structure, with a special focus on the anticancer 
drug cisplatin and its derivatives. Such drugs are generally believed to mainly target DNA by preferentially binding to the 
N7 atoms of two neighbouring guanines.[1] Nevertheless, additional potential targets are likely to exist, including RNA.[2]
In fact, cisplatin was shown to inhibit RNA-dependent processes.[2] Moreover, in the last decades several biochemical 
studies have been reported confirming the interaction of platinum drugs with RNA.[2,3] However, still very little is known on 
RNA structural changes upon platinum binding. The presence in RNA of loops, bulges and junctions, eventually important 
for tertiary contacts, possibly opens up a multifaceted scenario for RNA-platinum drug interaction.
The goal of our project is to obtain structural information on how platinum drugs interact with RNA, to evaluate 
actual structural preferences in the binding. For this purpose, we use a 27nt RNA hairpin model system derived from 
the yeast mitochondrial group II intron Sc.ai5γ.[4] The structure of this construct in solution is known,[5] and it contains 
secondary structure motifs common in RNAs.[6] Different platination agents are used, including cisplatin and oxaliplatin. 
The platination products are characterised by several techniques, like mass spectrometry, UV spectroscopy and gel mobility 
shift assays. We are currently optimising large scale platination conditions to obtain higher amount of pure platinated 
sample to be used for structure evaluation by NMR spectroscopy.
Acknowledgements. Financial support by the Swiss National Science Foundation (Ambizione fellowship PZ00P2_136726 
to DD), by the University of Zurich and within the COST Action CM1105 is gratefully acknowledged.
1. Aldeerden RA, Hall MD, Hambley TW. 2006. J. Chem. Educ., 83: 728-734.
2. Chapman EG, Hostetter AA, Osborn MF, Miller AL, DeRose VJ. 2011. Met. Ions Life Sci., 9: 347-377.
3. See for example Papsai P, Snygg AS, Aldag J, Elmroth SKC. 2008. Dalton Trans., 5225-5234.
4. Sigel RKO. 2005. Eur. J. Inorg. Chem., 2281-2292.
5. Donghi D, Pechlaner M, Sigel RKO, unpublished.
6. Butcher SE, Pyle AM. 2011. Acc. Chem. Res., 44: 1302-1311.
296 C Crystallographic Studies of the Complex between G-quadruplex RNA and the RGG Domain 
of Fragile X Mental Retardation Protein
Nikita Vasilyev1, Anna Polonskaia2, Dinshaw J. Patel2, Alexander Serganov1
1Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New 
York, NY; 2Structural Biology Program, Memorial Sloan-Kettering Cancer Center, New York, NY
Fragile X syndrome is one of the leading causes of inherited mental retardation and autism. The syndrome is 
associated with the loss of functional Fragile X Mental Retardation Protein (FMRP). In neurons, FMRP binds to a 
subset of neuronal mRNAs, normally activated by specific receptors, and inhibits translation of these mRNAs. FMRP 
contains three canonical RNA-binding domains: two KH domains and an arginine-glycine rich (RGG) box. The RGG 
motif recognizes mRNAs that contain guanine-rich regions capable of forming guanine quartets. We have determined 
the crystal structure of the complex between the RGG peptide and a guanine-rich RNA at 2.8 Å resolution. The RNA 
structure revealed formation of three G-quartets assembled in a potassium-stabilized G-quadruplex and connected to 
a helical stem. The RGG peptide interacts predominantly with the stem and the adjacent junction through base-paring 
with guanine bases and the sugar-phosphate backbone. The structure explains previous biochemical observations and 
suggests the molecular principles of FMRP binding to natural mRNAs.
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298 B Synthesis of fluorophore- and spin-labeled RNA using deoxyribozymes
Lea Büttner1, Fatemeh Javadi-Zarnaghi1, Claudia Höbartner1
1Max Planck Institute for biophysical Chemistry, Research Group Nucleic Acid Chemistry, 37077 Göttingen, 
Germany
Studying the multifaceted functions of non-coding RNAs by biophysical techniques such as electron paramagnetic 
resonance (EPR) spectroscopy and fluorescence measurements requires the site-specific installation of spectroscopic 
labels. Several synthetic approaches are known to directly incorporate modifications via solid-phase synthesis or 
install reporter groups post-synthetically on pre-functionalized RNA. The investigation of longer RNAs than routinely 
achievable by chemical synthesis demands the ligation of labeled RNA fragments, which is traditionally performed 
with (protein) enzymes T4 DNA ligase or T4 RNA ligase.
Here we report on an alternative approach for obtaining long labeled RNAs by employing DNA enzymes 
(deoxyribozymes) for the site-specific attachment of reporter groups, as well as for the efficient ligation of labeled 
RNA fragments. Deoxyribozymes are artificial single stranded DNA molecules that are identified by in vitro selection 
and serve as useful tools for practical applications. Synthetically beneficial DNA enzymes require only metal ions 
(usually Mg2+ or Mn2+) as cofactors for their catalytic activity, function at neutral pH and can easily be isolated and 
reused for  multiple reactions. For the site-specific, posttranscriptional labeling of RNA, we capitalized on a DNA 
enzyme that has been shown to accept GTP as substrate to attach a single nucleotide to the branch site adenosine of a 
model RNA.1 We have optimized this reaction based on our recent finding of lanthanide-assisted acceleration of DNA-
catalyzed RNA ligations. In this report, we demonstrate the attachment of chemically modified nucleotide analogs that 
introduce bioorthogonal functional groups or directly install detectable probes at desired target sites (see Figure). In a 
general sense, this deoxyribozyme combines in one molecule the functions of target-site selection and catalysis of the 
labeling reaction. Guidelines for the general application of the deoxyribozyme-based labeling strategy are developed 
and the approach is exemplified for the synthesis of spin-labeled and fluorescently labeled S-adenosylmethionine 
(SAM)-binding riboswitch RNAs.
1. C. Höbartner, S.K. Silverman, Angew. Chem. Int. Ed. 2007, 46, 7420-7424.
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299 C Spin-labeled cytidine nucleotides in long synthetic RNAs: solid-phase synthesis, post-
synthetic labeling, ligation and EPR-spectroscopic characterization
Claudia Höbartner1, Jan Seikowski1, Lea Büttner1, Katarzyna Wawrzyniak1, Anne Ochmann1, Falk Wachowius1, 
Giuseppe Sicoli2
1Max Planck Research Group Nucleic Acid Chemistry, Max Planck Institute for biophysical Chemistry, Am 
Fassberg 11, 37077 Göttingen, Germany; 2Max Planck Institute for biophysical Chemistry, Am Fassberg 11, 
37077 Göttingen, Germany
Chemically stable nitroxide radicals that can be monitored by electron paramagnetic resonance (EPR) spectroscopy 
can provide information on structural and dynamic properties of functional RNAs, such as for example riboswitches. 
Since natural RNA is diamagnetic, the site-specific installation of nitroxide spin-labels is required. A number of 
post-synthetic strategies have been established for the attachment of nitroxide spin labels at various sites in pre-
functionalized RNA, but advanced EPR techniques and instrumentation demand the development of new spin-
labeling approaches for RNA. Challenges that need to be addressed include the synthesis of rigid spin labels and the 
preparation of long spin-labeled RNA by combined chemical and enzymatic strategies.
We highlight the synthesis and application of the nitroxide-containing nucleoside C¸m, reported as the first 
rigid spin label for paramagnetic modification of RNA by solid-phase synthesis[1,2] and the convertible nucleoside 
approach that enabled the direct attachment of TEMPO and proxyl spin labels at the exocyclic N4-amino group of 
cytidine and 2’-O-methylcytidine nucleotides in RNA.[3,4] Recent results on the synthesis of long spin-labeled RNAs 
will be discussed, based on using deoxyribozymes as alternatives to protein enzymes for ligation of spin-labeled RNA. 
To obtain site-specifically labeled long riboswitch RNAs beyond the limit of solid-phase synthesis, we report the 
ligation of paramagnetic RNA using an in vitro selected deoxyribozyme as catalyst, and demonstrate the synthesis of 
TEMPO-labeled 53-nt SAM-III and 118-nt SAM-I riboswitch domains (SAM = S-adenosylmethionine).[4]
1. C. Höbartner, G. Sicoli, F. Wachowius, D.B. Gophane, S.T. Sigurdsson, Synthesis and characterization of RNA containing a 
rigid and nonperturbing cytidine-derived spin label, J. Org. Chem. 2012, 77, 7749.
2. I. Tkach, S. Pornsuwan, C. Höbartner, F. Wachowius, S.T. Sigurdsson, T. Baranova, U. Diederichsen, G. Sicoli, M. Bennati, 
‘Orientation selection in distance measurements between nitroxide spin labels at 94 GHz EPR with variable dual frequency 
irradiation‘, Phys. Chem. Chem. Phys. 2013, 15, 3433.
3. G. Sicoli, F. Wachowius, M. Bennati, C. Höbartner, Probing secondary structures of spin-labeled RNA by pulsed EPR 
spectroscopy, Angew. Chem. Int. Ed. 2010, 49, 6443.
4. L. Büttner, J. Seikowski, K. Wawrzyniak, A. Ochmann, C. Höbartner, 2013, submitted.
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300 A Inhibition of Bcl-2 using photo-crosslinking antisense oligonucleotides
Akio Kobori1, Yuko Nagae1, Asako Yamayoshi1, Akira Murakami1
1Kyoto Institute of Technology
Oligonucleotide analogues forming covalent bonds with complementary nucleotides in a sequence-specific 
manner under physiological conditions are of potential clinical and biological interest. In particular, photoresponsive 
oligonucleotide analogues which cross-link with complementary nucleotides using photo-irradiation as a trigger of 
the reaction have been developed to investigate and control gene functions without damaging living systems. These 
oligonucleotide analogues have photoresponsive moieties introduced on a site which does not affect duplex or triplex 
formation. The introduced photoresponsive moieties, which are non-reactive or less reactive toward bio-molecules in 
their original form, generate highly reactive species after photo-irradiation. We have reported that oligonucleotides 
having a psplaren derivative (Ps) at the 2’-O hydroxy group of adenosine (2’-Ps-eom) recognize one base difference in 
the target sequences under clinically relevant conditions. Using 2’-Ps-eom, we successfully achieved the inhibition of 
K-ras-immortalized cell proliferation (K12V) but not of Vco cells that contain the wild-type K-ras gene. Considering 
the potential benefits of photoresponsive cross-linking reagent-nucleotide conjugates, it is important to develop new 
photoresponsive groups that could give high yields and exhibit specific reactive characteristics to target nucleobases 
located in specific positions in the target sequence. In this study, we newly synthesized photo-cross-linking ODNs 
having a photoresponsive a-chloroaldehyde (PCA) group at the 5’-end of the ODN. The PCA group was comprised 
of an a-chloro bis(2-nitrobenzyl)acetal group, which was converted to an a-chloroaldehyde group after 1 min of UV 
irradiation. Photo-cross-linking studies revealed that the oligonucleotide conjugates underwent sequence-selective 
cross-linking to target nucleotides in a time-dependent manner under physiological conditions.
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301 B Translational regulation by ligand-inducible formation of RNA pseudoknot
Saki Matsumoto1, Changfeng Hong1, Asako Murata1, Kazuhiko Nakatani1
1The Institute of Scientific and Industrial Research, Osaka University
RNA secondary structures play crucial roles for noncoding RNAs in catalyzing biological reactions, controlling 
gene expression, responding to cellular signals, and so on. A small molecule that binds specifically to target RNA and 
induces a particular secondary structure might be a promising tool for gene regulation and gene therapy. We have 
developed a series of synthetic small molecules that can specifically bind to G-G mismatches in double-stranded DNA. 
Naphtyridine carbamate tetramer (NCTn), one of such mismatch binding molecules, consists of four naphthyridine 
units connected by flexible methylene linker -(CH
2
)n- and selectively binds to the CGG/CGG triad in dsDNA by 
forming hydrogen bonding with guanine bases. Our previous study has shown that NCTn can bind to (CGG)n sequence 
in single-stranded region of RNA and act as a molecular glue for promoting duplex formation from two single strand. 
Here we demonstrated that NCTn can induce a pseudoknot structure in RNA by the simultaneous binding between the 
loop region and the single-stranded tail as illustrated in Figure and furthermore, ligand-inducible formation of RNA 
pseudoknot can regulate translation of target gene by frame shifting.
 We used VPK pseudoknot, which causes ribosomal frameshifting in mouse mammary tumor viruses, as the 
structural template for engineering to NCTn-inducible pseudoknots. Ribosomal frameshifting is the translational 
recoding mechanism used in many viruses, which is promoted by a heptanucleotide slippery sequence and an adjacent 
mRNA secondary structure, most often an mRNA pseudoknot. The ribosome is stalled at a pseudoknot and forced 
to shift one nucleotide backwards into an overlapping reading frame and to translate an entirely new sequence of 
amino acids. We designed NCTn-inducible frameshifting system by introducing a potential binding site (CGG/CGG 
triad) for NCTn in VPK sequence (mmVPK) located between the initiation codon and the firefly luciferase gene. The 
frameshifting efficiency increased by NCTn-induced pseudoknot folding can be detected by increase in luciferase 
activity. To evaluate the effect of NCTn on translation of the firefly luciferase gene, in vitro protein synthesis assay 
was performed. In the presence of NCT8, frameshifting efficiency gradually increased in a concentration-dependent 
manner, whereas only slight increase of frameshifting efficiency was observed without NCT8. Similar results were 
obtained for other NCTn ligands. These results suggested that NCTn could induce pseudoknot formation and regulate 
frameshifting efficiency. The detail of NCTn-induced frameshifting will be discussed.
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302 C Targeting secondary structures of pre-miRNA by small molecules: Development of 
potential inhibitors of pre-miRNA processing
Asako Murata1, Ayako Sugai1, Takeo Fukuzumi1, Shiori Umemoto1, Chikara Dohno1, Kazuhiko Nakatani1
1Osaka University
MicroRNAs (miRNA) are involved in many biological processes including development, differentiation and 
carcinogenesis through translational repression by binding to a target mRNA. Inhibition of miRNA pathways by 
altering miRNA expression and/or maturation in cells would modulate gene expression, and enable us to understand 
miRNA regulatory effects on various biological processes. Anti-miRNA oligonucleotide (antagomir) is the most 
readily available tool to knock-down the expression of an endogenous miRNA, and thereby perturb miRNA-
mediated gene regulation in a sequence specific manner. In addition to the antagomir approach, a small molecule 
that bind to precursor-miRNA (pre-miRNA) and inhibit Dicer-catalyzed pre-miRNA processing will provide other 
options for modulating miRNA-mediated gene regulation. Several groups have shown that small molecules such as 
aminoglycosides, peptides, and peptoids would be potential inhibitors of Dicer-catalyzed pre-miRNA processing.
We have previously reported the synthesis and structure-activity relationships of xanthone and thioxanthone 
derivatives as the fluorescent indicators for detecting the interactions between RNA and small molecules [J. Am. 
Chem. Soc. 2010, 132, 3660., Chem. Eur. J. 2012, 18, 9999.]. Some of the 2,7-disubstituted xanthone and thioxanthone 
derivatives preferentially bind to certain secondary structures of RNA such as loops and bulges rather than double-
stranded regions. Since most pre-miRNAs have such secondary structures, we explored a possibility of inhibitory 
activity of the xanthone and thioxanthone derivatives against the dicing reaction upon their binding to pre-miRNA. 
We herein report that an aminoalkoxy-substituted thioxanthone derivative interferes Dicer-mediated processing of 
pre-miRNA (the figure below). Chemically synthesized pre-miR-29a was digested by human recombinant dicer in the 
absence or presence of xanthone and thioxanthone deriviative, and the resulting products were analyzed by denaturing 
PAGE. X2SS, one of the thioxhanthone derivatives we synthesized, effectively suppressed the formation of both the 
intermediate and mature miR-29a, indicating the inhibitory effect of X2SS on pre-miR-29a processing. Analysis 
of the dicing reaction of pre-miR-29a mutant revealed that binding of X2SS close to a cleavage site is capable of 
interfering the processing of pre-miR-29a. Information about the interaction between these xanthone derivatives and 
pre-miRNAs will enable us to design and develop new small molecule-based inhibitors for miRNA pathway.
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304 B Chemical Synthesis of 3’-Aminoacyl-tRNA Mimics to Investigate Antibiotic Induced 
Ribosome Stalling
Lukas Rigger1, Shanmugapriya Sothiselvam2, Nora Vázquez-Laslop2, Alexander Mankin2, Ronald Micura1
1Institute of Organic Chemistry, Center for Molecular Biosciences Innsbruck (CMBI), Leopold Franzens 
University, Innsbruck, Austria; 2Center for Pharmaceutical Biotechnology, University of Illinois at Chicago, 
USA
Nascent proteins leave the ribosome through the peptide exit tunnel. For decades it has been thought that this 
tunnel plays a passive role in protein synthesis. Yet there are interactions between the nascent peptide and the ribosome 
that can lead to ribosome stalling. Such translation arrest is used for regulation of gene expression. Recent studies 
showed that the nature of the donor and acceptor substrates for the peptidyl transfer reaction plays an important role 
in the mechanism of programmed translation arrest [1]. To clarify whether charge or size of the aminoacyl moiety 
of the substrates is important for translation arrest, amino acids – natural and unnatural – covalently bound to RNA 
via hydrolysis-resistant linkages are required. Starting from orthogonally protected 3’-deoxy-3’-azido adenosine we 
synthesize functionalized solid supports for automated oligonucleotide-peptide synthesis [2]. With those in hand, we 
have efficient access to 3’-deoxy-3’-amide-linked aminoacyl-tRNA mimics. These conjugates represent important 
substrates for ribosomal stalling assays to shed light on the mechanism of translation arrest.
1. Ramu, H., Vázquez-Laslop, N., Klepacki, D., Dai, Q., Piccirilli, J., Micura, R., & Mankin, A. S. (2011). Nascent Peptide in 
the Ribosome Exit Tunnel Affects Functional Properties of the A-Site of the Peptidyl Transferase Center. Molecular Cell, 
41(3), 321–330.
2. Moroder, H., Steger, J., Graber, D., Fauster, K., Trappl, K., Marquez, V. Polacek, N., Wilson, D. N., Micura, R. (2009). 
Non-Hydrolyzable RNA-Peptide Conjugates: A Powerful Advance in the Synthesis of Mimics for 3′-Peptidyl tRNA 
Termini. Angewandte Chemie International Edition, 48(22), 4056–4060.
Financial support from the Austrian Science Fund FWF (P21640, I317) is gratefully acknowledged.
303 A Suppression of miR-29a maturation by ligand binding
Takahiro Otabe1, Asako Murata1, Fumie Takei1, Kazuhiko Nakatani1
1The Institute of Scientific and Industrial Research, Osaka University, Japan
In recent years, the discovery of functional non-coding RNA (ncRNA) has raised the interest to modulate the function 
of ncRNA molecules. Small molecules that bind to specific secondary structural motifs in RNA will provide valuable tools 
for modulating and studying RNA function.
We have developed a series of naphthyridine derivatives that can bind to single nucleotide bulges in DNA duplexes. 
Among these derivatives, N,N-bis(3-aminopropyl)-2,7-diamino-1,8-naphthyridine (DANP) was found to bind to cytosine 
and guanine bulges in RNA duplexes. The stabilizing effect of DANP on the complex with bulged RNA duplexes, however, 
was rather smaller than that observed for bulged DNA duplexes. The results of molecular modeling of RNA-DANP complex 
indicate that stacking interaction of DANP with the neighboring bases in the RNA duplex would be insufficient compared 
with that of DNA-DANP complex, which explain the reduced ability of DANP for stabilizing the RNA-DANP complex. We 
therefore designed BzDANP that has the same hydrogen-bonding surface as that of DANP but has an expanded aromatic 
plane in order to examine the effect of the molecular size and the π-stacking with the neighboring base pairs on binding 
affinity with RNA duplexes.
In this study, we describe the synthesis and the evaluation of binding capability of BzDANP to RNA duplexes containing 
a single nucleotide bulge. BzDANP was synthesized from 2-amino-7-bromo-isoquinoline as a starting material in five steps. 
The binding ability of BzDANP to RNA duplexes containing a single bulge was evaluated by thermal melting studies. 
A significant increase in melting temperature with RNA duplexes containing a single bulge was observed in presence of 
the BzDANP, suggesting the increased stabilizing effect of BzDANP on bulged RNA duplex relative to DANP. Next we 
explored a potential inhibitory of BzDANP against the dicing reaction of precursor-miRNA (pre-miRNA) upon binding to 
its secondary structures. Pre-miR-29a has a cytosine bulge near the putative cleavage sites by Dicer, so we expected that the 
binding of BzDANP to the bulge would interfere the dicing reaction of pre-miR-29a. Chemically synthesized pre-miR-29a 
was digested with recombinant human Dicer and the reaction products were analyzed by denaturing PAGE. Dicer digested 
pre-miR-29a to produce multiple bands on the gel when stained with SYBER GOLD. The rapidly migrating bands were 
obviously mature miR-29a and star miR-29a, and the others are likely intermediates where anick was made at either strand 
of the stem. The band intensity of both mature miR-29a and intermediates were decreased with increasing concentration of 
BzDANP, suggesting the inhibitory effect of BzDANP on pre-miR-29a processing.
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306 A Versatile phosphoramidation reactions for effective labeling and conjugation of nucleic 
acids
Tzu-Pin Wang1, Yu-Chih Su1
1Department of Medicinal and Applied Chemistry, Kaohsiung Medical University
Chemical conjugations of post-synthetic nucleic acids with macromolecules or smaller tag molecules are common 
approaches to study nucleic acids in chemistry and biology, and to exploit nucleic acids for medical applications. 
For example, conjugations of nucleic acids such as oligonucleotide siRNA and miRNA with peptides to acquire 
peptide-oligonucleotide conjugates (POCs) is especially useful to circumvent cell delivery and specificity problems 
of RNA as therapeutic agents. Recently, my laboratory has developed an aqueous-phase two-step nucleic acid 
phosphoramidation method for effective POC synthesis (Wang et al., 2010,Bioconjugate Chem. 21, 1642–1655; Wang et 
al., 2012, Bioconjugate Chem., 23, 2417-2433). Here we discuss the chemistry of nucleic acid phosphoramidation 
reactions and applications of the reactions for post-synthetic RNA conjugation and labeling essential to chemical and 
biological studies of RNA. When coupling with bio-orthogonal reactions such as click reactions, phosphoramidation 
reactions could be an even more powerful approach for nucleic acid conjugation and labeling. We are expecting that 
phosphoramidation reactions will have broader applications in conjugation and labeling of nucleic acids useful in 
fundamental research and in clinic.
305 C Coumarin fluorochrome binds to Rev responsible element RNA with extremely large 
absorption shift
Tetsuya Tsuda1, Takeo Fukuzumi1, Kazuhiko Nakatani1
1Osaka University
Since the discovery of a role for RNA in modulating gene expression, functional RNA has become an attractive 
drug target. However, there is not much report of the synthetic molecules that bind to RNA. Because of the complicated 
conformation of RNA, it is difficult to design binding molecules only by the conventional molecular design. The development 
of ligands that bind selectively to a particular structure and sequence of RNA is useful to understand and modulate the 
function of RNA. In this study, we focused on the design and synthesis of novel ccoumarin derivatives that can bind to 
particular secondary structures of RNA. It is well known that C7-substituted coumarin derivatives with electron-donating 
group at the C7 position show strong fluorescence. In addition, further substitution with a electron-accepting group at the C3 
position change their electron spectrum, which are characterized by such as red shift of absorption maximum and increase 
of fluorescence intensity. Considering these characters of coumarin, we envisioned that modification of coumarin at C3 and 
C7 positions enable us to observe binding of coumarin derivatives to RNA as a change in electronic spectrum.
We designed and synthesized a series of coumarin derivatives, in which piperazinyl group at the C7 position is introduced 
as a electron-donating group. The piperazinyl group would facilitate binding to RNA, due to its positive charge. Various 
functional groups, such as acetyl and benzoyl group, pyridine analogues, benzimidazole analogues, and 1,8-naphthyridine 
analogues is introduced to coumarin at the C3 position. Binding affinity of these coumarin derivatives to RNA were 
investigated by the absorption and fluorescence spectra in the presence of RNA. We used Rev responsible element (RRE), 
as the model RNA that consist of an internal loop and a terminal loop, and double-strand regions. 7-Piperadinylcoumarin, 
a control compound that does not have any functional group at the C3 position, showed only a small change of electronic 
spectrum when titrated with RRE. In contrast, apparent large red shift of absorption maximum from 398 nm to 460 nm was 
observed in the coumarin derivative having 2’-aminonaphthyridine at the C3 position (TT7) with one equivalent of RRE. 
To investigate the binding site of TT7 to RRE, we prepared three RRE-mutants. RRE-mutant 1 lacked both the internal 
and hairpin loops of RRE, RRE-mutant 2 lacked the hairpin loop, and RRE-mutants 3 lacked the internal loop. Large red 
shift of absorption maximum was also observed when TT7 was titrated with RRE-mutant 2 or 3. These results suggested 
that TT7 bound selectively to the hairpin loop and changed to absorption spectrum.
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307 B CACNA2D4: a novel paradigm for the application of antisense-mediated gene therapy to 
the cure of retinal dystrophies
Niccolo Bacchi1, Gian Carlo Demontis2, Simona Casarosa1, Michela Alessandra Denti1
1Laboratory of RNA Biology and Biotechnology, Centre for Integrative Biology(CIBIO), University of Trento, 
Trento, Italy; 2Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology, University of Pisa, 
Pisa, Italy
Retinal dystrophies are a large set of genetic diseases that lead to partial or complete blindness as a consequence of 
retinal degeneration. No available cures have been reported so far. Antisense RNA-based correction approaches have 
important advantages over the extensively investigated gene therapy approaches. In particular, they would allow 
expression at the natural site and under physiological circumstances. The use of appropriately engineered small nuclear 
RNA-U1 (U1snRNA) can induce therapeutic “exon skipping” and restore gene expression impaired by different 
types of mutations. We are currently developing a U1snRNA based therapeutic approach for the cure of Autosomal 
Recessive Cone Dystrophy 4 (RCD4, OMIM #608171), caused by a mutation in the L-type calcium channel accessory 
subunit CACNA2D4. We will test the feasibility of this approach on in vitro (minigene systems, patients derived cells) 
and in vivo (mutant Cacna2d4S4804X mice) models. The results of our work will foster current  knowledge on RNA-
based therapies, on their safety and on their effectiveness in the treatment of retinal dystrophies.
This work was supported by a “Giovani Ricercatori” Grant (GR-2008-1136933) by the Italian Ministry of Health.
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308 C ANTISENSE RNA-INDUCED EXON-SKIPPING FOR THE GENE THERAPY OF 
FRONTOTEMPORAL DEMENTIA AND PARKINSONISM ASSOCIATED WITH CHROMOSOME 
17 (FTDP-17).
Giuseppina Covello1, Kavitha Siva1, Lara Mari3, Elena Marchesi Marchesi3, Perrone Daniela Perrone3, Michela 
Alessandra Denti2
1CIBIO (Centre for Integrative Biology)-UNITN; 2CIBO (Centre for Integrative Biology)- UNITN, via 
delle regole, 101, 38123 Mattarello (TN) Italy CNR, Padua, Italy; 3Dipartimento di Biologia ed evoluzione, 
Università degli Studi di Ferrara
Tau, encoded by a single gene on chromosome 17p21, is a cytoskeletal component expressed in the central nervous 
system (CNS), with a role in neurogenesis, axonal maintenance and axonal transport. A number of neurodegenerative 
diseases, including FTDP-17 (rare autosomal dominant condition), are characterized by intra-neuronal accumulation 
of the tau protein.
The genetic linkage between tau protein and FTDP-17 seems to be, for about half of the cases of FTDP-17, 
mutations affecting the alternative splicing of exon 10 (E10) of the tau mRNA. The aberrant inclusion of E10 in the 
tau mRNA, in fact, leads to the aggregation of tau as Neurofibrillary Tangles (NFTs) in brain
The project explores the feasibility of an antisense (as-) RNA-based gene therapy to correct tau splicing in FTDP-
17.
We first tested whether it was possible to modulate E10 alternative splicing by the usage of Antisense Oligo-
Nucleotides (AONs) that mask specific sites regulating splicing pathways.
RT-PCR and Western blot analyses showed that the transfection of specific AONs is able to alter the splicing 
behaviour of tau E10 in the rat endogenous transcript (PC-12 cell lines), with variable efficiencies depending on the 
concentration of the AONs and on the targeted sequence. The results were confirmed by transfection of Scramble 
Control Oligonucleotides that had no effects on E10 inclusion at the same concentration.
Based on these results, we constructed Adeno-Associated Viral (AAV) vectors coding for specific as-RNAs. We 
embedded the as-RNA sequences in chimeric U snRNA vectors whose promoters themselves lead to long-term as-
RNA expression. We tested whether, the splicing behaviour of tau is corrected in endogenous rat mRNA by these 
chimeric antisense sn-RNAs.
To evaluate the effects of AONs/Chimeric Antisense-snRNA on the human tau pre-mRNA, we constructed a 
minigene reporter system, containing luciferase and that recapitulates to a large extent the behaviour of E10 in the 
context of the full-length tau gene. We carried out co-transfection into HeLa cells and evaluated the induction of E10 
skipping by Luciferase Expression Assay, Real Time-PCR and Western blot analyses. Further work will be directed to 
test the therapeutic efficacy of the AONs and AAV-vectored as-RNAs in the animal model of FTDP-17 (T-279 mouse).
This project was supported by TELETHON Italia Grant GGP08244
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310 B Identification of novel anti-obesity genes in primary human adipocytes using RNAi 
screening
Akanksha Gangar1, Didier Grillot1, Sandrine Martin1, Valerie Linhart1, Alizon Riou-Eymard1, Raphaelle Guillard1, 
Kim Carrein5, Maarten Van Balen5, Brigitta Witte4, Nick Vandeghinste5, Marlijn Steger2, David Fischer2, Steve De 
Vos5, Dominique Langin6, Vladimir Stich3, Stephane Huet1
1GlaxoSmithKline, 25-27 avenue du Québec, 91951 Les Ulis, France; 2BioFocus, Darwinweg 24, 2333 CR, 
Leiden, The Netherlands; 3Department of Sports Medicine, 3rd Faculty of Medicine, Charles University, 
Prague, Czech Republic; 4Galapagos, Darwinweg 24, 2333 CR, Leiden, The Netherlands; 5Galapagos, 
Generaal De Wittelaan L11A3, 2800 Mechelen, Belgium; 6Inserm, UMR1048, Obesity Research Laboratory, 
Team 4, I2MC, Institute of Metabolic and Cardiovascular Diseases, Toulouse, France
Obesity is an epidemic health problem worldwide. It is characterized by excess fat deposit in the adipose tissue. An increase 
in adiposity is associated with a constellation of disorders known as the metabolic syndrome including insulin resistance, type 2 
diabetes, hypertension and atherogenic dyslipidemia that contribute to the increased risk for cardiovascular morbidity & mortality. 
A multidisciplinary research effort involving a combination of clinical, biochemical and omics approaches appears mandatory to 
increase knowledge in the complexity of biological traits, processes associated with obesity and to identify novel targets for drug 
discovery.
We sought to identify novel genes implicated in adipose fat reduction by affecting triglyceride hydrolysis and/or increasing 
the metabolic capacity of the adipocytes. These gene products directly or components in the signaling pathway(s) of these gene 
products can be used as drug targets for the development of novel targeted anti-obesity therapies.
We employed loss-of-function RNAi genetic screen using an adenoviral shRNA library to identify genes involved in the 
reduction of adipose mass. The adenoviral shRNA library was generated against a set of target human genes known to be 
modulated in human overweight, obese or metabolic syndrome subjects. shRNA adenoviral transductions were performed in 
primary human sub-cutaneous adipocytes and five different read-outs (lipolysis, lipid droplet formation, adiponectin secretion, 
mitochondrial function and gene expression) were monitored. This was followed by confirmation of specific shRNAs to induce 
the desired phenotype by in-depth experimental analysis. Furthermore, “hits” were substantiated by correlation with the clinical 
parameters. This strategy allowed for the identification of several new genes involved in adipose functions along with some genes 
reported previously in published studies. We have reason to believe that some of these newly discovered genes may represent 
potential novel anti-obesity drug targets.
309 A Messenger RNA as a novel therapeutic approach
Antonin de Fougerolles1
1Moderna Therapeutics
Moderna is pioneering messenger RNA Therapeutics™, a novel biotherapeutic modality with the unprecedented 
capability of stimulating the body’s natural ability to produce therapeutic proteins. If successful in human clinical 
trials, this advance will usher in the first entirely new way of making therapeutic proteins since the development of 
recombinant technology more than 30 years ago, with dramatic implications for both patients and industry. Moderna is 
using this approach to develop first-ever treatments for a wide range of diseases that cannot be addressed today using 
existing technologies, and to drastically reduce the time and expense associated with creating therapeutic proteins 
using recombinant technologies.
Any protein biologic, antibody or vaccine can be rapidly made using mRNA.  The technology is “cell-free”, and 
alleviates the need for laborious and expensive in vitro tissue culture or protein manufacture and purification.  A new 
messenger RNA can be developed very quickly, in only a matter of hours (when producing a known mRNA) to weeks 
(when going from concept to new drug), thereby saving precious time and R&D resources.  Moderna has conducted 
proof of concept studies in numerous preclinical models, including non-human primates and has demonstrated the 
ability to induce in vivo production of dozens of intracellular and secreted therapeutic proteins through intramuscular, 
subcutaneous or intravenous administration. Pre-clinical programs have been established focused on four key 
therapeutic areas: oncology supportive care, inherited genetic disorders, hemophilia and diabetes. Results will be 
discussed.
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311 C Inhibition of the HIV -1 virus RRE-Rev interaction by small molecule Rev mimics. A new 
synthetic scaffold for specific recognition of RNA structure.
Luis Gonzalez-Bulnes1, Ignacio Ibañez4, Luis Miguel Bedoya2, Silvia Catalan3, Jose Alcami2, Santos Fustero3, Jose 
Gallego1
1Universidad Catolica de Valencia, Valencia Spain; 2Instituto de Salud Carlos III, Madrid Spain; 3Universidad 
de Valencia and Centro de Investigacion Principe Felipe, Valencia Spain; 4Universidad de Valencia and 
Centro de Investigación Principe Felipe, Valencia Spain
Functional and structured RNA motifs are not easily targeted by antisense agents and have the advantage of 
their high sequence and/or three-dimensional structure conservation. However, leaving aside natural products binding 
to sites within bacterial ribosomal RNA, the development of small RNA-binding agents has been hampered by 
the difficulties posed by these structures, which have limited physicochemical diversity and are often flexible. In 
order for this approach to be successful, it is essential to identify novel chemical scaffolds capable of specifically 
recognizing these motifs1. The Rev Recognition Element (RRE) is a strongly conserved 350 -nucleotide structure 
located in the env gene of human immunodeficiency virus type-1 (HIV-1) RNA. Within subdomain IIB of the RRE, 
the unusually widened major groove of a large 5:6 internal loop forms a high-affinity complex with the arginine-rich 
α-helix of the virally-encoded protein Rev, Rev34 -50. This interaction is essential for virus viability, as it triggers a 
cascade of events allowing the transport of unspliced or incompletely spliced viral RNA molecules to the cytoplasm 
of the infected cell. The RRE-Rev system offers unique advantages for drug design: the three-dimensional structures 
of the RRE-Rev34-50 complex and of unbound RRE and Rev are known. Making use of these advantages, we used 
structure-based methods to design small molecule mimics of Rev with a novel chemical scaffold. A set of these 
ligands was subsequently synthesized and tested in vitro and in vivo. Surface plasmon resonance and isothermal 
titration calorimetry experiments indicated that the compounds bound specifically to the RRE with an affinity of 5 
µM. Nuclear magnetic resonance spectroscopy analyses showed that they occupied the binding site of Rev34 -50 in 
the major groove of the IIB loop, inducing an RNA conformational change strickingly similar to that detected upon 
Rev34-50 binding. Fluorescence polarization experiments indicated that these terphenyls were capable of inhibiting 
the RRE-Rev34 -50 interaction in vitro. Cellular assays demonstrated that the most potent inhibitors blocked HIV -1 
replication in vivo and exerted this effect post- transcriptionally, as expected2. Most of the small RNA-binding agents 
described so far are related to peptides or antibiotics, or were discovered by screening. To our knowledge, this is the 
first time that a new organic scaffold with RNA-based activity has been designed de novo.
1. Gallego, J. & Varani, G. Targeting RNA with Small Molecule Drugs: Therapeutic Promise and Chemical Challenges. Acc. 
Chem. Res. 34, 836 -843 (2001).
2. Gonzalez-Bulnes, L.; Ibañez, I.; Bedoya, L.M.; Catalan, S.; Alcami, J.; Fustero, S.; Gallego, J. Patent application 
P201330235, 21-2-2013.
Poster Abstracts RNA 2013 •  Davos, Switzerland •  June 11-16, 2013
184  •   Therapeutic RNAs
312 A RNA aptamer C3 is a non-ATP site inhibitor of the MAP kinase ERK2
Sabine Lennarz1, Günter Mayer2
1University of Bonn, Life & Medical Science Institute, Gerhard-Domagk-Str.1, 53121 Bonn, Germany; 
2University of Bonn
Mitogen-activated protein kinases (MAPK) play a central role during signal transduction in eukaryotes. The ERK 
(extracellular signal-regulated kinase) MAP kinase pathway is of profound importance for cellular processes, such as 
proliferation and differentiation.
Since aberrant ERK signaling is a potent driver of oncogenesis in most human cancers, much attention has been focused 
on the development of inhibitors that target this pathway. The major class of available MAP kinase inhibitors is represented 
by so-called ATP analogues that inhibit phosphorylation of substrates and downstream signaling by competing with ATP 
in cells. Unfortunately, ATP-analogues often display poor specificity because the ATP-site is highly conserved amongst 
kinases. Thus, there is a high demand for the development of novel MAP kinase signaling inhibitors that enable selective 
inhibition by targeting kinase domains and individual sub-domains specifically.
Besides low-molecular weight ligands and antibodies, aptamers represent a promising class of molecules that can be 
applied extra- and intracellularly as high affine and specific inhibitors of biomolecules. Aptamers are short, single stranded 
nucleic acids that fold into a well-defined three-dimensional structure upon which they bind to a specific target molecule.
By performing an in vitro selection approach, we identified a RNA aptamer, namely C3, which bound to the MAP 
kinases ERK1 and ERK2 with high affinity and, furthermore, revealed high specificity, since no binding to other members 
of the MAP kinase superfamily or a panel of 10 other kinases was detected. More importantly, we were able to show that 
this aptamer interacts with ERK2 in an ATP-independent manner.
Aptamer C3 was identified as an inhibitor with an alternative and novel mode of action in respect of kinase activity 
perturbation. We could detect that the putative binding site of C3 on ERK2 includes the so-called “F-recruitment site” 
docking domain. By targeting a domain on ERK2 that is involved in regulating interactions with activators and substrate 
proteins, we were able to potently inhibit the activation of ERK2 by its activating kinase MEK1 in vitro. Future studies will 
be performed to investigate the aptamers potential to selectively block interactions of ERK2 with substrates.
Taken together, our data indicates that aptamer C3 binds to a physiologically relevant side on ERK and therefore could 
pave the way for the development of alternative acting and selective kinase inhibitors.
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313 B mRNA transfection - a transient transgene expression in human mesenchymal stem cells 
as an attractive tool for regenerative medicine
Adam Nowakowski1, Anna Andrzejewska1, Hanna Kozlowska2, Piotr Walczak4, Barbara Lukomska1, Miroslaw 
Janowski3
1NeuroRepair Department, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, 
Poland; 2Advanced Microscopy Platform, Mossakowski Medical Research Centre, Polish Academy of 
Sciences, Warsaw, Poland; 3NeuroRepair Department, Mossakowski Medical Research Centre, Polish 
Academy of Sciences, Warsaw, Poland; Russell H. Morgan Dept. of Radiology and Radiological Science, 
Division of MR Research; Cellular Imaging Section and Vascular Biology Program, Institute for Cell 
Engineering, The Johns Hopkins University School of Medicine, Baltimore, USA; Department of 
Neurosurgery, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland; 4Russell 
H. Morgan Dept. of Radiology and Radiological Science, Division of MR Research; Cellular Imaging Section 
and Vascular Biology Program, Institute for Cell Engineering, The Johns Hopkins University School of 
Medicine, Baltimore, USA
Introduction: Adult human bone marrow-derived mesenchymal stem cells (hMSCs) display a variety of beneficial 
properties. In stroke, therapeutic effects have been reported after the systemic delivery of hMSCs. It seems that 
a minimally invasive, intra-arterial route is an attractive method for stem cell transplantation to the injured brain. 
However, hMSCs lack the intrinsic mechanisms that make possible homing of the cells from the circulatory system to 
the area of infarction. It has been shown that genetic engineering can be effectively used for overexpression of certain 
molecules responsible for adhesion and transendothelial migration of systemically delivered cells. It is hypothesized 
that transient expression of integrins may be sufficient for promoting diapedesis and cell homing to the brain after 
intra-arterial delivery. Since hMSCs known for being extremely difficult to transfect using DNA plasmid vector, we 
investigated an mRNA transfection method for high efficiency expression of transgenes in hMSCs.
Methods: Human mesenchymal stem cells (hMSCs, PT-2501, Lonza) were cultured in a humidified atmosphere 
at 37oC and 5% CO
2
 in an appropriate medium MSCBM (PT-3238, Lonza) supplemented with 10% MCGS (PT-
4106E, Lonza), L-glutamine (PT-4107E, Lonza), and gentamicin sulfate (GA-1000, PT-4504E, Lonza). Cells were 
maintained in 75 cm2 flasks but for transgene induction experiments were transferred to 24-well plates and seeded at a 
density of 15,000 cells/well. Plasmid DNA-eGFP (BD Biosciences) at a dose of 0.5 and 1.0 µg/well, and mRNA-eGFP 
(StemGent) at doses of 0.12, 0.25, and 0.5 µg/well were used. Four transfection agents, The Lipofectamine® 2000 
(Invitrogen), TransIT-2020 (Mirus), TransIT ® - mRNA (Mirus) and StemfectTM RNA Transfection Kit (StemGent) 
were tested. The transfection efficiency was assessed over 21 days using GFP fluorescent signal detection by confocal 
microscopy.
Results: Consistently with previous reports the efficiency for pDNA-eGFP transfections of hMSCs was very 
low, less than 1%. In contrast, mRNA-eGFP transfection resulted in an efficiency exceeding 95% in all of the tested 
conditions. mRNA-eGFP dose of 0.5µg/well and the use of Lipofectamine® 2000 was the most effective method for 
transgene expression, lasting up to three weeks.
Conclusions: The mRNA transfection is an attractive tool for inducing transient expression of transgenes in 
otherwise difficult to transfect hMSCs. Due to its non-integration nature mRNA is highly desirable gene delivery 
technique for clinical applications. This engineering method for  hMSCs may open new opportunities in regenerative 
medicine.
Supported by a National Centre for Research and Development grant No 101 in ERA-NET NEURON project: 
“MEMS-IRBI”
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315 A RNA-i Therapy for Fronto Temporal Dementia and Parkinsonism Linked to Chromosome 17
Kavitha Siva1, Giuseppina Covello2, Michela Alessandra Denti2
1PhD student at Centre for Integrative Biology (CIBIO), University of Trento,Italy; 2Centre for Integrative 
Biology (CIBIO), University of Trento, Italy
Abnormalities of microtubule associated protein tau have been shown to be linked to pathogenesis of 
neurodegenerative disease collectively termed as “Tauopathies. Gene mutations in tau lead to perturbation of gene 
splicing and tau fibrillization leading to formation of tau aggregates. A missense mutation in exon 10 at codon 279, 
results in an asparagine to lysine substitution (N279K). This impinges alternative splicing of exon 10 of the tau 
mRNA, and amends the normal ratio of 4Rtau/3Rtau,This in turn leads to an increased expression of 4R tau causing 
agglomeration of tau proteins.
 RNA interference has proven to be an efficient strategy for silencing mutant alleles of dominant disease genes as 
in Alzheimer’s disease, Machado-Joseph disease, Spinocerebellar ataxia type 3 and tau mutation (V337M) that causes 
fronto-temporal dementia.
This project explores the feasibility of a siRNA-based gene therapy to enable post-transcriptional gene silencing 
of Exon10 in FTDP-17. A panel of siRNAs targeting Tau exon 10 have been synthesised, which will be further tested 
upon PC12 cells and Ren cells. The outcome of RNA interference will be tested by both RT-PCR and western blot 
analysis. Based on these results, the small interfering RNA sequences will be embedded in siRNA expressing vector 
(psiUx) relying on strong and ubiquitous pol II dependent promoter of human U1 small nuclear RNA (U1 snRNA) 
gene. Allele specific silencing effects of these constructs will be monitored and analysed in PC12 cells. The effect 
on human tau pre-mRNA, will be monitored via a mini-gene reporter system, recapitulating to a large extent the 
behaviour of exon 10 in the context of tau gene.
Further work will be directed to test the therapeutic efficacy of the AAV-vectored sh-RNAs in the animal model 
of FTDP-17 (T-279 mouse) which recapitulates the disease from a histopathological and behavioural point of view. 
Preliminary data on the behavioural analysis will be presented.
314 C Combined systemic and local morpholino treatment rescues the phenotype of the SMA 
Delta 7 mouse model
Marc-David Ruepp1, Monica Nizzardo3, Chiara Simone3, Sabrina Salani3, Federica Rizzo3, Margherita Ruggieri3, 
Simona Brajkovic3, Hong Moulton2, Oliver Mühlemann1, Nereo Bresolin3, Giacomo P. Comi3, Stefania Corti3
1Department of Chemistry and Biochemistry, University of Bern, Bern, Switzerland; 2Biomedical Sciences, 
College of Veterinary Medicine, Oregon State University, Corvallis, OR 97331; 3Dino Ferrari Centre, 
Neuroscience Section, Department of Pathophysiology and Transplantation (DEPT), University of Milan, 
Neurology Unit, IRCCS Foundation Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
Spinal muscular atrophy (SMA) is a childhood fatal motor neuron disease caused by mutations in the Survival 
Motor Neuron 1 (SMN1) gene, currently without effective treatment. One possible therapeutic approach is the use 
of antisense oligonucleotides (ASOs) to redirect the splicing of a paralogous gene, SMN2, to increase the production 
of functional SMN protein. A range of ASOs with different chemical properties is suitable for these applications, 
including a morpholino (MO) variant, which has a particularly excellent safety, and efficacy profile. We used a 25-
nt MO oligomer sequence against the ISS-N1 region of SMN2 (HSMN2Ex7D(-10-34)) with superior efficacy to 
previously described sequences also in transgenic SMA Δ7 mice. The combined local and systemic administration 
of MO (bare or conjugated to octa-guanidine) is necessary to increase full-length SMN expression, leading to robust 
neuropathological features improvement and survival rescue. Additionally, several snRNA levels that are dysregulated 
in SMA mice could be restored by MO treatment. These results demonstrate that MO therapy is efficacious and can 
result in phenotypic rescue. These data provide important insights for the development of therapeutic strategies in 
SMA patients.
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316 B Studies on structure-function relationships of the snoRNP assembly machinery
Christiane Branlant1, Régis Back12, Benjamin Rothé13, Jonathan Bizarro5, Magali Blaud11, Marc Quinternet4, 
Solange Morera8, Philippe Meyer7, Cyril Dominguez2, Frédéric Alain3, Edouard Bertrand6, Xavier Manival10, Bruno 
Charpentier9
1UMR IMoPA 7365 CNRS-Université, Biopôle, faculté de Médecine, 54505 Vandoeuvre les Nancy, France; 
2Departement of Biochemistry, University of Leicester, Leicester, UK; 3ETH, Zurich, Schwitzerland; 
4FR3209 CNRS, Biopôle, Faculté de Médecine, 54505 Vandoeuvre les Nancy CEDEX, France; 5IGMM, 
UMR 5535, UM2 Montpellier CEDEX 5 France; 6IGMM, UMR5535, CNRS-UM2, Montpellier CDEX 5, 
France; 7Laboratoire de crystallographie et RMN Biologique, UMR 8015, Université Paris Descartes, Paris; 
8LEBS, UPR CNRS 3082, Bâtiment 34,91198, Gif sur Yvette, France; 9UMR 7365 CNRS-UL, Bâtiment 
Biopôle, Faculté de Médecine, 54505 Vandoeuvre les Nancy, France; 10UMR 7365 IMoPA CNRS-UL, Biopôle, 
Faculté de Médecine, 54505 Vandoeuvre les Nancy CEDEX, France; 11UMR IMoPA, Biopôle, faculté de 
médecine, 54505 Vandoeuvre les Nancy CEDEX, France; 12UMR IMoPA, Biopôle, Faculté de médecine, 54505 
Vandoeuvre les Nancy, France; 13UMR IMoPA, Lorraine Université, Biopôle, Faculté de Médecine, 54505 
Vandoeuvre les Nancy, France
As well pre-rRNA processing as pre-mRNA splicing depends upon activity of ribonucleoprotein particles. These 
RNPs are generated by association of sets of proteins onto small non coding RNAs, such as snoRNAs, scaRNAs 
or UsnRNAs. Work from the recent years demonstrated that like spliceosomal UsnRNP assembly, the assembly of 
snoRNPs which are involved in pre-rRNA processing and that of scaRNPs that are involved in UsnRNA modification 
depend upon cellular factors required to increase the efficiency and accuracy of assembly. We and others have 
identified an important factor of the snoRNP assembly machinery, the Rsa1(yeast)/NUFIP(human) protein. This 
plateform protein associates with nascent RNPs by binding to the snoRNP RNA primary binding protein (Snu13 in 
yeast, 15.5K in human). Rsa1/NUFIP is able to bind to several other snoRNP core proteins and can recruit the R2TP 
complex a co-chaperon of the Hsp90 protein. The yeast R2TP complex contains proteins: Tah1, Pih1, Rvb1 and Rvb2. 
Tah1 forms a heterodimer with Pih1 and binds to Hsp90 by interaction with the Hsp90 C-terminal region. The idea 
is that by its numerous interactions with the core proteins and cellular factors, Rsa1 favors the specific recruitment of 
snoRNP proteins on the snoRNA and their remodeling, leading to stable mature snoRNPs. We focused our effort on 
understanding the mechanism of action and architecture of the C/D box snoRNP assembly machinery. We used yeast 
genetic approaches to determine the order of action of the cellular factors and identify their domains of interaction. 
In parallel, we developed structure-function analyses on components of the snoRNP assembly machinery based on 
NMR and other biophysical-chemical approaches. Studies on the R2TP-Hsp90 are as much important as this complex 
is involved in other assembly processes, in particular RNA polymerase assembly.
Although they play similar functions in snoRNP assembly, proteins Rsa1 and NUFIP show limited sequence 
homology. Only one 31 amino acid long sequence is strongly conserved. We showed that this peptide is crucial for 
the Rsa1p/NUFIP activity in box C/D snoRNP assembly. We identified an essential sub-fragment and solved its 
3D structure by NMR. Then, by using the known 3D structure of yeast Snu13, we built a 3D model of the Rsa1-
Snu13 interaction. We validated this model by biophysical methods and functional assays in yeast. In parallel, we 
purified Tah1 at a high degree of purity and established the 3D structure of free Tah1 and Tah1 bound to Hsp90. Our 
data explain how Tah1 specifically recognizes Hsp90. We characterized the interacting domains of Tah1p and Pih1p. 
We showed that Rsa1 bound to Snu13p can interact with another assembly factor Hit1 and also characterized the 
interacting domains. We will present the present stage of our functional and structural studies and their implication in 
terms of mechanism of action of the snoRNP assembly machinery.
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318 A Mitochondrial poly(A) polymerase is involved in tRNA editing
Mario Fiedler1, Elmar Wahle1, Christiane Rammelt1
1Institut of Biochemistry and Biotechnology; MLU Halle-Wittenberg; Germany
Transcription of the mitochondrial genome results in long polycistronic precursors, which are processed mainly 
by endonucleolytic release of the tRNAs that are interspersed between rRNAs and mRNAs. Interestingly, in most 
metazoan mitochondrial genomes, genes for some tRNAs overlap with downstream genes encoded on the same 
strand: in the case of human mitochondria the genes for tRNATyr and tRNACys share one nucleotide. The processing 
of the precursor transcript releases a complete tRNACys whereas tRNATyr lacks the 3’ terminal nucleotide, the so-
called discriminator 1. This nucleotide has to be added before the tRNA can be matured by addition of the CCA end 
and subsequently aminoacylated. The enzyme responsible for this editing reaction has not been identified so far. 
Since the overlapping nucleotide is an adenosine, we tested whether the mitochondrial poly(A) polymerase (PAPD1) 
is involved in the reaction. We show that the tRNATyr lacking the discriminator is a substrate for PAPD1 in vitro. In 
vivo, knock-down of PAPD1 leads not only to a decrease of oligoadenylated tRNA species, but also to a decrease of 
mature tRNATyr carrying both the correct discriminator as well as the CCA end, whereas the number of tRNA species 
lacking the discriminator and the CCA end was increased correspondingly. Therefore, we suggest that PAPD1 is the 
enzyme responsible for the addition of the discriminator base.
1. Reichert, A., Rothbauer, U. & Mörl, M. Processing and editing of overlapping tRNAs in human mitochondria. J. Biol. 
Chem. 273, 31977–31984 (1998).
317 C Lateral tRNA gene transfer in Methanobrevibacter ruminantium
Patricia Chan1, Todd Lowe1
1University of California Santa Cruz
The increase of the available microbial genomes has enabled thorough comparative studies across multiple species. 
Substantial differences in gene content among closely related species in addition to the similarities found among 
distant species provide evidence of genetic information exchange. One well-known example is Thermotoga maritima, 
a thermophilic bacteria reported to contain 24% of genes that are homologs from archaea [1]. While multiple possible 
mechanisms may involve in the process of lateral gene transfer, most research have been solely focused on examining 
the origin of protein-coding genes. The extent of non-coding RNA gene transfer across species remains unclear.
During our study of Methanobrevibacter ruminantium, an archaeon that was isolated from bovine rumen fluid, we 
identified 59 tRNA genes as compared to 36 in its close relative, Methanobrevibacter smithii. A detailed inspection 
shows that 20 of these tRNA genes have a second copy with different sequence but same anticodon. While a small 
number of archaeal tRNAs has two copies in a genome, over 90% of them are single-copy genes. More unexpectedly, 
a copy of these 20 tRNA genes was found in a cluster within a region of 4000 bp. This represents about four times the 
size of the largest archaeal tRNA gene cluster. In addition, a tRNA-ArgACG that has never been found in archaea [2] 
was also identified in this cluster. Another round of gene prediction using bacterial tRNA model suggests that these 
21 tRNA genes may have a bacterial origin. The 13% of bacterial homologs reported in a previous study [3] and some 
found upstream of the tRNA cluster further confirm the foreign insertion of this region.
Lateral gene transfer has been considered as a powerful evolutionary force for microbial genomes. However, 
the reasons and the biological significance of this event are not fully understood. Our finding demonstrates the first 
example of tRNA gene transfer between archaea and bacteria and highlights opportunities for new RNA biology.
1. Nelson et al. (1999) Nature 399:323-9.
2. Grojean et al. (2007) Nucleic Acids Symp Ser (Oxf):15-6.
3. Leahy et al. (2010) PLoS One 5:e8926.
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320 C Gene expression analysis of nematode-specific tRNAs (nev-tRNAs) that can decode an 
alternative genetic code
Kiyofumi Hamashima1, Yoshiki Andachi2, Masaru Tomita1, Yuji Kohara2, Akio Kanai1
1Institute for Advanced Biosciences, Keio University; 2Genome Biology Laboratory, Center for Genetic 
Resource Information, National Institute of Genetics, Research Organization of Information and Systems
 Transfer RNAs (tRNAs) are small RNA molecules that play a crucial role in protein biosynthesis as the links 
between the codons and the amino acids. Although translational fidelity is essential for protein and cell integrity, 
which is achieved by accurate tRNA aminoacylation, we have previously found unexpected nematode tRNAs (nev-
tRNAs) that possess a glycine or isoleucine anticodon but can be charged with leucine (1). An in vitro translation 
analysis showed that nev-tRNAs can be incorporated into eukaryotic ribosomes and participate in protein biosynthesis, 
indicating that nev-tRNAs decode an alternative genetic code for leucine at least in vitro.
 To understand the biological function of these unusual tRNAs, we first performed gene expression analyses 
of nev-tRNAs in Caenorhabditis elegans and C. brenneri, which has more number of nev-tRNAs than any other 
nematodes. The expression of nev-tRNAGly (CCC) and nev-tRNAIle (UAU) genes in mixed stage (egg, larvae 1-4, 
adult) of both species was detected by RT-PCR and northern blot analysis, but the levels are quite lower than those of 
general tRNAs. Further expression analysis during nematodes development and the results showed that the expression 
levels in egg and adult stages are higher than those of other stages. Taken together, our findings suggest that the 
expression of nev-tRNAs might be generally down-regulated, but stimulated in specific conditions and play a certain 
role, for example, in development. Now, we are constructing an over-expression system of heat-inducible nev-tRNA 
genes in C. elegans for multi-omics approach. Possible functions of this RNA molecule are discussed.
1. Hamashima, K. et al., (2012) Nucleic Acids Res, 40, 3653-3662.
319 B High throughput quantification of tRNA function reveals unexpected interactions 
between tRNA residues
Michael Guy1, David Young2, Yoshiko Kon1, Xiaoju Zhang1, Matthew Payea1, Kimberly Dean1, David Mathews1, 
Elizabeth Grayhack1, Stanley Fields3, Eric Phizicky1
1University of Rochester Medical School; 2University of Washington; 3University of Washington, Howard 
Hughes Medical Institute
Evolution has fine-tuned tRNAs to allow for their efficient and accurate participation in translation, and much has been 
learned about the structural and functional roles played by many specific residues.  However, it is not known precisely how each 
residue and modification contributes to the structure and function of tRNAs; nor is it known how much tolerance tRNAs have to 
mutation.  Here we report a high throughput method to comprehensively quantify the effects of every possible single mutation and 
of many combinations of mutations on the function of an individual yeast suppressor tRNA, SUP4ochre (SUP4oc).  Application of 
this method resulted in the identification of several unexpected interactions in tRNA.
 We generated a library of 95,000 SUP4oc variants in which all residues (except for anticodon residues N
34
-N36 and residue 
N37) contain random mutations at a 3% frequency. To quantify individual tRNA activity, we transformed the library into a strain 
carrying a SUP4oc-suppressable codon in GFP, whose expression can be compared to a control RFP (Dean, K. M. and Grayhack, 
E. J. (2012) RNA 18:2335-2344). Then, we sorted the SUP4oc transformants by fluorescence-activated cell sorting to separate 
cells into bins based on GFP/RFP expression, and analyzed the bins by recovering the SUP4oc genes and deep sequencing.  A 
measure of the function of each variant tRNA is derived from the fractional representation of the sequence reads of the variant 
in each bin (Fowler, D. M., et al., (2010) Nature Meth. 7:741-746).  Individual analysis of 35 variants shows that experimentally 
determined GFP/RFP values measured by flow cytometry correlate well with quantification of function by deep sequencing. 
These experiments yielded surprising results.  First, we detected GFP suppression in 137 of 213 possible single mutant 
SUP4oc variants, 75 of which display more than 50% of wild-type activity.  This result suggests that there is remarkable 
tolerance in the tRNA sequences that are acceptable for function.  Second, we found a number of double mutant variants that are 
unexpectedly active given the activities of their constituent single mutants, and whose function is not easily explained by simple 
compensatory effects of residues that interact.  We individually reconstructed and tested 12 such double mutant variants, and 
found that 11 of them recapitulated the data from deep sequencing.  We will discuss possible explanations for these unexpectedly 
active variants, as well as our progress using this methodology to explore other important questions in tRNA biology, including 
the comprehensive analysis of determinants for the rapid tRNA decay pathway.
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322 B Biochemical Characterization of Archaeal RNase E-like Protein, FAU-1 in Pyrococcus 
furiosus
Yoshiki Ikeda1, Asako Sato1, Masaru Tomita1, Akio Kanai1
1Inst. Adv. Biosci., Keio Univ.
Ribosomal RNAs (rRNAs) are important non-coding RNAs in all organisms. It is reported that precursor rRNAs 
(pre-rRNAs) are processed to mature rRNAs by various ribonucleases (RNases). RNase E is one of well-known 
endoribonucleases to process a pre-5S rRNA in Escherichia coli. However, in archaea, a processing enzyme of pre-
5S rRNA has not been clearly understood yet. Previously, we identified an RNA-binding protein called FAU-1 that 
consists of 472 amino acids residues in the hyperthermophilic archaeon Pyrococcus furiosus. We showed that the 
N-terminal half of the FAU-1 had a degree of similarity (25%) with RNase E from E. coli (Kanai et al., 2003). In the 
current research, we detected an endoribonuclease activity of the FAU-1 protein.
First, the recombinant FAU-1 protein with a His6 tag sequence was induced in E. coli. Then, we purified the FAU-
1 to near homogeneity by a His-affinity column chromatography, followed by a RESOURCE-Q ion exchange column 
chromatography. Using the purified protein, it was tested whether the FAU-1 was able to process P. furiosus pre-5S 
rRNA in vitro. As a result, accumulation of the FAU-1-dependent cleavage was observed by Northern blot analysis, and 
the cleavage site can be mapped at approximately 10 bases upstream of the 5’-end of mature P. furiosus 5S rRNA. A 
cleavage site specificity by the FAU-1 was also examined using a short RNA probe (73 nt) partially representing 
the P. furiosus pre-5S rRNA. The result showed that FAU-1 preferentially cleaved the AU-rich sequences of the RNA 
probe. Next, to confirm that FAU-1 actually possessed the RNase activity, we constructed a plasmid encoding mutant 
FAU-1 lacking 170-189 amino acid residues that showed a high degree of amino acid similarity among closely related 
proteins in archaeal species. Consequently, the mutant protein markedly reduced the FAU-1-dependent cleavage 
against the pre-5S rRNA, showing that the FAU-1 is an endoribonuclease and possibly involved in the pre-5S rRNA 
processing.
In previous study, it is reported that 5’ end of the pre-5S rRNA is processed by tRNase Z in archaeon Haloferax 
volcanii, and transfer RNA (tRNA)-like structure in the 5’ end of pre-5S rRNA is necessary to recognize by tRNase Z 
(Hölzle et al., 2008). However, such tRNA-like structure has not been found in most of archaeal pre-5S rRNAs. Our 
results suggest that the FAU-1 could provide an alternative pathway to process the pre-5S rRNA in archaea.
321 A Structure and Kinetic Mechanism of Protein-only RNase P from A. thaliana
Michael Howard1, Markos Koutmos2, Carol Fierke1
1University of Michigan; 2Uniformed Services University of the Health Sciences
Ribonuclease P (RNase P) catalyzes the maturation of the 5′ end of tRNA precursors. Typically these enzymes 
are ribonucleoproteins with a conserved RNA component responsible for catalysis. However,  protein-only RNase 
P  (PRORP)  enzymes  process precursor tRNAs in human mitochondria and in all tRNA-using compartments 
of Arabidopsis thaliana. PRORP enzymes are nuclear encoded and conserved among many eukaryotes. Here we 
report the crystal structure of PRORP1 from A. thaliana at 1.75 Å resolution, revealing a prototypical metallonuclease 
domain tethered to a pentatricopeptide repeat (PPR) domain by a structural zinc-binding domain.   The metallonuclease 
domain is a novel high-resolution structure of a Nedd4-BP1, YacP Nucleases (NYN) domain that is a member of 
the PIN domain-like fold superfamily, including the FLAP nuclease family. In order to understand how this new 
family of metallonucleases function a kinetic mechanism is required. A minimal kinetic mechanism was derived from 
measuring steady-state, single-turnover, and binding kinetics. These data suggest a two-step binding mechanism, 
followed by cleavage of the phosphodiester bond with a maximal rate constant of 4 min-1. Product release is faster than 
phosphodiester bond hydrolysis and is not the rate-limiting step under steady-state conditions. These studies allow for 
a molecular-level comparison of the catalytic strategies used by the only known naturally evolved protein and RNA-
based catalysts that perform the same biological function, pre-tRNA maturation, thereby providing insight into the 
differences between the prebiotic RNA world and the present protein-dominated world.
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324 A Identification of proteins co-purifying with the yeast RNA exosome and their effect on the 
complex stabilization
Rogerio Lourenco1, Fernando Gonzales1, Carla Oliveira1
1Department of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, Brazil
The eukaryotic RNA exosome is a conserved multiprotein complex essential for processing, degradation, and 
quality control of a wide variety of RNAs. The complex is formed by a nine-subunit core that associates with two 
hydrolytic 3’-5’ exoribonucleases. The involvement of the exosome in different RNA processing pathways suggests 
that protein cofactors are required for directing the complex to its substrates. We have previously characterized the 
functions of nuclear proteins that interact with the exosome and modulate its function in the pre-rRNA processing 
pathway, and are currently interested in identifying other proteins that might associate with the exosome and influence 
its assembly, stability and activity.  Therefore, we have carried out protein co-immunoprecipitation experiments 
by means of the TAP method, followed by anion-exchange or size-exclusion chromatography. According to mass 
spectrometry analyses, the exosome core subunits were co-purified with the tagged subunits. These purified complexes 
are being used in complex stability analyses and RNA degradation assays to evaluate their in vitro activity. In addition, 
we are testing other purification conditions to investigate whether amino acid substitutions in one of the core subunits 
affect the ability of the exosome to interact with distinct cofactors.
Supported by FAPESP
323 C Strong anion exchange fast performance liquid chromatography as a versatile tool for 
preparation and purification of RNA produced by in vitro transcription
Jiri Koubek1, Ku Feng Lin5, Yet Ran Chen2, Richard Ping Cheng3, Joseph Jen Tse Huang4
1Chemical Biology and Molecular Biophysics Program, Taiwan International Graduate Program, Institute of 
Chemistry, Academia Sinica, No.128, Sec. 2, Academia Road, Nankang, Taipei 11529, Taiwan; Department 
of Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 10617, Taiwan; 2Agricultural 
Biotechnology Research Center, Academia Sinica, No.128, Sec. 2, Academia Road, Nankang, Taipei 11529, 
Taiwan; 3Department of Chemistry, National Taiwan University, No. 1, Sec. 4, Roosevelt Road, Taipei 10617, 
Taiwan.; 4Institute of Chemistry, Academia Sinica, No.128, Sec. 2, Academia Road, Nankang, Taipei 11529, 
Taiwan; “5Institute of Chemistry, Academia Sinica, No.128, Sec. 2, Academia Road, Nankang, Taipei 11529, 
Taiwan
In vitro transcription is a common technique for producing large quantities of RNAthat requires exquisite control 
of a number of variables including template preparations, enzyme selection, transcription reaction conditions and 
purification protocols.
Here we demonstrate the use of strong anion exchange fast performance liquid chromatography (FPLC) as a 
simple, fast and robust technique for RNA production by in vitro transcription. With this method, we purified short 
transcription templates from unreacted reagents in large quantities; only minor changes to the protocol were necessary 
to readily obtain nuclease free pyrophosphatase. In addition, in vitro transcription reactions were monitored by strong 
anion exchange FPLC to enable facile optimization of reaction conditions. Transcribed tRNA was purified by strong 
anion exchange FPLC and the functionality of purified tRNA was confirmed by enzymatic assay. Every procedure 
described here required only minimum sample manipulation and was completed within 30 minutes.
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325 B tRNAscan-SE and GtRNAdb: Improving Detection and Functional Prediction Based on 
Genomic Context, Structure, and Expression of Transfer RNAs
Todd Lowe1, Patricia Chan1, Aaron Cozen1, Andrew Holmes1, Jay Kim1, Eva Robinson1
1University of California, Santa Cruz
Transfer RNAs (tRNAs) are the largest, most complex non-coding RNA family that is universal to all living things. 
tRNAs are central to the flow of genetic information from messenger RNAs to proteins, and as ancient molecules, have 
acquired or retained a variety of other distinct functions in the cell (1, 2). The breadth and complexity of these functions 
are still coming into focus, but new hints are emerging from the study of genomic context, atypical structural variants, 
and differential expression/ChIP-seq patterns observed for various subsets of tRNAs.  While there are now other useful, 
specialized tRNA detection methods available, tRNAscan-SE (3) and the Genomic tRNA Database (4) continue to be 
the most common source of gene predictions. Over the past decade, we have collected a large number of feature requests 
and algorithmic improvements that we are now actively implementing. These improvements will enhance the ability of 
tRNAscan-SE to more accurately identify and classify both typical and atypical tRNAs, identify partial tRNAs, and estimate 
biological relevance based on structural features, evolutionary conservation, and gene expression data. The GtRNAdb 
is being redesigned to integrate gene expression and other functional data, and automatically identify inconsistencies or 
unexpected features of full-genome gene sets.  These analyses have already identified numerous outliers meriting closer 
study in vertebrate and microbial genomes. We present a variety of new observations from our work, including in-depth 
analyses of the human tRNA gene set.
We highly encourage tRNA researchers to contribute additional feature requests for tRNAscan-SE, as well as gene 
expression, population SNP variants, modification, and tRNA editing data to incorporate into the improved GtRNAdb 
(lowe@soe.ucsc.edu).
1. Phizicky, E.M. and Hopper, A.K. (2010) tRNA biology charges to the front. Genes & development, 24, 1832-1860.
2. Geslain, R. and Pan, T. (2011) tRNA: Vast reservoir of RNA molecules with unexpected regulatory function. Proc Natl 
Acad Sci U S A, 108, 16489-16490.
3. Lowe, T.M. and Eddy, S.R. (1997) tRNAscan-SE: a program for improved detection of transfer RNA genes in genomic 
sequence. Nucleic Acids Res, 25, 955-964.
4. Chan, P.P. and Lowe, T.M. (2009) GtRNAdb: a database of transfer RNA genes detected in genomic sequence. Nucleic 
Acids Res, 37, D93-97.
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326 C RIP-seq analysis of eukaryotic Sm proteins reveals interactions between snRNPs and 
mature mRNAs
Zhipeng Lu1, Xiaojun Guan2, Greg Matera1
1Department of Biology, UNC at Chapel Hill; 2Sequenom, San Diago, California
Sm proteins are a family of highly conserved RNA-binding factors present in all three domains of life. Sm proteins 
usually form hexameric or heptameric rings and associate with a variety of RNAs, and these RNP complexes perform 
many important roles in RNA metabolism. In bacteria, the Sm ortholog (called Hfq) associates with small (s)RNAs 
to regulate target mRNA stability and translation. In eukaryotes, Sm proteins bind small nuclear RNAs (snRNAs) 
to form snRNPs, which are basic components of the pre-mRNA splicing machinery. However, little is known about 
other functions of Sm proteins in eukaryotic cells, given their divergent roles in bacteria and archaea. Our lab recently 
found that Sm proteins are required for germ cell specification in Drosophila. This discovery led us to hypothesize that 
Sm proteins play important, but so far unrecognized, roles in RNA metabolism and fundamental cellular processes in 
eukaryotes.
To test this hypothesis, we developed a strategy to discover novel RNPs by deep sequencing immunopurified 
RNAs (RIP-seq) that associate with several distinct Sm proteins in Drosophila ovaries. Using this approach, we 
discovered, in addition to the known snRNAs, a highly reproducible subset of Sm-associated mRNAs and several 
novel, unannotated non-coding RNAs. One of the newly identified ncRNA is a bona fide snRNA, with a clearly 
recognizable Sm binding site and an snRNA-like secondary structure. We showed that the association between mRNAs 
and Sm proteins is independent of splicing, and distinct from the LSm1-7-mRNA interaction, which regulates mRNA 
degradation. Many of the Sm-associated mRNAs encode mitochondrial and ribosomal/translation-related proteins. 
We further verified these Sm-associated RNAs using RT-PCR on several different tissue/cell types.
Several lines of evidence suggest that Sm proteins associate with mRNAs indirectly. To characterize these RNP 
complexes, we performed immunoprecipitations with an anti-TMG cap antibody.  Together with publicly available 
RIP-seq data targeting U1-70K (a U1 snRNP protein), we showed that Sm-associated mRNAs also co-purify with 
snRNAs and snRNP-specific proteins. Correspondingly, we identified potential snRNA base pairing interactions 
within these Sm-associated mRNAs. These data suggest that snRNPs interact with mature mRNAs directly through 
base pairing, raising an interesting similarity to the prokaryotic Sm (Hfq)-containing sRNPs.
To test whether this snRNP-mature mRNA interaction is conserved in evolution, we performed Sm RIP-seq 
in human HeLa cells. In addition to the spliceosomal snRNAs, we identified one of the histone mRNAs as highly 
enriched, confirming a previous report on U2 snRNP - histone mRNA interaction (Friend et al., 2007, Mol. Cell). We 
also identified many other mature human mRNAs associated with Sm proteins, suggesting that the snRNP-mature 
mRNA interaction is conserved in eukaryotes.
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328 B Thiolation of specific tRNAs by URM1 is required for efficient translation a subset of 
proteins by promoting ribosomal A-site binding
Namit Ranjan1, Vanessa Rezgui1, Patrick Pedrioli4, Kshitiz Tyagi4, Marina Rodnina3, Andrey Konevega2, Joerg 
Mittelstaet3, Matthias Peter1
1ETH Zürich; 24B.P. Konstantinov Petersburg Nuclear Physics Institute; 3Max Plank Institute, Göttingen; 
4University of Dundee
Faithful protein synthesis relies on correct and efficient recognition of codons by tRNA molecules. To ensure this key role, 
tRNA molecules undergo many different modifications. In particular the wobble position, nucleotide 34, of the anti-codon 
is a hot spot for modifications and is thought to be functionally important for translation efficiency and fidelity. The wobble 
Uracil of tRNALYSUUU, tRNA
GLU
UUC
, and tRNAGLNUUG is universally modified to 5-methyl-2-thio derivatives. Specifically, in 
eukaryotes these tRNAs bear the 5-methoxycarbonyl-methyl-2-thio modification (mcm5s2). Previous in vitro studies have 
implicated this modification in modulating the wobble capacity of these tRNAs, however the exact in vivo function of 
this modification has been largely unexplored. In Saccharomyces cerevisiae, the URM1-pathway is responsible for tRNA 
thiolation at the Uracil-34 and is important for resistance to various stresses such as nutrient starvation and oxidative agents.
In this study, we show that thiolation is not required for general translation but rather regulates translation of a subset 
of mRNAs. We performed a proteome wide analysis to identify changes in protein abundance induced by lack of thiolation. 
Subsequent bioinformatic analysis revealed that tRNA thiolation is required for the efficient translation of a subset of 
mRNAs rich in the cognate AAA, CAA, and GAA codons. Further analysis of selected candidates revealed that the 
decreases in protein abundance were not mediated by differential transcription nor degradation and therefore likely results 
from differential translation. Codon usage and translation regulation was assessed in vivo using a codon-specific fluorescent 
translation reporter in single cells. Indeed, we found that expression of translation reporters enriched for AAA, CAA or 
GAA codons was impaired in cells lacking URM1, while reporters enriched for the synonymous AAG codons showed 
wild-type expression levels. Furthermore, in vitro studies using native tRNAs from yeast showed that thiolation enhances 
ribosomal A-site binding and thereby increases peptide bond formation rates.
Taken together our data, show that tRNA thiolation at the wobble position is important to control expression of a subset 
of mRNAs rich in AAA, CAA, and GAA codons and that this is mediated by increased A-site binding to the ribosome. We 
suggest a model in which tRNA modification regulates expression of a subset of mRNAs enriched for specific codons under 
stress conditions.
327 A Absence of a Universal Element for tRNAHis Identity in Eucarya
Bhalchandra Rao1, Jane Jackman1
1The Ohio State University
Stringent discrimination between tRNA substrates by cognate aminoacyl-tRNA synthetase (aaRS) is essential for 
high fidelity gene expression. Identity elements within tRNAs aid this discrimination at a kinetic level. The identity 
element for histidyl tRNAs (tRNAHis), an extra guanosine at its 5’-end (G
-1
), is essential for recognition and efficient 
histidylation by HisRS and its occurrence is conserved across bacteria, archaea and eukarya. In eukaryotes, the G
-1
 is 
acquired post-transcriptionally by an unusual 3’-5’ addition reaction catalyzed by the essential Thg1 enzyme which 
was first identified in S. cerevisiae. Due to the critical nature of the G
-1
 identity element, the presence of a Thg1 gene 
is widespread in eukaryotes and until recently, no examples of eukaryotic histidyl-tRNAs that lack the essential G
-1
 
had been identified.
We recently investigated several eukaryotes, including Acanthamoeba castellanii and Typanosoma brucei that 
lack any identifiable Thg1 homolog. Sequencing of tRNAHis isolated from these organisms revealed that they lack 
the universally conserved G-1 residue and thus appear to be exceptions to the general rule for tRNAHis identity. Due 
to the previously well-characterized dependence on the G-1 residue for recognition by HisRS, we tested the effect of 
G-1 on aminoacylation activity catalyzed by purified A. castellanii HisRS (AcHisRS) and T. brucei HisRS (TbHisRS) 
and observed that the presence of G-1 is not required for efficient histidylation by AcHisRS and TbHisRS. Yeast 
genetic complementation and steady state kinetic assays confirm that the recognition of tRNAHis by AcaHisRS at the 
cellular and kinetic level is truly independent of G-1 suggesting an alternate mechanism for tRNAHis recognition in 
comparison to the other eukaryotic HisRS. Hence, here we report the first instances of a tRNAHis/HisRS pair which 
do not conform to previously accepted dogma for tRNAHis identity and thus set the stage for further investigations 
of the co-evolution of this G-1 residue for tRNAHis identity, role of Thg1 enzymes in tRNAHis maturation and 
mechanisms for substrate recognition by HisRS.
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330 A A Protease that Cleaves the C-terminal Domain of the RtcB-type RNA Ligase in the 
Hyperthermophilic Archaeon Pyrococcus furiosus
Asako Sato1, Takeshi Masuda1, Masaru Tomita1, Takashi Itoh2, Akio Kanai1
1Institute for Advanced Biosciences, Keio University; 2RIKEN BioResource Center
RNA ligase is an enzyme that can catalyze the ligation of RNA molecules through phosphodiester bond formation. 
So far, three heat-stable RNA ligases are known in the hyperthermophilic archaeon, P. furiosus. The three enzymes are: 
(1) a putative 2’, 5’ RNA ligase (PF0027 protein), (2) an RtcB-type RNA ligase (PF1615 protein) and (3) a T4-type 
RNA ligase (PF0353 protein). The RtcB-type RNA ligase is reported as the missing component in tRNA maturation 
and the enzyme is able to ligate spliced tRNA halves into mature-sized tRNAs (Englert, M. et al. PNAS 2011).
Using purified recombinant RtcB RNA ligase as a substrate, we detected a protease activity in the Pyrococcus whole-
cell extract that specifically cleaved the C-terminal portion (approximately 5 kDa) of the RtcB RNA ligase. No 
cleavage of the other two RNA ligases was observed. Protease inhibitors suggested that the responsible enzyme was a 
chymotrypsin-like serine protease, and gel filtration analysis of the whole cell extract showed that the protease activity 
was eluted at approximately 400 kDa. Moreover, gel filtration combined with western blotting analysis showed 
that Pyrococcus RtcB ligase formed a protein complex in the cell, and Blue-native PAGE analysis also suggested 
that the purified Pyrococcus RtcB RNA ligase formed a homo-oligomer complex. Since the RtcB RNA ligase lacking 
the C-terminal portion was able to form the homo-oligomer complex, the C-terminal portion was suggested to be not 
involved in the oligomerization activity. Meanwhile, the expression of the recombinant RtcB RNA ligase lacking 
the C-terminal portion became lower inEscherichia coli and the purified enzyme lost the RNA ligation activity. Our 
results suggest that a protease in Pyrococcus can cleave the RtcB RNA ligase and regulate its activity.
329 C A comprehensive analysis of the natural variation of tRNA modification in two 
Saccharomyces species
Peter Sarin1, Sebastian Leidel1
1Max Planck Institute for Molecular Biomedicine
Transfer RNA (tRNA) is essential for protein synthesis by linking messenger RNA (mRNA) codons to the respective 
peptide sequence of proteins. Notably, tRNA molecules are decorated by a plethora of chemical modifications of their 
nucleobases or sugar backbone. Many of these RNA modifications are conserved throughout evolution, implying 
their importance. However, little is known about their in vivo function and whether RNA modifications are regulated. 
Furthermore, to date there has not been a single comprehensive study that analyzes the variation of tRNA modification 
in any species at the population level.
During evolution, yeast has adapted to grow in many ecological niches enabling it to cope with a wide range of 
external stress factors. This has led to a specific adaptation of cellular metabolism to very specific types of stress in 
different yeast strains. To elucidate how tRNA modification systems have evolved to modulate cellular adaptation to 
stress, we set out to analyze modified tRNA nucleosides in a large set of Saccharomyces cerevisiae and Saccharomyces 
paradoxus strains isolated from various environmental habitats. By means of two-dimensional thin layer 
chromatography (TLC) we have performed tentative characterization of basal level tRNA modification at logarithmic 
growth conditions for a total of 73 Saccharomyces strains.
Our preliminary screen shows variance in tRNA modification, allowing us to cluster strains according to their 
tRNA modification levels. We observed considerable variability of tRNA modification levels in S. cerevisiaestrains. 
Surprisingly, this variability was much lower in S. paradoxus although the genetic diversity of the strains used in 
our analysis was larger than that of S. cerevisiae. Furthermore, mapping the strains according to single nucleotide 
polymorphisms (SNPs) in tRNA modification genes yields a similar clustering. This might imply, that key SNPs are 
essential in modulating basal level tRNA modification.
We are currently verifying our analysis using high performance liquid chromatography (HPLC) coupled with 
mass spectrometry to define the first comprehensive, quantitative high-resolution inventory of tRNA modification 
in representative Saccharomyces populations. Utilizing this approach will allow us to generate the first species wide 
analysis of tRNA modification.
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332 C Playing RNase P evolution: replacing a complex ribonucleoprotein enzyme with a single 
protein
Christoph Weber1, Roland K. Hartmann3, Andreas Hartig2, Walter Rossmanith1
1Center for Anatomy & Cell Biology, Medical University of Vienna, Austria; 2Department of Biochemistry 
and Cell Biology, Max F. Perutz Laboratories, University of Vienna, Austria; 3Institute of Pharmaceutical 
Chemistry, Philipps-University Marburg, Germany
RNase P is the endonuclease that removes 5’ extensions from tRNA precursors. Despite their uniform and rather simple 
functional role, members of the RNase P enzyme family are of exceptional diversity. In their more ancient and widespread 
form, RNase P enzymes are ribonucleoproteins (RNP) based on a structurally conserved RNA molecule forming their 
catalytic core. In bacteria, a single small protein associates with the catalytic RNA; in the nucleus of some Eukarya (e.g., 
animals and fungi), however, the RNP reaches considerable complexity by including a set of up to 10 different proteins. 
A fundamentally different form of RNase P is composed of a single 60-kDa protein termed “proteinaceous” RNase P 
(PRORP) and is restricted to Eukarya. First found in mitochondria and chloroplasts, PRORPs were recently also found to 
be responsible for nuclear tRNA maturation in plants and trypanosomatids. In contrast to the complexity of the RNP form of 
nuclear RNase P, PRORPs have generally remained “simple”, with the notable exception of animal mitochondrial RNase P, 
which is a multi-enzyme assemblage.
The evolutionary constraints and driving forces underlying this bewildering diversity of RNase P enzymes remain 
largely obscure. Increased enzyme versatility with respect to substrate range was suggested to be a possible reason for the 
complexity of the nuclear RNP-form of the enzyme. However, the finding that some organisms use a single protein for 
nuclear RNase P function challenges this view and suggests that either a single protein is as versatile as a complex RNP, or 
the spectrum of biological functions of the two enzyme forms in their host organisms is different.
By genome engineering, we replaced yeast nuclear RNase P with PRORP3 derived from A. thaliana. A thorough 
phenotypical characterization of different RNase P-swapped strains did not reveal any fundamental difference in the ability 
to grow under diverse environmental conditions or in their overall fitness. This indicates that a single protein is able to fully 
fill the biological role of nuclear RNase P in yeast, which naturally is a 10-component RNP. Molecular analyses moreover 
revealed normal levels of tRNAs and no evidence for alterations in a variety of suggested non-tRNA substrates that were 
previously reported to accumulate in an RNase P-deficiency model. Our results suggest that there is no inherent need for or 
advantage of RNA-based catalysis or enzyme complexity to cope with (nuclear) RNase P function.
331 B Human mitochondrial RNase P and its multiple faces
Elisa Vilardo1, Nadia Brillante1, Christa Nachbagauer1, Walter Rossmanith1
1Center for Anatomy & Cell Biology, Medical University of Vienna, Austria
The mitochondrial genome is transcribed as long polycistronic precursor RNAs, encoding a complete set of tRNAs 
interspersed among rRNAs and coding RNAs. The processing of the tRNAs determines the concomitant release of 
all the RNAs required for mitochondrial protein synthesis. We have previously identified the human mitochondrial 
RNase P, the endonuclease responsible for 5’ processing of tRNAs, which consists of three protein subunits. Moreover, 
we have shown that two of these subunits of RNase P constitute the methyltransferase responsible for methylation of 
purines at position 9, a modification supposed to be crucial for the proper folding of tRNAs. The human mitochondrial 
enzyme is unusual because of its ability to methylate both A and G at position 9 of tRNAs. Furthermore, in contrast 
to related methyltransferases, it includes as subunit a short-chain dehydrogenase, involved in the degradation of 
fatty and amino acids and thus with no obvious connection to tRNA maturation and function. The tRNA cleavage, 
tRNA methylation and dehydrogenase activities, physically associated in human mitochondrial RNase P complex, are 
nevertheless uncoupled and independent from each other. Thus, human mitochondrial RNase P is a multifunctional 
complex gathering diverse enzymatic activities related to tRNA maturation and beyond
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
tRNA, snRNA, snoRNA, rRNA  •   197
334 B A Genome-wide Analysis to Identify Novel Genes Involved in tRNA Metabolism and 
Subcellular Trafficking
Jingyan Wu1, Anita K. Hopper1
1Department of Molecular Genetics, Center for RNA biology, The Ohio State University, Columbus, OH, 
43214, USA
tRNAs are major components of the cell’s protein synthesis machinery. In addition to this essential role in gene 
expression, they also contribute to other diverse functions including protein degradation, apoptosis, cellular response 
to stress, and tumorigenesis. tRNAs are transcribed in the nucleus. After the removal of the 5’ and 3’ ends and the 
addition of CCA and some modifications, tRNAs are exported to the cytoplasm where they complete their biogenesis 
and fulfill their functions. In both yeast and vertebrate cells, the subcellular movement of tRNAs involves the initial 
export of tRNAs from the nucleus to the cytoplasm, retrograde nuclear import of cytoplasmic tRNAs, and re-export 
of the imported tRNAs back to the cytoplasm. Although tRNAs have been studied for decades, some major players 
in tRNA metabolism and subcellular movement remain unknown. For example, there is an unknown nuclear export 
pathway for intron-containing tRNAs in yeast. The overall aim of my research is to identify and characterize all 
the missing gene products involved in tRNA biology, using yeast, S. cerevisiae, as a model organism. My strategy 
is to conduct a genome-wide assessment of the impact of every gene upon tRNAs utilizing the yeast deletion and 
temperature-sensitive (ts) collections. To conduct this screen in a timely fashion, I’ve developed a rapid method for 
genome-wide analysis of small RNAs from strains in the mutant collections. This method implements three optimized 
techniques: a procedure for growing small yeast cultures in 96-deepwell plates, a fast procedure for small RNA 
isolation from the plates, and a sensitive nonradioactive Northern method for RNA detection (Wu et al., in press). To 
date, 3168 mutants in the deletion and ts collections have been analyzed; several candidates that affect tRNA biology 
have been identified and verified. For example, deletion of GLN3 causes defects in the early steps of tRNA biogenesis. 
We hypothesize that Gln3, a well-characterized nitrogen-responsive transcription factor, plays a novel role in pre-
tRNAs processing. This study will uncover important factors that function in tRNA metabolism and intracellular 
trafficking, which will contribute to a better understanding of the complexity of tRNA biology.
333 A tRNA maturation abnormalities connected to stress conditions and transcription 
deregulation
Dominika Wichtowska1, Anita K. Hopper2, Magdalena Boguta1
1Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Pawinskiego 5a, 02-106 Warsaw, 
Poland; 2Molecular Genetics Department and Center for RNA Biology, Ohio State University, 800 Riffe 
Building 496 W 12th Ave Columbus, OH 43210, USA
The normal processing order for transfer RNA (tRNA) in yeast generally starts with cleavage of 5’ leader sequence 
from primary tRNA transcripts; this is then followed by removal of the 3’ trailer sequence and, finally, by pre-tRNA 
splicing. We identified an unanticpated tRNA species which migrated slower than the species commonly assumed 
to be the primary transcript. This aberrant RNA was observed in wild type strain when the cells were propagated 
on nonfermentable carbon source or at elevated temperature; the aberrant tRNA was also detected in rex1Δ strain 
which is defective in the 3’-5’ exoribonuclease that participates in 3’ end processing. Preliminary sequencing indicates 
that the aberrant tRNA species from wild type cells results from maturation defects at the 3’ end rather than from 
Pol III transcription termination defects. Additional studies show that there is diversification of this processing step 
among the different tRNA families. We also studied tRNA processing in cells lacking Maf1, the general negative 
regulator of Pol III transcription. Interestingly, whenmaf1Δ cells were grown on nonfermentable carbon sources, they 
generated end-processed intron-containing tRNAs species which migrated faster than pre-tRNAs from wild type 
cells. The migration of the aberrant tRNAs and other intermediates detected from maf1Δ cells suggests that there 
is/are alternative pathway(s) for tRNA maturation or degradation in the absence of Maf1. We are in the process of 
conducting large scale sequencing of tRNAs isolated from maf1Δ cells.
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336 A Characterization of Rbtf1 and its role in ribosome synthesis
Lukas Bammert1, Ulrike Kutay1
1ETH Zürich
Ribosome biogenesis is essential for the translational capacity of a cell and its regulation is tightly linked to 
the rate of cellular growth. Synthesis of ribosomes is one of the most energy consuming cellular processes, as these 
macromolecular machineries are present in high abundance and built up of a complex structure of RNA and proteins. 
Ribosome biogenesis includes transcription of rRNA, expression of ribosomal proteins and the activity of ribosomal 
maturation factors, which are processing rRNA and assembling ribosomal particles. In human cells, the regulatory 
network upstream of ribosome synthesis appears very complex; yet little is known as to how the various nutrient and 
growth factor induced signaling pathways cooperate to regulate ribosome synthesis.
We have recently performed a genome-wide siRNA screen to identify the cellular repertoire of factors involved in 
human 40S subunit biogenesis. The screen identified a number of candidate proteins that control ribosome synthesis, 
including the uncharacterized, putative transcription factor Rbtf1. We show that Rbtf1 is essential for both 40S and 60S 
subunit production. Rbtf1 is a nucleoplasmic protein, which is not required for rRNA transcription by RNA polymerase 
I, but for nuclear maturation of ribosomal subunits. Based on these data, we are testing how Rbtf1 influences ribosome 
synthesis by its potential function as a transcription factor and how Rbtf1 could link upstream signaling pathways to 
ribosome biogenesis.
335 C Expanded Function of Trans-Editing Domains To Edit Non-canonical Amino Acids Prevents 
Errors In Translation
Jo Marie Bacusmo1, Birgit Alber2, Karin Musier-Forsyth1
1Department of Chemistry and Biochemistry and Center for RNA Biology; 2Department of Microbiology, The 
Ohio State University, Columbus, OH, USA
Aminoacyl-tRNA synthetases (ARSs) activate specific amino acids and attach them to cognate tRNAs for use in protein 
synthesis. ARSs often misactivate isosteric standard and non-proteinaceous amino acids, potentially resulting in errors 
in translation that could be detrimental to cell survival. In the case of prolyl-tRNA synthetases (ProRS), smaller Ala and 
similar sized Cys are misactivated together with non-standard amino acids 4-hydroxyproline, azetidine, and α-aminobutyrate 
(Abu). Thus, due to ProRS promiscuity, editing mechanisms have evolved to ensure fidelity in Pro codon translation. In 
many bacterial systems, a so-called “triple-sieve” editing mechanism is employed, which consists of the ProRS active site 
that discriminates amino acids based primarily on volume and size (i.e., the “coarse sieve”), the ProRS editing domain 
(INS) that hydrolyzes Ala-tRNAPro in cis (i.e., the “fine sieve”), and a single-domain INS homolog YbaK that clears Cys-
tRNAPro in trans. The latter occurs via a novel mechanism involving substrate sulfhydryl side-chain chemistry (i.e., the 
“chemical sieve”). Although these mechanisms clear standard non-cognate amino acids, how non-canonical amino acids 
are prevented from misincorporation is unclear. Moreover, many different combinations of INS-likecis and trans-editing 
domains exist in bacteria. For example, the metabolically versatile bacterium Rhodopseudomonas palustris (Rp) encodes 
a ProRS containing a truncated INS domain that we have shown is catalytically inactive, in addition to two distinct, INS 
homologs YbaK and ProXp-x. The function of the latter is unknown. In this work, Rp ProXp-x was cloned and purified 
and shown to have only weak activity in preventing mischarging of Ala-tRNAPro and Cys-tRNAPro in vitro. Comparison 
of known crystal structures reveals that the putative substrate-binding pocket of ProXp-x is larger than that of INS, which 
suggests substrates larger than Ala are preferred. Indeed, we demonstrate here that ProXp-x shows robust editing of the non-
canonical amino acid Abu, a metabolite involved in catabolic and metabolic pathways of numerous amino acids to which 
ARSs are exposed. Rp ProRS specificity for activation of Pro over Abu is only about 1,000:1, which strongly suggests that 
editing is required in vivo. Furthermore, Abu is mischarged onto tRNAs not only by ProRS, but also by ValRS and IleRS 
and ProXp-x also displays robust editing of Abu-tRNAVal. Taken together, these data suggest that Abu-tRNA editing by 
the trans-editing factor ProXp-x is likely to be a critical checkpoint to ensure high fidelity in codon translation.
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338 C Exploring translation in S. pombe using ribosomal profiling
Caia Duncan1, Juan Mata1
1Department of Biochemistry, University of Cambridge, UK
Ribosomal profiling is a powerful technique to measure translation genome-wide in growing cells.  By comparing 
ribosome protected fragments to mRNA abundance, translation efficiency can be calculated for every translated 
mRNA.  Schizosaccharomyces pombe  has been extensively characterized at the mRNA level; however, much less 
is known about translational control.  To address this question we have performed ribosomal profiling of a wild 
type S. pombe strain.  Analysis of our data has allowed the identification of translation start sites, uORFs, potential 
frameshifting events and translation of annotated non-coding RNAs.  In addition, we have estimated translational 
efficiencies and identified subsets of poorly-translated genes that may be subject to translational repression.  We are 
currently performing ribosomal profiling of S. pombe cells during meiotic differentiation and under stress conditions 
to investigate how translation is regulated in response to environmental and developmental cues.
337 B When p53 senses faulty ribosomes: Induction of Tp53 correlates with enhanced 
expression of c-Myc target nucleolar proteins in Rpl11-deficient zebrafish
Anirban Chakraborty1, Tamayo Uechi2, Pierre-Emmanuel Gleizes1, Naoya Kenmochi2
1CNRS, Laboratoire de Biologie Moléculaire Eucaryote (LBME), Toulouse, France; 2Frontier Science 
Research Center, University of Miyazaki, Japan
Nucleolar proteins play critical role in rRNA processing and pre-ribosomal assembly within the nucleolus. 
Impaired ribosome biogenesis causes nucleolar stress that triggers a p53 signaling pathway. Studies in cell lines 
have identified RPL11 as a key mediator in this pathway because of its ability to directly interact with MDM2, the 
negative regulator of p53. Interestingly, RPL11 has also been shown to control the transcriptional activity of c-Myc, an 
oncoprotein that positively regulates ribosome biogenesis. Contrary to the cell-line based results, we have previously 
demonstrated that loss of Rpl11 activates the Tp53 pathway in zebrafish. To gain further insight into the mechanism 
of Tp53 induction in response to Rpl11 deficiency, we analyzed the level of c-Myc and several c-Myc target nucleolar 
proteins in Rpl11-deficient zebrafish. Quantitative RT-PCR revealed 3-5 fold upregulation of c-Myc and the majority 
of its target nucleolar proteins, including those that bind to MDM2 or modify p53, in Rpl11-deficent zebrafish. In 
situ hybridization showed an enrichment of nucleolar protein transcripts in the head region of the Rpl11-deficient 
zebrafish, where morphological abnormalities and tp53 localization were more pronounced. Furthermore, a time-
course analysis indicated that the overexpression of nucleolar proteins coincided with the activation of Tp53 response 
in the Rpl11-deficient zebrafish. Rpl11 deficiency also led to defective rRNA processing and decreased abundance of 
functional ribosomes in zebrafish, indicating an impaired ribosome biogenesis. Many nucleolar proteins analyzed in 
this study are known p53 modulators. Therefore our results suggest a model in which increased c-Myc activity upon 
Rpl11 loss-of-function stimulates synthesis of nucleolar proteins, which, in turn, may trigger a p53 response.
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340 B Antibiotic-mediated frameshift during translation of the leader ORF reveals a new 
principle of gene regulation
Pulkit Gupta1, Nora Vazquez-Laslop1, Alexander Mankin1
1University of Illinois at Chicago
The antibiotic-inducible gene ermC encodes an rRNA methyltransferase that renders bacteria resistant to 
macrolide antibiotics. The ermC gene is preceded by a 19 codon-long regulatory ORF. In the absence of antibiotic, 
the secondary structure of the intergenic region occludes the ribosome binding site and the initiation codon of the 
methyltransferase gene impeding its expression. The currently known classic mechanism of antibiotic-mediated 
induction of ermC expression operates via nascent peptide dependent ribosome stalling. A ribosome with bound 
erythromycin, an inducing macrolide antibiotic, stalls at a strategic location of theermCL ORF and triggers mRNA 
isomerization. The conformational switch frees the ermC initiation region, allowing a drug-free ribosome to initiate 
expression of the resistance gene. Ribosome stalling critically depends on the sequence of the leader peptide and on 
the structure of the inducing macrolide antibiotic which binds to the ribosomal exit tunnel. Interestingly, the new 
generation of macrolides, the ketolides, which also bind in the exit tunnel, are unable to direct ribosome stalling 
at ermCL. Yet, puzzlingly, ketolide telithromycin can induce expression of ermC. We have unraveled the mechanism 
of ketolide-mediated induction of ermC. The novel mechanism uncovers a novel principle of gene regulation based on 
readthrough of the stop codon of the regulatory gene and reveals the previously unknown ability of macrolide drugs 
to cause translational frameshifting.
The mechanism of ketolide-mediated induction of ermC operates via antibiotic-induced -1 frameshift that takes 
place at the two last sense codons of the ermCL leader ORF. The N-terminal amino acid sequence of the ErmCL 
peptide allows it to thread through the antibiotic obstructed exit tunnel without displacing the drug. Consequently, the 
ribosomes with bound antibiotic reach the end of the ORF. The ’slippery sequence’ encompassing the two last sense 
codons of ermCL and the presence of the antibiotic in the tunnel are the prerequisites for the freameshift to occur. After 
switching to the  -1 frame, ribosomes can translate the entire intergenic region without encountering any stop codons until 
they reach the beginning of the ermC gene. Unfolding of the mRNA structure by translating ribosomes or re-initiation of 
translation likely facilitate expression of the resistance cistron. Our findings reveal a new paradigm of gene regulation by 
programmed frameshift at the regulatory ORF and open new venues for development of superior antibiotics.
339 A Escherichia coli ribosomal protein S1 unfolds structured mRNAs onto the ribosome for 
active translation initiation
Mélodie Duval1, Alexey Korepanov2, Olivier Fuchsbauer1, Pierre Fechter1, Ronald Micura4, Bruno Klaholz3, 
Stefano Marzi1, Pascale Romby1
1IBMC-CNRS, Strasbourg; 2IBPC-CNRS, Paris; 3IGBMC, Illkirch; 4Leopold Franzens University, Innsbruck
Many bacterial mRNAs adopt structures in their 5’ untranslated regions that modulate the accessibility of the 
30S ribosomal subunit. Structured mRNAs interact with the 30S in a two-step pathway where the docking of a 
folded mRNA precedes an accommodation step. Here, we demonstrate that ribosomal protein S1 endows the 30S 
with an RNA chaperone activity that is essential for the docking, the unfolding of structured mRNAs, and the correct 
positioning of the initiation codon inside the decoding channel. The first three OB-fold domains of S1 retain all 
the activities of the protein on the 30S subunit. We show that S1 is not required for all mRNAs and acts differently 
on mRNAs according to the signals present at their 5’ ends. Therefore, S1 confers activities to the ribosome that 
are adapted for a given mRNA creating heterogenous populations of ribosomal initiation complexes to selectively 
translate unstructured and structured mRNAs.
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341 C High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome
Yaser Hashem1, Amedee Des Georges1, Sarah Buss6, Fabrice Jossinet3, Amy Jobe2, Qin Zhang5, Robert Grassucci1, 
Chandrajit Bajaj5, Eric Westhof4, Susan Madison-Antenucci6, Joachim Frank1
1Columbia University / HHMI; 2Columbia University; 3Universite de Strasbourg; 4Universite de Strasbourg / 
CNRS; 5University of Texas; 6Wadsworth Center
Ribosomes, the protein factories of living cells, translate genetic information carried by messenger RNAs into 
proteins, and are thus involved in virtually all aspects of cellular development and maintenance. The few available 
structures of the eukaryotic ribosome reveal that it is more complex than its prokaryotic counterpart owing mainly 
to the presence of eukaryote-specific ribosomal proteins and additional ribosomal RNA insertions, called expansion 
segments. The structures also differ among species, partly in the size and arrangement of these expansion segments. 
Such differences are extreme in kinetoplastids. Here we present a high-resolution (~5A) cryo-electron microscopy 
structure of the ribosome of Trypanosoma brucei (figure1 below), the parasite that is transmitted by the tsetse fly 
and that causes African sleeping sickness. The atomic model reveals the unique features of this ribosome (figure2 
below), characterized mainly by the presence of unusually large expansion segments and ribosomal protein extensions 
leading to the formation of four additional inter-subunit bridges. We also find additional rRNA insertions, including 
one large rRNA domain that is not found in other eukaryotes. Furthermore, the structure reveals the five cleavage 
sites of the kinetoplastid large ribosomal subunit rRNA chain, which is known to be cleaved uniquely into six pieces, 
and suggests that the cleavage is important for the maintenance of the T. brucei ribosome in the observed structure. 
We discuss several possible implications of the large rRNA expansion segments for the translation regulation process 
and we show a possible link between the protein translation initiation process and expansion segments 6 and 7 on 
the small ribosomal subunit. The structure could serve as a basis for future experiments aimed at understanding the 
functional importance of these kinetoplastid-specific ribosomal features in protein translation regulation, an essential 
step towards finding effective and safe kinetoplastid-specific drugs.
1. Hashem et al., Nature 494, 385–389 (2013).
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342 A Cryo-EM structure of the mammalian ribosomal 43S preinitiation complex
Yaser Hashem1, Amedee Des Georges2, Vidya Dhote3, Robert Langlois1, Robert Grassucci1, Christopher U.T. 
Hellen3, Tatyana V. Pestova3, Joachim Frank2
1Columbia University / HHMI; 2Columbia University; 3SUNY Downstate Medical Center
Protein translation initiation in eukaryotes is a very complex process that involves a dozen of initiation factors and 
begins by the assembly of the 43S preinitiation complex. The process starts by the formation of the ternary complex 
(TC) from Met-tRNAi
Met, eukaryotic initiation factor 2 (eIF2) and GTP. Then the TC along with eukaryotic initiation 
factors 3, 1 and 1A (eIF3, eIF1 and eIF1A respectively) cooperatively bind to the small ribosomal subunit  subunit 
yielding the 43S preinitiation complex that is ready to bind the messenger RNA (mRNA) and scan for the initiation 
codon. Scanning on structured mRNAs in higher eukaryotes requires in addition the presence of DHX29, a DExH-
box protein that also binds directly to the 40S subunit. The assembly of most of these factors on the 40S subunit, and 
the structure of the 43S complex more generally, remained so far elusive to structural studies and has been subject 
to numerous speculations. Here, we present the first cryo-electron microscopy structure of the mammalian DHX29-
bound 43S complex (figure1 below). It reveals the assembly of the 43S complex and the binding sites of its different 
initiation factors including eIF3. Our structure reveals that eIF2 interacts with the 40S subunit via its alpha subunit 
and supports Met-tRNAi
Met in a novel eukaryotic P/I orientation (eP/I). The structural core of eIF3 resides on the back 
of the 40S subunit establishing a rather reduced interaction surface with the latter through two principal points of 
contact only, whereas DHX29 binds around helix 16. Although the assignment of eIF3 subunits is still controversial, 
our structure localizes at least three peripheral subunit of eIF3, thus representing the most complete structure of eIF3 
to date. In addition, we discuss eIF3 binding on the 40S subunit in the context of different relevant complexes such as 
40S-HCV IRES complex and the small ribosomal subunit from ribosomes of kinetoplatids, presenting extraordinarily 
large expansion segments. In conclusion, our structure provides insights into eukaryote-specific aspects of translation, 
including the mechanism of action of different initiation factors such as DHX29.
1. Hashem et al. Structural insights into  the mammalian ribosomal 43S preinitiation complex. Cell 2013 (in press)
2. Hashem et al. High-resolution cryo-electron microscopy structure of the Trypanosoma brucei ribosome. Nature 2013
3. Siridechadilok et al. Structural Roles for Human Translation Factor eIF3 in Initiation of Protein Synthesis. Science 2005
4. Spahn et al. Hepatitis C Virus IRES RNA-Induced Changes in the Conformation of the 40S Ribosomal 
Subunit. Science 2001
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343 B Alu RNPs target 40S ribosomal subunits to repress translation initiation
Elena Ivanova1, Audrey Berger1, Elena Alkalaeva2, Anne Scherrer1, Katharina Strub1
1Department of Cell Biology, University of Geneva, Switzerland; 2Engelhardt Institute of Molecular Biology, 
Moscow, Russia
In primate cells, non-coding cytoplasmic Alu RNAs transcribed from the repetitive Alu elements form complexes, 
referred to as Alu RNPs, with the protein heterodimer SRP9/14. SRP9/14 is also a part of the signal recognition particle 
(SRP), a ribonucleoprotein complex, which plays a key role in protein translocation into the endoplasmic reticulum. 
The SRP RNA gene is the phylogenetic precursor of the Alu elements. We found that biochemically purified Alu RNPs 
inhibit translation initiation in rabbit reticulocyte lysate on capped and non-capped mRNAs in a dose-dependent 
manner whereas the protein and the RNA moieties alone had no effect. The identity of the RNA moiety in the Alu RNP 
was important for function. RNP particles assembled on Alu RNA derived from the SRP RNA gene failed to inhibit 
initiation. Those containing RNAs from the oldAlu J and the younger Alu Sx families of Alu elements produced an 
intermediated phenotype whereas RNPs assembled on Alu RNA from the youngest Y family were the most efficient in 
translation inhibition indicating that this function was acquired during evolution. In the protein moiety of the Alu RNP, 
the presence of a positively charged domain composed of the C-terminal pentapeptide in SRP14 and three lysines in 
SRP9 was required to inhibit translation initiation. To investigate the mechanism of inhibition, we studied the effect 
of Alu RNPs on the in vitro assembly of different translation complexes. We found that Alu RNPs interfere with 48S 
complex formation by inhibiting the recruitment of the mRNA to the 43S complex. Moreover, Alu RNP repressed 
ribosomal complex assembly on the cricket paralysis virus IRES which occurs independently of any initiation factors, 
suggesting that Alu RNPs has a direct effect on 40S subunit. Consistently, we found SRP9/14 to be bound to 40S 
subunits upon their incubation with Alu RNPs. Our results describe a novel translational control mechanism in 
which Alu RNA ensures functional binding of SRP9/14 to the 40S ribosome and thereby prevents cap-dependent 
as well as IRES-mediated ribosome recruitment to the mRNA. This pathway might be activated in response to viral 
infection to interfere with IRES-dependent translation initiation.
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344 C Interactions of modified oligonucleotides with RNA of the prokaryotic and eukaryotic 
decoding site
Maciej Jasinski1, Sapna Thoduka2, Ryszard Stolarski3, Joanna Trylska2
1MISMaP College, The University of Warsaw, Zwirki i Wigury 93, 02-089 Warsaw, Poland; 2Centre of New 
Technologies, University of Warsaw, Zwirki i Wigury 93, 02-089 Warsaw, Poland; 3Department of Biophysics, 
Institute of Experimental Physics, Faculty of Physics, University of Warsaw, Zwirki i Wigury 93, 02-089 
Warsaw, Poland
Many known antibiotics that hinder protein synthesis in bacteria, target various functional regions of ribosomal 
RNA (rRNA). In principle, rRNA function can also be inhibited in a sequence-specific manner by using short 
oligonucleotides hybridizing with functional rRNA motifs. Indeed, some modified oligonucleotides were shown to 
hybridize with the RNA of bacterial ribosomes and inhibit the translation process1. Typically, the oligonucleotides are 
designed based solely on the sequence of rRNA, and the secondary and tertiary structures of the targeted rRNA motif 
are not taken into account. However, to increase the binding affinities of such oligonucleotides their interactions with 
RNA need to be fully elucidated, taking into account thermodynamic stability, structural and dynamical properties of 
the RNA target.
We have studied the binding of three S-DNA and 2’O-methyl-RNA decamers complementary to the models of 
prokaryotic and eukaryotic rRNA decoding sites (A-sites). We have used a structural model of the bacterial ribosomal 
target: the HX RNA construct2 (PDB: 3LOA), which contains a fragment of the helix h44 of 16S rRNA.
The thermodynamics of binding was determined by the UV-monitored thermal denaturations and isothermal 
titration calorimetry (ITC) experiments. We have studied the specificity of the oligonucleotides, by testing the effect 
of one, two or three mismatches on the binding process. We have also performed 300 ns explicit solvent molecular 
dynamics (MD) simulations of both rRNA models to characterize the flexibility of the targeted rRNA structures. 
The fluctuations of the nucleotides indicate which fragments of the target are more susceptible to strand invasion by 
oligonucleotides. We compare the solution binding experimental studies with the computational predictions derived 
from the analysis of the MD trajectories. We focus on the relationship between the flexibility of the target fragment 
and the binding energy between the oligonucleotide and the rRNA.
In addition, we have compared the results obtained for model structures with in vitro studies employing whole 
ribosomal subunits in a cell-free transcription/translation system. We are looking for correlations between the physical 
parameters of binding of the oligonucleotides with their inhibitory efficiency on bacterial translation. Detailed study 
of the interaction between modified oligonucleotides and rRNA model structures is crucial for understanding the 
mechanisms of action of the therapeutic antibacterial oligonucleotide-containing compounds.
1Abelian, A, et al. (2004). Biochem. J., 383, Pt 2:201-8.
2Dibrov, SM, et al. (2010). Nucleic Acids Res., 38, 13:4458-65.
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346 B Crystal structures of the protozoal cytoplasmic A site in complex with aminoglycosides
Jiro Kondo1, Mai Koganei1
1Sophia University
Parasitic infections recognized as neglected tropical diseases are a source of concern for several regions of the 
world. Aminoglycosides are potent antimicrobial agents, which have been extensively studied by biochemical and 
structural studies in prokaryotes. However, the molecular mechanism of their potential antiprotozoal activity is less 
well understood.
In the present study, we have determined crystal structures of the protozoal cytoplasmic A site (aminoacyl-tRNA 
decoding site) in complex with aminoglycosides possessing a 6’-hydroxy group on ring I. They specifically bind within 
the deep/major groove of the protozoal cytoplasmic A site, where they displace two universally conserved adenines 
A1492 and A1493 (according to the numbering used in E. coli 16S rRNA),  and stabilize the state called “on”. Since 
two bulged-out adenines are involved in contacts with mRNA-tRNA complex, the binding of aminoglycosides to 
the protozoal cytoplasmic A site may lead to reduced discrimination of cognate tRNAs versus near-cognate tRNAs, 
thereby compromising translation fidelity. 
Ring I of aminoglycosides with a 6’-hydroxy group stack on G1491, which is highly conserved in bacterial 
and protozoal species. In addition, ring I can form a pseudo pair with G1408 through two hydrogen bonds and one 
C-H...O bond. It is obvious from structural modeling that aminoglycosides with a 6’-ammonium group on ring I, such 
as gentamicin and kanamycin, cannot make the identical pseudo pair, because the ammonium group repels N1-H or 
N2-H of G1408. In fact, aminoglycosides with a 6’-ammonium group do not display antiprotozoal activity.
It is noteworthy that the secondary structure of the protozoal cytoplasmic A site is highly analogous to that of 
the bacterial A site with an A1408G mutation, which is the most prevalent antibiotic-resistant mutation found in 
clinical isolates. As evidence of this, the mutation is known to confer high-level resistance to aminoglycosides with a 
6’-ammonium group but moderate resistance to those with a 6’-hydroxy group.
The structure information obtained in this study would contribute towards the structure-based design of next-
generation aminoglycosides with high activities against parasitic protozoa and antibiotic-resistant bacteria.
345 A The intimate connection of RNA granules with human 4Es changes with use of different 
protein variants
Klára Kazdová1, Katerina Mocová1, Tomáš Mašek1, Silvia Mrvová1, Martin Pospíšek1
1Charles University in Prague, Department of Genetics and Microbiology
Three different eukaryotic translation initiation factors belonging to the 4E family are present in human cells. First, eIF4E1, 
which directs ribosome to the mRNA cap structure by recognizing it via residues Trp56 and Trp102. 4E1 initiates translation 
via interaction with the scaffolding protein eIF4G and is tightly controlled by 4E-binding proteins 4E-BP1,2,3. Second, eIF4E2, 
which possesses characteristic substitutions of Trp56 and Trp43 for tyrosines that cause weaker cap binding. In contrast to 4E1, 
4E2 does not bind the scaffolding protein 4G, however, it is still able to bind 4E-BPs. Therefore, it is assumably unable to initiate 
translation and a regulatory role has been assigned to it instead. It establishes anterior-posterior body axis in Drosophila embryo by 
inhibiting caudal and hunchback mRNAs translation and drives embryonic patterning by inhibiting HoxB4 and HoxB8 mRNAs 
in mouse oocytes. Recently, 4E2 has been shown to play important role in a non-canonical translation initiation during cellular 
response to hypoxia. Last, 4E3 has the Trp 43 and 56 substituted for Cys or Tyr, which weakens its cap binding even more than 
that of 4E2. Contrary to 4E2, 4E3 is able to bind 4G but not 4E-BPs and its direct role in 5’ mRNA cap recognition in translation 
initiation thus cannot be excluded. Each of the 4E1,2,3 proteins is present in human cells as several predicted variants arising 
from alternative mRNA splicing and alterations in transcription starts. We confirmed existence of some of them by cloning their 
cDNAs from human leukemic cells. To investigate subcellular distributions of the 4E1,2,3 protein variants corresponding to 
cloned cDNAs, we produced them as N-terminal GFP fusions in the human osteosarcoma cell line (U2OS). To our knowledge, 
subcellular localizations of only 4E1 and mouse 4E2 have been published till now. Contrary to strictly cytoplasmic distribution 
of mouse 4E2, we observed nuclear-cytoplasmic distribution of all the human 4E1,2,3 variants tested. Localizations of all the 
proteins were verified using antibodies against endogenous proteins. We were further interested whether all of the 4E1,2,3 variants 
form a part of RNA granules and thus could be involved in more general processes associated with mRNA turnover during normal 
conditions as well as under stresses. We found that during heat shock and oxidative stress both of the 4E1 variants tested localized 
to P-bodies (PB) and stress granules (SG). Contrary to that, all of the three 4E2 variants localized to PB only and 4E3 was not 
detected in any of those structures. Moreover, careful quantitative analysis of these data suggested different abilities to associate 
with PB between different protein variants of both 4E1 and 4E2 translation initiation factors. Our results thus indicate importance 
of alternative splicing for functional diversity of translation initiation factors belonging to the 4E family.
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348 A Function of Fap7 in the maturation of the ribosome small subunit
Jérôme Loc’h1, Magali Blaud2, Stéphane Réty3, Simon Lebaron5, Sander Granneman4, David Tollervey5, Patrick 
Deschamps3, Julie Jombart3, Joseph Bareille3, Nicolas Leulliot3
1LCRB, UMR 8015 CNRS, Faculté des Sciences Pharmaceutique et Biologique, Université Paris Descartes, 
75270 Paris Cedex 06, France.; 2LCRB, UMR 8015 CNRS, Faculté des Sciences Pharmaceutique et 
Biologique, Université Paris Descartes, 75270 Paris Cedex 06, France; 3LCRB, UMR 8015 CNRS, Faculté des 
Sciences Pharmaceutique et Biologique, Université Paris Descartes, 75270 Paris Cedex 06, France.; 4SynthSys 
Edinburgh, The University of Edinburgh, Scotland; 5Wellcome Trust Centre for Cell Biology, The University 
of Edinburgh, Scotland
Over 200 pre-ribosomal factors are involved in the maturation of ribosomes. Most of these factors are essential 
to cell survival, but their precise function remains elusive. One of the last steps of maturation of the ribosome small 
subunit is the cleavage of 20S pre-rRNA in 18S rRNA in the cytoplasm. This cleavage is carried out by the endonuclease 
Nob1 and also requires the presence of other factors such as the methyltransferase Dim1, and a plethora of NTPases 
including the Rio protein kinases, Prp43 and its cofactor Pfa1, the Ltv1 GTPase and the Fap7 NTPase.
The function of Fap7 is especially intriguing since the human homologue bears adenylate activity, an enzymatic 
activity not usually found during ribonucleoprotein biogenesis. In addition, the function of Fap7 is intimately linked 
to its interaction with the Rps14 ribosomal protein. The Rps14 C-terminal domain is essential for D-site cleavage and 
is located in proximity to the 18S rRNA 3’-extremity in the mature ribosome.  The deletion of this protein causes the 
5q syndrome that is phenotypically close to Diamond Blackfan anemia. The link between the enzymatic activity of 
Fap7 and its role in ribosome biogenesis remains enigmatic.
We have conducted functional and structural characterisation of the Fap7 protein alone and in complex with 
Rps14 and nucleotides. Using a combination of structural studies by X-ray crystallography, small angle X-ray 
scattering (SAXS) in solution, enzymatic studies on purified proteins, and in vitro D site cleavage reaction assays on 
purified pre-ribosomes, we were able to uncover the function of Fap7 within pre-40S ribosomes. We show that the 
Fap7/Rps14 interaction is involved in a major conformational change at the heart of the pre-ribosomes and that this 
structural rearrangement is necessary to expose the D-site for cleavage by the endonuclease Nob1. The link between 
the enzymatic activity and the conformational switch both before and after cleavage is currently been investigated.
347 C Rrp5 binds the pre-rRNA at multiple sites and is required for ribosomal processing and 
assembly
Simon Lebaron1, Åsa Segerstolpe3, Sarah French2, Sander Granneman4, Ann Beyer2, Lars Wieslander3, David 
Tollervey1
1Wellcome Trust Centre for Cell Biology, University of Edinburgh, Scotland; 2Department of Microbiology, 
University of Virginia Health System, USA; 3Department of Molecular Biology and Functional Genomics, 
Stockholm University, Sweden; 4SynthSys, Edinburgh, Scotland
The large, highly conserved ribosome synthesis factor Rrp5 has 12 S1 RNA binding domains and 7 TRP protein 
interaction domains, and is required for the early events in both 40S and 60S ribosomal subunit synthesis. In vivo 
complementation experiments show that the CTD of Rrp5 is required for pre-rRNA cleavage at sites A0-A2 on the 
pathway of 18S rRNA synthesis, whereas the NTD is required for A3 cleavage on the pathway of 5.8S/25S rRNA 
synthesis. Using the CRAC UV-crosslinking technique we identified multiple Rrp5 binding sites along the yeast pre-
rRNA. The strongest interactions were seen between sequences flanking A2 and the CTD and between sequences 
flanking A3 and the NTD. The CTD also crosslinked to the U3, U14 and snR10 snoRNAs that are required for normal 
cleavage at sites A0-A2. In contrast, the NTD crosslinked to the RNA component of RNase MRP, which cleaves site 
A3. Mathematical modeling of kinetic labeling data and EM analyses both indicate that co-transcriptional cleavage at 
sites A0-A2 is not stochastic, but occurs during a window when the transcribing polymerase is ~1.5kb 3’ to cleavage 
site A2 and within the 25S rRNA. Notably, a binding site for the Rrp5 CTD, which is required for A0-A2 cleavage, 
was found in the 25S rRNA region, suggesting that transcription through this Rrp5 binding site in 25S rRNA might 
set the timing for A2 cleavage. Dramatic support for a specific site in 25S was provided by crosslinking and ligation 
of hybrids (CLASH), which showed that the Rrp5 binding site in 25S base-pairs to the sequencing flanking cleavage 
sites A2. We propose that this long-range interaction, facilitated by Rrp5, plays a key role in coordinating the timing 
of pre-ribosomal assembly and processing.
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350 C Evolutionary decline for a nuclear-encoded human mitochondrial aminoacyl-tRNA 
synthetase
Hagen Schwenzer1, Gert Scheper2, Nathalie Zorn4, Luc Moulinier3, Agnès Gaudry1, Emmanuelle Leize4, Franck 
Martin1, Catherine Florentz1, Olivier Poch3, Marie Sissler1
1Architecture et Réactivité de l’ARN, CNRS, Université de Strasbourg, IBMC, 15 rue René Descartes, 
F-67084 Strasbourg Cedex, France; 2Department of Pediatrics and Child Neurology, VU University 
Medical Center, 1081 HV Amsterdam, The Netherlands.; 3Laboratoire de Bioinformatique et de Génomique 
Intégratives, IGBMC, 1 rue Laurent Fries BP-10142, F-67404 Illkirch Cedex, France; 4Laboratoire de 
Spectrométrie de Masse des Interactions et des Systèmes, Chimie de la Matière Complexe, 1 rue Blaise 
Pascal, F-67008 Strasbourg Cedex France
Mammalian mitochondrial aminoacyl-tRNA synthetases (mt-aaRSs) are nuclear-encoded and fulfill their activity 
in mitochondria. Their genes differ from the ones of cytosolic-adressed aaRSs. Many mammalian mt-aaRSs are of 
bacterial type and share structural domains with homologous bacterial enzymes of the same specificity, such as human 
mt aspartyl-tRNA synthetase (AspRS). Despite the fact that the mt-AspRS and AspRS fromE.coli have a common 
ancestor numerous functional idosyncrasies/discrepancies were reported for the human mitochondrial enzyme.
In order to enlarge the knowledge on mt-AspRS, the present study investigated a serendipitously amplified PCR 
fragment, which corresponds to an alternative spliced transcript. This isoform lacks the exon 13 coding for a region 
in the “Bacterial Insertion Domain” (BID). We showed that the alternative transcript was present in all tested tissues; 
co-existed with the full-length form, possesses a 5’-and 3’-UTRs, a poly-A tail and was bound to polysomes. The 
corresponding protein was hard to express in vitro and was not detectable in cellulo or in vivo, strongly suggesting a 
decreased stability. In addition, bioinformatic analysis revealed that the mean acid identities percentages of BID were 
divergent in opisthokont and protist sequences and distinguished them from the bacterial and viridiplantae ones. This 
suggests a loss of evolutionary pressure for this domain in non-viridiplantae AspRSs of mitochondrial location.
Altogether, the combination of released selective pressure with the occurrence of alternative splicing suggests that 
the new isoform serves as evolutionary playground towards a possible reshaping of the BID. This ongoing decline of 
the BID underlines a relaxation of the mt enzyme.
349 B Molecular characterization of ribosomal E-site function
Nicola Rusca1, Nina Clementi2, Matthias Erlacher2, Norbert Polacek1
1Department of Chemistry and Biochemistry, University of Bern, Bern, Switzerland; 2Innsbruck Biocenter, 
Division of Genomics and RNomics, Medical University Innsbruck, Austria
During the elongation cycle of protein biosynthesis, tRNAs travel through the ribosome by consecutive binding to 
the three ribosomal binding sites (A-, P-, and E-sites). While the A and P sites have been functionally well characterized 
in the past, the contribution of the E site to translation is still poorly understood in molecular terms. Footprinting and 
crystallographic studies indicated an interaction of A76 of E-tRNA with the nucleobase of the universally conserved 
23S rRNA residue C2394.
We use the ‘atomic mutagenesis’ approach,[a] which allows site-specific manipulation of functional rRNA groups 
in the context of reconstituted ribosomes, to identify critical interaction partners of E-tRNA with the 23S rRNA. The 
functional significance of E-site 23S rRNA nucleotides for protein synthesis was tested by performing in vitro translation 
reactions with chemically engineered ribosomes carrying either a deoxy-residue or an abasic nucleoside analog at 
position C2394, U1851, A2422, or G2421. Unexpectedly the removal of the nucleobase or the ribose 2’-OH at C2394 
had no effect on protein synthesis. Also modifications at U1851 or A2422 had no inhibitory effect. However, removing 
the nucleobase at G2421 completely inhibited in vitro translation. G2421 forms a base pair with C2395 and it was 
shown that A76 of E-tRNA stacks on the nucleobase of G2421. Subsequent standard mutagenesis highlighted the 
importance of a classical Watson-Crick 2421-2395 base pair regardless of the involved nucleobase identities. Ongoing 
work focuses on the importance of this universally conserved base pair in the 50S E-site on E-tRNA binding, reading 
frame maintenance and translation accuracy.
[a] Erlacher et al. (2011), Nat. Prot., 6:580-592.
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352 B Effect of tRNA core modifications and a D-loop sequence element on ribosomal decoding
Irina Shepotinovskaya1, Olke Uhlenbeck1
1Northwestern University, Evanston, IL USA
Unmodified tRNAs are capable of adopting the folded tertiary structure characteristic of native tRNAs, although they are 
less stable and more dynamic.  While unmodified tRNAs are often active enzyme substrates, their activity on ribosomes may 
be compromised. tRNAs lacking all or some of the modifications in the anticodon stem loop (ASL) show weaker ribosome 
binding, slower rates of dipeptide bond formation and increased misreading than their modified forms.(1) Here we focus on the 
decoding properties of modified and unmodified E. coli tRNA Ala(GGC), tRNA Gly(GCC) and tRNA Val(GAC), which are the 
only three E. coli elongator tRNAs that naturally lack ASL modifications, permitting the combined effects of the less studied 
modifications in the core of tRNA to be evaluated.
Using ribosome decoding assays in a “high fidelity” buffer at 25?C, we confirm the results of our  earlier experiments in RBB 
buffer indicating that the unmodified forms of all three of these tRNAs show identical rates of peptide bond formation (kpep) as 
their native counterparts. However, at elevated temperatures (37?C and 42?C), native tRNA Ala and tRNA Gly show substantially 
faster kpep values than at 25?C while the unmodified tRNAs remain slower. In-line probing experiments show that at 37?C the 
tRNA tertiary structure is partially disrupted when the modifications are absent, but not when the modifications are present. This 
conclusion is consistent with earlier studies indicating a stabilizing effect of the T54 and ψ55 modifications (2).
Interestingly, the kpep value of unmodified tRNA Val(GAC) remains equal to that of native tRNA Val(GAC) at all temperatures, 
suggesting that this tRNA does not need modifications to maintain its tertiary structure in the conditions tested. By measuring 
kpep with a set of unmodified tRNA Val/ tRNA Gly chimeras, the source of the increased kpep activity at higher temperatures was 
found to entirely be due to the presence of U20.1, which only occurs in tRNA Val. Removing U20.1 from unmodified tRNA Val 
makes it less active at 37?C, while adding U20.1 to tRNA Ala makes it more active at 37?C. In-line probing experiments confirm 
that the presence of U20.1 stabilizes the folded tertiary structure of tRNA.
A residue at position 20.1 (usually a U) is present in 40% of class 1 bacterial tRNAs.  Although most tRNA species either have 
20.1 or do not, a few such as tRNA Val(GAC) contain 20.1 in some bacteria and not in others. U20.1 is expected to be modified 
to D in many organisms. We are interested in understanding whether this residue acts as an independent stability element, why it 
is only present in certain tRNAs and how it acts to stabilize tRNA structure.
1. Basma EI Yacoubi, Marc Bailly, and Valerie de Crecy-Lagard (2012) Annu.Rev.Genet.,46,69-95
2. Mark Helm (2006) Nucleic Acids Res.,34,2,721-733
351 A The communication between ribosome biogenesis and cell cycle machinery
Md Shamsuzzaman1, Mamata Thapa1, Lasse Lindahl1
1University of Maryland, Baltimore county
Ribosome, the universal machine for decoding the genetic code into polypeptides, is a complex of RNAs 
and proteins that comprises over 50% of the cell mass in rapidly growing cells. Thus ribosome biosynthesis is 
required to support the growth and proliferation of cells and consumes a huge amount of cellular energy and other 
resources.  Disruption of normal ribosome biogenesis affects cellular growth and can result in cell abnormalities in 
proliferative cells. In humans these abnormalities are classified as ‘ribosomopathies’ and includes Diamond Black 
Fan Anemia, Shwachman Diamond syndrome, and increased propensity for some cancers.  Our lab is using budding 
yeast to establish basic parameters for the connection between disruption of ribosome biosynthesis and cell cycle 
progression.  So far, we have studied cell cycle progression, cell morphology and bud site selection after the repression 
of the synthesis of 54 of the 79 ribosomal proteins.
Interestingly, repression of the synthesis of specific ribosomal proteins generates different responses, including 
arrest (or delay) in G1 or G2/M stage of the cell cycle. Cell morphology includes cells with elongated buds, cells with 
more than one bud, and increased size of mother cells. Furthermore, repression of synthesis of new ribosomal proteins 
destabilized the existing pool of ribosomes.  Since responses specific to the repression of individual ribosomal protein 
genes results in a variety of phenotypes, these effects do not originate from just reduced protein synthesis capacity. 
We are currently investigating possible explanations, including abnormal localization and stability of the yeast cell 
cycle-dependent kinase Cdc28 and other cell cycle proteins and their mRNAs.
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353 C Non-ribosomal Interaction Partners of Ribosomal Protein S3
Tamsyn Stanborough1, Barbara Koch1, Valentin Mitterer1, Johannes Niederhauser1, Brigitte Pertschy1
1Institut für molekulare Biowissenschaften, Karl-Franzens-Universität Graz
The ribosomal protein S3 (Rps3) is an essential component of 40S ribosomal subunits. Rps3 contains a substantial 
amount of positively charged amino acids which facilitate its interactions with the negatively charged ribosomal RNA. 
Like other ribosomal proteins, Rps3 is prone to aggregation, which may be due to interactions of these regions with 
negatively charged components of the cytoplasm.
S. cerevisiae Rps3 engages in an interaction with the small ankyrin-repeat protein Yar1. Yar1, a 22 kDa protein, is 
hypothesized to contain two ankyrin-repeats, which are common protein-protein interaction motives. Yar1 is thought 
to bind and maintain the solubility of free Rps3 in the cytoplasm and deliver it to pre-ribosomes in the nucleus.
Yeast Rps3 shares 66 % identity and 78 % similarity with its human counterpart. We have been able to show using 
a yeast-2-hybrid analysis that human Rps3 interacts with the yeast ankyrin-repeat protein Yar1. As Rps3 is highly 
conserved from yeast to humans and ribosomal proteins undergo rapid turnover when not ribosomal bound, we are 
investigating whether a similar interaction may occur in human cells. Consequently, we are analyzing an ankyrin-
repeat protein candidate which interacts with and may stabilize free human Rps3. These data will be presented here.
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354 A Sequence-specific targeting of bacterial ribosomal RNA as a way to look for inhibition 
pockets
Sapna G. Thoduka1, Zofia Dabrowska1, Tomasz Witula1, Maciej Jasinski3, Anna Górska2, Joanna Trylska1
1Centre of New Technologies, University of Warsaw; 2Faculty of Mathematics, Informatics and Mechanics 
and Centre of New Technologies, University of Warsaw; 3MISDoMP and Centre of New Technologies, 
University of Warsaw
Many antibiotics inhibit protein synthesis in bacteria by interacting with their ribosomal RNA [1]. Unfortunately, 
bacteria have developed various resistance mechanisms to fight back existing drugs. Also, in most cases, the known 
antibiotics lack specificity toward pathogenic bacteria. Designing new scaffolds or modifying the known compounds 
has been of moderate success and most importantly will not eliminate the cross-resistance of related antibiotics. 
To design effective inhibitors of bacterial translation one has to explore new sites and possibly unknown inhibition 
mechanisms.
We have been looking for good inhibition sites by rational screening of the ribosomal RNA with short modified 
oligonucleotides as probes. The aim is to evaluate the effectiveness of these antisense single-stranded oligonucleotides 
in inhibiting translation by binding to ribosomal RNA in a sequence-dependent manner. The design of oligonucleotide 
sequences is based on the atomic-resolution structures of the ribosomes [2], bioinformatics analyses, and molecular 
dynamics simulations. Not only sequence complementarity but also the secondary and tertiary structure, flexibility 
and other physicochemical descriptors of ribosomal RNA and modified oligonucleotides are taken into account in the 
design process.
Next, we check the ability of such oligomers to inhibit protein synthesis in vitro in an optimized by us E. coli cell-
free transcription/translation system with β-galactosidase as a reporter protein. The oligonucleotides that have been 
tested are 2’O-methyl-RNA, peptide nucleic acid and locked nucleic acid. For example, we have identified potential 
2’O-methyl-RNA oligonucleotides (10-15 nucleotides long) that block the function of certain fragments of ribosomal 
inter-subunit bridges through steric hindrance, thereby halting protein synthesis. If the oligomer target site is in 
proximity to known antibiotic binding site we also check the synergistic (or antagonistic) effect of their combinations. 
To further investigate the mode of binding and confirm strand invasion of oligonucleotides we perform fluorescence 
spectroscopy, isothermal titration calorimetry and thermal denaturation studies on selected isolated ribosomal RNA 
fragments.
Acknowledgement: The authors are supported by the Foundation for Polish Science TEAM/2009-3/8 project (co-
financed by the European Regional Development Fund operated within Innovative Economy Operational Programme), 
National Science Centre and University of Warsaw (ICM KDM/G31-4).
1. Wilson, D. N. The A–Z of bacterial translation inhibitors. Crit. Rev. Biochem. Mol. Biol., 44, 393–433, 2009
2. Wimberly, B. T. The use of ribosomal crystal structures in antibiotic drug design. Curr. Opin. Investig. Drugs, 10, 750–765, 
2009
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356 C Investigating the function of the RNA helicase Prp43 and its cofactor Pfa1 in 40S 
ribosomal subunit synthesis
Stefan Unterweger1, Brigitte Pertschy2
1Institute for Molecular Biosciences, University of Graz, Austria; 2University of Graz, Austria
Ribosome biogenesis starts in the nucleus with the formation of pre-ribosomal subunits that undergo maturation 
steps in the nucleolus and in the cytoplasm after export through the nuclear pore complex. Cytoplasmic 40S maturation 
steps comprise structural changes and processing of the rRNA, but how these events play together in detail remains 
elusive.
The DEAH box RNA helicase Prp43 and its cofactor, the G-patch protein Pfa1 participate in multiple steps of 
ribosome biogenesis. Prp43 removes sno-RNAs from pre-ribosomal particles and is involved in rRNA processing 
events during both 60S and 40S subunit maturation. However, its exact functions at the different stages of ribosome 
synthesis are not known. Here we investigated the genetic network of Pfa1 and Prp43 with late pre-40S factors and 
ribosomal proteins in order to understand the 40S specific role of this enzyme.
355 B Molecular pathogenesis of ribosomopaties in zebrafish model for Diamond-Blackfan 
anemia
Tamayo Uechi1, Yukari Nakajima1, Hiroko Sonoda3, Masahiro keda3, Yutaka Suzuki2, Sumio Sugano2, Naoya 
Kenmochi1
1Frontier Science Research Center, Univ. of Miyazaki; 2Dept. of Medical Genome Science, Univ. of Tokyo; 
3Dept. of Veterinary Pharmacology, Univ. of Miyazaki
Ribosome biogenesis in eukaryotes involves a coordinated participation of ribosomal RNAs (rRNAs), ribosomal 
proteins (RPs), and a large number of accessory factors that contribute to processing of precursor rRNAs and assembly 
of ribosomal subunits. Recently, mutations in genes involved in ribosome biogenesis were identified in patients with 
various diseases, suggesting impaired ribosome can cause tissue-specific failures (ribosomopathies) via an unknown 
pathway. Diamond-Blackfan anemia (DBA) is one of such disorders, characterized by diminished numbers of erythroid 
progenitors. The DBA has been attributed to the defect in RP genes, such as RPS19 and nine other so far. However, it 
is still unclear how mutations in such ubiquitously expressed genes affect mainly erythropoiesis.
 To investigate the molecular mechanism underlying DBA, we have developed a zebrafish model for the anemia 
by repressing the translation initiation of rps19 mRNA with the Morpholino antisenseoligo. The knockdown embryos 
displayed a drastic reduction of red blood cells, whereas differentiation of other myeloid cells and endothelial cells 
seemed to be normal. The anemic phenotype was almost completely rescued by injection of synthesized rps19 mRNA, 
but not by mutated mRNAs with patient-type mutations. The DBA model also showed developmental abnormalities 
in the head and tail regions due to increased cellular apoptosis. A simultaneous inhibition of p53 gene rescued the 
morphological abnormalities, but did not alleviate the erythroid aplasia. This suggests that a tp53-independent but 
RPS19-dependent pathway could be responsible for defective erythropoiesis in DBA. To evaluate the impact of 
RPS19 deficiency on translation, we carried out a polysome profiling of our DBA model. The polysome patterns were 
similar between rps19 morphants and control embryos, although the amount of the heavier fractions was less in the 
morphants. Next, we carried out an RNA-Seq analysis of polysomal mRNAs purified from these embryos. We found 
that the translational efficiencies of about 300 genes were significantly changed in the rps19 morphants. These data 
will provide important information to understand the pathogenesis of DBA.
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358 B Ribosome biogenesis in plants and its impact on developmental processes
Benjamin Weis1, Sandra Missbach2, Enrico Schleiff1
1Molecular cell biology of plants, insitute for molecular biosciences, Goethe-University Frankfurt am Main, 
Germany; 2Novartis Vaccines and Diagnostics GmbH, Marburg, Germany
Ribosomes are highly complex ribonucleoprotein particles responsible for the synthesis of all proteins. Eukaryotic 
ribosomes consist of 79 ribosomal proteins and four ribosomal RNA molecules. Three of the four ribosomal RNAs 
(rRNA) are transcribed as a polycistronic transcript that is processed by endo- and exnucleolytic digestions to release 
the mature rRNAs. The processing path is well understood in yeast, but there is only limiting information on rRNA 
processing in plants. Only recently, a number of cleavage sites were mapped using mutants of the Arabidopsis orthologs 
of yeast Rat1/Xrn2 and Mtr4. rRNA processing and folding are prerequisite for the assembly of eukaryotic ribosomes, 
which additionally requires up to 200 ribosome assembly cofactors and more than 75 snoRNAs. Interestingly, In the 
plant model organism Arabidopsis thaliana, 2/3 of the ribosome biogenesis cofactors, that are orthologs of the yeast 
cofactors, are found multiple times in the genome pinpointing to additional or redundant functions of these factors. 
Furthermore, the different orthologs might be required at distinct developmental stages or in different tissues and thus, 
they link ribosome biogenesis to growth and development.
Here, we analyzed the rRNA processing pathway in Arabidopsis thaliana by northern blotting of wild type RNA 
to first define this pathway in more detail. Additionally, to gain further insights into ribosome biogenesis in plants 
and its link to other processes, we studied two late cofactors in Arabidopsis thaliana - the pre-40S endonuclease 
Nob1 responsible for D-cleavage and the pre-60S GTPase Lsg1 involved in the release of Nmd3 from pre-60S. 
Both are characterized in unicellular organisms (yeast and archaea), but information for multicellular eukaryotes 
like plants are lacking. Knock down of the Nob1 ortholog in Arabidopsis (atNob1) results in an accumulation of 
all precursors leading to 18S rRNA with the strongest accumulation in the P-A3 fragment. Furthermore, Nob1 links 
ribosome biogenesis to pollen and embryo development. For Lsg1p we find two orthologs in Arabidopsis (atLsg1-1 
and atLsg1-2). Knockout of atLsg1-2 shows significant alterations in the processing pathway. Interestingly, atLsg1-2 
links ribosome biogenesis to early leaf development. AtLsg1-1 appears to have lost its ribosome biogenesis function 
due to the lack of an important basic C-terminus, and we are currently investigating its alternative function.
357 A A New Role for NOT5 of the CCR4-NOT Complex in Connecting Transcription with 
Translation
Zoltan Villanyi1, Sujatha Subbana1, Olesya Panasenko1, Zoltan Pahi2, Imre Boros2, Martine Collart3
1Department Microbiology and Molecular Medicine University of Geneva, Faculty of Medicine; 2Department 
of Biochemistry and Molecular Biology, University of Szeged, Hungary; 3Department of Microbiology and 
Molecular Medicine, University of Geneva, Switzerland
The Ccr4-Not complex contributes to both transcription and cytoplasmic mRNA decay and is found both in 
the cytoplasm and in the nucleus1, like the Rpb4 subunit of RNA polymerase II,  recently reported to play a role in 
translation by interacting with the translation scaffold factor eiF32. In our work we show that Not5 is involved in the 
crosstalk between transcription and translation by contributing to the nuclear-cytoplasmic shuttling of Rpb4 and to the 
assembly of RNAPII on translating ribosomes. Indeed, first we found that the transctipion factor Rpb4 and translation 
factor eiF3 interactions are dependent upon the Not5 subunit of the Ccr4-Not complex. This can be explained by the fact 
that Not5 is required for the presence of Rpb4 in translating polysomes and in fact for the appropriate accumulation of 
Rpb4 in the cytoplasm under relevant conditions altogether. Second, besides Rpb4, several other polymerase subunits 
(Rpb1, Rpb2, Rpb9, Rpb11) are present in translating ribosome fractions, compatible with the publised data showing 
that assembly of the polymerase is cytoplasmic and with the new idea that this is co-translational. Not5 is not only 
required for Rpb4 cytoplasmic accumulation, but also for appropriate co-translational interaction of newly synthesiezd 
Rpb1 with its chaperones. Consequently RNA polymerase II is not appropriately assembled in cells lacking Not5, and 
subcomplexes containing various polymerase subunits accumulate. Hence Not5 of the Ccr4-Not complex is central 
to the integration of transcription and translation into a system that efficiently controls eukaryotic gene expression.
1. Collart MA, Panasenko OO. Gene 15: 42-53 (2012)
2. Harel-Sharvit et al., Cell 143: 552-563 (2010)
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360 A Transcription regulation by cAMP-CRP of the rmf gene for 100S ribosome formation
Hideji Yoshida1, Tomohiro Shimada2, Yasushi Maki1, Shou Furuike1, Masami Ueta4, Chieko Wada4, Akira Wada4, 
Akira Ishihama3
1Department of Physics, Osaka Medical College; 2Chemical Resources Laboratory, Tokyo Institute of 
Technology; 3Frontier Bioscience, Hosei University; 4Yoshida Biological Laboratory
In proteobacteria group gamma including Escherichia coli, protein synthesis is suppressed by the formation of 100S ribosomes 
under stress conditions such as nutrient starvation. The 100S ribosome, a dimer of 70S ribosomes, is formed after association of 
70S ribosome monomer with “Ribosome Modulation Factor” (RMF) [1]. Upon entry into the stationary growth phase, the 70S 
ribosomes are converted into 100S dimers, which are functionally inactive in translation. An E.coli strain deficient in the rmf gene 
cannot form 100S ribosomes and its lifetime is shorter than that of the wild-type strain, indicating that the transformation of 
ribosomes is an important strategy for E.coli survival under stress conditions.This ribosomal resting state is called the hibernation 
stage [2]. At present, however, little is known regarding the regulation of stationary-phase-coupled RMF expression.
After Genomic SELEX screening in vitro of regulation targets of CRP (cAMP receptor protein), the global regulator of genes 
for carbon source utilization, the rmf gene was predicted to be under the direct control of cAMP-CRP [3]. In order to confirm 
the regulation in vivo of rmf by cAMP-CRP, we investigated the effects of cAMP and CRP for the expression of RMF and the 
formation of 100S ribosome by using the deletion mutants of cyaA and crp genes. The results altogether, indicated the decreases 
in RMF production and 100S ribosome formation in the absence of cAMP-CRP. We concluded that cAMP-CRP is involved in 
transcription regulation of the rmf gene and the formation of 100S ribosome [4]. In addition, we will discuss other factors involved 
in ribosome dimerization.
1. Kato T, Yoshida H, Miyata T, Maki Y, Wada A, Namba K. 2010. Structure of the 100S Ribosome in the Hibernation Stage 
Revealed by Electron Cryomicroscopy. Strucuture. 18:719–724.
2. Yoshida H, Maki Y, Kato H, Fujisawa H, Izutsu K, Wada C, Wada A. 2002. The ribosome modulation factor (RMF) binding 
site on the 100S ribosome of Escherichia coli. J. Biochem. 132:983–989.
3. Shimada T, Fujita N, Yamamoto K, Ishihama A. 2011. Novel roles of cAMP receptor protein (CRP) in regulation of 
transport and metabolism of carbon sources. PLoS ONE. 6:e20081.
4. Shimada T, Yoshida H, Ishihama A. 2013. Involvement of cyclic AMP receptor protein in regulation of the rmf gene 
encoding the ribosome modulation factor in Escherichia coli. J. Bacteriol. 195:in press.
359 C Going through the motions: Network analysis reveals conserved intramolecular 
communication pathways within EF-Tu responsible for ribosome dependent GTPase 
activation and nucleotide exchange
Hans-Joachim Wieden1, Evan Mercier1, Fan Mo1, Dylan Girodat1
1Alberta RNA Research and Training Institute, Department of Chemistry and Biochemistry, University of 
Lethbridge, Canada
During the elongation cycle of bacterial protein synthesis elongation factor (EF) Tu delivers aminoacyl(aa)-tRNAs to 
the ribosome in a GTP-dependent manner. EF-Tu functions as a checkpoint in translation as correct codon/anticodon base 
pairing is required to send an activating signal over more than 80Å from the decoding centre on the small (30S) ribosomal 
subunit to the G domain of EF-Tu bound to the 50S large ribosomal subunit. Following dissociation from the ribosome 
EF-Tu?•GDP is recycled into its GTP-bound form through the interaction with its nucleotide exchange factor EF-Ts. Both 
functions require the transmission of signals form the respective interaction sites across EF-Tu to facilitate either GTP 
hydrolysis or nucleotide release. Little is known about the dynamic features governing signal transmission within a highly 
conserved protein such as EF-Tu and its particular evolutionary constraints.
Molecular dynamics (MD) simulations of EF-Tu and variants with single amino acid substitutions were performed and 
subsequently interrogated using network analysis methods. Here we report an intramolecular communication network for EF-
Tu representing a complex set of long-range signal transmission pathways. Using this network we identify communication 
pathways essential for efficient GTPase activation on the ribosome as well as EF-Ts-catalyzed nucleotide exchange. We find 
that single amino acid substitutions in EF-Tu can change the network organization dramatically and result in significantly 
reduced communication between domains across a set of universally conserved interdomain bridges. To validate our findings 
in vitro we have performed Michaelis-Menten analyses to study ribosome stimulated GTP hydrolysis of the EF-Tu•GTP 
binary complex. Aa-tRNA was omitted to isolate this signal pathway from any aa-tRNA contributions. Consistent with our 
network analysis, these results reveal that single amino acid substitutions in domain II reduce the stimulatory effect of the 
70S ribosome by five-fold, while not affecting 50S-dependent stimulation. Furthermore, variants of EF-Tu that disrupt the 
conserved interdomain bridges reduce the stimulatory effect of the 70S ribosome to a similar extent. Analyses of the EF-
Tu•EF-Ts binary complex revealed a different set of communication pathways promoting nucleotide exchange in EF-Tu which 
were validated using rapid-kinetics techniques to determine nucleotide binding properties of the respective EF-Tu variants.
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362 C One messenger RNA and three initiation codons govern the synthesis of two human 
Glycyl-tRNA synthetases isoforms
Jana Alexandrova1, Caroline Paulus1, Joëlle Rudinger-Thirion1, Magali Frugier1
1Institut de Biologie Moléculaire et Cellulaire, Architecture et Réactivité de l’ARN, Strasbourg
Human Glycyl-tRNA synthetase (GlyRS) is a housekeeping enzyme with a key role in protein synthesis, 
responsible for the charging of glycine on its cognate tRNA. In metazoans, there is a unique gene, GARS, which 
encodes both cytoplasmic and mitochondrial GlyRSs. At least 3 putative initiator AUG codons were found amongst 
the 300 first nucleotides of the mRNA: AUG#1 is not in frame and would initiate the translation of a 32 amino-acids 
peptide, AUG#2 and AUG#3 initiates the translation of the mitochondrial GlyRS precursor and the cytosolic form of 
GlyRS, respectively.
AUG codons were mutated, alone or in combination, and the expression efficiency as well as the subcellular 
localization (mitochondria, cytosol) of each GlyRS variant were determined. Our results show that, this mRNA codes 
mainly for the cytosolic form of GlyRS. This expression becomes mainly mitochondrial when AUG#1 is removed 
and exclusively mitochondrial when AUG#1 and AUG#3 are mutated together. On the contrary, the simultaneous 
presence of AUG#1 and AUG#2 does not allow any GlyRS translation. In vitro translation assays not only confirmed 
these results but also showed that AUG#1 is an efficient initiator codon (the design of a frame-shift mutant leads to the 
synthesis of an extra-long GlyRS).
Based on these observations, we hypothesized that the ribosome initiates translation at AUG#1, translates the 32 
amino acid long peptide through AUG#2, terminates at the stop codon and reinitiates translation at AUG#3 to produce 
the cytosolic GlyRS. However, when mitochondrial GlyRS is needed, the ribosome reinitiate translation at AUG#2, 
suggesting that the peptide translation is prematurely terminated. Indeed, the introduction of a stop codon between 
both initiation sites (AUG#1 and AUG#2) allowed recovering the synthesis of the mitochondrial form of GlyRS.
The very short 5’ UTR present in front of AUG#1 (only 15 nucleotides) as well as a dense structure characterized 
by a high GC content suggest the presence of a particular initiation mechanism. Moreover, the sequence of the short 
peptide (rich in Arginine and Proline residues) supports a regulatory mechanism based on the cellular level of Arg and 
Pro, which metabolism depends on mitochondria.
361 B Towards understanding the inhibitory effects of codon-anticodon wobble base pairing on 
the ribosome
Hani Zaher1, Rachel Green2
1Department of Biology, Washington University in St. Louis; 2HHMI, Department of Molecular Biology and 
Genetics, Johns Hopkins University School of Medicine
Accurate and rapid translation of the genetic code into functional peptides is a defining feature of the ribosome and 
the translation factors. The choice of codon within an mRNA has long been known to affect both translational efficiency 
and accuracy. While the first two positions of the codon are strictly decoded using Watson-Crick base pairing, the third 
position is often decoded using wobble base pairing. The inosine:adenosine (I:A) wobble base pair, a purine:purine 
base pair, is perhaps one of the most unusual; for example, the arginine CGA codon is nearly universally decoded by 
a tRNA isoacceptor bearing an ICG anticodon. InSaccharomyces cerevisiae, wobble decoding of the CGA codons 
appears to have a strong inhibitory effect on translation (Letzrig et al., RNA, 2010). Interestingly, the inhibitory effect 
is much more pronounced with CGA pairs relative to single codons suggesting synergy between consecutive decoding 
events. Previously, we have shown that in E. coli the quality of the P site tRNA-mRNA interaction has a profound 
effect on the decoding process in the A site of the ribosome where mismatches in the P site trigger iterated miscoding 
and eventually lead to premature termination. Given the results in yeast with consecutive CGA codons, we wondered 
whether the I:A base pair is acting like a mismatch inducing a process similar to that seen with E. coli. To this 
end we constructed reporters bearing stretches of synonymous arginine codons and characterized their translational 
efficiencies. Similar to earlier findings (Letzrig et al., RNA, 2010), a stretch of four CGA codons was sufficient to 
inhibit the production of full-length protein product. We further found these truncated products to be stabilized by the 
addition of the proteasome inhibitor MG132 or in the absence of the ribosome-bound E3 ligase LTN1. Remarkably, 
similar to the mismatch response seen in E. coli, mass-spec analysis of the stabilized truncated products revealed that 
the C-terminus gets extended with uncoded amino acids following the terminal encoded arginines. These findings 
suggest that I:A pairing induces iterated miscoding possibly similar to that previously observed in E. coli. We are 
currently extending these studies to identify factors responsible for the recognition of I:A wobble on the ribosome.
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364 B Translation of the human erythropoietin transcript is regulated by an upstream open 
reading frame in response to hypoxia
Cristina Barbosa1, Luísa Romão1
1Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Av. Padre Cruz, 1649-
016 Lisboa, PORTUGAL
In mammalian cells, most translational regulation is exerted at the cap-translation initiation step, where the AUG codon 
is identified and decoded. However, when translation is inhibited by cell stress, alternative mechanisms of translation 
initiation act to maintain the synthesis of certain proteins required either for the stress response or to aid recovery from the 
stress stimulus. These pathways are evolutionarily conserved and have been shown to dramatically impact translation. In 
many cases, features in the 5’ untranslated region (UTR) of these mRNAs are important for translational control. These 
include small structural elements, internal ribosome entry sites and regulatory upstream open reading frames (uORFs). 
uORFs modulate translation of the main ORF by decreasing the number and/or efficiency of scanning ribosomes to reinitiate 
at the start codon of the main ORF.
In its classical hormonal role, human erythropoietin (EPO) is a glycoprotein synthesized and released mainly from 
the kidney, which has a key role in hematopoiesis. However, recent studies have revealed that EPO is a multifunctional 
molecule produced and utilized by many tissues that rapidly responds to different cell stress stimuli and tissue injuries. Thus, 
it has the potential to be used as a therapeutic target/strategy for the treatment of several human disorders. Understanding the 
EPO translational control mechanisms will be valuable in the determination of these therapies. Knowing that human EPO 
transcript presents a 5’UTR with 181 nucleotides containing a 14-codon-uORF, conserved among different species, which 
might indicate its role in translational regulation, we aimed to prove this hypothesis.
To explore the role of the EPO uORF in controlling translation, we cloned the EPO 5’UTR, with the intact or disrupted 
uORF, fused to the firefly luciferase reporter cistron. HepG2, HEK293 and REPC cells were transiently transfected with 
these constructs. Luciferase activity was measured by luminometry and the corresponding mRNA levels were quantified 
by real-time RT-PCR to obtain translation efficiencies. Results have shown that the uORF can decrease the main ORF 
translation efficiency in about 3-fold. In addition, results support the conclusion that reinitiation, and in less extent leaky 
scanning, are responsible for the main ORF translation. Furthermore, this repression is released under hypoxia, specifically 
in REPC renal cells, via eIF2a phosphorylation. These findings provide a framework for understanding that production of 
high levels of EPO induced by hypoxia is also regulated at the translational level.
363 A A tale of two termini: profiling mRNA 5’-3’ interactions in vivo.
Stuart Archer1, Meghna Sobti3, Claus Hallwirth3, Jenni Yuan3, Traude Beilharz2, Thomas Preiss1
1John Curtin School of Medical Research, Australian National University, Canberra, Australia; 2Department 
of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia; 3Victor Chang Cardiac 
Research Institute, Sydney, Australia
Interactions between the 5’ and 3’ termini of mRNAs have long been postulated to occur in the cell. This “closed-
loop” model of mRNA is attractive from a number of viewpoints: functionally, the closed loop explains the ability of 
3’ UTR features to modulate events occurring at the 5’ end such as translation initiation, while mechanistically, the 5’ 
cap structure is known to bind the eIF4F complex, which also interacts with the poly(A)-tail via PABP, conceptually 
forming a closed loop mRNP if all interactions occur simultaneously.
Here we introduce a novel assay to detect the closed-loop conformation of specific mRNAs in vivo for the first 
time. Using Saccharomyces cerevisiae, we demonstrate that the closed-loop is the predominant conformation found in 
mRNAs bound by eIF4F, but also introduce the possibility that this structure is not adopted by all mRNAs during normal 
growth. While the closed-loop conformation has been reconstituted in vitroby mixing eIF4F and PABP with mRNA, 
the situation may be different in the cell. Various in vivo examples are known where interactions between the eIF4F 
subunits and PABP come under regulatory intervention, either globally or in a transcript-specific manner, resulting in 
reduced translational efficiency. Thus, detecting altered closed-loop status represents a catch-all method of identifying 
whether mRNA is under translational regulation. We are investigating the global and transcript-specific regulation of 
the closed-loop conformation in response to environmental cues, which will identify regulatory mechanisms that have 
been expanded upon during the evolution of more complex organisms to rapidly fine-tune gene expression.
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366 A Study of PTBP1-RRM12 in complex with an RNA-stemloop of the EMCV-IRES
Georg Braach1, Christophe Maris1, Frédéric H.-T. Allain1
1Institute for Molecular Biology and Biophysics, ETH Zürich, Schafmattstr. 30, 8093 Zürich, Switzerland
Internal ribosomal entry sites (IRESes) are large RNA structures present in the 5’ untranslated region (5’ UTR) of 
many viral and some cellular mRNAs(1). Unlike canonical translation initiation, IRES mediated translation initiation 
is 5’ cap independent but often requires cellular IRES trans-acting factors (ITAFs). The polypyrimidine tract binding 
protein 1 (PTBP1) is among the most frequently found ITAFs and might modulate the IRES activity by stabilization 
of the appropriate IRES structure(2).
PTBP1 harbors four RNA recognition motifs (RRMs) of which the 2 N-terminal RRMs, RRM1 and RRM2, act 
independently whereas the 2 C-terminal RRMs, RRM3 and RRM4, interact with each other, thereby orienting their 
RNA-binding surfaces in opposite directions(3). Thus, PTBP1 might be able to reorganize the structure of an RNA 
target by bringing distant binding sites into proximity.
PTB binding sites were mapped on the IRES of encephalomyocarditis virus (EMCV) by hydroxyl radical 
probing(4). It was found that two molecules of PTBP1 bind to the IRES of EMCV in a unique orientation: One 
PTBP1-molecule binds the IRES-domains H-L and the second one to domains D-F. The footprinting data suggests 
that RRM1 binds the UCUUU-pentaloop of the IRES-domain F and RRM2 binds its regular stem. We investigated the 
binding of RRM12 to domain F by NMR titrations: In contrast, our NMR-data suggest that RRM12 binds the isolated 
domain F with RRM2 contacting the loop. We present a preliminary structure of RRM2 bound to domain F.
1. Spriggs KA, Stoneley M, Bushell M, Willis AE. 2008. Biology of the cell / under the auspices of the European Cell Biology 
Organization 100: 27-38
2. Song Y, Tzima E, Ochs K, Bassili G, Trusheim H, et al. 2005. RNA 11: 1809-24
3. Vitali F, Henning A, Oberstrass FC, Hargous Y, Auweter SD, et al. 2006. EMBO J 25: 150-62
4. Kafasla P, Morgner N, Poyry TA, Curry S, Robinson CV, Jackson RJ. 2009. Mol Cell 34: 556-68
365 C Nanos recruits the CCR4-NOT complex to induce degradation of mRNA targets
Dipankar Bhandari1, Tobias Raisch1, Elisa Izaurralde1
1Department of Biochemistry, Max Planck Institute for Developmental Biology, Spemannstrasse 35, 72076 
Tübingen, Germany
The Nanos protein is a non-specific RNA-binding protein, which together with Pumilio represses translation of 
the maternally deposited hunchback (hb) mRNA and plays a major role in the establishment of the anterior-posterior 
body axis in Drosophila melanogaster. Previous studies have indicated that the hb 3’ UTR is sufficient for translational 
repression and that reporter mRNAs containing this 3’ UTR are translationally repressed and deadenylated in a Nanos- 
and Pumilio-dependent manner. However, the exact molecular mechanism of deadenylase complex recruitment to the 
mRNA reporter has so far remained elusive. Here we investigated the role of Nanos in the regulation of the hb 3’ UTR. 
The Nanos protein contains an N-terminal region predicted to be unstructured and two conserved C-terminal CCHC 
type zinc finger motifs. Using coimmunoprecipitation assays in Drosophila S2 cells, we show that Nanos interacts 
with both the CCR4-NOT and PAN2-PAN3 deadenylase complexes. Furthermore, we mapped the deadenylase-
binding region to a fragment within the unstructured part of the protein. An in vitro pull-down experiment revealed 
that Nanos interacts directly with the NOT module of the CCR4-NOT complex. We also show that the deadenylase-
binding region of Nanos is required to elicit mRNA degradation via the 5’-to-3’ decay pathway. In addition, our results 
show that tethered Nanos can promote both translational repression and mRNA degradation independently of Pumilio. 
Interestingly, the three human Nanos proteins, Nanos 1-3, also interact with the CCR4-NOT deadenylase complexes 
in human cells. Similar to Dm Nanos, human Nanos 1-3 promote the degradation of bound mRNAs. We conclude that 
Nanos proteins can recruit the CCR4-NOT complex to mRNA targets independently of Pumilio and that this activity 
is conserved amongst Nanos orthologs.
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368 C DDX3 Regulates Rac1 Translation, Modulates Wnt Signaling and Is Required for Cancer 
Cell Metastasis
Hung-Hsi Chen1, Hsin-I Yu1, Wei-Chih Cho1, Woan-Yuh Tarn1
1Institute of Biomedical Sciences, Academia Sinica
DDX3 is a DEAD-box RNA helicase involved in multiple steps of gene expression. DDX3 is upregulated in 
hepatocellular carcinoma tissues and in aggressive breast epithelial cancer cell lines, and is considered as a biomarker 
of metastasis in squamous cell/ adenosquamous carcinomas. The genetic and functional interactions between DDX3 
and β-catenin have been observed in the Wnt type of medulloblastoma. Therefore, DDX3 is a potential oncogene. 
To reveal oncogenic roles of DDX3 in metastasis, we analyzed phenotypes caused by DDX3 depletion in HEK293, 
cervical cancer HeLa and neuroblastoma N2A cell lines. In these cell lines, DDX3 depletion increases cell-cell adhesion 
and decreases cell-extracellular matrix adhesion, cell migration and invasion. Metastasis assays further demonstrate 
that DDX3 is required for efficient metastasis of cancer cells. These results suggest that DDX3 may play an oncogenic 
role in controlling cancer cell adhesion, migration and invasion/metastasis via modulating cytoskeleton organization. 
To uncover potential targets of DDX3 involved in cytoskeleton remodeling, we performed pathway analysis of 
DDX3 targets that are regulated at the level of mRNA translation, and identified multiple pathways involved Rac1 
functions. Our following experiments demonstrate that DDX3 may activate Rac1 translation perhaps by resolving 
its 5’UTR secondary structure. Moreover, we performed qRT-PCR array analysis of cell motility genes and found 
that transactivation of the Wnt/β-catenin target genes was down-regulated in DDX3 knockdown cells. Our results 
further showed that DDX3 depletion decreases β-catenin stability and attenuates Wnt/β-catenin signaling, and that 
Rac1 can rescue β-catenin expression and cell adhesion in DDX3 knockdown cells. Rac1 is a major factor of the Wnt 
PCP pathway that controls cell movement and also regulates the stability of β-catenin in the canonical Wnt pathway. 
Thus, our study unveils a molecular mechanism by which DDX3 controls cancer metastasis via regulating Rac1 and 
β-catenin signaling of cancer cells and supports DDX3 as a culprit in Wnt type tumors.
367 B CPEB3-controlled translation regulates memory consolidation
Hsu-Wen Chao1, Li-Yun Tsai1, Yi-Ling Lu1, Pei-Yi Lin1, Wen-Hsuan Huang1, Hsin-Jong Chou1, Wen-Hsin Lu1, Ping-
Tao Lee1, Yi-Shuian Huang1
1Institute of Biomedical Sciences, Academia Sinica, Taiwan
Long-term memory requires activity-dependent synthesis of plasticity-related proteins to strengthen synaptic 
efficacy and consequently consolidate memory. Cytoplasmic polyadenylation element binding protein(CPEB)3 is 
a sequence-specific RNA binding protein and represses translation via inhibiting the translation elongation factor 
2 (eEF2)1. Activation of N-methyl-D-aspartate (NMDA) receptors in neurons triggers the cleavage of CPEB3 by 
calpain 2 and subsequently leads to activity-related translation of CPEB3-targeted RNAs2. Recent studies indicate that 
the Drosophila homolog of CPEB3, Orb2, of which prion-oligommeric property is required for memory persistence 
in the fly3 and the glutamine (Q)-rich prion domain in Orb2 can be substituted functionally with the Q-rich motif 
in CPEB34, raising the question whether mammalian CPEB3 employs prion-like mechanism to sustain long-term 
memory. To understand the cellular and molecular contributions of CPEB3-controlled translation to learning and memory, 
we have generated CPEB3 knockout (KO) mice. The null mice display enhanced hippocampus-dependent memory 
and abnormal synaptic transmission in the Schaffer collateral pathway. Molecular and cellular characterizations reveal 
that the elevated PSD95 expression results in altered dynamics of NMDA-induced biochemical and morphological 
changes in the KO neurons. Together, CPEB3 functions as a negative regulator to confine the strength of consolidated 
memory. Our results overrule the possibility that CPEB3 can function like Orb2 as a prion to promote and persist 
memory formation. 
1. Chen PJ, Huang YS (2012) CPEB2-eEF2 interaction impedes HIF-1alpha RNA translation. EMBO J 31: 959-971
2. Wang CF, Huang YS (2012) Calpain 2 activated through N-methyl-D-aspartic acid receptor signaling cleaves CPEB3 and 
abrogates CPEB3-repressed translation in neurons. Mol Cell Biol 32: 3321-3332
3. Majumdar A, Cesario WC, White-Grindley E, Jiang H, Ren F, Khan MR, Li L, Choi EM, Kannan K, Guo F, 
Unruh J, Slaughter B, Si K (2012) Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of 
memory. Cell 148: 515-529
4. Kruttner S, Stepien B, Noordermeer JN, Mommaas MA, Mechtler K, Dickson BJ, Keleman K (2012) Drosophila CPEB 
Orb2A mediates memory independent of Its RNA-binding domain. Neuron 76: 383-395
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370 B Identification of DDX6 as a cellular modulator of VEGF expression under hypoxia
Sebastian de Vries1, Isabel S. Naarmann-de Vries1, Henning Urlaub2, Hongqi Lue3, Jürgen Bernhagen3, Antje 
Ostareck-Lederer1, Dirk Ostareck1
1Experimental Research Unit, Department of Intensive Care and Intermediate Care, University Hospital, 
RWTH Aachen University, Germany; 2Bioanalytical Mass Spectrometry, Max-Planck-Institute for 
Biophysical Chemistry, Goettingen, Germany, and Bioanalytics, Department of Clinical Chemistry, 
University Medical Center Goettingen, Germany; 3Institute of Biochemistry and Molecular Cell Biology, 
University Hospital, RWTH Aachen University, Germany
Vascular endothelial growth factor A (VEGF) is a crucial pro-angiogenic factor, which regulates blood vessel 
supply under physiologic and pathologic conditions. The VEGF mRNA 5’ untranslated region (5’UTR) bears internal 
ribosome entry sites (IRES), which confer sustained VEGF mRNA translation under hypoxia when 5’cap-dependent 
mRNA translation is inhibited. VEGF IRES-mediated initiation of translation requires the modulated interaction 
of trans-acting factors. To identify trans-acting factors that control VEGF mRNA translation under hypoxic conditions 
we established an in vitro translation system based on human adenocarcinoma cells (MCF-7). Cytoplasmic extracts 
of MCF-7 cells grown under hypoxia (1% oxygen) recapitulate VEGF IRES-mediated reporter mRNA translation. 
Employing the VEGF mRNA 5’UTR and 3’UTR in an tobramycin-aptamer RNA affinity purification approach 
we isolated interacting proteins from translational active MCF-7 extract prepared from cells grown either under 
normoxia or hypoxia. Interestingly, mass spectrometry analysis identified the DEAD-box RNA helicase 6 (DDX6) 
that interacts with the VEGF mRNA 5’UTR. Recombinant DDX6 inhibits VEGF IRES mediated translation initiation 
in normoxic MCF-7 extract in vitro. Under hypoxia the level of DDX6 declines and its interaction with VEGF mRNA 
is diminished in vivo. Depletion of DDX6 by RNAi further promotes VEGF expression in MCF-7 cells. Increased 
secretion of VEGF from DDX6 knock down cells positively affects vascular tube formation of human umbilical vein 
endothelial cells (HUVEC) in vitro. Our results indicate that the decrease of DDX6 under hypoxia contributes to the 
activation of VEGF expression and promotes its pro-angiogenic function.
369 A Inactivation of the mTORC1-eIF4E Pathway alters Stress Granules Formation
Laëtitia Coudert1, Marie-Josée Fournier1, Pauline Adjibade1, Rachid Mazroui1
1Department of Molecular Biology, Medical Biochemistry and Pathology. Faculty of Medicine, Laval 
University, CHUQ Research Centre/St-François d’Assise Research Center, Quebec (QC), Canada.
Stress granules (SG) are cytoplasmic multimeric RNA bodies that form under stress conditions known to inhibit 
cap-dependent translation.  SG contain translation initiation factors, RNA binding proteins like the Fragile Mental 
Retardation Protein (FMRP) and signaling molecules.  SG are known to inhibit apoptotic pathways, thus contributing 
to chemo- and radio-resistance in tumor cells.  However, whether stress granules formation involves oncogenic 
signaling pathways is currently unknown.  Herein, we report a novel role of the mTORC1-eIF4E pathway, a key 
regulator of cap-dependent translation initiation of oncogenic factors, in SG formation.  mTORC1 specifically drives 
the eIF4E-mediated formation of SG through the phosphorylation of 4E-BP1, a key factor known to inhibit formation 
of the mTORC1-dependent eIF4E-eIF4GI interactions.  Disrupting formation of SG by inactivation of mTOR with 
its specific inhibitor pp242 or by depletion of eIF4E or eIF4GI blocks the SG-associated antiapoptotic p21 pathway. 
Finally, pp242 sensitizes cancer cells to death in vitro and inhibits the growth of chemoresistant tumors in vivo.  This 
work therefore highlights a novel role of the oncogenic mTORC1-eIF4E pathway, namely the promotion of formation 
of antiapoptotic SG.
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372 A Changes in polysomal profiles in cells with aberrant RNA degradation
Zuzana Feketova1, Dmytro Ustianenko1, Hana Konecna1, Zbynek Zdrahal1, Stepanka Vanacova1
1Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Non-protein-coding RNAs (ncRNAs) are important in regulation of gene expression in many different ways. 
Very often they are connected with development, stress response and pathogenesis. One of the less known functions 
of ncRNA (excluding rRNAs, tRNAs and miRNAs) is the modulation of translation. Long non-coding RNAs for 
instance have been linked to both repression and stimulation of translation. We are interested in novel tRNA-derived 
small RNAs (tRFs) that are produced by endonucleases such as DICER, RNaseZ and angiogenin (1, 2). Angiogenin 
produced tRFs have a role in translational silencing and viral infection (3, 4).
Here we show, that 3’ to 5’ exoribonuclease DIS3L2 is involved in tRFs processing. DIS3L2 is a sequence 
homolog of the main exosomal ribonucleases DIS3 and DIS3L, that has been linked to Perlman syndrome (5). DIS3L2 
is localized to cytoplasm where it acts on tRFs in exosome-independent manner. Our results indicate that DIS3L2 
together with tRFs associates with ribosomes. Overexpression of wild type DIS3L2 in HEK293T cells causes changes 
in polysome to monosome ratios. We are currently investigating whether DIS3L2 is directly involved in translational 
regulation.
1. Haussecker et al. RNA. 2010
2. Sobala et al. Wiley Interd Reviews RNA. 2011
3. Ivanov et al. Mol Cell. 2011
4. Wang et. al. Mol Ther. 2013
5. Astuti et al. Nat Genet. 2012
371 C Molecular characterization of SMG1-UPFs complexes
Aurelien Deniaud1, Marcello Clerici1, Simonas Masiulis1, Volker BOEHM2, Niels GEHRING2, Stephen Cusack1, 
Christiane Schaffitzel1
1European Molecular Biology Laboratory, Grenoble Outstation, 6 rue Jules Horowitz, 38042 Grenoble Cedex 
9, France; 2University of Cologne, Institute for Genetics, Zuelpicher Str. 47a, 50674 Cologne, Germany
Non-sense Mediated mRNA Decay (NMD) allows the recognition of Premature Termination Codon (PTC)-
containing mRNAs1. This quality control mechanism is crucial to avoid putatively toxic truncated proteins in the 
cell2. PTCs are recognised by the SURF complex consisting of eRF1/eRF3/Upf1/SMG1-8-9 3, 4. Subsequent 
interaction of the SURF complex with the Upf2-3-Exon Junction Complex (EJC) triggers SMG1-mediated Upf1 
phosphorylation3,5.This phosphorylation is the key event initiating the mRNA decay cascade 1,5.
In order to dissect the molecular details of activation of the NMD pathway in vitro, we generated SMG1 PIK-like 
kinase alone, SMG1-9 and SMG1-8-9 complexes. The SMG1 kinase alone or in complex with SMG9 or SMG8-9 
is able to phosphorylate UPF1 expressed in insect cells as a non-phosphorylated form. We determined structures of 
SMG1-8-9 and a SMG1-8-9-UPF complex at low resolution by single particle electron microscopy. We solved the 
structures of all three UPF2 MIF4G domains and show that the MIF4G-3 domain not only binds UPF3 but also SMG1 
in a non-competitive manner 6. In fact, this could be the key interaction between the SURF and the UPF2-3-EJC 
complexes triggering UPF1 phosphorylation, translation termination at the PTC and faulty mRNA degradation.
1. Nicholson P, et al. Biochem Soc Trans. 2010. 2. Bhuvanagiri M, et al. Biochem J. 2010. 3. Kashima I, et 
al. Genes Dev. 2006. 4. Ivanov PV, et al. EMBO J. 2008. 5. Okada-Katsuhata Y, et al. Nucleic Acids Res. 2012. 6.
Clerici M, Deniaud A et al., in revision.
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374 C When small non-coding RNAs meet the ribosome: Tuning the translational machinery
Jennifer Gebetsberger1, Marek Zywicki3, Norbert Polacek2
1Department for Chemistry and Biochemistry (DCB), University of Bern, Switzerland; 2Department for 
Chemistry and Biochemistry, University of Bern, Switzerland; 3Laboratory of Computational Genomics, 
Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Poznan, Poland
The functions of ribosomes in translation are complex and involve different types of activities critical for decoding 
the genetic code, linkage of amino acids via amide bonds to form polypeptide chains, as well as the release and 
proper targeting of the synthesized protein. Non-protein-coding RNAs (ncRNAs) have been recognized to be crucial 
in establishing regulatory networks.[1] However all of the recently discovered ncRNAs involved in translation 
regulation target the mRNA rather than the ribosome. The main goal of this project is to identify potential novel 
ncRNAs that directly bind and possibly regulate the ribosome during protein biosynthesis. To address this question 
we applied various stress conditions to the archaeal model organism Haloferax volcanii and deep-sequenced the 
ribosome-associated small ncRNA interactome. In total we identified 6.250 ncRNA candidates. Significantly, we 
observed the emersed presence of tRNA-derived fragments (tRFs). These tRFs have been identified in all domains of 
life and represent a growing, yet functionally poorly understood, class of ncRNAs. Here we present evidence that tRFs 
from H. volcanii directly bind to ribosomes. In the presented genomic screen of the ribosome-associated RNome a 26 
residue long fragment originating from the 5’ part of valine tRNA was by far the most abundant tRF. The Val-tRF is 
processed in a stress- dependent manner and was found to primarily target the small ribosomal subunit in vitro and in 
vivo. As a consequence of ribosome binding, Val-tRF reduces protein synthesis by interfering with peptidyl transferase 
activity. Therefore this tRF functions as ribosome-bound small ncRNA capable of regulating gene expression in H. 
volcanii under environmental stress conditions probably by fine-tuning the rate of protein production.[2] Currently we 
are investigating the binding site of this tRF on the 30S subunit in more detail.
373 B Homeostatic regulation of AMPA receptors in synaptic plasticity: a posttranscriptional 
interplay between Caspr1 and the RNA-binding protein ZBP1.
Dominique Fernandes1, Luís Ribeiro2, Sandra Santos2, Ana Luísa Carvalho2
11. PDBEB, Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, 
Portugal; 2. Institute for Interdisciplinary Research, University of Coimbra, Portugal; 3. Center for 
Neurosciences and Cell Biology & Department of Life Sciences, University of Coimbra, Portugal; 23. Center 
for Neurosciences and Cell Biology & Department of Life Sciences, University of Coimbra, Portugal
Phenomena such as learning and memory rely on mechanisms of synaptic plasticity, which are highly dependent on the 
modulation of postsynaptic glutamate receptors of the AMPA-type (AMPARs). Moreover, a growing body of evidence suggests 
that posttranscriptional control of AMPAR subunits may also be fundamental for the expression of homeostatic synaptic plasticity, 
a mechanism known to adjust and stabilize synaptic strength upon chronic changes in neuronal activity. Despite evidence showing 
mRNA molecules for the GluA1 subunit of AMPARs strategically positioned for local protein synthesis in dendrites, little is yet 
known about the mechanisms regulating the availability of synaptic AMPAR transcripts and on how they underlie the expression 
of several forms of plasticity.
Our data identify the transmembrane protein Contactin associated protein 1 (Caspr1) as a novel potential posttranscriptional 
regulator of the GluA1 subunit of AMPARs. We show that Caspr1 regulates GluA1 protein by increasing GluA1 mRNA levels, 
an effect dependent on the presence of the 3’untranslated region of the transcript. Moreover, we propose that Caspr1 exerts its 
effects on GluA1 mRNA levels by activating a signaling cascade downstream of the tyrosine kinase Src, ultimately regulating 
the phosphorylation status of the Zipcode-binding protein 1 (ZBP1), a well described RNA-binding protein known to regulate 
the translation of several mRNAs. Furthermore, our results indicate that this mechanism may be regulated by neuronal activity. 
We demonstrate that a chronic blockade of activity significantly upregulates not only total and surface synaptic levels of GluA1, 
but also mRNA levels of this subunit. Moreover, protein and mRNA levels of endogenous Caspr1 are also increased upon 
homeostatic stimuli, as well as levels of phosphorylated ZBP1. Interestingly, it has been described that phosphorylation of ZBP1 
disrupts its binding to target mRNAs, allowing the translation of those transcripts. Accordingly, through a ribonucleoprotein 
immunoprecipitation protocol, we show that although in basal conditions ZBP1 is able to bind to GluA1 mRNA, upon chronic 
changes in activity levels of ZBP1-bound GluA1 mRNA are significantly decreased.
Taken together, our results start to uncover a novel posttranscriptional mechanism that may be fundamental to regulate 
synaptic availability of GluA1 transcripts and contribute to the expression of homeostatic plasticity phenomena.
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376 B The connection between mRNA binding by the DEAD-box helicase Ded1p and the kinetics 
of translation initiation.
Ulf-Peter Guenther1, Frank Tedeschi1, Akshay Tambe1, Sarah Geisler1, Jeff Coller1, Eckhard Jankowsky1
1Center for RNA Molecular Biology, Case Western Reserve University, Cleveland, OH
DEAD-box helicases are involved in virtually all steps of the RNA metabolism, but it remains challenging to 
define the molecular basis of their functions. Here we address this problem for the highly conserved DEAD-box 
helicase Ded1p from Saccharomyces cerevisae, which functions in translation initiation. Using a modified CLIP assay, 
we find that Ded1p binds to a large cross-section of cellular mRNAs. Binding sites are found throughout ORFs and on 
UTRs. Cognate sites do not display apparent sequence signatures. The most pronounced binding sites on the majority 
of mRNAs are located 30 to 80 nucleotides downstream of the initiation codon, suggesting position-dependent binding 
pattern of Ded1p on mRNAs. To examine the impact of mRNA binding by Ded1p on protein synthesis rates, we used 
a temperature-sensitive yeast strain with a genomically encoded Ded1 mutation which only impairs RNA binding, but 
causes a defect in translation initiation. We quantitatively measured the response of translation initiation to a sudden 
shift to non-permissive temperature in short time intervals over several minutes and found significant changes in the 
kinetic profile in the Ded1p mutant, compared to wt Ded1p. This kinetic approach provides a quantitative measure of 
the effect of Ded1p on translation initiation. We are currently analyzing the kinetics of this process on a transcriptome-
wide level, to determine the impact of Ded1p on rate constants of translation initiation for each individual mRNA.
375 A Observation of mRNA Surveillance in Living Yeast by Ribosome Profiling
Rachel Green1, Nicholas R. Guydosh1
1HHMI, Johns Hopkins University School of Medicine
The synthesis of proteins is a major step in gene expression and therefore represents a regulatory point for 
modulating cellular output. During elongation, ribosomes are thought to pause along the mRNA transcript upon 
colliding with various obstacles or translating specific sequence motifs. In addition, ribosomes halt if they arrive at 
the 3’ end of a transcript after failing to properly terminate or if the message is endonucleolytically cleaved. Genetic 
studies have suggested that the protein Dom34 and a GTPase binding partner, Hbs1, target mRNAs associated with 
paused ribosomes for degradation (Doma and Parker 2006, Nature 440:461-4). While biochemical data support this 
idea by showing that Dom34 directly binds and dissociates ribosomes (Shoemaker et al. 2010, Science 330:369-72), 
the natural cellular targets of Dom34 remain unknown. To identify functions of Dom34 in vivo, knockout and wild 
type strains of S. cerevisiae were subjected to a high-throughput footprinting analysis (ribosome profiling) that reveals 
the places where ribosomes are bound throughout the transcriptome. Sites where ribosomes are selectively enriched 
in the knockout strain relative to those in the wild type strain likely represent places where Dom34 dissociates paused 
ribosomes. These data reveal that ribosome occupancy on known pauses is not generally enhanced in the strain 
lacking Dom34. Instead, the targets of Dom34 include a small number of specialized targets in open reading frames. 
In addition, ribosomes are enriched at the 3’ end of many transcripts in the Dom34 deletion strain and generally covere 
<10 bp of polyadenine at the 3’ end of the protected fragment. These data imply that Dom34 dissociates ribosomes that 
bypass the stop codon and thus serves as a quality control factor required for recycling ribosomes that fail to terminate 
by the conventional pathway (mediated by eRF1, eRF3, and Rli1). These results support a general role for Dom34 in 
ribosome recycling in addition to a more specialized role on particular gene products.
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378 A Activation of HRI Kinase and Translation Control by Oxidative Stress
Bogdan Jovanovic1, Georg Stoecklin2
1DKFZ-ZMBH Alliance, University of Heidelberg; 2German Cancer Research Center, DKFZ-ZMBH 
Alliance, Heidelberg, Germany
Oxidative stress causes rapid inhibition of cellular protein synthesis through phosphorylation of the eukaryotic 
translation initiation factor 2α (eIF2α) by the heme-regulated inhibitor (HRI) kinase. Arsenite is a potent inducer of 
oxidative stress, and arsenite-induced translation inhibition leads to the assembly of stalled mRNAs in cytoplasmic 
stress granules (SGs). In line with the central role of HRI as a mediator of translation suppression, we observe that cells 
lacking HRI do not form SGs after arsenite treatment. The mechanism by which HRI is activated under conditions of 
oxidative stress, however, is not understood.
To address the mechanism of HRI activation, we asked whether HRI might undergo thiol conjugation under 
oxidative conditions. To this end, HEK293 cells were transfected with YFP-HRI and subjected to control conditions 
or oxidative stress. Prior to lysis, cells were treated with N-ethylmaleimide (NEM), which binds free thiols and 
thus prevents disulfide bond formation post lysis. YFP-HRI was immunoprecipitated and analyzed by western blot 
under non-reducing conditions, whereby disulfide bonds formed inside cells are retained. Our results show that HRI 
forms a covalent, high molecular weight complex, most likely a dimer, in cells exposed to arsenite- and hydrogen 
peroxide-induced oxidative stress. Further evidence for HRI dimerization was obtained by co-immunoprecipitation 
of HA-tagged HRI with YFP-HRI. Mass spectrometry analysis showed that HRI kinase is the only major component 
of the high molecular weight complex, compatible with HRI dimerization. Interestingly, we found that HRI forms 
a non-covalent dimer under normal conditions, whereas the covalent complex occurs only during oxidative stress, 
most likely by disulfide bond formation. Our results suggests that dimerization of HRI may be important for kinase 
activation. We are currently in the process of identifying cysteine residues involved in covalent complex formation, 
which will help us to fully understand the mechanism by which HRI is activated under conditions of oxidative stress.
377 C Splicing factor SRSF3 represses the translation of Programmed Cell Death 4 mRNA by 
associating with the 5’UTR
Sunjoo Jeong1
1Dankook University
SRSF3, an SR family of RNA binding proteins, is known to regulate alternative splicing of pre-mRNA in the 
nucleus and facilitate export of spliced mRNA to the cytoplasm. Despite its well established roles in mRNA processing 
in the nucleus, the mechanism by which it regulates the fate of exported mRNA in the cytoplasm remains poorly 
understood. Here, we provide evidence that SRSF3 not only regulates alternative splicing of the programmed cell 
death 4 (PDCD4) gene in the nucleus, but also modulates the translation of the PDCD4 mRNA in the cytoplasm. 
We showed that SRSF3 knockdown specifically enhanced PDCD4 translation as indicated by increased mRNA in 
polysome fractions whereas SRSF3 overexpression showed the opposite effect, suggesting that SRSF3 is involved in 
repressing PDCD4 translation. Moreover, we found that SRSF3 and PDCD4 mRNA colocalized in P-bodies (PBs) 
where translationally silenced mRNAs are deposited and the localization of PDCD4 mRNA in PBs was abrogated 
in SRSF3 knockdown cells. Ribo-IP experiments established that SRSF3 binds to PDCD4 mRNA, preferentially 
via its 5’UTR region, to mediate translational repression. Together, these data suggest that SRSF3 may function as a 
oncoprotein in mammalian cells, at least in part, through repressing the translation of a critical cell death regulator.
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380 C Translation of HTT mRNA with expanded CAGrepeats is regulated by the MID1–PP2A 
proteincomplex
Sybille Krauss1, Nadine Griesche1, Ewa Jastrzebska2, Changwei Chen4, Désiree Rutschow4, Clemens Achmüller5, 
Stephanie Dorn1, Sylvia M. Boesch3, Maciej Lalowski6, Erich Wanker6, Rainer Schneider5, Susann Schweiger4
1German Center for Neurodegenerative Diseases (DZNE), Sigmund-Freud-Str. 25, 53127, Bonn, Germany; 
2Department of Dermatology, Charité University Hospital, Charitéplatz1, 10117 Berlin, Germany; 
3Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria; 
4Division of Neuroscience, Medical Research Institute, Ninewels Hospital & Medical School, Dundee DD19SY, 
UK; 5Institute of Biochemistry and Center for Molecular Biosciences Innsbruck (CMBI), Innrain 80/82, 
A-6020 Innsbruck, Austria; 6Proteomics and Molecular Mechanisms of Neurodegenerative Diseases, Max 
Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Robert-Rössle-Strasse 10, 13092 Berlin, 
Germany
Expansion of CAG repeats is a common feature of various neurodegenerative disorders, including Huntington’s 
disease. Here we show that expanded CAG repeats bind to a translation regulatory protein complex containing MID1, 
protein phosphatase 2A and 40S ribosomal S6 kinase. Binding of the MID1–protein phosphatase 2A protein complex 
increases with CAG repeat size and stimulates translation of the CAG repeat expansion containing messenger RNA 
in a MID1-, protein phosphatase 2A- and mammalian target of rapamycindependent manner. Our data indicate that 
pathological CAG repeat expansions upregulate protein translation leading to an overproduction of aberrant protein 
and suggest that the MID1-complex may serve as a therapeutic target for the treatment of CAG repeat expansion 
disorders.
379 B Structural basis for translation termination by archaeal RF1 and GTP-bound EF1A complex
Kan Kobayashi1, Kazuki Saito2, Ryuichiro Ishitani1, Koichi Ito2, Osamu Nureki1
1Department of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Japan; 
2Division of Molecular Biology, Department of Basic Medical Science, The Institute of Medical Science, The 
University of Tokyo, Japan
Translation termination occurs when one of the three stop codons, UAA, UAG, or UGA, appears at the ribosomal A 
site. In this process, the stop codons are recognized by the class-I release factors (RFs). The single eukaryotic class-I RF, 
eRF1, recognizes all three stop codons and catalyzes polypeptide-chain release. The overall shape of eRF1 resembles 
that of a tRNA molecule. In addition, eRF1 forms a heterodimeric complex with eRF3, an elongation factor 1 alpha 
(EF1A)-related essential factor, to complete the overall translation termination process in a GTP-dependent manner. 
eRF3 is considered to deliver eRF1 to the ribosomal A site in the translation termination process. However, the 
structural details for the GTPase-mediated decoding of stop codons by eRFs and the detailed molecular mimicry of 
tRNA remain to be clarified. eRF1 homologues are widely conserved in archaea, suggesting the conservation of a 
similar translation termination mechanism in archaea. In archaea, archaeal EF1A (aEF1A) functionally interacts not 
only with tRNA but also archaeal RF1 (aRF1) and aPelota, which facilitates mRNA surveillance, in a GTP dependent 
manner, and considered to perform three different functions: translation elongation and termination as well as 
mRNA surveillance. Here, we will report the structure of aRF1 and GTP-bound aEF1A complex determined at 2.3 Å 
resolution. In the structure, aRF1 interacts with the tRNA recognition site of aEF1A by mimicking the shape of tRNA, 
and, as a result, the overall structure of the aRF1·aEF1A complex resembles that of the tRNA·EF-Tu (elongation factor 
from bacteria) complex. This strongly supports our proposal that aEF1A delivers aRF1 to the ribosomal A site in the 
translation termination as well as tRNA during the translation elongation. Furthermore, we will describe structural 
basis for the translation termination process in archaea.
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382 B Human DDX3 interacts with the HIV-1 Tat protein to facilitate viral mRNA translation
Ming-Chih Lai1, Shaw-Jenq Tsai1, H. Sunny Sun1
1National Cheng Kung University
Nuclear export and translation of intron-containing viral mRNAs are required for HIV-1 gene expression 
and replication. In this report, we provide evidence to show that DDX3 regulates the translation of HIV-1 mRNAs. 
We found that knockdown of DDX3 expression effectively inhibited HIV-1 production. Translation of HIV-1 early 
regulatory proteins, Tat and Rev, was impaired in DDX3-depleted cells. All HIV-1 transcripts share a highly structured 
5’ untranslated region (UTR) with inhibitory elements on translation of viral mRNAs, yet DDX3 promoted translation 
of reporter mRNAs containing the HIV-1 5’ UTR, especially with the transactivation response (TAR) hairpin. 
Interestingly, DDX3 directly interacts with HIV-1 Tat, a well-characterized transcriptional activator bound to the 
TAR hairpin. HIV-1 Tat is partially targeted to cytoplasmic stress granules upon DDX3 overexpression or cell stress 
conditions, suggesting a potential role of Tat/DDX3 complex in translation. We further demonstrated that HIV-1 Tat 
remains associated with translating mRNAs and facilitates translation of mRNAs containing the HIV-1 5’ UTR. Taken 
together, these findings indicate that DDX3 is recruited to the TAR hairpin by interaction with viral Tat to facilitate 
HIV-1 mRNA translation.
381 A Posttranscriptional control of the DNA damage response through TIAR
Vanesa Lafarga1, Johanna Schott1, Georg Stoecklin1
1German Cancer Research Center, DKFZ-ZMBH Alliance, Heidelberg, Germany
The RNA-binding proteins TIA1 and TIAR regulate splicing of pre-mRNAs in the nucleus and repress translation 
of mRNAs in the cytoplasm. In response of UVB treatment, cells reduce the global rate of protein synthesis, and 
TIAR was shown to mediate inhibition of translation after UVB. While UV induces single-strand DNA breaks that 
are repaired through nucleotide excision repair, g-radiation causes more severe double-strand breaks, which require 
homologous recombination or error-prone non-homologous end-joining for repair.
To date, regulation of translation in response to γ-radiation has not been investigated. Using human HCT116 
colon carcinoma cells, we found that the global rate of translation is attenuated in response to low dose γ-radiation 
in a TIAR-dependent manner. Importantly, knock down of TIAR reduces activation of the checkpoint kinase Chk2 
and specifically impairs maintenance of the G2/M checkpoint in response to γ-radiation. In the absence of TIAR, 
cells exposed to γ-radiation enter M-phase prematurely and show enhanced proliferation rates. This goes along with 
strongly increased numbers of micronuclei, which result from the failure to properly segregate damaged chromosomes. 
When we combined TIAR depletion with p53 deletion, we observed an additive effect on checkpoint de-regulation, 
indicating that TIAR is an important component of a p53-independent checkpoint mechanism. We have identified 
putative targets of TIAR involved in G2/M checkpoint maintenance by deep sequencing of TIAR-associated mRNAs. 
This approach is combined with the analysis of mRNAs whose translation is specifically altered in the absence of 
TIAR. Taken together, out data provide evidence for the important role of a posttranscriptional, TIAR-dependent 
mechanism in the maintenance of genome integrity.
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383 C Exploring the role of the GW182 protein, Gawky (Gw) during early Drosophila 
melanogaster embryogenesis
Jing Li1, Andrew Simmonds2
1Department of Cell Biology, University of Alberta; 2University of Alberta
The GW182 protein family is composed of multiple members, each having a high percentage of glycine-
tryptophan (GW) and troptophan-glycine (WG) repetitive amino acid sequences and an RNA recognition motif on 
the C-terminal end. The Drosophila GW182 single homologue, Gawky (Gw), has been shown to participate in the 
microRNA (miRNA) repression pathway.  A mutation in the gw gene results in an abnormal number of centrosome, 
chromosome mis-segregation and disrupted microtubule network in the nuclear mitosis during early embryogenesis 
(0-2hrs after egg deposition). Our work shows that Gw interacts with centrosomal structural protein centrosomin 
(CNN) and the interaction is mediated by RNA. Centrosomes have been seen adjacent to endogenous Gw bodies 
and the adjacent pattern is mitosis-phase specific in the early embryo. A subset of mRNA related to centrosomal 
organization function were found to associate with Gw. Notably, conserved miRNA-277-binding sites were predicted 
to be in the 3’ untranslated regions of 4 transcripts responsible for centrosomal organization that also interact with Gw. 
These results suggested that Gw potentially plays an vital role of organizing centrosome duplication.
Poster Abstracts RNA 2013 •  Davos, Switzerland •  June 11-16, 2013
226  •   Translational Regulation
384 A Global translational control during norovirus infection
Nicolas Locker1, Elizabeth Royall1, Lisa Roberts1, Majid Al-Sailawi1, Azimah Abdul-Wahad1, André Gerber1
1University of Surrey, Faculty of Health and Medical Sciences, Department of Microbial and Cellular 
Sciences, Guildford GU27HX, United Kingdom
Human norovirus (HuNV) is a member of the calicivirus family and is responsible for more than half of the 
viral gastroenteritis outbreaks, infecting over one million people last winter in Great Britain. Due to the lack of a 
suitable cell culture system, its replication mechanisms are poorly understood but two animal caliciviruses, the feline 
calicivirus (FCV) and mouse norovirus (MNV) provide models to increase our understanding of norovirus translation 
and replication.
Caliciviruses possess a positive-sense, single-stranded RNA genome of 7-8 kb, which functions as mRNA. Unlike 
most cellular mRNAs, the calicivirus RNA genome does not possess a 5’ cap structure but instead has a 13–15 
kDa viral protein, genome linked (VPg) acting as a novel proteinaceous “cap substitute” to direct translation and 
hijack the host protein synthesis machinery. In addition, viruses can silence the expression of genes involved in the 
anti-viral responses and the viral life cycle completion requires separated events occurring at different times since 
viral transcripts are used as template for both translation (mRNA) or replication (genomic RNA). Recent evidence 
suggests that the dynamic nature of both host and viral mRNA expression is a key coordinator of viral pathogenesis, 
with different host genes expressed at different times during infection, regulated through their storage and/or decay 
in subcellular compartments such as stress granules, to stall their translation, or processing bodies (P-bodies), for 
their further degradation. Viral proteins can also be found in these compartments, suggesting an important interplay 
between RNA turnover and viral life cycle.
Therefore to investigate global translational control during norovirus infection, and dissect host-pathogen 
interactions, we adopted a three-pronged strategy:
1. We analysed the regulation of translational factors during MNV and FCV infection and observed changes in the 
phosphorylation levels of eIF4E, eIF2alpha and 4E-BP1, and identified how MAPK and mTOR signalling pathways 
are controlling these events.
2. We investigated how infection affects the formation of P-bodies and stress granules and have evidence that 
MNV and FCV infection modulates the formation of stress granules.
3. We set out to dissect the global regulation of translational control by performing polysome profiling analysis to 
identify how host mRNAs expression is affected during MNV infection and will provide preliminary results.
The dissection of host-virus interactions during norovirus infection should ultimately contribute to the development 
and design of new antiviral therapy for this important human pathogen.
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386 C NALM-6 acute lymphoblastic leukaemia cell line has elevated level of the subunit b of 
translation initiation factor 3
Silvia Mrvova1, Katerina Mocova1, Martin Pospisek1, Tomas Masek1
1Dept. of Genetics and Microbiology, Charles University in Prague, Czech Republic
About 75 cases of acute lymphoblastic leukemia (ALL) are diagnosed yearly in the Czech Republic and many more 
throughout the world. The majority of these cases are in children and young adults, making ALL the most common form 
of malignancy in these age groups. The treatment protocols of ALL are complex and use 6–12 drugs. Many of those drugs 
directly or indirectly target translation, for example mTOR pathway. We studied possible role of translation initiation factor 
3 (eIF3) in ALL pathogenesis. eIF3 is a multi-subunit complex participating in all steps of translation initiation. Some of its 
13 subunits are also connected to fundamental cell processes such as protein degradation, cell cycle control, differentiation 
and apoptosis. Down-regulated or up-regulated expression of some of the eIF3 subunits was found to be typical for a variety 
of human cancers.
We quantified expression of individual eIF3 subunits (a, b, d, e, f, g, h, i, and j) by Real-time RT-PCR in lymphoblastic 
cell lines NALM-6, RS4;11, REH, TOM-1 carrying chromosomal aberrations characteristic for main types of ALL. As a 
non-leukemic control, we employed NC-NC cell line that represents B-cell precursor immortalized by EBV. Statistical 
evaluation of results revealed that the expression of eIF3b is significantly higher in NALM-6 than in REH, RS4;11, and 
TOM-1 cell lines. The level of eIF3b mRNA is comparable between NC-NC and NALM-6. The up-regulation of eIF3b in 
NALM-6 was also confirmed by quantitative Western blot analyses. Next, we tested an effect of eIF3b on growth speed 
of the ALL cell lines and found strong correlation between eIF3b expression level and their doubling time. NALM-6 and 
NC-NC grew faster and better than the other cell lines. On the contrary, TOM-1 grew the most slowly even in the presence 
of 20% FBS.
However, eIF3b subunit has not been considered to be the subunit of eIF3 which affects general translation primarily; 
we assume that eIF3b level could be somehow connected to the rate of translation. Our preliminary experiments also 
suggest that eIF3b expression level reflects rather a particular stage of B-cell development, which the particular ALL cell 
line is derived from, than a direct or indirect influence of specific chromosomal gene fusion.
Regarding NALM-6, the corresponding leukaemia is very aggressive, refractory to treatment, and patients have very 
poor chances of recovery.  We presume that deregulation of translation can contribute to poor prognosis of those patients.
385 B Cap-independent translational regulation of mammalian target of rapamycin (mTOR)
Ana Marques-Ramos1, Alexandre Teixeira2, Rafaela Lacerda1, Luísa Romão1
1Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal 
and Universidade de Lisboa, Faculdade de Ciências, Center for Biodiversity, Functional and Integrative 
Genomics, Lisboa, Portugal; 2Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo 
Jorge, Lisboa, Portugal and Centro de Investigação em Genética Molecular Humana, Faculdade de Ciências 
Médicas, Universidade Nova de Lisboa, Portugal
Regulation of translation is a key mechanism by which cells and organisms can rapidly change their gene 
expression patterns in response to extra- and intracellular stimuli. Translational control can occur on a global basis 
by modifications of the basic translation machinery, or selectively target defined subsets of mRNAs to maintain the 
synthesis of certain proteins required either for the stress response or to aid recovery from the stress. These pathways 
are evolutionary conserved and have been shown to significantly impact translation in organisms as diverse as yeast 
and humans. In many cases, features in the 5’ untranslated regions (5’UTRs) of the corresponding mRNAs, such as 
regulatory upstream open reading frames (uORFs) and internal ribosome entry sites (IRESs) are important for them 
to evade global repression of translation. IRES-mediated translation is an alternative to the cap-dependent mechanism 
of translation initiation that involves the direct recruitment of the ribosome to the vicinity of the initiation codon and 
may require several trans-acting proteins known as IRES trans-acting factors (ITAFs).
Mammalian target of rapamycin (mTOR) is a highly conserved kinase that is responsive to several cellular stimuli. 
Deregulation of mTOR signalling is implicated in major diseases, such as cancer, mainly due to its role in regulating 
protein synthesis. The main mTOR targets are proteins responsible for ribosome recruitment to the mRNA, thus, a 
specific inhibitor of mTOR, for example rapamycin, leads to global inhibition of translation. Knowing that in stress 
conditions such as hypoxia, overall protein synthesis is reduced, but synthesis of mTOR protein is not inhibited, we 
hypothesized that mTOR 5’UTR harbours an IRES allowing cap-independent synthesis of mTOR protein in stress 
conditions. By using dicistronic reporter plasmids we have tested and confirmed this hypothesis. Our findings provide 
a framework for understanding how translational reprogramming of mTOR mRNA is regulated in response to cellular 
stress conditions.
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388 B Translational regulation of human hemojuvelin expression via upstream open reading 
frames
Cláudia Onofre1, Cristina Barbosa1, Luísa Romão1
1Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Av. Padre Cruz, 1649-
016 Lisboa, PORTUGAL
Hemojuvelin (HJV) is a glycosylphosphatidylinositol (GPI)-linked membrane protein shown to be a co-receptor 
for class of ligands called bone morphogenetic proteins (BMPs). The HJV is involved on iron homeostasis through 
regulation of hepcidin transcription levels. Mutations on the hepcidin gene or in the HJV gene cause an early-onset 
inherited disorder associated to iron overload named juvenile hemochromatosis.
A better knowledge of the mechanisms implicated in HJV gene expression is crucial to understand its role in the 
iron homeostasis. The 5’ leader sequence of the human HJV mRNA has two upstream open reading frames (uORF) 
with 28 and 19 codons created by two upstream AUGs (uAUGs) that share the same stop codon. Reporter constructs 
containing several HJV 5’ leader sequences fused to the Firefly luciferase cistron were tested in HeLa and HepG2 cells 
to evaluate the effect of these uORFs in the translational regulation of HJV mRNA. Luciferase activity was measured 
by luminometry and the corresponding mRNA levels, quantified by real-time RT-PCR.
The results revealed that the HJV uORFs decrease the translational efficiency of the main ORF in about 6-fold. 
Furthermore, we have observed that the production of HJV protein is mainly due to translation reinitiation. Thus, 
HJV mRNA has a low leaky scanning ability that contributes to the translational repression of the main ORF. We 
also observed that the amino acid sequence of the uORF2-encoded peptide seems to cause ribosomal stalling, which 
also impedes translation of the downstream main ORF.  In addition, our preliminary results show that in HepG2 cells 
submitted to eIF2α phosphorylation or iron overload, the HJV uORFs-mediated translational repression is released. 
These results suggest that these uORFs play a role in regulating HJV expression levels in response to iron overload.
387 A Caspase-3 cleaves hnRNP K in erythroid differentiation
Isabel S. Naarmann-de Vries1, Henning Urlaub2, Dirk H. Ostareck1, Antje Ostareck-Lederer1
1Experimental Research Unit, Department of Intensive Care and Intermediate Care, University Hospital, 
RWTH Aachen University, Germany; 2Bioanalytical Mass Spectrometry, Max-Planck-Institute for 
Biophysical Chemistry, Goettingen, Germany, and Bioanalytics, Department of Clinical Chemistry, 
University Medical Center Goettingen, Germany
Post-transcriptional control of gene expression is crucial for the control of cellular differentiation. Erythroid 
precursor cells loose their organelles in a timely controlled manner during terminal maturation to functional 
erythrocytes. Extrusion of the nucleus precedes the release of young reticulocytes into the blood stream. The 
degradation of mitochondria is initiated by reticulocyte 15-lipoxygenase (r15-LOX) in mature reticulocytes. At that 
terminal stage the release of r15-LOX mRNA from its translational silenced state induces the synthesis of r15-LOX. 
Heterogeneous nuclear ribonucleoprotein K (hnRNP K) is a key regulator of r15-LOX mRNA translation. HnRNP 
K that binds to the differentiation control element (DICE) in the 3’ untranslated region (UTR) inhibits r15-LOX 
mRNA translation initiation. During erythroid cell maturation, activation of r15-LOX mRNA translation is mediated 
by post-translational modifications of hnRNP K and a decrease of the hnRNP K level. To further elucidate its function 
in the post-transcriptional control of gene expression we investigated hnRNP K degradation employing an inducible 
erythroid cell system that recapitulates both nuclear extrusion and the timely controlled degradation of mitochondria 
mediated by activation of r15-LOX synthesis. Interestingly, we detected a specific N-terminal cleavage intermediate 
of hnRNP K lacking DICE binding activity that appeared during erythroid differentiation and puromycin induced 
apoptosis. Employing mass spectrometry and enzymatic analyses we identified Caspase-3 as the enzyme that cleaves 
hnRNP K specifically. In vitro studies revealed that cleavage by Caspase-3 at amino acids (aa) D334-G335 removes 
the C-terminal hnRNP K homology (KH) domain 3 that confers binding of hnRNP K to the DICE. Our data suggest 
that the processing of hnRNP K by Caspase-3 provides a save-lock mechanism for its timely release from the r15-
LOX mRNA silencing complex and activation of r15-LOX mRNA synthesis in erythroid cell differentiation.
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390 A Translation of human LAT2 mRNA is controlled by a short upstream open reading frame
George Perdrizet1, Donghui Zhou1, Allison Wu1, Mariana Pavon1, Tao Pan1
1University of Chicago
Ribosome profiling has shown that ~25% of mammalian mRNA transcripts contain ribosome densities on short 
upstream open reading frames (uORFs) in the 5’ UTR. The functions and mechanisms of these uORFs are still poorly 
defined. Human LAT2 hydrophobic amino acid transporter mRNA is an example of a uORF containing transcript. A 
short polypeptide composed of ~40% phenylalanine and leucine is encoded by the LAT2 uORF.
We are investigating how this uORF regulates the translation of the LAT2 gene. Mutation of the uORF AUG start 
codon to AUC or AAG significantly decreases translation of the LAT2 protein coding open reading frame in vivo. 
Toeprinting experiments demonstrate uORF translation in vitro. These results are in contrast to known models of 
uORF function wherein uORF translation is generally inhibitory to translation and elimination of uORF would lead to 
increased levels of translation.  To elucidate the mechanism of uORF dependent translational regulation of LAT2, we 
performed additional toeprinting and photo-crosslinking experiments which indicate that the LAT2 5’ UTR can recruit 
ribosome independently of a 5’ cap. An additional ribosome binding site seems to be present between the uORF and 
the start of the LAT2 coding sequence. We propose a model where an inactive ribosome is initially bound within the 
LAT2 5’UTR. 5’ Cap dependent translation of the uORF by a second ribosome leads to RNA structural switch and 
thereby activates the first ribosome.  We are working on the validations of this model in vitro and in vivo.
389 C Gene silencing using artificial small RNAs derived from a natural RNA scaffold in 
Escherichia coli
Hongmarn Park1, Geunu Bak1, Sun Chang Kim2, Younghoon Lee1
1Department of Chemistry, KAIST, Daejeon 305-701, Korea; 2Department of Biological Sciences, KAIST, 
Daejeon 305-701, Korea
Small noncoding RNAs (sRNAs) function as central regulators in E. coli in response to diverse environmental 
growth conditions. While gene silencing by sRNAs is known to occur through RNA-RNA interactions, the detailed 
mechanisms underlying base-pairing between sRNA and target mRNAs in the cell remain unclear at present. In 
the current study, the mechanism of base pairing in vivo was explored using artificial sRNA (afsRNA) loaded with 
various target recognition sequences. An artificial small RNA (afsRNA) scaffold was designed from a natural sRNA, 
SibC. Using the lacZ reporter system, the gene silencing effects of afsRNAs were examined in E. coli. Substitution 
of the original target recognition sequence with a new sequence recognizing lacZ mRNA led to effective reduction 
of lacZ gene expression. The target recognition sequence was shortened to 10 nt without significant loss of gene 
silencing, although this minimal length was limited to specific target mRNA sequences. The presence of mismatched 
or unmatched regions in the middle of the target recognition sequences of afsRNAs hindered gene silencing, but 
internal loop-forming afsRNAs were more effective in gene silencing than bulge-forming afsRNAs. Notably, gene 
silencing by afsRNA was not decreased, but increased upon hfq disruption in E. coli, particularly when interactions 
between afsRNA and mRNA were weak, suggesting that Hfq is possibly involved in destabilization of the RNA-RNA 
duplex. This Hfq function, opposite to its known role in enhancing gene silencing, may contribute to reducing the off-
target effects of sRNA caused by unwanted target recognition through short base-parings, thereby increasing target 
specificity.
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392 C Two Retinoblastoma associated SNVs in RB1 form a RiboSNitch.
Wes Sanders1, Matt Halvorsen1, Justin Ritz1, Joshua Martin1, Alain Laederach2
1University of North Carolina, Chapel Hill; 2Biology Department at University of North Carolina Chapel Hill
Retinoblastoma (RB1) is a negative regulator of the cell cycle and also involved in tumor suppression.  Recent 
computational analysis of known, disease-associated Single Nucleotide Variants (SNVs) in the human genome suggest 
that two disease-associated SNVs found in the 5’ UTR of the RB1 gene alter the mRNA transcript structure.  These 
two mutations, G17C and G18U in RB1’s 5’ UTR, are also predicted to affect the structure of a putative Internal 
Ribosome Entry Site (IRES).  Using Selective 2’-Hydroxyl Acylation analyzed by Primer Extension (SHAPE) we 
have analyzed both the wild type (WT) RB1 and the RB1 mutants G17C and G18U.  The data reveal significant 
changes in SHAPE reactivity in both mutants compared to the WT along with structural changes to the IRES site, 
consistent with the computational prediction. The RB1 5’ UTR is thus a RiboSNitch, and our data suggest that SNV 
induced conformational change in mRNA is likely a drive of oncogenesis.
391 B Regulation of mRNA translation in late-phase activated macrophages
Sonja Reitter1, Johanna Schott2, Georg Stoecklin2
1German Cancer Research Canter, DKFZ-ZMBH Alliance, Heidelberg, Germany; 2German Cancer Research 
Center, DKFZ-ZMBH Alliance, Heidelberg, Germany
Macrophages strongly respond to different inflammatory stimuli such as bacterial lipopolysaccharide (LPS) with 
a coordinated release of cytokines, the production of oxygen radicals and by stimulating phagocytosis. In the early 
phase of activation, macrophages primarily secrete pro-inflammatory cytokines that trigger the immune response. 
Late after activation, macrophages produce anti-inflammatory cytokines to dampen the immune reaction and resolve 
inflammation. Moreover, macrophages in the late phase enter a state of unresponsiveness (endotoxin tolerance), during 
which they cannot be re-activated. This sequence of events requires tightly coordinated changes in the gene expression 
program of macrophages. While the regulation of transcription and mRNA stability during macrophage activation has 
been studied extensively, much less is known about the regulation of translation. Here we present a systematic analysis 
of changes in mRNA translation that occur in late-phase activated macrophages.
By recording polysome profiles of mouse RAW264.7 macrophages, we observed a global suppression of 
mRNA translation in late-phase activated macrophages. The percentage of polysomal ribosomes was reduced by 
50% after 16 hours of LPS treatment. To identify mRNAs whose translation rate is regulated specifically during this 
response, we performed microarray analysis of mRNAs associated with light and heavy polysomes. Thereby, we 
discovered 61 messenger RNAs that escape global translation suppression, indicating that their protein products are 
important for the late phase of macrophage activation. These mRNAs encode inhibitors of the NFkB transcription 
factor complex, proteins involved in producing reactive oxygen and nitrogen species, and a family of small GTPases 
known to participate in microbial defense. In addition, our analysis identified 52 mRNAs whose translation is actively 
suppressed in late-phase activated macrophages, including mRNAs encoding transcription factors and activators of 
inflammation. Our results strongly suggest that translation control contributes to the unresponsive state of late-phase 
activated macrophages. Currently, we are in the process of identifying regulatory elements within a selected number 
of the identified mRNAs. This will serve as a basis for further investigating the mechanisms by which specific control 
of translation is achieved.
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394 B Regulation of translation of collagen mRNAs by STRAP
Lela Stefanovic1, Milica Vukmirovic1, Branko Stefanovic1
1College of medicine, florida State University
Type I collagen is the most abundant protein in human body and is composed of two α1(I) and one α2(I) 
polypeptides, which are encoded by two different mRNAs. However, both collagen mRNAs contain in their 5’UTR 
a conserved structure, termed the 5’ stem-loop (5’SL). We have cloned LARP6 as the protein which binds 5’SL 
with high affinity and specificity.  This binding regulates translation of collagen mRNAs. Among other interactions, 
LARP6 also interacts with protein STRAP (also called unrip). STRAP is involved in translation of IRES containing 
mRNAs by interacting with protein unr and in formation of snRNPs by interacting with Gemin 7. The last 20 amino-
acids at the C-terminus of LARP6 are required for its interaction with STRAP, these amino-acids are conserved in 
unr and Gemin 7, representing the STRAP interacting epitope. Overexpression of STRAP restricts translation of 
collagen mRNAs, as evidenced by lower protein level and shift of collagen mRNAs from heavy polysomes.  Knock 
out of STRAP results in overexpression of collagen α1(I) and α2(I) polypeptides and high loading of collagen mRNAs 
onto polysomes. However, collagen polypeptides in the STRAP knock out cells are hyperglycosylated and fail to 
assemble into collagen triple helix. The hyperglycosylation takes place if the synthesis of α1(I) and α2(I) polypeptides 
is not coordinated, the randomly made polypeptides fail to productively fold into triple helix  and are exposed to the 
modifying enzymes for prolonged period of time. These results suggest that STRAP restricts random translation of 
collagen mRNAs and that this inhibition is necessary to coordinate translation of collagen α1(I) mRNA to that of α2(I) 
mRNA. A working model of regulation of collagen translation by STRAP will be presented.
393 A Regulation of translation of the most abudant protein in human body, type I collagen.
Branko Stefanovic1, Lela Stefanovic1, Azariyas Challa2, Zarko Manojlovic1
1College of Medicine, Florida State University; 2Yale School of Medicine
Type I collagen is the most abundant protein in human body and is composed of two α1(I) and one α2(I) polypeptides. 
During wound healing or in fibrosis the synthesis of type I collagen is increased several hundred fold, predominantly 
due to increased half life and more efficient translation of collagen mRNAs. A unique stem-loop structure in the 5’UTR 
of collagen mRNAs (5’SL) regulates translation by binding LARP6. LARP6 recruits positive and negative regulators 
of translation to collagen mRNAs to balance the synthesis of α1(I) and α2(I) chains. RNA helicase A (RHA) is 
recruited to facilitate translation initiation, without  RHA collagen mRNAs can not be loaded onto polysomes. LARP6 
also associates collagen mRNAs with vimentin and nonmuscle myosin filaments. Binding to vimentin stabilizes 
collagen mRNAs, while nonmuscle myosin is required for coordinated translation of α1(I) and α2(I) mRNAs. When 
nonmuscle myosin filaments are disrupted, collagen mRNAs fail to co-localize to discrete sites of their translation 
and the cells can secrete only homotrimers of α1(I) polypeptides. This suggests that for the proper assembly of type I 
collagen, collagen mRNAs must be co-localized and translated in coordination. On the other hand, Serine-Threonine 
kinase Receptor Associated Protein (STRAP) is recruited to restrict random translation of collagen mRNAs. Like 
RHA, STRAP is tethered to collagen mRNAs by interaction with LARP6.  STRAP prevents unrestricted translation of 
collagen mRNAs by interacting with eIF4A. In the absence of STRAP eIF4A freely associates with collagen mRNAs 
and promotes their loading onto the polysomes. This results in overproduction of collagen polypeptides, in imbalance 
of synthesis of α1(I) and α2(I) polypeptides and in their inefficient assembly into collagen heterotrimer. These defects 
can be partially restored by supplementing STRAP. The mechanism of coordinated translation of collagen mRNAs, 
mediated by binding of LARP6 to 5’SL of collagen mRNAs, will be presented.
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396 A The role of human RLI in cell proliferation and translational regulation
Marina Toompuu1, Kairi Kärblane1, Cecilia Sarmiento1, Erkki Truve1
1Tallinn University of Technology
RNase L inhibitor (RLI) belongs to the family of ABC (ATP-binding cassette) proteins, which carry out a broad 
range of functions. Human RLI was first characterized as an inhibitor of the antiviral 2-5A/RNase L system. The 
RNase L pathway, however, is only found in vertebrates, whereas RLI proteins are highly conserved from archaea to 
eukaryotes. Moreover, RLI is essential for the viability and development of several organisms. The central role of RLI 
remains therefore unexplained.
Recent studies link the role of RLI to several stages of eukaryotic translation, including initiation, termination and 
ribosome recycling. RLI has also been found to interact with a number of translational factors.
In this study, we show that human RLI downregulation has a strong effect on cultured cell proliferation, but does 
not significantly affect the total protein synthesis. We demonstrate the interaction of human RLI with some translation 
initiation factors, which are also essential for cell cycle regulation. We finally suggest that this interaction might be 
essential for the translational regulation of specific proteins involved in the cell cycle rather than for general translation.
395 C Dissecting the regulation of vFLIP expression, a Kaposi’s Sarcoma-associated Herpesvirus 
tumorigenesis factor
Mariam Sulaiman1, Margaret Carter1, Zulkefley Othman1, David Blackbourn2, Nicolas Locker1, Lisa Roberts1
1University of Surrey, Faculty of Health and Medical Sciences, Department of Microbial and Cellular 
Sciences, Guildford GU27HX, United Kingdom; 2Cancer Research UK Institute for Cancer Studies, 
University of Birmingham, Birmingham B15 2TT, United Kingdom
Kaposi’s Sarcoma-associated Herpesvirus (KSHV) is an oncogenic virus, the etiological agent of Kaposi’s 
Sarcoma (KS); it is also associated with multicentric Castleman’s disease (MCD) and primary effusion lymphoma 
(PEL). The infection is mainly latent in KSHV-induced tumour cells with only a few viral genes expressed that 
contribute to tumorigenesis. Among these, vFLIP interacts with the NFkB pathway to trigger the expression of anti-
apoptotic and pro-inflammatory genes.
The expression of vFLIP is mediated by an unusual internal ribosomal entry site (IRES) element. Using an in 
vitro system to dissect vFLIP IRES function we identified that a minimal IRES domain is located within a coding 
region upstream of the vFLIP gene. Furthermore, using specific inhibitors and proteomic analysis, we found that 
eIF4A and eIF4G, but also eIF4E, are required for initiation of translation on the vFLIP IRES. Novel IRES-interacting 
proteins, such as Y box-binding protein 1, were also identified. Currently, we are investigating the requirement of the 
IRES for these factors and analysing the RNA structure of the vFLIP IRES. By dissecting the structure and function of 
the vFLIP IRES we will determine how vFLIP expression is regulated during latent KSHV infection. This will deepen 
our understanding of the viral trigger responsible for NFkB activation and the oncogenic properties of KSHV. The 
ultimate aim is to define new mechanisms to inhibit KSHV-induced tumour formation.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
Translational Regulation  •   233
398 C Unravelling the role of dimerization for the STAR-domain RBP, GLD-1
Jane Wright1, Lea Dümpelmann1, Sanda Mülhäuser1, Heinz Gut1, Rafal Ciosk1
1Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
RNA-binding proteins (RBPs) are critical regulators of gene expression. Indeed, whether a particular mRNA is 
translated, repressed, or degraded, depends on its RBP and regulatory RNA interactions. The STAR family of RBPs 
includes developmental regulators such as C. elegans GLD-1, which is a key regulator of germ cell development 
with loss of GLD-1 resulting in a germline tumour. GLD-1 binds approximately 10% of all germline transcripts 
via GLD-1 binding motifs (GBMs) in UTRs1 resulting in translational repression and/or stabilisation of its target 
mRNAs2. Dimerization of RBPs is generally thought to be required for their functions in RNA-recognition, mRNP 
complex formation, RNA oligomerization and controlling the balance between an RBP and its targets. GLD-1 and 
its closest STAR protein family homologs, e.g. Quaking (QKI), can homodimerize3,4. Inhibiting QKI dimerization 
causes embryonic lethality although the molecular basis for this is unknown5. We find that dimerization of GLD-1 is 
generally not required for its function as it does not phenocopy the null mutant and the global RNA binding ability 
of dimerization mutant GLD-1 is largely unchanged. However, inhibiting GLD-1 dimerization does leads to a high 
percentage of sterile worms. We hypothesize that GLD-1 dimerization is involved in regulating specific mRNAs, 
possibly affecting different aspects of mRNA regulation for different targets.
1. Wright, J.E., et al. (2011) A quantitative RNA code for mRNA target selection by the germline fate determinant GLD-
1. Embo J 30, 533-545
2. Scheckel, C., et al. (2012) Genome-wide analysis of GLD-1-mediated mRNA regulation suggests a role in mRNA 
storage. PLoS Genet 8, e1002742
3. Beuck, C., et al. (2012) Structural analysis of the quaking homodimerization interface. Journal of molecular biology 423, 
766-781
4. Beuck, C., et al. (2010) Structure of the GLD-1 homodimerization domain: insights into STAR protein-mediated 
translational regulation. Structure 18, 377-389
5. Chen, T., and Richard, S. (1998) Structure-function analysis of Qk1: a lethal point mutation in mouse quaking prevents 
homodimerization. Mol Cell Biol 18, 4863-4871
397 B Dom34-mediated dissociation of non-translating ribosomes allows efficient restart of 
translation after stress**
Antonia van den Elzen1, Bertrand Séraphin1
1Equipe Labellisée La Ligue, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Centre 
National de Recherche Scientifique (CNRS) UMR 7104/Institut National de Santé et de Recherche Médicale 
(INSERM) U964/Université de Strasbourg, 67404 Illkirch, France
Dissociation of terminating ribosomes ensures the availability of the resulting subunits for new rounds of 
translation. Upon glucose depletion in yeast, translation rapidly ceases and free ribosomal subunits tightly associate, 
tethered by the Stm1 factor, forming a large pool of non-translating ribosomes. A mechanism dissociating Stm1-bound 
ribosome and allowing the reentry of these subunits in translation is thus required upon glucose repletion. Similar 
mechanisms must also exist in all cells as non-translating ribosomes temporarily accumulate under a variety of stress 
conditions and need to be released when translation resume.
The Dom34 and Hbs1 factors form a complex structurally similar to the one resulting from association of 
translation termination factors eRF1 and eRF3. Dom34 and Hbs1were initially characterized as implicated in the 
NGD RNA Quality Control Pathway. Consistently, recent biochemical analyses demonstrated that Dom34 and Hbs1, 
together with the factor Rli1, dissociated ribosomes stalled on a messenger RNA. These factors were also shown to 
dissociate associated ribosomal subunits in vitro. Dom34 and Hbs1are not essential for viability in yeast and the extent 
of their physiological function(s) remains unclear. Using a variety of assays, we found that Dom34-Hbs1 mediates 
the dissociation of non-translating ribosomes present in glucose-starved yeast, facilitating thereby an efficient restart 
of translation when glucose is supplied again. Our data show for the first time that Dom34 and Hbs1 dissociate non-
stalled, mature ribosomes in vivo. This suggests that these factors might have a general physiological role in affecting 
ribosomal subunit availability, thus impacting on translation initiation, possibly even in non-stress conditions.
**Abstract presented as an oral in Plenary Session 1 - Ribosome biogenesis and translation
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400 B Alternative polyadenylation in CD2 expression
Inês Boal-Carvalho1, Mafalda Pinto3, Juliana Miranda2, João Relvas4, Teresa Summavielle5, Alexandre Carmo3, 
Alexandra Moreira1
1Gene Regulation Group, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, 
Portugal; 2Gene Regulation Group, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 
Porto, Portugal; 3Cell Activation and Gene Expression Group, IBMC-Instituto de Biologia Molecular e 
Celular, Universidade do Porto, Porto, Portugal; 4Gial Cell Biology Group, IBMC-Instituto de Biologia 
Molecular e Celular, Universidade do Porto, Porto, Portugal; 5Molecular Neurobiology Group, IBMC-
Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal
Alternative polyadenylation (APA) in the 3’UTR has a fundamental role in gene expression in a variety of cellular programs: 
cellular differentiation, leukocyte activation and cancer. The physiological relevance of APA was accentuated by the observation 
that human T lymphocytes stimulated through T cell receptors express preferentially mRNA isoforms with shorter 3’UTRs. 
CD2 is a T cell surface glycoprotein involved in signaling transduction and T cell activation. Transcription of CD2 results in the 
formation of multiple mRNA species whose physiological function has remained undisclosed. CD2 contains a conserved 3’UTR 
across species, from rodents to humans, which may indicate the presence of regulatory elements in this region. CD2 3’UTR 
contains a proximal and a distal poly(A) signals that are used in human T lymphocytes to generate two mRNA species with 
different 3’UTR. In mouse, however, only the shorter mRNA produced by usage of the first poly (A) site has been reported in T 
cells. By immunohistochemistry, Northern blotting and RT-PCR using perfused rat brains, we now present evidence that CD2 is 
also expressed in different regions of the brain, specifically in the cortex, cerebellum, hippocampus and thalamus, which represent 
a significant part of the encephalon. CD2 appears to have a very low expression in the hippocampus, contrary to what happens in 
the cortex where relatively high levels of expression were detected. Additionally, we have mapped the 3’ ends of the CD2 mRNA 
isoforms by 3’RACE/sequencing to show that the two poly(A) signals are used generating two mRNAs with different 3’UTR 
lengths, both in the Jurkat T cell line as well as in the rat brain. Although some reports have described the expression of immune 
molecules in neurons the role of these molecules in the nervous system is still unknown. As the nervous system is similar to the 
immune system with respect to many phenomenological, functional and molecular properties, a potential role for CD2 in the brain 
will be discussed.
This work is funded by FEDER through Programa Operacional Fatores de Competitividade – COMPETE – and by National 
Funds through FCT - Fundação para a Ciência e a Tecnologia – project ref: PTDC/SAU-GMG/116621/2010 and FCOMP-01-
0124-FEDER-022718 (PEst-C/SAU/LA0002/2011).
399 A Tdrd7, a RNA binding protein, acts to restrict Epha2 protein synthesis in space and time 
during lens development
Ying Zhang1, Richard Maas1
1Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical 
School, Boston, MA, 02115, USA
The formation of tightly controlled cell-cell adhesions and adherens junctions with each other enables lens 
fiber cells to adopt a highly ordered structure that allows for the optical transparency of the mature ocular lens.  The 
precise spatial and temporal regulation of mRNA and local protein synthesis is essential for establishing functional 
compartments within eukaryotic cells, but whether such a process occurs during lens development is unclear.  We 
report here that Tdrd7, a Tudor domain-containing RNA binding protein, is required for maintaining lens fiber cell 
morphology and cell-cell interactions.  Lens fiber cells in cross section adopt a regular hexagonal pattern.  In contrast, 
lens fiber cells in Tdrd7 mutant mice appear irregular in cross section with blebbing of the cell membrane.  These 
phenotypes resemble those observed in the lenses of mice lacking Epha2, a receptor tyrosine kinase (RTK) in the 
Eph-Ephrin signaling pathway that can mediate diverse processes in development.  Tdrd7 expression is spatially 
and temporal regulated during lens development.  Tdrd7 is initially expressed in distinct cytoplasmic granules in 
lens fiber cells at the onset of lens vesicle formation, and then shifts to nuclei when lens fiber cells differentiation 
commences.  Previous RNA-immunoprecipitation (RIP) experiments by us have shown that Tdrd7 can bind Epha2 
mRNA.  Examination of Tdrd7 null lenses shows decreased Epha2 protein but not mRNA.  Moreover, Epha2, which 
is localized primarily to the short ends of fiber cells, is mislocalized in the Tdrd7-null lens, suggesting that Tdrd7 acts 
to help restrict Epha2 protein synthesis in time and space.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
3’ end processing  •   235
402 A Assessing the “geometry” of the TRAMP and exosome complexes.
Clémentine Delan-Forino1, Stepanka Vanacova2, David Tollervey1
1Wellcome Trust Center for Cell Biology, University of Edinburgh, UK; 2CEITEC, Masaryk University, 
Czech Republic
The exosome complex plays major roles in RNA 3’->5’ processing and surveillance activities. The TRAMP 
polyadenylation complexes are major cofactors for the nuclear exosome and play key roles in nuclear RNA quality 
control. The TRAMP complexes include the RNA helicase Mtr4 together with a Zn-knuckle RNA binding protein 
(Air1 or Air 2) and a poly(A) polymerase (Trf4 or Tr5). However, Mtr4 is an essential exosome cofactor of all its 
characterized nuclear RNA degradation and processing activities, whereas only surveillance activities are known to 
require the other TRAMP components. Recent structural analyses of Mtr4 have identified an “Arch” domain, which 
acts independently of the helicase activity and is required to stimulate exosome function in vivo and in vitro. An in 
vivo crosslinking technique (CRAC) was used to compare RNA targets of intact Mtr4 and an Mtr4-Archless construct, 
lacking the Arch domain. Substantial differences between RNA species associated with the two constructs were 
revealed. In particular, Mtr4-Arch shows reduced targeting of pre-rRNA species, consistent with observed defects in 
pre-rRNA processing and growth. In addition, the fraction of Mtr4-associated RNA sequences that carry TRAMP-
generated, non-encoded oligo(A) tails was lower in strains lacking Arch domain. This is consistent with the reported 
role for Mtr4 in the regulation of oligoadenylation of target RNAs by the TRAMP complex.
In vitro functional and structural analyses show that RNA is threaded through the central channel of the exosome. 
However, it is also feasible that substrates could be “docked” directly to the ribonucleases Rrp44 and Rrp6. We have 
proposed that highly structured RNAs may be docked, rather than threaded through the lumen of the exosome core 
structure, and that this might help distinguish RNAs targeted for maturation or decay. To assess how Mtr4 affects the 
interaction of the core exosome with these different substrate classes, we performed CRAC on the exonuclease Rrp44 
(WT and catalytic mutant) in strains expressing Mtr4-Archless and in strains with mutation that occlude the RNA 
channel within the exosome. High-throughput sequencing is currently being carried out. These analyses should clarify 
the role of Mtr4 and the Arch domain in substrate recruitment, exosome activation, and mode of degradation.
401 C Post-transcriptional regulation of COX-2
Ashley Cornett1, Carol Lutz1
1Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry-New Jersey, New 
Jersey Medical School and the Graduate School of Biomedical Sciences, Newark, NJ
The oxidative conversion of arachidonic acid to prostaglandin H
2
 is carried out by a set of two enzymes termed 
cycloxygenases, abbreviated as COX.  COX-1 is constitutively expressed in normal tissues, while COX-2, which is 
not expressed in normal tissues, is transiently induced from external stimuli, such as pro-inflammatory cytokines. 
COX-2 is also overexpressed in numerous cancers. We show that COX-2 protein expression is constitutive in a lung 
cancer cell line, A549, but not expressed in a normal bronchial cell line, Beas2B.  Previous work from our lab has 
shown that COX-2 has two polyadenylation signals present in its 3’UTR that can potentially be utilized.  Alternative 
polyadenylation is a post-transcriptional mechanism by which mRNAs can produce variable 3’ untranslated region 
(UTR) lengths is through usage of alternative poly(A) sites.  Our RNAse H-coupled RT-PCR data indicates that both 
COX-2 mRNA isoforms, resulting from usage of two different poly(A) sites, are transcribed in A549 lung cancer cells. 
Another means of post-transcriptional regulation is mediated through microRNA repression.  We have Real-Time 
qPCR data and microarray data that show decreased expression of specific miRs in lung cancer cells as compared to 
normal lung cells. The biological function of COX-2 is to produce prostaglandins; we have also demonstrated that 
COX-2 specific miRs can modulate resulting prostaglandins produced.  We speculate that many post-transcriptional 
mechanisms work in concert to regulate COX-2 expression, which may explain the employment of an alternative 
poly(A) signal.
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404 C Transcriptional and translational profiles in stimulated T lymphocytes
Andreas Gruber1, Georges Martin1, Philipp Müller2, Nitish Mittal1, Alexander Schmidt4, Walter Keller1, Jean 
Pieters3, Mihaela Zavolan1
1Computational and Systems Biology, Biozentrum, University of Basel, Switzerland; 2Department of 
Biomedicine, University Hospital Basel, Switzerland; 3Infection Biology, Biozentrum, University of Basel, 
Switzerland; 4Proteomics Core Facility, Biozentrum, University of Basel, Switzerland
The many processing steps to which RNA polymerase II transcripts are subjected include cleavage and 
polyadenylation within the 3’ untranslated region. Many genes have multiple polyadenylation sites, whose differential 
use results in different mRNA isoforms. Although the processing efficiency for pre-mRNAs is largely determined by 
the strength of their polyadenylation signals, recent studies showed that polyadenylation site choice can be influenced 
by several protein factors that have long been known to be involved in pre-mRNA processing. One of the model 
systems in which systematic changes in the use of polyadenylation sites are studied is T cell activation, but similar 
changes have also been observed in development and cell differentiation.
In this study we undertook a systematic investigation of the pattern of poly(A) site selection and its influence 
on the level of protein synthesis during activation of T cells. By deep sequencing of mRNA 3’ ends we mapped 
polyadenylation sites in resting and activated murine and human lymphocytes. At the same time we measured global 
transcript and protein levels. Through computational analysis we inferred genes that undergo a significant shift in 
polyadenylation site use between the two states and we characterized the properties of the respective sites. Because 
shorter transcripts isoforms lack sequence elements with negative impact on mRNA stability and translation -such as 
miRNA binding sites- it has been hypothesized that the shorter transcript isoforms are associated with an increased 
protein production as found in highly proliferating cancer cells. Here, we investigated this hypothesis by measurements 
of mRNA, 3’ end processing and protein levels in primary cells under noncancerous conditions.
403 B Role of mRNA 3’ processing in the progression of the DNA damage response (DDR)
Emral Devany1, Xiaokan Zhang2, Mirjana Persaud2, Frida Kleiman2
1Chemistry and Biochemistry Dept., Hunter College and City University of New York; 2Chemistry and 
Biochemistry Department, Hunter College and Graduate Center of City University of New York
The cellular response to DNA damage could be either in the survival mode, where DNA repair and cell cycle arrest 
occur, or in the death mode, where apoptosis is induced. The mRNA 3’-end processing machinery is involved in the 
response to DNA damage. As the poly(A) tail in the 3’ end of mRNAs is important to control mRNA stability, mRNA 
export and translation; the regulation of 3’-end processing during DDR represents an important mechanism to control 
gene expression. Recently, we have described a novel feedback loop between p53 and polyA specific ribonuclease 
(PARN), where PARN deadenylase keeps p53 levels low in non-stress conditions by destabilizing p53 mRNA through 
the AU-rich elements (AREs) present in the 3’UTR. After UV, the p53 expression levels increase resulting in the 
p53-mediated activation of PARN deadenylase, which represents a mechanism of p53-mediated regulation of gene 
expression in a transactivation-independent manner.
As the levels of p53 expression increase after DNA damage treatment, the PARN-mediated down-regulation 
of p53 mRNA should be reverted during the progression of DDR. It has been shown that HuR, an ubiquitously 
expressed ARE-binding protein, binds the AREs in p53 3’UTR resulting in the regulation of p53 mRNA translation 
and expression upon stress. Our results also indicate that under normal conditions Ago2 and PARN bind to a region 
in the p53 3’UTR where a miRNA-binding site and ARE sequence overlap, and both of them dissociate after UV 
treatment. Interestingly, our results indicate that under DNA damaging conditions HuR can compete for binding to 
the p53 3’UTR with both PARN and Ago2 in in vitro and in vivo assays, resulting in the release of PARN and Ago2 
and in the increase of p53 expression levels. Based on these results, our working model is that the dynamic binding of 
PARN, Ago2 and HuR to the p53 3’UTR plays a role in the progression of DDR.
Together our studies provide new insights into p53 function and the mechanisms behind the regulation of mRNA 
3’ end processing in different cellular conditions, providing new approaches in the design of new cancer therapies.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
3’ end processing  •   237
406 B Towards the understanding of the CTD-code
Karel Kubicek1, Olga Jasnovidova2, Jakub Macosek2, Richard Stefl2
1CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 5/A4, CZ-62500 Brno, 
Czech Republic; 2CEITEC - Central European Institute of Technology, Masaryk University, Kamenice 5/A4, 
CZ-62500 Brno, Czech Republic
RNA polymerase II (RNAPII) is not only the fundamental enzyme involved in the gene expression but also the 
central coordinator of co-transcriptional processing. RNAPII associates with a large number of enzymes and protein/
RNA-binding factors through its C-terminal domain (CTD). The CTD consists of tandem repeats of the heptapeptide 
consensus Y1S2P3T4S5P6S7. The CTD is dynamically post-translationally modified, e.g. phosphorylated at various 
positions. These phosphorylations creates specific patterns of the CTD, which predominate at different stage of the 
transcription cycle, control the recruitment, activation, and displacement of various factors involved in transcription 
and RNA processing.
The CTD is flexible but it can acquire diverse structures upon binding with corresponding protein factors. Our study 
that combines various approaches ranging from nuclear magnetic resonance (NMR), through fluorescent anisotropy 
(FA) to small angle x-ray scattering (SAXS) aims to understand how the full-length CTD is modulated upon binding 
with multiple copies of protein factors containing CTD-interacting domains. By combining the recombinant protein 
technology, with the afore mentioned techniques we are trying to uncover how proteins are organized along the whole 
CTD length at atomic level. Revealing the structural behavior of the CTD will help to understand the role of CTD and 
its post-translational modifications in the regulation of the transcription cycle.
405 A Shifting targets: microRNA variants and alternative polyadenylation in cardiac 
hypertrophy
Carly J. Hynes1, David T. Humphreys3, Nicola J. Smith2, Hardip R. Patel1, Robert M. Graham2, Jennifer L. Clancy1, 
Thomas Preiss1
1Genome Biology Department, The John Curtin School of Medical Research, The Australian National 
University, Acton, Australia, ACT 0200; 2Molecular Cardiology and Biophysics Division, Victor Chang 
Cardiac Research Institute, Darlinghurst, Australia, NSW 2010; 3Molecular Genetics Division, Victor Chang 
Cardiac Research Institute, Darlinghurst, Australia, NSW 2010
Emerging findings indicate that cells can produce both miRNAs and their mRNA targets in multiple processing 
variants as a means to increase the complexity of miRNA-mediated control in a tissue and developmental stage-specific 
manner. MiRNAs play critical roles in the heart, and we hypothesise that during the cardiac hypertrophic response 
there are changes to both miRNA processing and mRNA 3’ polyadenylation site selection, which will alter miRNA/
mRNA interactions. Transverse Aortic Constriction (TAC), a model of left ventricular hypertrophy, was used to obtain 
pre-hypertrophic and hypertrophic cardiomyocytes. TAC led to pressure overload and left ventricular hypertrophy, 
characterised by an increase in left ventricular weight and induction of hypertrophic markers.
RNA was then extracted from purified cardiomyocytes for next-generation sequencing of small RNAs and mRNA 
3’ ends. Several miRNAs were deregulated prior to the development of hypertrophy and in the hypertrophic hearts. 
Processing variants, such as isomiRs and unexpected arm bias, of key cardiac miRNAs were also identified that could 
potentially alter their targeting specificity. Furthermore, numerous mRNAs encoding important cardiac functions are 
subjected to alternative polyadenylation that alters the length of the 3’UTR.  The 3’UTR length changes may alter the 
extent to which miRNAs can regulate these mRNAs. The sequencing has produced global information on expression 
changes to both miRNA sequence and mRNA 3’UTR lengths, allowing us to form a systems level understanding of 
miRNA-regulation during cardiac hypertrophy.
The realisation that cardiac miRNAs and their targets exist as currently under-appreciated variants with potentially 
complex effects on target specificities has important implications for the role of miRNAs in cardiac disease.
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408 A FUS protein interacts with U7 snRNP and plays a role in replication-dependant histone 
genes expression
Katarzyna Dorota Raczynska1, Marc David Ruepp2, Zofia Szweykowska-Kulinska3, Artur Jarmolowski3, Daniel 
Schümperli4
1Department of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz 
University, Poznan, Poland, Institute of Cell Biology, University of Bern, Switzerland; 2Department of 
Chemistry and Biochemistry, University of Bern, Switzerland; 3Department of Gene Expression, Institute 
of Molecular Biology and Biotechnology, Adam Mickiewicz University, Poznan, Poland; 4Institute of Cell 
Biology, University of Bern, Switzerland
The U7 small nuclear ribonucleoprotein (U7 snRNP) is an essential factor mediating the unique 3’end processing 
of non-polyadenylated, replication-dependent histone mRNAs in metazoans. These histone genes expression and 
processing of their transcripts are cell cycle-regulated mechanisms that recruit a number of specific proteins as well 
as common factors required for expression and maturation of polyadenylated mRNAs. However, despite all the 
knowledge we have so far, there are still gaps in understanding of core histone RNA 3’ end processing, its coupling to 
transcription and regulation during cell cycle. To further elucidate this phenomena we used affinity chromatography 
based on tagged version of U7 snRNA molecule to identify proteins associated with U7 snRNP/U7 snRNA that could 
be potentially involved in core histone genes expression in human cells.
Mass spectrometric analysis of affinity-purified fraction revealed, among others, multifunctional RNA/DNA-
binding protein FUS/TLS (fused in sarcoma/translocated in liposarcoma) as a new factor interacting with U7 snRNA/
RNP. Co-immunoprecipitation and RIP experiments confirmed the binding between FUS and the U7 RNA/snRNP. 
Interestingly, FUS:U7 snRNA interaction seems to be activated in S phase where the core histone genes are expressed. 
Moreover, FUS co-fractionates in 10-50% continuous glycerol gradient with other factors involved in histone pre-
mRNAs 3’end processing. However, this unique 3’end maturation was not disturbed upon FUS knockdown. Instead, 
we found that FUS depletion leads to a de-regulation of expression from selected histone promoters, suggesting that 
FUS is rather involved in regulation of core histone genes transcription. Thus, FUS bound to U7 snRNP can play a role 
in coupling between transcription and 3’end processing of replication dependant histone mRNAs.
407 C Enhancer of RNA Interference -1-LIKE-1: One More Player in the RNA Processing Game of 
the Chloroplast
Glykeria Mermigka1, Ioannis Vlatakis1, Eugenia vamvaka2, Jutta Helm2, Heiko Schumacher2, Kriton Kalantidis3
1University of Crete, Department of Biology; 2Institute of Molecular Biology & Biotechnology; 3University of 
Crete, Department of Biology & 2. Institute of Molecular Biology & Biotechnology
Ribonucleases are a group of enzymes widely distributed in nature. In the chloroplast, a network of post-
transcriptional modifications of RNA molecules is mediated by ribonucleases. Our lab found that ENHANCER 
OF RNA INTEREFERENCE-1-LIKE-1 (ERL1, named following plant nomenclature conventions) in Arabidopsis 
thaliana, is such an enzyme. ERL1 belongs to a family of exoribonucleases which share a common 3’-5’exonuclease 
domain (EXOIII domain) containing a highly conserved DEDD motif. Homologues of ERL1 fullfil various functions 
in RNA metabolism by participating in tRNA and rRNA processing in bacteria and in the regulation of RNAi and rRNA 
maturation pathways in eukaryotes. By confocal microscopy we showed that ERL1 is targeted to the chloroplasts. We 
have generated Arabidopsis thaliana and Nicotiana benthamiana plants that misexpress ERL1. The misexpression of 
ERL1 leads to phenotypes indicative of defects in chloroplasts development. Since ERL1 acts in the chloroplast, we 
used these transgenic lines to study the impact of ERL1 on chloroplastic related genes and measured the chlorophyll 
content. In addition we showed that in vitro purified ERL1 protein is capable of processing different RNA substrates. 
Altogether our results suggest that ERL1 is another piece in the puzzle of the complex posttranscriptional regulatory 
machinery of the chloroplasts.
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410 C The U7 snRNP revisited: a complex of the core U7 snRNP, FLASH and multiple 
polyadenylation factors controls 3’ end processing of histone pre-mRNAs in vertebrates 
and invertebrates
Ivan Sabath1, Aleksandra Skrajna3, Xiao-cui Yang2, Michal Dadlez4, William F. Marzluff2, Zbigniew Dominski2
1Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, NC 
27599, USA; 2Department of Biochemistry and Biophysics, Program in Molecular Biology and Biotechnology, 
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; 3Institute of Biochemistry and 
Biophysics, Polish Academy of Sciences; 4Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 
Institute of Genetics and Biotechnology, Warsaw University, 02-106 Warsaw, Pawinskiego 5A, Poland
Animal replication-dependent histone pre-mRNAs are processed at the 3’ end by endonucleolytic cleavage that is not 
followed by polyadenylation.  The cleavage reaction is catalyzed by CPSF73 and depends on binding of the U7 snRNP to a 
sequence in histone pre-mRNA downstream of the cleavage site.  In the past 10 years the U7 snRNP has been portrayed as a 
simple complex of an approximately 60-nucleotide U7 snRNA and a unique Sm ring in which the spliceosomal-specific proteins 
SmD1 and SmD2 are replaced by the related Lsm10 and Lsm11.  We recently showed that in both vertebrates and invertebrates, 
Lsm11 interacts with a protein called FLASH and that this interaction is essential for processing.  We now demonstrate that 
the U7 snRNP isolated from mammalian and Drosophila nuclear extracts is stably associated with FLASH and a number of 
polyadenylation factors that we refer to as the Histone pre-mRNA Cleavage Complex (HCC). The association of the HCC 
with the core U7 snRNP critically depends on the interaction between Lsm11 and FLASH. The mammalian HCC consists of 
symplekin, CstF64 and all six CPSF subunits, including the CPSF73 endonuclease.  FLASH is severely limiting in mammalian 
nuclear extracts, likely explaining the inability of previous studies to identify the composite structure of the U7 snRNP and its 
association with the polyadenylation factors. In Drosophila nuclear extracts, FLASH is abundant and quantitatively associated 
with the U7 snRNP.  TheDrosophila HCC has a similar composition to the mammalian HCC but lacks two CPSF subunits, Fip1 
and CPSF30.  In both mammalian and Drosophila nuclear extracts, the composite U7 snRNP bearing FLASH and multiple 
polyadenylation factors is subsequently recruited to histone pre-mRNA for 3’ end processing. However, of these polyadenylation 
factors only three are essential for the cleavage reaction in vivo: CPSF73, CPSF100 and symplekin. The other subunits are likely 
passive spectators or play nonessential regulatory roles. Collectively, our studies revealed an unexpected complexity of the U7 
snRNP and suggest that this factor functions as an RNA-guided multi-subunit nuclease where the U7 snRNA recognizes the 
substrate and together with three proteins of the Sm ring, SmD3, SmB and Lsm10, defines the site of cleavage that is carried out 
by the catalytic component, CPSF73.
409 B Mammalian mRNA 3’end formation: is this the end? New insight on CstF64
Valentina Romeo1, Daniel Schümperli2
1Institute for Cell Biology, University of Bern; 2Univerity of Bern, Institute for Cell Biology
Constitutive polyadenylation (CPA) and alternative polyA site selection (APS) participate in the control of cell life. 
Together with splicing, they generate alternative mRNA/protein isoforms, and/or mRNAs containing different regulatory 
elements in their 3’ untranslated regions. Alterations of these reactions often occurs in cancer and in neurological disorders. 
In this context CstF plays a critical role. This complex consists of three subunits of 77, 64 and 50 kDa and seems to act as a 
hexamer at least in some steps of CPA. CstF64 binds preferentially to a G/U rich downstream sequence element and thereby 
helps to define the polyadenylation site. Several reports indicate that CstF64 is crucial in cell growth and development. 
Importantly, several tissue-specific splicing isoforms of CstF64 and a paralogue on chromosome 19 (CstF64Tau) have been 
described. This leads to our main hypothesis that changes in CstF64/CstF64Tau ratio or in the abundance of various CstF64 
splicing isoforms may be important in regulating APS in cell growth and development. Interestingly, CstF77 and 64, but not 
50, are also involved in replication-dependent histone RNA 3’ end processing even if there is no direct evidence of any RNA 
binding activity. This obviously raises questions about the function of CstF in histone mRNA processing.
Firstly, we analysed the CstF64/CstF64Tau ratio in HeLa cells throughout the cell cycle. This revealed a small but 
interesting differential expression of the two paralogues in diverse phases. Moreover, by using an inducible knock-down 
system, we were able to show a defect of CstF64 (and for less extends CstF64T) lacking cells in G1 to S phase transition. 
Our current research aims to shed light on the role of CstF64 and CstF64Tau in cell cycle progression and/or histone 
mRNA 3’end processing. We are currently performing IPs, in vivo processing assay for histone mRNAs and dissecting the 
molecular basis of this deregulation by studying recombinant protein interactions.
Secondly, we investigated the CstF64 splicing pattern during retinoic acid-induced differentiation of the human 
neuroblastoma cell line SH-SY5Y. In this system we detected a concrete and substantial change in the ratio of specific 
splicing isoforms. Interestingly, the protein variants differ in their predicted structures and possibly protein:protein 
interaction properties. We are characterizing the biological implication of these changes by knocking down specifically 
all the endogenous CstF64 isoforms and expressing RNAi-resistant versions of individual variants. In such context, we 
plan to study global polyadenylation site preferences by polyA-seq experiments and proteins associated with the expressed 
CstF64 variants by immunoprecipitation. Furthermore, we will analyse the functional impact of these CstF64 isoform 
manipulations on cell differentiation and growth.
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411 A A search for new factors involved in 3’ end processing of histone pre-mRNAs: proteins 
interacting with a complex of the conserved stem-loop and the Stem-Loop Binding 
Protein (SLBP) in Drosophila.
Aleksandra Skrajna1, Xiao-cui Yang2, Ivan Sabath2, Michal Dadlez3, William F. Marzluff2, Zbigniew Dominski2
1Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Pawinskiego 5A, 
Poland; 2Department of Biochemistry and Biophysics, Program in Molecular Biology and Biotechnology, 
University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; 3Institute of Biochemistry and 
Biophysics, Polish Academy of Sciences, Institute of Genetics and Biotechnology, Warsaw University, 02-106 
Warsaw, Pawinskiego 5A, Poland
3’ end processing of animal replication-dependent histone pre-mRNAs occurs through a single-step endonucleolytic 
cleavage that is not followed by polyadenylation. Cleavage depends on two cis-elements in histone pre-mRNA: a highly 
conserved stem-loop structure (SL) and a variable purine-sequence, the Histone Downstream Element (HDE). The SL 
interacts with the Stem-Loop Binding Protein, whereas the HDE is a binding site for U7 snRNP. We recently showed 
that U7 snRNP in addition to the U7-specific Sm ring and U7 snRNA contains FLASH and a number of polyadenylation 
factors, including the CPSF73 endonuclease. Mammalian histone pre-mRNAs are cleaved by this enzyme at a fixed 
distance from the HDE.  SLBP and the SL structure are dispensable for processing, although they have a stimulatory 
effect by stabilizing U7 snRNP on histone pre-mRNA. This indicates that the mammalian U7 snRNP alone can recruit 
the entire machinery required for processing.  In contrast, cleavage of Drosophila histone pre-mRNAs depends on 
both the SLBP and the U7 snRNP and invariably occurs 4 nucleotides after the stem. In Drosophila nuclear extracts, 
the U7 snRNP containing CPSF73 and other polyadenylation factors is efficiently recruited to the HDE even in the 
absence of SLBP. Thus, Drosophila SLBP must function in processing by recruiting an essential factor that in turn 
may interact with the machinery contributed by U7 snRNP.  We used Drosophila histone pre-mRNA prebound to 
recombinant SLBP to purify proteins from Drosophila nuclear extracts that interact with the complex but not with the 
histone pre-mRNA lacking SLBP. Mass spectrometry identified three proteins that fit these criteria: NOT1, a DHX-
type helicase and the methyltransferase responsible for modifying the 2’ hydroxyl of the cap.  Importantly, these three 
proteins do not interact with the complex of SLBP and the SL followed by 4 only nucleotides, suggesting that they 
are involved in 3’ end processing of histone pre-mRNAs rather than in processes operating on mature histone mRNA. 
We identified a different complex that interacts with the 3’ end of mature histone mRNA. This complex consists of 
multiple aminoacyl-tRNA synthetases and binds to the terminal portion of the SL in a manner independent of binding 
of SLBP.  Potential roles of proteins that interact with the SL in histone pre-mRNA and mRNA in 3’ end processing 
and post-processing events and their precise mode of binding in the presence and absence of SLBP are being currently 
investigated.
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413 C A triple helix structure is able to functionally replace a poly(A) tail
Jeremy Wilusz1, Laura Lu1, Phillip Sharp1
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 
02139
The MALAT1 locus is commonly misregulated in many human cancers and produces an abundant long nuclear-
retained noncoding RNA. Despite being transcribed by RNA polymerase II, the 3’ end of MALAT1 is produced not 
by canonical cleavage/polyadenylation but instead by recognition and cleavage of a tRNA-like structure by RNase P. 
Mature MALAT1 thus lacks a poly(A) tail yet is expressed at a level higher than many protein-coding genes in vivo. 
We find that the 3’ ends of MALAT1 and the MEN beta long noncoding RNAs are protected from 3’-5’ exonucleases 
by highly conserved triple helical structures. Surprisingly, when these structures are placed downstream from an ORF, 
the transcript is efficiently translated in mammalian cells despite the lack of a poly(A) tail. The triple helix therefore 
also functions as a translational enhancer, and mutations in this region separate this translation activity from simple 
effects on RNA stability or transport. This unusual form of translational control appears to be highly evolutionarily 
conserved as we now find that reporter mRNAs ending in a triple helix are efficiently translated in yeast. We are 
additionally investigating if endogenous MALAT1 may actually produce short peptides. These results provide new 
insights into how transcripts that lack poly(A) tails are stabilized and regulated and suggest that RNA triple helical 
structures likely have key regulatory functions in vivo.
412 B Enhancer of RNA INTERFERENCE -1-LIKE-1: The ERI1 Plant Homologue Involved in the RNA 
Processing Game of the Chloroplast
Ioannis Vlatakis1, Glykeria Mermigka2, Jutta Helm2, Heiko Schumacher2, Eugenia Vamvaka2, Kriton Kalantidis1
1Institute of Molecular biology and Biotechnology (IMBB) of Crete, Biology department University of Crete; 
2Biology department, University of Crete
Ribonucleases are a group of enzymes widely distributed in nature. In the chloroplasts, a network of post-
transcriptional modifications of RNA molecules, is mediated by ribonucleases. Our lab found that ENHANCER 
OF RNA INTEREFERENCE-1-LIKE-1 (ERL1, named following plant nomenclature conventions) in Arabidopsis 
thaliana, is such an enzyme. ERL1 belongs to a family of exoribonucleases which share a common 3’-5’exonuclease 
domain (EXOIII domain) containing a highly conserved DEDD motif. Homologues of ERL1 fulfill various functions 
in RNA metabolism by participating in tRNA and rRNA processing in bacteria  and in the regulation of RNAi and 
rRNA maturation pathways in eukaryotes. By confocal microscopy we showed that Arabidopsis ERL1 is targeted to the 
chloroplasts. We have generated Arabidopsis thaliana and Nicotiana benthamiana plants that misexpress ERL1. The 
misexpression of ERL1 leads to phenotypes indicative of defects in chloroplasts development in both plant species. 
Since ERL1 acts in the chloroplast, we used these transgenic lines to study the impact of ERL1 on chloroplastic related 
genes and measured the chlorophyll content. In addition we showed that in vitro purified ERL1 protein is capable 
of processing different RNA substrates (5S rRNA precursor and siRNA-like oligos).Recently, an RNA sequencing 
analysis complemented by Northern blot analysis has showed alterations at the expression and processing levels of 
certain operons in the absence of plant ERIL1. Altogether our results suggest that ERL1 is another piece in the puzzle 
of the complex posttranscriptional regulatory machinery of the chloroplasts.
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415 B Regulation of stress granules formation during calicivirus infection
MAJID AL-SAILAWI1, Nicolas Locker1, Elizabeth Royall1, Lisa Roberts1
1University of Surrey
Caliciviruses are single-stranded positive RNA viruses that are responsible for several important diseases in human 
and animal hosts. To date, the replication mechanisms of human caliciviruses are poorly understood because of a lack 
of a suitable cell culture system. Feline calicivirus (FCV) or mouse norovirus (MNV) share many properties with the 
human caliciviruses, and provide models to increase our understanding of calicivirus translation and replication.
Recent evidence suggests that the dynamic nature of mRNA expression is a key coordinator of viral pathogenesis, 
with different host genes expressed at different times during infection. The expression of mRNAs can be regulated 
through their storage and/or decay in subcellular compartments such as stress granules, to stall their translation, or 
processing bodies   (P-bodies), for their further degradation. Moreover, proteins within P-bodies or stress granules 
can enhance or limit viral infection. Viral proteins can also be found in these compartments, suggesting an important 
interplay between RNA turnover and viral life cycle.
This is an exciting emerging field in virology and we have set out to investigate how calicivirus infection affects 
and regulates the formation of P-bodies and stress granules for efficient replication and will present evidence that 
calicivirus infection modulates the formation of stress granules.
414 A FPA, a regulator of alternative polyadenylation, is closely associated with cleavage and 
polyadenylation factors in vivo
Vasiliki Zacharaki1, Katarzyna Rataj1, Gordon Simpson2
1School of Life Sciences Research, University of Dundee, Dundee, UK; 2School of Life Sciences Research, 
University of Dundee, Dundee, UK and James Hutton Institute, Invergowrie, Dundee, UK
Alternative cleavage and polyadenylation influences the coding and regulatory potential of mRNA and where 
transcription termination occurs. Although widespread, few regulators of this process are known. First identified 
because of its role in flower development, the Arabidopsis thaliana SPEN family protein FPA is a rare example of 
a trans-acting regulator of poly(A) site choice (Hornyik et al., 2010). The characterization of FPA therefore provides 
an opportunity to reveal novel mechanisms by which poly(A) site selection can be controlled. Here we show that FPA 
is closely associated with core components of the cleavage and polyadenylation apparatus in vivo.
In order to understand how FPA might function, we developed a novel proteomics procedure based on the cross-
linking of native protein interactions in living cells using formaldehyde. We then used statistical analysis of multiple 
biological replicates to compare proteins co-purified with FPA and the well-studied splicing factor U2B” as a control. 
We found that U2B” associates with known components of the U2snRNP and spliceosome as expected, but found 
little overlap between these proteins and those associated with FPA. Most proteins associated with FPA had domains 
connected to RNA processing and several had previously been identified as components of the same genetic pathway 
controlling flower development as FPA. Strikingly, almost all core components of the cleavage and polyadenylation 
machinery co-purified with FPA. We have substantiated these data with genetic analyses, revealing for example, that 
the function of FPA in promoting flower development requires an Arabidopsis protein related to the core cleavage, 
polyadenylation and termination factor Pcf11. Experiments designed to identify which of these co-purified proteins 
FPA interacts with directly are now in progress.
These findings establish a simple, generally useful procedure for label-free in vivo proteomic analysis of proteins 
involved in RNA processing. In addition, they suggest that the mechanism by which FPA regulates poly(A) site choice 
involves close, and possibly direct, association with the core cleavage and polyadenylation machinery.
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417 A Molecular genetic exploration of the yeast DEAH helicase, Mtr4, arch domain
James Anderson1, Yan Li1, Joseph Burclaff1
1Marquette University
Our interest in understanding how RNAs are recognized and tagged for degradation by the yeast TRAMP complex 
led us to explore the role of the Mtr4 arch domain in how it functions as an enzyme and a member of the TRAMP 
complex. Mutations in the Mtr4 arch domain were identified using a genetic screen to uncover mutations in the arch 
domain and c-terminus that inhibit the ability of Mtr4 to support degradation of hypomodified tRNAiMet. From this 
screen, 40 independent mutants were identified that had either one or more mutations in the arch domain. Six mutants 
within the arch domain and two mutants in the c-terminus, each with the strongest inhibitory effect on Mtr4 were 
chosen for further characterization.
Recombinant Mtr4 proteins and each mutant were expressed and purified from E. coli and tested for ATPase 
activity in the presence and absence of total tRNA and synthetic RNAs of 108 nt and 76 nt and predicted to have 
little to no structure were used in stimulating Mtr4 enzymatic activity. Enzymatic assays run in triplicate were used to 
determine the Km for ATP, Kapp for RNA and Vmax for RNAs. Our analysis demonstrated that total E coli tRNA and 
synthetic yeast tRNAiMet are poor at stimulating Mtr4 ATPase activity. The predicted unstructure RNAs stimulated 
Mtr4 ATPase activity much more robustly than did tRNA as we would have expected based on ours and other peoples 
work.
416 C Exploring the role of mouse DEAH helicase, skiv2l2, in processing and degradation of non 
coding RNAs in neuronal N2A cells using high throughput pA-seq analysis
James Anderson1, Jane Dorweiler1, Fengchao Wang1, Jun Zhu2, Stephen Munroe1
1Marquette University; 2National Heart Lung and Blood Institute, National Institutes of Health
Production and function of RNAs demands accurate transcription, processing and protein binding that is interogated 
by a number of mechansims. RNA surveillance and degradation insures that inaccurately transcribed or processed RNAs 
are efficiently removed by nuclease degradation.  The RNA surveillance complex, TRAMP, has been characterized 
and studied quite effectively in the yeast model organism, Saccharomyces cerevisiae. Proteins orthologous to yeast 
TRAMP complex proteins were identified in mus musculus, however the study of RNA surveillance in mammals has 
only recently begun.  In this work we have used small interfering RNAs to target orthologs of yeast proteins that 
function in RNA surveillance (Mtr4p and Rrp6p) in mouse N2A cells. 
We used paired-end high-throughput sequencing of polyadenylated RNAs (pA-seq) to quantify the effects 
of mMtr4 and mRrp6 knockdowns on RNA surveillance and processing. We demonstrate that there is no 
difference in the accumulation or location of polyadenylation in protein coding mRNAs upon depletion of mMtr4 or 
mRrp6.  Several targets of TRAMP mediated RNA surveillance from work in yeast do accumulate as polyadenylated 
RNAs in the mMtr4KD compared to control knockdowns.  We also identified a novel target of mMtr4 dependent 
RNA surveillance.  The 5’ leading portion of a pri-miRNA is liberated from the pre-miRNA by Drosha cleavage, 
and generally thought to be degraded.  Our data demonstrate that mMtr4 plays an important role in degrading these 
byproducts of miRNA processing. We continue to mine the current dataset for familiar, new or novel targets of mMtr4 
and will report our findings.
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419 C The NOT2/NOT5 Module of the CCR4-NOT Complex is Required for Assembly of the 
Exosome
Olesya Bukach1, Virginie Ribaud1, Geoffroy Colau1, Martine Collart1
1University of Geneva
The exosome is a conserved eukaryotic multi-subunit complex that plays a key role in processing and/or degradation 
of essentially all types of cellular RNAs. A different conserved multi-subunit complex known to specifically contribute 
to degradation of mRNAs is the Ccr4-Not complex. It carries Ccr4, the major cellular deadenylase in the yeast S. 
cerevisiae, several Ccr4-associated factors (Caf1, Caf40 and Caf130) and 5 Not proteins (Not1-5). In this study, 
we determine that one functional module of the Ccr4-Not complex composed of Not5 and Not2 contributes to the 
functional assembly of the exosome. Indeed, both Not2 and Not5 are important for exosome-dependent processing of 
7S rRNA in vivo, and their deletion suppresses improper processing of the 5.8 S + 30 rRNA due to lack of the Rrp6 
exonculease. The N-terminal domain of Rrp4 interacts with Rrp44 in the 10-subunit exosome associated with RNA 
and is improperly integrated into exosome complexes in the absence of Not2 or Not5. These results identify for the 
first time cellular components important for exosome assembly in vivo.
418 B mRNA degradation on the ribosome in Drosophila cells
Sanja Antic1, Anna Skucha1, Silke Dorner1
1Max F. Perutz Laboratories, University of Vienna, Vienna, Austria
The translation and degradation of mRNAs are two key steps in gene expression. Consequently, both processes are 
highly regulated and targeted by many factors including miRNAs. Even though translation and mRNA degradation are 
tightly coupled, it was suggested that mRNAs are degraded after their dissociation from the ribosomes in cytoplasmic 
bodies, named P-bodies. Only recently the possibility of co-translational mRNA degradation in yeast was discussed. 
However, at this point it is unclear whether mRNA degradation on the ribosome would be limited to particular mRNA 
species and could also occur in multicellular eukaryotes.
We have investigated the possibility of co-translational mRNA degradation in Drosophila cells. The co-purification 
of mRNA degradation factors with heavy fractions of polysome profiles of cell lysates was an important first step. 
However, since P-bodies could co-migrate with heavy polysome fractions we further established the affinity purification 
of ribosomes from Drosophila S2 cell lysates. We could demonstrate the co-purification of various deadenylation 
and decapping factors with ribosomes. Interestingly, also the factors of the miRNA effector components, AGO1 and 
GW182, co-purify with ribosomes. Ongoing experiments investigate the general abundance of decapped mRNAs 
on ribosomes. In summary our findings strongly suggest the ribosome as an alternative site for mRNA degradation 
in Drosophila.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
RNA Turnover  •   245
421 B Control of mRNA metabolism by deadenylation
Jeff Coller1
1Case Western Reserve University
The presence of a polyadenosine tail is an important determinant of mRNA translation and stability.  The regulated 
removal of the tail, i.e. deadenylation, leads to either translational quiescence or mRNA degradation.  Deadenylation, 
therefore, is a critical node in gene expression and is especially important in certain biological contexts such as in 
the early embryo and in neurons.  All mRNAs deadenylate at different rates; some fast, some slow.  In addition, 
deadenylation is enhanced by message-specific regulatory factors.  For instance, many 3’ UTR binding proteins 
and the miRNA machinery drive post-transcriptional regulation (in part) by facilitating deadenylation.  Despite the 
importance of deadenylation, little is known about how differential rates of poly(A) tail shortening are achieved. 
One clue comes from studies that show that mRNA translation rates are intimately connected to deadenylation rate. 
Our recent work has begun to tease out the complex molecular details that intertwine translation and deadenylation. 
Moreover, we have concentrated on understanding the function of protein factors that facilitate removal of the poly(A) 
tail.  Deadenylation is catalyzed by the CCR4-NOT protein complex. The function of distinct members of this complex 
as well as how these factors influence rates of deadenylation will be discussed. 
420 A Adipogenesis is efficiently regulated by SMG1 via staufen1-mediated mRNA decay
Hana Cho1, Kyoung Mi Kim1, Sisu Han1, Yoon Ki Kim
1School of Life Sciences and Biotechnology, Korea University, Seoul 136-701, Republic of Korea
Suppressor of morphogenesis in genitalia 1 (SMG1), a member of the phosphatidylinositol 3-kinase-related 
kinases family, is involved in nonsense-mediated mRNA decay (NMD). SMG1 phosphorylates Upf1, a key NMD 
factor. Subsequently, hyperphosphorylated Upf1 associates with SMG5-7 or proline-rich nuclear receptor coregulatory 
protein (PNRC2) to elicit rapid mRNA degradation. Upf1 is also known to be involved in staufen 1 (Stau1)-mediated 
mRNA decay (SMD), closely related to NMD. However, the biological and molecular roles of SMG1 in SMD remain 
unknown. Here, we provide evidence that SMG1 is involved in SMD. SMG1 is complexed with SMD factors and 
overexpression of a kinase-inactive mutant of SMG1 inhibits SMD efficiency. Accordingly, the cellular localization of 
Stau1 into processing bodies is dependent on the level of Upf1 phosphorylation. We also find that the level of SMG1 
increases during adipogenesis and downregulation of SMG1 delays efficient adipogenesis, suggesting the functional 
involvement of SMG1 in adipogenesis via SMD.
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423 A Control of mRNA decay by Puf proteins regulates ribosome biogenesis
Anthony Fischer1, Wendy Olivas1
1University of Missouri - St. Louis
The Puf family of eukaryotic RNA-binding proteins plays important roles in stem cell maintenance, cell 
development, and differentiation by binding conserved elements within the 3’ UTR of target mRNAs, typically 
resulting in mRNA degradation and/or translational repression.  Puf proteins are characterized by their repeat domains 
composed of eight tandem repeats of ~36 amino acids, whereby each repeat contacts one base within an 8-10 nt 
target sequence containing a conserved UGU.  Once bound to an mRNA target, Puf proteins elicit RNA repression by 
inhibition of cap-binding events or recruitment of mRNA decay factors.  The yeastSaccharomyces cerevisiae expresses 
six Puf proteins, and hundreds of candidate mRNA targets of these Pufs have been predicted from physical association 
or bioinformatic screens.  We have focused on understanding the mechanistic roles of Pufs in regulating such target 
mRNAs. One of our studies analyzed several of the predicted Puf4p targets that had the highest conservation of 
consensus binding sequence for Puf4p, and are all involved in various steps of ribosome biogenesis.  Analysis of target 
mRNA steady state levels in wild-type versus PUF4Δ strains revealed only small differences between the two strains, 
which prompted us to examine these mRNA targets in other PUF deletion strains.  Our data demonstrate that regulation 
of all the targets examined is controlled by the combination of Puf4p and Puf5p, suggesting a “partial redundancy” 
of these two Puf proteins.  Over-expression of Puf4p causes delays in processing of the rRNA 35S precursor.  Puf4p 
also appears to play a role in the export of pre-ribosomal subunits.  Together, the data suggests that Puf proteins play 
a global role in ribosome biogenesis through the decay of their target mRNAs.
422 C The structural and functional organization of the TRAMP complex
Sebastian Falk1, John Weir4, Peter Reichelt2, Jendrik Hentschel5, Fabien Bonneau3, Elena Conti3
1Max Planck Institute of Biochemistry - Department of Structural Cell Biology; 2Max Planck Insitute of 
Biochemistry - Department of Structural Cell Biology; 3Max Planck Institue of Biochemistry - Department 
of Structural Cell Biology; 4Max Planck Institute of Molecular Physiology - Department of Mechanistic Cell 
Biology; 5Institute of Molecular Biology and Biophysics, ETH Zurich
The TRAMP complex is involved in the processing and surveillance of various non-coding RNAs produced by 
all three RNA polymerases in the cell nucleus. TRAMP adds an oligo-adenylated tail to the 3’ end of selected RNAs 
and prompts their degradation by the exosome. The polyadenylation core of the TRAMP complex consists of the non-
canonical poly(A)polymerase Trf4 and the zinc-knuckle protein Air2 (or their paralogues Trf5 and Air1). The delivery 
of polyadenylated RNAs to the exosome is likely mediated by the third subunit of the TRAMP complex, the RNA 
helicase Mtr4.
The RNA targets of TRAMP have been found to carry short oligoadenylated tails in vivo. It has been suggested 
that Mtr4 restricts the number of adenosines added by Trf4-Air2 by recognizing the 3’ end of the RNA that is being 
polyadenylated. To visualize how the interaction between Mtr4 and Trf4-Air2 might underpin their regulation, we 
have studied the overall architecture of the S. cerevisiae TRAMP complex by combining SAXS reconstructions and 
crystal structures with interaction data obtained by crosslinking, mass spectrometry, biochemical and biophysical 
experiments. The results challenge a direct read-out mechanism of the poly-adenylated 3’ end by Mtr4 and instead 
suggest a model where RNAs are first unwound by the Mtr4 helicase and then fed to the poly(A)polymerase.
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424 B Transcriptome analysis reveals thousands of targets of nonsense-mediated mRNA decay 
that offer clues to the mechanism in human, fish, and fly
Courtney French1, Gang Wei4, Angela Brooks2, Thomas Gallagher5, Li Yang3, Brenton Gravely6, Sharon Amacher5, 
Steven Brenner1
1University of California, Berkeley; 2Broad Institute of MIT and Harvard; 3Chinese Academy of Sciences; 
4Fudan University; 5Ohio State University; 6University of Connecticut
Many alternatively spliced isoforms contain a premature termination codon that targets them for degradation by 
the nonsense-mediated mRNA decay RNA surveillance system (NMD). Some such unproductive splicing events have 
a regulatory function, whereby alternative splicing and NMD act together to impact protein expression. Numerous 
RNA-binding proteins, including all the human SR splicing factors, are regulated by alternative splicing coupled to 
NMD, in conjunction with highly- or ultra-conserved elements [1,2]. The “50nt rule” is the prevailing model for how 
premature termination codons are defined in mammals, and requires a splice junction downstream of the stop codon. 
[3]. There is evidence that this rule holds in Arabidopsis [4] but not in other eukaryotes including Drosophila [5]. 
There is also evidence that a longer 3’ UTR triggers NMD in yeast, plants, flies, and mammals [4,6,7].
To survey the targets of NMD genome-wide in human, zebrafish, and fly, we have performed RNA-Seq analysis 
on cells where NMD has been inhibited via knockdown of UPF1, a critical protein in the degradation pathway. We 
found that hundreds to thousands of genes produce alternative isoforms that are degraded by NMD in each of the three 
species, including over 20% of the genes alternatively spliced in human HeLa cells. These genes, potentially subject to 
regulation through NMD, are involved in many functional categories and, in human and fly, are significantly enriched 
for RNA splice factors, indicating that auto- and cross-regulation of splice factors through NMD is widespread. We 
also found a significant enrichment for ultraconserved elements in the human NMD targets, and usually these elements 
overlapped a poison cassette exon.
We were able to gain insight into what defines NMD targets from our RNA-Seq data. We found that the 50nt rule 
is a strong predictor of NMD degradation in human cells, and also seems to play a role in zebrafish and, surprisingly, 
in fly. In contrast, we found little correlation between the likelihood of degradation by NMD and 3’ UTR length in 
any of the three species. In fly, we see no enrichment for longer 3’ UTRs in isoforms degraded by NMD, unless they 
have an intron.  Other features have also been associated with propensity for NMD.  We also found that thousands of 
transcripts have uORFs that seem to affect their likelihood of degradation.
Ultimately, our findings demonstrate that gene expression regulation through NMD is widespread in human, 
zebrafish, and fly, and that NMD is strongly predicted by the 50nt rule but not by 3’ UTR length.
1. Lareau, L. F., et al. Nature 446, 926–929 (2007)
2. Ni, J. Z. et al. Genes Dev. 21, 708–718 (2007)
3. Nagy E. and Maquat,L.E. Trends Biochem. Sci. 23, 198–199. (1998)
4. Kerényi, Z. et al. EMBO J. 27, 1585–1595 (2008)
5. Gatfield, D. et al. EMBO J. 22, 3960–3970 (2003)
6. Hansen, K. D. et al. PLoS Genet. 5, e1000525 (2009)
7. Hogg, J. R. & Goff, S. Cell 143, 379–389 (2010)
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426 A Poly(A)-specific ribonuclease (PARN): Mechanisms of processivity and catalysis
Niklas Henriksson1, Mikael Nissbeck1, Per Nilsson1, Magnus Lindell1, Samuel Flores1, Santhosh Dhanraj2, 
Hongbing Li2, Yigal Dror2, Anders Virtanen1
1Uppsala University, Uppsala, Sweden; 2The Hospital for Sick Children, Toronto, Canada
Poly(A)-specific ribonuclease (PARN) is a divalent metal-ion dependent poly(A)-specific, processive and cap-
interacting 3’-5’ exoribonuclease that efficiently degrades poly(A) tails of eukaryotic mRNAs. PARN is unique among 
the poly(A) degrading nucleases, being the only one that has the capacity to directly interact during poly(A) hydrolysis 
with both the m7G-cap structure and the poly(A) tail of the mRNA. On the basis of biochemical and structural 
evidence we present and discuss a working model for PARN action. The model defines two alternating reaction steps, 
a translocation event that pushes the scissile bond of the poly(A) substrate into the catalytic center of the active site 
followed by a hydrolytic event that cleaves the scissile bond. The two reaction steps are repeated and in each cycle 
one AMP residue is released. The reaction cycle depends on the coordinated movements of the RNA recognition motif 
(RRM), which pushes the substrate into the active site, and a catalytically essential His residue of the catalytic center. 
The model also provides a plausible mechanistic framework for how the m7G-cap structure could allosterically affect 
the hydrolytic activity of PARN. Structural and functional data supporting the model will be presented. Significantly, 
we have found that divalent metal ions are required for both hydrolysis and substrate translocation in the active site. 
Our data imply that three divalent metal ions are required for proper action. Two ions participate in hydrolysis while 
the third plays a key role during translocation. The generality of this proposal in relationship to other processive 
enzymes participating in cleavage or formation of phosphodiester bonds will be discussed.
425 C Retroviral strategies for NMD evasion
Zhiyun Ge1, Stacey L. Baker1, J. Robert Hogg1
1Biochemistry and Biophysics Center; National Heart, Lung and Blood Institute; National Institutes of 
Health; Bethesda, MD, USA
The nonsense-mediated mRNA decay pathway recognizes and degrades transcripts containing long 3’ untranslated 
regions (3’UTRs). To counteract this activity and maintain proper gene expression, retroviruses have evolved RNA 
elements capable of protecting transcripts from 3’UTR length-dependent decay. The best-characterized retroviral 
NMD-antagonizing element, the RNA stability element (RSE) of the Rous Sarcoma Virus, stabilizes both retroviral and 
synthetic reporter mRNAs containing long 3’UTRs. This large (~ 400 nt) RNA segment sits immediately downstream 
of the viral gagtermination codon, preventing it from being recognized as premature. Using an RNA-based affinity 
purification approach, we have identified a complex of proteins specifically recruited to the RSE. These proteins are 
currently under investigation for potential roles in stabilizing retroviral and cellular RNAs.
Second, we find that retroviral recoding elements that promote translational frameshifting or readthrough 
antagonize NMD at two distinct steps. Relatively frequent stop codon bypass can reduce steady-state accumulation 
of Upf1 in mRNPs, disrupting its ability to monitor 3’UTR length. In addition, using variants of the Moloney murine 
leukemia virus (M-MLV) recoding pseudoknot, we find that less frequent readthrough events permit recovery of Upf1 
binding to mRNPs but remain able to inhibit degradation of mRNAs containing long 3’UTRs. Our data indicate that 
diverse viral and cellular recoding sequences can similarly inhibit NMD, suggesting that suppression of NMD is a 
general feature of translational readthrough. We are currently investigating the ability of translational readthrough to 
disrupt the molecular events preceding commitment to nonsense-mediated decay.
This research is supported by the Intramural Research Program, National Heart, Lung, and Blood Institute, 
National Institutes of Health
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428 C Identification of novel UPF1 target transcripts by direct determination of whole 
transcriptome stability.
Naoto Imamachi1, Hidenori Tani1, Kazi Abdus Salam1, Rena Mizutani1, Takuma Irie3, Tetsushi Yada2, Yutaka 
Suzuki3, Nobuyoshi Akimitsu1
1Radioisotope Center, The University of Tokyo, Japan; 2Department of Intelligence Science and Technology, 
Graduate School of Informatics, Kyoto University, Kyoto, Japan.; 3Department of Medical Genome Sciences, 
Graduate School of Frontier Sciences, The University of Tokyo, Japan
UPF1, an evolutionarily conserved protein, plays the central role in nonsense-mediated mRNA decay (NMD), 
which eliminates aberrant mRNAs harboring premature termination codon (PTC), preventing the accumulation of 
nonfunctional or potentially harmful truncated proteins. UPF1 is also involved in staufen1 (STAU1)-mediated mRNA 
decay (SMD) as well as replication-dependent histone mRNA decay. Thus, UPF1 is an important factor not only 
for the RNA quality control system but also for the regulation of physiological gene expression through regulation 
of RNA stability. In this work, we directly measured the stability of whole transcriptome in UPF1 knock-down 
HeLa cells by BRIC-seq method (5¢-bromo-uridine immunoprecipitation chase–deep sequencing analysis) that was 
developed by us. We successfully determined the half-lives of ~10,000 transcripts, and found that 785 transcripts were 
stabilized in UPF1 knock-down HeLa cells. Among 785 stabilized transcripts, the expressions of only 76 transcripts 
were increased and remaining 709 transcripts were not altered. RNA immunoprecipitation experiment showed that 
UPF1 bound to the transcripts whose decay was interfered but their expression was not changed, suggesting that UPF1 
directly destabilizes 709 transcripts. Most of the transcripts identified as UPF1 targets in this study were not found in 
previous studies, therefore, we identify novel hundreds of UPF1 targets in HeLa cells. Moreover, we found that GC-
rich sequence is statistically enriched among UPF1 target transcript, suggesting that UPF1 regulates the stability of 
mRNAs harboring GC-rich sequence.
427 B DHX34 activates NMD by promoting the transition from the SURF to the DECID complex.
Nele Hug1, Oscar Llorca2, Javier Caceres1
1MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, UK; 
2Spanish National Research Council (CSIC), Centro de Investigaciones Biológicas (CIB), Ramiro de Maeztu 9 
Madrid (Spain)
Nonsense-mediated decay (NMD) is a surveillance mechanism that degrades aberrant mRNAs.  A complex 
comprising the NMD factors SMG1 and UPF1 and the translation termination factors eRF1 and eRF3 (SURF) is 
assembled in the vicinity of a premature termination codon. Subsequently, an interaction with the exon junction 
complex induces the formation of the decay-inducing complex (DECID) and triggers NMD (1). We previously 
identified the DExD/H box protein DHX34 as a novel NMD factor in C. elegans and showed that it acts in the NMD 
pathway both in human cells and also in zebrafish (2,3). Here, we investigate the mechanism by which DHX34 
activates NMD in human cells. We show that DHX34 is an RNA-binding protein that is recruited to the SURF 
complex via its preferential interaction with hypo-phosphorylated UPF1 and the kinase SMG-1. A series of molecular 
transitions induced by DHX34 include an enhanced recruitment of UPF2, increased UPF1 phosphorylation and finally 
dissociation of eRF3 from UPF1.  These molecular transitions are dependent on the ATPase activity of DHX34. 
Altogether, these results show that DHX34 has a central role in NMD by triggering the conversion from the SURF 
into the DECID complex.  Undergoing structural studies using cryo-EM with DHX34 in combination with NMD core 
factors will help establish the precise mechanism of DHX34 in the activation of NMD.
1. Kashima,I., Yamashita,A., Izumi,N., Kataoka,N., Morishita,R., Hoshino,S., Ohno,M., Dreyfuss,G., Ohno,S. (2006) Genes 
Dev., 20, 355-367.
2. Longman,D., Plasterk,R.H., Johnstone,I.L. and Cáceres,J.F. (2007) Genes Dev., 21, 1075-1085.
3. Anastasaki C, Longman D, Capper A, Patton EE, Cáceres JF (2011) Nucleic Acids Res. , 39, 3686-3694.
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429 A RT-qPCR Reference Genes and Potassium Stress Responses in the Haloarchaeon, 
Haloarcula marismortui
Matthew W. Jensen1, Scott Matlock1, Carlene H. Reinheimer1, Andrea Gorrell1
1University of Northern British Columbia, Department of Chemistry
Potassium ion transport is of interest in many systems as K+ concentrations are thought to be used to maintain 
or change a membrane potential.  In halophiles, such as Haloarcula marismortui, intracellular potassium ion (K+) 
concentration is postulated to be a mechanism for balancing the osmotic pressure experienced in a hyper-saline 
environment1, and unlike most organisms, these concentrations have been reported to be in excess of 3M 2,3. We 
are interested in the dependence of these halophiles upon the external and internal K+ concentration with respect to 
osmotic stress.
We demonstrate that cellular generation time for the halophile varies with extracellular K+ concentration, and 
growth occurs on alternative monovalent ions including lithium, rubidium, and caesium at concentrations equivalent 
to the observed K+ optima. We have also shown that intracellular ion concentrations  correlate to ion concentrations in 
the media. Our results suggest Har. marismortui is both highly selective for, and an excellent scavenger of K+.
In light of this information, we used qRT-PCR to analyze the change in expression of any postulated potassium 
transport systems. Genome analysis5 indicates the possible existence of three separate potassium channel/transport 
systems in Har. marismortui, Trk, MthK and Pch.  These are othologous to the Esherichia coli K-transport systems 
KcsA and Kch.  TrkA and MthK are both KcsA  orthologs, the is the constitutive K channel in E. coli6, while 
Pch is the ortholog of the Kch channel. Kch is similar to the voltage-gated K channels (Kv channels) in eukaryotic 
K-channels as it has a similar P-loop region, even though specific sequence identity is low, and is expressed under low 
K+ conditions in E. coli as it has an active transport mechanism6. As prior archaeal qRT-PCR studies appear to use 
only a single reference gene, we assessed the stability of several canadidate genes in order to meet the minimum of 
3 reference genes as recommended by the MIQE Guidelines4. Using these novel references, expression of potassium 
channel genes was examined in cellular shock (5 min, 2 h) and stable growth (2 week) conditions at each of the 
analyzed K+ conditions.
1. Oren, A., et al (1990) Int. J. Syst. Bacteriol. 40, 209-210.
2. Christian, J. H. B. & Waltho, J. A. (1962) Biochim Biophys Acta 65, 506-508.
3. Ginzburg, M., et al (1970) J Gen Physiol 55, 187-207.
4. Bustin, S. A., et al. (2009) Clinical Chemistry 55, 611-622.
5. Baliga N.S. et al (2004) Genome Res 14:2221-2234.
6. Loukin, S. H. et al (2005) J. Gen. Physiol. 125, 521-527.
7. Kuo, M. M-C., et al (2003) EMBO Journal 22, 4049-4058.
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431 C Expression of nonsense-mediated decay factors is controlled by conserved feedback 
loops and responds to salt stress in plants
Anil Kesarwani1, Gabriele Drechsel1, Andreas Wachter1
1Center for Plant Molecular Biology (ZMBP), University of Tübingen, Auf der Morgenstelle 28, 72076 
Tübingen, Germany
Nonsense-mediated decay (NMD) is a conserved eukaryotic mRNA surveillance pathway that selectively 
recognizes aberrant transcripts and targets them for degradation. NMD target transcripts can be generated by faulty 
gene expression or selectively produced to serve gene regulation. NMD is triggered by cis-acting elements, comprising 
premature termination codons (PTCs), upstream open reading frames (uORFs), long 3’ untranslated regions (UTRs), 
and 3’ UTR-located introns. Recent studies indicated that more than 10% of all genes from Arabidopsis thaliana produce 
at least one NMD transcript variant, suggesting a major role of NMD in shaping the plant transcriptome. However, it is 
unclear whether NMD activity is constitutive or can be altered under certain developmental or stress conditions. Here 
we present data suggesting feedback regulation of NMD factor expression in A. thaliana. The transcripts from three 
of the core NMD factors (UPF1, UPF3, and SMG7) contain long 3’ UTRs and/or 3’ UTR-positioned introns and are 
upregulated in NMD-impaired seedlings. Furthermore, transcript levels of these NMD factors are elevated upon salt 
stress in seedlings, which might be explained by diminished NMD activity under these conditions. In line with this, the 
transcript from another core NMD factor, UPF2, that lacks any NMD eliciting feature display unchanged expression 
upon both NMD impairment and salt stress. Interestingly, we found that both feedback and salt stress regulation 
of NMD factors is also present in Nicotiana benthamiana, revealing evolutionary conservation of NMD control in 
different plant species. Our data suggest that NMD activity might be significantly altered under certain conditions, 
which we currently further investigate by use of an in vivo NMD reporter system.
430 B Investigation of premature termination codon recognition in nonsense-mediated mRNA 
decay
Raphael Joncourt1, Andrea Eberle2, Oliver Mühlemann1
1Department for Chemistry and Biochemistry, University of Bern, Switzerland; 2Department of Molecular 
Biology and Functional Genomics, Stockholm University, Sweden
Nonsense-mediated mRNA decay (NMD) is best known for its role in quality control of mRNAs. Premature 
translation termination codons (PTCs) are recognized and the corresponding mRNA gets rapidly degraded. The basic 
mechanism of NMD appears to be conserved from yeast to mammals. According to the current working model, 
aberrant translation termination leads to NMD. It is thought that correct termination requires the interaction of the 
ribosome at the stop codon with the poly(A)-binding protein (PABP) mediated through eukaryotic release factor 3 
(eRF3). The model predicts that in the absence of this interaction, the NMD core factor UPF1 binds to eRF3 instead 
and initiates the assembly of an NMD complex that ultimately leads to mRNA degradation. However, the exact 
mechanism that allows distinguishing between proper and aberrant (i.e. NMD-inducing) translation termination is not 
yet well understood.
We address this question using a tethering approach in which proteins of interest are bound to a reporter transcript 
into the vicinity of a PTC. Subsequently, the ability of the tethered proteins to inhibit NMD and thus to stabilize the 
reporter transcript is assessed. Preliminary results revealed that the C-terminal domain interacting with eRF3 seems 
not to be necessary for tethered PABP to suppress NMD. In contrast, the N-terminal part of PABP, consisting of 4 RNA 
recognition motifs (RRMs) and interacting with eukaryotic initiation factor 4G (eIF4G), retains the ability to inhibit 
NMD. Tethered eIF4G is also able to stabilize the reporter transcript, it is however not yet clear if this is a direct or 
indirect effect. There are indications that this stabilization might be due to endogenous PABP being recruited, but also 
that the interaction of eIF4G to initiation factor 3 (eIF3) might play a role. The results obtained so far suggest that 
PABP undoubtedly has an important function for the suppression of NMD, but that there might be other factors able 
to complement or circumvent its actions.
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433 B Direct Visualization of Alternative RNA Substrate Recruiting Pathways in Yeast Exosome
Jun-Jie Liu1, Ailong Ke2, Hong-Wei Wang1
1School of Life Sciences, Tsinghua University; 2Cornell University
The multi-subunit exosome complex plays crucial roles in RNA degradation and processing both in cytoplasm 
and nucleus by cleaving RNA substrates from their 3’ end. From archaea to eukaryotes, exosome has a structurally 
conserved core complex consisting of nine subunits forming a ring-like structure with a channel in the center allowing 
single stranded RNA to go through. Eukaryotic core complex has lost its exonuclease activity but gains its RNase 
activity through two additional hydrolytic 3’ to 5’ exoribonucleases, Rrp44 and Rrp6, that both bind to the core. Rrp44 
degrades RNA substrates processively while Rrp6 degrades RNA distributively.
Structural analysis revealed that Rrp44 protein situates at the bottom of the core facing the core channel exit. In 
tune with a similar function of the archaeal exosome, biochemical data indicate that RNA substrates with long single 
stranded 3’ overhangs are first channeled through the eukaryotic exosome core before being degraded by Rrp44. 
This “through-core” route is supported by the most recent crystal structure of the yeast Rrp44-exosome (RE) in 
complex with an RNA substrate with a 5’ hairpin and long 3’ end single stranded overhang. On the other hand, recent 
transcriptom data suggested the presence of alternative route for RNA substrates with shorter 3’ end single stranded 
overhangs to be processed by exosome. Our previous reconstruction of the apo-RE complex revealed multi-porous 
structure suggesting the potential for RNA substrates to take multiple routes including the “through-core” and some 
“direct access” routes to get access to Rrp44’s exonuclease site.
In order to further probe the mechanism of RNA degradation by exosome especially the recruitment route of 
RNA substrates, we have performed biochemical and single particle electron microscopy analysis on yeast Rrp44-
exosome in concert with RNA substrates. We used model structured RNA and linear RNA substrates with 3’ end 
single stranded tails of various lengths as a molecular ruler to determine the length of RNA required for interaction 
with and degradation by the exosome. We exploited single particle reconstruction of the RE-RNA complexes to reveal 
the substrate induced conformational change of the complex. Single particle electron microscopy analysis of Rrp44-
exosome in complex streptavidin-labeled RNA substrates provided us direct visual evidence of the alternative RNA 
recruiting pathways by Rrp44-exosome complex.
432 A High-resolution characterization of regulatory sequences within a mammalian 3’ UTR
Katla Kristjansdottir1, RaeAnna Wilson1, Elizabeth Fogarty1, Andrew Grimson1
1Cornell University
Many important gene regulatory events occur post-transcriptionally, typically by regulation of mRNA translation 
and decay rates. Post-transcriptional regulatory events are usually controlled by trans-acting factors (such as 
microRNAs) that bind to cis-acting sequence elements (cis-elements), which are often located within the 3’ untranslated 
regions (3’ UTRs) of mRNAs. Importantly, previous analyses suggest that typical mammalian 3’ UTRs contain many 
different cis-elements and that certain cis-elements can interact in synergistic or inhibitory ways. While many cis-
elements have been identified, most of our current understanding of their function is based on analysis of elements 
in isolation rather than in combination with other elements. The work presented aims to better understand the range 
of regulatory sequences within a 3’ UTR and how sequences within 3’ UTRs interact with one another. Towards that 
goal, I have been studying in detail the 3’ UTR of the mouse HMGA2 gene, which is known to direct substantial post-
transcriptional regulation of its mRNA. The regulatory information within this 3′ UTR is particularly important, since 
HMGA2 over-expression due to 3’ UTR truncations is found in many types of cancer and is linked with a poor 
prognosis.
To identify regions that confer regulation, I used reporter assays to assess the regulatory information within 
100 nucleotide (nt) segments (100mers) tiled across the HMGA2 UTR, generating a high-resolution cis-regulation 
map of the UTR. This map shows several new regions of regulation beyond those previously described. For each 
strongly regulating 100mer, I am currently identifying the specific cis-elements responsible, which will be critical in 
identifying the trans-factors involved. To understand how interactions between cis-elements contribute to regulation, 
I also measured 200 nt segments (200mers) tiled across the 3’ UTR. If elements within two adjacent 100mers do not 
interact, we expect the regulatory potential of the corresponding 200mer to be recapitulated by the regulatory potential 
of the 100mers. By looking for 200mers that fail to be recapitulated in this manner, I have been able to identify four 
regions that contain cis-elements that may be interacting. I am currently working on characterizing those interactions 
towards a mechanistic understanding of their function. Getting a complete picture of the cis-regulatory information 
within 3’ UTRs, and how the cis-elements can interact to control the mRNA, is an important step towards a fuller 
understanding of post-transcriptional gene regulation.
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435 A The mRNA quality control factors Ski7 and Hbs1 evolved from an alternatively spliced 
gene that produced Ski7-like and Hbs1-like proteins.
Alexandra N. Marshall1, Maria Camila Montealegre1, Claudia Jiménez-López1, Michael C. Lorenz1, Ambro van Hoof1
1University of Texas Health Science Center at Houston
One major function of mRNA degradation is to maintain fidelity of gene expression by specifically targeting aberrant 
mRNAs for rapid degradation. Two Saccharomyces cerevisiae paralogs play central roles in this process. The recognition and 
degradation of mRNAs that lack a stop codon requires Ski7 and the RNA exosome, while the recognition and degradation of 
mRNAs with stalled ribosomes in the middle of an ORF requires Hbs1 and an unknown endonuclease. In addition to its role 
in recognizing nonstop mRNAs, Ski7 has a second role as a cytoplasmic exosome cofactor. Ski7 and Hbs1 are paralogs that 
arose in budding yeast about 100 million years ago, and thus most other eukaryotes only contain one corresponding gene. 
How other eukaryotes recognize and degrade nonstop and no-go mRNAs, and whether they contain a Ski7-like exosome 
cofactor was not fully understood.
Lachancea kluyveri is closely related to budding yeast, but like other eukaryotes has only one SKI7/HBS1 gene. rt-PCR, 
RNA-seq and Western blot analysis show that this one gene encodes two distinct proteins through alternative splicing. 
Furthermore, the longer splice isoform functions as Ski7, while the shorter splice isoform functions as Hbs1. Thus, the 
expression of two distinct proteins to recognize nonstop and no-go mRNAs is more widespread than anticipated.
While alternative splicing is much less common in fungi than in mammals, the alternative splicing of SKI7/HBS1 is 
conserved in both the ascomycetes and the basidiomycetes as shown by rt-PCR and bioinformatics analysis. Although 
alternative splicing of SKI7/HBS1 is conserved, the exact mechanism has changed several times during fungal evolution, 
such that both alternative 3’ splice sites, alternative first exons, and likely other mechanisms are used. Strikingly, 
other than S. cerevisiae and its close relatives, the only other fungi where we failed to detect alternative splicing are 
in the Schizosaccharomyces genus. While this genus is very distantly related to S. cerevisiae, it also contains an 
uncharacterized SKI7 gene in addition to its canonical HBS1 gene. This comparison of splicing strategies in diverse fungi 
provides a model to understand the evolutionary changes in alternative splicing.
The human genome also contains only a single ortholog whose major splicing isoform resembles Hbs1, both in 
sequence and biochemical activity. However, the human gene is also alternatively spliced, and our results suggest that the 
alternatively spliced isoform functions as the missing Ski7-like cytoplasmic exosome cofactor.
434 C SMG7 recruits the CCR4-NOT complex for degradation of NMD targets
Belinda Loh1, Stefanie Jonas1, Elisa Izaurralde1
1Max Planck Institute for Developmental Biology
The nonsense-mediated mRNA decay (NMD) pathway triggers rapid degradation of aberrant mRNAs that contain 
premature translation termination codons (PTCs). In metazoans, NMD requires three 14-3-3-like proteins: SMG5, 
SMG6, and SMG7. These proteins are recruited to PTC-containing mRNAs through the interaction of their 14-3-3-like 
domains with phosphorylated UPF1, the central NMD effector. The recruitment of SMG5, SMG6, and SMG7 causes 
NMD target degradation. SMG6 possesses an active PIN domain at its C-terminus that cleaves the target mRNA in 
the vicinity of the PTC.  On the other hand, tethered SMG7 has been shown to degrade mRNA efficiently through its 
Proline-rich C-terminus (PC) region, which is necessary and sufficient for this activity. Previous studies indicate that 
SMG7-mediated mRNA degradation requires the general mRNA decay enzymes. However, the mechanism by which 
these enzymes are recruited to the target mRNA has remained unclear. To determine how SMG7 elicits mRNA decay, 
we used the Tandem-Affinity Purification (TAP-tag) methodology to identify interacting partners. Amongst the SMG7-
binding proteins, we found all subunits of the CCR4-NOT complex that are responsible for deadenylation of mRNAs. 
We further show that the PC-region of SMG7 is responsible for binding POP2, the catalytically active component of 
the CCR4-NOT complex. Additional mapping experiments of POP2 reveal that the catalytic domain alone is sufficient 
to bind the PC region of SMG7. Over-expression of catalytically inactive POP2 shows stabilization of SMG7-tethered 
RNA and PTC-containing reporter RNA. In addition, over-expression of a catalytically inactive DCP2, the decapping 
enzyme, also results in stabilization of NMD targets. Functional studies in human cells demonstrate that the PC region 
of SMG7 is required for NMD only in cells depleted of SMG6. Together with previously published data, our findings 
show that the 5’ to 3’ decay pathway is utilized in the SMG7-dependent degradation of NMD targets.
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437 C Global analysis of exosome target introns
Elina Niemelä1, Ali Oghabian1, Ger Pruijn2, Mikko Frilander1
1Institute of Biotechnology, University of Helsinki, Finland; 2NCMLS/IMM, Radboud University Nijmegen, 
Netherlands
U12-type introns are a class of rare introns in the genomes of diverse eukaryotes. They number over 800 introns in the 
human genome, making up less than 0.5 % of our introns (Turunen et al., 2013). These introns have earlier been shown to splice 
at a slower rate compared to the major U2-dependent pathway. This suggests a rate-limiting regulatory function for the minor 
spliceosome in the nuclear processing of transcripts containing U12-type introns (Patel et al. 2002). In support to this model, an 
elevated level of unspliced U12-type introns have been detected in the steady-state RNA populations in various organisms (Patel 
et al. 2002; Pessa et al. 2006; Pessa et al. 2010) However, both the mechanism of slower splicing kinetics and the fate of mRNAs 
containing unspliced U12-type introns remain unknown.
Here we have analyzed globally the effect of exosome processing on the nuclear pre-mRNA transcripts by inactivating either 
the Rrp41 or Dis3 subunit of the exosome. Using SOLiD RNA sequencing technology, we report 30-120 million mapped cellular 
compartment specific reads per sample allowing the detection of unspliced pre-mRNAs.
We show that Rrp41 and Dis3 knockdowns stabilize an overlapping set of U12-type introns, with a total of 132 stabilized 
introns using 2-fold upregulation as cutoff. At least 3-fold upregulated introns total 84, and at least 4-fold upregulated introns 
number 57, covering a remarkable fraction of the human U12 intron set (15 %, 9.5 % and 6.5 %, respectively). Collectively 
the median U12-type intron retention distribution shifts towards upregulation in the knockdown, contrary to U2-type introns, 
whose distribution shows no change. Validation of the top stabilized introns is performed using RT-PCR. Finally, we explore the 
characteristics of introns targeted by the exosome.
1. Patel AA, McCarthy M, Steitz JA. (2002) The splicing of U12-type introns can be a rate-limiting step in gene expression. 
EMBO J. 21:3804-15.
2. Pessa HK, Ruokolainen A, Frilander MJ. (2006) The abundance of the spliceosomal snRNPs is not limiting the splicing of 
U12-type introns. RNA. 12:1883-92.
3. Pessa HK, Greco D, Kvist J, Wahlström G, Heino TI, Auvinen P, Frilander MJ. (2010) Gene expression profiling of U12-
type spliceosome mutant Drosophila reveals widespread changes in metabolic pathways. PLoS One. 5:e13215.
4. Turunen JJ, Niemelä EH, Verma B, Frilander MJ. (2013) The significant other: splicing by the minor spliceosome. Wiley 
Interdiscip Rev RNA. 4:61-76.
436 B Functional analysis of IMP3, a RNA-binding protein
Rena Mizutani1, Yutaka Suzuki2, Nobuyoshi Akimitsu1
1Radioisotope Center, The University of Tokyo, Tokyo, Japan; 2Department of Medical Genome Sciences, 
Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan
RNA-binding proteins regulate multiple steps of post-transcriptional gene expression, and it is important to 
know the target RNAs of RNA-binding proteins. The RNA binding protein IMP3 (Insulin-like growth factor 2 (IGF-
2) mRNA-binding protein 3) is an oncofetal protein, emerging as a useful indicator of the progression and prognoses 
of several cancers. According to preceding study, IMP3 binds to IGF-2 mRNA thereby activating its translation, 
and stabilizes CD44 mRNA. IMP3 has a potential not to be simply a marker of prognosis in cancer cells, but also to 
regulate cancer progression. However, little is known about the function of IMP3 in cancer cells because transcripts 
regulated by IMP3 are unclear. In this study, we tried to identify RNA targets of IMP3 through genome-wide analysis.
Initially, we tried to identify RNAs bound to IMP3 by RNA immunoprecipitaion followed by deep sequencing 
(RIP-seq). We then determined 2201 RNAs enried in IMP3 immunoprecipitant as candidates of IMP3 binding RNAs. 
We also determined the expression levels of whole transcripts in IMP3-depleted HeLa TO cells by deep sequencing 
analysis. The expression levels of 65 transcripts were increased in IMP3-depleted cells. Among them, 15 transcripts 
were bound to IMP3, and we judged these 15 transcripts are regulated by IMP3. We measured the stability of the 
RNA targets of IMP3 in IMP3-depleted HeLa TO cells using BRIC-method, an inhibitor-free method for directly 
measuring RNA stability. CDK18 mRNA, SOCS2 mRNA, LRFN3 mRNA and CCDC92 mRNA were stabilized by 
depletion of IMP3. Our results suggest that IMP3 promotes RNA degradation of RNA targets, and might regulate 
cell growth through control of RNA stability of CDK18 and SOCS2, negative regulators of cell growth. This is a first 
demonstration that IMP3 is a RNA destabilizing factor for a set of transcripts.
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439 B Assessing differential susceptibility of mRNAs to NMD
Christoph Schweingruber1, Oliver Mühlemann2
1Departement für Chemie und Biochemie, University of Bern, Switzerland; Graduate School for Cellular and 
Biomedical Sciences, University of Bern, Switzerland; 2Departement für Chemie und Biochemie, University 
of Bern, Switzerland
Nonsense-mediated mRNA decay (NMD) co-translationally reduces the steady state levels of many physiological 
mRNAs, hence acting as a post-transcriptional gene regulation mechanism. The fate of the mRNA is decided during 
translation termination. According to the „unified NMD model“, the interaction of the poly(A)-binding protein 
(PABPC1) with the eukaryotic release factor 3 (eRF3), bound to the terminating ribosome, typifies normal translation 
termination. In contrast, if the distance from the termination codon (TC) to the poly(A) tail is too large for the PABPC1-
eRF3 interaction to occur efficiently, the recruitment of the SURF complex to the ribosome, through the binding to 
eRF3 and eRF1, is facilitated instead. This step initiates the cascade of events that result in the rapid decay of the 
mRNA [1]. This model predicts that spatial rearrangements of the 3’-UTR altering the physical distance between TC 
and poly(A) tail could serve as a novel post-transcriptional mechanism for gene regulation. However, no physiological 
mRNAs being regulated by this putative mechanism has been identified so far [2,3]. Therefore, our goal is to identify 
endogenous mRNAs that are NMD-sensitive under certain conditions but NMD-resistant under other conditions. As 
an experimental model we have established a human neuroblastoma cell line that can be differentiated in culture into 
a neuronal-like state and in which we can inactivate NMD by induction of an RNAi-mediated depletion of UPF1. 
Whole transcriptome analysis was performed by RNA-Seq on undifferentiated and differentiated cells, either with 
or without UPF1 depletion and the bioinformatics analysis is ongoing. If such putative physiological mRNAs that 
are differentially regulated by NMD indeed exist, they should be revealed by comparing the transcriptomes under 
these four conditions. In addition, this analysis will provide new insights into the post-transcriptional regulation in a 
neuronal-like background.
438 A A Novel Role for the Arginine Methyltransferase CARM1 in Nonsense Mediated Decay: 
Implications for Spinal Muscular Atrophy
Gabriel Sanchez1, Jocelyn Cote1
1Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5
Spinal muscular atrophy (SMA) is amongst the leading genetic causes of infant deaths and is characterized by specific 
degeneration and loss of spinal cord motoneurons. It is caused by the disruption of the “survival of motor neurons” gene 
(SMN1), which plays an essential role in the cytoplasmic assembly of core snRNPs.  To date, we still do not understand why the 
motoneurons are the most affected cell type in response to a deficiency in this protein. It has been proposed that motoneurons are 
more sensitive to low snRNPs levels and splicing defects. Alternatively, it has also been proposed that SMN may have a distinct 
function specifically in motoneurons.  We recently uncovered that SMN normally represses CARM1 translation, thus leading to 
an increase of CARM1 expression in SMA. Since our results obtained for the past 4 years strongly suggest a key role of CARM1 
in the etiology of SMA, we decided to investigate the impact of an increase of CARM1 in the disease. Amongst the different 
cellular roles of CARM1, we decided to focus on the relationship between the massive alteration of splicing in SMA and the fact 
that CARM1 can regulate this mechanism. Thus, our objective is to identify splicing targets that are misregulated by CARM1 in 
the pathology.
While pursuing splicing targets regulated by CARM1, we uncovered a completely novel function for CARM1 as a regulator 
of nonsense-mediated mRNA decay (NMD). Interestingly, in our preliminary results we identified USPL1, as a target regulated 
by CARM1. USPL1 is a gene which has been found to be mis-spliced in a number of difference SMA cell culture and in vivo 
models. This gene can generate two transcripts including or not alternative exon 2. In SMA, it was reported that the splicing 
variant containing exon 2 is enriched. Upon analysis of the sequences of these two USPL1 splicing isoforms, we observed that 
the transcript without the exon 2 in fact matched the criteria to be a NMD-regulated target. To test this hypothesis, we decided to 
inhibit the NMD pathway by using either drugs or a RNAi strategy against UPF1 (the main effector of NMD). Thanks to these 
strategies, we were able to confirm that this variant was a NMD target. Afterwards, to confirm a role of CARM1 in the NMD 
mechanism, we used a well-accepted NMD reporter assay which allowed us to validate our hypothesis. Furthermore, by using co-
immunoprecipitation experiments, we observed an interaction between CARM1 and both UPF1 and UPF2, but not with UPF3 or 
components of the EJC, suggesting CARM1 is not recruited co-transcriptionally to NND transcripts and may actually play a direct 
role in the early activating steps of NMD.  Finally, our preliminary screen has identified a few additional NMD targets regulated 
by CARM1, that are also misregulated in SMA.  Altogether, identification of the full spectrum activities of CARM1 may provide 
crucial insights into our understanding of the etiology of SMA.
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441 A Acetylation of CAF1a and BTG2 accelerates general mRNA degradation
Sahil Sharma1, Georg Stoecklin1
1German Cancer Research Center, DKFZ-ZMBH Alliance, Heidelberg, Germany
The half-life of most mRNAs is determined by the rate of poly(A) tail shortening. In metazoans, two deadenylases, 
CAF1a and CAF1b, play a major role in removing poly(A) tails in the cytoplasm, thereby initiating degradation of 
mRNAs. The CAF1 enzymes are integral components of the CCR4-CAF1-NOT complex, which is actively recruited 
to mRNAs destined for degradation. In addition, CAF1a and CAF1b interact with the TOB/BTG family of proteins, 
which promote the activity of CAF1 enzymes. Given the central importance of CAF1 deadenylases in mRNA turnover, 
we examined whether their activity is regulated.
Here we report that hyperacetylation strongly promotes the interaction between human CAF1a and BTG2 in-vivo. 
In accordance with this finding, hyperacetylation accelerated degradation of stable mRNAs. Hyperacetylation also 
caused a general loss of poly-A tails, pointing towards a general activation of deadenylation. Using an anti acetyl-
lysine antibody on purified proteins, we found that both CAF1a and BTG2 are directly acetylated. By testing candidate 
enzymes, we were able to identify two acetyl transferases that promote acetylation of CAF1a and BTG2, as well as a 
deacetylase that removes lysine acetylation on both proteins.
Mass spectrometry revealed acetylated lysine residues on both CAF1a and BTG2. Mutation of two lysine residues 
in BTG2 was sufficient to abolish acetylation. Importantly, the same mutation also prevented proteasome-dependent 
degradation of BTG2, indicating that acetylation stabilizes BTG2. The analysis of reporter mRNA degradation further 
suggested that the activities of CAF1 and BTG2 are enhanced by hyperacetylation. Taken together, our data show for 
the first time that acetylation plays an important role in regulating posttranscriptional gene expression by promoting 
the general turnover of mRNAs.
440 C Structural insights into the Dhh1-Pat1 interaction
Humayun Sharif1, Sevim Ozgur1, Elena Conti1
1Max Planck Institute of Biochemistry, Martinsried, Germany
Eukaryotic mRNA turnover starts with the shortening of the 3′ poly (A) tail and continues with either 3′-5′ 
degradation by the exosome complex or with decapping and 5′-3′ degradation by Xrn1. Decapping is catalyzed by the 
Dcp1-Dcp2 complex and is regulated by several co-activator proteins, including Dhh1, Pat1, Edc3 and the heptameric 
Lsm 1-7 complex. All these factors are conserved from yeast to humans.
Pat1 is a multidomain protein. It uses the N-terminal domain to interact with Dhh1 and the C-terminal domain 
to interact with Lsm1-7. As such, Pat1 is believed to act as a bridging factor between the 3′ end and the 5′ end of the 
message. Dhh1 (also known as Rck or DDX6 in metazoans) is a DEAD-box protein. Like all other members of the 
DEAD-box family, Dhh1 is expected to bind RNA via the two RecA domains. In addition, Dhh1 interacts with another 
enhancer of decapping, Edc3. How Dhh1 interacts with Pat1 and how this affects the RNA-binding and protein-
protein binding properties of this DEAD-box protein is unclear.
We have determined the 2.8 Å crystal structure of yeast Dhh1 bound to the N-terminal domain of Pat1. The 
structure reveals an evolutionary conserved recognition mechanism that we have confirmed by testing mutations in in 
vitro assays with the yeast proteins and in co-immunoprecipitation assays with the corresponding human orthologues. 
Comparison with the known structures of human DDX6-Edc3 and of DEAD-box proteins bound to RNA reveals how 
Pat1 binding impacts on other macromolecular interactions mediated by Dhh1.
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443 C MKT1: a hub in a post-transcriptional regulatory network
Aditi Singh1, Igor Minia1, Dorothea Droll1, Abeer Fadda1, Esteban Erben1, Christine Clayton1
1Zentrum für Molekulare Biologie der Universität Heidelberg, DKFZ-ZMBH Alliance, Heidelberg, Germany
Trypanosomes are uniquely reliant upon post-transcriptional mechanisms for the control of gene expression. 
We previously found that stabilisation of trypanosome mRNAs during heat shock depends on binding of the zinc 
finger protein ZC3H11 to the 3’-untranslated regions of target mRNAs; also, tethering of ZC3H11 to a reporter 
mRNA increases reporter expression, suggesting an active stabilisation mechanism. We have now found that 
ZC3H11interacts with trypanosome MKT1 and PBP1, and that interactions with both proteins are required for 
ZC3H11 activity in the tethering assay. Saccharomyces cerevisiae Mkt1p facilitates yeast survival during stress, while 
yeast Pbp1p interacts with Lsm12p and the poly(A) binding protein Pab1p. Both Pbp1p and its human homologue, 
Ataxin-2, are stress granule components.
Trypanosome MKT1, like Mkt1p, interacts with PBP1 and LSM12, and trypanosome PBP1 interacts 
with trypanosome poly(A) binding proteins. MKT1, PBP1 and LSM12 are all essential for parasite survival, and 
all increase reporter expression in the tethering assay, as does poly(A) binding protein. MKT1, like Mkt1p, is 
polysome associated. MKT1 and PBP1 are distributed throughout the cytoplasm at the normal growth temperature 
and after heat shock, but concentrated in stress granules during starvation. Stabliisation of heat-shock mRNAs could 
result from cooperative interactions between ZC3H11, MKT1, PBP1 and poly(A) binding proteins, resulting in 
enhanced protection of the poly(A) tail against deadenylation.
A two-hybrid assay, analysed by deep sequencing, revealed that MKT1 interacts with at least 10 proteins with 
RNA-binding domains, some of which were also active in a high throughput tethering assay. There were, however, 
also possible interactions with the mRNA degradation machinery. We suggest, therefore, that trypanosome MKT1 is 
at the centre of a post-transcriptional regulatory network.
442 B Mpn1, mutated in poikiloderma with neutropenia protein 1, unveils cellular surveillance 
of catalytic spliceosomal small nuclear RNAs.
Vadim Shchepachev1, Charlotte Soneson2, Claus M. Azzalin1
1ETH Zürich; 2Swiss Institute of Bioinformatics
We have recently demonstrated that Mpn1 is an evolutionary conserved RNA exonuclease that trims the 3’-end 
polyuridine (oilgoU) tail of the spliceosomal small nuclear RNA (snRNA) U6 post-transcriptionally. Fission yeast 
strains deleted for the mpn1+ gene and cells from human patients affected by the rare genodermatosis poikiloderma 
with neutropenia (PN), which is associated to mutation in the hMPN1 gene, carry aberrant U6 molecules with oligoU 
tails that are longer than in normal cells and are devoid of their typical 2’-3’ cyclic phosphate groups. We have also 
shown that lack of Mpn1 leads to increased U6 degradation rates, revealing that Mpn1 promotes U6 stability, and 
proposed the existence of a quality control of U6. Here we show that in mpn1Δ yeast cells, U6 oligoU tails are largely 
adenylated, indicating that 2’-3’ cyclic phosphate groups may prevent adenylation. Adenylated U6 also accrues in 
cells deleted for the nuclear exosome component rrp6+ and in double mutants mpn1Δ/rrp6Δ: thus Rrp6 is at least in 
part responsible for the degradation of U6 molecules that have not been processed by Mpn1. Ectopically expressed, 
catalytically inactive U6 molecules are not processed by Mpn1 confirming the existence of a cellular RNA surveillance 
pathway able to discriminate between catalytically active and inactive U6, and to communicate the outcome of the 
quality check to Mpn1. We also find that human Mpn1 processes not only U6 but also U6atac, an snRNA component of 
the minor U12-type spliceosome. Similarly to U6, in PN cells, U6atac lacks a 3’ end cyclic phosphate and is degraded 
more rapidly than in cells from healthy individuals. Our data unveil an intricate cellular circuit dedicated to the quality 
control of major and minor spliceosome components, and pave the way for understanding the molecular bases of PN.
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445 B CBP1 mRNA is cleaved and produces nonstop mRNA in a tRNA splicing endonuclease 
activity dependent manner
Tatsuhisa Tsuboi1, Yutaka Suzuki2, Tohru Yoshihisa3, Toshifumi Inada1
1Graduate School of Pharmaceutical Sciences, Tohoku University; 2Graduate School of Frontier Sciences, The 
University of Tokyo; 3Graduate School of Science, Nagoya University
Cells have surveillance systems that eliminate aberrant mRNAs to prevent the production of potentially harmful 
protein products. Non-Stop Decay (NSD) rapidly degrades an aberrant mRNA lacking a termination codon (nonstop 
mRNA) that is produced mainly by polyadenylation within an ORF. No-Go Decay (NGD) leads to an endonucleolytic 
cleavage of the mRNA when a ribosome is stalled on the ORF, and produces nonstop mRNA. We recently reported 
that the Dom34:Hbs1 stimulates degradation of the nonstop mRNA by dissociating the ribosome that is stalled at the 
3’ end of the mRNA. However, an endonuclease and an endogenous target of NGD have not been identified. tRNA 
splicing endonuclease is reported to localized to mitochondria outer membrane to play a role of itself, although there 
is a possibility that it cleaves a cytoplasmic mRNA.
Here, we report that CBP1 mRNA is cleaved and produces nonstop mRNA in a tRNA splicing endonuclease 
activity dependent manner. CBP1 is a nuclear encoded protein that is imported into mitochondria. Deletion analyses 
revealed a mitochondria targeting signal and a 652-726nt sequence of CBP1 are indispensable for the cleavage. 
Furthermore, a 643-738nt sequence of CBP1 inserted between a GFP ORF and a HIS3 ORF of a GFP-HIS3 reporter 
sufficiently induced the endonucleolytic cleavage when a mitochondria targeting signal was also inserted at the amino 
terminus of GFP. Also, tRNA splicing endonuclease component sen54 and sen2mutant cells lacking endonuclease 
activity eliminated the cleavage of CBP1 and GFP-HIS3 reporter mRNAs. These results suggest that CBP1 mRNA is 
localized to the mitochondria to be cleaved by Sen splicing endonuclease complex. This is the first implication for the 
correlation between mRNA quality control and mRNA localization to organelle. Now, we are analyzing endogenous 
mRNAs encoding proteins localized to mitochondria whether to be endonucleolytically cleaved or not by using RNA-
seq.
444 A Structural basis for the multiple roles Edc3 plays in mRNA degradation
Remco Sprangers1, Simon Fromm2, Charlotte Meylan2, Niklas Hoffmann2, Anna-Lisa Fuchs2, Vincent Truffault2
1Max Planck institute for Developmental Biology. Tuebingen, Germany; 2Max Planck Institute for 
Developmental Biology
The Dcp1:Dcp2 decapping complex catalyzes the removal of the protecting 5’ cap structure from mRNA. Adaptor 
proteins, including Edc3 (enhancer of decapping 3), modulate this decapping process through multiple mechanisms. 
First, the Edc3 protein enhances the activity of the Dcp2 enzyme directly. Secondly, Edc3 is involved in the formation 
of cellular processing bodies. Finally, Edc3 is important for the deadenylation independent degradation of the Rps28b 
mRNA. In the latter case, cellular Rps28b protein levels are regulated through a unique auto-regulatory pathway, 
where Rps28b that is not in complex with the ribosome binds to a specific stem-loop in the 3’-UTR of its own 
messenger-RNA.
To understand how the Edc3 protein is able to preform these multiple functions, we solved the structure of the 
yeast Edc3 LSm domain in complex with a short helical leucine-rich motif (HLM) from Dcp2. Based on that structure, 
we identified additional HLMs in the disordered C-terminal extension of Dcp2 that can interact with Edc3. We show 
that these multiple HLMs in Dcp2, together with the dimeric nature of Edc3, can lead to the formation of a network 
of intermolecular interaction. Our experiments thus provide initial insights into one of the mechanisms that underlie 
processing body formation. Finally, we solved the structure of the Edc3 LSm domain in complex with the Rps28b 
protein. These data display how the dimeric Edc3 protein is able to bring the Rps28b mRNA and the Dcp1:Dcp2 
decapping complex together, thereby targeting the mRNA for degradation.
In summary, we show that the Edc3 LSm domain is a plastic platform for multiple protein:protein interactions that 
are important for the regulation of mRNA degradation.
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447 A Activation of RNA cap methylation by CDK1
Michael Aregger1, Victoria H. Cowling1
1MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee, 
DD1 3AU, UK
Eukaryotic RNA polymerase II transcripts, such as mRNA, are modified by the addition of a 7-methylguanosine 
cap which is essential for gene expression and cell viability. The methyl cap stabilises mRNA by protecting it from 5’ 
to 3’ exoribonucleolytic degradation, and interacts with the cap-binding complex (CBC) and the eukaryotic initiation 
factor 4E (eIF4E), thus promoting transcription, splicing, polyadenylation, nuclear export and translation initiation. In 
mammals, 7-methylguanosine cap formation is catalysed by the capping enzyme (RNGTT) which adds a guanosine 
cap to the nascent mRNA and the RNA guanine-7 methyltransferase complex (RNMT-RAM) that methylates the cap. 
The catalytic domain of the methyltransferase complex resides on RNMT whereas RAM has a regulatory effect.
Recent work demonstrated that methyl cap formation is a regulated process. The transcription factors E2F1 
and c-Myc can increase 7-methylguanosine levels of specific transcripts. Futhermore, methyl cap synthesis can be 
regulated under normal and stress conditions such as amino acid starvation.
In order to better understand the molecular mechanisms that regulate cap methylation in human cells we 
investigated RNMT post-translational modifications. Analysis by orthophosphate labelling and mass spectrometry 
revealed that RNMT is phosphorylated. We identified the predominant phosphorylation site and demonstrated that 
Cyclin-dependent kinase 1 (CDK1/Cyclin B) is responsible for RNMT phosphorylation during G2/M phase of the 
cell cycle. Interestingly, RNMT phosphorylation increases cap methyltransferase activity in vitro and loss of this 
phosphorylation site reduces cell proliferation. Preliminary data suggests that RNMT phosphorylation regulates gene 
expression in gene-specific manner.
Currently, we are investigating why RNMT is phosphorylated during G2/M phase and why RNMT phosphorylation 
regulates specific transcripts.
446 C Enriched density of UPF1 in 3’ untranslated regions results from its translation-dependent 
displacement from coding sequences
David Zünd1, Andreas Gruber2, Mihaela Zavolan2, Oliver Mühlemann3
1Dept. of Chemistry and Biochemistry, University of Bern, CH-3012 Bern, Switzerland; Graduate School for 
Cellular and Biomedical Sciences, University of Bern, Switzerland; “2Biozentrum, University of Basel, CH-
4056 Basel, Switzerland;
The RNA helicase UPF1 is best known for its key function in mRNA nonsense-mediated mRNA decay 
(NMD), but has also been implicated in additional mRNA turnover mechanisms, telomere homeostasis, and DNA 
replication. In NMD, UPF1 recruitment to target mRNAs is thought to occur through interaction with release factors 
at terminating ribosomes, but evidence for translation-independent interaction of UPF1 with the 3’ untranslated 
region (UTR) of mRNAs has also been reported. To map UPF1 binding sites transcriptome-wide, we performed 
individual-nucleotide resolution UV crosslinking and immunoprecipitation (iCLIP) in human cells, untreated or after 
inhibiting translation by puromycin. Our results revealed a strongly enriched association of UPF1 with 3’ UTRs in 
undisturbed, translationally active cells. After translation inhibition, a significant increase in UPF1 binding to coding 
sequence (CDS) was observed, indicating that UPF1 binds RNA before translation and gets displaced from the CDS 
by translating ribosomes. Our evidence for translation-independent UPF1-RNA interaction, which is corroborated by 
UPF1 crosslinking to long non-coding RNAs, suggests that the decision to trigger NMD occurs after association of 
UPF1 with mRNA, presumably through activation of RNA-bound UPF1 by aberrant translation termination.
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448 B An emerging role for double-stranded RNA binding domains: regulating the sub-cellular 
localization of proteins
Pierre Barraud1, Silpi Banerjee3, Stephan Emmerth2, Weaam Ibrahim1, Katrina Woolcock2, Marc Bühler2, Michael 
Jantsch3, Frédéric Allain1
1ETH Zürich; 2Friedrich Miescher Institute for Biomedical Research Basel; 3Max F. Perutz Laboratories 
Vienna
Double-stranded RNA binding domains (dsRBDs) are well characterized RNA binding domains that bind 
specifically to double-stranded RNA (dsRNA) [1]. DsRBD-containing proteins are therefore implicated in many 
biological processes involving dsRNA such as gene silencing through RNA interference pathways, regulation of 
translation, RNA processing and messenger-RNA editing. Strikingly, increasing examples of dsRBDs involved in 
the regulation of protein sub-cellular localization suggest a new important function for a sub-class of dsRBDs. For 
instance, the fission yeast dicer (Dcr1) contains a C-terminal dsRBD that has been shown to be essential for nuclear 
retention of the protein [2]. Additionally, the third dsRBD of the human mRNA deaminase enzyme ADAR1 has been 
shown to harbour a nuclear localization signal essential to target ADAR1 to its nuclear substrates [3].
We used solution NMR spectroscopy to get insights into the molecular determinants regulating the sub-cellular 
localization of these dsRBD-containing proteins. On the one hand, the structure of the C-terminal dsRBD of Dcr1 
revealed an extended dsRBD fold embedding an unexpected zinc-binding motif [4]. This unconventional zinc-
binding site, which is highly conserved among dicers in yeasts, extends the canonical dsRBD fold thereby generating 
a conserved and adjustable platform involved in the regulation of the subcellular localization of Dcr1 [5]. Strikingly, 
although the extended dsRBD of Dcr1 binds to dsRNA, this property is dispensable for proper functioning of Dcr1 
in the RNAi pathway. This raises the attractive possibility that this new class of extended dsRBD might generally 
function in nucleo-cytoplasmic trafficking and not substrate binding. On the other hand, the structure of ADAR1 
dsRBD3 also revealed an extended dsRBD fold with additional structured elements. As in the case of Dcr1, the 
extension to the canonical dsRBD fold is critical for targeting ADAR1 to the nucleus. Even though it lacks the 
well-established PY-NLS motif, this extension participates in the interaction with Transportin 1 (also referred to as 
Karyopherin-β2), thereby promoting ADAR1 nuclear import. As for Dcr1’s dsRBD, ADAR1 dsRBD3 fully retains 
the capacity to bind to dsRNA, suggesting that extending the dsRBD fold would be a widespread strategy to acquire 
additional function without loosing the original dsRNA binding activity.
1. Masliah, Barraud & Allain (2013) Cell. Mol. Life Sci. in press.
2. Emmerth et al. (2010) Dev. Cell 18:102-113.
3. Fritz et al. (2009) Mol. Cell. Biol. 29:1487-1497.
4. Barraud et al. (2011) EMBO J. 30:4223-4235.
5. Woolcock et al. (2012) Genes Dev. 26:683-692.
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450 A A Hundred million sites located in majority of human genes are subject to A-to-I RNA 
editing
Lily Bazak1, Ami Haviv1, Michal Barak1, Jasmine Jacob-Hirsch1, Karen Kesarcas2, Gideon Rechavi2, Jin Billy Li3, 
Erez Y. Levanon1, Eli Eisenberg4
1Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel; 
2Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel; 3Department of 
Genetics, Stanford University School of Medicine, Stanford, California 94305, USA; 4Raymond and Beverly 
Sackler School of Physics and Astronomy, Tel-Aviv University, Tel Aviv 69978, Israel
RNA molecules carry the  information encoded in the genome  and  reflect  its  content.  Adenosine-to-inosine 
modification of RNA molecules (A-to-I RNA editing)  by ADAR proteins  converts a genomically encoded adenosine 
(A) into inosine (I).  It  is known  that most RNA editing in human  take  place in the primate specific Alu sequences 
but the scope of this phenomenon and its effect of transcriptome diversity is not clear yet. Here we show, by  analyzing 
large-scale  RNA-seq data and by  performing ultra-deep
sequencing of selected Alu sequences, that the scope of editing is much larger than was anticipated. More than 
700,000  Alu repeats  can form  dsRNA structures, and virtually all adenosines within these Alu repeats undergo A-to-I 
editing to some extent. Moreover, we observe editing of transcripts resulting from residual anti-sense expression, 
doubling the number  of edited  sites  in the  human  genome. The total number is thus estimated to  exceed  100 
million sites. Our ultra-high coverage enables us to probe editing levels  that  span a wide range,  with few  sites  being 
fully  converted  while  most sites  exhibit low levels (<1%).  Our finding set the stage for exploring how this primate-
specific diversification of the transcriptome is utilized.
449 C Revealing the full scope of Alu editing - over a hundred million genomic sites are subject 
to primate-specific A-to-I RNA editing
Lily Bazak1, Ami Haviv1, Michal Barak1, Jasmine Jacob-Hirsch1, Karen Kesarcas2, Gideon Rechavi2, Jin Billy Li3, 
Erez Y. Levanon1, Eli Eisenberg4
1Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 52900, Israel; 
2Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer 52621, Israel; 3Department of 
Genetics, Stanford University School of Medicine, Stanford, California 94305, USA; 4Raymond and Beverly 
Sackler School of Physics and Astronomy, Tel-Aviv University, Tel Aviv 69978, Israel
RNA molecules carry the information encoded in the genome and reflect its content. Adenosine-to-inosine 
modification of RNA molecules (A-to-I RNA editing) by ADAR proteins converts a genomically encoded adenosine 
(A) into inosine (I). It is known that most RNA editing in human take place in the primate specific Alu sequences but 
the extent of this phenomenon and its effect on transcriptome diversity is not clear yet.
Analyzing large-scale RNA-seq data and by performing ultra-deep sequencing of selected Alu sequences, we 
show that the scope of editing is much larger than was anticipated. More than 700,000 Alu repeats can form dsRNA 
structures, and virtually all adenosines within these Alu repeats undergo A-to-I editing to some extent. Moreover, we 
observe editing of transcripts resulting from residual anti-sense expression, doubling the number of edited sites in the 
human genome. The total number is thus estimated to exceed a hundred million sites. Our ultra-high coverage enables 
us to probe editing levels that span a wide range, with few sites being fully converted while most sites exhibit low 
(<1%) levels.
We further studied the effect of Alu editing on transcriptome diversity. The number of different variants seem to 
grow with coverage, with no sign of saturation. Looking at the information included in each Alu repeat in terms of 
its editing pattern, Shanon’s information entropy ranges from 5 to 9 bits per Alu. The average number of inosines per 
transcribed Alu also varies considerably among the randomly selected Alus, ranging between 1 and 19 inosines per 
transcript. Finally, we estimate the number of Alu-derived inosines to be roughly 100,000-fold higher than the number 
of inosines located in the Q/R of the glutamate receptor.
These finding naturally lead to the question of how this primate-specific diversification of the transcriptome is 
utilized.
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452 C Alu inverted repeats induce human specific site selective A-to-I RNA editing
Chammiran Daniel1, Gilad Silberberg3, Marie Öhman2
1Department of Molecular Biosciences, The WennerGren Institute, Stockholm University; 2Department 
of Molecular Biosciences, The WennerGren Institute, Stockholm University; 3Department of Molecular 
Biosciences, The WennerGren Institute, Stockholm University
RNA editing by adenosine (A) deamination to inosine (I) is a common event in the human transcriptome due to 
the high frequency of Alu elements. Alu inverted repeats are targeted for A-to-I editing because of their ability to form 
hairpin structures of double stranded RNA, a requisite for ADAR editing. Recent high throughput sequencing (RNA-
Seq) has revealed several hundred thousand edited sites within these Alu repeats.Nevertheless, the function of editing 
within repetitive elements is largely unknown. Using bioinformatic and experimental analyses we show that primate 
specific site selective editing in non-repetitive sequence often is found adjacent to Alu inverted repeats. We propose 
that Alu elements forming long, almost completely base paired structures can work as recruitment elements for the 
ADAR proteins and thereby induce editing in non-repetitive sequence. One primate specific site of editing is located 
in the transcript coding for the DNA repair enzyme NEIL1. Editing within exon 6 of this mRNA recodes a lysine for 
an arginine (K/R). We show that efficient editing at this site is dependent on the presence of a cis-acting Alu inverted 
repeat located 200 nucleotides upstream of the K/R site. We found this site to be efficiently edited also in rhesus 
monkey but not in mouse and rat. The upstream Alu inverted repeat in NEIL1 is conserved between rhesus and 
human. We propose that recruitment of ADAR to Alu elements increase the local concentration of the editing enzyme 
and thereby increase editing efficiency at other sites located in less stable duplex structures. We therefore suggest 
that Alu repeats can work as editing inducers, specifically increasing the variability in the human transcriptome. 
451 B MODOMICS: a database of RNA modification pathways - new developments
Janusz Bujnicki1, Magdalena Machnicka1, Kaja Milanowska3, Kristian Rother3, Mark Helm4, Henri Grosjean2, 
Elzbieta Purta1, Okan Osman Oglou4, Malgorzata Kurkowska1, Anna Olchowik1, Witold Januszewski1, Stanislaw 
Dunin-Horkawicz1, Pawel Piatkowski1, Sebastian Kalinowski3
1Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology 
in Warsaw, Ul. Ks. Trojdena 4, 02-109 Warsaw, Poland.; 2Centre de Génétique Moléculaire, UPR 3404, 
CNRS, Université Paris-Sud, FRC 3115, 1 avenue de la Terrasse, 91190 Gif-sur-Yvette, France; 3Faculty of 
Biology, Adam Mickiewicz University, ul. Umultowska 89, PL-61-614 Poznan, Poland; 4Institut für Pharmazie 
und Biochemie, Johannes Gutenberg-Universität, Staudinger Weg 5, D-55128 Mainz, Germany
MODOMICS is a database of RNA modifications that provides comprehensive information concerning the 
chemical structures of modified ribonucleosides, their biosynthetic pathways, location of modified residues in RNA 
sequences, and RNA-modifying enzymes. In the current database version, accessible at http://modomics.genesilico.
pl, we included new features: a census of human and yeast snoRNAs involved in RNA-guided RNA modification, 
a new section covering the 5′ end capping process, and a catalogue of “building blocks” for chemical synthesis of a 
large variety of modified nucleosides. The MODOMICS collections of RNA modifications, RNA-modifying enzymes 
and modified RNAs have been also updated. A number of newly identified modified ribonucleosides and more than 
one hundred functionally and structurally characterized proteins from various organisms have been added. In the RNA 
sequences section, snRNAs and snoRNAs with experimentally mapped modified nucleosides have been added and 
the current collection of rRNA and tRNA sequences has been substantially enlarged. To facilitate literature searches, 
each record in MODOMICS has been cross-referenced to other databases and to selected key publications. New 
options for database searching and querying have been implemented, including a BLAST search of protein sequences 
and a PARALIGN search of the collected nucleic acid sequences.Finally, we have developed a new nomenclature for 
nucleic acid modifications.
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453 A Identifying the function of highly conserved residues for pseudouridine formation 
through a combination of in silico and in vitro studies
Jenna Friedt1, Fern Leavens1, Evan Mercier1, Hans-Joachim Wieden1, Ute Kothe1
1Department of Chemistry and Biochemistry, University of Lethbridge, Lethbridge, AB, Canada
Pseudouridine  is the most abundant post-transcriptional RNA modification and is formed through the 
isomerization of uridine to pseudouridine by enzymes known as pseudouridine synthases. These enzymes share a 
common catalytic domain and active site structure including a strictly conserved aspartate residue that is essential 
for catalysis. However, the exact mechanism of pseudouridine formation is still unknown. Here, a combination of in 
silico and in vitro studies was used to identify residues involved in catalysis in order to better understand the catalytic 
mechanism of pseudouridine synthases. First, molecular dynamics simulations of the E. coli pseudouridine synthase 
TruB, responsible for the formation of pseudouridine 55 in tRNA, were performed in the absence of substrate for 40 ns 
in two functionally different conformations. The simulations revealed two highly conserved residues, R181 and D90, 
that showed differential interaction patterns with the catalytic D48 residue. As known from crystallographic studies, 
R181 can form a hydrogen bond with the catalytic D48 residue. Interestingly however, R181 can also interact with the 
second-shell residue D90. This suggests that R181 may switch between two conformations, facilitated by D90. This 
switch might in turn be important for catalysis. To test this hypothesis, in vitro mutational studies on R181 and D90 
were conducted to identify the precise roles of R181 and D90 for TruB’s function. Although substrate binding was 
not affected by amino acid substitutions at these positions, catalysis was severely impaired. Upon changing D90 to 
glutamate, asparagine or alanine, the rate of pseudouridine formation decreased 30 to 600-fold, respectively. Likewise, 
substituting R181 with lysine reduced the catalytic rate over 2500-fold while substitutions with methionine or alanine 
caused a reduction of more than 5000-fold. Our findings suggest that R181 and D90 work together to position the 
catalytic residue D48 which is critical for efficient pseudouridine formation. Further experiments and molecular 
dynamics simulations are underway to identify in which step of TruB’s mechanism R181 and D90 are involved. In 
summary, the use of molecular dynamics simulations in combination with in vitro assays has enabled us to identify 
two residues important for catalysis and will assist in determining the mechanism of pseudouridine formation that may 
be common to all pseudouridine synthases.
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454 B Identification of the last rRNA methylase YhiR E.coli using a new technique
Anna Golovina1, Margarita Dzama3, Petr Sergiev2, Olga Dontsova2
1A.N. Belozersky Institute of Physico-Chemical Biology MSU; 2Chemistry Department of Moscow State 
University; 3Faculty of Bioingeneering and Bioinformatics of Moscow State University
The prokaryotic rRNA is highly modified, and one of two major types of these modifications is methylation. The 
role of methylated nucleotides in ribosome remains undiscovered yet but is still intriguing. The key obstacle arises at 
the first step of this study: the lack of information about the enzyme that modifies the concrete nucleotide renders the 
problem practically insoluble.
Here we suggest a very simple and useful method that allowed us to identify the last rRNA methylase YhiR (RlmJ). 
The proposed method is based on a melting of RNA-DNA duplexes formed by rRNA and two oligodeoxyribonucleotides 
with different length that are both complementary to rRNA in area of concrete modified nucleotide of rRNA (see figure 
1). In our system the shorter oligonucleotide is modified by the Black Hole Quencher (BHQ1) at the 3’-terminus 
and hybridizes accurately with the nucleotide of interest and some neighboring nucleotides of rRNA. The longer 
oligonucleotide is modified by FAM at the 5’-terminus and hybridizes with the rRNA just near the shorter one.
We showed that the correct pair of such oligonucleotides allows us to get a remarkable difference in differential 
melting curves between methylated and non-methylated nucleotide in rRNA.
We proceeded to the search for the last rRNA methylase that modifies nucleotide A2030 of 23S rRNA. The set 
of annotated and putative rRNA methylases was chosen to be analyzed: YbiN, YecP, YjhP, YafS, SmtA, YmfD, LasT, 
YfiF, YfiC, YiiV, YecO, YgiQ, KsgA, YhiR, YhdJ and YafE. We compared rRNAs isolated from knockout strains 
lacking one of listed genes using our melting method and received differential melting curves that showed a great 
difference in its character for the rRNA from the knockout strain ΔyhiR (see figure 2).
Owing to these results we found a very short way to following demonstration of functional activity of the new 
enzyme. We showed that YhiR is actually SAM-dependent methylase that specifically methylates nucleotide A2030 
of 23S rRNA. Moreover, it acts at the first stage of ribosome assembly, when the 23S rRNA is free from ribosomal 
proteins.
Thus, we demonstrate a very simple and convenient technique for rapid identification of rRNA modifying enzymes.
FAM
BHQ1
rRNA
Modiﬁed nucleotide
Figure 1.  rRNA-DNA duplex.  The long oligodeoxyribonucleotide 
modiﬁed by FAM is coloured by orange. The short one is modiﬁed 
by BHQ1 and coloured by blue.
Figure 2. Diﬀerential curves for rRNA from corresponding 
knockout strains and wild type (RFU - relative ﬂuorescence units).
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455 C RAM: a novel and essential component of RNA cap methylation
Thomas Gonatopoulos-Pournatzis1, Victoria H. Cowling1
1MRC Protein Phosphorylation and Ubiquitylation Unit, College of Life Sciences, University of Dundee, 
Dundee, Dow Street, DD1 5EH, U.K.
Eukaryotic gene expression is dependent on the 7-methylguanosine cap moiety, which is located at the 5’ end of 
all RNA polymerase II primary transcripts. The 7-methylguanosine cap has a central role in most gene expression 
layers including transcription, splicing, nuclear export of both mRNA and snRNA, mRNA translation and decay and 
miRNA processing. The enzymes that catalyze the formation of the 7-methylguanosine cap are recruited to RNA 
polymerase II at the initial stages of transcription. The final step in this process, N-7 methylation of the guanosine cap, 
is catalyzed by the RNA guanine-7 methyltransferase, RNMT.
Recently, we demonstrated that RNMT does not function as a monomer but instead forms a heterodimer with a 
protein we designated as RAM (RNMT activating mini-protein), which is a novel component of the mammalian cap 
methyltransferase complex. The vast majority of cellular RNMT was found in a complex with RAM and vice versa. 
RAM is an RNA-binding protein, promoting recruitment of RNA to RNMT. RAM also increases recombinant and 
cellular RNMT cap methyltransferase activity and it is required for guanine-7 methylation in vivo. Therefore, we 
described RAM as an “obligate activator” of the human cap methyltransferase. As expected of a protein essential for 
cap methylation, RAM is required for mRNA translation, and loss of RAM results in loss of cell viability1.
Here we dissect RAM functional domains and we demonstrate that RAM and RNMT can protect each other from 
proteasomal degradation. RAM N-terminus, which mediates RNMT interaction, is sufficient for stabilizing RNMT. 
However, the minimal RAM domain that is required for RNMT activation is more extensive than the minimal RAM 
domain that mediates the interaction with RNMT. This may suggest that upon RAM binding RNMT undergoes a 
major conformational change. Current studies focused on determining the crystal structure of RAM–RNMT complex 
will shed light on this hypothesis.
In addition, here we demonstrate that RAM C-terminus is essential for RAM nuclear accumulation. Although 
RNMT contains three classical nuclear localization signals (NLS) and utilizes the Importin-α/β pathway for its 
nuclear import, RAM does not contain a classical NLS. Therefore, it was speculated that RAM is imported into 
the nucleus via RNMT interaction. However, the observation that RAM–RNMT interaction is not sufficient for 
RAM nuclear localization indicates that RAM contains its own NLS. Preliminary results suggest that RAM nuclear 
localization is mediated by Transportin-1, which recognizes a PY-NLS motif at RAM C-terminus. These data propose 
that RNMT and RAM utilize distinct nuclear import pathways and that the cap methyltransferase complex is only 
formed in the nucleus.
1. Gonatopoulos-Pournatzis, T., et al., RAM/Fam103a1 is required for mRNA cap methylation. Molecular cell 44, 585–96 
(2011).
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457 B Structural and Functional Analysis of Archaeal ATP-dependent RNA Ligase.
Kiong Ho1, Huiqiong Gu3, Yuko Takagi3, Katsuhiko Murakami2
1University at Buffalo, University of Tsukuba; 2Pennsylvania State University; 3University at Buffalo
Archaea possess two different RNA ligases that catalyze the formation of 3’-5’ phosphodiester bond; a monomeric 
RtcB/tRNA ligase that joins 2’-3’ cyclic phosphate and 5’-hydroxyl RNA, and a homodimeric ATP-dependent RNA 
ligase, that joins a 3’-hydroxyl to a 5’-phosphate RNA. Here we report the structure and mechanism of ATP-dependent 
RNA ligase from Methanobacterium thermoautotrophicum (MthRnl). Crystal structure of MthRnl in complex with 
ATP, AMP-CPP-Mg, and ligase-AMP intermediate were solved. Analysis of mutational effects on individual steps of 
the ligation pathway underscored how different functional groups come into play during the ligase-adenylylation (step 
1) reaction versus the subsequent steps of RNA-adenylylation (step 2) and phosphodiester formation (step 3), and 
how does the homodimic quaternary structure contributes to the ligation reaction. Putative RNA binding surface on 
the MthRnl was identified through mutagenesis. Mutational analysis within the dimer interface suggests that Phe272, 
Phe273, Ilu304 and Ilu305 contribute to the stability of the dimer, and contributes to the ligation activity. A proposed 
model on how MthRnl recognize the break in RNA strands will be discussed.
456 A Conserved circuitry in eukaryotes for crucial Trm7 modifications of the tRNA anticodon loop
Michael Guy1, Eric Phizicky1
1University of Rochester Medical School
Post-transcriptional modification of the anticodon loop of tRNA is critical for translation and proper cell growth. 
We recently reported that lack of 2’-O-methylated C
32
 (Cm
32
) and Nm
34
 in Saccharomyces cerevisiae trm7-? mutants 
causes slow growth due to reduced function of tRNAPhe, but not of the other Trm7 substrates tRNATrp and tRNALeu(UAA) 
(Guy M. P. et al., (2012) RNA. 10:1921-33).  In addition, we described a complex circuitry for anticodon loop 
modification, in which Trm7 also requires its interacting partner Trm732 for Cm
32
 formation and its interacting partner 
Trm734 for Nm
34
 formation, and showed that Cm
32
 and Gm
34
 formation drives subsequent production of yW
37
 from 
m1G
37
 on tRNAPhe. 
Available evidence suggests that the circuitry for Trm7 modification of tRNA is conserved and is important 
in other eukaryotes.  2’-O-methylation of the anticodon loop of tRNA is common to all characterized eukaryotic 
tRNAPhe and tRNATrp species, and putative TRM7, TRM732, and TRM734 orthologs are found in the vast majority of 
eukaryotes.  Moreover, the putative human TRM7 homolog FTSJ1 is associated with X-linked mental retardation, and 
the putative Schizosaccharomyces pombe Trm7 homolog is reported to be essential in high throughput studies.  
Consistent with a conserved circuitry and function, our results demonstrate that Trm7 and Trm732 orthologs from 
humans, S. pombe, and Drosophila complement the corresponding S. cerevisiae mutants, and in each case can function 
with the corresponding S. cerevisiae interacting partner.  Furthermore, we find that S. pombe trm732-? and trm734-? 
mutants lack Cm
32
 and Gm
34
 respectively in their tRNAPhe.  Thus, we suggest that the circuitry of Trm7, Trm732, and 
Trm734 is conserved in eukaryotes for modification of the anticodon loop of substrate tRNAs.
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459 A 2´-SCF3 Modified Pyrimidine Nucleosides as Labels for Probing RNA Structure and 
Function by 19F NMR Spectroscopy
Marija Košutic1, Katja Fauster2, Christoph Kreutz2, Ronald Micura2
1University of Innsbruck; 2Institute of Organic Chemistry, University of Innsbruck, Innsbruck, Austria
The high natural abundance and intrinsic sensitivity of 19F make it a perfect orthogonal NMR probe for investigating 
RNA and other biomolecules in in vitro and in vivo systems. Incorporation of three equivalent fluorine atoms into a 
biomolecule provides experimental performance at micromolar concentrations which is a significant improvement 
compared to the low millimolar range required for the single-atom labels. In this study, we present synthetic pathways 
to 2´-SCF3 labeled uridine [1] and cytidine building blocks and their incorporation into oligoribonucleotides using 
the 2´-O-TOM-methodology for RNA solid-phase synthesis. Furthermore, the efficient synthetic access to 2′-SCF3 
modified RNA prompted us to evaluate the new label in 19F NMR applications. Here, we demonstrate three examples: 
1) probing of the secondary structure of bistable RNA; 2) verification of RNA–protein interactions; and 3) attesting a 
rationally designed riboswitch module.
1. Fauster, K., Kreutz, C., & Micura, R. (2012). 2′-SCF3 Uridine –A Powerful Label for Probing Structure and Function of 
RNA by 19F NMR Spectroscopy. Angewandte Chemie International Edition, 51(52), 13080-13084.
Financial support from the EU REA FP7 (Marie Curie ITN RNPnet 289007) and the Austrian Science Fund FWF 
(I317, P21641 to R.M.; I844 to C.K.) is gratefully acknowledged.
458 C Consequences of FilaminA editing
Mamta Jain1, Maja Stulic1, Dieter Pullirsch1, Michael Jantsch1
1Max F. Perutz Laboratories, University of Vienna, Austria
RNA editing by ADARs (Adenosine deaminases that act on RNA) is a highly conserved phenomenon leading 
to diversification of the transcriptome. Of all RNA editing events, Adenosine to Inosine conversion is most common 
in metazoan, where it affects structured RNAs. A-I conversion occurs in many non coding sequences but is also 
found at highly conserved protein coding sites. One of such target encodes Filamin A (FLNA). Filamin A is an actin 
cross-linking protein known to be involved in a variety of functions including cell migration, cell adhesion and cell 
signaling. Filamin A is built of 24 Ig-fold repeats and editing at one site in repeat 22 leads to a single amino acid change 
(Glutamine to Arginine) in the protein. Although the function of Filamin A is quite well known, the significance of 
FLNA editing is poorly understood.
In order to understand the role of FLNA editing, we generated a mouse deficient in FLNA editing (FlnAΔECS). 
Homozygous null mice are viable, fertile and show normal development. The behavioral and physiological phenotyping 
in these mice highlighted a significant difference in social discrimination and acoustic startle response. Using deep 
sequencing method from various mouse organs, we found that FLNA editing is highest in the gastrointestinal tract, 
heart and dorsal aorta. In agreement with FLNA’s function as an actin organizing protein, we observed disorganized 
actin in the epithelial surface of stomach and large intestine of FLNAΔECS mice. Upon challenge with DSS (Dextran 
sodium sulfate) to induce colitis, our preliminary analyses demonstrate that FlnAΔECS mice show more severe 
inflammation as compared to controls. This suggests that FLNA editing could function to give protection against 
epithelial inflammation. Further studies would test the role of FLNA editing in the pathophysiology of colitis and its 
underlying mechanisms.
Parallel studies focusing on the effect of FLNA editing on cellular phenotypes highlighted its role in cell migration. 
FlnAΔECS mEFs show much reduced cell migration which was found to be matrix dependent as compared to controls. 
Currently, we are studying actin remodelling and Integrin signaling in these cells to understand the mechanism by 
which FLNA editing is involved in cell migration.
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461 C A single-molecule study on the molecular mechanism of microRNA uridylation
Luuk Loeff1, Kyu-Hyeon Yeom3, Mohamed Fareh1, V. Narry Kim2, Chirlmin Joo1
1Kavli Institute of NanoScience and Department of BioNanoScience, Delft University of Technology, Delft, 
The Netherlands; 2Institute for Basic Science and School of Biological Sciences, Seoul National University, 
Seoul 151-742, Korea; 3Kavli Institute of NanoScience and Department of BioNanoScience, Delft University 
of Technology, Delft, The Netherlands & Institute for Basic Science and School of Biological Sciences, Seoul 
National University, Seoul 151-742, Korea
MicroRNAs are a class of short non-coding RNAs which play a key role in the regulation of gene expression 
in eukaryotes. Even though the birth and maturation of these small RNAs are well-characterized, the regulation and 
degradation pathways have only recently been explored. Previously, we and other groups showed that TUT4 (Terminal 
Uridylyl Transferase 4) uridylates precursor microRNA (pre-miRNA) in coordination with Lin28 and thus acts as a 
posttranscriptional repressor of microRNA maturation. Using single-molecule fluorescence spectroscopy, we show 
that Lin28 mediates a stable interaction between TUT4 and pre-miRNA [Ref-2011]. With FRET, we further show that 
TUT4 maintains the tight contact with pre-miRNA and Lin28, while it captures the 3’ end of RNA and brings this to 
its catalytic domain. This mechanism leads to the formation of a unique closed loop of the U tail (see figure 1 below) 
[Ref-unpublished]. Our study provides insight into the molecular mechanism of Lin28-mediated oligo-uridylation. In 
addition, it may give a hint to a general mechanism of action of terminal uridylyl transferases.
460 B A Quantitative Atlas of RNA Editing in Mammals Reveals Dynamic Spatiotemporal 
Regulation
Jin Billy Li1, Meng How Tan1, Robert Piskol1
1Stanford University Department of Genetics
RNA editing is as an important post-transcriptional mechanism that diversifies the transcriptome, but accurate, 
genome-wide measurements of editing levels are lacking, especially in mammals. Here, we build a comprehensive 
atlas of RNA editing sites in multiple human and mouse normal tissues, different developmental stages, as well as 
tissues from ADAR1, ADAR2, FMRP, and Pin1 knockout mice. We apply a high throughput  microfluidic-based, 
targeted sequencing approach to capture thousands of human and mouse editing sites identified by us and others. The 
global patterns discovered in our accurate measurements reveal dynamic regulation of RNA editing. We are carrying 
out functional assays to interpret the functionality of several editing sites that are differentially edited. Our results are 
unprecedented at its scale, and will facilitate understanding of how RNA editing is regulated in different biological 
contexts.
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463 B The role of ADAR1 in the innate immune response
Niamh Mannion1, Sam Greenwood1, Xianghua Li1, Mary O’Connell1
1MRC Human Genetics Unit, IGMM, University of Edinburgh, Crewe Road, Edinburgh, EH42XU, UK
Adenosine deaminases acting on RNA (ADAR) catalyze the conversion of adenosine (A) to inosine (I) within double-
stranded RNA (dsRNA). ADARs edit short duplex RNAs site selectively whereas longer dsRNA duplexes are promiscuously 
edited.  A-to-I editing within exons results in recoding events that can alter the functional properties of the encoded proteins. 
However, the majority of editing events (?99% in humans) are promiscuous and occur within non-coding regions of RNA, 
in Alu and other repetitive elements. The biological function of this promiscuous editing is unknown.
In vertebrates there are two catalytically active ADARs; ADAR1 and ADAR2. Adar1 null mice die by day E12.5 due 
to haematopoietic defects resulting from liver disintegration which is associated with an aberrant rise in interferon (IFN). It 
is not known what unedited substrate(s) causes this lethality in the absence of Adar1.
Recently in collaboration with the group of Y. Crow we demonstrate that mutations in ADAR1 cause the human 
autoimmune disease Aicardi-Goutieres Syndrome (AGS) 1. Similar to the phenotype in the Adar null mice, AGS patients 
display heightened levels of IFN and increased expression of IFN stimulated genes (ISGs). The catalytic activity of 
the ADAR1 mutants were assayed ex vivo on a known substrate for ADAR1 and revealed that all of the mutant proteins with 
the exception of the previously identified catalytically inactive G1007R mutation edited the transcript efficiently. The other 
mutations are in the deaminase domain of ADAR1 but how they cause a disease phenotype is unknown.
We have recently rescued the Adar1 null mouse to birth by generating a double homozygous for a gene encoding a 
key innate immune signalling protein. RNA sequencing and RT-qPCR of immune gene transcript was performed on E11.5 
whole embryos and the results reveal that the aberrant rise in type I IFN, inflammatory cytokines and ISGs observed 
in Adar1-/- embryos are rescued in the double knockout embryos.
We propose that ADAR1 plays a major role in the regulation of endogenous cellular dsRNAs and in the absence 
of ADAR1, cellular RNAs aberrantly stimulate an innate immune response which leads to autoimmune disease phenotypes 
such as those seen in AGS patients.
1. Rice, G.I. et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nat 
Genet 44, 1243-8 (2012).
462 A Structural features of Cbf5 and guide RNA involved in the functions of archaeal box H/ACA 
RNP complexes
Mrinmoyee Majumder1, Ramesh Gupta1
1Biochemistry & Molecular Biology, Southern Illinois University, Carbondale, Illinois 62901-4413, USA
Pseudouridine (Ψ), the C-5 ribosyl isomer of uridine, is commonly found at several positions of stable RNAs 
of all organisms. In addition to single or multi-site specific protein-only Ψ synthases, Eukarya and Archaea have 
specific ribonucleoprotein (RNP) complexes that can also produce Ψ at many sites of different cellular RNAs. Each 
complex contains a distinct box H/ACA guide RNA and four core proteins, Cbf5 (NAP57 or dyskerin in mammals), 
Gar1, Nop10 and L7Ae (Nhp2 in Eukarya). Cbf5 is the Ψ synthase in these complexes. Here, we show that Ψs at 23S 
rRNA positions 1940, 1942 and 2605 of Haloferax volcanii (E. coli positions 1915, 1917 and 2572) are absent in both 
Cbf5 and a double stem-loop box H/ACA RNA deleted strains. Plasmid borne copies of cbf5 and the RNA can rescue 
the syntheses of these Ψs. Based on Pyrococcousfuriosus crystal structure (PDB code 2EY4) we identified several 
potential residues and structures in H. volcanii Cbf5, which play important role in pseudouridylation. We mutated 
these structures and determined their in vivo effects towards Ψ production at the three rRNA positions. Mutations 
of some residues that are conserved in all Ψ synthases, and certain residues in the thumb loop resulted in absence of 
Ψs at all three positions. However, mutations of a few residues abolished one of the three Ψs, and some mutations 
showed partial Ψ production. Similarly, by changing a number of structures and mutating certain nucleotides in a 
single stem-loop box H/ACA RNA (the stem-loop responsible for Y2605 in H. volcanii) we show that the conserved 
3’ ACA (AUA here) trinucleotide is not essential for Y formation in vivo and also in vitro (usingMethanocaldococcous 
jannaschii recombinant proteins). However, this trinucleotide is required for a stable binding of the Cbf5 to the guide 
RNA. Furthermore, a proper kink-turn with the two highly conserved G:A pairs (5’ and 3’) is essential for L7Ae 
binding as well as pseudouridylation. The guide-target pairings at both 5’ and 3’ sides of the Y pocket are needed 
for the modification. This study determines certain essential structures of both Cbf5 and box H/ACA guide RNA in 
Archaea that are necessary for a functional RNP formation.
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465 A tRNA wobble uridine hypomodification decreases the decoding efficiency of cognate 
codons in vivo
Danny D. Nedialkova1, Sebastian A. Leidel1
1Max Planck Institute for Molecular Biomedicine, Max Planck Research Group for RNA Biology, Munster, 
48149, Germany
Nucleotide modifications in tRNA are ubiquitous in all domains of life and those in the tRNA anticodon are important 
for accurate codon recognition during translation. Thiolation at the 2-carbon (s2) of the wobble uridine (U34) base is 
universally conserved in three tRNA species - tE(UUC), tK(UUU), and tQ(UUG). In the cytoplasm of eukaryotes, U34 also 
carries a 5-methoxycarbonylmethyl group (mcm5). The ELP complex is required for mcm5 formation, while the URM1 
pathway mediates 2-thiolation. Aberrant U34 modification is associated with diverse phenotypes such as hypersensitivity to 
a wide range of chemical stresses in yeast, neurological dysfunction in nematodes, and cytokinesis defects in human cells. 
In yeast, the phenotypes can be suppressed by overexpressing hypomodified tK(UUU) and tQ(UUG), but the underlying 
molecular mechanisms are unknown. To delineate them, we analyzed the in vivo roles of U34 modification in Saccharomyces 
cerevisiae. We found that the stress sensitivities of cells lacking URM1 pathway or ELP complex genes are increased 
in strains deleted for chaperones linked to protein synthesis. Wild-type and U34 modification-deficient yeast exhibited 
similar polysome profiles, arguing against broad defects in translation elongation in the mutant strains. Thus, we explored 
potential codon-specific defects in translation by ribosome profiling. This approach allowed us to quantitatively compare 
transcriptome-wide ribosome occupancy in wild type and a U34 thiolation-deficient strain (ncs2Δ) grown in rich medium or 
subjected to diamide-induced oxidative stress. Diamide treatment led to widespread changes in gene expression with similar 
magnitude in both strains, suggesting that, despite the hypersensitivity of ncs2Δ to diamide, lack of U34 thiolation does 
not compromise the cellular response to this stress. The number of transcripts with altered ribosome loading in the deletion 
strain, however, was larger in the expression response elicited by diamide. Strikingly, we detected significantly higher 
ribosome occupancy for codons read by the hypomodified tRNAs in the putative A site within RPFs from ncs2Δ yeast. This 
effect was discernible in both unstressed and diamide-treated cells and was accompanied by smaller increases of cognate 
codon occupancy upstream of the A site. Our data thus suggests that U34 hypomodification is associated with translational 
slowdown at cognate codons in vivo that may be intensified by combinations of these codons. We are currently investigating 
whether this phenomenon is conserved in Caenorhabditis elegans and what its impact is on protein abundance and function.
464 C Functional implications from the atomic model of the poly(U) polymerase Cid1
Paola Munoz-Tello1, Caroline Gabus1, Stephane Thore1
1Molecular Biology Department, University of Geneva, 30 Quai Ernest Ansermet, Geneva 1211, Switzerland
In eukaryotes, mRNA degradation begins with poly(A) tail removal, followed by decapping, and finally mRNA 
digestion by exonucleases. In recent years, the major influence of 3’end uridylation as a regulatory step within several 
RNA degradation pathways has driven attention toward the poly(U) polymerase (PUP) enzymes. The protein Cid1 is 
the prototype of the PUP enzyme found in higher eukaryotes. We have determined the atomic structures of the Cid1 
protein bound to its substrate and to its minimal product. Point mutations highlight key residues implicated in the 
catalytic cycle. Our study further underlines the RNA binding properties of Cid1, in particular for the stabilization 
of the substrate RNA molecule. Functional characterization of these features are critical for our understanding of 
miRNAs, histone mRNAs and, more generally, for cellular RNA degradation.
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467 C A Comprehensive Analysis of RNA Modifying Enzymes in Zebrafish
Marion Pesch1, Erez Raz2, Jana Pfeiffer2, Ursula Jordan2, Sebastian Leidel1
1Max Planck Institute for Molecular Biomedicine; 2Westfaelische Wilhelms-Universitaet Muenster
The chemical modification of RNA nucleosides is a widespread phenomenon that occurs in all species analyzed 
so far. Some of these modifications are highly conserved throughout evolution and most enzymes required for their 
generation have been identified and characterized. Nevertheless, we are still lacking insights into the in vivo functions 
of most of these modifications. Interestingly, in lower eukaryotes, deletion of most RNA modification pathways is not 
essential. In contrast, deletion of RNA modifying enzymes in higher eukaryotes can lead to severe phenotypes. While 
most research has been performed in single cell organisms, we know only little about RNA modification pathways in 
vertebrates. Do RNA modification defects generally lead to more severe phenotypes in higher eukaryotes and are RNA 
modification enzymes differentially regulated during development and in different tissues?
To gain insights into the spatio-temporal regulation of RNA modification pathways, we undertook a comprehensive 
analysis of the expression patterns of RNA modification genes in zebrafish (Danio rerio) using in situhybridization. 
To this end, we identified homologues of all known RNA modification genes in yeast and analyzed their expression 
patterns throughout zebrafish embryogenesis using embryos at 4h, 10h, 24h, 48h and 72h post fertilization (hpf).
Here we present the expression patterns of 56 putative RNA modification genes and knockdown experiments of 
selected candidates in zebrafish. We found, that expression levels of RNA modification genes differ. Furthermore, we 
observed an upregulation of RNA modifying genes during later embryogenesis (24hpf, 48hpf, 72hpf) in particular 
tissues: brain, eyes, branchial and pharyngeal arches, pectoral fin buds and myomeres. Our results provide insights 
into the developmental regulation of RNA modification genes in zebrafish and lay the basis for future investigations 
of the in vivo functions of RNA modifying genes in vertebrates.
466 B Localization of ADAR1 to cytoplasmic stress granules
Siew Kit Ng1, Rebekka Weissbach1, Deirdre Scadden1
1Department of Biochemistry, University of Cambridge, UK
Adenosine Deaminases that act on RNA (ADARs) catalyze the conversion of adenosine (A) to inosine (I) within 
double stranded RNA (dsRNA).  Of the three isoforms of ADARs that exist in mammalian cells, only ADAR1 and 
ADAR2 appear to have catalytic activity.  Moreover, differences in subcellular localization suggest that the various 
ADARs may be involved in different pathways.  Analysis of ADAR-null mutants has highlighted the importance of 
ADARs for normal cell function.
Various studies have demonstrated that ADAR1 p150 plays a role in stress pathways and is essential for survival. 
Deletion of ADAR1 p150 in mammalian cells results in an embryonic lethal phenotype due to widespread apoptosis. 
Moreover, a recent study revealed that the loss of ADAR1 p150 also led to global upregulation of interferon-stimulated 
genes.  Apoptosis in the absence of ADAR1 was most likely a consequence of failing to keep the interferon response in 
check.  In addition to these observations, we have recently demonstrated that ADAR1 localizes to cytoplasmic stress 
granules in mammalian cells following either oxidative stress or interferon induction1.
We have now used immunofluorescence analyses to investigate which domain(s) of ADAR1 p150 are essential 
for localization to cytoplasmic stress granules.  We have thus demonstrated that the first Z-DNA binding domain (Zα 
domain), which is uniquely found in ADAR1 p150, is sufficient for localization to stress granules. Furthermore, we have 
shown that mutation of several key amino acids involved in Z-DNA or Z-RNA binding, as determined from structural 
analyses, significantly impairs localization.  In contrast, the second Z-DNA binding domain (zβ domain), which is 
unable to independently bind Z-DNA or Z-RNA, is insufficient for localization to stress granules.  Importantly, we 
have shown that editing activity is not required for localization.  While unexpected, these observations are in keeping 
with a previous study that showed that the Z-DNA binding protein 1 (ZBP1) localized to stress granules during various 
stress conditions.  Moreover, we have gone on to show that the Zα domain from ZBP1 is also sufficient for localization 
to stress granules.  We are now further characterizing the requirements for localization of proteins containing Z-DNA 
(or Z-RNA) binding domains to cytoplasmic stress granules.
1Weissbach, R. and Scadden, A.D.J. (2012). Tudor-SN and ADAR1 are components of cytoplasmic stress 
granules. RNA, 18, 462–471.
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469 B RNA methylation: a mechanism for post-transcriptional regulation that is deregulated in 
cancer?
Tennille Sibbritt1, Hardip Patel1, Brian Parker1, David Humphreys3, Jeffrey Squires3, Susan Clark2, Thomas Preiss1
1Genome Biology Department, The John Curtin School of Medical Research, The Australian National 
University, Canberra, ACT, Australia; 2Cancer Program, The Garvan Institute of Medical Research, 
Darlinghurst, NSW, Australia; 3Molecular Genetics Department, The Victor Chang Cardiac Research 
Institute, Darlinghurst, NSW, Australia
Internal methylation of eukaryotic RNA in the form of N6-methyladenosine (m6A) and 5-methylcytosine (m5C) 
have been known to exist for decades, however, laborious detection methods have limited the understanding of 
their role. With the availability of high-throughput sequencing techniques, these drawbacks have been overcome, 
revealing non-random distribution of internal methylation in a wide variety of RNA biotypes. Early investigation 
into the prevalence of 5-methylcytosine (m5C) in RNA has largely been confined to tRNA and rRNA. Recently, we 
implemented a bisulfite sequencing-based technique for transcriptome-wide as well as locus-specific detection of 
m5C and mapped thousands of m5C sites in the human transcriptome including in mRNA and non-coding RNA. 
Biased distribution of m5C between and within mRNAs, e.g. enrichment in the untranslated regions, is consistent with 
roles in post-transcriptional regulation of gene expression. m5C is a key DNA modification associated with epigenetic 
gene regulation in mammalian cells and is also known to be deregulated in cancer. We have now begun to investigate 
the enzymes responsible for modifying mRNA by an RNAi approach as well as a role of RNA methylation in cancer 
by comparing the m5C profiles of normal prostate cells (PrEC) and metastatic prostate cancer cells (LNCaP). Analysis 
of the recorded patterns of m5C sites in mRNA show many transcripts are differentially methylated between each cell 
line. Currently, we are consolidating and extending the potential link of m5C to post-transcriptional regulation and 
cancer, as well as addressing the molecular function of methylation in mRNA.
468 A Differential expression of Human ADAT subunits
Adrián Gabriel Torres1, Adélaïde Saint-Leger1, Francisco Miguel Torres1, Eva Maria Novoa1, Anna Tor1, Lluís 
Ribas de Pouplana2
1Institute for Research in Biomedicine (IRB Barcelona); 2Institute for Research in Biomedicine (IRB 
Barcelona) and Catalan Institution for Research and Advanced Studies (ICREA)
We have reported that two specific tRNA wobble base modifications contributed to genome evolution and extant 
codon usage biases. We showed that, contrary to prior observations, genomic codon usage and tRNA gene frequencies 
correlate in Bacteria and Eukarya if these two modifications are taken into account, and that presence or absence of 
these modifications explains patterns of gene expression observed in previous studies. We experimentally demonstrated 
that human gene expression levels correlate well with genomic codon composition if these identified modifications 
are considered [1].
As a continuation to this work we have started to characterize the biological role of ADAT (adenosine deaminases 
acting on tRNA) in mammalian cells, and in particular the potential effects of variations in the levels of ADAT activity 
upon the human proteome. Our initial results indicate that ADAT levels do indeed vary, and that this variation is due 
to changes in the levels of one of the enzyme’s subunits. We will discuss these results at the meeting.
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470 C Engineered guideRNA-Dependent Deaminases - A Tool to Modify mRNA
Thorsten Stafforst1, Marius Schneider2
1Interfaculty Institute of Biochemistry, Eberhard-Karls University, Tübingen, Germany; 2Interfaculty 
Institute of Biochemistry, University Tübingen, Germany
RNA modification is an important mechanism in higher organisms to alter gene expression and to diversify the 
gene products.[1] Modifications include pseudo-uridinylation, 2’-hydroxymethylation, and adenosine-to-inosine 
(A-to-I) editing. In contrast to other modifications, the effect of A-to-I editing is readily predictable since inosine is 
read as guanosine in biochemical reactions. Thus, A-to-I editing formally introduces an A-to-G point mutation on 
the RNA-level and results, for instance, in 1) the highly specific reprogramming of single amino acid codons, and 
2) the alteration of RNA splice patterns.[1,2] Consulting the table of the genetic code one finds that 12 out of the 20 
canonical amino acids could be targeted including Asp, Glu, Asn, Gln, His, Lys, Arg, Ser, Thr, Tyr, Ile, and Met/Start, 
and all three Stop codons, a striking accumulation of residues that are essential for enzyme catalysis, posttranslational 
modification (signaling), and general protein function. Consequently, harnessing enzymatic A-to-I deamination would 
make it possible to manipulate RNAs and their protein products in a currently unprecedented manner.
A-to-I editing normally operates via a protein-guided mechanism, thus its re-direction towards new targets has 
not been achieved yet. In our study,[3] we now present a simple way to steer deaminase activity towards user-defined 
sites on mRNA in order to introduce point mutations. To achieve the most rational and arbitrary target selection, we 
turned hADAR1 into a guide-RNA-dependent enzyme by covalently attaching a guide-RNA to its deaminase domain 
(see Figure). The potential and limitations of re-directing RNA-editing for application in biochemistry and medicine 
will be discussed.
1. K. Nishikura, Annu. Rev. Biochem. 2010, 79, 321.
2. S. M. Rueter, C. M. Burns, S. A. Coode, P. Mookherjee, R. B. Emeson, Science 1995, 267, 1491.
3. T. Stafforst, M. F. Schneider, Angew. Chem. Int. Ed. 2012, 51, 11166.
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471 A Impact of inverted SINEs on gene expression
Mansoureh Tajaddod1, Konstantin Licht1, Florian Huber1, Michael Jantsch1
1Department of Chromosome Biology, Max F. Perutz Laboratories University of Vienna, Dr. Bohr Gasse 9, 
A-1030 Vienna
The short interspersed elements (SINEs) comprise the largest family of repetitive elements in the mammalian 
genome and are enriched in gene rich regions. SINEs frequently occur within genes where they are mostly located 
in introns and UTRs. SINEs can have a dramatic impact on the transcriptome by several means such as repressing 
global transcription by impairing polymerase II activity, affecting folding and splicing, or by triggering Staufen 
mediated decay. In addition, SINE elements in inverted orientation can basepair and have been reported to control 
gene expression. As underlying mechanisms, RNA-editing, sequence specific degradation, or translational control has 
been discussed.
Here we aim at determining the impact of inverted, basepaired SINEs located in 3’ UTRs on gene expression. 
So far we could show that the presence of inverted SINE in 3’ UTRs can repress gene expression and reduce mRNA 
levels. Using knock out cells we could show that the reduced gene expression is sequence-independent and does not 
rely on known double-stranded RNA-dependent pathways, such as Dicer, Staufen, PKR, or ADAR.
The reduced RNA levels measured for RNAs containing basepaired double-stranded SINEs could not be correlated 
with an increase in mRNA decay. It therefore seems possible that inverted SINES can control the rate of RNA synthesis.
Thus, besides the previously reported nuclear retention and translational repression induced by inverted SINEs, 
a third mechanism may be triggered. The signals and pathways required for this repression are currently being 
investigated.
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472 B RNA-binding proteins regulate substrate-specific changes in A to I editing patterns
Aamira Tariq1, Wojciech Garncarz2, Oliver Pusch4, Ales Balik3, Michael Jantsch1
1Department of Chromosome Biology, Max F. Perutz Laboratories, University of Vienna; 2Center for 
Molecular Medicine, Austrian Academy of Sciences; 3Institute of Physiology, Department of Cellular 
Neurophysiology, Academy of Sciences of the Czech Republic; 4Medical University of Vienna, Center for 
Anatomy & Cell Biology
RNA-editing by adenosine deaminases that act on RNA (ADARs) converts adenosines to inosines in structured 
or double-stranded RNAs. As inosines are interpreted as guanosines by most cellular machineries, this type of RNA-
editing greatly diversifies the transcriptome, by altering splicing, processing, localization, and translation of coding 
and non-coding RNAs. Consistently, RNA-editing by ADARs is an essential process in mammals.
Interestingly, editing levels vary in different tissues, during development, and also in pathogenic conditions. 
Frequently, editing levels do not reflect the levels of ADARs found in a particular tissue or cell type. Hence it appears, 
as if additional factors may stimulate or repress editing in specific tissues. To isolate such factors we have performed 
a yeast screen that allows to detect changes in editing via the expression of a reporter gene.
From this screen we have isolated both repressors and enhancers of editing. Three proteins that repress ADAR2 
mediated RNA-editing are the RNA-binding proteins RPS14, SFRS9, and DDX15. Overexpression or depletion of 
these proteins in mammalian cells can decrease or increase editing levels by 15% thus allowing a modulation of RNA 
editing up to 30%. Interestingly, the three proteins alter RNA-editing in a substrate-specific manner, changing the 
RNA editing levels of some, but not all editing targets. This substrate specificity correlates well with the RNA-binding 
preferences of the three proteins.
In mammalian cells, SFRS9 significantly affects editing of the two substrates CFLAR and cyFIP2, while the 
ribosomal protein RPS14 mostly inhibits editing of cyFIP2 mRNA. The helicase DDX15, in turn, has only a minor 
effect on mammalian editing substrates. However, lack of DDX15 has a strong effect on the editing of 3’ UTRs in C. 
elegans.
Expression of the three factors decreases during mouse brain development nicely showing an inverse correlation 
with the increase in global editing observed during brain development.
Most interestingly, expression levels of SFRS9 and DDX15 respond strongly to neuronal stimulation or repression 
of rat brain cultures. The fluctuation of these two factors again correlates nicely with the observed changes in editing 
levels in repressed or stimulated brain slices.
Colocalization and immunoprecipitation studies demonstrate a direct interaction of SFRS9 and RPS14 with 
ADAR2, while DDX15 associates with other helicases and splicing factors. Our data show that different editing sites 
can be specifically altered in their editing pattern by changing the local RNP landscape.
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474 A Genetic analysis of the Prp28-bypass mutant reveals further insights on U1 snRNP/5’ 
splice site interaction
Shang-Lin Chang1, Tien-Hsien Chang1
1Genomics Research Center, Academia Sinica, Taipei, Taiwan
Essential genes are mostly ancient, conserved, and indispensable components in the genome. Most of them are 
involved in critical cellular processes, representing the “core genome” of an organism. However, recent studies have 
shown that a number of essential genes can be made dispensable in the presence of specific “bypass mutations”, 
providing nonconventional routes to understand the functions of essential genes. We have previously shown that the 
otherwise essential Prp28 DExD/H-box splicing factor, known to facilitate the U1/U6 switch at the 5’ splice site (5’ss) 
during spliceosomal assembly, can be bypassed by specific alterations in U1-snRNP-related components.   These 
alterations include specific changes in U1C, Snu71, Prp42, Cbp80, and Ynl187.  Detailed analyses on one of bypass 
mutants, i.e., the prp28Δ U1C-[L13F] strain, suggested that weakening the U1-5’ss base pairing is likely to account 
for dispensing the essential Prp28.  These results indicated that Prp28 counteracts the stabilizing effect of U1C. 
To dissect the intricate U1 snRNP/5’ss interactions, we sought to isolate dominant mutations capable of rescuing 
the cold-sensitive (cs) phenotype of the Prp28-bypass strain (see above), which reflects the stalling of U1 snRNP 
dissociation from the 5’ss at low temperature in the absence of Prp28. The isolated 24 mutations are mapped to at 
least three linkage groups.  Cloning of the suppressor genes from two linkage groups revealed specific mutations, 
often locate at the conserved positions, in genes encoding U1C and Snu71. Identification of the third linkage group 
is underway. These data suggest U1C and Snu71 may engage specific protein-protein or RNA-protein interactions 
on U1 snRNP/5’ss during pre-mRNA splicing. Ongoing biochemical analyses via 4-thioU and psoralen crosslinking 
shall provide mechanistic insights into the roles of these U1 snRNP components, which remain largely unclear. The 
described approach for probing complex mechanism should be applicable to other systems in which an essential gene 
can be bypassed. 
473 C Enzymes involved in human cap structure formation: their structure and function
Maria Werner1, Miroslaw Smietanski1, Elzbieta Purta1, Katarzyna H. Kaminska1, Janusz Stepinski2, Edward 
Darzynkiewicz2, Marcin Nowotny1, Janusz M. Bujnicki3
1International Institute of Molecular and Cell Biology in Warsaw, Trojdena 4, PL-02-109 Warsaw, Poland; 
2Division of Biophysics, Institute of Experimental Physics, Faculty of Physics, University of Warsaw, 02-089 
Warsaw, Poland; 3International Institute of Molecular and Cell Biology in Warsaw, Trojdena 4, PL-02-109 
Warsaw, Poland; Laboratory of Bioinformatics, Institute of Molecular Biology and Biotechnology, Faculty of 
Biology, Adam Mickiewicz University, Umultowska 89, PL-61-614 Poznan, Poland
The 5′ cap of human messenger RNA consists of an inverted 7-methylguanosine linked to the first transcribed 
nucleotide by a unique 5′ - 5′ triphosphate bond followed by 2′-O-ribose methylation of the first and often the second 
transcribed nucleotides, serving to modify efficiency of transcript processing, translation and stability. Enzymes 
that methylate ribose moieties of the first and the second nucleotide of the transcript, named hMTr1 and hMTr2 
respectively, have been recently identified. Both enzymes contain related catalytic domains with a Rossmann-like 
fold characteristic for the RFM superfamily of methyltransferases (MTases), as well as additional domains. However 
their structures and mechanisms of substrate recognition and methylation remain unknown. We report the crystal 
structure of methyltransferase (MTase) domain of hMTr1 in an unliganded form, as a ternary complex with a cofactor 
S-adenosyl methionine (SAM) and a 5′ mRNA cap analogue, and a complex with SAM and a short capped RNA. 
These structures reveal that with the exception of the methylated guanosine, the interactions occur between the 
protein and the phosphodiester backbone of the RNA molecule. This suggests that substrate binding and methylation 
are sequence–independent. Based on the crystal structure of hMTr1 catalytic domain as a template we generated a 
comparative model of the hMTr2 catalytic domain and carried out mutational analysis of hMTr2, which disclosed 
residues important for RNA and SAM binding. Inability to establish human somatic cells lacking HMTR2 coding 
sequence argues for an essential function of its protein product in cell metabolism.
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476 C Biophysical characterization of the recombinant S. cerevisiae Lsm2-8 complex
Elizabeth Dunn1, Trushar Patel3, Richard Fahlman2, Calvin Yip5, Sean McKenna3, Stephen Rader4
1Department of Biochemistry and Molecular Biology, University of British Columbia; 2Department of 
Biochemistry, University of Alberta; 3Department of Chemistry, University of Manitoba; 4Department of 
Chemistry, University of Northern British Columbia; 5Life Sciences Institute, University of British Columbia
Biochemical and biophysical studies of macromolecules have historically focused on simple systems, frequently 
monomers or dimers of proteins. Many of the most important cellular processes, however, are carried out by 
complicated, multicomponent assemblies. A prime example of this is the spliceosome, the nuclear complex that carries 
out pre-mRNA splicing, which in S. cerevisiae contains five small, nuclear RNAs (snRNAs) and nearly 100 proteins. 
While the study of such complex systems has taken on increased urgency as their importance has become clearer, their 
recombinant expression and purification remain challenging.
In this poster, we report the development of a method to express and purify the hetero-heptameric LSm complex of 
proteins that associates with U6 snRNA. U6 is the most highly conserved snRNA, and substantial evidence suggests 
that it is intimately involved in the catalytic steps of splicing. The investigation of U6 function is complicated by its 
highly dynamic nature: it exists by itself as the U6 small, nuclear ribonucleoprotein (U6 snRNP), as a base-paired 
complex with U4 in several particles, and as a base-paired complex with U2 in the active spliceosome. The U6-
associated Lsm proteins are known to play a role in base pair formation with U4, and, intriguingly, they have been 
shown to dissociate from U6 prior to spliceosome activation, suggesting they may have additional functions.
We present a system for simultaneously expressing all seven U6-associated Lsm proteins recombinantly in E. 
coli. The proteins appear to express at approximately stoichiometric levels, and co-purify as a single peak by gel 
filtration chromatography. Mass spectrometry confirms the presence of all seven proteins in the complex, and electron 
microscopy demonstrates that they assemble into toruses, as predicted from previous studies. Ab initio models of the 
molecular envelope based on SAXS data are consistent with crystal structures of homologous protein complexes. We 
are currently characterizing the ability of the Lsm complex to associate with U6 snRNA and Prp24. Interestingly, the 
complex appears to dramatically promote the association of U4 and U6, even in the absence of any other proteins. We 
anticipate that this system will be useful for the expression and analysis of numerous other protein complexes.
475 B Chemical tools for investigating alternative RNA splicing
Sara De Ornellas1, Ian Eperon2, Glenn Burley1
1University of Strathclyde; 2University of Leicester
Splicing is the processing of pre-mRNA introns and exons to give mRNA for protein biosynthesis.  Most eukaryotic 
genes contain multiple introns and exons.  Alternative RNA splicing determines which combinations of exons are 
spliced, and therefore which protein isoform is synthesised.  The variety of the possible isoforms gives rise to the 
diversity of the proteome; ca. 20k protein-coding genes in the human genome give rise to ca.100k transcripts.
Although splicing effects protein diversity and is critical in many genetic diseases, the molecular mechanism of 
regulation is not well understood.  Pre-mRNA contains regions which act as exonic splicing enhancers (ESEs) which 
bind to SR proteins and enhance splicing.  Knowledge of the mechanism of ESEs can help understanding of splice site 
selection at the molecular level, as well as in the development of therapeutic strategies for the treatment of splicing-
related genetic diseases such as spinal muscular atrophy (SMA).  Our approach to investigation of these mechanisms 
focuses on the development and application of novel chemical tools for probing these complex biological systems. 
Through the development of a new chemical approach, we have recently shown evidence that ESEs do not act via 
RNA looping mechanisms.  Recent results in this area will be presented.
1. Perrett, A.J.; Dickinson, R.L.; Krpetic, Z., Brust, M.; Lewis, H.; Eperon, I.C.; Burley, G.A. Conjugation of PEG and gold 
nanoparticles to increase the accessibility and valency of tethered RNA splicing enhancers. Chemical Science, 2013, 4, 
257-265.
2. Lewis, H.; Perrett, A.J.; Burley, G.A.; Eperon, I.C. An RNA splicing enhancer that does not act by looping.  Angewandte 
Chemie International Edition, 2012, 39, 9800-9803.
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478 B Role of U2 stem IIb in splicing progression
Alberto Moldon1, Charles Query1
1Albert Einstein College of Medicine
The highly dynamic properties of the spliceosome complicate its structural analysis. Previous studies have 
reported U2 snRNA conformations representative of different stages in the splicing process. The branch site loop 
(BSL) is formed at the BS-recognition step, U2 stem IIc and IIa alternate between more stable steps, and U2/6 helices 
I and II are present during the catalytic steps.  Here we study the role of U2 stem IIb.  We combined deletions of stem 
IIb with ATPase/helicase mutants to test for roles at different times and with splicing-defective reporters to detect 
consequences on the progression of splicing.  U2 stem IIb deletion interacted genetically with Prp5 (which is thought 
to open the BSL), with Prp2 (which activates the catalytic spliceosome) and with Prp22 (which disassembles spliced 
mRNA from the spliceosome).  U2 stem IIb mutants also exacerbated defects of most of the reporters tested.
We also show that there is a complex network of tertiary interactions among stem IIb, nts 26-30 of U2 snRNA, and 
Prp5, and that stem IIb integrity is needed for Prp5 recruitment.  These results indicate a functional relationship among 
these structures.  One hypothesis is that base-pairing interactions between U2 stem IIb and nts 26-30 of U2 compete 
with other interactions to help disrupt the BSL or U2/6 helix Ia.  To better understand this, we designed point mutants 
to hyperstabilize or destabilize putative alternative conformations formed between stem IIb and nucleotides 26-30 of 
U2 and analyzed suboptimal splicing reporters.  We show that some reporters improve when the alternative structures 
are stabilized, suggesting a role in opening the catalytic core, whereas others are improved when the alternative 
structures are destabilized, suggesting roles in promoting stabilization of the complex.
We conclude that U2 stem IIb facilitates opening of the BSL during the BS-recognition step, opening of the catalytic 
core during transitions between stable conformation, and spliceosome disassembly.  This role can be by recruitment 
of ATPases/helicases that promote the changes, by competition between alternative base-pairing interactions, or both.
477 A smFRET studies of U6 during spliceosome activation in budding yeast
Megan Mayerle1, John Abelson1, Christine Guthrie1
1University of California San Francisco
Both splicing fidelity and chemistry rely on a defined series of snRNA structural rearrangements catalyzed by 
DExD/H helicases and regulated via other trans-acting factors. The highly conserved snRNA U6 plays a direct role 
in splicing catalysis. Catalysis requires the presence of a 3’ U6 internal stem loop (ISL) structure that coordinates 
catalytically essential Mg2+ ions analogously to domain V of group II introns.  To prevent aberrant ISL formation 
U6 conformation is very highly regulated. U6 arrives at pre-mRNA base-paired with U4 in the U4/U6-U5 tri-snRNP, 
which sequesters the U6 ISL, blocking premature U6 activity. U4/U6 unwinding allows for the mutually exclusive 
U2/U6 interactions required for catalysis to form. In yeast U4/U6 unwinding is performed by DExD/H box helicase 
Brr2, a component of the U5 snRNP. Intriguingly, it has been shown that, in the presence of ATP and Mg2+, Brr2 
will unwind U4/U6 duplexes in purified tri-snRNP in the absence of pre-mRNA, which indicates that Brr2 activity 
must be carefully regulated in vivo. Previous experiments indicate that Brr2 activity is modulated by U5 component 
Prp8 and Snu114, however Prp8, and Snu114 are tri-snRNP components as well and must also be tightly temporally 
and spatially regulated. Despite extensive knowledge of the players involved, the kinetics and fundamental molecular 
mechanisms of U4/U6 unwinding by Brr2 and its regulation are currently unknown. This deficiency results from 
inherent limits to bulk experimental systems wherein the multiple reversible steps in spliceosome assembly proceed 
asynchronously, and the splicing reaction itself is inefficient. We are currently generating and testing reagents required 
to perform smFRET. We have developed a Cy3/Cy5 intramolecular U6 labeling scheme to monitor the formation 
of the U6 ISL, which assembles into U6 snRNPs and is capable of in vitro splicing. Using this system, we can 
provide fundamental kinetic and molecular information on U4/U6 unwinding, and how unwinding is regulated during 
spliceosome activation.
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480 A Prp8-substrate interactions in yeast spliceosomes
Christine Norman1, Andy Newman1, Kiyoshi Nagai1
1MRC Laboratory of Molecular Biology, Cambridge, UK
The U5 snRNP protein Prp8 interacts with all 3 sites of chemistry in pre-mRNA substrates and with crucial 
residues in U5 and U6 snRNAs. These contacts have been mapped to the central region of yeast Prp8 by site-specific 
RNA-protein cross-linking and cleavage at engineered protease sites [Turner et al., RNA 12: 375-386 (2006)]. We 
have now used cleavage at natural and engineered Methionine residues by Cyanogen Bromide to map Prp8 contacts 
with the spliceosome’s catalytic RNA core in more detail. Spliceosomes were stalled between catalytic steps 1 and 2 
by 3’ splice site mutations AG>AC or AG>AdG and captured via an epitope tag on Prp19 or one of the step 2-specific 
splicing factors [Slu7 or Prp18]. These techniques enabled us to monitor and physically map Prp8 contacts with the 
intron Branch Point [BP] and the 3’ Splice Site [3’-SS].
Branch Point and 3’ Splice Site cross-links map between residues 1585 and 1598 in yeast Prp8. In our recent 
structure of Prp8 [Galej et al., Nature 493: 638-643 (2013)] this sequence is part of a highly conserved linker region 
between the Reverse Transcriptase [RT] and Endonuclease [En] domains. Alanine-scanning mutagenesis of this 
region of Prp8 produced mutants in or near the cross-linked peptide with slow growth or lethal phenotypes. Moreover 
splicing assays in vitro revealed that these mutations caused accumulation of splicing intermediates. The cross-links 
from 2 of the sites of splicing chemistry [BP and 3’-SS] together with the positions of numerous splice site suppressor 
mutations unambiguously locate the spliceosome’s catalytic RNA core to a cavity formed by the RT, En and RNaseH-
like domains of Prp8.
479 C Conserved Slu7 motif confers the preference for distal splice sites in yeast
Eva Nicova1, Katerina Abrhamova1, Ondrej Gahura1, Vanda Munzarova1, Frantisek Puta1, Petr Folk1
1Department of Cell Biology, Faculty of Science, Charles University in Prague, Praha, Czech Republic
Mechanisms governing proper 3’ splice site (3’ ss) selection for the 2nd catalytic reaction of splicing, which 
are important for alternative 3’ ss usage in Metazoans, are only incompletely understood. In S. cerevisiae, sequence 
specific (re)positioning of 3’ ss for catalysis occurs only after lariat formation.
Splicing in S. cerevisiae represents a unique system to examine the evolutionarily conserved splicing factors in a 
simplified setting. One of the key factors that is necessary for 3´ ss positioning is the essential 2nd step factor Slu7, 
which associates with the spliceosome only immediately before or during the 1st step. Slu7 was found in vitro to be 
required for splicing of introns with 3´ ss located >9 bp from BP (Brys and Schwer, 1996). Allele slu7-1, isolated 
through its synthetic lethality with U5 mutants, suppressed the usage of distal splice sites in recombinant splicing 
substrates (Frank and Guthrie, 1992). Slu7 contains several highly conserved regions, but its N-terminal 199 amino 
acids, including a putative zinc knuckle motif (aa 122-135), are dispensable for the essential function (Zhang and 
Schwer, 1997).
Using the screen for synthetic lethality and subsequent direct testing, we identified genetic interactions between the 
allele of the splicing factor PRP45 (prp45(1-169)) and several mutations of SLU7 (Gahura et al. 2009). The mutations 
mapped between arginines 247 and 271 within the essential part of SLU7. Analyses of splicing in vivo revealed second 
step splicing defects and impaired utilization of suboptimal splicing substrates. Importantly, several point mutations 
suppressed the utilization of distant splice site when two competing sites were present on a recombinant substrate. This 
feature was most prominent when the proximal splice site was close to BP (~10 bp). The novel SLU7 mutations also 
shifted the utilization of cryptic splice sites on an endogenous gene in favor of the proximal AG. The newly identified 
Slu7 motif, unlike, e.g., the zinc knuckle motif, is part of the structure that is responsible for efficient positioning of 
distal splice sites for catalysis. More extensive mutational analysis of this region is under way to elucidate the role that 
this part of the protein plays in pre-mRNA splicing.
This work was co-financed by the European Social Fund Project no. CZ.1.07/2.3.00/30.0022, MSM0021620858, 
and the Charles University grant SVV265211.
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482 C A new role for U2 snRNA in alternate 3’ ss selection
Jorge Pérez-Valle1, Josep Vilardell2
1Dept. Molecular Genomics, IBMB, Barcelona 08028, Spain, 2ICREA & Dept. Molecular Genomics, IBMB, 
Barcelona 08028, Spain
We have documented how several sequence features in the intronic region downstream from the BS act together 
to define the 3’ ss. Briefly, the yeast spliceosome will pick any HAG (H = A, C, G) present in a window of ~35 nt, 
starting at position 10 from the BS; and because stems, loops, and bulges are not included in this window, pre-mRNA 
folding plays a critical role in 3’ss selection. Interestingly, this does not apply to the first nt after the BS; and instead 
our results are more consistent with the requirement to have this region unfolded for efficient splicing. They show that 
in a reporter with two 3’ss, one blocked by a stem and the other within spliceosomal reach, a switch in 3’ss selection 
can be induced by placing the stem at 10 nt or less from the BS. According to our model, a stem near the BS will not be 
formed, and this would both make available the occluded AG and place the downstream AG outside the spliceosomal 
window. The “exclusion zone” downstream from the BS would be also consistent with the proposed interaction of a 
number of essential spliceosomal factors with positions downstream the BS. However the molecular reasons for this 
remain unclear.
A genetic screen has revealed a role for U2 snRNA in modulating this 3’ss selection switch. Thus, in cells 
expressing U2 U40C the requirement for the unfolded region downstream from the BS is reduced and the 3’ss switch 
described above takes place closer to the BS. Position U40 is part of the U2 BSL stem-loop, which has been shown 
to play a role in BS identification (Perriman & Ares (2010) Mol. Cell). U40C stabilizes the BSL and promotes BS 
recognition as reported. However, other mutations that also stabilize the BSL, such as U44A, and U40G G32C, do not 
reproduce the U40C effect on 3’ ss selection.
We have analyzed the intronic requirements for the U2-U40C phenotype and our data are consistent with the 
shifted recognition of the BS, by three nucleotides, for the first step of splicing. This shift occurs as well with the wt 
U2, albeit to a lesser extent. Surprisingly, with either U2 wt or U40C the shift is independent of having a stem near 
the BS. We are investigating the role of the regular BS in this process, as well as the molecular reasons behind the 
U2-U40C phenotype, distinct from other mutations that stabilize the BSL.
481 B Identification of new natural compounds that modulate splicing in vitro and in cells
Andrea Pawellek1, Ursula Ryder1, Angus Lamond1
1Centre for Gene Regulation & Expression, College of Life Sciences, Dundee, DD1 5EH, Scotland, UK
Pre-mRNA splicing is an important step in gene expression. However in contrast to the other steps involved in 
gene expression, such as transcription and translation, few specific chemical inhibitors have been characterized that 
block specific steps in the splicing mechanism and which can be used to dissect the splicing process. Therefore, the 
identification of specific and selective splicing inhibitors/modifiers would not only be extremely valuable for research 
purposes as tool compounds, but also potentially useful for therapeutic applications.
To date compounds that have been described to be general splicing inhibitors include: Spliceostatin A (1), 
Isoginketin (2) and Pladienolide B (3), which are all natural products. In addition, several other natural compounds 
derived either from extracts of plants, or microbes, have also been reported either to inhibit splicing in vitro, or to 
change splicing of certain transcripts in cells.
We have screened a restricted set of compounds and identified a new group of closely related natural products, 
typified by the structure we term GRE010, which not only inhibit human pre-mRNA splicing in vitro but also alter 
the splicing of a subset of pre-mRNAs in vivo in a variety of different human cells lines. Interestingly, treatment of 
cells with GRE010 also leads to the specific relocation of early assembly splicing factors within the nucleus, which 
correlates with their inhibition of splicing and spliceosome assembly in vitro at a step after an A complex is formed. 
We are currently investigating the effect of GRE010 on splicing and cell growth in greater detail.
1. Kaida D et al.,Nat Chem Biol. 2007 Sep;3(9):576-83. Epub 2007 Jul 22
2. Kristine O’Brien et al., J Biol Chem. 2008 November 28; 283(48): 33147–33154
3. Kotake Y,et al., Nat Chem Biol. 2007 Sep;3(9):570-5. Epub 2007 Jul 22.
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484 B Conservation of U2 protein – branch site interactions between yeast and human, as 
investigated by UV crosslinking
Cornelius Schneider1, Klaus Hartmuth1, Dmitry Agafonov1, Patrizia Fabrizio1, Reinhard Lührmann1
1Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
The multiple structural rearrangements occurring during catalytic activation of the spliceosome are only poorly 
understood at the molecular level. In the early assembly of human spliceosomes the U2 SF3a and SF3b proteins help to 
recruit the U2 snRNP to the branchsite by engaging in multiple contacts with a region upstream of the branchsite (the 
so-called “anchoring site”), the branchsite itself and a region downstream of it (Gozani et al., Genes and Dev. 2000). 
While most of the U2 proteins in the yeast S. cerevisiae are evolutionarily conserved, it is not clear whether they interact 
in a similar way with the extended branchsite region in yeast spliceosomes and whether an equivalent to the human 
anchoring site exists in yeast pre-mRNAs. While it is clear that the affinity of the U2 proteins for the spliceosome is 
significantly lowered during catalytic activation, it is not known whether this leads to a remodeling of U2 protein-
pre-mRNA interactions. To address these questions we have started to investigate protein-RNA interactions by UV 
crosslinking of purified yeast spliceosomes stalled at specific assembly stages such as the Bact, B* or C complex, 
using our recently developed, purified yeast splicing system (Warkocki et al., NSMB 2009). For this purpose we have 
assembled spliceosomes onto actin-pre-mRNA constructs that harbored either site-specifically 32P -labeled nucleotides 
or defined 32P-labeled RNA stretches, focusing initially on the intronic region in and around the branchsite. Crosslinked 
spliceosomes were digested with ribonucleases and crosslinked 32P-labeled proteins were initially identified by 2D 
gel electrophoresis (Agafonov et al., MCB 2011) and by immunoprecipitation. Our results indicate that the region 
directly upstream of the branchsite is a major interaction platform of the U2 snRNP proteins in yeast Bact complexes. 
Some proteins also crosslink within the branchsite, as well as to the intronic region downstream of it, suggesting that 
interaction of U2 proteins with the extended branchsite region of the pre-mRNA is conserved in eukaryotes. During 
catalytic activation and the first step of splicing, we do not observe any significant changes in the interaction pattern. 
This suggests that the U2 proteins remain in close contact with the extended branchsite region even after the first step of 
splicing. In addition to U2 SF3a and SF3b proteins, several additional proteins, which are currently being characterized, 
are crosslinked to the branchsite region in a dynamic manner. We are currently extending our crosslinking approach to 
study protein interactions with other regions of the pre-mRNA within purified yeast spliceosomes.
483 A BRAF branch point mutation confers Vemurafenib resistance
Maayan Salton1, Ty Voss1, Poulikos Poulikakos2, Tom Misteli1
1NIH/NCI; 2Mount Sinai School of Medicine
The serine/threonine kinase BRAF is a proto-oncogene that acts in the MAP kinase pathway, connecting mitogen 
signals to transcription of proliferation genes. Constitutively activating mutations of BRAF are the cause of more 
than 60% of melanomas. The most prevalent BRAF melanoma mutation is V600E which constitutively activates 
downstream signaling pathways. Vemurafenib is a potent inhibitor of BRAF (V600E), however, patients rapidly 
develop resistance. One Vemurafenib resistance mechanism is the emergence BRAF (V600E) splicing isoform lacking 
exons 4 to 8 (3-9 isoform), harboring the RAS-binding domain. Here we show that a branch point (BP) mutation in 
intron 8 of BRAF (V600E) is the cause for the emergence of the BRAF 3-9 isoform in a subset of melanoma cells. We 
show that impairing BP recognition by either silencing SF3b155 or by the use of spliceostatin A promotes 3-9 usage. 
Using a BRAF minigene, we show that the BP mutation changes the ratio of splicing of the reporter minigene in favor 
of the 3-9 isoform. Similarly, increased intron 3 length favors 3-9 splicing, suggesting slower removal of intron 3 as 
the reason for mis-splicing. In support, slower removal of intron 3 compared to intron 4 was also found in the BP 
mutated melanoma cells. We identified SRp55 binding sites in the vicinity of the mutated BP and silencing of SRp55 
in the BP mutant cells reduced the 3-9 splicing. These observations represent the first steps in characterizing aberrant 
BRAF splicing responsible for Vemurafenib resistance and they might point to a therapeutic strategy to eliminate 
Vemurafenib resistance.
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485 C Identification of small molecule pre-mRNA splicing inhibitors using a stage-specific, high-
throughput in vitro splicing assay
Anzhela Sidarovich1, Timur R. Samatov1, Sonja Sievers2, Cindy L. Will1, Henning Urlaub1, Herbert Waldmann2, 
Reinhard Lührmann1
1Max-Planck-Institute of Biophysical Chemistry, Goettingen, Germany; 2Max-Planck-Institute for Molecular 
Physiology, Compound Management and Screening Center (COMAS), Dortmund, Germany
Disruption/misregulation of alternative and constitutive splicing are the cause or a severity modulator of many human diseases, 
including among others cancer and, neurodegenerative and autoimmune diseases, making the spliceosome a highly attractive 
drug target. Small molecule inhibitors that block discrete steps of the extremely dynamic functional cycle of the spliceosome 
would not only be of potential therapeutic value, but also be highly useful for the detailed investigation of the structure and 
function of the spliceosome. However, only a limited number of small molecule inhibitors that specifically target the pre-mRNA 
splicing machinery have been identified to date. We previously established a robust, rapid and sensitive high throughput in 
vitro splicing assay, which monitors in the wells of a microplate the formation of step I spliceosomes (i.e. the spliceosomal C 
complex) by measuring the association of a FLAG-tagged version of the DEAD box ATPase, Abstrakt, which is incorporated 
into the spliceosome first upon C complex formation1. Using this assay, we screened a chemical library of approximately 160,000 
compounds at 50 μM concentration. All compounds showing at least a 50% decrease in the signal intensity of bound Abstrakt 
were subjected to a second test, and reproducible hits were finally tested in an in vitro splicing assay using 32P-labeled adenovirus-
derived MINX-MS2 pre-mRNA as substrate. Ten compounds were confirmed to be inhibitors of pre-mRNA splicing in vitro, 
and exhibited IC
50
 values ranging from 3 to 50 µM. To determine at precisely which stage they inhibit splicing, we performed 
a splicing time course and analysed the spliceosomal complexes formed by native agarose gel electrophoresis. At least one 
compound (hereafter designated 28), led to an accumulation of A complexes and a complex migrating slightly faster than the B 
complex. To characterize in more detail spliceosomal complexes formed in the presence of compound 28, we subjected the stalled 
splicing reactions to glycerol-gradient centrifugation and purified the complexes in a given peak by MS2-MBP affinity selection. 
Initial analyses of the RNA and protein composition of complexes affinity-purified from the “B-like” peak, suggest that compound 
28 may stall splicing at a novel stage of the spliceosome activation step. This apparently unique property may allow us to obtain 
a novel snapshot of the spliceosome assembly pathway for detailed structural and functional investigations, and thus to improve 
our limited understanding of the dynamic rearrangement of spliceosomal components during spliceosome activation.
1Samatov et al., Chembiochem. 2012, 13:640-644
486 A Localization of the pre-mRNA path in the activated yeast spliceosome by immuno-EM
Chengfu Sun1, Norbert Rigo1, Patrizia Fabrizio1, Berthold Kastner1, Reinhard Luehrmann1
1Department of Cellular Biochemistry, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
The spliceosome is a highly dynamic molecular machine whose composition is not static and whose structure 
undergoes several rearrangements during each cycle of splicing. A particularly dramatic structural rearrangement of 
the spliceosome occurs during the transition from the pre-catalytic B complex, which contains all of the spliceosomal 
snRNPs U1, U2, U4/U6 and U5, to the activated Bact complex. This remodeling step involves the dissociation of 
the U1 and U4 snRNPs, allowing the U6 snRNA to basepair with both the branchsite-bound U2 snRNA and the 
5’end of the intron, forming a network of RNA-RNA base pair interactions that is thought to be at the heart of 
the spliceosome’s catalytic center. While the biochemical composition of the various assembly stages of the yeast 
spliceosome is relatively well known, the ultrastructural study of isolated yeast spliceosomes is at a relatively early 
stage. Recently, we presented initial, high-quality electron microscopy images of yeast B and Bact spliceosomes (Mol 
Cell, 2009, 36:593). 2D images of the Bact complex exhibit a mushroom-like appearance, consisting of a main, slightly 
asymmetric body (the “mushroom cap”), from which a “mushroom stalk” is seen to emerge as a slightly tapered, ca. 
15 nm-long protuberance.
A first step in understanding the spliceosome’s architecture is to localize the position of individual spliceosomal 
components and functional centers. To topographically locate the emerging catalytic center of the purified yeast 
Bact complex, we first determined by DNA oligonucleotide-directed RNAse H digestion, accessible regions of the pre-
mRNA closest to nucleotides of the 5’ splice site and branch site. For EM localization studies, biotinylated 2’-OMe-
RNA oligonucleotides were annealed to these accessible regions. The position of the bound oligonucleotides was then 
visualized by EM at the surface of the Bact complex using anti-biotin antibodies. We also inserted MS2 hairpin loops 
at defined positions of the exons and the intron, and mapped their positions in the Bact complex as well. The identified 
positions in the Bact EM map give first hints as to the path of the pre-mRNA in the yeast Bact complex and further define 
the possible location of the emerging catalytic core at the center of the mushroom cap.
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488 C The G patch protein Spp2 couples Prp2-mediated ATP hydrolysis to catalytic activation of 
the yeast spliceosome
Zbigniew Warkocki1, Jana Schmitzová1, Claudia Höbartner2, Patrizia Fabrizio1, Reinhard Lührmann1
1Max Planck Institute for Biophysical Chemistry, Department of Cellular Biochemistry, Göttingen, Germany; 
2Research Group of Nucleic Acid Chemistry, Göttingen, Germany
The spliceosome is a dynamic molecular machine that is continuously remodeled during its assembly and catalytic cycle. 
A major structural rearrangement occurs during the transition from the activated Bact complex to the catalytically competent B* 
complex, which entails the loss and destabilization of numerous spliceosomal proteins. This structural rearrangement is driven by 
the DEAH-box ATPase Prp2  in cooperation with its essential co-factor Spp2. Basic questions concerning the requirements for 
triggering Prp2’s ATPase activity and how Prp2-mediated ATP hydrolysis is coupled to the Bact to B* complex transition have not 
been answered yet. The role of the G patch protein Spp2 in this process is also not well understood. It has been shown, however, 
that Spp2 may interact in solution with the C-terminal DUF domain of Prp2 via its G patch region (MCB 24, 2004,10101). Here 
we have addressed these questions using a purified yeast splicing system (NSMB 16, 2009, 1237).
The major findings are as follows: (1) Spp2 significantly enhances the oligo(U)30-stimulated, but not the unstimulated, 
intrinsic ATPase activity of Prp2 in solution. (2) Prp2 binds stably to purified Bact spliceosomes in the absence of Spp2 and vice 
versa. The stability of Spp2 binding to the Bact complex is enhanced in the presence of Prp2, suggesting that they interact with 
each other in the spliceosome. (3) We have measured for the first time the spliceosome-dependent NTPase activity of Prp2 (using 
UTP instead of ATP as exogenous source of energy to avoid measuring possible ATPase activities of other endogenous ATPases 
such as Brr2) and show that Bact spliceosomes efficiently trigger Prp2-mediated UTP hydrolysis in the absence of Spp2, with an 
initial hydrolysis rate of about 120 UTP•Prp2-spliceosome-1•min-1, which does not significantly level off after 10 min. However, 
Bact spliceosomes do not undergo catalytic activation under these conditions. (4) In the presence of Spp2, Prp2 in the spliceosome 
exhibits a similar initial rate of UTP hydrolysis, which levels off after 5-7 min. This effect is even more pronounced in the 
presence of both Spp2 and Cwc25, suggesting that in the presence of the latter factors, the spliceosome is remodeled and looses 
its binding site for Prp2.
In conclusion, our data suggest that certain structural elements of the Bact spliceosome can efficiently trigger the NTPase 
activity of Prp2 even in the absence of Spp2. UTP hydrolysis by Prp2 in the spliceosome observed in the absence of Spp2 
is, however, unproductive in that it does not lead to catalytic activation of the Bact spliceosome. The energy of Prp2-mediated 
UTP hydrolysis can only be coupled to structural rearrangements of the spliceosome that yield the B* complex when Spp2 is 
simultaneously present in the spliceosome.
487 B Functional and structural analysis of Cwc25 required for first-step splicing
Hui-Fang Wang1, Chi-Kang Tseng2, Ting-Wei Chiang2, Soo-Chen Cheng2
1Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan; Faculty of Life Science and Institute of 
Genomic Science, National Yang-Ming University, Taipei, Taiwan; 2Institute of Molecular Biology, Academia 
Sinica, Taipei, Taiwan
Cwc25 is a first-step splicing factor that acts after Prp2 and is recruited to the spliceosome in the presence of 
Yju2. Previous study shows that Cwc25 with four copies of V5 tagged at the N-terminus has better first-step splicing 
activity, but binds to the spliceosome more stably when tagged at the C-terminus. These results indicate that tags 
at different positions of the protein would affect the function of the protein. We therefore systematically analyzed 
positional and length effects of the tag on Yju2 and Cwc25 on the splicing activity. Splicing was carried out in 
extracts depleted of both Yju2 and Cwc25, and complemented with different versions of tagged Yju2 and Cwc25. 
It was found that while splicing was moderately affected when only one protein contained additional residues at 
the N-terminus, splicing was impaired when both Yju2 and Cwc25 contained additional residues at the N-terminus. 
We also examined how the structure of Cwc25 affects its function.  The N-terminus of Cwc25 is conserved while 
the C-terminus is highly diverse.  A series of C-terminally truncated forms of Cwc25 were constructed.  Analysis 
of the splicing reaction and spliceosome association revealed that deletions of Cwc25 in the C-terminus resulted in 
destabilization of Cwc25 binding to the spliceosome, suggesting that the C-terminal region of Cwc25 may play a role 
in stabilizing the association of Cwc25 with the spliceosome.
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489 A Chromatin affects the splicing efficiency by regulating the U2snRNP activity
Eric Allemand1, Michael P. Myers4, Jose Garcia-Bernado2, Annick Harel-Bellan2, Adrian R. Krainer3, Christian 
Muchardt1
1Institut Pasteur, CNRS URA2578, Unité de Régulation Epigénétique, Paris, France, F-75015; 2CNRS, Gif-
sur-Yvette, France, F-91191; 3CEA Saclay, Gif-sur-Yvette, France, F-91191; 3Cold Spring Harbor Laboratory, 
Cold Spring Harbor, New York 11724, USA; 4ICGEB Trieste, Padriciano 99, 34012 Trieste, Italy
A number of studies propose a role of the chromatin in the regulation of splicing. Many of these observations 
are based on in vivo experiments therefore a caveat of these studies is their correlative nature. Here, we present 
an in vitro system that reproduces the coupling of transcription/splicing, chromatin remodeling/transcription, and, 
for the first time, chromatin remodeling/splicing. Using this system, we demonstrate that the chromatin regulates the 
splicing efficiency in a co-transcriptional manner, independently of the recruitment of SR proteins by Pol II. Thus, we 
hypothesized that chromatin factors could have a structural role in the regulation of splicing. Using a high-throughput 
siRNA screen, we identified several chromatin factors affecting splicing, among which are regulators of acetylation 
and methylation of histones, chromatin remodelers, transcription regulators and nucleosome components. Using the 
U2snRNP to purify spliceosome, we show that several of these chromatin factors are physically associated to the 
splicing machinery, suggesting a functional coupling between the chromatin and the U2snRNP. Consistent with this 
proposal, alternative exons controlled by the active U2snRNP1 are miss-regulated in absence of specific chromatin 
factors. These findings allowed us to propose a model in which chromatin modulates efficiency of splicing through the 
co-transcriptional regulation of the U2snRNP activity.
1. Nuclear Matrix Factor hnRNP U/SAF-A Exerts a Global Control of Alternative Splicing by Regulating U2 snRNP 
Maturation.
2. Xiao R. et al., Mol. Cell., 2012
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490 B The Evolutionary Landscape of Alternative Splicing and its Regulation in Vertebrate 
Species
Nuno Barbosa-Morais1, Qun Pan2, Manuel Irimia2, Serge Gueroussov6, Eesha Sharma6, Emil Nachman6, Hui 
Xiong7, Leo Lee7, Valentina Slobodeniuc2, Claudia Kutter9, Stephen Watt9, Recep Çolak3, TaeHyung Kim3, Christine 
Misquitta-Ali2, Michael Wilson8, Philip Kim5, Duncan Odom10, Brendan Frey4, Benjamin Blencowe6
1Banting and Best Department of Medical Research, Donnelly Centre, University of Toronto, Ontario, M5S 
3E1, Canada / Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal; 
2Banting and Best Department of Medical Research, Donnelly Centre, University of Toronto, Ontario, M5S 
3E1, Canada; 3Banting and Best Department of Medical Research, Donnelly Centre, University of Toronto, 
Ontario, M5S 3E1, Canada / Department of Computer Science, University of Toronto, Ontario, M5S 2E4, 
Canada; 4Banting and Best Department of Medical Research, Donnelly Centre, University of Toronto, 
Ontario, M5S 3E1, Canada / Department of Electrical and Computer Engineering, University of Toronto, 
Canada; 5Banting and Best Department of Medical Research, Donnelly Centre, University of Toronto, 
Ontario, M5S 3E1, Canada / Department of Molecular Genetics, University of Toronto, Ontario, M5S 1A8, 
Canada / Department of Computer Science, University of Toronto, Ontario, M5S 2E4, Canada; 6Banting and 
Best Department of Medical Research, Donnelly Centre, University of Toronto, Ontario, M5S 3E1, Canada 
/ Department of Molecular Genetics, University of Toronto, Ontario, M5S 1A8, Canada; 7Department of 
Electrical and Computer Engineering, University of Toronto, Canada; 8Hospital for Sick Children, Toronto, 
Ontario, M5G 1X8, Canada / Department of Molecular Genetics, University of Toronto, Ontario, M5S 
1A8, Canada / University of Cambridge, CRUK-Cambridge Institute, Robinson Way, Cambridge CB2 
0RE, UK; 9University of Cambridge, CRUK-Cambridge Institute, Robinson Way, Cambridge CB2 0RE, 
UK; 10University of Cambridge, CRUK-Cambridge Institute, Robinson Way, Cambridge CB2 0RE, UK / 
Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridge, CB10 1SA, UK
How species with similar repertoires of protein coding genes differ so dramatically at the phenotypic level is 
poorly understood. Alternative splicing (AS) has been proposed to play an important role in phenotypic differences, 
because it is a widespread process by which diverse mRNA and protein isoforms can be produced from individual 
genes. By comparing the transcriptomes of multiple organs from ten vertebrate species spanning ~350 million years 
of evolution, we observe significant increases in the frequency of “cassette” exon events associated with proximity 
to the primate lineage [1]. Moreover, in species separated by at least six million years, the exon-skipping profiles of 
physiologically equivalent organs have diverged to the extent that they are more strongly related to the species identity 
than to organ type. These species-dependent AS patterns are controlled by a largely conserved cis-regulatory code, 
together with specific changes in trans-acting factors. In particular, we have identified and characterized species and 
lineage -classifying “cassette” exon AS events that are predicted to remodel protein-protein interactions involved in 
gene regulation and other processes. Our recent results indicate that these AS events have further contribute to the 
major transcriptomic differences underlying phenotypic differences between vertebrate species (refer to abstract by 
Serge Gueroussov et al.). We have also expanded our evolutionary comparisons to the analysis of other classes of AS 
events, including alternative retained introns. Intron retention is known to play important roles in the control of mRNA 
export, localization and turnover by nonsense-mediated decay. Our initial results suggest widespread roles for intron 
retention throughout vertebrate evolution, and also that this type of AS regulation has impacted the same biological 
processes and pathways in multiple species. Finally, we are also using our datasets to investigate possible roles of 
intergenic and antisense non-coding RNAs (ncRNAs) in the regulation of AS. Results from these analyses will be 
presented.
1. Barbosa-Morais, N.L. et al (2012). Science 338(6114):1587-93
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492 A PTB regulates the alternative splicing of the apoptotic gene BCL-X
Pamela Bielli1, Matteo Bordi1, Claudio Sette2
1IRCSS Fondazione Santa Lucia, Rome, Italy; 2Department of Biomedicine and Prevention, Tor Vergata 
University, Rome, Italy
Alternative splicing is a key cellular mechanism to control gene expression, which is frequently altered in 
cancer cells. Mutations in splice sites, or regulatory sequences, as well as aberrant expression of splicing factors can 
contribute to defective splicing in cancer cells. Interestingly, changes in splicing regulation were shown to correlate 
with disease progression, whereas the specific splicing signature of cancer cells was employed to stratify patients with 
high accuracy.
An example of splicing-regulated gene with strong relevance for cancer is BCL-X. Alternative usage of the 5’ splice 
sites located in exon 2 of BCL-X promotes the generation of two splice variants, the anti-apoptotic long variant (BCL-
XL) and the pro-apoptotic short variant (BCL-Xs). Here, we identified the hnRNP I (PTB) protein as a novel regulator 
of BCL-X splicing. PTB was isolated by RNA chromatography as one of the splicing factors that associate with the 
alternatively spliced region of exon 2. Overexpression of PTB in HEK293T cells modulates 5’ splice site selection 
in BCL-X exon 2, thereby favouring the pro-apoptotic BCL-Xsvariant. Conversely, depletion of PTB promotes the 
BCL-XL variant. Crosslink immunoprecipitation (CLIP) experiments showed that PTB directly binds BCL-X exon 2 
RNA in a sequence-dependent manner.
PTB is up-regulated in human glioblastoma and ovarian cancer. The PTB gene encodes at least three splice 
variants, named PTB1, PTB2 and PTB4. Interestingly, we observed that PTB1 was more efficient than PTB4 in 
promoting BCL-Xs. Moreover, by analysing several glioblastoma cell lines originated from tumours at different 
stages, we observed a positive correlation between the BCL-X S/L and the PTB1/PTB4 ratio. This finding suggests 
that a switch in PTB variants may favour the reduced expression of the pro-apoptotic form of BCL-X in glioblastoma 
cells. We are currently addressing this issue by evaluating apoptosis and cell survival in glioblastoma cells selectively 
silenced for PTB4 or for both variants.
Thus, our results identify BCL-X as a new splicing target for PTB and uncover a potential novel role for this RNA 
binding protein in the regulation of apoptosis.
491 C TNF influences alternative stop codon usage in DAPK mRNA
Natalya Benderska1, Stefan Stamm2, Regine Schneider-Stock1
1Department of Experimental Tumor Pathology, Institute of Pathology, University Erlangen-Nuremberg, 
Erlangen, Germany; 2Department of Molecular and Cellular Biochemistry, University Kentucky, Lexington, 
USA
Death-associated protein kinase (DAPK) pre-mRNA is undergoing alternative splicing leading to the production 
of two isoforms, which elicit antagonistic functions. DAPKα mediates induction of apoptosis whereas the DAPKβ 
isoform, extended by ten amino acids on the C-terminus, inhibits cell death. Until now nothing is known about 
the splicing elements regulating the introduction of an alternative stop-codon in the DAPK pre-mRNA. External 
signals leading to disproportion of DAPK transcripts are unknown as well. Therefore, this study aims to initiate the 
investigation of the complex regulatory mechanisms of DAPK splicing. We thus started to determine the regulatory 
mechanism of DAPK splicing.
To investigate the functional role of these isoforms in inflammation process we generated U937T macrophage 
cell lines stably expressing human DAPKα or DAPKβ. DAPKα over-expression in differentiated macrophages led to 
a significant increase (up to 3-fold) in apoptosis accompanied by a significant decrease in TNF secretion. Although 
DAPKβ over-expression supressed TNF secretion by macrophages the β-isoform does not enforce apoptosis. 
Interestingly, preliminary work demonstrated different pattern of α and β DAPK mRNA expression in normal and 
malignant intestinal epithelial cells. From these findings we suggest that a change in alternative splice site usage 
seems to be caused by cellular stress induced by cytokine over-production. To further study the role of TNF in DAPK 
alternative splicing we generated a DAPK minigene containing a retained intron inside of exon 26. TNF treated 
HEK293 cells transfected with the DAPK minigene showed a promotion of DAPKα isoform containing an intron 
retained sequence. Screening of splicing factors potentially involved in alternative stop-codon usage is ongoing.
This study will provide important information about possible triggering of DAPK isoforms in inflammatory and 
apoptotic pathways.
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494 C Alternative splicing in the regulation of the barley circadian clock
Cristiane Calixto1, Robbie Waugh2, John Brown1
1Division of Plant Sciences, University of Dundee at The James Hutton Institute, Scotland; 2Cell and 
Molecular Sciences, The James Hutton Institute, Scotland
The circadian clock is a cellular mechanism able to organize several physiological processes in anticipation/
preparation to daily changes. As sessile organisms, plants strongly rely on the circadian clock to match processes 
such as leaf movement, immune responses and flowering according to the right time of the day/season. This ‘internal 
clock’ is maintained and run by clock genes and most of what is known about them in plants comes from studies 
in Arabidopsis. Regulation of the circadian clock in plants is complex involving interlocked expression feedback loops, 
control of protein phosphorylation and degradation, and chromatin remodelling. Recently, extensive alternative splicing 
(AS) was shown to regulate clock genes through dynamic changes in AS transcripts, some of which are temperature-
dependent and altered levels of productive mRNAs through AS/NMD [1]. In particular, low temperatures reduced 
the levels of LHY transcript and protein without affecting the promoter strength, which suggests that its expression 
is regulated post-transcriptionally by AS events that produce nonfunctional transcripts. In addition, temperature-
dependent AS had opposite effects on pairs of partially redundant clock components (LHY/CCA1; PRR7/PRR9). This 
raised the question of whether clock genes and their modes of regulation are conserved in other higher plants, such 
as crop species. We have now carried out a robust in silico analysis using 27 Arabidopsis core clock/clock-associated 
genes and have identified 21 barley genes, 60% of which are true Arabidopsis orthologues. Most of the barley clock 
genes have a clear daily rhythm which is maintained in constant light conditions. Mutations of the barley clock genes 
HvPpd-H1 (a putative orthologue of AtPRR7) and HvElf3 strongly affect flowering time (earliness) and have extended 
the geographic range where barley is grown. We show that both mutations affect expression of clock genes involved 
in flowering time: the Hvppd-H1 mutation affects expression levels and phase while the Hvelf3 mutation also causes 
arhythmicity of some of these genes which helps to explain their earliness. We have identified AS in some of the core 
orthologues and are addressing temperature-specific AS in barley. This novel layer of fine clock control observed in 
two different species, a model plant and a crop species, might help our understanding of plant adaptation in different 
environments and ultimately may offer a new range of targets for plant improvement.
1. James et al (2012) Plant Cell 24: 961-981
493 B The many lives of Co-transcriptional Splicing
Mattia Brugiolo1, Lydia Herzel1, Karla Neugebauer1
1The Max Planck Institute of Molecular Cell Biology and Genetics
Researchers working in multiple model organisms – notably yeast, insects and mammalian cells – have shown that 
pre-mRNA can be spliced during the process of transcription (i.e. co-transcriptionally), as well as after transcription 
termination (i.e. post-transcriptionally). Since 2010, eight studies have used global datasets as counting tools, in order 
to quantify co-transcriptional intron removal. The consensus view, based on four organisms, is that the majority of 
splicing events takes place co-transcriptionally in most cells and tissues. We present a summary of the various global 
datasets and how bioinformatic analyses were conducted. The agreement between budding yeast and higher metazoans 
indicates that budding yeast is an excellent model for investigating mechanisms of coupling between transcription and 
splicing. We have previously reported the phenomenon of Terminal Exon Pausing (TEP), in which RNA polymerase 
II pausing within short last exons correlates with a high degree of co-transcriptional splicing (Carrillo Oesterreich et 
al 2010 Mol Cell, 40(4):571-581). We have initially focused on potential roles for nucleosome positioning, elongation 
factors and selected RNA binding proteins. Data on their contribution to TEP and co-transcriptional splicing will be 
presented.
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495 A The Nuclear Matrix Protein Matrin 3 is a Regulator of Alternative Splicing
Miguel Coelho1, Melis Kayikci2, Nicolas Bellora3, Jernej Ule2, Eduardo Eyras3, Christopher Smith1
1Department of Biochemistry, University of Cambridge, UK; 2MRC-LMB, UK; 3Universitat Pompeu Fabra 
Barcelona, Spain
Polypyrimidine Tract Binding protein (PTB) regulates an extensive range of alternative splicing events (ASE), and 
is composed of four RRM domains. In an MS2-tethering assay the second RRM and the following linker are sufficient 
to promote exon skipping. Short linear peptide motifs of the form [S/G][I/L]LGxfP, known as PTB RRM Interacting 
motifs (PRI), which are present in multiple copies in the PTB-coregulator Raver1, bind to the “dorsal” surface of 
RRM2. A key Tyr247 residue in RRM2 is critical for this interaction. Seeking to better understand the mechanism of 
splicing regulation by PTB, we used proteomics to identify proteins that bind to the PTB minimal repressor domain 
and are sensitive to mutation of Tyr247. The two strongest interactors were Raver1 and the nuclear matrix protein 
Matrin 3. The interaction with Matrin3 was mediated by a conserved GILGPPP motif, which is both necessary 
and sufficient for interaction with PTB. Matrin3 is composed of two DNA binding zinc-finger domains as well as 
two tandem RRMs. It is known to interact with RNA processing and transcription factors, and a mutation in this 
protein is associated with a type of distal myopathy, although its precise molecular function is unclear. We tested the 
consequences of Matrin3 knockdown in HeLa cells using splice-sensitive microarrays. Multiple ASEs were strongly 
affected, suggesting the activity of Matrin3 both as a splicing repressor and activator. There was a significant overlap 
between ASEs regulated by Matrin3 and PTB, but strikingly the majority of Matrin3 events were not co-regulated by 
PTB. Matrin3 targeted events showed a significant enrichment for chromatin proteins. Structure-function analyses 
indicated that the ZF domains are dispensable but Matrin3 requires its RRMs for splicing activity suggesting it binds 
directly to RNA. A number of 5-mer motifs are significantly enriched around Matrin3 repressed exons and adjacent to 
the downstream constitutive exon, including pyrimidine-rich motifs similar to optimal PTB sites. These motifs were 
also enriched among Matrin3 target exons that are not regulated by PTB. Strikingly, we found that Matrin3 activity 
was abolished by mutations of its GILGPPP motif for both PTB co-regulated and PTB-independent events, suggesting 
that this motif can mediate interactions with other splicing regulators. Our data indicate that Matrin 3 is not only 
functional as a nuclear matrix component but also as an active splicing regulator in the nucleoplasm.
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496 B Damage-induced alternative splicing in MDM2: Identifying cis elements and trans factors
Daniel Comiskey1, Ravi Singh1, Aixa Tapia-Santos1, Dawn Chandler1
1The Ohio State University
The MDM2 oncogene encodes a protein that negatively regulates p53 by targeting it for proteasome-mediated 
degradation.  Through the induction of DNA damage and in cancer, MDM2 is alternatively spliced into a variety of 
isoforms.  The MDM2-ALT1 isoform, comprised of exons 3 and 12 is generated in cells in response to genotoxic 
stress.  MDM2-ALT1 lacks a p53-binding domain and abrogates full-length MDM2 from binding p53 by sequestering 
it.  This leads to the stabilization of p53, causing cell cycle arrest and/or apoptosis.  However, as mutations accumulate 
to uncouple the p53 pathway, MDM2-ALT1 becomes an oncogenic driver.  For instance, MDM2-ALT1 is observed in 
numerous cancers including over 85% of rhabdomyosarcomas and is correlative with high-grade metastatic disease.  It 
is therefore critical to understand the regulation of stress-induced MDM2 alternative splicing to identify novel targets 
for anticancer therapies.
In order to study the alternative splicing of MDM2 we have developed an in vitro splicing system 
using MDM2 minigenes and normal and cisplatin-treated HeLa S3 nuclear extracts.  The MDM2 3-11-12 minigene 
predominantly excludes exon 11 under UV and cisplatin treatment both in vivo and in vitro, recapitulating the behavior 
of the endogenous gene.  Using ESEfinder 3.0 we identified predicted binding sites for splicing regulators SC35 and 
SF2/ASF in exon 11 of the MDM2 minigene and made mutations in their predicted binding sites to uncover their roles 
in splicing of MDM2.
We confirmed the affinity of these regulatory proteins for their predicted targets through RNA oligonucleotide 
pull downs using the wild-type and mutant sequences of each binding site.  We then performed in vitro splicing 
and demonstrated that disrupting SC35 sites led to exclusion of exon 11 and disrupting the SF2/ASF site promoted 
inclusion of exon 11.  Additionally, overexpression of SF2/ASF in MCF-7 cells led to skipping of exon 11 in our 
wild-type MDM2 minigene, while the corresponding site mutant was impervious to SF2/ASF expression.  When we 
knocked down expression of SC35 in SC35 Tet-Off mouse embryonic fibroblasts our wild-type MDM2 minigene 
caused exclusion of exon 11 and the corresponding SC35 site mutants did not.  We are currently performing splicing 
assembly assays to determine whether SC35 and SF2/ASF interact with core splicing machinery to facilitate skipping 
of exon 11 under damage.
To summarize, we have found that SC35 promotes the inclusion of MDM2 exon 11 under normal conditions, 
whereas SF2/ASF causes the exclusion of MDM2 exon 11 under damaged conditions.  This is consistent with the 
canonical role of SC35 as a positive regulator of splicing, but suggests a negative regulatory role for SF2/ASF.  Taken 
together, these data provide insight into the regulation of damage-induced MDM2 alternative splicing by SC35 and 
SF2/ASF and present potential targets to modulate MDM2 alternative splicing in cancer.
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498 A Is Prp16 remodelling of helix I during the two steps of pre-mRNA splicing carried out 
through the Nineteen Complex protein Cwc2?
Rogerio de Almeida1, Dharshika Pathiranage1, Rebecca Hogg Hogg1, Raymond O’Keefe1
1The University of Manchester
The DEAH box ATPase Prp16 has dual functions during the two catalytically steps of splicing. In the first 
catalytically step, in the absence of ATP, Prp16 stabilizes the binding of Cwc25 to the spliceosome and proofreads 
5’splice site cleavage. To allow the second step of splicing Prp16, in an ATP-dependent manner, releases Cwc25 to 
allow for the binding of Prp22, Prp18 and Slu7. Because mutations in U2/U6 helix I are able to suppress a mutation in 
PRP16, it is thought that helix I is destabilized/remodelled by Prp16 between the two steps of splicing. 
Cwc2 is a splicing factor that is part of the Prp19 complex (NTC). Cwc2 contains a Torus domain, an RNA 
recognition motif (RRM) and interacts directly with Prp19. Previously we showed that Cwc2 interacts directly with 
the U6 snRNA. We have now performed a large scale genetic analysis of Cwc2 mutants and over 80 snRNA mutants 
and found only one synthetic lethal interaction between Cwc2 and U6 in helix I. Mutations in the Cwc2 N-terminal 
Torus domain combined with the U6 mutation A56C, U57C in U2/U6 helix I leads to lethality because this U6 
mutation destabilizes U2/U6 base-pairing. This lethality can however be suppressed by mutations that restore helix I 
base pairing between U2 and U6, suggesting that Cwc2 participates in U2/U6 helix I formation and/or stabilization.
We hypothesize that Cwc2 may be the target of Prp16 helix I destabilization/remodelling as Cwc2 directly interacts 
with helix I through the whole splicing cycle. Mutation in a conserved region of the Cwc2 Torus domain is able to 
suppress the cold sensitive prp16-302 phenotype indicating a functional interaction between Cwc2 and Prp16. Initial 
crosslinking analysis suggests that Cwc2-U6 interaction is altered with a Prp16 first step mutant but is not altered with 
a dominant negative Prp16 second step mutant. As Prp16 does not directly interact with U2/U6 helix I, we propose that 
the destabilization/remodelling of U2/U6 helix I by Prp16 is carried out through Cwc2. We are currently investigating 
whether other spliceosomal ATPases exert their activity through the NTC.
497 C H3K9me3 and its role in pre-mRNA splicing.
Eva Duskova1, Martina Huranova2, Fernando Carrillo Oesterreich3, David Stanek1
1Institute of Molecular Genetics of the ASCR, v. v. i.; 2Biozentrum, Universitz of Basel, Basel; 3Max Plank 
Institute of Molecular Cell Biology and Genetics, Dresden
Splicing of the pre-mRNA occurs mainly co-transcriptionally. Close relationship between transcription and 
splicing was recently extended to chromatin modifications, which affect splicing outcome. Our bioinformatics analysis 
revealed specific enrichment of H3K9me3 across splicing sites on actively transcribed genes. To study the impact of 
H3K9me3 on co-transcriptional splicing we prepared inducible stable cell lines expressing methyltransferase and 
demethylase. We monitor changes of H3K9me3 on selected gene and we analyze splicing efficiency. Our results 
suggest role of H3K9me3 in definition of splice sites and efficiency of co-transcriptional splicing.
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499 B Selective constraint on mRNA splicing pattern by protein structural requirement
Jean-Christophe Gelly1, Hsuan-Yu Lin3, Alexandre G. de Brevern1, Trees-Juen Chuang2, Feng-Chi Chen3
1INSERM, France; 2Academia Sinica, Taiwan; 3National Health Research Institutes, Taiwan
Alternative splicing (AS) of messenger RNA can significantly increase transcriptome diversity in complex 
organisms. Different AS transcript isoforms can be translated into peptide sequences of  different lengths andfunctions. 
In mRNA splicing events, whether the splicing patterns are constrained by protein structural requirements remains 
unclear. Here we address this issue by examining whether the intactness of three-dimensional protein structural units 
(compact units in protein structures, namely Protein Units (PUs)) tends to be preserved in AS events in human. We show 
that PUs tend to occur in constitutively spliced exons (CSEs) and to overlap constitutive exon boundaries. In addition, 
when PUs are located at the boundaries between two alternatively spliced exons (ASEs), these neighboring ASEs tend 
to co-occur in different transcript isoforms. Moreover, the PU-spanned ASE pairs tend to have a higher frequency 
of being included in transcript isoforms. ASE regions that overlap with PUs also have lower nonsynonymous-to-
synonymous substitution rate ratios than those that do not overlap with PUs, indicating stronger negative selection 
pressure in PU-overlapped ASE regions. Notably, we found that PUs have protein domain- and structural orderness-
independent effects on mRNA splicing. Overall, our results suggest that fine-scale protein structural requirements 
have significant influences on the splicing patterns of human mRNAs.
1. Gelly J-C, Lin HY, de Brevern A.G.*, Chuang TJ*, and Chen FC*. 2012. Selective Constraint on Human Pre-mRNA 
Splicing by Protein Structural Properties. Genome Biology and Evolution 4(9):966-75.
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500 C Alternative splicing and gene expression in cardiomyocytes and cardiac fibroblasts during 
development
Jimena Giudice1, Zheng Xia3, Marissa Ruddy1, Wei Li4, Thomas A. Cooper2
1Department of Pathology and Immunology. Baylor College of Medicine. Houston. TX. USA.; 2Department 
of Pathology and Immunology. Department of Molecular and Cellular Biology. Department of Molecular 
Physiology and Biophysics. Baylor College of Medicine, Houston, TX, USA.; 3Division of Biostatistics, Dan 
L. Duncan Cancer Center. Baylor College of Medicine, Houston, TX, USA.; 4Division of Biostatistics, Dan 
L. Duncan Cancer Center. Department of Molecular and Cellular Biology. 4. Department of Molecular 
Physiology and Biophysics. Baylor College of Medicine, Houston, TX, USA.
Alternative splicing (AS) expands the proteomic complexity in mammals. During postnatal development the fetal 
heart converts to adult function through transcriptional and posttranscriptional mechanisms, including AS regulation. 
The RNA binding proteins CELF1 and MBNL1 coordinately regulate AS during heart development affecting >40% 
of the developmental transitions: CELF1 is down regulated 10-fold after birth; MBNL1 is up regulated 4-fold. Heart 
tissue is ~20% cardiomyocytes (CMs), ~66% cardiac fibroblasts (CFs), epithelial and vascular cells. CMs provide 
contractility through excitation contraction coupling (ECC) and CFs provide a mechanical scaffold, electrophysiological 
conduction and signaling through paracrine function and direct CF-CM communication.
AS and gene expression transitions were studied by RNA-seq from total hearts of embryonic day 17, postnatal 
day 1 (PN1), 10, 28 and adult mice (>150 million paired-end reads, >80% genome alignment per sample). AS events 
identified by RNA-seq correlated well with RT-PCR validation (r2=0.8). Gene ontology (GO) analysis revealed 
different enriched categories between developmental stages: protein transport and endocytosis between PN1-PN28; 
transcription and chromatin modifications between PN28-adult. Among CELF1 / MBNL1 dependent AS, endocytosis 
was an enriched functional target.
We also isolated CMs and CFs for RNA preparation within 3 hours from PN1-3, PN28-30, and adult mice for 
RNA-seq (>160 million paired-end reads, >84% genome alignment per sample). While CM-up regulated genes were 
enriched in mitochondrial metabolism categories, similar processes were enriched in CF-down regulated genes. A 
similar connection was found between CM-down regulation and CF-up regulation (cytokines, adhesion, JAK-stat and 
MAPK signaling) consistent with CMs-CFs communication in vivo. In terms of AS, more transitions were found in 
CMs (999) than in CFs (409). Interestingly in CMs 30% responded to MBNL1, 27% to CELF1 and between these 
2 groups there was >50% overlap. Similarly with total heart, endocytosis was enriched in CMs suggesting a role of 
AS in vesicular traffic, membrane organization and invagination. Possibly this enrichment reflects: i) ligands/growth 
factors uptake changes, ii) surface density of ion channels changes, iii) the deep architecture reorganization involved 
in the postnatal maturation of sarcoplasmic reticulum and T-tubules which are crucial for ECC.
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502 B Investigating the role of PTBP1 alternative exon 9 in the evolution of lineage-specific 
alternative splicing in vertebrates
Serge Gueroussov1, Jean-Philippe Lambert3, Nuno Barbosa-Morais2, Anne-Claude Gingras3, Benjamin Blencowe2
1Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 1A8, Canada.; 2Banting 
and Best Department of Medical Research, Donnelly Centre, University of Toronto, Toronto, Ontario M5S 
3E1, Canada.; 3Samuel Lunenfeld Research Institute, Mount Sinai Hospital, 600 University Avenue, Toronto 
M5G 1X5, Canada.
Through the use of comparative transcriptomics we and others have recently shown that alternative splicing (AS) 
patterns have diverged dramatically over the course of vertebrate evolution 1,2 (refer to abstract by Nuno Barbosa-Morais et 
al.). While the majority of species-specific AS differences appear to be governed by changes in the use of a largely conserved 
cis-regulatory splicing code, a subset of pronounced species- and lineage-specific AS events are found in trans-acting 
splicing regulators. These AS events are enriched in disordered regions of proteins and are expected to modulate surface 
interactions. One such AS event involves mammalian-specific skipping of exon 9 of the splicing regulator PTBP1. This 
exon encodes a 26 amino acid sequence located within a highly disordered linker region that connects RNA Recognition 
Motifs (RRMs) 2 and 3. To investigate the functional significance of this lineage-dependent AS event, we generated 293 
cell lines that selectively express PTBP1 isoforms with and without exon 9.  RNA-Seq profiling of these lines revealed 
over 100 cassette alternative exons that are differentially-regulated by the two isoforms. Remarkably, the level of splicing 
of these exons is significantly correlated with the relative expression of the two PTBP1 isoforms across diverse organs 
and vertebrate species. To investigate the mechanism by which differential inclusion of PTBP1 exon 9 affects lineage-
specific AS patterns, we employed isoform-specific immunoprecipitation and quantitative mass spectrometry. Interestingly, 
exon 9 exclusion results in a several-fold increase in the interaction between PTBP1 and its RRM-containing co-regulator, 
RAVER1. In summary, a subset of AS differences between vertebrate species can be linked to the differential inclusion of 
a single alternative exon in the splicing regulator PTBP1. This exon appears to function, at least in part, by modulating the 
interaction between PTBP1 and its co-regulator RAVER1.
1. Barbosa-Morais, N. et al. 2012. The evolutionary landscape of alternative splicing in vertebrate species. Science 338: 
1587–93.
2. Merkin, J., Russell, C., Chen, P., and Burge, C. 2012. Evolutionary dynamics of gene and isoform regulation in Mammalian 
tissues. Science 338: 1593–9.
501 A Assessing influence of mutations in first nucleotides of exons on splicing of the BTK and 
SERPING1 genes.
Lucie Grodecká1, Pavla Lockerová2, Barbora Ravcukova1, Emanuelle Buratti3, Francisco Baralle3, Tomas Freiberger1
1Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech 
Republic; 2Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation, Brno, Czech 
Republic; 3International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
Mutations in the first nucleotide of exons (E+1) mostly affect splicing when found in AG-dependent 3’ splice sites (3’ ss), 
whereas exons with AG-independent splice sites are resistant to this type of mutation. In introns, AG-dependency is determined 
by the quality of the polypyrimidine tract, its length, and degeneracy. Because of this complex interplay between interdependent 
factors the mRNA splicing outcome of substitutions in 3’ ss may be difficult to assess just from primary nucleotide sequence data. 
Recent study showed that mutations in the +1 G impaired splicing in exons with preceding polypyrimidine stretches (PPS) from 
4 nt to 10 nt long whereas those with PPS from 9 to 16 nt long were normally spliced.1
In order to test this rule, we have used a minigene system to analyze the influence of five +1 G substitutions found 
in BTK and SERPING1 genes on pre-mRNA splicing. Two of the mutations with the PPS length of 8 and 10 nts led to splicing 
aberration, while the other three with PPS length of 6; 6 and 8 nts did not affect the splicing. The two groups of sequences were 
slightly better distinguishable from each other according to the number of pyrimidines in 25 nts from the 3’ ss, although we 
detected one outlier in the non-aberrant group.
Next, we examined how the most commonly used in silico splicing prediction tools would cope with the effect of these 
mutations on splicing. Both predictions of polypyrimidine tracts according to Kol and Schwartz failed in the discrimination 
between the AG-dependent and AG-independent 3’ ss. Much better were the outcomes of splice site predictors. In the NNSPLICE 
program the border value discerning between the two groups of sequences was 7 % difference of the splice site score. One of the 
aberrant and one of the non-aberrant species showed that value. Analogous border value in the MaxEnt predictor was 20 % score 
difference, which clearly discerned the sequences according to their AG-dependency. Excellent results gave the PSSM predictions 
that showed 1 % score difference for all splicing non-affecting variants and 3 % difference for both splicing-affecting variants. 
We conclude that these in silico tools may be helpful for assessing the effect of a +1 G mutation on splicing. However, rather than 
generally recommended minimum of 10 % score difference for splicing affecting mutations, one should use values specific for 
each prediction tool.
1. Fu Y, Masuda A, Ito M, Shinmi J, Ohno K, Nucleic Acids Res 39 (2011) 4396-4404.
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504 A SR proteins regulate from cellular environment dependent splicing
Egle Jakubauskiene1, Egle Jakubauskiene1, Laurynas Vilys1, Yuichi Makino3, Lorenz Poellinger2, Arvydas Kanopka1
1Institute of Biotechnology, Vilnius Lithuania; 2CMB, Karolinska Institute, Stockholm, Sweden; 3Division of 
Internal Medicine, Asahikawa
Oxygen (O2) is essential for the life of all aerobic organisms. In mammals, at the whole body level, oxygen 
supply is optimized by tight regulation of ventilation, arterial blood hemoglobin saturation and systemic oxygen 
transport. The oxygen tension has been demonstrated to be a key regulator to optimize specific organ functions.
Hypoxia-inducible factors (HIF-1α; HIF-2α; HIF-3α) are a transcriptional complex that plays a central role in oxygen-
regulated gene expression. HIFs DNA binding complex consists of a heterodimer of HIF-α and HIF-β - identical to 
the previously identified arylhydrocarbon receptor (AhR) nuclear translocator (ARNT). All these proteins belong to 
the family of basic helix-loop-helix (bHLH) proteins that contain a PAS domain. HIFs bind to hypoxia responsive 
elements (HRE) and activate the transcription of a variety of genes involved in the regulation of erythropoiesis, 
angiogenesis, vasomotor control and energy metabolism.
In mice a dominant negative regulator of hypoxia-inducible gene expression (IPAS) is generated in hypoxic 
cells by alternative splicing from HIF-3α pre-mRNA. In this study, we aim to understand the molecular mechanisms, 
regulation of which underlay the alternative HIF-3α/IPAS pre-mRNA splicing process.
We report that: 1) HIF-3α splice sites are efficiently used in HeLa cell nuclear extracts prepared under normoxic 
conditions, and very inefficiently in HeLa cell nuclear extracts prepared under hypoxic conditions; 2) IPAS splice sites 
used very inefficiently in HeLa extracts prepared under normoxic conditions, and used in HeLa cell nuclear extracts 
prepared under hypoxic conditions; 3) UV crosslinking results revealed that SR proteins isolated from normoxic 
and hypoxic cells interact with RNA differentially.Regulation of HIF-3α/IPAS pre-mRNA splicing dependent from 
oxygen tension is under further investigation.
503 C Prp45 affects early stage of spliceosome assembly and pre-mRNA abundance in yeast
Martina Hálová1, Ondrej Gahura1, Zdenek Cit1, Tomáš Dráb1, Anna Valentová1, Katerina Abrhámová1, František 
Puta1, Petr Folk1
1Department of Cell Biology, Faculty of Science, Charles University in Prague, Praha, Czech Republic
Prp45 is an evolutionarily conserved essential splicing factor that was found to be part of B, C, and post catalytic 
spliceosomal complexes; Prp45 is believed to enter the splicing cycle as part of the Prp19 complex (NTC). Previously, 
we reported that the C-terminal part of Prp45 regulates the partition of the second step helicase Prp22 in Cwc2 
pull-downs and affects the fidelity of 3’ splice site choice in S. cerevisiae. Using substrates non-conforming to the 
consensus, we also found that branch site mutations decrease 1st step efficiency in prp45(1-169) cells relative to WT 
(Gahura et al., 2009).
Our recent data indicate that Prp45, besides its role in the 2nd splicing step, affects spliceosome function also before 
the first transesterification. We found that truncation of Prp45 (prp45(1-169)) resulted in pre-mRNA accumulation of 
intron containing genes but that the corresponding mRNA levels remained unchanged with the exceptions of long 
intron genes such as COF1 and IMD4. We employed Mer1-dependent reporter substrates, SpR and ExR, which yielded 
translated products when either spliced or not spliced, respectively. Cells expressing truncated Prp45 displayed SpR/
ExR ratios which were consistent with a defect before the first transesterification. We also examined Mer1-dependent 
pre-mRNA and mRNA accumulation of MER2 and other endogenous meiotic genes. prp45(1-169) cells accumulated 
~three times higher levels of MER2 pre-mRNA than WT cells only when Mer1 was present (i.e., spliceosome was 
assembling on the pre-mRNA). ChIP experiments also revealed the impaired recruitment of Prp45(1-169)-HA to intron 
containing genes. Co-transcriptional association of other splicing factors with intron containing genes in prp45(1-
169) cells was differentially affected, suggesting that Prp45 plays role before the B complex formation. Notably, we 
found earlier that S. pombe U2AF35, which forms part of early spliceosome and pre-dates NTC in the splicing cycle, 
interacts with Prp45 homolog SNW1 (Ambrozkova et al., 2001).
This work was supported by MSM0021620858 and the Charles University grants 471117 and SVV265211.
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506 C Elucidation of UP1 binding to RNA substrates: Does RNA structure matter?
Jeffrey Levengood1, Carrie Rollins1, Michele Tolbert1, Blanton Tolbert2
1Case Western Reserve University; 2Case Western Reserve University, Chemistry Department
The RNA binding protein hnRNP A1 performs numerous functions: mRNA transportation, splicing regulation, 
translation initiation, and telomere biogenesis.  Many infectious agents utilize hnRNP A1 for its RNA binding 
capabilities.  Two such agents are HIV-1 and Enterovirus 71 (EV71).  In HIV-1 infection, hnRNP A1 acts as 
a trans splicing regulator.  Meanwhile, in EV71, hnRNP A1 stimulates IRES-mediated translation.  These functions of 
hnRNP A1 could provide targets for small molecules which block the binding of hnRNP A1 to viral RNA.
In our studies of hnRNP A1 binding to RNA, sub-domains of larger constructs are investigated.  The DNA 
unwinding protein UP1, which consists of the two RRM domains of hnRNP A1, is being used in all our experiments. 
The RNA constructs used are SL3 (ESS3) of HIV-1 splice site A7 and SLII of the EV71 IRES.  Previous experiments 
have revealed both stem loops bind UP1.
By working with RNA constructs of different structure, we hope to determine if RNA structure is a significant 
factor for UP1 recognition.  Previous studies have shown UP1 binds UAG sequences in single stranded RNA.  Our 
studies have shown UP1 binds ESS3 at its hairpin loop.  SLII has two binding sites, a hairpin loop and a 5 nucleotide 
bulge which contains a UAG sequence.  Examination of UP1 binding to its RNA substrates has been done by NMR 
and ITC.  NMR has shown residues in UP1 potentially involved in RNA binding.  ITC experiments have revealed the 
thermodynamic profile of UP1 binding to SLII and ESS3.
505 B High-resolution Rbfox2 binding patterns predict widespread splicing regulation in mouse 
embryonic stem cells
Mohini Jangi1, Paul Boutz1, Phillip Sharp1
1Koch Institute, MIT Department of Biology
The Rbfox family is unique among splicing regulators, which generally recognize degenerate sequence elements, in its 
recognition of a well-defined motif, UGCAUG.  Yet recent observations imply the existence of additional determinants in 
defining a functional binding event.  Notably, RBFOX2 CLIP(cross-linking immunoprecipitation)-seq in human embryonic 
stem cells suggested that RBFOX2 occupied only a subset of UGCAUG motifs in expressed transcripts and that not all 
binding events were motif-dependent (Yeo et al., 2009).  Using complementary CLIP-seq and RNA-seq approaches, we 
explored the relationship between binding and splicing regulation by Rbfox2 in mouse embryonic stem cells (mESCs).  To 
determine Rbfox2-dependent splicing changes in mESCs, we performed RNA-seq upon shRNA-mediated depletion of 
Rbfox2.  Analysis of splicing changes between control and Rbfox2 knockdown using the MISO algorithm (Katz et al., 2010) 
revealed hundreds of putative Rbfox2-regulated splicing events in all major modes of alternative splicing.  Expression of a 
human RBFOX2 transgene in an Rbfox2 knockdown background resulted in titratable rescue of Rbfox2-dependent splicing 
changes.  We identified direct targets of Rbfox2 regulation in mESCs using a variant of iCLIP (individual-nucleotide 
resolution CLIP) (Konig et al., 2011; Ule et al., 2005) for epitope-tagged RBFOX2 in mESCs.  RBFOX2 binding was 
enriched in cassette-associated and mutually exclusive exon-associated introns relative to constitutively-spliced introns. 
Sixty percent of crosslink clusters harbored a motif closely related to the canonical UGCAUG motif.  By overlaying 
RBFOX2 CLIP signal onto Rbfox2-enhanced and –repressed exons determined by MISO, we generated an Rbfox2 RNA 
map largely consistent with prior observations of position-dependent regulation.  We applied the binding criteria inferred 
from this RNA map to all mouse exons and predicted the regulation of hundreds of additional exons bound by RBFOX2 
in flanking introns.  Surprisingly, many of these putative Rbfox2-regulated splicing events were predicted to be associated 
with splicing-coupled nonsense-mediated mRNA decay (NMD).  Rbfox2-dependent splicing changes that resulted in 
unstable mature transcripts may have been underrepresented in our RNA-seq data; however, these events were identifiable 
in the RBFOX2 CLIP-seq because the crosslink signal originated from pre-mRNA prior to the generation of an NMD 
isoform.  We are currently investigating the extent to which Rbfox2 and the NMD machinery coordinately control isoform 
expression.  We propose that Rbfox2, in part through the regulation of unstable isoforms, orchestrates a more dynamic and 
widespread network of splicing decisions than previously appreciated.
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507 A Thailanstatins: New Pre-mRNA Splicing Inhibitors and Potent Antiproliferative Agents 
Discovered from Burkholderia thailandensis MSMB43
Xiangyang Liu1, Sreya Biswas2, Michael Berg3, Christopher Antapli2, Gideon Dreyfuss3, Yi Q. “Eric” Cheng1
1UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, Texas 
76107, United States; 2Department of Biological Sciences, University of Wisconsin–Milwaukee, Milwaukee, 
Wisconsin 53201, United States; 3Howard Hughes Medical Institute, Department of Biochemistry and 
Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, United States
More than 90% of human genes undergo alternative slicing, which results in protein variants far greater than 
the number of the encoding genes. While this processing inherently provides for transcriptome diversity, aberrant 
alternative splicing has been implicated in numerous diseases conditions such as cancer and neurodegeneration. 
The cellular machinery of alternative splicing has thus become a valid drug target, and dozens of small molecule 
effectors interrogating the alternative splicing process have been identified and evaluated as drug candidates. The 
aim of our research is to discover new natural products from rare bacterial species that target eukaryotic epigenetics 
and gene transcriptional regulation including alternative splicing. Mining the genome sequence of Burkholderia 
thailandensis MSMB43 revealed a cryptic biosynthetic gene cluster highly resembling that of FR901464, a prototype 
pre-mRNA splicing inhibitor produced by Pseudomonas sp. No. 2663. Transcriptioal analysis identified a cultivation 
condition in which a key gene of the cryptic gene cluster is adequately expressed. Consequently, three new compounds, 
named thailanstatins A, B and C, have been isolated from the fermentation broth of B. thailandensis MSMB43 through 
natural product chemistry (see Figure 1 below). Thailanstatins belong to the FR901464-family of microbial products 
biosynthesized by a hybrid polyketide synthease-nonribosomal peptide synthetase pathway. They have an overall 
structural similarity with FR901464, but differ by lacking an unstable hydroxyl group and by having a carboxyl 
moiety which together endow the compouds with a significantly greater stability than FR901464 under physiologically 
relevant conditions. In vitro assays showed that thailanstatins inhibit pre-mRNA splicing as potently as FR901464, 
with half-maximal inhibitory concentrations in the single to sub mM range, causing pre-mRNA to accumulate and 
preventing the production of mRNA and splicing intermediates. In vitro cell culture assays indicated that thailanstatins 
also possess potent antiproliferative activities in representative human cancer cell lines, with half-maximal growth 
inhibitory concentrations in the single nM range (see Table 1 below). This work provides new chemical entities as 
reagents for research and as drug candidates for development, and validates theBurkholderia species as an exciting 
new source of bioactive natural products.
 
Table 1. Properties of Thailanstatins in comparison with FR901464 
Natural Product Half-
life (t1/2, 
hr) 
Pre-mRNA 
splicing 
inhibitory 
activity (IC50 
in μM) 
Antiproliferative activity (GI50 in nM) 
DU-145 
(prostate 
cancer cell 
line) 
NCI-H232A 
(non-small cell 
lung cancer 
cell line) 
MDA-MB-231 
(triple-negative 
breast cancer 
cell line) 
SKOV-3 
(ovarian 
cancer cell 
line) 
Thailanstatin A >78 0.65±0.36 1.11±0.02 2.26±0.17 2.58±0.11 2.69±0.37 
Thailanstatin B 19 6.18±2.47 3.00±0.92 2.50±0.06 6.22±1.67 4.94±1.76 
Thailanstatin C 25 6.84±2.90 2.98±0.90 3.67±0.53 8.82±2.20 5.57±2.01 
FR901464 10 0.58±0.07 1.05±0.02 1.94±0.24 2.10±0.19 1.06±0.01 
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509 C Real-time kinetics of human pre-mRNA splicing
Robert Martin1, José Rino1, Célia Carvalho1, Tomas Kirchhausen2, Maria Carmo-Fonseca1
1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal; 2Department 
of Cell Biology, Harvard Medical School, Immune Disease Institute and Program in Molecular and Cellular 
Medicine at Children’s Hospital, Boston, Massachusetts, USA
We have developed a system to visualize splicing in real-time in living human cells. We combined genomic 
integration of a single reporter gene in human cells, intron labelling with the MS2 technique and spinning disk confocal 
microscopy to directly image the kinetics of intron excision from pre-mRNA. The fluorescence intensity associated 
with a single transcription site, which appears as a diffraction-limited object, is quantified as a function of time. 
Increments in the fluorescence signal result from de novo transcription of MS2-binding sites, and its disappearance 
reflects intron excision. Fluctuations in fluorescence intensity are used to determine the intron lifetime. We also 
determined the number of introns present at each individual transcription site at any given time point based on the 
number of GFP molecules bound to intronic MS2-stem loops. The results reveal different splicing kinetics depending 
on intron length and splice site strength. These results have important implications for mechanistic understanding of 
splicing regulation in the live-cell context.
508 B Effects of SR Protein Expression on HIV-1 Splicing
Le Luo1, Alan Cochrane2, Blanton Tolbert1
1Department of Chemistry, Case Western Reserve University; 2Department of Molecular Genetics, University 
of Toronto
From a single 9kb polycistronic transcript, HIV-1 generates more than 40 mRNAs, which encode the full viral 
protein complement. This process is largely regulated by the host protein factors that belong to hnRNP and SR protein 
families. Generally, hnRNP proteins function to suppress splicing by binding the RNA silencer elements; counteracting 
hnRNP proteins, SR proteins up-regulate splicing through interaction with RNA enhancer elements. Here, we show 
that the expression levels of SR proteins modulate the relative abundance of HIV transcript levels. In particular, 
changes in SRp20 levels (up or down) negatively affect HIV-1 RNA metabolism, resulting in altered balance of 
RNA splicing that decreases unspliced viral RNA abundance as well as altered splice site selection that modulates 
Tat expression. Overexpression of 9G8 enhances HIV-1 gene expression while its depletion suppresses synthesis of 
HIV-1 Gag and, to a lesser extent, Env production. To test whether SRp20 directly or indirectly affects HIV transcript 
levels, viral RNA IP analysis was performed using a U2OS cell line that stably express non-infectious HIV provirus 
along with Myc-tagged SRp20 protein. The preliminary result indicates SRp20 specifically binds to HIV transcript. 
Quantitative experiments are underway to determine the binding preference of SRp20 to the HIV unspliced, singly 
spliced, and multiply spliced RNA classes.
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510 A Sex-specific alternative splicing in the head of Drosophila melanogaster and its 
underlying regulatory mechanisms
Carmen Mohr1, Marco Blanchette Blanchette2, Britta Hartmann1
1Institute of Human Genetics; Freiburg University Medical Center, Freiburg, Germany; 2Stowers Institute for 
Medical Research, Kansas City, USA
Drosophila sex-determination is a prime example of an alternative splicing cascade where Sex-lethal (SXL) as a 
master regulator controls alternative splicing of the key sex-determination genes Sxl, transformer (tra),male-specific-
lethal (mls-2), doublesex (dsx) and fruitless (fru).
The recent discovery that the number of sex-specifically spliced genes is magnitudes higher than expected, suggests 
a more extensive post-transcriptional regulation program, which may act together with transcriptional changes to shape 
sex determination in Drosophila melanogaster. The question arises of how these events are regulated. Interestingly, 
some of the sex-specific alternative splicing (AS) changes in adult fly heads are lost in genetically manipulated flies 
lacking a germline, suggesting that signals from the germline control sex-specific AS in distant tissues. A similar 
scenario might be true for male-derived accessory gland proteins that are transferred via the seminal fluid during 
copulation from males to females. We use the Drosophila model system to identify new regulatory concepts in sex-
determination and take advantage of the genetic accessibility of Drosophila to study alternative splicing directly in 
vivo.
To determine to what extent sex-specific AS is present in the head, and what influence the germline and mating 
process have on the AS pattern, we analyzed the transcriptome of adult wild type, tud, and virgin female and male fly 
heads, using Next Generation Sequencing (NGS). Significant sex-specific expression changes were observed in 218 
genes and AS changes in 230 genes (corresponding to 407 AS events).  In addition, the experiments showed that AS 
is highly regulated in the heads of germline-less and virgin flies. Indeed, first analysis of the data suggests that appr. 
30-40 % of the AS events in the head depend on the germline and mating process, respectively.
Dual fluorescence minigene reporters are excellent tools to monitor AS, but have not been used in Drosophila so 
far. As tools for cell culture and in vivo experiments, these reporters can be used to identify trans-acting and cis-
acting regulatory elements of the splicing process. For large scale analysis, AS of these reporters in cell culture can 
be analyzed using FACS.  For different promising candidate genes of the NGS experiments, AS reporters are being 
established and the data will be presented. For example, we constructed a dual fluorescence reporter minigene to 
monitor sqd AS, using its endogenous promoter. Differences in AS of sqd were recapitulated in Drosophila S2 cells. 
Differential isoform expression, using transgenic flies carrying this reporter was detected in the cortex of the nervous 
system with one isoform showing higher levels in the mushroom body.
This established system enables to monitor AS directly in vivo and allows to identify trans-acting and cis-acting 
regulatory elements of the splicing process.
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512 C A highly conserved GC-rich element regulates alternative splicing of mRNA for the variant 
thyroid hormone receptor TRa2
Stephen Munroe1
1Marquette University
In mammals the THRA gene is alternatively spliced and encodes two proteins: TRα1, the α-thyroid hormone 
receptor, which is widely expressed in all vertebrates; and TRα2, a non-hormone binding variant present only in 
eutherian mammals. Coding sequences unique to TRα2 share an antisense overlap with those of Rev-erbα (NR1D1), 
a nuclear receptor and core component of the mammalian circadian clock. Intronic and exonic splicing enhancers for 
TRα2 have evolved in the context of sequences required for expression of Rev-erbα mRNA. Of particular interest is 
a GC-rich region (designated G30) at the 5’ end of the terminal exon that encodes the unique C-terminal sequence of 
TRα2 mRNA. This sequence is antisense to the 3’UTR of Rev-erbα and tightly conserved in all eutherian Rev-erbα 
mRNAs, but not in those from marsupials or monotremes that do not express TRα2. Closely spaced deletions and 
substitutions within G30, differing by as little as a single nucleotide, have dramatically different effects on TRα2 
splicing depending on their precise position. For example, deletion of 12 nucleotides can lead to >95% inhibition or 
>2.5-fold enhancement of TRα2 splicing. Substitutions of 2 or more nucleotides within G30 also display a range of 
effects. Our results suggest that G30 is a highly structured sequence, possibly a G-quadruplex, and part of a larger 
complex splicing regulatory element that exerts both positive and negative effects on TRα2 expression. Factors bound 
to G30 may interact directly with the 3’splice site and polyadenylation site that define the terminal exon. Alternatively, 
this element may affect splicing via effects on transcription within this bidirectionally transcribed region. Further 
experiments to distinguish between these possibilities are underway.
511 B Structural investigation of hnRNP G interaction with SMN RNA
Ahmed Moursy1, Antoine Clery1, Frederic Allain1
1ETH Zürich
The protein hnRNP G is an important regulator of gene expression in human cells. This factor modulates splicing 
of several pre-mRNAs including Survival of Motor Neuron (SMN). SMN is encoded by two genes SMN1 and SMN2, 
which differ by five nucleotides. As a result, a different set of splicing factors is recruited on SMN2 resulting in 
exon 7 skipping in most of its transcripts. Inclusion of this exon is essential for the production of functional SMN 
proteins(1). A homozygous loss of SMN1 gene results in the insufficient production of active proteins from the SMN2 
gene causing the Spinal Muscular Atrophy (SMA) disease. As the SMN2 gene is systematically present in the genome 
of SMA patients, a promising strategy to cure SMA is to target the splicing of SMN2 transcripts to increase the 
percentage of exon 7 inclusion and consequently the production of functional SMN proteins(2).
HnRNP G was previously proposed to be recruited by Tra2-β1 upstream its binding site on SMN exon 7(3) and 
together, they activate the inclusion of this exon(1). The specificity of RNA recognition by hnRNP G remains elusive. 
Based on high sequence identity between the RNA Recognition Motifs (RRMs) of hnRNPG and RBMY, its paralogue 
in testis that binds CAA containing RNA motifs(4), it was suggested that hnRNP G could bind similar sequences on 
SMN exon 7(3). In this study, we use NMR spectroscopy to better characterise the mode of RNA recognition of this 
protein. We solved the structure of hnRNP G RRM in complex with the SMN exon 7 derived 5’-AUCAAA-3’ RNA. 
The structure reveals that the RRM recognises specifically two successive adenines utilizing its β-sheet surface and, 
more surprisingly, its C-terminal extremity. This mode of recognition differs from what was previously reported for 
RBMY which, unlike hnRNP G, recognises an additional cytosine 5’ to the two adenines(4). We could show that the 
recognition of this additional cytosine by RBMY RRM occurs only in the context of interaction with a stem-loop 
RNA. Interestingly, two stretches of successive adenines are present in the putative hnRNP G binding site on SMN 
and we tested the importance of hnRNP G binding to them for exon 7 splicing both in vitro and in vivo.
In conclusion, this study reveals the mode of RNA recognition of hnRNP G and brings novel information about 
regulation of SMN exon7 alternative splicing by this protein.
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513 A The centrosomal kinase NEK2 is a novel splicing factor kinase
Chiara Naro1, Federica Barbagallo1, Paolo Chieffi2, James Stevenin3, Maria Paola Paronetto4, Claudio Sette1
1Department of Biomedicine and Prevention, University of Rome “Tor Vergata,” Rome, Italy; 2Department of 
Experimental Medicine, II University of Naples, Naples, Italy; 3Department of Functional Genomics, Institut 
de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), University of Strasbourg, Strasbourg, 
France; 4Department of Health Sciences, University of Rome “Foro Italico”
NEK2 is a serine/threonine kinase belonging to the family of the NIMA kinases, which are well known as key 
regulators of the cell cycle. In particular, NEK2 promotes centrosomes splitting and insures correct chromosomes 
segregation during the G2/M phase of the cell cycle through the phosphorylation of specific substrates, such as the 
centrosomal protein c-Nap1. Aberrant expression and activity of NEK2 leads to dysregulation of the centrosome cycle 
and aneuploidy. Thus, a tight regulation of NEK2 activity and expression is needed during cell cycle progression.
NEK2, as other centrosomal kinases, is up-regulated in several human cancers, such as breast carcinoma, testicular 
seminoma, and myeloma, and its expression levels have been proposed as an accurate prognostic marker.
In both testicular seminomas and myelomas, NEK2 overexpression correlates with its nuclear localization. This 
observation suggests the existence of unknown nuclear functions for NEK2 in cancer cells, which have been object 
of our further investigation.
We found that NEK2 localizes in the nucleus of cancer cells derived from several different tissue and in particular 
it localizes in their splicing speckles. Moreover, NEK2 interacts with several splicing factors and phosphorylates some 
of them, like the proto-oncogene SRSF1. Overexpression of NEK2 exerts the same effect of the SR protein kinase 
SRPK1 on phosphorylation of endogenous SR-proteins. Moreover, NEK2 and SRPK1 similarly affect the splicing 
activity of SRSF1 towards reporter minigenes and its endogenous targets.
Our results identify NEK2 as a novel kinase involved in splicing regulation, suggesting that part of its oncogenic 
activity may be ascribed to its ability to modulate this key step in the regulation of gene expression, which is frequently 
altered in cancer cells.
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514 B Reconstructing alternative splicing of SMN exon 7 by NMR, SRM-Mass-Spectrometry and 
mathematical modeling
Yaroslav Nikolaev1, Martin Soste2, Paola Picotti2, Dagmar Iber3, Frederic Allain1
1ETH Zurich, Molecular Biology and Biophysics; 2ETH Zurich, Biochemistry; 3ETH Zurich, Computational 
Biology
Spinal Muscular Atrophy (SMA) is a lethal neurodegenerative disease affecting human infants with an incidence 
rate of 1 in 6000 live births. SMA phenotype is strongly connected to skipping of exon 7 in the Survival Motor 
Neuron 2 (SMN2) gene, which appears to be primarily driven by a single silent mutation in +6 position of the exon 
(c.840C>T). According to available data this mutation converts binding site of the positive SMN splicing regulator 
SRSF1 into the site of the negative regulator hnRNP A1 (A1). Despite substantial research efforts the exact molecular 
mechanisms leading to exon 7 skipping are still poorly understood. Among the reasons for such limited progress is the 
complexity of exon 7 splicing regulation, which involves interplay of at least 5 regulator proteins.
In this project we aim to explain the mechanism of SMN exon 7 skipping by building a holistic model of this system 
using Nuclear Magnetic Resonance Spectroscopy (NMR), Selected-Reaction-Monitoring Mass-Spectrometry (SRM-
MS) and mathematical modeling. We use SRM-MS to measure the exact in vivo concentrations of five regulatory 
proteins (hnRNPs A1 and G, SRSF1, Tra2b1, SRp30c). Next, we are constructing an in vitro model of the system 
by mixing selectively labelled protein regulators and target SMN RNAs, aiming to visualize all protein-RNA and 
protein-protein interactions in NMR tube under conditions matching those found in vivo. Third, we are integrating 
the obtained MS, NMR and other biophysical data into a predictive mathematical model to explain the mechanism of 
exon 7 alternative splicing. Finally, we plan to validate the predictions of the resulting models against exon 7 splicing 
assays in cell extracts.
Preliminary in vitro reconstructions involving three core system components (SRSF1, A1 and target 24nt SMN 
ESE/ESS RNA) have shown promising results. NMR data indicates that SRSF1 is not completely displaced from 
SMN2 ESE/ESS sequence under equimolar A1:SRSF1 ratio (100 µM each). SRM-MS analyses show that nuclear 
concentration of A1 is 4.5-fold higher than that of SRSF1 (90 µM A1 vs 20 µM SRSF1). These facts suggest that 
increased nuclear concentrations of A1 shall be important for it to drive the exclusion of SMN2 exon 7.
To evaluate possible co-transcriptional effects we performed time-resolved NMR analysis of in vitro transcription 
of the target SMN sequences in the presence of A1 and SRSF1 factors. This analysis shows that folding rate of the 
target RNA may be slowing down in the presence of regulator proteins, suggesting additional kinetic control in exon 
7 alternative splicing.
We expect that extending the core in vitro and mathematical models to include remaining regulator proteins will 
eventually allow predicting the outcome of SMN exon 7 splicing based solely on the knowledge of concentrations of 
involved regulators.
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516 A Functional characterization of the RNA-binding protein Acinus: its role in pre-mRNA 
processing and apoptosis
Julie Rodor1, Magdalena Maslon1, Javier Caceres1
1MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, UK
Acinus (Apoptotic Chromatin Condensation Inducer in the Nucleus) is an RNA-binding protein originally 
identified for its role in inducing nuclear changes during apoptosis (1). This protein has also been found to be an 
auxiliary component of the Exon Junction Complex (EJC), which is deposited at exon junctions as a consequence 
of pre-mRNA splicing (2). A role for Acinus in splicing is also suggested by its association with RNPS1 and SAP18 
proteins in the ASAP (apoptosis- and splicing-associated protein) complex.
In order to uncover the cellular functions of Acinus, we searched for endogenous RNA targets using the Cross-
Linking Immunoprecipitation protocol (iCLIP) that allows the mapping of protein-RNA interactions at an individual 
nucleotide resolution. We found that Acinus is mostly associated with constitutively expressed exons of protein-
coding transcripts. Interestingly, Acinus binding is excluded from the region where the core EJC is deposited (20/24nt 
before the exon-exon junction). We also identified non-coding RNAs targets of Acinus.
An exon-junction array was used to investigate changes in gene expression and alternative splicing following 
siRNA-mediated depletion of Acinus in HeLa cells. This analysis revealed changes in expression levels of around 450 
genes as well as changes in 250 splicing events. A large number of genes presenting a change in alternative splicing 
were associated with an Acinus binding site, suggesting a direct role of this RNA-binding protein in the event. We are 
also investigating whether the role of Acinus during apoptosis involves its binding to specific RNAs. The combination 
of these approaches will help us to uncover the role of Acinus in pre-mRNA splicing, apoptosis and other cellular 
processes.
1. Sahara et al. (1999) Nature, 401, 168-73.
2. Tange et al. (2005) RNA, 11, 1869-83. 
515 C Comprehensive Mapping of the Splicing Regulatory Circuitry Involved in Cell Proliferation 
and Apoptosis
Panagiotis Papasaikas1, Juan Ramon Tejedor1, Luisa Vigevani1, Juan Valcarcel2
1Centre for Genomic Regulation (CRG) and UPF, Dr. Aiguader 88, 08003 Barcelona, Spain; 2Centre for 
Genomic Regulation (CRG) and UPF, Dr. Aiguader 88, 08003 Barcelona, Spain, Institució Catalana de 
Recerca i Estudis Avançats (ICREA), Pg. Lluis Companys 23, 08010 Barcelona, Spain
We present an integrated experimental and computational approach aimed to derive a comprehensive functional 
interactions map of the Splicing Regulators involved in cell proliferation and apoptosis. Our strategy is based on 
screening the effects of knock down (KD) of 300 individual genes encoding factors implicated in the splicing process 
and its regulation on 37 selected targets. The target list encompasses alternative splicing events implicated in tumor 
progression including apoptotic regulators, signaling molecules and metabolic enzymes. Splicing output of the targets 
upon KD is robustly quantified by high-throughput capillary electrophoresis. In turn this information is used as 
input for state-of-the-art methods for Graphical Model Selection and Analysis in order to recover the structure of the 
underlying splicing regulatory circuitry and to identify distinct modules within its topology.
Our method accurately captures well-established functional associations demonstrating its validity as a general 
tool for mapping out the splicing regulatory landscape. We are further able to identify several novel associations and 
to differentiate between those critical for general or alternative splicing regulation.  One compelling feature of our 
approach is the possibility to extend the screening to physiological / pharmacological treatments in order to link their 
effects to the splicing regulatory circuitry that underlies cell proliferation and apoptosis. As a proof of principle we 
map the associations of splicing-arresting drugs and iron-homeostasis to the functional network of splicing regulators.
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518 C hnRNP A1 promotes exon 6 inclusion of apoptotic Fas gene.
Haihong Shen1
1Gwangju Institute of Science and Technology
Fas is a transmembrane cell surface protein recognized by Fas ligand (FasL). When FasL binds to Fas, the target 
cells undergo apoptosis. A soluble Fas molecule that lacks the transmembrane domain is produced from skipping of 
exon 6 encoding this region in alternative splicing procedure. The soluble Fas molecule has the opposite function 
of intact Fas molecule, protecting cells from apoptosis. Here we show that knockdown of hnRNP A1 promotes 
exon 6 skipping of Fas pre-mRNA, whereas overexpression of hnRNP A1 reduces exon 6 skipping. Based on the 
bioinformatics approach, we have hypothesized that hnRNP A1 functions through interrupting 5’ splice site selection 
of exon 5 by interacting with its potential binding site close to 5’ splice site of exon 5. Consistent with our hypothesis, 
we demonstrate that mutations of the hnRNP A1 binding site on exon 5 disrupted the effects of hnRNP A1 on exon 
6 inclusion. RNA pull-down assay and then western blot analysis with hnRNP A1 antibody prove that hnRNP A1 
contacts the potential binding site RNA sequence on exon 5 but not the mutant sequence. In addition, we show that 
the mutation of 5’ splice site on exon 5 to a less conserved sequence destructed the effects of hnRNP A1 on exon 6 
inclusion. Therefore we conclude that hnRNP A1 interacts with exon 5 to promote distal exon 6 inclusion of Fas pre-
mRNA. Our study reveals a novel alternative splicing mechanism of Fas pre-mRNA.
517 B Widespread regulatory functions of Polypyrimidine Tract-Binding Proteins in splicing and 
development of Arabidopsis thaliana
Christina Rühl1, André Kahles2, Gabriele Wagner1, Gabriele Drechsel1, Gunnar Rätsch2, Andreas Wachter1
1Center for Plant Molecular Biology, University of Tübingen, Germany; 2Computational Biology Center, 
Sloan-Kettering Institute, New York
The process of alternative splicing (AS) is not only common in mammalian systems, but also a widespread phenomenon 
in plants, with currently ~60% of all multiexon genes from Arabidopsis thaliana being reported to be associated with AS 
events. Among the regulators of AS are polypyrimidine tract-binding proteins (PTBs), of which three homologues have 
been identified in Arabidopsis thaliana. While the proteins encoded by At3g01150 (PTB1) and At5g53180 (PTB2) are 
closely related, the protein encoded by At1g43190 (PTB3) exhibits a quite low level of sequence similarity to the other 
two. Using a misexpression approach for all Arabidopsis PTBs to investigate PTB-dependent changes in global splicing 
patterns, we have identified ~450 putative At-PTB regulation targets, thus providing the first evidence of a widespread AS 
regulatory role of plant PTBs. Interestingly, a major role in splicing control was only observed for At-PTB1 and At-PTB2, 
but not At-PTB3. The observed reciprocal changes of AS ratios upon up- and downregulation of At-PTBs indicated a direct 
regulation of the identified targets by these proteins. Using electrophoretic mobility shift assays (EMSAs), direct RNA/
protein interactions could be demonstrated for the target candidate phytochrome interacting factor PIF6 with At-PTB2. 
Furthermore, PTB binding motifs within the PIF6 pre-mRNA have been identified. To address a possible correlation of 
PTB binding positions and the splicing outcome, the role of polypyrimidine stretches located in different positions around 
a regulated cassette exon is being examined using a mutational approach.
With respect to the biological functions of plant PTBs, we have reported several flowering time regulators as well 
as PIF6, to exhibit a PTB-dependent alteration of splicing and/or expression patterns. Single T-DNA mutants in At-
PTB1 and At-PTB2 did not exhibit a visible phenotype, whereas the respective double mutant has been reported to be 
nonviable. To further elucidate the functional implications of At-PTB1/2, we are aiming to generate plants having the lowest 
tolerable levels of these splicing factors. Therefore, we are using an approach based on the combination of T-DNA insertion 
lines and artificial microRNAs (amiRNA). Interestingly, first phenotypical analyses indicated an earlier onset of senescence, 
as well as stunted growth and a serrated leaf phenotype upon combining the At-PTB2 knockout with an At-PTB1 targeting 
amiRNA.
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519 A Unusual evolutionary insertion of G-tracts creates splice variants of distinct localization 
and function in human cells
Muhammad Sohail1, Wenguang Cao1, Sam Kung2, Lisheng Wang3, Eftekhar Eftekharpour1, Jiuyong Xie4
1Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada; 2Department 
of Immunology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada; 3Departments of 
Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.; 
4Departments of Physiology, Biochemistry & Medical Genetics, Faculty of Medicine, University of Manitoba, 
Winnipeg, Canada.
Alternative splicing contributes greatly to the proteomic complexity in higher eukaryotes particularly humans. 
However, the underlying molecular mechanisms for the evolvement of alternative exons during evolution and its 
functional consequences remain largely unknown. The polypyrimidine tract (Py) and 3′ AG are often close to each 
other within a consensus sequence (Y)nNYAG at the 3’ splice site. In contrast to this arrangement for exon inclusion, 
here we report an unusually evolved G-tract insertion between the Py and AG for exon skipping, and consequently a 
variant protein of distinct localization and function in human cells.
We identified 130 3’ splice sites containing G-tracts between the Py and 3’ AG in a human genome search. 
Interestingly, examination of several such elements indicates that they are inserted evolutionarily in higher species. 
Particularly G-tracts upstream of the exon 3 of the PRMT5 (protein arginine methyl transferase 5) gene are gradually 
evolved from none in fish to one in certain lower and two in higher mammals. Contrary to the intronic G-tracts at 
other locations that are often splicing enhancers, these G-tracts are splicing repressors in mini-gene splicing reporter 
assays. Moreover, the repression is strong in humans but barely detectable in fish for both mini-gene reporter and 
endogeneous exons. In in vitro UV crosslinking and immunoprecipitation assays, the G-tract element is bound by 
hnRNP H and inhibitory of U2AF65 binding to Py. Consistently, hnRNP F/H knockdown enhances the inclusion 
of endogenous exon 3 in HeLa cells. Together these suggest that the unusually localized G tracts are evolutionarily 
inserted splicing repressors bound by a regulatory protein in human cells.
To understand the consequences of the G-tract-mediated skipping of exon 3 in humans, we examined the expression 
profiles and expressed each of the splice variant separately in cells. The variants are differentially expressed among 
cells or during differentiation. With exon 3 included, a full length protein is produced but restricted to discrete Golgi-
like structures while as with the exon skipped, a shorter protein is produced and spread all over the cell. Consistent 
result is obtained when each variant was knocked down by siRNA interference. Importantly, the full length but not 
the shorter isoform greatly increases the fragmentation of the Golgi apparatus in co-immunostaining assays with an 
antibody against the Golgi marker Giantin. Therefore, the two protein isoforms have distinct localization and function.
These data demonstrate that the unusual evolutionary insertion of G-tracts creates an alternative exon of distinct 
localization and function in human cells. This is likely a mechanism common to the emergence of a group of alternative 
exons that contribute to the proteomic complexity in humans. 
Supported by The Natural Sciences and Engineering Research Council of Canada (NSERC).
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521 C A Role for the Polyadenosine Binding Protein, Nab2, in Splicing and Quality Control
Sharon Soucek1, Megan Bergkessel2, Deepti Bellur3, Christine Guthrie2, Jonathan Staley3, Anita Corbett1
1Emory University School of Medicine; 2University of California San Francisco; 3University of Chicago
Gene expression is temporally and spatially regulated to produce a precise protein expression profile that dictates 
the function of each cell. From the onset of transcription, RNA binding proteins immediately associate with a nascent 
mRNA transcript and guide it through post-transcriptional processing events like 5’-capping, splicing, and 3’-end 
processing. Many messenger ribonucleoproteins (mRNP) that contact the mRNA transcript throughout its post-
transcriptional journey have more than one role in mRNA biogenesis to ensure proper processing of an mRNA transcript 
and avoid production of faulty proteins. These processing steps are highly conserved with much of the mechanistic 
information gleaned from studies in budding yeast. The essential S. cerevisiae zinc-finger nuclear polyadenosine RNA 
binding protein, Nab2, has been implicated in control of poly(A) tail length and mRNA export; however, a role for this 
protein in splicing has not been explored. To globally examine splicing of endogenous intron-containing transcripts, 
we performed a splicing microarray usingnab2 mutant cells.  A mild constitutive splicing defect was detected in 
these nab2 mutant cells.  Consistent with a role for Nab2 in modulating splicing, we also detected defects in splicing 
in an in vitro splicing assay. To begin to understand which splicing step depends on Nab2, we tested for genetic 
interactions between NAB2 alleles and splicing factors required at different steps in splicing.  We observed synthetic 
lethality with splicing factors required early in splicing.  A physical interaction was confirmed between Nab2 and the 
commitment complex proteins, Mud2 and Msl5, which are critical for both splicing and nuclear retention of unspliced 
transcripts. We then utilized a novel GFP reporter to track splicing and retention in Nab2 and Mud2 double mutants 
and found an exacerbated splicing defect as well as a reduction in pre-mRNA leakage. Alleles of NAB2also genetically 
interact with the mRNA decay machinery, suggesting that this atypical polyadenosine RNA binding protein acts as a 
nuclear watchdog to prevent accumulation and export of aberrant unspliced mRNAs. Our findings identify a role for 
Nab2 in regulating splicing and offer insights into how splicing and quality control are coupled in S. cerevisiae.
520 B Mechanisms regulating alternative splicing of Dscam
Matthias Soller1, Irmgard Haussmann1, Yash Hemani1, Pinar Ustaoglu1
1School of Biosciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, U.K.
The Drosophila Dscam gene encodes a cell adhesion molecule of the immunoglobulin superfamily and is required 
for neuronal wiring and phagocytosis in the immune system. A hallmark of the Dscam gene is the extraordinary 
molecular diversity that can be generated by mutually exclusive alternative splicing in four exon clusters resulting in 
38’016 different isoforms. The Dscam splicing pattern has to be different in neighboring mushroom body neurons for 
normal neuronal development and is altered upon pathogen exposure in immune cells.
To study the mechanisms regulating Dscam mutually exclusive splicing we focused on the exon 9 cluster 
containing 33 variable exons. We have developed a transgenic fly model containing a reporter gene recapitulating 
alternative splicing of the endogenous gene. Current models for mutually exclusive splicing in the Dscam exon 6 
cluster propose that the variable cluster is kept in a repressed state until one variable exon is chosen. Key to the release 
of the chosen exon from repression seems to be RNA base pairing between evolutionary conserved sequences in the 
vicinity of 5’ and 3’ splice sites of the proximal intron resulting in inclusion of the chosen exon. In the exon 4 and 9 
clusters, RNA secondary structure has also been postulated to play an essential role, yet in the distal intron to bring 
its 5’ and 3’ splice sites together. Using transgenic flies we are currently testing these models and present our analysis 
characterizing sequence requirements for exon selection and for mutually exclusive splicing in the exon 9 cluster. Our 
results will provide important insights into the regulatory mechanisms governing Dscam mutually exclusive splicing. 
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523 B Muscleblind and Fox proteins cooperate to change a splicing program involved in stem 
cell differentiation and maintenance.
Julian P Venables1, Laure Lapasset4, Gilles Gadea2, Philippe Fort2, Roscoe Klinck5, Emmanuel Vignal2, Panagiotis 
Prinos5, Benoit Chabot5, Sherif Abou Elela5, Pierre Roux2, Jean-Marc Lemaitre3, Jamal Tazi6
1Institut de Génétique Moléculaire de Montpellier, UMR 5535 - Newcastle University; 2CRBM Montpellier 
France; 3Institut de Génétique Fonctionnelle de Montpellier, UMR 5203 France; 4Institut de Génétique 
Moléculaire de Montpellier, UMR 5535 - France; 5Laboratoire de génomique fonctionnelle de l’Université 
de Sherbrooke Canada; 6University of Montpellier 2 Institut universitaire de France Institute of Molecular 
Genetics of Montpellier UMR5535
Reprogramming somatic cells into induced pluripotent stem cells (iPS cells) types that bear much similarity to 
Embryonic Stem cells has provided a vast amount of insight into the pathways, mechanisms, and key transcription 
factors involved in pluripotency. Here we have used human iPS cells derived from normal and senescent fibroblasts 
to uncover key splicing regulators instrumental in establishing an alternative splicing profile that characterizes 
pluripotency. Our approach was based on the use of 47 alternative splice events in genes involved in cancer and 
apoptosis to identify robust alternative changes induced by knock down of selected 49 splicing factors in 5 different 
cell lines and compare them to similar changes occurring during reversible stem cells induction and re-differentiation. 
We discovered that two RNA-binding proteins, namely MBNL1 and RBFOX2, when knocked down, accounted for 
more than 90% of the splicing changes. Strikingly, MBNL1 expression was completely abrogated in stem cells and 
re-expressed late during mesoderm redifferentiation. We speculate that MBNL1 sequestration by target RNA repeats 
in cases of Myotonic Dystrophy may impair differentiation of stem cells and contribute to skeletal muscle wasting.
522 A Prp40p WW Domain is Critical for Splicing of Introns Containing Non-canonical Branch 
Site Sequences in Saccharomyces cerevisiae
Luh Tung1, Chung-Shu Yeh5, Fu-Lung Yeh4, Hsuan-Kai Wang3, Jeffrey A Pleiss2, Tien-Hsien Chang4
1Genomics Research Center, Academia Sinica; 2Department of Molecular Biology and Genetics, Cornell 
University; 3Genome and Systems Biology Program, National Taiwan University; Genomics Research Center, 
Academia Sinica; 4Genomics Research Center, Academia Sinica; 5Institute of Biochemstry and Molecular 
Biology, National Yang-Ming University; Genomics Research Center, Academia Sinica
The WW domain is a protein domain with two highly conserved tryptophans that binds proline-rich peptide 
motifs.  Prp40p is a yeast-specific and essential U1-snRNP protein that harbors two WW repeats at its N-terminus, 
which were thought to interact with the proline-rich region of BBP (branch-site binding protein) for promoting the 
formation of commitment complexes.  Surprisingly, earlier studies by others showed independence of the conserved 
WW repeats in splicing and contranscriptional spliceosome assembly.  We have carefully approached the same 
issue and discovered that WW repeats are in fact critical for splicing of introns containing non-canonical branch site 
sequences (e.g. GAUUAAC vs. canonical UACUAAC) in vivo.  To exclude the possibility of gene-specific bias, 
we employed a splicing reporter system and found that when the branch-site sequence is changed into GAUUAAC, 
splicing became sensitive to the loss of either WW repeats and, most apparently in particular, the loss of both WW 
repeats.  This sensitivity appears most dramatic when cell growth was assayed at 37°C.  To further determine in 
detail the WW repeats’ function, and therefore Prp40p’s, in splicing, we used splicing-sensitive microarray to identify 
intron-containing genes that are susceptible to the loss of Prp40p WW repeats.  To enhance our understanding of 
the function of the Prp40p-WW repeats from an entirely different angle, we searched for gene deletions that cause 
synthetic lethality or sickness in combination with the prp40-?N mutation in the Synthetic Genetic Array (SGA) 
platform.  Finally, we applied the BPA chemical cross-linking approach to directly test the hypothesis that the WW 
repeats indeed interact with the proline-rich region in BBP in vivo.  In summary, we uncovered a hitherto hidden 
splicing role for the WW domain of Prp40p in the light of their relationships to the role of BBP.  Because the branch 
site sequences is less conserved in mammals than that in yeast, the WW-domain containing proteins in mammals may 
play regulating roles at the branch site recognition in splicing.
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525 A Splice-sensitive array profiling suggests a role for STAR proteins and PTB in control of 
smooth muscle cell alternative splicing.
Selina Xiao Wang1, Martina Hallegger2, Clare Gooding1, Adrian Buckroyd1, Miriam Llorian1, Nicolas Bellora4, 
Eduardo Eyras4, Melis Kayikci3, Jernej Ule3, Christopher Smith1
1Department of Biochemistry, University of Cambridge, UK; 2Department of Physiology, Anatomy & 
Genetics, University of Oxford, UK; 3MRC-LMB, UK; 4Universitat Pompeu Fabra Barcelona, Spain
Tissue-specific alternative splicing has been extensively investigated in striated muscles (heart and skeletal muscle), and a 
large amount is known about the relevant RNA sequence elements and RNA binding proteins involved. By contrast, the regulation 
of alternative splicing in smooth muscle cells (SMCs) has been relatively neglected. Vascular SMCs show phenotypic plasticity 
and can interconvert between a differentiated ‘contractile’ phenotype and a more proliferative ‘synthetic’ phenotype marked by 
increased synthesis of extracellular matrix proteins. This phenotypic modulation process plays a significant pathophysiological role 
in various cardiovascular diseases. While the transcriptional changes during phenotypic modulation have been well investigated, 
knowledge about the global changes in alternative splicing has been very limited.
We have used splice-sensitive microarrays to interrogate global changes in both transcript levels and alternative splicing 
during phenotypic modulation of mouse aorta and bladder smooth muscle. Genes affected by alternative splicing showed distinct 
functional enrichments from those that were transcriptionally up or down-regulated. Splicing particularly affected cytoskeletal 
proteins, while ion channels and receptors were transcriptionally down-regulated and receptor binding and extracellular matrix 
proteins were upregulated. Nucleic acid binding proteins were significantly depleted among the transcriptionally regulated genes. 
We identified sets of cassette exons that were substantially up or down-regulated during phenotypic modulation. Computational 
analysis showed that exons that are included in contractile SMCs are associated with PTB-binding motifs on the upstream 
side, where PTB represses splicing. Downstream of these exons there was a substantial enrichment of motifs resembling the 
binding sites for members of the signal transduction and activation of RNA (STAR) protein family (UUAAC, UAACC, ACUAA, 
CUAAC), which have not previously been associated with regulation of splicing in SMCs. Candidate STAR-regulated exons with 
potential binding sites in downstream intron were manually identified from 50 top-ranked events and the splicing pattern changes 
of 7 events (Ncam1 exon 2, Atp2b4 exon 20, Cacna2d1 exon 23, Ppp4r1 exon 3, Sfrs10 exon 2, and Bnip2exon 10, Ppp1r12a exon 
24) were validated by RT-PCR. In preliminary experiments using an Ncam1 exon 2 minigene reporter in proliferative rat PAC1 
cells, overexpression of Sam68, SLM1 and SF1 significantly increased Ncam1 exon 2 inclusion, with Sam68 being the strongest 
regulator. These initial observations suggest that STAR proteins might act widely to promote inclusion of cassette exons in 
contractile SMCs, while many of the same exons might be repressed by PTB in de-differentiated cells. 
524 C SWI/SNF regulates alternative trans-splicing of the mod(mdg4) gene
Johan Waldholm1, Simei Yu1, Stefanie Böhm1, Neus Visa1
1Department of Molecular Biosciences, WGI, Stockholm University, SE-10691 Stockholm, Sweden
Trans-splicing is a pre-mRNA maturation event by which two pre-mRNA molecules are spliced together forming 
a processed mRNA. In this study, we show that Brahma, the ATPase of the SWI/SNF chromatin-remodeling complex, 
modulates the abundance of trans-spliced transcripts derived from the mod(mdg4) locus of Drosophila melanogaster. 
We have characterized the expression of anti-sense mod(mdg4) transcripts in S2 cells, mapped transcription start sites 
and cleavage sites, identified and quantified cis-spliced and trans-spliced transcripts, and got insight into the regulation 
of the mod(mdg4) trans-splicing. Using RNA interference and over-expression of recombinant Brahma proteins, we 
show that the levels of Brahma affect the levels of a trans-spliced mod(mdg4) mRNA isoform in S2 cells. The trans-
splicing effect is independent of the ATPase activity of Brahma, which suggests that the mechanism by which Brahma 
modulates trans-splicing is independent of its chromatin remodeling activity. Interestingly, we also observed a similar 
effect on trans-splicing in vivo when reducing the levels of Brahma in larvae.
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527 C The Ribosome-OME II: Alternative Splicing for Ribosomal Proteins?
Jonathan R Warner1
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461
“Transcripts from ~95% of multiexon (human) genes undergo alternative splicing.”1
“92-94% of human genes undergo alternative splicing. (sic)” 2
Ribosomal proteins (RPs) are highly conserved across diverged species, a necessary their positioning in the compact, 
complex structure of the ribosome.  To what degree does alternative splicing affect the nature and the structure of the 
ribosome?  Could alternative splicing of transcripts of RP genes lead to production of proteins with non-ribosomal functions?
To approach these questions we have examined the splice junctions of RP gene transcripts from several multi-Gbyte 
RNA-seq databases.  The results are as follows:
Abundant alternative splicing is rare.  In no case did we observe tissue-dependent alternative splicing.  In only one 
case, RPS24, have we observed substantial tissue-specific three-way alternative splicing, leading to S24 proteins whose 
C-termini: …VGAGKKPKE vary in the last three amino acids.
There are many cases where one or even two exons are skipped, usually in less than 2% of observed transcripts.  This 
usually leads to a truncated protein due to a nearby stop codon.  Since this could result in nonsense-mediated decay, the 
actual frequency of such intron skipping could be much greater.  For several genes, in a few % of cases an intron is mis-
spliced (?), leading to the deletion of one to 19 aa from the middle of the RP.  Are such RPs incorporated into the ribosome?
Finally there are several cases in which 0.1 to 5% of the mRNAs are mis-spliced (?) to encode a protein with the 
N-terminal portion of a RP followed by 10 to 100 additional AA.  Since RPs are very abundant proteins, these fusion 
proteins have the potential to play as yet unknown, non-ribosomal functions in the cell.  In none of these cases were the 
appropriate tryptic peptides observed in the Mass Spec database GPMDB.
Supported by NIGMS  RO1 25532
RNA-seq data for multiple tissues was kindly provided by the Gene Expression Applications research group at Illumina, 
Inc.
1. Pan &…. & Blencowe, Nature Genetics 40, 1413-1416, 2008
2. Wang &…. & Burge,  Nature 456, 470-476, 2008
526 B EJC can regulate alternative splicing in mammalian cells
Zhen Wang1, Valentine Murigneux1, Hervé Le Hir1
1IBENS, 46 rue de l’Ulm, Paris 75005
The exon junction complex (EJC) is a dynamic multi-protein complex deposited onto nuclear spliced mRNAs 20-
24 nucleotides upstream of exon-exon junctions. The four core proteins, eIF4A3, Magoh, Y14 and MLN51 are stably 
bound to mRNAs during their lifecycle in the cells, serving as a binding platform for other nuclear and cytoplasmic 
proteins. Therefore, the EJC plays an important role in connecting splicing to downstream post-transcriptional events 
including mRNA transport, translation and stability. Despite EJCs are deposited onto mRNAs after splicing, recent 
evidences have shown that the EJC is also involved in splicing regulation of specific events both in Drosophila and 
mammalian cells. However, the mechanism for this new function of EJC in splicing remains largely unknown. To study 
whether EJC is directly involved in alternative splicing regulation in a genome-wide manner, we performed RNA-
seq experiments in HeLa cells with siRNA against EJC components as well as the NMD factor Upf1. Differential 
expression analysis showed that EJCs affect only a specific set of gene expression changes. Differential exon usage 
were analysed using MISO and Diffsplice programs, and these identified all types of alternative splicing changes 
on a global scale in EJC knockdown cells. These splicing changes are specific to EJC core proteins, as knockdown 
of eIF4A3, Y14 and MLN51 showed the same splicing changes. The splicing changes can be rescued by a siRNA-
resistant form of eIF4A3, indicating a direct involvement of EJC core proteins in regulating alternative splicing. Taken 
together, these data indicate that EJC core proteins are involved directly in alternative splicing regulation on a global 
scale.
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529 B Regulation of alternative splicing by QKI protein in lung cancer
Fengyang Zong1, Xing Fu1, Feng Wang1, Wenjuan Wei1, Lijuan Cao1, Hongbin Ji1, Jingyi Hui1
1Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of 
Sciences, Shanghai, China
Lung cancer is the leading cause of cancer-related death worldwide. Changes in alternative splicing have been 
implicated in lung tumorigenesis. However, the functional links between alternative splicing and lung cancer are not 
well studied. In this study, we observed that RNA-binding protein QKI is down-regulated in non-small cell lung cancer 
(NSCLC) tissues. Overexpression of QKI in lung cancer cells inhibits cell proliferation and transformation. Using a 
combined RNAi and RNA-Seq analysis, we identified several hundreds of alternatively spliced genes regulated by 
QKI and validated at least 24 lung cancer-related events in lung cancer tissues. We have obtained evidence that QKI 
inhibits cell proliferation through isoform-switch of its targets. To understand the mechanism of splicing regulation by 
QKI, we generated an RNA map of QKI and revealed that QKI can positively and negatively control exon inclusion in 
a binding-site position-dependent manner. Additionally, we showed that QKI affects splice site selection by competing 
with core splicing factors. Our findingsdemonstrate that QKI regulates a number of splicing events in lung cancer cells 
and contributes to lung tumorigenesis by modulating alternative splicing of its targets.
528 A hnRNP A1 and Secondary Structure Coordinate Alternative Splicing of Mag
Ruth Zearfoss1, Emily Johnson1, Sean Ryder1
1University of Massachusetts Medical School
Myelin is a lipid-rich structure that protects neurons from degeneration and facilitates the propagation of electrical 
impulses along axons.  In the central nervous system, it is formed by a specialized glial cell called an oligodendrocyte, 
which extends hundreds of spiraling processes to nearby axons and ensheathes them.  A major protein component 
of myelin in the vertebrate central nervous system is myelin-associated glycoprotein (MAG).  MAG is positioned at 
the periaxonal interface of the myelin structure, where its position allows it to mediate communication between the 
neuron and the oligodendrocyte, inhibiting axon outgrowth and protecting neurons from degeneration. The Mag pre-
mRNA is alternatively spliced to produce two developmentally regulated transcripts.  The longer mRNA contains an 
alternative cassette exon that has a stop codon, yielding a protein with a truncated C-terminus.  How Mag alternative 
splicing is regulated is not clear.  Here, we describe an evolutionarily conserved stem loop structure that overlaps 
the Mag exon 12 5′ splice site.  The non-consensus 5′ splice site occupies the loop of the stem and is able to interact 
with the splicing repressor hnRNP A1.  Analysis of a series of splicing reporters shows that both the sequence and the 
structure of the element regulate Mag alternative splicing.    
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530 C Site-Specific Intercalation of Doxorubicin Disrupts the Iron-Responsive Element RNA – 
Iron Regulatory Protein Interaction
Luigi Alvarado1, Kyle Eggleston1, Sam Lin1, Virginia Smith3, Adegboyega Oyelere2, Kwaku Dayie1
1University of Maryland, Center for Biomolecular Structure & Organization, College Park, MD, U.S.A.; 
2Georgia Institute of Technology, Atlanta, GA, U.S.A.; 3United States Naval Academy, Annapolis, MD, U.S.A.
A widely utilized chemotherapy drug, doxorubicin, has recently been shown to bind to a mammalian 5’ untranslated 
region Iron Responsive Element (IRE) RNA. In conjunction with the Iron Regulatory Protein (IRP), IRE RNA is 
involved in cellular iron homeostasis at the translational level. This tight RNA-protein complex prevents ribosomal 
assembly, hindering translation initiation of iron storage proteins, i.e. ferritin, under low cellular iron conditions. 
Conversely, iron overload is conducive to complex dissociation, allowing for up-regulation of the same proteins. 
However, this system is not entirely efficient. Some anemic patients receive adjuvant chelation therapies upon chronic 
blood transfusions to sequester excess labile iron. The use of doxorubicin to promote RNA-protein dissociation could 
potentially allow for downstream up-regulation of ferritin (see figure 1 below). In this work, we show how doxorubicin 
interacts specifically with IRE RNA using multidimensional nuclear magnetic resonance, fluorescence spectroscopy, 
and electrophoretic mobility shift assays. All three approaches converge on the observation that the IRE-IRP complex 
formation is disrupted by doxorubicin. Obtaining further data on the RNA-protein-drug interactions may lead to 
unveiling a validated RNA target as a complementary treatment of anemia.
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532 B Regulation of human telomerase by the helicase RHAU, a quadruplex resolvase.
Evan Booy1, Markus Meier1, Trushar Patel1, Ryan Howard1, Natalie Okun1, Oksana Marushchak1, Jörg Stetefeld1, 
Sean McKenna1
1Department of Chemistry, University of Manitoba, Winnipeg, Manitoba, Canada
Telomere extension is mediated by telomerase, an essential eukaryotic reverse transcriptase, and human cells have 
developmental and tissue-specific strategies for telomerase repression to ensure a defined cellular lifespan1. Human 
telomerase is a ribonucleoprotein complex containing a protein component (hTERT) and an essential RNA component 
(hTR). The 5’ region of hTR RNA contains several guanosine rich tracts that form four-stranded tetrad structures stabilized 
by hydrogen bonds (G-quadruplexes). Previous evidence suggests that a G-quadruplex within this hTR disrupts the 
formation of an important base-paired structure within hTR known as the P1 helix, a critical element in defining the 
template boundary for reverse transcription2; 3. RHAU, also known as DHX36, is an ATP-dependent RNA helicase that 
belongs to the DExH/D family of RNA modifying enzymes4. RHAU possesses the unique ability to preferentially bind 
and unwind G-quadruplexes5. Herein, we present the characterization of the RHAU-hTR quadruplex interaction using 
biophysical and structural approaches, confirming the importance of the RHAU-specific motif in the interaction with hTR. 
We demonstrate that the helicase activity of RHAU is sufficient to unwind the quadruplex and promote an interaction with 
25 internal nucleotides to form a stable P1 helix, and we have investigated the functional implications of this interaction. 
Screening of the human transcriptome for novel RNA-quadruplex interaction partners of RHAU identified PITX1 mRNA as 
a hit, with the protein product being an established transcriptional repressor of hTERT6. We present data demonstrating that 
RNA quadruplexes in the 3’-untranslated region of PITX1 mRNA are RHAU binding sites, and we detail our investigations 
into the functional mechanisms whereby PITX1 regulation is achieved by RHAU and components of the RNAi machinery. 
Together, the data implicate the unwinding of RNA quadruplexes by RHAU in multiple facets of telomerase regulation.
1. Djojosubroto, M. W., et al. (2003). Mol Cells 15, 164-75.
2. Lattmann, S., et al. (2011). Nucleic Acids Res 39, 9390-404.
3. Sexton, A. N. & Collins, K. Mol Cell Biol 31, 736-43.
4. Fuller-Pace, F. V. (2006). Nucleic Acids Res 34, 4206-15.
5. Vaughn, J. P., et al. (2005). J Biol Chem 280, 38117-20.
6. Qi, D. L., et al. (2011). Mol Cell Biol 31, 1624-36.
531 A Defining a eukaryotic core mRNA interactome: the landscape of RNA-binding proteins in 
yeast and its conservation in mammals
Benedikt Beckmann1, Alfredo Castello1, Bernd Fischer1, Rastislav Horos1, Claudia Strein1, Katrin Eichelbaum1, 
Sophia Föhr1, Thomas Preiss2, Lars Steinmetz1, Jeroen Krijgsveld1, Matthias Hentze1
1EMBL Heidelberg; 2Victor Chang Cardiac Research Institute Sydney
We recently defined the mRNA interactome of proliferating human HeLa cells, identifying 860 mRNA-binding 
proteins (mRBPs) and implicating more than 300 previously unknown RBPs in RNA biology [1]. We here report 
the next step forward, work on the unicellular yeast Saccharomyces cerevisiae. Yeast is of particular interest for its 
availability of advanced genetic tools for studies in vivo, and -in conjunction with the mammalian interactomes- 
allows definition of conserved RBPs and their function across evolution.
We developed an adapted protocol for interactome capture [2] in yeast based on PAR-crosslinking (Photoactivatable-
Ribonucleoside-Enhanced Crosslinking). Using quantitative proteomics, we identified 678 high confidence (m)RBPs 
(FDR<0.01), including many previously unknown ones. We confirm 101 out of the 120 recently reported RBPs [3], 
and newly identify 283 additional high confidence RBPs. 
Cross referencing with human mRNA interactomes [1, 4] defines 259 members of an evolutionarily conserved “core“ 
mRNA interactome including many RBPs involved in central processes of RNA metabolism (e.g. processing, transport, 
translation). One of the most unexpected aspects is the occurence of several members of the oxidoreductase family 
that was previously unlinked to RNA biology. Among others, these include GAPDH, thioredoxin 1 and 2, and alcohol 
dehydrogenase 1 (ADH1). Moreover, the emerging core interactome includes a defined set of enzymes from diverse pathways 
in intermediary metabolism, suggesting connections between cell metabolism and the regulation of gene expression [5]. 
Castello A, Fischer B et al.  Cell. 2012; 149(6)
1. Castello A et al. Nature Protocols. 2013; 8(3)
2. Mitchell SF et al. Nat Struct Mol Biol. 2013; 20(1)
3. Baltz AG et al. Mol Cell. 2012; 46(5)
4. Hentze MW and Preiss T, Trends Biochem Sci. 2010; 35(8)
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534 A GOLLD: a large, structured, noncoding RNA from bacteria and bacteriophages
Andy Chen1, Ronald Breaker2
1Yale University; 2Yale University; Howard Hughes Medical Institute
The Giant, Ornate, Lake- and Lactobacillales-Derived (GOLLD) RNAs belong to a class of large, structured 
non-coding RNAs found in many bacteria and phages. The function of these RNAs is unknown, but their size and 
conserved structure are reminiscent of large, sophisticated ribozymes such as ribosomes, self-splicing introns, and 
RNase P1. More than 600 of these RNAs have been found in both bacteria and phages, and they are frequently encoded 
next to tRNA genes.  Although little is known about GOLLD RNAs, they are a candidate for a new class of ribozyme. 
Commonly, large ribozymes perform their functions in complex with other proteins or RNAs. Because GOLLD 
is a ribozyme candidate, we sought to identify any interacting partners, which may help elucidate the RNA function. 
Using formaldehyde-crosslinking, we developed a bead-assisted pulldown procedure to identify interacting molecules. 
Preliminary data shows that much more rRNA was pulled down when GOLLD was expressed, compared with when 
GOLLD was not expressed. Therefore, most of the rRNA in the bead-bound fraction appears to have been cross-linked 
to GOLLD. In addition, reverse-phase chromatography shows that GOLLD RNAs co-elute with the 23S ribosomal 
RNA, which is consistent with previous results, suggesting that GOLLD RNAs may be performing functions related 
to ribosomes. However, more in-depth experiments are required to rule out any spurious interactions.
1. Weinberg Z, Perreault J, Meyer MM, Breaker RR. Exceptional structured noncoding RNAs revealed by bacterial 
metagenome analysis. 2009. Nature. 462: 656-9.
533 C In vivo dynamics of SR protein-RNA interactions
Serena Capozi1, Eugenia Basyuk1, Antoine Cléry2, Frédéric Allain2, Edouard Bertrand1
1IGMM - CNRS UMR5535; 1919 route de Mende; 34293 Montpellier Cedex 5; 2ETH Zurich; Institute of 
Molecular Biology and Biophysics; Schafmattstr. 20; HPK G9; CH-8093 Zürich
SR proteins are well known to play a key role as regulators of constitutive and alternative splicing. They show a 
modular structure characterized by one or two N-terminal copies of an RNA recognition motif (RRM) and a C-terminal 
serine/arginine (RS) dipeptide-rich domain. SR proteins act as splicing activators by binding ESE sequences via their 
RRM domain and then recruiting components of the splicing machinery. To select splice sites, SR proteins recognize 
short degenerated motifs present in multiple copies at ESEs. Similar cryptic motifs are also frequently present in pre-
mRNAs and this low specificity of binding contrasts with the great fidelity splicing and exon definition. Our aim is to 
provide a detailed kinetic analysis of SR proteins-RNA interaction in living cells, by measuring the binding dynamics 
of SR proteins on model RNAs. To this aim, we use FRAP (fluorescence recovery after photobleaching) on GFP-SR 
tagged proteins and GFP-RRM tagged domains. To measure binding on specific RNAs, we FRAP the transcription 
site of MS2-tagged RNAs that contain repetitions of a binding site for an SR protein. In the long term, we aim at 
translating the statistical binding data obtained by techniques such as CLIP into a residency time on RNA, and we 
would like to test the hypothesis that combinatorial binding and protein-protein interactions can stabilize individual 
binding events.
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536 C AURA 2.0: empowering post-transcriptional regulatory networks discovery
Erik Dassi1, Toma Tebaldi1, Angela Re1, Sara Leo1, Daniele Peroni1, Luigi Pasini1, Alessandro Quattrone1
1Laboratory of Translational Genomics, Centre for Integrative Biology, University of Trento, Italy
The increasingly recognized importance of post-transcriptional regulation (PTR) is leading to the collection of 
more data than ever before. However, this pieces of data remain dispersed throughout many isolated databases or even 
lying in the literature, posing multiple obstacles to data integration and eventually preventing the discovery of the 
regulatory networks underlying these processes.
In order to address this issue, we originally developed the Atlas of UTR Regulatory Activity (AURA), now at 
its second and vastly enhanced iteration. AURA is a meta-database focused on all aspects of post-transcriptional 
regulation as mediated by the untranslated regions of mRNA. On top of a rich UTRs annotation layer, AURA 
contains experimental data on RNA-binding proteins and noncoding-RNAs  binding sites, cis-elements, phylogenetic 
conservation and much more. Collected data covers multiple species, namely human and model organisms such as 
mouse, yeast and zebrafish. To allow for seamless data integration workflows, AURA also offers several data mining 
features, with particular focus on network generation, functional enrichment and UTR sequence analysis.
Regularly updated with the newest data and additional features, AURA aims at becoming a valuable toolbox for 
the PTR researcher and to stimulate the formation of an active community of users and contributors, able to eventually 
benefit the whole research field. AURA (soon available in its 2.0 version) is freely accessible at http://aura.science.
unitn.it .
535 B Dynamic transition upon protein-RNA complex formation: PTB RRM1 interaction with an 
IRES stem-loop
Fred F. Damberger1, Christophe Maris1, Frédéric H.-T. Allain1, Sapna Ravindranathan2
1ETH Zurich, Institute of Molecular Biology & Biophysics, Zurich, Switzerland; 2Central NMR Facility, 
National Chemical Laboratory, Pune 411008, India
We are examining the interaction of the N-terminal RNA recognition motif domain (RRM1) of the Polypyrimidine 
Tract Binding (PTB) protein with a stem-loop RNA that contains a UCUUU pentaloop present in the Internal 
Ribosomal Entry Site (IRES) of Foot-and-Mouth disease virus (FMDV), Encyphalomyocarditis virus (EMCV) and 
Theiler’s Murine Encephalomyelitis Virus (TMEV). Where as previous structure determinations of PTB-RRM1 bound 
to the single-stranded RNA CUCUCU showed that recognition is achieved through canonical RRM-RNA interactions 
via the β-sheet surface of RRM1 and the loops connecting the β-strands [1], our structure determination of PTB 
RRM1 bound to the stemloop RNA shows that the C-terminal tail of RRM1 which includes part of the extensive 
linker connecting RRM1 to RRM2 in PTB forms an additional α-helix which docks to β2 of the β-sheet. Interestingly 
the newly formed α-helix makes no contacts to the RNA raising the question of how the C-terminal part of RRM1 
is able to sense the binding of a structured RNA to the β-sheet. NMR measurements and site directed mutagenesis 
at the interface of the C-terminal helix and the β-sheet indicate that RRM1 is in a dynamic equilibrium between 
conformations where the C-terminal helix is docked to the β-sheet and other conformations where it is not. NMR 
relaxation dispersion measurements reveal that a dynamic network connects the C-terminal tail with the adjacent 
β-sheet and remote structural elements which are involved in binding the stemloop. This network which couples 
binding of RRM1 to a stemloop RNA with formation of an additional secondary structure element shows how PTB 
can adapt to recognize an ordered RNA target in the context of IRES mediated translation.
1. Oberstrass F.C. et al. (2005) 309, 2054-2057.
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537 A The QUA2 domain of GLD-1 recognizes an additional nucleotide and modulates RNA 
binding affinity
Gerrit Daubner1, Stefan Gerhardy1, Frédéric Allain1
1Institute of Molecular Biology and Biophysics, ETH Zürich, Switzerland
The members of the STAR (signal transduction and activation of RNA) protein family are key players in post-
transcriptional processing and are especially essential for developmental processes, including the germline and the 
vertebrate nervous system. Recent data hint to implications of these proteins in cancer [1] and neurological diseases 
like human inherited ataxia, multiple sclerosis or schizophrenia [2]. In order to gain more insights into the role of the 
STAR protein family in these diseases, it is inevitable to understand their molecular basis of RNA interaction. 
All STAR proteins share a very high sequence similarity in their RNA-binding domain, an extended KH domain 
(KH-QUA2), and contain an N-terminal dimerization domain (QUA1), with the exception of SF1 [3] .The family 
member GLD-1 (Germline defective 1) is a germline specific translational repressor in C. elegans and was suggested 
to associate with 10% of all germline detected mRNA to date [4]. It is essential for germ cell development [5] and 
can therefore be seen as its key regulatory factor. GLD-1 (Germline defective 1) binds as dimer to a single, highly 
conserved TGE-repeat found within the 3’ UTR of its mRNA targets. The importance of the RNA-binding domain 
for the function of GLD-1 is emphasized by critical mutations within the KH domain, leading to tumor formation 
or masculinization of the hermaphrodite germline [6]. While the mammalian homolog SF1 recognizes specifically 
a hexanucleotide RNA sequence, a recently conducted immunoprecipitation assay for GLD-1 proposed a consensus 
sequence spanning a heptanucleotide [7]. This emphasizes the need of structural data for the RNA binding domain of 
GLD-1, since the solution structure of SF1 is not sufficient to explain this difference in RNA recognition [8]. 
We determined the solution structure of the monomeric GLD-1 KH-QUA2 domain bound to its primary target 
site within the TGE repeat of the tra-2 gene [9]. In contrast to SF1, the QUA2 domain adopts a slightly different 
orientation and is thus indeed able to specifically recognize an additional nucleotide with an increase in RNA-binding 
affinity. In addition, this structure provides a rational for previously published mutagenesis data and subsequently 
answers the remaining questions about RNA specificity of GLD-1. In conclusion, our data explains the differences to 
the homologous structure of SF1, provides thus a rational for previous studies on GLD-1 and forms an important basis 
to understand the impact of the QUA2 domain on RNA binding for the whole STAR protein family.
1. Novikov et al, Mol Cell Biol, 2011
2. McInnes & Lauriat, Neuroscience and biobehavioral reviews, 2006
3. Artzt & Wu, Adv Exp Med Biol, 2010
4. Scheckel et al, PLoS Genet, 2012
5. Francis et al, Genetics, 1995
6. Jones et al, Dev Biol, 1996
7. Wright et al, EMBO J, 2011
8. Liu et al, Science, 2001
9. Jan et al, EMBO J, 1999
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539 C Structural and Dynamic Investigation on ETR-3 RRMs and their Interaction with AU-rich 
RNAs
Nana Diarra dit Konte1, Frédéric Allain1
1ETH Zürich
The ELAV type RNA-binding protein 3 (ETR-3) is a RNA binding protein involved in many aspects of RNA metabolism. 
ETR-3 interacts with UG repeats in the context of splicing [1]. Sequence specificity for UG repeats and notably the UGUU motif 
has been confirmed by systematic evolution of ligands by exponential enrichment (SELEX) [2]. However, ETR-3 has also been 
shown to regulate the cyclooxygenase-2 (COX-2) mRNA stability and translation by binding to AU-rich sequences in the 3’UTR 
region [3].
ETR-3 belongs to the CUG-BP and ELAV like factor (CELF) family. The members have two RNA recognition motifs 
(RRM) separated from a third one by a divergent domain (approx. 200 amino acids). The RRMs are extremely conserved among 
the family; over 90% identity between ETR-3 and CUG-BP1, its closest homolog. The solution structure of CUG-BP1 RRM3 
in complex with (UG)3 has been solved by NMR spectroscopy
[4]and X-ray crystallography structures of CUG-BP1 RRM1 and 
RRM2 bound to RNAs containing the UGUU motif have been published [5]. Although these structures provide very detailed 
insight in the binding mode to UG rich RNAs, it remains unclear how ETR-3 recognizes AU rich RNAs and how both RRM1 and 
RRM2 are oriented upon RNA binding.
We aim at solving the structure of ETR-3 RRM12 and RRM3 bound to AU rich RNA. This will allow us to explain the 
discrepancies between the natural targets and the sequences obtained by SELEX. We established that RRM1 and RRM2 are semi-
independent in the free form and we could show that both RRM12 and RRM3 bind to 5’-AUUUAAUU-3’ sequence found in 
COX-2 mRNA. Dynamics studies on RRM12 in complex with the octamer demonstrated that RRM12 tumbles slower in complex 
than the free protein suggesting a rigidification of RRM12. In addition, we have a preliminary structure of RRM3 in complex 
with 5’-UUUAA-3’. In cell experiments demonstrated that RRM12 is sufficient to regulate the translation and unlike splicing, the 
divergent domain is not necessary for COX-2 mRNA translation inhibition.  
1. Cooper, T. A., et al., Molecular and Cellular Biology (1998). 
2. Faustino, N. A. et al., Molecular and Cellular Biology (2005).  
3. Mukhopadhyay, D., C. et al., Molecular Cell (2003).
4. Tsuda K., et al., NAR (2009). 
5. Teplova M., et al., Structure (2010).  
538 B Control of Mammalian Germ Cell Differentiation by the RNA-Binding Protein DAZL
Renaud Desgraz1, Katherine Romer2, David C Page1
1Whitehead Institute for Biomedical Reseach, Howard Hughes Medical Institute and Massachusetts Institute 
of Technology, Cambridge, MA, 02142; 2Whitehead Institute for Biomedical Research, Howard Hughes 
Medical Institute and Massachusetts Insitute of Technology, Department of Biology, Cambridge, MA, 02142
Female and male gametes (egg and sperm) differentiate from embryonic germ cells. Translational control by RNA-
binding proteins (RBP) is a central mechanism of germ cell biology and many of the germ cell RBPs are essential and 
conserved across a wide range of species. Despite this conservation, RBP interacting transcripts and the spatiotemporal 
regulation of these transcripts have remained largely elusive. Mammalian primordial germ cells (PGC) are specified 
in the proximal epiblast around embryonic day 7.5 and subsequently migrate to the somatic gonad. Upon entering the 
gonad, PGCs downregulate pluripotency markers and initiate the sex-specific differentiation programs. Female PGCs 
initiate meiosis before arresting in diplotene whereas male PGCs undergo cell cycle arrest and initiate spermatogenesis 
after birth. DAZL is a conserved RBP expressed in PGCs when they enter the gonad and its expression in germ cells is 
essential for both the downregulation of the pluripotency program and the sex-specific cellular differentiation events. 
Dazl gene inactivation in mice leads to embryonic germ cell death and sterility. Despite its central role in germ cell 
differentiation and survival we ignore the transcripts bound and regulated by DAZL. We have used iCLIP, an unbiased 
whole genome approach to identify and characterize DAZL-RNA interactions in mammalian germ cells. We show 
that DAZL-regulated transcripts are enriched for genes encoding cell cycle regulators of all phases of the cell cycle. 
We also show that DAZL binds preferentially to the 3’ UTR of its target transcripts near the stop codon. Finally we 
have combined single molecule FISH and immunofluoresence to characterize the DAZL-RNA interactions in vivo. 
DAZL appears to regulate the cell cycle transitions occurring in germ cells by binding to the 3’ UTR and promoting 
the translation of cell cycle regulators but the molecular mechanism regulating DAZL-RNA interactions remains to be 
addressed and will further our understanding of translational control of germ cell biology and fertility.
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541 B RNA-binding protein EWSR1 regulates CCDC6
Sujitha Duggimpudi1, Erik Larrson2, Arndt Borkhardt1, Jessica Hoell1
1Department of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent 
Health, Heinrich Heine University, Duesseldorf, Germany.; 2Department of Medical Biochemistry and Cell 
biology, Institute of Biomedicine, The Sahlgrenska Academy, University of Gothenburg, Sweden.
Dysregulation in the interactions between RNA and RNA-binding proteins (RBPs) by mutations, translocations 
or over expression results in several diseases. Altered protein expression of the ubiquitously expressed FET family of 
proteins FUS, EWSR1 and TAF15 has been shown to cause neurological diseases as well as sarcomas and leukemias. PAR-
CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking & Immunoprecipitation), a technique to study the RNA 
interactome of any RBP, was applied to the FET family proteins as described in our previous study (Hoell et al, Nat Struct 
Mol Biol 2011) and global RNA targets of these proteins were defined. In the present study we focussed on EWSR1 which 
is fused to several DNA binding proteins (e.g. FLI-1, ERG, ETV-1) to form active transcription factors in Ewing Sarcoma.
Ewing Sarcoma is the second most common bone and soft tissue malignancy in adolescents and young adults. Research 
so far focused nearly exclusively on the above-mentioned fusion proteins and the lost RNA binding capabilities of the 
C-terminal portion of EWSR1 remained unexplored. In order to study the functional impact of the loss of one wild type 
allele of EWSR1 on sarcomagenesis, we tested several mRNA targets predicted by PAR-CLIP including MDM2, CCDC6, 
CBFB and FGF9. Our results showed that there was a clear reduction in the expression levels of all the above selected genes 
in the EWSR1 knock down samples compared to the controls. Among the selected targets we chose to further investigate 
CCDC6 (Coiled Coil Domain Containing 6) which showed the strongest regulation.
CCDC6 is important in cell cycle regulation and acts as a check point control for transition of cells from S to G2 phase. 
It is also predicted to be a tumor suppressor gene and is down regulated in adenocarcinoma of the lung, colorectal carcinoma, 
thyroid carcinoma and small cell lung cancer. Interplay between CCDC6 and EWSR1 was further explored using forward 
and reverse genetic approaches in HEK 293 T cells and Ewing Sarcoma cell line MHH-ES-1. Protein levels of CCDC6 
were down regulated upon EWSR1 knock down and up regulated upon EWSR1 over expression. Furthermore, EWSR1 
knockdown results indecreased proliferation rates and increased cell death compared to the controls hinting at a defective 
cell cycle progression. Defects in cell cycle and proliferation are often known to trigger carcinomagenesis. Taken together, 
our results confirm the regulation of CCDC6 by EWSR1on mRNA and protein level and the role they play in regulating cell 
cycle which further helps us to understand the underlying mechanisms in the development of Ewing Sarcoma.
540 A Interactions between RBFOX2 and pre-microRNA-20b terminal loop
Afzal Dogar1, Julian Zagalak1, Moritz Stoltz1, Harry Towbin1, Michel Erich2, Frédéric Allain2, Jonathan Hall1
1Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zurich, 
Zurich, Switzerland; 2Institute of Molecular Biology and Biophysics, ETH Zürich, Schafmattstrasse 30, 8093 
Zürich (Switzerland)
Several RNA binding proteins originally known for their role in pre-mRNA processing have recently been found 
to also operate during the biogenesis of microRNAs. RBFOX2, a known regulator of alternative splicing, specifically 
binds to GCAUG motifs in the pre-mRNAs to regulate inclusion or exclusion of flanking exons. We identified several 
chemically synthesized pre-miRNA hairpins that bound to RBFOX2 in vitro. One of these, hsa-miR-20b contained 
the characteristic GCAUG recognition motif in the terminal loop region. As determined by surface plasmon resonance 
(SPR), the recombinant RRM domain of RBFOX interacted with the syn-pre-miR-20b with moderate affinity (3.6 
µM). Mutation of G5 residue, which is essential for RBFOX2 binding to GCAUA completely abrogated the binding. 
The overexpression of miR-20b by transfection of its chemically synthesized precursor or by a pri-miRNA plasmid 
suppressed RBFOX2 protein levels. Upon G to A mutation in the loop, RBFOX2 suppression activity was lost. These 
data reveal a novel connection of RBFOX2 to microRNAs, in addition to alternative splicing.
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542 C Dead End, a protein counteracting miRNA-mediated repression of tumour suppressor 
genes, contains non-canonical RNA binding domains
Malgorzata Duszczyk1, Frédéric Allain1
1Institute of Molecular Biology and Biophysics, ETH Zurich, 8093 Zurich, Switzerland
The protein Dead End (Dnd1) is necessary for proper development of germ cells in zebrafish and mammals 
[1]. Truncations in the Dnd1 gene have been shown to promote the formation of germ-cell tumors [2]. Recently the 
molecular function of Dnd1 has been exposed as a negative modulator of miRNA activity, when it was shown that it 
can counteract repression of several tumour suppressor genes (p27, LATS2) by the miR-221 family by blocking the 
accessibility of the mRNAs targeted by these miRNAs [3,4,5]. It was suggested that Dnd1 blocks access of miRNAs 
to their targets by binding to conserved U-rich regions (URRs) in close proximity to the miRNA seed sequences in the 
mRNA target 3’UTRs (see Figure 1 below). 
Dnd1 contains two RNA recognition motifs (RRMs). To understand how Dnd1 recognizes its targets and inhibits 
miRNA-based gene silencing at the molecular level we aim to solve the three-dimensional structure of the Dnd1 
RRMs in complex with RNA derived from one of Dnd1’s 3’UTR-targets. We have identified short RNA oligomers 
derived from the p27 tumour suppressor mRNA 3’UTR that bind to the Dnd1 RRM1 and double RRM12 as shown 
by NMR chemical shift perturbation mapping and ITC. In addition, ITC measurements have shown that both RRMs 
are necessary for tight binding, suggesting that the two RRMs are working cooperatively in recognizing their mRNA-
targets. 
The solution structure of RRM12 shows that Dnd1’s both RRMs contain non-canonical helical and beta-hairpin 
extensions to the classical RRM fold. The RNA binding site includes these non-canonical elements in addition to the 
RRM1 canonical beta-sheet RNA interaction surface. NMR based structure determination of a RRM12-p27-3’UTR 
complex is underway.
Figure 1:
A) miRISC binding through recognition of a complementary ‘seed’ sequence by the miRNA in the complex 
prevents translation of the mRNA
B) When Dnd1 binds to U-rich regions (URRs) next to the miRNA recognition sequence it blocks access of 
miRISC and the mRNA is translated
1. Weidinger G et al. Dead End, a novel vertebrate germ plasm component, is required for zebrafish primordial germ cell 
migration and survival. Curr Biol 2003; 13:1429-34. 
2. Youngren KK et al. The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 
2005; 435:360-4.
3. le Sage C et al. Regulation  of  the  p27(Kip1)  tumor  suppressor  by  miR-221  and miR-222 promotes cancer cell 
proliferation. EMBO J 2007; 26: 3699–3708.
4. Voorhoeve PM et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. 
Cell 2006; 124:1169–1181.
5. Kedde M et al. RNA-Binding Protein Dnd1 Inhibits MicroRNA Access to Target mRNA. Cell 2007; 131:1273-86.
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544 B Post-transcriptional regulation of SMN2 expression by hnRNP G and LARP Family proteins
Ana Miguel Fernandes1, Ana Luísa Gomes1, Mariana Oliveira1, Gonçalo Costa3, Isabel Peixeiro1, Ana Margarida 
Matos1, Carlos Cordeiro4, Margarida Gama-Carvalho2
1Gene Expression and Bioinformatics Unit, BioFIG – Center for Functional and Integrative Genomics, 
Faculty of Sciences, University of Lisbon, Portugal; 2Gene Expression and Bioinformatics Unit, BioFIG 
– Center for Functional and Integrative Genomics, Faculty of Sciences, University of Lisbon, Portugal; 
Department of Chemistry and Biochemistry, Faculty of Sciences, University of Lisbon, Portugal; 3Center 
for Chemistry and Biochemistry, Faculty of Sciences, University of Lisbon, Portugal; 4Center for Chemistry 
and Biochemistry, Faculty of Sciences, University of Lisbon, Portugal; Department of Chemistry and 
Biochemistry, Faculty of Sciences, University of Lisbon, Portugal
Spinal Muscular Atrophy (SMA) is a recessive autosomal neurodegenerative disease caused by the loss of Survival Motor 
Neuron 1 gene (SMN1). Previous studies have implicated SMN in RNA metabolism, namely in the biosynthesis of small nuclear 
ribonucleoprotein complexes, and there is evidence that SMN is involved in axonal mRNA transport. Furthermore, in humans 
there is an almost identical genomic copy of SMN1, the SMN2 gene. SMN2 contains a silent mutation in exon 7 that greatly impairs 
splicing, leading to the predominant production of a truncated SMN protein that is thought to be rapidly degraded. Interestingly, 
SMA severity is inversely correlated to the number of SMN2 copies present in the genome. Therefore, SMA would be a strong 
target for the development of new therapies regarding mRNA stability and translation control. It is widely accepted that mRNA 
stability and translation are greatly influenced by the action of RNA binding proteins and microRNAs that bind untranslated 
regions of mRNAs. Hence, identification of proteins binding to SMN2 mRNA would provide a greater insight on mechanisms 
underlying its expression and ultimately uncover novel targets that favor mRNA stabilization and/or increased translation. In 
this work we have used in vitro transcribed biotin-labeled probes covering the 3’ UTR of SMN2 mRNA to perform pull-down 
assays to identify proteins binding its 3’UTR. Several proteins were identified by peptide-mass fingerprinting, among which 
were proteins described as having a role in mRNA metabolism, namely hnRNP G (hnG) and members of the La-Related Protein 
(LARP) family, including a novel LARP1 isoform. As LARP family members remain poorly studied, we characterized LARP 
isoform expression in the cell lines used in this work by RT-qPCR, confirming the existence of the novel isoform identified by 
mass-spec. Overexpression of hnG and LARPs resulted in increased expression of both a luciferase reporter containing the SMN 
3’UTR sequence and of the endogenous SMN protein. Characterization of SMN mRNA levels identified different mechanisms of 
action for these proteins at the level of mRNA stability and translation. In order to further clarify the effect of hnG and LARPs on 
SMN2 expression, hnG and LARPs were co-transfected with various SMN2-3’UTR deletion mutants fused to firely luciferase. 
Our data supports a role for hnG and LARPs as positive modulators of SMN mRNA expression. 
543 A Potential substrates of the RNase MRP complex in cell cycle regulation
Franziska Eckmann1, Anika Wehrle2, Anika Salfelder2, Romy Keppler2, Ekkehart Lausch2, Bernhard Zabel2
1Center for Pediatrics and Adolescent Medicine, University Hospital Freiburg, Germany; 2Pediatrics and 
Adolescent Medicine, University Hospital Freiburg, Freiburg, Germany
The RNase MRP complex is composed of the RNA component of mitochondrial RNA processing endoribonuclease 
(RMRP) and five additional protein components. This RNAse MRP complex plays a role in the tailoring of the 5’end 
of the 5.8S rRNA. 
RMRP is the first non-coding RNA which is associated with a human disease. Patients with cartilage-hair hypoplasia 
(CHH) have recessive mutations in RMRP; they are affected by skeletal dysplasia and a predisposition for various 
tumours. Recent studies have shown that RMRP also forms a complex with TERT (telomerase reverse transcriptase). 
This RNA-protein complex may have a RNA-dependent RNA polymerase activity. An isolated deficieny in TERT 
causes Diskeratosis congenital (DC). Intruigingly, the clinical manifestations of DC are very similar to CHH. In RNA-
protein complex formation, the limiting factor is TERT. One consequence of impaired TERT function is progressive 
telomere shortening in proliferating cells. This results in cell cycle arrest and the induction of DNA repair mechanisms. 
Cell cycle genes such as p53 and p21 (also known as cyclin-dependent kinase inhibitor 1 or CDK-interacting protein 
1) play an important role in these processes. Malfunction of these genes may lead to tumor formation and cellular 
senescence. 
A negative correlation between expression of TERT and RMRP level has already been shown in some cell lines. 
The interaction of RMRP, TERT, and cell cycle genes could provide an explanation for the tumour susceptibility of 
CHH patients.
We will present preliminary data on the role of RMRP in cell cycle regulation and senescence.
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545 C Characterization of the potential role for RNA-binding protein FUS/TLS in DNA damage 
response: A quantitative proteomic approach
Giuseppe Filosa1, Marc-David Ruepp3, Carolina Lenzken1, Alessia Loffreda1, Oliver Mühlemann3, Angela Bachi2, 
Silvia Barabino1
1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy; 2Biomolecular 
Mass Spectrometry Unit, San Raffaele Scientific Institute, Milan, Italy; 3Department of Chemistry and 
Biochemistry, University of Bern, Bern, Switzerland
FUS/TLS (fused in sarcoma/translocated in liposarcoma) is a ubiquitously expressed protein of the hnRNP family, 
that has been discovered as fused to transcription factors in several human sarcomas and found in protein aggregates 
in neurons of patients with an inherited form of Amyotrophic Lateral Sclerosis [Vance C. et al., 2009].
FUS is a 53 kDa nuclear protein that contains structural domains, such as a RNA Recognition Motif (RRM) and 
a zinc finger motif, that give to FUS the ability to bind to both RNA and DNA sequences. It has been implicated 
in a variety of cellular processes, such as pre-mRNA splicing, miRNA processing, gene expression control and 
transcriptional regulation [Fiesel FC. and Kahle PJ., 2011].
Moreover, some evidences link FUS to genome stability control and DNA damage response: mice lacking FUS 
are hypersensitive to ionizing radiation (IR) and show high levels of chromosome instability and, in response to 
double-strand breaks, FUS is phosphorylated by the protein kinase ATM [Kuroda M. et al., 2000; Hicks GG. et al., 
2000; Gardiner M. et al., 2008].
Furthermore, preliminary results of mass spectrometric identification of FUS interacting proteins in HEK293 
cells, expressing a recombinant flag-tagged FUS protein, highlighted the interactions with proteins involved in DNA 
damage response, such as DNA-PK, XRCC-5/-6, and ERCC-6, raising the possibilities that FUS is involved in this 
pathway, even though its role still needs to be clarified.
This study aims to investigate the biological roles of FUS in human cells and in particular the putative role in 
DNA damage response through the characterization of the proteomic profile of the neuroblastoma cell line SH-SY5Y 
upon FUS inducible depletion, by a quantitative proteomic approach. The SH-SY5Y cell line that will be used in 
this study expresses, in presence of tetracycline, a shRNA that targets FUS mRNA, leading to FUS protein depletion 
(SH-SY5Y FUS iKD cells). To quantify changes in proteins expression levels a SILAC strategy (Stable Isotope 
Labeling by Amino acids in Cell culture) will be conducted on SH-SY5Y FUS iKD cells and a control SH-SY5Y cell 
line (that expresses a mock shRNA) and the relative changes in proteins levels will be evaluated after five and seven 
days upon FUS depletion, by nanoliquid chromatography coupled to tandem mass spectrometry (nLC-MS/MS) and 
bioinformatics analysis.
Preliminary experiments demonstrated that the SH-SY5Y FUS iKD cells, when subjected to genotoxic stress 
(high dose of IR), upon inducible depletion of FUS, showed a increased phosphorylation of gH2AX with respect to 
control cells, suggesting an higher activation of the DNA damage response.
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547 B The Runt domain of AML1 (RUNX1) binds a sequence-conserved RNA motif that mimics a 
DNA element
Junichi Fukunaga1, Yusuke Nomura4, Ryo Amano2, Yoichiro Tanaka5, Taku Tanaka3, Yoshikazu Nakamura6, Gota 
Kawai2, Tomoko Kozu1 , Taiichi Sakamoto3
1Saitama Cancer Center and CREST; 2Chiba Institute of Technology; 3Chiba Institute of Technology and 
CREST; 4Chiba Institute of Technology, Tokyo University of Science, and CREST; 5Saitama Cancer Center, 
Yokohama National University, and CREST; 6University of Tokyo and CREST
AML1 (RUNX1) is a key transcription factor for hematopoiesis that binds to the Runt-binding double-stranded 
DNA element (RDE) of target genes through its N-terminal Runt domain.  Aberrations in the AML1 gene are frequently 
found in human leukemia.  To better understand AML1 and its potential utility for diagnosis and therapy, we obtained 
RNA aptamers that bind specifically to the AML1 Runt domain.  Enzymatic probing and NMR analyses revealed that 
Apt1-S, which is a truncated variant of one of the aptamers, has a CACG tetraloop and two stem regions separated 
by an internal loop.  All the isolated aptamers were found to contain the conserved sequence motif 5′-NNCCAC-3′ 
and 5′-GCGMGN′N′-3′ (M:A or C; N and N′ form Watson–Crick base pairs).  The motif contains one AC mismatch 
and one base bulged out.  Mutational analysis of Apt1-S showed that three guanines of the motif are important for 
Runt binding as are the three guanines of RDE, which are directly recognized by three arginine residues of the Runt 
domain.  Mutational analyses of the Runt domain revealed that the amino acid residues used for Apt1-S binding were 
similar to those used for RDE binding.  Furthermore, the aptamer competed with RDE for binding to the Runt domain 
in vitro.  These results demonstrated that the Runt domain of the AML1 protein binds to the motif of the aptamer 
that mimics DNA.  Our findings should provide new insights into RNA function and utility in both basic and applied 
sciences.
546 A A novel PAR-CLIP based approach using RRM mutations reveals RNA recognition 
mechanisms of HuR
Matthew Friedersdorf1, Jack Keene1
1Department of Molecular Genetics and Microbiology, Duke University
HuR is a ubiquitous, multi-functional RBP that contains three RNA recognition motifs (RRMs) which allows it to 
recognize several closely related low complexity U-rich elements including the AU-rich element (ARE). However, it 
is unclear how each of the RRMs contributes to recognizing these elements and whether they have distinct preferences 
among the global set of targets. This is especially true for the third RRM which is known to bind U-rich RNA but has 
also been suggested to bind to poly(A) sequences; moreover, RRM3 is thought to be pivotal for in vitro multimerization 
of HuR. To address this we have combined a mutational approach with a modified version of PAR-CLIP, a technique 
for identifying global RNA-protein interactions. Our novel approach includes correcting for previously unaccounted 
for background binding and using a combination of deletion and point mutants designed from published RRM/RNA 
co-crystal structures. Our data agrees with previous findings that all three RRMs are not required for RNA recognition 
but that at least two RRMs are required for binding to most sites. Furthermore, our data also demonstrate that RRM3 
can recognize sequences similar to RRMs 1 and 2 and that inactivation of RRM3 doesn’t dramatically alter the 
sequence preference of HuR. Interestingly, while the three RRMs are at least partially redundant for recognizing 
similar sequences our data suggests that they have unique roles in determining where HuR binds globally. Specifically, 
inactivation of RRM3 resulted in fewer HuR binding sites in close proximity to other HuR binding sites, especially 
within intronic sequences. This suggests that RRM3 initiates and/or stabilizes multimerization of HuR in vivo, a 
mechanism previously proposed to explain how HuR competes with miRNAs. However, since our data indicate 
multimerization is predominately in introns this may relate to the ability of HuR to regulate splicing as well. This 
mechanism of RRM3-dependent multimerization potentially extends beyond HuR and may apply to the roughly 100 
other 3 RRM-containing RBPs, nearly all of which share similar inter-domain spacing patterns.
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549 A Testing Protein Sequestration Candidates for RNA-Mediated Disease
Marianne Goodwin1, Apoorva Mohan1, Maurice Swanson1
1University of Florida and Center for NeuroGenetics, Gainesville, FL, USA
RNA-mediated pathogenesis is a disease mechanism caused by the synthesis of mutant RNAs that have gained 
deleterious functions1. For microsatellite disorders where mutant expansions occur within non-coding regions, 
transcription leads to expansion RNAs (RNAexp) that are toxic because they either sequester or trigger abnormal 
activities for RNA-binding proteins and possibly other types of cellular factors. For protein sequestration, this disease 
pathway is exemplified by the progressive neuromuscular disease myotonic dystrophy (dystrophia myotonica, DM), 
which is caused by C(C)TG expansions in either the untranslated or intronic regions of two different genes leading 
to the synthesis of C(C)UGexp RNAs that recruit and inhibit the alternative splicing activities of the muscleblind-like 
(MBNL) family of RNA-binding proteins2. Here, we use a crosslinking approach to confirm sequestration of MBNL2 
to DMPK CUG and CNBP CCUG repeats in human autopsy brain tissues obtained from DM1 and DM2 patients, 
respectively.  In parallel, we map MBNL2 binding sites to splicing target RNAs in normal and disease control samples 
to investigate how loss of MBNL2 function alters the central nervous system transcriptome. Finally, we use this 
assay to validate or refute the binding of proposed sequestered factors in human brains affected by other neurological 
diseases caused by microsatellite expansions.  We propose this method as a validation assay to test the sequestration 
of specific factors by toxic RNAs in human disease tissues.  
1Poulos, M.G., Batra, R., Charizanis, K., and M.S. Swanson. 2011. Developments in RNA splicing and disease. 
Cold Spring Harb. Perspect. Biol. 3: a000778.
2Charizanis, K. et al. 2012. Muscleblind-Like 2 mediated alternative splicing in the developing brain and 
dysregulation in myotonic dystrophy. Neuron 75:437-450.
548 C Predicting RNA-Protein Interactions: The Hunt for the Code of Recognition
Christian Garde1, Jan Gorodkin2, Christopher T. Workman1
1Technical University of Denmark, Department of Systems Biology, Center for Biological Sequence Analysis; 
2University of Copenhagen, Faculty of Life Sciences, Center for Non-Coding RNA in Technology and Health
Predicting RNA-Protein Interactions: The Hunt for the Code of Recognition
Protein-RNA interactions are found to be pivotal in a wide variety of cellular processes ranging from gene 
regulation to host defenses against pathogens. In addition to their fundamental biological regulatory role, the impact 
of faulty protein-RNA based regulation on metabolic and immunological diseases emphasizes the motivation for 
understanding the principles behind protein–RNA recognition for medical research. In the presented study, covariant 
residue patterns between families of interacting protein and RNA were investigated. Co-crystal structures of RNA 
binding proteins and RNA targets were collected from the Protein Data Bank and filtered in order to only retain 
crystals of non-synthetic molecules. The protein and RNA sequences that were found to interact using a five Angstrom 
distance threshold were extracted from the co-crystal structures and subjected to structural alignment against the 
Pfam and Rfam databases. Covariance analysis of the alignments of protein-RNA pairs were conducted using mutual 
information and the recently published RIsearch method [1] for RNA-RNA interactions was adapted to infer protein-
RNA specificity models. This approach was verified on examples with well-known specificity and by comparison to 
interactions found in the co-crystal structures. 
The presented study constitutes a method which can predict novel protein-RNA interactions, aid in the mapping 
of regulatory networks, and contributes to deciphering the code of recognition between protein and RNA. 
1. Wenzel A, Akbasli E, Gorodkin J. RIsearch: fast RNA-RNA interaction search using a simplified nearest-neighbor energy 
model. Bioinformatics. 2012 Nov 1;28(21):2738-46.
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551 C Codon-usage effects and functional characterization of physicochemical complementarity 
between mRNA and cognate protein sequences
Mario Hlevnjak1, Lily Chan1, Anton A. Polyansky1, Bojan Zagrovic1
1Max F. Perutz Laboratories, University of Vienna, Vienna, Austria
We recently reported a persistent correlation between mRNA coding-sequence pyrimidine content and the 
propensity of cognate protein sequences to interact with pyrimidine mimetics as captured by the polar requirement 
amino-acid scale. Moreover, strong correlations were observed both on the whole proteome level and on the level of 
individual protein-mRNA sequence profiles. On the basis of these findings, we hypothesized that mRNA coding regions 
may in general be physically complementary to and therefore directly interact with cognate protein regions, especially 
if both polymers are unstructured. Here, we explore how codon usage affects these correlations by systematically 
varying the pyrimidine content of degenerate codons, while keeping the cognate protein polar requirement fixed. Next, 
we re-evaluate the correlations between the properties of two biopolymers, both on the level of sequence averages 
as well as individual profiles, and compare them against correlations observed for the native sets. We find that the 
levels of matching in present-day proteomes can be both significantly increased or decreased depending on particular 
codons, while still preserving the specific native codon usage bias for all proteomes tested (M. jannaschii, E. coli, S. 
cerevisiae and H. sapiens). Finally, we explore the relationship between the level of mRNA-protein complementary 
matching and biological function by analyzing the enrichment or depletion of functional Gene Ontology terms in 
different segments of the profile-matching distribution and find that certain molecular functions can easily be related 
to the mRNA-protein complementarity hypothesis.
550 B Computational study of interactions between amino acids and nucleobases in aqueous 
solvent
Matea Hajnic1, Juan Osorio Iregui1, Thomas Malzac1, Bojan Zagrovic1
1Department of Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, 
Vienna, Austria
The genetic code table provides a universally conserved link between the sequences of cognate mRNA and 
protein pairs. However, a question, which still remains unanswered, is why a particular nucleotide triplet codes for a 
particular amino acid? A potential connection between physicochemical properties of codons and cognate amino acids 
i.e. of mRNA and cognate protein sequences was recently explored[1]. Surprisingly, it was shown that mRNA coding-
sequence pyrimidine content strongly correlates with the average propensity of protein sequences to be solubilized 
by pyrimidine mimetics (protein polar requirement), hinting at the possibility of complementary binding between 
these two biopolymers being not only responsible for defining the genetic code, but also playing an important role 
in present-day cells. To further examine potential interactions between proteins and their mRNAs on a microscopic 
level, molecular dynamics simulations were employed to derive scales of amino-acid solubility in nucleobase-water 
solutions. These were then used to obtain proteome-wide correlations of average sequence properties of mRNAs and 
cognate proteins and to compare them with previously observed ones using the polar requirement scale. Structural and 
energetic analysis of different amino acids in nucleobase-water solutions revealed that amino acids generally tend to 
interact more readily with nucleobases than with water molecules, with differing propensities depending on the exact 
system studied. Taken together, newly generated propensity scales provided proteome-wide correlations between 
compositional properties of mRNAs and cognate proteins that were comparable in strength to those obtained when 
the polar requirement scale was used, but differed in direction in several important cases. This allowed us to further 
explore the mRNA-protein complementarity hypothesis and probe its limits and overall validity.
1. Hlevnjak M, Polyansky AA, Zagrovic B (2012) Sequence signatures of direct complementarity between mRNAs and 
cognate proteins on multiple levels. Nucleic Acids Res. [Epub ahead of print]
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553 B Post-transcriptional control of macrophage activation by HuR.
Panagiota Kafasla1, Orsalia Hazapis3, Martin Reczko3, Dimitris Kontoyiannis2
1BSRC “Al. Fleming”, Vari, Greece; 2Biological Sciences Research Center “Al. Fleming, Vari, Greece; 3BSRC 
“Al. Fleming”, Vari, Greece
Post-transcriptional control of the expression of inflammatory molecules is emerging as an efficient and rapid 
way to regulate the development and the resolution of inflammation. It requires the assemblies of RNA-binding 
proteins (RBPs) and non-coding RNAs onto specific elements on their RNA targets in Ribonucleoprotein particles 
(RNPs) which control mRNA maturation, turnover and translation. One of the key players, with an established role 
in translation and turnover of inflammatory mediators is the RNA-binding protein HuR. HuR binds to AU-rich 
elements (AREs), and through this binding it has been suggested to act as a stabiliser of mRNAs, either by positively 
regulating their translation, or by inhibiting their decay. However, data have emerged suggesting its role as a negative 
regulator of pathologic inflammation: transgenic systems of inducible and macrophage specific HuR overexpression 
in mice suppress translation of inflammatory mRNAs (Katsanou et al 2005); mutant mice lacking HuR from the 
myeloid lineage (LysCre+Elavl1fl/fl) show exacerbations in the biosynthesis of inflammatory cytokines and chemokines 
(Yiakouvaki et al 2012). Therefore, HuR appears to be a pleiotropic regulator of the expression of inflammatory 
mRNAs, a role slightly more complicated than its original assignment as an mRNA stabilizer.
To further understand the role of this RBP in post-transcriptional control of inflammatory gene expression we 
applied PAR-CLIP on resting and activated bone marrow derived macrophages. Analysis of the RNA targets identified 
reveals HuR’s differential contribution towards the development of macrophage activation.
552 A Establishment of a Fluorescence Cross Correlation Spectroscopy (FCCS) based assay to 
measure Argonaute – siRNA interaction
Leonhard Jakob1, Michael Hannus2, Stefan Hannus2, Gunter Meister1
1University of Regensburg; 2Intana Bioscience GmbH
Argonaute Proteins are the key players in the RNA interference mechanism (RNAi) by which double stranded RNA 
leads to the loss of an mRNA homologous sequence. Synthetic short interfering RNA duplexes (siRNAs) effectively 
can be used to downregulate certain genes of interest at the mRNA level. Therefore siRNAs targeting the same target 
RNA can exhibit different knockdown efficiencies or lead to unwanted off-target effects.
Here we report the measurement of the molecular interactions between siRNAs and Ago proteins via Fluorescence 
Cross Correlation Spectroscopy (FCCS). With this method information about the size, the rate of diffusion and 
concentration of each fluorescently labeled particle can be obtained. This is achieved by analyzing the time-dependent 
fluctuation of the fluorescence signal of Cyanine-5 (Cy5) labeled siRNAs and GFP fused Ago proteins through a 
confocal detection volume.
The aim of the project is to establish an FCCS based assay to measure direct interactions of Ago Proteins with 
siRNAs and to examine whether the affinity of a certain siRNA correlates with its knockdown potency in vivo. 
Furthermore this assay provides the possibility to identify potential regulatory sites of Argonaute proteins by comparing 
the binding kinetics of Ago mutants with the respective wildtype protein.
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555 A The RNA-binding Protein Repertoire of Embryonic Stem Cells
S. Chul Kwon1, Hyerim Yi1, Katrin Eichelbaum2, Sophia Föhr2, Bernd Fischer2, Kwon Tae You1, Tuan Anh Nguyen1, 
Alfredo Castello2, Jeroen Krijgsveld2, Matthias W. Hentze3, V. Narry Kim1
1Institute for Basic Science (IBS); School of Biological Sciences, Seoul National University, Seoul 151-742, 
Korea; 2European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, Heidelberg 69117, Germany; 
3European Molecular Biology Laboratory (EMBL), Meyerhofstrasse 1, Heidelberg 69117, Germany; 
Molecular Genetics Division, Victor Chang Cardiac Research Institute, Sydney NSW 2010, Australia
RNA-binding proteins (RBPs) play essential roles in RNA-mediated gene regulation, and yet the current 
annotation of RBP is largely limited to those with known RNA-binding domains. To systematically identify the 
RBPs of embryonic stem cells (ESCs), we here employ “interactome capture”, which combines UV-crosslinking 
of RBPs to RNA in living cells, oligo(dT) capture, and mass spectrometry. From mouse ESCs, 555 proteins are 
defined here to constitute the mESC RNA-interactome, which includes 283 proteins not previously known to bind 
RNA. Interestingly, 39 novel RBP candidates are highly expressed in ESCs when compared to differentiated cells, 
suggesting that they may play important roles in stem cell physiology. Among them, two well-known E3 ubiquitin 
ligases (Trim25/Efp and Trim71/Lin41) are validated as novel RBPs, revealing a potential link between RNA biology 
and post-translational modification pathways. Our mESC RNA-interactome confirms RBPs recently found in HeLa 
and HEK293 studies and expands the atlas of RBPs with novel candidates, providing a valuable resource for the study 
of RNA-RBP networks in stem cells.
554 C Repetitive RNA unwinding of a single RNA helicase A
Hye Ran Koh1, Li Xing3, Lawrence Kleiman3, Sua Myong2
1Department of Physics, University of Illinois, Urbana, IL 61801, USA & Institute for Genomic Biology, 
Urbana, IL 61801, USA; 2Institute for Genomic Biology, Urbana, IL 61801, USA & Department of 
Bioengineering, University of Illinois, Urbana, IL61801, USA; 3Lady Davis Institute for Medical Research 
and McGill AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canada & Department of Medicine, 
McGill University, Montreal, Quebec, Canada
RNA helicase A (RHA) plays diverse roles in cellular machinery as a transcriptional co-activator, an essential 
cofactor for normal gastrulation during mammalian embryogenesis and a translational activator of complex cellular 
and retroviral mRNAs as like human immunodeficiency virus (HIV). Consisting of two double stranded RNA binding 
domains (dsRBDs) at the N-terminus, helicase core and a single stranded RNA (ssRNA)-binding RGG domain at the 
C-terminus, dsRBDs and RGG domain of RHA have been proposed to possess regulatory functions in its helicase 
activity. However, it has not been tackled yet how RHA plays a role as a transcriptional co-activator and how the 
subdomain as like dsRBDs controls the helicase activity of RHA owing to lack in the molecular detail of the RNA 
unwinding process by RHA. Here, we provided the detailed molecular mechanism of RNA unwinding by RHA, taking 
an advantage of a single-molecule technique, which unveiled the molecular details of the RNA unwinding process 
by RHA, including the characterization of every single step in the RNA unwinding process, the repetitive unwinding 
characteristic of RHA after its loading to dsRNA, and dsRBDs-controlled RHA loading or activation. Moreover, we 
directly showed that the repetitive RNA unwinding by RHA cleared the hydrogen bonds in dsRNA efficiently, making 
it easily access to the complementary ssRNA, which gives a hint how RHA acts as a transcriptional co-activator in a 
molecular point of view.
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557 C RBP atlas: an exploration of interactions between mRNA and proteins and their impact on 
cardiomyocyte biology
Yalin Liao1, Alfredo Castello2, Sophia Foehr2, Stefan Leicht2, Rastislav Horos2, Jeroen Krijgsveld2, Matthias 
Hentze2, Thomas Preiss1
1John Curtin School of Medical Research, Australian National University, Australia; 2European Molecular 
Biology Laboratory (EMBL), Heidelberg, Germany
RNA-binding proteins (RBPs) control all aspects of RNA fate and defects in their function underlie a broad 
spectrum of human pathologies. Employing a combination of UV-crosslinking of proteins to RNA in living cells with 
identification of those co-purifying with poly(A)+ RNA by mass spectrometry, we recently identified 860 proteins as 
the “mRNA interactome” of human HeLa cells.1 Over 300 of these RBPs were not previously known to bind RNA and 
their identification sheds new light on RBPs in disease, RNA-binding enzymes of intermediary metabolism, RNA-
binding kinases, and RNA-binding architectures. We have now adapted this approach to identify the mRNA interactome 
of murine HL-1 cardiomyocytes. The HL-1 cell line maintains the ability to contract and other differentiated cardiac 
morphological and functional properties in culture.2  Our analyses reveal both, RBPs commonly detected in cells of 
different origin as well as more cardiomyocyte-specific RBPs. Ongoing work is focused on detecting changes in the 
cardiomyocyte mRNA interactome under conditions of pathophysiological stress and on identifying the RNA targets 
of selected cardiomyocyte RBPs using RBP pull-down followed by next generation sequencing of co-purifying RNA. 
Altogether, these investigations will map networks of post-transcriptional gene regulation in cardiomyocytes and 
might reveal their involvement in molecular processes commonly at play in heart disease.
1. Castelló, A. et al. (2012). Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell, 149(6), 
1393–1406.
2. Claycomb, W. C. et al. (1998). HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of 
the adult cardiomyocyte. Proc Natl Acad Sci USA, 95(6), 2979–2984.
556 B Drosophila Gemin5 binds to UsnRNAs and another specific group of ncRNAs
Sheila SK Li1, Jonathan PY Lau1, Tinyi Chu1, Brian Qin2, Ting-Fung Chan2, Terrence CK Lau1
1Department of Biology and Chemistry, City University of Hong Kong, Hong Kong SAR.; 2School of Life 
Sciences, The Chinese University of Hong Kong, Hong Kong SAR.
Pre-messenger RNA (pre-mRNA) splicing is an indispensable step in protein synthesis. Human RNA splicing is 
mediated by spliceosome, the molecular machinery that is comprised of various U small nuclear ribonucleoproteins 
(UsnRNPs). The UsnRNPs biogenesis is highly regulated by a protein complex called the Survival of Motor Neuron 
complex (SMN complex). The SMN complex is composed of the SMN protein, sm proteins and Gemin2-8. Gemin5 
has been identified as the UsnRNAs-binding protein in SMN complex. Rigor mortis (Rig) is the gene homolog of 
human Gemin5 in Drosophila. It is found highly expressed in the central nervous system of larvae and the ovaries 
of adult flies. We showed that Rig protein share the same function of human Gemin5 in binding UsnRNAs with high 
affinity and specificity. By means of RNA immunoprecipitation and next-generation sequencing, we further revealed 
that Rig binds to another group of non-coding RNAs, suggesting that Rig is involved in other pathways of RNA 
binding or RNA biogenesis. 
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559 B Neurodegenerative diseases: quantitative predictions of protein-RNA interaction
Domenica Marchese1, 2, Davide Cirillo1, 2, Gian Gaetano Tartaglia1
1Centre for Genomic Regulation (CRG), Dr. Aiguader 88, 08003 Barcelona, Spain 2Universitat Pompeu Fabra 
(UPF), 08003 Barcelona, Spain.
Although neurodegenerative diseases are traditionally described as protein disorders leading to amyloidosis (Rubinsztein 2006; 
Dobson 1999), very recent evidence indicates that protein-RNA associations are involved in a number of neuropathies. Using our 
computational method catRAPID (Bellucci et al. 2011) we analyzed interactions between protein and RNA molecules  linked to 
neurodegeneration. In particular, we focused on: 1) FMR1, whose codon expansion (55-200 CGG repeats) in the 5’ untranslated region 
of the gene is associated to Fragile X-associated Tremor/Ataxia Syndrome (FXTAS); 2) Iron regulatory protein 1 (IRP1) translational 
regulation of Alzheimer’s and Parkinson’s disease related genes through the recognition of IRE (Iron-Responsive Element). 
According to our calculations, CGG repeats in the 5’UTR of FMR1 gene, have a strong propensity to sequester MBNL1 
and hnRNP-G and all the proteins (hnRNP-A1, hnRNP-A2/B1, hnRNP-C, hnRNP-D, hnRNP-E and hnRNP-C) that were found 
to colocalize with CGG repeats by Sellier et al. 2010. In agreement with experimental evidence we also find poor sequestration 
propensity for FMRP and CUGBP1, while we predict that PURa, which colocalizes with cytoplasmic CGG repeats in flies (Jin et 
al. 2007) but not in mammalian cells where it is strictly nuclear, interacts with CGG repeats. Interestingly, we predict that SAM68, 
essential for the recruitment of other proteins but not interacting with CGG repeats from experimental evidence, does not interact 
with CGG repeats. Nevertheless, among its annotated protein interactors we find that cold-inducible RNA-binding protein CIRBP 
and polypyrimidine tract-binding protein 2 PTBP2, have a propensity to be sequestered by CGG repeats which increases with its 
length, thus suggesting that they could mediate SAM68 sequestration. 
With regards to Irp1, our method correctly predicts that the 5’-UTRs of ferritin and APP interact with IRP-1 in several regions 
along the protein sequence, which is consistent with experimental evidence (Rogers et al., 2002; Walden et al. 2006). In addition, in 
line with what reported by Cho et al., we discovered that 87% of the mutations in the CAGAGC motif strongly reduce IRP-1 binding 
ability. Interestingly, one RNA stem loop within the 5’-UTR of human a-synuclein transcript that has been predicted to be structurally 
related to the IRE element present in ferritin mRNA, has the highest propensity to bind to IRP-1 according to our calculations. 
In conclusion, we propose catRAPID for predictions of protein-RNA associations, to flag putative interactions and select 
candidates for experimental studies. Our method allows processing of a large amount of protein-RNA pairs and can lead to finding 
previously unknown interactions.
558 A Multifunctional interleukin-6 receptor aptamers
Eileen Magbanua1, Ulrich Hahn1
1Institute of Biochemistry and Molecular Biology, University of Hamburg
An aptamer can form a defined tree dimensional structure which leads molecules to exhibit high affinities to 
inorganic or organic molecules. In our lab an RNA aptamer with high affinity (Kd = 20 nM) to the human interleukin 
6 receptor (IL-6R) was selected. This aptamer triggers IL-6 receptor-mediated uptake without affecting IL-6R 
interactions with its natural ligands IL-6 and gp130. Furthermore, we were able to use the 19 nt long aptamer for 
cargo delivery into IL-6R presenting cells. The tree dimensional structure of the RNA aptamer was identified as an 
intrinsic all parallel quadruplex structure. The affinity of the aptamer to IL-6R was highly dependent on quadruplex 
structure formation and abolished by replacing one guanine being involved in quadruplex formation. Additionally, we 
could demonstrate that the IL-6R aptamer served as effective HIV de novo infection inhibitor by binding gp120 as 
primary target. Gp120 is presented on the surface of HIV particles and responsible for infection process. The presence 
of the aptamer during HIV de novo infection leads to prevention of infection due to blockade of gp120-CD4 complex 
formation. Structural similarities of IL-6R and gp120 could not be observed explaining the affinity of an aptamer to 
two different targets.
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561 A Knock-out mice and HITS-CLIP reveal that the SGs assembly factor G3BP preferentially 
binds intron-retaining transcripts and controls their stability in the brain
Sophie Martin1, Juan Gonzáles-Vallinas2, Nicolas Bellora2, Manuel Irimia6, Latifa Zekri3, Alexandra Metz3, Karim 
Chebli3, Michel Vignes4, Eduardo Eyras2, Javier F Caceres5, Ben J Blencowe6, Jamal Tazi1
1Institut de Génétique Moléculaire de Montpellier, CNRS; 2Computational Genomics Group Universitat 
pompeu Fabra PRBB; 3IGMM CNRS; 4Institut des Biomolécules Max Mousseron; 5MRC Human Genetics 
Unit; 6The Donnelly center, University of Toronto
Stress granules (SGs) are non-membranous cytoplasmic foci formed as a cellular protective response to 
environmental stress, such as elevated temperature, oxidative stress, hypoxia, osmotic shock, UV irradiation, glucose 
deprivation or viral infection. SGs share common properties with other granules like processing bodies or neuronal 
transport granules. G3BP (RasGAP-SH3-domain Binding Protein) is a key factor involved in SGs assembly. To assess 
the physiological function of G3BP, we generated viable G3bp1-knockout (KO) mice, which demonstrated behavioral 
defects linked to the central nervous system (CNS) associated with ataxia phenotype. Immunohistochemistry 
pinpointed high expression of G3BP in the cytoplasm of hippocampal neurons and Purkinje cells of the cerebellum 
of wild-type (WT) mice. Also, electrophysiological measurements revealed that the absence of G3BP1 leads to an 
enhancement of short-term potentiation (STP) and long-term depression (LTD) in the CA1 area of G3bp1 KO mice 
compared to WT mice. Consistently, G3BP1-deficiency in neurons leads to an increase in intracellular calcium and 
calcium release in response to (S)-3,5-Dihydroxyphenylglycine (DHPG), a selective agonist of group I metabotropic 
glutamate receptors. HITS-CLIP (High-Throughput Sequencing after Cross-Linking and ImmunoPrecipitation) 
experiments were carried out on WT and KO mouse brain to identify G3BP-associated RNAs. Surprisingly, many 
G3BP’s targets turn out to be non-coding RNA sequences, essentially snoRNAs and intronic sequences. Interestingly, 
transcripts with retained introns appear to be enriched in the cerebellum compared to the rest of the brain. G3BP1 
depletion leads to a decrease in the expression of these intronic sequences in the cerebellum. In particular, G3BP1 is 
essential to repress mature Grm5 (metabotropic glutamate receptor 5) expression in the cerebellum by stabilization 
of the intron in its pre-mRNA. This study suggests a new mechanism of gene regulation, important in the cerebellum, 
based on stabilization of silenced premature RNA transcripts, which might be converted to mature transcripts and 
translated or targeted for degradation upon G3BP depletion.
560 C RNA helicase function in yeast ribosome biogenesis
Roman Martin1, Philipp Hackert1, Maike Ruprecht2, Stefan Simm2, Enrico Schleiff2, Markus Bohnsack1
1Centre for Biochemistry and Molecular Cell Biology, Göttingen University, Göttingen, Germany; 2Institute 
for Molecular Biosciences, Goethe University, Frankfurt, Germany
The synthesis of cytoplasmic ribosomes in Eukaryotes is best understood in the yeast Saccharomyces cerevisiae. 
Here, the pathway requires more than 200 non-ribosomal proteins, such as GTPases, nucleases and RNA helicases. 
In addition, 75 small nucleolar RNAs (snoRNAs) are involved and base-pair with pre-ribosomal RNA, and many are 
predicted to require helicase activities for their release. Since the knowledge on the 19 RNA helicases involved in 
ribosome biogenesis is still limited and molecular and regulatory functions of these enzymes seem to be diverse, the 
elucidation of their roles has remained a challenging task.
Using the UV cross-linking and analysis of cDNAs (CRAC) approach, Solexa deep sequencing and bioinformatics, 
we have identified RNA binding sites of helicases involved in ribosome biogenesis. One protein that we are studying 
is Rok1, a RNA helicase required for the maturation of the small ribosomal subunit. We have previously shown that 
Rok1 acts in the release of snR30, a box H/ACA snoRNA that is required for pre-rRNA processing. Interestingly, 
Rok1 crosslinks to a region in the eukaryotic expansion segment 6 of 18S rRNA at the snR30 basepairing site, which 
is in line with a direct involvement of Rok1 in the unwinding of snR30 from pre-ribosomal RNA.
We are currently analyzing CRAC data for several other RNA helicases, most of which are involved in the 
biogenesis of the large ribosomal subunit. These data will provide the basis for further functional analysis of the 
specific roles of RNA helicases in ribosome biogenesis. 
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562 B A co-evolution network of binding contacts between protein L25 and 5S rRNA
Zhichao Miao1, Eric Westhof2
1Architecture et Réactivité de l’ARN, Institut de biologie moléculaire et cellulaire du CNRS, 67000 
Strasbourg France; 2Architecture et Réactivité de l’ARN, Université de Strasbourg, Institut de biologie 
moléculaire et cellulaire du CNRS, 67000 Strasbourg France
RNA-protein interactions are central to all critical processes in the living cells. With the growth in the number of 
structures of RNA-protein complexes and in sequence data, a systematic analysis and study of RNA-protein interactions 
could help us understanding recognition mechanisms of RNA-protein binding in order to predict them. Here we chose 
to study the complex structure of ribosomal protein L25 and 5S rRNA for which detailed structural interactions are 
available. We analyzed binding and co-evolution patterns between them both on structure and sequence. Mutual 
Information (MI), a co-evolution analysis, determines residue pairs that show a statistically significant correlations, 
which result from both direct couplings and multitudinous couplings. Direct-coupling analysis (DCA), can discriminate 
the two kinds of couplings and give direct information (DI) between residue pairs. We used DCA to characterize co-
evolution between L25 and 5S rRNA. 
First, we found a highly connected co-evolution network constituted by the RNA binding residues in L25. We 
applied DCA to L25 and found the result correlates with the structural contact map. Besides, the top co-evolving 
residue pairs were plotted as a network and clustered. The largest cluster is not only more connected but also includes 
most of the RNA binding residues. This implies RNA binding may result in co-evolution between RNA binding 
residues. 
Secondly, we found RNA binding residues are separate in the sequence but close in structure. A score is assigned 
by sequence distance |i-j| divided by the contact distance between residue i and j. It is higher for RNA binding residues 
than average. RNA-binding was found to cluster on L25 surface and being more conserved than others. A main reason 
for this observation could be that the local secondary structure features prevent the sequentially close residues from 
spatial proximity while they are required to cluster in structure to bind to a RNA motif. Thus, L25 needs to separate 
the RNA binding sites in sequence and gather them in space. 
Then, we applied DCA in 5s rRNA, which is the first time it is applied to RNA co-evolution analysis. The results 
not only show that DI offers less noise than MI but also maps well with RNA structure. The co-evolving nucleotide 
pairs correlate to most of the base pairs. It validates us DCA could be effective for RNA system and demonstrates its 
potential in RNA structure prediction. 
Finally, DCA was applied between L25 and 5s rRNA. 1424 protein and RNA sequence pairs for different species 
were collected, aligned and measured by DCA. The top co-evolving residue nucleotide pairs correspond to the key 
binding sites: five of the top six direct coupling pairs are proximal in structure and three of them map to key hydrogen 
bonds. The same strategy was extended to L5-5S rRNA and L18-5S rRNA binding, and results were similar. This 
reveals the great potential of DCA in RNA-protein interaction prediction. 
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
RNA-Protein Interactions  •   329
564 A Sequence specific code in RRM–RNA interactions
Martyna Nowacka1, Stanislaw Dunin-Horkawicz1, Kama Wojcik1, Janusz Bujnicki1
1International Institute of Molecular and Cell Biology in Warsaw
RNA–recognition motif (RRM) is a well known RNA interacting protein domain. RRMs are commonly present in 
all kingdoms of life and play a role at every stage of RNA life cycle: processing, splicing, editing, export, degradation 
and regulation of translation. Despite the large body of data available on sequence-specific RRM-RNA interactions, 
including numerous structures of RRM–RNA complexes, the “recognition code” is still not fully understood, 
and we cannot predict the RRM ligand specificity from its protein sequence alone. In this project we are using a 
multidisciplinary approach towards better understanding of RRM–RNA recognition. By combining bioinformatics 
(including sequence analyses, artificial intelligence methods, protein structure prediction, and protein–RNA docking) 
and biochemical and biophysical methods, we aim to provide the general understanding of the recognition code of 
RRMs in the evolutionary context. Thus far, comparative analyses of the RRMs and RRM–like sequences were used 
to build a database, where RRMs are classified into families based on sequence similarity. In silico analysis of RRM–
RNA complexes, for which structure information is available, has been used to infer global trends in the formation 
of specific protein–RNA contacts. This is the starting point to assign substrate specificity and/or modulating affinity 
within the various RRM’s families. Computational predictions of new RRM–RNA specificities are first tested in vitro 
and will be validated in human cell lines and submitted to structural studies. We have already started characterizing 
substrate specificity of novel RRMs with unknown mode of action using in vitro selection (SELEX). This approach 
revealed new interactions that are currently being further characterized. We aim to obtain information about specificity 
and build structural models of RRM-RNA structure for at least one member of each RRM family present in our 
database.
563 C Mechanism of action of the CCCH zinc finger protein TbZC3H11 upon heat shock
Igor Minia1, Dorothea Droll1, Aditi Singh1, Christine Clayton1
1Zentrum für Molekulare Biologie der Universität Heidelberg, DKFZ-ZMBH Alliance Heidelberg, Germany
Most organisms induce transcription of heat-shock genes in response to temperature upshifts. However, 
Kinetoplastids, including important pathogens of human, animals and plants, control their gene expression almost 
entirely at the post-transcriptional level. Thus, amounts of heat-shock proteins after heat shock are regulated by mRNA 
stability and translation efficiency.
We showed previously that mRNAs encoding chaperones and co-chaperones are selectively stabilized by the 
Trypanosoma brucei CCCH zinc finger protein ZC3H11. Many target transcripts that interact with ZC3H11 contain a 
non-classical AU-rich element (UAU repeats) in the 3’-untransalted region. It has been shown that the ZC3H11 CCCH 
zinc finger domain is important for the interaction, with little discrimination between (UAU)n repeats and the classical 
AU-rich element which is bound by Tis-11 family proteins, (UAUU)n repeats.
Members of mammalian Tis11 family, however, contain two tandem CCCH zinc finger domains through which 
they bind to AU-rich elements, but in contrast, ZC3H11 has only one such domain. Hence, ZC3H11 should dimerize 
to gain reasonable RNA-binding specificity. Indeed, multimerization was apparent in gel-shift assays, and co-
immunoprecipitation of V5- and myc-tagged versions of protein also confirmed dimerization.
It was shown that ZC3H11 expression is significantly induced upon heat shock. So, currently we are investigating 
the mechanism by which amounts of ZC3H11 and its activity are regulated. Like TTP and BRF-1, ZC3H11 is 
phosphorylated, but precise sites of the modification are as yet unknown. We do, however, have preliminary evidence 
that levels of ZC3H11 are – like those of TTP and BRF-1 – regulated through proteasomal degradation. Indeed, pulse-
chase/immunoprecipitation analysis revealed that half-life of ZC3H11 protein increases upon heat-shock. In addition, 
polysome profiling showed that ZC3H11 mRNA is shifted to polysome fraction upon heat shock, what might explain 
elevated amounts of protein in response to temperature upshifts.
We propose that ZC3H11 operates via interactions with MKT1 and PBP1, which result in recruitment of PABP to 
the 3’-UTR and consequent RNA stabilization by protection from deadenylation.
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566 C Division of labor: separation of loading and unwinding units in an oligomer of the DEAD-
box helicase Ded1p
Andrea Putnam1, Huijue Jia1, Fei Liu1, Eckhard Jankowsky1
1Center for RNA Molecular Biology and Department of Biochemistry, Case Western Reserve University
DEAD-box RNA helicases perform ATP-dependent RNA and RNP remodeling reactions, including unwinding of 
RNA duplexes.  In several DEAD-box proteins, RNA, nucleotide, and protein binding depend on the oligomeric state 
of the protein, but the impact of oligomerization on the function of DEAD-box helicases has not been examined.  Here 
we have investigated oligomerization by the DEAD-box protein Ded1p from Saccharomyces cerevisiae.
During duplex unwinding, Ded1p forms an oligomer with at least three units. Two units of Ded1p associate with 
single stranded RNA proximal to duplex regions, and generate nearly all of the ATP hydrolysis observed during an 
unwinding reaction. Replacing the single stranded RNA with DNA, eliminates the majority of ATPase activity while 
having no significant effect on substrate binding or unwinding activity. Immobilization of two units of Ded1p on 
the single stranded RNA with a non-hydrolyzable ATP analog inhibits ATPase activity while promoting unwinding. 
Together these data suggest that two units of Ded1p serve as a loading platform to direct a third unit of Ded1p to 
the duplex for unwinding.  We further show that the loading and unwinding units of the oligomer are functionally 
distinct in both ATP utilization and RNA binding, and we find that the C-terminal domain of Ded1p is critical for 
oligomerization.  Moreover, a physiological interaction partner of Ded1p, eIF4G, interacts through the C-terminus of 
Ded1p and prevents oligomerization.  Collectively, our findings reveal that oligomerization plays an important and 
underappreciated role in the biochemical function of Ded1p.  
565 B Regulation of mRNA metabolism by U2AF65 splicing factor - novel mechanisms for the 
coordination of gene expression?
Isabel Peixeiro1, Samuel Casaca1, Margarida Gama-Carvalho1
1Gene Expression and Bioinformatics Unit, BioFIG – Center for Functional and Integrative Genomics, 
Faculty of Sciences, University of Lisbon, Portugal
In eukaryotes, gene expression is a highly controlled process that requires a coordinated regulation at several 
levels. Post-transcriptional processes can quickly impact cell function through the modulation of mRNA transport, 
stability and translation. RNA-binding proteins (RBPs) were shown to determine the fate of several mRNA targets, 
thus affecting multiple cellular processes.
 We have previously demonstrated that U2AF65 and PTB, two mammalian splicing factors that recognize pyrimidine 
tracts, associate with a discrete subset of cellular mRNAs. The functional classification of these interaction profiles 
revealed underlying mRNA populations encoding proteins involved in common cellular functions. This strongly 
suggests that their expression is coordinated through overlapping post-transcriptional networks defined by U2AF65 
and PTB. In fact, the mRNA population associated with U2AF65 shows a significant enrichment for molecules that 
encode proteins involved in RNA processing and cell cycle regulation.
Here we characterize the function of U2AF65 as a modulator of the mRNA metabolism by taking advantage of 
the lambda N-based tethering system. The artificial tethering of U2AF65 downstream of the coding sequence (CDS) 
resulted in downregulation of the luciferase reporter. Furthermore, we demonstrate that overexpression of U2AF65 
has an inhibitory effect on the expression of a reporter gene fusing the luciferase CDS with the 3’UTR of U2AF65, 
without affecting the reporter mRNA levels. The 3’UTR of U2AF65 presents several predicted U2AF65 binding 
motifs that bind to recombinant U2AF65. In fact, we show that overexpression of exogenous U2AF65 results in 
decreased endogenous U2AF65 protein levels, suggesting the existence of a feedback regulatory mechanism. These 
observations point to U2AF65 as a negative regulator of gene mRNA metabolism, in contrast with its known role as 
an enhancer of splicing and 3’end processing.
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568 B Imbalance of Zfp36l2-RNA-binding protein results in female infertility
Silvia Ramos1
1University of North Carolina at Chapel Hill
ZFP36L2 is a CCCH tandem zinc finger protein that can destabilize certain AU-rich element-containing transcripts 
in cell transfection studies. ZFP36L2 has been implicated in the physiological control of female fertility. In the C57/
BL6 mouse, a mutation in Zfp36l2 that results in the decreased expression of a form of ZFP36L2 in which the 29 amino 
terminal amino acids had been deleted, revealed that DeltaN-Zfp36l2 eggs could be fertilized but did not progress 
beyond the two-cell stage of development. Also when DeltaN-Zfp36l2 females were subjected to superovulation 
protocols they released 50% fewer eggs than the WT. This suggested a possible additional defect in ovulation and 
oocyte maturation despite evidence of normal ovarian histology.
To further investigate we introduced the DeltaN-Zfp36l2 mutation into the SV129 mouse strain, which has been 
reported to respond well to superovulation protocols. DeltaN-Zfp36l2 mutation in this strain also resulted in complete 
female infertility. Unexpectedly, these females failed to release oocytes using superovulation protocols, prompting us 
to investigate the oocyte maturation. Remarkably, only 20% of DeltaN-Zfp36l2 oocytes matured ex vivo, while 80% 
of the WT oocytes maturated spontaneously. This suggests that DeltaN-Zfp36l2 either inhibits processes involved in 
the release from, or favor  those involved in the maintenance of, meiotic arrest. 
The cAMP/PKA pathway is critical for maintaining meiotic arrest. Treatment of DeltaN-Zfp36l2 oocytes with 
PKA inhibitors doubled the percentage of oocytes able to overcome the DeltaN-Zfp36l2-linked meiotic arrest. The 
investigation of the mechanism involved in this arrest, led us to discover that LHR mRNA is the first specific and 
physiological RNA target for Zfp36l2. Decreased expression levels of Zfp36l2 in the ovaries resulted in sustained 
high levels of LHR mRNA during ovulation. Therefore, lack of the normal down regulation of LHR mRNA levels in 
the ovaries results in anovulation and arrest of the oocytes. This is the first time that a imbalance of a specific mRNA 
in vivo is directly associated with Zfp36l2 function. Thus, the Zfp36l2-RNA-binding protein can be the basis of some 
cases of unexplained female infertility in humans.   
567 A Manipulating endogenous RNAs with synthetic RNA-binding proteins
Oliver Rackham1, MF Razif1, KK Nygård1, TS Chia1, ME Hibbs1, SM Davies1, I Small2, A Filipovska1
1Western Australian Institute for Medical Research and Centre for Medical Research, The University of 
Western Australia, Perth, WA 6000, Australia; 2Australian Research Council Centre of Excellence in Plant 
Energy Biology
Post-transcriptional regulation of gene expression is ubiquitous and fundamental for the control of cell growth, 
differentiation and the complex developmental programs of multicellular eukaryotes. Because of their modular 
structure, repeat domain proteins are particularly well suited for these processes and have been widely adopted 
throughout evolution. We have expanded the RNA recognition code of Pumilio and FBF homology (PUF) proteins, 
enabling the design of RNA-binding proteins with programmable specificities. Furthermore, in recent work we have 
created synthetic proteins from another family of RNA-binding repeat domain proteins: the pentatricopeptide repeat 
(PPR) proteins. These artificial proteins have revealed the code for RNA binding by natural PPR domains and provide 
unique tools for manipulating endogenous RNAs. We show that designer RNA-binding proteins can be used to 
selectively manipulate the expression of endogenous mRNAs in human cells. The design of proteins that can bind any 
RNA sequence of interest and modulate its function will be important to elucidate the mechanisms by which genes are 
controlled at the RNA level and may provide potential therapeutics in the future. 
1. Filipovska A, Razif MF, Nygård KK, Rackham O. (2011) A universal code for RNA recognition by PUF proteins. Nature 
Chemical Biology 7(7): 425-427. 
2. Filipovska A, Rackham O. (2012) Modular recognition of nucleic acids by PUF, TALE and PPR proteins. Mol. Biosyst. 
8(3): 699-708.
3. Filipovska A, Rackham O. (2011) Designer RNA-binding proteins: new tools for manipulating the transcriptome. RNA 
Biology 8(6): 978-83.
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570 A Architecture of catalytic complexes essential for synthesis and co-translational insertion 
of selenocysteine in humans
Miljan Simonovic1, Rachel Schmidt1, Malgorzata Dobosz-Bartoszek1
1University of Illinois at Chicago
Fundamental and highly conserved biological processes such as RNA transcription, posttranscriptional RNA 
modification, mRNA splicing, and protein synthesis are governed by complexes formed between proteins and nucleic 
acids. Upon formation of a particular binary, ternary or a higher order nucleoprotein complex, a protein or RNA 
catalyzes a reaction yielding a product critical for another biological process. Surprisingly, structural studies on these 
complexes revealed that the major principles of protein-nucleic acid recognition are often not universal and unified. 
Perhaps the least understood are the interactions stabilizing catalytic complexes required for synthesis, decoding and 
co-translational insertion of the 21st amino acid, selenocysteine. These processes, which are essential for the structure 
and function of selenoproteins and a number of vital cellular functions, can be divided into three general steps. In the 
first step, which is conserved in all organisms, seryl tRNA synthetase ‘erroneously’ attaches serine to selenocysteine 
tRNA (tRNASec). Subsequently, a specific kinase (PSTK) and synthase (SepSecS) convert the seryl group into the 
selenocysteinyl moiety while being attached to tRNASec. In the final step, a specialized elongation factor, EFsec, selects 
and delivers to the ribosome selenocysteinyl-tRNASec where it facilitates decoding of the selenocysteine UGA codon. 
Although the process outline was drawn over a decade ago, it is still not understood how these enzymes recognize 
tRNASec among other, more abundant elongator tRNAs. Herein, we present results from biophysical studies on various 
complexes from the human selenocysteine pathway. To determine the architecture of the individual complexes and to 
understand how tRNASec is specifically recognized, X-ray crystallography, small angle X-ray scattering, multi angle 
light scattering, and analytical ultracentrifugation methods were employed. Our results provide the first comprehensive 
view onto the organization of the selenocysteine synthetic machinery in humans.
569 C Structure-specific RNase footprinting in multiple cell types reveals protein-binding sites 
throughout the human transcriptome
Ian Silverman1, Fan Li2, Anissa Alexander1, Daniel Beiting3, Nur Selamoglu4, Fevzi Daldal4, Brian Gregory5
1Department of Biology, Cell and Molecular Biology Graduate Group, Penn Genome Frontiers Institute, 
University of Pennsylvania, Philadelphia, PA 19104; 2Department of Biology, Genomics and Computational 
Biology Graduate Group, Penn Genome Frontiers Institute University of Pennsylvania, Philadelphia, PA 
19104; 3Department of Biology, Penn Genome Frontiers Institute, University of Pennsylvania, Philadelphia, 
PA 19104; 4Department of Biology, University of Pennsylvania, Philadelphia, PA 19104; 5Department of 
Biology, cell and molecular biology graduate group, genomics and computational biology graduate group, 
and penn genome frontiers institute, all at university of Pennsylvania, Philadelphia, pa 19104
RNAs are continuously associated with RNA-binding proteins (RBPs), and these interactions are necessary for 
their function and regulation. RBPs bind to target RNAs through sequence and/or structure-specific interactions. 
Increasingly, in vivo binding sites and sequence motifs for RBPs are being determined through the use of Crosslinking 
and Immunoprecipitation (CLIP) experiments, and several variant protocols.  While these approaches have proven 
useful in determining the binding locations of individual RBPs, no current method allows global assessment of the 
extent and diversity of RNA-RBP interactions in both unprocessed and mature mRNAs. We developed a structure-
specific RNase-mediated protein footprint sequencing approach to reveal the protein-protected sites (PPSs) of RNAs 
throughout the transcriptome, and applied it to three human cell types. The structure-specific nature of this assay 
allows for empirical determination of RNA base-pairing probabilities at protein-interaction sites. From this analysis, 
we uncover general principles of RNA-protein interactions, including an increased propensity for protein binding in 
the 3’ UTR near the stop codon. Furthermore, we identify known and putative RNA-protein interaction sites and RBP-
bound sequence motifs, and using RNA-affinity chromatography combined with mass spectrometry, we identified 
proteins that bind to known and novel sequence and structural motifs. Finally, we find that disease-associated single-
nucleotide polymorphisms (SNPs) often affect RNA-protein interactions, revealing a likely molecular mechanism 
for numerous SNPs. Overall, we provide a global view of RNA-protein interaction sites and protein-bound RNA 
secondary structure in multiple cell types and provide a framework for the study of these features on a global scale.
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572 C Human DIS3L2 exonuclease is involved in the processing of tRNA-derived small RNAs
Dmytro Ustianenko1, Biter Bilen2, Katerina Chalupnikova1, Zuzana Feketova1, Georges Martin2, Mihaela Zavolan2, 
Stepanka Vanacova1
1CEITEC-Central European Institute of Technology, Masaryk University, Kamenice 5, 625 00, Brno, Czech 
Republic; 2Biozentrum, University of Basel, Klingelbergstrasse 50 / 70CH - 4056 Basel, Switzerland
Processing of noncoding RNAs in eukaryotes involves the 3’ to 5’ exoribonucleolytic activity of type II ribonucleases 
that are part of the exosome complex. While in yeast it is known that the catalytic activity resides in Rrp44/Dis3 
subunit, the functions of the three human Dis3 homologs have not been well characterized. In this work we aimed to 
uncover the physiological RNA targets of DIS3L2, the DIS3 homolog whose mutation is at the origin of the Perlman 
syndrome. We show that DIS3L2 is an exosome-independent cytoplasmic exoribonuclease, and through crosslinking 
and immunoprecipitation followed by RNA sequencing, we demonstrate that DIS3L2 is involved in the formation of 
tRNA-derived small RNAs (tRFs). A fraction of DIS3L2 along with its tRFs associates with ribosomes and DIS3L2 
overexpression alters the polysome/monosome ratio, suggesting that DIS3L2 is involved in translational regulation. 
Most importantly, we found that the DIS3L2-dependent tRNA-derived fragments associate with Argonaute2 (AGO2) 
pointing to a crosstalk between the DIS3L2-dependent processing of tRNAs and AGO2-dependent regulation of gene 
expression the human cells.
571 B hnRNP A1 Interacts with Conserved RNA IRES Elements in Enterovirus 71
Michele Tolbert1, Jeffery Levengood1, Mei-Ling Li2, Blanton Tolbert1
1Case Western Reserve University, Department of Chemistry; 2Robert Wood Johnson Medical School, 
Department of Molecular Genetics, Microbiology and Immunology
Enterovirus 71 (EV71) is an emerging threat to public health, there are currently no approved vaccines or treatment. 
A key step in the early EV71 life cycle is the translation of viral non-structural proteins that initiate viral replication. 
Due to the lack of m7G cap in the viral 5’ UTR, EV71 utilizes its own highly structured six stem loop type I IRES to co-
opt host proteins. A key IRES trans-acting factor involved in IRES regulation is hnRNP A1. Prior research has shown 
that hnRNP A1 relocates from the nucleus to the cytoplasm and interacts with Stem Loop II (SLII) of the EV71 IRES, 
making it likely that SLII is critical in viral IRES dependent activity. Despite its importance in modulating viral IRES 
mediated translation and thus downstream replication events, little is known about the mechanism of how hnRNP A1 
and SLII interact. A series of RNA biophysical studies, bioinformatics, and viral assays were utilized to characterize 
the two-step binding nature of this interaction. We show that host hnRNP A1 interacts with SLII in a novel manner 
involving two distinct conserved motifs: (1) a lower five nucleotide bulge containing a canonical UAG hnRNP A1 
nucleotide binding motif and (2) an apical six nucleotide hairpin loop containing a CCA hnRNP A1 binding motif. 
In vivo studies further demonstrate that mutation of the UAG motif in the lower bulge abrogates IRES activity and 
viral replication in host cells. Since it is likely that the structure of SLII modulates this novel binding mechanism, a 
preliminary high resolution model of SLII was determined. Knowledge of this unique IRES:hnRNP A1 molecular 
mechanism can pave the way for novel anti-EV71 therapies and treatment.
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574 B Tethered Domains and Flexible Regions in tRNase ZL, the Long Form of tRNase Z
Christopher Wilson1, Emmanuel Chang2, Louis Levinger2
1Brandeis; 2York College of The City University of New York
tRNase Z, a member of the metallo-β-lactamase family, endonucleolytically removes the pre-tRNA 3’ trailer in a 
step central to tRNA maturation.  The short form (tRNase ZS) is the only one found in bacteria and archaebacteria and 
is also present in some eukaryotes. The homologous long form (tRNase ZL), exclusively found in eukaryotes, consists 
of related amino- and carboxy-domains, suggesting that tRNase ZL arose from a tandem duplication of tRNase ZS 
followed by interdependent divergence of the domains. X-ray crystallographic structures of tRNase ZS reveal a 
flexible arm (FA) extruded from the body of tRNase Z remote from the active site that binds tRNA far from the scissile 
bond. No tRNase ZL structures have been solved; alternative biophysical studies are therefore needed to illuminate 
its functional characteristics. Structural analyses of tRNase ZL performed by limited proteolysis, two dimensional gel 
electrophoresis and mass spectrometry establish stability of the amino and carboxy domains and flexibility of the FA 
and inter-domain tether, with implications for tRNase ZL function. 
573 A HIV Nucleocapsid Protein Precursors are Effective Nucleic Acid Chaperone Proteins
Wei Wang1, Mithun Mitra1, Robert Gorelick2, Zhengrong Wu1, Karin Musier-Forsyth1
1Department of Chemistry and Biochemistry, Ohio State Biochemistry Program, Center for Retrovirus 
Research, and Center for RNA Biology, The Ohio State University, Columbus, OH 43210; 2AIDS and Cancer 
Virus Program, SAIC-Frederick, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 
21702
During HIV-1 maturation, Gag is processed by the viral protease at five cleavage sites. Three different forms of nucleocapsid 
protein, NCp15 (NCp9+p6), NCp9 and NCp7 appear successively in this process. Previous work has shown that the virus 
containing NCp15 shows greatly reduced infectivity, while the virus with NCp9 is still infectious.1 These data suggest that 
NCp15 lacks one or more necessary functions during viral infection. Mature NCp7 is a nucleic acid (NA) binding and chaperone 
protein, involved in destabilizing and remodeling NAs during reverse transcription. We hypothesize that HIV-1 NCp15 may be a 
poor chaperone, which may explain why the virus containing NCp15 is not infectious. To test this idea, the chaperone activity of 
NCp7, NCp9 and NCp15 was compared. Gel-shift annealing assays show that NCp15 anneals tRNA to the primer-binding site 
at a similar rate as NCp7, whereas NCp9 is the most robust chaperone protein. Sedimentation assays to measure NA aggregation 
show a similar trend, i.e., NCp9>NCp15~NCp7. Mutating all 8 of the C-terminal acidic residues of NCp15 to Ala improves 
the annealing and aggregation activity of NCp15 to the level of NCp9. NMR chemical shift perturbation results suggest that in 
solution, the p6 domain of HIV-1 NCp15 folds back and interacts with the zinc fingers of NCp7 at residues F16, A25, K33 and 
K38. Our results suggest that this interaction slightly reduces chaperone function. 
Taken together, our data show that HIV-1 NC precursors are effective chaperone proteins and differences in chaperone 
activity do not explain the requirement for NCp15 processing. We also determined that mutations in NCp15, designed to eliminate 
the interaction of the p6 domain with TSG101 or Vpr, failed to rescue viral infectivity. A recent study showed that HIV-1 virions 
containing NCp15 have irregular core structures,2 which may affect reverse transcription and viral replication. It has also been 
reported that NCp15-NA complexes have altered morphology compared to NCp7-NA complexes,3 which may explain the irregular 
cores and the requirement for NCp15 processing. This work has been funded by NCI, contract no.: HHSN261200800001E with 
SAIC-Frederick, Inc.
1. Coren, L. et al. (2007) J. Virol. 81, 10047-10054
2. De Marco, A. et al. (2012) J. Virol. 86, 13708-13716
3. Mirambeau, G. et al. (2006) J. Mol. Biol. 364, 496-511
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576 A Crystal structure of the active conformation of the Shigella flexneri VapC toxin at 1.9 Å 
resolution
Kehan Xu1, Emil Dedic1, Patricia Cob-Cantal1, Christian Dienemann1, Andreas Bøggild1, Kristoffer S. Winther2, 
Kenn Gerdes2, Ditlev Brodersen1
1Centre for mRNP Biogenesis and Metabolism, Department of Molecular Biology and Genetics, Aarhus 
University, Gustav Wieds Vej 10C, Aarhus C, DK-8000, Denmark; 2Centre for Bacterial Cell Biology, Institute 
for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, NE2 4AX, United Kingdom
Toxin-antitoxin (TA) loci have been found in all prokaryotic genomes that have been sequenced to date and typically 
encode two proteins, a toxin that inhibits cell growth and an antitoxin that upon binding its corresponding toxin, neutralizes 
its action [1]. The VapC toxins contain an N-terminal ribonuclease motif belonging to the PilT N-terminus (PIN) domain 
type, harbouring four highly conserved acidic residues known to be essential for metal ion coordination. The toxin VapC 
(MvpT) from the Gram-negative pathogen Shigella flexneri is capable of globally down-regulating translation by specifically 
cleaving initiator tRNAfMet in the anticodon region following release from a tight complex formed with the antitoxin, 
VapB [2]. We have previously determined the crystal structure of the VapC-VapB toxin-antitoxin complex from Shigella 
flexneri [3] and a structure of the isolated form of an archaeal VapC is also available [4]. 
Here, we present the first structure of the active form of VapC from a pathogenic bacterium. Recombinant VapC 
from Shigella flexneri harbouring an active site mutation was overexpressed in Escherichia coli, purified to homogeneity, 
crystallized and the structure was determined at 1.9 Å resolution by x-ray crystallography. Comparison with the antitoxin-
inhibited structure from the VapC-VapB complex [3] reveals that VapC most likely is active as a dimer in which movements 
of two α-helices surrounding the active site create a more compact active site conformation upon release of the antitoxin.
1. Winther, K. S. & Gerdes, K. (2011). Proceedings of the National Academy of Sciences of the United States of America 108, 
7403-7407.
2. Gerdes K, Wagner EG. RNA antitoxins. Curr Opin Microbiol. 2007;10:117–124.
3. Dienemann, C., Boggild, A., Winther, K. S., Gerdes, K. & Brodersen, D. E. (2011). Journal of molecular biology 414, 713-
722
4. Bunker, R. D., McKenzie, J. L., Baker, E. N. & Arcus, V. L. (2008). Proteins 72, 510-518
575 C Poly(A) binding protein 1 and formation of processing bodies in human
Jingwei Xie1, Guennadi Kozlov1, Kalle Gehring1
1Department of Biochemsitry, McGill University
Poly(A) binding protein 1 (PABPC1) is an essential translation initiation factor. PABPC1 circularizes mRNA 
together with mRNA cap binding proteins, bridged by eIF4G. While PABPC1 is found at stress granules and absent 
from processing bodies in human, we find a mechanism how PABPC1 contributes to formation of processing bodies. 
This helps us understand the dynamics of RNA-protein granules. 
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577 B Alanine scanning of the aa-tRNA binding interface of Escherishia coli EF-Tu
Emine Yikilmaz1, Olke Uhlenbeck1
1Northwestern University
The extensive interface formed between EF-Tu and aa-tRNA includes more than 20 amino acid residues that 
are highly conserved among bacteria. In order to evaluate the individual contributions of these residues to the 
thermodynamics of ternary complex formation and their function on the ribosome, 22 point mutations of E. coli EF-Tu 
were prepared that usually changed the native amino acid side chain to alanine. After expression and purification, each 
mutant protein was activated with GTP, bound to aa-tRNA, and the dissociation rate of the complex (koff) determined 
by a ribonuclease protection assay (1).  While nearly all the mutant proteins were able to form a ternary complex, some 
of the EF-Tu residues showed aa-tRNA dependent thermodynamic contributions and many of the residues showed 
decreased binding affinities. The R377A EF-Tu mutant, in which arginine side chain influences secondary structure 
elements around the tRNA interface, has a faster koff for every aa-tRNA tested. In addition, R223A mutation increases 
tRNA affinity for aa-tRNAs, presumably by slowing down the conformational changes that lead to dissociation of 
the ternary complex. Although the effect on binding affinities were quite variable among the different mutations, 
it is striking that the data closely resembles a similar set of data determined for the ternary complex of Thermus 
thermophilus EF-Tu and Phe-tRNAPhe (2). This indicates that the protein-tRNA interfaces from the two bacteria are 
not only similar in sequence, but are similar thermodynamically.
We also studied the performance of these mutant proteins in decoding using ribosomes purified from E. coli (3). 
Except for R223A, most of the mutant proteins are active GTPases. It is possible that removal of R223 side chain 
alters the ribosome binding affinity of the EF-Tu. The ability of each mutant protein to release from aa-tRNA on the 
ribosome after the GTP hydrolysis step was evaluated using the T1 mutant of Tyr-tRNATyr. This tRNATyr variant has an 
altered T-stem that hyperstabilizes binding to native E. coli EF-Tu sufficiently that the rate of peptide bond formation 
(kpep) is extremely slow (4-5). Most of the EF-Tu residues that interact with the 3’-ACCA end and T-stem residues 
of T1 Tyr-tRNATyr are able to stimulate kpep with T1 Tyr-tRNA
Tyr compared to wild type EF-Tu. Thus, by weakening 
binding to aa-tRNA, the EF-Tu mutations are able to overcome the rate limiting block in release of the hyperstabilized 
aa-tRNA from the protein on the ribosome. This suggests that the energetics of the interface between EF-Tu and aa-
tRNA on the ribosome is similar to that of the free ternary complex.
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578 C Evidence of direct complementary binding between mRNAs and cognate proteins
Bojan Zagrovic1, Mario Hlevnjak1, Anton Polyansky1
1Max F. Perutz Laboratories & University of Vienna, Vienna, Austria
The ability to interact with mRNA has recently been reported for many known RNA binding proteins, but 
surprisingly also for different proteins without recognizable RNA binding domains including several transcription 
factors and metabolic enzymes. In particular, direct binding to cognate mRNAs has been detected for various proteins 
creating a strong impetus to search for functional significance and basic physico-chemical principles behind such 
interactions. Here, we bioinformatically compare pyrimidine content of natural mRNA coding sequences with the 
propensity of cognate protein sequences to interact with pyrimidines (1). The latter is captured by polar requirement, 
an experimental measure of amino-acid solubility in aqueous solutions of pyrimidine mimetics pyridines. By analyzing 
proteomes of 15 different species, we find that pyrimidine density profiles of individual mRNAs remarkably mirror 
polar-requirement profiles of cognate protein sequences. For example, 4953 human proteins exhibit a correlation 
between the two with a Pearson coefficient |R|>0.8 (illustrated in Figure 1 for hemoglobin alpha-subunit, ATF3 and 
p53). In other words, pyrimidine-rich regions in mRNAs quantitatively correspond to regions in cognate proteins 
containing amino acids that prefer to interact with pyrimidine mimetics and vice versa. Moreover, by studying 
randomized genetic codes, we show that the natural genetic code is highly optimized to preserve these correlations. 
Finally, we derive interaction preferences between amino acids and RNA bases by analyzing known 3D-structures 
of protein-RNA complexes. Using this tool we both confirm the above findings for pyrimidines and also demonstrate 
an analogous behavior for purines with some exceptions. Overall, our results redefine the stereo-chemical hypothesis 
concerning the origin of the genetic code and provide evidence of direct templating of proteins from mRNAs before 
the development of ribosomal decoding. Moreover, our findings support the possibility of direct complementary 
interactions between mRNAs and cognate proteins even in present-day cells, especially if both are unstructured, with 
potential implications extending to all facets of nucleic acid/protein biology. 
1. Hlevnjak M, Polyansky AA & Zagrovic B, Nucleic Acids Research, 2012, 40: 8874-8882.
Figure 1
Examples of matching between mRNA coding-sequence pyrimidine-density profiles and cognate proteins’ affinity 
profiles for pyrimidine mimetics. All profiles have been smoothed with a window of 21 codons/amino acids. Amino-
acid affinity is defined in thermodynamic sense whereby low values indicate high affinity and vice versa.
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580 B A genome-wide RNAi screen identifies novel 40S ribosome synthesis factors in human 
cells
Lukas Badertscher1, Thomas Wild1, Lukas Bammert1, Michael Stebler2, Andreas Vonderheit2, Christian Montellese1, 
Karol Kozak2, Gábor Csúcs2, Peter Horvath2, Ulrike Kutay1
1Institute of Biochemistry, ETH Zurich, Switzerland; 2Light Microscopy and Screening Centre, ETH Zurich, 
Switzerland
Ribosome biogenesis is a complex, highly compartmentalized process that is assisted by more than 150 non-
ribosomal proteins, known as trans-acting factors. Our current knowledge on ribosome biogenesis mostly derives 
from data in yeast, however little is known about this process in mammalian cells.
To shed light on the cellular repertoire of factors involved in ribosome synthesis in mammals, we have performed 
a genome-wide siRNA screen on 40S subunit biogenesis in HeLa cells using a visual assay relying on RPS2-YFP 
localization as read-out. Our approach allowed us to compile a list of approximately 400 factors that are required for 
biogenesis of the 40S subunit. Among the identified proteins are several expected factors, such as the ribosomal proteins 
themselves, human homologues of yeast ribosome biogenesis factors, as well as splicing factors and nucleoporins. 
In addition, we identify components of the ubiquitin-proteasome system, of various signaling pathways, metabolic 
enzymes and uncharacterized proteins.
Of our follow-up studies, we will present data on two different proteins that had not been previously linked to the 
maturation of ribosomes. One is an uncharacterized protein that we named CRBF1, for which we show that it localizes 
to nucleoli. Depletion of CRBF1 leads to defects in rRNA processing as demonstrated by FISH and Northern blotting 
experiments. Proteomic analysis identified CRBF1 as part of a pre-ribosomal particle, indicating a direct function for 
CRBF1 in ribosome synthesis. The second factor is an enzyme involved in amino acid metabolism that plays a central 
role in cellular energy homeostasis. Its requirement for ribosome synthesis might potentially explain some of the 
specific metabolic needs of cancer cell growth.
579 A Responses of the mRNA interactome to genotoxic stress
Elisabeth Zielonka1, Alfredo Castello1, Benedikt Beckmann1, Rastislav Horos1, Anne-Marie Alleaume1, Claudia 
Strein1, Sophia Foehr1, Bernd Fischer1, Jeroen Krijgsveld1, Matthias Hentze1
1EMBL Heidelberg, Germany
RNA-binding proteins (RBP) play critical roles in stress responses like DNA damage through interactions with 
elements in functionally-related RNAs, called regulons. One of the most cytotoxic forms of DNA damage are DNA 
double strand breaks (DSB), which can cause mutagenic events or even cell death. This project focuses on the plasticity 
of the global RBP network (mRNA interactome) and RNA-regulons of mouse fibroblasts (NIH-3T3 cells) in response 
to genotoxic stress. Using interactome capture [1; 2] and high-resolution proteomics, we will define the RBP´s that 
respond during genotoxic stress. By further employing deep sequencing and crosslink-IP approaches, we will identify 
genotoxic stress RBP targets and assay their influence on cell survival. Taken together, this project aims to address key 
questions of the DNA damage response and the implication of RNA-regulons. 
1. Castello A. et al., Cell 2012, 149 (6)
2. Castello A. et al., Nat Protoc. 2013, 8 (3)
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582 A Dissecting RNA-binding protein complexes
Anne Baude1, Kristin Wächter1, Stefan Hüttelmaier1
1Institute of Molecular Medicine, Division of Molecular Cell Biology, Martin-Luther-University Halle- 
Wittenberg, Halle (Saale), Germany
The cytoplasmic control of mRNAs is essentially facilitated via specific mRNPs expected to comprise transcript 
specific and dynamic subsets of RNA-binding proteins (RBPs). Some of these associate directly with the RNA via 
specific cis-determinants whereas others are expected to associate primarily via protein-association and form only 
transient and potentially unspecific contacts with targeted mRNAs.
The cytoplasmic control of mRNAs is essentially facilitated via specific mRNPs expected to comprise transcript 
specific and dynamic subsets of RNA-binding proteins (RBPs). Some of these associate directly with the RNA via 
specific cis-determinants whereas others are expected to associate primarily via protein-association and form only 
transient and potentially unspecific contacts with targeted mRNAs. 
The RNA-binding protein IGF2BP1 (IGF2 mRNA binding protein) was demonstrated to stabilize the c-myc 
(MYC) mRNA, presumably by associating with a cis-determinant in the coding region of the MYC transcript , the so 
called ‘Coding Region instability Determinant (CRD)’. Moreover, the protein which is also termed ZBP1 (Zipcode 
Binding Protein 1) regulates the spatiotemporal control of b-actin mRNA (ACTB) translation and directs subcellular 
sorting of this transcript at least in primary cells. All these regulatory processes are presumed to be facilitated by a 
number of distinct mRNPs of unknown composition. To reveal how IGF2BP1-associated RBPs modulate the fate of 
ACTB and MYC mRNAs in tumor-derived cells we established an MS2-tethering approach using in vitro transcribed 
RNAs. This allows us to investigate which RBPs associate directly or indirectly with the analysed transcripts. If and 
how identified RBPs modulate the fate of MYC and/or ACTB transcripts is currently analysed by loss-of-function 
analyses (LOF) using shRNA-mediated knockdown. 
581 C Characterization and in vivo functional analysis of the Schizosaccharomyces pombe ICln 
gene
Adrien Barbarossa1, Henry Neel1, Etienne Antoine1, Thierry Gostan1, Johann Soret1, Remy Bordonne1
1Institut de Génétique Moléculaire de Montpellier UMR 5535 CNRS, 1919 route de Mende, Université 
Montpellier 1 et 2, 34293 Montpellier cedex 5, France
Numerous studies indicate that assembly of the eukaryotic spliceosomal snRNPs is a multistep process following 
an ordered pathway. The methylosome and the SMN (Survival of Motor Neuron) complexes are essential players in 
early steps of this pathway. The methylosome, composed by pICln, WD45 and PRMT5 proteins, recruits Sm proteins 
via the pICln subunit and symmetrically dimethylates arginines within the C-tails of Sm proteins. The SMN complex 
further facilitates the loading of Sm proteins onto the snRNAs resulting in the formation of snRNP particles. In these 
early steps, pICln is an important regulator of snRNP assembly since it acts as an assembly chaperone while the SMN 
complex acts as a catalyst.
To expand our understanding of pICln and SMN functional relationships in vivo, we performed a genetic analysis 
of an uncharacterized S. pombe pICln homologue. Although not essential, the S. pombe ICln protein is important 
for optimal yeast cell growth. The human pICln gene complements the icln∆ slow growth phenotype demonstrating 
that the identified SpICln sequence represents the bona fide human homolog. Consistent with the role inferred for 
human pICln using in vitro experiments, we found that the SpICln protein is required for optimal production of the 
spliceosomal snRNPs and for efficient splicing in vivo. Genetic interaction approaches demonstrate furthermore that 
modulation of  ICln activity is unable to compensate for defects induced by SMN mutations, and reciprocally. Using a 
genome-wide approach and RT-PCR validation tests, we show also that splicing is altered differentially in icln∆ cells. 
Our data are consistent with the emerging view that splice site selection and spliceosome kinetics are highly dependent 
on the concentration of core spliceosomal components.
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584 C Ribosomal protein clusters orchestrate the hierarchical construction of eukaryotic large 
ribosomal subunit structural domains in vivo
Michael Gamalinda1, Uli Ohmayer2, Jelena Jakovljevic1, Beril Kumcuoglu1, Philipp Milkereit2, John Woolford, Jr.1
1Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, USA; 2Institut für 
Biochemie, Genetik und Mikrobiologie, Universität Regensburg, Regensburg, Germany
Ribosomes, the protein factories of the cell, are fundamental players that link genotypes with phenotypes. These 
nanomachines are made up of two subunits, each characterized by ribosomal proteins interspersed over a complex lattice 
of the ribosomal RNA (rRNA) core. Biogenesis of ribosomes in eukaryotes begins in the nucleolus with the transcription 
of precursor ribosomal RNA (pre-rRNA). This primary transcript is then modified, processed, folded, and assembled with 
ribosomal proteins, as nascent subunits traffic to the cytoplasm. In yeast, these events require more than 200 trans-acting 
biogenesis factors, which are thought to facilitate alternating cascades of rRNA folding and protein binding.
Assembly of small subunits is better understood relative to large subunits, both in vitro in bacteria and in vivo in 
eukaryotes. Construction of small ribosomal subunits proceeds via the formation of two stable intermediates: the body 
domain is first formed, followed by the creation of the head domain. In eukaryotes, assembly of these structural domains is 
also correlated with early and late pre-rRNA processing steps, respectively. In contrast, description of assembly intermediates 
for eukaryotic 60S subunits has largely been limited to cataloguing their protein composition, and understanding very late 
cytoplasmic steps in subunit maturation. Information on the timing of construction of assembly neighborhoods in pre-60S 
particles, and how this is coupled to protein binding and pre-rRNA maturation remain fragmentary. In this study, we began 
to fill this gap by systematically analyzing the roles of r-proteins in 60S subunit assembly in vivo. 
We show that assembly of eukaryotic large ribosomal subunits proceeds via the formation of three sequential pre-
ribosomal intermediates that correspond to the proper folding and construction of specific neighborhoods in the large subunit. 
The solvent-exposed interface of the large subunit is first stably assembled, followed by the domain surrounding the rim of 
the polypeptide exit tunnel, then finally, the central protuberance and the subunit interface bearing the catalytic center. We 
also discuss how formation of these structural neighborhoods is coupled with catalysis of pre-rRNA processing steps and 
nucleocytoplasmic export, by stable association of critical trans-acting biogenesis factors required for these events. This 
significantly contributes to our understanding of how the large ribosomal subunit and similarly complex ribonucleoproteins 
are put together in living cells.
583 B Reconstitution of the Uridine-rich snRNP Assembly Machinery
Clemens Englbrecht1, Nils Neuenkirchen1, Ashwin Chari2, Jürgen Ohmer1, Utz Fischer1
1University of Würzburg, Biochemistry, Würzburg, Germany; 2Research Group of 3D Electron 
Cryomicroscopy, Max-Planck-Institute for Biophysical Chemistry, Göttingen, Germany
Splicing U snRNPs are the major trans-acting factors of the pre-mRNA processing spliceosome. These factors 
contain a common RNP core composed of seven Sm proteins bound to an snRNA whose assembly is mediated by 
PRMT5 and SMN complexes. Assembly of snRNPs from RNA and protein is an essential pre-requisite for spliceosome 
formation. In vivo, this is facilitated in a highly complex biogenesis pathway. Initially, the snRNA to be assembled 
into an snRNP is exported from its site of transcription to the cytoplasm. Here, the assembly of the Sm proteins onto 
U snRNAs takes place. The snRNP is eventually transported to the nucleus and incorporated into the spliceosome. 
Several groups including ours have identified a unique machinery that assists the assembly of spliceosomal U snRNPs. 
This machinery consists of two cooperating units termed SMN-complex and PRMT5-complex, respectively. While 
the SMN-complex loads Sm proteins onto the snRNA and hence acts as an RNP-assembler, the PRMT5 complex 
functions upstream in this pathway. It acts as an assembly chaperone by forcing Sm proteins into a higher order 
structure (termed 6S complex) required for the subsequent transfer onto the SMN-complex. Here we present the total 
reconstitution of the U snRNP assembly machinery from recombinant sources, which allowed us mechanistic insight 
into its mode of action. The 6S snRNP assembly intermediate forms in a stepwise manner on the PRMT5 complex 
and is, upon completion, displaced by pICln or pICln-Sm complexes, thus allowing a new round of 6S formation. The 
Sm proteins pre-arranged in the 6S complex are then transferred en bloc onto the SMN complex. The SMN complex 
functions as a scaffold that allows a kinetic proofreading and the association of Sm proteins only with cognate RNA 
targets. Reconstituted SMN complex containing the SMN(E134K) missense mutation, which is linked to spinal 
muscular atrophy (SMA), interferes with the RNP-chaperone system and prevents productive U snRNP assembly. 
Our data reveal an elaborate interplay of U snRNP assembly factors and provide new insight into the cellular defects 
in SMA.
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586 B Identification of a chloroplast ribonucleoprotein complex containing trans-splicing 
factors, intron RNAs and novel components
Jessica Jacobs1, Christina Marx1, Vera Kock1, Olga Reifschneider1, Stephanie Glanz1, Ulrich Kück1
1Ruhr-University Bochum, General and Molecular Botany
Chlamydomonas reinhardtii is widely used for analysis of nucleus-encoded factors that are thought to promote 
the maturation of chloroplast precursor RNAs. To elucidate the function and composition of ribonucleoprotein 
complexes that are presumably part of a transcript specific chloroplast spliceosome, we are studying the expression of 
the chloroplast encoded psaA gene [1]. The psaA gene is separated into three exons, which are widely distributed over 
the plastom and flanked by consensus sequences typical for group II introns. The exons are transcribed individually 
and the major transcript is then assembled in trans. Here, we present a novel trans-splicing mutant, which is affected 
in splicing of the first psaA intron. Genomic complementation led to the identification of the mutant gene encoding 
Raa4, a protein of 112.4 kDa, which shares no strong sequence identity with other known proteins [2]. The chloroplast 
localization of Raa4 was confirmed by confocal fluorescence microscopy, using a GFP-tagged fusion protein. RNA 
binding-studies showed that Raa4 binds specifically to domains D2 and D3, but not to other conserved domains of 
the tripartite group II intron. In addition, we used a combined experimental approach including yeast-two hybrid 
screening, tandem affinity purification (TAP) and mass spectrometry to identify putative interaction partners of Raa4.
1. Jacobs J, Glanz S, Bunse-Graßmann A, Kruse O, Kück U (2010) Europ J Cell Biol 89: 932-939
2. Glanz S, Jacobs J, Kock V, Mishra A, Kück U (2012) Plant J 69:421-431
585 A 5’-cytosine methylation of C2278 in 25S rRNA stabilizes 60S ribosomal subunit in yeast
Andriana Halacheva1, Martin Koš1
1Biochemistry Centre, University of Heidelberg
During ribosome biogenesis the eukaryotic ribosomal RNAs are extensively modified at more than 100 sites by 
methylation and pseudouridylation. The direct role of most of these modifications for either the biogenesis, stability 
or activity of the ribosome remains unclear. Among these modification is a highly conserved 5’-methylation of the 
cytosine 2278, located at the base of the helix 71 in the domain IV of the yeast 25S rRNA. The equivalent site is 
methylated in both eukaryotes and prokaryotes, however, its function is unknown. We have identified Rcm1p as 
the long elusive RNA methyltransferase of C2278 in yeast. Deletion of RCM1 gene and/or snR75, snoRNA guiding 
2’-O-ribose methylation of an adjacent G2288, leads to destabilization of 60S ribosomal subunit. SILAC analyses 
confirm partial loss of a group of ribosomal proteins located in the vicinity of the modified residues. SHAPE analyses 
confirm changes in the 25S rRNA conformation of the helix 71 and the surrounding. Our results show that the two 
studied modifications are important for stability of the rRNA structure and interaction with ribosomal proteins. 
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587 C The structural organization of the box C/D sRNP
Audrone Lapinaite1, Bernd Simon1, Frank Gabel2, Magdalena Rakwalska-Bange1, Teresa Carlomagno1
1The European Molecular Biology Laboratory, Heidelberg, Germany; 2Institut de Biologie Structurale, 
Grenoble, France
The post-transcriptional modifications of ribonucleotides occur during the biosynthesis of the RNA in functionally 
important regions and are essential for the structure, folding, stability and functions of the host RNAs [1].
Our research is focused on the most common RNA modification, which is ribose 2’-OH methylation. RNA 
methylation in eukaryots and archaea is mediated by box C/D s(no)RNP complex. The archaeal sRNP complex 
is asymmetric and constituted by three core proteins assembled around small non-coding guide RNA. The gRNA 
contains two similar conserved motifs: box C/D and box C’/D’. The C box (RUGAUAG, being R purine) is close to 
the 5’ end and the D box (CUGA) is near the 3’ end. The related boxes C’ and D’ are in the internal region. The gRNA 
in sRNP forms base pairs with complementary target RNAs and selects the 5th nucleotide upstream from box D for 
methylation [2].
The complex assembly is initiated by L7Ae interaction with the K-turn and K-loop motifs of the box C/D guide 
RNA. Nop5 binds to the preformed L7Ae-RNA core subcomplex and facilitates binding of the Fibrillarin, which is a 
SAM-dependent methyltransferase [3].
Recently, the box C/D sRNP has been crystallized using a symmetric guide sRNA consisting of two separate 
strands, base-paired with the corresponding targets [4]. The structure suggests that the catalytically active complex is 
constituted by two copies of each protein assembled around one molecule of gRNA (~200 kDa) and is consistent with 
the classical mono-RNP model.
Another study demonstrates that the full box C/D sRNP complex is constituted by four copies of each protein and 
two copies of gRNA (di-RNP, ~ 400 kDa). A cross-methylation mechanism, during which the movement of Fibrillarin 
to the substrate-guide double strand facilitates release of one copy of L7Ae, was proposed [5].
Therefore, the assembly architecture and the functional regulation of this important enzyme remain to date 
contradictory.
Here we embark in the structural study of the box C/D sRNP complex from Pyrococcus furiosus in solution with 
a combination of NMR, small angle nuclear scattering (SANS) and restrained molecular modeling. Our study reveals 
a surprising mode of assembly of the complex in solution, which supports the di-RNP hypothesis, while showing a 
substantially different mode of RNA and proteins assembly with respect to that previously published [5]. Our structure 
explains the selectivity of the methylation and turn-over and furthermore provides a structural understanding for the 
asymmetry of the complex in all organisms.
1. Decatur, W. A. & Fournier, M. J. (2002). Trends Biochem.Sci. 27, 344-351.
2. Reichow, S.L. et al. (2007). Nucleic Acids Res 35, 1452-1464.
3. Aittaleb, M. et al. (2003). Nat. Struct. Biol. 10, 256-263.
4. Lin, J. et al. (2011). Nature 469, 559-563.
5. Xue, S. et al. (2010). Mol. Cell. 39, 939-949.
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589 B Characterisation of the human UTP-B complex and its role in ribosome biogenesis
Matthias S. Leisegang1, Carmen Doebele1, Ana S. Ramirez1, Katherine E. Sloan2, Stefan Simm3, Enrico Schleiff3, 
Michael Karas4, Nicholas J. Watkins2, Markus T. Bohnsack1
1Centre for Biochemistry and Molecular Cell Biology, Göttingen University, Göttingen, Germany; 2Institute 
for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne, UK; 3Institute for Molecular 
Biosciences, Goethe University, Frankfurt, Germany; 4Institute of Pharmaceutical Chemistry, Goethe 
University, Frankfurt, Germany
Ribosome biogenesis in eukaryotes requires a multitude of cofactors, many of which are recruited as pre-assembled 
modules. This has been analysed best for the assembly of early 90S pre-ribosomal intermediates in yeast, where 
several subcomplexes and RNPs assemble co-transcriptionally on the pre-rRNA. Among them is the UTP-B complex, 
which in yeast consists of six proteins, Pwp2, Dip2/Utp12, Utp6, Utp13, Utp18, and Utp21.
We are studying the roles of RNA helicases and other cofactors in ribosome biogenesis. Using affinity purification 
and mass spectrometry to analyse the composition of the human UTP-B complex, we identified homologues of yeast 
UTP-B proteins as well as candidates for human-specific components of the complex. Among them is the DEAD-
box RNA helicase DDX21, for which we have identified putative binding sites on pre-rRNA using UV Crosslinking 
and Analysis of cDNA (CRAC) and deep sequencing. Interestingly, the potential interaction sites of DDX21 map to 
rRNA sequences of both the small and the large ribosomal subunit and some of the crosslinking sites cluster in the 3D 
structure of the ribosome. Preliminary results suggest a role of DDX21 in the regulation of snoRNP binding to pre-
ribosomal complexes and it might have other roles in ribosome synthesis.
Taken together, we show that the human UTP-B complex has acquired additional components compared to its 
yeast counterpart, enabling it to perform more extensive functions in ribosome biogenesis.
588 A Budding yeast telomerase RNA: Zooming in for more definition of a large RNA.
Nancy Laterreur1, Isabelle Dionne2, Jean-François Noël2, Stephanie Larose2, Raymund Wellinger3
1Unviersité de Sherbrooke; 2Université de Sherbrooke; 3Unviersité de Sherbrooke
Budding yeast telomerase RNA: Zooming in for more definition of a large RNA.
The RNA components of telomerases appear to be subject to extremely rapid evolution. For example, RNA 
transcription and maturation pathways vary widely and the RNA cannot easily be grouped with others. We showed 
that the budding yeast telomerase RNA, called Tlc1, can be classified as a snRNA. Not only is the 5’-TMG cap and 
a passage through the nucleolus fitting that model, we determined that the 3’-termination pathway is dictated by the 
classical non-coding RNA termination factors Nrd1 and Nab3 at sites near the mature polyA- 3’-end of the RNA. In 
order to understand its biology better, we also began investigating the transcriptional control of the Tlc1 RNA. Guided 
by phylogenetic comparisons, we discovered canonical SCB boxes in the promoter and a series of heterologous gene 
expression experiments demonstrate that these short sequence elements can be functional for directing cell cycle 
controlled transcription. Targeted mutagenesis of the SCB has functional consequences such as reduced levels of the 
RNA and short telomeres. Finally, using a tagged version of Tlc1 as target, RNA mediated ChIP experiments show a 
clear induction of transcription at the end of G1 of the cell cycle. We therefore hypothesize that the telomerase RNA, 
just as the RNA encoding Est1p, is made specifically at the entry of S-phase, together with a number of S-phase 
specific genes. 
I will also present our investigations on a sub-structure in Tlc1 that has as of yet unknown functions. This approach, 
again based on phylogenetic comparisons, uncovered a new conserved substructure that we call CS2a on the stem-
loop (SL) IVc. It is near an area shown to be involved in the binding of Est1p and therefore could be intimately 
associated with telomerase-telomere interactions. Indeed, targeting this new CS2a element by mutagenesis yielded 
evidence for loss of telomerase function in vivo. This effect can be explained by a loss of Est1-binding and therefore is 
Est1p-dependent. Surprisingly however, specific mutations that should only affect the predicted distal structure of SL 
IVc, but not Est1p-association, strongly affected catalytic telomerase activity. Using strains that carry a deletion of the 
EST1 gene, we were able to conclude that this new function of the distal area in SL IVc we call TeSS, for Telomerase 
Stimulating Structure, indeed is Est1p-independent. I will present our description of the molecular functions of TeSS 
and hypothesize that this substructure may be a new commonality between all telomerase RNAs. 
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592 B Structural basis of Brr2-Prp8 interaction and its implications for Retinitis Pigmentosa 
disease type 13 and U5 snRNP biogenesis
Thi Hoang Duong Nguyen1, Jade Li1, Wojciech P Galej1, Hiroyuki Oshikane1, Andrew J Newman1, Kiyoshi Nagai1
1MRC - Laboratory of Molecular Biology
U5 small nuclear ribonucleoprotein particle (U5 snRNP) is one of the five canonical subunits of the spliceosome 
and three of its protein components, Brr2, Prp8 and Snu114, play a crucial role in the formation of the spliceosome’s 
active site. Brr2 is a Ski2-like helicase (246 KDa in yeast), which disrupts the extensively basepaired U4/U6 snRNA 
duplex and allows U6 snRNA to engage in an intricate RNA interaction network that forms the active centre of the 
spliceosome. Here we present the structure of yeast Brr2 in complex with the Jab1/MPN domain of Prp8, which has 
been shown to stimulate Brr2 helicase activity [1]. The residues in the Jab1/MPN domain, whose mutations in human 
cause the degenerative eye disease Retinitis Pigmentosa type 13 (RP13), are found at or near the interface with Brr2, 
providing crucial insights into the molecular pathology of RP13. In the cytoplasm Prp8 forms a precursor complex 
with U5 snRNA, seven Sm proteins, Snu114 and Aar2 but after nuclear import Brr2 replaces Aar2 to form mature U5 
snRNP [2]. Together with the recent structure of Prp8885-2413-Aar2 complex [3], our structure provides important insight 
into U5 snRNP biogenesis.
1. Maeder, C., Kutach, A. K. & Guthrie, C. ATP-dependent unwinding of U4/U6 snRNAs by the Brr2 helicase required the 
C-terminus of Prp8. Nat. Struct. Mol. Biol. 2009; 16: 42-8.
2. Boon, K. L. et al. Prp8 mutations that cause human retinitis pigmentosa lead to a U5 snRNP maturation defect in yeast. 
Nat. Struct. Mol. Biol. 2007; 14: 1077-83. 
3. Galej, W. P., Oubridge, C., Newman, A. J., and Nagai, K. Crystal structure of Prp8 reveals active site cavity of the 
spliceosome. Nature 2013; 493: 638-43.
590 C Messenger Ribonucleoprotein Assembly Requires the DEAD-box Protein Dbp2 and 
Enzymatic Modulation by Yra1
Wai Kit Ma1, Sara Cloutier2, Elizabeth Tran2
1Department of Biochemistry, Purdue University, West Lafayette, Indiana.; 2Department of Biochemistry, 
Purdue University, West Lafayette, Indiana
Eukaryotic gene expression involves numerous biochemical steps that are dependent on RNA structure 
and ribonucleoprotein (RNP) complex formation. DEAD-box RNA helicases are one class of enzymes that play 
fundamental roles in RNA and RNP structure in all aspects of RNA metabolism. However, the precise biological roles 
for the vast majority of these enzymes are not fully understood. 
In an effort to define the biological roles of DEAD-box proteins, our laboratory recently provided evidence that 
the DEAD-box protein Dbp2 functions in nuclear gene expression steps in Saccharomyces cerevisiae. Moreover, our 
studies showed that Dbp2 is an enzymatically active ATPase in vitro that is required for both repression of aberrant 
initiation and proper transcription termination. Furthermore, we found that Dbp2 associates with transcriptionally active 
chromatin, suggesting that this enzyme functions in co-transcriptional mRNP assembly. We now provide evidence 
that DBP2 interacts genetically and physically with the mRNA export factor Yra1. In addition, we find that Dbp2 is 
required for in vivo assembly of mRNA-binding proteins Yra1, Nab2 and Mex67 onto poly(A)+ RNA. Strikingly, 
to uncover the biochemical mechanism, we find that Dbp2 displays strong annealing activity at levels higher than 
any other published DEAD-box proteins to date.  Yra1 controls this activity by inhibiting duplex unwinding without 
decreasing ATP hydrolysis activity. Here, we will present evidence that Dbp2 functions as an mRNA chaperone, 
constituting a previously unrecognized mechanism for co-transcriptional assembly of mRNPs in the nucleus. 
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594 A Implication of the SMN complex in the biogenesis and steady state level of the Signal 
Recognition Particle
Nathalie Piazzon1, Florence Schlotter1, Suzie Lefebvre4, Maxime Dodré1, Agnès Mereau2, Johann Soret3, Aurore 
Besse5, Martine Barkats5, Rémy Bordonné3, Séverine Massenet1 , Christiane Branlant1
1CNRS-Université de Lorraine; 2CNRS-Université de Rennes1; 3CNRS-Université Montpellier I and II; 
4CNRS-Université Paris Diderot; 5INSERM-CNRS-Institut de Myologie-Université Pierre et Marie Curie-
Paris
Spinal muscular atrophy is a severe motor neuron disease caused by reduced levels of the ubiquitous SMN 
protein. SMN is part of a complex that is essential for spliceosomal UsnRNP biogenesis. Signal Recognition Particle 
(SRP) is a ribonucleoprotein particle crucial for cotranslational targeting of secretory and membrane proteins to the 
endoplasmic reticulum. SRP biogenesis is a nucleo-cytoplasmic multistep process in which the protein components, 
except SRP54, assemble with 7S RNA in the nucleolus. Then, SRP54 is incorporated after export of the pre-particle 
into the cytoplasm. The assembly factors necessary for SRP biogenesis remain to be identified. Here, we show that 7S 
RNA binds to purified SMN complexes in vitro and that SMN complexes associate with SRP in cellular extracts, and 
we identified the RNA determinants required. Moreover, we report a specific reduction of 7S RNA levels in the spinal 
cord of SMN-deficient mice, and in a S. pombe strain carrying a temperature-degron allele of SMN. Additionally, 
micro-injected antibodies directed against SMN or Gemin2 interfere with the association of SRP54 with 7S RNA in 
X. laevis oocytes. Our data show that reduced levels of the SMN protein lead to defect in SRP steady-state level and 
describe the SMN complex as the first identified cellular factor required for SRP biogenesis. 
593 C Surveillance of spliceosomal snRNP assembly in the cell nucleus
Ivan Novotny1, Daniel Mateju1, Martin Sveda2, Zdenek Knejzlik2, David Stanek1
1Department of RNA Biology, Institute of Molecular Genetics ASCR, Prague, Czech Republic; 2Department 
of Biochemistry and Microbiology and Center of Applied Genomics, Institute of Chemical Technology, 
Prague, Czech Republic
Assembly of spliceosomal snRNPs and their incorporation into the spliceosome has been well described. Here, we 
provide evidence about a surveillance pathway that detects snRNP assembly intermediates and sequesters them in a 
nuclear structure called the Cajal body. We inhibited different stages of tri-snRNP assembly and in all cases observed 
retention of immature snRNP complexes in Cajal bodies. Next, we show that the protein SART3 is essential for 
targeting and retention of non-assembled snRNPs in Cajal bodies. We provide evidence that SART3 associates with 
U4 and U6 snRNPs as well as with coilin, a building protein of Cajal bodies. SART3 thus represents the factor that 
interacts with non-assembled snRNPs and anchors them in Cajal bodies. In addition, depletion of SART3 sensitizes 
cells to inhibition of snRNP formation, which provides a functional significance for surveillance pathway. Finally 
we show that Cajal bodies are inducible structures and inhibition of snRNP assembly stimulates formation of Cajal 
bodies in primary fibroblasts that normally lack Cajal bodies. Surprisingly, induced Cajal bodies accumulate only 
those snRNPs whose assembly pathway was perturbed, which provides the first evidence that individual metabolic 
pathways that concentrate in Cajal bodies are independent. 
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596 C The 5S RNP couples ribosome production to p53 regulation
Katherine Sloan1, Nicholas Watkins1
1Newcastle University
Ribosomopathies, including Diamond Blackfan anemia and Treacher Collins syndrome, are genetic diseases 
caused by defects in ribosome biogenesis. In several of these ribosomopathies, activation of the tumour suppressor p53 
in response to impaired ribosome production plays an important pathogenic role. Paradoxically, many ribosomopathies 
are also associated with cancer predisposition. It is proposed that when ribosome biogenesis is blocked, two ribosomal 
proteins, RPL5 and RPL11, function to activate p53. RPL5 and RPL11, together with the 5S rRNA, form the 5S RNP, 
an essential sub-complex of the large ribosomal subunit (LSU). Both RPL5 and RPL11 bind to and inhibit HDM2, 
the E3 ubiquitin ligase that targets p53 for degradation. Conflicting reports suggest that RPL5 and RPL11 function 
either together or independently to repress HDM2. Furthermore, it is currently unclear whether the third component 
of the 5S RNP, the 5S rRNA, also plays a role in this process. Indeed, mechanistic insight into 5S RNP formation, its 
integration into the ribosome, and how this is coupled to p53 regulation is lacking in human cells.
Here we show that the 5S rRNA, as well as RPL5 and RPL11, is indeed required for p53 activation when ribosome 
biogenesis is blocked. In addition, the whole 5S RNP complex is required for p53 homeostasis in normal cells. 
We find that the levels of free, non-ribosomal 5S RNP in the nucleoplasm correlate with the amount of p53 in the 
cell. Indeed, our data indicate that factors that regulate 5S RNP formation, its nucleolar retention/localisation and its 
integration into the ribosome, determine the amount of free complex that can interact with and regulate HDM2 in the 
nucleoplasm. For example, knockdown of the human ribosome biogenesis factors RRS1 or BXDC1 inhibits 5S RNP 
nucleolar localisation and causes p53 activation. Furthermore, the known tumour suppressors, PICT1 and PAK1IP1, 
that both regulate p53, are in fact essential LSU biogenesis factors and PICT1 is needed for 5S RNP recruitment into 
the ribosome.
Following oncogene overexpression p14ARF inhibits ribosome biogenesis and activates p53 by repressing HDM2. 
We show that all three components of the 5S RNP are required for p14ARF mediated activation of p53. This provides 
evidence that blocking ribosome production is important for the cellular response to oncogene misregulation. Our data 
therefore reveal that the assembled 5S RNP complex, rather than its individual components, is a critical modulator of 
multiple signalling pathways coupling the regulation of cellular proliferation to ribosome biogenesis.
595 B The rRNA methyltransferase Bud23 interacts with the DEAH-box RNA helicase Ecm16 to 
promote cleavage at A2
Richa Sardana1, Arlen Johnson1
1The University of Texas at Austin
The small ribosomal subunit assembles co-transcriptionally on the nascent primary transcript. Early processing 
events at A0, A1 and A2 require U3 snoRNA in the context of the SSU Processome. Cleavage at site A2 releases the pre-
40S particle from the primary transcript. We previously identified Bud23 as a conserved eukaryotic methyltransferase 
responsible for the base modification G1575 in yeast (G1338 in bacteria) and more recently we have found that 
Bud23 is required for efficient cleavage at A2. Here, we report that Bud23 interacts with the DEAH-box RNA helicase 
Ecm16 (Dhr1). Ecm16 has previously been implicated in cleavages at A2 and, to a lesser degree, at A1. RNA helicases 
often require protein cofactors to provide substrate specificity and these interactions are typically through the N- or 
C-terminal domains of helicases that extend beyond their catalytic cores. We used yeast 2-hybrid analysis to map 
the binding site of Bud23 to the N-terminal extension of Ecm16. To characterize the particle that Ecm16 acts on, we 
used a catalytically inactive Ecm16 mutant. Whereas wild-type Ecm16 does not stably associate with preribosomal 
particles, this mutant does and sediments at approximately 40S. Immunoprecipitation of this mutant reveals a striking 
accumulation of 21S rRNA and contains U3 snoRNA, Mpp10 and Bud23 among others. 21S rRNA has undergone 
cleavage at A1 and A3 but not A2. As U3snoRNA is required for cleavages at A0, A1 and A2 these results show that 
the cleavage pathway has been arrested before A2 cleavage. The accumulation of Mpp10 and Bud23 in the arrested 
Ecm16 particle is reflected in the altered sedimentation of these proteins, now cosedimenting with Ecm16 at ~40S. 
These results imply that Bud23 enters the preribosomal particle while U3 is present and shortly before cleavage at 
A2. Although Bud23 binding is important for 40S biogenesis, its methyltransferase activity is not. We propose that 
Bud23 recognition of its binding site signals completion of folding of the major domains of the small subunit, coupling 
Ecm16 activity to assembly status of the subunit. 
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598 B The Ribosome-OME I: Big Data & the Ribosome
Jonathan R Warner1, Varun Gupta1
1Department of Cell Biology, Albert Einstein College of Medicine, Bronx, NY 10461
Ribosomes are abundant.  Each contains one copy of each of 80 ribosomal proteins (RPs).  Therefore, to a first 
approximation one might expect cells to live with equal numbers of the mRNAs for each of the RPs.  The massive 
transcriptome data for human cells and tissues provides an opportunity to test this assumption. Yet, this expectation 
has not been satisfied, due in large part to the following problem: each authentic RP gene is diluted by an average of 
20 pseudo-RP genes1, nearly perfect cDNA copies presumably inserted into the genome during the abundant ribosome 
synthesis of oogenesis.  Thus mapping the reads of an RNA-seq analysis against the genome leads to many ambiguous 
identities.  While the various mapping programs deal with this problem in different ways, the result is often an unreliable 
measure of the actual value, sometimes suggesting 100-fold differences in the level of mRNA for the different RPs.
Modifying the usual mapping systems to provide more accurate assessment of the actual values of RP mRNAs led 
us to two observations: I) there is substantial variation of the abundance of any given RP mRNA among different cell 
types, and even among different determinations on the same cell type, e.g., from the ENCODE consortium. II) there is 
a reproducible difference between the mRNA levels for different RPs, but only over a ~five-fold range.  Nevertheless, 
this result suggests either a substantial regulation of translational rate AND/OR an overexpression of many RPs, with 
rapid degradation of the excess, as has been recently suggested2.
An interesting example is RPL41, that encodes a protein of 24 AA, 17 of which are R or K. It consistently has 
more mRNA than any other RP.  Is this because the efficiency of translation on monosomes is low, or because of the 
concentration of basic amino acids leads to slow translation.3
Supported by NIGMS  RO1 25532
RNA-seq data for multiple tissues was kindly provided by the Gene Expression Applications research group at 
Illumina, Inc.
1 Balasubramanian et al Genome Biology, 10:R2, 2009
2 Lam, Lamond, Mann, & Anderson  Current Biology 17, 749, 2007
3 Charneski & Hurst   PLoS Biology 11, e1001508, 2013
597 A Dissecting the splicing-dependent mRNA binding of ASAP complexes
Anna-Lena Steckelberg1, Niels H. Gehring1
1Institute for Genetics, Cologne
The exon-junction complex (EJC) is a multi-protein complex, which is deposited on the mRNA by the spliceosome. 
It binds in a sequence-independent manner 20-24 nucleotides upstream of an exon-exon junction. The EJC core 
consists of four different proteins: eIF4A3, MAGOH, Y14 and Barentsz (Btz). This core complex serves as a binding 
platform for many associated proteins referred to as peripheral EJC components. Within the peripheral EJC, the 
proteins RNPS1, Acinus and SAP18 form a stable trimeric sub-complex, the ASAP complex. The recently solved 
crystal structure of the ASAP complex reveals how RNPS1, Acinus and SAP18 interact in vitro. However, it remains 
elusive how the ASAP complex assembles in living cells and which factors mediate its interaction with spliced mRNA 
and the EJC core.
We studied ASAP complex assembly in cell extracts with a combination of co-IP experiments and in vitro splicing 
assays. Using deletion mutants, we defined domains of RNPS1 and Acinus that are required for ASAP complex 
formation and mRNA interaction. Furthermore, we identified single point mutations of RNPS1, Acinus and SAP18 
that partially or completely disrupt the ASAP complex and analyzed their capability to bind mRNA. Interestingly, 
formation of the trimeric complex is a prerequisite for the interaction with spliced mRNA and its bound protein 
complexes. The molecular basis of the interaction between ASAP complex and EJC is currently further characterized. 
Taken together, our data suggest that interactions of EJCs and ASAP complexes contribute to the assembly of 
splicing-dependent mRNPs.
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600 A PX1 regulates protoxylem cell fate via RNA processing
Kamil Ruzicka1, Ana Campilho3, Sedeer El-Showk3, Dominique Eeckhout4, Geert De Jaeger4, Jan Hejatko2, Mikko 
Frilander3, Yka Helariutta3
1CEITEC Masaryk University, Brno, Czech Republic, Institute of Biotechnology, Helsinki, Finland; 2CEITEC 
Masaryk University, Brno, Czech Republic; 3University of Helsinki, Finland; 4VIB, Gent, Belgium
Plant hormones cytokinin and auxin have been established as essential regulators of Arabidopsis vascular cell 
fate. Protein AHP6, a member of cytokinin transduction cascade, has been demonstrated to play a critical role during 
protoxylem development. In order to put AHP6 protein in a broader functional context, we made genetic screen, using 
AHP6prom:GFP as a marker of cytokinin activity in the protoxylem cells. 
We isolated mutant px1, which shows a decreased AHP6prom:GFP activity, accompanied with aberrant protoxylem 
formation and altered hormonal responses. PX1 codes for a weak allele of an embryonic lethal gene (EMB2016) which 
is, based on homology to known Drosophila proteins, involved in RNA processing, however with unclear function. 
In order to elucidate the molecular role of EMB2016 complex, we made a tandem affinity purification (TAP) 
experiment. We identified homologs of EMB2016 interactors known from Drosophila, underlying the evolutionarily 
conserved character of the EMB2016 module, and mRNA adenine modifying enzyme, showing thus a novel functional 
link in this respect. An extensive phenotype analysis confirmed functional relevance of these interactions. In addition, 
transcriptional profiling revealed broad changes in auxin and cytokinin responsive genes expression in the px1 genetic 
background.
In summary, we demonstrate the importance of adenine modifications in mRNA within the framework of hormonal 
regulations and developmental processes.
599 C Cytoplasmic RNA regulatory networks orchestrate male gametogenesis
Ryuji Minasaki1, Christina Hirsch1, Christian Eckmann1
1Max Planck Institute for Molecular Cell Biology and Genetics (MPI-CBG)
Tissue and organ formation requires the generation of complex protein expression patterns. Regulated protein 
synthesis, in the form of cytoplasmic post-transcriptional mRNA regulation, is a powerful mechanism to shape 
protein gradients across cells and tissues in space and time. Translational control is vital during metazoan germ cell 
development and early embryogenesis. Our past research was devoted to elucidating the molecular mechanisms of 
germ cell development in Caenorhabditis elegans. We primarily focused on the regulation of the tumor suppressor 
GLD-1, itself an RNA-binding protein and translational repressor. While GLD-1 protein expression is essential for 
female meiosis and gld-1 mRNA regulation is a paradigm of translational control, loss of gld-1 expression has no 
impact on male germ cell development. However, by studying the RNA regulatory network in males, we discovered 
essential and novel roles of highly conserved RNA-modifying enzymes and RNA-binding protein families.
A pivotal mechanism of translational control is anchored around the poly(A) tail, which influences mRNA 
stability and ribosomal engagement. Two opposing forces, deadenylases and non-canonical poly(A) polymerases, 
are envisioned to dynamically regulate poly(A) tail lengths in the cytoplasm, as a consequence of mRNA-associated 
factors, such as CPEBs. By focusing on male meiosis, we identified an intricate RNA regulatory web built of all 
four encoded CPEBs, which interface with two distinct cytoplasmic poly(A) polymerases, GLD-2 and GLD-4, and 
members of the PUF (Pumilio/FBF) protein family. Importantly, the process of meiotic chromosome segregation in 
most species is different between male and female germ cells. We find that these conserved sex-specific differences 
are reflected in a rewiring of the poly(A) tail control network in male vs. female germ cells to achieve gamete-specific 
gene expression. I will present our biochemical, genetic and cell biological data that reveal spatially and temporally 
resolved activities of all four CPEBs as master regulators of male germ cell development.
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602 C Insights into the nuclear mRNA export machinery of Trypanosoma brucei
Anna Dostalova1, Sandro Käser2, Marina Cristodero3, Bernd Schimanski1
1Department of Parasitology, Faculty of Science, Charles University of Prague, Czech Republic; 2Department 
of Chemistry and Biochemistry, University of Bern, Bern, Switzerland; 3Institute of Cell Biology, University 
of Bern, Bern, Switzerland
Trypanosoma brucei is a unicellular protist parasite causing devastating diseases such as human sleeping sickness and 
Nagana in sub-Saharan Africa. Trypanosomes diverged early in evolution and show significant differences in their gene 
expression compared to higher eukaryotes. For instance, due to a lack of individual gene promoters, large polycistronic 
pre-mRNA molecules are transcribed from which individual mRNAs mature by trans-splicing and polyadenylation. In the 
absence of transcriptional control, regulation of gene expression occurs on the post-transcriptional level mainly by control 
of transcript stability and translation. We are investigating the process of nuclear mRNA export as a potential additional 
way of post-transcriptional gene regulation in T. brucei. The active translocation of mature mRNA from the nucleus to 
the cytoplasm is well understood in higher eukaryotes ranging from yeast to human - model organisms belonging to the 
eukaryotic supergroup of Opisthokonta. Their export factors such as the TREX complex and the export receptor Mex67-
Mtr2 are well described and appear to be highly conserved. Trypanosomes are members of the supergroup of Excavata and 
the high divergence between Opisthokonta and Excavata makes it difficult to identify orthologous export factors based on 
sequence similarity. Hence, biochemical approaches are needed to identify the export machinery of the parasites. One of 
the few conserved factors are the orthologs of yeast Mex67 and Sub2. Here, we report the functional characterization of 
TbMex67. RNAi mediated downregulation of TbMex67 affects cell growth and leads to a nuclear retention of bulk mRNA. 
In contrast to all known orthologs, Mex67 of kinetoplastid species including T. brucei and other important pathogens 
like T. cruzi and Leishmania spp. contains a N-terminal zinc finger motif. We show that this parasite-specific feature is 
indispensable for the function of TbMex67. Overexpression of mutated versions of TbMex67 causes a dominant negative 
effect indicating that essential interacting proteins are sequestered. We used tandem affinity purification of PTP-tagged 
TbMex67 to identify such proteins and isolated two candidates that are essential for mRNA export as well. TbMtr2 interacts 
with TbMex67 to form the stable export receptor Mex67-Mtr2. TbIMP1 in contrast, belongs to the family of importins and 
is required for shuttling of TbMex67. Our data show that the heterodimeric export receptor is conserved throughout the 
eukaryotic kingdom. However, the zinc finger motif is unique to kinetoplastids and may play a parasite specific role.
601 B Hepatitis B virus post-transcriptional element promotes mRNA export via the cellular 
mRNA export machinery TREX
Binkai Chi1, Hong Cheng2
1Institute of Biochemistry and Cell Biology; 2State Key Laboratory of Molecular Biology, Institute of 
Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 
Shanghai 200031, China
In eukaryotes, mRNA export factors are recruited to intron-containing mRNA during splicing, but recruited 
to intronless transcript probably via specific cis-elements.  Hepatitis B viral RNAs are unspliced RNAs that are 
exported dependent on post-transcriptional element (PRE).  However, the mechanism for PRE-mediated mRNA 
export is still unclear.   We found that PRE drastically enhances cytoplasmic accumulation and expression of cDNA 
transcipts.  Systematic deletion analysis indentified two ~100 nt minimum sub-elements in PRE.   MS2-MBP affinity 
purification of proteins bound to these subelements identified TREX components as well as several TREX-associating 
RNA-binding proteins.  Consistent with this result, TREX components efficiently and specifically associate with in 
vitro transcribed PRE, and this association is both cap- and ATP-dependent.    Importantly, knockdown of TREX 
components and the mRNA export receptor TAP inhibited PRE-mediated mRNA export.   Furthermore, by comparison 
of two functional sub-elements, we identified a 12 nt consensus motif which was sufficient to promote mRNA export 
when multimerized.  Together, our results indicate that PRE enhances the export of intronless mRNA by recruiting 
TREX.  Our study suggests that HBV RNAs competes with cellular mRNAs for cellular mRNA export proteins, 
facilitates viral RNA export and simultaneously inhibits cellular mRNA export. 
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604 B Growth cone local mRNA translation of nuclear proteins in the spatio-temporal regulation 
of neurite outgrowth
Francesca Moretti1, Olivier Pertz1
1Department of Biomedicine, University of Basel
Neuronal cells exploit local mRNA translation to regulate crucial processes such as neuronal survival, axon 
pathfinding and synapse formation. Local translation and retrograde transport of transcription factors emerges as a 
new paradigm to regulate nuclear gene expression in response to signaling events at distal ends of axons and dendrites. 
We identified a panel of mRNAs that encode nuclear proteins in growth cones of extending neurites (protrusions that 
are the precursors of axons and dendrites), suggesting that an analogous paradigm might also operate at the very initial 
phases of neuronal differentiation. We present results on a growth cone localized mRNA encoding a histone-interacting 
protein with a described role in transcriptional regulation. We show that the knock-down of this mRNA in neuronal 
cells induces transcriptional changes and impairs neurite outgrowth. Conversely, the overexpression of the encoded 
protein induces robust neurite outgrowth. Interestingly, the overexpression phenotype is strictly dependent on the 
presence of the mRNA 3’UTR, which we identified as a determinant that mediates growth cone mRNA localization. 
We are currently testing whether this protein is locally synthesized in growth cones and retrogradely transported to the 
cell nucleus. Our initial results suggest that local mRNA translation of a histone-interacting protein might serve as a 
mechanism to couple the dynamic neurite outgrowth process with transcriptional regulation in the nucleus. 
FM acknowledges support from a long-term EMBO postdoctoral fellowship.
603 A Assembly of TREX complex components on mRNAs
Agnieszka M. Gromadzka1, Niels Gehring1
1Institute for Genetics, University of Cologne, Germany
After their transcription in the nucleus, mRNAs are exported to the cytoplasm as ribonucleoprotein complexes 
(RNPs). Correctly processed mRNAs associate with a varying set of adaptor proteins that eventually direct the 
recruitment of the general export receptor NXF1. Although many studies have been carried out on export adaptors, 
the exact determinants for the interaction of the mammalian export machinery with export competent mRNAs remain 
unclear.
Here, we analyze the recruitment of the export factors UAP56, DDX39 and ALYREF using in vitro spliced 
mRNAs. Surprisingly, no preferential interaction of UAP56, DDX39 and ALYREF with spliced mRNAs was detected. 
While all three factors favor an association with the 5’ end of spliced and non-spliced mRNAs, a contribution of exon 
junction complexes and 3’ sequences to the RNA-binding of UAP56, DDX39 and particularly ALYREF could be 
detected. Hence, the cooperative interaction of export factors with exon junction complexes on mRNA with multiple 
introns may explain the preferential export of spliced mRNAs.
This study provides insights into the process of mammalian mRNA export and its dependence on splicing and the 
presence of exon junction complexes. Next, we aim to define the hierarchy of export adaptor recruitment leading to 
the efficient export of mammalian mRNAs.
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605 C Genome-wide identification of mRNAs associated with Survival of Motor Neuron proteins 
and whose axonal localization is decreased upon SMN deficiency
Florence Rage1, Nawal Boulisfane1, Rihan Khalil1, Henry Neel1, Thierry Gostan1, Remy Bordonne1, Johann Soret1
1CNRS
Spinal Muscular Atrophy is a neuromuscular disease resulting from mutations in the SMN1 gene which encodes 
the Survival Motor Neuron (SMN) protein. SMN is part of a large complex that is essential for the biogenesis of 
spliceosomal small nuclear RNPs. Using SMA animal models, it has been reported that SMN deficiency, similar to 
that occurring in severe SMA, alters the stoichiometry of snRNAs and causes widespread pre-mRNA splicing defects 
in numerous transcripts of diverse genes (1, 2). However, whether the specific degeneration of motor neurons is caused 
by one or more aberrantly spliced transcript or by the cumulative effect of numerous splicing alterations remains to be 
determined. SMN also colocalizes with mRNAs in granules that are actively transported in neuronal processes and it 
was recently shown that SMN knockdown results in a reduction of poly(A) mRNA levels in the axonal compartment 
of primary motor neurons (3), suggesting thereby that SMN-containing complexes might be involved in the axonal 
localization of a large number of mRNAs. However, the full repertoire of SMN-associated RNAs has not yet been 
characterized.
To address this question, we have used murine motor neuron-like NSC-34 cells and RNA Immuno-Precipitation 
experiments coupled to microarray analyses (RIP-Chip) to perform a genome-wide analysis of RNA species present 
in mRNP complexes containing either the full length SMN protein (fl-SMN) or a recently described truncated axonal 
form (a-SMN). This approach allowed us to identify distinct but overlapping subsets of mRNAs associated with fl-
SMN and a-SMN. Combination of fluorescent in situ hybridization (FISH) and immuno-fluorescence (IF) experiments 
indicated that several mRNAs colocalize with the SMN proteins in neurites and axons of differentiated NSC-34 cells. 
Interestingly, the axonal localization of some of these mRNAs is affected in SMN-depleted cells, suggesting that 
SMN-deficiency could result in the mislocalization of numerous mRNPs required for axonogenesis.
1. Gabanella et al. (2007) PLoS ONE 2, e921.
2. Zhang et al. (2008) Cell 133: 585–600.
3. Fallini et al. (2011) J. Neurosci. 31: 3914–3925.
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606 A Tetramolecular Fluorescence Complementation for Detection of Specific RNAs in Vitro
Anna K. Rath1, Stefanie J. Kellermann1, Andrea Rentmeister1
1University of Hamburg, Institute of Biochemistry and Molecular Biology, Martin-Luther-King-Platz 6, 
20146 Hamburg, Germany
Asymmetric localization of mRNA is a mechanism to regulate gene expression spatially as well as temporally and 
contributes to many important developmental processes. To study localization mechanisms various probes for RNA 
imaging have been established. These probes can be nucleic acid- or protein-based and give a characteristic fluorescent 
signal upon binding to target RNAs. Still, nucleic acid-based probes–e. g. molecular beacons or forced intercalation 
probes–cannot be produced inside cells, complicating in vivo imaging.1 Protein-based probes fused to split fluorescent 
reporters can be expressed by the cellular machinery. Sequence-specific binding of proteins to their target RNA and 
subsequent reconstitution of the fused fluorescent reporter allow RNA detection. However, the traditional fluorescent 
reporters based on split-GFP are large and self-assemble spontaneously, causing significant background.2 
To circumvent these limitations we used a three-body split-GFP and developed a reporter system for detection of 
specific RNA in vitro.3 This system consists of four components: two Pumilio variants each fused to just one β-sheet of 
GFP, a GFP detector, and the target RNA, which triggers assembly of the whole complex (see figure 1 below). We used 
this system to differentiate between closely related RNAs after as little as 10 minutes with a background fluorescence 
of merely 1.4 %.4 Since complex background of RNA and cell lysate did not prevent fluorescence complementation, 
detection of RNA with our system could become possible in vivo.
The ability to detect single stranded RNA sequence specifically might also be useful for detection of SNPs or 
discrimination of microRNAs. We currently extend our system to allow fast and easy detection of any given RNA of 
interest.
1. G. Bao, W. J. Rhee, A. Tsourkas, Annu Rev Biomed Eng 2009, 11, 25-47. 
2. Y. Kodama, C.-D. Hu, BioTechniques 2010, 49, 793– 805.
3. G. S. Waldo, S. Cabantous (Los Alamos National Security, LLC), US 7,666,606 B2, 2010.
4. S. J. Kellermann, A. K. Rath, A. Rentmeister, Chembiochem 2013, 14, 200-204.
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607 B Resolving conflicts between Transcription and Replication: a new potential role for the 
mRNA export factor Yra1, regulated by its post-translational modifications.
Evelina Tutucci1, Noël Yeh Martin1, Valentina Infantino1, Benoît Palancade2, Françoise Stutz1
1Dept. of Cell Biology, University of Geneva, Geneva, Switzerland; ”Frontiers in Genetics” National Center 
for Competence in Research (NCCR), Geneva, Switzerland; 2Institut Jacques Monod, Paris, France.
The maintenance of genome integrity is one of the most challenging tasks eukaryotic cells have to face. One 
considerable source of endogenous damage is generated by defects in DNA replication that lead to replication forks 
stalling and collapse.  Particularly during S-phase, cells have to resolve conflicts between replication and transcription, 
when DNA synthesis is impaired by the RNA polymerase and by factors involved in mRNA processing and export. 
The mechanism underling this stress response is not yet elucidated.
Intriguingly, one common factor of these processes is the essential and conserved protein Yra1/REF. Yra1 has 
a well-characterized role as mRNA export adaptor working in association with the mRNA export receptor Mex67/
TAP and the poly(A) binding protein Nab2. We previously reported that Yra1 is a pluri-ubiquitinated protein and 
we showed that its ubiquitination by the E3 ubiquitin ligase Tom1 is involved in mRNA export regulation (Iglesias, 
Tutucci et al. 2010).In addition Yra1 is found at origins of replication, but its function in this context is unknown 
(Swaminathan, Kile et al. 2007).
Our recent work suggests a new role for the mRNA export factor Yra1 in the regulation of cell cycle progression, 
and shows that Yra1 ubiquitination and in turn Yra1 levels, are sensitive to replication stress caused by different DNA 
damaging factors. Moreover, we observed that Yra1 is a sumoylated protein and we identified the SUMO-dependent 
Slx5/Slx8 complex as the second E3 ubiquitin ligase complex involved in Yra1 post-translational modification. 
Interestingly this ubiquitin-ligase complex binds the DNA and deletion of either gene is paralleled by a general 
increase in genomic instability (Nagai, Dubrana et al. 2008).
With this work we propose Yra1 as a new factor involved in genome integrity maintenance and we suggest that 
Yra1 is a sensor of DNA damage and a player in the S-phase stress response. In addition, the fact that Yra1 is present 
both at the transcription sites and at origins of replication, suggests a role for this protein in resolving conflicts between 
transcription and replication during S-phase.
1. Iglesias, N., E. Tutucci, et al. (2010). “Ubiquitin-mediated mRNP dynamics and surveillance prior to budding yeast mRNA 
export.” Genes Dev 24(17):1927-1938.
2. Nagai, S., K. Dubrana, et al. (2008). “Functional targeting of DNA damage to a nuclear pore-associated SUMO-dependent 
ubiquitin ligase.” Science322(5901): 597-602.
3. Swaminathan, S., A. C. Kile, et al. (2007). “Yra1 is required for S phase entry and affects Dia2 binding to replication 
origins.” Mol Cell Biol 27(13): 4674-4684.
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609 A mRNA transport and translation regulate neuritogenesis
Hsin-I Yu1, Hung-Hsi Chen1, Wei-Chih Cho1, Woan-Yuh Tarn2
1IBMS, Academia Sinica; 2Institute of Biomedical Sciences, Academia Sinica
Post-transcriptional regulation of mRNA processing is involved in neural development and disease. Transport 
of mRNA and local translation in neurites are important mechanisms for neuron to control their development and 
function including neuritogenesis, synapse formation and synaptic plasticity. We have been focusing on two factors in 
neuronal RNA granules, the RNA-binding protein hnRNP Q1 and DEAD-box RNA helicase DDX3, to explore how 
they may regulate mRNA transport and translation during neuritogenesis. Using siRNA-mediated knockdown, we 
found that hnRNP Q1 and DDX3 could regulate neuritogenesis likely by regulating mRNA transport and translation, 
respectively, in primary cortical neurons and N2A cells. Knockdown of hnRNP Q1 increased neurite complexity 
in both primary cortical neurons and N2A cells. A search for mRNA targets of hnRNP Q1 identified functionally 
coherent sets of mRNAs involved in Cdc42-mediated cytoskeleton remodeling. Knockdown of hnRNP Q1 indeed 
reduced the level of several mRNAs encoding the components of the Cdc42/N-WASP/Arp2/3 pathway in neurites. 
This result suggests that hnRNP Q1 may participate in localization of mRNAs encoding Cdc42 signaling factors in 
neurites, and thereby regulate actin dynamics and control neuronal morphogenesis (Mol. Cell. Biol. 32, 2224, 2012). 
Knockdown of DDX3 inhibits neurite outgrowth in both cortical neurons and N2A cells. A screening of potential 
mRNA targets of DDX3-regulated translation identified functionally coherent genes involved in the Rac1-mediated 
signaling pathway. We demonstrated by using immunoblotting, immunostaining and quantitative RT-PCR that DDX3 
knockdown reduced the level of Rac1 protein but not mRNA. Moreover, RNA pulldown and in vitro translation showed 
that DDX3 associated with the 5’ UTR of Rac1 mRNA and regulated Rac1 translation in N2A cells. Furthermore, 
overexpression of constitutively active Rac1 could partially rescue neurite outgrowth defects in N2A cells. Therefore, 
our and others’ studies indicate that functionally coherent mRNAs can be regulated by single proteins as mRNA 
regulons at the mRNA transport and translation levels in neurons. Cdc42 and Rac1 are critical molecules in regulating 
cytoskeleton remodeling and cell polarity. Identification of mRNA regulons encoding Cdc42 and Rac1 signaling 
factors may provide us insights into how they regulate neuritogenesis as well as build polarity in neurons.
608 C Ubiquitin and SUMO regulate Yra1: linking mRNA export factor to genome stability
Evelina Tutucci1, Benoit Palancade2, Noel Yeh Martin1, Valentina Infantino1, Françoise Stutz1
1Dept. of Cell Biology, University of Geneva, Geneva, Switzerland; 2Institut Jacques Monod, Paris, France.
The nuclear periphery is a fundamental compartment to organize DNA domains and ensures proper transcription, 
replication and genome integrity.
The Nuclear Pore Complex has a well-established role in telomere tethering and subtelomeric repression at the 
nuclear periphery (Therizols, et al. 2006) and the loss of NPC subunits is synthetic lethal with components of the 
homologous recombination pathway (Pan X, et al. 2006). Intriguingly, the NPC physically interacts with the SUMO-
dependent ubiquitin ligases Slx5-Slx8 that localize at irreparable DSBs (Nagai, et al. 2008). Moreover, the NPC-
bound SUMO-protease Ulp1 prevents accumulation of DSBs (Palancade, et al. 2007) underlining the importance of 
sumoylation and ubiquitination in the DNA damage response.
Our earlier work (Iglesias, Tutucci et al. 2010) has shown that Yra1, an essential protein acting at the nuclear 
periphery and involved in transcription elongation, 3’ processing, transcription termination and finally mRNA export, 
is released from the mRNP following ubiquitination by the E3 ligase Tom1 allowing proper mRNA export. Our recent 
studies identified Slx5-Slx8 as an additional E3 ligase involved in the regulation of Yra1 ubiquitination. Consistently, 
Yra1 is sumoylated and regulated by the protease Ulp1. Notably, the levels of Yra1 ubiquitination change in response 
to DNA damage. Our data highlight the importance of both sumoylation and ubiquitination in the regulation of Yra1 
and suggest a new potential role of this mRNA export factor in the control of genome integrity.  
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611 C Altered microRNA expression profile in ALS: Role in the regulation of NFL mRNA levels
Danae Campos-Melo1, Cristian Droppelmann1, Kathryn Volkening2, Michael J. Strong2
1Molecular Brain Research Group, Robarts Research Institute, Western University, London, Ontario, 
Canada; 2Molecular Brain Research Group, Robarts Research Institute and Department of Clinical 
Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, 
Canada
Amyotrophic lateral sclerosis (ALS) is a progressive, adult onset neurodegenerative disease of motor neurons 
(MN). The MN degeneration is associated with the formation of neurofilament aggregates and a selective suppression 
of low molecular weight neurofilament (NFL) mRNA.  The preferential localization of NFL mRNA to P-bodies in 
ALS suggests that the suppression of its levels is related to an increase in RNA degradation. In addition, in vitro 
experiments in which human NFL (hNFL) mRNA was incubated with spinal cord (SC) homogenates pretreated with 
RNase showed that RNA species contribute to NFL mRNA destabilization in ALS. Considering that microRNAs 
(miRNAs) are key mRNA stability determinants and play a critical role in degeneration, they presented a likely 
candidate to explain our previous results. MiRNAs are small non-coding RNAs that participate in mRNA degradation 
mainly through base pairing interactions with the mRNA 3’ untranslated region (UTR). In this study our objective was 
to characterize the miRNA expression profile in ventral lumbar SC tissue in sporadic ALS (sALS) and controls. We 
analyzed a large group of miRNAs and we found that the majority of dysregulated miRNAs are down-regulated in 
sALS. Ingenuity Pathway Analysis showed that these dysregulated miRNAs are linked with nervous system function 
and cell death. We used two prediction algorithms to develop a panel of miRNAs that have recognition elements within 
the hNFL 3’UTR. Finally, we investigated the functional relevance of these miRNAs using reporter gene assays and 
rqRT-PCR from HEK293T cells co-transfected with different hNFL mRNA 3’UTRs linked to a reporter gene and 
miRNAs predicted to interact with the 3’UTR. Our data suggest a potential role of several miRNAs in the selective 
decrease of NFL mRNA observed in ALS that could contribute to the etiology of neurofilamentous aggregates and the 
ALS pathology.
610 B S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1
Vered Ben-Hur1, Polina Denichenko1, Zahava Siegfried1, Avi Maimon1, Adrian Krainer2, Ben Davidson3, Rotem 
Karni1
1Department of Biochemistry and Molecular Biology, Hebrew University-Hadassah Medical School; 2Cold 
Spring Harbor Laboratory, NY; 3Oslo University Hospital, Norwegian Radium Hospital
Ribosomal S6 Kinase 1 (S6K1) is a major mTOR downstream signaling molecule which regulates cell size and 
translation efficiency. Here we report that short isoforms of S6K1 are over-produced in breast cancer cell lines and 
tumors. Overexpression of S6K1 short isoforms induces transformation of human breast epithelial cells. The long 
S6K1 variant (Iso-1) induced opposite effects: It inhibits Ras-induced transformation and tumor formation, while its 
knockdown or knockout induced transformation, suggesting that Iso-1 has a tumor suppressor activity. We further 
found that S6K1 short isoforms bind and activate mTORC1, elevating 4E-BP1 phosphorylation, cap-dependent 
translation and Mcl-1 protein levels.  Both a phosphorylation-defective 4E-BP1 mutant and the mTORC1 inhibitor 
rapamycin partially blocked the oncogenic effects of S6K1 short isoforms, suggesting that these are mediated by 
mTORC1 and 4E-BP1. Thus, alternative splicing of S6K1 acts as a molecular switch in breast cancer cells elevating 
oncogenic isoforms that activate mTORC1.
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613 B Retinitis pigmentosa mutations of hBrr2 reduce splicing fidelity
Zuzana Cvacková1, Daniel Mateju1, David Stanek1
1Laboratory of RNA Biology, Institute of Molecular Genetics ASCR
hBrr2 is a DExD/H-box RNA helicase crucial for pre-mRNA splicing and its mutations cause autosomal dominant 
retinal disorder retinitis pigmentosa. In this study, we prepared S1087L and R1090L mutations of human Brr2 using 
BAC recombineering and expressed them stably in human cell culture. Mutations in hBrr2 did not compromise 
snRNP assembly and both mutants were incorporated into the spliceosome as the wild-type protein. Surprisingly, cells 
expressing RP mutants exhibited increased splicing efficiency of the LDHA gene. Next, we found that depletion of 
endogenous hBrr2 enhanced usage of a cryptic splice site while splicing at the correct splice site was inhibited. Proper 
splicing of optimal and cryptic splice sites was restored in cells expressing wild-type hBrr2 but not in cells expressing 
the RP mutants. Taken together, our data suggest that hBrr2 is an important factor in splice site recognition and that 
the RP-linked mutations S1087L and R1090L affect this hBrr2 function, possibly leading to the increased usage of 
cryptic splice-sites.
612 A Novel TAL1 targets beyond protein coding genes: identification of TAL1-regulated 
microRNA genes in T-cell acute lymphoblastic leukemia
Nádia C. Correia1, Francisco J. Enguita1, Frank Speleman2, João T Barata3
1Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Portugal; 2Center for 
Medical Genetics, Ghent University, Belgium; 3Instituto de Medicina Molecular, Lisboa
The transcription factor TAL1 is downregulated early in T-cell development and frequently overexpressed in T-cell acute 
lymphoblastic leukemia (T-ALL). To identify a TAL1-dependent microRNA gene expression profile, we ectopically expressed 
TAL1 in the TAL1-negative T-ALL cell line P12 and performed low density array analysis. Initially, we identified eight microRNA 
genes whose expression changed significantly upon TAL1 overexpression. We then validated these results by quantitative PCR 
analysis after enforcing or silencing the expression of TAL1 in TAL1-negative and TAL1-positive T-ALL cell lines, respectively. 
This approach confirmed that miR-135a, miR-223 and miR-330-3p are upregulated by TAL1, whereas miR-146b-5p and miR-
545 are downregulated. To assess the possibility that these microRNAs are direct targets of TAL1, we searched publicly available 
TAL1 ChIP-seq data (GSE29181) for the presence of TAL1 binding peaks up to 10kb upstream of the transcription start site (TSS) 
of each microRNA gene. We identified one peak in a putative promoter region for miR-146b, suggesting that this gene may be a 
transcriptional target of TAL1. Furthermore, two peaks can be observed upstream of miR-223 TSS. Because miR-223 has already 
been shown to play a pro-tumorigenic role in T-ALL, although not in the context of TAL1, we performed TAL1 ChIP-qPCR in 
JURKAT and CCRF-CEM cells using primers designed for the genomic areas covered by the two peaks in the miR-223 locus. We 
confirmed that upon TAL1 IP there is more than 2-fold enrichment in the amplified area within 3.5kbs upstream of the miR-223 
TSS. These results indicate that miR-223 is a direct target of TAL1 in T-ALL. Interestingly, analysis of microRNA gene expression 
profiles in different T-ALL subsets revealed that TAL/LMO primary samples display higher levels of miR-223 (p=0.03) and tend 
to express lower levels of miR-146b-5p (p=0.09) than other T-ALL cases. Moreover, miR-223 and miR-135a appear to follow the 
same pattern of expression along normal human thymocyte development as TAL1, with high levels in CD34+ T-cell precursors 
and sharp downregulation in more differentiated subsets. In contrast, miR-146b-5p, which is negatively regulated by TAL1, is 
mostly expressed in mature, single-positive thymic subsets. Overall, our studies identify several TAL1 downstream micro RNA 
target genes, of which miR-146b and miR-223 may be directly regulated, and suggest that they may be components of TAL1 
downstream regulatory networks involved in normal hematopoietic development and in T-ALL. Their actual participation in this 
malignancy and/or in TAL1-mediated physiological effects in hematopoiesis requires investigation. We are currently exploring 
the functional consequences of these microRNAs modulation in the development of the malignancy. We Expect to present these 
results in this congress.
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615 A Ddx5/Ddx17 RNA helicases control multiple layers of gene expression during TGFß-
induced Epithelial-to-Mesenchymal Transition (EMT)
Etienne Dardenne1, 2 , 3, 4, 5, Fattet Laurent1, 2 , 3, 4, 5, Mathieu Deygas1, 2 , 3, 4, 5, Micaela Polay-Espinoza1, 2 , 3, 4, 5, Cyril 
Bourgeois1, 2 , 3, 4, 5, Ruth Rimokh1, 2 , 3, 4, 5, Didier Auboeuf1, 2 , 3, 4, 5
1Université de Lyon; 2Inserm U1052; 3CNRS UMR5286; 4Centre de Recherche en Cancérologie de Lyon; 
5Université Lyon 1, F-69000 Lyon, France.
It is well known that Epithelial-to-Mesenchymal Transition (EMT) plays an important role in differentiation and is corrupted 
during tumorigenesis. TGFβ is a potent inducer of EMT, through the activation of Smads, leading to transcription of EMT 
master genes (Snail, Zeb, Twist) that regulate epithelial and mesenchymal gene expression. Evidence shows that EMT result 
from regulation of gene expression programs at the post-transcriptional level (alternative splicing and miRNAs). Ddx5 has been 
reported to favor EMT and is known to be a transcriptional coactivator of Smads. Ddx5 and its paralog Ddx17 are also implicated 
in alternative splicing.
To characterize the role of Ddx5/17 during TGFβ-induced EMT, we used the human mammary epithelial cell line MCF10A 
and showed that Ddx5/17 depletion by siRNAs inhibited the induction of EMT in response to TGFβ. Ddx5 and Ddx17 interact 
with smad3 and act as smad3 co-activator to induced expression of EMT transcription factor snail1&2. Consequently under 
ddx5/17 depletion, TGFβ no longer repressed the expression of E-cadherin and Ocludin, two proteins implicated in the cell-cell 
junction. Accordingly, cells are stilled attached and are not able to migrate. These results confirmed that Ddx5/17 are necessary 
for TGFβ -induced EMT. 
Paradoxically, we observed that Ddx5/17 endogenous expression decreased after 48 hours of TGFβ treatment. We show that 
miR-181b is induced by TGFβ in a Ddx5/17 dependant maner and target Ddx5/17 in a feedback loop control. Our hypothesis is 
that Ddx5/17 decreased expression contributes to the development of cellular programs during EMT. Indeed, Ddx5/17 depletion 
increased: 1- the expression of Zeb1, a EMT transcription factor and others mesenchymal markers in response to TGFβ and 2- 
the formation of Actin stress fibers. Finally, using exon arrays, we show that Ddx5/17 participate to the regulation of alternative 
splicing events induced during EMT. Indeed Ddx5 and Ddx17 control alternative splicing of a large subset of genes including 
Enah, Stx16 and Fn1, genes relevant in the EMT process. 
In conclusion, Ddx5 and ddx17 are necessary to initiate TGFβ signaling, but their decreased expression in a second phase 
could contribute to the completion of the cascade of events leading to TGFβ -induced EMT in particular at the splicing level. In 
this context Ddx5/17 control different steps of gene expression (transcription, miRNA and alternative splicing), to drive TGFβ 
-induced EMT. 
614 C An Exon-Specific U1 approach to correct SMN protein deficiency in spinal muscular 
atrophy (SMA)
Andrea Dal Mas1, Erica Bussani1, Malgorzata Rogalska1, Franco Pagani1
1International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
A significant proportion of disease-causing mutations affect pre-mRNA splicing inducing skipping of the exon 
from the mature transcript. We recently showed that modified U1snRNAs targeting non-conserved intronic sequences 
downstream of the 5’ss (Exon Specific U1s) are able to correct different types of splicing mutations associated with 
defective exon definition  (Fernandez et al HMG 2012). Using coagulation F9, CFTR and SMN2 models, we identified 
an ExSpeU1 able to rescue exon skipping caused by mutations at the polypyrimidine tract, the 5’ss or the ESEs. To 
investigate their efficacy and potential applicability in vivo we used a cellular model of spinal muscular atrophy 
(SMA) where improvement of SMN2 exon 7 skipping due to a silent exonic substitution is a reliable therapeutic 
strategy. In SMA-derived primary fibroblasts, lentiviral-mediated transduction of ExSpe U1s rescued SMN2 exon 
7 splicing pattern. The increase in the amount of the correct full length (FL) mRNA resulted in a corresponding 
improvement of the SMN protein to a level present in unaffected fibroblasts. Furthermore, using the Hek293 Flip-In 
cell system, we show that corresponding levels of SMN2 exon 7 splicing rescue can be obtained by expression of only 
one chromosome-integrated copy of the ExSpe U1 gene.To understand the ExSpeU1s splicing enhancing mechanism 
we investigate the U1 components and the possible direct interference with ISSs.  All model systems showed an 
ISS downstream the 5’ss. However, the ISS deletions rescued with variable efficiency only some types of splicing 
mutations and U7 RNAs targeting the ISSs had no effect on splicing suggesting that ExSpeU1 are only partially 
acting through an antisense mechanism that target the ISS.. On the other hand, ExSpeU1 mutants previously reported 
to affect 70K and U1A binding when tested in vivo, only slightly reduce, or do not affect, the splicing enhancement. 
In the CFTR case, side-directed mutagenesis showed that an RNA secondary structure-dependent accessibility of the 
5’ss regulates splicing.  All together, these data suggest that multiple factors are involved in the ExSpeU1-dependent 
improvement of exon definition
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617 C The RNA binding protein Quaking regulates monocyte adhesion and differentiation
Ruben de Bruin1, Janine van Gils1, Hetty de Boer1, Jacques Duijs1, Erik Biessen2, Ton Rabelink1, Lily Shiue3, 
Manuel Ares Jr3, Anton Jan van Zonneveld1, Eric van der Veer1
1Leiden University Medical Center; 2Maastricht University Medical Center; 3University of California Santa 
Cruz
Circulating monocytes are actively recruited to sites of tissue injury. The adherence of these cells to the activated 
endothelium leads to their extravasation into the sub-endothelial space where they differentiate into macrophages. 
Despite the fact that the cell surface receptors that regulate this adhesion process, such as p-selectin glycoprotein 
ligand-1 and b-integrins, have been characterized, the factors that regulate monocyte activation, adhesion and 
differentiation are poorly understood.
Here, we show that the RNA-binding protein Quaking (QKI) critically regulates monocyte activation, adhesion 
and differentiation. First, we identified that QKI is lowly expressed in human peripheral blood monocytes, while FACS 
sorting of monocyte subsets from peripheral blood and subsequent RNA isolation revealed that QKI mRNA expression 
is potently induced in a specific, activated subset of human circulating monocytes (CD14+ CD16+).  Interestingly, the 
activation and differentiation of monocytes into macrophages was coupled with a striking induction of QKI protein 
(n=6).  This finding was supported by laser capture micro dissection and immunohistochemistry studies where we 
validated that QKI mRNA and protein is highly expressed in macrophages in human atherosclerotic lesions. To gain 
mechanistic insight we utilized lentiviral short-hairpin RNAs to specifically abrogate QKI protein levels in human 
THP-1 and U937 monocytes. A reduction of QKI resulted in decreased adhesion using a cell perfusion assay (p<0,05 
n=6), together with perturbed migration and differentiation. Subsequently, our discovery that QKI colocalizes with 
RNA species within spreading initiation centers of adhering monocytes, indicates that QKI could play a central role in 
regulating the translocation of RNA species required for the development of focal adhesions. Finally, we demonstrate 
that the transplantation of bone marrow from mice with decreased levels of QKI (quaking viable), into LDLR-/- mice 
fed a high-fat diet, leads to significantly reduced macrophage content in atherosclerotic lesions (p<0,05 n=13). 
Collectively, we have identified that QKI critically regulates monocyte activation, adhesion and macrophage 
differentiation. We therefore propose that the targeted reduction of QKI in monocytes could be an effective means of 
limiting the severity of the systemic or local inflammatory response in disease.
616 B Overexpression of miR-29b and miR-122 in the invasive ductal carcinoma of the breast
Patricia R Darin1, Juliana S Zanetti2, Alfredo Ribeiro-Silva2, Fernando L De Lucca1
1Department of Biochemistry and Immunology, School of Medicine, University of São Paulo, Ribeirão Preto, 
SP., Brazil; 2Department of Pathology and Legal Medicine, School of Medicine, University of São Paulo, 
Ribeirão Preto, SP., Brazil
MicroRNAs (miRNAs) are key regulators of gene expression in eukaryotic cells. Current computational 
predictions suggest that miRNAs regulate the expression of 30% of human protein-coding genes. Several studies 
indicate that miRNAs regulate genes of signaling pathways involved in important cellular processes, including cell 
proliferation and apoptosis. The pro-apoptotic RNA-dependent protein kinase (PKR) signaling pathway is activated 
by PACT (protein activator of PKR). Recently, PACT was shown to be a target of miR-29b and miR-122 and the 
role played by these miRNAs in the breast cancer is still unknown. The aim of this study was to investigate whether 
the expression of miR-29b and miR-122 is deregulated in the invasive ductal carcinoma (IDC) of the breast using 
Formalin-Fixed, Paraffin-Embedded (FFPE) tissues. The expression of miRNAs and PACT was evaluated by real 
time PCR and immunohistochemistry, respectively. The normal breast FFPE samples were used as control. Our results 
showed an upregulation of miR-29b (8-fold; p < 0.01) and miR-122 (19-fold; p < 0.005) in the FFPE samples of IDC. 
We also observed that PACT expression was reduced by ~ 50% which is consistent with previous studies showing 
that miR-29b and miR-122 negatively regulate this PKR activator. Thus, the reduction of PACT expression may be 
accompanied by the decrease of the pro-apoptotic PKR pathway activation. Taken together, our results suggest that 
the overexpression of miR-29b and miR-122 in IDC is contributing for the inhibition of apoptosis and, therefore, these 
miRNAs may be involved in progression of the human breast cancer.
The research has been supported by FAPESP.
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619 B Mechanisms of Post-Trascriptional Regulation of Gene Expression in Dementias
Francesca Fontana1, Margherita Grasso1, Valerio Del Vescovo1, Giuseppina Covello1, Michela Alessandra Denti1
1Cibio-Centre for Integrative Biology
MicroRNAs (miRNAs) are noncoding RNA of 18-25 nt, capable of regulating mRNA translation and gene 
expression at the post-trascriptional level. MiRNAs mis-expression is often associated with human diseases, such 
as cancers and neurodegenerative pathology conditions. The main objective of this study is an analysis of the post-
transcriptional regulation by miRNAs of two important genes, MAPT and PGRN, involved in Frontotemporal 
Dementia with Parkinsonism linked to chromosome 17 (FTDP-17). This is one of the major degenerative dementia 
syndromes, characterized by atrophy of the prefrontal and anterior temporal lobes. Several studies identified 
43 pathogenic mutations in MAPT, that encodes for microtubule associated tau protein. In the brain tau protein 
has important functions in microtubule (MT) assembly, stability and has a relevant role in neurogenesis, axonal 
maintenance and transport. The disruption of its function has devastating effects on neuronal integrity and in most 
neurodegenerative diseases forms neurofibrillary tangles (NFT) accumulation, that trigger neuronal loss. Recently, 
the discovery of 56 mutations in the progranulin gene (PGRN) explained the heterogeneity of patients affected by 
FTDP-17. PGRN encodes a secreted precursor protein called progranulin, that is expressed in neurons, microglia and 
represents an important growth factor involved in the regulation of multiple processes. MiRNAs may be a contributing 
factor in neurodegenerative diseases. This project focuses on the expression of selected miRNAs in cell lines and 
primary neurons and on the validation of the miRNAs targeting of PGRN and MAPT 3’UTR. Moreover, we aimed 
at understanding the influence of SNPs in PGRN 3’UTR on the effect of validated miRNAs and finding if there is a 
causal role of miRNA deregulation in FTD, through cell systems and mice brains.
618 A Rho Guanine Nucleotide Exchange Factor: A Novel RNA Binding Protein Involved in the 
Pathology of Amyotrophic Lateral Sclerosis
Cristian Droppelmann1, Brian Keller1, Danae Campos-Melo1, Jian Wang4, Martin Duennwald2, Rob Hegele4, 
Kathryn Volkening3, Michael J. Strong3
1Molecular Brain Research Group, Robarts Research Institute, Western University, London, Ontario, 
Canada; 2Department of Pathology, Schulich School of Medicine and Dentistry, Western University, London, 
Ontario, Canada; 3Molecular Brain Research Group, Robarts Research Institute and Department of Clinical 
Neurological Sciences, Schulich School of Medicine and Dentistry, Western University, London, Ontario, 
Canada; 4Vascular Biology Research Group, Robarts Research Institute, Western University, London, 
Ontario, Canada
Amyotrophic lateral sclerosis (ALS) is an adult-onset progressive disorder characterized by degeneration of motor 
neurons. Although the cause of the disease remains elusive, protein aggregate formation in motor neurons, including 
neurofilamentous aggregates, is a neuropathological hallmark. Recent evidence supports the hypothesis that alterations 
in RNA metabolism in motor neurons can lead to the development of these aggregates. In mice, p190RhoGEF, a guanine 
nucleotide exchange factor, is involved in neurofilament protein aggregation in a RNA-triggered transgenic model of motor 
neuron disease. However, no information was known regarding the function of the human homologue of p190RhoGEF 
called Rho Guanine Nucleotide Exchange Factor (RGNEF) and its role in ALS. Here we studied the function of RGNEF 
and its involvement in the ALS pathology. We observed that RGNEF is an RNA binding protein that binds NFL mRNA. 
In addition, we demonstrated that RGNEF affects NFL mRNA stability via 3’UTR destabilization. The over-expression 
of RGNEF in a human cell line significantly decreased the level of endogenous NFL protein and its over-expression in 
yeast showed cytotoxicity comparable to TDP-43, another protein involved in ALS. When the pathology of RGNEF was 
analyzed we observed extensive cytoplasmic inclusions in ALS spinal motor neurons that co-localized with ubiquitin, 
p62/Sequestosome-1, TDP-43 and FUS/TLS (all of them known neurodegenerative markers). Finally, we investigated for 
genetic alterations performing sequencing of the gene that codifies for RGNEF (ARHGEF28). We found a new frameshift 
mutation and extensive regions of the gene with homozygosis in familial ALS cases. Our results provide further evidence 
that RNA metabolism pathways are integral to ALS pathology. This is also the first described link between ALS and a RNA 
binding protein with aggregate formation that is also a central cell signalling pathway molecule.
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620 C MicroRNAs as lung cancer biomarkers
Margherita Grasso1, Valerio Del Vescovo2, Chiara Cantaloni4, Leonardo Ricci3, Mattia Barbareschi4, Michela 
Alessandra Denti1, Rotem Karni1
1Centre of Integrative Biology, University of Trento, Italy; 2Centre of Integrative Biology, University of 
Trento, Italy; Institute of Molecular Biology gGmbH (IMB), Mainz, Germany; 3Department of Physics, 
University of Trento, Italy; 4Unit of Surgical Pathology, S. Chiara Hospital, Trento, Italy
Lung cancer is the leading cause of cancer-related death worldwide, with a 5- year survival rate of only ~15%1. The 
cause of this high mortality is due to the poor prognosis caused by a late disease presentation, tumour heterogeneities 
and limited understanding of tumour biology. Histologically, lung cancer is classified into small cell lung cancer 
(SCLC) and non-small cell lung cancer (NSCLC). NSCLC is comprised of two most common subtypes, i.e., Squamous 
Cell Carcinoma (SQCC), Adenocarcinoma (ADC), and an additional type called Large Cell Carcinoma (LCC). With 
the emergence of targeted therapies directed against specific cellular alterations, an accurate classification became 
necessary2. In this context, the pattern of miRNAs expression could be useful in improving the classification of lung 
cancers and predicting their behavior. The relative quantification of miR-205 and miR-21 was reported by us and 
others to be a useful marker for differentiating subtypes of NSCLCs3,4,5,6. However, the majority of NSCLC patients 
have advanced disease stage at the time of diagnosis. It is therefore important to find diagnostic methods based on 
detection of early events. For this reason we compared the expression of miR-21 and miR-205 between cytological 
and histological samples to obtain a less invasive early method of diagnosis.
Besides ADC and SQCC, lung tumors include also a spectrum of neuroendocrine (NE) lesions with different 
histology, biology and dramatically different clinical behaviour, which include typical carcinoids (TC), atypical 
carcinoids (ATC), large cell neuroendocrine carcinomas (LCNEC) and small cell lung carcinomas (SCLC)7. In the 
present study we analyzed miR-375 and miR-192 expression to obtain a method to distinguish NE versus non-NE 
lung tumors and the different categories of NE lung tumors. By using a Support Vector Machine (SVM) algorithm we 
assessed whether, on the basis of miRNAs expression, it is possible to recognize different subtypes of lung cancers.
1. A. Jemal et al., CA Cancer J Clin 2009, 59, p. 225-249.
2. J.W. Neal, Oncologist 2010, 15, p. 3-5.
3. J.A. Bishop et al., Clin Cancer Res 2010, 16, p. 610-619.
4. D. Lebanony et al., J Clin Oncol 2009, 27, p. 2030-2037.
5. V. Del Vescovo et al., Am J Surg Pathol 2011, 35, p. 268-7527.
6. M. Barbareschi et al., Am J Clin Pathol 2011, 136, p. 773-782.
7. M. Barbareschi et al., J Pathol 1992, 166, p. 343-350.
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621 A hnRNP A2/B1 regulated alternative splicing of key signal transduction components and is 
essential for breast cancer metastasis.
Regina Golan-Gerstl1, Ilana Lebenthal-Loinger1, Ben Davidson4, Jasmine Jacobs3, Gideon Rechavi2, Rotem Karni1, 
Michela Alessandra Denti1
1Department of Biochemistry and Molecular Biology, Hebrew University-Hadassah Medical School; 2Chaim 
Sheba Medical Center, Tel Hashomer and Tel Aviv University; 3Chaim Sheba Medical Center, Tel Hashomer, 
Tel Aviv; 4Oslo University, Faculty of Medicine
Alternative splicing is a key control point in gene expression, and it is now becoming clear that it is also a process 
whose misregulation in cancer can contribute significantly to malignancy by regulating the expression of isoforms 
of various oncogenes and tumor suppressor genes. However, the role of alternative splicing regulators, or splicing 
factors, in cancer development and progression, is mostly unknown. Our recent studies indicate that some alternative 
splicing factors can be oncogenic, which partly involves the activation of known signaling pathways in novel ways.     
Our results suggest that the splicing factor hnRNP A2/B1 is up-regulated in cancer and act as oncoproteins in 
several steps of cancer development and progression. Our aim is to use this factor as a model to reveal the functional 
roles of alternative splicing in cancer development, tumor maintenance and metastasis and the molecular mechanisms 
involved. Using a combination of both in vitro and in vivo cancer model systems in which we can manipulate the 
expression of hnRNP A2/B1 we discovered its role in cancer initiation and progression. 
Since hnRNP A2/B1 is a broad regulator of alternative splicing, we hypothesize that its overexpression will 
change the splicing landscape of a large set of currently unknown target genes which might be novel determinants of 
survival, motility, invasiveness and other properties of tumor cells. In order to reveal the full spectrum of hnRNP A1/
A2 splicing targets we performed RNA deep sequencing analysis of cells with hnRNP A2/B1 and discovered that it 
regulates several key pathways known to regulate invasion survival and metastasis.    
This study discovered the biological functions of hnRNP A2/B1 in normal development and in cancer and identified 
the alternative splicing events it regulates. Furthermore, the therapeutic potential of our future discoveries is immense. 
Currently only a handful of drugable targets to treat cancer are available. The potential of identifying critical splicing 
events that are essential for cancer initiation or progression and can be modified by splice-site specific competitive 
oligonucleotides have great promise for future anti cancer therapy.
622 B The role of the simtron, miR-1225, and its host gene, PKD1, in autosomal dominant 
polycystic kidney disease
Mallory A. Havens1, Frank Rigo2, Michelle L. Hastings1
1Department of Cell Biology and Anatomy, Chicago Medical School, Rosalind Franklin University of 
Medicine and Science, North Chicago, IL, 60064, USA; 2Isis Pharmaceuticals , Carlsbad, CA, 92010, USA.
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the leading genetic cause of end stage renal disease 
and affects 1:1000 individuals worldwide. Currently, there is no cure for ADPKD. ADPKD has variable severity and 
heterogeneity, which emphasizes the need for the identification of disease modifiers and new therapeutic targets. The 
gene PKD1 is responsible of 85% of ADPKD cases and contains the microRNA miR-1225 within highly conserved 
intron 45. However, the role of miR-1225 has not been examined in ADPKD pathogenesis. Here, we investigate the 
coexpression of miR-1225 and its host gene, PKD1 and the potential functional role of miR-1225 in ADPKD. We 
find that miR-1225 expression is regulated in a tissue-specific manner in humans and is inversely related to PKD1 
expression during mouse kidney development. Also, we discovered that the SR protein SRSF5 is a regulator of miR-
1225 biogenesis. In order to investigate the role of miR-1225 in ADPKD, we tested human pathogenic mutations 
in PKD1 intron 45 and determined their affect on miR-1225 abundance and mRNA splicing. To further elucidate a 
possible role for miR-1225 in ADPKD in vivo, we designed antisense oligonucleotides (ASOs) that alter miR-1225 
abundance without affecting PKD1 pre-mRNA splicing and are testing them in mice. These data suggest a potential 
role for miR-1225 in disease pathogenesis along with its host gene, PKD1.
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623 C Interplay of oncogenic transcription factor b-catenin with SR protein SRSF3 contributes to 
the alternative splicing of tumor-related genes
Jung Hur1, Sunjoo Jeong1
1Dankook University
b-Catenin regulates the expression of many genes critical for cell proliferation and fate determination during 
development and stem cell maintenance under the control of Wnt signaling pathway. Constitutively active b-catenin 
was found in epithelial cancers including colon cancer, which indicates it as an important regulator for cancer 
initiation and progression. Interestingly, transcription factor b-catenin could also binds RNA, so it could influence 
altered transcriptome by regulating the splicing step of gene expression. Here we demonstrate that mutant b-catenin 
found in colon cancer cells significantly alters the splicing patterns of tumor-related genes, including p53 tumor 
suppressor gene. b-Catenin recognizes and associates near the alternative splicing site and regulates the alternative 
splicing. Interestingly, SRSF3 protein occupied the same alternative exon of p53 and repressed the alternative splicing, 
which could be abrogated by b-catenin. Such a crosstalk of the oncogenic transcription factor and splicing regulator 
could contribute globally to multitudes of genes important for tumorigenesis. We will discuss on a novel mechanism 
for b-catenin to regulate alternative splicing, and propose the model how b-catenin enhance the oncogenic RNA 
expression profiles in cancer cells. It will explain partially why b-catenin have a greater impact on oncogenic RNA 
expression network. Finally, we hope to provide new concepts in the therapeutic intervention of cancer development, 
targeting aberrant RNA binding property of b-catenin protein in cancer cells. 
1. HK Lee, YS Choi, YA Park and S Jeong (2006) Cancer Res., 66, 10560-10566 
2. HK Lee and S Jeong (2006) Nucleic Acids Res., 34, 5705-5714 
3. KH Choi*, MW Park* et al., and S Jeong (2006) Mol. Cancer Ther., 5, 2428-2434 
4. HK Lee et al., and S Jeong (2007) Cancer Res, 67, 9315-9321
5. MY Kim, J Hur and S Jeong (2009) BMB Reports, 42, 125-130
6. S Jeong, HK Lee and MY Kim (2009) Methods Mol. Biol. 542, 363-377 
7. I Kim*, H Kwak*, HK Lee, S Hyun and S Jeong (2012) Nucleic Acids Res.,40, 6863-6872 
624 A Exploring the in vivo functions of the mammalian tRNA ligase
Jennifer Jurkin1, Therese Kaufmann1, Johannes Popow1, Javier Martinez1
1IMBA- Institute of Molecular Biotechnology of the Austrian Academy of Sciences
Our laboratory has recently identified an elusive protein complex in human cells displaying tRNA ligase activity. 
The human tRNA ligase is a pentamer consisting of the catalytic subunit HSPC117, the DEAD box helicase Ddx1 
and three proteins of unknown function - CGI-99, Fam98B and Ashwin. Only cells depleted of the essential subunit 
HSPC117 fail to complete tRNA splicing.
We envision additional roles for the mammalian tRNA ligase in RNA processing and RNA metabolic pathways, 
particularly given the more extensive functions of tRNA ligases in other organisms that include for example hac1 
mRNA splicing during the unfolded protein response as well as RNA repair. To elucidate the in vivo function of the 
mammalian tRNA ligase, we generated an HSPC117 knock-out mouse. Since the complete knock-out of HSPC117 
leads to early embryonic lethality, we are currently focusing on the depletion of HSPC117 in the brain and cells of 
the immune system. Mammalian RNA ligation and RNA ligase enzymes are relatively unexplored. We hope that 
our mouse models will provide insights into the role of mammalian RNA ligation in diverse cellular functions, and 
potentially connect the failure of these functions to human disease. 
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626 C The Involvement of miRNA Dysregulation in Amyotrophic Lateral Sclerosis
Alessia Loffreda1, Marc-David Ruepp2, Rémy Bruggmann3, Oliver Mühlemann2, Silvia Barabino1
1Department of Biotechnology and Biosciences, University of Milano-Bicocca, Piazza della Scienza 2, 
Milan, Italy; 2Department of Chemistry and Biochemistry, University of Bern, CH-3012 Bern, Switzerland; 
3Interfacultary Bioinformatics Support, Department of Biology, University of Bern, CH-3012 Bern, 
Switzerland
ALS is a neurodegenerative disease that specifically affects upper and lower motor neurons leading to progressive 
paralysis and death. There is currently no effective treatment. Thus, identification of the signaling pathways and 
cellular mediators of ALS remains a major challenge in the search for novel therapeutic approaches. Recent studies 
have shown that non-coding RNAs have a significant impact on normal CNS development and onset and progression 
of neurological disorders. Based on this evidence we specifically test the hypothesis that misregulation of miRNA 
expression is a common feature in familiar ALS. Hence, we are exploiting human neuroblastoma cell lines either 
expressing the SOD1(G93A) mutation or depleted from Fused in Sarcoma (FUS) as tools to investigate the role 
of miRNAs in familiar ALS. To this end we performed a genome-wide scale miRNA expression on these cells, 
using whole-genome small RNA deep-sequencing followed by quantitative real time validation (qPCR). This strategy 
allowed us to find a group of dysregulated miRNAs, which are predicted to play a role in the motorneurons physiology 
and pathology. We verified our data on cDNA derived from SOD1-ALS mice models at early stage of the disease 
and on cDNA derived from lymphocytes from a small group of ALS patients. In the future, we plan to define the 
mechanisms responsible for the miRNA dysregulation, by silencing or stimulating the signal transduction pathways 
putatively involved in miRNA expression and regulation.
625 B The FUS protein is required for cell proliferation
Silvia Carolina Lenzken1, Alessia Loffreda1, Monica Lupi4, Sudharshan Elangovan1, Marc-David Ruepp2, Raffaele 
Calogero3, Giovanna Damia4, Oliver Mühlemann2, Silvia Barabino1
1Dipartimento di Biotecnologie e Bioscienze, Università di Milano – Bicocca, Milano, Italy; 2Department of 
Chemistry and Biochemistry, University of Bern, Switzerland; 3Department of Informatics, University of 
Torino, Italy; 4Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
FUS/TLS (fused in sarcoma/translocated in liposarcoma) protein, a ubiquitously expressed and highly conserved RNA 
binding protein, has been linked to a variety of cellular processes from mRNA processing to DNA repair. However, the 
precise function of FUS is not well understood. Recently, mutations in the FUS gene have been identified in familial and 
sporadic patients of Amyotrophic Lateral Sclerosis, a fatal neurodegenerative disorder characterized by dysfunction and 
death of motor neurons. 
Based on the observation that some mutations in the FUS gene induce cytoplasmic accumulation of FUS aggregates, we 
decided to explore a loss-of-function situation (i.e. inhibition of FUS’ nuclear function) to unravel the role of this protein. 
To this purpose, we have generated a SH-SY5Y human neuroblastoma cell line which expresses a doxycycline induced 
shRNA targeting FUS that efficiently depletes the protein. In order to characterize this cell line, we have characterized the 
poly(A) fraction by RNA deep sequencing. Preliminary results show that FUS depletion affects both mRNA expression 
and alternative splicing. Upon FUS depletion 330 genes are downregulated and 81 are upregulated. We also found that 
395 splicing isoforms were downregulated, while 426 were upregulated. Currently, we are focusing our attention on the 
pathways which are mostly affected by FUS depletion. In addition, we are currently characterizing how FUS depletion 
affects cell proliferation and survival. We find that the lack of FUS impairs cell proliferation but does not induce apoptosis.
Finally, since MEFs and B-lymphocytes derived from FUS knockdown mice display major sensitivity to ionizing 
radiation and chromosomal aberrations [1,2], we are exploring the effects of DNA damage in FUS-depleted cells by 
monitoring important components of DNA Damage Response (DDR). Taken together, these studies may contribute to 
our knowledge of the role of FUS in these cellular processes and will allow us to draw a clearer picture of mechanisms of 
neurodegenerative diseases. 
1. Kuroda M. et al. (2000) EMBO J. Feb 1;19(3):453-62.
2. Hicks GG. et al. (2000) Nat Genet. 2000 Feb;24(2):175-9.
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628 B Uncovering the role of microRNAs in SMA
Philipp Odermatt1, Daniel Schümperli2
1University of Bern; 2Institute of Cell Biology, University of Bern
Spinal muscular atrophy (SMA) is caused by low level of the survival of motor neuron protein (SMN). As a 
consequence, the α-motor neurons of the spinal cord die causing muscle weakness and paralysis. SMN is ubiquitously 
expressed and involved in the assembly and maturation of small nuclear ribonucleoproteins (snRNPs) and is thus 
essential for survival of all cells. The question why low levels of SMN cause a motor neuron-specific disease such as 
SMA still needs to be answered. An attractive hypothesis is that SMN may help to regulate the transport, translation 
or stability of mRNAs that are localised to the axon and that a defect in this function may be the primary cause of 
SMA. In neurons, translationally repressed mRNAs are transported along the dendrites as part of ribonucleoproteins 
particles (mRNPs). These mRNAs are kept in a translationally repressed state by several factors, including miRNAs. 
Upon synaptic activation, the miRNAs dissociate from their targets, and local protein synthesis takes place. My aim 
is to see whether SMN could interplay with miRNAs and regulate the activity of moto-axonal mRNPs. To investigate 
these aspects, an inducible human neuroblastoma SMN knock down cell line was created and micro RNA levels of 
certain miRNA candidates (based on a literature search) are being monitored by qPCR under control and knock down 
conditions. Preliminary results showed only little changes of the candidate micro RNAs in the cell line model. In a 
next step, motor neurons will be extracted by laser micro dissection from the severe mouse model and deep sequencing 
analysis will be performed to analyse the miRNA repertoire in these cells. This should help to define the repertoire of 
miRNAs affected by the loss of SMN in the severe SMA mouse. The localization of these candidate miRNAs in the 
cells will then additionally be monitored by miRNA in situ hybridisation in the cell line model and in slice cultures.
627 A Differential LMNA splicing leads to metabolic disorders
Isabel Cristina Lopez-Mejía1, Marion de Toledo1, Carine Chavey1, Celia Lopez Herrera1, Patricia Cavelier1, 
François Casas3, Guillaume Beranger2, Ez-Zoubir Amri2, Lluis Fajas4, Jamal Tazi1
1CNRS; 2IBV; 3INRA; 4UNIL
In humans,  A-type lamins arise from LMNA gene by alternative RNA processing. The two main A-type lamins 
are lamin A and lamin C. Progerin is a truncated version of lamin A protein, involved in Hutchinson-Gilford progeria 
syndrome (HGPS), a premature aging disease. Most of the times, Progerin expression is due to a single splicing 
mutation in the exon 11 of LMNA gene (c.1824C>T; p.G608G).
Mutant mice carrying the equivalent HGPS splicing mutation in the Lmna gene (c.1827C>T; p.G609G) also 
accumulate progerin and phenocopy the main cellular alterations and clinical defects of HGPS patients. We demonstrate 
that changes in the splicing ratio between lamin A and progerin are key factors for lifespan since the LmnaG609G/G609G 
mice lived no longer than 5 months, whereas LmnaG609G/+ mice lived up to one year. Strikingly, mice expressing only 
the lamin C isoform, due to targeted inactivation of lamin A (herein called LmnaLCS/LCS mice), lived longer than wild 
type mice. The initial characterization of LmnaG609G/G609G and LmnaLCS/LCS mice indicates that lamin isoforms expression 
influences adipose tissue homeostasis. We observed that progeria mice are lean compared to control mice whereas 
LCS mice become fat under chow diet. These modifications of body weight are correlated with an alteration of 
adipose tissue size without changes in food intake. Moreover oxymax analysis showed an increase in O2 consumption 
in progeria mice compared to the control mice, whereas LCS/LCS mice have a lower O2 consumption. Finally, 
microarray analysis of white adipose tissue revealed that a set of genes varies in opposite way between progeria 
and LCS mice. Interestingly, many of these genes are involved in energy metabolism. All these data showed that 
alterations in LMNA alternative splicing lead to a strong metabolic phenotype, characterized by a dysregulation of 
adipose tissue homeostasis.
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630 A Mutation of a Zinc Finger Polyadenosine RNA Binding Protein Causes Autosomal 
Recessive Intellectual Disability
Jennifer Rha1, Sara Leung1, Gary Bassell1, Anita Corbett1
1Emory University
Intellectual disability affects between 1-3% of people across the world. Patients with intellectual disability suffer 
from significantly subaverage intellectual function (IQ ≤70), which impinges on quality of life. In a collaborative 
effort, we have recently identified the first gene encoding a polyadenosine RNA binding protein, ZC3H14 (Zinc finger 
CysCysCysHis domain-containing protein 14), which is mutated in inherited nonsyndromic autosomal recessive 
intellectual disability. This finding uncovers the molecular basis for disease in these patients and provides strong 
evidence that ZC3H14 is essential for proper brain function. ZC3H14 is an evolutionarily conserved member of 
a novel class of tandem zinc finger (CCCH) polyadenosine RNA binding proteins. Studies of ZC3H14 orthologs 
in budding yeast and Drosophila provide insight into the role of this protein in post-transcriptional regulation of 
gene expression, specifically in the proper control of 3’-end polyadenylation of mRNA. Despite studies in yeast and 
Drosophila, functional characterization of ZC3H14 in vertebrates is crucial for understanding the role of this protein 
in brain function and the molecular mechanism underlying intellectual disability in these patients. Therefore, we have 
developed a conditional ZC3H14 knockout mouse utilizing the Cre/loxP system to extend our studies to vertebrate 
ZC3H14 and address our hypothesis that ZC3H14 is required for proper expression of target mRNAs that are critical 
for neuronal function. We utilized the EIIa-Cre transgenic line, in which Cre-recombinase is expressed ubiquitously, 
to knockout ZC3H14 expression. EIIa-Cre +, ZC3H14 -/- mice are viable, suggesting that ZC3H14 is not essential. 
These ZC3H14 knockout mice provide us with an optimal model to study the requirement for ZC3H14 in higher order 
brain function. We are currently performing preliminary analyses to define molecular and functional effects of the 
loss of ZC3H14 by examining aspects of neuronal morphology, overall brain architecture, and cognitive behavior. 
Additionally, we will extend our observations from yeast and Drosophila and specifically investigate the role of 
ZC3H14 in 3’-end polyadenylation of mRNA for the first time in the mouse model organism. By understanding how 
ZC3H14 regulates target mRNAs—and thus their expression—in mice, we can begin to define the role of ZC3H14 
in for normal brain function. Our long-term goal is to understand how dysregulation of post-transcriptional control of 
mRNA in neurons leads to neuronal dysfunction and consequently impaired brain function.
629 C Anti-inflammatory function of miR-146a in human primary keratinocytes and atopic 
dermatitis
Ana Rebane1, Toomas Runnel1, Alar Aab1, Beate Rückert2, Julia Maslovskaja1, Mario Plaas5, Maya Zimmermann2, 
Lajos Kemeny4, Külli Kingo3, Cezmi A. Akdis2
1SIAF, University of Zurich, Switzerland; University of Tartu, Estonia; 2SIAF, University of Zurich, 
Switzerland; 3Tartu University, Tartu University Hospital, Estonia; 4University of Szeged, Hungary; 
5University of Tartu, Estonia
Previously, miR-146a has been shown to regulate immune responses in different cell types. We carried out miRNA 
expression profiling and determined elevated expression of miR-146a in keratinocytes and skin from atopic dermatitis 
(AD) patients. Our results show that miRNA-146a is up-regulated by proinflammatory cytokines, such as TNF-alpha 
and IL1-beta, but not by IFN-gamma in primary keratinocytes. To study miR-146a functions further, we transfected 
miR-146a precursors or inhibitors into primary keratinocytes treated with IFN-gamma, TNF-alpha or IL1-beta. These 
experiments reveal that miR-146a hinders the capacity of primary keratinocytes to produce several inflammation-
related cytokines and chemokines, such as CCL5, IL-8 and IL-6 both in mRNA and protein level. Over-expression of 
miR-146a suppresses proliferation and cytokine induced apoptosis of primary keratinocytes. mRNA array and pathway 
analysis of miR-146a-influenced genes demonstrates that miR-146a down-regulates mRNAs encoding proteins from 
NF-kappaB pathway as well as proteins involved in regulation of apoptosis and proliferation. siRNA inhibition of 
two miR-146a targets from NF-kappaB pathway, CARD10 and IRAK1 show that both these proteins are needed for 
production of IL-8, however, only CARD10 influences the expression of CCL5. We also demonstrate that miR-146a-
deficient mice acquire similar Th2 type skin inflammation as wild type mice in mouse AD model. Concordant with the 
in vitro studies, elevated expression of IFN-gamma and CCL5 was detected in inflamed skin from miR-146a-/- mice, 
which indicates that anti-inflammatory function of miR-146a becomes more important in the chronic phase of skin 
inflammation. Together, our data show that miR-146a has a strong anti-inflammatory effect in human keratinocytes 
and its expression level may influence the course and intensity of AD-related skin inflammation. 
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632 C Splice variant specific blood biomarkers of Parkinson’s disease
Jose Santiago1, Clemens Scherzer2, Harvard Biomarker Study Group2, Judith Potashkin1
1The Cellular and Molecular Pharmacology Department, The Chicago Medical School, Rosalind Franklin 
University of Medicine and Science, North Chicago, IL; 2Center for Neurologic Diseases, Harvard Medical 
School and Brigham and Women’s Hospital, Cambridge, MA
Diagnosis of Parkinson’s disease (PD) currently relies on assessment of motor symptoms.  Distinguishing between 
PD and atypical parkinsonian disorders (APD) such as progressive supranuclear palsy and multiple system atrophy 
is sometime difficult based solely on clinical symptoms.  Identification of sensitive minimally invasive risk markers 
would be beneficial so that proper therapeutic intervention may be initiated as early as possible. We used splice 
variant-specific microarrays to identify mRNAs whose expression is altered in peripheral blood of early-stage PD 
patients compared to healthy and neurodegenerative disease controls participating in the Diagnostic and Prognostic 
Biomarkers in Parkinson Disease study.  Thirteen splice variants were identified that can be used to distinguish samples 
from PD patients and controls with 90% sensitivity and 94% specificity1. Six splice variants were identified that may 
be used to classify APD patients with 95% sensitivity and 94% specificity1.  Preliminary results indicate that 9 of 
the risk markers may also be used to distinguish PD patients from healthy controls who participated in the Harvard 
NeuroDiscovery Biomarker study. 
Network analysis of splice variant and transcription/RNA stability PD risk markers and genes associated with PD 
identified the transcription factor HNF4alpha (HNF4a) as a potential therapeutic target for PD. HNF4a plays a role in 
regulating genes involved in gluconeogenesis, lipid metabolism, and fatty acid metabolism.  Hnf4a gene expression is 
up-regulated in the substantia nigra of PD patients2 and the striatum of Parkinsonian mice3.
1Potashkin et al., PLoS one 7: e43595
2Zhang et al., PloS one 5: e11464
3Kurz et a;., PloS one 5: e11464
631 B A novel function for MiR-10a in the pathogenesis of atopic dermatitis
Toomas Runnel1, Maya Zimmermann3, Külli Kingo2, Cezmi A. Akdis3, Ana Rebane4
1Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos; Institute of Molecular 
and Cellular Biology, University of Tartu, Estonia; 2Department of Dermatology, Tartu University Hospital, 
Estonia; 3Swiss Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos; 4Swiss 
Institute of Allergy and Asthma Research (SIAF), University of Zürich, Davos; Institute of Biomedicine, 
University of Tartu, Estonia
MiR-10 family genes, including miR-10a, are located in the Hox gene clusters and are known to be the regulators for Hox 
genes, suggesting they might have a role in fetal development. miR-10a is almost nonexistent in embryonic stem cell lines hES1 
and hES2 and embryonic carcinoma Ep2102 line. miR-10a expression starts to increase during endodermal differentiation and is 
quite high in both embryonic and normal adult liver as well as several other inner organs. Additionally, miR-10a has been reported 
to be expressed in the skin, in conventional and induced regulatory T cells, where it is induced by retinoic acid and TGF-β. Besides 
other functions, retinoic acid and TGF-β control cell proliferation and promote regulatory T cell differentiation.
Our results demonstrate that miR-10a is upregulated in keratinocytes and skin biopsies from atopic dermatitis (AD) patients 
compared to healthy individuals. This finding led us to investigate further, whether miR-10a would be an important player in the 
pathogenesis of AD. First, we stimulated primary keratinocytes and peripheral blood mononuclear cells (PBMCs) with various 
pro-inflammatory cytokines, TGF-β, retinoic acid, histamine and their combinations. Histamine occurs naturally in mast cells 
and basophils, and is released upon allergen cross-linking of IgE antibodies and then triggers an inflammatory response. Our 
experiments revealed miR-10a to be upregulated by histamine in primary keratinocytes, but not by retinoic acid, TGF-β or 
pro-inflammatory cytokines. In PBMCs, retinoic acid stimulation induced notable upregulation of miR-10a, which was further 
enhanced by costimulation with TGF-β, whereas histamine treatment had no significant effect. To study the function of miR-10a 
in inflammatory response of KCs, we overexpressed miR-10a in KCs and observed downregulation of IRAK1 and IL-8 mRNAs. 
IRAK1 and IL-8 are both mediators of innate immune response involved in regulation of NF-kB pathway, but are not predicted as 
direct targets of miR-10a. Computational target prediction with Targetscan revealed transcription factor cAMP responsive element 
binding protein 1, also known as CREB1, and several MAP Kinase pathway genes as relevant and evolutionally conserved targets 
of miR-10a. Currently, we are studying the function of miR-10a in keratinocytes and verifying the the effect of miR-10a on 
putative targets. In conclusion, our data suggest that miR-10a has anti-inflammatory function in keratinocytes and migth influence 
the development of AD.
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634 B Knockdown of human Dyskerin, the protein linked to Dyskeratosis congenita, blocks large 
ribosomal subunit production and activates p53 via RPL5 and RPL11
Katherine Sloan1, Andria Pelava1, Claudia Schneider1, Nicholas Watkins1
1Newcastle University
Dyskerin (Cbf5), NOP10, NHP2 and GAR1 are core components of H/ACA snoRNPs and as such, are important 
for ribosome biogenesis. In yeast, most H/ACA snoRNPs catalyse rRNA pseudouridylation, but two complexes, 
snR30 and snR10, are instead required for 18S rRNA processing. Utp23 is an snR30-specific protein that is also 
essential for just small subunit biogenesis. In humans, H/ACA snoRNPs are important for pseudouridylation although 
little is known about their role in pre-rRNA processing. The human H/ACA snoRNP proteins are also associated with 
scaRNAs (snRNA modification) and the telomerase complex (telomere maintenance). Mutations in Dyskerin, NOP10 
and NHP2 result in a genetic disease, Dyskeratosis congenita (DKC). DKC patients have shorter telomeres, consistent 
with a telomerase defect. There is, however, evidence that this disease may also arise due to a defect in ribosome 
biogenesis.
The interaction between the essential yeast 18S rRNA processing factor, Utp23 and snR30 (U17 snoRNA in 
humans) is conserved in human cells. We now show that human UTP23 is also required for 18S, but not 28S and 5.8S, 
rRNA processing. In contrast, knockdown of the human H/ACA snoRNP proteins surprisingly lead to a block in the 
production of the large ribosomal subunit (LSU) RNAs, 5.8S and 28S, but not 18S rRNA processing. Northern blot 
analysis revealed that depletion of Dyskerin, NOP10, NHP2 or GAR1 blocks the primary cleavage in ITS1 at site 2. 
Similar defects are seen after the knockdown of LSU biogenesis factors, such as BOP1 or RBM28. Our data therefore 
suggest that the function of human UTP23 is separate from that of the H/ACA snoRNPs.
Several genetic diseases, such as Diamond Blackfan anemia, are due to defects in ribosome biogenesis. These 
defects are proposed to result in the accumulation of free ribosomal proteins, RPL5 and RPL11, which bind and 
suppress the activity of HDM2, a suppressor of p53. We show that knockdown of Dyskerin in MCF7 cells leads p53 
activation in an RPL5- and RPL11-dependent manner. Taken together, our data indicate that Dyskerin, and the H/ACA 
snoRNPs are essential for LSU biogenesis in humans. This is in contrast to yeast where they are essential for SSU 
production. Furthermore, we also speculate that DKC patients are likely to have defects in ribosome biogenesis which 
result in increased p53 levels.
633 A Hepatitis C virus induced up-regulation of miR-27 expression promotes hepatic 
triglyceride accumulation
Ragunath Singaravelu1, Ran Chen2, Rodney Lyn1, Daniel Jones3, Rodney Russell3, Shifawn O’Hara4, Jenny Cheng4, 
Lorne Tyrrell2, Yanouchka Rouleau4, John Pezacki1
1University of Ottawa, Ottawa, Ontario, Canada, K1N 6N5, and National Research Council Canada, Ottawa, 
Ontario, Canada, K1A 0R6; 2Department of Medical Microbiology and Immunology, University of Alberta, 
and Li Ka Shing Institute of Virology, Katz Centre for Pharmacy and Health Research, Edmonton, Alberta, 
Canada, T6G 2S2; 3Immunology and Infectious Diseases, Faculty of Medicine, Memorial University of 
Newfoundland, St. John’s, Newfoundland, Canada, A1B 3V6; 4National Research Council of Canada, Ottawa, 
Ontario, Canada, K1A 0R6
MicroRNAs (miRNAs) are small RNAs that post-transcriptionally regulate gene expression.  Their aberrant 
expression is commonly linked with diseased states, including hepatitis C virus (HCV) infection.  To-date, there is a 
limited understanding of the biological relevance of HCV-induced changes in hepatic miRNA expression.  Herein, 
we demonstrate that HCV replication induces the expression of miR-27 in cell culture and in vivo HCV infectious 
models.  Furthermore, we establish that miR-27 overexpression in hepatocytes results in intracellular triglyceride 
accumulation and larger lipid droplets, as observed by triglyceride assays and coherent anti-Stokes Raman scattering 
(CARS) microscopy.  This triglyceride accumulation coincides with miR-27 mediated down-regulation of host factors 
with known roles in triglyceride homeostasis, as measured by qRT-PCR.  These repressed genes include PPAR-α, 
a transcription factor regulating the expression of genes associated with fatty acid catabolism, and ANGPTL3, an 
inhibitor of fatty acid uptake. We further demonstrate that treatment with a PPAR-α agonist, bezafibrate, is able to 
reverse the miR-27 induced lipid accumulation in Huh7 cells.  This miR-27 mediated repression of PPAR-α signaling 
represents a novel potential mechanism of HCV-induced hepatic steatosis.  This link was further demonstrated in vivo 
through the correlation between miR-27 expression levels and hepatic lipid accumulation in HCV infected SCID-
beige/Alb-uPa mice.  Lastly, overexpression of miR-27 was found to inhibit viral replication in hepatoma cells stably 
expressing full-length genomic HCV replicon.  Conclusion: Collectively, our results highlight HCV’s induction of 
miR-27 expression as a novel mechanism of steatosis, as well as the HCV therapeutic potential of miR-27.
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636 A RNase MRP is involved in chondrogenic differentiation
Mandy M.F. Steinbusch1, Marjolein M.J. Caron1, Franziska Eckmann2, Ekkehart Lausch2, Bernhard Zabel2, 
Lodewijk W. van Rhijn1, Tim J.M. Welting1
1Department of Orthopaedic Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands; 
2Centre for Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
The ribonuclease mitochondrial RNA processing (RMRP) gene encodes the RNA component of a multi-protein-RNA 
complex called RNase MRP. This small nucleolar ribonucleoprotein particle is implicated in various cellular processes, including 
ribosomal biogenesis, mitochondrial RNA cleavage, cell cycle regulation and has been linked to telomerase. Mutations in the 
RMRP gene cause Cartilage Hair Hypoplasia (CHH). The phenotypic hallmark of CHH is dwarfism. We therefore hypothesized 
that RNase MRP is involved in chondrogenic differentiation of the growth plate during skeletal development. 
To investigate the expression of RNase MRP during growth plate development RNase MRP protein subunits Rpp25, Rpp38 and 
Rpp40 were immunohistochemically detected in growth plates of 6 week old mice. Identical distribution patterns were observed: 
resting zone chondrocytes expressed RNase MRP proteins. Weak expression levels were observed in proliferative chondrocytes. 
Expression of RNase MRP proteins was clearly detectable in hypertrophic chondrocytes. This temporospatial expression was 
confirmed using in vitro culture models for chondrogenic differentiation. In chondrogenic ATDC5 and human bone marrow 
stem cells RMRP, Rpp25, Rpp30 and Rpp40 expression was upregulated from day 14 in differentiation onward, simultaneously 
with markers for chondrocyte hypertrophy. Chondrocyte proliferation and differentiation has shown to be tightly regulated by 
parathyroid hormone-related peptide (PTHrP), by preventing terminal differentiation of chondrocytes. We therefore investigated 
the effect of PTHrP on RMRP expression during chondrocyte differentiation in ATDC5 cells. PTHrP-mediated inhibition 
of chondrogenic differentiation displayed a dose dependent decrease in RMRP levels, indicating a relation between PTHrP, 
chondrogenic differentiation and RMRP expression. Interfering with RMRP expression using RMRP-specific siRNAs resulted in 
impaired chondrogenic marker expression. In addition, RMRP knockdown resulted in increased expression of early chondrogenic 
transcriptional regulator Bapx1/Nkx3.2, suggesting a regulatory role for RMRP in determining chondrocyte differentiation. 
Moreover, bone morphogenic protein-2, a known stimulator of hypertrophy, increases RMRP expression during chondrogenic 
differentiation of ATDC5 cells. Finally, transdifferentiation of CHH patient-derived dermal fibroblasts into chondrocyte-like cells 
indicated a more than 50% reduced Col10a1 expression in patient-derived fibroblasts as compared to control cultures. 
In conclusion, our data indicate that RNase MRP is involved in chondrogenic development of the growth plate and appears 
to be predominantly associated with terminal hypertrophic differentiation. In addition, our data provide novel insight into the 
underlying molecular mechanism causing the CHH-associated skeletal phenotype. 
635 C Exonic splicing mutations in Mendelian disorders are more prevalent than currently 
estimated: the example of Lynch syndrome-associated MLH1 exon 10 variants
Omar Soukarieh1, Mohamad Hamieh1, Pascaline Gaildrat1, Stéphanie Baert-Desurmont3, Mario Tosi1, Alexandra 
Martins1, Thierry Frébourg2
1Inserm U1079, University of Rouen, Institute for Research and Innovation in Biomedicine, Rouen, France; 
2Inserm U1079, University of Rouen, Institute for Research and Innovation in Biomedicine, Rouen, France; 
and Department of Genetics, University Hospital, Rouen, France; 3Department of Genetics, University 
Hospital, Rouen, France
The identification of a causal mutation is essential for molecular diagnosis and clinical management of Mendelian diseases. 
Even if new-generation exome sequencing has greatly improved the detection of exonic changes, the biological interpretation of most 
exonic variants remains challenging. More often than not, the impact of exonic variants is evaluated by assuming a direct effect on 
protein sequence. However, it is currently known that exonic variants can also affect RNA maturation, stability and/or translation. 
To evaluate the prevalence of RNA splicing mutations among disease-associated exonic variants we use MLH1, a gene 
implicated in hereditary colorectal cancer (also called Lynch Syndrome), as a model system. Here, we analyzed the effect on 
splicing of all single-substitutions reported on the Leiden Open Variation Database in the exon 10 of MLH1 (n=22), including 
15 missense, 3 nonsense and 4 synonymous mutations. Ex vivo splicing assays with representative minigenes revealed that 17 
out of the 22 mutations had an impact on splicing. We detected the following alterations: (i) creation of an internal splice site, 
(ii) increased exon 10 inclusion, and (iii) increased exon 10 skipping.  Remarkably, a significant number of variants located 
away from splice sites increased/decreased exon 10 inclusion (n=3/n=7), an effect that could not be predicted by commonly 
used bioinformatics approaches. These variants were further analyzed by using a completely heterologous minigene particularly 
sensitive to the presence of splicing regulatory sequences. Our results indicate that indeed these mutations alter exonic splicing 
regulatory elements.  This observation led us to test a newly developed in silico tool aiming at detecting exonic splicing regulatory 
elements. With very few exceptions, we found the predictions produced by this new tool to be concordant with our minigene-
derived data. When possible, results were also compared with those obtained by analyzing RNA extracted from patients’ blood 
cells, and found to be concordant.  
Overall, this study shows that the exon 10 of MLH1 is very sensitive to splicing mutations, and indicates that the number 
of exonic splicing mutations in Lynch Syndrome, and very probably in many other Mendelian disorders, may be currently 
underestimated. Moreover, our results highlight the predictive potential of a newly developed in silico tool in pinpointing exonic 
variants that affect RNA splicing.
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638 C Spliceosome Integrity is Defective in the Motor Neuron Diseases ALS and SMA
Hitomi Tsuiji1, Yohei Iguchi2, Asako Furuya1, Kenji Sakimura3, Shigeo Murayama4, Gen Sobue2, Koji Yamanaka1
1RIKEN Brain Science Institute, Saitama, Japan; 2Nagoya Univ. Grad. Schl. Med., Aichi, Japan; 3Niigata 
University, Niigata, Japan; 4Tokyo Metropolitan Geriatric Hospital, Tokyo, Japan
Two motor neuron diseases, amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA), are caused 
by distinct genes involved in RNA metabolism, TDP-43 and FUS/TLS, and SMN, respectively. However, whether 
there is a shared defective mechanism in RNA metabolism common to these two diseases remains unclear. Here, 
we show that TDP-43 and FUS/TLS localize in nuclear Gems through an association with SMN, and that all three 
proteins function in spliceosome maintenance. We also show that in ALS, Gems are lost, U snRNA levels are up-
regulated and spliceosomal U snRNPs abnormally and extensively accumulate in motor neuron nuclei, but not in the 
temporal lobe of FTLD with TDP-43 pathology. This aberrant accumulation of U snRNAs in ALS motor neurons is 
in direct contrast to SMA motor neurons, which show reduced amounts of U snRNAs, while both have defects in the 
spliceosome. These findings indicate that a profound loss of spliceosome integrity is a critical mechanism common to 
neurodegeneration in ALS and SMA, and may explain cell-type specific vulnerability of motor neurons (Tsuiji et al., 
EMBO Molecular Medicine, in press).  We also found that TDP-43 lacking its Gly-rich region can regulate splicing of 
one of its target Sortilin1, but does not localize in Gem, does not associate with snRNPs, and shows reduced activity 
to down-regulate the expression of its own mRNA. These results indicate that the C-terminal Gly-rich region of 
TDP-43, in which most ALS-mutations reside, is important for full activity of TDP-43 and may play crucial role in 
neurodegeneration. To verify our hypothesis, we generated knock-in mice with TDP-43 lacking the Gly-rich region, 
and the expression of TDP-43 lacking the Gly-rich region in brain and spinal cord was confirmed. Further progress 
will be discussed.
637 B TDRD3 recruits FMRP and the topoisomerase TOP3ß to spliced mRNAs and provides a 
molecular link between schizophrenia and fragile X syndrome
Georg Stoll1, Bastian Linder1, Cornelia Brosi1, Aarno Palotie4, Nelson Freimer2, Olli Pietilainen4, Oliver Ploettner3, 
Utz Fischer1
1University of Wuerzburg; 2Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and 
Human Behavior, UCLA, Los Angeles, California, USA; 3Pharma Research and Early Development, Roche 
Diagnostics GmbH, Germany; 4Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK
The fragile X mental retardation protein (FMRP) affected in fragile X syndrome is a key regulator of eukaryotic 
mRNA translation. However, how it is recruited into target mRNA-protein complexes (mRNPs) remains enigmatic. 
We have previously identified an interactor of FMRP, the Tudor domain containing protein TDRD3, whose binding is 
disrupted by the highly pathogenic I304N missense mutation of FMRP. TDRD3 also associates with the exon junction 
complex (EJC) and binds asymmetrically dimethylated arginines (aDMA) in histones and the C-terminal domain of 
RNA-polymerase II. Therefore, we reasoned that TDRD3 might function in the recruitment of FMRP to mRNPs. 
Here we report that FMRP and TDRD3 form a complex with a third component, the DNA topoisomerase TOP3β. 
Interestingly, deletion of the gene encoding TOP3β is associated with schizophrenia and intellectual disability. We 
provide evidence that this enzyme, previously implicated only in the unwinding of DNA, is a cytoplasmic RNA binding 
protein (RBP). Thus, the etiologies of schizophrenia and FXS might intersect at the post-transcriptional regulation of 
mRNPs containing TOP3β and FMRP. Interestingly, formation of the TOP3β-TDRD3-FMRP complex and its ability 
to recognize aDMA are essential for the concomitant integration of TOP3β and FMRP into mRNPs. The biochemical 
composition of these mRNPs and their association with polyribosomes further suggests that they are engaged in the 
pioneer round of translation. Hence, our data uncover a novel mechanism for the recruitment of FMRP into mRNPs 
that is independent of RNA cis-elements and provide a molecular link between two neuropsychiatric disorders.
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640 B Investigating the role and regulation of microRNA-10a in Acute Myeloid Leukaemia 
bearing the Nucleophosmin1 mutation
Thi Thanh Vu1, Catalina Palma1, Adam Bryant1, Dima Al Sheikha1, Vivek jayaswal2, David Ma1
1Blood, Stem Cells and Cancer Research, St Vincent’s Hospital, Sydney, Australia; 2School of Mathematics 
and Statistics, Sydney Bioinformatics Centre for Mathematical Biology, University of Sydney, SYDNEY, 
NSW, Australia
An increasing body of evidence has demonstrated the role of microRNAs in cancers. Acute Myeloid Leukemia (AML) 
associated with Nucleophosmin1 gene mutation (NPM1c+) accounts for a third of AML cases (1). Our previous work has reported 
a unique microRNA signature in AML-NPM1c+ samples which is dominated by 19.6-fold increase in hsa-miR-10a expression 
in the NPM1c+ AML compared to wild type (wt) samples (2). We have demonstrated the role of miR-10a in apoptosis using 
human OCI-AML3 cell line, which is the only cell line known to harbour NPM1c+.  The knock down of miR-10a results in 
an increase in cell death and a decrease in colony forming potential. These effects thought to be mediated through miR-10a 
targeting of ARNT, GTFH1, ID4, KLF4, MAPRE1, NR4A3, RB1CC1 and TFAP2C (confirmed by luciferase assay), all of which 
are associated with neoplastic transformation. This suggests that miR-10a may act as a pro-survival factor in vitro. We aim to 
expand our study on miR-10a’s leukaemic role in AML by knockdown of miR-10a in AML clinical samples. MiR-10a has been 
previously reported to be negatively regulated by methylation (3). To explore the mechanism that leads to the dysregulation of 
miR-10a in NPMc+AML, we assess the role of methylation of the CpG islands, which is located within 2kb upstream of the 
miR-10a promoter. Mutations in DNA methyltransferase, DNMT3A has been frequently found in NPMc+AML (4), leading to 
our investigation if DNMT3A mutations are associated with differential methylation patterns in NPM1c+AML, explaining the 
specificity of miR-10a overexpression in this AML subtype. 
1. Falini, B., Gionfriddo, I., Cecchetti, F., Ballanti, S., Pettirossi, V., and Martelli, M. P. (2011) Acute myeloid leukemia with 
mutated nucleophosmin (NPM1): any hope for a targeted therapy? Blood reviews 25, 247-254
2. Bryant, A., Palma, C. A., Jayaswal, V., Yang, Y. W., Lutherborrow, M., and Ma, D. D. (2012) miR-10a is aberrantly 
overexpressed in Nucleophosmin1 mutated acute myeloid leukaemia and its suppression induces cell death. Molecular 
cancer 11, 8
3. Han, L., Witmer, P. D., Casey, E., Valle, D., and Sukumar, S. (2007) DNA methylation regulates MicroRNA expression. 
Cancer biology & therapy 6, 1284-1288
4. Ley, T. J., Ding, L., Walter, M. J., McLellan, M. D., et al. (2010) DNMT3A mutations in acute myeloid leukemia. The New 
England journal of medicine 363, 2424-2433
639 A The RNA-binding protein Quaking critically regulates vascular smooth muscle cell 
phenotype
Eric van der Veer1, Ruben de Bruin1, Adriaan Kraaijeveld1, Margreet de Vries1, Tonio Pera1, Filip Segers3, Janine 
van Gils1, Marko Roeten1, Ilze Bot2, Anique Janssen3, Pieter Hiemstra1, Ton Rabelink1, Antoine de Vries1, Paul 
Quax1, Wouter Jukema1, Erik Biessen3, Anton Jan van Zonneveld1
1Leiden University Medical Center; 2Leiden/Amsterdam Center for Drug Research; 3Maastricht University 
Medical Center
Rationale: RNA-binding proteins are critical regulators of post-transcriptional RNAs, and can influence pre-
mRNA splicing, mRNA localization, and stability. The RNA-binding protein Quaking (QKI) is essential for embryonic 
blood vessel development. However, the role of QKI in the adult vasculature, and in particular in vascular smooth 
muscle cells (VSMC), is currently unknown. 
Objective: We sought to determine the role of the RNA-binding protein Quaking (QKI) in regulating adult VSMC 
function and plasticity.
Methods and Results: We identified that the RNA-binding protein Quaking (QKI) is highly expressed by 
neointimal VSMCs of human coronary restenotic lesions, but not in healthy vessels. In a mouse model of vascular 
injury, we observed reduced neointima hyperplasia in Qkv mice, which have decreased QKI expression. Concordantly, 
abrogation of QKI attenuated fibroproliferative properties of VSMCs, while potently inducing contractile apparatus 
protein expression, rendering non-contractile VSMCs with the capacity to contract. We identified that QKI localizes 
to the spliceosome, where it interacts with the myocardin pre-mRNA and impacts the myocd_v3 / myocd_v1 balance. 
This shift in the transcriptional coactivation activity of Myocardin following arterial damage is tightly coupled with 
QKI expression levels. 
Conclusions: We propose that QKI is a central regulator of VSMC phenotypic plasticity and that intervention in 
QKI activity can ameliorate pathogenic, fibroproliferative responses to vascular injury. 
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642 A FUS mutations strongly promote FUS-SMN and FUS-RNAP II interactions
Tomohiro Yamazaki1, Robin Reed1
1Department of Cell Biology, Harvard Medical School
The motor neuron disease ALS has no known treatment and disease mechanisms are not understood. Previously, 
we characterized the interactome of the ALS-causative protein FUS and discovered that FUS associates abundantly 
with U1 snRNP and SMN, the protein deficient in the motor neuron disease spinal muscular atrophy (SMA). These 
and other data indicate that ALS and SMA share a molecular pathway (Yamazaki et al., Cell Reports 2012, 2:799). 
To gain insights into the function of FUS and its role in ALS, we have now carried out extensive analysis of the 
FUS interactome using FUS antibodies recognizing different epitopes. We found that FUS associates with RNAP 
II as well as several transcription-related proteins. To gain insights into the potential roles of these factors in ALS 
pathogenesis, we analyzed their interactions with FUS deletion mutants. As reported previously (Wang et al Nature 
2008, 454:126), our data indicate that FUS forms an intramolecular interaction in which its N and C terminal regions 
bind to one another. We find a striking increase in the association of both SMN and RNAP II with FUS when it 
contains deletions that disrupt this intramolecular interaction. U1 snRNP binds with similar efficiency to full length 
FUS and the FUS mutants.  Moreover, we find that the N-terminal prion-like domain and the C-terminal RGG-rich 
region show increased levels of binding to a number of proteins in nuclear extract.  Thus, ALS-causing mutations in 
these regions of FUS could be pathogenic due to the increased interaction with SMN, RNAPII, and/or the proteins that 
we are in the process of identifying.
641 C RNA binding protein FUS acts to mediate nuclear-mitochondrial communication
Jane Wu1
1Northwestern University
Genetic mutations in & dysregulation of the gene encoding Fused in Sarcoma (FUS) have been associated with 
FUS proteinopathies, neurodegenerative disorders including ALS and frontotemporal lobar degeneration with FUS 
pathology (FTLD-FUS). However, cellular defects underlying FUS proteinopathies are unclear. Our recent work 
show sthat FUS expression leads to increased fragmentation of mitochondria and production of reactive oxygen 
species (ROS). Immunoelectron microscopy (IEM) and biochemical fractionation experiments reveal that FUS is 
detected not only in the nucleus but also in association with mitochondria. Increased FUS protein levels accompanied 
by marked mitochondrial damage have been detected in brain samples of FUS proteinopathy. Screening genetic 
modifiers of FUS-induced neurodegeneration using transgenic flies expressing the human FUS led to identification 
of mitochondrial protein HSP60 whose downregulation partially rescued FUS-induced neurodegeneration. Our study 
uncovers a previous unknown role of FUS in mediating nuclear-mitochondrial communication. Our data provide 
evidence for mitochondrial damage induced by FUS expression and suggest that mitochondrial defects may be an early 
event in FUS proteinopathies. Slowing down or reversing mitochondrial damage may provide therapeutic benefits in 
treating these devastating diseases. Mechanisms underlying FUS-induced mitochondrial impairment and implications 
of our findings will be discussed.
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644 C Deep-sequencing of the Peach Latent Mosaic Viroid Reveals New Aspects of Population 
Heterogeneity
François Bolduc1, Jean-Pierre Sehi Glouzon2, Rafael Najmanovich1, Shengrui Wang3, Jean-Pierre Perreault1
1Département de biochimie, Faculté de médecine et des sciences de la santé, Pavillon de Recherche Appliquée 
au Cancer, Université de Sherbrooke, Sherbrooke, Québec, Canada.; 2Département d’informatique, 
Faculté des sciences, Département de biochimie, Faculté de médecine et des sciences de la santé, Pavillon de 
Recherche Appliquée au Cancer, Université de Sherbrooke, Sherbrooke, Québec, Canada.; 3Département 
d’informatique, Faculté des sciences, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Viroids are small circular single-stranded infectious RNAs that are characterized by a relatively high mutation level. 
Knowledge of their sequence heterogeneity remains largely elusive and previous studies, using Sanger sequencing, 
were based on a limited number of sequences. In an attempt to address sequence heterogeneity from a population 
dynamics perspective, a GF305-indicator peach tree was infected with a single variant of the Avsunviroidae family 
member Peach latent mosaic viroid (PLMVd). Six months post-inoculation, full-length circular conformers of PLMVd 
were isolated and deep-sequenced. We devised an original approach to the bioinformatics refinement of our sequence 
libraries involving important phenotypic data, based on the systematic analysis of hammerhead self-cleavage activity. 
Two distinct libraries yielded a total of 2,186 different PLMVd variants. Sequence variants exhibiting up to ~20% of 
mutations relative to the inoculated viroid were retrieved, clearly illustrating the high level of divergence dynamics 
within a unique population. Moreover, we show that ~50% of positions remained perfectly conserved, including 
several small streches as well as a small motif reminiscent of a GNRA tetraloop which are the result of various 
selective pressures. Using a novel hierarchical clustering algorithm, the different variants harvested were subdivided 
into either 7 or 8 clusters depending upon the library analyzed. We found that most sequences contained an average 
of 4.6 to 6.3 mutations compared to the variant used to initially inoculate the plant. This study provides a reliable 
pipeline for the treatment of viroid deep-sequencing. It also sheds new light on the extent of sequence variation a 
viroid population can sustain, and which may give rise to a quasi-species.
643 B Endogenous shRNA Induces the Large-scale Trans-determination of Mesenchymal Stem 
Cells into Hematopoietic Stem Cells with High Purity.
James Yin1
1The military general hospital of Beijing, and Institute of Biophysics
Our preliminary studies in 2008 discovered 2564 new endogenous short hairpin RNAs (shRNAs) in human by 
bioinformatics and solexa sequencing, one (termed as shR-EID1 or shR-337) of which has been found to induce 
conversion of MSCs into HSCs by inhibiting the expression of EIA-like inhibitor of differentiation 1(EID1). EID1 
interacts with CREB binding protein (CBP) and p300, which have at least 400 interacting protein partners (25), and 
these proteins play a crucial role during hematopoiesis. Mesenchymal stem cells (MSCs) can differentiate into cells 
of bone, endothelium, adipose tissue, cartilage, muscle, and brain. However, whether they can transdeterminate into 
hematopoietic stem cells (HSCs) remains unsolved. 
We report here that human MSCs with CD44+,CD29+, CD105+, CD166+,CD133-,and CD34- could differentiate 
into hematopoietic stem cells (CD150+/CD49f+/CD133+/CD34+) and their descending blood cells in vitro, when 
transfected with a new endogenous shRNA.  The sRNA was high-effectively delivered into MSCs by a novel peptide 
means. These induced MSC-HSCs could form different types of hematopoietic colonies as nature-occurring HSCs 
did. Upon transplantation into sublethally irradiated NOD/SCID mice, these MSC-HSCs engrafted and differentiated 
into all hematopoietic lineages such as erythrocytes, lymphocytes, myelocytes and thrombocyte. Furthermore, we 
demonstrated the first evidence that the transdetermination of MSCs was induced by acetylation of histone proteins 
and activation of many transcriptional factors. These transfected MSCs could be converted into other types of stem 
cells in the presence of appropriate cytokines. Together, our findings identify the endogenous shRNA that dictates a 
directed differentiation of MSCs toward HSCs and open up a new source for HSCs used for the treatment of blood 
diseases and artificial stem cell-made blood.
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646 B Mechanistic insights into EMCV-IRES translation initiation
Nathalie Chamond1, Jules Deforges1, Nathalie Ulryck1, Audrey Brossard2, Bruno Sargueil1
1CNRS - Université Paris Descartes - UMR8015; 2CNRS - Université Paris Descartes - UMR8015
Most of eukaryotic mRNAs are translated by the cap-dependent pathway which relies on the recognition of the 
cap structure. This is mediated by the eIF4F complex which contains the eIF4A helicase and the eIF4G platform which 
coordinates 40S and mRNA association. Viruses have developed many ways to hijack their host translation machinery, 
among which, internal entry of the ribosome which allows a direct recruitment of the initiation complex near or at the 
AUG codon, without requiring a 5’-cap. This mechanism relies on RNA structures called IRESes (Internal Ribosome 
Entry Sites), generally present in the 5’-UTR. Although numerous viral IRESes have been identified, they differ 
from one another, leading to the hypothesis that many different mechanisms exist. Initiation of translation on type II 
IRESes such as those present in the Encephalomyocarditis Virus (EMCV) and in the Foot and Mouth Disease Virus 
(FMDV) recruit eIF4G/A which in the presence of ATP restructures the border of the IRES. These conformational 
changes are thought to allow the recruitment of 43S pre-initiation complexes via the eI4G/eIF3 interaction. However, 
eIF4G mutants lacking the ability to contact eIF3 efficiently promote initiation on EMCV-IRES. This prompted us to 
evaluate a direct binding of the 40S subunit to EMCV-IRES. By using a combination of approaches we were able to 
demonstrate that EMCV-IRES directly binds the 40S subunit leading to a stable binary complex. Deletion mutants 
show that the region between the H and L domains is necessary for optimal 40S binding which is in agreement with 
their requirement for optimal IRES activity. This was further confirmed by footprinting analysis that identifies the H 
domain as part of the 40S binding site. In addition, as previous results on EMCV translation indicated that the nature 
of the downstream gene interferes with translation efficiency, we analyzed 40S binding from constructs presenting 
different open reading frames. Toe-print analysis of these RNAs in the presence of 40S subunits unravels a specific 
structure in the open reading frame that influences positioning of the mRNA in the 40S decoding groove. Taken 
together, these results allow us to refine the model for EMCV-IRES translation initiation.
645 A Reduced HBsAg expression in occult HBV infection: alteration of a post-transcriptional 
regulatory mechanism?
Daniel Candotti1, Jean-Pierre Allain2
1National Health Service Blood & Transplant UK; 2Department of Haematology, University of Cambridge, UK
Background and aims. Occult hepatitis B virus (HBV) infection (OBI) is defined as low plasma level of HBV DNA with 
undetectable HBV surface antigen outside the pre-seroconversion window period. Previous work suggested that some OBI 
might be associated with various mutations in genomic regulatory elements negatively affecting viral replication. Recent studies 
suggested that Pre-S2/S mRNA splicing might be essential for S protein expression. On the other hand, such splicing must be 
strongly controlled to prevent the accumulation of nonfunctional spliced S mRNA. The functional relationship between S mRNA 
splicing and S protein expression and the potential negative effect of specific mutations was investigated in OBI carriers.
Methods. The Pre-S2/S mRNA 5’ splice donor site sequence of 176 OBI and 381 HBsAg+ control strains (genotype A-E) 
were analyzed. The influence of mutations on local RNA folding was evaluated using MFOLD program. The effect of selected 
mutations on splicing and S protein expression was tested by transient transfection experiments in Huh7 cells with cloned S gene 
with or without the distant HBV posttranscriptional regulatory element (PRE) of OBIs and controls, as well as mutated whole 
genome.
Results. In vitro S mRNA splicing was confirmed irrespective of HBV genotype and was effective whether an autologous 
or heterologous promoter controlled S gene transcription. Splicing positions seemed to be mainly conserved across strains but 
splicing variants were also found. Irrespective of HBV genotype, 51% of OBI sequences presented substitutions adjacent to 
the 5’ splicing donor site compared to 31% of controls (P<0.05). These substitutions were predicted to disrupt a putative stem-
loop structure in 54% of OBI variants. OBI strains appeared to be competent in S protein expression. However, the amount of 
HBsAg in culture supernatant was significantly lower in the majority of cells transfected with the S sequences from OBI strains 
when compared to HBsAg+ strains. Mutating the 5’ donor site prevented splicing and resulted in significant reduction of HBsAg 
production. Similarly, the double mutation A453G/G463A observed in two OBI strains interfered with splicing and HBsAg 
production.
Conclusions. These preliminary data indicate that the sequence and context surrounding a 5’ splicing site within the S 
gene is important for efficient HBV S mRNA expression. This region within the S gene appears to be a new post-transcriptional 
regulatory element in addition to PRE essential for the efficient expression of unspliced S mRNA among HBV strains.
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648 A HMGA1 interaction with HIV-1 TAR modulates basal and Tat-dependent HIV transcription.
Sebastian Eilebrecht1, Emmanuelle Wilhelm2, Brendan Bell2, Arndt Benecke1
1Institut des Hautes Etudes Scientifiques, Bures sur Yvette, France & VRI, Créteil, France; 2De´partement de 
Microbiologie et d’Infectologie, Universite´ de sherbrooke, Sherbrooke, Canada
During transcription of the HIV genome the transactivating response element (TAR) located in the nascent viral 
transcript is playing a key role as a binding platform for host cellular co-factors as well as the viral transactivator of 
transcription (Tat). The Tat/TAR interaction is involved in the activation and recruitment of the host cellular positive 
transcription elongation factor b (P-TEFb), which subsequently releases the transcriptional block of RNA polymerase 
II in order to activate efficient viral transcription elongation. 
We have recently identified the chromatin master regulator HMGA1 to interact with 7SK non-coding RNA in a 
regulatory fashion [1,2]. Here we show a highly specific interaction between HMGA1 and HIV-1 TAR, which leads to 
a reduction of HIV-1 promoter activity both in the absence and in the presence of Tat. HMGA1 competes with Tat for 
TAR binding and 7SK RNA competes with HIV-1 TAR for HMGA1 binding. These results support a model, in which 
HMGA1 blocks the binding of transcription activating factors --- such as Tat --- to TAR [3].
Thus, the interaction of HMGA1 with HIV-1 TAR might contribute to viral latency, which is the main reason for 
the inability of HAART to cure HIV infection.
1. Eilebrecht, S., Brysbaert, G., Wegert, T., Urlaub, H., Benecke, B.J. and Benecke, A. (2011) 7SK small nuclear RNA directly 
affects HMGA1 function in transcription regulation. Nucleic Acids Res, 39, 2057-2072.
2. Eilebrecht, S., Becavin, C., Leger, H., Benecke, B.J. and Benecke, A. (2011) HMGA1-dependent and independent 7SK 
RNA gene regulatory activity. RNA Biol, 8.
3. Eilebrecht S., Wilhelm E., Benecke B.-J., Bell B. and Benecke A. (2013) HMGA1 directly interacts with TAR to modulate 
basal and Tat-dependent HIV transcription. RNA Biol, in press.
647 C Modulation of HIV-1 gene expression by binding of UHM-containing splicing factors to a 
ULM motif in the Rev protein
Lorenzo Corsini1, Michelle Vincendeau3, Marta Pabis1, Kostas Tripsianes1, Thomas Güttler4, Toby Gibson2, Ruth 
Brack-Werner3, Michael Sattler1
1Institute of Structural Biology, Helmholtz Zentrum München, Neuherberg, Germany, Biomolecular NMR 
and Center for Integrated Protein Science Munich, Department Chemie, TU München, Garching, Germany; 
2EMBL Heidelberg, Germany; 3Institute of Virology, Helmholtz Zentrum München, Neuherberg, Germany; 
4MPI for Biophysical Chemistry, Göttingen, Germany
Human immunodeficiency virus type 1 (HIV-1) is a lentivirus encoding the Gag, Pol and Env proteins common 
to all retroviruses and several specific regulatory proteins. The HIV-1 regulatory protein Rev is essential for virus 
replication and ensures the expression of partially spliced and unspliced transcripts. Rev binds to the Rev-responsive 
element (RRE) in viral mRNAs in the nucleus and recruits factors required for the export of these viral mRNAs to the 
cytoplasm. Numerous additional functions have been shown for Rev and Rev has also been implicated in regulating 
the splicing of viral transcripts. 
We identified a ULM-like motif in the RRE-binding region of the Rev protein. ULMs (UHM ligand motifs) mediate 
protein-protein interactions and modulate spliceosome assembly through their binding to UHMs (U2AF homology 
motifs). We therefore investigated whether the Rev ULM can interact with UHMs present in host splicing factors. 
Isothermal titration calorimetry and NMR titration experiments showed that Rev ULM binds to the UHMs of SPF45 
and U2AF65. The crystal structure of the SPF45-UHM bound to the Rev ULM revealed that the Rev ULM adopts an 
extended conformation upon binding to SFP45. Structural analysis and biochemical experiments demonstrate that the 
highly conserved W45 in the Rev ULM is crucial for Rev-UHM interactions. Moreover, W45 was shown to ensure the 
ability of SPF45 to displace single Rev subunits from Rev-RRE SLIIB oligomeric complexes. Finally, we show, that 
W45 is important for proper processing of HIV transcripts in human cells. We propose that W45 and thus Rev-ULM 
interactions with UHM splicing factors contribute to the regulation of HIV-1 splicing and gene expression.
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650 C Domain interactions in adenovirus virus-associated RNA I mediate high-affinity PKR 
binding
Katherine Launer-Felty1, James Cole2
1Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT, USA; 2Department of 
Chemistry, Department of Molecular and Cell Biology, University of Connecticut, Storrs, CT, USA
Adenovirus virus-associated RNA I (VA I) is a short, non-coding transcript that functions to inhibit the activity 
of protein kinase R (PKR), a component of the innate immunity pathway. PKR recognizes dsRNA and other RNAs 
containing duplex regions and is activated via dimerization and autophosphorylation.  VA I contains three domains: an 
apical stem-loop, a highly-structured central domain, and a terminal stem.   Although all three domains contain duplex 
regions that are of appropriate length for PKR recognition, previous work suggests that PKR binding is localized to 
the apical stem and central domain regions.  We have characterized the stiochiometry and affinity of PKR binding 
to VA I and several deletion constructs using analytical ultracentrifugation.  PKR binds to wild-type VA I with a 1:1 
stoichiometry and a surprisingly high affinity (Kd = 334nM).  Although PKR is capable of binding the isolated terminal 
stem, deletion of this domain does not affect PKR binding affinity or inhibition of autophorylation.  Consistent with 
this observation, chemical probing data show that the secondary and tertiary structure of the apical stem and central 
domain do not change upon removal of the terminal stem. PKR is capable of binding to the isolated apical stem, albeit 
with greatly-reduced affinity, but does not bind to the isolated central domain. These results indicate that interactions 
between the apical stem and the central domain are necessary to form a high-affinity PKR binding site.  Our data 
support a model whereby VA I functions as a PKR inhibitor because it binds a monomer tightly but does not permit 
PKR dimerization.
649 B Thermodynamics of HIV-1 Reverse Transcriptase in action elucidates the mechanism of 
action of non-nucleoside inhibitors
Bec Guillaume1, Meyer Benoit1, Marie-Aline Gerard1, Jessica Steger2, Katja Fauster2, Ronald Micura2, Philippe 
Dumas1, Eric Ennifar1
1Architecture et Réactivité des ARN, CNRS/Université de Strasbourg, Institut de Biologie Moléculaire et 
Cellulaire, 15 rue René Descartes, 67084 Strasbourg, France; 2Institute of Organic Chemistry, Center for 
Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, 6020 Innsbruck, Austria
HIV-1 reverse transcriptase (RT) is a heterodimeric enzyme that converts the genomic viral RNA into proviral 
DNA. Despite intensive biochemical and structural studies, direct thermodynamic data regarding RT interactions 
with its substrates are still lacking. Here we addressed the mechanism of action of RT and of non-nucleoside RT 
inhibitors (NNRTIs) by isothermal titration calorimetry (ITC). Using a new incremental-ITC approach, a step-by-step 
thermodynamic dissection of the RT polymerization activity showed that most of the driving force for DNA synthesis is 
provided by initial dNTP binding. Significant differences are observed between nucleotide incorporation in elongation 
(RT bound to a DNA duplex) and in initiation (RT bound to the HIV-1 Primer Binding Site RNA/tRNALys(3) duplex) 
of reverse-transcription. Surprisingly, thermodynamic and kinetic data led to a complete re-interpretation of the 
mechanism of inhibition of NNRTIs. Binding of NNRTIs to preformed RT/DNA or RNA complexes is hindered by 
a kinetic barrier and NNRTIs mostly interact with free RT. Once formed, RT/NNRTI complexes bind NA either in a 
seemingly polymerase-competent orientation, or form high-affinity dead-end complexes, both RT/NNRTI/DNA or /
RNA complexes being unable to bind the incoming nucleotide substrate.
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652 B Structural rearrangements of HIV-2 RNA during dimerization
Katarzyna Pachulska-Wieczorek1, Katarzyna J. Purzycka1, Ryszard W. Adamiak1
1RNA Structure and Function Laboratory, Institute of Bioorganic Chemistry, Polish Academy of Sciences
Human retroviruses HIV-1 and HIV-2 are characterized by similar genome organization, virion structure and 
replication cycle. Like other retroviruses, they possess dimeric RNA genome assembled from two identical sense 
strands, interacting near their 5′-ends. The full-length HIV-2 RNA serve both as genomic RNA which are packaged 
into nascent virions and as the template for translation of Gag and Gag-Pol precursor polyproteins. HIV-2 dimerization 
and encapsidation signals are linked and located in the leader RNA region (5’ UTR). Dimerization is a regulated 
process that involves several RNA structural changes governed by the Gag and NC proteins. 
In order to gain a deeper understanding of HIV-2 RNA dimerization and packaging, we applied chemoenzymatic 
probing to the in vitro assembled loose dimer. Our studies indicated that the dimeric structure is held by the direct 
interactions of the palindromic sequences within SL1 and TAR domains. Our combined structural and functional 
analysis allowed us to characterize previously unknown structural rearrangements and extensive tertiary interactions 
crucial for the mature dimer formation. It is presumed that in the case of HIV-2, co-tranlational capture of the full-
length RNA by nucleocapsid domain of Gag ensures encapsidation specificity Our results on nucleocapsid protein 
binding provide new insight into mechanism of HIV-2 genomic RNA differentiation from other gag mRNA species. 
651 A Phosphorylation of hepatitis C virus RNA polymerase Ser29 and Ser42 by PRK2 regulates 
HCV replication
Jae-Su Moon1, Song-Hee Han1, Jong-Won Oh1
1Yonsei Univeristy
Post-translational phosphorylation has important roles in regulating the structure and function of proteins and 
modulating protein-protein interactions for the rapid regulation of phosphosignaling pathways. In virus-infected cells, 
the function, stability, and subcellular localization of virus-encoded proteins can be altered by host kinase-mediated 
phosphorylation. Indeed, growing numbers of virus-encoded phosphoproteins have been reported recently and they 
are implicated in viral pathogenesis, virion assembly, and genome replication. For plus-strand RNA viruses, the viral 
RNA genome is replicated by virus-encoded RNA-dependent RNA polymerases (RdRps). RdRps of several plus-
strand RNA viruses, including the hepatitis C virus (HCV), are phosphoproteins, and the phosphorylation of some 
viral RdRps has been shown to play an important role in viral replication. 
The nonstructural protein (NS) 5B protein of HCV is the viral RdRp essential for viral RNA genome replication. 
We have previously shown that HCV viral genome replication is functionally linked to NS5B phosphorylation status 
regulated by the protein kinase C-related kinase 2 (PRK2). Here, we use a combination of biochemical studies and 
reverse genetics to show that the phosphorylation of HCV NS5B is required for viral RNA replication. Phosphoamino 
acid analysis of both in vitro and metabolically-labeled NS5B showed that PRK2 phosphorylates NS5B exclusively 
at the serine residues. By in vitro kinase assays using a series of deletions and site-specific mutants of NS5B and 
mass spectrometry analysis, we identified two PRK2 phosphorylation sites, Ser29 and Ser42, on the Δ1 finger loop 
region of NS5B that extensively interacts with the thumb subdomain of NS5B. Colony-forming assays using drug-
selectable HCV subgenomic RNA replicons revealed that the prevention of phosphorylation by Ala substitution at 
either Ser29 or Ser42 impairs HCV RNA replication. Furthermore, reverse genetics studies using HCV infectious 
clones with mutations at Ser29 or Ser42 showed that preventing phosphorylation resulted in the suppression of viral 
replication. Molecular modeling revealed that phosphorylation of NS5B stabilizes the interactions between the Δ1 
loop and the thumb subdomain, which are important for the formation of the closed conformation of NS5B known to 
be important for de novo RNA synthesis. Collectively, our results provide evidence that HCV NS5B phosphorylation 
has a regulatory role during the HCV RNA replication process.
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654 A DNA habitat and RNA inhabitants: Relevant questions of a qualitative RNA sociology
Guenther Witzany1
1Telos - Philosophische Praxis
Background: Most molecular biological concepts result out of physical chemical assumptions on the genetic code 
that are basically more then 40 years old. Recent empirical data on genetic code compositions and rearrangements by 
mobile genetic elements and non-coding RNAs together with results of virus research and their role in evolution does 
not really fit into these concepts.
Results: If we look at the abundance of regulatory RNAs and persistent viruses in host genomes, the key players 
that edit genetic code of host genomes are consortia of interacting RNA agents and viruses that drive evolutionary 
novelty, integration into cellular DNA and regulation of cellular processes in all steps of development. There is 
increasing evidence that all cellular life is colonized by exogenous and/or endogenous viruses in a non-lytic but 
persistent lifestyle. They prefer cellular genomes as habitat and determine genetic host (group) identity. 
Conclusions: If we take a step away from the mainstream molecular biology (including the physical chemical 
properties of quasispecies and mutant spectra) and systems biology (non-reductionistic physicalism) and move 
towards a more consortial thinking of cooperative ensembles of RNA stem loops, viruses, and subviral remnants of 
former infection events, we should move towards a kind of RNA sociology. Qualitative RNA-sociology emphasizes 
understanding of social interactions through analysis of active RNA sequences according contextual needs, i.e. the 
primacy of interactional motifs, that means functions prior to sequence syntax. In this respect the exaptations of former 
(infection derived) inventions to more appropriate cellular needs fit ideally into these investigations, that means the 
highly dynamic modular perspective on these interacting agents.
This talk will present some relevant questions of a qualitative RNA sociology that may complete molecular 
biological terms and methods.
653 C RNA Packaging NTPase is Needed for Transcription in Double-stranded RNA 
Bacteriophage phi6
Xiaoyu Sun1, Markus Pirttimaa2, Dennis Bamford2, Minna Poranen2
1Department of Biosciences, University of Helsinki; 2Department of Biosciences, University of Helsinki
Bacteriophage phi6 has three segments of genomic double-stranded RNA [S (2948bp), M (4063bp) and L 
(6374bp)] which are enclosed into a polymerase complex (PC), a particle displaying icosahedral symmetry. The PC 
of phi6 is a delicate enzymatic machinery which can selectively recognize and package the plus-sense single-stranded 
RNA (ssRNA) genomic precursors, preform minus-stranded synthesis to form dsRNA genomes (replication) and 
apply dsRNA as a template for plus-stranded synthesis (transcription). phi6 PC is composed of the main structural 
proteins P1, the RNA-dependent RNA polymerase P2, the packaging nucleoside triphosphatase (NTPase) P4 and 
the assembly cofactor P7. The hexameric packaging NTPase P4 resides on 5-fold symmetric vertex of the outer 
surface of PC. It is essential for the PC nucleation during self-assembly and required for phi6 ssRNA packaging 
and transcription. The particles with ~90% reduced level of P4, referred to P4-deficient particles, can only preform 
ssRNA packaging and replication but do not display the transcription activity. In this study, we applied the purified 
P4 on P4-deficient particles for assembly studies. The reconstituted PC products had high occupancy of P4 with a 
higher velocity in rate-zonal centrifugation than the P4-deficient particles. Further morphological analyses indicated 
that the P4 reconstitution induced conformation change of the shell from an expanded form to a compact form, 
which suggested that P4 occupancy level contributed to the dodecahedral symmetry of the empty PC. Our result also 
indicated that the transcription reaction was dependent on high occupancy of P4 hexamers on PC, which might be 
attributed to the access provided for export of nascent plus-sense ssRNAs. 
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656 C Identification of RNA targets for the nuclear multidomain cyclophilin atCyp59 and their 
effect on PPIase activity
Olga Bannikova1, Marek Zywicki2, Yamile Marquez1, Tatsiana Skrahina1, Maria Kalyna1, Andrea Barta1
1Max F Perutz Laboratories, Medical University of Vienna; 2Innsbruck Biocenter, Medical University 
Innsbruck
AtCyp59 is a multidomain cyclophilin containing a peptidyl-prolyl cis/trans isomerase (PPIase) domain and an 
evolutionarily highly conserved RRM domain. It has been shown to bind to the C-terminal repeat domain (CTD) of 
RNA polymerase II and to influence transcription significantly. To isolate RNA targets of AtCyp59 we employed a 
genomic SELEX method which is an unbiased approach to select potential RNA binding partners. Analysis of the 
selected RNAs revealed an RNA binding motif whose binding was verified by gel shift assays in vitro and by RNA 
immunopreciptation assays of AtCyp59 in vivo. Interestingly, genome-wide analysis showed that the consensus motif 
was present in at least 70 % of the annotated transcript and we show that this RNA motif is evolutionarily highly 
conserved. Most importantly, we show that binding also occurs on unprocessed transcripts in vivo and that binding of 
specific RNAs inhibits the PPIase activity of AtCyp59 in vitro. Taken together, the available data suggest that this type 
of cyclophilins have an important function in transcription regulation. Figure 1 presents a model where in the course 
of transcription RNA-dependent inhibition of the PPIase activity of AtCyp59 influences RNA polymerase II activity.
655 B Distinct PPR proteins are responsible for coupling of mRNA editing, polyadenylation and 
translation in mitochondria of trypanosomes
Inna Afasizheva1, Lan Huang2, Ruslan Afasizhev1
1Department of Molecular & Cell Biology, Boston University Medical Campus, Boston, MA 02118, USA; 
2Department of Physiology & Biophysics, School of Medicine, University of California-Irvine, Irvine, CA 
92697, USA
The majority of trypanosomal mitochondrial pre-mRNAs undergo massive uridine insertion/ deletion editing 
which creates open reading frames. However, our recent findings indicated that pre- and post-editing processing 
steps are also required to produce translation-competent mRNAs. Pre-editing addition of short 3′ A-tails exerts no 
influence on unedited pre-mRNA stability, but stabilizes transcripts that are edited beyond few initial sites. The post-
editing extension of A-tails into A/U heteropolymers by KPAP1 poly(A) polymerase and RET1 TUTase commits 
fully-edited mRNAs to translation. To identify factors responsible for coupling of editing, polyadenylation and 
translation we built a comprehensive protein interactions network of respective machineries. The ensuing RNAi screen 
distinguished several pentatricopeptide repeat-containing (PPR) RNA binding proteins acting to: 1) stabilize mRNA 
prior to polyadenylation (PPR15); 2) block premature mRNA uridylation (PPR14) and 3) induce transcript-specific 
adenylation/ uridylation (PPR26 and PPR28). PPR15 is similar to the kinetoplast polyadenylation/ uridylation factor 
1 (KPAF1) and is an integral subunit of the polyadenylation complex. PPR14 associates transiently with both KPAP1 
and RET1, and is likely to be a membrane-anchored protein. Unexpectedly, PPR26 and PPR28 are stably associated 
with small ribosomal subunit (SSU) and the polyadenylation complex. Investigation of these PPR proteins suggested 
that pre-mRNA is initially stabilized by PPR15 binding which may also recruit poly(A) polymerase resulting in 
A-tail addition. Initiation of RNA editing at the 3′ region displaces PPR15 leaving A-tail as the main cis-acting 
stability element. We propose that SSU-associated PPR proteins, such as PPR26 and PPR28, recognize specific RNA 
sequences and stimulate transcript-selective A/U-tailing thereby committing mRNA for translation. Finally, PPR14 is 
likely to be actively disengaged from fully-edited mRNA to allow for A/U-tail addition.
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657 A Impact of specific RNA Pol II CTD phosphorylation patterns
Anne Helmrich1, Daniel Schümperli1
University of Bern, Switzerland
The human RNA polymerase II (Pol II) largest subunit contains a C-terminal domain (CTD) with 52 Tyr1-Ser2-
Pro3-Thr4-Ser5-Pro6-Ser7 (21 consensus and 31 non-consensus) repeats. Tyr1, Ser2, Thr4, Ser5 and Ser7 residues 
undergo dynamic phosphorylation and dephosphorylation throughout the transcription cycle in a gene specific manner. 
Whereas Serine modifications are known to orchestrate the binding of transcription and RNA processing factors to the 
transcription machinery, the impact of distinct phosphorylation combinations in guiding RNA-processing factors to 
specific genes remain to be investigated, as well as the role of consensus versus non-consensus heptapeptides.
To address these open questions, we perform in vitro phosphorylation studies and generate CTDs with defined 
modification patterns, either on a full-length 52 repeat or a shortened construct which lacks the non-consensus queue. 
Binding targets are identified in mass spectrometry approaches and localized by chromatin immunoprecipitation. 
Further in vivo studies will help understanding the distinct roles of specific CTD modifications.
658 B SC35 and Promoter-Associated Nascent RNA Function like HIV Tat and TAR to Regulate 
Transcription Pause Release
Xiong Ji1, Xiang-Dong Fu2
1Wuhan University, China; 2UC, San Diego
Paused RNAP II at gene promoters produces short nascent RNA of unknown function, and the transition to 
productive elongation requires active recruitment of the transcription elongation factor P-TEFb.  On the HIV-1 
promoter, the virus-encoded protein Tat activates transcription elongation by relocating P-TEFb from the inhibitory 
7SK complex to promoter proximally paused RNAP II via binding the TAR element in nascent viral RNA, but whether 
cellular genes use an analogous mechanism to activate transcription is unclear.  We present evidence that SC35 (also 
known as SRSF2, a prototypical SR family splicing factor) has functions analogous to Tat, and that SC35 binding sites 
in nascent transcripts play roles equivalent to TAR in overcoming RNAP II pausing near the transcription start.  These 
findings reveal an unanticipated SR protein function, a role for promoter-proximal nascent RNA at a discrete step in 
gene expression, and a unifying mechanism for transcription activation of viral and cellular genes.
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660 A Paraspeckle formation during NEAT1 lncRNA biogenesis is integrated by the SWI/SNF 
chromatin remodeling complex
Tetsuya Kawaguchi1, Akie Tanigawa1, Takao Naganuma1, Tetsuro Hirose1
1Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST)
The paraspeckle is a unique subnuclear structure formed around the specific long noncoding RNA (lncRNA), NEAT1. 
NEAT1 lncRNA are comprised of two alternatively processed isoform transcripts, NEAT1_1 and NEAT1_2, in which the 
longer NEAT1_2 isoform is indispensible for paraspeckle formation (Sasaki et al., PNAS 2009). We recently identified 35 
novel paraspeckle-localized proteins (PSPs) in which seven PSPs act as essential factors for paraspeckle formation through 
facilitating the steps required for the NEAT1 lncRNA biogenesis (Naganuma et al., EMBO J 2012). Here, we identified 
the SWI/SNF chromatin remodeling complexes as additional paraspeckle-localized factors that interacted with multiple 
essential PSPs. RNAi knockdown revealed that the intact SWI/SNF complex is required for the paraspeckle formation. This 
was supported by another observation that paraspeckle was undetectable in the SWI/SNF-deficient adrenal carcinoma cell 
line. What is the molecular mechanism underlying the function of the SWI/SNF complex in the parasepckle construction? 
Knockdown of the SWI/SNF components did not affect expression level of the essential NEAT1_2 isoform. Interestingly, 
the EU-pulse labeling experiment revealed that the transcript level of the newly synthesized nascent NEAT1_1 isoform was 
markedly increased in the SWI/SNF-depleted cells, although NEAT1_1 per se is dispensable for paraspeckle formation. We 
found that the association of the elongating form of RNA polymerase II (RNAPII) with phosphoserine 2 in the C-terminal 
domain was markedly increased in NEAT1_1 region and the most prominently increased at the NEAT1_1 terminator in 
the SWI/SNF-depleted cells. These data suggest that the SWI/SNF complex attenuates the elongation of RNA polymerase 
II (RNAPII) in the NEAT1_1 region. It raised an intriguing possibility that the optimized RNAPII elongation gives the 
proper environment for the assembly of various PSPs onto the nascent NEAT1 lncRNA which is required for the subsequent 
formation of the intact parasepeckle structure. We found that the RNA-protein and the protein-protein interactions between 
NEAT1 lncRNA and three essential PSPs were substantially weaken in the absence of SWI/SNF complex. We confirmed that 
the SWI/SNF complex interacted with RNAPII, the essential PSPs and NEAT1 lcnRNA. Taken together we argue that the 
SWI/SNF complex integrates the co-transcriptional ribonucleoprotein assembly onto the nascent NEAT1 lncRNA, which 
is required for the subsequent construction of the intact parasepckle, through controlling RNAPII elongation. Elucidation 
of the detail mechanism of the co-transcriptional assembly of ribonucleoprotein complexes onto NEAT1 lncRNA will tell 
us about the molecular basis underlying the fate determination of nuclear-retained lncRNAs distinct from that of mRNAs. 
659 C Not5 of the CCR4-NOT complex contributes to assembly of the SAGA coactivator complex.
Sari Kassem1, Martine Collart2
1PhD, Collart”s group, Department of Microbiology and Molecular Medicine, CMU, Rue Michel servet 1, 
University of Geneva, Switzerland; 2University of Geneva
CCR4-NOT is a conserved eukaryotic multi-subunit complex that plays a role at every step of gene regulation. 
A variety of evidences in our laboratory indicate that a unique function of the CCR4-NOT complex might be to 
contribute to the assembly of other multi-protein complexes. One such complex is the histone acetyltransferase and 
deubiquitinase SAGA complex. Former data have revealed that global histone acetylation is reduced in mutants of 
SAGA and CCR4-NOT, in particular in cells lacking the Not5 subunit. Our current results show that there is both 
physical and genetical interaction between the two complexes. In addition we find severe alterations in SAGA complex 
integrity in cells lacking Not5, which can explain the acetylation defect previously observed in cells, and which also 
correlates with several modifications of the core subunits of the SAGA complex. Further characterization of SAGA in 
wild-type and not5 mutant cells has indicated that Not5 might connect a GAPDH family member, Tdh3, also known 
as a moonlighting protein, to SAGA, and thereby contribute to proper SAGA assembly. Taken together, our results 
suggest a key role for Not5 in both SAGA integrity and function. 
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662 C Widespread regulation of mRNA steady-state levels through alternative splicing-
dependent mechanisms
Eugene V. Makeyev1
1Nanyang Technological University, Singapore
Differentiated cells acquire unique structural and functional traits through coordinated expression of lineage-
specific genes. An extensive battery of genes encoding components of the synaptic transmission machinery and 
specialized cytoskeletal proteins is activated during neuronal differentiation, whereas genes required for neural stem 
cell (NSC) proliferation are turned off. We have recently shown that in non-neuronal cells, polypyrimidine tract-
binding protein (Ptbp1/PTB/hnRNP I) represses splicing of 3’-terminal introns in pre-mRNAs encoding critical 
presynaptic proteins. This inhibits export of the incompletely spliced mRNAs to the cytoplasm and triggers their 
nuclear degradation. Clearance of these intron-containing transcripts occurs independently of nonsense-mediated decay 
(NMD) and requires components of the nuclear RNA quality control machinery. When Ptbp1 expression decreases 
during neuronal differentiation, the regulated introns are spliced out thus allowing translation-competent mRNAs 
to accumulate in the cytoplasm. Our unpublished work suggests that Ptbp1 additionally promotes expression of a 
large subset of non-neuronal genes by suppressing splicing patterns that lead to NMD. We show that this mechanism 
dampens the expression of these genes during neuronal differentiation. Thus, differentiation-induced changes in 
cellular mRNA steady-state levels appear to be frequently controlled by alternative splicing-mediated mechanisms.
661 B The RNA exosome promotes a transcription termination pathway coupled to RNA decay
Jean-Francois Lemay1, Marc Larochelle1, Samuel Marguerat2, Jürg Bähler3, Francois Bachand1
1Université de Sherbrooke, Département de Biochimie, Pavillon de Recherche Appliquée sur le Cancer, 
Sherbrooke, Qc, J1E 4K8, Canada; 2Imperial College London, Quantitative Gene Expression Group, MRC 
Clinical Sciences Centre, London W12 0NN, UK.; 3University College London, Department of Genetics, 
Evolution and Environment and UCL Cancer Institute, London WC1E 6BT, UK.
The transcription cycle is composed of three essential steps that consist of initiation, elongation, and termination. 
Termination is probably the least understood of these three steps in eukaryotic cells. For protein-coding genes, 
termination is normally initiated by the endonucleolytic cleavage of the nascent mRNA, which generates an entry 
point for a 5’-3’ exonuclease-dependent termination pathway known as the torpedo model. In contrast to this 5’-3’ 
termination pathway, we provide evidence for a new mechanism of transcription termination that depends on the 3’-5’ 
exonuclease activity of the RNA exosome. Accordingly, transcriptome-wide analyses of fission yeast cells depleted 
for exosome subunits reveal widespread accumulation of 3’-extended transcripts from coding and noncoding genes, 
whereas mature RNA levels are not reduced. Importantly, the detection of read-through RNAs in exosome-deficient 
cells strongly correlates with a genome-wide increase in RNA polymerase II density at the 3’ end of genes, consistent 
with transcription termination defects in the absence of a functional exosome. We show that RNA exosome subunits 
are present along transcribed genes and are recruited in a transcription-dependent manner, supporting a direct role 
for the exosome in promoting transcription termination. Our results also indicate that the exonucleolytic activity, but 
not the endonucleolytic function of the Dis3 catalytic subunit is required for exosome-dependent termination. These 
findings support a reverse torpedo model in which the 3’-5’ exonucleolytic activity of the RNA exosome promotes the 
release of RNAPII and the concomitant degradation of the nascent transcript. 
Poster Abstracts RNA 2013 •  Davos, Switzerland •  June 11-16, 2013
382  •   Interconnections Between Gene Expression Processes
664 B Traf3 alternative splicing during T cell activation: functional consequences and regulatory 
insights
Monika Michel1, Ilka Wilhelmi1, Marco Preussner1, Florian Heyd1
1Philipps-University Marburg
The non-canonical NFkB (ncNFkB) pathway regulates the expression of chemokines required for secondary 
lymphoid organ formation and maintenance and thus plays a pivotal role in adaptive immunity. ncNFkB activity 
is controlled by the kinase NIK, which itself is negatively regulated by the full-length isoform of Traf3. Here we 
show that T cell specific and activation-dependent alternative splicing generates a Traf3 isoform lacking exon 8 
(Traf3DE8) that, in contrast to the full-length protein, activates ncNFkB signaling. Traf3DE8 disrupts the NIK-Traf3-
Traf2 complex and allows accumulation of NIK to initiate ncNFkB signaling in activated T cells. ncNFkB activity 
results in the expression of several chemokines, among them CxCL13, both in a model T cell line and in primary 
human CD4+ T cells. As CxCL13 plays an important role in B cell migration and activation, our data suggest an 
involvement and provide a mechanistic basis for Traf3 alternative splicing and ncNFkB activation in regulating T cell 
dependent adaptive immunity.
To start investigating the mechanism of activation-induced Traf3 alternative splicing we have used minigene 
analysis and defined an intronic cis-regulatory element. RNA-protein interaction studies and an siRNA screen have 
yielded candidate trans-acting factors that we are now testing for their involvement in regulating Traf3 exon 8 exclusion 
in activated T cells.  
663 A Alternative splice variant of chromatin regulators drive specific transcription
Oriane Mauger1, Eric Allemand1, Christian Muchardt1, Eric Batsché1
1Epigenetic Regulation Unit, URA2578 CNRS, Inserm, Institut Pasteur, France
Both alternative splicing and epigenetic regulations are deregulated in pathogenesis. These two processes are 
connected and recent studies describe how chromatin-born information can participate in the regulation of the 
alternative splicing. However, the question of how the alternative splicing can influence the chromatin regulation is not 
well evaluated. Here, we present evidences describing the functions of splicing variants coding for well-characterized 
chromatin regulators: the histone methyl-transferases EHMT2 and Suv39H2, the Polycomb subunit EED, and the 
NURF subunit BPTF. We showed that, while these chromatin regulators are expressed in all the tissues we tested, the 
expression levels of the different isoforms is cell-type specific. In particular, the relative proportion of the different 
EHMT2 isoforms is specifically correlated with the epithelial-mesenchymal transition, suggesting that alternative 
splicing affects the activity of these proteins on cell differentiation. 
In order to further investigate the function of the different isoforms generated by alternative splicing, we have 
followed their activity on the transcriptional regulation of known target genes. For this purpose, we have developed 
a new strategy of siRNAs design where the sequence of the siRNAs we use, base-pair with splice junctions and so, 
target only spliced process mRNA which is expected to reduce off-target effects. This allows us to deplete the cells 
from either all the species of mRNA or just designated splice variants. Inversely, we have also generated isoform-
carried lentiviruses, allowing us to rescue the expression of some alternative spliced variants. 
Our study reveals how alternative splicing regulation affects the function of chromatin regulator, which in turn, 
modulate the transcription of target genes.
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665 C The Bre5-Ubp3 complex links RNA surveillance to RNA Polymerase II regulation by 
ubiquitylation
Laura Milligan1, Sander Granneman3, Grzegorz Kudla2, Ross Alexander1, Jean Beggs1, David Tollervey1
1Wellcome Trust Centre for Cell Biology, University of Edinburgh, EH9 3JR, UK; 2MRC Human Genetics 
Unit MRC IGMM, University of Edinburgh; 3University of Edinburgh, Institute of Structural and Molecular 
Biology
To identify novel nuclear RNA surveillance factors, yeast genome-wide screens were preformed for synthetic 
lethal (sl) interactions with loss of exosome cofactors Rrp47/Lrp1, Air1 or Air2. Each screen identified both Bre5 
and Ubp3, which form a complex with protein de-ubiquitinase activity, suggesting links between RNA surveillance 
and ubiquitylation. Bre5 has a potential RRM and we confirmed RNA binding in vitro and in vivo. The CRAC UV 
crosslinking approach identified many Bre5 targets, transcriptome-wide. On intron containing genes, Bre5 hits were 
enriched over exon 2. Splicing-dependent transcription pausing over exon 2 has been reported, and a genetic screen 
using an allele of the splicing factor Prp45 that exacerbates this pausing also identified sl interactions with Bre5 and 
Ubp3. Ubp3 was previously shown to deubiquitylate RNAPII in vitro and levels of ubiquitylated RNAPII were elevated 
in ubp3∆ strains following DNA damage. CRAC was used to identify RNAPII interaction sites, transcriptome-wide; 
this provided data similar to ChIP, but strand specific and with nucleotide resolution. In addition, we specifically 
mapped the location of ubiquitylated RNAPII. This confirmed that levels of RNAPII ubiquitylation are elevated over 
Bre5 target genes. High-resolution, kinetic analysis of transcription and splicing of a reporter transcript revealed that 
the absence of Bre5 causes a delay in the release of RNAPII paused over exon II. We propose that splicing-induced, 
exon 2 pausing of RNAPII, results in its ubiquitylation to prevent further elongation while co-transcriptional splicing 
occurs. Recognition of the nascent transcript by Bre5 triggers de-ubiquitylation of RNAPII by Ubp3, allowing the 
polymerase to resume transcription following splicing. The Bre5-Ubp3 complex therefore provides a link between 
RNA surveillance and regulation of RNAPII activity by ubiquitylation.
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666 A Double-stranded RNA-expressing plasmids selectively inhibit translation of exogenous 
mRNAs
Jana Nejepinska1, Radek Malik1, Petr Svoboda1
1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic
Double-stranded RNA (dsRNA) is linked to different effects in mammalian cells, including sequence-specific RNA 
interference, sequence-independent interferon response, and editing by adenosine deaminases. We have previously 
shown that long hairpin dsRNA expression in cultured cells does not necessarily activate the interferon response, it is 
poorly processed into siRNAs, and it is partially edited. Here, we demonstrate that dsRNA-expressing plasmids inhibit 
expression of transiently cotransfected reporter plasmids but they have a minimal impact on expression of endogenous 
genes or reporters stably integrated in the genome. The inhibition is concentration-dependent and independent of cell 
type, transfection method, or hairpin sequence. Deep sequencing data show low but detectable processing of hairpin 
RNA into small RNAs and preferential A-to-I editing of the dsRNA region (see figure 1 below). The inhibition likely 
occurs at the level of translation initiation and is mediated by the local and transient activation of protein kinase R. 
In conclusion, we demonstrate that expression from plasmids can be repressed if one of co-transfected plasmids 
generates dsRNA. We showed previously that the potential to generate dsRNA cannot be efficiently predicted and 
involves also commonly used plasmids. Moreover, our results indicate that cells can distinguish between endogenous 
and exogenous mRNAs and selectively inhibit the translation of foreign mRNAs in response to dsRNA.
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668 C IMAGEtags for imaging Pol II activity in real time with RNA reporters
Judhajeet Ray1, Ilchung Shin1, Vinayak Gupta1, Jonathan Beasley2, Lee Bendickson2, George A Kraus2, Marit 
Nilsen-Hamilton1
1Iowa State University and Ames Laboratory, US DOE; 2Iowa State University
RNA based molecular imaging provides a new means of understanding of cellular events such as transcription and 
splicing. However the current techniques to visualize gene expression with RNA reporters are limited by the use of 
fluorescent proteins or by the need for highly abundant RNAs. We have developed an RNA reporter system known as 
IMAGEtags (Intracellular MultiAptamer GEnetic tags) for imaging promoter activity in real time in individual living 
cells by a FRET signal.  The RNA reporter uses strings of RNA aptamers that can be expressed from an inducible or 
constitutive promoter.  The tobramycin and PDC RNA aptamers were expressed in yeast from the GAL1, ADH1 or 
ACT1 promoters of a plasmid vector, which was transformed into the yeast cells. The cells are incubated with their 
ligands that are separately conjugated with the FRET pairs, Cy3 and Cy5. Following incubation with the dyes the 
cells are imaged. The constitutive ACT1 and ADH1 showed higher FRET signals compared to the control. FRET 
signals from the GAL1 promoter were seen to increase as a function of time after adding the galactose inducer and in 
parallel with the reporter RNA that was measured on a population basis. Cellular heterogeneity in FRET signals was 
also observed, which are consistent with the concept of stochasticity of transcriptional events in a cell population. 
IMAGEtags can be applied to studies of gene expression from pol II promoters in single cells and in real time.  The 
system is simple, sensitive and applicable to many cell types and experimental conditions.
667 B Molecular mechanisms of RNA Polymerase II termination mediated by contacts with Rat1 
and CF IA
Erika Pearson1, Claire Moore1
1Tufts University School of Medicine
Proper RNA Polymerase II (Pol II) transcription termination is needed to generate stable transcripts, prevent 
transcriptional interference with downstream loci, and allow recycling of Pol II back to the promoter.  Termination 
is tightly coordinated with 3’ end RNA processing and is intricately regulated by a variety of different cis- and trans-
acting factors.  Although many eukaryotic termination factors have been identified, the precise molecular mechanisms 
governing this essential process remain to be elucidated.  A major limitation in our understanding of termination has 
been the lack of a defined, easily manipulated in vitro system.  We have thus developed and characterized an in vitro 
transcription system for the assay of factor-driven Pol II termination.  In this system, we generate promoter-driven 
stalled elongation complexes from yeast whole cell extract and challenge these complexes with purified termination 
factors.  We show for the first time that the exonuclease Rat1, in complex with its stabilizing partner Rai1, can 
elicit release of stalled Pol II in vitro and can do so in the absence of other termination factors.  We also find that 
Rtt103, which interacts with the Pol II C-terminal domain (CTD) and with Rat1, can rescue termination activity of 
an exonucleolytic-deficient Rat1 mutant.  In light of our findings, we posit a model whereby functional nucleolytic 
activity is not the feature of Rat1 that ultimately promotes termination.  Degradation of the nascent transcript allows 
Rat1 to pursue Pol II in a guided fashion and to arrive at the site of RNA exit from Pol II.  Upon this arrival, however, 
our model suggests that it is perhaps the specific and direct contact between Rat1 and Pol II that transmits the signal 
to terminate transcription.
To further explore the role of direct interactions between Pol II and termination factors, we have characterized 
a Pol II variant with a deletion of the flap domain, an evolutionarily conserved, surface-exposed region within the 
vicinity of the RNA exit channel.  This Pol II variant is not defective for transcription elongation but exhibits defective 
termination of short RNAs in vitro and of snoRNAs in vivo.  Additionally, the mutation significantly alters the in 
vitro and in vivo interactions between Pol II and Cleavage Factor IA (CF IA), a complex important for both 3’ end 
processing and termination.  These findings suggest that contacts of proteins with the body of Pol II, in addition to 
those formed with the CTD, are important for efficient termination.
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670 B Messenger RNA decay rates feedback to influence transcription and buffer gene 
expression in mammalian cells
Carol Wilusz1, Ju Youn Lee2, Jerome Lee1, Ashley Neff1, Stephen Coleman1, Ashton Herrington1, Bin Tian2, Jeffrey 
Wilusz1
1Colorado State University; 2New Jersey Medical School, University of Medicine & Dentistry, NJ
There is considerable evidence that transcription influences mRNA decay and several models for how this can 
occur have been put forward.  However, we believe that the cell may also have mechanisms by which mRNA decay 
rates can also feedback and influence transcription.  This assertion is based on some recent results generated in our 
laboratories.  First, we examined the differences in mRNA decay between human foreskin fibroblasts (HFF) and 
genetically identical induced pluripotent stem (iPS) cells that were derived from these HFFs.  Not surprisingly, there 
were many differences in mRNA decay rates, but when we assessed changes in mRNA abundance between the two 
cells we were surprised to find that there was a negative correlation between decay and abundance.   Transcripts that 
were more stable in iPS cells were frequently of lower abundance than in HFFs.  Conversely, destabilized transcripts 
tended to be more abundant. Next, we examined the effects of perturbing mRNA decay on transcription.  We undertook 
a global analysis of mRNA decay rates in C2C12 myoblasts following depletion of the deadenylase PARN.  We 
determined that several mRNAs were significantly stabilized in a PARN knockdown cell line. Intriguingly, as before, 
we found that the abundance of these stabilized transcripts either was not altered, or was slightly reduced. The opposite 
was true for the transcripts that were destabilized in PARN KD cells – their abundance tended to increase.  We believe 
that these destabilized mRNAs are affected through indirect mechanisms making the opposing effects on transcription 
even more surprising as they are unlikely to be mediated by effects of PARN on either transcription or mRNA decay. 
To investigate this phenomenon further, we validated the changes in mRNA decay and abundance for four of the 
stabilized transcripts by qRT-PCR. We then measured the abundance of newly transcribed pre-mRNAs as an indicator 
of transcription rate.  In each case, despite clear decreases in mRNA decay rates, the mRNA abundance and pre-
mRNA abundance was surprisingly reduced instead of increased as current models would predict.  These results imply 
that the cell is able to buffer mRNA levels by down-regulating transcription to compensate for reduced mRNA decay. 
669 A A Novel Poly(A) RNA-Binding Protein Regulates a Key Subunit of ATP Synthase in Breast 
Cancer Cells
Callie Wigington1, Paula Vertino2, Anita Corbett1
1Emory University, Department of Biochemistry; 2Emory University, Winship Cancer Institute
Poly(A)-binding proteins, or Pabs, comprise one class of RNA-binding proteins that influence multiple steps in gene 
expression from polyadenylation within the nucleus to translation in the cytoplasm. All previously characterized Pabs interact with 
polyadenosine RNA via RNA Recognition motifs; however, a novel family of nuclear Pabs utilizes tandem CCCH zinc fingers 
for polyadenosine RNA recognition. The human member of this family of zinc finger Pabs is termed Zinc Finger CCCH-type 
containing #14 (ZC3H14) and has recently been linked to a form of non-syndromic intellectual disability as well as the estrogen 
receptor status of breast tumors. Although the function of ZC3H14 is unknown, the budding yeast counterpart, Nab2, ensures 
proper poly(A) tail length and mRNA export from the nucleus, suggesting a role for ZC3H14 in post-transcriptional regulation. In 
an effort to understand the post-transcriptional function of ZC3H14 as well as to gain insight into the spectrum of targets of nuclear 
Pabs, we employed a genome-wide microarray analysis of transcripts affected upon knockdown of the novel Pab, ZC3H14, or the 
well-characterized nuclear Pab, PABPN1. To focus on targets of relevance to breast cancer, experiments used MCF7 breast cancer 
cells. Knockdown of PABPN1 significantly affected ~17% of expressed transcripts as compared to knockdown of ZC3H14, which 
affected only ~1% of expressed transcripts. Results from this study show that PABPN1 affects the steady-state level of a large 
fraction of the transcriptome, which is consistent with the model that PABPN1 is a global polyadenylation factor. In contrast, 
knockdown of ZC3H14 affected a much smaller fraction of the transcripts, suggesting that ZC3H14 may have specific mRNA 
targets in these cells. One intriguing target that we selected for further analysis is the ATP Synthase Fo Subunit C, or ATP5G1. ATP 
Synthase is the central enzyme in oxidative phosphorylation and is responsible for the majority of ATP production in mammalian 
cells. The steady-state level of ATP5G1 is robustly decreased upon knockdown of ZC3H14, but not PABPN1. Interestingly, our 
data demonstrates that ZC3H14 specifically affects the steady-state mRNA level of ATP5G1 and not other ATP Synthase subunits, 
suggesting specificity. We are able to rescue the decrease in ATP5G1 by addition of a siRNA-resistant ZC3H14 plasmid. ATP5G1 
is a rate-limiting component in Fo Subunit C assembly and ultimately ATP Synthase activity, and we observe that the effect of 
ZC3H14 on ATP5G1 results in decreased cellular ATP levels. Interestingly, upon RNA-IP of ZC3H14, we observe enrichment for 
ATP5G1 as well as other subunit C components, suggesting that ZC3H14 may partner with another factor to specifically regulate 
ATP5G1 levels. This data suggests that ZC3H14 may play a role in regulating cellular energy levels, which has broad implications 
for proper neuronal function as well as cancer.
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672 A The tissue specific and eco-responsive transcriptome of Drosophila
James Brown1, Nathan Boley7, Robert Eisman3, Michael Duff6, Kenneth Wan4, Ben Booth4, Ann Hammonds4, Carrie 
Davis2, Lucy Cherbas3, Piero Carninci5, Thomas Gingeras2, Peter Cherbas3, Thomas Kaufman3, Roger Hoskins4, 
Brenton Graveley8, Susan Celniker4, Marcus Stoiber1, Marlene Oeffinger1, Peter Bickel1
1Department of Statistics, University of California Berkeley; 2Cold Spring Harbor Laboratory, CSHL; 
3Indiana University, Center for Genomics and Bioinformatics; 4Lawrence Berkeley National Laboratory, 
Genome Dynamics; 5RIKEN Yokohama Institute, Omics Science Center; 6University of Connecticut Health 
Center, Department of Genetics and Developmental Biology; 7University of California, Berkeley, Statistics; 
8University ofConnecticut Health Center, Department of Genetics and Developmental Biology
Integrative analysis of RNA sequencing data from Drosophila melanogaster reveals an animal transcriptome of 
unprecedented complexity, comprising discrete, tissue-specific transcripts. To decipher the information encoded in and 
probe the dynamics of the transcriptome, we generated and analyzed strand-specific poly(A)+ RNA-seq, CAGE, and 
cDNA sequences from 30 developmental time-course samples, 29 tissues, and 21 environmental perturbations in D. 
melanogaster which we call the Fly LifeMap. Although 55% of all genes and 66% of spliced genes may encode more 
than one protein isoform, a set of 47 largely neural-specific genes are the targets of RNA editing, extensive alternative 
mRNA splicing and have the potential to encode more than 1000 transcript isoforms each. The magnitudes of RNA 
splicing changes are much larger between tissues than throughout development or in response to environmental 
perturbations, and the majority of sex-specific splicing is gonad-specific. The gonads produce comparatively few 
protein isoforms per gene but express hundreds of previously unknown protein-coding and noncoding genes. The 
gonads also express antisense transcripts at key conserved developmental genes, including eve, Dcr-2, and CTCF. 
In neural tissue, antisense transcription is largely due to extension of 3’UTRs resulting in overlap with neighboring 
genes. In gonads, antisense transcription is due to independent transcription initiating at gonad-specific promoters. 
Most RNA-seq reads are accounted for within transcripts models, and we observe little evidence of pervasive 
transcription outside of primary transcripts. In summary, the Drosophila transcriptome is substantially more complex 
than previously recognized and arises from tissue-specific, combinatorial usage of well-defined promoter elements, 
splice sites, and polyadenylation sites.
671 C The human protein Nol12- ribosome biogenesis meets DNA damage and senescence
Pierre-Joachim Zindy1, Christian Trahan1, Karen Wei1, Jordi Ros Rodriguez1, Marlene Oeffinger2
1Institut de recherches cliniques de Montréal (IRCM), Montreal, Canada; 2Institut de recherches cliniques de 
Montréal (IRCM); Département de biochimie, Université de Montréal; Division of Experimental Medicine, 
McGill University, Canada.
It has been shown, in yeast as well as mammalian cells, that ribosome biogenesis and cell proliferation are two intimately 
linked processes. Defects in either one can lead to disease. To understand the differences between yeast and mammalian ribosome 
biogenesis and how the latter is integrated into cell division and proliferation pathways in higher eukaryotes, we are investigating 
the role of different ribosome biogenesis factors in human cells. 
Here we focus on Nol12, the human ortholog of yeast Rrp17p, which has recently been described as a 5’-3’ exonuclease 
required for 5′ end processing of 5.8S and 25S rRNAs. Nol12 is a member of a conserved family of proteins and Nol12 orthologs 
have been related to dMyc-stimulated cell growth, proliferation and eye development in Drosophila, nucleolar architecture and 
function in rat as well as ribosome biogenesis in mouse.
We have studied the impact of Nol12 knockdown in human cells, using shRNAs, siRNAs, biochemical assays and proteomics. 
Cells lacking Nol12 are defective not only in pre-60S processing, as previously observed in yeast, but interestingly also in the 
maturation of 40S precursor RNAs. Moreover, we found that in the absence of Nol12, nucleolar architecture was severely affected, 
a hallmark for ribosome defects in mammalian cells. In addition, cells were not progressing through the cell cycle, accumulating 
in G1, a checkpoint that has been closely associated with defects in ribosome biogenesis; However, these cells were also unable to 
efficiently undergo G2/M progression, resulting in an accumulation of cyclin D1 and depletion of cyclin B1. In the past it has been 
shown that altered ribosome biogenesis is responsible for p53 stabilization through the action of several ribosomal proteins and 
MDM2, leading to G1 arrest, making this a p53-dependent response. However, in cells absent of Nol12, the effects on pre-rRNA 
processing, nucleolar architecture and G1 block seemed to occur in a p53-independent manner, while block of cells in G2/M was 
not observed in HCTp53 -/- cells; c-myc was also not upregulated in these cells. Interestingly, a similar observation has been made 
in cells where disruption of 40S and 60S ribosome biogenesis was shown to lead to the activation of a novel G2/M checkpoint, 
while p53 was induced in these cells. In addition to cell cycle checkpoints, the DNA damage response pathway was also activated 
in the absence of Nol12 and cells went into senescence 48hrs after knockdown. 
Our results suggest that the exonuclease Nol12 may have additional function to that during ribosome biogenesis, involving DNA 
damage, which in its absence leads to an activation of G1 checkpoint in a p53 as well as ribosome biogenesis-independent manner.
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674 C Beyond the ribosome, antagonistic functions played by a pair of ribosomal proteins 
paralogs
Anne-Cecile Duc1, Yong Zhang1, Shuyun Rao1, Xiao-Li Sun1, Alison Bilbee1, Michele Rhodes1, Qin Li1, Dietmar 
Kappes1, Jennifer Rhodes1, David Wiest1
1Fox Chase Cancer Center
While ribosomal proteins are increasingly found to play a role beside their involvement in protein synthesis 
within the ribosome. It is also still controversial whether their paralogs have essential or distinct functions, and this 
has not been explored in vertebrates.  Previous work from our lab showed that the Ribosomal Protein Large Subunit 
22 (RPL22), or rather, its absence, interfered with T-cell development in a lineage-specific manner. Unlike the lack 
of most other ribosomal proteins that lead to deleterious effects, RPL22 deletion in mice specifically inhibits T-cell 
commitment to the α/β, but not the γ/δ lineage. RPL22 paralog RPL22-Like1 does not rescue this lineage-specific 
defect. Strikingly, despite being highly homologous, RPL22 and RPL22-Like1 appear to play distinct and antagonistic 
roles. The focus of this research is to understand the roles of RPL22 and RPL22-Like1 in hematopoietic development. 
We found that they regulate the emergence of hematopoietic stem cells by controlling expression of Smad1.  Emergence 
of T-cell lineage and hematopoeitic stem cells were investigated using zebrafish embryos, as well as in vitro RNA-
proteins interactions to address this first example of ribosomal protein paralogs performing antagonistic functions in 
a tissue-restricted manner. 
673 B Modeling the RNA-binding specificity of GLD-1 suggests a function of coding region-
located sites in translational repression
Anneke Brümmer1, Shivendra Kishore2, Deni Subasic3, Michael Hengartner3, Mihaela Zavolan2
1Biozentrum, University of Basel, Switzerland; 2Biozentrum, University of Basel, Klingelberstrasse 50-70, 
4056 Basel, Switzerland; 3Institute of Molecular Life Sciences, University of Zurich, Switzerland
To understand the function of RNA-binding proteins (RBPs) encoded in animal genomes, it is important to 
identify their target RNAs. Although it is generally accepted that the binding specificity of an RBP is well described 
in terms of the nucleotide sequence of its binding sites, other factors such as the structural accessibility of binding 
sites or their clustering, to enable binding of RBP multimers, are also believed to play a role. Here we focus on GLD-
1, a translational regulator in Caenorhabditis elegans, whose binding specificity and targets have been studied with 
a variety of methods such as CLIP (crosslinking and immunoprecipitation), RIP-Chip (microarray measurement of 
RNAs associated with an immunoprecipitated protein), profiling of polysome-associated mRNAs and biophysical 
determination of binding affinities of GLD-1 for short nucleotide sequences. The latter approach appears to allow 
an accurate reconstruction of the sequence specificity of the protein and may be applied to uncover the specificity 
and function of other RBPs. Taking into account the accessibility of putative target sites significantly improves the 
prediction of our GLD-1 binding model, in particular due to a more accurate prediction of binding in the transcript 
coding regions. Relating GLD-1 binding to translational repression and stabilization of its target transcripts we find 
that binding sites along the entire transcripts contribute to functional responses. 
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676 B Global gene regulation mediated by intron retention during T cell activation
Ting Ni1, Wenjing Yang3, Weiqun Peng2, Keji Zhao4, Jun Zhu1
1Genetics and Development Biology Center, National Heart Lung Blood Institute; 2Department of Physics, 
George Washington University; 3Genetics and Development Biology Center; 4system biology center, National 
Heart Lung Blood Institute
Large-scale genomics studies have shown that gene activation and/or repression, as determined at the steady-state 
mRNA level, are often demarcated by corresponding changes in variant histone marks (e.g. H3K4me3, H3K9me3). 
Such concordance, however, is lacking for transcripts differentially expressed between resting and activated human 
CD4+ T cells, suggesting posttranscriptional gene regulation might be involved. To solve this conundrum, strand-
specific RNA-seq was employed to profile T-cell transcriptomes before and after extracellular stimulation. Our 
results showed that resting T cells exhibit a higher than expected level of intronic tags, the proportion of which is 
significantly reduced upon T cell activation. Intron retention in fact is a widespread phenomenon as demonstrated 
by IRI (intron retention index) analysis, a newly devised approach to monitor intron retention at the individual gene 
level. In addition, by integrating a large collection of ChIP-seq data, we further demonstrated that intron-retained 
transcripts are unstable and possibly degraded by RNA surveillance complex in the nucleus. More strikingly, fold 
change in intron retention level is negatively correlated with that of steady-state mRNA level, indicating that global 
intron retention may serves as a major contributor for gene regulation during T cell activation. Supporting this notion, 
majority of the genes upregulated in activated T cells are accompanied with a significant reduction in intron retention. 
Of them, 267 genes are likely to be regulated solely at the posttranscriptional level, and are highly enriched in the 
pathwyas that are essential for proper T cell proliferation and cytokine release. Taken together, our study uncovered 
a novel posttranscriptional mechanism mediated by global intron retention. It can bypass the requirement for de novo 
transcript synthesis and therefore shorten the responding time to extracellular stimuli such as acute infection. 
675 A Clindamycin ribosome interactions: a molecular dynamics study
Katarzyna Kulczycka-Mierzejewska1, Joanna Trylska2, Joanna Sadlej3
1College of Inter-Faculty Individual Studies in Mathematics and Natural Sciences, University of Warsaw, 
Poland; 2Centre of New Technologies, University of Warsaw, Poland; 3Faculty of Chemistry, University of 
Warsaw, Poland
Antibiotics are drugs that treat the diseases of bacterial and fungal origin. Secondary uses include strengthening the immune 
system in cases of lowered immunity. Clindamycin is one of the antibiotics from the lincosamide class which are used to treat 
diseases caused mostly by Gram-positive bacteria and against some protozoal diseases. Lincosamidesinteract with the bacterial 
large (50S) ribosomal subunit and inhibit the process of protein synthesis leading to bacterial cell death. The increase of resistance 
of many bacterial strains against known antibiotics is caused by the expanded use of antibiotics in medical practice and veterinary. 
This is a very important reason for continuous work to find new, better and more effective antibacterial drugs.
Mutations of the antibiotic target are one of the common modifications that lead to bacterial resistance because such alterations 
typically prevent proper binding of the antibiotic in the targeted site. Currently, there are three structures of clindamycin in the 
complex with the 50S1,2,3 ribosomal subunit available in the Protein Data Bank coming from different organisms. Interestingly, 
two of the structures show significantly different conformations of the drug. The aim of this study was to compare the dynamic 
properties of the clindamycin binding site in the 50S subunit with and without the A2058G mutation to understand why this 
nucleotide substitution blocks the binding of lincosamides. To achieve this goal we applied full-atom
molecular dynamics. Using the NAMD [4] package we performed four types of simulations: (1) the complex of clindamycin 
with the fragment of the 50S subunit of the ribosome as well as (2) the unbound ribosome fragment, (3) the complex of clindamycin 
with the mutated ribosome fragment and (4) the unbound mutated ribosome fragment.
To prepare the starting systems for the simulations we chose the 3OFZ 50S subunit structure from Escherichia coli, which 
consists of ribosomal RNA, ribosomal proteins, one clindamycin molecule, magnesium and zinc ions and crystal waters. For our 
simulations, we cut a sphere with the radius of about 20Å around clindamycin to account for the long-range interactions of the 
antibiotics in the 50S subunit. We added 228 K+ ions to neutralize the charge and approximately 27000 TIP3P water molecules to 
solvate the system shaped in a truncated octahedron around the complex. The effect of the mutation on clindamycin positioning 
in the binding cleft resulting from these molecular dynamics simulations will be discussed.
Poster Abstracts RNA 2013 •  Davos, Switzerland •  June 11-16, 2013
390  •   RNA system biology
677 C Large-scale analysis of eukaryotic RNA-binding protein binding preferences and 
exploration of their roles in post-transcriptional gene regulation
Debashish Ray1, Hilal Kazan3, Kate Cook5, Matthew Weirauch2, Hamed Najafabadi4, Xiao Li5, Mihai Albu1, Hong 
Zheng5, Ally Yang5, Hong Na5, Serge Gueroussov1, Manuel Irimia1, Andrew Fraser1, Benjamin Blencowe1, Quaid 
Morris1, Timothy Hughes1
1Donnelly Centre, University of Toronto, Toronto, CANADA M5S 3E1; 2Center for Autoimmune Genomics 
and Etiology (CAGE) and Divisions of Rheumatology and Biomedical Informatics, Cincinnati Children’s 
Hospital Medical Center, Cincinnati, OH 45229; 3Department of Computer Science, University of Toronto, 
Toronto, CANADA M5S 2E4; 4Department of Electrical and Computer Engineering, University of Toronto, 
Toronto, CANADA M5S 3G4; 5Department of Molecular Genetics, University of Toronto, Toronto, CANADA 
M5S 1A8
Hundreds of genes in eukaryotic genomes encode RNA-binding proteins (RBPs) but few have well-defined 
RNA-binding preferences or experimentally defined RNA targets. We have developed a combined biochemical and 
computational approach, termed RNAcompete, to analyze the RNA-binding preferences of RBPs (Ray, Kazan et al. 
Nature Biotechnology 2009). Motifs identified using RNAcompete haven been shown to be comparable to RNA-
binding data from in vitro selection (e.g. SELEX) and immunoprecipitation (e.g. CLIP) experiments. Here, we use 
RNAcompete to conduct the first large-scale analysis of RNA-binding preferences for 207 RBPs from 20 diverse 
kingdoms across eukarya. We find that most RBPs do not have strict requirements for RNA secondary structure and 
bind to short ssRNA sequences. Furthermore, the binding motifs of homologous RBPs display deep evolutionary 
conservation, such that the recognition preferences for a large fraction of metazoan RBPs can be inferred from the 
sequences of their binding domains. We are also able to utilize RNAcompete-derived motifs during transcriptome 
analyses in metazoans to facilitate identification of RBP-RNA interactions enriched in mRNA subsets and associated 
with specific post-transcriptional processes. The collection of motifs derived from our RNAcompete experiments will 
be invaluable for understanding the interactions between RBPs and RNA, as well as their functional relevance.
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678 A RNase disruption of transcriptional positive auto-regulation is essential for energy-
efficient phenotypic switching
Elisabeth Wurtmann1, Alexander Ratushny2, Min Pan1, Karlyn Beer3, John Aitchison2, Nitin Baliga1
1Institute for Systems Biology, Seattle, WA; 2Seattle Biomedical Research Institute, Seattle, WA; 3University of 
Washington, Seattle, WA
The distinct response kinetics of transcriptional and post-transcriptional regulation, and their non-uniform use 
across genes and environments, suggests that selective interplay of these mechanisms might be an evolved strategy 
to generate characteristic responses1–4. On the transcriptional level, the arrangement of transcription factors and their 
target genes into recurring network motifs generates response dynamics that are suited to particular information-
processing functions5. Characteristic network topologies have also been observed at the post-transcriptional level with 
noncoding RNAs preferentially organized in feedforward loops6. Here, we have investigated whether the architecture 
of ribonuclease interactions in a gene regulatory network has any significant implication for environmental response 
strategies of an organism. We have discovered that RNases act in a characteristic regulatory motif that conserves 
energy by mediating efficient conditional phenotypic switching in both bacteria and archaea. Through analysis of the 
E. coli gene regulatory network, we made the intriguing observation that RNases preferentially target operons that 
are regulated by a transcriptional positive auto-regulation (PAR) loop, which is known to mediate bistable phenotypic 
switching5. A mathematical model for this regulatory motif predicted that relative to transcriptional repression, 
RNase-disruption of a PAR loop (RPAR) mediates significantly faster repression of target genes. Indeed, we find 
the RPAR motif to be essential for favorable bioenergetics of the salt-in strategy of salinity adaptation by extremely 
halophilic archaea. Specifically, the RPAR motif coordinates diverse metabolic functions to shift potassium uptake 
from a proton-gradient symport to a ATP-driven process in response to a wide array of environmental changes that 
alter membrane potential. Our results demonstrate that interplay of transcriptional and post-transcriptional regulation 
in a RPAR motif is a general principle by which prokaryotes regulate critical energy-consuming metabolic functions.
1. Shimoni, Y. et al. Regulation of gene expression by small non-coding RNAs: a quantitative view. Mol Syst Biol 3, 138 
(2007).
2. Ingolia, N.T., Ghaemmaghami, S., Newman, J.R.S. & Weissman, J.S. Genome-wide analysis in vivo of translation with 
nucleotide resolution using ribosome profiling. Science 324, 218–223 (2009).
3. Miller, C. et al. Dynamic transcriptome analysis measures rates of mRNA synthesis and decay in yeast. Mol Syst Biol 7, 
(2011).
4. Evguenieva-Hackenberg, E. & Klug, G. New aspects of RNA processing in prokaryotes. Curr Opin Microbiol 14, 587–592 
(2011).
5. Alon, U. Network motifs: theory and experimental approaches. Nat Rev Genet 8, 450–461 (2007).
6. Beisel, C.L. & Storz, G. Base pairing small RNAs and their roles in global regulatory networks. FEMS Microbiol Rev 34, 
866–882 (2010).
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679 B A Potential Role for snoRNAs in PKR Activation during Metabolic Stress
Osama Youssef1, Takahisa Nakamura3, Gökhan Hotamisligil2, Brenda Bass1
1Department of Biochemistry, University of Utah, Salt Lake City, UT; 2Department of Genetics and Complex 
Diseases, Harvard School of Public Health, Boston, MA; 3Division of Endocrinology at Cincinnati Children’s 
Hospital Medical Center, Cincinnati, OH
PKR (Protein Kinase RNA activated) is a member of the stress-response kinase family. Catalytically active PKR 
inhibits translation by phosphorylating the eukaryotic initiation factor, eIF2a. PKR contains a regulatory dsRNA-
binding domain at its N-terminus and a catalytic kinase domain at its C-terminus.  
PKR has long been known to be activated by viral dsRNA as part of the mammalian immune response. However, 
PKR kinase activity is also stimulated under conditions of metabolic stress in mice. This stimulation requires a 
functional kinase domain, as well as a functional dsRNA-binding domain. However, the cellular dsRNA required for 
PKR activation during metabolic stress is unknown. We investigated this question using Mouse Embryonic Fibroblast 
(MEF) cells expressing wildtype PKR (PKRWT) or PKR with a point mutation in each dsRNA-binding motif (PKRRM). 
Cells were incubated in the presence or absence of palmitic acid (PA), to mimic a high-fat or regular diet, respectively, 
followed by immunoprecipitation of PKR. PKR immunopurified RNAs from two different sets of three biological 
replicates were subjected to high-throughput sequencing. Since it is predicted that PKRRM does not bind to RNA 
activator(s), RNAs enriched in both immunopurified PKRWT and PKRRM after PA treatment were excluded from our 
analysis.
We found that 122, and 90, exons were enriched by ≥ 2-fold in PKRWT samples after PA treatment (FDR ≤ 5%) 
in the first and second datasets, respectively. Interestingly, 43% and 78% of the enriched exons encode snoRNAs in 
the first and second datasets, respectively. An alternative bioinformatics approach using a sliding window across the 
genome showed that 224 regions were enriched in PKRWT after PA treatment (Fold increase ≥ 2, q-value FDR ≤ 5%). 
Of these, 112 were snoRNAs; the large majority of the remaining regions were annotated mRNA transcripts, but a few 
unannotated regions and lncRNAs were also observed.
Immunoprecipitation of PKR in extracts of UV-crosslinked cells, followed by RT-qPCR, was used to confirm that 
snoRNAs specifically associated with PKRWT after PA treatment. These studies showed that snoRNAs were enriched 
in PKRWT after PA treatment, but not in the PKRRM samples.
CHO cells haploinsufficient for the spliceosomal protein SmD3 maintain pre-mRNA splicing, but show reduced 
levels of intronic snoRNAs1. Consistent with the idea that snoRNAs trigger PKR activation after PA treatment, wildtype 
CHO cells, but not SmD3 haploinsufficient cells, showed increased PKR phosphorylation after PA treatment. Further, 
the decrease in PKR phosphorylation in mutant cells correlated with a decrease in JNK phosphorylation. 
Using gel-shift assays we also find that PKRWT, but not PKRRM, binds directly to snoRNAs. 
Our results support an unprecedented and unexpected model whereby snoRNAs play a role in the activation of 
PKR under metabolic stress.
1Scruggs, Michel, Ory, Schaffer, 2012 MCB.
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681 A DNA methylation level is differentially correlated with the evolutionary features of coding 
exons in different genic positions
Trees-Juen Chuang1, Feng-Chi Chen2, Yen-Zho Chen1
1Genomics Research Center, Academia Sinica; 2Biostatistics and Bioinformatics, Institute of Population 
Health Sciences, National Health Research Institutes
DNA cytosine methylation is a central epigenetic marker. It is usually mutagenic, and may increase the level 
of sequence divergence. However, methylated genes have been reported to evolve more slowly than unmethylated 
genes. Hence, there is a controversy on whether DNA methylation is correlated with increased or decreased protein 
evolutionary rates. We hypothesize that this controversy has resulted from the differential correlations between 
DNA methylation and the evolutionary rates of coding exons in different genic positions. To test this hypothesis, we 
compare human-mouse and human-macaque exonic evolutionary rates against experimentally determined single-
base-resolution DNA methylation data derived from multiple human cell types. We show that DNA methylation is 
significantly related to within-gene variations in evolutionary rates. First, DNA methylation level is more strongly 
correlated with C-to-T mutations at CpG dinucleotides in the first coding exons than in the internal and last exons, 
although it is positively correlated with the synonymous substitution rate in all exon positions. Second, for the first 
exons, DNA methylation level is negatively correlated with exonic expression level, but positively correlated with 
both nonsynonymous substitution rate and the sample specificity of DNA methylation level. For the internal and last 
exons, however, we observe the opposite correlations. Our results imply that DNA methylation level is differentially 
correlated with the biological (and evolutionary) features of coding exons in different genic positions. The first exons 
appear more prone to the mutagenic effects, whereas the other exons are more influenced by the regulatory effects of 
DNA methylation.
680 C RNAs in silico: learning from accelerated molecular dynamics
Giovanni Bussi1
1Scuola Internazionale Superiore di Studi Avanzati
Ribonucleic acid (RNA) is acquiring a large importance in cell biology, as more functions that it accomplishes 
are discovered. However, experimental characterization of RNAs dynamical behavior at atomistic level is difficult. 
Molecular simulations at atomistic detail, in combination with state-of-the-art free-energy techniques, can bridge the 
gap providing an unparalleled perspective on the mechanism and dynamics of RNA folding, conformational transitions, 
and of RNA/protein interactions. Two recent applications of these techniques will be discussed. The first is focused on 
a characterization of the zipping and unzipping mechanisms for a RNA double strand [1]. Results are compared with 
experimental findings, including analysis of X-ray data [2], ultrafast spectroscopy [3] and thermodynamic data [4]. 
Implications on the directionality of RNA processing enzymes are also discussed. The second application is a study 
of the interaction between TAR RNA from HIV and a cyclic binding peptide of pharmaceutical relevance [5]. This is 
done by introducing a suitable acceleration technique that allows for a blind prediction of the bound structure. Results 
are in nice agreement with previous NMR experiments [6].
1. Colizzi and Bussi, J. Am. Chem. Soc. (2012), 134, 5173.
2. Mohan, Hsiao, VanDeusen, Gallagher, Krohn, Kalahar, Wartell, and Williams, J. Phys. Chem. B (2009), 113, 2614.
3. Liu, Zhao, and Xia, Biochemistry (2008), 47, 5962.
4. Turner, Sugimoto, and Freier, Annu. Rev. Biophys. Biophys. Chem. (1988), 17, 167.
5. Do, Carloni, Varani and Bussi, J. Chem. Theory Comput. (2013) ASAP, doi:10.1021/ct3009914
6. Davidson, Leeper, Athanassiou, Patora-Komisarska, Karn, Robinson, and Varani, Proc. Natl. Acad. Sci. U. S. A. (2009), 
106, 11931.
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683 C Determining optimal flanking regions of RNA secondary structures for experimental 
analysis
Nikolai Hecker1, Stefan E. Seemann1, Jakob Hull Havgaard1, Radhakrishnan Sabarinathan1, Henrik Nielsen4, 
Mikkel Christensen-Dalsgaard4, Peter F. Stadler3, Ivo Hofacker2, Jan Gorodkin1
1Center for non-coding RNA in Technology and Health, IKHV, University of Copenhagen, Denmark; 2Center 
for non-coding RNA in Technology and Health, Bioinformatics and Computational Biology Group, Institute 
for Theoretical Chemistry, University of Vienna, Austria; 3Center for non-coding RNA in Technology 
and Health, Bioinformatics Group, Department of Computer Science and Interdisciplinary Center for 
Bioinformatics, University of Leipzig, Germany; 4Center for non-coding RNA in Technology and Health, 
Department of Cellular and Molecular Medicine, University of Copenhagen, Denmark
Multiple sequence and structural alignments are often used to perform more accurate RNA secondary structure predictions 
than folding single sequences. As such they provide useful consensus structures for different experiments, e.g. structure probing. 
However, design of probing or other experimental analysis often require considering the structure of a single sequence in question 
and in addition a sequence flanking the predicted structure. Both aspects contribute to the structure of a single sequence to deviate 
from the corresponding consensus structure extracted from the structural alignment that contains the comparative information. 
To address this, we have developed a tool, RNAcfold (RNA context folding), that determines optimal flanking regions and 
can cope with arbitrary requirements for the minimum size of flanking regions up- and downstream of the specific structure in 
question. This is done by making use of constrained folding as implemented in the ViennaRNA Package while selecting the size 
of the flanking regions so that the probability for observing the structure in the region corresponding to the extracted structure 
from the structural alignment is maximized. In more detail, the probability is determined by the fraction of the partition function 
over all allowed secondary structures which satisfy the constraints compared to the partition function over all allowed secondary 
structures without constraints.
The Rfam database 11.0 was processed for number of sequences and structure content resulting in 324 suitable structure 
alignments. Next, the similarity between consensus structures and minimum free energy structures corresponding to optimal 
flanking regions or to fixed sized flanking regions was evaluated for each sequence. We evaluated the agreement between the 
folded structures (with and without optimal extension of flanking regions, respectively) to the consensus structure from Rfam 
using Matthews correlation coefficients (MCC). We report improvements for all combinations of minimum flanking regions in 
the range 0 to 50 (in steps of 10) for 5’ and 3’ UTRs. For example, a typical set up of a minimum 0 nt in 5’UTR and 30nt 3’UTR, 
the average improvement is 0.05 in MCC and for 15.74% of the families an improvement of more than 0.1 in MCC is obtained.
682 B Exome-Wide Computational Prediction of Evolutionarily Conserved CIS-Regulatory 
G-Quadruplex Motifs
Scott Frees1, Camille Menendez2, Matthew Crum2, Paramjeet Bagga2
1TAS-Computer Science, Ramapo College of New Jersey, Mahwah, New Jersey, 07430, USA.; 2TAS-
Bioinformatics, Ramapo College of New Jersey, Mahwah, New Jersey, 07430, USA.
G-quadruplex structures formed by guanine rich nucleic acids have been implicated in important biological 
processes, human disease, and as therapeutic targets. Recently there has been much interest in studying the potential 
roles of RNA G-quadruplexes as cis-regulatory elements in post-transcriptional gene expression.  Due to the technical 
limitations of experimental approaches, genome-wide  computational analyses are needed for large-scale studies of 
G-quadruplexes.  However, most computational methods have difficulty validating their predictions without laborious 
wet laboratory testing. We have developed a new method to map evolutionarily conserved G-quadruplex motifs in 
nucleic acid sequences. Cross-species motif conservation provides evidence for their biological relevance.  We have 
implemented our method to develop a web-based software application and an exome-wide  database of G-quadruplex 
motifs conserved across species. We have used these tools to study homologous G-quadruplex motifs in the context of 
5′-, 3′-UTRs (untranslated regions)  and coding sections of aligned mRNA sequences. 
Our database contains more than 400,000 predicted homologous G-quadruplexes in the exomes of  Homo sapiens, 
Mus musculus, Pan troglodytes, Canis lupus familiaris, Danio rerio, Caenorhabditis elegans, and Kluyveromyces 
lactis, constituting over 90,000 total genes. Conserved G-quadruplexes were mapped in the 5’- and 3’-UTRs of a 
large variety of genes, including which are involved in apoptosis, brain development, epigenetics, cell proliferation, 
oncogenesis, and transcription. We are using the database to study G-quadruplex composition, as well as distribution 
in the untranslated and translated exome regions with a view to investigate their biological roles as cis-regulatory 
elements. 
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685 B Terminator: a method for precise detection of ncRNA ends and terminal stem-loops using 
chimeric reads from RNA-seq
Zhipeng Lu1, Greg Matera1
1Department of Biology, UNC at Chapel Hill
Non-coding (nc)RNAs play important roles in many aspects of gene regulation, and other cellular processes. The 
functions of ncRNAs are determined by both primary sequence and secondary structure, which typically act via base-pairing 
with other nucleic acid targets, or interacting with proteins and small molecules. Recent years have seen the development of 
a variety of computational and experimental methods that characterize novel ncRNA sequence and structure. One of these 
methods, RNA-seq, has been widely used for its high sensitivity and versatility. 
Within RNA-seq data sets, we have discovered that many of the unmappable reads are chimeric. That is, these reads 
consists of two parts, one from the 5’ or 3’ end of the RNA, the other from the internal part of the opposite strand. This 
phenomenon clearly suggests self-priming from, and ligation with, terminal stem-loops during cDNA library preparation. 
Using the chimeric reads from existing RNA-seq data, we developed a program, called Terminator, to precisely determine 
the ends of ncRNAs and provide support for the predicted terminal stem-loops.
To obtain chimeric reads, we first use a short read mapper capable of partial mapping (not end-to-end) to analyze 
the original RNA-seq data, and select the partial reads. We then map the unmappable parts to the vicinity of the mapped 
locations, on the opposite strand. Finally, reads with two parts mapped to opposite strands are used to construct an ncRNA 
sequence/structure map. The terminally mapped half-reads indicate terminal stem-loops, whereas the internally mapped 
parts indicate single-stranded regions.
We have tested our method in several species (including Drosophila and human) in datasets that contain self-primed 
ncRNA reads. We confirmed the terminal stem loops and ends of well-studied ncRNAs, and also refined the precise ends 
for many newly discovered ncRNAs. 
The combination of fast short-read mappers (we used bowtie2) and rapid local mapping of normally unmappable 
fragments allows efficient processing of large numbers of datasets in a short time, and therefore increases the sensitivity of 
our method. Terminal stem-loops and internal single-stranded regions are common features of most snRNAs and snoRNAs, 
and many other types of ncRNAs. With the ever-increasing amount of publicly available RNA-seq datasets, Terminator will 
be a useful tool for studying ncRNAs.  
684 A EASANA: RNA-Seq and Affymetrix HTA2 data analysis, visualization and interpretation
Frédéric Lemoine1, Caroline Hégo1, Olivier Ariste1, Bertrand Coulom1, Marc Rajaud1, Pierre de la Grange1
1GenoSplice
Recent advances in technologies allow to study the transcriptome as we never could before but also increase amount 
and complexity of data (up to several billion). Thus, analyzing such “big data” is challenging, time consuming, and needs the 
development of efficient and user-friendly tools. In this context, for public or private organization researchers, it is quite difficult 
to manage these new bioinformatics issues.
We developed a dedicated analysis and visualization tool for transcriptomics data named EASANA (publicly available at 
https://www.easana.com). This tool allows to display gene intensity taking into account the genomic context at the exon level. 
EASANA was first applied to Affymetrix Exon Array data (Jia et al., Cell 2012; Ameyar-Zazoua et al., Nat Struct Mol Biol 2012; 
Moreira et al., EMBO Mol Med 2013; Gandoura et al., J Hepatol 2013) and was recently improved to handle exon-exon junction 
intensity regulation information (Shen et al., Nucleic Acids Res. 2013). EASANA now enables the analysis and visualization of 
data from the last generation expression technologies. In particular, EASANA can now manage data from RNA-Seq experiments 
and from the last generation of splicing-sensitive microarray that include exon-exon junction probes (Xu et al., PNAS 2011): the 
Affymetrix HTA2 (Human Transcriptome Array 2.0).
EASANA handles all main types of RNA-Seq data (Illumina, SOLiD, 454…) and provide results at both gene and exon 
levels. For exon level analysis, EASANA analyzes regulation of alternative splicing as well as alternative first and terminal exons, 
known or not in publicly available gene annotations (i.e., new exon-exon junctions can be found). In addition, detection analysis 
of fusion transcripts and SNP/indel are also included.
A comparison between Illumina RNA-Seq and HTA2 using Human Muscle vs. Liver tissues will be presented: Detection 
sensibility, number of regulated genes and splicing pattern regulation will be detailed.
In March 2013, Affymetrix launched its new expression array named HTA2. As for RNA-Seq data, EASANA allows the 
analysis and visualization for data from this new generation array. Analyses at both gene and exon levels are provided and 
we currently develop algorithm to detect potential fusion transcripts from high-density expression microarray such as HTA2 
(Affymetrix named GenoSplice as its preferred data analysis service provider for HTA2 data).
In addition to analyze genomics data, we provide help in the experimental design (e.g., number of replicates, sequencing 
depth), help in the biological interpretation of data (e.g., functional analysis of results), and follow-up until publication of results 
(scientific article and/or patent).
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687 A A new and systematic approach to analyse the population of sRNAs at the genome scale.
Antonin Marchais1, Alexis Sarrazin1, Arturo Marí Ordóñez1, Olivier Voinnet1
1ETHZ
The deep sequencing of small RNAs (sRNAs) provides a snapshot of RNA populations in the cells in specific 
conditions or tissues. In eukaryotes, these data usually reveal a complex mixture of miRNAs, siRNAs and degradation 
products, detected at different states of maturation or degradation, and mainly enriched for the sRNAs stabilised by 
their interaction with proteins or by their interaction with complementary RNAs. Despite the apparent noise created 
by the overlapping of these sub-populations of sRNAs, classical tools are able to characterize some of them using 
the rules of maturation described in the last decade. For instance, the sRNA sizes, the 2nt 3’ overhangs and the 2D 
structures allow the detection of miRNAs, whereas the sizes, the 2nt 3’ overhangs and their grouping along several 
hundred nucleotides defines siRNA clusters. These clusters occasional reveal phased sRNAs, illustrating DICER 
processivity.
In plants, the number of DICER and AGO proteins increases the complexity of this categorization and to bypass 
this problem we are forced to work with complex mutants. Moreover, the typical rules of sRNA maturation seem often 
insufficient to completely understand the observations. 
By integrating tools classically used to discover correlations and periodicities in signal processing, our work 
focuses on the development of a new methodology to analyse in-depth the sRNA-seq data at the genome scale. 
The final goal is to achieve a more resolutive analysis with the current maturation rules and to discover new rules 
or signatures linked to the processivity of the DICERs and the known functional interactions between the proteins 
involved in silencing.
For instance in A. thaliana, RDR6 long double stranded RNA products are known to be mainly processed by 
DCL4 into 21nt siRNAs; from deep sequencing data analysis however, we also observed processing at a lower rate 
into 24nt siRNAs by DCL3. By the measure of cross-correlation of the genomic positions of these 21 and 24mers, 
our approach allowed us to propose a model for the ordered processing of these dsRNA substrates by both DICER 
proteins. 
686 C Uncovering markers of cell identity change from transcriptome profiles
Nancy Mah1, Jean-Fred Fontaine1, Miguel Andrade-Navarro1
1Computational Biology and Data Mining, Max Delbrück Center for Molecular Medicine, Berlin, Germany
Understanding the control of cellular reprogramming is crucial to improve and create protocols for its induction, to 
find out about the mechanisms that lead to pathological or failed changes of cell identity in cancer and developmental 
diseases, and to better understand cell pluripotency and differentiation. There is increasing evidence that modifications 
in common regulatory networks are required to facilitate changes of cell identity such as induced reprogramming, 
cancer and differentiation. For example, genes related to the epithelial to mesenchymal transition (EMT) are modified 
both during reprogramming and cancer. Our goal is to find genes expressed in cells that are undergoing changes in 
identity through the examination of gene expression profiles from cancer, reprogramming and differentiation.
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689 C The Conserved Structures of Right-Handed Polymerases
Heli Mönttinen1, Janne Ravantti2, Minna Poranen1
1Department of Biosciences, University of Helsinki; 2Department of Biosciences and Institute of 
Biotechnology, University of Helsinki
Viral RNA-dependent RNA polymerases (vRdRp) have the classical right-handed polymerase structure containing 
three conserved subdomains: thumb, palm and fingers. The catalysis reaction is run by two catalytic ions in the palm 
subdomain. Interestingly, in the vRdRp of the phage φ6, a manganese ion has been observed around 6 Å from the 
catalytic ion binding site. This non-catalytic ion was later shown to be needed for the template binding, nucleotide 
coordination and catalysis. An ion in a similar position has also been observed in several other vRdRps. Now, we have 
identified the non-catalytic ion binding site by using structural alignment. Our results suggest that the non-catalytic ion 
binding site is common for positive-stranded and double-stranded RNA polymerases. Furthermore, we have studied 
the common structural features and evolutionary relationships of the right-handed polymerases by using a novel 
structural classification method. This study covers vRdRps, single-subunit DNA-dependent RNA polymerases, RNA-
dependent DNA polymerases and DNA-dependent DNA polymerases. These results provide information about the 
structural and functional conservation of the right-handed polymerases. 
688 B Stepwise co-evolution between bacterial CRP/FNR-type transcription factors and their 
transcriptional networks
Motomu Matsui1, Masaru Tomita1, Akio Kanai1
1Institute for Advanced Biosciences, Keio University; Systems Biology Program, Graduate School of Media 
and Governance, Keio University
Transcription is a key system in all living organisms. Transcription factors (TFs), in particular, play a central regulatory 
role(s) in this system, although the evolutionary scenarios of TFs and their coevolution with their target genes are poorly 
understood. Determining the relationships between the TFs and their target genes from an evolutionary perspective should 
contribute to our understanding of not only the variety of transcription regulation systems but also the archaic transcriptional 
networks. 
The CRP/FNR-type TFs are members of a well-characterized global TF family in bacteria and have two conserved 
domains: the N-terminal ligand-binding domain for small molecules (e.g., cAMP, NO, or O
2
) and the C-terminal DNA-
binding domain. Although the CRP/FNR-type TFs recognize very similar consensus DNA target sequences, they can 
regulate different sets of genes in response to environmental signals. To clarify the evolution of the CRP/FNR-type TFs 
throughout the bacterial kingdom, we undertook a comprehensive computational analysis of a large number of annotated 
CRP/FNR-type TFs and the corresponding bacterial genomes. Based on the amino acid sequence similarities among 1,455 
annotated CRP/FNR-type TFs, spectral clustering classified the TFs into 12 representative groups, and stepwise clustering 
allowed us to propose a possible process of protein evolution. Although each cluster mainly consists of functionally distinct 
members (e.g., CRP, NTC, FLP, and FixK), FNR-related TFs are found in several groups and are distributed in a wide 
range of bacterial phyla in the sequence similarity network. This result suggests that the CRP/FNR-type TFs originated 
from an ancestral FNR protein, involved in nitrogen fixation. Furthermore, a phylogenetic profiling analysis showed that 
combinations of TFs and their target genes have fluctuated dynamically during bacterial evolution. A genome-wide analysis 
of TF-binding sites also suggested that the diversity of the transcriptional regulatory system was derived by the stepwise 
adaptation of TF-binding sites to the evolution of TFs. 
We are now expanding the survey objects and analyzing the transcriptional networks using the whole set of known TFs 
(approximately 300 proteins) in Escherichia coli. These results will be discussed in this conference.
1. Matsui M., Tomita M. and Kanai A. (2013) Genome Biol. Evol. 5(2), 267-282.
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691 B IntEREst: Intron-Exon Retention Estimation using RNA-seq data
Ali Oghabian1, Elina Niemelä1, Mikko Frilander1
1Institute of Biotechnology, University of Helsinki, Finland
RNA sequencing is widely used today for studying gene expression analysis as well as identifying and quantifying 
various mRNA processing intermediates in the cells. To estimate the levels of the partially spliced or unspliced 
transcripts in a cell from RNA-seq data we have developed IntEREst (Intron-Exon Retention Estimation) pipeline in 
R. The IntEREst pipeline can be run in parallel to increase the performance.
In this study we employed IntEREst to investigate the global analysis of the nuclear processing of the unspliced U12-
type introns by the exosome, a ribonuclease complex involved in RNA turnover using ABI’s SOLiD 4 transcriptome 
sequencing data. TheU12-type introns are a distinct subset of nuclear introns and constitute >0.5 % of all introns (~800 
introns in humans). They are removed via a separate spliceosome (so called U12-dependent spliceosome) while the 
normal U2-type introns are removed by the U2-dependent spliceosome. Earlier studies have shown that the splicing 
rate of the U12-type introns in the nucleus is slower than that of the U2-type, suggesting that the U12-type introns can 
regulate the levels of their “host” mRNAs in the cell. Consistently, an elevated level of unspliced U12-type introns have 
been detected in the steady-state mRNA populations in various organisms. Here we investigated the hypothesis that 
due to slower splicing, the unspliced mRNAs containing U12-type introns in the nucleus are preferentially degraded 
by the exosome complex. Exosome is a ribonucleoprotein complex that participates in numerous RNA processing and 
trimming steps but also degrades RNAs that either aberrant or accumulate in wrong compartments. We compared the 
retention levels of the U12- and U2-type introns in nuclear and cytoplasmic fractions in control cells and in cells in 
which the exosome function has been disabled (e.g. knockdown of the Rrp41 and Dis3 subunits). Analyzing more than 
100,000,000 paired reads (50 bps + 35 bps, with ~100-200 bps library) that were mapped to U12 intron containing 
genes, we discovered that exosome inactivation stabilizes unspliced U12-type introns as opposed to the U2-type 
introns. Moreover, the effects of Rrp41 and Dis3 knockdowns were not identical, suggesting different regulatory roles 
for the two subunits. Finally, we also confirm in genome-wide fashion that unspliced U12-type introns are indeed 
overrepresented as compared to U2-type introns.
690 A Discovering Conserved CIS-Regulatory G-Quadruplex Motifs in the Transcripts of Human 
CHD8 Gene Involved in Autism
Emma Murray1, Lawrence D’Antonio2, Paramjeet Bagga2
1TAS-Bioinformatics, Ramapo College of New Jersey, Mahwah, New Jersey, USA; 2Ramapo College of New 
Jersey
The human CHD8 (Chromodomain helicase DNA binding protein 8) is a chromatin remodeling agent. CHD8 
represses transcription by enlisting the help of histone H1 at target genes where it remodels the chromatin. CHD8 
binds to beta-catenin and suppresses the activity of p53/TP53-mediated apoptosis, thus negatively regulating the 
Wnt-signaling pathway. Mutations in the transcribed region of the human CHD8 gene have been linked to autism. 
Studying regulation of human CHD8 gene expression is expected to enhance our understanding of its function and 
role in human disease.
G-quadruplexes are highly stable three-dimensional structures formed in guanine rich DNA and RNA sequences. 
G-quadruplex structure consists of square coplanar arrays of G-tetrads. RNA G-quaduplexes have received significant 
attention because of their importance in biological processes such as regulation of protein synthesis and mRNA 
turnover.
The goal of this project has been to study the role of G-quadruplex forming motifsin regulating gene expression 
of human CHD8.
Using computational tools developed in our lab, we adopted a bioinformatics approach to map evolutionarily 
conserved G-quadruplexes in five orthologs of the humanCHD8 gene:  chimpanzee, dog, bovine, mouse and rat. We 
discovered three highly conserved G-quadruplex motifs in the 3’-UTR of CHD8 mRNA. Two of these motifs were 
associated with microRNA target sites and one of them was found in close proximity to the polyadenylation signal. We 
found evolutionarily conserved G-quadruplex motifs in the 5” flanking region of the alternatively transcribed human 
CHD8 isoform 1. Conserved G-quadruplexes were also found near the splice sites of alternative isoforms.
Our analysis suggests that conserved G-quadruplexes could potentially regulate translation efficiency, mRNA 
stability, and polyadenylation of the CHD8 mRNAs. Our results also suggest that G-quadruplexes could play a role in 
alternative transcription, as well as, alternative splicing.
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692 C Understanding without reading: analog encoding of physico-chemical properties of 
proteins in cognate messenger RNA
Anton Polyansky1, Mario Hlevnjak1, Bojan Zagrovic1
1Department of Structural and Computational Biology, Max F. Perutz Laboratories, University of Vienna, 
Campus Vienna Biocenter 5, A-1030 Vienna, Austria
Being related by the genetic code, messenger RNAs (mRNAs) and cognate proteins are polymers with mutually 
interdependent compositions, which further imply the possibility of a potential connection between their physico-
chemical properties. How efficiently do different characteristics of mRNA coding regions reflect the features of 
cognate proteins and is it possible for the cell to obtain information about proteins from their mRNAs without first 
reading them on the ribosome? We address these issues in a theoretical proteome-wide analysis and show that average 
protein hydrophobicity, calculated from either sequences or 3D structures, can be encoded in an analog way by 
many different mRNA sequence properties with the only constraint being that pyrimidine and purine bases should be 
clearly distinguishable. Moreover, average characteristics of mRNA sequences allow for a reasonable discrimination 
between human proteins with different cellular localization and, in particular, cytosolic and membrane proteins, even 
in the absence of signal-peptide-based mechanisms. We discuss our findings in the context of protein and mRNA 
localization and propose that this cellular process may be partly determined by basic physico-chemical rationales and 
interdependencies between the two biomolecules.
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693 A cWords – systematic microRNA regulatory motif discovery from mRNA expression data
Simon H. Rasmussen1, Anders Jacobsen2, Anders Krogh1
1Bioinformatics Centre, Department of Biology, University of Copenhagen, Ole Maaløes Vej 5, 2200 
Copenhagen N, Denmark.; 2Computational Biology Center, Memorial Sloan-Kettering Cancer Center, New 
York, NY, USA
Background: Post-transcriptional regulation of gene expression by small RNAs and RNA binding proteins 
is of fundamental importance in development of complex organisms, and dysregulation of regulatory RNAs can 
influence onset, progression and potential treatment of many diseases. Post-transcriptional regulation by small RNAs 
is mediated through partial complementary binding to messenger RNAs leaving nucleotide signatures or motifs 
throughout the entire transcriptome. Computational methods for discovery and analysis of sequence motifs in high-
throughput mRNA expression profiling experiments are becoming increasingly important tools for the identification 
of post-transcriptional regulatory motifs and the inference of the regulators and their targets.
Results: cWords is a method designed for regulatory motif discovery in differential case-control mRNA 
expression datasets. We have improved the algorithms and statistical methods of cWords resulting in at least a factor 
100 speed gain over the previous implementation. On a benchmark dataset of 19 microRNA (miRNA) perturbation 
experiments cWords showed equal or better performance than two comparable methods, miREDUCE and Sylamer. 
We have developed rigorous motif clustering and visualization that accompany the cWords analysis for more intuitive 
and effective data interpretation. To demonstrate the versatility of cWords we show that it can also be used for 
identification of potential siRNA off-target binding. Moreover, cWords analysis of an experiment profiling mRNAs 
bound by Argonaute (AGO) ribonucleoprotein particles discovered endogenous miRNA binding motifs (Figure 1). 
The binding sites that occur in the mRNAs most bound by AGO as reported by cWords are shown in Figure 1A and 
these words correspond to the target sites of most expressed miRNAs in HEK293 cells, which are ranked in Figure 1B.
Conclusions: cWords is an unbiased, flexible and easy to use tool designed for regulatory motif discovery in 
differential case-control mRNA expression datasets. cWords is based on rigorous statistical methods that demonstrate 
comparable or better performance than other existing methods. Rich visualization of results promotes intuitive and 
efficient interpretation of data. cWords is available as a stand-alone Open Source program at Github https://github.
com/simras/cWords and as a web-service at: http://servers.binf.ku.dk/cwords/.
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Figure 1. Word enrichment of AGO bound mRNAs. (A) cWords word cluster plot showing 7mer 
3’UTR words correlated with AGO binding in HEK293 cells. The top 10 words are annotated with
IDs of the most abundant miRNAs in HEK293 cells. (B) Top 20 most abundant miRNAs in HEK293
cells, listing expression (relative clone frequency) and seed site (position 2-8) for each miRNA.
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695 C Searching the coding region for microRNA targets
Jiri Vanicek1, Ray Marin1, Miroslav Sulc1
1EPFL
Finding microRNA targets in the coding region is difficult due to the overwhelming signal encoding the amino 
acid sequence. Here we introduce an algorithm (called PACCMIT-CDS [1]) that finds potential microRNA targets 
within coding sequences by searching for conserved motifs that are complementary to the microRNA seed region and 
also overrepresented in comparison with a background model preserving both codon usage and amino acid sequence. 
Precision and sensitivity of PACCMIT-CDS are evaluated using PAR-CLIP and proteomics datasets. Thanks to the 
properly constructed background, the new algorithm achieves a lower rate of false positives and better ranking of 
predictions than do currently available algorithms, designed to find microRNA targets within 3’UTRs.
1. R. M. Marín, M. Šulc, and J. Vaníček, RNA, in press (2013), http://rnajournal.cshlp.org/lookup/doi/10.1261/
rna.035634.112. 
694 B Analysis of structural and functional impact of UTR single nucleotide variants identified in 
the non-small cell lung cancer by RNA-sequencing
Radhakrishnan Sabarinathan1, Anne Wenzel3, Peter Novotny4, Krishna R Kalari5, Jan Gorodkin2
1Center for non-coding RNA in Technology and Health, IKVH, University of Copenhagen; 2Center for 
non-coding RNA in Technology and Health, IKHV, University of Copenhagen; 3Center for non-coding 
RNA in Technology and Health, IKVH, University of Copenhagen; 4Bioinformatics Centre, Department of 
Biology and Biotech Research and Innovation Centre, Copenhagen University; 5Division of Biostatistics and 
Bioinformatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA
Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, with high prevalence of mutations 
in KRAS gene. Tumors harboring these mutations tend to be aggressive and resistant to chemotherapy. In a recent 
study, the transcriptome of the tumors cells harboring mutant KRAS and wild-type KRAS have been compared to 
identify the differentially expressed genes, alternative splicing and single nucleotide variations (SNVs). About 40% 
of the total SNVs (73,717) identified were mapped to the UTR regions of mRNAs, however, their effects on the UTR 
region have not been analyzed due to the lack of comprehensive computational pipeline. It is known that the UTR 
regions of mRNA harbor sequence and structural motifs that are involved in the post-transcriptional regulations of 
gene expression. SNVs mapped to these regions may cause sequence or structural changes that can interfere with 
the functions of UTR. Thus, we designed a pipeline to predict the effect of SNVs on the secondary structure of UTR 
(using RNAsnp) as well as miRNA target sites within the UTR regions of mRNAs (using TargetScan, miRanda 
and RIsearch). With our comprehensive computational pipeline, we predicted 492 out of 29,290 UTR SNVs have 
significant effect on the local RNA secondary structure of the UTR regions (corresponding to 429 genes). Of these 
492 SNVs, 117 SNVs were present in 104 genes involved in cancer related pathway.  On the other hand, 302 out of 
29,290 UTR SNVs were predicted to cause changes in the miRNA target site within the UTRs of 289 genes. Of these 
302 SNVs, 73 were present in 67 genes involved in cancer related pathway. On these 67 genes, 85 miRNAs were 
predicted to bind either in the wild- type or mutant. We found 54 out of these 85 miRNAs overlap with lung cancer 
associated miRNAs from PhenomiR database, while six miRNAs are associated specifically with NSCLC according 
to microRNA body map database. 
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697 B Segmentation of Proximal RNA Binding Sites from High-throughput Sequencing Data 
Using a Density-Based Clustering Approach
Bob Zimmermann1, Renée Schroeder1
1University of Vienna
High-throughput sequencing has been widely used to find novel protein-binding RNAs, utilizing methods such 
as CLIP-Seq and Genomic SELEX. Typical analyses of the high-throughput data employ the use of a histogram of 
the aligned read count per base, the intensity of which indicates, for a specific region of an RNA, the underlying 
sequence’s relative occurrence of binding events in the experiment. This technique can, however, obscure the precise 
locations of binding sites in close proximity to each other, which would be found when analyzing high-throughput 
data for enzymes whose activity require multiple RNA binding sites, as well as for overlapping distinct ncRNA loci 
derived from processing events. We present a density clustering approach based on the OPTICS algorithm which 
can detect any number of RNA binding sites indicated by the data without prior knowledge of the expected length 
or number of binding sites in the transcript. Combined with histogram analysis as post-processing, the algorithm can 
detect minimal-length proximal binding sites of RNAs binding yeast RNA Polymerase II derived from Genomic 
SELEX data. Band-shift assays show that output of the algorithm corresponds both to the correct length as well as the 
binding affinity. The algorithm represents a novel approach to processing read data and is fast enough to run to large 
data sets after alignment of the reads is performed. It can be applied to many types of high-throughput sequencing data 
to deconvolute proximal DNA and RNA binding sites encoded in the genome. A C implementation of the algorithm 
will be available at http://alu.abc.univie.ac.at/hillfinder
696 A PyCRAC CLIP data analyses predict a prominent role for Nrd1 and Nab3 in regulation of 
protein coding gene expression in yeast
Shaun Webb1, Ralph D Hector2, Grzegorz Kudla4, Sander Granneman3
1Wellcome Trust Centre for Cell Biology, University of Edinburgh; 2Institute for Structural and Molecular 
Biology, Centre for Synthetic and Systems Biology (SynthSys), University of Edinburgh; 3Institute for 
Structural and Molecular Biology, Centre for Synthetic and Systems Biology (SynthSys), University of 
Edinburgh; 4MRC Human Genetics Unit, University of Edinburgh
RNA-binding proteins play crucial roles in the synthesis, processing and degradation of RNA in a cell. To better 
understand the function of RNA-binding proteins, it is important to identify their RNA substrates and the sites of 
interaction. This would help to better predict their function and lead to the design of more focused functional analyses. 
The development of CLIP and related techniques has made it possible to identify direct protein-RNA interactions in 
vivo at nucleotide resolution. 
The analysis of the high-throughput sequencing datasets, however, can be daunting, and demands more than 
a basic knowledge in bioinformatics and computer programming skills. The development of pyCRAC was driven 
by a requirement for a set of user-friendly, flexible and coherent set of tools tailored to handle CLIP and related 
RNA sequencing data. With a large number of valuable CLIP datasets now publically available, pyCRAC provides a 
comprehensive set of easy to use tools that allow the less experienced researcher to (fully) exploit these data.
To illustrate the functionality of pyCRAC, we have used the toolset to reanalyse recently published Nrd1 and 
Nab3 PAR-CLIP data, and we have also experimentally validated some of our findings. We found that Nrd1-Nab3 
bound between 20 to 30% of protein-coding transcripts and we speculate that the proposed Nrd1-Nab3 “fail-safe” 
transcription termination mechanism is commonly used to prevent transcriptional read-through of mRNA coding 
genes. Nrd1 and Nab3 targets were also significantly enriched for enzymes and permeases involved in nucleotide/
amino acid uptake and proteins involved in mitochondrial organization, indicating Nrd1-Nab3 function is tightly 
integrated with the nutrient response. Notably, transcripts encoding mRNA export and turnover factors were also 
frequently targeted. We conclude that Nrd1 and Nab3 play a prominent role in the regulation of protein coding gene 
expression, in particular genes involved in the nutrient response. Results from our in silico and experimental analyses 
will be presented.
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699 A Comprehensive identification of RNA 5’ ends in E. coli
Ivana Bilusic Vilagos1, Bob Zimmermann1, Meghan Lybecker1, Nadia Tukhtubaeva1, Renée Schroeder1
1Max F. Perutz Laboratories, Vienna, Austria
Recent prokaryotic transcriptome studies, led by advances in sequencing that have improved the technique’s 
sensitivity, report antisense transcription to be more prevalent than previously expected. As many as 70% of annotated 
genes have been reported to have antisense counterparts that are regularly expressed at low levels. Although function 
of these widespread antisense transcripts is not known, they are often considered to be product of background or 
pervasive transcription.
We adapted and modified the standard RNA-seq library preparation method in order to discriminate between 
pervasive transcription products and stable, likely regulated, transcripts with a defined 5’ end. The modification of the 
library preparation allowed us to specifically enrich for 5’ ends resulting in most comprehensive overview of E. coli 
transcripts featuring stable 5’ ends. Moreover, we were able to distinguish between primary transcriptional start sites 
(TSSs) with 5’ triphosphate and stable 5’ ends resulting from ribonuclease processing, bearing a monophosphate. We 
identified alternative TSSs of known genes as well as novel TSSs giving rise to unexpected short, mostly antisense 
RNAs. In addition, we monitored the influence  of well-known RNA chaperone Hfq on TSSs profile. Expression of 
novel short RNAs, as well as their dependence on Hfq were confirmed by Northern blot analysis, further supporting 
the sequencing data. Overall, our data suggests strands opposite to annotated genes have potential to code for regulated 
RNAs with discrete 5’ ends.
698 C Full-Length Transcript Sequencing: Looking Beyond the ENCODE data
Kin Fai Au1, Elizabeth Tseng3, Vittorio Sebastiano4, Lawrence Lee2, Renee Reijo Pera4, Wing Hung Wong1, Jason G. 
Underwood3
1Stanford University, Department of Statistics, Stanford, CA USA; 2Invitae, Inc., San Francisco, CA USA; 
3Pacific Biosciences of California, Menlo Park, CA USA; 4Stanford University, Center for Human Embryonic 
Stem Cell Research and Education, Stanford, CA USA
Most RNA-seq experiments to date use short cDNA reads to assemble and count putative transcripts.  These 
methods can infer alternative events such as splicing or transcription start sites, but cannot correlate events that are far 
apart on the original transcript since short reads cannot truly assemble the original, single RNA molecule.   To address 
this deficiency, we applied the long read length capabilities of the PacBio® RS to sequence full-length cDNA molecules 
derived from human H1 stem cell polyA RNA.  This cell line, a Tier 1 sample for the ENCODE project, has been 
extensively characterized by multiple 2nd generation sequencing approaches, including RNA-seq to assist in transcript 
assembly.  We hypothesized that the long reads would help not only to assign the most common full-length mRNA 
isoforms in the H1 line, but also assist in assembling transcripts that are difficult with current algorithms.  
We demonstrate that several full-length library preparation methods generate sequencing libraries that are highly 
enriched in full-length cDNA molecules.  This was shown using a reference-based approach of aligning putative 
full-length cDNA reads to known transcripts in the Gencode set.  By this alignment method, we detect many known 
full-length transcripts spanning a range from 500 bp to 6000 bp in length.  We also present genome-based alignment 
approaches using gapped alignment methods that account for splicing events.  To assist the genome-based approach, 
we have developed an error correction method, LSC, which uses short-read data to improve the alignments of long full-
length cDNA sequences.  Using both long and short reads, we developed an isoform detection and prediction pipeline. 
We report our findings on detecting novel splicing events and the discovery of new ncRNAs that are not apparent from 
Cufflinks short-read assembly alone.  As an unintended benefit, this methodology also captures transcript maturation 
in action, as retained intron events can often be seen in the full-length reads.  The methods and algorithms for long-
read cDNA sequence determination will assist researchers to better characterize the transcriptome’s true form and help 
unlock combinatorial RNA processing regulation that cannot be observed in previous RNA-seq data sets.  
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700 B Engineered “restriction RNases” for sequence-specific cleavage of dsRNA and RNA in DNA-
RNA hybrids
Janusz Bujnicki1, Krzysztof Skowronek1, Agata Sulej1, Dariusz Pianka1, Irina Tuszynska1, Marcin Nowotny2, Justyna 
Czarnecka1
1Laboratory of Bioinformatics and Protein Engineering, International Institute of Molecular and Cell Biology 
in Warsaw, Ul. Ks. Trojdena 4, 02-109 Warsaw, Poland.; 2Laboratory of Protein Structure, International 
Institute of Molecular and Cell Biology in Warsaw, Ul. Ks. Trojdena 4, 02-109 Warsaw, Poland.
Ribonucleases (RNases) are valuable tools applied in the analysis of RNA sequence, structure and function. Their 
substrate specificity is limited to recognition of single bases or distinct secondary structures in the substrate. Thus far, 
there have been no RNases available for purely sequence-dependent fragmentation of RNA, analogous to restriction 
enzymes for DNA. We have therefore searched for existing RNases that could be engineered to become sequence-
specific. Using a combination of bioinformatics methods and experimental protein engineering we have obtained 
prototypes of two sequence-specific “restriction RNases” (RRNases): one that cleaves both strands of dsRNA within a 
target sequence, and one that cleaves RNA within DNA-RNA hybrids at a particular distance from the target sequence. 
Based on structural analysis of enzymes from the RNase III superfamily we identified loops that could be extended 
to make specific contacts with bases in the dsRNA substrate. Biochemical characterization of selected members that 
possess extended versions of such loops revealed that some of them indeed exhibit sequence specificity. For one 
of such enzymes we constructed a structural model of a protein-RNA complex, and used it to guide site-directed 
mutagenesis aimed at elucidating the molecular basis of specificity and to increase the selectivity of cleavage. The 
obtained prototype RRNase recognizes a partially degenerated hexanucleotide target sequence and is capable of 
cleaving individual sites in long dsRNA molecules.
A prototype RRNase that cleaves the RNA strand in DNA-RNA hybrids 5 nucleotides from a nonanucleotide 
recognition sequence was constructed by fusing two functionally distinct domains: a non-specific RNase HI and a 
zinc finger that recognizes a sequence in DNA-RNA hybrids. The optimization of the fusion enzyme’s specificity was 
guided by a structural model of the protein-substrate complex and involved a number of steps, including site-directed 
mutagenesis of the RNase moiety and optimization of the interdomain linker length. 
For both types of RRNases we implemented methods of specificity engineering, to enable generation of variants 
specific for other target sequences, making it feasible to acquire a library of enzymes that recognize and cleave a 
variety of sequences, much like the commercially available assortment of restriction enzymes. Potentially, RRNases 
may be used in vitro for production of RNA molecules with defined length and termini, which may be a cheaper 
alternative to chemical synthesis; they may be also used in vivo for targeted RNA degradation.
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702 A Comparing the transcriptome of mouse and human using RNA sequencing
Allissa Dillman1, Melissa McCoy1, Marcel van der Brug2, Mark Cookson1
1National Institutes of Health; 2Diagnostics Discovery Department, Genentech, Inc.
Mice are often used as model organisms for human disease. There are many cases, however, in which mouse 
models do not recapitulate all of the symptoms present in the relevant human disease.  This is especially true in models 
of neurological disease.  The brain is an incredibly complex organ and understanding what makes the human brain 
unique and what it shares with its rodent models may help us to understand why some models are have better face 
validity than others.  RNA sequencing (RNA-Seq) is uniquely applicable for direct comparison of gene expression 
between species as it does not require the use of sequence-specific probes, as is the case with microarray.    We have 
used RNA-Seq to create a high-resolution transcriptome data set of mouse cerebral cortex and human frontal cortex. 
We found a large number of genes more highly expressed in one species as compared to the other. We validated a 
number of these findings using independent techniques.  Taking advantage of the sequencing information found with 
RNA-seq we also noted that conserved A-to-I RNA editing sites were nonsynonymous coding changes in all but one 
case. We propose this dataset as a helpful resource for interrogating gene expression differences between humans and 
mice.
701 C miR-Direct: RT-qPCR analysis of plasma microRNAs without prior RNA extraction
Anne Dallas1, Sumedha Jayasena1, Brian Johnston2, Heini Ilves1, Michael Mostachetti1, Sergei Kazakov1
1Somagenics, Inc., Santa Cruz, CA, USA; 2Somagenics, Inc., Santa Cruz; and Department of Pediatrics, 
Stanford University School of Medicine, Stanford, CA, USA
Circulating microRNAs (miRNAs) have great potential as biomarkers, but current methods for their detection are 
hampered by inconsistent RNA recovery during isolation, by the difficulty of eliminating RT-PCR inhibitors, and by 
the low concentration at which most miRNAs appear in blood. Here we describe a novel method (miR-Direct™) in 
which miRNAs or other small RNAs (or fragments of large RNAs) of interest can be enriched from plasma samples 
and directly quantified by RT-qPCR without prior extraction of total RNA. miR-Direct consists of the following 
steps: (1) treatment of plasma with agents that release miRNAs from lipid and/or protein complexes; (2) capture 
of miRNAs of interest by hybridization with specific probes attached to magnetic beads; (3) washing the captured 
miRNAs to remove inhibitors of amplification reactions present in plasma and the release buffer; (4) release of the 
captured miRNAs into solution; and (5) detection of the released miRNAs using an RT-qPCR assay. We compared 
two such assays, SomaGenics’ miR-ID® and Life Technologies’ TaqMan® microRNA assay, for detection of three 
circulating miRNAs (hsa-miR-16, hsa-miR-148a and hsa-miR-125b) as well as a spike-in control (cel-miR-39). In 
this comparison, miR-ID detection produced significantly lower cycle threshold (Ct) values than TaqMan detection, 
and Ct values showed the expected dependence on starting plasma volume only with miR-ID. The miR-Direct method 
reduces the variable loss of small RNAs that is usually seen with standard total RNA isolation conditions.  Because 
sample processing (up to the qPCR step) is a one-tube process, the method is highly amenable to automation. Because 
irrelevant RNA and DNA is removed prior to the amplification steps, background is low and sensitivity high, resulting 
in accurate expression profiling of small RNAs and determinations of absolute copy numbers. 
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703 B Genome-wide profiling of RNA secondary structure in planta
Yiliang Ding1, Chun Kit Kwok1, Yin Tang1, Philip Bevilacqua1, Sarah Assmann1
1Pennsylvania State University
RNA structure plays critical roles in regulating various post-transcription events involved in translation, splicing, 
and polyadenylation. However, lack of genome-wide in vivo RNA structural data limits our understanding of how 
RNAs fold and regulate gene expression in vivo.  Herein we develop a platform to probe RNA structures on a genome-
wide scale in vivo. With the application of next generation sequencing, we establish high-throughput in vivo RNA 
secondary structure profiling in Arabidopsis thaliana, a model plant species and modern eukaryote. This platform 
probes the RNA secondary structures of more than 10,000 transcripts, provides even coverage of each transcript, and 
gives excellent agreement on rRNA structures as a benchmark. This platform provides an accurate and quantitative 
genome-wide RNA structural map in vivo that reveals native RNA structural features that relate to numerous biological 
processes including translation initiation and regulation, alternative polyadenylation, and alternative splicing. This 
platform can be applied to different organisms, different tissues and different treatments which will allow the role of 
RNA structures in gene regulation to be understood on a genome-wide scale.    
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704 C Post-transcriptional regulation of mitochondrial gene expression
Aleksandra Filipovska1, Ganqiang Liu4, Stefan Siira1, Timothy Mercer3, Anne-Marie Shearwood1, Dimitar 
Azmanov1, Stefan Davies1, John Mattick2, Oliver Rackham1
1Western Australian Institute for Medical Research and Centre for Medical Research, The University of 
Western Australia, Perth, WA 6000, Australia; 2Garvan Institute of Medical Research, Sydney, New South 
Wales, 2010, Australia and University of New South Wales, Sydney, NSW, 2052, Australia.; 3Institute for 
Molecular Bioscience, The University of Queensland, Brisbane QLD 4072, Australia; 4Institute for Molecular 
Bioscience, The University of Queensland, Brisbane QLD 4072, Australia and Garvan Institute of Medical 
Research, Sydney, New South Wales, 2010, Australia
Human mitochondria contain a small and compact genome that is transcribed as long polycistronic transcripts that encompass 
each strand of the genome, which are processed into mature mRNAs, tRNAs and rRNAs within the mitochondrial matrix. Recently 
we provided the first comprehensive map of the human mitochondrial transcriptome by near-exhaustive deep sequencing of long 
and small RNA fractions from purified mitochondria (1). We have identified previously undescribed transcripts, including small 
RNA and long non-coding RNAs encoded by the mitochondrial genome (2). Furthermore despite their common polycistronic 
origin, we observed wide variation between individual tRNAs, mRNAs, and rRNA amounts, indicating the importance of 
RNA-binding proteins in the regulation of mitochondrial gene expression (3). We have investigated the roles of the mammalian 
pentatricopeptide repeat (PPR) proteins and found that these RNA-binding proteins are all localized to mitochondria where they 
regulate mitochondrial gene expression. Mammalian PPR proteins have diverse roles in RNA metabolism and translation that 
are important for mitochondrial function and cell health. To investigate the importance of RNA-binding proteins in mitochondria 
globally we have established new methods for massively parallel sequencing and analyses of RNase-accessible regions of human 
mitochondrial RNA. We have identified specific regions within mitochondrial transcripts that are bound by RNA-binding proteins. 
These mitochondrial protein footprints indicate that RNA-binding proteins as well as small RNAs play a significant role in the 
regulation of mitochondrial gene expression.
1. Mercer, T. R., Neph, S., Dinger, M. E., Crawford, J., Smith, M. A., Shearwood, A.-M. J., Haugen, E., Bracken, C. 
P., Rackham, O., Stamatoyannopoulos, J. A., Filipovska, A., and Mattick, J. S. (2011) The Human Mitochondrial 
Transcriptome. Cell 146, 645–658
2. Rackham, O., Shearwood, A.-M. J., Mercer, T. R., Davies, S. M. K., Mattick, J. S., and Filipovska, A. (2011) Long 
noncoding RNAs are generated from the mitochondrial genome and regulated by nuclear-encoded proteins. RNA 17, 
2085–2093
3. Rackham, O., Mercer, T. R., and Filipovska, A. (2012) The human mitochondrial transcriptome and the RNA-binding 
proteins that regulate its expression. WIREs RNA 3, 675–695
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705 A Investigating ligation bias in small RNA library construction for high-throughput 
sequencing and the effect of different 3’ and 5’ adapters
Ryan Fuchs1, Zhiyi Sun1, Fanglei Zhuang1, G. Brett Robb1
1New England Biolabs
High-throughput sequencing (HTS) has become a powerful tool for the detection of and sequence characterization 
of microRNAs (miRNA) and other small RNAs (sRNA).  Unfortunately, the use of HTS data to determine the relative 
quantity of different miRNAs in a sample has been shown to be inconsistent with quantitative PCR and Northern 
Blot results.  Several recent studies have concluded that the major contributor to this inconsistency is bias introduced 
during the construction of sRNA libraries for HTS and that the bias is primarily derived from the adapter ligation 
steps; specifically when single stranded adapters are sequentially ligated to the 3’ and 5’-end of sRNAs using T4 RNA 
ligases.  In our current study we investigate the effects of ligation bias by using a defined mixture of 962 miRNA 
sequences and several combinations of adapters in HTS library construction.  Our results provide insight about the 
nature of ligation bias and allowed us to design adapters which reduce ligation bias and produce HTS results that more 
accurately reflect the actual concentrations of miRNAs in the defined starting material.
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706 B tRid, a method for eliminating tRNAs without sequence information of tRNAs
Kazuki Futai1, Hiroaki Suga2
1Department of Chemistry, Graduate School of Science, The University of Tokyo (Present affiliation: Life 
Science Center of Tsukuba Advanced Research Alliance, University of Tsukuba)
We here report a unique method, designated as tRid, for eliminating tremendous amount of tRNAs from any 
organism’s RNA without knowing the sequence information of tRNAs. The key component of tRid is a flexible tRNA-
acylation ribozyme, known as flexizyme. This catalyst is able to recognize the 3’-end CCA of tRNA, which is common 
sequence to all tRNAs used in organisms, and adds any one of a diverse repertoire of natural/non-natural amino acids 
to the 3’-OH of tRNA. Therefore, selective removal of tRNA would be possible through the aminoacylation using a 
biotinylated amino acid (Fig. 1).
For demonstrating tRid, HeLa S3 and E. coli <200 nt RNAs were treated by modified flexizyme, whose 3’-end 
nucleotide is oxidatively cleaved by sodium periodate for suppressing self-contamination of flexizyme (Fig. 2). After 
the treatment, 70-100 nt RNAs were purified and sequenced. As a result, the ratio of tRNAs derived from HeLa S3 
and E. coli were decreased from 89% to 35% and 85% to 30%, respectively. This result means that tRid does not 
need the information of tRNA sequences so that it can eliminate tRNAs from any kinds of organism’s RNA. For 
application of tRid, we tried to discover novel tRNA-sized RNAs from 70-100 nt RNAs treated by tRid. The ratio of 
tRNA-sized RNAs derived from HeLa S3 and E. coli were increased from 11% to 65% and 15% to 70%, respectively. 
We discovered several novel sRNAs from the enriched E. coli tRNA-sized RNAs and elucidated that these sRNAs 
are transcribed as similar size of tRNA by northern blotting. This result demonstrates tRid facilitates the efficient 
exploration of novel tRNA-sized RNAs. For another application of tRid, we purified <200 nt RNAs from pond water, 
which contains various kinds of microorganisms, and eliminated tRNAs by tRid. As a result, the ratio of tRNAs was 
decreased from 90% to 46% and the ratio of tRNA-sized RNAs was increased from 10% to 54%. This result means 
that tRid can be applied to metatranscriptome analysis.
In conclusion, tRid is a general-purpose method, which can eliminate any organism’s tRNAs without the sequence 
information of tRNAs and can be applied various studies that is difficult to do because of the tremendous amounts of 
tRNAs. 
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708 A Dynamic responses of the hepatocytic mRNA interactome to metabolic reprogramming
Rastislav Horos1, Alfredo Castello1, Bernd Fischer1, Katrin Eichelbaum1, Sophia Foehr1, Anne-Marie Alleaume1, 
Claudia Strein1, Benedikt Beckmann1, Jeroen Krijgsveld1, Matthias Hentze1
1European Molecular Biology Laboratory, Heidelberg, 69117, Germany
mRNAs are regulated at multiple steps throughout their lifetime by RNA-binding proteins (RBPs) which collectively 
represent the “mRNA interactome” of a cell. Interestingly, many unexpected proteins such as metabolic enzymes were 
found to bind mRNAs in vivo [1, 2], potentially playing important roles interconnecting posttranscriptional regulation 
with cellular metabolism [3]. IRP1/aconitase represents a well studied example, which, depending on intracellular 
iron levels, switches between functions as an enzyme or an RBP controlling mRNAs involved in iron metabolism. As 
liver cells represent a metabolically critical cell type, we determined the mRNA interactome of hepatocytic HuH-7 
cells by in vivo RNA-protein crosslinking, isolation of mRNP complexes by oligo-d(T) chromatography and analysis 
by quantitative mass spectrometry [4]. We identified 726 proteins, including known RBPs, expected RBPs that are 
expressed in the hepatic cells, and many previously unknown RBPs. Interestingly, especially enzymes of central 
energy metabolism pathways display mRNA binding, notably of the glycolytic pathway and the TCA cycle. Next, 
cells were treated with the glycolytic inhibitor 2-deoxyglucose or left untreated prior to interactome capture and 
comparative quantitative proteomic analysis. We will describe the responses of the HuH-7 cell mRNA interactome 
to altered glycolysis, and report the development of comparative, quantitative interactome capture as an informative 
experimental approach to characterize the states and responses of cellular systems. 
1. Castello, A., et al., Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins. Cell, 2012. 149(6): p. 
1393-406.
2. Baltz, A.G., et al., The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. Mol Cell, 
2012. 46(5): p. 674-90.
3. Hentze, M.W. and T. Preiss, The REM phase of gene regulation. Trends Biochem Sci, 2010. 35(8): p. 423-6.
4. Castello, A., et al., System-wide identification of RNA-binding proteins by interactome capture. Nat Protoc, 2013. 8(3): p. 
491-500.
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710 C Screening of the RNase-sensitive subnuclear structures identified the Sam68 nuclear 
body that was built on RNA with novel protein components
Taro Mannen1, Naoki Goshima1, Tetsuro Hirose1
1Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 
Tokyo, Japan
The mammalian cell nucleus contains membraneless suborganelles characterized by a distinct set of resident 
proteins and referred to as nuclear bodies. The nuclear bodies are thought to serve as the sites for biogenesis of various 
RNA species, the storage and assembly of ribonucleoprotein complexes and the retention of specific RNA species. 
We have been studying on the nuclear paraspeckle that is formed around the architectural NEAT1 long noncoding 
RNA (lncRNA) (Sasaki et al., PNAS 2009, Naganuma et al., EMBO J 2012). Here, we searched for additional nuclear 
bodies that were built on unidentified architectural RNAs by screening of the “RNase-sensitive nuclear bodies” using 
10432 fluorescence-tagged human full-length (FLJ) cDNA clones (Goshima et al., Nat methods 2008). First, we 
chose 463 FLJ cDNA clones whose fluorescently tagged-protein products were localized in certain nuclear foci. 
Subsequently, we explored whether the respective nuclear focus was abolished or diffused upon RNase treatment 
after cell permeabilization. “The RNase-sensitivity screening” identified 25 tagged proteins that required RNA for 
their localization in distinct nuclear foci. Immunostaining of the corresponding endogenous proteins confirmed that 
the Sam68 nuclear body (SNB) was an RNase-sensitive structure. The above screening simultaneously identified five 
novel SNB proteins (SNB1-5) whose localization in SNB were also abolished by RNase treatment. RNAi of each 
SNB component revealed that two RNA-binding proteins (Sam68 and SNB3) were required for SNB formation. Our 
data argue that the SNB structural core is built on certain nuclear RNA(s) that collaborate with at least two RNA-
binding proteins.
709 B Cytoplasmic mRNA Capping and the Implications of Cap Homeostasis
Daniel Kiss1, Ralf Bundschuh2, Daniel Schoenberg1
1Department of Molecular and Cellular Biochemistry, The Center for RNA Biology, The Ohio State 
University; 2Department of Physics, The Ohio State University
Until recently, the removal of an mRNA’s 5’ cap structure was thought to be an irreversible step leading to the 
degradation of the decapped mRNA.  Our lab has discovered and begun to characterize the cytoplasmic capping 
enzyme (cCE) complex, which restores the 5’ cap onto certain decapped mRNAs.  Results of experiments aimed 
at identifying recapping targets led to the discovery of cap homeostasis, a process by which some mRNAs undergo 
cyclical decapping followed by recapping.    The regulated decapping and recapping of these mRNAs may function 
as mechanism for cells to survey and regulate their translation.  Our previous work described the development of cells 
that are stably transfected with a tetracycline-inducible dominant negative form of cCE. Expressing dominant negative 
cCE increased the population of uncapped transcripts, and these were shifted from polysomes to non-translating 
mRNPs.  Importantly, this is specific to recapping targets as the translation of control transcripts was unchanged. 
Interestingly, 5’ RACE experiments performed with RNA from cells inhibited for cytoplasmic capping identified 
transcripts that were missing portions of their 5’ ends, raising the possibility that cytoplasmic capping may enable 
the translation of N-terminally truncated proteins as well as full-length proteins from the same parent transcript.   We 
couple informatics approaches with 5’ RACE and sequencing to assess the diversity of these validated cCE targets 
and to pinpoint the locations where these transcripts are recapped.  Finally, we are adapting ribosome profiling for use 
in our dominant negative cCE cell line as a way to ascertain the prevalence and functional effects of cap homeostasis 
on a transcriptomic level.
Supported by NIH grant GM084177 to DRS.  DLK is supported by a Pelotonia postdoctoral fellowship and by 
NIH grant T32 CA0093338-34. 
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712 B Discovery of gene expression inhibitors using a high throughput single-cell analysis 
system
Scott Stevens1, Matthew Sorenson1
1University of Texas at Austin
The many macromolecular machines involved in eukaryotic gene expression have been individually studied 
in model organisms for decades.  These efforts have been enhanced by the use of specific reporter genes that are 
sensitive to defects in an individual process.  In recent years, it has become increasingly evident that gene expression 
processes in eukaryotes involve communication and coordination between all of the gene expression machineries. 
We have previously described the development of a versatile gene expression reporter for budding yeast that employs 
high-throughput flow cytometry.  Cells harboring the reporter generate green and red fluorescence from spliced and 
unspliced transcripts respectively.  Our reporter exhibits a unique signature for defects in many gene expression 
processes including transcription, pre-mRNA splicing, NMD, mRNA export and mRNA decay.  Using a high 
throughput approach we have genetically explored contributions of knockout mutations to gene expression.
Many of the pathways in gene expression are targets for therapeutics and naturally occurring small molecules 
have provided a wealth of information about those pathways.  Further work to identify novel targets and effectors will 
enhance our understanding of the control of gene expression and, importantly, provide potential new drug candidates. 
We have adapted our reporter assay to perform high-throughput screening for small molecule inhibitors of specific 
gene expression processes using an inducible version of our reporter.  In our pilot study, we screened hundreds of 
small molecules that have a history of use in human clinical trials.  We have followed these experiments with an 
expanded library of thousands of small molecules.  By means of plate reader and flow cytometry analysis, we have 
identified many small molecules that modulate gene expression and affect cell growth.  We are exploring the nature 
of the putative inhibition by these compounds which behave like pre-mRNA splicing, RNA decay or NMD inhibitors 
in our assay.  Additionally, by virtue of the single-cell nature of our assay, we have identified molecules that increase 
cell-to-cell variation in reporter expression.  We are currently identifying patterns between our primary hit compounds 
and the effect on eukaryotic gene expression pathways.
711 A In vivo capture of RBPs bound to defined RNA species
Birgit Schuster1, Alfredo Castello1, Benedikt Beckmann1, Bruno Galy2, Matthias Hentze1
1European Molecular Biology Laboratory (EMBL), Germany; 2Molecular Biology Laboratory (EMBL), 
Germany
Recently, a comprehensive and unbiased method, called mRNA interactome capture, was developed for global 
identification of RBPs in living cells [1; 2; 3]. The design of this method focuses on determination of complete mRNA 
interactomes, but cannot be applied to capture RBPs assembled on defined RNA species. Methods to identify RNAs 
bound by single RBPs were successfully setup before (CLIP, PAR-CLIP, HITS-ClIP [reviewed in 4]). However, 
identifying RBPs that bind a particular RNA has been challenging so far. Here we present an experimental approach to 
determine all RBPs bound to a defined RNA species in vivo, which should enable studying the plasticity of particular 
Ribonucleoproteins (RNPs) throughout the different steps of RNA life, under changing cellular conditions (e.g. stress 
and disease) or different cellular stages.  Using the global mRNA interactome capture approach including in vivo UV 
crosslinking as a starting point, we tailor the pull-down protocol by making use of DNA/LNA mixmer oligonucleotides 
as specific bait. Our proof of principle model is based on luciferase reporter constructs that allow introducing known 
RNA motifs upstream or downstream of the targeted open reading frame. We will discuss performance parameters of 
our approach to meet an urgent need in RNA research.
1. Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C, Davey NE, Humphreys DT, Preiss T, Steinmetz 
LM, Krijgsveld J, Hentze MW.     Cell. 2012; 149 (6)
2. Baltz AG, Munschauer M, Schwanhäusser B, Vasile A, Murakawa Y, Schueler M, Youngs N, Penfold-Brown D, Drew K, 
Milek M, Wyler E, Bonneau R.  et al. Mol. Cell 2012 46 (5)
3. Castello A, Horos R, Strein C, Fischer B, Eichelbaum K, Steinmetz LM, Krijgsveld J, Hentze MW. Nature Protoc. 2013; 8 
(3)
4. Milek M, Wyler E, Landthaler M. Semin. Cell Dev.Biol. (2012) 23 (2)
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713 C Imaging trinucleotide repeat RNA in live cells using Spinach2, an RNA tag with enhanced 
brightness and thermostability
Rita Strack1, Samie Jaffrey1
1Weill Cornell College of Medicine
Decades of research have revealed the vast array and crucial roles of RNA at all levels of gene expression. Imaging 
RNAs in real time in living cells is vitally important for studying these processes, but is technically challenging. A 
genetically encoded RNA mimic of GFP called Spinach was recently described that provides a markedly simplified 
approach for imaging RNAs in living systems. Spinach is an aptamer that binds a small molecule chromophore. 
Separately, both Spinach and the chromophore are nonfluorescent; however, when bound the Spinach-chromophore 
complex is brightly fluorescent, allowing specific imaging of tagged RNAs in living cells. Although powerful, Spinach 
suffers from limited sensitivity in mammalian systems due to low thermal stability, poor folding, and ion sensitivity. 
For this reason, we subjected Spinach to targeted mutagenesis and developed Spinach2. Spinach2 has enhanced 
brightness, thermal stability, and folding relative to Spinach, and performs robustly in both bacterial mammalian cells. 
We have used Spinach2 to study toxic CGG-repeat containing RNAs in a model of Fragile-X tremor ataxia syndrome 
and show that Spinach2 is a versatile new tool for in vivo imaging.
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714 A Programmable sequence-specific click-labeling of RNA using archaeal box C/D RNP 
methyltransferases
Migle Tomkuviene1, Beatrice Clouet-d’Orval3, Elmar Weinhold2, Saulius Klimasauskas4
1Vilnius University Institute of Biotechnology, Vilnius, Lithuania; 2Institute of Organic Chemistry, RWTH 
Aachen University, Aachen, Germany; 3Laboratory of Microbiology and Molecular Genetics, CNRS-UMR 5100, 
Toulouse, France; 4Vilnius University, Institute of Biotechnology, Department of Biological DNA modification
Biophysical and mechanistic investigation of RNA function requires site-specific incorporation of spectroscopic and 
chemical probes. In nature, a particular class of RNA methyltransferases, box C/D ribonucleoprotein complexes (C/D 
RNPs), direct AdoMet-dependent site-specific 2‘-O-methylation to numerous biological sites [1]. Precise base pairing of 
a guide RNA and the substrate selects the target nucleotide (Fig. 1A). We have combined the specificity of C/D RNP 
machinery with synthetic AdoMet analogs to incorporate a reactive group which could be further appended with a desired 
label (Fig. 1B and 1C). Therefore we have in vitro reconstituted a C/D RNP from the thermophilic archaeon Pyrococcus 
abyssi and demonstrated its ability to transfer a prop-2-ynyl group from a synthetic cofactor analog [2] to both the wild-type 
and newly programmed target sites in model tRNA and pre-mRNA molecules. Target selection of the RNP was programmed 
by changing a 12 nt guide sequence in a 64-nt C/D guide RNA leading to efficient derivatization of three out of four new 
targets in each RNA substrate. We also show that the transferred terminal alkyne can be further appended with a fluorophore 
using a bioorthogonal azide-alkyne 1,3-cycloaddition (click) reaction (Fig. 2). The described approach [3] for the first time 
permits synthetically tunable sequence-specific labeling of RNA with single-nucleotide precision.
1. Reichow, S.L. et al. (2007) The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res., 35(5), 
1452–1464.
2. Willnow, S. et al. (2012) A selenium-based click AdoMet analog for versatile substrate labeling with wild-type protein 
methyltransferases. ChemBioChem, 13:8, 1167–1173.
3. Tomkuviene, M. et al. (2012) Programmable sequence-specific click-labeling of RNA using archaeal box C/D RNP 
methyltransferases. Nucleic Acids Res., 40(14), 6765-73.
Figure 1. Archaeal C/D RNP-directed sequence-specific modification and labeling of target RNA. (A) Schematic 
structure of a C/D RNP complex with substrate RNA. Core proteins L7Ae, Nop5p and aFib are bound at the C/D and 
C’/D’ sites of a guide RNA. One of the variable guide sequences is shown base-paired to a target sequence (green) of 
a substrate RNA. Modification occurs at a nucleotide complementary to the 5th position upstream from the D box; (B) 
C/D RNP-directed transfer of an activated side chain (red) from a cofactor S-adenosyl-L-methionine (AdoMet, X=S 
and R=methyl) or its analog SeAdoYn (X=Se and R=prop-2-ynyl) onto an RNA substrate; (C) Two-step labeling of 
target RNA via a C/D RNP-directed alkynylation, followed by Cu(I)-assisted click-coupling of a fluorophore azide 
(blue).
Figure 2. C/D RNP-dependent fluorescent labeling of predetermined sites in a model tRNA substrate via guide 
RNA-directed enzymatic propynylation and click-coupling of an Eterneon(480/635) azide. 
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716 C Identification of novel post-transcriptional regulatory sequences
Erin Wissink1, Elizabeth Fogarty1, Andrew Grimson1
1Department of Molecular Biology & Genetics, Cornell University
Post-transcriptional events are essential for an organism’s proper function and development, and misregulation of 
these events often results in cancers and other diseases in humans. Identifying sites within mRNAs that determine their 
post-transcriptional fates is therefore an essential step towards understanding post-transcriptional regulatory pathways. 
Such sites are typically found in the gene’s untranslated regions (5’UTR and 3’UTRs), where they recruit trans-acting 
factors to control mRNA localization, decay rates, and translation efficiency. Many UTR regulatory sequences, as well 
as their mechanisms of action, still remain to be discovered.
One method we utilized was to use comparative genomics to identify preferentially conserved sequences in UTRs. 
We focused on those sequences that do not match binding sites for known trans-factors, and used traditional reporter 
assays in cell culture to validate multiple novel motifs. We are currently investigating the mechanisms by which a set 
of these sequences mediate post-transcriptional regulation. Although our approach has been successful in identifying 
novel regulatory sequences, it is not practical for large-scale validation of the thousands of conserved sequences 
observed in human UTRs.
To begin globally assessing 3’UTR sequences for regulatory ability, we developed an assay to test thousands of 
possible regulatory sequences in parallel. We generated large GFP reporter libraries in which random short sequences 
were inserted within the 3’UTR. When these reporters were integrated into the genome of cultured human cells, the 
GFP intensity corresponded to the post-transcriptional regulatory potential of the inserted sequence: cells with low 
GFP intensity contained a sequence that downregulated expression, and vice versa. We isolated cells undergoing 
differential expression and identified the proportions of each inserted short sequence in the different cell populations. 
We performed this screen in the context of three different human 3’UTRs and identified sequences that alter post-
transcriptional gene regulation. We will compare this functional data to sequences conserved in human 3’UTRs. 
Additionally, our approach can identify sites undergoing rapid evolution without prior knowledge of the trans-
factors. Because of the widespread impact of post-transcriptional regulation, knowing which sequences act in post-
transcriptional regulation will help us to better understand human health and disease.
715 B A new technique for live cell RNA detection that enables single cell analysis and live cell 
sorting
Don Weldon1, Ronald Orallo1, Alex Ko1, Yuko Williams1, Grace Johnston1
1EMD Millipore
Understanding gene expression provides a window into the regulation of all cellular activity. To better understand 
and measure gene expression, various methods have been developed. Traditional techniques require long and laborious 
sample preparations and are prone to potential amplification bias. Other techniques involve transfections, cell fixation 
and cell lysis which could introduce unwanted change in expression levels. 
A method for performing RNA detection in live cells would provide more biologically relevant information. Our 
technique allows for single-cell detection to accurately measure gene expression levels of living cells without stressful 
or harmful treatments. Because this technique does not involve harsh chemicals or transfection procedures, the data 
collected more accurately reflects a natural cell state. Furthermore following detection the cells remain unchanged and 
available for downstream assays. 
This technique utilizes a gold nanoparticle surrounded by a high density oligonucleotide target specific sequence 
hybridized to complementary probes. Once in the cell, the gold nanoparticle will detect its target and release the 
fluorescent probe. The unquenched probe can then be accurately measured by flow cytometry for single cell RNA 
detection. 
Here we show experiments using this technique for detection of RNA in single cells and live cell sorting by FACS 
with correlating qPCR data. In addition we prove this technique does not alter gene expression or affect cell health.
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718 C Prostate cancer exosomes offering novel circulating non-coding RNA biomarkers for early 
cancer diagnosis and prognosis.
Topic: Non-coding & Regulatory RNAs
Samuel E. Brennan1*, Nham Tran2*, Aled Clayton3, Eileen M. McGowan1, Paul J. Cozzi4, Rosetta Martiniello-Wilks1,2 
1 Translational Cancer Research Group, School of Medical and Molecular Biosciences, Faculty of Science, 
University of Technology Sydney (UTS), NSW, Australia;  2Centre for Health Technologies, Faculty of 
Engineering and Information Technology, UTS; 3Velindre Cancer Centre, Cardiff University, Wales, UK;  
4Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia
Prostate cancer (PCa) can be cured in approx. 80% of men presenting with early, organ confined disease following 
surgery to remove the prostate.   The commonly used blood test for prostate-specific antigen (PSA) shows elevated 
serum levels in men with PCa. Unfortunately, PSA alone is a poor predictor of disease outcome (prognosis) and 
invasive prostate biopsies are required to determine the PCa stage and prognosis.  As a result, poor testing compliance 
results in most men presenting with advanced disease which is largely incurable. Thus, we are investigating the utility 
of RNAs enriched in cellular nanovesicles (40-100nm in size) released into the circulation, to develop novel non-
invasive biomarker tests for early PCa diagnosis and prognosis. 
Total RNA was isolated from human prostate epithelial cells, established PCa cell lines and their culture supernatant 
exosomes. The microRNA (miRNA) and messenger RNA (mRNA) expression profiles from these sources were 
analysed using the Affymetrix and Arraystar microarray platforms and the data were mined using Partek Genomics 
Suite. Biomarker candidates were then validated using qPCR.
The expression profiles revealed a vast number of differentially expressed miRNAs and mRNAs in PCa exosomes 
that can be readily developed into potential biomarkers.  In brief, many miRNAs were up-regulated in PCa exosomes 
while the majority of mRNAs were down-regulated. Gene set analyses further suggested that differentially expressed 
exosomal RNAs were associated with various aspects of cancer development and progression. Exosomes show 
potential as sources for novel circulating biomarker discovery. 
RNA 2013 Late Additions
717 B Maintenance of adult beta–cell identity by microRNAs and transcription factors
Topic: Non-coding & Regulatory RNAs
Eran Hornstein, Amitai Mandelbaum, Sharon Kredo-Russo, Tal Melkman-Zehavi
Hornstein lab, Department of Molecular Genetics, Weizmann Institute of Science
Normal physiology depends on defined functional output of differentiated cells. A century of Developmental–
Biology studies revealed diverse mechanisms for differentiation, however once ‘terminally’ differentiated, cells are 
thought to naïvely stay put. However differentiated cells are surprisingly fragile, for example, phenotypic collapse 
and de–differentiation of beta–cells was recently discovered in pathogenesis of type 2 diabetes. These discoveries 
necessitate investigations of mechanisms for maintenance of robust cell–type identity over decades in the adult 
organism? microRNAs, which are small non-coding RNAs, are known to impart robustness to development. Our 
investigations reveal that microRNAs are providing means for continuous maintenance of adult beta–cell identity 
and therefore are important genetic components in metabolic disorders including in diabetes. This provides a new 
framework for miRNA function in adult tissues and in human disease.
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720 C Equilibrium-dependent ribosomal recoding mechanisms in RNA viruses
Topic: Translational Regulation
Carolina Salguero, Michael A. Durney, Victoria M. D’Souza
Department of Molecular & Cellular Biology Harvard University, Cambridge, MA, USA
RNA viruses have evolved mRNA-mediated recoding mechanisms to regulate gene expression at the translational 
level. Two of such mechanisms, codon readthrough and programed -1 frameshift, allow the ribosome to bypass a 
stop codon and synthesize fusion viral proteins. The frequency by which these events occur is important for efficient 
viral infectivity, and is regulated by domains in the translating mRNA (in the case of the SARScorona virus and the 
murine leukemia virus, the domains are pseudoknots). Although aspects of frameshifting have received considerable 
attention, an understanding of the RNA structures and structural rearrangements that influence the efficiency is lacking. 
Our results from murine leukemia virus indicate that retroviral gene expression is regulated by a dynamic, proton-
driven equilibrium between an active, read-through permissive, and an inactive pseudoknot conformation. We are now 
working towards a complete structural and mechanistic understanding of the frameshifting frequency in SARS-corona 
virus by combining structural studies with biochemical in-vivo and in-vitro experiments. Specifically, to understand 
the basis for how the recoding frequency is maintained, we determined the structures of the mRNA signal in both 
frameshifting conformations: permissive and nonpermissive. These structures allowed us to engineer mutants to test 
our equilibrium model and generalize the results for equilibrium-dependent recoding to include both readthrough and 
frameshift mechanisms.
719 C Cold shock domain protein functions in reprogramming from differentiated cells to stem 
cells in the moss Physcomitrella patens
Topic: Riboregulation in Development
Chen Li1, 2, Yosuke Tamada1, 2, Mitsuyasu Hasebe1, 2
1National Institute for Basic Biology, Okazaki, Japan; 2School of Life Science, The Graduate University for 
Advanced Studies, Okazaki, Japan 
Differentiated cells of the moss Physcomitrella patens have a high ability of being reprogrammed into stem 
cells. For instance, after leaf excision, differentiated leaf cells facing the cut are reprogrammed. Here we show that 
P. patens Cold Shock domain Protein (PpCSP), which is a homolog of one mammalian induced pluripotent stem 
cell (iPS) factor Lin28, plays a positive role in the reprogramming. In Physcomitrella genome, there are four PpCSP 
paralogous genes (PpCSP1 to PpCSP4), which encode highly similar RNA binding proteins. All of these four CSP 
proteins are localized in cytoplasm. The promoter activity and the localization of fluorescent proteins fused to the 
native PpCSP proteins showed that all PpCSP proteins accumulate in leaf cells facing the cut after excision and is 
maintained in reprogrammed stem cells. PpCSP1 mRNA is regulated by putative degradation activity in its 3’ UTR. 
Stabilized PpCSP1 mRNA lines by excluding the degradation signal region showed enhanced reprogramming in cells 
not facing to the cut. Quadruple PpCSP mutants exhibited lower and delayed reprogramming. These data indicate 
that PpCSPs redundantly function as positive factors in the reprogramming. To reveal the molecular function of 
PpCSPs, transcriptome analysis was performed to seek downstream factors of PpCSP1. We found several candidate 
genes positively regulated by PpCSP1. Furthermore, to find the interacting factors of cytoplasmic PpCSP1 protein, 
we performed isobaric Tags for Relative and Absolute Quantitation (iTRAQ). PolyA-binding protein was identified 
and may have function together with PpCSP1. At last, by using 32P labeled RNA, we confirmed that PpCSP1 could 
bind with mRNA in general. We currently search for target mRNAs of PpCSP1 by RNA-immunoprecipitation assay.
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722 A Identification of novel methyltransferases, responsible for N-1 methyl-adenosine base 
modification of 25S rRNA in S.cerevisiae
Topic: tRNA, snRNA, snoRNA, rRNA
Sunny Sharma1, 2, Christian Peifer 1, 2, Peter Kötter 1, 2, Karl-Dieter Entian 1, 2
1Institute of Molecular Biosciences, Goethe University Frankfurt am Main, Germany-60438; 2Excellence 
Cluster: Frankfurt am Main, Germany-60438.
S.cerevisiae contains two N-1 methyl adenosine (m1A) base modifications in the helix 25.1 and helix 65 of 25S 
rRNA. The enzymes responsible for these base modifications remained elusive for a long time. We identified ribosomal 
RNA processing protein 8 (Rrp8) and Bmt2, a previously uncharacterised ORF as a methyltransferases involved in 
m1A645 and m1A2142 modification of 25S rRNA, respectively. The genes were identified by RP-HPLC screening of 
all deletion mutants of putative RNA methyltransferase and was confirmed by gene complementation and phenotypic 
characterization. Furthermore, we analysed the significance of m1A645 and m1A2142 modification in ribosome 
synthesis and translation. Intriguingly, the loss of m1A645 modification retards the cell growth at lower temperature 
and cause significant defect in 60S assembly. On the other hand loss of m1A2142 modification confers anisomycin 
and hydrogen peroxide hypersensitivity to the cells. Our results emphasize the importance of RNA modifications in 
cellular physiology.
1. Peifer, C., Sharma, S., Watzinger, P., Lamberth, S., Kotter, P., & Entian, K. D. (2013). Yeast Rrp8p, a novel 
methyltransferase responsible for m1A 645 base modification of 25S rRNA. Nucleic Acids Research, 41(2), 1151–1163. 
doi:10.1093/nar/gks1102
2. Sharma, S., Watzinger, P., Kötter, P., & Entian, K.-D. (2013). Identification of a novel methyltransferase, Bmt2, responsible 
for the N-1-methyl-adenosine base modification of 25S rRNA in Saccharomyces cerevisiae. Nucleic Acids Research. 
doi:10.1093/nar/gkt195
721 C Functional and Structural Characterization of a Thermostable RNA/DNA Dependent RNA 
Polymerase
Topic: RNA protein interactions
Xinlei Qian1, Eugene Makeyev1, Julien Lescar1
1School of Biological Sciences, Nanyang Technological University, Division of Structural Biology and 
Biochemistry, 61, Biopolis Drive, PROTEOS, Singapore 138673, Phone: (+65) 65 86 97 06
The discovery of RNA interference (RNAi) in the late 1990s has revolutionized biological research with great 
potential for therapy. Since double-stranded RNAs (dsRNAs) are required for various RNAi applications, there is 
a need for cost-effective methods for producing large quantities of high-quality dsRNA molecules, including using 
enzymatic approaches, as an alternative to chemical synthesis. Here, we characterize at the functional and structural 
level a thermostable RNA polymerase named QT2 that can use either DNA or RNA as a template. We present the 
crystal structure of the catalytic domain of QT2 (113 kDa) at a resolution of 3.2 Å. The results indicate that the enzyme 
could form a useful tool to generate large pools of dsRNA molecules. We will present our structural studies with a 
view to dissect the molecular basis of its various catalytic activities and the molecular basis for its thermostability.
RNA 2013 •  Davos, Switzerland •  June 11-16, 2013 Poster Abstracts
RNA 2013 Late Additions  •   419
723 A Functional link between U1 snRNA 5’-end AU di-nucleotides and the mRNA cap-binding 
complex
Topic: Splicing Regulation
Jui-Hui Chen1, Chung-Shu Yeh1, 2, Jeffrey A. Pleiss3 and Tien-Hsien Chang1
1Genomics Research Center, Academia Sinica, Taipei, Taiwan; 2Insititute of Biochemistry and Molecular 
Biology, National Yang-Ming University, Taipei, Taiwan; 3Department of Molecular Biology and Genetics, 
Cornell University, Ithaca, New York, USA
Binding of the U1 snRNP to pre-mRNA 5’ splice site (5’ss) plays a critical role in splicing by committing the 
pre-mRNA substrate to the splicing pathway. The interaction between U1 snRNP and the 5’ss is mediated in part by 
Watson-and-Crick basepairing of the U1 snRNA’s 5’-end (from the 3rd to the 9th positions) to the relatively conserved 
5’ss (GUAUGU, in the budding yeast). Intriguingly, despite no apparent participation of the first two AU residues 
of the U1 snRNA in interacting with the 5’ss, these two positions are highly conserved from fungi to metazoans. To 
investigate the role of these two residues in splicing, we systematically mutated them, at the U1 snRNA gene (SNR19) 
level, to all possible combinations. The majority of mutants exhibit no statistically significant difference in terms of 
fitness from that of the wild-type cells, suggesting that the AU dinucleotides may not be crucial.  However, the AU-
to-UU (AU>UU) mutant is greatly compromised in fitness and exhibits a cold-sensitive phenotype. Primer-extension 
analysis shows that the otherwise unique transcriptional start of SNR19 in the AU>UU mutant is dramatically altered 
and results in multiple 5’-end-truncated and non-functional U1 snRNAs. Quantitative real-time PCR as well as 
splicing-sensitive microarray analysis show a global accumulation of pre-mRNAs, suggesting that insufficient 
production of functional U1 snRNA in the AU>UU mutant significantly compromises splicing. Moreover, genome-
wide synthetic-lethal screen uncovered two categories of genes that are functionally related to the AU>UU mutation: 
splicing as well as transcription-related genes. Detailed analysis pinpoints that the most appealing candidates are the 
normally nonessential cap-binding proteins, Cbp20p and Cbp80p, which become indispensible upon altering the AU 
di-nucleotides in essentially all variations. This result thus strongly suggests that the AU di-nucleotides indeed have a 
role in splicing mediated through the cap-binding complex. The mechanistic details of this novel link are being defined 
biochemically.
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